Any 0 3 0 3 O
surgical 4 12 4 12 B-treatment
therapy 13 20 13 20 I-treatment
in 21 23 21 23 O
the 24 27 24 27 O
area 28 32 28 32 O
of 33 35 33 35 O
the 36 39 36 39 O
oral 40 44 40 44 O
cavity 45 51 45 51 O
or 52 54 52 54 O
pharynx 55 62 55 62 O
within 63 69 63 69 O
the 70 73 70 73 O
last 74 78 74 78 B-upper_bound
2 79 80 79 80 I-upper_bound
weeks 81 86 81 86 I-upper_bound

Any 0 3 87 90 O
tumor 4 9 91 96 B-cancer
stage 10 15 97 102 O
, 15 16 102 103 O
any 17 20 104 107 O
N 21 22 108 109 O
, 22 23 109 110 O
M0 24 26 111 113 O

ECOG 0 4 114 118 B-clinical_variable
performance 5 16 119 130 I-clinical_variable
status 17 23 131 137 I-clinical_variable
0 24 25 138 139 B-lower_bound
or 26 28 140 142 O
1 29 30 143 144 B-upper_bound

Known 0 5 145 150 O
hypersensitivity 6 22 151 167 O
to 23 25 168 170 O
Olaparib 26 34 171 179 B-allergy_name

Patient 0 7 180 187 O
is 8 10 188 190 O
≥ 11 12 191 192 O
18 13 15 193 195 B-lower_bound
years 16 21 196 201 I-lower_bound
old 22 25 202 205 O

Prior 0 5 206 211 O
or 6 8 212 214 O
ongoing 9 16 215 222 O
treatment 17 26 223 232 O
with 27 31 233 237 O
a 32 33 238 239 O
PARP1 34 39 240 245 B-treatment
inhibitor 40 49 246 255 I-treatment

Absolute 0 8 0 8 B-clinical_variable
Neutrophils 9 20 9 20 I-clinical_variable
> 21 22 21 22 O
1,500/µL 23 31 23 31 B-lower_bound

Creatinine 0 10 32 42 B-clinical_variable
clearance 11 20 43 52 I-clinical_variable
> 21 22 53 54 O
60 23 25 55 57 B-lower_bound
mL 26 28 58 60 I-lower_bound
/ 28 29 60 61 I-lower_bound
min/1.73 29 37 61 69 I-lower_bound
m2 38 40 70 72 I-lower_bound
for 41 44 73 76 O
subjects 45 53 77 85 O
with 54 58 86 90 O
above 59 64 91 96 O
normal 65 71 97 103 O
AST 72 75 104 107 B-clinical_variable
and 76 79 108 111 O
ALT 80 83 112 115 B-clinical_variable
with 84 88 116 120 O
alkaline 89 97 121 129 B-clinical_variable
phosphatase 98 109 130 141 I-clinical_variable
within 110 116 142 148 O
< 117 118 149 150 O
1.5 119 122 151 154 B-upper_bound
times 123 128 155 160 I-upper_bound
upper 129 134 161 166 I-upper_bound
limit 135 140 167 172 I-upper_bound
of 141 143 173 175 I-upper_bound
normal 144 150 176 182 I-upper_bound

Creatinine 0 10 183 193 B-clinical_variable
within 11 17 194 200 O
normal 18 24 201 207 O
institutional 25 38 208 221 O
limits 39 45 222 228 O

ECOG 0 4 229 233 B-clinical_variable
performance 5 16 234 245 I-clinical_variable
status 17 23 246 252 I-clinical_variable
0 24 25 253 254 B-lower_bound
- 25 26 254 255 O
1(Appendix 26 36 255 265 B-upper_bound
A 37 38 266 267 O
) 38 39 267 268 O

Hemoglobin 0 10 269 279 B-clinical_variable
> 11 12 280 281 O
10 13 15 282 284 B-lower_bound
g 16 17 285 286 I-lower_bound
/ 17 18 286 287 I-lower_bound
dL 18 20 287 289 I-lower_bound

IB 0 2 290 292 B-cancer
( 3 4 293 294 O
T2NO 4 8 294 298 B-cancer
) 8 9 298 299 O
, 9 10 299 300 O
II 11 13 301 303 B-cancer
& 14 15 304 305 O
IIIA 16 20 306 310 B-cancer
( 21 22 311 312 O
N2 22 24 312 314 B-clinical_variable
negative 25 33 315 323 O
) 33 34 323 324 O

Known 0 5 325 330 O
Hepatitis 6 15 331 340 B-chronic_disease
B 16 17 341 342 I-chronic_disease
on 18 20 343 345 O
immunomodulators 21 37 346 362 B-treatment
( 38 39 363 364 O
i.e. 39 43 364 368 O
interferon 44 54 369 379 B-treatment
) 54 55 379 380 O

Known 0 5 381 386 O
Hepatitis 6 15 387 396 O
C 16 17 397 398 O
on 18 20 399 401 O
immunomodulators 21 37 402 418 O
( 38 39 419 420 O
i.e. 39 43 420 424 O
interferon 44 54 425 435 B-treatment
) 54 55 435 436 O

Leukocytes 0 10 437 447 B-clinical_variable
> 11 12 448 449 O
3,000/µL 13 21 450 458 B-lower_bound

No 0 2 459 461 O
prior 3 8 462 467 B-treatment
vaccine 9 16 468 475 I-treatment
therapy 17 24 476 483 I-treatment

Patients 0 8 484 492 O
may 9 12 493 496 O
not 13 16 497 500 O
be 17 19 501 503 O
receiving 20 29 504 513 O
any 30 33 514 517 O
steroids 34 42 518 526 B-treatment
or 43 45 527 529 O
other 46 51 530 535 O
anti 52 56 536 540 B-treatment
- 56 57 540 541 I-treatment
immune 57 63 541 547 I-treatment
therapy 64 71 548 555 I-treatment
at 72 74 556 558 O
the 75 78 559 562 O
time 79 83 563 567 O
of 84 86 568 570 O
registration 87 99 571 583 O

Platelets 0 9 584 593 B-clinical_variable
> 10 11 594 595 O
100,000/µL 12 22 596 606 B-lower_bound

Pregnant 0 8 607 615 B-pregnancy
women 9 14 616 621 B-gender

Stage 0 5 622 627 B-cancer
IA(T1NO 6 13 628 635 I-cancer
) 13 14 635 636 I-cancer

Subjects 0 8 637 645 O
may 9 12 646 649 O
not 13 16 650 653 O
be 17 19 654 656 O
receiving 20 29 657 666 O
any 30 33 667 670 O
other 34 39 671 676 O
investigational 40 55 677 692 B-treatment
agents 56 62 693 699 I-treatment

Subjects 0 8 700 708 O
must 9 13 709 713 O
be 14 16 714 716 O
within 17 23 717 723 O
4 24 25 724 725 B-lower_bound
to 26 28 726 728 O
12 29 31 729 731 B-upper_bound
weeks 32 37 732 737 I-upper_bound
of 38 40 738 740 O
standard 41 49 741 749 O
of 50 52 750 752 O
care 53 57 753 757 O
treatment 58 67 758 767 B-treatment
for 68 71 768 771 O
their 72 77 772 777 O
particular 78 88 778 788 O
stage 89 94 789 794 O
of 95 97 795 797 O
disease 98 105 798 805 O

Subjects 0 8 806 814 O
must 9 13 815 819 O
have 14 18 820 824 O
histologically 19 33 825 839 O
or 34 36 840 842 O
cytologically 37 50 843 856 O
confirmed 51 60 857 866 O
non 61 64 867 870 B-cancer
- 64 65 870 871 I-cancer
small 65 70 871 876 I-cancer
cell 71 75 877 881 I-cancer
lung 76 80 882 886 I-cancer
cancer 81 87 887 893 I-cancer
( 88 89 894 895 I-cancer
NSCLC 89 94 895 900 I-cancer

Subjects 0 8 901 909 O
must 9 13 910 914 O
not 14 17 915 918 O
be 18 20 919 921 O
more 21 25 922 926 O
than 26 30 927 931 O
12 31 33 932 934 B-lower_bound
weeks 34 39 935 940 I-lower_bound
from 40 44 941 945 O
standard 45 53 946 954 O
of 54 56 955 957 O
care 57 61 958 962 O
treatment 62 71 963 972 B-treatment
for 72 75 973 976 O
their 76 81 977 982 O
particular 82 92 983 993 O
stage 93 98 994 999 O
of 99 101 1000 1002 O
disease 102 109 1003 1010 O

Subjects 0 8 1011 1019 O
must 9 13 1020 1024 O
not 14 17 1025 1028 O
have 18 22 1029 1033 O
post 23 27 1034 1038 B-chronic_disease
- 27 28 1038 1039 I-chronic_disease
obstructive 28 39 1039 1050 I-chronic_disease
pneumonia 40 49 1051 1060 I-chronic_disease
or 50 52 1061 1063 O
other 53 58 1064 1069 O
serious 59 66 1070 1077 B-chronic_disease
infection 67 76 1078 1087 I-chronic_disease
at 77 79 1088 1090 O
the 80 83 1091 1094 O
time 84 88 1095 1099 O
of 89 91 1100 1102 O
registration 92 104 1103 1115 O
or 105 107 1116 1118 O
other 108 113 1119 1124 O
serious 114 121 1125 1132 O
underlying 122 132 1133 1143 O
medical 133 140 1144 1151 O
condition 141 150 1152 1161 O
that 151 155 1162 1166 O
would 156 161 1167 1172 O
impair 162 168 1173 1179 O
the 169 172 1180 1183 O
ability 173 180 1184 1191 O
of 181 183 1192 1194 O
the 184 187 1195 1198 O
subjects 188 196 1199 1207 O
to 197 199 1208 1210 O
receive 200 207 1211 1218 O
protocol 208 216 1219 1227 O
treatment 217 226 1228 1237 B-treatment

Subjects 0 8 1238 1246 O
with 9 13 1247 1251 O
a 14 15 1252 1253 O
history 16 23 1254 1261 O
of 24 26 1262 1264 O
known 27 32 1265 1270 O
autoimmune 33 43 1271 1281 B-chronic_disease

Total 0 5 1282 1287 B-clinical_variable
Bilirubin 6 15 1288 1297 I-clinical_variable
within 16 22 1298 1304 O
normal 23 29 1305 1311 O
institutional 30 43 1312 1325 O
limits 44 50 1326 1332 O

Uncontrolled 0 12 1333 1345 O
intercurrent 13 25 1346 1358 O
illness 26 33 1359 1366 O
including 34 43 1367 1376 O
, 43 44 1376 1377 O
but 45 48 1378 1381 O
not 49 52 1382 1385 O
limited 53 60 1386 1393 O
to 61 63 1394 1396 O
, 63 64 1396 1397 O
ongoing 65 72 1398 1405 O
or 73 75 1406 1408 O
active 76 82 1409 1415 B-chronic_disease
infection 83 92 1416 1425 I-chronic_disease
, 92 93 1425 1426 O
symptomatic 94 105 1427 1438 O
congestive 106 116 1439 1449 B-chronic_disease
heart 117 122 1450 1455 I-chronic_disease
failure 123 130 1456 1463 I-chronic_disease
, 130 131 1463 1464 O
unstable 132 140 1465 1473 B-chronic_disease
angina 141 147 1474 1480 I-chronic_disease
pectoris 148 156 1481 1489 O
, 156 157 1489 1490 O
cardiac 158 165 1491 1498 B-chronic_disease
arrhythmia 166 176 1499 1509 I-chronic_disease
, 176 177 1509 1510 O
or 178 180 1511 1513 O
psychiatric 181 192 1514 1525 B-chronic_disease
illness 193 200 1526 1533 I-chronic_disease
/ 200 201 1533 1534 O
social 201 207 1534 1540 O
situations 208 218 1541 1551 O
that 219 223 1552 1556 O
would 224 229 1557 1562 O
limit 230 235 1563 1568 O
compliance 236 246 1569 1579 O
with 247 251 1580 1584 O
study 252 257 1585 1590 O
requirements 258 270 1591 1603 O

Women 0 5 1604 1609 B-gender

at 0 2 1610 1612 O
least 3 8 1613 1618 O
18 9 11 1619 1621 B-lower_bound
years 12 17 1622 1627 I-lower_bound
of 18 20 1628 1630 O
age 21 24 1631 1634 B-age

known 0 5 1635 1640 O
HIV 6 9 1641 1644 B-chronic_disease
- 9 10 1644 1645 O
positive 10 18 1645 1653 O
patients 19 27 1654 1662 O

men 0 3 1663 1666 B-gender

9 0 1 0 1 B-lower_bound
to 2 4 2 4 O
14 5 7 5 7 B-upper_bound
years 8 13 8 13 I-upper_bound
of 14 16 14 16 O
age 17 20 17 20 B-age

Contraindication 0 16 21 37 O
to 17 19 38 40 O
robotic 20 27 41 48 B-treatment
- 27 28 48 49 I-treatment
assisted 28 36 49 57 I-treatment
manual 37 43 58 64 I-treatment
training 44 52 65 73 I-treatment
such 53 57 74 78 O
acute 58 63 79 84 O
and 64 67 85 88 O
pronounced 68 78 89 99 O
pain 79 83 100 104 O
symptoms 84 92 105 113 O
despite 93 100 114 121 O
conventional 101 113 122 134 B-treatment
pain 114 118 135 139 I-treatment
therapy 119 126 140 147 I-treatment
of 127 129 148 150 I-treatment
the 130 133 151 154 I-treatment
upper 134 139 155 160 I-treatment
- 139 140 160 161 I-treatment
limb 140 144 161 165 I-treatment
, 144 145 165 166 O
lack 146 150 167 171 O
of 151 153 172 174 O
compliance 154 164 175 185 O
, 164 165 185 186 O
high 166 170 187 191 O
- 170 171 191 192 O
grade 171 176 192 197 O
ataxia 177 183 198 204 B-chronic_disease
, 183 184 204 205 O
advanced 185 193 206 214 O
osteoporosis 194 206 215 227 B-chronic_disease
, 206 207 227 228 O
and 208 211 229 232 O
fractures 212 221 233 242 O
of 222 224 243 245 O
the 225 228 246 249 O
upper 229 234 250 255 O
- 234 235 255 256 O
limb 235 239 256 260 O

Diagnosis 0 9 261 270 O
of 10 12 271 273 O
CP 13 15 274 276 B-chronic_disease
with 16 20 277 281 O
upper 21 26 282 287 O
- 26 27 287 288 O
limb 27 31 288 292 O
impairment 32 42 293 303 O

Manual 0 6 304 310 B-clinical_variable
Ability 7 14 311 318 I-clinical_variable
Classification 15 29 319 333 I-clinical_variable
Scale 30 35 334 339 I-clinical_variable
Level 36 41 340 345 I-clinical_variable
II 42 44 346 348 I-clinical_variable
or 45 47 349 351 I-clinical_variable
III 48 51 352 355 I-clinical_variable

Modified 0 8 356 364 B-clinical_variable
Ashworth 9 17 365 373 I-clinical_variable
Scale 18 23 374 379 I-clinical_variable
( 24 25 380 381 I-clinical_variable
MAS 25 28 381 384 I-clinical_variable
) 28 29 384 385 I-clinical_variable
of 30 32 386 388 O
4 33 34 389 390 O
in 35 37 391 393 O
the 38 41 394 397 O
upper 42 47 398 403 O
- 47 48 403 404 O
limb 48 52 404 408 O

Recent 0 6 409 415 O
use 7 10 416 419 O
of 11 13 420 422 O
upper 14 19 423 428 B-treatment
- 19 20 428 429 I-treatment
limb 20 24 429 433 I-treatment
robotic 25 32 434 441 I-treatment
- 32 33 441 442 I-treatment
assisted 33 41 442 450 I-treatment
training 42 50 451 459 I-treatment
within 51 57 460 466 O
the 58 61 467 470 O
last 62 66 471 475 B-upper_bound
3 67 68 476 477 I-upper_bound
months 69 75 478 484 I-upper_bound

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
hemiplegia 13 23 13 23 B-chronic_disease

Wrist 0 5 24 29 B-clinical_variable
range 6 11 30 35 I-clinical_variable
of 12 14 36 38 O
motion 15 21 39 45 O
of 22 24 46 48 O
at 25 27 49 51 O
least 28 33 52 57 O
10 34 36 58 60 B-lower_bound
degrees 37 44 61 68 I-lower_bound

Age 0 3 0 3 B-age
greater 4 11 4 11 O
than 12 16 12 16 O
or 17 19 17 19 O
equal 20 25 20 25 O
to 26 28 26 28 O
18 29 31 29 31 B-lower_bound
years 32 37 32 37 I-lower_bound

Atazanavir 0 10 38 48 B-treatment
, 10 11 48 49 O
clarithromycin 12 26 50 64 B-treatment
, 26 27 64 65 O
indinavir 28 37 66 75 B-treatment
, 37 38 75 76 O
itraconazole 39 51 77 89 B-treatment
, 51 52 89 90 O
ketoconazole 53 65 91 103 B-treatment
, 65 66 103 104 O
nefazodone 67 77 105 115 B-treatment
, 77 78 115 116 O
nelfinavir 79 89 117 127 B-treatment
, 89 90 127 128 O
ritonavir 91 100 129 138 B-treatment
, 100 101 138 139 O
saquinavir 102 112 140 150 B-treatment
, 112 113 150 151 O
telithromycin 114 127 152 165 B-treatment
, 127 128 165 166 O
amprenavir 129 139 167 177 B-treatment
, 139 140 177 178 O
aprepitant 141 151 179 189 B-treatment
, 151 152 189 190 O
diltiazem 153 162 191 200 B-treatment
, 162 163 200 201 O
erythromycin 164 176 202 214 B-treatment
, 176 177 214 215 O
fluconazole 178 189 216 227 B-treatment
, 189 190 227 228 O
fosamprenavir 191 204 229 242 B-treatment
, 204 205 242 243 O
grapefruit 206 216 244 254 O
juice 217 222 255 260 O
, 222 223 260 261 O
verapamil 224 233 262 271 B-treatment

Creatinine 0 10 272 282 B-clinical_variable
> 11 12 283 284 O
1.5 13 16 285 288 B-lower_bound
, 16 17 288 289 O
and/or 18 24 290 296 O
estimated 25 34 297 306 O
creatinine 35 45 307 317 B-clinical_variable
clearance 46 55 318 327 I-clinical_variable
less 56 60 328 332 O
than 61 65 333 337 O
30 66 68 338 340 B-upper_bound
mL 69 71 341 343 I-upper_bound
/ 71 72 343 344 I-upper_bound
min 72 75 344 347 I-upper_bound

Cyclosporine 0 12 348 360 B-treatment
, 12 13 360 361 O
ranolazine 14 24 362 372 B-treatment

MUA 0 3 373 376 B-treatment
indicated 4 13 377 386 O
within 14 20 387 393 O
5 21 22 394 395 B-lower_bound
to 23 25 396 398 O
12 26 28 399 401 B-upper_bound
weeks 29 34 402 407 I-upper_bound
of 35 37 408 410 O
primary 38 45 411 418 B-treatment
surgery 46 53 419 426 I-treatment

Non 0 3 427 430 B-language_fluency
- 3 4 430 431 I-language_fluency
English 4 11 431 438 I-language_fluency
speaking 12 20 439 447 I-language_fluency
patients 21 29 448 456 I-language_fluency

Patients 0 8 457 465 O
concurrently 9 21 466 478 O
taking 22 28 479 485 O
medications 29 40 486 497 O
that 41 45 498 502 O
increase 46 54 503 511 O
the 55 58 512 515 O
risk 59 63 516 520 O
for 64 67 521 524 O
myopathy 68 76 525 533 B-chronic_disease
and 77 80 534 537 O
rhabdomyolysis 81 95 538 552 B-chronic_disease

Patients 0 8 553 561 O
requiring 9 18 562 571 O
bilateral 19 28 572 581 B-treatment
MUA 29 32 582 585 I-treatment

Patients 0 8 586 594 O
with 9 13 595 599 O
hepatic 14 21 600 607 B-chronic_disease
disease 22 29 608 615 I-chronic_disease
( 30 31 616 617 O
known 31 36 617 622 O
liver 37 42 623 628 B-chronic_disease
disease 43 50 629 636 I-chronic_disease
, 50 51 636 637 O
cirrhosis 52 61 638 647 B-chronic_disease
, 61 62 647 648 O
and/or 63 69 649 655 O
AST 70 73 656 659 B-clinical_variable
/ 73 74 659 660 I-clinical_variable
ALT>60 74 80 660 666 I-clinical_variable
) 80 81 666 667 O

Patients 0 8 668 676 O
with 9 13 677 681 O
less 14 18 682 686 O
than 19 23 687 691 O
10 24 26 692 694 B-upper_bound
degrees 27 34 695 702 I-upper_bound
of 35 37 703 705 O
a 38 39 706 707 O
flexion 40 47 708 715 B-treatment
contracture 48 59 716 727 I-treatment

Patients 0 8 728 736 O
with 9 13 737 741 O
renal 14 19 742 747 B-chronic_disease
disease 20 27 748 755 I-chronic_disease

Patients 0 8 756 764 O
with 9 13 765 769 O
reported 14 22 770 778 O
allergy 23 30 779 786 O
to 31 33 787 789 O
colchicine 34 44 790 800 B-allergy_name

Pregnant 0 8 801 809 B-pregnancy
patients 9 17 810 818 O

Primary 0 7 819 826 O
Diagnosis 8 17 827 836 O
of 18 20 837 839 O
OA 21 23 840 842 B-chronic_disease
for 24 27 843 846 O
TKA 28 31 847 850 B-treatment

Revision 0 8 851 859 B-treatment
TKA 9 12 860 863 I-treatment

atorvastatin 0 12 864 876 B-treatment
, 12 13 876 877 O
fluvastatin 14 25 878 889 B-treatment
, 25 26 889 890 O
pravastatin 27 38 891 902 B-treatment
, 38 39 902 903 O
simvastatin 40 51 904 915 B-treatment
, 51 52 915 916 O
fibrates 53 61 917 925 B-treatment
, 61 62 925 926 O
gemfibrozil 63 74 927 938 B-treatment
, 74 75 938 939 O
digoxin 76 83 940 947 B-treatment

knee 0 4 948 952 B-clinical_variable
flexion 5 12 953 960 I-clinical_variable
angle 13 18 961 966 I-clinical_variable
less 19 23 967 971 O
than 24 28 972 976 O
90 29 31 977 979 B-upper_bound
° 31 32 979 980 I-upper_bound

Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
( 17 18 17 18 O
Symptomatic 18 29 18 29 O
bacterial 30 39 30 39 B-chronic_disease
and 40 43 40 43 O
fungal 44 50 44 50 B-chronic_disease
infection 51 60 51 60 I-chronic_disease
- 61 62 61 62 O
newly 63 68 63 68 O
diagnosed 69 78 69 78 O
and/or 79 85 79 85 O
requiring 86 95 86 95 O
treatment 96 105 96 105 O
) 105 106 105 106 O

Biopsy 0 6 107 113 B-treatment
- 6 7 113 114 O
proven 7 13 114 120 O
neuroendocrine 14 28 121 135 B-cancer
tumor 29 34 136 141 I-cancer

Contraindications 0 17 142 159 O
to 18 20 160 162 O
arteriography 21 34 163 176 B-allergy_name
and 35 38 177 180 O
selective 39 48 181 190 O
visceral 49 57 191 199 O
catheterization 58 73 200 215 B-allergy_name

Contraindications 0 17 216 233 O
to 18 20 234 236 O
hepatic 21 28 237 244 B-treatment
artery 29 35 245 251 I-treatment
embolization 36 48 252 264 I-treatment

INR 0 3 265 268 B-clinical_variable
≤ 4 5 269 270 O
1.5 6 9 271 274 B-upper_bound

Measurable 0 10 275 285 O
metastasis 11 21 286 296 B-cancer
to 22 24 297 299 I-cancer
liver 25 30 300 305 I-cancer
with 31 35 306 310 O
at 36 38 311 313 O
least 39 44 314 319 O
one 45 48 320 323 B-lower_bound
dimension 49 58 324 333 I-lower_bound
≥ 59 60 334 335 O
1.0 61 64 336 339 B-lower_bound
cm 65 67 340 342 I-lower_bound

Participants 0 12 343 355 O
18 13 15 356 358 B-lower_bound
years 16 21 359 364 I-lower_bound
and 22 25 365 368 O
older 26 31 369 374 O

Patients 0 8 375 383 O
must 9 13 384 388 O
be 14 16 389 391 O
at 17 19 392 394 O
least 20 25 395 400 O
one 26 29 401 404 B-lower_bound
month 30 35 405 410 I-lower_bound
beyond 36 42 411 417 O
prior 43 48 418 423 B-treatment
chemotherapy 49 61 424 436 I-treatment
, 61 62 436 437 O
PRRT 63 67 438 442 B-treatment
, 67 68 442 443 O
ablation 69 77 444 452 B-treatment
or 78 80 453 455 O
surgery 81 88 456 463 B-treatment
, 88 89 463 464 O
and 90 93 465 468 O
have 94 98 469 473 O
recovered 99 108 474 483 O
from 109 113 484 488 O
all 114 117 489 492 O
therapy 118 125 493 500 B-treatment
- 125 126 500 501 I-treatment
associated 126 136 501 511 I-treatment
toxicities 137 147 512 522 I-treatment

Performance 0 11 523 534 B-clinical_variable
status 12 18 535 541 I-clinical_variable
0 19 20 542 543 B-lower_bound
- 20 21 543 544 O
2 21 22 544 545 B-upper_bound
on 23 25 546 548 O
Zubrod 26 32 549 555 B-clinical_variable
/ 32 33 555 556 I-clinical_variable
ECOG 33 37 556 560 I-clinical_variable
Performance 38 49 561 572 I-clinical_variable
Scale 50 55 573 578 I-clinical_variable

Platelet 0 8 579 587 B-clinical_variable
count 9 14 588 593 I-clinical_variable
> 15 16 594 595 O
50 17 19 596 598 B-lower_bound
thousands 20 29 599 608 I-lower_bound
/ 29 30 608 609 I-lower_bound
uL 30 32 609 611 I-lower_bound

Pregnant 0 8 612 620 B-pregnancy

Prior 0 5 621 626 O
hepatic 6 13 627 634 B-treatment
arterial 14 22 635 643 I-treatment
therapy 23 30 644 651 I-treatment

Prior 0 5 652 657 B-treatment
surgical 6 14 658 666 I-treatment
resection 15 24 667 676 I-treatment
or 25 27 677 679 O
ablation 28 36 680 688 B-treatment
of 37 39 689 691 O
liver 40 45 692 697 B-cancer
metastases 46 56 698 708 I-cancer
is 57 59 709 711 O
acceptable 60 70 712 722 O

Serum 0 5 723 728 B-clinical_variable
Bilirubin 6 15 729 738 I-clinical_variable
≤ 16 17 739 740 O
2.0 18 21 741 744 B-upper_bound
mg 22 24 745 747 I-upper_bound
/ 24 25 747 748 I-upper_bound
dL 25 27 748 750 I-upper_bound

Serum 0 5 751 756 B-clinical_variable
albumin 6 13 757 764 I-clinical_variable
≥ 14 15 765 766 O
3.0 16 19 767 770 B-lower_bound
g 20 21 771 772 I-lower_bound
/ 21 22 772 773 I-lower_bound
dL 22 24 773 775 I-lower_bound

Serum 0 5 776 781 B-clinical_variable
creatinine 6 16 782 792 I-clinical_variable
< 17 18 793 794 O
2.0 19 22 795 798 B-upper_bound
mg 23 25 799 801 I-upper_bound
/ 25 26 801 802 I-upper_bound
dL 26 28 802 804 I-upper_bound

There 0 5 805 810 O
must 6 10 811 815 O
be 11 13 816 818 O
no 14 16 819 821 O
plans 17 22 822 827 O
for 23 26 828 831 O
the 27 30 832 835 O
patient 31 38 836 843 O
to 39 41 844 846 O
receive 42 49 847 854 O
other 50 55 855 860 O
concomitant 56 67 861 872 B-treatment
therapy 68 75 873 880 I-treatment
while 76 81 881 886 O
on 82 84 887 889 O
this 85 89 890 894 O
protocol 90 98 895 903 B-treatment
treatment 99 108 904 913 I-treatment
( 109 110 914 915 O
other 110 115 915 920 O
than 116 120 921 925 O
somatostatin 121 133 926 938 O
analogs 134 141 939 946 O
or 142 144 947 949 O
bone 145 149 950 954 O
- 149 150 954 955 O
strengthening 150 163 955 968 O
agents 164 170 969 975 O
) 170 171 975 976 O

Tumor 0 5 977 982 B-cancer
burden 6 12 983 989 O
dominant 13 21 990 998 O
in 22 24 999 1001 O
the 25 28 1002 1005 O
liver 29 34 1006 1011 O

Women 0 5 1012 1017 B-gender
/ 5 6 1017 1018 I-gender
men 6 9 1018 1021 I-gender
of 10 12 1022 1024 O
reproductive 13 25 1025 1037 O
potential 26 35 1038 1047 O
may 36 39 1048 1051 O
not 40 43 1052 1055 O
participate 44 55 1056 1067 O
unless 56 62 1068 1074 O
they 63 67 1075 1079 O
have 68 72 1080 1084 O
agreed 73 79 1085 1091 B-contraception_consent
to 80 82 1092 1094 I-contraception_consent
use 83 86 1095 1098 I-contraception_consent
an 87 89 1099 1101 I-contraception_consent
effective 90 99 1102 1111 I-contraception_consent
contraceptive 100 113 1112 1125 I-contraception_consent
method 114 120 1126 1132 I-contraception_consent

bleeding 0 8 1133 1141 B-chronic_disease
diathesis 9 18 1142 1151 I-chronic_disease
not 19 22 1152 1155 O
correctable 23 34 1156 1167 O
by 35 37 1168 1170 O
usual 38 43 1171 1176 O
forms 44 49 1177 1182 O
of 50 52 1183 1185 O
therapy 53 60 1186 1193 B-treatment

criteria 0 8 1194 1202 O
in 9 11 1203 1205 O
the 12 15 1206 1209 O
liver 16 21 1210 1215 O
OR 22 24 1216 1218 O
baseline 25 33 1219 1227 B-clinical_variable
tumor 34 39 1228 1233 I-clinical_variable
burden 40 46 1234 1240 I-clinical_variable
> 47 48 1241 1242 O
25 48 50 1242 1244 B-lower_bound
% 50 51 1244 1245 I-lower_bound
of 52 54 1246 1248 O
the 55 58 1249 1252 O
liver 59 64 1253 1258 O
volume 65 71 1259 1265 O

hepatic 0 7 1266 1273 B-chronic_disease
encephalopathy 8 22 1274 1288 I-chronic_disease

hepatic 0 7 1289 1296 B-treatment
radiation 8 17 1297 1306 I-treatment
therapy 18 25 1307 1314 I-treatment

intolerance 0 11 1315 1326 O
to 12 14 1327 1329 O
contrast 15 23 1330 1338 B-allergy_name
media 24 29 1339 1344 I-allergy_name

lactating 0 9 1345 1354 O
women 10 15 1355 1360 B-gender
may 16 19 1361 1364 O
not 20 23 1365 1368 O
participate 24 35 1369 1380 O
due 36 39 1381 1384 O
to 40 42 1385 1387 O
the 43 46 1388 1391 O
embryotoxic 47 58 1392 1403 O
effects 59 66 1404 1411 O
of 67 69 1412 1414 O
protocol 70 78 1415 1423 B-treatment
treatment 79 88 1424 1433 I-treatment

liver 0 5 1434 1439 B-cancer
tumor 6 11 1440 1445 I-cancer
burden 12 18 1446 1452 O
less 19 23 1453 1457 O
than 24 28 1458 1462 O
or 29 31 1463 1465 O
equal 32 37 1466 1471 O
to 38 40 1472 1474 O
70 41 43 1475 1477 B-upper_bound
% 43 44 1477 1478 I-upper_bound
of 45 47 1479 1481 O
the 48 51 1482 1485 O
total 52 57 1486 1491 B-clinical_variable
liver 58 63 1492 1497 I-clinical_variable
volume 64 70 1498 1504 I-clinical_variable
by 71 73 1505 1507 O
visual 74 80 1508 1514 O
estimate 81 89 1515 1523 O

morphologically 0 15 1524 1539 B-cancer
progressive 16 27 1540 1551 I-cancer
tumor 28 33 1552 1557 I-cancer
by 34 36 1558 1560 O
RECIST 37 43 1561 1567 O

narcotics 0 9 1568 1577 B-treatment

portal 0 6 1578 1584 B-chronic_disease
hypertension 7 19 1585 1597 I-chronic_disease
with 20 24 1598 1602 O
hepatofugal 25 36 1603 1614 O
flow 37 41 1615 1619 O

portal 0 6 1620 1626 B-chronic_disease
vein 7 11 1627 1631 I-chronic_disease
occlusion 12 21 1632 1641 I-chronic_disease
without 22 29 1642 1649 O
hepatopedal 30 41 1650 1661 O
collateral 42 52 1662 1672 O
flow 53 57 1673 1677 O
demonstrated 58 70 1678 1690 O
by 71 73 1691 1693 O
angiography 74 85 1694 1705 B-treatment

sedatives 0 9 1706 1715 B-treatment

severe 0 6 1716 1722 B-chronic_disease
peripheral 7 17 1723 1733 I-chronic_disease
vascular 18 26 1734 1742 I-chronic_disease
disease 27 34 1743 1750 I-chronic_disease
precluding 35 45 1751 1761 O
catheterization 46 61 1762 1777 B-treatment

transpapillary 0 14 1778 1792 B-treatment
biliary 15 22 1793 1800 I-treatment
stent 23 28 1801 1806 I-treatment

fall 0 4 0 4 O
from 5 9 5 9 O
height 10 16 10 16 B-clinical_variable
greater 17 24 17 24 O
than 25 29 25 29 O
10 30 32 30 32 B-lower_bound
feet 33 37 33 37 I-lower_bound

falls 0 5 38 43 O
from 6 10 44 48 O
less 11 15 49 53 O
than 16 20 54 58 O
10 21 23 59 61 B-upper_bound
feet 24 28 62 66 I-upper_bound

open 0 4 67 71 O
fracture 5 13 72 80 O
that 14 18 81 85 O
would 19 24 86 91 O
typically 25 34 92 101 O
require 35 42 102 109 O
operative 43 52 110 119 B-treatment
reduction 53 62 120 129 I-treatment
and 63 66 130 133 I-treatment
fixation 67 75 134 142 I-treatment

wound 0 5 143 148 O
greater 6 13 149 156 O
than 14 18 157 161 O
1 19 20 162 163 B-lower_bound
cm 20 22 163 165 I-lower_bound
in 23 25 166 168 O
length 26 32 169 175 O

wound 0 5 176 181 O
less 6 10 182 186 O
than 11 15 187 191 O
1 16 17 192 193 B-upper_bound
cm 17 19 193 195 I-upper_bound
in 20 22 196 198 O
length 23 29 199 205 O
and 30 33 206 209 O
the 34 37 210 213 O
bone 38 42 214 218 O
not 43 46 219 222 O
visualized 47 57 223 233 O
through 58 65 234 241 O
the 66 69 242 245 O
skin 70 74 246 250 O

> 0 1 0 1 O
6 2 3 2 3 B-lower_bound
one 4 7 4 7 O
hour 8 12 8 12 O
classes 13 20 13 20 O
of 21 23 21 23 O
meditation 24 34 24 34 O
or 35 37 35 37 O
other 38 43 38 43 O
mind 44 48 44 48 O
- 48 49 48 49 O
body 49 53 49 53 O
disciplines 54 65 54 65 O
( 66 67 66 67 O
e.g. 67 71 67 71 O
, 71 72 71 72 O
Tai 73 76 73 76 O
chi 77 80 77 80 O
or 81 83 81 83 O
yoga 84 88 84 88 O
) 88 89 88 89 O
within 90 96 90 96 O
the 97 100 97 100 O
last 101 105 101 105 B-upper_bound
6 106 107 106 107 I-upper_bound
months 108 114 108 114 I-upper_bound

Active 0 6 115 121 O
conditions 7 17 122 132 O
which 18 23 133 138 O
may 24 27 139 142 O
also 28 32 143 147 O
cause 33 38 148 153 O
depressive 39 49 154 164 O
symptoms 50 58 165 173 O
( 59 60 174 175 O
e.g. 60 64 175 179 O
epilepsy 65 73 180 188 B-chronic_disease
, 73 74 188 189 O
hypothyroidism 75 89 190 204 B-chronic_disease
) 89 90 204 205 O

Active 0 6 206 212 O
suicidal 7 15 213 221 B-chronic_disease
intent 16 22 222 228 I-chronic_disease
within 23 29 229 235 O
the 30 33 236 239 O
past 34 38 240 244 O
year 39 43 245 249 O
( 44 45 250 251 O
yes 45 48 251 254 O
on 49 51 255 257 O
item 52 56 258 262 O
4 57 58 263 264 O
or 59 61 265 267 O
5 62 63 268 269 O
on 64 66 270 272 O
the 67 70 273 276 O
Columbia 71 79 277 285 O
- 79 80 285 286 O
Suicide 80 87 286 293 O
Severity 88 96 294 302 O
Rating 97 103 303 309 O
Scale 104 109 310 315 O
) 109 110 315 316 O

English 0 7 317 324 B-language_fluency
language 8 16 325 333 I-language_fluency
proficiency 17 28 334 345 I-language_fluency

Medical 0 7 346 353 B-chronic_disease
conditions 8 18 354 364 I-chronic_disease
that 19 23 365 369 O
may 24 27 370 373 O
make 28 32 374 378 O
participation 33 46 379 392 O
unsafe 47 53 393 399 O
( 54 55 400 401 O
e.g. 55 59 401 405 O
, 59 60 405 406 O
diabetes 61 69 407 415 B-chronic_disease
[ 70 71 416 417 I-chronic_disease
I 71 72 417 418 I-chronic_disease
& 73 74 419 420 I-chronic_disease
II 75 77 421 423 I-chronic_disease
] 77 78 423 424 I-chronic_disease
, 78 79 424 425 O
cardiovascular 80 94 426 440 B-chronic_disease
disease 95 102 441 448 I-chronic_disease
, 102 103 448 449 O
hypertension 104 116 450 462 B-chronic_disease
[ 117 118 463 464 O
> 118 119 464 465 O
140 119 122 465 468 B-lower_bound
systolic 123 131 469 477 B-clinical_variable
and/or 132 138 478 484 O
> 139 140 485 486 O
90 140 142 486 488 O
diastolic 143 152 489 498 B-clinical_variable
] 152 153 498 499 O
, 153 154 499 500 O
hypotension 155 166 501 512 B-chronic_disease
[ 167 168 513 514 O
< 168 169 514 515 O
90 169 171 515 517 O
systolic 172 180 518 526 O
and/or 181 187 527 533 O
< 188 189 534 535 O
60 189 191 535 537 B-upper_bound
diastolic 192 201 538 547 O
, 201 202 547 548 O
during 203 209 549 555 O
screening 210 219 556 565 O
] 219 220 565 566 O
, 220 221 566 567 O
orthostatic 222 233 568 579 B-chronic_disease
hypotension 234 245 580 591 I-chronic_disease
[ 246 247 592 593 O
systolic 247 255 593 601 O
drop 256 260 602 606 O
of 261 263 607 609 O
20 264 266 610 612 O
points 267 273 613 619 O
or 274 276 620 622 O
10 277 279 623 625 O
point 280 285 626 631 O
diastolic 286 295 632 641 O
or 296 298 642 644 O
heart 299 304 645 650 O
rate 305 309 651 655 O
increase 310 318 656 664 O
by 319 321 665 667 O
10 322 324 668 670 O
] 324 325 670 671 O
, 325 326 671 672 O
autoimmune 327 337 673 683 B-chronic_disease
disorders 338 347 684 693 I-chronic_disease
, 347 348 693 694 O
malignancy 349 359 695 705 B-cancer
, 359 360 705 706 O
or 361 363 707 709 O
autonomic 364 373 710 719 B-chronic_disease
dysfunction 374 385 720 731 I-chronic_disease
) 385 386 731 732 O

Pregnancy 0 9 733 742 B-pregnancy

Psychotropic 0 12 743 755 B-treatment
medication 13 23 756 766 I-treatment
use 24 27 767 770 O
that 28 32 771 775 O
has 33 36 776 779 O
been 37 41 780 784 O
stable 42 48 785 791 O
for 49 52 792 795 O
<3 53 55 796 798 O
months 56 62 799 805 I-upper_bound

Score 0 5 806 811 O
of 6 8 812 814 O
> 9 10 815 816 O
23 10 12 816 818 B-lower_bound
on 13 15 819 821 O
the 16 19 822 825 O
Inventory 20 29 826 835 B-clinical_variable
of 30 32 836 838 I-clinical_variable
Depressive 33 43 839 849 I-clinical_variable
Symptomatology 44 58 850 864 I-clinical_variable
- 59 60 865 866 I-clinical_variable
Clinician 61 70 867 876 I-clinical_variable
Rated 71 76 877 882 I-clinical_variable
( 77 78 883 884 I-clinical_variable
IDS 78 81 884 887 I-clinical_variable
- 81 82 887 888 I-clinical_variable
CR 82 84 888 890 I-clinical_variable
) 84 85 890 891 I-clinical_variable

Unsafe 0 6 892 898 B-chronic_disease
cardiac 7 14 899 906 I-chronic_disease
status 15 21 907 913 I-chronic_disease
as 22 24 914 916 O
defined 25 32 917 924 O
by 33 35 925 927 O
abnormal 36 44 928 936 O
ECG 45 48 937 940 B-treatment
reading 49 56 941 948 O
at 57 59 949 951 O
screening 60 69 952 961 O
visit 70 75 962 967 O

Women 0 5 968 973 B-gender
of 6 8 974 976 O
childbearing 9 21 977 989 O
potential 22 31 990 999 O
must 32 36 1000 1004 O
use 37 40 1005 1008 O
an 41 43 1009 1011 O
acceptable 44 54 1012 1022 O
form 55 59 1023 1027 O
of 60 62 1028 1030 O
birth 63 68 1031 1036 O
control 69 76 1037 1044 O

ages 0 4 1045 1049 B-age
18 5 7 1050 1052 B-lower_bound
- 7 8 1052 1053 O
60 8 10 1053 1055 B-upper_bound

bipolar 0 7 1056 1063 B-chronic_disease
disorder 8 16 1064 1072 I-chronic_disease

eating 0 6 1073 1079 B-chronic_disease
disorders 7 16 1080 1089 I-chronic_disease

neurologic 0 10 1090 1100 B-chronic_disease
disorders 11 20 1101 1110 I-chronic_disease

planned 0 7 1111 1118 B-pregnancy
pregnancy 8 17 1119 1128 I-pregnancy
during 18 24 1129 1135 O
study 25 30 1136 1141 O

psychotic 0 9 1142 1151 B-chronic_disease
disorders 10 19 1152 1161 I-chronic_disease

substance 0 9 1162 1171 O
abuse 10 15 1172 1177 O
or 16 18 1178 1180 O
dependence 19 29 1181 1191 O
( 30 31 1192 1193 O
within 31 37 1193 1199 O
the 38 41 1200 1203 O
last 42 46 1204 1208 B-upper_bound
year 47 51 1209 1213 I-upper_bound
) 51 52 1213 1214 O

Age 0 3 0 3 B-age
greater 4 11 4 11 O
than 12 16 12 16 O
or 17 19 17 19 O
equal 20 25 20 25 O
to18 26 30 26 30 O
years 31 36 31 36 I-lower_bound

At 0 2 37 39 O
the 3 6 40 43 O
time 7 11 44 48 O
of 12 14 49 51 O
registration 15 27 52 64 O
, 27 28 64 65 O
all 29 32 66 69 O
subjects 33 41 70 78 O
must 42 46 79 83 O
be 47 49 84 86 O
removed 50 57 87 94 O
greater 58 65 95 102 O
than 66 70 103 107 O
or 71 73 108 110 O
equal 74 79 111 116 O
to 80 82 117 119 O
28 83 85 120 122 B-lower_bound
days 86 90 123 127 I-lower_bound
from 91 95 128 132 O
any 96 99 133 136 O
investigational 100 115 137 152 O
agents 116 122 153 159 O

Karnofsky 0 9 160 169 B-clinical_variable
greater 10 17 170 177 O
than 18 22 178 182 O
or 23 25 183 185 O
equal 26 31 186 191 O
to 32 34 192 194 O
60 35 37 195 197 B-lower_bound
% 37 38 197 198 I-lower_bound

Patients 0 8 199 207 O
may 9 12 208 211 O
not 13 16 212 215 O
have 17 21 216 220 O
had 22 25 221 224 O
prior 26 31 225 230 B-treatment
chemotherapy 32 44 231 243 I-treatment
or 45 47 244 246 O
biologic 48 56 247 255 B-treatment
therapy 57 64 256 263 I-treatment
in 65 67 264 266 O
the 68 71 267 270 O
4 72 73 271 272 B-upper_bound
weeks 74 79 273 278 I-upper_bound
prior 80 85 279 284 I-upper_bound
to 86 88 285 287 O
study 89 94 288 293 O
entry 95 100 294 299 O
. 100 101 299 300 O
For 102 105 301 304 O
patients 106 114 305 313 O
who 115 118 314 317 O
have 119 123 318 322 O
been 124 128 323 327 O
treated 129 136 328 335 O
with 137 141 336 340 O
targeted 142 150 341 349 B-treatment
therapy 151 158 350 357 I-treatment
, 158 159 357 358 O
5 160 161 359 360 O
half 162 166 361 365 O
- 166 167 365 366 O
lives 167 172 366 371 O
of 173 175 372 374 O
that 176 180 375 379 O
therapy 181 188 380 387 O
( 189 190 388 389 O
or 190 192 389 391 O
28 193 195 392 394 O
days 196 200 395 399 O
, 200 201 399 400 O
whichever 202 211 401 410 O
is 212 214 411 413 O
shorter 215 222 414 421 O
) 222 223 421 422 O
must 224 228 423 427 O
have 229 233 428 432 O
passed 234 240 433 439 O
prior 241 246 440 445 O
to 247 249 446 448 O
enrollment 250 260 449 459 O
in 261 263 460 462 O
the 264 267 463 466 O
study 268 273 467 472 O

Patients 0 8 473 481 O
must 9 13 482 486 O
be 14 16 487 489 O
in 17 19 490 492 O
adequate 20 28 493 501 O
general 29 36 502 509 O
medical 37 44 510 517 O
health 45 51 518 524 O
to 52 54 525 527 O
safely 55 61 528 534 O
tolerate 62 70 535 543 O
a 71 72 544 545 O
craniotomy 73 83 546 556 B-treatment

Patients 0 8 557 565 O
must 9 13 566 570 O
have 14 18 571 575 O
histologically 19 33 576 590 O
confirmed 34 43 591 600 O
glioblastoma 44 56 601 613 B-cancer
/ 56 57 613 614 O
gliosarcoma 57 68 614 625 B-cancer
confirmed 69 78 626 635 O
by 79 81 636 638 O
the 82 85 639 642 O
Laboratory 86 96 643 653 O
of 97 99 654 656 O
Pathology 100 109 657 666 O
, 109 110 666 667 O
NCI 111 114 668 671 O

Patients 0 8 672 680 O
unwilling 9 18 681 690 O
to 19 21 691 693 O
undergo 22 29 694 701 O
craniotomy 30 40 702 712 B-treatment

Pregnant 0 8 713 721 B-pregnancy
women 9 14 722 727 B-gender
are 15 18 728 731 O
excluded 19 27 732 740 O
from 28 32 741 745 O
this 33 37 746 750 O
study 38 43 751 756 O
because 44 51 757 764 O
the 52 55 765 768 O
safety 56 62 769 775 O
of 63 65 776 778 O
PP2A 66 70 779 783 B-treatment
inhibition 71 81 784 794 I-treatment
on 82 84 795 797 O
a 85 86 798 799 O
developing 87 97 800 810 O
fetus 98 103 811 816 O
has 104 107 817 820 O
not 108 111 821 824 O
been 112 116 825 829 O
established 117 128 830 841 O

The 0 3 842 845 O
effects 4 11 846 853 O
of 12 14 854 856 O
LB100 15 20 857 862 B-treatment
on 21 23 863 865 O
the 24 27 866 869 O
developing 28 38 870 880 O
human 39 44 881 886 O
fetus 45 50 887 892 O
are 51 54 893 896 O
unknown 55 62 897 904 O
. 62 63 904 905 O
For 64 67 906 909 O
this 68 72 910 914 O
reason 73 79 915 921 O
, 79 80 921 922 O
women 81 86 923 928 B-gender
of 87 89 929 931 O
child 90 95 932 937 O
- 95 96 937 938 O
bearing 96 103 938 945 O
potential 104 113 946 955 O
and 114 117 956 959 O
men 118 121 960 963 O
must 122 126 964 968 O
agree 127 132 969 974 B-contraception_consent
to 133 135 975 977 I-contraception_consent
use 136 139 978 981 I-contraception_consent
adequate 140 148 982 990 I-contraception_consent
contraception 149 162 991 1004 I-contraception_consent
( 163 164 1005 1006 O
hormonal 164 172 1006 1014 B-contraception_consent
or 173 175 1015 1017 O
barrier 176 183 1018 1025 B-contraception_consent
method 184 190 1026 1032 I-contraception_consent
of 191 193 1033 1035 I-contraception_consent
birth 194 199 1036 1041 I-contraception_consent
control 200 207 1042 1049 I-contraception_consent
; 207 208 1049 1050 O
abstinence 209 219 1051 1061 B-contraception_consent
) 219 220 1061 1062 O
prior 221 226 1063 1068 O
to 227 229 1069 1071 O
study 230 235 1072 1077 O
entry 236 241 1078 1083 O
and 242 245 1084 1087 O
for 246 249 1088 1091 O
the 250 253 1092 1095 O
duration 254 262 1096 1104 O
of 263 265 1105 1107 O
study 266 271 1108 1113 O
participation 272 285 1114 1127 O
. 285 286 1127 1128 O
Should 287 293 1129 1135 O
a 294 295 1136 1137 O
woman 296 301 1138 1143 B-gender
become 302 308 1144 1150 B-pregnancy
pregnant 309 317 1151 1159 I-pregnancy
or 318 320 1160 1162 O
suspect 321 328 1163 1170 O
she 329 332 1171 1174 O
is 333 335 1175 1177 O
pregnant 336 344 1178 1186 O
while 345 350 1187 1192 O
she 351 354 1193 1196 O
or 355 357 1197 1199 O
her 358 361 1200 1203 O
partner 362 369 1204 1211 O
is 370 372 1212 1214 O
participating 373 386 1215 1228 O
in 387 389 1229 1231 O
this 390 394 1232 1236 O
study 395 400 1237 1242 O
, 400 401 1242 1243 O
she 402 405 1244 1247 O
should 406 412 1248 1254 O
inform 413 419 1255 1261 O
her 420 423 1262 1265 O
treating 424 432 1266 1274 O
physician 433 442 1275 1284 O
immediately 443 454 1285 1296 O

Uncontrolled 0 12 1297 1309 O
intercurrent 13 25 1310 1322 B-chronic_disease
illness 26 33 1323 1330 I-chronic_disease
including 34 43 1331 1340 O
, 43 44 1340 1341 O
but 45 48 1342 1345 O
not 49 52 1346 1349 O
limited 53 60 1350 1357 O
to 61 63 1358 1360 O
, 63 64 1360 1361 O
ongoing 65 72 1362 1369 O
or 73 75 1370 1372 O
active 76 82 1373 1379 B-chronic_disease
infection 83 92 1380 1389 I-chronic_disease
, 92 93 1389 1390 O
symptomatic 94 105 1391 1402 O
congestive 106 116 1403 1413 B-chronic_disease
heart 117 122 1414 1419 I-chronic_disease
failure 123 130 1420 1427 I-chronic_disease
, 130 131 1427 1428 O
unstable 132 140 1429 1437 B-chronic_disease
angina 141 147 1438 1444 I-chronic_disease
pectoris 148 156 1445 1453 I-chronic_disease
, 156 157 1453 1454 I-chronic_disease
cardiac 158 165 1455 1462 B-chronic_disease
arrhythmia 166 176 1463 1473 I-chronic_disease

psychiatric 0 11 1474 1485 B-chronic_disease
illness 12 19 1486 1493 I-chronic_disease
/ 19 20 1493 1494 O
social 20 26 1494 1500 O
situations 27 37 1501 1511 O
that 38 42 1512 1516 O
would 43 48 1517 1522 O
limit 49 54 1523 1528 O
compliance 55 65 1529 1539 O
with 66 70 1540 1544 O
study 71 76 1545 1550 O
requirements 77 89 1551 1563 O

Subject 0 7 0 7 O
has 8 11 8 11 O
a 12 13 12 13 O
history 14 21 14 21 O
of 22 24 22 24 O
RYGB 25 29 25 29 B-treatment
or 30 32 30 32 O
SG 33 35 33 35 B-treatment
weight 36 42 36 42 I-treatment
loss 43 47 43 47 I-treatment
surgery 48 55 48 55 I-treatment
at 56 58 56 58 O
least 59 64 59 64 O
6 65 66 65 66 B-lower_bound
months 67 73 67 73 I-lower_bound
ago 74 77 74 77 O

Subject 0 7 78 85 O
has 8 11 86 89 O
a 12 13 90 91 O
history 14 21 92 99 O
of 22 24 100 102 O
hospitalization 25 40 103 118 B-treatment
for 41 44 119 122 O
acute 45 50 123 128 B-chronic_disease
illness 51 58 129 136 I-chronic_disease
in 59 61 137 139 O
the 62 65 140 143 O
previous 66 74 144 152 B-upper_bound
3 75 76 153 154 I-upper_bound
months 77 83 155 161 I-upper_bound

Subject 0 7 162 169 O
has 8 11 170 173 O
current 12 19 174 181 O
active 20 26 182 188 O
malignant 27 36 189 198 B-cancer
neoplasm 37 45 199 207 I-cancer

Subject 0 7 208 215 O
has 8 11 216 219 O
gastrointestinal 12 28 220 236 O
disease 29 36 237 244 O
that 37 41 245 249 O
involve 42 49 250 257 O
increased 50 59 258 267 O
inflammation 60 72 268 280 O
or 73 75 281 283 O
blood 76 81 284 289 O
loss 82 86 290 294 O
( 87 88 295 296 O
e.g. 88 92 296 300 O
Crohn 93 98 301 306 B-chronic_disease
's 98 100 306 308 I-chronic_disease
disease 101 108 309 316 I-chronic_disease
, 108 109 316 317 O
Ulcerative 110 120 318 328 B-chronic_disease
colitis 121 128 329 336 I-chronic_disease
) 128 129 336 337 O

Subject 0 7 338 345 O
has 8 11 346 349 O
had 12 15 350 353 O
parenteral 16 26 354 364 B-treatment
iron 27 31 365 369 I-treatment
less 32 36 370 374 O
than 37 41 375 379 O
one 42 45 380 383 B-upper_bound
month 46 51 384 389 I-upper_bound
before 52 58 390 396 O
screening 59 68 397 406 O
visit 69 74 407 412 O

Subject 0 7 413 420 O
has 8 11 421 424 O
history 12 19 425 432 O
of 20 22 433 435 O
surgical 23 31 436 444 B-treatment
revision 32 40 445 453 I-treatment
or 41 43 454 456 O
conversion 44 54 457 467 O
of 55 57 468 470 O
bariatric 58 67 471 480 B-treatment
procedure 68 77 481 490 I-treatment

Subject 0 7 491 498 O
has 8 11 499 502 O
severe 12 18 503 509 O
anemia 19 25 510 516 B-chronic_disease
, 25 26 516 517 O
with 27 31 518 522 O
a 32 33 523 524 O
hemoglobin 34 44 525 535 B-clinical_variable
> 45 46 536 537 O
7.0 47 50 538 541 B-lower_bound
g 51 52 542 543 I-lower_bound
/ 52 53 543 544 I-lower_bound
dL 53 55 544 546 I-lower_bound

Subject 0 7 547 554 O
is 8 10 555 557 O
at 11 13 558 560 O
least 14 19 561 566 O
18 20 22 567 569 B-lower_bound
but 23 26 570 573 O
not 27 30 574 577 O
more 31 35 578 582 O
than 36 40 583 587 O
65 41 43 588 590 B-upper_bound
years 44 49 591 596 I-upper_bound
of 50 52 597 599 O
age 53 56 600 603 B-age

Subject 0 7 604 611 O
is 8 10 612 614 O
female 11 17 615 621 B-gender

Subject 0 7 622 629 O
is 8 10 630 632 O
pregnant 11 19 633 641 B-pregnancy

Subject 0 7 642 649 O
is 8 10 650 652 O
taking 11 17 653 659 O
an 18 20 660 662 O
erythropoietin 21 35 663 677 B-treatment
stimulating 36 47 678 689 I-treatment
medication 48 58 690 700 I-treatment
or 59 61 701 703 O
is 62 64 704 706 O
on 65 67 707 709 O
hemodialysis 68 80 710 722 B-treatment

Subject 0 7 723 730 O
is 8 10 731 733 O
under 11 16 734 739 O
a 17 18 740 741 O
treatment 19 28 742 751 B-treatment
regimen 29 36 752 759 I-treatment
that 37 41 760 764 O
requires 42 50 765 773 O
iron 51 55 774 778 B-treatment
supplementation 56 71 779 794 I-treatment
greater 72 79 795 802 O
than 80 84 803 807 O
standard 85 93 808 816 O
of 94 96 817 819 O
care 97 101 820 824 O

Subject 0 7 825 832 O
meets 8 13 833 838 O
at 14 16 839 841 O
least 17 22 842 847 O
2 23 24 848 849 B-lower_bound
of 25 27 850 852 O
the 28 31 853 856 O
4 32 33 857 858 B-upper_bound
previously 34 44 859 869 O
mentioned 45 54 870 879 O
conditions 55 65 880 890 O
classifying 66 77 891 902 O
them 78 82 903 907 O
as 83 85 908 910 O
iron 86 90 911 915 O
deficient 91 100 916 925 O

history 0 7 926 933 O
of 8 10 934 936 O
malignancy 11 21 937 947 B-cancer
other 22 27 948 953 O
than 28 32 954 958 O
localized 33 42 959 968 O
basal 43 48 969 974 B-cancer
cell 49 53 975 979 I-cancer
cancer 54 60 980 986 I-cancer
of 61 63 987 989 I-cancer
skin 64 68 990 994 I-cancer
during 69 75 995 1001 O
previous 76 84 1002 1010 B-upper_bound
5 85 86 1011 1012 I-upper_bound
years 87 92 1013 1018 I-upper_bound

> 0 1 0 1 O
= 1 2 1 2 O
140 3 6 3 6 B-lower_bound
mmHg 7 11 7 11 I-lower_bound
or 12 14 12 14 O
diastolic 15 24 15 24 B-clinical_variable
blood 25 30 25 30 I-clinical_variable
pressure 31 39 31 39 I-clinical_variable
( 40 41 40 41 I-clinical_variable
DBP 41 44 41 44 I-clinical_variable
) 44 45 44 45 I-clinical_variable
of 46 48 46 48 O
> 49 50 49 50 O
= 50 51 50 51 O
90mmHg 52 58 52 58 B-lower_bound

A 0 1 59 60 O
bilateral 2 11 61 70 B-treatment
oophorectomy 12 24 71 83 I-treatment
( 25 26 84 85 O
ovariectomy 26 37 85 96 B-treatment
) 37 38 96 97 O

A 0 1 98 99 O
hysterectomy 2 14 100 112 B-treatment

Absolute 0 8 113 121 B-clinical_variable
neutrophil 9 19 122 132 I-clinical_variable
count 20 25 133 138 I-clinical_variable
( 26 27 139 140 I-clinical_variable
ANC 27 30 140 143 I-clinical_variable
) 30 31 143 144 I-clinical_variable
> 32 33 145 146 O
= 33 34 146 147 O
1.5 35 38 148 151 B-lower_bound
x 39 40 152 153 I-lower_bound
10 41 43 154 156 I-lower_bound
^ 43 44 156 157 I-lower_bound
9 44 45 157 158 I-lower_bound
/ 45 46 158 159 I-lower_bound
L 46 47 159 160 I-lower_bound

Activated 0 9 161 170 B-clinical_variable
partial 10 17 171 178 I-clinical_variable
thromboplastin 18 32 179 193 I-clinical_variable
time 33 37 194 198 I-clinical_variable
( 38 39 199 200 I-clinical_variable
aPTT 39 43 200 204 I-clinical_variable
) 43 44 204 205 I-clinical_variable
= 45 46 206 207 O
< 46 47 207 208 O
1.2 48 51 209 212 B-upper_bound
x 52 53 213 214 I-upper_bound
ULN 54 57 215 218 I-upper_bound

Active 0 6 219 225 B-chronic_disease
peptic 7 13 226 232 I-chronic_disease
ulcer 14 19 233 238 I-chronic_disease
disease 20 27 239 246 I-chronic_disease

Adjuvant 0 8 247 255 B-treatment
therapy 9 16 256 263 I-treatment
will 17 21 264 268 O
not 22 25 269 272 O
count 26 31 273 278 O
towards 32 39 279 286 O
prior 40 45 287 292 B-treatment
treatment 46 55 293 302 I-treatment
for 56 59 303 306 O
metastatic 60 70 307 317 B-cancer
disease 71 78 318 325 I-cancer
, 78 79 325 326 O
unless 80 86 327 333 O
the 87 90 334 337 O
patient 91 98 338 345 O
relapsed 99 107 346 354 O

Alanine 0 7 355 362 B-clinical_variable
aminotransferase 8 24 363 379 I-clinical_variable
( 25 26 380 381 I-clinical_variable
ALT 26 29 381 384 I-clinical_variable
) 29 30 384 385 I-clinical_variable
and 31 34 386 389 O
aspartate 35 44 390 399 B-clinical_variable
aminotransferase 45 61 400 416 I-clinical_variable
( 62 63 417 418 I-clinical_variable
AST 63 66 418 421 I-clinical_variable
) 66 67 421 422 I-clinical_variable
= 68 69 423 424 O
< 69 70 424 425 O
2.5 71 74 426 429 B-upper_bound
x 75 76 430 431 I-upper_bound
ULN 77 80 432 435 I-upper_bound

Any 0 3 436 439 O
ongoing 4 11 440 447 O
toxicity 12 20 448 456 O
from 21 25 457 461 O
prior 26 31 462 467 B-treatment
anti 32 36 468 472 I-treatment
- 36 37 472 473 I-treatment
cancer 37 43 473 479 I-treatment
therapy 44 51 480 487 I-treatment

Any 0 3 488 491 O
prior 4 9 492 497 B-treatment
treatment 10 19 498 507 I-treatment
with 20 24 508 512 I-treatment
gemcitabine 25 36 513 524 I-treatment

Any 0 3 525 528 O
prior 4 9 529 534 B-treatment
treatment 10 19 535 544 I-treatment
with 20 24 545 549 I-treatment
pazopanib 25 34 550 559 I-treatment
or 35 37 560 562 O
vascular 38 46 563 571 B-clinical_variable
endothelial 47 58 572 583 I-clinical_variable
growth 59 65 584 590 I-clinical_variable
factor 66 72 591 597 I-clinical_variable
( 73 74 598 599 I-clinical_variable
VEGF 74 78 599 603 I-clinical_variable
) 78 79 603 604 I-clinical_variable
or 80 82 605 607 O
vascular 83 91 608 616 B-treatment
endothelial 92 103 617 628 I-treatment
growth 104 110 629 635 I-treatment
factor 111 117 636 642 I-treatment
receptor 118 126 643 651 I-treatment
( 127 128 652 653 I-treatment
VEGFR)-targeting 128 144 653 669 I-treatment
agents 145 151 670 676 I-treatment
( 152 153 677 678 O
eg 153 155 678 680 O
. 155 156 680 681 O
sorafenib 157 166 682 691 B-treatment
, 166 167 691 692 O
sunitinib 168 177 693 702 B-treatment
, 177 178 702 703 O
and 179 182 704 707 O
bevacizumab 183 194 708 719 B-treatment
) 194 195 719 720 O

Any 0 3 721 724 O
serious 4 11 725 732 O
and/or 12 18 733 739 O
unstable 19 27 740 748 O
pre 28 31 749 752 O
- 31 32 752 753 O
existing 32 40 753 761 O
medical 41 48 762 769 B-chronic_disease
, 48 49 769 770 O
psychiatric 50 61 771 782 B-chronic_disease
, 61 62 782 783 O
or 63 65 784 786 O
other 66 71 787 792 O
condition 72 81 793 802 O
that 82 86 803 807 O
could 87 92 808 813 O
interfere 93 102 814 823 O
with 103 107 824 828 O
subject 108 115 829 836 O
's 115 117 836 838 O
safety 118 124 839 845 O
, 124 125 845 846 O
provision 126 135 847 856 O
of 136 138 857 859 O
informed 139 147 860 868 O
consent 148 155 869 876 O
, 155 156 876 877 O
or 157 159 878 880 O
compliance 160 170 881 891 O
to 171 173 892 894 O
study 174 179 895 900 O
procedures 180 190 901 911 O

Cardiac 0 7 912 919 B-treatment
angioplasty 8 19 920 931 I-treatment
or 20 22 932 934 O
stenting 23 31 935 943 B-treatment

Chemotherapy 0 12 944 956 B-treatment
, 12 13 956 957 O
immunotherapy 14 27 958 971 B-treatment
, 27 28 971 972 O
biologic 29 37 973 981 B-treatment
therapy 38 45 982 989 I-treatment
, 45 46 989 990 O
investigational 47 62 991 1006 B-treatment
therapy 63 70 1007 1014 I-treatment
or 71 73 1015 1017 O
hormonal 74 82 1018 1026 B-treatment
therapy 83 90 1027 1034 I-treatment

Childbearing 0 12 1035 1047 O
potential 13 22 1048 1057 O
, 22 23 1057 1058 O
including 24 33 1059 1068 O
any 34 37 1069 1072 O
female 38 44 1073 1079 B-gender
who 45 48 1080 1083 O
has 49 52 1084 1087 O
had 53 56 1088 1091 O
a 57 58 1092 1093 O
negative 59 67 1094 1102 B-pregnancy
serum 68 73 1103 1108 I-pregnancy
pregnancy 74 83 1109 1118 I-pregnancy
test 84 88 1119 1123 O

Class 0 5 1124 1129 B-lower_bound
III 6 9 1130 1133 I-lower_bound
or 10 12 1134 1136 O
IV 13 15 1137 1139 B-upper_bound
congestive 16 26 1140 1150 B-chronic_disease
heart 27 32 1151 1156 I-chronic_disease
failure 33 40 1157 1164 I-chronic_disease
, 40 41 1164 1165 O
as 42 44 1166 1168 O
defined 45 52 1169 1176 O
by 53 55 1177 1179 O
the 56 59 1180 1183 O
New 60 63 1184 1187 B-clinical_variable
York 64 68 1188 1192 I-clinical_variable
Heart 69 74 1193 1198 I-clinical_variable
Association 75 86 1199 1210 I-clinical_variable
( 87 88 1211 1212 I-clinical_variable
NYHA 88 92 1212 1216 I-clinical_variable
) 92 93 1216 1217 I-clinical_variable

Clinically 0 10 1218 1228 O
significant 11 22 1229 1240 O
gastrointestinal 23 39 1241 1257 B-chronic_disease
abnormalities 40 53 1258 1271 I-chronic_disease
that 54 58 1272 1276 O
may 59 62 1277 1280 O
affect 63 69 1281 1287 O
absorption 70 80 1288 1298 O
of 81 83 1299 1301 O
investigational 84 99 1302 1317 B-treatment
produc 100 106 1318 1324 I-treatment

Coronary 0 8 1325 1333 B-treatment
artery 9 15 1334 1340 I-treatment
bypass 16 22 1341 1347 I-treatment
graft 23 28 1348 1353 I-treatment
surgery 29 36 1354 1361 I-treatment

Corrected 0 9 1362 1371 B-clinical_variable
QT 10 12 1372 1374 I-clinical_variable
interval 13 21 1375 1383 I-clinical_variable
( 22 23 1384 1385 I-clinical_variable
QTc 23 26 1385 1388 I-clinical_variable
) 26 27 1388 1389 I-clinical_variable
> 28 29 1390 1391 O
480 30 33 1392 1395 B-lower_bound
milliseconds 34 46 1396 1408 I-lower_bound
( 47 48 1409 1410 I-lower_bound
msecs 48 53 1410 1415 I-lower_bound
) 53 54 1415 1416 I-lower_bound
using 55 60 1417 1422 O
Bazett 61 67 1423 1429 O
's 67 69 1429 1431 O
formula 70 77 1432 1439 O

Eastern 0 7 1440 1447 B-clinical_variable
Cooperative 8 19 1448 1459 I-clinical_variable
Oncology 20 28 1460 1468 I-clinical_variable
Group 29 34 1469 1474 I-clinical_variable
( 35 36 1475 1476 I-clinical_variable
ECOG 36 40 1476 1480 I-clinical_variable
) 40 41 1480 1481 I-clinical_variable
performance 42 53 1482 1493 I-clinical_variable
status 54 60 1494 1500 I-clinical_variable
of 61 63 1501 1503 O
0 64 65 1504 1505 B-lower_bound
- 65 66 1505 1506 O
2 66 67 1506 1507 B-upper_bound

Evidence 0 8 1508 1516 O
of 9 11 1517 1519 O
active 12 18 1520 1526 B-chronic_disease
bleeding 19 27 1527 1535 I-chronic_disease
or 28 30 1536 1538 O
bleeding 31 39 1539 1547 B-chronic_disease
diathesis 40 49 1548 1557 I-chronic_disease

Female 0 6 1558 1564 B-gender
subjects 7 15 1565 1573 I-gender
who 16 19 1574 1577 O
are 20 23 1578 1581 O
lactating 24 33 1582 1591 O
should 34 40 1592 1598 O
discontinue 41 52 1599 1610 O
nursing 53 60 1611 1618 O
prior 61 66 1619 1624 O
to 67 69 1625 1627 O
the 70 73 1628 1631 O
first 74 79 1632 1637 O
dose 80 84 1638 1642 O
of 85 87 1643 1645 O
study 88 93 1646 1651 B-treatment
drug 94 98 1652 1656 I-treatment
and 99 102 1657 1660 O
should 103 109 1661 1667 O
refrain 110 117 1668 1675 O
from 118 122 1676 1680 O
nursing 123 130 1681 1688 O
throughout 131 141 1689 1699 O
the 142 145 1700 1703 O
treatment 146 155 1704 1713 B-treatment
period 156 162 1714 1720 O

Hemoglobin 0 10 1721 1731 B-clinical_variable
> 11 12 1732 1733 O
= 12 13 1733 1734 O
9 14 15 1735 1736 B-lower_bound
g 16 17 1737 1738 I-lower_bound
/ 17 18 1738 1739 I-lower_bound
dL 18 20 1739 1741 I-lower_bound
( 21 22 1742 1743 I-lower_bound
5.6 22 25 1743 1746 I-lower_bound
mmol 26 30 1747 1751 I-lower_bound
/ 30 31 1751 1752 I-lower_bound
L 31 32 1752 1753 I-lower_bound
) 32 33 1753 1754 I-lower_bound

Hemoptysis 0 10 1755 1765 B-chronic_disease
in 11 13 1766 1768 O
excess 14 20 1769 1775 O
of 21 23 1776 1778 O
2.5 24 27 1779 1782 O
mL 28 30 1783 1785 O
( 31 32 1786 1787 O
or 32 34 1787 1789 O
one 35 38 1790 1793 O
half 39 43 1794 1798 O
teaspoon 44 52 1799 1807 O
) 52 53 1807 1808 O
within 54 60 1809 1815 O
8 61 62 1816 1817 B-upper_bound
weeks 63 68 1818 1823 I-upper_bound
of 69 71 1824 1826 O
first 72 77 1827 1832 O
dose 78 82 1833 1837 O
of 83 85 1838 1840 O
study 86 91 1841 1846 O
drug 92 96 1847 1851 O

Histologically 0 14 1852 1866 O
confirmed 15 24 1867 1876 O
diagnosis 25 34 1877 1886 O
of 35 37 1887 1889 O
metastatic 38 48 1890 1900 B-cancer
or 49 51 1901 1903 O
unresectable 52 64 1904 1916 O
soft 65 69 1917 1921 B-cancer
tissue 70 76 1922 1928 I-cancer
sarcoma 77 84 1929 1936 I-cancer
, 84 85 1936 1937 O
excluding 86 95 1938 1947 O
gastrointestinal 96 112 1948 1964 B-cancer
stromal 113 120 1965 1972 I-cancer
tumors 121 127 1973 1979 I-cancer
, 127 128 1979 1980 O
Kaposi 129 135 1981 1987 B-cancer
's 135 137 1987 1989 I-cancer
sarcoma 138 145 1990 1997 I-cancer
, 145 146 1997 1998 O
Ewing 147 152 1999 2004 B-cancer
's 152 154 2004 2006 I-cancer
family 155 161 2007 2013 I-cancer
of 162 164 2014 2016 I-cancer
tumors 165 171 2017 2023 I-cancer
, 171 172 2023 2024 O
and 173 176 2025 2028 O
embryonal 177 186 2029 2038 B-cancer
or 187 189 2039 2041 O
alveolar 190 198 2042 2050 B-cancer
rhabdomyosarcoma 199 215 2051 2067 I-cancer

History 0 7 2068 2075 O
of 8 10 2076 2078 O
abdominal 11 20 2079 2088 B-chronic_disease
fistula 21 28 2089 2096 I-chronic_disease
, 28 29 2096 2097 O
gastrointestinal 30 46 2098 2114 B-chronic_disease
perforation 47 58 2115 2126 I-chronic_disease
, 58 59 2126 2127 O
or 60 62 2128 2130 O
intra 63 68 2131 2136 B-chronic_disease
- 68 69 2136 2137 I-chronic_disease
abdominal 69 78 2137 2146 I-chronic_disease
abscess 79 86 2147 2154 I-chronic_disease

History 0 7 2155 2162 O
of 8 10 2163 2165 O
any 11 14 2166 2169 O
one 15 18 2170 2173 O
or 19 21 2174 2176 O
more 22 26 2177 2181 O
of 27 29 2182 2184 O
the 30 33 2185 2188 O
following 34 43 2189 2198 O
cardiovascular 44 58 2199 2213 B-chronic_disease
conditions 59 69 2214 2224 O

History 0 7 2225 2232 O
of 8 10 2233 2235 O
cerebrovascular 11 26 2236 2251 B-chronic_disease
accident 27 35 2252 2260 I-chronic_disease
including 36 45 2261 2270 O
transient 46 55 2271 2280 B-chronic_disease
ischemic 56 64 2281 2289 I-chronic_disease
attack 65 71 2290 2296 I-chronic_disease
( 72 73 2297 2298 I-chronic_disease
TIA 73 76 2298 2301 I-chronic_disease
) 76 77 2301 2302 I-chronic_disease
, 77 78 2302 2303 O
pulmonary 79 88 2304 2313 B-chronic_disease
embolism 89 97 2314 2322 I-chronic_disease
or 98 100 2323 2325 O
untreated 101 110 2326 2335 O
deep 111 115 2336 2340 B-chronic_disease
venous 116 122 2341 2347 I-chronic_disease
thrombosis 123 133 2348 2358 I-chronic_disease
( 134 135 2359 2360 I-chronic_disease
DVT 135 138 2360 2363 I-chronic_disease
) 138 139 2363 2364 I-chronic_disease

History 0 7 2365 2372 O
or 8 10 2373 2375 O
clinical 11 19 2376 2384 O
evidence 20 28 2385 2393 O
of 29 31 2394 2396 O
central 32 39 2397 2404 B-cancer
nervous 40 47 2405 2412 I-cancer
system 48 54 2413 2419 I-cancer
( 55 56 2420 2421 I-cancer
CNS 56 59 2421 2424 I-cancer
) 59 60 2424 2425 I-cancer
metastases 61 71 2426 2436 I-cancer
or 72 74 2437 2439 O
leptomeningeal 75 89 2440 2454 B-cancer
carcinomatosis 90 104 2455 2469 I-cancer
, 104 105 2469 2470 O
except 106 112 2471 2477 O
for 113 116 2478 2481 O
individuals 117 128 2482 2493 O
who 129 132 2494 2497 O
have 133 137 2498 2502 O
previously 138 148 2503 2513 O
- 148 149 2513 2514 O
treated 149 156 2514 2521 O
CNS 157 160 2522 2525 B-cancer
metastases 161 171 2526 2536 I-cancer
, 171 172 2536 2537 O
are 173 176 2538 2541 O
asymptomatic 177 189 2542 2554 O

Implants 0 8 2555 2563 O
of 9 11 2564 2566 O
levonorgestrel 12 26 2567 2581 B-treatment

Inflammatory 0 12 2582 2594 B-chronic_disease
bowel 13 18 2595 2600 I-chronic_disease
disease 19 26 2601 2608 I-chronic_disease
( 27 28 2609 2610 O
e.g. 28 32 2610 2614 O
ulcerative 33 43 2615 2625 B-chronic_disease
colitis 44 51 2626 2633 I-chronic_disease
, 51 52 2633 2634 O
Crohn 53 58 2635 2640 B-chronic_disease
's 58 60 2640 2642 I-chronic_disease
disease 61 68 2643 2650 I-chronic_disease
) 68 69 2650 2651 O
, 69 70 2651 2652 O
or 71 73 2653 2655 O
other 74 79 2656 2661 O
gastrointestinal 80 96 2662 2678 B-chronic_disease
conditions 97 107 2679 2689 I-chronic_disease
with 108 112 2690 2694 O
increased 113 122 2695 2704 O
risk 123 127 2705 2709 O
of 128 130 2710 2712 O
perforation 131 142 2713 2724 B-chronic_disease

Injectable 0 10 2725 2735 B-treatment
progesterone 11 23 2736 2748 I-treatment

Intrauterine 0 12 2749 2761 B-contraception_consent
device 13 19 2762 2768 I-contraception_consent
( 20 21 2769 2770 I-contraception_consent
IUD 21 24 2770 2773 I-contraception_consent
) 24 25 2773 2774 I-contraception_consent
or 26 28 2775 2777 O
intrauterine 29 41 2778 2790 B-contraception_consent
system 42 48 2791 2797 I-contraception_consent
( 49 50 2798 2799 I-contraception_consent
IUS 50 53 2799 2802 I-contraception_consent
) 53 54 2802 2803 I-contraception_consent
with 55 59 2804 2808 O
a 60 61 2809 2810 O
documented 62 72 2811 2821 O
failure 73 80 2822 2829 O
rate 81 85 2830 2834 O
of 86 88 2835 2837 O
less 89 93 2838 2842 O
than 94 98 2843 2847 O
1 99 100 2848 2849 B-upper_bound
% 100 101 2849 2850 I-upper_bound
per 102 105 2851 2854 I-upper_bound
year 106 110 2855 2859 I-upper_bound

Known 0 5 2860 2865 O
endobronchial 6 19 2866 2879 B-cancer
lesions 20 27 2880 2887 I-cancer
and/or 28 34 2888 2894 O
lesions 35 42 2895 2902 O
infiltrating 43 55 2903 2915 O
major 56 61 2916 2921 O
pulmonary 62 71 2922 2931 O
vessels 72 79 2932 2939 O
that 80 84 2940 2944 O
increase 85 93 2945 2953 O
the 94 97 2954 2957 O
risk 98 102 2958 2962 O
of 103 105 2963 2965 O
pulmonary 106 115 2966 2975 B-chronic_disease
hemorrhage 116 126 2976 2986 I-chronic_disease

Known 0 5 2987 2992 O
intraluminal 6 18 2993 3005 B-cancer
metastatic 19 29 3006 3016 I-cancer
lesion 30 36 3017 3023 O
/ 36 37 3023 3024 O
s 37 38 3024 3025 O
with 39 43 3026 3030 O
risk 44 48 3031 3035 O
of 49 51 3036 3038 O
bleeding 52 60 3039 3047 O

Major 0 5 3048 3053 B-treatment
resection 6 15 3054 3063 I-treatment
of 16 18 3064 3066 O
the 19 22 3067 3070 O
stomach 23 30 3071 3078 O
or 31 33 3079 3081 O
small 34 39 3082 3087 O
bowel 40 45 3088 3093 O

Malabsorption 0 13 3094 3107 B-chronic_disease
syndrome 14 22 3108 3116 I-chronic_disease

Male 0 4 3117 3121 B-gender
partner 5 12 3122 3129 O
sterilization 13 26 3130 3143 B-treatment
( 27 28 3144 3145 O
vasectomy 28 37 3145 3154 B-treatment
with 38 42 3155 3159 O
documentation 43 56 3160 3173 O
of 57 59 3174 3176 O
azoospermia 60 71 3177 3188 B-chronic_disease
) 71 72 3188 3189 O
prior 73 78 3190 3195 O
to 79 81 3196 3198 O
the 82 85 3199 3202 O
female 86 92 3203 3209 B-gender
subject 93 100 3210 3217 I-gender
's 100 102 3217 3219 I-gender
entry 103 108 3220 3225 O
into 109 113 3226 3230 O
the 114 117 3231 3234 O
study 118 123 3235 3240 O
, 123 124 3240 3241 O
and 125 128 3242 3245 O
this 129 133 3246 3250 O
male 134 138 3251 3255 O
is 139 141 3256 3258 O
the 142 145 3259 3262 O
sole 146 150 3263 3267 O
partner 151 158 3268 3275 O
for 159 162 3276 3279 O
that 163 167 3280 3284 O
subject 168 175 3285 3292 O

Measurable 0 10 3293 3303 O
disease 11 18 3304 3311 O
per 19 22 3312 3315 O
Response 23 31 3316 3324 B-treatment
Evaluation 32 42 3325 3335 I-treatment
Criteria 43 51 3336 3344 I-treatment
in 52 54 3345 3347 I-treatment
Solid 55 60 3348 3353 I-treatment
Tumors 61 67 3354 3360 I-treatment
( 68 69 3361 3362 I-treatment
RECIST 69 75 3362 3368 I-treatment
) 75 76 3368 3369 I-treatment
1.1 77 80 3370 3373 I-treatment

Myocardial 0 10 3374 3384 B-chronic_disease
infarction 11 21 3385 3395 I-chronic_disease

Oral 0 4 3396 3400 B-contraception_consent
contraceptive 5 18 3401 3414 I-contraception_consent
, 18 19 3414 3415 O
either 20 26 3416 3422 O
combined 27 35 3423 3431 O
or 36 38 3432 3434 O
progesterone 39 51 3435 3447 O
alone 52 57 3448 3453 O

Patients 0 8 3454 3462 O
must 9 13 3463 3467 O
have 14 18 3468 3472 O
received 19 27 3473 3481 O
at 28 30 3482 3484 O
least 31 36 3485 3490 O
one 37 40 3491 3494 B-lower_bound
, 40 41 3494 3495 O
but 42 45 3496 3499 O
not 46 49 3500 3503 O
more 50 54 3504 3508 O
than 55 59 3509 3513 O
three 60 65 3514 3519 B-upper_bound
, 65 66 3519 3520 O
systemic 67 75 3521 3529 B-treatment
regimens 76 84 3530 3538 I-treatment
for 85 88 3539 3542 O
treatment 89 98 3543 3552 B-treatment
of 99 101 3553 3555 O
metastatic 102 112 3556 3566 B-cancer
soft 113 117 3567 3571 I-cancer
tissue 118 124 3572 3578 I-cancer
sarcoma 125 132 3579 3586 I-cancer

Percutaneous 0 12 3587 3599 B-contraception_consent
contraceptive 13 26 3600 3613 I-contraception_consent
patches 27 34 3614 3621 I-contraception_consent

Platelets 0 9 3622 3631 B-clinical_variable
> 10 11 3632 3633 O
= 11 12 3633 3634 O
100 13 16 3635 3638 B-lower_bound
x 17 18 3639 3640 I-lower_bound
10 19 21 3641 3643 I-lower_bound
^ 21 22 3643 3644 I-lower_bound
9 22 23 3644 3645 I-lower_bound
/ 23 24 3645 3646 I-lower_bound
L 24 25 3646 3647 I-lower_bound

Poorly 0 6 3648 3654 O
controlled 7 17 3655 3665 O
hypertension 18 30 3666 3678 B-chronic_disease
( 31 32 3679 3680 O
defined 32 39 3680 3687 O
as 40 42 3688 3690 O
systolic 43 51 3691 3699 B-clinical_variable
blood 52 57 3700 3705 I-clinical_variable
pressure 58 66 3706 3714 I-clinical_variable
( 67 68 3715 3716 I-clinical_variable
SBP 68 71 3716 3719 I-clinical_variable
) 71 72 3719 3720 I-clinical_variable

Presence 0 8 3721 3729 O
of 9 11 3730 3732 O
uncontrolled 12 24 3733 3745 B-chronic_disease
infection 25 34 3746 3755 I-chronic_disease

Prior 0 5 3756 3761 B-treatment
major 6 11 3762 3767 I-treatment
surgery 12 19 3768 3775 I-treatment
or 20 22 3776 3778 O
trauma 23 29 3779 3785 B-chronic_disease

Prior 0 5 3786 3791 O
malignancy 6 16 3792 3802 B-cancer

Prothrombin 0 11 3803 3814 B-clinical_variable
time 12 16 3815 3819 I-clinical_variable
( 17 18 3820 3821 I-clinical_variable
PT 18 20 3821 3823 I-clinical_variable
) 20 21 3823 3824 I-clinical_variable
or 22 24 3825 3827 O
international 25 38 3828 3841 B-clinical_variable
normalized 39 49 3842 3852 I-clinical_variable
ratio 50 55 3853 3858 I-clinical_variable
( 56 57 3859 3860 I-clinical_variable
INR 57 60 3860 3863 I-clinical_variable
) 60 61 3863 3864 I-clinical_variable
= 62 63 3865 3866 O
< 63 64 3866 3867 O
1.2 65 68 3868 3871 B-upper_bound
x 69 70 3872 3873 I-upper_bound
upper 71 76 3874 3879 I-upper_bound
limit 77 82 3880 3885 I-upper_bound
of 83 85 3886 3888 I-upper_bound
normal 86 92 3889 3895 I-upper_bound
( 93 94 3896 3897 I-upper_bound
ULN 94 97 3897 3900 I-upper_bound
) 97 98 3900 3901 I-upper_bound

Radiation 0 9 3902 3911 B-treatment
therapy 10 17 3912 3919 I-treatment
, 17 18 3919 3920 O
surgery 19 26 3921 3928 B-treatment
or 27 29 3929 3931 O
tumor 30 35 3932 3937 B-treatment
embolization 36 48 3938 3950 I-treatment

Serum 0 5 3951 3956 B-clinical_variable
creatinine 6 16 3957 3967 I-clinical_variable
= 17 18 3968 3969 O
< 18 19 3969 3970 O
1.5 20 23 3971 3974 B-upper_bound
mg 24 26 3975 3977 I-upper_bound
/ 26 27 3977 3978 I-upper_bound
dL 27 29 3978 3980 I-upper_bound
( 30 31 3981 3982 I-upper_bound
133 31 34 3982 3985 I-upper_bound
umol 35 39 3986 3990 I-upper_bound
/ 39 40 3990 3991 I-upper_bound
L 40 41 3991 3992 I-upper_bound
) 41 42 3992 3993 I-upper_bound

Subjects 0 8 3994 4002 O
not 9 12 4003 4006 O
using 13 18 4007 4012 O
hormone 19 26 4013 4020 B-treatment
replacement 27 38 4021 4032 I-treatment
therapy 39 46 4033 4040 I-treatment
( 47 48 4041 4042 I-treatment
HRT 48 51 4042 4045 I-treatment
) 51 52 4045 4046 I-treatment
must 53 57 4047 4051 O
have 58 62 4052 4056 O
experienced 63 74 4057 4068 O
total 75 80 4069 4074 O
cessation 81 90 4075 4084 O
of 91 93 4085 4087 O
menses 94 100 4088 4094 O

Subjects 0 8 4095 4103 O
using 9 14 4104 4109 O
HRT 15 18 4110 4113 B-treatment
must 19 23 4114 4118 O
have 24 28 4119 4123 O
experienced 29 40 4124 4135 O
total 41 46 4136 4141 O
cessation 47 56 4142 4151 B-chronic_disease
of 57 59 4152 4154 I-chronic_disease
menses 60 66 4155 4161 I-chronic_disease

Symptomatic 0 11 4162 4173 O
peripheral 12 22 4174 4184 B-chronic_disease
vascular 23 31 4185 4193 I-chronic_disease
disease 32 39 4194 4201 I-chronic_disease

Total 0 5 4202 4207 O
bilirubin 6 15 4208 4217 B-clinical_variable
= 16 17 4218 4219 O
< 17 18 4219 4220 O
1.5 19 22 4221 4224 B-upper_bound
x 23 24 4225 4226 I-upper_bound
ULN 25 28 4227 4230 I-upper_bound

Unable 0 6 4231 4237 O
or 7 9 4238 4240 O
unwilling 10 19 4241 4250 O
to 20 22 4251 4253 O
discontinue 23 34 4254 4265 O
use 35 38 4266 4269 O
of 39 41 4270 4272 O
prohibited 42 52 4273 4283 O
medications 53 64 4284 4295 B-treatment

Unstable 0 8 4296 4304 B-chronic_disease
angina 9 15 4305 4311 I-chronic_disease

Urine 0 5 4312 4317 B-clinical_variable
protein 6 13 4318 4325 I-clinical_variable
to 14 16 4326 4328 I-clinical_variable
creatinine 17 27 4329 4339 I-clinical_variable
ratio 28 33 4340 4345 I-clinical_variable
( 34 35 4346 4347 I-clinical_variable
UPC 35 38 4347 4350 I-clinical_variable
) 38 39 4350 4351 I-clinical_variable
< 40 41 4352 4353 O
1 42 43 4354 4355 B-upper_bound

administration 0 14 4356 4370 O
of 15 17 4371 4373 O
any 18 21 4374 4377 O
non 22 25 4378 4381 O
- 25 26 4381 4382 O
oncologic 26 35 4382 4391 O
investigational 36 51 4392 4407 B-treatment
drug 52 56 4408 4412 I-treatment

concomitant 0 11 4413 4424 O
elevations 12 22 4425 4435 O
in 23 25 4436 4438 O
bilirubin 26 35 4439 4448 B-clinical_variable
and 36 39 4449 4452 O
AST 40 43 4453 4456 B-clinical_variable
/ 43 44 4456 4457 O
ALT 44 47 4457 4460 B-clinical_variable
above 48 53 4461 4466 O
1.0 54 57 4467 4470 B-lower_bound
x 58 59 4471 4472 I-lower_bound
ULN 60 63 4473 4476 I-lower_bound
( 64 65 4477 4478 I-lower_bound
upper 65 70 4478 4483 I-lower_bound
limit 71 76 4484 4489 I-lower_bound
of 77 79 4490 4492 I-lower_bound
normal 80 86 4493 4499 I-lower_bound
) 86 87 4499 4500 I-lower_bound
are 88 91 4501 4504 O
not 92 95 4505 4508 O
permitted 96 105 4509 4518 O

for 0 3 4519 4522 O
14 4 6 4523 4525 B-upper_bound
days 7 11 4526 4530 I-upper_bound
before 12 18 4531 4537 I-upper_bound
exposure 19 27 4538 4546 O
to 28 30 4547 4549 O
investigational 31 46 4550 4565 B-treatment
product 47 54 4566 4573 I-treatment
, 54 55 4573 4574 O
through 56 63 4575 4582 O
the 64 67 4583 4586 O
dosing 68 74 4587 4593 O
period 75 81 4594 4600 O

for 0 3 4601 4604 O
14 4 6 4605 4607 B-upper_bound
days 7 11 4608 4612 I-upper_bound
following 12 21 4613 4622 O
the 22 25 4623 4626 O
last 26 30 4627 4631 O
dose 31 35 4632 4636 O
of 36 38 4637 4639 O
study 39 44 4640 4645 O
drug 45 49 4646 4650 O

for 0 3 4651 4654 O
6 4 5 4655 4656 B-upper_bound
months 6 12 4657 4663 I-upper_bound
prior 13 18 4664 4669 I-upper_bound
to 19 21 4670 4672 O
first 22 27 4673 4678 O
dose 28 32 4679 4683 O
of 33 35 4684 4686 O
study 36 41 4687 4692 B-treatment
drug 42 46 4693 4697 I-treatment

for 0 3 4698 4701 O
> 4 5 4702 4703 O
= 5 6 4703 4704 O
1 7 8 4705 4706 B-lower_bound
year 9 13 4707 4711 I-lower_bound
and 14 17 4712 4715 O
be 18 20 4716 4718 O
greater 21 28 4719 4726 O
than 29 33 4727 4731 O
45 34 36 4732 4734 B-lower_bound
years 37 42 4735 4740 I-lower_bound
in 43 45 4741 4743 O
age 46 49 4744 4747 B-age

for 0 3 4748 4751 O
> 4 5 4752 4753 O
= 5 6 4753 4754 O
1 7 8 4755 4756 B-lower_bound
year 9 13 4757 4761 I-lower_bound
and 14 17 4762 4765 O
be 18 20 4766 4768 O
greater 21 28 4769 4776 O
than 29 33 4777 4781 O
45 34 36 4782 4784 B-lower_bound
years 37 42 4785 4790 I-lower_bound
of 43 45 4791 4793 O
age 46 49 4794 4797 B-age

for 0 3 4798 4801 O
at 4 6 4802 4804 O
least 7 12 4805 4810 O
14 13 15 4811 4813 B-lower_bound
days 16 20 4814 4818 I-lower_bound
or 21 23 4819 4821 O
five 24 28 4822 4826 B-lower_bound
half 29 33 4827 4831 I-lower_bound
- 33 34 4831 4832 I-lower_bound
lives 34 39 4832 4837 I-lower_bound
of 40 42 4838 4840 I-lower_bound
a 43 44 4841 4842 I-lower_bound
drug 45 49 4843 4847 I-lower_bound
( 50 51 4848 4849 O
whichever 51 60 4849 4858 O
is 61 63 4859 4861 O
longer 64 70 4862 4868 O
) 70 71 4868 4869 O

for 0 3 4870 4873 O
at 4 6 4874 4876 O
least 7 12 4877 4882 O
21 13 15 4883 4885 B-lower_bound
days 16 20 4886 4890 I-lower_bound
after 21 26 4891 4896 O
the 27 30 4897 4900 O
last 31 35 4901 4905 O
dose 36 40 4906 4910 O
of 41 43 4911 4913 O
investigational 44 59 4914 4929 B-treatment
product 60 67 4930 4937 I-treatment

for 0 3 4938 4941 O
at 4 6 4942 4944 O
least 7 12 4945 4950 O
6 13 14 4951 4952 B-lower_bound
weeks 15 20 4953 4958 I-lower_bound
are 21 24 4959 4962 O
eligible 25 33 4963 4971 O

have 0 4 4972 4976 O
had 5 8 4977 4980 O
documented 9 19 4981 4991 O
evidence 20 28 4992 5000 O
of 29 31 5001 5003 O
menopause 32 41 5004 5013 O
based 42 47 5014 5019 O
on 48 50 5020 5022 O
FSH 51 54 5023 5026 B-treatment
and 55 58 5027 5030 O
estradiol 59 68 5031 5040 B-clinical_variable
concentrations 69 83 5041 5055 I-clinical_variable
prior 84 89 5056 5061 O
to 90 92 5062 5064 O
initiation 93 103 5065 5075 O
of 104 106 5076 5078 O
HRT 107 110 5079 5082 B-treatment

have 0 4 5083 5087 O
had 5 8 5088 5091 O
no 9 11 5092 5094 O
requirement 12 23 5095 5106 O
for 24 27 5107 5110 O
steroids 28 36 5111 5119 B-treatment
or 37 39 5120 5122 O
anti 40 44 5123 5127 B-treatment
- 44 45 5127 5128 I-treatment
seizure 45 52 5128 5135 I-treatment
medication 53 63 5136 5146 I-treatment

must 0 4 5147 5151 O
be 5 7 5152 5154 O
willing 8 15 5155 5162 O
to 16 18 5163 5165 O
comply 19 25 5166 5172 O
with 26 30 5173 5177 O
treatment 31 40 5178 5187 B-treatment
and 41 44 5188 5191 O
follow 45 51 5192 5198 O
- 51 52 5198 5199 O
up 52 54 5199 5201 O

patients 0 8 5202 5210 O
must 9 13 5211 5215 O
have 14 18 5216 5220 O
had 19 22 5221 5224 O
a 23 24 5225 5226 O
prior 25 30 5227 5232 B-treatment
anthracycline 31 44 5233 5246 I-treatment
in 45 47 5247 5249 O
either 48 54 5250 5256 O
the 55 58 5257 5260 O
adjuvant 59 67 5261 5269 O
or 68 70 5270 5272 O
metastatic 71 81 5273 5283 B-cancer
setting 82 89 5284 5291 O
unless 90 96 5292 5298 O
medically 97 106 5299 5308 O
inappropriate 107 120 5309 5322 O
for 121 124 5323 5326 O
the 125 128 5327 5330 O
patient 129 136 5331 5338 O

presence 0 8 5339 5347 O
of 9 11 5348 5350 O
any 12 15 5351 5354 O
non 16 19 5355 5358 B-chronic_disease
- 19 20 5358 5359 I-chronic_disease
healing 20 27 5359 5366 I-chronic_disease
wound 28 33 5367 5372 I-chronic_disease
, 33 34 5372 5373 O
fracture 35 43 5374 5382 B-chronic_disease
, 43 44 5382 5383 O
or 45 47 5384 5386 O
ulcer 48 53 5387 5392 B-chronic_disease
( 54 55 5393 5394 O
procedures 55 65 5394 5404 O
such 66 70 5405 5409 O
as 71 73 5410 5412 O
catheter 74 82 5413 5421 B-treatment
placement 83 92 5422 5431 I-treatment
not 93 96 5432 5435 O
considered 97 107 5436 5446 O
to 108 110 5447 5449 O
be 111 113 5450 5452 O
major 114 119 5453 5458 O

prior 0 5 5459 5464 B-treatment
to 6 8 5465 5467 I-treatment
the 9 12 5468 5471 I-treatment
first 13 18 5472 5477 I-treatment
dose 19 23 5478 5482 I-treatment
of 24 26 5483 5485 I-treatment
study 27 32 5486 5491 I-treatment
drug 33 37 5492 5496 I-treatment
and 38 41 5497 5500 O
for 42 45 5501 5504 O
the 46 49 5505 5508 O
duration 50 58 5509 5517 O
of 59 61 5518 5520 O
the 62 65 5521 5524 O
study 66 71 5525 5530 O

subjects 0 8 5531 5539 O
may 9 12 5540 5543 O
not 13 16 5544 5547 O
have 17 21 5548 5552 O
had 22 25 5553 5556 O
a 26 27 5557 5558 O
transfusion 28 39 5559 5570 B-treatment
within 40 46 5571 5577 O
7 47 48 5578 5579 B-upper_bound
days 49 53 5580 5584 I-upper_bound
of 54 56 5585 5587 O
screening 57 66 5588 5597 O
assessment 67 77 5598 5608 O

subjects 0 8 5609 5617 O
must 9 13 5618 5622 O
have 14 18 5623 5627 O
a 19 20 5628 5629 O
24 21 23 5630 5632 B-clinical_variable
- 23 24 5632 5633 I-clinical_variable
hour 24 28 5633 5637 I-clinical_variable
urine 29 34 5638 5643 I-clinical_variable
protein 35 42 5644 5651 I-clinical_variable
value 43 48 5652 5657 I-clinical_variable
< 49 50 5658 5659 O
1 51 52 5660 5661 B-upper_bound
g 53 54 5662 5663 I-upper_bound
to 55 57 5664 5666 O
be 58 60 5667 5669 O
eligible 61 69 5670 5678 O

subjects 0 8 5679 5687 O
who 9 12 5688 5691 O
have 13 17 5692 5696 O
had 18 21 5697 5700 O
another 22 29 5701 5708 O
malignancy 30 40 5709 5719 B-cancer
and 41 44 5720 5723 O
have 45 49 5724 5728 O
been 50 54 5729 5733 O
disease 55 62 5734 5741 O
- 62 63 5741 5742 O
free 63 67 5742 5746 O

subjects 0 8 5747 5755 O
with 9 13 5756 5760 O
a 14 15 5761 5762 O
history 16 23 5763 5770 O
of 24 26 5771 5773 O
completely 27 37 5774 5784 O
resected 38 46 5785 5793 O
non 47 50 5794 5797 B-cancer
- 50 51 5797 5798 I-cancer
melanomatous 51 63 5798 5810 I-cancer
skin 64 68 5811 5815 I-cancer
carcinoma 69 78 5816 5825 I-cancer
, 78 79 5825 5826 O
successfully 80 92 5827 5839 O
treated 93 100 5840 5847 O
in 101 103 5848 5850 B-cancer
situ 104 108 5851 5855 I-cancer
carcinoma 109 118 5856 5865 I-cancer
, 118 119 5865 5866 O
or 120 122 5867 5869 O
successfully 123 135 5870 5882 O
treated 136 143 5883 5890 O
bladder 144 151 5891 5898 B-cancer
cancer 152 158 5899 5905 I-cancer
are 159 162 5906 5909 O
eligible 163 171 5910 5918 O

subjects 0 8 5919 5927 O
with 9 13 5928 5932 O
recent 14 20 5933 5939 O
DVT 21 24 5940 5943 B-chronic_disease
who 25 28 5944 5947 O
have 29 33 5948 5952 O
been 34 38 5953 5957 O
treated 39 46 5958 5965 O
with 47 51 5966 5970 O
therapeutic 52 63 5971 5982 B-treatment
anti 64 68 5983 5987 I-treatment
- 68 69 5987 5988 I-treatment
coagulating 69 80 5988 5999 I-treatment
agents 81 87 6000 6006 I-treatment

use 0 3 6007 6010 O
of 4 6 6011 6013 O
urine 7 12 6014 6019 B-treatment
dipstick 13 21 6020 6028 I-treatment
for 22 25 6029 6032 O
renal 26 31 6033 6038 O
function 32 40 6039 6047 O
assessment 41 51 6048 6058 O
is 52 54 6059 6061 O
not 55 58 6062 6065 O
acceptable 59 69 6066 6076 O

within 0 6 6077 6083 O
1 7 8 6084 6085 B-upper_bound
year 9 13 6086 6090 I-upper_bound
of 14 16 6091 6093 O
completing 17 27 6094 6104 O
adjuvant 28 36 6105 6113 B-treatment
therapy 37 44 6114 6121 I-treatment

within 0 6 6122 6128 O
14 7 9 6129 6131 B-upper_bound
days 10 14 6132 6136 I-upper_bound
or 15 17 6137 6139 O
five 18 22 6140 6144 O
half 23 27 6145 6149 O
- 27 28 6149 6150 O
lives 28 33 6150 6155 O
of 34 36 6156 6158 O
a 37 38 6159 6160 O
drug 39 43 6161 6165 O
( 44 45 6166 6167 O
whichever 45 54 6167 6176 O
is 55 57 6177 6179 O
longer 58 64 6180 6186 O
) 64 65 6186 6187 O
prior 66 71 6188 6193 O
to 72 74 6194 6196 O
the 75 78 6197 6200 O
first 79 84 6201 6206 O
dose 85 89 6207 6211 O
of 90 92 6212 6214 O
pazopanib 93 102 6215 6224 B-treatment

within 0 6 6225 6231 O
14 7 9 6232 6234 B-upper_bound
days 10 14 6235 6239 I-upper_bound
prior 15 20 6240 6245 I-upper_bound
to 21 23 6246 6248 O
the 24 27 6249 6252 O
first 28 33 6253 6258 O
dose 34 38 6259 6263 O
of 39 41 6264 6266 O
pazopanib 42 51 6267 6276 B-treatment

within 0 6 6277 6283 O
28 7 9 6284 6286 B-upper_bound
days 10 14 6287 6291 I-upper_bound
prior 15 20 6292 6297 I-upper_bound
to 21 23 6298 6300 O
beginning 24 33 6301 6310 O
study 34 39 6311 6316 B-treatment
treatment 40 49 6317 6326 I-treatment

within 0 6 6327 6333 O
28 7 9 6334 6336 B-upper_bound
days 10 14 6337 6341 I-upper_bound
prior 15 20 6342 6347 I-upper_bound
to 21 23 6348 6350 O
first 24 29 6351 6356 O
dose 30 34 6357 6361 O
of 35 37 6362 6364 O
study 38 43 6365 6370 B-treatment
drug 44 48 6371 6375 I-treatment

within 0 6 6376 6382 O
30 7 9 6383 6385 B-upper_bound
days 10 14 6386 6390 I-upper_bound
or 15 17 6391 6393 O
5 18 19 6394 6395 B-upper_bound
half 20 24 6396 6400 I-upper_bound
- 24 25 6400 6401 I-upper_bound
lives 25 30 6401 6406 I-upper_bound
whichever 31 40 6407 6416 O
is 41 43 6417 6419 O
longer 44 50 6420 6426 O
prior 51 56 6427 6432 O
to 57 59 6433 6435 O
receiving 60 69 6436 6445 O
the 70 73 6446 6449 O
first 74 79 6450 6455 O
dose 80 84 6456 6460 O
of 85 87 6461 6463 O
study 88 93 6464 6469 B-treatment
treatment 94 103 6470 6479 I-treatment

within 0 6 6480 6486 O
7 7 8 6487 6488 B-upper_bound
days 9 13 6489 6493 I-upper_bound
prior 14 19 6494 6499 I-upper_bound
to 20 22 6500 6502 O
the 23 26 6503 6506 O
first 27 32 6507 6512 O
dose 33 37 6513 6517 O
of 38 40 6518 6520 O
study 41 46 6521 6526 B-treatment
treatment 47 56 6527 6536 I-treatment

within 0 6 6537 6543 O
the 7 10 6544 6547 O
past 11 15 6548 6552 B-upper_bound
6 16 17 6553 6554 I-upper_bound
months 18 24 6555 6561 I-upper_bound

12 0 2 0 2 O
months 3 9 3 9 O
of 10 12 10 12 O
spontaneous 13 24 13 24 O
amenorrhea 25 35 25 35 B-chronic_disease

6 0 1 36 37 O
months 2 8 38 44 O
of 9 11 45 47 O
spontaneous 12 23 48 59 O
amenorrhea 24 34 60 70 B-chronic_disease
with 35 39 71 75 O
serum 40 45 76 81 B-clinical_variable
FSH 46 49 82 85 I-clinical_variable
levels 50 56 86 92 I-clinical_variable
≥ 57 58 93 94 O
40 59 61 95 97 B-lower_bound
IU 62 64 98 100 I-lower_bound
/ 64 65 100 101 I-lower_bound
ml 65 67 101 103 I-lower_bound

INR 0 3 104 107 B-clinical_variable
> 4 5 108 109 O
1.3 5 8 109 112 B-lower_bound

Personal 0 8 113 121 B-clinical_variable
Health 9 15 122 128 I-clinical_variable
Questionnaire 16 29 129 142 I-clinical_variable
Depression 30 40 143 153 I-clinical_variable
Scale 41 46 154 159 I-clinical_variable
( 47 48 160 161 I-clinical_variable
PHQ-8 48 53 161 166 I-clinical_variable
) 53 54 166 167 I-clinical_variable
> 54 55 167 168 O
15 56 58 169 171 B-lower_bound

aged 0 4 172 176 B-age
40 5 7 177 179 B-lower_bound
to 8 10 180 182 O
65 11 13 183 185 B-upper_bound
years 14 19 186 191 I-upper_bound

all 0 3 192 195 O
other 4 9 196 201 O
anti 10 14 202 206 B-treatment
- 14 15 206 207 I-treatment
platelet 15 23 207 215 I-treatment

anticoagulation 0 15 216 231 B-treatment
medications 16 27 232 243 I-treatment
will 28 32 244 248 O
be 33 35 249 251 O
discontinued 36 48 252 264 O
with 49 53 265 269 O
the 54 57 270 273 O
permission 58 68 274 284 O
of 69 71 285 287 O
the 72 75 288 291 O
participant 76 87 292 303 O
's 87 89 303 305 O
prescribing 90 101 306 317 O
physician 102 111 318 327 O

conditions 0 10 328 338 O
that 11 15 339 343 O
can 16 19 344 347 O
affect 20 26 348 354 O
depressive 27 37 355 365 B-chronic_disease
symptoms 38 46 366 374 I-chronic_disease
( 47 48 375 376 O
e.g. 48 52 376 380 O
, 52 53 380 381 O
current 54 61 382 389 O
diagnosis 62 71 390 399 O
of 72 74 400 402 O
major 75 80 403 408 B-chronic_disease
depression 81 91 409 419 I-chronic_disease
, 91 92 419 420 O
bipolar 93 100 421 428 B-chronic_disease
disorder 101 109 429 437 I-chronic_disease
, 109 110 437 438 O
or 111 113 439 441 O
other 114 119 442 447 B-chronic_disease
Axis 120 124 448 452 I-chronic_disease
I 125 126 453 454 I-chronic_disease
Psychiatric 127 138 455 466 I-chronic_disease
disorder 139 147 467 475 I-chronic_disease
) 147 148 475 476 O

contralateral 0 13 477 490 O
( 14 15 491 492 O
left 15 19 492 496 O
- 19 20 496 497 O
sided 20 25 497 502 O
) 25 26 502 503 O
phrenic 27 34 504 511 B-chronic_disease
nerve 35 40 512 517 I-chronic_disease
paralysis 41 50 518 527 I-chronic_disease

creatinine 0 10 528 538 B-clinical_variable
≥ 11 12 539 540 O
2 13 14 541 542 B-lower_bound
mg 15 17 543 545 I-lower_bound
/ 17 18 545 546 I-lower_bound
ml 18 20 546 548 I-lower_bound

dementia 0 8 549 557 B-chronic_disease
/ 8 9 557 558 O
mild 9 13 558 562 B-chronic_disease
cognitive 14 23 563 572 I-chronic_disease
impairment 24 34 573 583 I-chronic_disease
, 34 35 583 584 O
Mini 36 40 585 589 B-clinical_variable
- 40 41 589 590 I-clinical_variable
Mental 41 47 590 596 I-clinical_variable
State 48 53 597 602 I-clinical_variable
Exam 54 58 603 607 I-clinical_variable
( 59 60 608 609 I-clinical_variable
MMSE 60 64 609 613 I-clinical_variable
) 64 65 613 614 I-clinical_variable
less 66 70 615 619 O
than 71 75 620 624 O
or 76 78 625 627 O
equal 79 84 628 633 O
to 85 87 634 636 O
27 88 90 637 639 B-upper_bound
) 90 91 639 640 O
at 92 94 641 643 O
baseline 95 103 644 652 O

diaphragmatic 0 13 653 666 O
paresis 14 21 667 674 O
; 21 22 674 675 O
history 23 30 676 683 O
of 31 33 684 686 O
seizure 34 41 687 694 B-chronic_disease
, 41 42 694 695 O
coma 43 47 696 700 B-chronic_disease
, 47 48 700 701 O
or 49 51 702 704 O
stroke 52 58 705 711 B-chronic_disease

for 0 3 712 715 O
whom 4 8 716 720 O
hormone 9 16 721 728 B-treatment
therapy 17 24 729 736 I-treatment
is 25 27 737 739 O
contraindicated 28 43 740 755 O

for 0 3 756 759 O
women 4 9 760 765 B-gender
who 10 13 766 769 O
refuse 14 20 770 776 O
any 21 24 777 780 O
oral 25 29 781 785 B-treatment
therap 30 36 786 792 I-treatment

hemoglobin<9.0 0 14 793 807 B-clinical_variable

history 0 7 808 815 O
of 8 10 816 818 O
neurologic 11 21 819 829 B-chronic_disease
deficit 22 29 830 837 O
to 30 32 838 840 O
the 33 36 841 844 O
brachial 37 45 845 853 O
plexus 46 52 854 860 O

inability 0 9 861 870 O
to 10 12 871 873 O
tolerate 13 21 874 882 O
small 22 27 883 888 O
, 27 28 888 889 O
enclosed 29 37 890 898 O
spaces 38 44 899 905 O
without 45 52 906 913 O
anxiety 53 60 914 921 B-chronic_disease
( 61 62 922 923 O
e.g. 62 66 923 927 O
claustrophobia 67 81 928 942 B-chronic_disease
) 81 82 942 943 O

including 0 9 944 953 O
oral 10 14 954 958 O
( 15 16 959 960 O
2 16 17 960 961 O
months 18 24 962 968 O
) 24 25 968 969 O
or 26 28 970 972 O
transdermal 29 40 973 984 B-treatment
hormone 41 48 985 992 I-treatment
therapy(1 49 58 993 1002 I-treatment
month 59 64 1003 1008 O
) 64 65 1008 1009 O
, 65 66 1009 1010 O
botanicals 67 77 1011 1021 O

most 0 4 1022 1026 O
but 5 8 1027 1030 O
not 9 12 1031 1034 O
all 13 16 1035 1038 O
spinal 17 23 1039 1045 B-treatment
cord 24 28 1046 1050 I-treatment
stimulators 29 40 1051 1062 I-treatment
or 41 43 1063 1065 O
deep 44 48 1066 1070 B-treatment
brain 49 54 1071 1076 I-treatment
stimulator 55 65 1077 1087 I-treatment
, 65 66 1087 1088 O
ferrous 67 74 1089 1096 O
- 74 75 1096 1097 O
containing 75 85 1097 1107 O
metals 86 92 1108 1114 O
within 93 99 1115 1121 O
the 100 103 1122 1125 O
body 104 108 1126 1130 O
( 109 110 1131 1132 O
e.g. 110 114 1132 1136 O
, 114 115 1136 1137 O
braces 116 122 1138 1144 O
, 122 123 1144 1145 O
aneurysm 124 132 1146 1154 O
clips 133 138 1155 1160 O
, 138 139 1160 1161 O
shrapnel 140 148 1162 1170 O
/ 148 149 1170 1171 O
retained 149 157 1171 1179 O
particles 158 167 1180 1189 O
) 167 168 1189 1190 O

oral 0 4 1191 1195 O
contraceptives(2 5 21 1196 1212 O
months 22 28 1213 1219 I-upper_bound
) 28 29 1219 1220 O

platelets 0 9 1221 1230 B-clinical_variable
< 10 11 1231 1232 O
100,000 11 18 1232 1239 B-upper_bound
, 18 19 1239 1240 O
BUN 20 23 1241 1244 B-clinical_variable
≥ 24 25 1245 1246 O
30mg 26 30 1247 1251 B-lower_bound
/ 30 31 1251 1252 I-lower_bound
dl 31 33 1252 1254 I-lower_bound

post 0 4 1255 1259 O
- 4 5 1259 1260 O
menopausal 5 15 1260 1270 O
women 16 21 1271 1276 B-gender
whose 22 27 1277 1282 O
vasomotor 28 37 1283 1292 O
symptoms 38 46 1293 1301 O
are 47 50 1302 1305 O
refractory 51 61 1306 1316 O
to 62 64 1317 1319 O
approved 65 73 1320 1328 O
oral 74 78 1329 1333 B-treatment
treatments 79 89 1334 1344 I-treatment
( 90 91 1345 1346 O
i.e. 91 95 1346 1350 O
, 95 96 1350 1351 O
hormone 97 104 1352 1359 B-treatment
therapy 105 112 1360 1367 I-treatment
or 113 115 1368 1370 O
paroxetine 116 126 1371 1381 B-treatment
) 126 127 1381 1382 O

pregabalin 0 10 1383 1393 B-treatment
, 10 11 1393 1394 O
clonidine 12 21 1395 1404 B-treatment
, 21 22 1404 1405 O
selective 23 32 1406 1415 O
estrogen 33 41 1416 1424 O
receptor 42 50 1425 1433 O
modulators 51 61 1434 1444 O
, 61 62 1444 1445 O
aromatase 63 72 1446 1455 B-treatment
inhibitors 73 83 1456 1466 I-treatment
, 83 84 1466 1467 O
tissue 85 91 1468 1474 O
selective 92 101 1475 1484 O
estrogen 102 110 1485 1493 O
complexes 111 120 1494 1503 O

safety 0 6 1504 1510 O
labs 7 11 1511 1515 O
within 12 18 1516 1522 O
30 19 21 1523 1525 B-upper_bound
days 22 26 1526 1530 I-upper_bound
of 27 29 1531 1533 O
SGB 30 33 1534 1537 B-treatment
intervention 34 46 1538 1550 O

serotonin 0 9 1551 1560 B-treatment
norepinephrine 10 24 1561 1575 I-treatment
reuptake 25 33 1576 1584 I-treatment
inhibitors 34 44 1585 1595 I-treatment
( 45 46 1596 1597 I-treatment
SNRI 46 50 1597 1601 I-treatment
) 50 51 1601 1602 I-treatment

serotonin 0 9 1603 1612 B-treatment
selective 10 19 1613 1622 I-treatment
reuptake 20 28 1623 1631 I-treatment
inhibitors 29 39 1632 1642 I-treatment
( 40 41 1643 1644 I-treatment
SSRI 41 45 1644 1648 I-treatment
) 45 46 1648 1649 I-treatment
( 47 48 1650 1651 O
2 48 49 1651 1652 O
weeks 50 55 1653 1658 O
) 55 56 1658 1659 O

serum 0 5 1660 1665 B-clinical_variable
potassium 6 15 1666 1675 I-clinical_variable
( 16 17 1676 1677 I-clinical_variable
K+ 17 19 1677 1679 I-clinical_variable
) 19 20 1679 1680 I-clinical_variable
≤ 21 22 1681 1682 O
3.5 23 26 1683 1686 B-upper_bound
or 27 29 1687 1689 O
≥ 30 31 1690 1691 O
5.0 32 35 1692 1695 B-lower_bound
mEq 36 39 1696 1699 I-lower_bound
/ 39 40 1699 1700 I-lower_bound
L 40 41 1700 1701 I-lower_bound
allergic 42 50 1702 1710 O
reactions 51 60 1711 1720 O
or 61 63 1721 1723 O
contraindications 64 81 1724 1741 O
to 82 84 1742 1744 O
a 85 86 1745 1746 O
local 87 92 1747 1752 B-allergy_name
anesthetic 93 103 1753 1763 I-allergy_name
or 104 106 1764 1766 O
contrast 107 115 1767 1775 B-allergy_name
dye 116 119 1776 1779 I-allergy_name

sham 0 4 1780 1784 B-treatment
treatment 5 14 1785 1794 I-treatment

stroke 0 6 1795 1801 B-chronic_disease

systolic 0 8 1802 1810 B-clinical_variable
blood 9 14 1811 1816 I-clinical_variable
pressure 15 23 1817 1825 I-clinical_variable
( 24 25 1826 1827 I-clinical_variable
SBP 25 28 1827 1830 I-clinical_variable
) 28 29 1830 1831 I-clinical_variable
> 30 31 1832 1833 O
140 31 34 1833 1836 B-lower_bound
mm 35 37 1837 1839 I-lower_bound
Hg 38 40 1840 1842 I-lower_bound
or 41 43 1843 1845 O
diastolic 44 53 1846 1855 B-clinical_variable
blood 54 59 1856 1861 I-clinical_variable
pressure 60 68 1862 1870 I-clinical_variable
( 69 70 1871 1872 I-clinical_variable
DBP 70 73 1872 1875 I-clinical_variable
) 73 74 1875 1876 I-clinical_variable
> 75 76 1877 1878 O
90 76 78 1878 1880 B-lower_bound
mm 79 81 1881 1883 I-lower_bound
Hg 82 84 1884 1886 I-lower_bound

traumatic 0 9 1887 1896 B-chronic_disease
brain 10 15 1897 1902 I-chronic_disease
injury 16 22 1903 1909 I-chronic_disease

weight 0 6 1910 1916 B-clinical_variable
> 7 8 1917 1918 O
300 9 12 1919 1922 B-lower_bound
lbs 13 16 1923 1926 I-lower_bound
. 16 17 1926 1927 O
unless 18 24 1928 1934 O
height 25 31 1935 1941 O
is 32 34 1942 1944 O
sufficiently 35 47 1945 1957 O
high 48 52 1958 1962 O
[ 53 54 1963 1964 O
e.g. 54 58 1964 1968 O
, 58 59 1968 1969 O
+ 60 61 1970 1971 O
5'11 62 66 1972 1976 O
] 66 67 1976 1977 O
so 68 70 1978 1980 O
that 71 75 1981 1985 O
waist 76 81 1986 1991 O
and 82 85 1992 1995 O
shoulder 86 94 1996 2004 O
circumference 95 108 2005 2018 O
do 109 111 2019 2021 O
not 112 115 2022 2025 O
prevent 116 123 2026 2033 O
her 124 127 2034 2037 O
from 128 132 2038 2042 O
fitting 133 140 2043 2050 O
in 141 143 2051 2053 O
the 144 147 2054 2057 O
scanner 148 155 2058 2065 O

willingness 0 11 2066 2077 O
to 12 14 2078 2080 O
undergo 15 22 2081 2088 O
fluoroscopy 23 34 2089 2100 B-treatment
- 34 35 2100 2101 O
guided 35 41 2101 2107 O
SGB 42 45 2108 2111 O

A 0 1 0 1 O
reasonable 2 12 2 12 O
attempt 13 20 13 20 O
should 21 27 21 27 O
be 28 30 28 30 O
made 31 35 31 35 O
to 36 38 36 38 O
make 39 43 39 43 O
a 44 45 44 45 O
pathologic 46 56 46 56 O
diagnosis 57 66 57 66 O
of 67 69 67 69 O
malignancy 70 80 70 80 B-cancer

Acquired 0 8 81 89 B-chronic_disease
Immune 9 15 90 96 I-chronic_disease
Deficiency 16 26 97 107 I-chronic_disease
Syndrome 27 35 108 116 I-chronic_disease
( 36 37 117 118 I-chronic_disease
AIDS 37 41 118 122 I-chronic_disease
) 41 42 122 123 I-chronic_disease
based 43 48 124 129 O
on 49 51 130 132 O
CDC 52 55 133 136 O
criteria 56 64 137 145 O

Additional 0 10 146 156 O
labs 11 15 157 161 O
within 16 22 162 168 O
14 23 25 169 171 B-upper_bound
days 26 30 172 176 I-upper_bound
prior 31 36 177 182 I-upper_bound
to 37 39 183 185 O
registration 40 52 186 198 O

Age 0 3 199 202 B-age
> 4 5 203 204 O
/= 5 7 204 206 O
18 8 10 207 209 B-lower_bound
years 11 16 210 215 I-lower_bound

CBC 0 3 216 219 B-clinical_variable
/ 3 4 219 220 O
differential 4 16 220 232 O
obtained 17 25 233 241 O
within 26 32 242 248 O
14 33 35 249 251 B-upper_bound
days 36 40 252 256 I-upper_bound
prior 41 46 257 262 I-upper_bound
to 47 49 263 265 O
registration 50 62 266 278 O
with 63 67 279 283 O
adequate 68 76 284 292 O
bone 77 81 293 297 O
marrow 82 88 298 304 O
function 89 97 305 313 O

CT 0 2 314 316 O
scan 3 7 317 321 O
of 8 10 322 324 O
the 11 14 325 328 O
chest 15 20 329 334 O
, 20 21 334 335 O
abdomen 22 29 336 343 O
and 30 33 344 347 O
pelvis 34 40 348 354 O
with 41 45 355 359 O
IV 46 48 360 362 O
and 49 52 363 366 O
oral 53 57 367 371 O
contrast 58 66 372 380 O
within 67 73 381 387 O
8 74 75 388 389 B-upper_bound
weeks 76 81 390 395 I-upper_bound
of 82 84 396 398 O
registration 85 97 399 411 O

ECOG 0 4 412 416 B-clinical_variable
performance 5 16 417 428 I-clinical_variable
status 17 23 429 435 I-clinical_variable
0 24 25 436 437 B-lower_bound
- 25 26 437 438 O
1 26 27 438 439 B-upper_bound

HIV 0 3 440 443 B-chronic_disease
testing 4 11 444 451 O
is 12 14 452 454 O
not 15 18 455 458 O
manditory 19 28 459 468 O
for 29 32 469 472 O
this 33 37 473 477 O
protocol 38 46 478 486 O

Hepatic 0 7 487 494 B-chronic_disease
insufficiency 8 21 495 508 I-chronic_disease
resulting 22 31 509 518 O
in 32 34 519 521 O
clinical 35 43 522 530 O
jaundice 44 52 531 539 B-chronic_disease
and/or 53 59 540 546 O
coagulation 60 71 547 558 B-chronic_disease
defects 72 79 559 566 I-chronic_disease

Metastatic 0 10 567 577 B-cancer
disease 11 18 578 585 I-cancer
as 19 21 586 588 O
defined 22 29 589 596 O
by 30 32 597 599 O
the 33 36 600 603 O
multi 37 42 604 609 O
- 42 43 609 610 O
disciplinary 43 55 610 622 O
team 56 60 623 627 O

Negative 0 8 628 636 B-pregnancy
serum 9 14 637 642 I-pregnancy
pregnancy 15 24 643 652 I-pregnancy
test 25 29 653 657 O
within 30 36 658 664 O
2 37 38 665 666 B-upper_bound
weeks 39 44 667 672 I-upper_bound
prior 45 50 673 678 I-upper_bound
to 51 53 679 681 O
registration 54 66 682 694 O
for 67 70 695 698 O
women 71 76 699 704 B-gender
of 77 79 705 707 O
childbearing 80 92 708 720 O
potential 93 102 721 730 O

Pathologic 0 10 731 741 O
or 11 13 742 744 O
clinical 14 22 745 753 O
diagnosis 23 32 754 763 O
of 33 35 764 766 O
a 36 37 767 768 O
new 38 41 769 772 O
pancreatic 42 52 773 783 B-cancer
adenocarcinoma 53 67 784 798 I-cancer

Pregnant 0 8 799 807 B-pregnancy
women 9 14 808 813 B-gender
or 15 17 814 816 O
lactating 18 27 817 826 O
women 28 33 827 832 O

Prior 0 5 833 838 B-treatment
anti 6 10 839 843 I-treatment
- 10 11 843 844 I-treatment
cancer 11 17 844 850 I-treatment
therapy 18 25 851 858 I-treatment
for 26 29 859 862 O
a 30 31 863 864 O
pancreatic 32 42 865 875 B-cancer
tumor 43 48 876 881 I-cancer

Prior 0 5 882 887 O
malignancy 6 16 888 898 B-cancer
within 17 23 899 905 O
the 24 27 906 909 O
last 28 32 910 914 B-upper_bound
3 33 34 915 916 I-upper_bound
years 35 40 917 922 I-upper_bound

Whole 0 5 923 928 B-treatment
body 6 10 929 933 I-treatment
PET 11 14 934 937 I-treatment
scan 15 19 938 942 I-treatment
within 20 26 943 949 O
8 27 28 950 951 B-upper_bound
weeks 29 34 952 957 I-upper_bound
of 35 37 958 960 O
registration 38 50 961 973 O

AGE 0 3 0 3 B-age
: 3 4 3 4 O
≤ 5 6 5 6 O
30 7 9 7 9 B-upper_bound
years 10 15 10 15 I-upper_bound
of 16 18 16 18 O
age 19 22 19 22 B-age

Age 0 3 23 26 B-age
- 3 4 26 27 O
adjusted 4 12 27 35 O
normal 13 19 36 42 O
serum 20 25 43 48 B-clinical_variable
creatinine 26 36 49 59 I-clinical_variable

At 0 2 60 62 O
least 3 8 63 68 O
2 9 10 69 70 B-lower_bound
months 11 17 71 77 I-lower_bound
post 18 22 78 82 O
- 22 23 82 83 O
autologous 23 33 83 93 O
stem 34 38 94 98 B-treatment
cell 39 43 99 103 I-treatment
transplant 44 54 104 114 I-treatment
or 55 57 115 117 O
at 58 60 118 120 O
least 61 66 121 126 O
3 67 68 127 128 B-lower_bound
months 69 75 129 135 I-lower_bound
post 76 80 136 140 O
- 80 81 140 141 O
allogeneic 81 91 141 151 B-treatment
transplant 92 102 152 162 I-treatment

Biologic 0 8 163 171 B-treatment
( 9 10 172 173 I-treatment
anti 10 14 173 177 I-treatment
- 14 15 177 178 I-treatment
cancer 15 21 178 184 I-treatment
agent 22 27 185 190 I-treatment
) 27 28 190 191 I-treatment

Clinically 0 10 192 202 O
significant 11 22 203 214 O
unrelated 23 32 215 224 O
systemic 33 41 225 233 B-chronic_disease
illness 42 49 234 241 I-chronic_disease

Curative 0 8 242 250 O
therapy 9 16 251 258 B-treatment
may 17 20 259 262 O
include 21 28 263 270 O
surgery 29 36 271 278 B-treatment
, 36 37 278 279 O
radiation 38 47 280 289 B-treatment
therapy 48 55 290 297 I-treatment
, 55 56 297 298 O
chemotherapy 57 69 299 311 B-treatment
, 69 70 311 312 O
or 71 73 313 315 O
any 74 77 316 319 O
combination 78 89 320 331 O
of 90 92 332 334 O
these 93 98 335 340 O
modalities 99 109 341 351 O

Defined 0 7 352 359 O
as 8 10 360 362 O
no 11 13 363 365 O
dyspnea 14 21 366 373 B-chronic_disease
at 22 24 374 376 O
rest 25 29 377 381 O

Histologically 0 14 382 396 O
confirmed 15 24 397 406 O
malignant 25 34 407 416 O
solid 35 40 417 422 B-cancer
tumors 41 47 423 429 I-cancer
, 47 48 429 430 O
which 49 54 431 436 O
may 55 58 437 440 O
include 59 66 441 448 O
but 67 70 449 452 O
are 71 74 453 456 O
not 75 78 457 460 O
limited 79 86 461 468 O
to 87 89 469 471 O
rhabdomyosarcoma 90 106 472 488 B-cancer
and 107 110 489 492 O
other 111 116 493 498 O
soft 117 121 499 503 B-cancer
tissue 122 128 504 510 I-cancer
sarcomas 129 137 511 519 I-cancer
, 137 138 519 520 O
Ewing 139 144 521 526 B-cancer
's 144 146 526 528 I-cancer
sarcoma 147 154 529 536 I-cancer
family 155 161 537 543 O
of 162 164 544 546 O
tumors 165 171 547 553 O
, 171 172 553 554 O
osteosarcoma 173 185 555 567 B-cancer
, 185 186 567 568 O
neuroblastoma 187 200 569 582 B-cancer
, 200 201 582 583 O
Wilms 202 207 584 589 B-cancer
' 207 208 589 590 I-cancer
tumor 209 214 591 596 I-cancer
, 214 215 596 597 O
hepatic 216 223 598 605 B-cancer
tumors 224 230 606 612 I-cancer
, 230 231 612 613 O
germ 232 236 614 618 B-cancer
cell 237 241 619 623 I-cancer
tumors 242 248 624 630 I-cancer
, 248 249 630 631 O
and 250 253 632 635 O
desmoid 254 261 636 643 B-cancer
tumors 262 268 644 650 I-cancer

Immunotherapy 0 13 651 664 B-treatment

Implant 0 7 665 672 B-treatment
or 8 10 673 675 O
prosthesis 11 21 676 686 B-treatment
or 22 24 687 689 O
scar 25 29 690 694 O
tissue 30 36 695 701 O
within 37 43 702 708 O
the 44 47 709 712 O
path 48 52 713 717 O
of 53 55 718 720 O
the 56 59 721 724 O
HIFU 60 64 725 729 B-treatment
beam 65 69 730 734 I-treatment

Inability 0 9 735 744 O
to 10 12 745 747 O
tolerate 13 21 748 756 O
stationary 22 32 757 767 O
position 33 41 768 776 O
during 42 48 777 783 O
HIFU 49 53 784 788 B-treatment

Inability 0 9 789 798 O
to 10 12 799 801 O
undergo 13 20 802 809 O
MRI 21 24 810 813 B-treatment
and/or 25 31 814 820 O
contraindication 32 48 821 837 O
for 49 52 838 841 O
MRI 53 56 842 845 O

Lesion 0 6 846 852 B-cancer
in 7 9 853 855 I-cancer
the 10 13 856 859 I-cancer
skull 14 19 860 865 I-cancer

Myelosuppressive 0 16 866 882 B-treatment
chemotherapy 17 29 883 895 I-treatment

No 0 2 896 898 O
limitation 3 13 899 909 O
on 14 16 910 912 O
the 17 20 913 916 O
number 21 27 917 923 O
of 28 30 924 926 O
prior 31 36 927 932 B-treatment
chemotherapy 37 49 933 945 I-treatment
regimens 50 58 946 954 I-treatment
that 59 63 955 959 O
the 64 67 960 963 O
patient 68 75 964 971 O
may 76 79 972 975 O
have 80 84 976 980 O
received 85 93 981 989 O
prior 94 99 990 995 O
to 100 102 996 998 O
study 103 108 999 1004 O
entry 109 114 1005 1010 O

No 0 2 1011 1013 O
other 3 8 1014 1019 O
anti 9 13 1020 1024 B-treatment
- 13 14 1024 1025 I-treatment
cancer 14 20 1025 1031 I-treatment
therapy 21 28 1032 1039 I-treatment
( 29 30 1040 1041 O
chemotherapy 30 42 1041 1053 B-treatment
, 42 43 1053 1054 O
biological 44 54 1055 1065 B-treatment
therapy 55 62 1066 1073 I-treatment
, 62 63 1073 1074 O
radiation 64 73 1075 1084 B-treatment
therapy 74 81 1085 1092 I-treatment
) 81 82 1092 1093 O
is 83 85 1094 1096 O
permitted 86 95 1097 1106 O
during 96 102 1107 1113 O
HIFU 103 107 1114 1118 B-treatment
treatment 108 117 1119 1128 I-treatment
and 118 121 1129 1132 O
post 122 126 1133 1137 O
treatment 127 136 1138 1147 O
follow 137 143 1148 1154 O
up 144 146 1155 1157 O
for 147 150 1158 1161 O
tolerability 151 163 1162 1174 O

Normal 0 6 1175 1181 B-clinical_variable
PT 7 9 1182 1184 I-clinical_variable
, 9 10 1184 1185 O
PTT 11 14 1186 1189 B-clinical_variable
and 15 18 1190 1193 O
INR 19 22 1194 1197 B-clinical_variable
< 23 24 1198 1199 O
1.5 25 28 1200 1203 B-upper_bound
x 29 30 1204 1205 I-upper_bound
ULN 31 34 1206 1209 I-upper_bound

Patients 0 8 1210 1218 O
> 9 10 1219 1220 O
10 11 13 1221 1223 B-lower_bound
years 14 19 1224 1229 I-lower_bound
old 20 23 1230 1233 O

Patients 0 8 1234 1242 O
currently 9 18 1243 1252 O
receiving 19 28 1253 1262 O
other 29 34 1263 1268 O
anticancer 35 45 1269 1279 B-treatment
agents 46 52 1280 1286 I-treatment

Patients 0 8 1287 1295 O
currently 9 18 1296 1305 O
receiving 19 28 1306 1315 O
other 29 34 1316 1321 O
investigational 35 50 1322 1337 B-treatment
agents 51 57 1338 1344 I-treatment

Patients 0 8 1345 1353 O
must 9 13 1354 1358 O
have 14 18 1359 1363 O
fully 19 24 1364 1369 O
recovered 25 34 1370 1379 O
from 35 39 1380 1384 O
the 40 43 1385 1388 O
acute 44 49 1389 1394 O
toxic 50 55 1395 1400 O
effects 56 63 1401 1408 O
of 64 66 1409 1411 O
all 67 70 1412 1415 O
prior 71 76 1416 1421 B-treatment
chemotherapy 77 89 1422 1434 I-treatment
, 89 90 1434 1435 O
immunotherapy 91 104 1436 1449 B-treatment
, 104 105 1449 1450 O
or 106 108 1451 1453 O
radiotherapy 109 121 1454 1466 B-treatment
prior 122 127 1467 1472 O
to 128 130 1473 1475 O
entering 131 139 1476 1484 O
on 140 142 1485 1487 O
this 143 147 1488 1492 O
study 148 153 1493 1498 O

Patients 0 8 1499 1507 O
who 9 12 1508 1511 O
are 13 16 1512 1515 O
unable 17 23 1516 1522 O
to 24 26 1523 1525 O
walk 27 31 1526 1530 O
because 32 39 1531 1538 O
of 40 42 1539 1541 O
paralysis 43 52 1542 1551 B-chronic_disease
or 53 55 1552 1554 O
motor 56 61 1555 1560 O
weakness 62 70 1561 1569 O
, 70 71 1569 1570 O
but 72 75 1571 1574 O
who 76 79 1575 1578 O
are 80 83 1579 1582 O
up 84 86 1583 1585 O
in 87 89 1586 1588 O
a 90 91 1589 1590 O
wheelchair 92 102 1591 1601 O
will 103 107 1602 1606 O
be 108 110 1607 1609 O
considered 111 121 1610 1620 O
ambulatory 122 132 1621 1631 O
for 133 136 1632 1635 O
the 137 140 1636 1639 O
purpose 141 148 1640 1647 O
of 149 151 1648 1650 O
calculating 152 163 1651 1662 O
the 164 167 1663 1666 O
performance 168 179 1667 1678 O
score 180 185 1679 1684 O

Peripheral 0 10 1685 1695 O
absolute 11 19 1696 1704 B-clinical_variable
neutrophil 20 30 1705 1715 I-clinical_variable
count 31 36 1716 1721 I-clinical_variable
( 37 38 1722 1723 I-clinical_variable
ANC 38 41 1723 1726 I-clinical_variable
) 41 42 1726 1727 I-clinical_variable
of 43 45 1728 1730 O
≥750/µL 46 53 1731 1738 O

Platelet 0 8 1739 1747 B-clinical_variable
count 9 14 1748 1753 I-clinical_variable
≥75,000/µL 15 25 1754 1764 O

Radiation 0 9 1765 1774 B-treatment
therapy 10 17 1775 1782 I-treatment

Radiographically 0 16 1783 1799 O
evaluable 17 26 1800 1809 O
or 27 29 1810 1812 O
measurable 30 40 1813 1823 O
solid 41 46 1824 1829 B-cancer
tumor 47 52 1830 1835 I-cancer
target 53 59 1836 1842 O
lesion(s 60 68 1843 1851 O
) 68 69 1851 1852 O

Stem 0 4 1853 1857 B-treatment
Cell 5 9 1858 1862 I-treatment
Transplantation 10 25 1863 1878 I-treatment

Target 0 6 1879 1885 O
< 7 8 1886 1887 O
1 8 9 1887 1888 B-upper_bound
cm 10 12 1889 1891 I-upper_bound
from 13 17 1892 1896 O
nerve 18 23 1897 1902 B-clinical_variable
plexus 24 30 1903 1909 I-clinical_variable

Target 0 6 1910 1916 B-cancer
lesions 7 14 1917 1924 I-cancer
that 15 19 1925 1929 O
are 20 23 1930 1933 O
pulmonary 24 33 1934 1943 B-cancer
primary 34 41 1944 1951 I-cancer
tumors 42 48 1952 1958 I-cancer
or 49 51 1959 1961 O
metastases 52 62 1962 1972 B-cancer

The 0 3 1973 1976 O
last 4 8 1977 1981 O
dose 9 13 1982 1986 O
of 14 16 1987 1989 O
all 17 20 1990 1993 O
biologic 21 29 1994 2002 B-treatment
agents 30 36 2003 2009 I-treatment
for 37 40 2010 2013 O
the 41 44 2014 2017 O
treatment 45 54 2018 2027 B-treatment
of 55 57 2028 2030 O
the 58 61 2031 2034 O
patient 62 69 2035 2042 O
's 69 71 2042 2044 O
cancer 72 78 2045 2051 B-cancer
( 79 80 2052 2053 O
such 80 84 2053 2057 O
as 85 87 2058 2060 O
retinoids 88 97 2061 2070 B-cancer
or 98 100 2071 2073 O
tyrosine 101 109 2074 2082 B-treatment
kinase 110 116 2083 2089 I-treatment
inhibitors 117 127 2090 2100 I-treatment
) 127 128 2100 2101 O

The 0 3 2102 2105 O
last 4 8 2106 2110 O
dose 9 13 2111 2115 O
of 14 16 2116 2118 O
all 17 20 2119 2122 O
myelosuppressive 21 37 2123 2139 B-treatment
anticancer 38 48 2140 2150 I-treatment
drugs 49 54 2151 2156 I-treatment

The 0 3 2157 2160 O
last 4 8 2161 2165 O
dose 9 13 2166 2170 O
of 14 16 2171 2173 O
all 17 20 2174 2177 O
other 21 26 2178 2183 O
local 27 32 2184 2189 B-treatment
palliative 33 43 2190 2200 I-treatment
( 44 45 2201 2202 I-treatment
limited 45 52 2202 2209 I-treatment
port 53 57 2210 2214 I-treatment
) 57 58 2214 2215 I-treatment
radiation 59 68 2216 2225 I-treatment

The 0 3 2226 2229 O
last 4 8 2230 2234 O
dose 9 13 2235 2239 O
of 14 16 2240 2242 O
colony 17 23 2243 2249 B-treatment
stimulating 24 35 2250 2261 I-treatment
factors 36 43 2262 2269 I-treatment

The 0 3 2270 2273 O
last 4 8 2274 2278 O
dose 9 13 2279 2283 O
of 14 16 2284 2286 O
immunotherapy 17 30 2287 2300 B-treatment
( 31 32 2301 2302 O
monoclonal 32 42 2302 2312 B-treatment
antibody 43 51 2313 2321 I-treatment
or 52 54 2322 2324 O
vaccine 55 62 2325 2332 B-treatment
) 62 63 2332 2333 O

The 0 3 2334 2337 O
last 4 8 2338 2342 O
dose 9 13 2343 2347 O
of 14 16 2348 2350 O
radiation 17 26 2351 2360 B-treatment
to 27 29 2361 2363 O
more 30 34 2364 2368 O
than 35 39 2369 2373 O
25 40 42 2374 2376 B-lower_bound
% 43 44 2377 2378 I-lower_bound
of 45 47 2379 2381 O
marrow 48 54 2382 2388 O
containing 55 65 2389 2399 O
bones 66 71 2400 2405 O
( 72 73 2406 2407 O
pelvis 73 79 2407 2413 O
, 79 80 2413 2414 O
spine 81 86 2415 2420 O
, 86 87 2420 2421 O
skull 88 93 2422 2427 O
) 93 94 2427 2428 O

The 0 3 2429 2432 O
patient 4 11 2433 2440 O
's 11 13 2440 2442 O
cancer 14 20 2443 2449 B-cancer
must 21 25 2450 2454 O
have 26 30 2455 2459 O
relapsed 31 39 2460 2468 O
after 40 45 2469 2474 O
or 46 48 2475 2477 O
failed 49 55 2478 2484 O
to 56 58 2485 2487 O
respond 59 66 2488 2495 O
to 67 69 2496 2498 O
frontline 70 79 2499 2508 O
curative 80 88 2509 2517 O
therapy 89 96 2518 2525 B-treatment
and 97 100 2526 2529 O
there 101 106 2530 2535 O
must 107 111 2536 2540 O
not 112 115 2541 2544 O
be 116 118 2545 2547 O
other 119 124 2548 2553 O
potentially 125 136 2554 2565 O
curative 137 145 2566 2574 O
treatment 146 155 2575 2584 B-treatment
options 156 163 2585 2592 O
available 164 173 2593 2602 O

a 0 1 2603 2604 O
creatinine 2 12 2605 2615 B-clinical_variable
clearance 13 22 2616 2625 I-clinical_variable
≥60 23 26 2626 2629 O
mL 27 29 2630 2632 I-lower_bound
/ 29 30 2632 2633 I-lower_bound
min/1.73 30 38 2633 2641 I-lower_bound
m2 39 41 2642 2644 I-lower_bound

children 0 8 2645 2653 O
≤ 9 10 2654 2655 O
10 11 13 2656 2658 B-upper_bound
years 14 19 2659 2664 I-upper_bound
old 20 23 2665 2668 O

filgrastim 0 10 2669 2679 B-treatment
, 10 11 2679 2680 O
sargramostim 12 24 2681 2693 B-treatment
, 24 25 2693 2694 O
and 26 29 2695 2698 O
erythropoietin 30 44 2699 2713 B-treatment

may 0 3 2714 2717 O
receive 4 11 2718 2725 O
transfusions 12 24 2726 2738 B-treatment

must 0 4 2739 2743 O
be 5 7 2744 2746 O
at 8 10 2747 2749 O
least 11 16 2750 2755 O
1 17 18 2756 2757 B-lower_bound
week 19 23 2758 2762 I-lower_bound
prior 24 29 2763 2768 I-lower_bound
to 30 32 2769 2771 O
study 33 38 2772 2777 O
entry 39 44 2778 2783 O

must 0 4 2784 2788 O
be 5 7 2789 2791 O
at 8 10 2792 2794 O
least 11 16 2795 2800 O
2 17 18 2801 2802 B-lower_bound
weeks 19 24 2803 2808 I-lower_bound
prior 25 30 2809 2814 I-lower_bound
to 31 33 2815 2817 O
study 34 39 2818 2823 O
entry 40 45 2824 2829 O

must 0 4 2830 2834 O
be 5 7 2835 2837 O
at 8 10 2838 2840 O
least 11 16 2841 2846 O
3 17 18 2847 2848 B-lower_bound
weeks 19 24 2849 2854 I-lower_bound
prior 25 30 2855 2860 I-lower_bound
to 31 33 2861 2863 O
study 34 39 2864 2869 O
entry 40 45 2870 2875 O

must 0 4 2876 2880 O
be 5 7 2881 2883 O
at 8 10 2884 2886 O
least 11 16 2887 2892 O
4 17 18 2893 2894 B-lower_bound
weeks 19 24 2895 2900 I-lower_bound
prior 25 30 2901 2906 I-lower_bound
to 31 33 2907 2909 O
study 34 39 2910 2915 O
entry 40 45 2916 2921 O

must 0 4 2922 2926 O
have 5 9 2927 2931 O
a 10 11 2932 2933 O
Karnofsky 12 21 2934 2943 B-clinical_variable
performance 22 33 2944 2955 I-clinical_variable
level 34 39 2956 2961 I-clinical_variable
≥ 40 41 2962 2963 O
50 42 44 2964 2966 B-lower_bound
% 44 45 2966 2967 I-lower_bound

must 0 4 2968 2972 O
have 5 9 2973 2977 O
a 10 11 2978 2979 O
Lansky 12 18 2980 2986 B-clinical_variable
performance 19 30 2987 2998 I-clinical_variable
level 31 36 2999 3004 I-clinical_variable
≥ 37 38 3005 3006 O
50 39 41 3007 3009 B-lower_bound
% 41 42 3009 3010 I-lower_bound

pegfilgrastim 0 13 3011 3024 B-treatment

serious 0 7 3025 3032 B-chronic_disease
infections 8 18 3033 3043 I-chronic_disease
, 18 19 3043 3044 O
hepatic 20 27 3045 3052 B-chronic_disease
, 27 28 3052 3053 O
renal 29 34 3054 3059 B-chronic_disease
or 35 37 3060 3062 O
other 38 43 3063 3068 O
organ 44 49 3069 3074 B-chronic_disease
dysfunction 50 61 3075 3086 I-chronic_disease
, 61 62 3086 3087 O
which 63 68 3088 3093 O
in 69 71 3094 3096 O
the 72 75 3097 3100 O
judgment 76 84 3101 3109 O
of 85 87 3110 3112 O
the 88 91 3113 3116 O
Principal 92 101 3117 3126 O
or 102 104 3127 3129 O
Associate 105 114 3130 3139 O
Investigator 115 127 3140 3152 O
would 128 133 3153 3158 O
compromise 134 144 3159 3169 O
the 145 148 3170 3173 O
patient 149 156 3174 3181 O
's 156 158 3181 3183 O
ability 159 166 3184 3191 O
to 167 169 3192 3194 O
tolerate 170 178 3195 3203 O
the 179 182 3204 3207 O
general 183 190 3208 3215 O
anesthetic 191 201 3216 3226 O
required 202 210 3227 3235 O
for 211 214 3236 3239 O
the 215 218 3240 3243 O
procedure 219 228 3244 3253 O

Active 0 6 0 6 O
malignancy 7 17 7 17 B-cancer

Body 0 4 18 22 B-bmi
mass 5 9 23 27 I-bmi
index 10 15 28 33 I-bmi
( 16 17 34 35 I-bmi
BMI 17 20 35 38 I-bmi
) 20 21 38 39 I-bmi
> 22 23 40 41 O
45 23 25 41 43 B-lower_bound
kg 26 28 44 46 I-lower_bound
/ 28 29 46 47 I-lower_bound
m2 29 31 47 49 I-lower_bound

Compensated 0 11 50 61 O
liver 12 17 62 67 B-chronic_disease
disease 18 25 68 75 I-chronic_disease

Contra 0 6 76 82 O
- 6 7 82 83 O
indication 7 17 83 93 O
to 18 20 94 96 O
liver 21 26 97 102 B-treatment
biopsy 27 33 103 109 I-treatment

Diabetic 0 8 110 118 B-chronic_disease
ketoacidosis 9 21 119 131 I-chronic_disease

Evidence 0 8 132 140 O
of 9 11 141 143 O
another 12 19 144 151 O
form 20 24 152 156 O
of 25 27 157 159 O
liver 28 33 160 165 B-chronic_disease
disease 34 41 166 173 I-chronic_disease

HB 0 2 174 176 B-clinical_variable
antigen 3 10 177 184 I-clinical_variable
> 11 12 185 186 O
0 12 13 186 187 B-lower_bound
, 13 14 187 188 O
HCV 15 18 189 192 B-clinical_variable
Polymerase 19 29 193 203 I-clinical_variable
chain 30 35 204 209 I-clinical_variable
reaction 36 44 210 218 I-clinical_variable
( 45 46 219 220 I-clinical_variable
PCR 46 49 220 223 I-clinical_variable
) 49 50 223 224 I-clinical_variable
tests 51 56 225 230 I-clinical_variable
> 57 58 231 232 O
0 58 59 232 233 O
( 60 61 234 235 O
patients 61 69 235 243 O
with 70 74 244 248 O
a 75 76 249 250 O
history 77 84 251 258 O
of 85 87 259 261 O
HCV 88 91 262 265 B-chronic_disease
infection 92 101 266 275 I-chronic_disease
can 102 105 276 279 O
be 106 108 280 282 O
included 109 117 283 291 O
if 118 120 292 294 O
HCV 121 124 295 298 O
PCR 125 128 299 302 O
is 129 131 303 305 O
negative 132 140 306 314 O
since 141 146 315 320 O
more 147 151 321 325 O
than 152 156 326 330 O
3 157 158 331 332 B-lower_bound
years 159 164 333 338 I-lower_bound
) 164 165 338 339 O
, 165 166 339 340 O
HIV 167 170 341 344 B-chronic_disease
infection 171 180 345 354 I-chronic_disease

Have 0 4 355 359 O
a 5 6 360 361 O
known 7 12 362 367 O
hypersensitivity 13 29 368 384 O
to 30 32 385 387 O
any 33 36 388 391 O
of 37 39 392 394 O
the 40 43 395 398 O
ingredients 44 55 399 410 O
or 56 58 411 413 O
excipients 59 69 414 424 O
of 70 72 425 427 O
the 73 76 428 431 O
Investigational 77 92 432 447 B-allergy_name
medicinal 93 102 448 457 I-allergy_name
product 103 110 458 465 I-allergy_name
( 111 112 466 467 I-allergy_name
IMP 112 115 467 470 I-allergy_name
) 115 116 470 471 I-allergy_name

Have 0 4 472 476 O
a 5 6 477 478 O
stable 7 13 479 485 O
weight 14 20 486 492 B-clinical_variable
since 21 26 493 498 O
the 27 30 499 502 O
liver 31 36 503 508 B-treatment
biopsy 37 43 509 515 I-treatment
was 44 47 516 519 O
performed 48 57 520 529 O
defined 58 65 530 537 O
by 66 68 538 540 O
no 69 71 541 543 O
more 72 76 544 548 O
than 77 81 549 553 O
a 82 83 554 555 O
5 84 85 556 557 B-lower_bound
% 86 87 558 559 I-lower_bound
loss 88 92 560 564 O
of 93 95 565 567 O
initial 96 103 568 575 O
body 104 108 576 580 B-clinical_variable
weight 109 115 581 587 I-clinical_variable

Hemostasis 0 10 588 598 B-chronic_disease
disorders 11 20 599 608 I-chronic_disease
or 21 23 609 611 O
current 24 31 612 619 O
treatment 32 41 620 629 O
with 42 46 630 634 O
anticoagulants 47 61 635 649 B-treatment

History 0 7 650 657 O
of 8 10 658 660 O
gastrointestinal 11 27 661 677 B-treatment
malabsorptive 28 41 678 691 I-treatment
bariatric 42 51 692 701 I-treatment
surgery 52 59 702 709 I-treatment
within 60 66 710 716 O
less 67 71 717 721 O
than 72 76 722 726 O
5 77 78 727 728 B-upper_bound
years 79 84 729 734 I-upper_bound
or 85 87 735 737 O
ingestion 88 97 738 747 O
of 98 100 748 750 O
drugs 101 106 751 756 O
known 107 112 757 762 O
to 113 115 763 765 O
produce 116 123 766 773 O
hepatic 124 131 774 781 O
steatosis 132 141 782 791 O
including 142 151 792 801 O
corticosteroids 152 167 802 817 B-treatment
, 167 168 817 818 O
high 169 173 819 823 B-treatment
- 173 174 823 824 I-treatment
dose 174 178 824 828 I-treatment
estrogens 179 188 829 838 I-treatment
, 188 189 838 839 O
methotrexate 190 202 840 852 B-treatment
, 202 203 852 853 O
tetracycline 204 216 854 866 B-treatment
or 217 219 867 869 O
amiodarone 220 230 870 880 B-treatment
in 231 233 881 883 O
the 234 237 884 887 O
previous 238 246 888 896 B-upper_bound
6 247 248 897 898 I-upper_bound
months 249 255 899 905 I-upper_bound

History 0 7 906 913 O
of 8 10 914 916 O
, 10 11 916 917 O
or 12 14 918 920 O
current 15 22 921 928 O
cardiac 23 30 929 936 B-chronic_disease
dysrhythmias 31 43 937 949 I-chronic_disease
and/or 44 50 950 956 O
a 51 52 957 958 O
history 53 60 959 966 O
of 61 63 967 969 O
cardiovascular 64 78 970 984 B-chronic_disease
disease 79 86 985 992 I-chronic_disease
event 87 92 993 998 O
, 92 93 998 999 O
including 94 103 1000 1009 O
myocardial 104 114 1010 1020 B-chronic_disease
infarction 115 125 1021 1031 I-chronic_disease
, 125 126 1031 1032 O
except 127 133 1033 1039 O
patients 134 142 1040 1048 O
with 143 147 1049 1053 O
only 148 152 1054 1058 O
well 153 157 1059 1063 O
controlled 158 168 1064 1074 O
hypertension 169 181 1075 1087 O

NASH 0 4 1088 1092 B-chronic_disease
histological 5 17 1093 1105 O
diagnosis 18 27 1106 1115 O
according 28 37 1116 1125 O
to 38 40 1126 1128 O
the 41 44 1129 1132 O
currently 45 54 1133 1142 O
accepted 55 63 1143 1151 O
definition 64 74 1152 1162 O
of 75 77 1163 1165 O
both 78 82 1166 1170 O
EASL 83 87 1171 1175 O
and 88 91 1176 1179 O
AASLD 92 97 1180 1185 B-chronic_disease
, 97 98 1185 1186 O
requiring 99 108 1187 1196 O
the 109 112 1197 1200 O
combined 113 121 1201 1209 O
presence 122 130 1210 1218 O
of 131 133 1219 1221 O
steatosis 134 143 1222 1231 O
( 144 145 1232 1233 O
any 145 148 1233 1236 O
degree 149 155 1237 1243 B-clinical_variable
≥ 156 157 1244 1245 O
5 158 159 1246 1247 B-lower_bound
% 159 160 1247 1248 I-lower_bound
) 160 161 1248 1249 O
+ 162 163 1250 1251 O
lobular 164 171 1252 1259 O
inflammation 172 184 1260 1272 O
of 185 187 1273 1275 O
any 188 191 1276 1279 O
degree 192 198 1280 1286 O
+ 199 200 1287 1288 O
liver 201 206 1289 1294 O
cell 207 211 1295 1299 O
ballooning 212 222 1300 1310 O
of 223 225 1311 1313 O
any 226 229 1314 1317 O
amount 230 236 1318 1324 O
, 236 237 1324 1325 O
on 238 240 1326 1328 O
a 241 242 1329 1330 O
liver 243 248 1331 1336 B-treatment
biopsy 249 255 1337 1343 I-treatment
performed 256 265 1344 1353 O
≤ 266 267 1354 1355 O
6 268 269 1356 1357 B-upper_bound
months 270 276 1358 1364 I-upper_bound
before 277 283 1365 1371 O
screening 284 293 1372 1381 O
in 294 296 1382 1384 O
the 297 300 1385 1388 O
study 301 306 1389 1394 O
or 307 309 1395 1397 O
at 310 312 1398 1400 O
screening 313 322 1401 1410 O
and 323 326 1411 1414 O
confirmed 327 336 1415 1424 O
by 337 339 1425 1427 O
central 340 347 1428 1435 O
reading 348 355 1436 1443 O
during 356 362 1444 1450 O
the 363 366 1451 1454 O
screening 367 376 1455 1464 O
period 377 383 1465 1471 O

No 0 2 1472 1474 O
other 3 8 1475 1480 O
causes 9 15 1481 1487 O
of 16 18 1488 1490 O
chronic 19 26 1491 1498 B-chronic_disease
liver 27 32 1499 1504 I-chronic_disease
disease 33 40 1505 1512 I-chronic_disease
( 41 42 1513 1514 O
autoimmune 42 52 1514 1524 B-chronic_disease
, 52 53 1524 1525 O
primary 54 61 1526 1533 B-chronic_disease
biliary 62 69 1534 1541 I-chronic_disease
cholangitis 70 81 1542 1553 I-chronic_disease
, 81 82 1553 1554 O
Hepatitis 83 92 1555 1564 B-chronic_disease
B 93 94 1565 1566 I-chronic_disease
virus 95 100 1567 1572 I-chronic_disease
( 101 102 1573 1574 I-chronic_disease
HBV 102 105 1574 1577 I-chronic_disease
) 105 106 1577 1578 I-chronic_disease
, 106 107 1578 1579 O
hepatitis 108 117 1580 1589 B-chronic_disease
C 118 119 1590 1591 I-chronic_disease
virus 120 125 1592 1597 I-chronic_disease
( 126 127 1598 1599 I-chronic_disease
HCV 127 130 1599 1602 I-chronic_disease
) 130 131 1602 1603 I-chronic_disease
, 131 132 1603 1604 O
Wilson 133 139 1605 1611 B-chronic_disease
's 139 141 1611 1613 I-chronic_disease
, 141 142 1613 1614 O
α-1 143 146 1615 1618 B-chronic_disease
- 146 147 1618 1619 I-chronic_disease
antitrypsin 147 158 1619 1630 I-chronic_disease
deficiency 159 169 1631 1641 I-chronic_disease
, 169 170 1641 1642 O
hemochromatosis 171 186 1643 1658 B-chronic_disease
, 186 187 1658 1659 O
etc 188 191 1660 1663 O
… 191 192 1663 1664 O
) 192 193 1664 1665 O

Osteopenia 0 10 1666 1676 O
or 11 13 1677 1679 O
any 14 17 1680 1683 O
other 18 23 1684 1689 O
well 24 28 1690 1694 O
documented 29 39 1695 1705 O
Bone 40 44 1706 1710 B-chronic_disease
disease 45 52 1711 1718 I-chronic_disease

Participation 0 13 1719 1732 O
in 14 16 1733 1735 O
any 17 20 1736 1739 O
other 21 26 1740 1745 O
clinical 27 35 1746 1754 O
study 36 41 1755 1760 O
within 42 48 1761 1767 O
the 49 52 1768 1771 O
previous 53 61 1772 1780 O
3 62 63 1781 1782 B-upper_bound
months 64 70 1783 1789 I-upper_bound

Pregnancy 0 9 1790 1799 B-pregnancy

SAF 0 3 1800 1803 B-clinical_variable
Activity 4 12 1804 1812 I-clinical_variable
score 13 18 1813 1818 I-clinical_variable
of 19 21 1819 1821 O
3 22 23 1822 1823 B-lower_bound
or 24 26 1824 1826 O
4 27 28 1827 1828 B-upper_bound
( 29 30 1829 1830 O
> 30 31 1830 1831 O
2 31 32 1831 1832 B-lower_bound
) 32 33 1832 1833 O

SAF 0 3 1834 1837 B-clinical_variable
Fibrosis 4 12 1838 1846 I-clinical_variable
score 13 18 1847 1852 I-clinical_variable
< 19 20 1853 1854 O
4 21 22 1855 1856 B-upper_bound

SAF 0 3 1857 1860 B-clinical_variable
Steatosis 4 13 1861 1870 I-clinical_variable
score 14 19 1871 1876 I-clinical_variable
≥ 20 21 1877 1878 O
1 22 23 1879 1880 B-lower_bound

Subject 0 7 1881 1888 O
agrees 8 14 1889 1895 O
to 15 17 1896 1898 O
have 18 22 1899 1903 O
a 23 24 1904 1905 O
liver 25 30 1906 1911 B-treatment
biopsy 31 37 1912 1918 I-treatment
performed 38 47 1919 1928 O
after 48 53 1929 1934 O
24 54 56 1935 1937 B-lower_bound
weeks 57 62 1938 1943 I-lower_bound
of 63 65 1944 1946 O
treatment 66 75 1947 1956 O

Type 0 4 1957 1961 B-chronic_disease
1 5 6 1962 1963 I-chronic_disease
diabetes 7 15 1964 1972 I-chronic_disease
and 16 19 1973 1976 I-chronic_disease
type 20 24 1977 1981 I-chronic_disease
2 25 26 1982 1983 I-chronic_disease
diabetic 27 35 1984 1992 O
patient 36 43 1993 2000 O
on 44 46 2001 2003 O
insulin 47 54 2004 2011 B-treatment

Unstable 0 8 2012 2020 O
metabolic 9 18 2021 2030 B-chronic_disease
condition 19 28 2031 2040 I-chronic_disease

Weight 0 6 2041 2047 O
change 7 13 2048 2054 O
> 14 15 2055 2056 O
5 16 17 2057 2058 B-lower_bound
kg 17 19 2058 2060 I-lower_bound
in 20 22 2061 2063 O
the 23 26 2064 2067 O
last 27 31 2068 2072 B-upper_bound
three 32 37 2073 2078 I-upper_bound
months 38 44 2079 2085 I-upper_bound
, 44 45 2085 2086 O
diabetes 46 54 2087 2095 B-chronic_disease
with 55 59 2096 2100 O
poor 60 64 2101 2105 O
glycemic 65 73 2106 2114 O
control 74 81 2115 2122 O
( 82 83 2123 2124 O
HbA1c 83 88 2124 2129 B-clinical_variable
> 89 90 2130 2131 O
8.5 91 94 2132 2135 B-lower_bound
% 94 95 2135 2136 I-lower_bound
) 95 96 2136 2137 O
, 96 97 2137 2138 O
introduction 98 110 2139 2151 O
of 111 113 2152 2154 O
an 114 116 2155 2157 O
antidiabetic 117 129 2158 2170 B-chronic_disease
or 130 132 2171 2173 O
of 133 135 2174 2176 O
an 136 138 2177 2179 O
anti 139 143 2180 2184 B-treatment
- 143 144 2184 2185 I-treatment
obesity 144 151 2185 2192 I-treatment
drug 152 156 2193 2197 I-treatment
/ 156 157 2197 2198 O
malabsorptive 157 170 2198 2211 B-chronic_disease
or 171 173 2212 2214 O
restrictive 174 185 2215 2226 B-treatment
bariatric 186 195 2227 2236 I-treatment
( 196 197 2237 2238 O
weight 197 203 2238 2244 O
loss 204 208 2245 2249 O
) 208 209 2249 2250 O
surgery 210 217 2251 2258 B-treatment
in 218 220 2259 2261 O
the 221 224 2262 2265 O
past 225 229 2266 2270 O
6 230 231 2271 2272 B-upper_bound
months 232 238 2273 2279 I-upper_bound
prior 239 244 2280 2285 I-upper_bound
to 245 247 2286 2288 O
screening 248 257 2289 2298 O

age 0 3 2299 2302 B-age
≥18 4 7 2303 2306 O
years 8 13 2307 2312 I-lower_bound

cutaneous 0 9 2313 2322 B-cancer
basocellular 10 22 2323 2335 I-cancer
carcinoma 23 32 2336 2345 I-cancer

have 0 4 2346 2350 O
a 5 6 2351 2352 O
stable 7 13 2353 2359 O
type 14 18 2360 2364 B-chronic_disease
2 19 20 2365 2366 I-chronic_disease
diabetes 21 29 2367 2375 I-chronic_disease
, 29 30 2375 2376 O
defined 31 38 2377 2384 O
as 39 41 2385 2387 O
HbA1c 42 47 2388 2393 B-clinical_variable
< 48 49 2394 2395 O
8.5 50 53 2396 2399 B-upper_bound
% 53 54 2399 2400 I-upper_bound
and 55 58 2401 2404 O
fasting 59 66 2405 2412 B-clinical_variable
glycemia 67 75 2413 2421 I-clinical_variable
< 76 77 2422 2423 O
10 77 79 2423 2425 B-upper_bound
mmol 80 84 2426 2430 I-upper_bound
/ 84 85 2430 2431 I-upper_bound
L 85 86 2431 2432 I-upper_bound
, 86 87 2432 2433 O
no 88 90 2434 2436 O
changes 91 98 2437 2444 O
in 99 101 2445 2447 O
medication 102 112 2448 2458 O
in 113 115 2459 2461 O
the 116 119 2462 2465 O
previous 120 128 2466 2474 B-upper_bound
6 129 130 2475 2476 I-upper_bound
months 131 137 2477 2483 I-upper_bound
, 137 138 2483 2484 O
and 139 142 2485 2488 O
no 143 145 2489 2491 O
new 146 149 2492 2495 O
symptoms 150 158 2496 2504 O
associated 159 169 2505 2515 O
with 170 174 2516 2520 O
decompensated 175 188 2521 2534 O
diabetes 189 197 2535 2543 O
in 198 200 2544 2546 O
the 201 204 2547 2550 O
previous 205 213 2551 2559 B-upper_bound
3 214 215 2560 2561 I-upper_bound
months 216 222 2562 2568 I-upper_bound

inability 0 9 2569 2578 O
to 10 12 2579 2581 O
adhere 13 19 2582 2588 O
to 20 22 2589 2591 O
adequate 23 31 2592 2600 B-contraception_consent
contraception 32 45 2601 2614 I-contraception_consent
in 46 48 2615 2617 O
women 49 54 2618 2623 B-gender
of 55 57 2624 2626 O
child 58 63 2627 2632 O
- 63 64 2632 2633 O
bearing 64 71 2633 2640 O
potential 72 81 2641 2650 O

18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
75 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

Current 0 7 19 26 O
diagnosis 8 17 27 36 O
of 18 20 37 39 O
Cushing 21 28 40 47 B-chronic_disease
's 28 30 47 49 I-chronic_disease
syndrome 31 39 50 58 I-chronic_disease

History 0 7 59 66 O
of 8 10 67 69 O
schizophrenia 11 24 70 83 B-chronic_disease
or 25 27 84 86 O
bipolar 28 35 87 94 B-chronic_disease
disorder 36 44 95 103 I-chronic_disease

Known 0 5 104 109 O
intracranial 6 18 110 122 B-cancer
mass 19 23 123 127 I-cancer
or 24 26 128 130 O
cerebral 27 35 131 139 B-chronic_disease
aneurysm 36 44 140 148 I-chronic_disease
or 45 47 149 151 O
raised 48 54 152 158 O
intraocular 55 66 159 170 O
pressure 67 75 171 179 O

Planned 0 7 180 187 O
elective 8 16 188 196 O
VATS 17 21 197 201 B-treatment
pulmonary 22 31 202 211 I-treatment
lobectomy 32 41 212 221 I-treatment

Pregnancy 0 9 222 231 B-pregnancy

Severe 0 6 232 238 B-chronic_disease
renal 7 12 239 244 I-chronic_disease
impairment 13 23 245 255 I-chronic_disease
( 24 25 256 257 O
creatinine 25 35 257 267 B-clinical_variable
clearance 36 45 268 277 I-clinical_variable
based 46 51 278 283 I-clinical_variable
GFR 52 55 284 287 I-clinical_variable
of 56 58 288 290 O
< 59 60 291 292 O
30ml 60 64 292 296 B-upper_bound
/ 64 65 296 297 I-upper_bound
min 65 68 297 300 I-upper_bound
) 68 69 300 301 O

Steroid 0 7 302 309 B-treatment
treatment 8 17 310 319 I-treatment
> 18 19 320 321 O
10mg 20 24 322 326 B-lower_bound
/ 24 25 326 327 I-lower_bound
day 25 28 327 330 I-lower_bound
of 29 31 331 333 O
Prednisolone 32 44 334 346 B-treatment
or 45 47 347 349 O
its 48 51 350 353 O
equivalent 52 62 354 364 O
for 63 66 365 368 O
> 67 68 369 370 O
3 69 70 371 372 B-lower_bound
weeks 71 76 373 378 I-lower_bound
within 77 83 379 385 O
the 84 87 386 389 O
last 88 92 390 394 B-upper_bound
3 93 94 395 396 I-upper_bound
months 95 101 397 403 I-upper_bound

Histologically 0 14 0 14 O
confirmed 15 24 15 24 O
solid 25 30 25 30 B-cancer
tumor 31 36 31 36 I-cancer
or 37 39 37 39 O
hematologic 40 51 40 51 B-cancer
malignancy 52 62 52 62 I-cancer

Negative 0 8 63 71 B-pregnancy
pregnancy 9 18 72 81 I-pregnancy
test 19 23 82 86 O

Not 0 3 87 90 B-pregnancy
pregnant 4 12 91 99 I-pregnancy
or 13 15 100 102 O
nursing 16 23 103 110 O

Be 0 2 0 2 O
21 3 5 3 5 B-lower_bound
years 6 11 6 11 I-lower_bound
of 12 14 12 14 O
age 15 18 15 18 B-age
or 19 21 19 21 O
older 22 27 22 27 O

Be 0 2 28 30 O
able 3 7 31 35 O
to 8 10 36 38 O
read 11 15 39 43 B-language_fluency
English 16 23 44 51 I-language_fluency

For 0 3 52 55 O
caregivers 4 14 56 66 O
, 14 15 66 67 O
be 16 18 68 70 O
currently 19 28 71 80 O
undergoing 29 39 81 91 O
active 40 46 92 98 O
treatment 47 56 99 108 O
for 57 60 109 112 O
cancer 61 67 113 119 B-cancer

Have 0 4 120 124 O
had 5 8 125 128 O
a 9 10 129 130 O
diagnosis 11 20 131 140 O
of 21 23 141 143 O
cancer 24 30 144 150 B-cancer

cancer 0 6 151 157 B-cancer
survivors 7 16 158 167 O

continued 0 9 168 177 O
adjuvant 10 18 178 186 B-treatment
treatment 19 28 187 196 I-treatment

have 0 4 197 201 O
completed 5 14 202 211 O
primary 15 22 212 219 B-treatment
surgery 23 30 220 227 I-treatment
, 30 31 227 228 O
chemotherapy 32 44 229 241 B-treatment
, 44 45 241 242 O
and/or 46 52 243 249 O
radiation 53 62 250 259 B-treatment

squamous 0 8 260 268 B-cancer
and 9 12 269 272 O
basal 13 18 273 278 B-cancer
cell 19 23 279 283 I-cancer
[ 24 25 284 285 I-cancer
skin 25 29 285 289 I-cancer
cancers 30 37 290 297 I-cancer
] 37 38 297 298 I-cancer

transgender 0 11 299 310 B-gender

Current 0 7 0 7 O
suicide 8 15 8 15 B-chronic_disease
risk 16 20 16 20 O

History 0 7 21 28 O
of 8 10 29 31 O
head 11 15 32 36 B-chronic_disease
injury 16 22 37 43 I-chronic_disease
, 22 23 43 44 O
epilepsy 24 32 45 53 B-chronic_disease
or 33 35 54 56 O
seizure 36 43 57 64 B-chronic_disease
disorder 44 52 65 73 I-chronic_disease
, 52 53 73 74 O
non 54 57 75 78 B-treatment
- 57 58 78 79 I-treatment
removable 58 67 79 88 I-treatment
metallic 68 76 89 97 I-treatment
implants 77 85 98 106 I-treatment
or 86 88 107 109 O
objects 89 96 110 117 O
in 97 99 118 120 O
or 100 102 121 123 O
around 103 109 124 130 O
the 110 113 131 134 O
head 114 118 135 139 O

It 0 2 140 142 O
is 3 5 143 145 O
the 6 9 146 149 O
judgment 10 18 150 158 O
of 19 21 159 161 O
the 22 25 162 165 O
investigator 26 38 166 178 O
that 39 43 179 183 O
the 44 47 184 187 O
patient 48 55 188 195 O
may 56 59 196 199 O
be 60 62 200 202 O
at 63 65 203 205 O
risk 66 70 206 210 O
for 71 74 211 214 O
suicide 75 82 215 222 B-chronic_disease

Presence 0 8 223 231 O
of 9 11 232 234 O
an 12 14 235 237 O
Axis 15 19 238 242 B-chronic_disease
II 20 22 243 245 I-chronic_disease
disorder 23 31 246 254 I-chronic_disease
felt 32 36 255 259 O
by 37 39 260 262 O
the 40 43 263 266 O
investigator 44 56 267 279 O
to 57 59 280 282 O
potentially 60 71 283 294 O
interfere 72 81 295 304 O
with 82 86 305 309 O
study 87 92 310 315 O
compliance 93 103 316 326 O

Should 0 6 327 333 O
not 7 10 334 337 O
have 11 15 338 342 O
a 16 17 343 344 O
lifetime 18 26 345 353 O
history 27 34 354 361 O
of 35 37 362 364 O
lack 38 42 365 369 O
of 43 45 370 372 O
response 46 54 373 381 O
to 55 57 382 384 O
ECT 58 61 385 388 B-treatment
or 62 64 389 391 O
VNS 65 68 392 395 B-treatment

The 0 3 396 399 O
duration 4 12 400 408 O
of 13 15 409 411 O
the 16 19 412 415 O
current 20 27 416 423 O
depressive 28 38 424 434 B-chronic_disease
episode 39 46 435 442 I-chronic_disease
must 47 51 443 447 O
be 52 54 448 450 O
at 55 57 451 453 O
least 58 63 454 459 O
4 64 65 460 461 B-lower_bound
weeks 66 71 462 467 I-lower_bound
and 72 75 468 471 O
no 76 78 472 474 O
longer 79 85 475 481 O
than 86 90 482 486 O
3 91 92 487 488 B-upper_bound
years 93 98 489 494 I-upper_bound
in 99 101 495 497 O
length 102 108 498 504 O

The 0 3 505 508 O
mood 4 8 509 513 B-treatment
stabilizer 9 19 514 524 I-treatment
must 20 24 525 529 O
be 25 27 530 532 O
at 28 30 533 535 O
a 31 32 536 537 O
stable 33 39 538 544 O
dose 40 44 545 549 O
for 45 48 550 553 O
at 49 51 554 556 O
least 52 57 557 562 O
four 58 62 563 567 B-lower_bound
days 63 67 568 572 I-lower_bound
before 68 74 573 579 I-lower_bound
starting 75 83 580 588 O
TMS 84 87 589 592 B-treatment
treatment 88 97 593 602 I-treatment

The 0 3 603 606 O
patient 4 11 607 614 O
has 12 15 615 618 O
attempted 16 25 619 628 B-chronic_disease
suicide 26 33 629 636 I-chronic_disease
within 34 40 637 643 O
the 41 44 644 647 O
past 45 49 648 652 B-upper_bound
12 50 52 653 655 I-upper_bound
months 53 59 656 662 I-upper_bound
prior 60 65 663 668 I-upper_bound
to 66 68 669 671 O
Screening 69 78 672 681 O

Women 0 5 682 687 B-gender
of 6 8 688 690 O
child 9 14 691 696 O
- 14 15 696 697 O
bearing 15 22 697 704 O
potential 23 32 705 714 O
who 33 36 715 718 O
are 37 40 719 722 O
not 41 44 723 726 O
using 45 50 727 732 O
a 51 52 733 734 O
medically 53 62 735 744 O
accepted 63 71 745 753 O
means 72 77 754 759 O
of 78 80 760 762 O
contraception 81 94 763 776 O
when 95 99 777 781 O
engaging 100 108 782 790 O
in 109 111 791 793 O
sexual 112 118 794 800 O
intercourse 119 130 801 812 O

at 0 2 813 815 O
least 3 8 816 821 O
18 9 11 822 824 B-lower_bound
years 12 17 825 830 I-lower_bound
old 18 21 831 834 O

female 0 6 835 841 B-gender
of 7 9 842 844 O
childbearing 10 22 845 857 O
potential 23 32 858 867 O

have 0 4 868 872 O
a 5 6 873 874 O
MADRS 7 12 875 880 B-clinical_variable
score 13 18 881 886 I-clinical_variable
of 19 21 887 889 O
at 22 24 890 892 O
least 25 30 893 898 O
20 31 33 899 901 B-lower_bound
at 34 36 902 904 O
screening 37 46 905 914 O

have 0 4 915 919 O
a 5 6 920 921 O
negative 7 15 922 930 B-pregnancy
urine 16 21 931 936 I-pregnancy
pregnancy 22 31 937 946 I-pregnancy
test 32 36 947 951 O
at 37 39 952 954 O
screening 40 49 955 964 O

have 0 4 965 969 O
no 5 7 970 972 O
previous 8 16 973 981 O
history 17 24 982 989 O
of 25 27 990 992 O
psychosis 28 37 993 1002 B-chronic_disease
or 38 40 1003 1005 O
substance 41 50 1006 1015 O
dependence 51 61 1016 1026 O
or 62 64 1027 1029 O
abuse 65 70 1030 1035 O
within 71 77 1036 1042 O
the 78 81 1043 1046 O
six 82 85 1047 1050 B-upper_bound
months 86 92 1051 1057 I-upper_bound
prior 93 98 1058 1063 I-upper_bound
to 99 101 1064 1066 O
Screening 102 111 1067 1076 O

meet 0 4 1077 1081 O
DSM-5 5 10 1082 1087 O
criteria 11 19 1088 1096 O
for 20 23 1097 1100 O
bipolar 24 31 1101 1108 B-chronic_disease
( 32 33 1109 1110 O
either 33 39 1110 1116 O
I 40 41 1117 1118 O
or 42 44 1119 1121 O
II 45 47 1122 1124 O
) 47 48 1124 1125 O
depression 49 59 1126 1136 B-chronic_disease
by 60 62 1137 1139 O
clinical 63 71 1140 1148 O
interview 72 81 1149 1158 O
and 82 85 1159 1162 O
M.I.N.I 86 93 1163 1170 O

planning 0 8 1171 1179 B-pregnancy
a 9 10 1180 1181 I-pregnancy
pregnancy 11 20 1182 1191 I-pregnancy

women 0 5 1192 1197 B-gender
who 6 9 1198 1201 O
are 10 13 1202 1205 O
pregnant 14 22 1206 1214 B-pregnancy

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
70 6 8 6 8 B-upper_bound
years 9 14 9 14 I-lower_bound
OR 15 17 15 17 O
KPS 18 21 18 21 B-clinical_variable
≤ 22 23 22 23 O
70 24 26 24 26 O

Any 0 3 27 30 O
nodal 4 9 31 36 B-clinical_variable
or 10 12 37 39 I-clinical_variable
extranodal 13 23 40 50 I-clinical_variable
tumor 24 29 51 56 I-clinical_variable
mass 30 34 57 61 I-clinical_variable
≥7 35 37 62 64 O
cm 37 39 64 66 I-lower_bound
in 40 42 67 69 O
greatest 43 51 70 78 O
dimension 52 61 79 88 O

Contraindication 0 16 89 105 O
to 17 19 106 108 O
use 20 23 109 112 O
of 24 26 113 115 O
rituximab 27 36 116 125 B-treatment
or 37 39 126 128 O
prednisone 40 50 129 139 B-treatment

Cytopenias 0 10 140 150 B-chronic_disease
( 11 12 151 152 O
leukocytes 12 22 152 162 B-clinical_variable
< 23 24 163 164 O
1 24 25 164 165 B-upper_bound
× 26 27 166 167 I-upper_bound
109 28 31 168 171 I-upper_bound
/ 31 32 171 172 I-upper_bound
L 32 33 172 173 I-upper_bound
and/or 34 40 174 180 O
platelets 41 50 181 190 B-clinical_variable
, 51 52 191 192 O
100 52 55 192 195 B-upper_bound
× 56 57 196 197 I-upper_bound
109 58 61 198 201 I-upper_bound
/ 61 62 201 202 I-upper_bound
L 62 63 202 203 I-upper_bound
) 63 64 203 204 O

Enrollment 0 10 205 215 O
in 11 13 216 218 O
a 14 15 219 220 O
Phase 16 21 221 226 B-treatment
I 22 23 227 228 I-treatment
trial 24 29 229 234 I-treatment

Evidence 0 8 235 243 O
of 9 11 244 246 O
active 12 18 247 253 O
hepatitis 19 28 254 263 B-chronic_disease
B 29 30 264 265 I-chronic_disease
infection 31 40 266 275 I-chronic_disease
( 41 42 276 277 O
i.e. 42 46 277 281 O
patients 47 55 282 290 O
testing 56 63 291 298 O
positive 64 72 299 307 O
hepatitis 73 82 308 317 O
B 83 84 318 319 O
surface 85 92 320 327 O
antigen 93 100 328 335 O
or 101 103 336 338 O
viral 104 109 339 344 O
DNA 110 113 345 348 O
by 114 116 349 351 O
PCR 117 120 352 355 B-treatment
analysis 121 129 356 364 I-treatment
) 129 130 364 365 O

Fluent 0 6 366 372 B-language_fluency
in 7 9 373 375 I-language_fluency
English 10 17 376 383 I-language_fluency
( 18 19 384 385 O
because 19 26 385 392 O
not 27 30 393 396 O
all 31 34 397 400 O
components 35 45 401 411 O
of 46 48 412 414 O
the 49 52 415 418 O
GA 53 55 419 421 O
have 56 60 422 426 O
been 61 65 427 431 O
validated 66 75 432 441 O
in 76 78 442 444 O
other 79 84 445 450 O
languages 85 94 451 460 O
) 94 95 460 461 O

History 0 7 462 469 O
of 8 10 470 472 O
any 11 14 473 476 O
serious 15 22 477 484 O
adverse 23 30 485 492 O
reaction 31 39 493 501 O
to 40 42 502 504 O
either 43 49 505 511 O
a 50 51 512 513 O
corticosteroid 52 66 514 528 B-treatment
or 67 69 529 531 O
rituximab 70 79 532 541 B-treatment
not 80 83 542 545 O
including 84 93 546 555 O
rituximab 94 103 556 565 B-clinical_variable
infusion 104 112 566 574 I-clinical_variable
reactions 113 122 575 584 I-clinical_variable
≤ 123 124 585 586 O
Grade 125 130 587 592 B-upper_bound
3 131 132 593 594 I-upper_bound

Indolent 0 8 595 603 O
histology 9 18 604 613 O
with 19 23 614 618 O
one 24 27 619 622 O
of 28 30 623 625 O
the 31 34 626 629 O
following 35 44 630 639 O
markers 45 52 640 647 O
of 53 55 648 650 O
large 56 61 651 656 O
tumor 62 67 657 662 B-cancer
burden 68 74 663 669 O
( 75 76 670 671 O
67 76 78 671 673 O
) 78 79 673 674 O

Intended 0 8 675 683 O
initial 9 16 684 691 O
treatment 17 26 692 701 B-treatment
to 27 29 702 704 O
include 30 37 705 712 O
≥2 38 40 713 715 O
cycles 41 47 716 722 O
of 48 50 723 725 O
R 51 52 726 727 B-treatment
- 52 53 727 728 I-treatment
CHOP 53 57 728 732 I-treatment
, 57 58 732 733 O
R 59 60 734 735 B-treatment
- 60 61 735 736 I-treatment
EPOCH 61 66 736 741 I-treatment
or 67 69 742 744 O
R 70 71 745 746 B-treatment
- 71 72 746 747 I-treatment
CEPP 72 76 747 751 I-treatment
using 77 82 752 757 O
standard 83 91 758 766 O
doses 92 97 767 772 O
and 98 101 773 776 O
schedule.(68 102 114 777 789 O
, 114 115 789 790 O
69 116 118 791 793 O
) 118 119 793 794 O
R 120 121 795 796 O
- 121 122 796 797 O
CHOP 122 126 797 801 O
chemoimmunotherapy 127 145 802 820 B-treatment
may 146 149 821 824 O
be 150 152 825 827 O
given 153 158 828 833 O
every 159 164 834 839 O
14 165 167 840 842 O
days 168 172 843 847 O
or 173 175 848 850 O
every 176 181 851 856 O
21 182 184 857 859 O
days 185 189 860 864 O

Leukemic 0 8 865 873 B-cancer
phase 9 14 874 879 I-cancer
( 15 16 880 881 O
malignant 16 25 881 890 B-clinical_variable
cells 26 31 891 896 I-clinical_variable
≥5 32 34 897 899 O
x 35 36 900 901 I-lower_bound
109 37 40 902 905 I-lower_bound
/ 40 41 905 906 I-lower_bound
L 41 42 906 907 I-lower_bound
) 42 43 907 908 O

Must 0 4 909 913 O
be 5 7 914 916 O
starting 8 16 917 925 O
a 17 18 926 927 O
new 19 22 928 931 O
chemotherapy 23 35 932 944 B-treatment
regimen 36 43 945 952 I-treatment
( 44 45 953 954 O
patients 45 53 954 962 O
whose 54 59 963 968 O
treatment 60 69 969 978 B-treatment
regimen 70 77 979 986 I-treatment
includes 78 86 987 995 O
an 87 89 996 998 O
immunomodulatory 90 106 999 1015 B-treatment
agent 107 112 1016 1021 I-treatment
such 113 117 1022 1026 O
as 118 120 1027 1029 O
lenalidomide 121 133 1030 1042 B-treatment
or 134 136 1043 1045 O
small 137 142 1046 1051 B-treatment
molecule 143 151 1052 1060 I-treatment
targeted 152 160 1061 1069 I-treatment
agents 161 167 1070 1076 I-treatment
such 168 172 1077 1081 O
as 173 175 1082 1084 O
Ibrutinib 176 185 1085 1094 B-treatment
or 186 188 1095 1097 O
Idelelasib 189 199 1098 1108 B-treatment

Must 0 4 1109 1113 O
meet 5 9 1114 1118 O
criteria 10 18 1119 1127 O
for 19 22 1128 1131 O
initiation 23 33 1132 1142 O
of 34 36 1143 1145 O
treatment 37 46 1146 1155 B-treatment

Pathologically 0 14 1156 1170 O
confirmed 15 24 1171 1180 O
NHL 25 28 1181 1184 B-clinical_variable

Pathologically 0 14 1185 1199 O
confirmed 15 24 1200 1209 O
diagnosis 25 34 1210 1219 O
of 35 37 1220 1222 O
DLBCL 38 43 1223 1228 B-cancer
, 43 44 1228 1229 O
with 45 49 1230 1234 O
or 50 52 1235 1237 O
without 53 60 1238 1245 O
simultaneous 61 73 1246 1258 O
or 74 76 1259 1261 O
antecedent 77 87 1262 1272 O
indolent 88 96 1273 1281 O
lymphoma 97 105 1282 1290 B-cancer

Patients 0 8 1291 1299 O
enrolled 9 17 1300 1308 O
on 18 20 1309 1311 O
another 21 28 1312 1319 O
clinical 29 37 1320 1328 O
trial 38 43 1329 1334 O
which 44 49 1335 1340 O
prohibits 50 59 1341 1350 O
the 60 63 1351 1354 O
use 64 67 1355 1358 O
of 68 70 1359 1361 O
pre 71 74 1362 1365 O
- 74 75 1365 1366 O
phase 75 80 1366 1371 O
therapy 81 88 1372 1379 B-treatment
or 89 91 1380 1382 O
any 92 95 1383 1386 O
of 96 98 1387 1389 O
its 99 102 1390 1393 O
components 103 113 1394 1404 O

Patients 0 8 1405 1413 B-clinical_variable
scoring 9 16 1414 1421 I-clinical_variable
≥ 17 18 1422 1423 O
11 19 21 1424 1426 B-lower_bound
on 22 24 1427 1429 O
the 25 28 1430 1433 O
BOMC 29 33 1434 1438 O
( 34 35 1439 1440 O
implying 35 43 1440 1448 O
cognitive 44 53 1449 1458 B-chronic_disease
impairment 54 64 1459 1469 I-chronic_disease
) 64 65 1469 1470 O
will 66 70 1471 1475 O
be 71 73 1476 1478 O
excluded 74 82 1479 1487 O
since 83 88 1488 1493 O
their 89 94 1494 1499 O
ability 95 102 1500 1507 O
to 103 105 1508 1510 O
reliably 106 114 1511 1519 O
complete 115 123 1520 1528 O
the 124 127 1529 1532 O
questionnaire 128 141 1533 1546 O
will 142 146 1547 1551 O
be 147 149 1552 1554 O
in 150 152 1555 1557 O
doubt 153 158 1558 1563 O
Subjects 159 167 1564 1572 O
meeting 168 175 1573 1580 O
the 176 179 1581 1584 O
following 180 189 1585 1594 O
criteria 190 198 1595 1603 O
will 199 203 1604 1608 O
be 204 206 1609 1611 O
excluded 207 215 1612 1620 O
from 216 220 1621 1625 O
enrollment 221 231 1626 1636 O
in 232 234 1637 1639 O
the 235 238 1640 1643 O
pre 239 242 1644 1647 O
- 242 243 1647 1648 O
phase 243 248 1648 1653 O
arm 249 252 1654 1657 O
of 253 255 1658 1660 O
the 256 259 1661 1664 O
study 260 265 1665 1670 O
, 265 266 1670 1671 O
but 267 270 1672 1675 O
may 271 274 1676 1679 O
be 275 277 1680 1682 O
included 278 286 1683 1691 O
in 287 289 1692 1694 O
the 290 293 1695 1698 O
GA 294 296 1699 1701 O
only 297 301 1702 1706 O
arm 302 305 1707 1710 O

Patients 0 8 1711 1719 O
with 9 13 1720 1724 O
evidence 14 22 1725 1733 O
of 23 25 1734 1736 O
past 26 30 1737 1741 O
infection 31 40 1742 1751 B-chronic_disease
without 41 48 1752 1759 O
active 49 55 1760 1766 O
viremia 56 63 1767 1774 B-chronic_disease
( 64 65 1775 1776 O
i.e. 65 69 1776 1780 O
positive 70 78 1781 1789 O
hepatitis 79 88 1790 1799 B-chronic_disease
B 89 90 1800 1801 I-chronic_disease
core 91 95 1802 1806 O
antibody 96 104 1807 1815 O
, 104 105 1815 1816 O
negative 106 114 1817 1825 O
hepatitis 115 124 1826 1835 B-chronic_disease
B 125 126 1836 1837 I-chronic_disease
surface 127 134 1838 1845 I-chronic_disease
antigen 135 142 1846 1853 I-chronic_disease
and 143 146 1854 1857 O
negative 147 155 1858 1866 O
hepatitis 156 165 1867 1876 O
B 166 167 1877 1878 O
DNA 168 171 1879 1882 B-clinical_variable
PCR 172 175 1883 1886 I-clinical_variable
) 175 176 1886 1887 O
will 177 181 1888 1892 O
be 182 184 1893 1895 O
treated 185 192 1896 1903 O
with 193 197 1904 1908 O
entecavir 198 207 1909 1918 B-treatment
as 208 210 1919 1921 O
per 211 214 1922 1925 O
institutional 215 228 1926 1939 O
guidelines 229 239 1940 1950 O

Previously 0 10 1951 1961 O
untreated 11 20 1962 1971 O
for 21 24 1972 1975 O
DLBCL 25 30 1976 1981 B-cancer

Serous 0 6 1982 1988 B-chronic_disease
effusion 7 15 1989 1997 I-chronic_disease
( 16 17 1998 1999 O
plural 17 23 1999 2005 B-chronic_disease
effusion 24 32 2006 2014 I-chronic_disease
or 33 35 2015 2017 O
peritoneal 36 46 2018 2028 B-chronic_disease
ascites 47 54 2029 2036 I-chronic_disease
) 54 55 2036 2037 O

Substantial 0 11 2038 2049 O
splenomegaly 12 24 2050 2062 B-chronic_disease

Systemic 0 8 2063 2071 B-chronic_disease
fungal 9 15 2072 2078 I-chronic_disease
infection 16 25 2079 2088 I-chronic_disease

Uncontrolled 0 12 2089 2101 O
diabetes 13 21 2102 2110 B-chronic_disease
mellitus 22 30 2111 2119 I-chronic_disease

Ureteral 0 8 2120 2128 B-chronic_disease
compression 9 20 2129 2140 I-chronic_disease

patients 0 8 2141 2149 O
being 9 14 2150 2155 O
treated 15 22 2156 2163 O
with 23 27 2164 2168 O
a 28 29 2169 2170 O
single 30 36 2171 2177 B-treatment
agent 37 42 2178 2183 I-treatment
monoclonal 43 53 2184 2194 I-treatment
antibody 54 62 2195 2203 I-treatment

≥3 0 2 2204 2206 O
nodal 3 8 2207 2212 O
masses 9 15 2213 2219 O
that 16 20 2220 2224 O
are 21 24 2225 2228 O
each 25 29 2229 2233 O
≥3 30 32 2234 2236 O
cm 33 35 2237 2239 I-lower_bound
in 36 38 2240 2242 O
greatest 39 47 2243 2251 O
dimension 48 57 2252 2261 O

≥60 0 3 2262 2265 O
years 4 9 2266 2271 I-lower_bound
old 10 13 2272 2275 O

Admission 0 9 0 9 O
to 10 12 10 12 O
the 13 16 13 16 O
hospital 17 25 17 25 O
( 26 27 26 27 O
for 27 30 27 30 O
> 31 32 31 32 O
24h 33 36 33 36 B-lower_bound
) 36 37 36 37 O
at 38 40 38 40 O
the 41 44 41 44 O
time 45 49 45 49 O
of 50 52 50 52 O
diagnosis 53 62 53 62 O

Male 0 4 63 67 B-gender
gender 5 11 68 74 I-gender

New 0 3 75 78 O
- 3 4 78 79 O
onset 4 9 79 84 O
( 10 11 85 86 O
within 11 17 86 92 O
7 18 19 93 94 B-upper_bound
days 20 24 95 99 I-upper_bound
) 24 25 99 100 O
of 26 28 101 103 O
at 29 31 104 106 O
least 32 37 107 112 O
one 38 41 113 116 O
of 42 44 117 119 O
the 45 48 120 123 O
following 49 58 124 133 O
symptoms 59 67 134 142 O
/ 67 68 142 143 O
findings 68 76 143 151 O
: 76 77 151 152 O
dysuria 78 85 153 160 B-chronic_disease
, 85 86 160 161 O
urinary 87 94 162 169 B-chronic_disease
frequency 95 104 170 179 I-chronic_disease
, 104 105 179 180 O
urgency 106 113 181 188 B-chronic_disease
, 113 114 188 189 O
hematuria 115 124 190 199 B-chronic_disease
, 124 125 199 200 O
perineal 126 134 201 209 B-chronic_disease
pain 135 139 210 214 I-chronic_disease
, 139 140 214 215 O
supra 141 146 216 221 O
- 146 147 221 222 I-chronic_disease
pubic 147 152 222 227 I-chronic_disease
pain 153 157 228 232 I-chronic_disease
, 157 158 232 233 O
costovertebral 159 173 234 248 B-chronic_disease
angle 174 179 249 254 I-chronic_disease
tenderness 180 190 255 265 I-chronic_disease
, 190 191 265 266 O
or 192 194 267 269 O
flank 195 200 270 275 B-chronic_disease
pain 201 205 276 280 I-chronic_disease

Other 0 5 281 286 O
antimicrobial 6 19 287 300 B-treatment
therapy 20 27 301 308 I-treatment
( 28 29 309 310 O
new 29 32 310 313 O
or 33 35 314 316 O
ongoing 36 43 317 324 O
) 43 44 324 325 O
prescribed 45 55 326 336 O
for 56 59 337 340 O
a 60 61 341 342 O
non 62 65 343 346 O
- 65 66 346 347 O
UTI 66 69 347 350 B-chronic_disease
diagnosis 70 79 351 360 O
( 80 81 361 362 O
e.g. 81 85 362 366 O
, 85 86 366 367 O
cellulitis 87 97 368 378 B-chronic_disease
, 97 98 378 379 O
pneumonia 99 108 380 389 B-chronic_disease
, 108 109 389 390 O
etc 110 113 391 394 O
. 113 114 394 395 O
) 114 115 395 396 O

Prescribed 0 10 397 407 O
treatment 11 20 408 417 O
with 21 25 418 422 O
at 26 28 423 425 O
least 29 34 426 431 O
7 35 36 432 433 B-lower_bound
days 37 41 434 438 I-lower_bound
, 41 42 438 439 O
but 43 46 440 443 O
not 47 50 444 447 O
more 51 55 448 452 O
than 56 60 453 457 O
14 61 63 458 460 B-upper_bound
days 64 68 461 465 I-upper_bound
, 68 69 465 466 O
of 70 72 467 469 O
either 73 79 470 476 O
ciprofloxacin 80 93 477 490 B-treatment
or 94 96 491 493 O
TMP 97 100 494 497 B-treatment
- 100 101 497 498 I-treatment
SMZ 101 104 498 501 I-treatment

Symptoms 0 8 502 510 O
thought 9 16 511 518 O
more 17 21 519 523 O
likely 22 28 524 530 O
to 29 31 531 533 O
be 32 34 534 536 O
caused 35 41 537 543 O
by 42 44 544 546 O
a 45 46 547 548 O
non 47 50 549 552 O
- 50 51 552 553 O
UTI 51 54 553 556 B-chronic_disease
diagnosis 55 64 557 566 O
( 65 66 567 568 O
e.g. 66 70 568 572 O
, 70 71 572 573 O
urinary 72 79 574 581 B-chronic_disease
calculus 80 88 582 590 I-chronic_disease
, 88 89 590 591 O
sexually 90 98 592 600 B-chronic_disease
transmitted 99 110 601 612 I-chronic_disease
infection 111 120 613 622 I-chronic_disease
, 120 121 622 623 O
etc 122 125 624 627 O
. 125 126 627 628 O
) 126 127 628 629 O

Treated 0 7 630 637 O
as 8 10 638 640 O
an 11 13 641 643 O
outpatient 14 24 644 654 O
( 25 26 655 656 O
Primary 26 33 656 663 O
Care 34 38 664 668 O
Center 39 45 669 675 O
or 46 48 676 678 O
Emergency 49 58 679 688 O
Department 59 69 689 699 O
) 69 70 699 700 O
, 70 71 700 701 O
with 72 76 702 706 O
< 77 78 707 708 O
24 79 81 709 711 B-upper_bound
hours 82 87 712 717 I-upper_bound
observation 88 99 718 729 O
in 100 102 730 732 O
the 103 106 733 736 O
hospital 107 115 737 745 O
or 116 118 746 748 O
Emergency 119 128 749 758 O
Department 129 139 759 769 O
following 140 149 770 779 O
the 150 153 780 783 O
time 154 158 784 788 O
of 159 161 789 791 O
initial 162 169 792 799 O
diagnosis 170 179 800 809 O

Treatment 0 9 810 819 O
for 10 13 820 823 O
UTI 14 17 824 827 B-chronic_disease
in 18 20 828 830 O
past 21 25 831 835 B-upper_bound
14 26 28 836 838 I-upper_bound
days 29 33 839 843 I-upper_bound

Treatment 0 9 844 853 B-treatment
initiated 10 19 854 863 O
with 20 24 864 868 O
an 25 27 869 871 O
empiric 28 35 872 879 B-treatment
antimicrobial 36 49 880 893 I-treatment
regimen 50 57 894 901 I-treatment
that 58 62 902 906 O
is 63 65 907 909 O
underdosed 66 76 910 920 O
, 76 77 920 921 O
based 78 83 922 927 O
on 84 86 928 930 O
current 87 94 931 938 O
guidelines 95 105 939 949 O
and 106 109 950 953 O
reviews 110 117 954 961 O

Treatment 0 9 962 971 O
initiated 10 19 972 981 O
with 20 24 982 986 O
an 25 27 987 989 O
empiric 28 35 990 997 B-treatment
antimicrobial 36 49 998 1011 I-treatment
to 50 52 1012 1014 O
which 53 58 1015 1020 O
the 59 62 1021 1024 O
organism 63 71 1025 1033 O
isolated 72 80 1034 1042 O
in 81 83 1043 1045 O
the 84 87 1046 1049 O
urine 88 93 1050 1055 O
culture 94 101 1056 1063 O
is 102 104 1064 1066 O
non 105 108 1067 1070 O
- 108 109 1070 1071 O
susceptible 109 120 1071 1082 O
based 121 126 1083 1088 O
on 127 129 1089 1091 O
standard 130 138 1092 1100 O
laboratory 139 149 1101 1111 O
criteria 150 158 1112 1120 O

Pregnancy 0 9 0 9 B-pregnancy
and 10 13 10 13 O
current 14 21 14 21 O
BMI 22 25 22 25 B-bmi
> 26 27 26 27 O
= 27 28 27 28 O
30 28 30 28 30 B-lower_bound

Self 0 4 31 35 O
- 4 5 35 36 O
reported 5 13 36 44 O
frequent 14 22 45 53 O
snoring 23 30 54 61 O
( 31 32 62 63 O
> 32 33 63 64 O
= 33 34 64 65 O
3x 34 36 65 67 B-lower_bound
/ 36 37 67 68 I-lower_bound
week 37 41 68 72 I-lower_bound
over 42 46 73 77 O
past 47 51 78 82 O
month 52 57 83 88 O
) 57 58 88 89 O
or 59 61 90 92 O
self 62 66 93 97 O
- 66 67 97 98 O
reported 67 75 98 106 O
non 76 79 107 110 O
- 79 80 110 111 O
snorer 80 86 111 117 O

diagnosis 0 9 118 127 O
of 10 12 128 130 O
pregestational 13 27 131 145 B-chronic_disease
diabetes 28 36 146 154 I-chronic_disease

self 0 4 155 159 O
- 4 5 159 160 O
report 5 11 160 166 O
a 12 13 167 168 O
history 14 21 169 176 O
of 22 24 177 179 O
sleep 25 30 180 185 B-chronic_disease
apena 31 36 186 191 I-chronic_disease
and 37 40 192 195 O
who 41 44 196 199 O
are 45 48 200 203 O
using 49 54 204 209 O
or 55 57 210 212 O
were 58 62 213 217 O
receommended 63 75 218 230 O
by 76 78 231 233 O
a 79 80 234 235 O
physican 81 89 236 244 O
to 90 92 245 247 O
use 93 96 248 251 O
a 97 98 252 253 O
PAP 99 102 254 257 B-treatment
device 103 109 258 264 I-treatment
already 110 117 265 272 O

women 0 5 273 278 B-gender
between 6 13 279 286 O
14 14 16 287 289 B-lower_bound
0/7 17 20 290 293 I-lower_bound
and 21 24 294 297 O
20 25 27 298 300 B-upper_bound
6/7 28 31 301 304 I-upper_bound
weeks 32 37 305 310 I-upper_bound
gestation 38 47 311 320 I-upper_bound
at 48 50 321 323 O
the 51 54 324 327 O
time 55 59 328 332 O
of 60 62 333 335 O
their 63 68 336 341 O
initial 69 76 342 349 O
PSG 77 80 350 353 O
assessment 81 91 354 364 O

Abnormal 0 8 0 8 O
resting 9 16 9 16 O
12 17 19 17 19 B-clinical_variable
- 19 20 19 20 I-clinical_variable
lead 20 24 20 24 I-clinical_variable
ECG 25 28 25 28 I-clinical_variable
( 29 30 29 30 O
e.g. 30 34 30 34 O
, 34 35 34 35 O
evidence 36 44 36 44 O
of 45 47 45 47 O
myocardial 48 58 48 58 B-chronic_disease
infarction 59 69 59 69 I-chronic_disease
, 69 70 69 70 O
left 71 75 71 75 B-chronic_disease
ventricular 76 87 76 87 I-chronic_disease
hypertrophy 88 99 88 99 I-chronic_disease
, 99 100 99 100 O
left 101 105 101 105 B-chronic_disease
- 105 106 105 106 I-chronic_disease
bundle 106 112 106 112 I-chronic_disease
branch 113 119 113 119 I-chronic_disease
block 120 125 120 125 I-chronic_disease
, 125 126 125 126 O
2nd 127 130 127 130 B-lower_bound
or 131 133 131 133 O
3rd 134 137 134 137 B-upper_bound
degree 138 144 138 144 O
AV 145 147 145 147 B-chronic_disease
block 148 153 148 153 I-chronic_disease
, 153 154 153 154 O
atrial 155 161 155 161 B-chronic_disease
fibrillation 162 174 162 174 I-chronic_disease
/ 174 175 174 175 O
flutter 175 182 175 182 O
) 182 183 182 183 O

Age 0 3 184 187 B-age
is 4 6 188 190 O
> 7 8 191 192 O
or 9 11 193 195 O
= 12 13 196 197 O
18 14 16 198 200 B-lower_bound
and 17 20 201 204 O
< 21 22 205 206 O
or 23 25 207 209 O
= 26 27 210 211 O
79 28 30 212 214 B-upper_bound
years 31 36 215 220 I-upper_bound
of 37 39 221 223 O
age 40 43 224 227 B-age

Any 0 3 228 231 O
condition 4 13 232 241 O
that 14 18 242 246 O
, 18 19 246 247 O
in 20 22 248 250 O
the 23 26 251 254 O
view 27 31 255 259 O
of 32 34 260 262 O
the 35 38 263 266 O
PI 39 41 267 269 O
, 41 42 269 270 O
places 43 49 271 277 O
the 50 53 278 281 O
subject 54 61 282 289 O
at 62 64 290 292 O
high 65 69 293 297 O
risk 70 74 298 302 O
of 75 77 303 305 O
poor 78 82 306 310 O
treatment 83 92 311 320 B-treatment
compliance 93 103 321 331 O
or 104 106 332 334 O
of 107 109 335 337 O
not 110 113 338 341 O
completing 114 124 342 352 O
the 125 128 353 356 O
study 129 134 357 362 O

Any 0 3 363 366 O
surgery 4 11 367 374 B-treatment
within 12 18 375 381 O
30 19 21 382 384 B-upper_bound
days 22 26 385 389 I-upper_bound
of 27 29 390 392 O
screening 30 39 393 402 O

Blood 0 5 403 408 B-treatment
chemistries 6 17 409 420 I-treatment
indicative 18 28 421 431 I-treatment
of 29 31 432 434 O
normal 32 38 435 441 O
renal 39 44 442 447 O
( 45 46 448 449 O
creatinine 46 56 449 459 B-clinical_variable
< 57 58 460 461 O
2.0 58 61 461 464 B-upper_bound
mg 62 64 465 467 I-upper_bound
/ 64 65 467 468 I-upper_bound
dl 65 67 468 470 I-upper_bound
) 67 68 470 471 O
, 68 69 471 472 O
liver 70 75 473 478 O
( 76 77 479 480 O
<3 77 79 480 482 O
times 80 85 483 488 I-upper_bound
upper 86 91 489 494 I-upper_bound
limit 92 97 495 500 I-upper_bound
for 98 101 501 504 O
ALT 102 105 505 508 B-clinical_variable
, 105 106 508 509 O
AST 107 110 510 513 B-clinical_variable
) 110 111 513 514 O
, 111 112 514 515 O
and 113 116 516 519 O
thyroid 117 124 520 527 O
function 125 133 528 536 O
( 134 135 537 538 O
TSH 135 138 538 541 B-clinical_variable
between 139 146 542 549 O
0.4 147 150 550 553 B-lower_bound
- 151 152 554 555 O
5.0 153 156 556 559 B-upper_bound
mU 157 159 560 562 I-upper_bound
/ 159 160 562 563 I-upper_bound
L 160 161 563 564 I-upper_bound
) 161 162 564 565 O

Healthy 0 7 566 573 O
, 7 8 573 574 O
as 9 11 575 577 O
determined 12 22 578 588 O
by 23 25 589 591 O
health 26 32 592 598 O
history 33 40 599 606 O
questionnaire 41 54 607 620 O
, 54 55 620 621 O
blood 56 61 622 627 O
chemistries 62 73 628 639 O
, 73 74 639 640 O
12 75 77 641 643 O
- 77 78 643 644 O
lead 78 82 644 648 O
ECG 83 86 649 652 B-clinical_variable

History 0 7 653 660 O
of 8 10 661 663 O
HIV 11 14 664 667 B-chronic_disease
infection 15 24 668 677 O
, 24 25 677 678 O
hepatic 26 33 679 686 B-chronic_disease
cirrhosis 34 43 687 696 I-chronic_disease
, 43 44 696 697 O
other 45 50 698 703 O
preexisting 51 62 704 715 O
liver 63 68 716 721 B-chronic_disease
disease 69 76 722 729 I-chronic_disease
, 76 77 729 730 O
or 78 80 731 733 O
positive 81 89 734 742 O
HIV 90 93 743 746 O
, 93 94 746 747 O
Hepatitis 95 104 748 757 B-chronic_disease
B 105 106 758 759 I-chronic_disease
or 107 109 760 762 O
C 110 111 763 764 B-chronic_disease
test 112 116 765 769 O
at 117 119 770 772 O
screening 120 129 773 782 O

History 0 7 783 790 O
of 8 10 791 793 O
alcohol 11 18 794 801 O
abuse 19 24 802 807 O
or 25 27 808 810 O
> 28 29 811 812 O
10 29 31 812 814 B-lower_bound
alcoholic 32 41 815 824 I-lower_bound
units 42 47 825 830 I-lower_bound
per 48 51 831 834 I-lower_bound
week 52 56 835 839 I-lower_bound
( 57 58 840 841 O
1 58 59 841 842 O
unit= 60 65 843 848 O
1 66 67 849 850 O
beer 68 72 851 855 O
, 72 73 855 856 O
1 74 75 857 858 O
glass 76 81 859 864 O
of 82 84 865 867 O
wine 85 89 868 872 O
, 89 90 872 873 O
1 91 92 874 875 O
mixed 93 98 876 881 O
cocktail 99 107 882 890 O
containing 108 118 891 901 O
1 119 120 902 903 O
oz 121 123 904 906 O
alcohol 124 131 907 914 O
) 131 132 914 915 O

History 0 7 916 923 O
of 8 10 924 926 O
cardiovascular 11 25 927 941 B-chronic_disease
disease 26 33 942 949 I-chronic_disease
such 34 38 950 954 O
as 39 41 955 957 O
heart 42 47 958 963 B-treatment
angioplasty 48 59 964 975 I-treatment
/ 59 60 975 976 O
stent 60 65 976 981 B-treatment
or 66 68 982 984 I-treatment
bypass 69 75 985 991 I-treatment
surgery 76 83 992 999 I-treatment
, 83 84 999 1000 O
myocardial 85 95 1001 1011 B-chronic_disease
infarction 96 106 1012 1022 I-chronic_disease
, 106 107 1022 1023 O
stroke 108 114 1024 1030 B-chronic_disease
, 114 115 1030 1031 O
heart 116 121 1032 1037 B-chronic_disease
failure 122 129 1038 1045 I-chronic_disease
with 130 134 1046 1050 O
or 135 137 1051 1053 O
without 138 145 1054 1061 O
left 146 150 1062 1066 B-clinical_variable
ventricular 151 162 1067 1078 I-clinical_variable
ejection 163 171 1079 1087 I-clinical_variable
fraction 172 180 1088 1096 I-clinical_variable
< 181 182 1097 1098 O
40 182 184 1098 1100 B-upper_bound
% 184 185 1100 1101 I-upper_bound
, 185 186 1101 1102 O
cardiomyopathy 187 201 1103 1117 B-chronic_disease
, 201 202 1117 1118 O
valvular 203 211 1119 1127 B-chronic_disease
heart 212 217 1128 1133 I-chronic_disease
disease 218 225 1134 1141 I-chronic_disease
, 225 226 1141 1142 O
cardiomyopathy 227 241 1143 1157 O
, 241 242 1157 1158 O
heart 243 248 1159 1164 B-treatment
transplantation 249 264 1165 1180 I-treatment
, 264 265 1180 1181 O
Type 266 270 1182 1186 B-chronic_disease
2 271 272 1187 1188 I-chronic_disease
and 273 276 1189 1192 I-chronic_disease
Type 277 281 1193 1197 I-chronic_disease
1 282 283 1198 1199 I-chronic_disease
diabetes 284 292 1200 1208 I-chronic_disease

History 0 7 1209 1216 O
of 8 10 1217 1219 O
chronic 11 18 1220 1227 B-chronic_disease
obstructive 19 30 1228 1239 I-chronic_disease
pulmonary 31 40 1240 1249 I-chronic_disease
disease 41 48 1250 1257 I-chronic_disease
( 49 50 1258 1259 I-chronic_disease
COPD 50 54 1259 1263 I-chronic_disease
) 54 55 1263 1264 I-chronic_disease

History 0 7 1265 1272 O
of 8 10 1273 1275 O
co 11 13 1276 1278 O
- 13 14 1278 1279 O
morbid 14 20 1279 1285 O
condition 21 30 1286 1295 O
that 31 35 1296 1300 O
would 36 41 1301 1306 O
limit 42 47 1307 1312 O
life 48 52 1313 1317 B-clinical_variable
expectancy 53 63 1318 1328 I-clinical_variable
to 64 66 1329 1331 O
< 67 68 1332 1333 O
6 69 70 1334 1335 B-upper_bound
months 71 77 1336 1342 I-upper_bound

History 0 7 1343 1350 O
of 8 10 1351 1353 O
gastric 11 18 1354 1361 B-chronic_disease
ulcers 19 25 1362 1368 I-chronic_disease
, 25 26 1368 1369 O
bleeding 27 35 1370 1378 B-chronic_disease
disorders 36 45 1379 1388 I-chronic_disease
, 45 46 1388 1389 O
dyspepsia 47 56 1390 1399 B-chronic_disease
, 56 57 1399 1400 O
severe 58 64 1401 1407 O
gastroesophageal 65 81 1408 1424 B-chronic_disease
reflux 82 88 1425 1431 I-chronic_disease
disease 89 96 1432 1439 I-chronic_disease
( 97 98 1440 1441 I-chronic_disease
GERD 98 102 1441 1445 I-chronic_disease
) 102 103 1445 1446 I-chronic_disease
, 103 104 1446 1447 O
or 105 107 1448 1450 O
metabolic 108 117 1451 1460 B-chronic_disease
acidosis 118 126 1461 1469 I-chronic_disease

History 0 7 1470 1477 O
of 8 10 1478 1480 O
recent 11 17 1481 1487 O
chicken 18 25 1488 1495 B-chronic_disease
pox 26 29 1496 1499 I-chronic_disease
, 29 30 1499 1500 O
shingles 31 39 1501 1509 B-chronic_disease
or 40 42 1510 1512 O
influenza 43 52 1513 1522 B-chronic_disease
( 53 54 1523 1524 O
ie 54 56 1524 1526 O
. 56 57 1526 1527 O
, 57 58 1527 1528 O
risk 59 63 1529 1533 O
of 64 66 1534 1536 O
Reye 67 71 1537 1541 B-chronic_disease
's 71 73 1541 1543 I-chronic_disease
syndrome 74 82 1544 1552 I-chronic_disease
) 82 83 1552 1553 O

History 0 7 1554 1561 O
of 8 10 1562 1564 O
renal 11 16 1565 1570 B-chronic_disease
failure 17 24 1571 1578 I-chronic_disease
, 24 25 1578 1579 O
dialysis 26 34 1580 1588 B-chronic_disease
or 35 37 1589 1591 O
kidney 38 44 1592 1598 B-treatment
transplant 45 55 1599 1609 I-treatment

History 0 7 1610 1617 O
of 8 10 1618 1620 O
rheumatoid 11 21 1621 1631 B-chronic_disease
arthritis 22 31 1632 1641 I-chronic_disease
, 31 32 1641 1642 O
Grave 33 38 1643 1648 B-chronic_disease
's 38 40 1648 1650 I-chronic_disease
disease 41 48 1651 1658 I-chronic_disease
, 48 49 1658 1659 O
systemic 50 58 1660 1668 B-chronic_disease
lupus 59 64 1669 1674 I-chronic_disease
erythematosis 65 78 1675 1688 I-chronic_disease
, 78 79 1688 1689 O
and 80 83 1690 1693 O
Wegener 84 91 1694 1701 B-chronic_disease
's 91 93 1701 1703 I-chronic_disease
granulomatosis 94 108 1704 1718 I-chronic_disease

If 0 2 1719 1721 O
currently 3 12 1722 1731 O
receiving 13 22 1732 1741 O
treatment 23 32 1742 1751 B-treatment
with 33 37 1752 1756 O
or 38 40 1757 1759 O
taking 41 47 1760 1766 O
any 48 51 1767 1770 O
of 52 54 1771 1773 O
the 55 58 1774 1777 O
following 59 68 1778 1787 O
supplements 69 80 1788 1799 O
, 80 81 1799 1800 O
be 82 84 1801 1803 O
willing 85 92 1804 1811 O
and 93 96 1812 1815 O
able 97 101 1816 1820 O
to 102 104 1821 1823 O
discontinue 105 116 1824 1835 O
taking 117 123 1836 1842 O
them 124 128 1843 1847 O
for 129 132 1848 1851 O
2 133 134 1852 1853 B-upper_bound
weeks 135 140 1854 1859 I-upper_bound
prior 141 146 1860 1865 I-upper_bound
and 147 150 1866 1869 O
throughout 151 161 1870 1880 O
the 162 165 1881 1884 O
treatment 166 175 1885 1894 O
period 176 182 1895 1901 O
: 182 183 1901 1902 O
Vitamin 184 191 1903 1910 B-treatment
C 192 193 1911 1912 I-treatment
, 193 194 1912 1913 I-treatment
E 195 196 1914 1915 I-treatment
or 197 199 1916 1918 O
other 200 205 1919 1924 O
multivitamins 206 219 1925 1938 O
containing 220 230 1939 1949 O
vitamin 231 238 1950 1957 B-treatment
C 239 240 1958 1959 I-treatment
or 241 243 1960 1962 I-treatment
E 244 245 1963 1964 I-treatment
; 245 246 1964 1965 O
or 247 249 1966 1968 O
omega-3 250 257 1969 1976 B-treatment
fatty 258 263 1977 1982 I-treatment
acids 264 269 1983 1988 I-treatment

No 0 2 1989 1991 O
history 3 10 1992 1999 O
of 11 13 2000 2002 O
cardiovascular 14 28 2003 2017 B-chronic_disease
disease 29 36 2018 2025 I-chronic_disease
( 37 38 2026 2027 O
e.g. 38 42 2027 2031 O
, 42 43 2031 2032 O
heart 44 49 2033 2038 B-chronic_disease
attack 50 56 2039 2045 I-chronic_disease
, 56 57 2045 2046 O
stroke 58 64 2047 2053 B-chronic_disease
, 64 65 2053 2054 O
heart 66 71 2055 2060 B-chronic_disease
failure 72 79 2061 2068 I-chronic_disease
, 79 80 2068 2069 O
valvular 81 89 2070 2078 B-chronic_disease
heart 90 95 2079 2084 I-chronic_disease
disease 96 103 2085 2092 I-chronic_disease
, 103 104 2092 2093 O
cardiomyopathy 105 119 2094 2108 B-chronic_disease
) 119 120 2108 2109 O
, 120 121 2109 2110 O
Type 122 126 2111 2115 B-chronic_disease
1 127 128 2116 2117 I-chronic_disease
or 129 131 2118 2120 O
Type 132 136 2121 2125 B-chronic_disease
2 137 138 2126 2127 I-chronic_disease
diabetes 139 147 2128 2136 I-chronic_disease
, 147 148 2136 2137 O
or 149 151 2138 2140 O
peripheral 152 162 2141 2151 B-chronic_disease
arterial 163 171 2152 2160 I-chronic_disease
disease 172 179 2161 2168 I-chronic_disease

Non 0 3 2169 2172 O
- 3 4 2172 2173 O
smokers 4 11 2173 2180 O
, 11 12 2180 2181 O
defined 13 20 2182 2189 O
as 21 23 2190 2192 O
no 24 26 2193 2195 O
history 27 34 2196 2203 O
of 35 37 2204 2206 O
smoking 38 45 2207 2214 O
or 46 48 2215 2217 O
no 49 51 2218 2220 O
smoking 52 59 2221 2228 O
for 60 63 2229 2232 O
at 64 66 2233 2235 O
least 67 72 2236 2241 O
the 73 76 2242 2245 O
past 77 81 2246 2250 B-lower_bound
1 82 83 2251 2252 I-lower_bound
year 84 88 2253 2257 I-lower_bound

Normal 0 6 2258 2264 O
resting 7 14 2265 2272 O
12 15 17 2273 2275 O
- 17 18 2275 2276 O
lead 18 22 2276 2280 O
ECG 23 26 2281 2284 B-treatment
( 27 28 2285 2286 O
no 28 30 2286 2288 O
evidence 31 39 2289 2297 O
of 40 42 2298 2300 O
myocardial 43 53 2301 2311 B-chronic_disease
infarction 54 64 2312 2322 I-chronic_disease
, 64 65 2322 2323 O
left 66 70 2324 2328 B-chronic_disease
ventricular 71 82 2329 2340 I-chronic_disease
hypertrophy 83 94 2341 2352 I-chronic_disease
, 94 95 2352 2353 O
left 96 100 2354 2358 B-chronic_disease
- 100 101 2358 2359 I-chronic_disease
bundle 101 107 2359 2365 I-chronic_disease
branch 108 114 2366 2372 I-chronic_disease
block 115 120 2373 2378 I-chronic_disease
, 120 121 2378 2379 O
2nd 122 125 2380 2383 B-chronic_disease
or 126 128 2384 2386 I-chronic_disease
3rd 129 132 2387 2390 I-chronic_disease
degree 133 139 2391 2397 I-chronic_disease
AV 140 142 2398 2400 I-chronic_disease
block 143 148 2401 2406 I-chronic_disease
, 148 149 2406 2407 O
atrial 150 156 2408 2414 B-chronic_disease
fibrillation 157 169 2415 2427 I-chronic_disease
/ 169 170 2427 2428 I-chronic_disease
flutter 170 177 2428 2435 I-chronic_disease
) 177 178 2435 2436 O

On 0 2 2437 2439 O
weight 3 9 2440 2446 B-treatment
loss 10 14 2447 2451 I-treatment
drugs 15 20 2452 2457 I-treatment
( 21 22 2458 2459 O
e.g. 22 26 2459 2463 O
, 26 27 2463 2464 O
Xenical 28 35 2465 2472 B-treatment
( 36 37 2473 2474 O
orlistat 37 45 2474 2482 B-treatment
) 45 46 2482 2483 O
, 46 47 2483 2484 O
Meridia 48 55 2485 2492 B-treatment
( 56 57 2493 2494 O
sibutramine 57 68 2494 2505 B-treatment
) 68 69 2505 2506 O
, 69 70 2506 2507 O
Acutrim 71 78 2508 2515 B-treatment
( 79 80 2516 2517 O
phenylpropanol 80 94 2517 2531 B-treatment
- 94 95 2531 2532 I-treatment
amine 95 100 2532 2537 I-treatment
) 100 101 2537 2538 O
, 101 102 2538 2539 O
or 103 105 2540 2542 O
similar 106 113 2543 2550 O
over 114 118 2551 2555 B-treatment
- 118 119 2555 2556 I-treatment
the 119 122 2556 2559 I-treatment
- 122 123 2559 2560 I-treatment
counter 123 130 2560 2567 I-treatment
medications 131 142 2568 2579 I-treatment
) 142 143 2579 2580 O
within 144 150 2581 2587 O
3 151 152 2588 2589 B-upper_bound
months 153 159 2590 2596 I-upper_bound
of 160 162 2597 2599 O
screening 163 172 2600 2609 O

Pregnant 0 8 2610 2618 B-pregnancy

Recent 0 6 2619 2625 O
flu 7 10 2626 2629 O
- 10 11 2629 2630 O
like 11 15 2630 2634 O
symptoms 16 24 2635 2643 O
within 25 31 2644 2650 O
the 32 35 2651 2654 O
past 36 40 2655 2659 B-upper_bound
2 41 42 2660 2661 I-upper_bound
weeks 43 48 2662 2667 I-upper_bound

Serious 0 7 2668 2675 O
neurologic 8 18 2676 2686 B-chronic_disease
disorders 19 28 2687 2696 I-chronic_disease
including 29 38 2697 2706 O
seizures 39 47 2707 2715 B-chronic_disease

Serum 0 5 2716 2721 B-clinical_variable
creatinine 6 16 2722 2732 I-clinical_variable
> 17 18 2733 2734 O
2.0 19 22 2735 2738 B-lower_bound
mg 23 25 2739 2741 I-lower_bound
/ 25 26 2741 2742 I-lower_bound
dL 26 28 2742 2744 I-lower_bound

Smoking 0 7 2745 2752 O
or 8 10 2753 2755 O
history 11 18 2756 2763 O
of 19 21 2764 2766 O
smoking 22 29 2767 2774 O
within 30 36 2775 2781 O
past 37 41 2782 2786 B-upper_bound
one 42 45 2787 2790 I-upper_bound
year 46 50 2791 2795 I-upper_bound

Systolic 0 8 2796 2804 B-clinical_variable
blood 9 14 2805 2810 I-clinical_variable
pressure 15 23 2811 2819 I-clinical_variable
> 24 25 2820 2821 O
/= 25 27 2821 2823 O
130 28 31 2824 2827 B-lower_bound
mmHg 32 36 2828 2832 I-lower_bound
and 37 40 2833 2836 O
< 41 42 2837 2838 O
180 42 45 2838 2841 B-upper_bound
mmHg 46 50 2842 2846 I-upper_bound

Systolic 0 8 2847 2855 B-clinical_variable
blood 9 14 2856 2861 I-clinical_variable
pressure 15 23 2862 2870 I-clinical_variable
> 24 25 2871 2872 O
/=180 25 30 2872 2877 O
mmHg 31 35 2878 2882 I-lower_bound
or 36 38 2883 2885 O
diastolic 39 48 2886 2895 B-clinical_variable
blood 49 54 2896 2901 I-clinical_variable
pressure 55 63 2902 2910 I-clinical_variable
> 64 65 2911 2912 O
110 65 68 2912 2915 B-lower_bound
mmHg 69 73 2916 2920 I-lower_bound

Taking 0 6 2921 2927 O
Phosphodiesterase 7 24 2928 2945 B-treatment
( 25 26 2946 2947 I-treatment
PDE 26 29 2947 2950 I-treatment
) 29 30 2950 2951 I-treatment
5 31 32 2952 2953 I-treatment
inhibitors 33 43 2954 2964 I-treatment
( 44 45 2965 2966 O
e.g. 45 49 2966 2970 O
, 49 50 2970 2971 O
Viagra 51 57 2972 2978 B-treatment
® 57 58 2978 2979 I-treatment
, 58 59 2979 2980 O
Cialis 60 66 2981 2987 B-treatment
® 66 67 2987 2988 I-treatment
, 67 68 2988 2989 O
Levitra 69 76 2990 2997 B-treatment
® 76 77 2997 2998 I-treatment
, 77 78 2998 2999 O
or 79 81 3000 3002 O
Revatio 82 89 3003 3010 B-treatment
® 89 90 3010 3011 I-treatment
) 90 91 3011 3012 O
; 91 92 3012 3013 O
PDE 93 96 3014 3017 B-treatment
3 97 98 3018 3019 I-treatment
inhibitors 99 109 3020 3030 I-treatment
( 110 111 3031 3032 O
e.g. 111 115 3032 3036 O
, 115 116 3036 3037 O
cilostazol 117 127 3038 3048 B-treatment
, 127 128 3048 3049 O
milrinone 129 138 3050 3059 B-treatment
, 138 139 3059 3060 O
or 140 142 3061 3063 O
vesnarinone 143 154 3064 3075 B-treatment
) 154 155 3075 3076 O
; 155 156 3076 3077 O
lithium 157 164 3078 3085 B-treatment

Taking 0 6 3086 3092 O
blood 7 12 3093 3098 B-treatment
thinners 13 21 3099 3107 I-treatment
such 22 26 3108 3112 O
as 27 29 3113 3115 O
coumadin 30 38 3116 3124 B-treatment
( 39 40 3125 3126 O
Warfarin 40 48 3126 3134 B-treatment
) 48 49 3134 3135 O
, 49 50 3135 3136 O
enoxaparin 51 61 3137 3147 B-treatment
( 62 63 3148 3149 O
Lovenox 63 70 3149 3156 B-treatment
) 70 71 3156 3157 O
; 71 72 3157 3158 O
clopidogrel 73 84 3159 3170 B-treatment
( 85 86 3171 3172 O
Plavix 86 92 3172 3178 B-treatment
) 92 93 3178 3179 O
; 93 94 3179 3180 O
dipyridamole 95 107 3181 3193 B-treatment
( 108 109 3194 3195 O
Persantine 109 119 3195 3205 B-treatment
) 119 120 3205 3206 O
; 120 121 3206 3207 O
heparin 122 129 3208 3215 B-treatment

Taking 0 6 3216 3222 O
chronic 7 14 3223 3230 B-treatment
non 15 18 3231 3234 I-treatment
- 18 19 3234 3235 I-treatment
steroidal 19 28 3235 3244 I-treatment
anti 29 33 3245 3249 I-treatment
- 33 34 3249 3250 I-treatment
inflammatory 34 46 3250 3262 I-treatment
drugs 47 52 3263 3268 I-treatment
( 53 54 3269 3270 I-treatment
NSAIDS 54 60 3270 3276 I-treatment
) 60 61 3276 3277 I-treatment
such 62 66 3278 3282 O
as 67 69 3283 3285 O
aspirin 70 77 3286 3293 B-treatment
, 77 78 3293 3294 O
indomethacin 79 91 3295 3307 B-treatment
, 91 92 3307 3308 O
naproxen 93 101 3309 3317 B-treatment
, 101 102 3317 3318 O
acetaminophen 103 116 3319 3332 B-treatment
( 117 118 3333 3334 I-treatment
Tylenol 118 125 3334 3341 I-treatment
) 125 126 3341 3342 I-treatment
, 126 127 3342 3343 O
ibuprofen 128 137 3344 3353 B-treatment
( 138 139 3354 3355 O
Advil 139 144 3355 3360 B-treatment
, 144 145 3360 3361 O
Motrin 146 152 3362 3368 B-treatment
) 152 153 3368 3369 O
and 154 157 3370 3373 O
not 158 161 3374 3377 O
able 162 166 3378 3382 O
or 167 169 3383 3385 O
willing 170 177 3386 3393 O
to 178 180 3394 3396 O
go 181 183 3397 3399 O
off 184 187 3400 3403 O
of 188 190 3404 3406 O
for 191 194 3407 3410 O
2 195 196 3411 3412 B-upper_bound
weeks 197 202 3413 3418 I-upper_bound
prior 203 208 3419 3424 I-upper_bound
and 209 212 3425 3428 O
during 213 219 3429 3435 O
the 220 223 3436 3439 O
study 224 229 3440 3445 O

Taking 0 6 3446 3452 O
cox-2 7 12 3453 3458 B-treatment
inhibitors 13 23 3459 3469 I-treatment
( 24 25 3470 3471 O
Celebrex 25 33 3471 3479 B-treatment
, 33 34 3479 3480 O
Vioxx 35 40 3481 3486 B-treatment
, 40 41 3486 3487 O
etc 42 45 3488 3491 O
) 45 46 3491 3492 O
or 47 49 3493 3495 O
allopurinol 50 61 3496 3507 B-treatment
( 62 63 3508 3509 O
Zyloprim 63 71 3509 3517 B-treatment
, 71 72 3517 3518 O
Lopurin 73 80 3519 3526 B-treatment
, 80 81 3526 3527 O
Allopurin 82 91 3528 3537 B-treatment
) 91 92 3537 3538 O

Taking 0 6 3539 3545 O
diabetic 7 15 3546 3554 O
medications 16 27 3555 3566 O
( 28 29 3567 3568 O
Metformin 29 38 3568 3577 B-treatment
, 38 39 3577 3578 O
glyburide 40 49 3579 3588 B-treatment
, 49 50 3588 3589 O
insulin 51 58 3590 3597 B-treatment
, 58 59 3597 3598 O
etc 60 63 3599 3602 O
. 63 64 3602 3603 O
) 64 65 3603 3604 O
, 65 66 3604 3605 O
thiazolidinediones 67 85 3606 3624 B-treatment
( 86 87 3625 3626 O
Avandia 87 94 3626 3633 B-treatment
, 94 95 3633 3634 O
Rezulin 96 103 3635 3642 B-treatment
, 103 104 3642 3643 O
Actos 105 110 3644 3649 B-treatment
) 110 111 3649 3650 O

Taking 0 6 3651 3657 O
lipid 7 12 3658 3663 O
lowering 13 21 3664 3672 O
( 22 23 3673 3674 O
e.g. 23 27 3674 3678 O
, 27 28 3678 3679 O
statins 29 36 3680 3687 B-treatment
, 36 37 3687 3688 O
niacin 38 44 3689 3695 B-treatment
) 44 45 3695 3696 O
, 45 46 3696 3697 O
glycemic 47 55 3698 3706 O
control 56 63 3707 3714 O
( 64 65 3715 3716 O
e.g. 65 69 3716 3720 O
metformin 70 79 3721 3730 B-treatment
, 79 80 3730 3731 O
insulin 81 88 3732 3739 B-treatment
) 88 89 3739 3740 O
, 89 90 3740 3741 O
anticoagulation 91 106 3742 3757 B-treatment
, 106 107 3757 3758 O
anti 108 112 3759 3763 B-treatment
- 112 113 3763 3764 I-treatment
seizure 113 120 3764 3771 I-treatment
, 120 121 3771 3772 O
anti 122 126 3773 3777 B-treatment
- 126 127 3777 3778 I-treatment
depression 127 137 3778 3788 I-treatment
or 138 140 3789 3791 O
antipsychotic 141 154 3792 3805 B-treatment
agents 155 161 3806 3812 I-treatment

Taking 0 6 3813 3819 O
steroids 7 15 3820 3828 B-treatment
or 16 18 3829 3831 O
biologics 19 28 3832 3841 B-treatment
: 29 30 3842 3843 O
corticosteroids 31 46 3844 3859 B-treatment
( 47 48 3860 3861 O
prednisone 48 58 3861 3871 B-treatment
) 58 59 3871 3872 O
; 59 60 3872 3873 O
methotrexate 61 73 3874 3886 B-treatment
, 73 74 3886 3887 O
infliximab 75 85 3888 3898 B-treatment
( 86 87 3899 3900 I-treatment
Remicade 87 95 3900 3908 I-treatment
) 95 96 3908 3909 O
, 96 97 3909 3910 O
etanercept 98 108 3911 3921 B-treatment
( 109 110 3922 3923 I-treatment
Enbrel 110 116 3923 3929 I-treatment
) 116 117 3929 3930 I-treatment
; 117 118 3930 3931 O
anakinra 119 127 3932 3940 B-treatment

Taking 0 6 3941 3947 O
thyroid 7 14 3948 3955 B-treatment
medications 15 26 3956 3967 I-treatment
such 27 31 3968 3972 O
as 32 34 3973 3975 O
levothyroxine 35 48 3976 3989 B-treatment
( 49 50 3990 3991 O
Levoxyl 50 57 3991 3998 B-treatment
, 57 58 3998 3999 O
Synthroid 59 68 4000 4009 B-treatment
, 68 69 4009 4010 O
Levoxyl 70 77 4011 4018 O
, 77 78 4018 4019 O
Unithroid 79 88 4020 4029 B-treatment
) 88 89 4029 4030 O
; 89 90 4030 4031 O
Levodopa 91 99 4032 4040 B-treatment

Use 0 3 4041 4044 O
of 4 6 4045 4047 O
any 7 10 4048 4051 O
investigational 11 26 4052 4067 B-treatment
product 27 34 4068 4075 I-treatment
or 35 37 4076 4078 O
investigational 38 53 4079 4094 B-treatment
medical 54 61 4095 4102 I-treatment
device 62 68 4103 4109 I-treatment
within 69 75 4110 4116 O
30 76 78 4117 4119 B-upper_bound
days 79 83 4120 4124 I-upper_bound
prior 84 89 4125 4130 I-upper_bound
to 90 92 4131 4133 O
screening 93 102 4134 4143 O
, 102 103 4143 4144 O
or 104 106 4145 4147 O
requirement 107 118 4148 4159 O
for 119 122 4160 4163 O
any 123 126 4164 4167 O
investigational 127 142 4168 4183 B-treatment
agent 143 148 4184 4189 I-treatment
prior 149 154 4190 4195 O
to 155 157 4196 4198 O
completion 158 168 4199 4209 O
of 169 171 4210 4212 O
all 172 175 4213 4216 O
scheduled 176 185 4217 4226 O
study 186 191 4227 4232 O
assessments 192 203 4233 4244 O

Weight 0 6 4245 4251 B-clinical_variable
stable 7 13 4252 4258 I-clinical_variable
( 14 15 4259 4260 O
+ 15 16 4260 4261 O
/- 16 18 4261 4263 O
5 19 20 4264 4265 O
lbs 21 24 4266 4269 O
) 24 25 4269 4270 O
for 26 29 4271 4274 O
the 30 33 4275 4278 O
previous 34 42 4279 4287 B-upper_bound
3 43 44 4288 4289 I-upper_bound
months 45 51 4290 4296 I-upper_bound

hepatic 0 7 4297 4304 B-clinical_variable
enzyme 8 14 4305 4311 I-clinical_variable
( 15 16 4312 4313 O
ALT 16 19 4313 4316 B-clinical_variable
/ 19 20 4316 4317 I-clinical_variable
AST 20 23 4317 4320 I-clinical_variable
) 23 24 4320 4321 O
concentrations 25 39 4322 4336 O
> 40 41 4337 4338 O
3 42 43 4339 4340 B-lower_bound
times 44 49 4341 4346 I-lower_bound
the 50 53 4347 4350 I-lower_bound
upper 54 59 4351 4356 I-lower_bound
limit 60 65 4357 4362 I-lower_bound
of 66 68 4363 4365 I-lower_bound
normal 69 75 4366 4372 I-lower_bound

planning 0 8 4373 4381 B-pregnancy
to 9 11 4382 4384 I-pregnancy
become 12 18 4385 4391 I-pregnancy
pregnant 19 27 4392 4400 I-pregnancy
( 28 29 4401 4402 O
self 29 33 4402 4406 O
or 34 36 4407 4409 O
partner 37 44 4410 4417 O
) 44 45 4417 4418 O
at 46 48 4419 4421 O
any 49 52 4422 4425 O
time 53 57 4426 4430 O
during 58 64 4431 4437 O
the 65 68 4438 4441 O
study 69 74 4442 4447 O

Does 0 4 0 4 O
not 5 8 5 8 O
have 9 13 9 13 O
family 14 20 14 20 O
member 21 27 21 27 O
with 28 32 28 32 O
bipolar 33 40 33 40 B-chronic_disease
disorder 41 49 41 49 I-chronic_disease

English 0 7 50 57 B-language_fluency
- 7 8 57 58 I-language_fluency
speaking 8 16 58 66 I-language_fluency

Have 0 4 67 71 O
cared 5 10 72 77 O
/ 10 11 77 78 O
supported 11 20 78 87 O
them 21 25 88 92 O
for 26 29 93 96 O
at 30 32 97 99 O
least 33 38 100 105 O
the 39 42 106 109 O
last 43 47 110 114 B-upper_bound
6 48 49 115 116 I-upper_bound
months 50 56 117 123 I-upper_bound
in 57 59 124 126 O
the 60 63 127 130 O
last 64 68 131 135 O
year 69 73 136 140 O

Insomnia 0 8 0 8 B-clinical_variable
Severity 9 17 9 17 I-clinical_variable
Index 18 23 18 23 I-clinical_variable
( 24 25 24 25 I-clinical_variable
ISI 25 28 25 28 I-clinical_variable
) 28 29 28 29 I-clinical_variable
score 30 35 30 35 I-clinical_variable
> 36 37 36 37 O
10 38 40 38 40 B-lower_bound
indicating 41 51 41 51 O
at 52 54 52 54 O
least 55 60 55 60 O
mild 61 65 61 65 O
insomnia 66 74 66 74 B-chronic_disease

accept 0 6 75 81 O
PAP 7 10 82 85 B-treatment
as 11 13 86 88 O
primary 14 21 89 96 O
/ 21 22 96 97 O
sole 22 26 97 101 O
OSA 27 30 102 105 B-treatment
therapy 31 38 106 113 I-treatment

been 0 4 114 118 O
given 5 10 119 124 O
a 11 12 125 126 O
prescription 13 25 127 139 O
for 26 29 140 143 O
PAP 30 33 144 147 O
and 34 37 148 151 O
filled 38 44 152 158 O
it 45 47 159 161 O
within 48 54 162 168 O
the 55 58 169 172 O
last 59 63 173 177 B-upper_bound
3 64 65 178 179 I-upper_bound
months 66 72 180 186 I-upper_bound

change 0 6 187 193 O
in 7 9 194 196 O
thyroid 10 17 197 204 B-treatment
medication 18 28 205 215 I-treatment
dosage 29 35 216 222 O
or 36 38 223 225 O
received 39 47 226 234 O
a 48 49 235 236 O
new 50 53 237 240 O
prescription 54 66 241 253 O
for 67 70 254 257 O
thyroid 71 78 258 265 O
medication 79 89 266 276 O
3 90 91 277 278 B-upper_bound
months 92 98 279 285 I-upper_bound
before 99 105 286 292 I-upper_bound
the 106 109 293 296 O
screening 110 119 297 306 O
visit 120 125 307 312 O

comorbid 0 8 313 321 B-chronic_disease
narcolepsy 9 19 322 332 I-chronic_disease
, 19 20 332 333 O
idiopathic 21 31 334 344 B-chronic_disease
hypersomnia 32 43 345 356 I-chronic_disease

consuming 0 9 357 366 B-clinical_variable
> 10 11 367 368 O
2 12 13 369 370 B-lower_bound
alcoholic 14 23 371 380 I-lower_bound
beverages 24 33 381 390 I-lower_bound
per 34 37 391 394 I-lower_bound
day 38 41 395 398 I-lower_bound
on 42 44 399 401 O
a 45 46 402 403 O
regular 47 54 404 411 O
basis 55 60 412 417 O

consuming 0 9 418 427 O
marijuana 10 19 428 437 O
in 20 22 438 440 O
any 23 26 441 444 O
form 27 31 445 449 O
on 32 34 450 452 O
a 35 36 453 454 O
regular 37 44 455 462 O
basis 45 50 463 468 O
> 51 52 469 470 O
1 52 53 470 471 B-lower_bound
time 54 58 472 476 I-lower_bound
per 59 62 477 480 I-lower_bound
week 63 67 481 485 I-lower_bound
, 67 68 485 486 O
or 69 71 487 489 O
if 72 74 490 492 O
used 75 79 493 497 O
after 80 85 498 503 O
4:00 86 90 504 508 O
p.m 91 94 509 512 O

have 0 4 513 517 O
a 5 6 518 519 O
diagnosis 7 16 520 529 O
of 17 19 530 532 O
OSA 20 23 533 536 B-chronic_disease
with 24 28 537 541 O
an 29 31 542 544 O
AHI 32 35 545 548 B-clinical_variable
> 36 37 549 550 O
5 38 39 551 552 B-lower_bound
on 40 42 553 555 O
a 43 44 556 557 O
diagnostic 45 55 558 568 O
polysomnogram 56 69 569 582 O

imminent 0 8 583 591 B-chronic_disease
risk 9 13 592 596 I-chronic_disease
for 14 17 597 600 I-chronic_disease
suicide 18 25 601 608 I-chronic_disease

lifetime 0 8 609 617 O
diagnosis 9 18 618 627 O
of 19 21 628 630 O
any 22 25 631 634 O
psychotic 26 35 635 644 B-chronic_disease
or 36 38 645 647 I-chronic_disease
bipolar 39 46 648 655 I-chronic_disease
disorder 47 55 656 664 I-chronic_disease
as 56 58 665 667 O
sleep 59 64 668 673 B-treatment
restriction 65 76 674 685 I-treatment
for 77 80 686 689 O
insomnia 81 89 690 698 B-chronic_disease
may 90 93 699 702 O
precipitate 94 105 703 714 O
hallucinations 106 120 715 729 O
and 121 124 730 733 O
mania 125 130 734 739 B-chronic_disease

participants 0 12 740 752 O
must 13 17 753 757 O
> 18 19 758 759 O
21 20 22 760 762 B-lower_bound
years 23 28 763 768 I-lower_bound
old 29 32 769 772 O

periodic 0 8 773 781 O
limb 9 13 782 786 O
movement 14 22 787 795 O
during 23 29 796 802 O
sleep 30 35 803 808 O
( 36 37 809 810 O
known 37 42 810 815 O
PLMS 43 47 816 820 B-clinical_variable
with 48 52 821 825 O
arousal 53 60 826 833 O
> 61 62 834 835 O
15 63 65 836 838 B-lower_bound
per 66 69 839 842 I-lower_bound
hour 70 74 843 847 I-lower_bound
) 74 75 847 848 O

restless 0 8 849 857 B-chronic_disease
legs 9 13 858 862 I-chronic_disease
syndrome 14 22 863 871 I-chronic_disease
( 23 24 872 873 O
score 24 29 873 878 O
of 30 32 879 881 O
> 33 34 882 883 O
11 34 36 883 885 B-lower_bound
in 37 39 886 888 O
the 40 43 889 892 O
IRLS 44 48 893 897 B-clinical_variable
) 48 49 897 898 O

terminal 0 8 899 907 B-chronic_disease
illness 9 16 908 915 I-chronic_disease
( 17 18 916 917 O
e.g. 18 22 917 921 O
, 22 23 921 922 O
cancer 24 30 923 929 B-cancer
) 30 31 929 930 O
, 31 32 930 931 O
or 33 35 932 934 O
neurological 36 48 935 947 B-chronic_disease
degenerative 49 61 948 960 I-chronic_disease
disease 62 69 961 968 I-chronic_disease
( 70 71 969 970 O
e.g. 71 75 970 974 O
, 75 76 974 975 O
dementia 77 85 976 984 B-chronic_disease
) 85 86 984 985 O

untreated 0 9 986 995 O
psychiatric 10 21 996 1007 B-chronic_disease
disorder 22 30 1008 1016 I-chronic_disease
( 31 32 1017 1018 O
e.g. 32 36 1018 1022 O
, 36 37 1022 1023 O
major 38 43 1024 1029 B-chronic_disease
depression 44 54 1030 1040 I-chronic_disease
) 54 55 1040 1041 O
found 56 61 1042 1047 O
on 62 64 1048 1050 O
structured 65 75 1051 1061 O
interviews 76 86 1062 1072 O
as 87 89 1073 1075 O
these 90 95 1076 1081 O
conditions 96 106 1082 1092 O
have 107 111 1093 1097 O
specific 112 120 1098 1106 O
treatments 121 131 1107 1117 B-treatment
and 132 135 1118 1121 O
it 136 138 1122 1124 O
would 139 144 1125 1130 O
be 145 147 1131 1133 O
inappropriate 148 161 1134 1147 O
not 162 165 1148 1151 O
to 166 168 1152 1154 O
offer 169 174 1155 1160 O
those 175 180 1161 1166 O
treatments 181 191 1167 1177 O

Currently 0 9 0 9 O
have 10 14 10 14 O
severe 15 21 15 21 B-chronic_disease
renal 22 27 22 27 I-chronic_disease
impairment 28 38 28 38 I-chronic_disease

Currently 0 9 39 48 O
receiving 10 19 49 58 O
any 20 23 59 62 O
other 24 29 63 68 O
treatment 30 39 69 78 O
for 40 43 79 82 O
levodopa 44 52 83 91 B-chronic_disease
- 52 53 91 92 I-chronic_disease
induced 53 60 92 99 I-chronic_disease
dyskinesia 61 71 100 110 I-chronic_disease
, 71 72 110 111 O
including 73 82 112 121 O
but 83 86 122 125 O
not 87 90 126 129 O
exclusive 91 100 130 139 O
to 101 103 140 142 O
deep 104 108 143 147 O
brain 109 114 148 153 O
stimulation 115 126 154 165 O

Currently 0 9 166 175 O
taking 10 16 176 182 O
a 17 18 183 184 O
levodopa 19 27 185 193 B-treatment
containing 28 38 194 204 O
medication 39 49 205 215 O
for 50 53 216 219 O
Parkinson 54 63 220 229 B-chronic_disease
's 63 65 229 231 I-chronic_disease
disease 66 73 232 239 I-chronic_disease

Currently 0 9 240 249 O
taking 10 16 250 256 O
between 17 24 257 264 O
200 25 28 265 268 B-lower_bound
- 28 29 268 269 O
500 29 32 269 272 B-upper_bound
mg 33 35 273 275 I-upper_bound
of 36 38 276 278 O
amantadine 39 49 279 289 B-treatment
daily 50 55 290 295 O
for 56 59 296 299 O
treatment 60 69 300 309 B-treatment
of 70 72 310 312 O
levodopa 73 81 313 321 B-chronic_disease
- 81 82 321 322 I-chronic_disease
induced 82 89 322 329 I-chronic_disease
dyskinesia 90 100 330 340 I-chronic_disease
with 101 105 341 345 O
insufficient 106 118 346 358 O
suppression 119 130 359 370 O
levodopa 131 139 371 379 O
- 139 140 379 380 O
induced 140 147 380 387 O
dyskinesia 148 158 388 398 O

Have 0 4 399 403 O
a 5 6 404 405 O
history 7 14 406 413 O
of 15 17 414 416 O
hepatic 18 25 417 424 B-chronic_disease
impairment 26 36 425 435 I-chronic_disease

Have 0 4 436 440 O
proprioceptive 5 19 441 455 B-chronic_disease
deficits 20 28 456 464 I-chronic_disease

Mild 0 4 465 469 O
to 5 7 470 472 O
Severe 8 14 473 479 O
dyskinesia 15 25 480 490 B-chronic_disease

Not 0 3 491 494 O
able 4 8 495 499 O
to 9 11 500 502 O
answer 12 18 503 509 O
a 19 20 510 511 O
patient 21 28 512 519 O
questionnaire 29 42 520 533 O
about 43 48 534 539 O
their 49 54 540 545 O
symptoms 55 63 546 554 O
of 64 66 555 557 O
Parkinson 67 76 558 567 B-chronic_disease
's 76 78 567 569 I-chronic_disease
disease 79 86 570 577 I-chronic_disease
and 87 90 578 581 O
dyskinesia 91 101 582 592 B-chronic_disease

Not 0 3 593 596 O
able 4 8 597 601 O
to 9 11 602 604 O
stand 12 17 605 610 O
unsupported 18 29 611 622 O
for 30 33 623 626 O
at 34 36 627 629 O
least 37 42 630 635 O
60 43 45 636 638 B-lower_bound
seconds 46 53 639 646 I-lower_bound

Parkinson 0 9 647 656 B-chronic_disease
's 9 11 656 658 I-chronic_disease
disease 12 19 659 666 I-chronic_disease
diagnosis 20 29 667 676 O

Pregnancy 0 9 677 686 B-pregnancy

Significant 0 11 687 698 B-chronic_disease
cognitive 12 21 699 708 I-chronic_disease
impairment 22 32 709 719 I-chronic_disease

Stable 0 6 720 726 B-treatment
medication 7 17 727 737 I-treatment
regimen 18 25 738 745 I-treatment
for 26 29 746 749 O
at 30 32 750 752 O
least 33 38 753 758 O
4 39 40 759 760 B-lower_bound
weeks 41 46 761 766 I-lower_bound
prior 47 52 767 772 I-lower_bound
to 53 55 773 775 O
study 56 61 776 781 O

Unable 0 6 782 788 O
to 7 9 789 791 O
swallow 10 17 792 799 O
study 18 23 800 805 B-treatment
drug 24 28 806 810 I-treatment
( 29 30 811 812 O
capsule 30 37 812 819 O
) 37 38 819 820 O

Current 0 7 0 7 O
use 8 11 8 11 O
of 12 14 12 14 O
opioid 15 21 15 21 B-treatment
pain 22 26 22 26 I-treatment
medications 27 38 27 38 I-treatment

Episodic 0 8 39 47 B-chronic_disease
migraine 9 17 48 56 I-chronic_disease
( 18 19 57 58 O
ICHD-3 19 25 58 64 O
- 25 26 64 65 O
beta 26 30 65 69 O
) 30 31 69 70 O
for 32 35 71 74 O
at 36 38 75 77 O
least 39 44 78 83 O
6 45 46 84 85 B-lower_bound
months 47 53 86 92 I-lower_bound
, 53 54 92 93 O
with 55 59 94 98 O
at 60 62 99 101 O
least 63 68 102 107 O
one 69 72 108 111 O
attack 73 79 112 118 O
per 80 83 119 122 O
month 84 89 123 128 O
and 90 93 129 132 O
less 94 98 133 137 O
than 99 103 138 142 O
15 104 106 143 145 B-upper_bound
attacks 107 114 146 153 I-upper_bound
per 115 118 154 157 I-upper_bound
month 119 124 158 163 I-upper_bound

History 0 7 164 171 O
of 8 10 172 174 O
neurological 11 23 175 187 B-chronic_disease
disorder 24 32 188 196 I-chronic_disease
( 33 34 197 198 O
e.g. 34 38 198 202 O
epilepsy 39 47 203 211 B-chronic_disease
, 47 48 211 212 O
stroke 49 55 213 219 B-chronic_disease
, 55 56 219 220 O
neuropathy 57 67 221 231 B-chronic_disease
, 67 68 231 232 O
neuropathic 69 80 233 244 B-chronic_disease
pain 81 85 245 249 I-chronic_disease
) 85 86 249 250 O

History 0 7 251 258 O
or 8 10 259 261 O
current 11 18 262 269 O
evidence 19 27 270 278 O
of 28 30 279 281 O
a 31 32 282 283 O
psychotic 33 42 284 293 B-chronic_disease
disorder 43 51 294 302 I-chronic_disease
( 52 53 303 304 O
e.g. 53 57 304 308 O
schizophrenia 58 71 309 322 B-chronic_disease
) 71 72 322 323 O
or 73 75 324 326 O
substance 76 85 327 336 O
abuse 86 91 337 342 O
; 91 92 342 343 O
bipolar 93 100 344 351 B-chronic_disease
or 101 103 352 354 O
severe 104 110 355 361 B-chronic_disease
major 111 116 362 367 I-chronic_disease
depression 117 127 368 378 I-chronic_disease
, 127 128 378 379 O
as 129 131 380 382 O
evidenced 132 141 383 392 O
by 142 144 393 395 O
Beck 145 149 396 400 B-clinical_variable
Depression 150 160 401 411 I-clinical_variable
score 161 166 412 417 I-clinical_variable
of 167 169 418 420 O
≥ 170 171 421 422 O
30 172 174 423 425 B-lower_bound

No 0 2 426 428 O
intake 3 9 429 435 O
of 10 12 436 438 O
opiate 13 19 439 445 B-treatment
medication 20 30 446 456 I-treatment
for 31 34 457 460 O
the 35 38 461 464 O
past 39 43 465 469 B-upper_bound
six 44 47 470 473 I-upper_bound
months 48 54 474 480 I-upper_bound

No 0 2 481 483 O
overuse 3 10 484 491 O
of 11 13 492 494 O
analgesic 14 23 495 504 B-treatment
medication 24 34 505 515 I-treatment
, 34 35 515 516 O
defined 36 43 517 524 O
as 44 46 525 527 O
regular 47 54 528 535 O
intake 55 61 536 542 O
on 62 64 543 545 O
≥15 65 68 546 549 O
days 69 73 550 554 I-lower_bound
per 74 77 555 558 I-lower_bound
month 78 83 559 564 I-lower_bound
for 84 87 565 568 O
more 88 92 569 573 O
than 93 97 574 578 O
3 98 99 579 580 B-lower_bound
months 100 106 581 587 I-lower_bound

Presence 0 8 588 596 O
of 9 11 597 599 O
any 12 15 600 603 O
other 16 21 604 609 O
systemic 22 30 610 618 O
or 31 33 619 621 O
chronic 34 41 622 629 B-chronic_disease
pain 42 46 630 634 I-chronic_disease
disorder 47 55 635 643 I-chronic_disease

Prior 0 5 644 649 B-treatment
use 6 9 650 653 I-treatment
of 10 12 654 656 I-treatment
tDCS 13 17 657 661 I-treatment

Current 0 7 0 7 B-pregnancy
pregnancy 8 17 8 17 I-pregnancy

Currently 0 9 18 27 O
on 10 12 28 30 O
pioglitazone 13 25 31 43 B-treatment
treatment 26 35 44 53 I-treatment
for 36 39 54 57 O
another 40 47 58 65 O
reason 48 54 66 72 O

HIV 0 3 73 76 B-chronic_disease
- 3 4 76 77 O
positive 4 12 77 85 O

History 0 7 86 93 O
of 8 10 94 96 O
bladder 11 18 97 104 B-cancer
cancer 19 25 105 111 I-cancer

History 0 7 112 119 O
of 8 10 120 122 O
cirrhosis 11 20 123 132 B-chronic_disease
of 21 23 133 135 I-chronic_disease
the 24 27 136 139 I-chronic_disease
liver 28 33 140 145 I-chronic_disease

History 0 7 146 153 O
of 8 10 154 156 O
diabetes 11 19 157 165 B-chronic_disease

History 0 7 166 173 O
of 8 10 174 176 O
heart 11 16 177 182 B-chronic_disease
failure 17 24 183 190 I-chronic_disease

Non 0 3 191 194 B-language_fluency
- 3 4 194 195 I-language_fluency
English 4 11 195 202 I-language_fluency
speaking 12 20 203 211 I-language_fluency

planning 0 8 212 220 B-pregnancy
to 9 11 221 223 I-pregnancy
become 12 18 224 230 I-pregnancy
pregnant 19 27 231 239 I-pregnancy
in 28 30 240 242 O
the 31 34 243 246 O
next 35 39 247 251 B-upper_bound
6 40 41 252 253 I-upper_bound
months 42 48 254 260 I-upper_bound

Acute 0 5 0 5 B-cancer
Promyelocytic 6 19 6 19 I-cancer
Leukemia 20 28 20 28 I-cancer

Age 0 3 29 32 B-age
≥18 4 7 33 36 O
years 8 13 37 42 I-lower_bound
at 14 16 43 45 O
the 17 20 46 49 O
time 21 25 50 54 O
of 26 28 55 57 O
informed 29 37 58 66 O
consent 38 45 67 74 O

Calculated 0 10 75 85 O
creatinine 11 21 86 96 B-clinical_variable
clearance 22 31 97 106 I-clinical_variable
≥30 32 35 107 110 O
mL 36 38 111 113 I-lower_bound
/ 38 39 113 114 I-lower_bound
min 39 42 114 117 I-lower_bound

Direct 0 6 118 124 O
bilirubin 7 16 125 134 B-clinical_variable
≤ 17 18 135 136 O
1.5 19 22 137 140 B-upper_bound
X 23 24 141 142 I-upper_bound
the 25 28 143 146 I-upper_bound
upper 29 34 147 152 I-upper_bound
limit 35 40 153 158 I-upper_bound
of 41 43 159 161 I-upper_bound
the 44 47 162 165 I-upper_bound
normal 48 54 166 172 I-upper_bound
range 55 60 173 178 I-upper_bound
( 61 62 179 180 I-upper_bound
ULN 62 65 180 183 I-upper_bound
) 65 66 183 184 I-upper_bound
, 66 67 184 185 O
alanine 68 75 186 193 B-clinical_variable
aminotransferase 76 92 194 210 I-clinical_variable
( 93 94 211 212 I-clinical_variable
ALT 94 97 212 215 I-clinical_variable
) 97 98 215 216 I-clinical_variable
and 99 102 217 220 O
aspartate 103 112 221 230 B-clinical_variable
aminotransferase 113 129 231 247 I-clinical_variable
( 130 131 248 249 I-clinical_variable
AST 131 134 249 252 I-clinical_variable
) 134 135 252 253 I-clinical_variable
≤ 136 137 254 255 O
3 138 139 256 257 B-upper_bound
X 140 141 258 259 I-upper_bound
ULN 142 145 260 263 I-upper_bound
unless 146 152 264 270 O
related 153 160 271 278 O
to 161 163 279 281 O
AML 164 167 282 285 B-cancer
or 168 170 286 288 O
Gilbert 171 178 289 296 B-chronic_disease
syndrome 179 187 297 305 I-chronic_disease
or 188 190 306 308 O
hemolysis 191 200 309 318 B-chronic_disease

Eastern 0 7 319 326 B-clinical_variable
Cooperative 8 19 327 338 I-clinical_variable
Oncology 20 28 339 347 I-clinical_variable
Group 29 34 348 353 I-clinical_variable
( 35 36 354 355 I-clinical_variable
ECOG 36 40 355 359 I-clinical_variable
) 40 41 359 360 I-clinical_variable
performance 42 53 361 372 I-clinical_variable
score 54 59 373 378 I-clinical_variable
0 60 61 379 380 B-lower_bound
- 61 62 380 381 O
2 62 63 381 382 B-upper_bound

In 0 2 383 385 O
first 3 8 386 391 O
or 9 11 392 394 O
subsequent 12 22 395 405 O
relapse 23 30 406 413 O
or 31 33 414 416 O
refractory 34 44 417 427 O
status 45 51 428 434 O
, 51 52 434 435 O
with 53 57 436 440 O
or 58 60 441 443 O
without 61 68 444 451 O
prior 69 74 452 457 B-treatment
hematopoietic 75 88 458 471 I-treatment
stem 89 93 472 476 I-treatment
cell 94 98 477 481 I-treatment
transplant 99 109 482 492 I-treatment
( 110 111 493 494 I-treatment
HSCT 111 115 494 498 I-treatment
) 115 116 498 499 I-treatment

LVEF 0 4 500 504 B-clinical_variable
≥ 5 6 505 506 O
45 7 9 507 509 B-lower_bound
% 9 10 509 510 I-lower_bound

Participation 0 13 511 524 O
in 14 16 525 527 O
clinical 17 25 528 536 B-treatment
trials 26 32 537 543 I-treatment
with 33 37 544 548 O
other 38 43 549 554 O
investigational 44 59 555 570 O
agents 60 66 571 577 O
not 67 70 578 581 O
included 71 79 582 590 O
in 80 82 591 593 O
this 83 87 594 598 O
trial 88 93 599 604 O
, 93 94 604 605 O
within 95 101 606 612 O
14 102 104 613 615 B-upper_bound
days 105 109 616 620 I-upper_bound
of 110 112 621 623 O
the 113 116 624 627 O
start 117 122 628 633 O
of 123 125 634 636 O
this 126 130 637 641 O
trial 131 136 642 647 O
and 137 140 648 651 O
throughout 141 151 652 662 O
the 152 155 663 666 O
duration 156 164 667 675 O
of 165 167 676 678 O
this 168 172 679 683 O
trial 173 178 684 689 O

Patients 0 8 690 698 O
with 9 13 699 703 O
MDS 14 17 704 707 B-cancer
transformed 18 29 708 719 O
to 30 32 720 722 O
AML 33 36 723 726 B-cancer
will 37 41 727 731 O
be 42 44 732 734 O
eligible 45 53 735 743 O
even 54 58 744 748 O
if 59 61 749 751 O
they 62 66 752 756 O
had 67 70 757 760 O
not 71 74 761 764 O
received 75 83 765 773 O
prior 84 89 774 779 B-treatment
therapy 90 97 780 787 I-treatment
for 98 101 788 791 O
AML 102 105 792 795 O

Pregnant 0 8 796 804 B-pregnancy

breast 0 6 805 811 O
feeding 7 14 812 819 O
women 15 20 820 825 B-gender

therapy 0 7 826 833 O
related 8 15 834 841 O
AML 16 19 842 845 O
( 20 21 846 847 O
t 21 22 847 848 B-cancer
- 22 23 848 849 I-cancer
AML 23 26 849 852 I-cancer
) 26 27 852 853 O
, 27 28 853 854 O
as 29 31 855 857 O
defined 32 39 858 865 O
by 40 42 866 868 O
World 43 48 869 874 O
Health 49 55 875 881 O
Organization 56 68 882 894 O
( 69 70 895 896 O
WHO 70 73 896 899 O
) 73 74 899 900 O
criteria 75 83 901 909 O

Abdominal 0 9 0 9 O
fistula 10 17 10 17 B-chronic_disease

Absolute 0 8 18 26 B-clinical_variable
Neutrophil 9 19 27 37 I-clinical_variable
Count 20 25 38 43 I-clinical_variable
( 26 27 44 45 I-clinical_variable
ANC 27 30 45 48 I-clinical_variable
) 30 31 48 49 I-clinical_variable
≥1,500 32 38 50 56 O
/ 38 39 56 57 I-lower_bound
mm3 39 42 57 60 I-lower_bound
( 43 44 61 62 O
no 44 46 62 64 O
CSF 47 50 65 68 O
support 51 58 69 76 O
) 58 59 76 77 O

Active 0 6 78 84 O
peptic 7 13 85 91 B-chronic_disease
ulcer 14 19 92 97 I-chronic_disease
disease 20 27 98 105 I-chronic_disease

Age 0 3 106 109 B-age
≥18 4 7 110 113 O
years 8 13 114 119 I-lower_bound

Alanine 0 7 120 127 B-clinical_variable
Aminotransferase 8 24 128 144 I-clinical_variable
( 25 26 145 146 I-clinical_variable
ALT 26 29 146 149 I-clinical_variable
) 29 30 149 150 I-clinical_variable
( 31 32 151 152 I-clinical_variable
SGPT 32 36 152 156 I-clinical_variable
) 36 37 156 157 I-clinical_variable
≤3.0 38 42 158 162 O
× 43 44 163 164 I-upper_bound
ULN 45 48 165 168 I-upper_bound

Any 0 3 169 172 O
history 4 11 173 180 O
of 12 14 181 183 O
congenital 15 25 184 194 O
long 26 30 195 199 O
QT 31 33 200 202 B-chronic_disease
syndrome 34 42 203 211 I-chronic_disease

Any 0 3 212 215 O
of 4 6 216 218 O
the 7 10 219 222 O
following 11 20 223 232 O
within 21 27 233 239 O
6 28 29 240 241 B-upper_bound
months 30 36 242 248 I-upper_bound
before 37 43 249 255 O
the 44 47 256 259 O
first 48 53 260 265 O
dose 54 58 266 270 O
of 59 61 271 273 O
study 62 67 274 279 O
treatment 68 77 280 289 B-treatment

Any 0 3 290 293 O
other 4 9 294 299 O
signs 10 15 300 305 O
indicative 16 26 306 316 O
of 27 29 317 319 O
pulmonary 30 39 320 329 B-chronic_disease
hemorrhage 40 50 330 340 I-chronic_disease
within 51 57 341 347 O
3 58 59 348 349 B-upper_bound
months 60 66 350 356 I-upper_bound
before 67 73 357 363 O
the 74 77 364 367 O
first 78 83 368 373 O
dose 84 88 374 378 O
of 89 91 379 381 O
study 92 97 382 387 O
treatment 98 107 388 397 B-treatment

Aspartate 0 9 398 407 B-clinical_variable
Aminotransferase 10 26 408 424 I-clinical_variable
( 27 28 425 426 I-clinical_variable
AST 28 31 426 429 I-clinical_variable
) 31 32 429 430 I-clinical_variable
( 33 34 431 432 I-clinical_variable
SGOT 34 38 432 436 I-clinical_variable
) 38 39 436 437 I-clinical_variable
≤3.0 40 44 438 442 O
× 45 46 443 444 I-upper_bound
ULN 47 50 445 448 I-upper_bound

Bilirubin 0 9 449 458 B-clinical_variable
( 10 11 459 460 O
Gilbert 11 18 460 467 B-chronic_disease
's 18 20 467 469 I-chronic_disease
Disease 21 28 470 477 I-chronic_disease
) 28 29 477 478 O
< 30 31 479 480 O
3.0 32 35 481 484 B-upper_bound
mg 36 38 485 487 I-upper_bound
/ 38 39 487 488 I-upper_bound
dL 39 41 488 490 I-upper_bound

Bilirubin 0 9 491 500 B-clinical_variable
≤ 10 11 501 502 O
1.5 12 15 503 506 B-upper_bound
x 16 17 507 508 I-upper_bound
upper 18 23 509 514 I-upper_bound
limit 24 29 515 520 I-upper_bound
of 30 32 521 523 I-upper_bound
normal 33 39 524 530 I-upper_bound
( 40 41 531 532 I-upper_bound
ULN 41 44 532 535 I-upper_bound
) 44 45 535 536 I-upper_bound

Bowel 0 5 537 542 B-chronic_disease
obstruction 6 17 543 554 I-chronic_disease
or 18 20 555 557 O
gastric 21 28 558 565 B-chronic_disease
outlet 29 35 566 572 I-chronic_disease
obstruction 36 47 573 584 I-chronic_disease

Cardiovascular 0 14 585 599 B-chronic_disease
disorders 15 24 600 609 I-chronic_disease

Clinically 0 10 610 620 O
- 10 11 620 621 O
significant 11 22 621 632 O
gastrointestinal 23 39 633 649 B-chronic_disease
bleeding 40 48 650 658 I-chronic_disease
within 49 55 659 665 O
6 56 57 666 667 B-upper_bound
months 58 64 668 674 I-upper_bound
before 65 71 675 681 I-upper_bound
the 72 75 682 685 O
first 76 81 686 691 O
dose 82 86 692 696 O
of 87 89 697 699 O
study 90 95 700 705 O
treatment 96 105 706 715 B-treatment
b. 106 108 716 718 O
Hemoptysis 108 118 718 728 B-clinical_variable
of 119 121 729 731 O
≥ 122 123 732 733 O
0.5 124 127 734 737 B-lower_bound
teaspoon 128 136 738 746 I-lower_bound
( 137 138 747 748 I-lower_bound
2.5ml 138 143 748 753 I-lower_bound
) 143 144 753 754 I-lower_bound
of 145 147 755 757 O
red 148 151 758 761 O
blood 152 157 762 767 O
within 158 164 768 774 O
3 165 166 775 776 B-upper_bound
months 167 173 777 783 I-upper_bound
before 174 180 784 790 I-upper_bound
the 181 184 791 794 O
first 185 190 795 800 O
dose 191 195 801 805 O
of 196 198 806 808 O
study 199 204 809 814 O
treatment 205 214 815 824 O

Concurrent 0 10 825 835 O
uncompensated 11 24 836 849 O
hypothyroidism 25 39 850 864 B-chronic_disease
or 40 42 865 867 O
thyroid 43 50 868 875 B-chronic_disease
dysfunction 51 62 876 887 I-chronic_disease
within 63 69 888 894 O
7 70 71 895 896 B-upper_bound
days 72 76 897 901 I-upper_bound
before 77 83 902 908 I-upper_bound
the 84 87 909 912 O
first 88 93 913 918 O
dose 94 98 919 923 O
of 99 101 924 926 O
study 102 107 927 932 O
treatment 108 117 933 942 B-treatment

Concurrent 0 10 943 953 O
uncontrolled 11 23 954 966 B-chronic_disease
hypertension 24 36 967 979 I-chronic_disease
defined 37 44 980 987 O
as 45 47 988 990 O
sustained 48 57 991 1000 O
BP 58 60 1001 1003 B-clinical_variable
> 61 62 1004 1005 O
140 63 66 1006 1009 B-lower_bound
mm 67 69 1010 1012 I-lower_bound
Hg 70 72 1013 1015 I-lower_bound
systolic 73 81 1016 1024 O
, 81 82 1024 1025 O
or 83 85 1026 1028 O
> 86 87 1029 1030 O
90 88 90 1031 1033 B-lower_bound
mm 91 93 1034 1036 I-lower_bound
Hg 94 96 1037 1039 I-lower_bound
diastolic 97 106 1040 1049 O
despite 107 114 1050 1057 O
optimal 115 122 1058 1065 B-treatment
antihypertensive 123 139 1066 1082 I-treatment
treatment 140 149 1083 1092 I-treatment
within 150 156 1093 1099 O
7 157 158 1100 1101 B-upper_bound
days 159 163 1102 1106 I-upper_bound
of 164 166 1107 1109 O
the 167 170 1110 1113 O
first 171 176 1114 1119 O
dose 177 181 1120 1124 O
of 182 184 1125 1127 O
study 185 190 1128 1133 O
treatment 191 200 1134 1143 O

Congestive 0 10 1144 1154 B-chronic_disease
heart 11 16 1155 1160 I-chronic_disease
failure 17 24 1161 1168 I-chronic_disease
( 25 26 1169 1170 I-chronic_disease
CHF 26 29 1170 1173 I-chronic_disease
): 29 31 1173 1175 I-chronic_disease
New 32 35 1176 1179 B-clinical_variable
York 36 40 1180 1184 I-clinical_variable
Heart 41 46 1185 1190 I-clinical_variable
Association 47 58 1191 1202 I-clinical_variable
( 59 60 1203 1204 I-clinical_variable
NYHA 60 64 1204 1208 I-clinical_variable
) 64 65 1208 1209 I-clinical_variable
Class 66 71 1210 1215 B-lower_bound
III 72 75 1216 1219 I-lower_bound
( 76 77 1220 1221 O
moderate 77 85 1221 1229 O
) 85 86 1229 1230 O
or 87 89 1231 1233 O
Class 90 95 1234 1239 B-upper_bound
IV 96 98 1240 1242 I-upper_bound
( 99 100 1243 1244 O
severe 100 106 1244 1250 O
) 106 107 1250 1251 O
at 108 110 1252 1254 O
the 111 114 1255 1258 O
time 115 119 1259 1263 O
of 120 122 1264 1266 O
screening 123 132 1267 1276 O

Creatinine 0 10 1277 1287 B-clinical_variable
clearance 11 20 1288 1297 I-clinical_variable
( 21 22 1298 1299 I-clinical_variable
CrCl 22 26 1299 1303 I-clinical_variable
) 26 27 1303 1304 I-clinical_variable
≥40 28 31 1305 1308 O
mL 32 34 1309 1311 I-lower_bound
/ 34 35 1311 1312 I-lower_bound
min 35 38 1312 1315 I-lower_bound

Eastern 0 7 1316 1323 B-clinical_variable
Cooperative 8 19 1324 1335 I-clinical_variable
Oncology 20 28 1336 1344 I-clinical_variable
Group 29 34 1345 1350 I-clinical_variable
( 35 36 1351 1352 I-clinical_variable
ECOG 36 40 1352 1356 I-clinical_variable
) 40 41 1356 1357 I-clinical_variable
performance 42 53 1358 1369 I-clinical_variable
status 54 60 1370 1376 I-clinical_variable
≤2 61 63 1377 1379 O

Female 0 6 1380 1386 B-gender
: 6 7 1386 1387 O
Multiply 8 16 1388 1396 O
above 17 22 1397 1402 O
result 23 29 1403 1409 O
by 30 32 1410 1412 O
0.85 33 37 1413 1417 B-lower_bound
≤ 38 39 1418 1419 O
1.5 40 43 1420 1423 B-upper_bound
x 44 45 1424 1425 I-upper_bound
ULN 46 49 1426 1429 I-upper_bound

First 0 5 1430 1435 O
dose 6 10 1436 1440 O
of 11 13 1441 1443 O
cabozantinib 14 26 1444 1456 B-treatment
occurs 27 33 1457 1463 O
at 34 36 1464 1466 O
least 37 42 1467 1472 O
28 43 45 1473 1475 B-lower_bound
days 46 50 1476 1480 I-lower_bound
after 51 56 1481 1486 O
surgery 57 64 1487 1494 B-treatment
, 64 65 1494 1495 O
and 66 69 1496 1499 O
the 70 73 1500 1503 O
subject 74 81 1504 1511 O
has 82 85 1512 1515 O
recovered 86 95 1516 1525 O
from 96 100 1526 1530 O
the 101 104 1531 1534 O
effects 105 112 1535 1542 O
of 113 115 1543 1545 O
surgery 116 123 1546 1553 O

For 0 3 1554 1557 O
this 4 8 1558 1562 O
reason 9 15 1563 1569 O
women 16 21 1570 1575 B-gender
of 22 24 1576 1578 O
child 25 30 1579 1584 O
- 30 31 1584 1585 O
bearing 31 38 1585 1592 O
potential 39 48 1593 1602 O
and 49 52 1603 1606 O
men 53 56 1607 1610 O
must 57 61 1611 1615 O
agree 62 67 1616 1621 B-contraception_consent
to 68 70 1622 1624 I-contraception_consent
use 71 74 1625 1628 I-contraception_consent
adequate 75 83 1629 1637 I-contraception_consent
contraception 84 97 1638 1651 I-contraception_consent
( 98 99 1652 1653 I-contraception_consent
hormonal 99 107 1653 1661 I-contraception_consent
or 108 110 1662 1664 I-contraception_consent
barrier 111 118 1665 1672 I-contraception_consent
method 119 125 1673 1679 I-contraception_consent
of 126 128 1680 1682 I-contraception_consent
birth 129 134 1683 1688 I-contraception_consent
control 135 142 1689 1696 I-contraception_consent
; 142 143 1696 1697 I-contraception_consent
abstinence 144 154 1698 1708 I-contraception_consent
) 154 155 1708 1709 I-contraception_consent
prior 156 161 1710 1715 O
to 162 164 1716 1718 O
study 165 170 1719 1724 O
entry 171 176 1725 1730 O
and 177 180 1731 1734 O
for 181 184 1735 1738 O
4 185 186 1739 1740 B-upper_bound
months 187 193 1741 1747 I-upper_bound
after 194 199 1748 1753 I-upper_bound
the 200 203 1754 1757 O
last 204 208 1758 1762 O
dose 209 213 1763 1767 O
of 214 216 1768 1770 O
study 217 222 1771 1776 B-treatment
drug 223 227 1777 1781 I-treatment
, 227 228 1781 1782 O
even 229 233 1783 1787 O
if 234 236 1788 1790 O
oral 237 241 1791 1795 O
contraceptives 242 256 1796 1810 O
are 257 260 1811 1814 O
used 261 265 1815 1819 O

Gastrointestinal 0 16 1820 1836 B-chronic_disease
disorders 17 26 1837 1846 I-chronic_disease
particularly 27 39 1847 1859 O
those 40 45 1860 1865 O
associated 46 56 1866 1876 O
with 57 61 1877 1881 O
a 62 63 1882 1883 O
high 64 68 1884 1888 O
risk 69 73 1889 1893 O
of 74 76 1894 1896 O
perforation 77 88 1897 1908 B-chronic_disease
or 89 91 1909 1911 O
fistula 92 99 1912 1919 B-chronic_disease
formation 100 109 1920 1929 I-chronic_disease

Gastrointestinal 0 16 1930 1946 B-chronic_disease
perforation 17 28 1947 1958 I-chronic_disease

Hemoglobin 0 10 1959 1969 B-clinical_variable
≥9 11 13 1970 1972 O
g 14 15 1973 1974 I-lower_bound
/ 15 16 1974 1975 I-lower_bound
dL 16 18 1975 1977 I-lower_bound

History 0 7 1978 1985 O
of 8 10 1986 1988 O
organ 11 16 1989 1994 B-treatment
transplant 17 27 1995 2005 I-treatment

History 0 7 2006 2013 O
of 8 10 2014 2016 O
surgery 11 18 2017 2024 B-treatment

Inflammatory 0 12 2025 2037 B-chronic_disease
bowel 13 18 2038 2043 I-chronic_disease
disease 19 26 2044 2051 I-chronic_disease
( 27 28 2052 2053 O
including 28 37 2053 2062 O
ulcerative 38 48 2063 2073 B-chronic_disease
colitis 49 56 2074 2081 I-chronic_disease
and 57 60 2082 2085 O
Crohn 61 66 2086 2091 B-chronic_disease
's 66 68 2091 2093 I-chronic_disease
disease 69 76 2094 2101 I-chronic_disease
) 76 77 2101 2102 O
, 77 78 2102 2103 O
diverticulitis 79 93 2104 2118 B-chronic_disease
, 93 94 2118 2119 O
cholecystitis 95 108 2120 2133 B-chronic_disease
, 108 109 2133 2134 O
symptomatic 110 121 2135 2146 O
cholangitis 122 133 2147 2158 B-chronic_disease
or 134 136 2159 2161 O
appendicitis 137 149 2162 2174 B-chronic_disease

Intra 0 5 2175 2180 B-chronic_disease
- 5 6 2180 2181 I-chronic_disease
abdominal 6 15 2181 2190 I-chronic_disease
abscess 16 23 2191 2198 I-chronic_disease

Intra 0 5 2199 2204 O
- 5 6 2204 2205 O
abdominal 6 15 2205 2214 O
tumor 16 21 2215 2220 B-cancer
/ 21 22 2220 2221 O
metastases 22 32 2221 2231 B-cancer
invading 33 41 2232 2240 O
GI 42 44 2241 2243 O
mucosa 45 51 2244 2250 O

Karnofsky 0 9 2251 2260 B-clinical_variable
≥60 10 13 2261 2264 O
% 13 14 2264 2265 I-lower_bound

Lipase 0 6 2266 2272 B-clinical_variable
( 7 8 2273 2274 O
no 8 10 2274 2276 O
radiologic 11 21 2277 2287 O
or 22 24 2288 2290 O
clinical 25 33 2291 2299 O
evidence 34 42 2300 2308 O
of 43 45 2309 2311 O
pancreatitis 46 58 2312 2324 B-chronic_disease
) 58 59 2324 2325 O
< 60 61 2326 2327 O
2.0 62 65 2328 2331 B-upper_bound
x 66 67 2332 2333 I-upper_bound
ULN 68 71 2334 2337 I-upper_bound

Malabsorption 0 13 2338 2351 B-chronic_disease
syndrome 14 22 2352 2360 I-chronic_disease

Male 0 4 2361 2365 B-gender
: 4 5 2365 2366 O
CrCl 6 10 2367 2371 O
( 11 12 2372 2373 O
mL 12 14 2373 2375 O
/ 14 15 2375 2376 O
min 15 18 2376 2379 O
) 18 19 2379 2380 O
= 20 21 2381 2382 O
( 22 23 2383 2384 O
140 23 26 2384 2387 O
- 27 28 2388 2389 O
age 29 32 2390 2393 B-age
) 32 33 2393 2394 O
× 34 35 2395 2396 O
wt 36 38 2397 2399 B-clinical_variable
( 39 40 2400 2401 O
kg 40 42 2401 2403 O
) 42 43 2403 2404 O
/ 44 45 2405 2406 O
( 46 47 2407 2408 O
serum 47 52 2408 2413 O
creatinine 53 63 2414 2424 O
× 64 65 2425 2426 O
72 66 68 2427 2429 O
) 68 69 2429 2430 O

Other 0 5 2431 2436 O
disorders 6 15 2437 2446 B-chronic_disease
associated 16 26 2447 2457 O
with 27 31 2458 2462 O
a 32 33 2463 2464 O
high 34 38 2465 2469 O
risk 39 43 2470 2474 O
of 44 46 2475 2477 O
fistula 47 54 2478 2485 O
formation 55 64 2486 2495 O
including 65 74 2496 2505 O
Percutaneous 75 87 2506 2518 B-treatment
Endoscopic 88 98 2519 2529 I-treatment
Gastrostomy 99 110 2530 2541 I-treatment
( 111 112 2542 2543 I-treatment
PEG 112 115 2543 2546 I-treatment
) 115 116 2546 2547 I-treatment
tube 117 121 2548 2552 I-treatment
placement 122 131 2553 2562 I-treatment
within 132 138 2563 2569 O
3 139 140 2570 2571 B-upper_bound
months 141 147 2572 2578 I-upper_bound
before 148 154 2579 2585 I-upper_bound
the 155 158 2586 2589 O
first 159 164 2590 2595 O
dose 165 169 2596 2600 O
of 170 172 2601 2603 O
study 173 178 2604 2609 B-treatment
therapy 179 186 2610 2617 I-treatment

Other 0 5 2618 2623 O
enzyme 6 12 2624 2630 O
inducing 13 21 2631 2639 O
agents 22 28 2640 2646 O
prohibited 29 39 2647 2657 O
within 40 46 2658 2664 O
2 47 48 2665 2666 B-upper_bound
weeks 49 54 2667 2672 I-upper_bound
before 55 61 2673 2679 I-upper_bound
the 62 65 2680 2683 O
first 66 71 2684 2689 O
dose 72 76 2690 2694 O
of 77 79 2695 2697 O
cabozantinib 80 92 2698 2710 B-treatment
include 93 100 2711 2718 O
rifampin 101 109 2719 2727 B-treatment
, 109 110 2727 2728 O
rifabutin 111 120 2729 2738 B-treatment
, 120 121 2738 2739 O
rifapentin 122 132 2740 2750 B-treatment
, 132 133 2750 2751 O
and 134 137 2752 2755 O
St. 138 141 2756 2759 B-treatment
John 142 146 2760 2764 I-treatment
's 146 148 2764 2766 I-treatment
Wort 149 153 2767 2771 I-treatment

Other 0 5 2772 2777 O
minor 6 11 2778 2783 B-treatment
surgery 12 19 2784 2791 I-treatment
within 20 26 2792 2798 O
28 27 29 2799 2801 B-upper_bound
days 30 34 2802 2806 I-upper_bound
of 35 37 2807 2809 O
the 38 41 2810 2813 O
first 42 47 2814 2819 O
dose 48 52 2820 2824 O
of 53 55 2825 2827 O
cabozantinib 56 68 2828 2840 B-treatment
if 69 71 2841 2843 O
there 72 77 2844 2849 O
were 78 82 2850 2854 O
no 83 85 2855 2857 O
wound 86 91 2858 2863 O
healing 92 99 2864 2871 O
complications 100 113 2872 2885 O

Patients 0 8 2886 2894 O
must 9 13 2895 2899 O
have 14 18 2900 2904 O
normal 19 25 2905 2911 O
organ 26 31 2912 2917 O
and 32 35 2918 2921 O
marrow 36 42 2922 2928 O
function 43 51 2929 2937 O
as 52 54 2938 2940 O
defined 55 62 2941 2948 O
below 63 68 2949 2954 O
: 68 69 2954 2955 O
( 70 71 2956 2957 O
within 71 77 2957 2963 O
4 78 79 2964 2965 B-upper_bound
days 80 84 2966 2970 I-upper_bound
of 85 87 2971 2973 O
beginning 88 97 2974 2983 O
treatment 98 107 2984 2993 B-treatment
unless 108 114 2994 3000 O
noted 115 120 3001 3006 O
otherwise 121 130 3007 3016 O
) 130 131 3016 3017 O

Patients 0 8 3018 3026 O
must 9 13 3027 3031 O
have 14 18 3032 3036 O
received 19 27 3037 3045 O
at 28 30 3046 3048 O
least 31 36 3049 3054 O
one 37 40 3055 3058 O
regimen 41 48 3059 3066 O
for 49 52 3067 3070 O
systemic 53 61 3071 3079 B-chronic_disease
disease 62 69 3080 3087 I-chronic_disease
which 70 75 3088 3093 O
may 76 79 3094 3097 O
be 80 82 3098 3100 O
cytotoxic 83 92 3101 3110 B-treatment
or 93 95 3111 3113 O
oral 96 100 3114 3118 B-treatment
tyrosine 101 109 3119 3127 I-treatment
kinase 110 116 3128 3134 I-treatment
inhibitor 117 126 3135 3144 I-treatment
therapy 127 134 3145 3152 I-treatment

Patients 0 8 3153 3161 O
must 9 13 3162 3166 O
have 14 18 3167 3171 O
tumor 19 24 3172 3177 B-cancer
tissue 25 31 3178 3184 O
available 32 41 3185 3194 O
for 42 45 3195 3198 O
submission 46 56 3199 3209 O
that 57 61 3210 3214 O
is 62 64 3215 3217 O
sufficient 65 75 3218 3228 O
to 76 78 3229 3231 O
complete 79 87 3232 3240 O
c 88 89 3241 3242 O
- 89 90 3242 3243 O
MET 90 93 3243 3246 O
Fluorescence 94 106 3247 3259 B-treatment
in 107 109 3260 3262 I-treatment
Situ 110 114 3263 3267 I-treatment
Hybridization 115 128 3268 3281 I-treatment
( 129 130 3282 3283 I-treatment
FISH 130 134 3283 3287 I-treatment
) 134 135 3287 3288 I-treatment
studies 136 143 3289 3296 O
as 144 146 3297 3299 O
well 147 151 3300 3304 O
as 152 154 3305 3307 O
routine 155 162 3308 3315 O
molecular 163 172 3316 3325 O
profiling 173 182 3326 3335 O
at 183 185 3336 3338 O
the 186 189 3339 3342 O
UPMC 190 194 3343 3347 O

Patients 0 8 3348 3356 O
receiving 9 18 3357 3366 O
glucocorticoids 19 34 3367 3382 B-treatment
must 35 39 3383 3387 O
be 40 42 3388 3390 O
on 43 45 3391 3393 O
a 46 47 3394 3395 O
stable 48 54 3396 3402 O
dose 55 59 3403 3407 O
of 60 62 3408 3410 O
glucocorticoids 63 78 3411 3426 O
during 79 85 3427 3433 O
the 86 89 3434 3437 O
5 90 91 3438 3439 B-upper_bound
days 92 96 3440 3444 I-upper_bound
prior 97 102 3445 3450 I-upper_bound
to 103 105 3451 3453 O
the 106 109 3454 3457 O
baseline 110 118 3458 3466 O
brain 119 124 3467 3472 B-treatment
imaging 125 132 3473 3480 I-treatment

Patients 0 8 3481 3489 O
who 9 12 3490 3493 O
have 13 17 3494 3498 O
undergone 18 27 3499 3508 O
treatment 28 37 3509 3518 B-treatment
for 38 41 3519 3522 O
their 42 47 3523 3528 O
brain 48 53 3529 3534 B-treatment
metastases 54 64 3535 3545 I-treatment
with 65 69 3546 3550 O
whole 70 75 3551 3556 B-treatment
brain 76 81 3557 3562 I-treatment
radiotherapy 82 94 3563 3575 I-treatment
, 94 95 3575 3576 O
stereotactic 96 108 3577 3589 B-treatment
radiosurgery 109 121 3590 3602 I-treatment
, 121 122 3602 3603 O
or 123 125 3604 3606 O
surgical 126 134 3607 3615 B-treatment
resection 135 144 3616 3625 I-treatment
must 145 149 3626 3630 O
be 150 152 3631 3633 O
clinically 153 163 3634 3644 O
stable 164 170 3645 3651 O
and 171 174 3652 3655 O
recovered 175 184 3656 3665 O
from 185 189 3666 3670 O
all 190 193 3671 3674 O
procedures 194 204 3675 3685 O
at 205 207 3686 3688 O
the 208 211 3689 3692 O
time 212 216 3693 3697 O
of 217 219 3698 3700 O
study 220 225 3701 3706 O
enrollment 226 236 3707 3717 O

Patients 0 8 3718 3726 O
with 9 13 3727 3731 O
clinically 14 24 3732 3742 O
asymptomatic 25 37 3743 3755 O
untreated 38 47 3756 3765 O
brain 48 53 3766 3771 B-cancer
metastases 54 64 3772 3782 I-cancer
will 65 69 3783 3787 O
be 70 72 3788 3790 O
allowed 73 80 3791 3798 O
on 81 83 3799 3801 O
trial 84 89 3802 3807 O
at 90 92 3808 3810 O
the 93 96 3811 3814 O
discretion 97 107 3815 3825 O
of 108 110 3826 3828 O
the 111 114 3829 3832 O
treating 115 123 3833 3841 O
physician 124 133 3842 3851 O

Patients 0 8 3852 3860 O
' 8 9 3860 3861 O
tumors 10 16 3862 3868 B-cancer
must 17 21 3869 3873 O
undergo 22 29 3874 3881 O
testing 30 37 3882 3889 O
for 38 41 3890 3893 O
Epidermal 42 51 3894 3903 B-treatment
Growth 52 58 3904 3910 I-treatment
Factor 59 65 3911 3917 I-treatment
Receptor 66 74 3918 3926 I-treatment
( 75 76 3927 3928 I-treatment
EGFR 76 80 3928 3932 I-treatment
) 80 81 3932 3933 I-treatment
exon 82 86 3934 3938 I-treatment
19 87 89 3939 3941 I-treatment
deletion 90 98 3942 3950 I-treatment
, 98 99 3950 3951 O
EGFR 100 104 3952 3956 B-treatment
exon 105 109 3957 3961 I-treatment
21 110 112 3962 3964 I-treatment
L858R 113 118 3965 3970 I-treatment
substitution 119 131 3971 3983 I-treatment
, 131 132 3983 3984 O
and 133 136 3985 3988 O
anaplastic 137 147 3989 3999 B-treatment
lymphoma 148 156 4000 4008 I-treatment
kinase 157 163 4009 4015 I-treatment
( 164 165 4016 4017 I-treatment
ALK 165 168 4017 4020 I-treatment
) 168 169 4020 4021 I-treatment
rearrangements 170 184 4022 4036 O

Platelets 0 9 4037 4046 B-clinical_variable
≥100,000 10 18 4047 4055 O
/ 18 19 4055 4056 I-lower_bound
mm3 19 22 4056 4059 I-lower_bound

Previously 0 10 4060 4070 O
treated 11 18 4071 4078 O
patients 19 27 4079 4087 O
with 28 32 4088 4092 O
non 33 36 4093 4096 B-cancer
- 36 37 4096 4097 I-cancer
squamous 37 45 4097 4105 I-cancer
NSCLC 46 51 4106 4111 I-cancer
who 52 55 4112 4115 O
have 56 60 4116 4120 O
had 61 64 4121 4124 O
brain 65 70 4125 4130 B-cancer
metastases 71 81 4131 4141 I-cancer
at 82 84 4142 4144 O
any 85 88 4145 4148 O
point 89 94 4149 4154 O
in 95 97 4155 4157 O
their 98 103 4158 4163 O
treatment 104 113 4164 4173 B-treatment
history 114 121 4174 4181 O

Prior 0 5 4182 4187 B-treatment
treatment 6 15 4188 4197 I-treatment
with 16 20 4198 4202 I-treatment
cabozantinib 21 33 4203 4215 I-treatment
or 34 36 4216 4218 O
other 37 42 4219 4224 O
c 43 44 4225 4226 B-treatment
- 44 45 4226 4227 I-treatment
MET 45 48 4227 4230 I-treatment
directed 49 57 4231 4239 I-treatment
therapy 58 65 4240 4247 I-treatment

Serious 0 7 4248 4255 O
active 8 14 4256 4262 B-chronic_disease
infection 15 24 4263 4272 I-chronic_disease
requiring 25 34 4273 4282 O
systemic 35 43 4283 4291 B-treatment
treatment 44 53 4292 4301 I-treatment
within 54 60 4302 4308 O
28 61 63 4309 4311 B-upper_bound
days 64 68 4312 4316 I-upper_bound
before 69 75 4317 4323 O
the 76 79 4324 4327 O
first 80 85 4328 4333 O
dose 86 90 4334 4338 O
of 91 93 4339 4341 O
study 94 99 4342 4347 O
treatment 100 109 4348 4357 O

Serious 0 7 4358 4365 B-chronic_disease
non 8 11 4366 4369 I-chronic_disease
- 11 12 4369 4370 I-chronic_disease
healing 12 19 4370 4377 I-chronic_disease
wound 20 25 4378 4383 I-chronic_disease
/ 25 26 4383 4384 O
ulcer 26 31 4384 4389 B-chronic_disease
/ 31 32 4389 4390 O
bone 32 36 4390 4394 O
fracture 37 45 4395 4403 O
within 46 52 4404 4410 O
28 53 55 4411 4413 B-upper_bound
days 56 60 4414 4418 I-upper_bound
before 61 67 4419 4425 I-upper_bound
the 68 71 4426 4429 O
first 72 77 4430 4435 O
dose 78 82 4436 4440 O
of 83 85 4441 4443 O
study 86 91 4444 4449 O
treatment 92 101 4450 4459 B-treatment

Serum 0 5 4460 4465 B-clinical_variable
creatinine 6 16 4466 4476 I-clinical_variable
≤ 17 18 4477 4478 O
1.5 19 22 4479 4482 B-upper_bound
x 23 24 4483 4484 I-upper_bound
ULN 25 28 4485 4488 I-upper_bound

Serum 0 5 4489 4494 B-clinical_variable
phosphorus 6 16 4495 4505 I-clinical_variable
, 16 17 4505 4506 O
calcium 18 25 4507 4514 B-clinical_variable
, 25 26 4514 4515 O
magnesium 27 36 4516 4525 B-clinical_variable
and 37 40 4526 4529 O
potassium 41 50 4530 4539 B-clinical_variable
≥ 51 52 4540 4541 O
LLN 53 56 4542 4545 O

Subjects 0 8 4546 4554 O
with 9 13 4555 4559 O
a 14 15 4560 4561 O
history 16 23 4562 4569 O
of 24 26 4570 4572 O
early 27 32 4573 4578 O
stage 33 38 4579 4584 O
or 39 41 4585 4587 O
locally 42 49 4588 4595 O
advanced 50 58 4596 4604 O
non 59 62 4605 4608 B-cancer
- 62 63 4608 4609 I-cancer
metastatic 63 73 4609 4619 I-cancer
prostate 74 82 4620 4628 I-cancer
cancer 83 89 4629 4635 I-cancer
within 90 96 4636 4642 O
2 97 98 4643 4644 B-upper_bound
years 99 104 4645 4650 I-upper_bound
of 105 107 4651 4653 O
the 108 111 4654 4657 O
start 112 117 4658 4663 O
of 118 120 4664 4666 O
study 121 126 4667 4672 O
treatment 127 136 4673 4682 B-treatment
may 137 140 4683 4686 O
be 141 143 4687 4689 O
included 144 152 4690 4698 O
in 153 155 4699 4701 O
the 156 159 4702 4705 O
study 160 165 4706 4711 O

The 0 3 4712 4715 O
subject 4 11 4716 4723 O
has 12 15 4724 4727 O
a 16 17 4728 4729 O
corrected 18 27 4730 4739 O
QT 28 30 4740 4742 B-clinical_variable
interval 31 39 4743 4751 I-clinical_variable
calculated 40 50 4752 4762 I-clinical_variable
by 51 53 4763 4765 I-clinical_variable
the 54 57 4766 4769 I-clinical_variable
Fridericia 58 68 4770 4780 I-clinical_variable
formula 69 76 4781 4788 I-clinical_variable
( 77 78 4789 4790 I-clinical_variable
QTcF 78 82 4790 4794 I-clinical_variable
) 82 83 4794 4795 I-clinical_variable
> 84 85 4796 4797 O
500 85 88 4797 4800 B-lower_bound
ms 89 91 4801 4803 I-lower_bound
within 92 98 4804 4810 O
28 99 101 4811 4813 B-upper_bound
days 102 106 4814 4818 I-upper_bound
before 107 113 4819 4825 I-upper_bound
randomization 114 127 4826 4839 O

The 0 3 4840 4843 O
subject 4 11 4844 4851 O
has 12 15 4852 4855 O
a 16 17 4856 4857 O
previously 18 28 4858 4868 O
identified 29 39 4869 4879 O
allergy 40 47 4880 4887 O
or 48 50 4888 4890 O
hypersensitivity 51 67 4891 4907 O
to 68 70 4908 4910 O
components 71 81 4911 4921 B-allergy_name
of 82 84 4922 4924 I-allergy_name
the 85 88 4925 4928 I-allergy_name
study 89 94 4929 4934 I-allergy_name
treatment 95 104 4935 4944 I-allergy_name
formulation 105 116 4945 4956 I-allergy_name

The 0 3 4957 4960 O
subject 4 11 4961 4968 O
has 12 15 4969 4972 O
evidence 16 24 4973 4981 O
of 25 27 4982 4984 O
acute 28 33 4985 4990 O
intracranial 34 46 4991 5003 B-chronic_disease
or 47 49 5004 5006 I-chronic_disease
intratumoral 50 62 5007 5019 I-chronic_disease
hemorrhage 63 73 5020 5030 I-chronic_disease
either 74 80 5031 5037 O
by 81 83 5038 5040 O
MRI 84 87 5041 5044 B-treatment
or 88 90 5045 5047 O
computerized 91 103 5048 5060 B-treatment
tomography 104 114 5061 5071 I-treatment
( 115 116 5072 5073 I-treatment
CT 116 118 5073 5075 I-treatment
) 118 119 5075 5076 I-treatment
scan 120 124 5077 5081 I-treatment

The 0 3 5082 5085 O
subject 4 11 5086 5093 O
has 12 15 5094 5097 O
evidence 16 24 5098 5106 O
of 25 27 5107 5109 O
tumor 28 33 5110 5115 B-cancer
invading 34 42 5116 5124 O
the 43 46 5125 5128 O
Gastro 47 53 5129 5135 O
Intestinal 54 64 5136 5146 O
( 65 66 5147 5148 O
GI 66 68 5148 5150 O
) 68 69 5150 5151 O
tract 70 75 5152 5157 O
( 76 77 5158 5159 O
esophagus 77 86 5159 5168 O
, 86 87 5168 5169 O
stomach 88 95 5170 5177 O
, 95 96 5177 5178 O
small 97 102 5179 5184 O
or 103 105 5185 5187 O
large 106 111 5188 5193 O
bowel 112 117 5194 5199 O
, 117 118 5199 5200 O
rectum 119 125 5201 5207 O
or 126 128 5208 5210 O
anus 129 133 5211 5215 O
) 133 134 5215 5216 O
, 134 135 5216 5217 O
or 136 138 5218 5220 O
any 139 142 5221 5224 O
evidence 143 151 5225 5233 O
of 152 154 5234 5236 O
endotracheal 155 167 5237 5249 B-cancer
or 168 170 5250 5252 O
endobronchial 171 184 5253 5266 B-cancer
tumor 185 190 5267 5272 I-cancer
within 191 197 5273 5279 O
28 198 200 5280 5282 B-upper_bound
days 201 205 5283 5287 I-upper_bound
before 206 212 5288 5294 I-upper_bound
the 213 216 5295 5298 O
first 217 222 5299 5304 O
dose 223 227 5305 5309 O
of 228 230 5310 5312 O
cabozantinib 231 243 5313 5325 B-treatment

The 0 3 5326 5329 O
subject 4 11 5330 5337 O
has 12 15 5338 5341 O
had 16 19 5342 5345 O
an 20 22 5346 5348 O
assessment 23 33 5349 5359 O
of 34 36 5360 5362 O
all 37 40 5363 5366 O
extracranial 41 53 5367 5379 B-chronic_disease
disease 54 61 5380 5387 I-chronic_disease
sites 62 67 5388 5393 O
( 68 69 5394 5395 O
e.g. 69 73 5395 5399 O
, 73 74 5399 5400 O
by 75 77 5401 5403 O
computerized 78 90 5404 5416 B-treatment
tomography 91 101 5417 5427 I-treatment
( 102 103 5428 5429 I-treatment
CT 103 105 5429 5431 I-treatment
) 105 106 5431 5432 I-treatment
scan 107 111 5433 5437 I-treatment
, 111 112 5437 5438 O
positron 113 121 5439 5447 B-treatment
emission 122 130 5448 5456 I-treatment
tomography 131 141 5457 5467 I-treatment
- 141 142 5467 5468 I-treatment
CT 142 144 5468 5470 I-treatment
, 144 145 5470 5471 O
and 146 149 5472 5475 O
bone 150 154 5476 5480 B-treatment
scan 155 159 5481 5485 I-treatment
as 160 162 5486 5488 O
appropriate 163 174 5489 5500 O
) 174 175 5500 5501 O
within 176 182 5502 5508 O
28 183 185 5509 5511 B-upper_bound
days 186 190 5512 5516 I-upper_bound
before 191 197 5517 5523 I-upper_bound
the 198 201 5524 5527 O
first 202 207 5528 5533 O
dose 208 212 5534 5538 O
of 213 215 5539 5541 O
cabozantinib 216 228 5542 5554 B-treatment

The 0 3 5555 5558 O
subject 4 11 5559 5566 O
has 12 15 5567 5570 O
had 16 19 5571 5574 O
evidence 20 28 5575 5583 O
within 29 35 5584 5590 O
2 36 37 5591 5592 B-upper_bound
years 38 43 5593 5598 I-upper_bound
of 44 46 5599 5601 O
the 47 50 5602 5605 O
start 51 56 5606 5611 O
of 57 59 5612 5614 O
study 60 65 5615 5620 O
treatment 66 75 5621 5630 B-treatment
of 76 78 5631 5633 O
another 79 86 5634 5641 O
malignancy 87 97 5642 5652 B-cancer
which 98 103 5653 5658 O
required 104 112 5659 5667 O
systemic 113 121 5668 5676 B-treatment
treatment 122 131 5677 5686 I-treatment

The 0 3 5687 5690 O
subject 4 11 5691 5698 O
has 12 15 5699 5702 O
not 16 19 5703 5706 O
recovered 20 29 5707 5716 O
to 30 32 5717 5719 O
baseline 33 41 5720 5728 O
or 42 44 5729 5731 O
CTCAE 45 50 5732 5737 B-clinical_variable
≤ 51 52 5738 5739 O
Grade 53 58 5740 5745 B-upper_bound
1 59 60 5746 5747 I-upper_bound
from 61 65 5748 5752 O
toxicity 66 74 5753 5761 O
due 75 78 5762 5765 O
to 79 81 5766 5768 O
all 82 85 5769 5772 O
prior 86 91 5773 5778 B-treatment
therapies 92 101 5779 5788 I-treatment

The 0 3 5789 5792 O
subject 4 11 5793 5800 O
has 12 15 5801 5804 O
prothrombin 16 27 5805 5816 B-clinical_variable
time 28 32 5817 5821 I-clinical_variable
( 33 34 5822 5823 I-clinical_variable
PT)/ 34 38 5823 5827 I-clinical_variable
International 39 52 5828 5841 B-clinical_variable
Normalized 53 63 5842 5852 I-clinical_variable
Ratio 64 69 5853 5858 I-clinical_variable
( 70 71 5859 5860 I-clinical_variable
INR 71 74 5860 5863 I-clinical_variable
) 74 75 5863 5864 I-clinical_variable
or 76 78 5865 5867 I-clinical_variable
partial 79 86 5868 5875 I-clinical_variable
thromboplastin 87 101 5876 5890 I-clinical_variable
time 102 106 5891 5895 I-clinical_variable
( 107 108 5896 5897 I-clinical_variable
PTT 108 111 5897 5900 I-clinical_variable
) 111 112 5900 5901 I-clinical_variable
test 113 117 5902 5906 O
≥ 118 119 5907 5908 O
1.3 120 123 5909 5912 B-lower_bound
x 124 125 5913 5914 I-lower_bound
the 126 129 5915 5918 I-lower_bound
laboratory 130 140 5919 5929 I-lower_bound
ULN 141 144 5930 5933 I-lower_bound
within 145 151 5934 5940 O
7 152 153 5941 5942 B-upper_bound
days 154 158 5943 5947 I-upper_bound
before 159 165 5948 5954 I-upper_bound
the 166 169 5955 5958 O
first 170 175 5959 5964 O
dose 176 180 5965 5969 O
of 181 183 5970 5972 O
study 184 189 5973 5978 O
treatment 190 199 5979 5988 B-treatment

The 0 3 5989 5992 O
subject 4 11 5993 6000 O
has 12 15 6001 6004 O
received 16 24 6005 6013 O
cytotoxic 25 34 6014 6023 B-treatment
chemotherapy 35 47 6024 6036 I-treatment
( 48 49 6037 6038 O
including 49 58 6038 6047 O
investigational 59 74 6048 6063 B-treatment
cytotoxic 75 84 6064 6073 I-treatment
chemotherapy 85 97 6074 6086 I-treatment
) 97 98 6086 6087 O
or 99 101 6088 6090 O
biologic 102 110 6091 6099 B-treatment
agents 111 117 6100 6106 I-treatment
( 118 119 6107 6108 O
e.g. 119 123 6108 6112 O
, 123 124 6112 6113 O
cytokines 125 134 6114 6123 B-treatment
or 135 137 6124 6126 O
antibodies 138 148 6127 6137 B-treatment
; 148 149 6137 6138 O
including 150 159 6139 6148 O
investigational 160 175 6149 6164 B-treatment
biologic 176 184 6165 6173 I-treatment
agents 185 191 6174 6180 I-treatment
) 191 192 6180 6181 O
within 193 199 6182 6188 O
3 200 201 6189 6190 B-upper_bound
weeks 202 207 6191 6196 I-upper_bound
, 207 208 6196 6197 O
or 209 211 6198 6200 O
nitrosoureas/ 212 225 6201 6214 B-treatment
mitomycin 226 235 6215 6224 B-treatment
C 236 237 6225 6226 I-treatment
within 238 244 6227 6233 O
6 245 246 6234 6235 B-upper_bound
weeks 247 252 6236 6241 I-upper_bound
before 253 259 6242 6248 I-upper_bound
the 260 263 6249 6252 O
first 264 269 6253 6258 O
dose 270 274 6259 6263 O
of 275 277 6264 6266 O
study 278 283 6267 6272 O
treatment 284 293 6273 6282 B-treatment

The 0 3 6283 6286 O
subject 4 11 6287 6294 O
has 12 15 6295 6298 O
received 16 24 6299 6307 B-treatment
enzyme 25 31 6308 6314 I-treatment
- 31 32 6314 6315 I-treatment
inducing 32 40 6315 6323 I-treatment
anti 41 45 6324 6328 I-treatment
- 45 46 6328 6329 I-treatment
epileptic 46 55 6329 6338 I-treatment
agents 56 62 6339 6345 I-treatment
within 63 69 6346 6352 O
2 70 71 6353 6354 B-upper_bound
weeks 72 77 6355 6360 I-upper_bound
before 78 84 6361 6367 O
the 85 88 6368 6371 O
first 89 94 6372 6377 O
dose 95 99 6378 6382 O
of 100 102 6383 6385 O
cabozantinib 103 115 6386 6398 B-treatment
( 116 117 6399 6400 O
e.g. 117 121 6400 6404 O
, 121 122 6404 6405 O
carbamazepine 123 136 6406 6419 B-treatment
, 136 137 6419 6420 O
phenytoin 138 147 6421 6430 B-treatment
, 147 148 6430 6431 O
phenobarbital 149 162 6432 6445 B-treatment
, 162 163 6445 6446 O
primidone 164 173 6447 6456 B-treatment
) 173 174 6456 6457 O

The 0 3 6458 6461 O
subject 4 11 6462 6469 O
has 12 15 6470 6473 O
received 16 24 6474 6482 O
prior 25 30 6483 6488 B-treatment
treatment 31 40 6489 6498 I-treatment
with 41 45 6499 6503 O
a 46 47 6504 6505 O
small 48 53 6506 6511 B-treatment
molecule 54 62 6512 6520 I-treatment
kinase 63 69 6521 6527 I-treatment
inhibitor 70 79 6528 6537 I-treatment
or 80 82 6538 6540 O
a 83 84 6541 6542 O
hormonal 85 93 6543 6551 B-treatment
therapy 94 101 6552 6559 I-treatment
( 102 103 6560 6561 O
including 103 112 6561 6570 O
investigational 113 128 6571 6586 B-treatment
kinase 129 135 6587 6593 I-treatment
inhibitors 136 146 6594 6604 I-treatment
or 147 149 6605 6607 I-treatment
hormones 150 158 6608 6616 I-treatment
) 158 159 6616 6617 O
within 160 166 6618 6624 O
14 167 169 6625 6627 B-upper_bound
days 170 174 6628 6632 I-upper_bound
or 175 177 6633 6635 O
five 178 182 6636 6640 O
half 183 187 6641 6645 O
- 187 188 6645 6646 O
lives 188 193 6646 6651 O
of 194 196 6652 6654 O
the 197 200 6655 6658 O
compound 201 209 6659 6667 O
or 210 212 6668 6670 O
active 213 219 6671 6677 O
metabolites 220 231 6678 6689 O
, 231 232 6689 6690 O
whichever 233 242 6691 6700 O
is 243 245 6701 6703 O
longer 246 252 6704 6710 O
, 252 253 6710 6711 O
before 254 260 6712 6718 O
the 261 264 6719 6722 O
first 265 270 6723 6728 O
dose 271 275 6729 6733 O
of 276 278 6734 6736 O
study 279 284 6737 6742 O
treatment 285 294 6743 6752 O

The 0 3 6753 6756 O
subject 4 11 6757 6764 O
has 12 15 6765 6768 O
received 16 24 6769 6777 O
radiation 25 34 6778 6787 B-treatment
therapy 35 42 6788 6795 I-treatment

The 0 3 6796 6799 O
subject 4 11 6800 6807 O
has 12 15 6808 6811 O
received 16 24 6812 6820 O
radionuclide 25 37 6821 6833 B-treatment
treatment 38 47 6834 6843 I-treatment
within 48 54 6844 6850 O
6 55 56 6851 6852 B-upper_bound
weeks 57 62 6853 6858 I-upper_bound
of 63 65 6859 6861 O
the 66 69 6862 6865 O
first 70 75 6866 6871 O
dose 76 80 6872 6876 O
of 81 83 6877 6879 O
study 84 89 6880 6885 O
treatment 90 99 6886 6895 O

The 0 3 6896 6899 O
subject 4 11 6900 6907 O
has 12 15 6908 6911 O
tumor 16 21 6912 6917 B-cancer
abutting 22 30 6918 6926 O
, 30 31 6926 6927 O
invading 32 40 6928 6936 O
or 41 43 6937 6939 O
encasing 44 52 6940 6948 O
any 53 56 6949 6952 O
major 57 62 6953 6958 O
blood 63 68 6959 6964 O
vessels 69 76 6965 6972 O

The 0 3 6973 6976 O
subject 4 11 6977 6984 O
is 12 14 6985 6987 O
receiving 15 24 6988 6997 O
concomitant 25 36 6998 7009 O
treatment 37 46 7010 7019 B-treatment
with 47 51 7020 7024 I-treatment
warfarin 52 60 7025 7033 I-treatment
, 60 61 7033 7034 O
warfarin 62 70 7035 7043 B-treatment
- 70 71 7043 7044 I-treatment
related 71 78 7044 7051 I-treatment
agents 79 85 7052 7058 I-treatment
, 85 86 7058 7059 O
or 87 89 7060 7062 O
low 90 93 7063 7066 B-treatment
molecular 94 103 7067 7076 I-treatment
weight 104 110 7077 7083 I-treatment
heparin 111 118 7084 7091 I-treatment
( 119 120 7092 7093 I-treatment
LMWH 120 124 7093 7097 I-treatment
) 124 125 7097 7098 I-treatment
at 126 128 7099 7101 O
the 129 132 7102 7105 O
time 133 137 7106 7110 O
of 138 140 7111 7113 O
study 141 146 7114 7119 O
entry 147 152 7120 7125 O
at 153 155 7126 7128 O
therapeutic 156 167 7129 7140 O
doses 168 173 7141 7146 O
. 173 174 7146 7147 O
Low 175 178 7148 7151 B-treatment
- 178 179 7151 7152 I-treatment
dose 179 183 7152 7156 I-treatment
warfarin 184 192 7157 7165 I-treatment
( 193 194 7166 7167 O
≤ 194 195 7167 7168 O
1 196 197 7169 7170 B-upper_bound
mg 198 200 7171 7173 I-upper_bound
/ 200 201 7173 7174 I-upper_bound
day 201 204 7174 7177 I-upper_bound
) 204 205 7177 7178 O
or 206 208 7179 7181 O
LMWH 209 213 7182 7186 O
at 214 216 7187 7189 O
prophylactic 217 229 7190 7202 O
doses 230 235 7203 7208 O

The 0 3 7209 7212 O
subject 4 11 7213 7220 O
must 12 16 7221 7225 O
have 17 21 7226 7230 O
a 22 23 7231 7232 O
baseline 24 32 7233 7241 O
brain 33 38 7242 7247 O
MRI 39 42 7248 7251 B-treatment
scan 43 47 7252 7256 I-treatment
or 48 50 7257 7259 O
CT 51 53 7260 7262 B-treatment
scan 54 58 7263 7267 I-treatment
of 59 61 7268 7270 I-treatment
the 62 65 7271 7274 I-treatment
head 66 70 7275 7279 I-treatment
( 71 72 7280 7281 O
in 72 74 7281 7283 O
patients 75 83 7284 7292 O
unable 84 90 7293 7299 O
to 91 93 7300 7302 O
obtain 94 100 7303 7309 O
an 101 103 7310 7312 O
MRI 104 107 7313 7316 O
) 107 108 7316 7317 O
within 109 115 7318 7324 O
14 116 118 7325 7327 B-upper_bound
days 119 123 7328 7332 I-upper_bound
prior 124 129 7333 7338 I-upper_bound
to 130 132 7339 7341 O
first 133 138 7342 7347 O
dose 139 143 7348 7352 O
of 144 146 7353 7355 O
cabozantinib 147 159 7356 7368 B-treatment

To 0 2 7369 7371 O
any 3 6 7372 7375 O
other 7 12 7376 7381 O
site(s 13 19 7382 7388 O
) 19 20 7388 7389 O
within 21 27 7390 7396 O
28 28 30 7397 7399 B-upper_bound
days 31 35 7400 7404 I-upper_bound
of 36 38 7405 7407 O
the 39 42 7408 7411 O
first 43 48 7412 7417 O
dose 49 53 7418 7422 O
of 54 56 7423 7425 O
study 57 62 7426 7431 B-treatment
treatment 63 72 7432 7441 I-treatment

To 0 2 7442 7444 O
bone 3 7 7445 7449 B-cancer
or 8 10 7450 7452 O
brain 11 16 7453 7458 B-cancer
metastasis 17 27 7459 7469 I-cancer
within 28 34 7470 7476 O
14 35 37 7477 7479 B-upper_bound
days 38 42 7480 7484 I-upper_bound
of 43 45 7485 7487 O
the 46 49 7488 7491 O
first 50 55 7492 7497 O
dose 56 60 7498 7502 O
of 61 63 7503 7505 O
study 64 69 7506 7511 O
treatment 70 79 7512 7521 B-treatment

To 0 2 7522 7524 O
the 3 6 7525 7528 O
thoracic 7 15 7529 7537 O
cavity 16 22 7538 7544 O
, 22 23 7544 7545 O
abdomen 24 31 7546 7553 O
or 32 34 7554 7556 O
pelvis 35 41 7557 7563 O
within 42 48 7564 7570 O
3 49 50 7571 7572 B-upper_bound
months 51 57 7573 7579 I-upper_bound
of 58 60 7580 7582 O
the 61 64 7583 7586 O
first 65 70 7587 7592 O
dose 71 75 7593 7597 O
of 76 78 7598 7600 O
study 79 84 7601 7606 O
treatment 85 94 7607 7616 B-treatment
or 95 97 7617 7619 O
has 98 101 7620 7623 O
with 102 106 7624 7628 O
ongoing 107 114 7629 7636 O
complications 115 128 7637 7650 O
or 129 131 7651 7653 O
is 132 134 7654 7656 O
without 135 142 7657 7664 O
complete 143 151 7665 7673 O
recovery 152 160 7674 7682 O
and 161 164 7683 7686 O
healing 165 172 7687 7694 O
from 173 177 7695 7699 O
prior 178 183 7700 7705 B-treatment
radiation 184 193 7706 7715 I-treatment
therapy 194 201 7716 7723 I-treatment

Urine 0 5 7724 7729 B-clinical_variable
protein 6 13 7730 7737 I-clinical_variable
/ 13 14 7737 7738 I-clinical_variable
creatinine 14 24 7738 7748 I-clinical_variable
ratio 25 30 7749 7754 I-clinical_variable
( 31 32 7755 7756 I-clinical_variable
UPCR 32 36 7756 7760 I-clinical_variable
) 36 37 7760 7761 I-clinical_variable
≤1 38 40 7762 7764 O

Women 0 5 7765 7770 B-gender
of 6 8 7771 7773 O
childbearing 9 21 7774 7786 O
potential 22 31 7787 7796 O
must 32 36 7797 7801 O
have 37 41 7802 7806 O
a 42 43 7807 7808 O
negative 44 52 7809 7817 B-pregnancy
serum 53 58 7818 7823 I-pregnancy
pregnancy 59 68 7824 7833 I-pregnancy
test 69 73 7834 7838 O
at 74 76 7839 7841 O
screening 77 86 7842 7851 O

c 0 1 7852 7853 O
- 1 2 7853 7854 O
MET 2 5 7854 7857 O
amplification 6 19 7858 7871 O
will 20 24 7872 7876 O
be 25 27 7877 7879 O
determined 28 38 7880 7890 O
by 39 41 7891 7893 O
FISH 42 46 7894 7898 B-treatment
ratio 47 52 7899 7904 O
( 53 54 7905 7906 O
c 54 55 7906 7907 B-clinical_variable
- 55 56 7907 7908 I-clinical_variable
MET 56 59 7908 7911 I-clinical_variable
/ 59 60 7911 7912 I-clinical_variable
CEP7 60 64 7912 7916 I-clinical_variable
) 64 65 7916 7917 O
> 66 67 7918 7919 O
2.0 68 71 7920 7923 B-lower_bound
, 71 72 7923 7924 O
based 73 78 7925 7930 O
on 79 81 7931 7933 O
testing 82 89 7934 7941 O
of 90 92 7942 7944 O
the 93 96 7945 7948 O
primary 97 104 7949 7956 O
tumor 105 110 7957 7962 B-cancer
and/or 111 117 7963 7969 O
site 118 122 7970 7974 O
of 123 125 7975 7977 O
metastatic 126 136 7978 7988 B-cancer
disease 137 144 7989 7996 I-cancer

clinically 0 10 7997 8007 O
- 10 11 8007 8008 O
significant 11 22 8008 8019 O
cardiac 23 30 8020 8027 O
arrhythmias 31 42 8028 8039 B-chronic_disease

myocardial 0 10 8040 8050 B-chronic_disease
infarction 11 21 8051 8061 I-chronic_disease
( 22 23 8062 8063 I-chronic_disease
MI 23 25 8063 8065 I-chronic_disease
) 25 26 8065 8066 I-chronic_disease

pregnant 0 8 8067 8075 B-pregnancy

stroke 0 6 8076 8082 B-chronic_disease
( 7 8 8083 8084 O
including 8 17 8084 8093 O
Transient 18 27 8094 8103 B-chronic_disease
Ischemic 28 36 8104 8112 I-chronic_disease
Attack 37 43 8113 8119 I-chronic_disease
( 44 45 8120 8121 I-chronic_disease
TIA 45 48 8121 8124 I-chronic_disease
) 48 49 8124 8125 I-chronic_disease
, 49 50 8125 8126 O
or 51 53 8127 8129 O
other 54 59 8130 8135 O
ischemic 60 68 8136 8144 O
event 69 74 8145 8150 O

thromboembolic 0 14 8151 8165 B-chronic_disease
event 15 20 8166 8171 O
requiring 21 30 8172 8181 O
therapeutic 31 42 8182 8193 B-treatment
anticoagulation 43 58 8194 8209 I-treatment

unstable 0 8 8210 8218 O
angina 9 15 8219 8225 B-chronic_disease
pectoris 16 24 8226 8234 I-chronic_disease

A 0 1 0 1 O
pre 2 5 2 5 O
- 5 6 5 6 O
existing 6 14 6 14 O
bronchopleural 15 29 15 29 B-chronic_disease
fistula 30 37 30 37 I-chronic_disease

Admit 0 5 38 43 O
BMI 6 9 44 47 B-bmi
> 10 11 48 49 O
30 11 13 49 51 B-lower_bound

Anticipate 0 10 52 62 O
placement 11 20 63 72 O
of 21 23 73 75 O
central 24 31 76 83 B-treatment
venous 32 38 84 90 I-treatment
line 39 43 91 95 I-treatment
within 44 50 96 102 O
24 51 53 103 105 B-upper_bound
hours 54 59 106 111 I-upper_bound
of 60 62 112 114 O
admission 63 72 115 124 O

Anuric 0 6 125 131 B-chronic_disease
renal 7 12 132 137 I-chronic_disease
failure 13 20 138 145 I-chronic_disease

Can 0 3 146 149 O
not 3 6 149 152 O
be 7 9 153 155 O
enterally 10 19 156 165 O
fed 20 23 166 169 O
within 24 30 170 176 O
24 31 33 177 179 B-upper_bound
hours 34 39 180 185 I-upper_bound
of 40 42 186 188 O
admission 43 52 189 198 O
according 53 62 199 208 O
to 63 65 209 211 O
the 66 69 212 215 O
admitting 70 79 216 225 O
physician 80 89 226 235 O

Exhibits 0 8 236 244 O
Acute 9 14 245 250 B-chronic_disease
Hypoxemic 15 24 251 260 I-chronic_disease
Respiratory 25 36 261 272 I-chronic_disease
Failure 37 44 273 280 I-chronic_disease

Expected 0 8 281 289 B-clinical_variable
survival 9 17 290 298 I-clinical_variable
< 18 19 299 300 O
24 19 21 300 302 B-upper_bound
hours 22 27 303 308 I-upper_bound
or 28 30 309 311 O
limitations 31 42 312 323 O
to 43 45 324 326 O
aggressive 46 56 327 337 O
ICU 57 60 338 341 O
care 61 65 342 346 O
( 66 67 347 348 O
DNR 67 70 348 351 O
) 70 71 351 352 O

Known 0 5 353 358 O
allergy 6 13 359 366 O
to 14 16 367 369 O
lactulose 17 26 370 379 B-allergy_name
or 27 29 380 382 O
mannitol 30 38 383 391 B-allergy_name

No 0 2 392 394 O
evidence 3 11 395 403 O
of 12 14 404 406 O
cardiac 15 22 407 414 B-chronic_disease
dysfunction 23 34 415 426 I-chronic_disease

On 0 2 427 429 O
extracorporeal 3 17 430 444 B-treatment
membrane 18 26 445 453 I-treatment
oxygenation 27 38 454 465 I-treatment
( 39 40 466 467 I-treatment
ECMO 40 44 467 471 I-treatment
) 44 45 471 472 I-treatment

One 0 3 473 476 B-lower_bound
month 4 9 477 482 I-lower_bound
to 10 12 483 485 O
16 13 15 486 488 B-upper_bound
years 16 21 489 494 I-upper_bound
of 22 24 495 497 O
age 25 28 498 501 B-age

PaO2 0 4 502 506 B-clinical_variable
/ 4 5 506 507 I-clinical_variable
FiO2 5 9 507 511 I-clinical_variable
≤ 10 11 512 513 O
300 12 15 514 517 B-upper_bound

Pregnant 0 8 518 526 B-pregnancy

Premature 0 9 527 536 O
infants 10 17 537 544 O
and 18 21 545 548 O
neonates 22 30 549 557 O
< 31 32 558 559 O
37 33 35 560 562 B-upper_bound
weeks 36 41 563 568 I-upper_bound
corrected 42 51 569 578 O
gestational 52 63 579 590 O
age 64 67 591 594 B-age

Receiving 0 9 595 604 O
active 10 16 605 611 O
CPR 17 20 612 615 B-treatment
when 21 25 616 620 O
admitted 26 34 621 629 O
to 35 37 630 632 O
the 38 41 633 636 O
PICU 42 46 637 641 O

Require 0 7 642 649 O
artificial 8 18 650 660 B-treatment
nutrition 19 28 661 670 I-treatment

SpO2 0 4 671 675 B-clinical_variable
/ 4 5 675 676 O
FiO2 5 9 676 680 B-clinical_variable
≤ 10 11 681 682 O
260 12 15 683 686 B-upper_bound

previous 0 8 687 695 O
bowel 9 14 696 701 B-treatment
surgery 15 22 702 709 I-treatment

short 0 5 710 715 B-chronic_disease
gut 6 9 716 719 I-chronic_disease
syndrome 10 18 720 728 I-chronic_disease

Active 0 6 0 6 O
central 7 14 7 14 O
nervous 15 22 15 22 O
system 23 29 23 29 O
( 30 31 30 31 O
CNS 31 34 31 34 O
) 34 35 34 35 O
involvement 36 47 36 47 O
of 48 50 48 50 O
the 51 54 51 54 O
underlying 55 65 55 65 O
malignancy 66 76 66 76 B-cancer

Acute 0 5 77 82 B-cancer
leukemia 6 14 83 91 I-cancer
not 15 18 92 95 O
in 19 21 96 98 O
remission 22 31 99 108 O

Chronic 0 7 109 116 B-chronic_disease
myelogenous 8 19 117 128 I-chronic_disease
leukemia 20 28 129 137 I-chronic_disease
( 29 30 138 139 I-chronic_disease
CML 30 33 139 142 I-chronic_disease
) 33 34 142 143 I-chronic_disease

Creatinine 0 10 144 154 B-clinical_variable
= 11 12 155 156 O
< 12 13 156 157 O
3 14 15 158 159 B-upper_bound
mg 16 18 160 162 I-upper_bound
/ 18 19 162 163 I-upper_bound
dL 19 21 163 165 I-upper_bound
or 22 24 166 168 O
estimated 25 34 169 178 O
creatinine 35 45 179 189 B-clinical_variable
clearance 46 55 190 199 I-clinical_variable
> 56 57 200 201 O
= 57 58 201 202 O
40ml 59 63 203 207 B-lower_bound
/ 63 64 207 208 I-lower_bound
min 64 67 208 211 I-lower_bound

Creatinine 0 10 212 222 B-clinical_variable
> 11 12 223 224 O
2 13 14 225 226 B-lower_bound
mg 15 17 227 229 I-lower_bound
/ 17 18 229 230 I-lower_bound
dL 18 20 230 232 I-lower_bound
and 21 24 233 236 O
an 25 27 237 239 O
estimated 28 37 240 249 B-clinical_variable
creatinine 38 48 250 260 I-clinical_variable
clearance 49 58 261 270 I-clinical_variable
= 59 60 271 272 O
< 60 61 272 273 O
40 62 64 274 276 B-upper_bound
mL 65 67 277 279 I-upper_bound
/ 67 68 279 280 I-upper_bound
min 68 71 280 283 I-upper_bound

Diffusing 0 9 284 293 B-clinical_variable
capacity 10 18 294 302 I-clinical_variable
of 19 21 303 305 I-clinical_variable
the 22 25 306 309 I-clinical_variable
lung 26 30 310 314 I-clinical_variable
for 31 34 315 318 I-clinical_variable
carbon 35 41 319 325 I-clinical_variable
monoxide 42 50 326 334 I-clinical_variable
( 51 52 335 336 I-clinical_variable
DLCO 52 56 336 340 I-clinical_variable
) 56 57 340 341 I-clinical_variable
< 58 59 342 343 O
40 60 62 344 346 B-upper_bound
% 62 63 346 347 I-upper_bound
predicted 64 73 348 357 O

Ejection 0 8 358 366 B-clinical_variable
fraction 9 17 367 375 I-clinical_variable
< 18 19 376 377 O
30 20 22 378 380 B-upper_bound
% 22 23 380 381 I-upper_bound

Females 0 7 382 389 B-gender
must 8 12 390 394 B-pregnancy
not 13 16 395 398 I-pregnancy
be 17 19 399 401 I-pregnancy
pregnant 20 28 402 410 I-pregnancy
or 29 31 411 413 O
lactating 32 41 414 423 O

Have 0 4 424 428 O
a 5 6 429 430 O
psychiatric 7 18 431 442 B-chronic_disease
disorder(s 19 29 443 453 I-chronic_disease
) 29 30 453 454 I-chronic_disease
or 31 33 455 457 O
psychosocial 34 46 458 470 B-chronic_disease
circumstance(s 47 61 471 485 I-chronic_disease
) 61 62 485 486 I-chronic_disease
which 63 68 487 492 O
in 69 71 493 495 O
the 72 75 496 499 O
opinion 76 83 500 507 O
of 84 86 508 510 O
the 87 90 511 514 O
primary 91 98 515 522 O
physician 99 108 523 532 O
would 109 114 533 538 O
place 115 120 539 544 O
the 121 124 545 548 O
patient 125 132 549 556 O
at 133 135 557 559 O
an 136 138 560 562 O
unacceptable 139 151 563 575 O
risk 152 156 576 580 O
from 157 161 581 585 O
transplant 162 172 586 596 B-treatment

Human 0 5 597 602 B-chronic_disease
immunodeficiency 6 22 603 619 I-chronic_disease
virus 23 28 620 625 I-chronic_disease
( 29 30 626 627 I-chronic_disease
HIV 30 33 627 630 I-chronic_disease
) 33 34 630 631 I-chronic_disease
positive 35 43 632 640 O

Karnofsky 0 9 641 650 B-clinical_variable
performance 10 21 651 662 I-clinical_variable
status 22 28 663 669 I-clinical_variable
( 29 30 670 671 I-clinical_variable
KPS 30 33 671 674 I-clinical_variable
) 33 34 674 675 I-clinical_variable
< 35 36 676 677 O
60 37 39 678 680 B-upper_bound
% 39 40 680 681 I-upper_bound

Must 0 4 682 686 O
be 5 7 687 689 O
18 8 10 690 692 B-lower_bound
- 10 11 692 693 O
75 11 13 693 695 B-upper_bound
years 14 19 696 701 I-upper_bound
of 20 22 702 704 O
age 23 26 705 708 B-age
, 26 27 708 709 O
inclusive 28 37 710 719 O

Must 0 4 720 724 O
be 5 7 725 727 O
an 8 10 728 730 O
HLA 11 14 731 734 O
- 14 15 734 735 O
matched 15 22 735 742 O
or 23 25 743 745 O
single 26 32 746 752 O
allele 33 39 753 759 O
mismatched 40 50 760 770 O
sibling 51 58 771 778 O
of 59 61 779 781 O
enrolled 62 70 782 790 O
transplant 71 81 791 801 B-treatment
patient 82 89 802 809 O

Must 0 4 810 814 O
be 5 7 815 817 O
capable 8 15 818 825 O
of 16 18 826 828 O
undergoing 19 29 829 839 O
leukapheresis 30 43 840 853 B-treatment

Must 0 4 854 858 O
be 5 7 859 861 O
in 8 10 862 864 O
a 11 12 865 866 O
state 13 18 867 872 O
of 19 21 873 875 O
general 22 29 876 883 O
good 30 34 884 888 O
health 35 41 889 895 O
and 42 45 896 899 O
have 46 50 900 904 O
completed 51 60 905 914 O
a 61 62 915 916 O
donor 63 68 917 922 O
evaluation 69 79 923 933 O
with 80 84 934 938 O
history 85 92 939 946 O
, 92 93 946 947 O
medical 94 101 948 955 O
examination 102 113 956 967 O
and 114 117 968 971 O
standard 118 126 972 980 O
blood 127 132 981 986 O
tests 133 138 987 992 O
within 139 145 993 999 O
35 146 148 1000 1002 B-upper_bound
days 149 153 1003 1007 I-upper_bound
of 154 156 1008 1010 O
starting 157 165 1011 1019 O
the 166 169 1020 1023 O
hematopoietic 170 183 1024 1037 B-treatment
cell 184 188 1038 1042 I-treatment
collection 189 199 1043 1053 I-treatment
procedure 200 209 1054 1063 I-treatment

Must 0 4 1064 1068 O
have 5 9 1069 1073 O
a 10 11 1074 1075 O
myeloid 12 19 1076 1083 O
or 20 22 1084 1086 O
lymphoid 23 31 1087 1095 B-cancer
malignant 32 41 1096 1105 I-cancer
disease 42 49 1106 1113 O
that 50 54 1114 1118 O
is 55 57 1119 1121 O
treated 58 65 1122 1129 O
with 66 70 1130 1134 O
TLI 71 74 1135 1138 B-treatment
and 75 78 1139 1142 O
ATG 79 82 1143 1146 B-treatment
reduced 83 90 1147 1154 O
intensity 91 100 1155 1164 O
conditioning 101 113 1165 1177 O
for 114 117 1178 1181 O
allogeneic 118 128 1182 1192 B-treatment
transplant 129 139 1193 1203 I-treatment
( 140 141 1204 1205 O
any 141 144 1205 1208 O
of 145 147 1209 1211 O
the 148 151 1212 1215 O
following 152 161 1216 1225 O
AML 162 165 1226 1229 B-cancer
, 165 166 1229 1230 O
myelodysplastic 167 182 1231 1246 B-cancer
syndrome 183 191 1247 1255 I-cancer
[ 192 193 1256 1257 I-cancer
MDS 193 196 1257 1260 I-cancer
] 196 197 1260 1261 I-cancer
, 197 198 1261 1262 O
myeloproliferative 199 217 1263 1281 B-cancer
disease 218 225 1282 1289 I-cancer
[ 226 227 1290 1291 I-cancer
MPD 227 230 1291 1294 I-cancer
] 230 231 1294 1295 I-cancer
, 231 232 1295 1296 O
CLL 233 236 1297 1300 B-cancer
, 236 237 1300 1301 O
B 238 239 1302 1303 B-cancer
or 240 242 1304 1306 I-cancer
T 243 244 1307 1308 I-cancer
- 244 245 1308 1309 I-cancer
cell 245 249 1309 1313 I-cancer
NHL 250 253 1314 1317 I-cancer
, 253 254 1317 1318 O
HL 255 257 1319 1321 O
) 257 258 1321 1322 O

Must 0 4 1323 1327 O
have 5 9 1328 1332 O
a 10 11 1333 1334 O
white 12 17 1335 1340 B-clinical_variable
blood 18 23 1341 1346 I-clinical_variable
cell 24 28 1347 1351 I-clinical_variable
count 29 34 1352 1357 I-clinical_variable
> 35 36 1358 1359 O
3.5 37 40 1360 1363 B-lower_bound
x 41 42 1364 1365 I-lower_bound
10 43 45 1366 1368 I-lower_bound
^ 45 46 1368 1369 I-lower_bound
9 46 47 1369 1370 I-lower_bound
/ 47 48 1370 1371 I-lower_bound
liter 48 53 1371 1376 I-lower_bound
, 53 54 1376 1377 O
platelets 55 64 1378 1387 B-clinical_variable
> 65 66 1388 1389 O
150 67 70 1390 1393 B-lower_bound
x 71 72 1394 1395 I-lower_bound
10 73 75 1396 1398 I-lower_bound
^ 75 76 1398 1399 I-lower_bound
9 76 77 1399 1400 I-lower_bound
/ 77 78 1400 1401 I-lower_bound
liter 78 83 1401 1406 I-lower_bound
and 84 87 1407 1410 O
hematocrit 88 98 1411 1421 B-clinical_variable
> 99 100 1422 1423 O
35 101 103 1424 1426 B-lower_bound
% 103 104 1426 1427 I-lower_bound

Must 0 4 1428 1432 O
not 5 8 1433 1436 O
be 9 11 1437 1439 O
seropositive 12 24 1440 1452 O
for 25 28 1453 1456 O
HIV 29 32 1457 1460 B-chronic_disease
1 33 34 1461 1462 I-chronic_disease
and 35 38 1463 1466 I-chronic_disease
2 39 40 1467 1468 I-chronic_disease
, 40 41 1468 1469 O
hepatitis 42 51 1470 1479 B-chronic_disease
B 52 53 1480 1481 I-chronic_disease
surface 54 61 1482 1489 O
antigen 62 69 1490 1497 O
, 69 70 1497 1498 O
hepatitis 71 80 1499 1508 B-chronic_disease
C 81 82 1509 1510 I-chronic_disease
antibody 83 91 1511 1519 O
, 91 92 1519 1520 O
human 93 98 1521 1526 B-chronic_disease
T 99 100 1527 1528 I-chronic_disease
- 100 101 1528 1529 I-chronic_disease
lymphotropic 101 113 1529 1541 I-chronic_disease
virus 114 119 1542 1547 I-chronic_disease
( 120 121 1548 1549 I-chronic_disease
HTLV 121 125 1549 1553 I-chronic_disease
) 125 126 1553 1554 I-chronic_disease
antibody 127 135 1555 1563 O
, 135 136 1563 1564 O
cytomegalovirus 137 152 1565 1580 B-chronic_disease
( 153 154 1581 1582 I-chronic_disease
CMV 154 157 1582 1585 I-chronic_disease
) 157 158 1585 1586 I-chronic_disease
immunoglobulin 159 173 1587 1601 I-chronic_disease
M 174 175 1602 1603 I-chronic_disease
( 176 177 1604 1605 I-chronic_disease
IgM 177 180 1605 1608 I-chronic_disease
) 180 181 1608 1609 I-chronic_disease
, 181 182 1609 1610 O
or 183 185 1611 1613 O
rapid 186 191 1614 1619 O
plasma 192 198 1620 1626 O
reagin 199 205 1627 1633 O
( 206 207 1634 1635 O
RPR 207 210 1635 1638 O
) 210 211 1638 1639 O
( 212 213 1640 1641 O
Treponema 213 222 1641 1650 O
) 222 223 1650 1651 O

Must 0 4 1652 1656 O
not 5 8 1657 1660 O
have 9 13 1661 1665 O
developed 14 23 1666 1675 O
a 24 25 1676 1677 O
new 26 29 1678 1681 O
malignancy 30 40 1682 1692 B-cancer
requiring 41 50 1693 1702 O
chemotherapy 51 63 1703 1715 B-treatment
or 64 66 1716 1718 O
radiation 67 76 1719 1728 B-treatment
in 77 79 1729 1731 O
the 80 83 1732 1735 O
interval 84 92 1736 1744 O
since 93 98 1745 1750 O
apheresis 99 108 1751 1760 B-treatment
for 109 112 1761 1764 O
initial 113 120 1765 1772 O
hematocrit 121 131 1773 1783 O
( 132 133 1784 1785 O
HCT 133 136 1785 1788 O
) 136 137 1788 1789 O

Must 0 4 1790 1794 O
not 5 8 1795 1798 O
have 9 13 1799 1803 O
psychological 14 27 1804 1817 B-chronic_disease
traits 28 34 1818 1824 O
or 35 37 1825 1827 O
psychological 38 51 1828 1841 O
or 52 54 1842 1844 O
medical 55 62 1845 1852 B-chronic_disease
conditions 63 73 1853 1863 I-chronic_disease
which 74 79 1864 1869 O
make 80 84 1870 1874 O
them 85 89 1875 1879 O
unlikely 90 98 1880 1888 O
to 99 101 1889 1891 O
tolerate 102 110 1892 1900 O
the 111 114 1901 1904 O
procedure 115 124 1905 1914 O

Patients 0 8 1915 1923 O
must 9 13 1924 1928 O
be 14 16 1929 1931 O
beyond 17 23 1932 1938 O
day 24 27 1939 1942 B-lower_bound
30 28 30 1943 1945 I-lower_bound
and 31 34 1946 1949 O
before 35 41 1950 1956 O
day 42 45 1957 1960 B-upper_bound
60 46 48 1961 1963 I-upper_bound
after 49 54 1964 1969 B-treatment
transplant 55 65 1970 1980 I-treatment

Patients 0 8 1981 1989 O
must 9 13 1990 1994 O
be 14 16 1995 1997 O
on 17 19 1998 2000 O
single 20 26 2001 2007 B-treatment
immune 27 33 2008 2014 I-treatment
suppression 34 45 2015 2026 I-treatment
therapy 46 53 2027 2034 I-treatment
with 54 58 2035 2039 I-treatment
either 59 65 2040 2046 I-treatment
tacrolimus 66 76 2047 2057 I-treatment
or 77 79 2058 2060 I-treatment
cyclosporine 80 92 2061 2073 I-treatment
at 93 95 2074 2076 O
the 96 99 2077 2080 O
time 100 104 2081 2085 O
of 105 107 2086 2088 O
CD8 108 111 2089 2092 B-treatment
+ 111 112 2092 2093 I-treatment
memory 113 119 2094 2100 I-treatment
T 120 121 2101 2102 I-treatment
- 121 122 2102 2103 I-treatment
cell 122 126 2103 2107 I-treatment
infusion 127 135 2108 2116 I-treatment

Patients 0 8 2117 2125 O
must 9 13 2126 2130 O
have 14 18 2131 2135 O
a 19 20 2136 2137 O
Karnofsky 21 30 2138 2147 B-clinical_variable
performance 31 42 2148 2159 I-clinical_variable
status 43 49 2160 2166 I-clinical_variable
of 50 52 2167 2169 O
> 53 54 2170 2171 O
= 54 55 2171 2172 O
60 56 58 2173 2175 B-lower_bound
% 58 59 2175 2176 I-lower_bound
at 60 62 2177 2179 O
the 63 66 2180 2183 O
time 67 71 2184 2188 O
of 72 74 2189 2191 O
the 75 78 2192 2195 O
CD8 79 82 2196 2199 B-treatment
+ 82 83 2199 2200 I-treatment
memory 84 90 2201 2207 I-treatment
T 91 92 2208 2209 I-treatment
- 92 93 2209 2210 I-treatment
cell 93 97 2210 2214 I-treatment
infusion 98 106 2215 2223 I-treatment

Patients 0 8 2224 2232 O
must 9 13 2233 2237 O
have 14 18 2238 2242 O
adequate 19 27 2243 2251 O
organ 28 33 2252 2257 O
function 34 42 2258 2266 O
and 43 46 2267 2270 O
performance 47 58 2271 2282 O
status 59 65 2283 2289 O
at 66 68 2290 2292 O
the 69 72 2293 2296 O
time 73 77 2297 2301 O
of 78 80 2302 2304 O
the 81 84 2305 2308 O
CD8 85 88 2309 2312 B-treatment
+ 88 89 2312 2313 I-treatment
memory 90 96 2314 2320 I-treatment
T 97 98 2321 2322 I-treatment
- 98 99 2322 2323 I-treatment
cell 99 103 2323 2327 I-treatment
infusion 104 112 2328 2336 I-treatment

Patients 0 8 2337 2345 O
must 9 13 2346 2350 O
have 14 18 2351 2355 O
evidence 19 27 2356 2364 O
of 28 30 2365 2367 O
mixed 31 36 2368 2373 O
CD3 37 40 2374 2377 B-clinical_variable
T 41 42 2378 2379 I-clinical_variable
- 42 43 2379 2380 I-clinical_variable
cell 43 47 2380 2384 I-clinical_variable
chimerism 48 57 2385 2394 I-clinical_variable
based 58 63 2395 2400 O
on 64 66 2401 2403 O
the 67 70 2404 2407 O
day 71 74 2408 2411 O
+28 75 78 2412 2415 O
( 79 80 2416 2417 O
+ 80 81 2417 2418 O
/- 81 83 2418 2420 O
7 84 85 2421 2422 O
days 86 90 2423 2427 O
) 90 91 2427 2428 O
blood 92 97 2429 2434 O
sample 98 104 2435 2441 O
showing 105 112 2442 2449 O
> 113 114 2450 2451 O
= 114 115 2451 2452 O
5 116 117 2453 2454 B-lower_bound
% 117 118 2454 2455 I-lower_bound
and 119 122 2456 2459 O
= 123 124 2460 2461 O
< 124 125 2461 2462 O
95 126 128 2463 2465 B-upper_bound
% 128 129 2465 2466 I-upper_bound
donor 130 135 2467 2472 O
type 136 140 2473 2477 O
cells 141 146 2478 2483 O

Patients 0 8 2484 2492 O
must 9 13 2493 2497 O
have 14 18 2498 2502 O
no 19 21 2503 2505 O
evidence 22 30 2506 2514 O
of 31 33 2515 2517 O
active 34 40 2518 2524 O
graft 41 46 2525 2530 B-chronic_disease
- 46 47 2530 2531 I-chronic_disease
versus 47 53 2531 2537 I-chronic_disease
- 53 54 2537 2538 I-chronic_disease
host 54 58 2538 2542 I-chronic_disease
disease 59 66 2543 2550 I-chronic_disease
at 67 69 2551 2553 O
the 70 73 2554 2557 O
time 74 78 2558 2562 O
of 79 81 2563 2565 O
the 82 85 2566 2569 O
CD8 86 89 2570 2573 B-treatment
+ 89 90 2573 2574 I-treatment
memory 91 97 2575 2581 I-treatment
T 98 99 2582 2583 I-treatment
- 99 100 2583 2584 I-treatment
cell 100 104 2584 2588 I-treatment
infusion 105 113 2589 2597 I-treatment

Patients 0 8 2598 2606 O
must 9 13 2607 2611 O
not 14 17 2612 2615 O
have 18 22 2616 2620 O
an 23 25 2621 2623 O
uncontrolled 26 38 2624 2636 O
bacterial 39 48 2637 2646 B-chronic_disease
, 48 49 2646 2647 O
fungal 50 56 2648 2654 B-chronic_disease
or 57 59 2655 2657 O
viral 60 65 2658 2663 B-chronic_disease
infection 66 75 2664 2673 I-chronic_disease
, 75 76 2673 2674 O
defined 77 84 2675 2682 O
as 85 87 2683 2685 O
progressive 88 99 2686 2697 O
symptoms 100 108 2698 2706 O
despite 109 116 2707 2714 O
therapy 117 124 2715 2722 B-treatment
, 124 125 2722 2723 O
at 126 128 2724 2726 O
the 129 132 2727 2730 O
time 133 137 2731 2735 O
of 138 140 2736 2738 O
the 141 144 2739 2742 O
CD8 145 148 2743 2746 B-treatment
+ 148 149 2746 2747 I-treatment
memory 150 156 2748 2754 I-treatment
T 157 158 2755 2756 I-treatment
- 158 159 2756 2757 I-treatment
cell 159 163 2757 2761 I-treatment
infusion 164 172 2762 2770 I-treatment

Patients 0 8 2771 2779 O
who 9 12 2780 2783 O
due 13 16 2784 2787 O
to 17 19 2788 2790 O
age 20 23 2791 2794 B-age
, 23 24 2794 2795 O
pre 25 28 2796 2799 O
- 28 29 2799 2800 O
existing 29 37 2800 2808 O
medical 38 45 2809 2816 B-chronic_disease
conditions 46 56 2817 2827 I-chronic_disease
, 56 57 2827 2828 O
or 58 60 2829 2831 O
, 60 61 2831 2832 O
prior 62 67 2833 2838 B-treatment
therapy 68 75 2839 2846 I-treatment
are 76 79 2847 2850 O
considered 80 90 2851 2861 O
to 91 93 2862 2864 O
be 94 96 2865 2867 O
at 97 99 2868 2870 O
high 100 104 2871 2875 O
risk 105 109 2876 2880 O
for 110 113 2881 2884 O
regimen 114 121 2885 2892 O
related 122 129 2893 2900 O
toxicity 130 138 2901 2909 O
associated 139 149 2910 2920 O
with 150 154 2921 2925 O
fully 155 160 2926 2931 O
ablative 161 169 2932 2940 O
transplant 170 180 2941 2951 O
conditioning 181 193 2952 2964 O
, 193 194 2964 2965 O
and 195 198 2966 2969 O
therefore 199 208 2970 2979 O
reduced 209 216 2980 2987 O
intensity 217 226 2988 2997 O
conditioning 227 239 2998 3010 O
is 240 242 3011 3013 O
recommended 243 254 3014 3025 O

Poorly 0 6 3026 3032 O
controlled 7 17 3033 3043 O
hypertension 18 30 3044 3056 B-chronic_disease
despite 31 38 3057 3064 O
multiple 39 47 3065 3073 O
antihypertensive 48 64 3074 3090 B-treatment
medication 65 75 3091 3101 I-treatment

Pregnant 0 8 3102 3110 B-pregnancy

Prior 0 5 3111 3116 O
malignancy 6 16 3117 3127 B-cancer

Progressive 0 11 3128 3139 O
hemato 12 18 3140 3146 B-cancer
- 18 19 3146 3147 I-cancer
lymphoid 19 27 3147 3155 I-cancer
malignancy 28 38 3156 3166 I-cancer
despite 39 46 3167 3174 O
conventional 47 59 3175 3187 B-treatment
therapy 60 67 3188 3195 I-treatment

SGOT 0 4 3196 3200 B-clinical_variable
or 5 7 3201 3203 O
SGPT 8 12 3204 3208 B-clinical_variable
= 13 14 3209 3210 O
< 14 15 3210 3211 O
4 16 17 3212 3213 B-upper_bound
x 18 19 3214 3215 I-upper_bound
ULN 20 23 3216 3219 I-upper_bound

Serum 0 5 3220 3225 B-clinical_variable
glutamic 6 14 3226 3234 I-clinical_variable
oxaloacetic 15 26 3235 3246 I-clinical_variable
transaminase 27 39 3247 3259 I-clinical_variable
( 40 41 3260 3261 I-clinical_variable
SGOT 41 45 3261 3265 I-clinical_variable
) 45 46 3265 3266 I-clinical_variable
or 47 49 3267 3269 O
serum 50 55 3270 3275 B-clinical_variable
glutamate 56 65 3276 3285 I-clinical_variable
pyruvate 66 74 3286 3294 I-clinical_variable
transaminase 75 87 3295 3307 I-clinical_variable
( 88 89 3308 3309 I-clinical_variable
SGPT 89 93 3309 3313 I-clinical_variable
) 93 94 3313 3314 I-clinical_variable
> 95 96 3315 3316 O
4 97 98 3317 3318 B-lower_bound
x 99 100 3319 3320 I-lower_bound
upper 101 106 3321 3326 I-lower_bound
limit 107 112 3327 3332 I-lower_bound
of 113 115 3333 3335 I-lower_bound
normal 116 122 3336 3342 I-lower_bound
( 123 124 3343 3344 I-lower_bound
ULN 124 127 3344 3347 I-lower_bound
) 127 128 3347 3348 I-lower_bound

Total 0 5 3349 3354 B-clinical_variable
bilirubin 6 15 3355 3364 I-clinical_variable
= 16 17 3365 3366 O
< 17 18 3366 3367 O
4 19 20 3368 3369 B-upper_bound
mg 21 23 3370 3372 I-upper_bound
/ 23 24 3372 3373 I-upper_bound
dL 24 26 3373 3375 I-upper_bound

Total 0 5 3376 3381 B-clinical_variable
bilirubin 6 15 3382 3391 I-clinical_variable
> 16 17 3392 3393 O
3 18 19 3394 3395 B-lower_bound
mg 20 22 3396 3398 I-lower_bound
/ 22 23 3398 3399 I-lower_bound
dL 23 25 3399 3401 I-lower_bound

Uncontrolled 0 12 3402 3414 O
bacterial 13 22 3415 3424 B-chronic_disease
, 22 23 3424 3425 O
viral 24 29 3426 3431 B-chronic_disease
or 30 32 3432 3434 O
fungal 33 39 3435 3441 B-chronic_disease
infection 40 49 3442 3451 I-chronic_disease
defined 50 57 3452 3459 O
as 58 60 3460 3462 O
currently 61 70 3463 3472 O
taking 71 77 3473 3479 O
medication 78 88 3480 3490 B-treatment
and 89 92 3491 3494 O
progression 93 104 3495 3506 O
of 105 107 3507 3509 O
clinical 108 116 3510 3518 O
symptoms 117 125 3519 3527 O

asymptomatic 0 12 3528 3540 O
viremia 13 20 3541 3548 B-chronic_disease

diagnosed 0 9 3549 3558 O
> 10 11 3559 3560 O
5 12 13 3561 3562 O
years 14 19 3563 3568 O
ago 20 23 3569 3572 O
without 24 31 3573 3580 O
evidence 32 40 3581 3589 O
of 41 43 3590 3592 O
disease 44 51 3593 3600 O
, 51 52 3600 3601 O
OR 53 55 3602 3604 O
treated 56 63 3605 3612 O
= 64 65 3613 3614 O
< 65 66 3614 3615 O
5 67 68 3616 3617 O
years 69 74 3618 3623 O
ago 75 78 3624 3627 O
but 79 82 3628 3631 O
have 83 87 3632 3636 O
a 88 89 3637 3638 O
greater 90 97 3639 3646 O
than 98 102 3647 3651 O
50 103 105 3652 3654 B-lower_bound
% 105 106 3654 3655 I-lower_bound
chance 107 113 3656 3662 O
of 114 116 3663 3665 O
life 117 121 3666 3670 B-clinical_variable
expectancy 122 132 3671 3681 I-clinical_variable
of 133 135 3682 3684 O
> 136 137 3685 3686 O
= 137 138 3686 3687 O
5 139 140 3688 3689 O
years 141 146 3690 3695 O
for 147 150 3696 3699 O
that 151 155 3700 3704 O
malignancy 156 166 3705 3715 B-cancer

donors 0 6 3716 3722 O
with 7 11 3723 3727 O
a 12 13 3728 3729 O
positive 14 22 3730 3738 O
hepatitis 23 32 3739 3748 B-chronic_disease
B 33 34 3749 3750 I-chronic_disease
PCR 35 38 3751 3754 O
test 39 43 3755 3759 O

donors 0 6 3760 3766 O
with 7 11 3767 3771 O
prior 12 17 3772 3777 O
evidence 18 26 3778 3786 O
of 27 29 3787 3789 O
hepatitis 30 39 3790 3799 B-chronic_disease
B 40 41 3800 3801 I-chronic_disease
core 42 46 3802 3806 O
antibody 47 55 3807 3815 O
positivity 56 66 3816 3826 O
will 67 71 3827 3831 O
have 72 76 3832 3836 O
a 77 78 3837 3838 O
polymerase 79 89 3839 3849 B-treatment
chain 90 95 3850 3855 I-treatment
reaction 96 104 3856 3864 I-treatment
( 105 106 3865 3866 I-treatment
PCR 106 109 3866 3869 I-treatment
) 109 110 3869 3870 I-treatment
test 111 115 3871 3875 O
done 116 120 3876 3880 O
to 121 123 3881 3883 O
evaluate 124 132 3884 3892 O
for 133 136 3893 3896 O
hepatitis 137 146 3897 3906 B-chronic_disease
B 147 148 3907 3908 I-chronic_disease
infection 149 158 3909 3918 I-chronic_disease

patients 0 8 3919 3927 O
with 9 13 3928 3932 O
a 14 15 3933 3934 O
history 16 23 3935 3942 O
of 24 26 3943 3945 O
acute 27 32 3946 3951 B-chronic_disease
GVHD 33 37 3952 3956 I-chronic_disease
overall 38 45 3957 3964 O
grade 46 51 3965 3970 O
II 52 54 3971 3973 O
based 55 60 3974 3979 O
on 61 63 3980 3982 O
skin 64 68 3983 3987 O
only 69 73 3988 3992 O
involvement 74 85 3993 4004 O
or 86 88 4005 4007 O
upper 89 94 4008 4013 O
gastrointestinal 95 111 4014 4030 O
( 112 113 4031 4032 O
GI 113 115 4032 4034 O
) 115 116 4034 4035 O
tract 117 122 4036 4041 O
involvement 123 134 4042 4053 O
only 135 139 4054 4058 O

patients 0 8 4059 4067 O
with 9 13 4068 4072 O
a 14 15 4073 4074 O
history 16 23 4075 4082 O
of 24 26 4083 4085 O
liver 27 32 4086 4091 B-chronic_disease
or 33 35 4092 4094 I-chronic_disease
lower 36 41 4095 4100 I-chronic_disease
GI 42 44 4101 4103 I-chronic_disease
tract 45 50 4104 4109 I-chronic_disease
GVHD 51 55 4110 4114 B-chronic_disease

prednisone 0 10 4115 4125 B-treatment
at 11 13 4126 4128 O
a 14 15 4129 4130 O
physiologic 16 27 4131 4142 O
dose 28 32 4143 4147 O
of 33 35 4148 4150 O
5 36 37 4151 4152 B-upper_bound
mg 38 40 4153 4155 I-upper_bound
per 41 44 4156 4159 I-upper_bound
day 45 48 4160 4163 I-upper_bound
or 49 51 4164 4166 O
less 52 56 4167 4171 O
is 57 59 4172 4174 O
allowed 60 67 4175 4182 O

uncontrolled 0 12 4183 4195 O
cardiac 13 20 4196 4203 B-chronic_disease
failure 21 28 4204 4211 I-chronic_disease

A 0 1 0 1 O
medical 2 9 2 9 B-chronic_disease
condition 10 19 10 19 I-chronic_disease
that 20 24 20 24 O
could 25 30 25 30 O
interfere 31 40 31 40 O
with 41 45 41 45 O
study 46 51 46 51 O
participation 52 65 52 65 O

Body 0 4 66 70 B-clinical_variable
weight 5 11 71 77 I-clinical_variable
less 12 16 78 82 O
than 17 21 83 87 O
50 22 24 88 90 B-upper_bound
kg 25 27 91 93 I-upper_bound

Participating 0 13 94 107 O
in 14 16 108 110 O
another 17 24 111 118 O
study 25 30 119 124 O
involving 31 40 125 134 O
an 41 43 135 137 O
investigational 44 59 138 153 B-treatment
medication 60 70 154 164 I-treatment

Undergoing 0 10 165 175 O
abdominoplasty 11 25 176 190 B-treatment
or 26 28 191 193 O
TRAM 29 33 194 198 B-treatment
flap 34 38 199 203 I-treatment
breast 39 45 204 210 I-treatment
reconstruction 46 60 211 225 I-treatment

Child 0 5 0 5 O
must 6 10 6 10 O
be 11 13 11 13 O
recipient 14 23 14 23 O
of 24 26 24 26 O
needs 27 32 27 32 O
based 33 38 33 38 O
Medicaid 39 47 39 47 O
or 48 50 48 50 O
family 51 57 51 57 O
income 58 64 58 64 O
must 65 69 65 69 O
be 70 72 70 72 O
at 73 75 73 75 O
or 76 78 76 78 O
below 79 84 79 84 O
150 85 88 85 88 B-upper_bound
% 88 89 88 89 I-upper_bound
Health 90 96 90 96 O
and 97 100 97 100 O
Human 101 106 101 106 O
Services 107 115 107 115 O
( 116 117 116 117 O
HHS 117 120 117 120 O
) 120 121 120 121 O
Poverty 122 129 122 129 O
Guidelines 130 140 130 140 O

Having 0 6 141 147 O
moderate 7 15 148 156 O
to 16 18 157 159 O
severe 19 25 160 166 O
mental 26 32 167 173 B-chronic_disease
disability 33 43 174 184 I-chronic_disease
( 44 45 185 186 O
based 45 50 186 191 O
on 51 53 192 194 O
medical 54 61 195 202 O
records 62 69 203 210 O
) 69 70 210 211 O

Inability 0 9 212 221 B-language_fluency
to 10 12 222 224 I-language_fluency
read 13 17 225 229 I-language_fluency
English 18 25 230 237 I-language_fluency

Adult 0 5 0 5 O
patients 6 14 6 14 O
undergoing 15 25 15 25 O
one 26 29 26 29 O
of 30 32 30 32 O
the 33 36 33 36 O
listed 37 43 37 43 O
major 44 49 44 49 B-treatment
surgeries 50 59 50 59 I-treatment
associated 60 70 60 70 O
with 71 75 71 75 O
possibility 76 87 76 87 O
of 88 90 88 90 O
significant 91 102 91 102 O
blood 103 108 103 108 O
loss 109 113 109 113 O

Any 0 3 114 117 O
patients 4 12 118 126 O
undergoing 13 23 127 137 O
Cardio 24 30 138 144 B-treatment
- 30 31 144 145 I-treatment
Pulmonary 31 40 145 154 I-treatment
Bypass 41 47 155 161 I-treatment
( 48 49 162 163 I-treatment
CPB 49 52 163 166 I-treatment
) 52 53 166 167 I-treatment

Any 0 3 168 171 O
patients 4 12 172 180 O
who 13 16 181 184 O
can 17 20 185 188 O
not 20 23 188 191 O
be 24 26 192 194 O
transfused 27 37 195 205 O
or 38 40 206 208 O
has 41 44 209 212 O
refused 45 52 213 220 O
consent 53 60 221 228 O
for 61 64 229 232 O
a 65 66 233 234 O
blood 67 72 235 240 B-treatment
transfusion 73 84 241 252 I-treatment

Any 0 3 253 256 O
patients 4 12 257 265 O
with 13 17 266 270 O
a 18 19 271 272 O
known 20 25 273 278 O
hemoglobinopathy 26 42 279 295 B-chronic_disease

At 0 2 296 298 O
least 3 8 299 304 O
one 9 12 305 308 O
finger 13 19 309 315 O
available 20 29 316 325 O
and 30 33 326 329 O
accessible 34 44 330 340 O
for 45 48 341 344 O
performing 49 59 345 355 O
non 60 63 356 359 O
- 63 64 359 360 O
invasive 64 72 360 368 O
hemoglobin 73 83 369 379 O
monitoring 84 94 380 390 O
( 95 96 391 392 O
preoperative 96 108 392 404 O
perfusion 109 118 405 414 B-clinical_variable
index 119 124 415 420 I-clinical_variable
greater 125 132 421 428 O
than 133 137 429 433 O
0.5 138 141 434 437 B-lower_bound
) 141 142 437 438 O

Patients 0 8 439 447 O
being 9 14 448 453 O
treated 15 22 454 461 O
by 23 25 462 464 O
any 26 29 465 468 O
artificial 30 40 469 479 O
oxygen 41 47 480 486 O
carriers 48 56 487 495 O
within 57 63 496 502 O
30 64 66 503 505 B-upper_bound
days 67 71 506 510 I-upper_bound
of 72 74 511 513 O
hospital 75 83 514 522 O
stay 84 88 523 527 O

Patients 0 8 528 536 O
who 9 12 537 540 O
are 13 16 541 544 O
actively 17 25 545 553 O
enrolled 26 34 554 562 O
in 35 37 563 565 O
or 38 40 566 568 O
within 41 47 569 575 O
30 48 50 576 578 B-upper_bound
days 51 55 579 583 I-upper_bound
of 56 58 584 586 O
completion 59 69 587 597 O
of 70 72 598 600 O
any 73 76 601 604 O
other 77 82 605 610 O
study 83 88 611 616 O
( 89 90 617 618 O
except 90 96 618 624 O
for 97 100 625 628 O
purely 101 107 629 635 O
observational 108 121 636 649 O
studies 122 129 650 657 O
with 130 134 658 662 O
no 135 137 663 665 O
intervention 138 150 666 678 O
) 150 151 678 679 O

Patients 0 8 680 688 O
who 9 12 689 692 O
are 13 16 693 696 O
pregnant 17 25 697 705 B-pregnancy

Patients 0 8 706 714 O
younger 9 16 715 722 O
than 17 21 723 727 O
18 22 24 728 730 B-upper_bound
years 25 30 731 736 I-upper_bound
old 31 34 737 740 O

Have 0 4 0 4 O
been 5 9 5 9 O
seen 10 14 10 14 O
in 15 17 15 17 O
diabetes 18 26 18 26 B-chronic_disease
clinic 27 33 27 33 O
in 34 36 34 36 O
the 37 40 37 40 O
last 41 45 41 45 B-upper_bound
6 46 47 46 47 I-upper_bound
months 48 54 48 54 I-upper_bound

HbA1c 0 5 55 60 B-clinical_variable
greater 6 13 61 68 O
than 14 18 69 73 O
or 19 21 74 76 O
equal 22 27 77 82 O
to 28 30 83 85 O
8 31 32 86 87 B-lower_bound
% 32 33 87 88 I-lower_bound
but 34 37 89 92 O
less 38 42 93 97 O
than 43 47 98 102 O
14 48 50 103 105 B-upper_bound
% 50 51 105 106 I-upper_bound

Hemolytic 0 9 107 116 B-chronic_disease
anemia 10 16 117 123 I-chronic_disease

Non 0 3 124 127 B-language_fluency
- 3 4 127 128 I-language_fluency
English 4 11 128 135 I-language_fluency
speaking 12 20 136 144 I-language_fluency

Significant 0 11 145 156 O
cognitive 12 21 157 166 B-chronic_disease
disability 22 32 167 177 I-chronic_disease

Pervasive 0 9 0 9 B-chronic_disease
Developmental 10 23 10 23 I-chronic_disease
Disorders 24 33 24 33 I-chronic_disease
( 34 35 34 35 I-chronic_disease
PDD 35 38 35 38 I-chronic_disease
) 38 39 38 39 I-chronic_disease
or 40 42 40 42 O
mental 43 49 43 49 B-chronic_disease
retardation 50 61 50 61 I-chronic_disease

age 0 3 62 65 B-age
17 4 6 66 68 B-lower_bound
- 6 7 68 69 O
21 7 9 69 71 B-upper_bound

recent 0 6 72 78 O
arrest 7 13 79 85 O
or 14 16 86 88 O
release 17 24 89 96 O
from 25 29 97 101 O
jail 30 34 102 106 O
/ 34 35 106 107 O
prison 35 41 107 113 O
/ 41 42 113 114 O
detention 42 51 114 123 O
( 52 53 124 125 O
within 53 59 125 131 O
the 60 63 132 135 O
past 64 68 136 140 B-upper_bound
18 69 71 141 143 I-upper_bound
months 72 78 144 150 I-upper_bound

A 0 1 0 1 O
life 2 6 2 6 B-clinical_variable
expectancy 7 17 7 17 I-clinical_variable
of 18 20 18 20 O
greater 21 28 21 28 O
than 29 33 29 33 O
24 34 36 34 36 B-lower_bound
weeks 37 42 37 42 I-lower_bound
at 43 45 43 45 O
Screening 46 55 46 55 O

Any 0 3 56 59 O
concurrent 4 14 60 70 O
uncontrolled 15 27 71 83 O
illness 28 35 84 91 O
, 35 36 91 92 O
including 37 46 93 102 O
mental 47 53 103 109 B-chronic_disease
illness 54 61 110 117 I-chronic_disease
or 62 64 118 120 O
substance 65 74 121 130 O
abuse 75 80 131 136 O
, 80 81 136 137 O
which 82 87 138 143 O
in 88 90 144 146 O
the 91 94 147 150 O
opinion 95 102 151 158 O
of 103 105 159 161 O
the 106 109 162 165 O
Investigator 110 122 166 178 O

Eastern 0 7 179 186 B-clinical_variable
Cooperative 8 19 187 198 I-clinical_variable
Oncology 20 28 199 207 I-clinical_variable
Group 29 34 208 213 I-clinical_variable
( 35 36 214 215 I-clinical_variable
ECOG 36 40 215 219 I-clinical_variable
) 40 41 219 220 I-clinical_variable
performance 42 53 221 232 I-clinical_variable
status 54 60 233 239 I-clinical_variable
of 61 63 240 242 O
0 64 65 243 244 B-lower_bound
to 66 68 245 247 O
1 69 70 248 249 B-upper_bound

Histopathologically 0 19 250 269 O
confirmed 20 29 270 279 O
diagnosis 30 39 280 289 O
of 40 42 290 292 O
metastatic 43 53 293 303 B-cancer
or 54 56 304 306 I-cancer
unresectable 57 69 307 319 I-cancer
malignant 70 79 320 329 I-cancer
melanoma 80 88 330 338 I-cancer

Known 0 5 339 344 O
infection 6 15 345 354 O
with 16 20 355 359 O
human 21 26 360 365 B-chronic_disease
immunodeficiency 27 43 366 382 I-chronic_disease
virus 44 49 383 388 I-chronic_disease
( 50 51 389 390 I-chronic_disease
HIV 51 54 390 393 I-chronic_disease
) 54 55 393 394 I-chronic_disease
, 55 56 394 395 O
hepatitis 57 66 396 405 B-chronic_disease
B 67 68 406 407 I-chronic_disease
virus 69 74 408 413 I-chronic_disease
( 75 76 414 415 I-chronic_disease
HBV 76 79 415 418 I-chronic_disease
) 79 80 418 419 I-chronic_disease
or 81 83 420 422 O
hepatitis 84 93 423 432 B-chronic_disease
C 94 95 433 434 I-chronic_disease
virus 96 101 435 440 I-chronic_disease
( 102 103 441 442 I-chronic_disease
HCV 103 106 442 445 I-chronic_disease
) 106 107 445 446 I-chronic_disease

Lactate 0 7 447 454 B-clinical_variable
dehydrogenase 8 21 455 468 I-clinical_variable
( 22 23 469 470 I-clinical_variable
LDH 23 26 470 473 I-clinical_variable
) 26 27 473 474 I-clinical_variable
< 28 29 475 476 O
= 29 30 476 477 O
2.0 30 33 477 480 B-upper_bound
times 34 39 481 486 I-upper_bound
the 40 43 487 490 I-upper_bound
ULN 44 47 491 494 I-upper_bound
range 48 53 495 500 O
of 54 56 501 503 O
each 57 61 504 508 O
institution 62 73 509 520 O

Ocular 0 6 521 527 B-cancer
melanoma 7 15 528 536 I-cancer
participants 16 28 537 549 O

Pregnant 0 8 550 558 B-pregnancy

Received 0 8 559 567 O
treatment 9 18 568 577 B-treatment
with 19 23 578 582 I-treatment
anti- 24 29 583 588 I-treatment
cytotoxic 30 39 589 598 I-treatment
T 40 41 599 600 I-treatment
- 41 42 600 601 I-treatment
lymphocyte 42 52 601 611 I-treatment
- 52 53 611 612 I-treatment
associated 53 63 612 622 I-treatment
protein 64 71 623 630 I-treatment
4 72 73 631 632 I-treatment
( 74 75 633 634 I-treatment
anti 75 79 634 638 I-treatment
- 79 80 638 639 I-treatment
CTLA-4 80 86 639 645 I-treatment
) 86 87 645 646 I-treatment
antibody 88 96 647 655 I-treatment
within 97 103 656 662 O
30 104 106 663 665 B-upper_bound
days 107 111 666 670 I-upper_bound
prior 112 117 671 676 I-upper_bound
to 118 120 677 679 O
the 121 124 680 683 O
start 125 130 684 689 O
of 131 133 690 692 O
CMP-001 134 141 693 700 O
dosing 142 148 701 707 O
on 149 151 708 710 O
Week 152 156 711 715 O
1 157 158 716 717 O
Day 159 162 718 721 O
1 163 164 722 723 O

Require 0 7 724 731 O
systemic 8 16 732 740 O
pharmacologic 17 30 741 754 O
doses 31 36 755 760 O
of 37 39 761 763 O
corticosteroids 40 55 764 779 B-treatment
at 56 58 780 782 O
or 59 61 783 785 O
above 62 67 786 791 O
the 68 71 792 795 O
equivalent 72 82 796 806 O
of 83 85 807 809 O
10 86 88 810 812 B-lower_bound
mg 89 91 813 815 I-lower_bound
/ 91 92 815 816 I-lower_bound
day 92 95 816 819 I-lower_bound
prednisone 96 106 820 830 B-treatment

Requires 0 8 831 839 O
prohibited 9 19 840 850 O
treatment 20 29 851 860 O
that 30 34 861 865 O
is 35 37 866 868 O
, 37 38 868 869 O
non 39 42 870 873 O
- 42 43 873 874 O
protocol 43 51 874 882 O
specified 52 61 883 892 O
anticancer 62 72 893 903 O
. 72 73 903 904 O
pharmacotherapy 74 89 905 920 B-treatment
, 89 90 920 921 O
surgery 91 98 922 929 B-treatment
or 99 101 930 932 O
conventional 102 114 933 945 B-treatment
radiotherapy 115 127 946 958 I-treatment
for 128 131 959 962 O
treatment 132 141 963 972 O
of 142 144 973 975 O
malignant 145 154 976 985 B-cancer
tumor 155 160 986 991 I-cancer
) 160 161 991 992 O

Severe 0 6 993 999 O
uncontrolled 7 19 1000 1012 O
cardiac 20 27 1013 1020 B-chronic_disease
disease 28 35 1021 1028 I-chronic_disease
within 36 42 1029 1035 O
6 43 44 1036 1037 B-upper_bound
months 45 51 1038 1044 I-upper_bound
of 52 54 1045 1047 O
screening 55 64 1048 1057 O
, 64 65 1057 1058 O
including 66 75 1059 1068 O
but 76 79 1069 1072 O
not 80 83 1073 1076 O
limited 84 91 1077 1084 O
to 92 94 1085 1087 O
uncontrolled 95 107 1088 1100 O
hypertension 108 120 1101 1113 B-chronic_disease
; 120 121 1113 1114 O
unstable 122 130 1115 1123 B-chronic_disease
angina 131 137 1124 1130 I-chronic_disease
; 137 138 1130 1131 O
myocardial 139 149 1132 1142 B-chronic_disease
infarction 150 160 1143 1153 I-chronic_disease
( 161 162 1154 1155 I-chronic_disease
MI 162 164 1155 1157 I-chronic_disease
) 164 165 1157 1158 I-chronic_disease
or 166 168 1159 1161 O
cerebrovascular 169 184 1162 1177 B-chronic_disease
accident 185 193 1178 1186 I-chronic_disease
( 194 195 1187 1188 I-chronic_disease
CVA 195 198 1188 1191 I-chronic_disease
) 198 199 1191 1192 I-chronic_disease

Women 0 5 1193 1198 B-gender
of 6 8 1199 1201 O
child 9 14 1202 1207 O
- 14 15 1207 1208 O
bearing 15 22 1208 1215 O
potential 23 32 1216 1225 O
who 33 36 1226 1229 O
are 37 40 1230 1233 O
unable 41 47 1234 1240 B-contraception_consent
or 48 50 1241 1243 I-contraception_consent
unwilling 51 60 1244 1253 I-contraception_consent
to 61 63 1254 1256 I-contraception_consent
use 64 67 1257 1260 I-contraception_consent
an 68 70 1261 1263 I-contraception_consent
acceptable 71 81 1264 1274 I-contraception_consent
method 82 88 1275 1281 I-contraception_consent
of 89 91 1282 1284 I-contraception_consent
contraception 92 105 1285 1298 I-contraception_consent

currently 0 9 1299 1308 O
receiving 10 19 1309 1318 O
treatment 20 29 1319 1328 O
with 30 34 1329 1333 O
the 35 38 1334 1337 O
anti 39 43 1338 1342 B-treatment
- 43 44 1342 1343 I-treatment
PD-1 44 48 1343 1347 I-treatment
antibody 49 57 1348 1356 I-treatment
pembrolizumab 58 71 1357 1370 I-treatment
either 72 78 1371 1377 O
alone 79 84 1378 1383 O
or 85 87 1384 1386 O
in 88 90 1387 1389 O
combination 91 102 1390 1401 O

have 0 4 1402 1406 O
a 5 6 1407 1408 O
best 7 11 1409 1413 O
response 12 20 1414 1422 O
of 21 23 1423 1425 O
either 24 30 1426 1432 O
Stable 31 37 1433 1439 B-chronic_disease
Disease 38 45 1440 1447 I-chronic_disease
( 46 47 1448 1449 I-chronic_disease
SD 47 49 1449 1451 I-chronic_disease
) 49 50 1451 1452 I-chronic_disease
or 51 53 1453 1455 O
Progressive 54 65 1456 1467 B-chronic_disease
Disease 66 73 1468 1475 I-chronic_disease
( 74 75 1476 1477 I-chronic_disease
PD 75 77 1477 1479 I-chronic_disease
) 77 78 1479 1480 I-chronic_disease
per 79 82 1481 1484 O
RECIST 83 89 1485 1491 O
Version 90 97 1492 1499 O
1.1 98 101 1500 1503 O
while 102 107 1504 1509 O
on 108 110 1510 1512 O
pembrolizumab 111 124 1513 1526 B-treatment

neutrophil 0 10 1527 1537 B-clinical_variable
count 11 16 1538 1543 I-clinical_variable
greater 17 24 1544 1551 O
than 25 29 1552 1556 O
or 30 32 1557 1559 O
equal 33 38 1560 1565 O
to 39 41 1566 1568 O
( 42 43 1569 1570 O
> 43 44 1570 1571 O
/= 44 46 1571 1573 O
) 46 47 1573 1574 O
1,000 48 53 1575 1580 B-lower_bound
/ 53 54 1580 1581 I-lower_bound
cubic 54 59 1581 1586 I-lower_bound
millimeter 60 70 1587 1597 I-lower_bound
( 71 72 1598 1599 I-lower_bound
mm^3 72 76 1599 1603 I-lower_bound
) 76 77 1603 1604 I-lower_bound

platelet 0 8 1605 1613 B-clinical_variable
count 9 14 1614 1619 I-clinical_variable
> 15 16 1620 1621 O
/=75,000 16 24 1621 1629 O
/ 24 25 1629 1630 I-lower_bound
mm^3 25 29 1630 1634 I-lower_bound

replacement 0 11 1635 1646 O
doses 12 17 1647 1652 O
, 17 18 1652 1653 O
topical 19 26 1654 1661 B-treatment
, 26 27 1661 1662 O
ophthalmologic 28 42 1663 1677 B-treatment
and 43 46 1678 1681 O
inhalational 47 59 1682 1694 B-treatment
steroids 60 68 1695 1703 I-treatment

serum 0 5 1704 1709 B-clinical_variable
creatinine 6 16 1710 1720 I-clinical_variable
< 17 18 1721 1722 O
= 18 19 1722 1723 O
1.5 19 22 1723 1726 B-upper_bound
times 23 28 1727 1732 I-upper_bound
the 29 32 1733 1736 I-upper_bound
ULN 33 36 1737 1740 I-upper_bound
range 37 42 1741 1746 O
of 43 45 1747 1749 O
each 46 50 1750 1754 O
institution 51 62 1755 1766 O

total 0 5 1767 1772 B-clinical_variable
bilirubin 6 15 1773 1782 I-clinical_variable
less 16 20 1783 1787 O
than 21 25 1788 1792 O
or 26 28 1793 1795 O
equal 29 34 1796 1801 O
to 35 37 1802 1804 O
( 38 39 1805 1806 O
< 39 40 1806 1807 O
=) 40 42 1807 1809 O
1.5 43 46 1810 1813 B-upper_bound
times 47 52 1814 1819 I-upper_bound
the 53 56 1820 1823 I-upper_bound
upper 57 62 1824 1829 I-upper_bound
limit 63 68 1830 1835 I-upper_bound
of 69 71 1836 1838 I-upper_bound
normal 72 78 1839 1845 I-upper_bound
( 79 80 1846 1847 I-upper_bound
ULN 80 83 1847 1850 I-upper_bound
) 83 84 1850 1851 I-upper_bound
of 85 87 1852 1854 O
each 88 92 1855 1859 O
institution 93 104 1860 1871 O

who 0 3 1872 1875 O
are 4 7 1876 1879 O
currently 8 17 1880 1889 O
receiving 18 27 1890 1899 O
steroids 28 36 1900 1908 B-treatment
at 37 39 1909 1911 O
a 40 41 1912 1913 O
dose 42 46 1914 1918 O
of 47 49 1919 1921 O
< 50 51 1922 1923 O
= 51 52 1923 1924 O
10 52 54 1924 1926 B-upper_bound
mg 55 57 1927 1929 I-upper_bound
/ 57 58 1929 1930 I-upper_bound
day 58 61 1930 1933 I-upper_bound
do 62 64 1934 1936 O
not 65 68 1937 1940 O
need 69 73 1941 1945 O
to 74 76 1946 1948 O
discontinue 77 88 1949 1960 O
steroids 89 97 1961 1969 O
prior 98 103 1970 1975 O
to 104 106 1976 1978 O
enrollment 107 117 1979 1989 O

who 0 3 1990 1993 O
developed 4 13 1994 2003 O
autoimmune 14 24 2004 2014 B-chronic_disease
disorders 25 34 2015 2024 I-chronic_disease
of 35 37 2025 2027 O
Grade 38 43 2028 2033 O
< 44 45 2034 2035 O
=3 45 47 2035 2037 O
may 48 51 2038 2041 O
enroll 52 58 2042 2048 O
if 59 61 2049 2051 O
the 62 65 2052 2055 O
disorder 66 74 2056 2064 O
has 75 78 2065 2068 O
resolved 79 87 2069 2077 O
to 88 90 2078 2080 O
Grade 91 96 2081 2086 O
< 97 98 2087 2088 O
= 98 99 2088 2089 O
1 99 100 2089 2090 B-upper_bound
and 101 104 2091 2094 O
the 105 108 2095 2098 O
participant 109 120 2099 2110 O
has 121 124 2111 2114 O
been 125 129 2115 2119 O
off 130 133 2120 2123 O
systemic 134 142 2124 2132 B-treatment
steroids 143 151 2133 2141 I-treatment
at 152 154 2142 2144 O
doses 155 160 2145 2150 O
greater 161 168 2151 2158 O
than 169 173 2159 2163 O
( 174 175 2164 2165 O
> 175 176 2165 2166 O
) 176 177 2166 2167 O
10 178 180 2168 2170 B-lower_bound
milligrams 181 191 2171 2181 I-lower_bound
per 192 195 2182 2185 I-lower_bound
day 196 199 2186 2189 I-lower_bound
( 200 201 2190 2191 I-lower_bound
mg 201 203 2191 2193 I-lower_bound
/ 203 204 2193 2194 I-lower_bound
day 204 207 2194 2197 I-lower_bound
) 207 208 2197 2198 I-lower_bound
for 209 212 2199 2202 O
at 213 215 2203 2205 O
least 216 221 2206 2211 O
2 222 223 2212 2213 B-lower_bound
weeks 224 229 2214 2219 I-lower_bound

who 0 3 2220 2223 O
have 4 8 2224 2228 O
a 9 10 2229 2230 O
history 11 18 2231 2238 O
of 19 21 2239 2241 O
adrenal 22 29 2242 2249 B-chronic_disease
insufficiency 30 43 2250 2263 I-chronic_disease

who 0 3 2264 2267 O
have 4 8 2268 2272 O
had 9 12 2273 2276 O
SD 13 15 2277 2279 O
must 16 20 2280 2284 O
have 21 25 2285 2289 O
been 26 30 2290 2294 O
on 31 33 2295 2297 O
pembrolizumab 34 47 2298 2311 B-treatment
for 48 51 2312 2315 O
at 52 54 2316 2318 O
least 55 60 2319 2324 O
12 61 63 2325 2327 B-lower_bound
weeks 64 69 2328 2333 I-lower_bound

who 0 3 2334 2337 O
have 4 8 2338 2342 O
previously 9 19 2343 2353 O
received 20 28 2354 2362 O
any 29 32 2363 2366 O
anti 33 37 2367 2371 B-treatment
- 37 38 2371 2372 I-treatment
PD-1 38 42 2372 2376 I-treatment
/ 42 43 2376 2377 I-treatment
PD 43 45 2377 2379 I-treatment
- 45 46 2379 2380 I-treatment
L1 46 48 2380 2382 I-treatment
therapy 49 56 2383 2390 I-treatment
, 56 57 2390 2391 O
alone 58 63 2392 2397 O
or 64 66 2398 2400 O
in 67 69 2401 2403 O
combination 70 81 2404 2415 O

FEV1 0 4 0 4 B-clinical_variable
% 4 5 4 5 I-clinical_variable
> 6 7 6 7 O
35 7 9 7 9 B-lower_bound
% 9 10 9 10 I-lower_bound
, 10 11 10 11 O
O2 12 14 12 14 B-clinical_variable
saturation 15 25 15 25 I-clinical_variable
> 26 27 26 27 O
90 27 29 27 29 B-lower_bound
% 29 30 29 30 I-lower_bound
on 31 33 31 33 O
room 34 38 34 38 O
air 39 42 39 42 O
, 42 43 42 43 O
clinically 44 54 44 54 O
stable 55 61 55 61 O
with 62 66 62 66 O
no 67 69 67 69 O
significant 70 81 70 81 O
changes 82 89 82 89 O
in 90 92 90 92 O
health 93 99 93 99 O
status 100 106 100 106 O
for 107 110 107 110 O
14 111 113 111 113 B-upper_bound
days 114 118 114 118 I-upper_bound
prior 119 124 119 124 I-upper_bound
to 125 127 125 127 O
Day 128 131 128 131 O
1 132 133 132 133 O

Pregnant 0 8 134 142 B-pregnancy

Use 0 3 143 146 O
of 4 6 147 149 O
any 7 10 150 153 O
investigational 11 26 154 169 O
drug 27 31 170 174 O
and/or 32 38 175 181 O
participated 39 51 182 194 O
in 52 54 195 197 O
any 55 58 198 201 O
interventional 59 73 202 216 O
clinical 74 82 217 225 O
trial 83 88 226 231 O
within 89 95 232 238 O
28 96 98 239 241 B-upper_bound
days 99 103 242 246 I-upper_bound
prior 104 109 247 252 I-upper_bound
to 110 112 253 255 O
screening 113 122 256 265 O

aged 0 4 266 270 B-age
16 5 7 271 273 B-lower_bound
- 7 8 273 274 O
80 8 10 274 276 B-upper_bound

clinically 0 10 277 287 O
stable 11 17 288 294 O
with 18 22 295 299 O
no 23 25 300 302 O
significant 26 37 303 314 O
changes 38 45 315 322 O
in 46 48 323 325 O
health 49 55 326 332 O
status 56 62 333 339 O
for 63 66 340 343 O
14 67 69 344 346 B-upper_bound
days 70 74 347 351 I-upper_bound
prior 75 80 352 357 I-upper_bound
to 81 83 358 360 O
Day 84 87 361 364 O
1 88 89 365 366 O

neurologic 0 10 0 10 B-chronic_disease
conditions 11 21 11 21 I-chronic_disease
( 22 23 22 23 O
neuropathy 23 33 23 33 B-chronic_disease
, 33 34 33 34 O
myopathy 35 43 35 43 B-chronic_disease
) 43 44 43 44 O

presence 0 8 45 53 O
of 9 11 54 56 O
at 12 14 57 59 O
least 15 20 60 65 O
one 21 24 66 69 B-lower_bound
painful 25 32 70 77 O
trigger 33 40 78 85 O
point 41 46 86 91 O
in 47 49 92 94 O
the 50 53 95 98 O
gluteals 54 62 99 107 O
( 63 64 108 109 O
gluteus 64 71 109 116 O
maximus 72 79 117 124 O
or 80 82 125 127 O
medius 83 89 128 134 O
) 89 90 134 135 O
and 91 94 136 139 O
infraspinatus 95 108 140 153 O
on 109 111 154 156 O
the 112 115 157 160 O
same 116 120 161 165 O
side 121 125 166 170 O

use 0 3 171 174 O
of 4 6 175 177 O
medication 7 17 178 188 O
( 18 19 189 190 O
antidepressants 19 34 190 205 B-treatment
, 34 35 205 206 O
opioids 36 43 207 214 B-treatment
) 43 44 214 215 O
and/or 45 51 216 222 O
acute 52 57 223 228 O
cervico 58 65 229 236 O
- 65 66 236 237 O
thoracic 66 74 237 245 O
injury 75 81 246 252 O
( 82 83 253 254 O
whiplash 83 91 254 262 O
, 91 92 262 263 O
facet 93 98 264 269 B-chronic_disease
irritation 99 109 270 280 I-chronic_disease
, 109 110 280 281 O
acute 111 116 282 287 B-chronic_disease
discopathy 117 127 288 298 I-chronic_disease
) 127 128 298 299 O
that 129 133 300 304 O
could 134 139 305 310 O
directly 140 148 311 319 O
influence 149 158 320 329 O
normal 159 165 330 336 O
somatosensory 166 179 337 350 O
processing 180 190 351 361 O
at 191 193 362 364 O
the 194 197 365 368 O
C5 198 200 369 371 O
segment 201 208 372 379 O
[ 209 210 380 381 O
Srbely 210 216 381 387 O
] 216 217 387 388 O

Any 0 3 0 3 O
patient 4 11 4 11 O
with 12 16 12 16 O
suspected 17 26 17 26 O
malignant 27 36 27 36 B-cancer
brain 37 42 37 42 I-cancer
tumor 43 48 43 48 I-cancer
on 49 51 49 51 O
diagnostic 52 62 52 62 O
MR 63 65 63 65 O
imaging 66 73 66 73 O
who 74 77 74 77 O
will 78 82 78 82 O
undergo 83 90 83 90 O
a 91 92 91 92 O
resection 93 102 93 102 B-treatment

Contraindication 0 16 103 119 O
to 17 19 120 122 O
MRI 20 23 123 126 O
( 24 25 127 128 O
metal 25 30 128 133 B-treatment
implants 31 39 134 142 I-treatment
) 39 40 142 143 O

Hemosiderosis 0 13 144 157 B-chronic_disease
/ 13 14 157 158 O
hemochromatosis 14 29 158 173 B-chronic_disease

Iron 0 4 174 178 B-chronic_disease
overload 5 13 179 187 I-chronic_disease
from 14 18 188 192 O
any 19 22 193 196 O
cause 23 28 197 202 O
( 29 30 203 204 O
not 30 33 204 207 O
just 34 38 208 212 O
hemosiderosis 39 52 213 226 B-chronic_disease
or 53 55 227 229 O
hemochromatosis 56 71 230 245 B-chronic_disease
) 71 72 245 246 O

Known 0 5 247 252 O
hypersensitivity 6 22 253 269 O
to 23 25 270 272 O
ferumoxytol 26 37 273 284 B-allergy_name
or 38 40 285 287 O
any 41 44 288 291 O
of 45 47 292 294 O
its 48 51 295 298 O
components 52 62 299 309 O

Pregnant 0 8 310 318 B-pregnancy
patients 9 17 319 327 O

severe 0 6 328 334 B-chronic_disease
chronic 7 14 335 342 I-chronic_disease
hemolysis 15 24 343 352 I-chronic_disease

A 0 1 0 1 O
biopsy 2 8 2 8 B-treatment
of 9 11 9 11 O
the 12 15 12 15 O
cirrhotic 16 25 16 25 B-chronic_disease
liver 26 31 26 31 I-chronic_disease
( 32 33 32 33 O
non 33 36 33 36 O
- 36 37 36 37 O
surgical 37 45 37 45 O
cohort 46 52 46 52 O
) 52 53 52 53 O

A 0 1 54 55 O
clinical 2 10 56 64 B-treatment
liver 11 16 65 70 I-treatment
biopsy 17 23 71 77 I-treatment
( 24 25 78 79 O
with 25 29 79 83 O
research 30 38 84 92 O
tissue 39 45 93 99 O
specimens 46 55 100 109 O
available 56 65 110 119 O
for 66 69 120 123 O
analysis 70 78 124 132 O
) 78 79 132 133 O
= 80 81 134 135 O
< 81 82 135 136 O
3 83 84 137 138 B-upper_bound
months 85 91 139 145 I-upper_bound
prior 92 97 146 151 I-upper_bound
to 98 100 152 154 O
pre 101 104 155 158 O
- 104 105 158 159 O
registration 105 117 159 171 O

An 0 2 172 174 O
indication 3 13 175 185 O
for 14 17 186 189 O
surgical 18 26 190 198 B-treatment
liver 27 32 199 204 I-treatment
resection 33 42 205 214 I-treatment

Any 0 3 215 218 O
prior 4 9 219 224 B-treatment
treatment 10 19 225 234 I-treatment
with 20 24 235 239 O
erlotinib 25 34 240 249 B-treatment
or 35 37 250 252 O
other 38 43 253 258 O
agent 44 49 259 264 O
whose 50 55 265 270 O
primary 56 63 271 278 O
mechanism 64 73 279 288 O
of 74 76 289 291 O
action 77 83 292 298 O
is 84 86 299 301 O
known 87 92 302 307 O
to 93 95 308 310 O
inhibit 96 103 311 318 O
EGFR 104 108 319 323 O

Aspartate 0 9 324 333 B-clinical_variable
aminotransferase 10 26 334 350 I-clinical_variable
( 27 28 351 352 I-clinical_variable
AST 28 31 352 355 I-clinical_variable
) 31 32 355 356 I-clinical_variable
( 33 34 357 358 B-clinical_variable
serum 34 39 358 363 I-clinical_variable
glutamic 40 48 364 372 I-clinical_variable
oxaloacetic 49 60 373 384 I-clinical_variable
transaminase 61 73 385 397 I-clinical_variable
[ 74 75 398 399 I-clinical_variable
SGOT 75 79 399 403 I-clinical_variable
] 79 80 403 404 I-clinical_variable
) 80 81 404 405 I-clinical_variable
and 82 85 406 409 O
alanine 86 93 410 417 B-clinical_variable
aminotransferase 94 110 418 434 I-clinical_variable
( 111 112 435 436 I-clinical_variable
ALT 112 115 436 439 I-clinical_variable
) 115 116 439 440 I-clinical_variable
( 117 118 441 442 B-clinical_variable
serum 118 123 442 447 I-clinical_variable
glutamate 124 133 448 457 I-clinical_variable
pyruvate 134 142 458 466 I-clinical_variable
transaminase 143 155 467 479 I-clinical_variable
[ 156 157 480 481 I-clinical_variable
SGPT 157 161 481 485 I-clinical_variable
] 161 162 485 486 I-clinical_variable
) 162 163 486 487 I-clinical_variable
= 164 165 488 489 O
< 165 166 489 490 O
5 167 168 491 492 B-upper_bound
x 169 170 493 494 I-upper_bound
institutional 171 184 495 508 I-upper_bound
ULN 185 188 509 512 I-upper_bound

Creatinine 0 10 513 523 B-clinical_variable
= 11 12 524 525 O
< 12 13 525 526 O
1.5 14 17 527 530 B-upper_bound
x 18 19 531 532 I-upper_bound
institutional 20 33 533 546 I-upper_bound
ULN 34 37 547 550 I-upper_bound

Eastern 0 7 551 558 B-clinical_variable
Cooperative 8 19 559 570 I-clinical_variable
Oncology 20 28 571 579 I-clinical_variable
Group 29 34 580 585 I-clinical_variable
( 35 36 586 587 I-clinical_variable
ECOG 36 40 587 591 I-clinical_variable
) 40 41 591 592 I-clinical_variable
performance 42 53 593 604 I-clinical_variable
status 54 60 605 611 I-clinical_variable
0 61 62 612 613 B-lower_bound
or 63 65 614 616 O
1 66 67 617 618 B-upper_bound

History 0 7 619 626 O
of 8 10 627 629 O
allergic 11 19 630 638 O
reactions 20 29 639 648 O
attributed 30 40 649 659 O
to 41 43 660 662 O
compounds 44 53 663 672 O
of 54 56 673 675 O
similar 57 64 676 683 O
chemical 65 73 684 692 O
or 74 76 693 695 O
biologic 77 85 696 704 O
composition 86 97 705 716 O
to 98 100 717 719 O
erlotinib 101 110 720 729 B-treatment
( 111 112 730 731 I-treatment
Tarceva 112 119 731 738 I-treatment
) 119 120 738 739 I-treatment

Individuals 0 11 740 751 O
with 12 16 752 756 O
a 17 18 757 758 O
clinical 19 27 759 767 O
diagnosis 28 37 768 777 O
fibrosis 38 46 778 786 B-chronic_disease
or 47 49 787 789 O
cirrhosis 50 59 790 799 B-chronic_disease
of 60 62 800 802 I-chronic_disease
the 63 66 803 806 I-chronic_disease
liver 67 72 807 812 I-chronic_disease
( 73 74 813 814 O
no 74 76 814 816 O
more 77 81 817 821 O
than 82 86 822 826 O
Child 87 92 827 832 O
- 92 93 832 833 O
Pugh 93 97 833 837 O
classification 98 112 838 852 O
A 113 114 853 854 O
; 114 115 854 855 O
Child 116 121 856 861 B-clinical_variable
- 121 122 861 862 I-clinical_variable
Pugh 122 126 862 866 I-clinical_variable
- 126 127 866 867 I-clinical_variable
Turcotte 127 135 867 875 I-clinical_variable
score 136 141 876 881 I-clinical_variable
of 142 144 882 884 O
6 145 146 885 886 B-upper_bound
or 147 149 887 889 O
less 150 154 890 894 O
) 154 155 894 895 O
who 156 159 896 899 O
have 160 164 900 904 O

International 0 13 905 918 B-clinical_variable
normalized 14 24 919 929 I-clinical_variable
ratio 25 30 930 935 I-clinical_variable
( 31 32 936 937 I-clinical_variable
INR 32 35 937 940 I-clinical_variable
) 35 36 940 941 I-clinical_variable
= 37 38 942 943 O
< 38 39 943 944 O
1.5 40 43 945 948 B-upper_bound

Non 0 3 949 952 O
- 3 4 952 953 O
surgical 4 12 953 961 O
cohort 13 19 962 968 O
only 20 24 969 973 O
: 24 25 973 974 O
pathology 26 35 975 984 O
report 36 42 985 991 O
from 43 47 992 996 O
clinical 48 56 997 1005 O
liver 57 62 1006 1011 B-treatment
biopsy 63 69 1012 1018 I-treatment
(= 70 72 1019 1021 O
< 72 73 1021 1022 O
3 74 75 1023 1024 B-upper_bound
months 76 82 1025 1031 I-upper_bound
prior 83 88 1032 1037 I-upper_bound
to 89 91 1038 1040 O
pre 92 95 1041 1044 O
- 95 96 1044 1045 O
registration 96 108 1045 1057 O
) 108 109 1057 1058 O
demonstrates 110 122 1059 1071 O
no 123 125 1072 1074 O
histologic 126 136 1075 1085 O
abnormalities 137 150 1086 1099 O
associated 151 161 1100 1110 O
with 162 166 1111 1115 O
chronic 167 174 1116 1123 B-chronic_disease
hepatitis 175 184 1124 1133 I-chronic_disease
, 184 185 1133 1134 O
steatohepatitis 186 201 1135 1150 B-chronic_disease
, 201 202 1150 1151 O
fibrosis 203 211 1152 1160 B-chronic_disease
, 211 212 1160 1161 O
or 213 215 1162 1164 O
cirrhosis 216 225 1165 1174 B-chronic_disease

Non 0 3 1175 1178 O
- 3 4 1178 1179 O
surgical 4 12 1179 1187 O
cohort 13 19 1188 1194 O
only 20 24 1195 1199 O
: 24 25 1199 1200 O
positive 26 34 1201 1209 O
phospho 35 42 1210 1217 O
- 42 43 1217 1218 O
EGFR 43 47 1218 1222 O
assessment 48 58 1223 1233 O
( 59 60 1234 1235 O
> 60 61 1235 1236 O
= 61 62 1236 1237 O
100 63 66 1238 1241 B-lower_bound
stained 67 74 1242 1249 B-clinical_variable
pixels 75 81 1250 1256 I-clinical_variable
) 81 82 1256 1257 O
from 83 87 1258 1262 O
tissue 88 94 1263 1269 O
obtained 95 103 1270 1278 O
from 104 108 1279 1283 O
previous 109 117 1284 1292 B-treatment
clinical 118 126 1293 1301 I-treatment
liver 127 132 1302 1307 I-treatment
biopsy 133 139 1308 1314 I-treatment

Not 0 3 1315 1318 B-pregnancy
pregnant 4 12 1319 1327 I-pregnancy
or 13 15 1328 1330 O
breast 16 22 1331 1337 O
feeding 23 30 1338 1345 O

Participants 0 12 1346 1358 O
who 13 16 1359 1362 O
can 17 20 1363 1366 O
not 20 23 1366 1369 O
have 24 28 1370 1374 O
their 29 34 1375 1380 O
warfarin 35 43 1381 1389 B-treatment
, 43 44 1389 1390 O
Lovenox 45 52 1391 1398 B-treatment
, 52 53 1398 1399 O
Plavix 54 60 1400 1406 B-treatment
, 60 61 1406 1407 O
or 62 64 1408 1410 O
other 65 70 1411 1416 O
comparable 71 81 1417 1427 B-treatment
medications 82 93 1428 1439 I-treatment
held 94 98 1440 1444 O
for 99 102 1445 1448 O
percutaneous 103 115 1449 1461 B-treatment
or 116 118 1462 1464 I-treatment
transjugular 119 131 1465 1477 I-treatment
liver 132 137 1478 1483 I-treatment
biopsy 138 144 1484 1490 I-treatment
and 145 148 1491 1494 O
surgery 149 156 1495 1502 B-treatment
if 157 159 1503 1505 O
so 160 162 1506 1508 O
indicated 163 172 1509 1518 O

Participants 0 12 1519 1531 O
who 13 16 1532 1535 O
regularly 17 26 1536 1545 O
( 27 28 1546 1547 O
> 28 29 1547 1548 O
= 29 30 1548 1549 O
2 31 32 1550 1551 B-lower_bound
times 33 38 1552 1557 I-lower_bound
per 39 42 1558 1561 O
week 43 47 1562 1566 O
) 47 48 1566 1567 O
use 49 52 1568 1571 O
drugs 53 58 1572 1577 O
that 59 63 1578 1582 O
alter 64 69 1583 1588 O
the 70 73 1589 1592 O
pH 74 76 1593 1595 O
of 77 79 1596 1598 O
the 80 83 1599 1602 O
gastrointestinal 84 100 1603 1619 O
( 101 102 1620 1621 O
GI 102 104 1621 1623 O
) 104 105 1623 1624 O
tract 106 111 1625 1630 O
, 111 112 1630 1631 O
such 113 117 1632 1636 O
as 118 120 1637 1639 O
proton 121 127 1640 1646 B-treatment
pump 128 132 1647 1651 I-treatment
inhibitors 133 143 1652 1662 I-treatment
( 144 145 1663 1664 I-treatment
PPI 145 148 1664 1667 I-treatment
) 148 149 1667 1668 I-treatment
and 150 153 1669 1672 O
antacids 154 162 1673 1681 B-treatment

Participants 0 12 1682 1694 O
with 13 17 1695 1699 O
a 18 19 1700 1701 O
known 20 25 1702 1707 O
diagnosis 26 35 1708 1717 O
of 36 38 1718 1720 O
human 39 44 1721 1726 B-chronic_disease
immunodeficiency 45 61 1727 1743 I-chronic_disease
virus 62 67 1744 1749 I-chronic_disease
( 68 69 1750 1751 I-chronic_disease
HIV 69 72 1751 1754 I-chronic_disease
) 72 73 1754 1755 I-chronic_disease

Percutaneous 0 12 1756 1768 B-treatment
or 13 15 1769 1771 O
transjugular 16 28 1772 1784 B-treatment
biopsy 29 35 1785 1791 I-treatment
of 36 38 1792 1794 O
cirrhotic 39 48 1795 1804 B-chronic_disease
liver 49 54 1805 1810 I-chronic_disease
at 55 57 1811 1813 O
least 58 63 1814 1819 O
7 64 65 1820 1821 B-lower_bound
days 66 70 1822 1826 I-lower_bound
prior 71 76 1827 1832 I-lower_bound
to 77 79 1833 1835 O
liver 80 85 1836 1841 B-treatment
resection 86 95 1842 1851 I-treatment
( 96 97 1852 1853 O
surgical 97 105 1853 1861 B-treatment
cohort 106 112 1862 1868 I-treatment
) 112 113 1868 1869 O

Platelets 0 9 1870 1879 B-clinical_variable
> 10 11 1880 1881 O
= 11 12 1881 1882 O
50 13 15 1883 1885 B-lower_bound
B 16 17 1886 1887 I-lower_bound
/ 17 18 1887 1888 I-lower_bound
L 18 19 1888 1889 I-lower_bound
( 20 21 1890 1891 I-lower_bound
10 21 23 1891 1893 I-lower_bound
^ 23 24 1893 1894 I-lower_bound
9 24 25 1894 1895 I-lower_bound
/ 25 26 1895 1896 I-lower_bound
L 26 27 1896 1897 I-lower_bound
) 27 28 1897 1898 I-lower_bound

Pre 0 3 1899 1902 O
- 3 4 1902 1903 O
intervention 4 16 1903 1915 O
biopsy 17 23 1916 1922 B-treatment
sample 24 30 1923 1929 O
collected 31 40 1930 1939 O

Receiving 0 9 1940 1949 O
any 10 13 1950 1953 O
other 14 19 1954 1959 O
investigational 20 35 1960 1975 B-treatment
agents 36 42 1976 1982 I-treatment
= 43 44 1983 1984 O
< 44 45 1984 1985 O
6 46 47 1986 1987 B-upper_bound
months 48 54 1988 1994 I-upper_bound
prior 55 60 1995 2000 I-upper_bound
to 61 63 2001 2003 O
registration 64 76 2004 2016 O

Surgical 0 8 2017 2025 B-treatment
cohort 9 15 2026 2032 O
( 16 17 2033 2034 O
cohort 17 23 2034 2040 O
A 24 25 2041 2042 O
only 26 30 2043 2047 O
): 30 32 2047 2049 O
percutaneous 33 45 2050 2062 B-treatment
or 46 48 2063 2065 O
transjugular 49 61 2066 2078 B-treatment
biopsy 62 68 2079 2085 I-treatment
incomplete 69 79 2086 2096 O
or 80 82 2097 2099 O
not 83 86 2100 2103 O
performed 87 96 2104 2113 O

Total 0 5 2114 2119 B-clinical_variable
bilirubin 6 15 2120 2129 I-clinical_variable
= 16 17 2130 2131 O
< 17 18 2131 2132 O
3 19 20 2133 2134 B-upper_bound
x 21 22 2135 2136 I-upper_bound
institutional 23 36 2137 2150 I-upper_bound
upper 37 42 2151 2156 I-upper_bound
limit 43 48 2157 2162 I-upper_bound
of 49 51 2163 2165 I-upper_bound
normal 52 58 2166 2172 I-upper_bound
( 59 60 2173 2174 I-upper_bound
ULN 60 63 2174 2177 I-upper_bound
) 63 64 2177 2178 I-upper_bound

Uncontrolled 0 12 2179 2191 O
intercurrent 13 25 2192 2204 B-chronic_disease
illness 26 33 2205 2212 I-chronic_disease
including 34 43 2213 2222 O
, 43 44 2222 2223 O
but 45 48 2224 2227 O
not 49 52 2228 2231 O
limited 53 60 2232 2239 O
to 61 63 2240 2242 O
, 63 64 2242 2243 O
ongoing 65 72 2244 2251 O
or 73 75 2252 2254 O
active 76 82 2255 2261 B-chronic_disease
infection 83 92 2262 2271 I-chronic_disease
, 92 93 2271 2272 O
symptomatic 94 105 2273 2284 O
congestive 106 116 2285 2295 B-chronic_disease
heart 117 122 2296 2301 I-chronic_disease
failure 123 130 2302 2309 I-chronic_disease
, 130 131 2309 2310 O
unstable 132 140 2311 2319 B-chronic_disease
angina 141 147 2320 2326 I-chronic_disease
pectoris 148 156 2327 2335 I-chronic_disease
, 156 157 2335 2336 O
or 158 160 2337 2339 O
psychiatric 161 172 2340 2351 B-chronic_disease
illness 173 180 2352 2359 I-chronic_disease
/ 180 181 2359 2360 O
social 181 187 2360 2366 B-chronic_disease
situations 188 198 2367 2377 I-chronic_disease
that 199 203 2378 2382 O
would 204 209 2383 2388 O
limit 210 215 2389 2394 O
compliance 216 226 2395 2405 O
with 227 231 2406 2410 O
study 232 237 2411 2416 O
requirements 238 250 2417 2429 O

Use 0 3 2430 2433 O
of 4 6 2434 2436 O
potent 7 13 2437 2443 O
CYP3A4 14 20 2444 2450 O
inhibitors 21 31 2451 2461 O
, 31 32 2461 2462 O
such 33 37 2463 2467 O
as 38 40 2468 2470 O
ketoconazole 41 53 2471 2483 B-treatment
, 53 54 2483 2484 O
atazanavir 55 65 2485 2495 B-treatment
, 65 66 2495 2496 O
clarithromycin 67 81 2497 2511 B-treatment
, 81 82 2511 2512 O
indinavir 83 92 2513 2522 B-treatment
, 92 93 2522 2523 O
itraconazole 94 106 2524 2536 B-treatment
, 106 107 2536 2537 O
nefazodone 108 118 2538 2548 B-treatment
, 118 119 2548 2549 O
nelfinavir 120 130 2550 2560 B-treatment
, 130 131 2560 2561 O
ritonavir 132 141 2562 2571 B-treatment
, 141 142 2571 2572 O
saquinavir 143 153 2573 2583 B-treatment
, 153 154 2583 2584 O
telithromycin 155 168 2585 2598 B-treatment
, 168 169 2598 2599 O
troleandomycin 170 184 2600 2614 B-treatment
, 184 185 2614 2615 O
voriconazole 186 198 2616 2628 B-treatment
, 198 199 2628 2629 O
and 200 203 2630 2633 O
grapefruit 204 214 2634 2644 B-treatment
or 215 217 2645 2647 O
grapefruit 218 228 2648 2658 B-treatment
juice 229 234 2659 2664 I-treatment

Willingness 0 11 2665 2676 O
to 12 14 2677 2679 O
authorize 15 24 2680 2689 O
collection 25 35 2690 2700 O
of 36 38 2701 2703 O
tissue 39 45 2704 2710 O
from 46 50 2711 2715 O
surgically 51 61 2716 2726 B-treatment
- 61 62 2726 2727 I-treatment
resected 62 70 2727 2735 I-treatment
liver 71 76 2736 2741 I-treatment
or 77 79 2742 2744 O
clinical 80 88 2745 2753 O
liver 89 94 2754 2759 B-treatment
biopsy 95 101 2760 2766 I-treatment
for 102 105 2767 2770 O
analyses 106 114 2771 2779 O

Willingness 0 11 2780 2791 O
to 12 14 2792 2794 O
discontinue 15 26 2795 2806 O
smoking 27 34 2807 2814 O
during 35 41 2815 2821 O
the 42 45 2822 2825 O
study 46 51 2826 2831 O
two 52 55 2832 2835 B-upper_bound
weeks 56 61 2836 2841 I-upper_bound
prior 62 67 2842 2847 I-upper_bound
to 68 70 2848 2850 O
beginning 71 80 2851 2860 O
the 81 84 2861 2864 O
study 85 90 2865 2870 O
and 91 94 2871 2874 O
willingness 95 106 2875 2886 O
to 107 109 2887 2889 O
not 110 113 2890 2893 O
smoke 114 119 2894 2899 O
while 120 125 2900 2905 O
taking 126 132 2906 2912 O
study 133 138 2913 2918 B-treatment
medication 139 149 2919 2929 I-treatment

Willingness 0 11 2930 2941 B-contraception_consent
to 12 14 2942 2944 I-contraception_consent
use 15 18 2945 2948 I-contraception_consent
adequate 19 27 2949 2957 I-contraception_consent
contraception 28 41 2958 2971 I-contraception_consent
to 42 44 2972 2974 O
avoid 45 50 2975 2980 O
pregnancy 51 60 2981 2990 B-pregnancy
or 61 63 2991 2993 O
impregnation 64 76 2994 3006 B-pregnancy
until 77 82 3007 3012 O
2 83 84 3013 3014 B-upper_bound
weeks 85 90 3015 3020 I-upper_bound
after 91 96 3021 3026 I-upper_bound
discontinuing 97 110 3027 3040 O
study 111 116 3041 3046 B-treatment
agent 117 122 3047 3052 I-treatment

individuals 0 11 3053 3064 O
who 12 15 3065 3068 O
use 16 19 3069 3072 O
prescription 20 32 3073 3085 O
PPIs 33 37 3086 3090 B-treatment
and 38 41 3091 3094 O
have 42 46 3095 3099 O
approval 47 55 3100 3108 O
from 56 60 3109 3113 O
their 61 66 3114 3119 O
primary 67 74 3120 3127 O
health 75 81 3128 3134 O
care 82 86 3135 3139 O
provider 87 95 3140 3148 O
to 96 98 3149 3151 O
discontinue 99 110 3152 3163 O
for 111 114 3164 3167 O
the 115 118 3168 3171 O
duration 119 127 3172 3180 O
of 128 130 3181 3183 O
clinical 131 139 3184 3192 O
trial 140 145 3193 3198 O
participation 146 159 3199 3212 O
may 160 163 3213 3216 O
be 164 166 3217 3219 O
enrolled 167 175 3220 3228 O
; 175 176 3228 3229 O
an 177 179 3230 3232 O
alternate 180 189 3233 3242 B-treatment
drug 190 194 3243 3247 I-treatment
to 195 197 3248 3250 O
control 198 205 3251 3258 O
gastroesophageal 206 222 3259 3275 B-chronic_disease
reflux 223 229 3276 3282 I-chronic_disease
disease 230 237 3283 3290 I-chronic_disease
( 238 239 3291 3292 I-chronic_disease
GERD)/peptic 239 251 3292 3304 I-chronic_disease
ulcer 252 257 3305 3310 I-chronic_disease
disease 258 265 3311 3318 I-chronic_disease
( 266 267 3319 3320 I-chronic_disease
PUD 267 270 3320 3323 I-chronic_disease
) 270 271 3323 3324 I-chronic_disease
symptoms 272 280 3325 3333 O
will 281 285 3334 3338 O
be 286 288 3339 3341 O
suggested 289 298 3342 3351 O

se 0 2 3352 3354 O
of 3 5 3355 3357 O
CYP3A4 6 12 3358 3364 B-treatment
inducers 13 21 3365 3373 I-treatment
such 22 26 3374 3378 O
as 27 29 3379 3381 O
rifampicin 30 40 3382 3392 B-treatment
, 40 41 3392 3393 O
rifabutin 42 51 3394 3403 B-treatment
, 51 52 3403 3404 O
rifapentine 53 64 3405 3416 B-treatment
, 64 65 3416 3417 O
phenytoin 66 75 3418 3427 B-treatment
, 75 76 3427 3428 O
carbamazepine 77 90 3429 3442 B-treatment
, 90 91 3442 3443 O
phenobarbital 92 105 3444 3457 B-treatment
, 105 106 3457 3458 O
and 107 110 3459 3462 O
St. 111 114 3463 3466 B-treatment
John 115 119 3467 3471 I-treatment
's 119 121 3471 3473 I-treatment
wort 122 126 3474 3478 I-treatment

women 0 5 3479 3484 B-gender
of 6 8 3485 3487 O
child 9 14 3488 3493 O
- 14 15 3493 3494 O
bearing 15 22 3494 3501 O
potential 23 32 3502 3511 O
and 33 36 3512 3515 O
men 37 40 3516 3519 O
must 41 45 3520 3524 O
agree 46 51 3525 3530 B-contraception_consent
to 52 54 3531 3533 I-contraception_consent
use 55 58 3534 3537 I-contraception_consent
adequate 59 67 3538 3546 I-contraception_consent
contraception 68 81 3547 3560 I-contraception_consent
( 82 83 3561 3562 I-contraception_consent
hormonal 83 91 3562 3570 I-contraception_consent
or 92 94 3571 3573 I-contraception_consent
barrier 95 102 3574 3581 I-contraception_consent
method 103 109 3582 3588 I-contraception_consent
of 110 112 3589 3591 I-contraception_consent
birth 113 118 3592 3597 I-contraception_consent
control 119 126 3598 3605 I-contraception_consent
; 126 127 3605 3606 I-contraception_consent
abstinence 128 138 3607 3617 I-contraception_consent
) 138 139 3617 3618 I-contraception_consent
prior 140 145 3619 3624 O
to 146 148 3625 3627 O
study 149 154 3628 3633 O
entry 155 160 3634 3639 O
and 161 164 3640 3643 O
for 165 168 3644 3647 O
the 169 172 3648 3651 O
duration 173 181 3652 3660 O
of 182 184 3661 3663 O
study 185 190 3664 3669 O
participation 191 204 3670 3683 O

( 0 1 0 1 O
LA 1 3 1 3 B-clinical_variable
volume 4 10 4 10 I-clinical_variable
index 11 16 11 16 I-clinical_variable
> 17 18 17 18 O
60 19 21 19 21 B-lower_bound
ml 22 24 22 24 I-lower_bound
/ 24 25 24 25 I-lower_bound
m2 25 27 25 27 I-lower_bound
) 27 28 27 28 O

AF 0 2 29 31 O
secondary 3 12 32 41 O
to 13 15 42 44 O
electrolyte 16 27 45 56 O
imbalance 28 37 57 66 O
, 37 38 66 67 O
thyroid 39 46 68 75 B-chronic_disease
disease 47 54 76 83 I-chronic_disease

ASD 0 3 84 87 B-treatment
closure 4 11 88 95 I-treatment
device 12 18 96 102 I-treatment
, 18 19 102 103 O
LAA 20 23 104 107 B-treatment
closure 24 31 108 115 I-treatment
device 32 38 116 122 I-treatment
, 38 39 122 123 O
prosthetic 40 50 124 134 B-treatment
mitral 51 57 135 141 I-treatment
or 58 60 142 144 I-treatment
tricuspid 61 70 145 154 I-treatment
valve 71 76 155 160 I-treatment

Congestive 0 10 161 171 B-chronic_disease
heart 11 16 172 177 I-chronic_disease
failure 17 24 178 185 I-chronic_disease
( 25 26 186 187 O
1 26 27 187 188 O
point 28 33 189 194 O
) 33 34 194 195 O

Contraindication 0 16 196 212 O
to 17 19 213 215 O
Warfarin 20 28 216 224 B-treatment
or 29 31 225 227 O
other 32 37 228 233 O
novel 38 43 234 239 B-treatment
oral 44 48 240 244 I-treatment
anticoagulants 49 63 245 259 I-treatment

LVEF 0 4 260 264 B-clinical_variable
> 5 6 265 266 O
or=40 6 11 266 271 O
% 11 12 271 272 I-lower_bound

NYHA 0 4 273 277 B-clinical_variable
Class 5 10 278 283 I-clinical_variable
0,I 11 14 284 287 B-lower_bound
, 14 15 287 288 O
II 16 18 289 291 B-upper_bound
stable 19 25 292 298 O
on 26 28 299 301 O
medical 29 36 302 309 B-treatment
therapy 37 44 310 317 I-treatment
for 45 48 318 321 O
> 49 50 322 323 O
3months 51 58 324 331 B-lower_bound

NYHA 0 4 332 336 B-clinical_variable
classes 5 12 337 344 I-clinical_variable
III 13 16 345 348 B-lower_bound
, 16 17 348 349 O
IV 18 20 350 352 B-upper_bound

acquired 0 8 353 361 B-chronic_disease
heart 9 14 362 367 I-chronic_disease
disease 15 22 368 375 I-chronic_disease
that 23 27 376 380 O
may 28 31 381 384 O
increase 32 40 385 393 O
risk 41 45 394 398 O
of 46 48 399 401 O
ablation 49 57 402 410 B-treatment
, 57 58 410 411 O
such 59 63 412 416 O
as 64 66 417 419 O
significant 67 78 420 431 O
ventricular 79 90 432 443 B-chronic_disease
septal 91 97 444 450 I-chronic_disease
defect 98 104 451 457 I-chronic_disease
post 105 109 458 462 O
myocardial 110 120 463 473 B-chronic_disease
infarction 121 131 474 484 I-chronic_disease

acute 0 5 485 490 B-chronic_disease
illness 6 13 491 498 I-chronic_disease
or 14 16 499 501 O
active 17 23 502 508 B-chronic_disease
systemic 24 32 509 517 I-chronic_disease
infection 33 42 518 527 I-chronic_disease
or 43 45 528 530 O
sepsis 46 52 531 537 B-chronic_disease
that 53 57 538 542 O
may 58 61 543 546 O
ordinarily 62 72 547 557 O
warrant 73 80 558 565 O
postponement 81 93 566 578 O
of 94 96 579 581 O
the 97 100 582 585 O
procedure 101 110 586 595 O

age 0 3 596 599 B-age
65 4 6 600 602 B-lower_bound
years 7 12 603 608 I-lower_bound
or 13 15 609 611 O
older 16 21 612 617 O
( 22 23 618 619 O
1 23 24 619 620 O
point 25 30 621 626 O
) 30 31 626 627 O

age 0 3 628 631 B-age
75 4 6 632 634 B-lower_bound
years 7 12 635 640 I-lower_bound
or 13 15 641 643 O
older 16 21 644 649 O
( 22 23 650 651 O
2 23 24 651 652 O
points 25 31 653 659 O
) 31 32 659 660 O

at 0 2 661 663 O
time 3 7 664 668 O
of 8 10 669 671 O
ablation 11 19 672 680 B-treatment
procedure 20 29 681 690 I-treatment
, 29 30 690 691 O
clinically 31 41 692 702 O
significant 42 53 703 714 O
abnormalities 54 67 715 728 O
in 68 70 729 731 O
serum 71 76 732 737 O
potassium 77 86 738 747 O
, 86 87 747 748 O
sodium 88 94 749 755 O
, 94 95 755 756 O
magnesium 96 105 757 766 O
or 106 108 767 769 O
other 109 114 770 775 O
electrolytes 115 127 776 788 O
that 128 132 789 793 O
affect 133 139 794 800 O
the 140 143 801 804 O
suitability 144 155 805 816 O
of 156 158 817 819 O
the 159 162 820 823 O
patient 163 170 824 831 O
for 171 174 832 835 O
ablation 175 183 836 844 O
at 184 186 845 847 O
that 187 191 848 852 O
time 192 196 853 857 O

atrial 0 6 858 864 B-chronic_disease
clot 7 11 865 869 I-chronic_disease
/ 11 12 869 870 I-chronic_disease
thrombus 12 20 870 878 I-chronic_disease
on 21 23 879 881 O
imaging 24 31 882 889 O
such 32 36 890 894 O
as 37 39 895 897 O
on 40 42 898 900 O
a 43 44 901 902 O
trans 45 50 903 908 B-treatment
- 50 51 908 909 I-treatment
esophageal 51 61 909 919 I-treatment
echocardiogram 62 76 920 934 I-treatment
( 77 78 935 936 I-treatment
TEE 78 81 936 939 I-treatment
) 81 82 939 940 I-treatment
within 83 89 941 947 O
72 90 92 948 950 B-upper_bound
hours 93 98 951 956 I-upper_bound
of 99 101 957 959 O
the 102 105 960 963 O
procedure 106 115 964 973 O

atrial 0 6 974 980 B-chronic_disease
fibrillation 7 19 981 993 I-chronic_disease
from 20 24 994 998 O
a 25 26 999 1000 O
reversible 27 37 1001 1011 O
cause 38 43 1012 1017 O
( 44 45 1018 1019 O
e.g. 45 49 1019 1023 O
, 49 50 1023 1024 O
surgery 51 58 1025 1032 B-treatment
, 58 59 1032 1033 O
hyperthyroidism 60 75 1034 1049 B-chronic_disease
, 75 76 1049 1050 O
pericarditis 77 89 1051 1063 B-chronic_disease
) 89 90 1063 1064 O

cardiac 0 7 1065 1072 B-treatment
or 8 10 1073 1075 O
thoracic 11 19 1076 1084 B-treatment
surgery 20 27 1085 1092 I-treatment
within 28 34 1093 1099 O
the 35 38 1100 1103 O
past 39 43 1104 1108 B-upper_bound
180 44 47 1109 1112 I-upper_bound
days 48 52 1113 1117 I-upper_bound

cardiac 0 7 1118 1125 B-treatment
transplantation 8 23 1126 1141 I-treatment
or 24 26 1142 1144 O
other 27 32 1145 1150 O
cardiac 33 40 1151 1158 B-treatment
surgery 41 48 1159 1166 I-treatment
planned 49 56 1167 1174 O
within 57 63 1175 1181 O
the 64 67 1182 1185 O
12 68 70 1186 1188 B-upper_bound
month 71 76 1189 1194 I-upper_bound
followup 77 85 1195 1203 O
period 86 92 1204 1210 O
of 93 95 1211 1213 O
the 96 99 1214 1217 O
trial 100 105 1218 1223 O

congenital 0 10 1224 1234 B-chronic_disease
heart 11 16 1235 1240 I-chronic_disease
disease 17 24 1241 1248 I-chronic_disease
where 25 30 1249 1254 O
the 31 34 1255 1258 O
abnormality 35 46 1259 1270 O
or 47 49 1271 1273 O
its 50 53 1274 1277 O
correction 54 64 1278 1288 O
prohibit 65 73 1289 1297 O
or 74 76 1298 1300 O
increase 77 85 1301 1309 O
the 86 89 1310 1313 O
risk 90 94 1314 1318 O
of 95 97 1319 1321 O
ablation 98 106 1322 1330 B-treatment

contraindication 0 16 1331 1347 O
to 17 19 1348 1350 O
Heparin 20 27 1351 1358 B-treatment

diabetes 0 8 1359 1367 B-chronic_disease
( 9 10 1368 1369 O
1 10 11 1369 1370 O
point 12 17 1371 1376 O
) 17 18 1376 1377 O

extreme 0 7 1378 1385 O
left 8 12 1386 1390 B-chronic_disease
atrial 13 19 1391 1397 I-chronic_disease
enlargement 20 31 1398 1409 I-chronic_disease

heart 0 5 1410 1415 B-chronic_disease
failure 6 13 1416 1423 I-chronic_disease
that 14 18 1424 1428 O
is 19 21 1429 1431 O
not 22 25 1432 1435 O
stable 26 32 1436 1442 O
on 33 35 1443 1445 O
medical 36 43 1446 1453 B-treatment
therapy 44 51 1454 1461 I-treatment

history 0 7 1462 1469 O
of 8 10 1470 1472 O
recent 11 17 1473 1479 O
cerebrovascular 18 33 1480 1495 B-chronic_disease
disease 34 41 1496 1503 I-chronic_disease
( 42 43 1504 1505 O
stroke 43 49 1505 1511 B-chronic_disease
or 50 52 1512 1514 O
TIA 53 56 1515 1518 B-chronic_disease
) 56 57 1518 1519 O
or 58 60 1520 1522 O
systemic 61 69 1523 1531 B-clinical_variable
thromboembolism 70 85 1532 1547 I-clinical_variable
within 86 92 1548 1554 O
< 93 94 1555 1556 O
6 95 96 1557 1558 B-upper_bound
months 97 103 1559 1565 I-upper_bound

history 0 7 1566 1573 O
of 8 10 1574 1576 O
significant 11 22 1577 1588 O
bleeding 23 31 1589 1597 B-chronic_disease
abnormalities 32 45 1598 1611 I-chronic_disease

history 0 7 1612 1619 O
of 8 10 1620 1622 O
significant 11 22 1623 1634 O
blood 23 28 1635 1640 B-chronic_disease
clotting 29 37 1641 1649 I-chronic_disease
abnormalities 38 51 1650 1663 I-chronic_disease
, 51 52 1663 1664 O
systemic 53 61 1665 1673 B-chronic_disease
thrombi 62 69 1674 1681 I-chronic_disease
or 70 72 1682 1684 O
systemic 73 81 1685 1693 B-chronic_disease
embolization 82 94 1694 1706 I-chronic_disease

hypertention 0 12 1707 1719 B-chronic_disease
( 13 14 1720 1721 O
1 14 15 1721 1722 O
point 16 21 1723 1728 O
) 21 22 1728 1729 O

in 0 2 1730 1732 O
whom 3 7 1733 1737 O
PVI 8 11 1738 1741 B-treatment
has 12 15 1742 1745 O
low 16 19 1746 1749 O
success 20 27 1750 1757 O
and 28 31 1758 1761 O
55 32 34 1762 1764 O
mm 35 37 1765 1767 O
baskets 38 45 1768 1775 O
are 46 49 1776 1779 O
too 50 53 1780 1783 O
small 54 59 1784 1789 O
for 60 63 1790 1793 O
the 64 67 1794 1797 O
atria 68 73 1798 1803 O

intramural 0 10 1804 1814 B-chronic_disease
thrombus 11 19 1815 1823 I-chronic_disease
or 20 22 1824 1826 O
other 23 28 1827 1832 O
cardiac 29 36 1833 1840 B-cancer
mass 37 41 1841 1845 I-cancer
that 42 46 1846 1850 O
may 47 50 1851 1854 O
adversely 51 60 1855 1864 O
effect 61 67 1865 1871 O
catheter 68 76 1872 1880 B-treatment
introduction 77 89 1881 1893 O
or 90 92 1894 1896 O
manipulation 93 105 1897 1909 O

left 0 4 1910 1914 B-clinical_variable
atrial 5 11 1915 1921 I-clinical_variable
diameter 12 20 1922 1930 I-clinical_variable
< 21 22 1931 1932 O
or= 22 25 1932 1935 O
5.5 26 29 1936 1939 B-upper_bound
cm 29 31 1939 1941 I-upper_bound

life 0 4 1942 1946 B-clinical_variable
expectancy 5 15 1947 1957 I-clinical_variable
less 16 20 1958 1962 O
than 21 25 1963 1967 O
12 26 28 1968 1970 B-upper_bound
months 29 35 1971 1977 I-upper_bound
( 36 37 1978 1979 O
the 37 40 1979 1982 O
followup 41 49 1983 1991 O
period 50 56 1992 1998 O
of 57 59 1999 2001 O
the 60 63 2002 2005 O
trial 64 69 2006 2011 O
) 69 70 2011 2012 O

male 0 4 2013 2017 B-gender
or 5 7 2018 2020 O
female 8 14 2021 2027 B-gender

myocardial 0 10 2028 2038 B-chronic_disease
infarction 11 21 2039 2049 I-chronic_disease
( 22 23 2050 2051 I-chronic_disease
MI 23 25 2051 2053 I-chronic_disease
) 25 26 2053 2054 I-chronic_disease
within 27 33 2055 2061 O
the 34 37 2062 2065 O
past 38 42 2066 2070 B-upper_bound
three 43 48 2071 2076 I-upper_bound
months 49 55 2077 2083 I-upper_bound

oral 0 4 2084 2088 B-treatment
anticoagulation 5 20 2089 2104 I-treatment
required 21 29 2105 2113 O
for 30 33 2114 2117 O
those 34 39 2118 2123 O
subjects 40 48 2124 2132 O
who 49 52 2133 2136 O
have 53 57 2137 2141 O
a 58 59 2142 2143 O
score 60 65 2144 2149 O
of 66 68 2150 2152 O
two 69 72 2153 2156 B-lower_bound
or 73 75 2157 2159 O
more 76 80 2160 2164 O
based 81 86 2165 2170 O
on 87 89 2171 2173 O
the 90 93 2174 2177 O
following 94 103 2178 2187 O
criteria 104 112 2188 2196 O
( 113 114 2197 2198 O
CHAD 114 118 2198 2202 B-clinical_variable
score 119 124 2203 2208 I-clinical_variable
) 124 125 2208 2209 O

prior 0 5 2210 2215 O
stroke 6 12 2216 2222 B-chronic_disease
or 13 15 2223 2225 O
transient 16 25 2226 2235 B-chronic_disease
ischemic 26 34 2236 2244 I-chronic_disease
attack 35 41 2245 2251 I-chronic_disease
( 42 43 2252 2253 O
2 43 44 2253 2254 O
points 45 51 2255 2261 O
) 51 52 2261 2262 O

pulmonary 0 9 2263 2272 B-chronic_disease
edema 10 15 2273 2278 I-chronic_disease
, 15 16 2278 2279 O
that 17 21 2280 2284 O
may 22 25 2285 2288 O
make 26 30 2289 2293 O
planned 31 38 2294 2301 O
anesthesia 39 49 2302 2312 B-treatment
or 50 52 2313 2315 O
sedation 53 61 2316 2324 B-treatment
difficult 62 71 2325 2334 O

refractory 0 10 2335 2345 O
to 11 13 2346 2348 O
at 14 16 2349 2351 O
least 17 22 2352 2357 O
one 23 26 2358 2361 B-lower_bound
Class 27 32 2362 2367 B-lower_bound
I 33 34 2368 2369 I-lower_bound
or 35 37 2370 2372 O
III 38 41 2373 2376 B-upper_bound
anti 42 46 2377 2381 B-treatment
- 46 47 2381 2382 I-treatment
arrhythmic 47 57 2382 2392 I-treatment
medications 58 69 2393 2404 I-treatment

reported 0 8 2405 2413 O
incidence 9 18 2414 2423 O
of 19 21 2424 2426 O
at 22 24 2427 2429 O
least 25 30 2430 2435 O
two 31 34 2436 2439 B-lower_bound
documented 35 45 2440 2450 O
episodes 46 54 2451 2459 O
of 55 57 2460 2462 O
symptomatic 58 69 2463 2474 O
paroxysmal 70 80 2475 2485 B-chronic_disease
atrial 81 87 2486 2492 I-chronic_disease
fibrillation 88 100 2493 2505 I-chronic_disease
( 101 102 2506 2507 I-chronic_disease
AF 102 104 2507 2509 I-chronic_disease
) 104 105 2509 2510 I-chronic_disease
during 106 112 2511 2517 O
the 113 116 2518 2521 O
three 117 122 2522 2527 B-upper_bound
months 123 129 2528 2534 I-upper_bound
preceding 130 139 2535 2544 I-upper_bound
trial 140 145 2545 2550 O
entry 146 151 2551 2556 O
( 152 153 2557 2558 O
at 153 155 2558 2560 O
least 156 161 2561 2566 O
1 162 163 2567 2568 B-lower_bound
episode 164 171 2569 2576 O
documented 172 182 2577 2587 O
by 183 185 2588 2590 O
12 186 188 2591 2593 B-treatment
- 188 189 2593 2594 I-treatment
lead 189 193 2594 2598 I-treatment
ECG 194 197 2599 2602 I-treatment
or 198 200 2603 2605 O
ECG 201 204 2606 2609 B-treatment
rhythm 205 211 2610 2616 I-treatment
strip 212 217 2617 2622 I-treatment
) 217 218 2622 2623 O

rheumatic 0 9 2624 2633 B-chronic_disease
valve 10 15 2634 2639 I-chronic_disease
disease 16 23 2640 2647 I-chronic_disease
, 23 24 2647 2648 O
since 25 30 2649 2654 O
this 31 35 2655 2659 O
produces 36 44 2660 2668 O
a 45 46 2669 2670 O
unique 47 53 2671 2677 O
AF 54 56 2678 2680 O
phenotype 57 66 2681 2690 O

sex 0 3 2691 2694 O
category 4 12 2695 2703 O
: 12 13 2703 2704 O
female 14 20 2705 2711 B-gender
( 21 22 2712 2713 O
1 22 23 2713 2714 O
point 24 29 2715 2720 O
) 29 30 2720 2721 O

significant 0 11 2722 2733 O
pulmonary 12 21 2734 2743 B-chronic_disease
disease 22 29 2744 2751 I-chronic_disease
( 30 31 2752 2753 O
e.g. 31 35 2753 2757 O
, 35 36 2757 2758 O
COPD 37 41 2759 2763 B-chronic_disease
) 41 42 2763 2764 O
or 43 45 2765 2767 O
any 46 49 2768 2771 O
other 50 55 2772 2777 O
disease 56 63 2778 2785 O
that 64 68 2786 2790 O
significantly 69 82 2791 2804 O
increase 83 91 2805 2813 O
the 92 95 2814 2817 O
risk 96 100 2818 2822 O
to 101 103 2823 2825 O
the 104 107 2826 2829 O
patient 108 115 2830 2837 O
from 116 120 2838 2842 O
sedation 121 129 2843 2851 O
or 130 132 2852 2854 O
anesthesia 133 143 2855 2865 O

significant 0 11 2866 2877 O
pulmonary 12 21 2878 2887 B-chronic_disease
embolus 22 29 2888 2895 I-chronic_disease
within 30 36 2896 2902 O
6 37 38 2903 2904 B-upper_bound
months 39 45 2905 2911 I-upper_bound
of 46 48 2912 2914 O
enrollment 49 59 2915 2925 O

stable 0 6 2926 2932 B-chronic_disease
/ 6 7 2932 2933 I-chronic_disease
unstable 7 15 2933 2941 I-chronic_disease
angina 16 22 2942 2948 I-chronic_disease
or 23 25 2949 2951 O
ongoing 26 33 2952 2959 O
myocardial 34 44 2960 2970 B-treatment
ischemia 45 53 2971 2979 I-treatment

structural 0 10 2980 2990 B-chronic_disease
heart 11 16 2991 2996 I-chronic_disease
disease 17 24 2997 3004 I-chronic_disease
of 25 27 3005 3007 O
clinical 28 36 3008 3016 O
significance 37 49 3017 3029 O

sustained 0 9 3030 3039 O
AF 10 12 3040 3042 B-chronic_disease
during 13 19 3043 3049 O
the 20 23 3050 3053 O
procedure 24 33 3054 3063 O

untreatable 0 11 3064 3075 O
allergy 12 19 3076 3083 O
to 20 22 3084 3086 O
contrast 23 31 3087 3095 B-allergy_name
media 32 37 3096 3101 I-allergy_name

vascular 0 8 3102 3110 B-chronic_disease
disease 9 16 3111 3118 I-chronic_disease
( 17 18 3119 3120 O
1 18 19 3120 3121 O
point 20 25 3122 3127 O
) 25 26 3127 3128 O

willingness 0 11 3129 3140 O
, 11 12 3140 3141 O
ability 13 20 3142 3149 O
and 21 24 3150 3153 O
commitment 25 35 3154 3164 O
to 36 38 3165 3167 O
participate 39 50 3168 3179 O
in 51 53 3180 3182 O
baseline 54 62 3183 3191 O
and 63 66 3192 3195 O
follow 67 73 3196 3202 O
- 73 74 3202 3203 O
up 74 76 3203 3205 O
evaluations 77 88 3206 3217 O
without 89 96 3218 3225 O
participation 97 110 3226 3239 O
in 111 113 3240 3242 O
another 114 121 3243 3250 B-treatment
clinical 122 130 3251 3259 I-treatment
trial 131 136 3260 3265 I-treatment
( 137 138 3266 3267 O
unless 138 144 3267 3273 O
documented 145 155 3274 3284 O
approval 156 164 3285 3293 O
received 165 173 3294 3302 O
from 174 178 3303 3307 O
both 179 183 3308 3312 O
sponsors 184 192 3313 3321 O
) 192 193 3321 3322 O

women 0 5 3323 3328 B-gender
without 6 13 3329 3336 O
childbearing 14 26 3337 3349 O
potential 27 36 3350 3359 O
or 37 39 3360 3362 O
women 40 45 3363 3368 O
of 46 48 3369 3371 O
childbearing 49 61 3372 3384 O
potential 62 71 3385 3394 O
who 72 75 3395 3398 O
are 76 79 3399 3402 O
not 80 83 3403 3406 B-pregnancy
pregnant 84 92 3407 3415 I-pregnancy
per 93 96 3416 3419 O
a 97 98 3420 3421 O
serum 99 104 3422 3427 O
HCG 105 108 3428 3431 O
test 109 113 3432 3436 O

Age 0 3 0 3 B-age
at 4 6 4 6 O
least 7 12 7 12 O
18 13 15 13 15 B-lower_bound
years 16 21 16 21 I-lower_bound
old 22 25 22 25 O

Creatinine 0 10 26 36 B-clinical_variable
clearance 11 20 37 46 I-clinical_variable
of 21 23 47 49 O
less 24 28 50 54 O
than 29 33 55 59 O
30 34 36 60 62 B-upper_bound
mL 37 39 63 65 I-upper_bound
/ 39 40 65 66 I-upper_bound
min 40 43 66 69 I-upper_bound
by 44 46 70 72 O
Cockcroft 47 56 73 82 O
- 56 57 82 83 O
Gault 57 62 83 88 O
estimate 63 71 89 97 O

Has 0 3 98 101 O
another 4 11 102 109 O
painful 12 19 110 117 O
condition 20 29 118 127 O
requiring 30 39 128 137 O
chronic 40 47 138 145 O
use 48 51 146 149 O
of 52 54 150 152 O
opioid 55 61 153 159 B-treatment
analgesic 62 71 160 169 I-treatment
, 71 72 169 170 O
gabapentin 73 83 171 181 B-treatment
, 83 84 181 182 O
or 85 87 183 185 O
pregabalin 88 98 186 196 B-treatment

History 0 7 197 204 O
of 8 10 205 207 O
angioedema 11 21 208 218 B-chronic_disease

History 0 7 219 226 O
of 8 10 227 229 O
hypersensitivity 11 27 230 246 O
to 28 30 247 249 O
pregabalin 31 41 250 260 B-allergy_name
or 42 44 261 263 O
gabapentin 45 55 264 274 B-allergy_name

History 0 7 275 282 O
of 8 10 283 285 O
seizure 11 18 286 293 B-chronic_disease
or 19 21 294 296 O
currently 22 31 297 306 O
taking 32 38 307 313 O
anti 39 43 314 318 B-treatment
- 43 44 318 319 I-treatment
epileptic 44 53 319 328 I-treatment
medication 54 64 329 339 I-treatment

History 0 7 340 347 O
of 8 10 348 350 O
serious 11 18 351 358 O
mood 19 23 359 363 B-chronic_disease
disorder 24 32 364 372 I-chronic_disease
or 33 35 373 375 O
attempted 36 45 376 385 B-chronic_disease
suicide 46 53 386 393 I-chronic_disease
as 54 56 394 396 O
determined 57 67 397 407 O
by 68 70 408 410 O
patients 71 79 411 419 O
history 80 87 420 427 O
and 88 91 428 431 O
physical 92 100 432 440 O
and 101 104 441 444 O
by 105 107 445 447 O
using 108 113 448 453 O
theDepression 114 127 454 467 O
Screening 128 137 468 477 O

New 0 3 478 481 B-clinical_variable
York 4 8 482 486 I-clinical_variable
Heart 9 14 487 492 I-clinical_variable
Association 15 26 493 504 I-clinical_variable
class 27 32 505 510 I-clinical_variable
III 33 36 511 514 B-lower_bound
or 37 39 515 517 O
IV 40 42 518 520 B-upper_bound
heart 43 48 521 526 B-chronic_disease
failure 49 56 527 534 I-chronic_disease

Patients 0 8 535 543 O
anticipated 9 20 544 555 O
to 21 23 556 558 O
receive 24 31 559 566 O
radiation 32 41 567 576 B-treatment
therapy 42 49 577 584 I-treatment
with 50 54 585 589 O
Protons 55 62 590 597 O

Patients 0 8 598 606 O
being 9 14 607 612 O
treated 15 22 613 620 O
for 23 26 621 624 O
oropharyngeal 27 40 625 638 B-cancer
cancer 41 47 639 645 I-cancer
with 48 52 646 650 O
undergoing 53 63 651 661 O
concurrent 64 74 662 672 O
chemotherapy 75 87 673 685 B-treatment
and 88 91 686 689 O
radiation 92 101 690 699 B-treatment
therapy 102 109 700 707 I-treatment
( 110 111 708 709 O
photons 111 118 709 716 O
) 118 119 716 717 O
for 120 123 718 721 O
a 124 125 722 723 O
histological 126 138 724 736 O
diagnosis 139 148 737 746 O
of 149 151 747 749 O
squamous 152 160 750 758 B-cancer
cell 161 165 759 763 I-cancer
carcinoma 166 175 764 773 I-cancer
to 176 178 774 776 O
the 179 182 777 780 O
head 183 187 781 785 O
and 188 191 786 789 O
neck 192 196 790 794 O
at 197 199 795 797 O
the 200 203 798 801 O
University 204 214 802 812 O
of 215 217 813 815 O
Pennsylvania 218 230 816 828 O

Platelets 0 9 829 838 B-clinical_variable
of 10 12 839 841 O
less 13 17 842 846 O
than 18 22 847 851 O
150 23 26 852 855 B-upper_bound
mg 27 29 856 858 I-upper_bound
/ 29 30 858 859 I-upper_bound
dL 30 32 859 861 I-upper_bound
or 33 35 862 864 O
history 36 43 865 872 O
of 44 46 873 875 O
thrombocytopenia 47 63 876 892 B-chronic_disease

Subjects 0 8 893 901 O
with 9 13 902 906 O
a 14 15 907 908 O
score 16 21 909 914 O
of 22 24 915 917 O
greater 25 32 918 925 O
than 33 37 926 930 O
10 38 40 931 933 B-lower_bound
or 41 43 934 936 O
those 44 49 937 942 O
answering 50 59 943 952 O
# 60 61 953 954 O
5 61 62 954 955 O
with 63 67 956 960 O
scores 68 74 961 967 O
greater 75 82 968 975 O
than 83 87 976 980 O
a 88 89 981 982 O
0 90 91 983 984 O
will 92 96 985 989 O
be 97 99 990 992 O
deemed 100 106 993 999 O
ineligible 107 117 1000 1010 O
to 118 120 1011 1013 O
be 121 123 1014 1016 O
enrolled 124 132 1017 1025 O
on 133 135 1026 1028 O
study 136 141 1029 1034 O

The 0 3 1035 1038 O
patient 4 11 1039 1046 O
has 12 15 1047 1050 O
any 16 19 1051 1054 O
uncontrolled 20 32 1055 1067 O
intercurrent 33 45 1068 1080 O
illness 46 53 1081 1088 O
including 54 63 1089 1098 O
but 64 67 1099 1102 O
not 68 71 1103 1106 O
limited 72 79 1107 1114 O
to 80 82 1115 1117 O
psychiatric 83 94 1118 1129 B-chronic_disease
illness 95 102 1130 1137 I-chronic_disease
/ 102 103 1137 1138 O
social 103 109 1138 1144 O
situations 110 120 1145 1155 O
that 121 125 1156 1160 O
would 126 131 1161 1166 O
limit 132 137 1167 1172 O
compliance 138 148 1173 1183 O
or 149 151 1184 1186 O
interfere 152 161 1187 1196 O
with 162 166 1197 1201 O
their 167 172 1202 1207 O
ability 173 180 1208 1215 O
to 181 183 1216 1218 O
participate 184 195 1219 1230 O

Treatment 0 9 1231 1240 B-treatment
entails 10 17 1241 1248 O
significant 18 29 1249 1260 O
risk 30 34 1261 1265 O
for 35 38 1266 1269 O
symptomatic 39 50 1270 1281 B-chronic_disease
mucositis 51 60 1282 1291 I-chronic_disease
likely 61 67 1292 1298 O
to 68 70 1299 1301 O
require 71 78 1302 1309 O
opioid 79 85 1310 1316 B-treatment
analgesia 86 95 1317 1326 I-treatment
, 95 96 1326 1327 O
as 97 99 1328 1330 O
per 100 103 1331 1334 O
the 104 107 1335 1338 O
discretion 108 118 1339 1349 O
of 119 121 1350 1352 O
treating 122 130 1353 1361 O
physician 131 140 1362 1371 O
/ 140 141 1371 1372 O
NP 141 143 1372 1374 O

> 0 1 0 1 O
4 2 3 2 3 B-lower_bound
weeks 4 9 4 9 I-lower_bound
since 10 15 10 15 O
major 16 21 16 21 B-treatment
surgery 22 29 22 29 I-treatment

Absolute 0 8 30 38 B-clinical_variable
neutrophil 9 19 39 49 I-clinical_variable
count 20 25 50 55 I-clinical_variable
> 26 27 56 57 O
= 27 28 57 58 O
1,500 29 34 59 64 B-lower_bound
/ 34 35 64 65 I-lower_bound
uL 35 37 65 67 I-lower_bound

Aspartate 0 9 68 77 B-clinical_variable
aminotransferase 10 26 78 94 I-clinical_variable
( 27 28 95 96 I-clinical_variable
AST 28 31 96 99 I-clinical_variable
) 31 32 99 100 I-clinical_variable
and 33 36 101 104 O
alanine 37 44 105 112 B-clinical_variable
aminotransferase 45 61 113 129 I-clinical_variable
( 62 63 130 131 I-clinical_variable
ALT 63 66 131 134 I-clinical_variable
) 66 67 134 135 I-clinical_variable
= 68 69 136 137 O
< 69 70 137 138 O
3 71 72 139 140 B-upper_bound
X 73 74 141 142 I-upper_bound
ULN 75 78 143 146 I-upper_bound

Bilirubin 0 9 147 156 B-clinical_variable
= 10 11 157 158 O
< 11 12 158 159 O
1.5 13 16 160 163 B-upper_bound
X 17 18 164 165 I-upper_bound
ULN 19 22 166 169 I-upper_bound

Creatinine 0 10 170 180 B-clinical_variable
< 11 12 181 182 O
1.5 13 16 183 186 B-upper_bound
X 17 18 187 188 I-upper_bound
upper 19 24 189 194 I-upper_bound
limit 25 30 195 200 I-upper_bound
of 31 33 201 203 I-upper_bound
normal 34 40 204 210 I-upper_bound
( 41 42 211 212 I-upper_bound
ULN 42 45 212 215 I-upper_bound
) 45 46 215 216 I-upper_bound

Eastern 0 7 217 224 B-clinical_variable
Cooperative 8 19 225 236 I-clinical_variable
Oncology 20 28 237 245 I-clinical_variable
Group 29 34 246 251 I-clinical_variable
( 35 36 252 253 I-clinical_variable
ECOG 36 40 253 257 I-clinical_variable
) 40 41 257 258 I-clinical_variable
performance 42 53 259 270 I-clinical_variable
status 54 60 271 277 I-clinical_variable
: 60 61 277 278 O
0 62 63 279 280 B-lower_bound
- 63 64 280 281 O
1 64 65 281 282 B-upper_bound

Estimated 0 9 283 292 O
glomerular 10 20 293 303 B-clinical_variable
filtration 21 31 304 314 I-clinical_variable
rate 32 36 315 319 I-clinical_variable
( 37 38 320 321 I-clinical_variable
GFR 38 41 321 324 I-clinical_variable
) 41 42 324 325 I-clinical_variable
> 43 44 326 327 O
30 45 47 328 330 B-lower_bound
ml 48 50 331 333 I-lower_bound
/ 50 51 333 334 I-lower_bound
min 51 54 334 337 I-lower_bound

Hemoglobin 0 10 338 348 B-clinical_variable
> 11 12 349 350 O
= 12 13 350 351 O
9 14 15 352 353 B-lower_bound
g 16 17 354 355 I-lower_bound
/ 17 18 355 356 I-lower_bound
dL 18 20 356 358 I-lower_bound

Negative 0 8 359 367 B-pregnancy
pregnancy 9 18 368 377 I-pregnancy
test 19 23 378 382 O
in 24 26 383 385 O
women 27 32 386 391 B-gender
of 33 35 392 394 O
childbearing 36 48 395 407 O
age 49 52 408 411 B-age

No 0 2 412 414 O
> 3 4 415 416 O
= 4 5 416 417 O
grade 6 11 418 423 B-lower_bound
2 12 13 424 425 I-lower_bound
sensory 14 21 426 433 O
peripheral 22 32 434 444 B-chronic_disease
neuropathy 33 43 445 455 I-chronic_disease

No 0 2 456 458 O
evidence 3 11 459 467 O
of 12 14 468 470 O
extrapancreatic 15 30 471 486 B-chronic_disease
disease 31 38 487 494 I-chronic_disease
by 39 41 495 497 O
cross 42 47 498 503 B-treatment
sectional 48 57 504 513 I-treatment
imaging 58 65 514 521 I-treatment
, 65 66 521 522 O
PET 67 70 523 526 B-treatment
scan 71 75 527 531 I-treatment
, 75 76 531 532 O
or 77 79 533 535 O
laparoscopy 80 91 536 547 B-treatment
, 91 92 547 548 O
including 93 102 549 558 O
nodal 103 108 559 564 O
involvement 109 120 565 576 O
beyond 121 127 577 583 O
the 128 131 584 587 O
peripancreatic 132 146 588 602 O
tissues 147 154 603 610 O
and/or 155 161 611 617 O
distant 162 169 618 625 O
metastases 170 180 626 636 B-cancer

No 0 2 637 639 O
evidence 3 11 640 648 O
of 12 14 649 651 O
tumor 15 20 652 657 B-cancer
extension 21 30 658 667 O
to 31 33 668 670 O
superior 34 42 671 679 O
mesenteric 43 53 680 690 O
artery 54 60 691 697 O
, 60 61 697 698 O
hepatic 62 69 699 706 O
artery 70 76 707 713 O
, 76 77 713 714 O
celiac 78 84 715 721 O
axis 85 89 722 726 O
, 89 90 726 727 O
aorta 91 96 728 733 O
, 96 97 733 734 O
or 98 100 735 737 O
inferior 101 109 738 746 O
vena 110 114 747 751 O
cava 115 119 752 756 O
, 119 120 756 757 O
and 121 124 758 761 O
no 125 127 762 764 O
evidence 128 136 765 773 O
of 137 139 774 776 O
occlusion 140 149 777 786 O
or 150 152 787 789 O
encasement 153 163 790 800 O
of 164 166 801 803 O
the 167 170 804 807 O
superior 171 179 808 816 O
mesenteric 180 190 817 827 O
vein 191 195 828 832 O
or 196 198 833 835 O
superior 199 207 836 844 O
mesenteric 208 218 845 855 O
vein 219 223 856 860 O
/ 223 224 860 861 O
portal 224 230 861 867 O
vein 231 235 868 872 O
confluence 236 246 873 883 O
, 246 247 883 884 O
as 248 250 885 887 O
assessed 251 259 888 896 O
by 260 262 897 899 O
computed 263 271 900 908 B-treatment
tomography 272 282 909 919 I-treatment
( 283 284 920 921 I-treatment
CT 284 286 921 923 I-treatment
) 286 287 923 924 I-treatment
using 288 293 925 930 O
pancreatic 294 304 931 941 B-treatment
protocol 305 313 942 950 I-treatment
( 314 315 951 952 O
or 315 317 952 954 O
magnetic 318 326 955 963 B-treatment
resonance 327 336 964 973 I-treatment
imaging 337 344 974 981 I-treatment
[ 345 346 982 983 I-treatment
MRI 346 349 983 986 I-treatment
] 349 350 986 987 I-treatment
in 351 353 988 990 O
patients 354 362 991 999 O
who 363 366 1000 1003 O
can 367 370 1004 1007 O
not 370 373 1007 1010 O
undergo 374 381 1011 1018 O
CT 382 384 1019 1021 O
) 384 385 1021 1022 O
and 386 389 1023 1026 O
EUS 390 393 1027 1030 B-treatment

No 0 2 1031 1033 O
history 3 10 1034 1041 O
of 11 13 1042 1044 O
chronic 14 21 1045 1052 B-chronic_disease
diarrhea 22 30 1053 1061 I-chronic_disease

No 0 2 1062 1064 O
interstitial 3 15 1065 1077 B-chronic_disease
pneumonia 16 25 1078 1087 I-chronic_disease
or 26 28 1088 1090 O
extensive 29 38 1091 1100 O
and 39 42 1101 1104 O
symptomatic 43 54 1105 1116 O
interstitial 55 67 1117 1129 B-chronic_disease
fibrosis 68 76 1130 1138 I-chronic_disease
of 77 79 1139 1141 I-chronic_disease
the 80 83 1142 1145 I-chronic_disease
lung 84 88 1146 1150 I-chronic_disease

No 0 2 1151 1153 O
other 3 8 1154 1159 O
concurrent 9 19 1160 1170 O
anticancer 20 30 1171 1181 B-treatment
therapy 31 38 1182 1189 I-treatment

No 0 2 1190 1192 O
other 3 8 1193 1198 O
malignancy 9 19 1199 1209 B-cancer
within 20 26 1210 1216 O
past 27 31 1217 1221 B-upper_bound
five 32 36 1222 1226 I-upper_bound
years 37 42 1227 1232 I-upper_bound

No 0 2 1233 1235 O
prior 3 8 1236 1241 B-treatment
treatment 9 18 1242 1251 I-treatment
( 19 20 1252 1253 O
chemotherapy 20 32 1253 1265 B-treatment
, 32 33 1265 1266 O
biological 34 44 1267 1277 B-treatment
therapy 45 52 1278 1285 I-treatment
, 52 53 1285 1286 O
or 54 56 1287 1289 O
radiotherapy 57 69 1290 1302 B-treatment
) 69 70 1302 1303 O
for 71 74 1304 1307 O
resectable 75 85 1308 1318 O
pancreatic 86 96 1319 1329 B-cancer
cancer 97 103 1330 1336 I-cancer

No 0 2 1337 1339 O
prior 3 8 1340 1345 B-treatment
treatment 9 18 1346 1355 I-treatment
with 19 23 1356 1360 I-treatment
oxaliplatin 24 35 1361 1372 I-treatment
, 35 36 1372 1373 I-treatment
irinotecan 37 47 1374 1384 I-treatment
( 48 49 1385 1386 I-treatment
irinotecan 49 59 1386 1396 I-treatment
hydrochloride 60 73 1397 1410 I-treatment
) 73 74 1410 1411 I-treatment
, 74 75 1411 1412 I-treatment
fluorouracil 76 88 1413 1425 I-treatment
or 89 91 1426 1428 I-treatment
capecitabine 92 104 1429 1441 I-treatment

No 0 2 1442 1444 O
significant 3 14 1445 1456 O
cardiac 15 22 1457 1464 B-chronic_disease
disease 23 30 1465 1472 I-chronic_disease
, 30 31 1472 1473 O
including 32 41 1474 1483 O
the 42 45 1484 1487 O
following 46 55 1488 1497 O
: 55 56 1497 1498 O
unstable 57 65 1499 1507 B-chronic_disease
angina 66 72 1508 1514 I-chronic_disease
, 72 73 1514 1515 O
New 74 77 1516 1519 B-clinical_variable
York 78 82 1520 1524 I-clinical_variable
Heart 83 88 1525 1530 I-clinical_variable
Association 89 100 1531 1542 I-clinical_variable
class 101 106 1543 1548 I-clinical_variable
II 107 109 1549 1551 B-lower_bound
- 109 110 1551 1552 O
IV 110 112 1552 1554 B-upper_bound
congestive 113 123 1555 1565 B-chronic_disease
heart 124 129 1566 1571 I-chronic_disease
failure 130 137 1572 1579 I-chronic_disease
, 137 138 1579 1580 O
myocardial 139 149 1581 1591 B-chronic_disease
infarction 150 160 1592 1602 I-chronic_disease
within 161 167 1603 1609 O
six 168 171 1610 1613 B-treatment
months 172 178 1614 1620 I-treatment
prior 179 184 1621 1626 I-treatment
to 185 187 1627 1629 O
study 188 193 1630 1635 O
enrollment 194 204 1636 1646 O

No 0 2 1647 1649 O
uncontrolled 3 15 1650 1662 O
seizure 16 23 1663 1670 B-chronic_disease
disorder 24 32 1671 1679 I-chronic_disease
, 32 33 1679 1680 O
active 34 40 1681 1687 O
neurological 41 53 1688 1700 B-chronic_disease
disease 54 61 1701 1708 I-chronic_disease
, 61 62 1708 1709 O
or 63 65 1710 1712 O
known 66 71 1713 1718 O
central 72 79 1719 1726 B-chronic_disease
nervous 80 87 1727 1734 I-chronic_disease
system 88 94 1735 1741 I-chronic_disease
( 95 96 1742 1743 I-chronic_disease
CNS 96 99 1743 1746 I-chronic_disease
) 99 100 1746 1747 I-chronic_disease
disease 101 108 1748 1755 I-chronic_disease

Not 0 3 1756 1759 B-pregnancy
pregnant 4 12 1760 1768 I-pregnancy
and 13 16 1769 1772 O
not 17 20 1773 1776 O
nursing 21 28 1777 1784 O

Pathologic 0 10 1785 1795 O
or 11 13 1796 1798 O
cytologic 14 23 1799 1808 O
documentation 24 37 1809 1822 O
of 38 40 1823 1825 O
pancreatic 41 51 1826 1836 B-cancer
adenocarcinoma 52 66 1837 1851 I-cancer

Patients 0 8 1852 1860 O
who 9 12 1861 1864 O
received 13 21 1865 1873 O
chemotherapy 22 34 1874 1886 B-treatment
> 35 36 1887 1888 O
5 37 38 1889 1890 B-lower_bound
years 39 44 1891 1896 I-lower_bound
ago 45 48 1897 1900 I-lower_bound
for 49 52 1901 1904 O
malignancies 53 65 1905 1917 B-cancer
other 66 71 1918 1923 O
than 72 76 1924 1928 O
pancreatic 77 87 1929 1939 B-cancer
cancer 88 94 1940 1946 I-cancer
are 95 98 1947 1950 O
eligible 99 107 1951 1959 O

Platelet 0 8 1960 1968 B-clinical_variable
count 9 14 1969 1974 I-clinical_variable
> 15 16 1975 1976 O
= 16 17 1976 1977 O
100,000 18 25 1978 1985 B-lower_bound
/ 25 26 1985 1986 I-lower_bound
uL 26 28 1986 1988 I-lower_bound

Resectable 0 10 1989 1999 B-cancer
pancreatic 11 21 2000 2010 I-cancer
adenocarcinoma 22 36 2011 2025 I-cancer
disease 37 44 2026 2033 I-cancer

There 0 5 2034 2039 O
is 6 8 2040 2042 O
no 9 11 2043 2045 O
evidence 12 20 2046 2054 O
of 21 23 2055 2057 O
the 24 27 2058 2061 O
second 28 34 2062 2068 O
malignancy 35 45 2069 2079 B-cancer
at 46 48 2080 2082 O
the 49 52 2083 2086 O
time 53 57 2087 2091 O
of 58 60 2092 2094 O
study 61 66 2095 2100 O
entry 67 72 2101 2106 O

basal 0 5 2107 2112 B-cancer
cell 6 10 2113 2117 I-cancer
carcinoma 11 20 2118 2127 I-cancer
of 21 23 2128 2130 I-cancer
the 24 27 2131 2134 I-cancer
skin 28 32 2135 2139 I-cancer
, 32 33 2139 2140 O
cervical 34 42 2141 2149 B-cancer
carcinoma 43 52 2150 2159 I-cancer
in 53 55 2160 2162 I-cancer
situ 56 60 2163 2167 I-cancer
, 60 61 2167 2168 O
or 62 64 2169 2171 O
non 65 68 2172 2175 B-cancer
- 68 69 2175 2176 I-cancer
metastatic 69 79 2176 2186 I-cancer
prostate 80 88 2187 2195 I-cancer
cancer 89 95 2196 2202 I-cancer

Age 0 3 0 3 B-age
10 4 6 4 6 B-lower_bound
- 6 7 6 7 O
17 7 9 7 9 B-upper_bound

At 0 2 10 12 O
least 3 8 13 18 O
80 9 11 19 21 B-upper_bound
% 11 12 21 22 I-lower_bound
compliance 13 23 23 33 O
with 24 28 34 38 O
headache 29 37 39 47 O
diary 38 43 48 53 O
( 44 45 54 55 O
i.e. 45 49 55 59 O
at 50 52 60 62 O
least 53 58 63 68 O
23 59 61 69 71 B-lower_bound
headache 62 70 72 80 O
diary 71 76 81 86 O
days 77 81 87 91 O
) 81 82 91 92 O
during 83 89 93 99 O
weeks 90 95 100 105 O
5 96 97 106 107 B-lower_bound
- 97 98 107 108 O
8 98 99 108 109 O
of 100 102 110 112 O
single 103 109 113 119 O
- 109 110 119 120 O
blind 110 115 120 125 O
placebo 116 123 126 133 O
treatment 124 133 134 143 O
pha 134 137 144 147 O

Concomitant 0 11 148 159 O
opioid 12 18 160 166 O
or 19 21 167 169 O
barbiturate 22 33 170 181 O
overuse 34 41 182 189 O
, 41 42 189 190 O
wherein 43 50 191 198 O
overuse 51 58 199 206 O
is 59 61 207 209 O
defined 62 69 210 217 O
as 70 72 218 220 O
≥4 73 75 221 223 O
days 76 80 224 228 I-lower_bound
per 81 84 229 232 O
month 85 90 233 238 O
of 91 93 239 241 O
barbiturate 94 105 242 253 O
containing 106 116 254 264 O
compounds 117 126 265 274 O
, 126 127 274 275 O
≥10 128 131 276 279 O
days 132 136 280 284 I-lower_bound
per 137 140 285 288 O
month 141 146 289 294 O
of 147 149 295 297 O
opioid 150 156 298 304 O
containing 157 167 305 315 O
compounds 168 177 316 325 O
as 178 180 326 328 O
these 181 186 329 334 O
may 187 190 335 338 O
impact 191 197 339 345 O
sleepiness 198 208 346 356 O
scales 209 215 357 363 O

History 0 7 364 371 O
of 8 10 372 374 O
seizures 11 19 375 383 B-chronic_disease
/ 19 20 383 384 O
epilepsy 20 28 384 392 B-chronic_disease

Inability 0 9 393 402 O
to 10 12 403 405 O
swallow 13 20 406 413 O
pills 21 26 414 419 O
after 27 32 420 425 O
teaching 33 41 426 434 O
and 42 45 435 438 O
practice 46 54 439 447 O
History 55 62 448 455 O
of 63 65 456 458 O
nocturnal 66 75 459 468 B-chronic_disease
asthma 76 82 469 475 I-chronic_disease
, 82 83 475 476 O
as 84 86 477 479 O
evidenced 87 96 480 489 O
by 97 99 490 492 O
a 100 101 493 494 O
having 102 108 495 501 O
a 109 110 502 503 O
diagnosis 111 120 504 513 O
of 121 123 514 516 O
asthma 124 130 517 523 O
and 131 134 524 527 O
symptoms 135 143 528 536 O
that 144 148 537 541 O
manifest 149 157 542 550 O
as 158 160 551 553 O
nighttime 161 170 554 563 O
awakening 171 180 564 573 O
due 181 184 574 577 O
to 185 187 578 580 O
cough 188 193 581 586 O
, 193 194 586 587 O
wheeze 195 201 588 594 O
, 201 202 594 595 O
and/or 203 209 596 602 O
shortness 210 219 603 612 O
of 220 222 613 615 O
breath 223 229 616 622 O

Pregnant 0 8 623 631 B-pregnancy

above 0 5 0 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound
of 15 17 15 17 O
age 18 21 18 21 B-age

drug 0 4 22 26 O
naive 5 10 27 32 O
, 10 11 32 33 O
or 12 14 34 36 O
have 15 19 37 41 O
been 20 24 42 46 O
on 25 27 47 49 O
metformin 28 37 50 59 B-treatment
less 38 42 60 64 O
than 43 47 65 69 O
3 48 49 70 71 B-upper_bound
months 50 56 72 78 I-upper_bound

subjects 0 8 79 87 O
with 9 13 88 92 O
type 14 18 93 97 B-chronic_disease
1 19 20 98 99 I-chronic_disease
diabetes 21 29 100 108 I-chronic_disease
or 30 32 109 111 O
GAD 33 36 112 115 B-chronic_disease
positive 37 45 116 124 O
subjects 46 54 125 133 O
or 55 57 134 136 O
subjects 58 66 137 145 O
with 67 71 146 150 O
long 72 76 151 155 O
standing 77 85 156 164 O
diabetes 86 94 165 173 O
( 95 96 174 175 O
> 96 97 175 176 O
2 97 98 176 177 B-lower_bound
years 99 104 178 183 I-lower_bound
) 104 105 183 184 O
or 106 108 185 187 O
subjects 109 117 188 196 O
who 118 121 197 200 O
are 122 125 201 204 O
not 126 129 205 208 O
drug 130 134 209 213 O
naive 135 140 214 219 O
or 141 143 220 222 O
have 144 148 223 227 O
been 149 153 228 232 O
on 154 156 233 235 O
metformin 157 166 236 245 O
more 167 171 246 250 O
than 172 176 251 255 O
3 177 178 256 257 B-lower_bound
months 179 185 258 264 I-lower_bound

subjects 0 8 265 273 O
with 9 13 274 278 O
type 14 18 279 283 B-chronic_disease
2 19 20 284 285 I-chronic_disease
diabetes 21 29 286 294 I-chronic_disease
diagnosed 30 39 295 304 O
during 40 46 305 311 O
the 47 50 312 315 O
past 51 55 316 320 B-upper_bound
2 56 57 321 322 I-upper_bound
years 58 63 323 328 I-upper_bound

Active 0 6 0 6 B-chronic_disease
sinusitis 7 16 7 16 I-chronic_disease

Adult 0 5 17 22 O
patient 6 13 23 30 O
undergoing 14 24 31 41 O
endoscopic 25 35 42 52 B-treatment
surgery 36 43 53 60 I-treatment
for 44 47 61 64 O
resection 48 57 65 74 O
of 58 60 75 77 O
pituitary 61 70 78 87 B-cancer
tumors 71 77 88 94 I-cancer
for 78 81 95 98 O
nonfunctioning 82 96 99 113 O
adenoma 97 104 114 121 B-cancer
, 104 105 121 122 O
acromegaly 106 116 123 133 B-chronic_disease
, 116 117 133 134 O
or 118 120 135 137 O
prolactinoma 121 133 138 150 B-cancer

Any 0 3 151 154 O
solid 4 9 155 160 B-treatment
organ 10 15 161 166 I-treatment
transplant 16 26 167 177 I-treatment
or 27 29 178 180 O
bone 30 34 181 185 B-treatment
marrow 35 41 186 192 I-treatment
transplant 42 52 193 203 I-treatment

Cirrhosis 0 9 204 213 B-chronic_disease

Concurrent 0 10 214 224 O
antibiotics 11 22 225 236 O
for 23 26 237 240 O
another 27 34 241 248 O
indication 35 45 249 259 O
( 46 47 260 261 O
i.e. 47 51 261 265 O
, 51 52 265 266 O
urinary 53 60 267 274 B-chronic_disease
tract 61 66 275 280 I-chronic_disease
infection 67 76 281 290 I-chronic_disease
) 76 77 290 291 O

Cushing 0 7 292 299 B-chronic_disease
's 7 9 299 301 I-chronic_disease
disease 10 17 302 309 I-chronic_disease

English 0 7 310 317 B-language_fluency
speaking 8 16 318 326 I-language_fluency

History 0 7 327 334 O
of 8 10 335 337 O
chronic 11 18 338 345 B-chronic_disease
sinusitis 19 28 346 355 I-chronic_disease

Immunodeficiency 0 16 356 372 B-chronic_disease

Pregnancy 0 9 373 382 B-pregnancy

Previous 0 8 383 391 O
sinus 9 14 392 397 B-treatment
surgery 15 22 398 405 I-treatment

Rathke 0 6 406 412 B-chronic_disease
's 6 8 412 414 I-chronic_disease
Cleft 9 14 415 420 I-chronic_disease
cyst 15 19 421 425 I-chronic_disease
or 20 22 426 428 O
pituitary 23 32 429 438 B-chronic_disease
cyst 33 37 439 443 I-chronic_disease

able 0 4 444 448 O
to 5 7 449 451 O
understand 8 18 452 462 O
the 19 22 463 466 O
ASK 23 26 467 470 B-clinical_variable
Nasal-12 27 35 471 479 I-clinical_variable
and 36 39 480 483 O
SNOT-22 40 47 484 491 B-clinical_variable
scales 48 54 492 498 O

hepatitis 0 9 499 508 B-chronic_disease

Attend 0 6 0 6 O
church 7 13 7 13 O
at 14 16 14 16 O
least 17 22 17 22 O
once 23 27 23 27 O
a 28 29 28 29 O
month 30 35 30 35 O
or 36 38 36 38 O
use 39 42 39 42 O
church 43 49 43 49 O
outreach 50 58 50 58 O
services 59 67 59 67 O
, 67 68 67 68 O
such 69 73 69 73 O
as 74 76 74 76 O
food 77 81 77 81 O
and 82 85 82 85 O
clothing 86 94 86 94 O
programs 95 103 95 103 O
, 103 104 103 104 O
at 105 107 105 107 O
least 108 113 108 113 O
4 114 115 114 115 B-lower_bound
times 116 121 116 121 I-lower_bound
per 122 125 122 125 I-lower_bound
year 126 130 126 130 I-lower_bound

Minors 0 6 131 137 O
18 7 9 138 140 B-upper_bound
and 10 13 141 144 O
under 14 19 145 150 O
are 20 23 151 154 O
intentionally 24 37 155 168 O
excluded 38 46 169 177 O
since 47 52 178 183 O
the 53 56 184 187 O
intervention 57 69 188 200 O
study 70 75 201 206 O
has 76 79 207 210 O
been 80 84 211 215 O
designed 85 93 216 224 O
specifically 94 106 225 237 O
for 107 110 238 241 O
adults 111 117 242 248 O
with 118 122 249 253 O
information 123 134 254 265 O
of 135 137 266 268 O
how 138 141 269 272 O
HIV 142 145 273 276 B-chronic_disease
affects 146 153 277 284 O
the 154 157 285 288 O
African 158 165 289 296 O
American 166 174 297 305 O
adult 175 180 306 311 O
population 181 191 312 322 O

aged 0 4 323 327 B-age
18 5 7 328 330 B-lower_bound
to 8 10 331 333 O
64 11 13 334 336 B-upper_bound

65 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
and 16 19 16 19 O
older 20 25 20 25 O

Acute 0 5 26 31 B-treatment
cardiac 6 13 32 39 I-treatment
surgery 14 21 40 47 I-treatment

Atrial 0 6 48 54 B-chronic_disease
fibrillation 7 19 55 67 I-chronic_disease

Be 0 2 68 70 O
English 3 10 71 78 B-language_fluency
- 10 11 78 79 I-language_fluency
speaking 11 19 79 87 I-language_fluency

Chronic 0 7 88 95 B-chronic_disease
ulcerative 8 18 96 106 I-chronic_disease
wounds 19 25 107 113 I-chronic_disease

Congestive 0 10 114 124 B-chronic_disease
Heart 11 16 125 130 I-chronic_disease
Failure 17 24 131 138 I-chronic_disease

Deep 0 4 139 143 B-chronic_disease
vein 5 9 144 148 I-chronic_disease
thrombosis 10 20 149 159 I-chronic_disease
/ 20 21 159 160 I-chronic_disease
pulmonary 21 30 160 169 I-chronic_disease
embolus 31 38 170 177 I-chronic_disease
( 39 40 178 179 I-chronic_disease
DVT 40 43 179 182 I-chronic_disease
/ 43 44 182 183 I-chronic_disease
PE 44 46 183 185 I-chronic_disease
) 46 47 185 186 I-chronic_disease

Depression 0 10 187 197 B-chronic_disease
/ 10 11 197 198 I-chronic_disease
mental 11 17 198 204 I-chronic_disease
health 18 24 205 211 I-chronic_disease

Diabetes 0 8 212 220 B-chronic_disease

Elective 0 8 221 229 B-treatment
joint 9 14 230 235 I-treatment
replacement 15 26 236 247 I-treatment
surgery 27 34 248 255 I-treatment

Gastrointestinal 0 16 256 272 B-chronic_disease
Bleed 17 22 273 278 I-chronic_disease

Have 0 4 279 283 O
at 5 7 284 286 O
least 8 13 287 292 O
3 14 15 293 294 B-lower_bound
comorbid 16 24 295 303 O
conditions 25 35 304 314 O

Heart 0 5 315 320 B-chronic_disease
Disease 6 13 321 328 I-chronic_disease

Hernia 0 6 329 335 B-chronic_disease

Hypertension 0 12 336 348 B-chronic_disease

Hypo 0 4 349 353 B-chronic_disease
/ 4 5 353 354 I-chronic_disease
Hyperthyroid 5 17 354 366 I-chronic_disease

Peripheral 0 10 367 377 B-chronic_disease
Arterial 11 19 378 386 I-chronic_disease
Disease 20 27 387 394 I-chronic_disease

Pneumonia 0 9 395 404 B-chronic_disease

Post 0 4 405 409 B-treatment
- 4 5 409 410 I-treatment
op 5 7 410 412 I-treatment
bowel 8 13 413 418 I-treatment
surgery 14 21 419 426 I-treatment

Post 0 4 427 431 O
- 4 5 431 432 O
op 5 7 432 434 O
pancreatic 8 18 435 445 B-treatment
surgery 19 26 446 453 I-treatment

Progressive 0 11 454 465 O
neurodegenerative 12 29 466 483 B-chronic_disease
diagnosis 30 39 484 493 I-chronic_disease
( 40 41 494 495 O
e.g. 41 45 495 499 O
Parkinson 46 55 500 509 B-chronic_disease
's 55 57 509 511 I-chronic_disease
, 57 58 511 512 O
MS 59 61 513 515 B-chronic_disease
, 61 62 515 516 O
ALS 63 66 517 520 B-chronic_disease
) 66 67 520 521 O

Referred 0 8 522 530 O
to 9 11 531 533 O
home 12 16 534 538 O
care 17 21 539 543 O
physical 22 30 544 552 B-treatment
therapy 31 38 553 560 I-treatment
following 39 48 561 570 O
acute 49 54 571 576 O
medical 55 62 577 584 O
deconditioning 63 77 585 599 O

Renal 0 5 600 605 B-chronic_disease
Failure 6 13 606 613 I-chronic_disease
( 14 15 614 615 O
no 15 17 615 617 O
dialysis 18 26 618 626 B-treatment
) 26 27 626 627 O

Score 0 5 628 633 O
of 6 8 634 636 O
< 9 10 637 638 O
20 10 12 638 640 B-upper_bound
on 13 15 641 643 O
SLUMS 16 21 644 649 O

Terminal 0 8 650 658 B-chronic_disease
illness 9 16 659 666 I-chronic_disease

Urinary 0 7 667 674 B-chronic_disease
Tract 8 13 675 680 I-chronic_disease
Infection 14 23 681 690 I-chronic_disease

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
3 6 7 6 7 B-lower_bound
years 8 13 8 13 I-lower_bound

Available 0 9 14 23 O
autologous 10 20 24 34 B-clinical_variable
transduced 21 31 35 45 I-clinical_variable
T 32 33 46 47 I-clinical_variable
lymphocytes 34 45 48 59 I-clinical_variable
with 46 50 60 64 O
greater 51 58 65 72 O
than 59 63 73 77 O
or 64 66 78 80 O
equal 67 72 81 86 O
to 73 75 87 89 O
15 76 78 90 92 B-lower_bound
% 78 79 92 93 I-lower_bound
expression 80 90 94 104 O
of 91 93 105 107 O
HER2 94 98 108 112 B-clinical_variable
CAR 99 102 113 116 O
determined 103 113 117 127 O
by 114 116 128 130 O
flow 117 121 131 135 O
- 121 122 135 136 O
cytometry 122 131 136 145 O
and 132 135 146 149 O
killing 136 143 150 157 O
of 144 146 158 160 O
HER2 147 151 161 165 O
- 151 152 165 166 O
positive 152 160 166 174 O
targets 161 168 175 182 O
greater 169 176 183 190 O
than 177 181 191 195 O
or 182 184 196 198 O
equal 185 190 199 204 O
to 191 193 205 207 O
20 194 196 208 210 B-lower_bound
% 196 197 210 211 I-lower_bound
in 198 200 212 214 O
cytotoxicity 201 213 215 227 B-treatment
assay 214 219 228 233 I-treatment

Bilirubin 0 9 234 243 B-clinical_variable
less 10 14 244 248 O
than 15 19 249 253 O
or 20 22 254 256 O
equal 23 28 257 262 O
to 29 31 263 265 O
3x 32 34 266 268 B-upper_bound
normal 35 41 269 275 I-upper_bound
, 41 42 275 276 O
AST 43 46 277 280 B-clinical_variable
less 47 51 281 285 O
than 52 56 286 290 O
or 57 59 291 293 O
equal 60 65 294 299 O
to 66 68 300 302 O
5x 69 71 303 305 B-upper_bound
normal 72 78 306 312 I-upper_bound
, 78 79 312 313 O
ALT 80 83 314 317 B-clinical_variable
less 84 88 318 322 O
than 89 93 323 327 O
or 94 96 328 330 O
equal 97 102 331 336 O
to 103 105 337 339 O
5x 106 108 340 342 O
, 108 109 342 343 O
serum 110 115 344 349 B-clinical_variable
creatinine 116 126 350 360 I-clinical_variable
less 127 131 361 365 O
than 132 136 366 370 O
or 137 139 371 373 O
equal 140 145 374 379 O
to 146 148 380 382 O
2x 149 151 383 385 B-upper_bound
upper 152 157 386 391 I-upper_bound
limit 158 163 392 397 I-upper_bound
of 164 166 398 400 I-upper_bound
normal 167 173 401 407 I-upper_bound
for 174 177 408 411 O
age 178 181 412 415 B-age
, 181 182 415 416 O
and 183 186 417 420 O
Hgb 187 190 421 424 B-clinical_variable
greater 191 198 425 432 O
than 199 203 433 437 O
or 204 206 438 440 O
equal 207 212 441 446 O
to 213 215 447 449 O
7.0 216 219 450 453 B-upper_bound

Dexamethasone 0 13 454 467 B-treatment
up 14 16 468 470 O
to 17 19 471 473 O
a 20 21 474 475 O
total 22 27 476 481 O
dose 28 32 482 486 O
of 33 35 487 489 O
2 36 37 490 491 B-upper_bound
mg 38 40 492 494 I-upper_bound
per 41 44 495 498 I-upper_bound
day 45 48 499 502 I-upper_bound
will 49 53 503 507 O
be 54 56 508 510 O
allowed 57 64 511 518 O
if 65 67 519 521 O
medically 68 77 522 531 O
indicated 78 87 532 541 O

Diagnosis 0 9 542 551 O
of 10 12 552 554 O
DIPG 13 17 555 559 B-cancer

HER2 0 4 560 564 O
expression 5 15 565 575 O
in 16 18 576 578 O
tumors 19 25 579 585 B-cancer
on 26 28 586 588 O
IHC 29 32 589 592 B-clinical_variable
should 33 39 593 599 O
be 40 42 600 602 O
greater 43 50 603 610 O
than 51 55 611 615 O
or 56 58 616 618 O
equal 59 64 619 624 O
to 65 67 625 627 O
grade 68 73 628 633 B-lower_bound
1 74 75 634 635 I-lower_bound
and 76 79 636 639 O
greater 80 87 640 647 O
than 88 92 648 652 O
or 93 95 653 655 O
equal 96 101 656 661 O
to 102 104 662 664 O
1 105 106 665 666 O
+ 106 107 666 667 O
intensity 108 117 668 677 B-clinical_variable
score 118 123 678 683 I-clinical_variable

History 0 7 684 691 O
of 8 10 692 694 O
hypersensitivity 11 27 695 711 O
reactions 28 37 712 721 O
to 38 40 722 724 O
murine 41 47 725 731 B-allergy_name
protein 48 55 732 739 I-allergy_name
- 55 56 739 740 I-allergy_name
containing 56 66 740 750 I-allergy_name
products 67 75 751 759 I-allergy_name

Immunohistochemistry 0 20 760 780 B-treatment
( 21 22 781 782 I-treatment
IHC 22 25 782 785 I-treatment
) 25 26 785 786 I-treatment
or 27 29 787 789 O
RT 30 32 790 792 B-treatment
- 32 33 792 793 I-treatment
PCR 33 36 793 796 I-treatment
will 37 41 797 801 O
be 42 44 802 804 O
used 45 49 805 809 O
to 50 52 810 812 O
determine 53 62 813 822 O
HER2 63 67 823 827 O
positivity 68 78 828 838 O
. 78 79 838 839 O
Results 80 87 840 847 O
will 88 92 848 852 O
be 93 95 853 855 O
compared 96 104 856 864 O
to 105 107 865 867 O
standard 108 116 868 876 O
controls 117 125 877 885 O

Karnofsky 0 9 886 895 B-clinical_variable
/ 9 10 895 896 O
Lansky 10 16 896 902 B-clinical_variable
score 17 22 903 908 I-clinical_variable
of 23 25 909 911 O
greater 26 33 912 919 O
than 34 38 920 924 O
or 39 41 925 927 O
equal 42 47 928 933 O
to 48 50 934 936 O
60 51 53 937 939 B-lower_bound

Karnofsky 0 9 940 949 B-clinical_variable
/ 9 10 949 950 I-clinical_variable
Lansky 10 16 950 956 I-clinical_variable
score 17 22 957 962 I-clinical_variable
≥ 23 24 963 964 O
60 25 27 965 967 B-lower_bound

Known 0 5 968 973 O
HIV 6 9 974 977 B-chronic_disease
positivity 10 20 978 988 O

Life 0 4 989 993 B-clinical_variable
expectancy 5 15 994 1004 I-clinical_variable
≥ 16 17 1005 1006 O
6 18 19 1007 1008 B-lower_bound
weeks 20 25 1009 1014 I-lower_bound

Pregnant 0 8 1015 1023 B-pregnancy
or 9 11 1024 1026 O
lactating 12 21 1027 1036 O

Pulse 0 5 1037 1042 B-clinical_variable
oximetry 6 14 1043 1051 I-clinical_variable
of 15 17 1052 1054 O
greater 18 25 1055 1062 O
than 26 30 1063 1067 O
or 31 33 1068 1070 O
equal 34 39 1071 1076 O
to 40 42 1077 1079 O
90 43 45 1080 1082 B-lower_bound
% 45 46 1082 1083 I-lower_bound
on 47 49 1084 1086 O
room 50 54 1087 1091 O
air 55 58 1092 1095 O

Recurrent 0 9 1096 1105 O
or 10 12 1106 1108 O
refractory 13 23 1109 1119 O
HER2 24 28 1120 1124 B-cancer
positive 29 37 1125 1133 I-cancer
primary 38 45 1134 1141 I-cancer
central 46 53 1142 1149 I-cancer
nervous 54 61 1150 1157 I-cancer
system 62 68 1158 1164 I-cancer
( 69 70 1165 1166 I-cancer
CNS 70 73 1166 1169 I-cancer
) 73 74 1169 1170 I-cancer
tumor 75 80 1171 1176 I-cancer
or 81 83 1177 1179 O
HER2 84 88 1180 1184 B-cancer
positive 89 97 1185 1193 I-cancer
tumor 98 103 1194 1199 I-cancer
metastatic 104 114 1200 1210 I-cancer
to 115 117 1211 1213 O
the 118 121 1214 1217 O
CNS 122 125 1218 1221 O

Recurrent 0 9 1222 1231 O
or 10 12 1232 1234 O
refractory 13 23 1235 1245 O
HER2 24 28 1246 1250 B-cancer
- 28 29 1250 1251 I-cancer
positive 29 37 1251 1259 I-cancer

Severe 0 6 1260 1266 O
intercurrent 7 19 1267 1279 B-chronic_disease
infection 20 29 1280 1289 I-chronic_disease

Sexually 0 8 1290 1298 O
active 9 15 1299 1305 O
subjects 16 24 1306 1314 O
must 25 29 1315 1319 O
be 30 32 1320 1322 O
willing 33 40 1323 1330 O
to 41 43 1331 1333 O
utilize 44 51 1334 1341 O
one 52 55 1342 1345 B-lower_bound
of 56 58 1346 1348 O
the 59 62 1349 1352 O
more 63 67 1353 1357 O
effective 68 77 1358 1367 O
birth 78 83 1368 1373 O
control 84 91 1374 1381 O
methods 92 99 1382 1389 O
for 100 103 1390 1393 O
6 104 105 1394 1395 O
months 106 112 1396 1402 O
after 113 118 1403 1408 O
the 119 122 1409 1412 O
T 123 124 1413 1414 B-treatment
cell 125 129 1415 1419 I-treatment
infusion 130 138 1420 1428 I-treatment

Steroid 0 7 1429 1436 O
dose 8 12 1437 1441 O
of 13 15 1442 1444 O
dexamethasone 16 29 1445 1458 B-treatment
greater 30 37 1459 1466 O
than 38 42 1467 1471 O
2 43 44 1472 1473 B-lower_bound
mg 45 47 1474 1476 I-lower_bound
per 48 51 1477 1480 O
day 52 55 1481 1484 O
( 56 57 1485 1486 O
or 57 59 1486 1488 O
equivalent 60 70 1489 1499 O
) 70 71 1499 1500 O

Subjects 0 8 1501 1509 O
having 9 15 1510 1516 O
a 16 17 1517 1518 O
tumor 18 23 1519 1524 B-treatment
resection 24 33 1525 1534 I-treatment
if 34 36 1535 1537 O
medically 37 46 1538 1547 O
feasible 47 55 1548 1556 O

Subjects 0 8 1557 1565 O
should 9 15 1566 1572 O
have 16 20 1573 1577 O
been 21 25 1578 1582 O
off 26 29 1583 1586 O
other 30 35 1587 1592 O
investigational 36 51 1593 1608 O
antineoplastic 52 66 1609 1623 B-treatment
therapy 67 74 1624 1631 I-treatment
for 75 78 1632 1635 O
two 79 82 1636 1639 B-upper_bound
weeks 83 88 1640 1645 I-upper_bound
prior 89 94 1646 1651 I-upper_bound
to 95 97 1652 1654 O
entry 98 103 1655 1660 O
in 104 106 1661 1663 O
this 107 111 1664 1668 O
study 112 117 1669 1674 O

Temozolomide 0 12 1675 1687 B-treatment
will 13 17 1688 1692 O
be 18 20 1693 1695 O
allowed 21 28 1696 1703 O
up 29 31 1704 1706 O
to 32 34 1707 1709 O
48 35 37 1710 1712 B-upper_bound
hours 38 43 1713 1718 I-upper_bound
preinfusion 44 55 1719 1730 O

The 0 3 1731 1734 O
male 4 8 1735 1739 B-gender
partner 9 16 1740 1747 O
should 17 23 1748 1754 O
use 24 27 1755 1758 O
a 28 29 1759 1760 O
condom 30 36 1761 1767 O

Wherein 0 7 1768 1775 O
grades 8 14 1776 1782 O
are 15 18 1783 1786 O
defines 19 26 1787 1794 O
as 27 29 1795 1797 O
: 29 30 1797 1798 O
Grade 31 36 1799 1804 O
0 37 38 1805 1806 O
: 38 39 1806 1807 O
no 40 42 1808 1810 O
staining 43 51 1811 1819 O
; 51 52 1819 1820 O
Grade 53 58 1821 1826 O
1 59 60 1827 1828 B-lower_bound
: 60 61 1828 1829 O
1 62 63 1830 1831 O
- 63 64 1831 1832 O
25 64 66 1832 1834 B-upper_bound
% 66 67 1834 1835 I-upper_bound
; 67 68 1835 1836 O
Grade 69 74 1837 1842 O
2 75 76 1843 1844 O
: 76 77 1844 1845 O
26 78 80 1846 1848 B-lower_bound
- 80 81 1848 1849 O
50 81 83 1849 1851 B-upper_bound
% 83 84 1851 1852 I-upper_bound
and 85 88 1853 1856 O
Grade 89 94 1857 1862 O
3 95 96 1863 1864 O
: 96 97 1864 1865 O
51 98 100 1866 1868 B-lower_bound
- 100 101 1868 1869 O
100 101 104 1869 1872 B-upper_bound
% 104 105 1872 1873 I-upper_bound
of 106 108 1874 1876 O
cell 109 113 1877 1881 O
staining 114 122 1882 1890 O
for 123 126 1891 1894 O
HER2 127 131 1895 1899 B-cancer
and 132 135 1900 1903 O
intensity 136 145 1904 1913 O
scores 146 152 1914 1920 O
are 153 156 1921 1924 O
: 156 157 1924 1925 O
negative 158 166 1926 1934 O
; 166 167 1934 1935 O
1 168 169 1936 1937 O
+ 169 170 1937 1938 O
; 170 171 1938 1939 O
2 172 173 1940 1941 O
+ 173 174 1941 1942 O
and 175 178 1943 1946 O
3 179 180 1947 1948 O
+ 180 181 1948 1949 O
using 182 187 1950 1955 O
breast 188 194 1956 1962 B-treatment
cancer 195 201 1963 1969 I-treatment
standard 202 210 1970 1978 I-treatment
arrays 211 217 1979 1985 I-treatment
as 218 220 1986 1988 O
a 221 222 1989 1990 O
guide 223 228 1991 1996 O
for 229 232 1997 2000 O
intensity 233 242 2001 2010 O

primary 0 7 2011 2018 B-cancer
CNS 8 11 2019 2022 I-cancer
tumor 12 17 2023 2028 I-cancer
or 18 20 2029 2031 O
HER2 21 25 2032 2036 B-cancer
- 25 26 2036 2037 I-cancer
positive 26 34 2037 2045 I-cancer
solid 35 40 2046 2051 I-cancer
tumor 41 46 2052 2057 I-cancer
metastatic 47 57 2058 2068 I-cancer
to 58 60 2069 2071 O
the 61 64 2072 2075 O
CNS 65 68 2076 2079 O

A 0 1 0 1 O
man 2 5 2 5 B-gender

Currently 0 9 6 15 O
experiencing 10 22 16 28 O
a 23 24 29 30 O
depressive 25 35 31 41 O
episode 36 43 42 49 O
as 44 46 50 52 O
part 47 51 53 57 O
of 52 54 58 60 O
Major 55 60 61 66 B-chronic_disease
Depressive 61 71 67 77 I-chronic_disease
Disorder 72 80 78 86 I-chronic_disease

Have 0 4 87 91 O
a 5 6 92 93 O
history 7 14 94 101 O
of 15 17 102 104 O
inadequate 18 28 105 115 O
response 29 37 116 124 O
/ 37 38 124 125 O
tolerability 38 50 125 137 O
to 51 53 138 140 O
escitalopram 54 66 141 153 B-treatment

Have 0 4 154 158 O
a 5 6 159 160 O
medical 7 14 161 168 O
condition 15 24 169 178 O
that 25 29 179 183 O
contradicts 30 41 184 195 O
treatment 42 51 196 205 B-treatment
with 52 56 206 210 I-treatment
escitalopram 57 69 211 223 I-treatment

Meet 0 4 224 228 O
criteria 5 13 229 237 O
for 14 17 238 241 O
substance 18 27 242 251 O
dependence 28 38 252 262 O
in 39 41 263 265 O
the 42 45 266 269 O
last 46 50 270 274 B-upper_bound
6 51 52 275 276 I-upper_bound
months 53 59 277 283 I-upper_bound

Pregnant 0 8 284 292 B-pregnancy

history 0 7 293 300 O
of 8 10 301 303 O
resistant 11 20 304 313 O
depression 21 31 314 324 B-chronic_disease

other 0 5 325 330 O
Axis 6 10 331 335 B-chronic_disease
I 11 12 336 337 I-chronic_disease
psychotic 13 22 338 347 I-chronic_disease
disorders 23 32 348 357 I-chronic_disease

schizoaffective 0 15 358 373 B-chronic_disease

schizophrenic 0 13 374 387 B-chronic_disease

substance 0 9 388 397 O
abuse 10 15 398 403 O
in 16 18 404 406 O
the 19 22 407 410 O
last 23 27 411 415 B-upper_bound
2 28 29 416 417 I-upper_bound
months 30 36 418 424 I-upper_bound

woman 0 5 425 430 B-gender

Certain 0 7 0 7 O
drugs 8 13 8 13 O
or 14 16 14 16 O
medications 17 28 17 28 B-treatment
consumed 29 37 29 37 O
within 38 44 38 44 O
the 45 48 45 48 O
past 49 53 49 53 O
week 54 58 54 58 O
including 59 68 59 68 O
any 69 72 69 72 O
psychoactive 73 85 73 85 B-treatment
drugs 86 91 86 91 I-treatment
( 92 93 92 93 O
e.g. 93 97 93 97 O
, 97 98 97 98 O
benzodiazepines 99 114 99 114 B-treatment
, 114 115 114 115 O
opiates 116 123 116 123 B-treatment
, 123 124 123 124 O
selective 125 134 125 134 B-treatment
serotonin 135 144 135 144 I-treatment
reuptake 145 153 145 153 I-treatment
inhibitors 154 164 154 164 I-treatment
, 164 165 164 165 O
dopamine 166 174 166 174 B-treatment
agonists 175 183 175 183 I-treatment
, 183 184 183 184 O
barbiturates 185 197 185 197 B-treatment
, 197 198 197 198 O
MDMA 199 203 199 203 B-treatment
, 203 204 203 204 O
LSD 205 208 205 208 B-treatment
, 208 209 208 209 O
psilocybin 210 220 210 220 B-treatment
, 220 221 220 221 O
peyote 222 228 222 228 B-treatment
, 228 229 228 229 O
phencyclidine 230 243 230 243 B-treatment
, 243 244 243 244 O
ketamine 245 253 245 253 B-treatment
) 253 254 253 254 O

MRI 0 3 255 258 B-treatment
contraindications 4 21 259 276 O
including 22 31 277 286 O
: 31 32 286 287 O
cardiac 33 40 288 295 B-treatment
pacemaker 41 50 296 305 I-treatment
, 50 51 305 306 O
metal 52 57 307 312 B-treatment
fragments 58 67 313 322 I-treatment
in 68 70 323 325 I-treatment
eyes 71 75 326 330 I-treatment
/ 75 76 330 331 I-treatment
skin 76 80 331 335 I-treatment
/ 80 81 335 336 I-treatment
body 81 85 336 340 I-treatment
( 86 87 341 342 I-treatment
shrapnel 87 95 342 350 I-treatment
) 95 96 350 351 I-treatment
, 96 97 351 352 O
aortic 98 104 353 359 B-treatment
/ 104 105 359 360 I-treatment
aneurysm 105 113 360 368 I-treatment
clips 114 119 369 374 I-treatment
, 119 120 374 375 O
prosthesis 121 131 376 386 B-treatment
, 131 132 386 387 O
by 133 135 388 390 B-treatment
- 135 136 390 391 I-treatment
pass 136 140 391 395 I-treatment
surgery 141 148 396 403 I-treatment
/ 148 149 403 404 I-treatment
coronary 149 157 404 412 I-treatment
artery 158 164 413 419 I-treatment
clips 165 170 420 425 I-treatment
, 170 171 425 426 O
hearing 172 179 427 434 B-treatment
aid 180 183 435 438 I-treatment
, 183 184 438 439 O
heart 185 190 440 445 B-treatment
valve 191 196 446 451 I-treatment
replacement 197 208 452 463 I-treatment
, 208 209 463 464 O
shunt 210 215 465 470 B-treatment
( 216 217 471 472 I-treatment
ventricular 217 228 472 483 I-treatment
or 229 231 484 486 I-treatment
spinal 232 238 487 493 I-treatment
) 238 239 493 494 I-treatment
, 239 240 494 495 O
electrodes 241 251 496 506 B-treatment
, 251 252 506 507 O
metal 253 258 508 513 B-treatment
plates 259 265 514 520 I-treatment
/ 265 266 520 521 I-treatment
pins 266 270 521 525 I-treatment
/ 270 271 525 526 I-treatment
screws/ 271 278 526 533 I-treatment
wires 279 284 534 539 I-treatment
, 284 285 539 540 O
or 286 288 541 543 O
neuro 289 294 544 549 B-treatment
/ 294 295 549 550 I-treatment
bio 295 298 550 553 I-treatment
- 298 299 553 554 I-treatment
stimulators 299 310 554 565 I-treatment
( 311 312 566 567 I-treatment
TENS 312 316 567 571 I-treatment
unit 317 321 572 576 I-treatment
) 321 322 576 577 I-treatment
, 322 323 577 578 O
persons 324 331 579 586 O
who 332 335 587 590 O
have 336 340 591 595 O
ever 341 345 596 600 O
been 346 350 601 605 O
a 351 352 606 607 O
professional 353 365 608 620 O
metal 366 371 621 626 O
worker 372 378 627 633 O
/ 378 379 633 634 O
welder 379 385 634 640 O
, 385 386 640 641 O
history 387 394 642 649 O
of 395 397 650 652 O
eye 398 401 653 656 B-treatment
surgery 402 409 657 664 I-treatment
/ 409 410 664 665 O
eyes 410 414 665 669 O
washed 415 421 670 676 O
out 422 425 677 680 O
because 426 433 681 688 O
of 434 436 689 691 O
metal 437 442 692 697 O
, 442 443 697 698 O
vision 444 450 699 705 O
problems 451 459 706 714 O
uncorrectable 460 473 715 728 O
with 474 478 729 733 O
lenses 479 485 734 740 O
, 485 486 740 741 O
inability 487 496 742 751 O
to 497 499 752 754 O
lie 500 503 755 758 O
still 504 509 759 764 O
on 510 512 765 767 O
one 513 516 768 771 O
's 516 518 771 773 O
back 519 523 774 778 O
for 524 527 779 782 O
60 528 530 783 785 B-lower_bound
- 530 531 785 786 O
120 531 534 786 789 B-upper_bound
minutes 535 542 790 797 I-upper_bound
; 542 543 797 798 O
prior 544 549 799 804 B-treatment
neurosurgery 550 562 805 817 I-treatment
; 562 563 817 818 O
tattoos 564 571 819 826 O
or 572 574 827 829 O
cosmetic 575 583 830 838 O
makeup 584 590 839 845 O
with 591 595 846 850 O
metal 596 601 851 856 O
dyes 602 606 857 861 O
, 606 607 861 862 O
unwillingness 608 621 863 876 O
to 622 624 877 879 O
remove 625 631 880 886 O
body 632 636 887 891 O
piercings 637 646 892 901 O
, 646 647 901 902 O
and 648 651 903 906 O
pregnancy 652 661 907 916 B-pregnancy

Participant 0 11 917 928 O
endorses 12 20 929 937 O
current 21 28 938 945 O
suicidal 29 37 946 954 B-chronic_disease
ideation 38 46 955 963 I-chronic_disease
with 47 51 964 968 O
intent 52 58 969 975 O
or 59 61 976 978 O
plan 62 66 979 983 O

Participant 0 11 984 995 O
has 12 15 996 999 O
a 16 17 1000 1001 O
history 18 25 1002 1009 O
of 26 28 1010 1012 O
unstable 29 37 1013 1021 O
liver 38 43 1022 1027 B-chronic_disease
or 44 46 1028 1030 O
renal 47 52 1031 1036 B-chronic_disease
insufficiency 53 66 1037 1050 I-chronic_disease
; 66 67 1050 1051 O
glaucoma 68 76 1052 1060 B-chronic_disease
; 76 77 1060 1061 O
diabetes 78 86 1062 1070 B-chronic_disease
; 86 87 1070 1071 O
significant 88 99 1072 1083 O
and 100 103 1084 1087 O
unstable 104 112 1088 1096 O
cardiac 113 120 1097 1104 B-chronic_disease
, 120 121 1104 1105 O
vascular 122 130 1106 1114 B-chronic_disease
, 130 131 1114 1115 O
pulmonary 132 141 1116 1125 B-chronic_disease
, 141 142 1125 1126 O
gastrointestinal 143 159 1127 1143 B-chronic_disease
, 159 160 1143 1144 O
endocrine 161 170 1145 1154 B-chronic_disease
, 170 171 1154 1155 O
neurologic 172 182 1156 1166 B-chronic_disease
, 182 183 1166 1167 O
hematologic 184 195 1168 1179 B-chronic_disease
, 195 196 1179 1180 O
rheumatologic 197 210 1181 1194 B-chronic_disease
, 210 211 1194 1195 O
or 212 214 1196 1198 O
metabolic 215 224 1199 1208 B-chronic_disease
disturbance 225 236 1209 1220 I-chronic_disease
; 236 237 1220 1221 O
or 238 240 1222 1224 O
any 241 244 1225 1228 O
other 245 250 1229 1234 O
condition 251 260 1235 1244 O
that 261 265 1245 1249 O
, 265 266 1249 1250 O
in 267 269 1251 1253 O
the 270 273 1254 1257 O
opinion 274 281 1258 1265 O
of 282 284 1266 1268 O
the 285 288 1269 1272 O
investigator 289 301 1273 1285 O
, 301 302 1285 1286 O
would 303 308 1287 1292 O
make 309 313 1293 1297 O
participation 314 327 1298 1311 O
not 328 331 1312 1315 O
be 332 334 1316 1318 O
in 335 337 1319 1321 O
the 338 341 1322 1325 O
best 342 346 1326 1330 O
interest 347 355 1331 1339 O
( 356 357 1340 1341 O
e.g. 357 361 1341 1345 O
, 361 362 1345 1346 O
compromise 363 373 1347 1357 O
the 374 377 1358 1361 O
well 378 382 1362 1366 O
- 382 383 1366 1367 O
being 383 388 1367 1372 O
) 388 389 1372 1373 O
of 390 392 1374 1376 O
the 393 396 1377 1380 O
subject 397 404 1381 1388 O
or 405 407 1389 1391 O
that 408 412 1392 1396 O
could 413 418 1397 1402 O
prevent 419 426 1403 1410 O
, 426 427 1410 1411 O
limit 428 433 1412 1417 O
, 433 434 1417 1418 O
or 435 437 1419 1421 O
confound 438 446 1422 1430 O
the 447 450 1431 1434 O
protocol 451 459 1435 1443 O
- 459 460 1443 1444 O
specified 460 469 1444 1453 O
assessments 470 481 1454 1465 O

Participant 0 11 1466 1477 O
is 12 14 1478 1480 O
morbidly 15 23 1481 1489 B-chronic_disease
obese 24 29 1490 1495 I-chronic_disease
( 30 31 1496 1497 O
BMI 31 34 1497 1500 B-bmi
> 35 36 1501 1502 O
40 37 39 1503 1505 B-lower_bound
) 39 40 1505 1506 O

Participant 0 11 1507 1518 O
meets 12 17 1519 1524 O
criteria 18 26 1525 1533 O
for 27 30 1534 1537 O
a 31 32 1538 1539 O
DSM5 33 37 1540 1544 B-chronic_disease
Axis-1 38 44 1545 1551 I-chronic_disease
disorder 45 53 1552 1560 I-chronic_disease

Pregnancy 0 9 1561 1570 B-pregnancy
as 10 12 1571 1573 O
detected 13 21 1574 1582 O
by 22 24 1583 1585 O
a 25 26 1586 1587 O
urine 27 32 1588 1593 O
test 33 37 1594 1598 O

They 0 4 1599 1603 O
must 5 9 1604 1608 O
be 10 12 1609 1611 O
able 13 17 1612 1616 O
to 18 20 1617 1619 O
provide 21 28 1620 1627 O
written 29 36 1628 1635 O
informed 37 45 1636 1644 O
consent 46 53 1645 1652 O
and 54 57 1653 1656 O
must 58 62 1657 1661 O
have 63 67 1662 1666 B-language_fluency
sufficient 68 78 1667 1677 I-language_fluency
proficiency 79 90 1678 1689 I-language_fluency
in 91 93 1690 1692 I-language_fluency
the 94 97 1693 1696 I-language_fluency
English 98 105 1697 1704 I-language_fluency
language 106 114 1705 1713 I-language_fluency
to 115 117 1714 1716 O
understand 118 128 1717 1727 O
and 129 132 1728 1731 O
complete 133 141 1732 1740 O
interviews 142 152 1741 1751 O
, 152 153 1751 1752 O
questionnaires 154 168 1753 1767 O
, 168 169 1767 1768 O
and 170 173 1769 1772 O
all 174 177 1773 1776 O
other 178 183 1777 1782 O
study 184 189 1783 1788 O
procedures 190 200 1789 1799 O

between 0 7 1800 1807 O
18 8 10 1808 1810 B-lower_bound
- 10 11 1810 1811 O
55 11 13 1811 1813 B-upper_bound
years 14 19 1814 1819 I-upper_bound
of 20 22 1820 1822 O
age 23 26 1823 1826 B-age

free 0 4 1827 1831 O
of 5 7 1832 1834 O
any 8 11 1835 1838 O
current 12 19 1839 1846 O
or 20 22 1847 1849 O
past 23 27 1850 1854 O
neurological 28 40 1855 1867 B-chronic_disease
or 41 43 1868 1870 I-chronic_disease
psychiatric 44 55 1871 1882 I-chronic_disease
illness 56 63 1883 1890 I-chronic_disease
, 63 64 1890 1891 O
and 65 68 1892 1895 O
capable 69 76 1896 1903 O
of 77 79 1904 1906 O
performing 80 90 1907 1917 O
all 91 94 1918 1921 O
tasks 95 100 1922 1927 O
during 101 107 1928 1934 O
each 108 112 1935 1939 O
session 113 120 1940 1947 O
of 121 123 1948 1950 O
the 124 127 1951 1954 O
experiment 128 138 1955 1965 O

we 0 2 1966 1968 O
require 3 10 1969 1976 O
the 11 14 1977 1980 O
participant 15 26 1981 1992 O
to 27 29 1993 1995 O
be 30 32 1996 1998 O
stably 33 39 1999 2005 O
medicated 40 49 2006 2015 O
prior 50 55 2016 2021 O
to 56 58 2022 2024 O
participation 59 72 2025 2038 O
( 73 74 2039 2040 O
defined 74 81 2040 2047 O
as 82 84 2048 2050 O
having 85 91 2051 2057 O
taken 92 97 2058 2063 O
the 98 101 2064 2067 O
medication 102 112 2068 2078 O
for 113 116 2079 2082 O
6 117 118 2083 2084 B-lower_bound
weeks 119 124 2085 2090 I-lower_bound
or 125 127 2091 2093 O
longer 128 134 2094 2100 O
) 134 135 2100 2101 O

Prisoners 0 9 0 9 O
and/or 10 16 10 16 O
those 17 22 17 22 O
who 23 26 23 26 O
may 27 30 27 30 O
be 31 33 31 33 O
pregnant 34 42 34 42 B-pregnancy

14 0 2 0 2 B-lower_bound
- 2 3 2 3 O
21 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
old 12 15 12 15 O

> 0 1 16 17 O
nine 2 6 18 22 O
menses 7 13 23 29 O
( 14 15 30 31 O
cycle 15 20 31 36 B-clinical_variable
length 21 27 37 43 I-clinical_variable
21 28 30 44 46 B-lower_bound
- 30 31 46 47 O
35 31 33 47 49 B-upper_bound
days 34 38 50 54 I-upper_bound
) 38 39 54 55 O
in 40 42 56 58 O
preceding 43 52 59 68 B-upper_bound
year 53 57 69 73 I-upper_bound

Amenorrhea 0 10 74 84 B-chronic_disease
( 11 12 85 86 O
for 12 15 86 89 O
AA 16 18 90 92 O
) 18 19 92 93 O

BMI 0 3 94 97 B-bmi
between 4 11 98 105 O
10th-90th 12 21 106 115 B-lower_bound
percentiles 22 33 116 127 I-upper_bound
for 34 37 128 131 O
age 38 41 132 135 B-age

Bone 0 4 136 140 B-clinical_variable
age 5 8 141 144 I-clinical_variable
( 9 10 145 146 I-clinical_variable
BA 10 12 146 148 I-clinical_variable
) 12 13 148 149 I-clinical_variable
> 14 15 150 151 O
15 15 17 151 153 B-lower_bound
years 18 23 154 159 I-lower_bound

Females 0 7 160 167 B-gender

absence 0 7 168 175 O
of 8 10 176 178 O
menses 11 17 179 185 O
for 18 21 186 189 O
> 22 23 190 191 O
three 24 29 192 197 B-lower_bound
months 30 36 198 204 I-lower_bound
( 37 38 205 206 I-lower_bound
74 38 40 206 208 I-lower_bound
) 40 41 208 209 I-lower_bound
within 42 48 210 216 O
a 49 50 217 218 O
period 51 57 219 225 O
of 58 60 226 228 O
oligomenorrhea 61 75 229 243 B-chronic_disease
( 76 77 244 245 O
cycle 77 82 245 250 B-clinical_variable
length 83 89 251 257 I-clinical_variable
> 90 91 258 259 O
six 92 95 260 263 B-lower_bound
weeks 96 101 264 269 I-lower_bound
) 101 102 269 270 O
for 103 106 271 274 O
> 107 108 275 276 O
six 108 111 276 279 B-lower_bound
months 112 118 280 286 I-lower_bound
, 118 119 286 287 O
or 120 122 288 290 O
absence 123 130 291 298 O
of 131 133 299 301 O
menarche 134 142 302 310 O
at 143 145 311 313 O
> 146 147 314 315 O
16 147 149 315 317 B-lower_bound
years 150 155 318 323 I-lower_bound

A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
any 15 18 15 18 O
current 19 26 19 26 O
psychiatric 27 38 27 38 B-chronic_disease
disorder 39 47 39 47 I-chronic_disease
other 48 53 48 53 O
than 54 58 54 58 O
Alcohol 59 66 59 66 B-chronic_disease
Use 67 70 67 70 I-chronic_disease
Disorder 71 79 71 79 I-chronic_disease
( 80 81 80 81 O
e.g. 81 85 81 85 O
Major 86 91 86 91 B-chronic_disease
Depressive 92 102 92 102 I-chronic_disease
Disorder 103 111 103 111 I-chronic_disease
, 111 112 111 112 O
Generalized 113 124 113 124 B-chronic_disease
Anxiety 125 132 125 132 I-chronic_disease
Disorder 133 141 133 141 I-chronic_disease
) 141 142 141 142 O
that 143 147 143 147 O
in 148 150 148 150 O
the 151 154 151 154 O
investigator 155 167 155 167 O
's 167 169 167 169 O
judgment 170 178 170 178 O
might 179 184 179 184 O
require 185 192 185 192 O
intervention 193 205 193 205 O
with 206 210 206 210 O
either 211 217 211 217 O
pharmacological 218 233 218 233 B-treatment
or 234 236 234 236 I-treatment
non 237 240 237 240 I-treatment
- 240 241 240 241 I-treatment
pharmacological 241 256 241 256 I-treatment
therapy 257 264 257 264 I-treatment
over 265 269 265 269 O
the 270 273 270 273 O
course 274 280 274 280 O
of 281 283 281 283 O
the 284 287 284 287 O
study 288 293 288 293 O

Agree 0 5 294 299 O
to 6 8 300 302 O
not 9 12 303 306 O
seek 13 17 307 311 O
additional 18 28 312 322 O
treatment 29 38 323 332 B-treatment

Currently 0 9 333 342 O
drinking 10 18 343 351 O
> 19 20 352 353 O
5/4 20 23 353 356 B-lower_bound
or 24 26 357 359 O
more 27 31 360 364 O
drinks 32 38 365 371 O
/ 38 39 371 372 O
day 39 42 372 375 O
for 43 46 376 379 O
men 47 50 380 383 B-gender
/ 50 51 383 384 O
women 51 56 384 389 B-gender
in 57 59 390 392 O
the 60 63 393 396 O
last 64 68 397 401 B-upper_bound
28 69 71 402 404 I-upper_bound
day 72 75 405 408 I-upper_bound

Currently 0 9 409 418 O
taking 10 16 419 425 O
any 17 20 426 429 O
psychotropic 21 33 430 442 B-treatment
medications 34 45 443 454 I-treatment

English 0 7 455 462 B-language_fluency
- 7 8 462 463 I-language_fluency
speaking 8 16 463 471 I-language_fluency
and 17 20 472 475 O
able 21 25 476 480 O
to 26 28 481 483 O
provide 29 36 484 491 O
informed 37 45 492 500 O
consent 46 53 501 508 O
and 54 57 509 512 O
comply 58 64 513 519 O
with 65 69 520 524 O
study 70 75 525 530 O
procedures 76 86 531 541 O

History 0 7 542 549 O
of 8 10 550 552 O
severe 11 17 553 559 O
alcohol 18 25 560 567 O
withdrawal 26 36 568 578 O
( 37 38 579 580 O
e.g. 38 42 580 584 O
seizure 43 50 585 592 B-chronic_disease
, 50 51 592 593 O
delirium 52 60 594 602 O
tremens 61 68 603 610 O
, 68 69 610 611 O
multiple 70 78 612 620 O
detoxifications 79 94 621 636 O
or 95 97 637 639 O
ER 98 100 640 642 O
visits 101 107 643 649 O
for 108 111 650 653 O
alcohol 112 119 654 661 O
withdrawal 120 130 662 672 O
) 130 131 672 673 O

Legally 0 7 674 681 O
mandated 8 16 682 690 O
to 17 19 691 693 O
receive 20 27 694 701 O
treatment 28 37 702 711 B-treatment

Lifetime 0 8 712 720 O
history 9 16 721 728 O
of 17 19 729 731 O
Bipolar 20 27 732 739 B-chronic_disease
Disorder 28 36 740 748 I-chronic_disease

Meets 0 5 749 754 O
DSM 6 9 755 758 O
- 9 10 758 759 O
V 10 11 759 760 O
criteria 12 20 761 769 O
for 21 24 770 773 O
current 25 32 774 781 O
Alcohol 33 40 782 789 B-chronic_disease
Use 41 44 790 793 I-chronic_disease
Disorder 45 53 794 802 I-chronic_disease

Neurological 0 12 803 815 B-chronic_disease
or 13 15 816 818 O
medical 16 23 819 826 B-chronic_disease
conditions 24 34 827 837 I-chronic_disease
that 35 39 838 842 O
would 40 45 843 848 O
interfere 46 55 849 858 O
with 56 60 859 863 O
MRI 61 64 864 867 B-treatment
scanning 65 73 868 876 O
( 74 75 877 878 O
e.g. 75 79 878 882 O
history 80 87 883 890 O
of 88 90 891 893 O
stroke 91 97 894 900 B-chronic_disease
, 97 98 900 901 O
seizure 99 106 902 909 B-chronic_disease
, 106 107 909 910 O
brain 108 113 911 916 B-cancer
tumor 114 119 917 922 I-cancer
, 119 120 922 923 O
brain 121 126 924 929 B-chronic_disease
infection 127 136 930 939 I-chronic_disease
, 136 137 939 940 O
multiple 138 146 941 949 B-chronic_disease
sclerosis 147 156 950 959 I-chronic_disease
, 156 157 959 960 O
metal 158 163 961 966 B-treatment
device 164 170 967 973 I-treatment
in 171 173 974 976 O
body 174 178 977 981 O
, 178 179 981 982 O
pregnancy 180 189 983 992 B-pregnancy
, 189 190 992 993 O
claustrophobia 191 205 994 1008 B-chronic_disease
) 205 206 1008 1009 O

Schizophrenia 0 13 1010 1023 B-chronic_disease
or 14 16 1024 1026 O
Schizoaffective 17 32 1027 1042 B-chronic_disease
Disorder 33 41 1043 1051 I-chronic_disease

Seeking 0 7 1052 1059 O
treatment 8 17 1060 1069 B-treatment
for 18 21 1070 1073 O
Alcohol 22 29 1074 1081 O
Use 30 33 1082 1085 O
Disorder 34 42 1086 1094 O

Significant 0 11 1095 1106 O
cognitive 12 21 1107 1116 B-chronic_disease
impairment 22 32 1117 1127 I-chronic_disease

Significant 0 11 1128 1139 O
risk 12 16 1140 1144 O
for 17 20 1145 1148 O
suicide 21 28 1149 1156 B-chronic_disease
or 29 31 1157 1159 O
violence 32 40 1160 1168 O

Willing 0 7 1169 1176 O
to 8 10 1177 1179 O
abstain 11 18 1180 1187 O
from 19 23 1188 1192 O
alcohol 24 31 1193 1200 O
completely 32 42 1201 1211 O
for 43 46 1212 1215 O
24 47 49 1216 1218 B-upper_bound
hours 50 55 1219 1224 I-upper_bound
on 56 58 1225 1227 O
3 59 60 1228 1229 O
separate 61 69 1230 1238 O
occasions 70 79 1239 1248 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1500 35 39 35 39 B-lower_bound
/ 39 40 39 40 I-lower_bound
mm^3 40 44 40 44 I-lower_bound

Alanine 0 7 45 52 B-clinical_variable
aminotransferase 8 24 53 69 I-clinical_variable
( 25 26 70 71 I-clinical_variable
ALT 26 29 71 74 I-clinical_variable
) 29 30 74 75 I-clinical_variable
< 31 32 76 77 O
2.5 33 36 78 81 B-upper_bound
times 37 42 82 87 I-upper_bound
ULN 43 46 88 91 I-upper_bound
; 46 47 91 92 O
in 48 50 93 95 O
the 51 54 96 99 O
case 55 59 100 104 O
of 60 62 105 107 O
known 63 68 108 113 O
( 69 70 114 115 O
radiological 70 82 115 127 O
and/or 83 89 128 134 O
biopsy 90 96 135 141 B-treatment
documented 97 107 142 152 O
) 107 108 152 153 O
liver 109 114 154 159 B-cancer
metastasis 115 125 160 170 I-cancer
, 125 126 170 171 O
ALT 127 130 172 175 O
< 131 132 176 177 O
5.0 133 136 178 181 B-upper_bound
times 137 142 182 187 I-upper_bound
ULN 143 146 188 191 I-upper_bound
is 147 149 192 194 O
acceptable 150 160 195 205 O

Bilirubin 0 9 206 215 B-clinical_variable
< 10 11 216 217 O
2 12 13 218 219 B-upper_bound
times 14 19 220 225 I-upper_bound
the 20 23 226 229 I-upper_bound
upper 24 29 230 235 I-upper_bound
limit 30 35 236 241 I-upper_bound
of 36 38 242 244 I-upper_bound
normal 39 45 245 251 I-upper_bound
( 46 47 252 253 I-upper_bound
ULN 47 50 253 256 I-upper_bound
) 50 51 256 257 I-upper_bound
( 52 53 258 259 O
except 53 59 259 265 O
patients 60 68 266 274 O
with 69 73 275 279 O
Gilbert 74 81 280 287 B-chronic_disease
's 81 83 287 289 I-chronic_disease
syndrome 84 92 290 298 I-chronic_disease
who 93 96 299 302 O
must 97 101 303 307 O
have 102 106 308 312 O
a 107 108 313 314 O
total 109 114 315 320 B-clinical_variable
bilirubin 115 124 321 330 I-clinical_variable
of 125 127 331 333 O
< 128 129 334 335 O
3 130 131 336 337 B-upper_bound
times 132 137 338 343 I-upper_bound
ULN 138 141 344 347 I-upper_bound
) 141 142 347 348 O

Concurrent 0 10 349 359 B-treatment
therapy 11 18 360 367 I-treatment
with 19 23 368 372 O
approved 24 32 373 381 O
or 33 35 382 384 O
investigational 36 51 385 400 B-treatment
anticancer 52 62 401 411 I-treatment
therapeutic 63 74 412 423 I-treatment

Congestive 0 10 424 434 B-chronic_disease
heart 11 16 435 440 I-chronic_disease
failure 17 24 441 448 I-chronic_disease
( 25 26 449 450 I-chronic_disease
CHF 26 29 450 453 I-chronic_disease
) 29 30 453 454 I-chronic_disease
of 31 33 455 457 O
New 34 37 458 461 B-clinical_variable
York 38 42 462 466 I-clinical_variable
Heart 43 48 467 472 I-clinical_variable
Association 49 60 473 484 I-clinical_variable
( 61 62 485 486 I-clinical_variable
NYHA 62 66 486 490 I-clinical_variable
) 66 67 490 491 I-clinical_variable
class 68 73 492 497 I-clinical_variable
> 74 75 498 499 O
= 75 76 499 500 O
3 77 78 501 502 B-lower_bound

Eastern 0 7 503 510 B-clinical_variable
Cooperative 8 19 511 522 I-clinical_variable
Oncology 20 28 523 531 I-clinical_variable
Group 29 34 532 537 I-clinical_variable
( 35 36 538 539 I-clinical_variable
ECOG 36 40 539 543 I-clinical_variable
) 40 41 543 544 I-clinical_variable
performance 42 53 545 556 I-clinical_variable
status 54 60 557 563 I-clinical_variable
of 61 63 564 566 O
0 64 65 567 568 B-lower_bound
- 65 66 568 569 O
1 66 67 569 570 B-upper_bound

Estimated 0 9 571 580 B-clinical_variable
creatinine 10 20 581 591 I-clinical_variable
clearance 21 30 592 601 I-clinical_variable
of 31 33 602 604 O
> 34 35 605 606 O
= 35 36 606 607 O
50 37 39 608 610 B-lower_bound
mL 40 42 611 613 I-lower_bound
/ 42 43 613 614 I-lower_bound
min 43 46 614 617 I-lower_bound
, 46 47 617 618 O
calculated 48 58 619 629 O
using 59 64 630 635 O
the 65 68 636 639 O
formula 69 76 640 647 O
of 77 79 648 650 O
Cockroft 80 88 651 659 O
and 89 92 660 663 O
Gault 93 98 664 669 O

Female 0 6 670 676 B-gender
patients 7 15 677 685 I-gender
of 16 18 686 688 O
child 19 24 689 694 O
- 24 25 694 695 O
bearing 25 32 695 702 O
potential 33 42 703 712 O
must 43 47 713 717 O
agree 48 53 718 723 B-contraception_consent
to 54 56 724 726 I-contraception_consent
use 57 60 727 730 I-contraception_consent
dual 61 65 731 735 I-contraception_consent
methods 66 73 736 743 I-contraception_consent
of 74 76 744 746 I-contraception_consent
contraception 77 90 747 760 I-contraception_consent
and 91 94 761 764 O
have 95 99 765 769 O
a 100 101 770 771 O
negative 102 110 772 780 B-pregnancy
serum 111 116 781 786 I-pregnancy
pregnancy 117 126 787 796 I-pregnancy
test 127 131 797 801 O
at 132 134 802 804 O
screening 135 144 805 814 O

Grade 0 5 815 820 B-clinical_variable
> 6 7 821 822 O
= 7 8 822 823 O
2 9 10 824 825 B-lower_bound
peripheral 11 21 826 836 B-chronic_disease
neuropathy 22 32 837 847 I-chronic_disease
within 33 39 848 854 O
14 40 42 855 857 B-upper_bound
days 43 47 858 862 I-upper_bound
prior 48 53 863 868 I-upper_bound
to 54 56 869 871 O
initiation 57 67 872 882 O
of 68 70 883 885 O
therapy 71 78 886 893 B-treatment

HBsAg 0 5 894 899 O
( 6 7 900 901 O
hepatitis 7 16 901 910 B-chronic_disease
B 17 18 911 912 I-chronic_disease
virus 19 24 913 918 I-chronic_disease
[ 25 26 919 920 I-chronic_disease
HBV 26 29 920 923 I-chronic_disease
] 29 30 923 924 I-chronic_disease
surface 31 38 925 932 O
antigen 39 46 933 940 O
) 46 47 940 941 O

History 0 7 942 949 O
of 8 10 950 952 O
seizures 11 19 953 961 B-chronic_disease
, 19 20 961 962 O
movement 21 29 963 971 B-chronic_disease
disorders 30 39 972 981 I-chronic_disease
or 40 42 982 984 O
cerebrovascular 43 58 985 1000 B-chronic_disease
accident 59 67 1001 1009 O
within 68 74 1010 1016 O
the 75 78 1017 1020 O
past 79 83 1021 1025 B-upper_bound
5 84 85 1026 1027 I-upper_bound
years 86 91 1028 1033 I-upper_bound

If 0 2 1034 1036 O
patient 3 10 1037 1044 O
did 11 14 1045 1048 O
not 15 18 1049 1052 O
receive 19 26 1053 1060 O
such 27 31 1061 1065 O
agents 32 38 1066 1072 O
, 38 39 1072 1073 O
rationale 40 49 1074 1083 O
for 50 53 1084 1087 O
not 54 57 1088 1091 O
treating 58 66 1092 1100 O
the 67 70 1101 1104 O
patients 71 79 1105 1113 O
with 80 84 1114 1118 O
the 85 88 1119 1122 O
629 89 92 1123 1126 O
agent 93 98 1127 1132 O
must 99 103 1133 1137 O
be 104 106 1138 1140 O
cleared 107 114 1141 1148 O
with 115 119 1149 1153 O
the 120 123 1154 1157 O
study 124 129 1158 1163 O
PI 130 132 1164 1166 O
( 133 134 1167 1168 O
ie 134 136 1168 1170 O
no 137 139 1171 1173 O
V600e 140 145 1174 1179 O
/ 145 146 1179 1180 O
k 146 147 1180 1181 O
BRAF 148 152 1182 1186 O
mutation 153 161 1187 1195 O
or 162 164 1196 1198 O
patient 165 172 1199 1206 O
with 173 177 1207 1211 O
autoimmunity 178 190 1212 1224 O
, 190 191 1224 1225 O
thus 192 196 1226 1230 O
630 197 200 1231 1234 O
not 201 204 1235 1238 O
eligible 205 213 1239 1247 O
for 214 217 1248 1251 O
biologic 218 226 1252 1260 B-treatment
therapy 227 234 1261 1268 I-treatment
) 234 235 1268 1269 O

Known 0 5 1270 1275 O
active 6 12 1276 1282 B-chronic_disease
hepatitis 13 22 1283 1292 I-chronic_disease
A 23 24 1293 1294 I-chronic_disease
, 24 25 1294 1295 I-chronic_disease
B 26 27 1296 1297 I-chronic_disease
, 27 28 1297 1298 I-chronic_disease
or 29 31 1299 1301 I-chronic_disease
C 32 33 1302 1303 I-chronic_disease
infection 34 43 1304 1313 I-chronic_disease

Known 0 5 1314 1319 O
to 6 8 1320 1322 O
be 9 11 1323 1325 O
human 12 17 1326 1331 B-chronic_disease
immunodeficiency 18 34 1332 1348 I-chronic_disease
virus 35 40 1349 1354 I-chronic_disease
( 41 42 1355 1356 I-chronic_disease
HIV 42 45 1356 1359 I-chronic_disease
) 45 46 1359 1360 I-chronic_disease
seropositive 47 59 1361 1373 O

Major 0 5 1374 1379 B-treatment
surgery 6 13 1380 1387 I-treatment
within 14 20 1388 1394 O
four 21 25 1395 1399 B-upper_bound
weeks 26 31 1400 1405 I-upper_bound
before 32 38 1406 1412 O
initiation 39 49 1413 1423 O
of 50 52 1424 1426 O
therapy 53 60 1427 1434 B-treatment

Myocardial 0 10 1435 1445 B-chronic_disease
infarction 11 21 1446 1456 I-chronic_disease
( 22 23 1457 1458 I-chronic_disease
MI 23 25 1458 1460 I-chronic_disease
) 25 26 1460 1461 I-chronic_disease
within 27 33 1462 1468 O
3 34 35 1469 1470 B-upper_bound
months 36 42 1471 1477 I-upper_bound
of 43 45 1478 1480 O
initiation 46 56 1481 1491 O
of 57 59 1492 1494 O
therapy 60 67 1495 1502 B-treatment

Participation 0 13 1503 1516 O
in 14 16 1517 1519 O
an 17 19 1520 1522 O
investigational 20 35 1523 1538 B-treatment
anti 36 40 1539 1543 I-treatment
- 40 41 1543 1544 I-treatment
cancer 41 47 1544 1550 I-treatment
study 48 53 1551 1556 O
within 54 60 1557 1563 O
3 61 62 1564 1565 B-upper_bound
weeks 63 68 1566 1571 I-upper_bound
prior 69 74 1572 1577 I-upper_bound
to 75 77 1578 1580 O
initiation 78 88 1581 1591 O
of 89 91 1592 1594 O
therapy 92 99 1595 1602 B-treatment

Patients 0 8 1603 1611 O
must 9 13 1612 1616 O
have 14 18 1617 1621 O
received 19 27 1622 1630 O
a 28 29 1631 1632 O
biologic 30 38 1633 1641 B-treatment
therapy 39 46 1642 1649 I-treatment
( 47 48 1650 1651 O
e.g. 48 52 1651 1655 O
interleukin 53 64 1656 1667 B-treatment
2 65 66 1668 1669 I-treatment
) 66 67 1669 1670 O

Patients 0 8 1671 1679 O
who 9 12 1680 1683 O
are 13 16 1684 1687 O
pregnant 17 25 1688 1696 B-pregnancy
or 26 28 1697 1699 O
lactating 29 38 1700 1709 O

Patients 0 8 1710 1718 O
will 9 13 1719 1723 O
be 14 16 1724 1726 O
excluded 17 25 1727 1735 O
if 26 28 1736 1738 O
they 29 33 1739 1743 O
have 34 38 1744 1748 O
had 39 42 1749 1752 O
a 43 44 1753 1754 O
major 45 50 1755 1760 B-treatment
resection 51 60 1761 1770 I-treatment
of 61 63 1771 1773 I-treatment
the 64 67 1774 1777 I-treatment
bowel 68 73 1778 1783 I-treatment
that 74 78 1784 1788 O
could 79 84 1789 1794 O
influence 85 94 1795 1804 O
absorption 95 105 1805 1815 O

Patients 0 8 1816 1824 O
with 9 13 1825 1829 O
active 14 20 1830 1836 O
central 21 28 1837 1844 B-cancer
nervous 29 36 1845 1852 I-cancer
system 37 43 1853 1859 I-cancer
( 44 45 1860 1861 I-cancer
CNS 45 48 1861 1864 I-cancer
) 48 49 1864 1865 I-cancer
malignancy 50 60 1866 1876 I-cancer

Patients 0 8 1877 1885 O
with 9 13 1886 1890 O
known 14 19 1891 1896 O
macular 20 27 1897 1904 B-chronic_disease
degeneration 28 40 1905 1917 I-chronic_disease
or 41 43 1918 1920 O
uncontrolled 44 56 1921 1933 O
glaucoma 57 65 1934 1942 B-chronic_disease

Patients 0 8 1943 1951 O
with 9 13 1952 1956 O
unresectable 14 26 1957 1969 O
melanoma 27 35 1970 1978 B-cancer

Platelet 0 8 1979 1987 B-clinical_variable
count 9 14 1988 1993 I-clinical_variable
> 15 16 1994 1995 O
= 16 17 1995 1996 O
100,000 18 25 1997 2004 B-lower_bound
/ 25 26 2004 2005 I-lower_bound
mm^3 26 30 2005 2009 I-lower_bound

Radiation 0 9 2010 2019 B-treatment
, 9 10 2019 2020 O
chemotherapy 11 23 2021 2033 B-treatment
, 23 24 2033 2034 O
immunotherapy 25 38 2035 2048 B-treatment
or 39 41 2049 2051 O
any 42 45 2052 2055 O
other 46 51 2056 2061 O
systemic 52 60 2062 2070 B-treatment
anticancer 61 71 2071 2081 I-treatment
therapy 72 79 2082 2089 I-treatment
= 80 81 2090 2091 O
< 81 82 2091 2092 O
2 83 84 2093 2094 B-upper_bound
weeks 85 90 2095 2100 I-upper_bound
prior 91 96 2101 2106 I-upper_bound
to 97 99 2107 2109 O
initiation 100 110 2110 2120 O
of 111 113 2121 2123 O
therapy 114 121 2124 2131 O

Serious 0 7 2132 2139 B-chronic_disease
psychiatric 8 19 2140 2151 I-chronic_disease
or 20 22 2152 2154 O
medical 23 30 2155 2162 O
conditions 31 41 2163 2173 O
that 42 46 2174 2178 O
could 47 52 2179 2184 O
interfere 53 62 2185 2194 O
with 63 67 2195 2199 O
treatment 68 77 2200 2209 O

Symptomatic 0 11 2210 2221 B-chronic_disease
ischemia 12 20 2222 2230 I-chronic_disease

Total 0 5 2231 2236 B-clinical_variable
white 6 11 2237 2242 I-clinical_variable
blood 12 17 2243 2248 I-clinical_variable
cell 18 22 2249 2253 I-clinical_variable
( 23 24 2254 2255 I-clinical_variable
WBC 24 27 2255 2258 I-clinical_variable
) 27 28 2258 2259 I-clinical_variable
count 29 34 2260 2265 I-clinical_variable
> 35 36 2266 2267 O
= 36 37 2267 2268 O
3000 38 42 2269 2273 B-lower_bound
/ 42 43 2273 2274 I-lower_bound
mm^3 43 47 2274 2278 I-lower_bound

Uncontrolled 0 12 2279 2291 O
active 13 19 2292 2298 B-chronic_disease
infection 20 29 2299 2308 I-chronic_disease
within 30 36 2309 2315 O
one 37 40 2316 2319 O
week 41 45 2320 2324 O
prior 46 51 2325 2330 O
to 52 54 2331 2333 O
first 55 60 2334 2339 O
dose 61 65 2340 2344 O

Uncontrolled 0 12 2345 2357 O
clinically 13 23 2358 2368 O
significant 24 35 2369 2380 O
conduction 36 46 2381 2391 O
abnormalities 47 60 2392 2405 O
( 61 62 2406 2407 O
e.g. 62 66 2407 2411 O
: 66 67 2411 2412 O
ventricular 68 79 2413 2424 B-chronic_disease
tachycardia 80 91 2425 2436 I-chronic_disease
on 92 94 2437 2439 O
antiarrhythmics 95 110 2440 2455 B-treatment
are 111 114 2456 2459 O
excluded 115 123 2460 2468 O
and 124 127 2469 2472 O
1st 128 131 2473 2476 B-chronic_disease
degree 132 138 2477 2483 I-chronic_disease
atrioventricular 139 155 2484 2500 I-chronic_disease
( 156 157 2501 2502 I-chronic_disease
AV 157 159 2502 2504 I-chronic_disease
) 159 160 2504 2505 I-chronic_disease
block 161 166 2506 2511 I-chronic_disease
or 167 169 2512 2514 O
asymptomatic 170 182 2515 2527 O
left 183 187 2528 2532 B-chronic_disease
anterior 188 196 2533 2541 I-chronic_disease
fascicular 197 207 2542 2552 I-chronic_disease
block 208 213 2553 2558 I-chronic_disease
[ 214 215 2559 2560 I-chronic_disease
LAFB]/right 215 226 2560 2571 I-chronic_disease
bundle 227 233 2572 2578 I-chronic_disease
branch 234 240 2579 2585 I-chronic_disease
block 241 246 2586 2591 I-chronic_disease
[ 247 248 2592 2593 I-chronic_disease
RBBB 248 252 2593 2597 I-chronic_disease
] 252 253 2597 2598 I-chronic_disease

Unstable 0 8 2599 2607 B-chronic_disease
cardiovascular 9 23 2608 2622 I-chronic_disease

a 0 1 2623 2624 O
BRAF 2 6 2625 2629 B-treatment
and/or 7 13 2630 2636 O
MEK 14 17 2637 2640 B-treatment
inhibitor 18 27 2641 2650 I-treatment
( 28 29 2651 2652 O
if 29 31 2652 2654 O
tumor 32 37 2655 2660 B-cancer
contains 38 46 2661 2669 O
the 47 50 2670 2673 O
V600E 51 56 2674 2679 B-clinical_variable
or 57 59 2680 2682 O
V600 60 64 2683 2687 B-clinical_variable
K 64 65 2687 2688 I-clinical_variable
mutation 66 74 2689 2697 I-clinical_variable
) 74 75 2697 2698 O
for 76 79 2699 2702 O
628 80 83 2703 2706 O
metastatic 84 94 2707 2717 B-cancer
disease 95 102 2718 2725 O

both 0 4 2726 2730 O
male 5 9 2731 2735 B-gender
and 10 13 2736 2739 I-gender
female 14 20 2740 2746 I-gender
patients 21 29 2747 2755 I-gender
, 29 30 2755 2756 O
effective 31 40 2757 2766 B-contraception_consent
methods 41 48 2767 2774 I-contraception_consent
of 49 51 2775 2777 I-contraception_consent
contraception 52 65 2778 2791 I-contraception_consent
must 66 70 2792 2796 I-contraception_consent
be 71 73 2797 2799 I-contraception_consent
used 74 78 2800 2804 I-contraception_consent
throughout 79 89 2805 2815 O
the 90 93 2816 2819 O
study 94 99 2820 2825 O
and 100 103 2826 2829 O
for 104 107 2830 2833 O
three 108 113 2834 2839 O
months 114 120 2840 2846 O
following 121 130 2847 2856 O
the 131 134 2857 2860 O
last 135 139 2861 2865 O
dose 140 144 2866 2870 O

gastrointestinal 0 16 2871 2887 B-chronic_disease
perforation 17 28 2888 2899 I-chronic_disease
within 29 35 2900 2906 O
28 36 38 2907 2909 B-upper_bound
days 39 43 2910 2914 I-upper_bound
prior 44 49 2915 2920 I-upper_bound
to 50 52 2921 2923 O
beginning 53 62 2924 2933 O
study 63 68 2934 2939 O
treatment 69 78 2940 2949 O

history 0 7 2950 2957 O
of 8 10 2958 2960 O
abdominal 11 20 2961 2970 B-chronic_disease
fistula 21 28 2971 2978 I-chronic_disease

inflammatory 0 12 2979 2991 B-chronic_disease
bowel 13 18 2992 2997 I-chronic_disease
disease 19 26 2998 3005 I-chronic_disease

known 0 5 3006 3011 O
to 6 8 3012 3014 O
be 9 11 3015 3017 O
positive 12 20 3018 3026 O
for 21 24 3027 3030 O
hepatitis 25 34 3031 3040 B-chronic_disease
C 35 36 3041 3042 I-chronic_disease
virus 37 42 3043 3048 I-chronic_disease
( 43 44 3049 3050 I-chronic_disease
HCV 44 47 3050 3053 I-chronic_disease
) 47 48 3053 3054 I-chronic_disease
ribonucleic 49 60 3055 3066 B-clinical_variable
acid 61 65 3067 3071 I-clinical_variable
( 66 67 3072 3073 I-clinical_variable
RNA 67 70 3073 3076 I-clinical_variable
) 70 71 3076 3077 I-clinical_variable

male 0 4 3078 3082 B-gender
patients 5 13 3083 3091 I-gender
must 14 18 3092 3096 O
use 19 22 3097 3100 B-contraception_consent
an 23 25 3101 3103 I-contraception_consent
effective 26 35 3104 3113 I-contraception_consent
barrier 36 43 3114 3121 I-contraception_consent
method 44 50 3122 3128 I-contraception_consent
of 51 53 3129 3131 I-contraception_consent
contraception 54 67 3132 3145 I-contraception_consent
if 68 70 3146 3148 O
sexually 71 79 3149 3157 O
active 80 86 3158 3164 O
with 87 91 3165 3169 O
a 92 93 3170 3171 O
female 94 100 3172 3178 B-gender
of 101 103 3179 3181 O
child 104 109 3182 3187 O
- 109 110 3187 3188 O
bearing 110 117 3188 3195 O
potential 118 127 3196 3205 O

other 0 5 3206 3211 O
gastrointestinal 6 22 3212 3228 B-chronic_disease
conditions 23 33 3229 3239 I-chronic_disease
with 34 38 3240 3244 O
increased 39 48 3245 3254 O
risk 49 53 3255 3259 O
of 54 56 3260 3262 O
perforation 57 68 3263 3274 O

Patient 0 7 0 7 O
has 8 11 8 11 O
a 12 13 12 13 O
Body 14 18 14 18 B-clinical_variable
Mass 19 23 19 23 I-clinical_variable
Index 24 29 24 29 I-clinical_variable
( 30 31 30 31 I-clinical_variable
BMI 31 34 31 34 I-clinical_variable
) 34 35 34 35 I-clinical_variable
> 36 37 36 37 O
45 38 40 38 40 B-lower_bound

Patient 0 7 41 48 O
has 8 11 49 52 O
a 12 13 53 54 O
failed 14 20 55 61 O
unicondylar 21 32 62 73 B-treatment
knee 33 37 74 78 I-treatment
prosthesis 38 48 79 89 I-treatment

Patient 0 7 90 97 O
has 8 11 98 101 O
a 12 13 102 103 O
known 14 19 104 109 O
sensitivity 20 31 110 121 O
to 32 34 122 124 O
device 35 41 125 131 B-allergy_name
materials 42 51 132 141 I-allergy_name

Patient 0 7 142 149 O
has 8 11 150 153 O
a 12 13 154 155 O
neuromuscular 14 27 156 169 B-chronic_disease
or 28 30 170 172 O
neurosensory 31 43 173 185 B-chronic_disease
deficiency 44 54 186 196 I-chronic_disease
, 54 55 196 197 O
which 56 61 198 203 O
limits 62 68 204 210 O
the 69 72 211 214 O
ability 73 80 215 222 O
to 81 83 223 225 O
evaluate 84 92 226 234 O
the 93 96 235 238 O
safety 97 103 239 245 O
and 104 107 246 249 O
efficacy 108 116 250 258 O
of 117 119 259 261 O
the 120 123 262 265 O
device 124 130 266 272 O

Patient 0 7 273 280 O
has 8 11 281 284 O
an 12 14 285 287 O
active 15 21 288 294 O
or 22 24 295 297 O
suspected 25 34 298 307 O
latent 35 41 308 314 B-chronic_disease
infection 42 51 315 324 I-chronic_disease
in 52 54 325 327 O
or 55 57 328 330 O
about 58 63 331 336 O
the 64 67 337 340 O
affected 68 76 341 349 O
knee 77 81 350 354 O
joint 82 87 355 360 O
at 88 90 361 363 O
time 91 95 364 368 O
of 96 98 369 371 O
study 99 104 372 377 O
device 105 111 378 384 B-treatment
implantation 112 124 385 397 I-treatment

Patient 0 7 398 405 O
is 8 10 406 408 O
a 11 12 409 410 O
candidate 13 22 411 420 O
for 23 26 421 424 O
revision 27 35 425 433 O
of 36 38 434 436 O
all 39 42 437 440 O
femoral 43 50 441 448 O
and 51 54 449 452 O
tibial 55 61 453 459 O
components 62 72 460 470 O
of 73 75 471 473 O
a 76 77 474 475 O
total 78 83 476 481 B-treatment
knee 84 88 482 486 I-treatment
replacement 89 100 487 498 I-treatment

Patient 0 7 499 506 O
is 8 10 507 509 O
a 11 12 510 511 O
male 13 17 512 516 B-gender
or 18 20 517 519 O
non 21 24 520 523 O
- 24 25 523 524 O
pregnant 25 33 524 532 B-pregnancy
female 34 40 533 539 B-gender

Patient 0 7 540 547 O
is 8 10 548 550 O
diagnosed 11 20 551 560 O
with 21 25 561 565 O
a 26 27 566 567 O
systemic 28 36 568 576 B-chronic_disease
disease 37 44 577 584 I-chronic_disease
( 45 46 585 586 O
e.g. 46 50 586 590 O
Lupus 51 56 591 596 B-chronic_disease
Erythematosus 57 70 597 610 I-chronic_disease
) 70 71 610 611 O
or 72 74 612 614 O
a 75 76 615 616 O
metabolic 77 86 617 626 B-chronic_disease
disorder 87 95 627 635 I-chronic_disease
( 96 97 636 637 O
e.g. 97 101 637 641 O
Paget 102 107 642 647 B-chronic_disease
's 107 109 647 649 I-chronic_disease
disease 110 117 650 657 I-chronic_disease
) 117 118 657 658 O
leading 119 126 659 666 O
to 127 129 667 669 O
progressive 130 141 670 681 O
bone 142 146 682 686 O
deterioration 147 160 687 700 O

Patient 0 7 701 708 O
is 8 10 709 711 O
immunologically 11 26 712 727 O
suppressed 27 37 728 738 O
or 38 40 739 741 O
receiving 41 50 742 751 O
steroids 51 59 752 760 B-treatment
in 60 62 761 763 O
excess 63 69 764 770 O
of 70 72 771 773 O
normal 73 79 774 780 O
physiological 80 93 781 794 O
requirements 94 106 795 807 O
( 107 108 808 809 O
e.g. 108 112 809 813 O
> 113 114 814 815 O
30 115 117 816 818 B-lower_bound
days 118 122 819 823 I-lower_bound
) 122 123 823 824 O

skeletally 0 10 825 835 O
mature 11 17 836 842 O
and 18 21 843 846 O
age 22 25 847 850 B-age
18 26 28 851 853 B-lower_bound
years 29 34 854 859 I-lower_bound
or 35 37 860 862 O
older 38 43 863 868 O
at 44 46 869 871 O
time 47 51 872 876 O
of 52 54 877 879 O
study 55 60 880 885 O
device 61 67 886 892 O
implantation 68 80 893 905 O

Age 0 3 0 3 B-age
: 3 4 3 4 O
12 5 7 5 7 B-lower_bound
- 7 8 7 8 O
16 8 10 8 10 B-upper_bound

Diagnosed 0 9 11 20 O
depression 10 20 21 31 B-chronic_disease
or 21 23 32 34 O
other 24 29 35 40 O
condition 30 39 41 50 O
that 40 44 51 55 O
may 45 48 56 59 O
impact 49 55 60 66 O
QoL 56 59 67 70 O

Latino 0 6 71 77 B-ethnicity
: 6 7 77 78 O
self 8 12 79 83 O
- 12 13 83 84 O
report 13 19 84 90 O

Obese 0 5 91 96 O
: 5 6 96 97 O
BMI 7 10 98 101 B-bmi
percentile 11 21 102 112 O
≥95th 22 27 113 118 O
percentile 28 38 119 129 I-lower_bound
for 39 42 130 133 O
age 43 46 134 137 B-age
and 47 50 138 141 O
gender 51 57 142 148 O
or 58 60 149 151 O
BMI 61 64 152 155 O
≥30 65 68 156 159 O
kg 69 71 160 162 I-lower_bound
/ 71 72 162 163 I-lower_bound
m22 72 75 163 166 I-lower_bound

Type 0 4 167 171 B-chronic_disease
2 5 6 172 173 I-chronic_disease
diabetes 7 15 174 182 I-chronic_disease
: 15 16 182 183 O
Fasting 17 24 184 191 B-clinical_variable
glucose 25 32 192 199 I-clinical_variable
≥126 33 37 200 204 O
mg 38 40 205 207 I-lower_bound
/ 40 41 207 208 I-lower_bound
dl 41 43 208 210 I-lower_bound
or 44 46 211 213 I-lower_bound
2 47 48 214 215 I-lower_bound
- 48 49 215 216 I-lower_bound
hour 49 53 216 220 I-lower_bound
glucose 54 61 221 228 I-lower_bound
≥200 62 66 229 233 O
mg 67 69 234 236 I-lower_bound
/ 69 70 236 237 I-lower_bound
dl 70 72 237 239 I-lower_bound

Concurrent 0 10 0 10 O
participation 11 24 11 24 O
in 25 27 25 27 O
other 28 33 28 33 O
experimental 34 46 34 46 O
trials 47 53 47 53 O
for 54 57 54 57 O
motor 58 63 58 63 B-treatment
dysfunction 64 75 64 75 I-treatment
treatment 76 85 76 85 I-treatment

Have 0 4 86 90 O
medical 5 12 91 98 O
conditions 13 23 99 109 O
that 24 28 110 114 O
would 29 34 115 120 O
place 35 40 121 126 O
volunteers 41 51 127 137 O
at 52 54 138 140 O
higher 55 61 141 147 O
risk 62 66 148 152 O
of 67 69 153 155 O
adverse 70 77 156 163 O
events 78 84 164 170 O
( 85 86 171 172 O
e.g. 86 90 172 176 O
, 90 91 176 177 O
renal 92 97 178 183 B-chronic_disease
disease 98 105 184 191 I-chronic_disease
, 105 106 191 192 O
frailty 107 114 193 200 O
, 114 115 200 201 O
pregnancy 116 125 202 211 B-pregnancy
, 125 126 211 212 O
dementia 127 135 213 221 B-chronic_disease
, 135 136 221 222 O
severe 137 143 223 229 O
pain 144 148 230 234 O
, 148 149 234 235 O
end 150 153 236 239 B-chronic_disease
- 153 154 239 240 I-chronic_disease
stage 154 159 240 245 I-chronic_disease
/ 159 160 245 246 I-chronic_disease
degenerative 160 172 246 258 I-chronic_disease
diseases 173 181 259 267 I-chronic_disease
) 181 182 267 268 O

Have 0 4 269 273 O
preserved 5 14 274 283 O
ability 15 22 284 291 O
to 23 25 292 294 O
comprehend 26 36 295 305 O
and 37 40 306 309 O
participate 41 52 310 321 O
in 53 55 322 324 O
basic 56 61 325 330 O
elements 62 70 331 339 O
of 71 73 340 342 O
the 74 77 343 346 O
therapy 78 85 347 354 B-treatment

Have 0 4 355 359 O
received 5 13 360 368 O
intensive 14 23 369 378 B-treatment
upper 24 29 379 384 I-treatment
- 29 30 384 385 I-treatment
extremity 30 39 385 394 I-treatment
rehabilitation 40 54 395 409 I-treatment
in 55 57 410 412 O
the 58 61 413 416 O
chronic 62 69 417 424 O
phase 70 75 425 430 O
post 76 80 431 435 B-chronic_disease
- 80 81 435 436 I-chronic_disease
stroke 81 87 436 442 I-chronic_disease

Males 0 5 443 448 B-gender

Receiving 0 9 449 458 O
Botox 10 15 459 464 B-treatment
therapy 16 23 465 472 I-treatment
currently 24 33 473 482 O
or 34 36 483 485 O
in 37 39 486 488 O
the 40 43 489 492 O
past 44 48 493 497 B-upper_bound
3 49 50 498 499 I-upper_bound
months 51 57 500 506 I-upper_bound

any 0 3 507 510 O
gender 4 10 511 517 O
identity 11 19 518 526 O
18 20 22 527 529 B-lower_bound
years 23 28 530 535 I-lower_bound
of 29 31 536 538 O
age 32 35 539 542 B-age
or 36 38 543 545 O
older 39 44 546 551 O

females 0 7 552 559 B-gender

Between 0 7 0 7 O
the 8 11 8 11 O
age 12 15 12 15 B-age
of 16 18 16 18 O
18 19 21 19 21 B-lower_bound
and 22 25 22 25 O
65 26 28 26 28 B-upper_bound

Current 0 7 29 36 O
diagnosis 8 17 37 46 O
of 18 20 47 49 O
bipolar 21 28 50 57 B-chronic_disease
disorder 29 37 58 66 I-chronic_disease
, 37 38 66 67 O
depression 39 49 68 78 B-chronic_disease
with 50 54 79 83 I-chronic_disease
psychotic 55 64 84 93 I-chronic_disease
features 65 73 94 102 I-chronic_disease
, 73 74 102 103 O
or 75 77 104 106 O
depression 78 88 107 117 O
severe 89 95 118 124 O
enough 96 102 125 131 O
to 103 105 132 134 O
require 106 113 135 142 O
immediate 114 123 143 152 O
psychiatric 124 135 153 164 B-treatment
treatment 136 145 165 174 I-treatment
( 146 147 175 176 O
i.e. 147 151 176 180 O
, 151 152 180 181 O
serious 153 160 182 189 B-chronic_disease
suicide 161 168 190 197 I-chronic_disease
risk 169 173 198 202 O
with 174 178 203 207 O
intent 179 185 208 214 O
and 186 189 215 218 O
plan 190 194 219 223 O
) 194 195 223 224 O

No 0 2 225 227 O
clear 3 8 228 233 O
trauma 9 15 234 240 B-chronic_disease
memory 16 22 241 247 I-chronic_disease
or 23 25 248 250 I-chronic_disease
trauma 26 32 251 257 I-chronic_disease
before 33 39 258 264 O
age 40 43 265 268 O
3 44 45 269 270 B-upper_bound

Unstable 0 8 271 279 O
dose 9 13 280 284 O
of 14 16 285 287 O
psychotropic 17 29 288 300 B-treatment
medications 30 41 301 312 I-treatment
in 42 44 313 315 O
the 45 48 316 319 O
prior 49 54 320 325 B-upper_bound
3 55 56 326 327 I-upper_bound
months 57 63 328 334 I-upper_bound

Unwilling 0 9 335 344 O
or 10 12 345 347 O
unable 13 19 348 354 O
to 20 22 355 357 O
discontinue 23 34 358 369 O
current 35 42 370 377 O
trauma 43 49 378 384 B-treatment
- 49 50 384 385 I-treatment
focused 50 57 385 392 I-treatment
psychotherapy 58 71 393 406 I-treatment

a 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
cardiovascular 15 29 15 29 B-chronic_disease
, 29 30 29 30 O
pulmonary 31 40 31 40 B-chronic_disease
, 40 41 40 41 O
or 42 44 42 44 O
digestive 45 54 45 54 B-chronic_disease
disease 55 62 55 62 I-chronic_disease

age 0 3 63 66 B-age
6 4 5 67 68 B-lower_bound
- 5 6 68 69 O
11 6 8 69 71 B-upper_bound

identified 0 10 72 82 O
by 11 13 83 85 O
parent 14 20 86 92 O
or 21 23 93 95 O
legal 24 29 96 101 O
guardian 30 38 102 110 O
as 39 41 111 113 O
Hispanic 42 50 114 122 B-ethnicity

overweight 0 10 123 133 B-chronic_disease
or 11 13 134 136 O
obese 14 19 137 142 B-chronic_disease
( 20 21 143 144 O
BMI 21 24 144 147 B-bmi
between 25 32 148 155 O
the 33 36 156 159 O
85th 37 41 160 164 B-lower_bound
and 42 45 165 168 O
99.9thth 46 54 169 177 B-upper_bound
( 55 56 178 179 O
< 56 57 179 180 O
99th 57 61 180 184 B-upper_bound
) 61 62 184 185 O
percentile 63 73 186 196 O
for 74 77 197 200 O
age 78 81 201 204 B-age
and 82 85 205 208 O
gender 86 92 209 215 O

parent 0 6 216 222 O
unable 7 13 223 229 O
or 14 16 230 232 O
not 17 20 233 236 O
willing 21 28 237 244 O
to 29 31 245 247 O
receive 32 39 248 255 O
text 40 44 256 260 B-technology_access
messages 45 53 261 269 I-technology_access

parent 0 6 270 276 O
without 7 14 277 284 B-technology_access
a 15 16 285 286 I-technology_access
cell 17 21 287 291 I-technology_access
phone 22 27 292 297 I-technology_access

Active 0 6 0 6 B-chronic_disease
tuberculosis 7 19 7 19 I-chronic_disease

Aged 0 4 20 24 B-age
16 5 7 25 27 B-lower_bound
- 8 9 28 29 O
65 10 12 30 32 B-upper_bound
years 13 18 33 38 I-upper_bound

Aged 0 4 39 43 B-age
18 5 7 44 46 B-lower_bound
- 7 8 46 47 O
69 8 10 47 49 B-upper_bound
years 11 16 50 55 I-upper_bound

Below 0 5 56 61 B-treatment
- 5 6 61 62 I-treatment
shoulder 6 14 62 70 I-treatment
amputation 15 25 71 81 I-treatment

Conditions 0 10 82 92 O
that 11 15 93 97 O
may 16 19 98 101 O
impact 20 26 102 108 O
functional 27 37 109 119 O
outcomes 38 46 120 128 O
including 47 56 129 138 O
Lipopolysaccharidosis 57 78 139 160 B-chronic_disease
and 79 82 161 164 O
amyloidosis 83 94 165 176 B-chronic_disease
( 95 96 177 178 O
may 96 99 178 181 O
impact 100 106 182 188 O
nerve 107 112 189 194 O
regeneration 113 125 195 207 O
) 125 126 207 208 O
or 127 129 209 211 O
rare 130 134 212 216 B-chronic_disease
disorders 135 144 217 226 I-chronic_disease
of 145 147 227 229 I-chronic_disease
bone 148 152 230 234 I-chronic_disease
healing 153 160 235 242 I-chronic_disease
like 161 165 243 247 O
osteopetrosis 166 179 248 261 B-chronic_disease

Conditions 0 10 262 272 O
that 11 15 273 277 O
may 16 19 278 281 O
impact 20 26 282 288 O
the 27 30 289 292 O
success 31 38 293 300 O
of 39 41 301 303 O
the 42 45 304 307 O
surgical 46 54 308 316 O
procedure 55 64 317 326 O
or 65 67 327 329 O
increase 68 76 330 338 O
the 77 80 339 342 O
risk 81 85 343 347 O
of 86 88 348 350 O
postoperative 89 102 351 364 O
complications 103 116 365 378 O
including 117 126 379 388 O
inherited 127 136 389 398 O
coagulopathies 137 151 399 413 O
like 152 156 414 418 O
Hemophilia 157 167 419 429 B-chronic_disease
, 167 168 429 430 O
Von 169 172 431 434 B-chronic_disease
- 172 173 434 435 I-chronic_disease
Willebrand 173 183 435 445 I-chronic_disease
's 183 185 445 447 I-chronic_disease
disease 186 193 448 455 I-chronic_disease
, 193 194 455 456 O
Protein 195 202 457 464 B-chronic_disease
C 203 204 465 466 I-chronic_disease
and 205 208 467 470 I-chronic_disease
S 209 210 471 472 I-chronic_disease
deficiency 211 221 473 483 I-chronic_disease
, 221 222 483 484 O
Thrombocythemias 223 239 485 501 B-chronic_disease
, 239 240 501 502 O
Thalassemias 241 253 503 515 B-chronic_disease
, 253 254 515 516 O
Sickle 255 261 517 523 B-chronic_disease
Cell 262 266 524 528 I-chronic_disease
disease 267 274 529 536 I-chronic_disease
, 274 275 536 537 O
etc 276 279 538 541 O

Conditions 0 10 542 552 O
that 11 15 553 557 O
, 15 16 557 558 O
in 17 19 559 561 O
the 20 23 562 565 O
opinion 24 31 566 573 O
of 32 34 574 576 O
the 35 38 577 580 O
study 39 44 581 586 O
team 45 49 587 591 O
, 49 50 591 592 O
may 51 54 593 596 O
impact 55 61 597 603 O
the 62 65 604 607 O
immunomodulatory 66 82 608 624 O
protocol 83 91 625 633 O
potentially 92 103 634 645 O
exposing 104 112 646 654 O
the 113 116 655 658 O
recipient 117 126 659 668 O
to 127 129 669 671 O
an 130 132 672 674 O
unacceptable 133 145 675 687 O
risk 146 150 688 692 O
under 151 156 693 698 O
immunosuppressive 157 174 699 716 B-treatment
treatment 175 184 717 726 I-treatment

Consents 0 8 727 735 O
to 9 11 736 738 O
bone 12 16 739 743 B-treatment
marrow 17 23 744 750 I-treatment
infusion 24 32 751 759 I-treatment
as 33 35 760 762 O
part 36 40 763 767 O
of 41 43 768 770 O
the 44 47 771 774 O
treatment 48 57 775 784 B-treatment
regime 58 64 785 791 I-treatment

Current 0 7 792 799 O
/ 7 8 799 800 O
recent 8 14 800 806 O
( 15 16 807 808 O
within 16 22 808 814 O
3 23 24 815 816 B-upper_bound
months 25 31 817 823 I-upper_bound
of 32 34 824 826 O
donation 35 43 827 835 O
/ 43 44 835 836 O
screening 44 53 836 845 O
consent 54 61 846 853 O
) 61 62 853 854 O
IV 63 65 855 857 O
drug 66 70 858 862 O
abuse 71 76 863 868 O

Functionless 0 12 869 881 O
or 13 15 882 884 O
minimally 16 25 885 894 O
functional 26 36 895 905 O
hand 37 41 906 910 O
desiring 42 50 911 919 O
removal 51 58 920 927 O
of 59 61 928 930 O
functionless 62 74 931 943 O
/ 75 76 944 945 O
minimally 77 86 946 955 O
functional 87 97 956 966 O
hand 98 102 967 971 O
followed 103 111 972 980 O
by 112 114 981 983 O
transplantation 115 130 984 999 B-treatment

HIV 0 3 1000 1003 B-chronic_disease
( 4 5 1004 1005 O
active 5 11 1005 1011 O
or 12 14 1012 1014 O
seropositive 15 27 1015 1027 O
) 27 28 1027 1028 O

Hepatitis 0 9 1029 1038 B-chronic_disease
B 10 11 1039 1040 I-chronic_disease
or 12 14 1041 1043 I-chronic_disease
C 15 16 1044 1045 I-chronic_disease

Infectious 0 10 1046 1056 O
, 10 11 1056 1057 O
post 12 16 1058 1062 O
infectious 17 27 1063 1073 O
, 27 28 1073 1074 O
or 29 31 1075 1077 O
inflammatory 32 44 1078 1090 O
( 45 46 1091 1092 O
axonal 46 52 1092 1098 B-chronic_disease
or 53 55 1099 1101 O
demyelinating 56 69 1102 1115 B-chronic_disease
) 69 70 1115 1116 O
neuropathy 71 81 1117 1127 B-chronic_disease

Inherited 0 9 1128 1137 O
peripheral 10 20 1138 1148 B-chronic_disease
neuropathy 21 31 1149 1159 I-chronic_disease

Male 0 4 1160 1164 B-gender
or 5 7 1165 1167 O
female 8 14 1168 1174 B-gender
and 15 18 1175 1178 O
of 19 21 1179 1181 O
any 22 25 1182 1185 O
race 26 30 1186 1190 O
, 30 31 1190 1191 O
color 32 37 1192 1197 O
or 38 40 1198 1200 O
ethnicity 41 50 1201 1210 O

Malignancy 0 10 1211 1221 B-cancer
( 11 12 1222 1223 O
within 12 18 1223 1229 O
past 19 23 1230 1234 B-upper_bound
5 24 25 1235 1236 I-upper_bound
years 26 31 1237 1242 I-upper_bound
) 31 32 1242 1243 O

Mixed 0 5 1244 1249 B-chronic_disease
connective 6 16 1250 1260 I-chronic_disease
tissue 17 23 1261 1267 I-chronic_disease
disease 24 31 1268 1275 I-chronic_disease

Mixed 0 5 1276 1281 O
connective 6 16 1282 1292 B-chronic_disease
tissue 17 23 1293 1299 I-chronic_disease
diseases 24 32 1300 1308 I-chronic_disease
and 33 36 1309 1312 O
collagen 37 45 1313 1321 B-chronic_disease
diseases 46 54 1322 1330 I-chronic_disease
can 55 58 1331 1334 O
result 59 65 1335 1341 O
in 66 68 1342 1344 O
poor 69 73 1345 1349 O
wound 74 79 1350 1355 O
healing 80 87 1356 1363 O
after 88 93 1364 1369 O
surgery 94 101 1370 1377 B-treatment

Negative 0 8 1378 1386 O
for 9 12 1387 1390 O
HIV 13 16 1391 1394 B-chronic_disease
at 17 19 1395 1397 O
transplant 20 30 1398 1408 B-treatment

Negative 0 8 1409 1417 O
for 9 12 1418 1421 O
malignancy 13 23 1422 1432 B-cancer
for 24 27 1433 1436 O
past 28 32 1437 1441 B-upper_bound
5 33 34 1442 1443 I-upper_bound
years 35 40 1444 1449 I-upper_bound

Negative 0 8 1450 1458 O
lymphocytotoxic 9 24 1459 1474 B-treatment
crossmatch 25 35 1475 1485 I-treatment

No 0 2 1486 1488 O
co 3 5 1489 1491 O
- 5 6 1491 1492 O
existing 6 14 1492 1500 O
medical 15 22 1501 1508 O
condition 23 32 1509 1518 O
which 33 38 1519 1524 O
, 38 39 1524 1525 O
in 40 42 1526 1528 O
the 43 46 1529 1532 O
opinion 47 54 1533 1540 O
of 55 57 1541 1543 O
the 58 61 1544 1547 O
study 62 67 1548 1553 O
team 68 72 1554 1558 O
, 72 73 1558 1559 O
could 74 79 1560 1565 O
affect 80 86 1566 1572 O
the 87 90 1573 1576 O
immunomodulatory 91 107 1577 1593 O
protocol 108 116 1594 1602 O
, 116 117 1602 1603 O
surgical 118 126 1604 1612 B-treatment
procedure 127 136 1613 1622 I-treatment
, 136 137 1622 1623 O
or 138 140 1624 1626 O
functional 141 151 1627 1637 O
results 152 159 1638 1645 O
( 160 161 1646 1647 O
see 161 164 1647 1650 O
Donor 165 170 1651 1656 O
and 171 174 1657 1660 O
Recipient 175 184 1661 1670 O
Exclusion 185 194 1671 1680 O
Criteria 195 203 1681 1689 O
below 204 209 1690 1695 O
. 209 210 1695 1696 O
If 211 213 1697 1699 O
the 214 217 1700 1703 O
condition 218 227 1704 1713 O
is 228 230 1714 1716 O
amenable 231 239 1717 1725 O
to 240 242 1726 1728 O
treatment 243 252 1729 1738 B-treatment
, 252 253 1738 1739 O
the 254 257 1740 1743 O
study 258 263 1744 1749 O
team 264 268 1750 1754 O
must 269 273 1755 1759 O
agree 274 279 1760 1765 O
that 280 284 1766 1770 O
said 285 289 1771 1775 O
condition 290 299 1776 1785 O
should 300 306 1786 1792 O
not 307 310 1793 1796 O
significantly 311 324 1797 1810 O
enhance 325 332 1811 1818 O
the 333 336 1819 1822 O
surgical 337 345 1823 1831 O
risks 346 351 1832 1837 O
of 352 354 1838 1840 O
upper 355 360 1841 1846 B-treatment
extremity 361 370 1847 1856 I-treatment
transplantation 371 386 1857 1872 I-treatment
. 386 387 1872 1873 O
) 387 388 1873 1874 O

Non 0 3 1875 1878 O
- 3 4 1878 1879 O
professional 4 16 1879 1891 O
tattoo 17 23 1892 1898 O
within 24 30 1899 1905 O
last 31 35 1906 1910 B-upper_bound
6 36 37 1911 1912 I-upper_bound
months 38 44 1913 1919 I-upper_bound

Paralysis 0 9 1920 1929 B-chronic_disease
of 10 12 1930 1932 I-chronic_disease
ischemic 13 21 1933 1941 I-chronic_disease
or 22 24 1942 1944 O
traumatic 25 34 1945 1954 O
origin 35 41 1955 1961 O

Patient 0 7 1962 1969 O
agrees 8 14 1970 1976 O
to 15 17 1977 1979 O
comply 18 24 1980 1986 O
with 25 29 1987 1991 O
the 30 33 1992 1995 O
protocol 34 42 1996 2004 O
and 43 46 2005 2008 O
states 47 53 2009 2015 O
a 54 55 2016 2017 O
dedication 56 66 2018 2028 O
to 67 69 2029 2031 O
the 70 73 2032 2035 O
immunomodulatory 74 90 2036 2052 B-treatment
treatment 91 100 2053 2062 I-treatment
regime 101 107 2063 2069 I-treatment

Personally 0 10 2070 2080 O
identifiable 11 23 2081 2093 O
tattoo 24 30 2094 2100 O
( 31 32 2101 2102 O
i.e. 32 36 2102 2106 O
, 36 37 2106 2107 O
donor 38 43 2108 2113 O
name 44 48 2114 2118 O
) 48 49 2118 2119 O
on 50 52 2120 2122 O
potential 53 62 2123 2132 B-treatment
transplant 63 73 2133 2143 I-treatment

Recent 0 6 2144 2150 O
( 7 8 2151 2152 O
≥6 8 10 2152 2154 O
months 11 17 2155 2161 I-lower_bound
) 17 18 2161 2162 O
or 19 21 2163 2165 O
remote 22 28 2166 2172 O
( 29 30 2173 2174 O
i.e. 30 34 2174 2178 O
, 34 35 2178 2179 O
several 36 43 2180 2187 O
decades 44 51 2188 2195 O
) 51 52 2195 2196 O
unilateral 53 63 2197 2207 O
or 64 66 2208 2210 O
bilateral 67 76 2211 2220 B-chronic_disease
upper 77 82 2221 2226 I-chronic_disease
limb 83 87 2227 2231 I-chronic_disease
loss 88 92 2232 2236 I-chronic_disease
( 93 94 2237 2238 O
below 94 99 2238 2243 O
the 100 103 2244 2247 O
shoulder 104 112 2248 2256 O
) 112 113 2256 2257 O
desiring 114 122 2258 2266 O
limb 123 127 2267 2271 B-treatment
transplantation 128 143 2272 2287 I-treatment

Sensitized 0 10 2288 2298 O
recipients 11 21 2299 2309 O
with 22 26 2310 2314 O
high 27 31 2315 2319 O
levels 32 38 2320 2326 O
( 39 40 2327 2328 O
50 40 42 2328 2330 O
% 42 43 2330 2331 O
) 43 44 2331 2332 O
of 45 47 2333 2335 O
panel 48 53 2336 2341 O
- 53 54 2341 2342 O
reactive 54 62 2342 2350 O
human 63 68 2351 2356 B-clinical_variable
leukocyte 69 78 2357 2366 I-clinical_variable
antigen 79 86 2367 2374 I-clinical_variable
( 87 88 2375 2376 I-clinical_variable
HLA 88 91 2376 2379 I-clinical_variable
) 91 92 2379 2380 I-clinical_variable
antibodies 93 103 2381 2391 O

Severe 0 6 2392 2398 O
deforming 7 16 2399 2408 O
rheumatoid 17 27 2409 2419 B-chronic_disease
or 28 30 2420 2422 O
osteoarthritis 31 45 2423 2437 B-chronic_disease
in 46 48 2438 2440 O
the 49 52 2441 2444 O
limb 53 57 2445 2449 O

Stable 0 6 2450 2456 O
donor 7 12 2457 2462 O
( 13 14 2463 2464 O
i.e. 14 18 2464 2468 O
, 18 19 2468 2469 O
does 20 24 2470 2474 O
not 25 28 2475 2478 O
require 29 36 2479 2486 O
excessive 37 46 2487 2496 O
vasopressors 47 59 2497 2509 B-treatment
to 60 62 2510 2512 O
maintain 63 71 2513 2521 O
blood 72 77 2522 2527 O
pressure 78 86 2528 2536 O
) 86 87 2536 2537 O

Toxic 0 5 2538 2543 B-chronic_disease
neuropathy 6 16 2544 2554 I-chronic_disease
( 17 18 2555 2556 O
i.e. 18 22 2556 2560 O
heavy 23 28 2561 2566 O
metal 29 34 2567 2572 O
poisoning 35 44 2573 2582 O
, 44 45 2582 2583 O
drug 46 50 2584 2588 O
toxicity 51 59 2589 2597 O
, 59 60 2597 2598 O
industrial 61 71 2599 2609 O
agent 72 77 2610 2615 O
exposure 78 86 2616 2624 O
) 86 87 2624 2625 O

Toxoplasmosis 0 13 2626 2639 B-chronic_disease

Type 0 4 2640 2644 B-chronic_disease
I 5 6 2645 2646 I-chronic_disease
( 7 8 2647 2648 I-chronic_disease
insulin 8 15 2648 2655 I-chronic_disease
- 15 16 2655 2656 I-chronic_disease
dependent 16 25 2656 2665 I-chronic_disease
) 25 26 2665 2666 I-chronic_disease
diabetes 27 35 2667 2675 I-chronic_disease
mellitus 36 44 2676 2684 I-chronic_disease

USA 0 3 2685 2688 O
citizen 4 11 2689 2696 O
or 12 14 2697 2699 O
equivalent 15 25 2700 2710 O
, 25 26 2710 2711 O
or 27 29 2712 2714 O
foreigner 30 39 2715 2724 O
with 40 44 2725 2729 O
documentation 45 58 2730 2743 O
of 59 61 2744 2746 O
ability 62 69 2747 2754 O
to 70 72 2755 2757 O
pay 73 76 2758 2761 O
for 77 80 2762 2765 O
transplant 81 91 2766 2776 B-treatment
and 92 95 2777 2780 O
required 96 104 2781 2789 O
follow 105 111 2790 2796 O
- 111 112 2796 2797 O
up 112 114 2797 2799 O
care 115 119 2800 2804 O

Untreated 0 9 2805 2814 O
sepsis 10 16 2815 2821 B-chronic_disease

Viral 0 5 2822 2827 B-chronic_disease
encephalitis 6 18 2828 2840 I-chronic_disease

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
to 9 11 9 11 O
≤ 12 13 12 13 O
65 14 16 14 16 B-upper_bound
years 17 22 17 22 I-upper_bound
of 23 25 23 25 O
age 26 29 26 29 B-age

At 0 2 30 32 O
Screening 3 12 33 42 O
and 13 16 43 46 O
Visit 17 22 47 52 O
1 23 24 53 54 O
( 25 26 55 56 O
Baseline 26 34 56 64 O
/ 34 35 64 65 O
Day 35 38 65 68 O
1 39 40 69 70 O
) 40 41 70 71 O
, 41 42 71 72 O
have 43 47 73 77 O
had 48 51 78 81 O
DLE 52 55 82 85 B-clinical_variable
covering 56 64 86 94 O
at 65 67 95 97 O
least 68 73 98 103 O
5 74 75 104 105 B-lower_bound
% 75 76 105 106 I-lower_bound
of 77 79 107 109 O
total 80 85 110 115 B-clinical_variable
body 86 90 116 120 I-clinical_variable
surface 91 98 121 128 I-clinical_variable
area 99 103 129 133 I-clinical_variable
( 104 105 134 135 I-clinical_variable
BSA 105 108 135 138 I-clinical_variable
) 108 109 138 139 I-clinical_variable
or 110 112 140 142 O
SLE 113 116 143 146 B-clinical_variable
with 117 121 147 151 I-clinical_variable
DLE 122 125 152 155 I-clinical_variable
covering 126 134 156 164 O
at 135 137 165 167 O
least 138 143 168 173 O
2 144 145 174 175 B-lower_bound
% 145 146 175 176 I-lower_bound
of 147 149 177 179 O
BSA 150 153 180 183 O
as 154 156 184 186 O
determined 157 167 187 197 O
by 168 170 198 200 O
the 171 174 201 204 O
hand 175 179 205 209 O
print 180 185 210 215 O
method 186 192 216 222 O
( 193 194 223 224 O
one 194 197 224 227 O
palm 198 202 228 232 O
is 203 205 233 235 O
equivalent 206 216 236 246 O
to 217 219 247 249 O
1 220 221 250 251 O
% 221 222 251 252 O
BSA 223 226 253 256 O
) 226 227 256 257 O

Concomitant 0 11 258 269 O
use 12 15 270 273 O
of 16 18 274 276 O
moderate 19 27 277 285 O
to 28 30 286 288 O
potent 31 37 289 295 O
inhibitors 38 48 296 306 O
and 49 52 307 310 O
inducers 53 61 311 319 O
of 62 64 320 322 O
CYP3A4/5 65 73 323 331 B-treatment

Other 0 5 332 337 O
skin 6 10 338 342 O
conditions 11 21 343 353 O
at 22 24 354 356 O
Baseline 25 33 357 365 O
that 34 38 366 370 O
would 39 44 371 376 O
interfere 45 54 377 386 O
with 55 59 387 391 O
evaluation 60 70 392 402 O
of 71 73 403 405 O
DLE 74 77 406 409 B-chronic_disease

Systemic 0 8 410 418 B-treatment
therapy 9 16 419 426 I-treatment
is 17 19 427 429 O
allowed 20 27 430 437 O
if 28 30 438 440 O
on 31 33 441 443 O
a 34 35 444 445 O
stable 36 42 446 452 O
dose 43 47 453 457 O
and 48 51 458 461 O
using 52 57 462 467 O
for 58 61 468 471 O
at 62 64 472 474 O
least 65 70 475 480 O
3 71 72 481 482 B-lower_bound
months 73 79 483 489 I-lower_bound
-background 80 91 490 501 O
therapies 92 101 502 511 O
outlined 102 110 512 520 O
in 111 113 521 523 O
Protocol 114 122 524 532 O

Topical 0 7 533 540 B-treatment
corticosteroid 8 22 541 555 I-treatment
within 23 29 556 562 O
the 30 33 563 566 O
past 34 38 567 571 B-upper_bound
2 39 40 572 573 I-upper_bound
weeks 41 46 574 579 I-upper_bound

Women 0 5 580 585 B-gender
of 6 8 586 588 O
childbearing 9 21 589 601 O
potential 22 31 602 611 O
must 32 36 612 616 O
use 37 40 617 620 B-contraception_consent
effective 41 50 621 630 I-contraception_consent
contraceptive 51 64 631 644 I-contraception_consent
methods 65 72 645 652 I-contraception_consent
in 73 75 653 655 O
order 76 81 656 661 O
to 82 84 662 664 O
participate 85 96 665 676 O
in 97 99 677 679 O
tofacitinib 100 111 680 691 B-treatment
clinical 112 120 692 700 O
studies 121 128 701 708 O

Women 0 5 709 714 B-gender
who 6 9 715 718 O
are 10 13 719 722 B-pregnancy
pregnant 14 22 723 731 I-pregnancy
or 23 25 732 734 O
wish 26 30 735 739 B-pregnancy
to 31 33 740 742 I-pregnancy
become 34 40 743 749 I-pregnancy
pregnant 41 49 750 758 I-pregnancy
, 49 50 758 759 O
or 51 53 760 762 O
who 54 57 763 766 O
are 58 61 767 770 O
lactating 62 71 771 780 O

with 0 4 781 785 O
clinical 5 13 786 794 O
diagnosis 14 23 795 804 O
of 24 26 805 807 O
DLE 27 30 808 811 B-chronic_disease
( 31 32 812 813 O
and 32 35 813 816 O
at 36 38 817 819 O
least 39 44 820 825 O
half 45 49 826 830 O
of 50 52 831 833 O
patients 53 61 834 842 O
with 62 66 843 847 O
a 67 68 848 849 O
diagnosis 69 78 850 859 O
of 79 81 860 862 O
SLE 82 85 863 866 B-chronic_disease
) 85 86 866 867 O
as 87 89 868 870 O
determined 90 100 871 881 O
by 101 103 882 884 O
the 104 107 885 888 O
Principal 108 117 889 898 O
Investigator 118 130 899 911 O
by 131 133 912 914 O
medical 134 141 915 922 O
history 142 149 923 930 O
and 150 153 931 934 O
physical 154 162 935 943 O
exam 163 167 944 948 O

> 0 1 0 1 O
500 1 4 1 4 B-lower_bound
mg 5 7 5 7 I-lower_bound
po 8 10 8 10 I-lower_bound
qd 11 13 11 13 I-lower_bound

Achieved 0 8 14 22 O
clinical 9 17 23 31 O
stability 18 27 32 41 O
( 28 29 42 43 O
e.g. 29 33 43 47 O
, 33 34 47 48 O
outpatient 35 45 49 59 O
status 46 52 60 66 O
for 53 56 67 70 O
at 57 59 71 73 O
least 60 65 74 79 O
1 66 67 80 81 B-lower_bound
month 68 73 82 87 I-lower_bound
before 74 80 88 94 O
study 81 86 95 100 O
entry 87 92 101 106 O
) 92 93 106 107 O

Any 0 3 108 111 O
neurological 4 16 112 124 B-chronic_disease
disorder 17 25 125 133 I-chronic_disease

Being 0 5 134 139 O
treated 6 13 140 147 O
with 14 18 148 152 O
benztropine 19 30 153 164 B-treatment
, 30 31 164 165 O
diphenhydramine 32 47 166 181 B-treatment
, 47 48 181 182 O
or 49 51 183 185 O
high 52 56 186 190 O
doses 57 62 191 196 O
of 63 65 197 199 O
clozapine 66 75 200 209 B-treatment

Between 0 7 210 217 O
18 8 10 218 220 B-lower_bound
and 11 14 221 224 O
35 15 17 225 227 B-upper_bound
years 18 23 228 233 I-upper_bound
of 24 26 234 236 O
age 27 30 237 240 B-age

Clinical 0 8 241 249 O
diagnosis 9 18 250 259 O
of 19 21 260 262 O
schizophrenia 22 35 263 276 B-chronic_disease
, 35 36 276 277 O
schizoaffective 37 52 278 293 B-chronic_disease
disorder 53 61 294 302 I-chronic_disease
, 61 62 302 303 O
psychosis 63 72 304 313 B-chronic_disease
Not 73 76 314 317 O
Otherwise 77 86 318 327 O
Specified 87 96 328 337 O
( 97 98 338 339 O
NOS 98 101 339 342 O
) 101 102 342 343 O
, 102 103 343 344 O
Unspecified 104 115 345 356 B-chronic_disease
Schizophrenia 116 129 357 370 I-chronic_disease
Spectrum 130 138 371 379 I-chronic_disease
Disorder 139 147 380 388 I-chronic_disease
, 147 148 388 389 O
Schizophrenia 149 162 390 403 O
Spectrum 163 171 404 412 O
Disorder 172 180 413 421 O
, 180 181 421 422 O
Specified 182 191 423 432 O

Is 0 2 433 435 O
fluent 3 9 436 442 B-language_fluency
and 10 13 443 446 I-language_fluency
proficient 14 24 447 457 I-language_fluency
in 25 27 458 460 I-language_fluency
the 28 31 461 464 I-language_fluency
English 32 39 465 472 I-language_fluency
language 40 48 473 481 I-language_fluency

olanzapine(to 0 13 482 495 B-treatment
be 14 16 496 498 O
determined 17 27 499 509 O
on 28 30 510 512 O
a 31 32 513 514 O
case 33 37 515 519 O
by 38 40 520 522 O
case 41 45 523 527 O
basis 46 51 528 533 O
) 51 52 533 534 O

schizophreniform 0 16 535 551 B-chronic_disease
disorder 17 25 552 560 I-chronic_disease
with 26 30 561 565 O
onset 31 36 566 571 O
of 37 39 572 574 O
first 40 45 575 580 O
psychotic 46 55 581 590 B-chronic_disease
episode 56 63 591 598 I-chronic_disease
within 64 70 599 605 O
the 71 74 606 609 O
last 75 79 610 614 B-upper_bound
2 80 81 615 616 I-upper_bound
years 82 87 617 622 I-upper_bound

Acute 0 5 0 5 O
- 5 6 5 6 O
onset 6 11 6 11 O
neuromuscular 12 25 12 25 B-chronic_disease
disease 26 33 26 33 I-chronic_disease

Cardiopulmonary 0 15 34 49 B-chronic_disease
Instability 16 27 50 61 O

Duration 0 8 62 70 O
of 9 11 71 73 O
mechanical 12 22 74 84 B-clinical_variable
ventilation 23 34 85 96 I-clinical_variable
> 35 36 97 98 O
14 36 38 98 100 B-lower_bound
days 39 43 101 105 I-lower_bound

Lower 0 5 106 111 B-treatment
- 5 6 111 112 I-treatment
extremity 6 15 112 121 I-treatment
amputee 16 23 122 129 I-treatment
or 24 26 130 132 I-treatment
paresis 27 34 133 140 I-treatment

Pitting 0 7 141 148 B-clinical_variable
edema 8 13 149 154 I-clinical_variable
grade 14 19 155 160 I-clinical_variable
≥3 20 22 161 163 O

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
or 9 11 9 11 O
older 12 17 12 17 O

Anxiety 0 7 18 25 B-clinical_variable
≥ 8 9 26 27 O
30mm/100 10 18 28 36 B-lower_bound
mm 18 20 36 38 I-lower_bound
measured 21 29 39 47 O
on 30 32 48 50 O
VAS 33 36 51 54 O
as 37 39 55 57 O
a 40 41 58 59 O
maximum 42 49 60 67 O
level 50 55 68 73 O
during 56 62 74 80 O
the 63 66 81 84 O
last 67 71 85 89 B-upper_bound
30 72 74 90 92 I-upper_bound
days 75 79 93 97 I-upper_bound

Focal 0 5 98 103 O
point 6 11 104 109 O
for 12 15 110 113 O
HIFU 16 20 114 118 B-treatment
treatment 21 30 119 128 I-treatment
must 31 35 129 133 O
also 36 40 134 138 O
be 41 43 139 141 O
at 44 46 142 144 O
least 47 52 145 150 O
3 53 54 151 152 B-lower_bound
mm 55 57 153 155 I-lower_bound
from 58 62 156 160 O
any 63 66 161 164 O
border 67 73 165 171 O
of 74 76 172 174 O
the 77 80 175 178 O
fibroadenoma 81 93 179 191 B-cancer

In 0 2 192 194 O
women 3 8 195 200 B-gender
≤ 9 10 201 202 O
35 11 13 203 205 B-upper_bound
years 14 19 206 211 I-upper_bound
old 20 23 212 215 O
, 23 24 215 216 O
a 25 26 217 218 O
single 27 33 219 225 O
view 34 38 226 230 O
mammogram 39 48 231 240 B-treatment
of 49 51 241 243 O
the 52 55 244 247 O
affected 56 64 248 256 O
breast 65 71 257 263 O
is 72 74 264 266 O
sufficient 75 85 267 277 O
for 86 89 278 281 O
evaluation 90 100 282 292 O
of 101 103 293 295 O
calcification 104 117 296 309 O

Pain 0 4 310 314 B-clinical_variable
≥ 5 6 315 316 O
30mm/100 7 15 317 325 B-lower_bound
mm 15 17 325 327 I-lower_bound
measured 18 26 328 336 O
on 27 29 337 339 O
VAS 30 33 340 343 B-clinical_variable
as 34 36 344 346 O
a 37 38 347 348 O
maximum 39 46 349 356 O
level 47 52 357 362 O
during 53 59 363 369 O
the 60 63 370 373 O
last 64 68 374 378 B-upper_bound
30 69 71 379 381 I-upper_bound
days 72 76 382 386 I-upper_bound

Patient 0 7 387 394 O
is 8 10 395 397 O
a 11 12 398 399 O
candidate 13 22 400 409 O
for 23 26 410 413 O
the 27 30 414 417 O
surgery 31 38 418 425 B-treatment

Patient 0 7 426 433 O
is 8 10 434 436 O
pregnant 11 19 437 445 B-pregnancy

Patient 0 7 446 453 O
with 8 12 454 458 O
history 13 20 459 466 O
of 21 23 467 469 O
breast 24 30 470 476 B-cancer
cancer 31 37 477 483 I-cancer
or 38 40 484 486 O
history 41 48 487 494 O
of 49 51 495 497 O
laser 52 57 498 503 B-treatment
or 58 60 504 506 I-treatment
radiation 61 70 507 516 I-treatment
therapy 71 78 517 524 I-treatment
to 79 81 525 527 O
the 82 85 528 531 O
target 86 92 532 538 O
breast 93 99 539 545 O

Patient 0 7 546 553 O
's 7 9 553 555 O
fibroadenoma 10 22 556 568 B-cancer
not 23 26 569 572 O
clearly 27 34 573 580 O
visible 35 42 581 588 O
on 43 45 589 591 O
the 46 49 592 595 O
ultrasound 50 60 596 606 O
images 61 67 607 613 O
( 68 69 614 615 O
in 69 71 615 617 O
B 72 73 618 619 O
mode 74 78 620 624 O
) 78 79 624 625 O
at 80 82 626 628 O
the 83 86 629 632 O
inclusion 87 96 633 642 O
visit 97 102 643 648 O

Patient 0 7 649 656 O
's 7 9 656 658 O
fibroadenoma 10 22 659 671 B-clinical_variable
size 23 27 672 676 I-clinical_variable
is 28 30 677 679 O
greater 31 38 680 687 O
or 39 41 688 690 O
equal 42 47 691 696 O
to 48 50 697 699 O
0.2 51 54 700 703 B-lower_bound
cc 55 57 704 706 I-lower_bound
and 58 61 707 710 O
less 62 66 711 715 O
than 67 71 716 720 O
10 72 74 721 723 B-upper_bound
cc 75 77 724 726 I-upper_bound
in 78 80 727 729 O
volume 81 87 730 736 O
( 88 89 737 738 O
measured 89 97 738 746 O
by 98 100 747 749 O
ultrasound 101 111 750 760 B-treatment
on 112 114 761 763 O
the 115 118 764 767 O
day 119 122 768 771 O
of 123 125 772 774 O
the 126 129 775 778 O
procedure 130 139 779 788 O
) 139 140 788 789 O

Presence 0 8 790 798 O
of 9 11 799 801 O
calcified 12 21 802 811 O
fibroadenoma 22 34 812 824 B-cancer

The 0 3 825 828 O
fibroadenoma 4 16 829 841 B-cancer
is 17 19 842 844 O
1 20 21 845 846 B-lower_bound
cm 22 24 847 849 I-lower_bound
or 25 27 850 852 O
greater 28 35 853 860 O
at 36 38 861 863 O
its 39 42 864 867 O
largest 43 50 868 875 O
dimension 51 60 876 885 O
and 61 64 886 889 O
no 65 67 890 892 O
less 68 72 893 897 O
than 73 77 898 902 O
7.5 78 81 903 906 B-upper_bound
mm 82 84 907 909 I-upper_bound
in 85 87 910 912 O
the 88 91 913 916 O
anterior 92 100 917 925 O
- 100 101 925 926 O
posterior 101 110 926 935 O
dimension 111 120 936 945 O
( 121 122 946 947 O
measured 122 130 947 955 O
by 131 133 956 958 O
ultrasound 134 144 959 969 B-treatment
) 144 145 969 970 O

The 0 3 971 974 O
rib 4 7 975 978 O
cage 8 12 979 983 O
should 13 19 984 990 O
not 20 23 991 994 O
be 24 26 995 997 O
in 27 29 998 1000 O
the 30 33 1001 1004 O
prefocal 34 42 1005 1013 O
ultrasound 43 53 1014 1024 O
path 54 58 1025 1029 O
or 59 61 1030 1032 O
behind 62 68 1033 1039 O
the 69 72 1040 1043 O
target 73 79 1044 1050 O
fibroadenoma 80 92 1051 1063 O
( 93 94 1064 1065 O
minimum 94 101 1065 1072 O
distance 102 110 1073 1081 O
from 111 115 1082 1086 O
the 116 119 1087 1090 O
posterior 120 129 1091 1100 O
wall 130 134 1101 1105 O
of 135 137 1106 1108 O
the 138 141 1109 1112 O
fibroadenoma 142 154 1113 1125 O
must 155 159 1126 1130 O
be 160 162 1131 1133 O
at 163 165 1134 1136 O
least 166 171 1137 1142 O
10 172 174 1143 1145 B-lower_bound
mm 175 177 1146 1148 I-lower_bound
) 177 178 1148 1149 O

Ultrasound 0 10 1150 1160 O
image 11 16 1161 1166 O
alone 17 22 1167 1172 O
for 23 26 1173 1176 O
patients 27 35 1177 1185 O
under 36 41 1186 1191 O
35 42 44 1192 1194 O
years 45 50 1195 1200 O
old 51 54 1201 1204 O
. 54 55 1204 1205 O
For 56 59 1206 1209 O
women 60 65 1210 1215 B-gender
older 66 71 1216 1221 O
than 72 76 1222 1226 O
35 77 79 1227 1229 O
years 80 85 1230 1235 O
, 85 86 1235 1236 O
a 87 88 1237 1238 O
mammogram 89 98 1239 1248 O
will 99 103 1249 1253 O
be 104 106 1254 1256 O
performed 107 116 1257 1266 O
in 117 119 1267 1269 O
addition 120 128 1270 1278 O
to 129 131 1279 1281 O
ultrasound 132 142 1282 1292 O

( 0 1 0 1 O
Bacillus 1 9 1 9 B-chronic_disease
tuberculosis 10 22 10 22 I-chronic_disease
) 22 23 22 23 O

Absolute 0 8 24 32 B-clinical_variable
neutrophil 9 19 33 43 I-clinical_variable
count 20 25 44 49 I-clinical_variable
( 26 27 50 51 I-clinical_variable
ANC 27 30 51 54 I-clinical_variable
) 30 31 54 55 I-clinical_variable
> 32 33 56 57 O
= 33 34 57 58 O
1,500 35 40 59 64 B-lower_bound
/mcL 41 45 65 69 I-lower_bound

Active 0 6 70 76 O
autoimmune 7 17 77 87 B-chronic_disease
disease 18 25 88 95 I-chronic_disease
that 26 30 96 100 O
has 31 34 101 104 O
required 35 43 105 113 O
systemic 44 52 114 122 B-treatment
treatment 53 62 123 132 I-treatment
in 63 65 133 135 O
the 66 69 136 139 O
past 70 74 140 144 B-upper_bound
2 75 76 145 146 I-upper_bound
years 77 82 147 152 I-upper_bound
( 83 84 153 154 O
i.e. 84 88 154 158 O
with 89 93 159 163 O
use 94 97 164 167 O
of 98 100 168 170 O
disease 101 108 171 178 B-treatment
modifying 109 118 179 188 I-treatment
agents 119 125 189 195 I-treatment
, 125 126 195 196 O
corticosteroids 127 142 197 212 B-treatment
or 143 145 213 215 O
immunosuppressive 146 163 216 233 B-treatment
drugs 164 169 234 239 I-treatment
) 169 170 239 240 O
; 170 171 240 241 O
replacement 172 183 242 253 B-treatment
therapy 184 191 254 261 I-treatment
( 192 193 262 263 O
eg 193 195 263 265 O
. 195 196 265 266 O
, 196 197 266 267 O
thyroxine 198 207 268 277 B-treatment
, 207 208 277 278 O
insulin 209 216 279 286 B-treatment
, 216 217 286 287 O
or 218 220 288 290 O
physiologic 221 232 291 302 B-treatment
corticosteroid 233 247 303 317 I-treatment
replacement 248 259 318 329 I-treatment
therapy 260 267 330 337 I-treatment
for 268 271 338 341 O
adrenal 272 279 342 349 B-chronic_disease
or 280 282 350 352 O
pituitary 283 292 353 362 B-chronic_disease
insufficiency 293 306 363 376 I-chronic_disease
, 306 307 376 377 O
etc 308 311 378 381 O
. 311 312 381 382 O
) 312 313 382 383 O
is 314 316 384 386 O
not 317 320 387 390 O
considered 321 331 391 401 O
a 332 333 402 403 O
form 334 338 404 408 O
of 339 341 409 411 O
systemic 342 350 412 420 O
treatment 351 360 421 430 O

Active 0 6 431 437 B-chronic_disease
infection 7 16 438 447 I-chronic_disease
requiring 17 26 448 457 O
systemic 27 35 458 466 B-treatment
therapy 36 43 467 474 I-treatment

Albumin 0 7 475 482 B-clinical_variable
> 8 9 483 484 O
= 9 10 484 485 O
2.5 11 14 486 489 B-lower_bound
mg 15 17 490 492 I-lower_bound
/ 17 18 492 493 I-lower_bound
dL 18 20 493 495 I-lower_bound

Anti 0 4 496 500 B-treatment
- 4 5 500 501 I-treatment
cancer 5 11 501 507 I-treatment
monoclonal 12 22 508 518 I-treatment
antibody 23 31 519 527 I-treatment
( 32 33 528 529 I-treatment
mAb 33 36 529 532 I-treatment
) 36 37 532 533 I-treatment
within 38 44 534 540 O
4 45 46 541 542 B-lower_bound
weeks 47 52 543 548 I-lower_bound
prior 53 58 549 554 I-upper_bound
to 59 61 555 557 O
study 62 67 558 563 O
day 68 71 564 567 O
1 72 73 568 569 O
or 74 76 570 572 O
who 77 80 573 576 O
has 81 84 577 580 O
not 85 88 581 584 O
recovered 89 98 585 594 O
( 99 100 595 596 O
i.e. 100 104 596 600 O
, 104 105 600 601 O
= 106 107 602 603 O
< 107 108 603 604 O
grade 109 114 605 610 B-upper_bound
1 115 116 611 612 I-upper_bound
or 117 119 613 615 O
at 120 122 616 618 O
baseline 123 131 619 627 O
) 131 132 627 628 O
from 133 137 629 633 O
adverse 138 145 634 641 O
events 146 152 642 648 O
due 153 156 649 652 O
to 157 159 653 655 O
agents 160 166 656 662 O
administered 167 179 663 675 O
more 180 184 676 680 O
than 185 189 681 685 O
4 190 191 686 687 O
weeks 192 197 688 693 O
earlier 198 205 694 701 O

Aspartate 0 9 702 711 B-clinical_variable
aminotransferase 10 26 712 728 I-clinical_variable
( 27 28 729 730 I-clinical_variable
AST 28 31 730 733 I-clinical_variable
) 31 32 733 734 I-clinical_variable
( 33 34 735 736 O
serum 34 39 736 741 B-clinical_variable
glutamic 40 48 742 750 I-clinical_variable
oxaloacetic 49 60 751 762 I-clinical_variable
transaminase 61 73 763 775 I-clinical_variable
[ 74 75 776 777 I-clinical_variable
SGOT 75 79 777 781 I-clinical_variable
] 79 80 781 782 I-clinical_variable
) 80 81 782 783 O
and 82 85 784 787 O
alanine 86 93 788 795 B-clinical_variable
aminotransferase 94 110 796 812 I-clinical_variable
( 111 112 813 814 I-clinical_variable
ALT 112 115 814 817 I-clinical_variable
) 115 116 817 818 I-clinical_variable
( 117 118 819 820 O
serum 118 123 820 825 B-clinical_variable
glutamate 124 133 826 835 I-clinical_variable
pyruvate 134 142 836 844 I-clinical_variable
transaminase 143 155 845 857 I-clinical_variable
[ 156 157 858 859 I-clinical_variable
SGPT 157 161 859 863 I-clinical_variable
] 161 162 863 864 I-clinical_variable
) 162 163 864 865 O
= 164 165 866 867 O
< 165 166 867 868 O
2.5 167 170 869 872 B-upper_bound
X 171 172 873 874 I-upper_bound
ULN 173 176 875 878 I-upper_bound
OR 177 179 879 881 O
= 180 181 882 883 O
< 181 182 883 884 O
5 183 184 885 886 O
X 185 186 887 888 O
ULN 187 190 889 892 O
for 191 194 893 896 O
subjects 195 203 897 905 O
with 204 208 906 910 O
liver 209 214 911 916 B-cancer
metastases 215 225 917 927 I-cancer

At 0 2 928 930 O
least 3 8 931 936 O
1 9 10 937 938 B-lower_bound
prior 11 16 939 944 B-treatment
chemotherapy 17 29 945 957 I-treatment
regimen 30 37 958 965 I-treatment
containing 38 48 966 976 I-treatment
cisplatin 49 58 977 986 I-treatment
or 59 61 987 989 O
carboplatin 62 73 990 1001 B-treatment

Chemotherapy 0 12 1002 1014 B-treatment
, 12 13 1014 1015 O
targeted 14 22 1016 1024 B-treatment
small 23 28 1025 1030 I-treatment
molecule 29 37 1031 1039 I-treatment
therapy 38 45 1040 1047 I-treatment
, 45 46 1047 1048 O
or 47 49 1049 1051 O
radiation 50 59 1052 1061 B-treatment
therapy 60 67 1062 1069 I-treatment
within 68 74 1070 1076 O
2 75 76 1077 1078 B-upper_bound
weeks 77 82 1079 1084 I-upper_bound
prior 83 88 1085 1090 I-upper_bound
to 89 91 1091 1093 O
study 92 97 1094 1099 O
day 98 101 1100 1103 O
1 102 103 1104 1105 O
or 104 106 1106 1108 O
who 107 110 1109 1112 O
has 111 114 1113 1116 O
not 115 118 1117 1120 O
recovered 119 128 1121 1130 O
( 129 130 1131 1132 O
i.e. 130 134 1132 1136 O
, 134 135 1136 1137 O
= 136 137 1138 1139 O
< 137 138 1139 1140 O
grade 139 144 1141 1146 B-upper_bound
1 145 146 1147 1148 I-upper_bound
or 147 149 1149 1151 O
at 150 152 1152 1154 O
baseline 153 161 1155 1163 O
) 161 162 1163 1164 O
from 163 167 1165 1169 O
adverse 168 175 1170 1177 O
events 176 182 1178 1184 O
due 183 186 1185 1188 O
to 187 189 1189 1191 O
a 190 191 1192 1193 O
previously 192 202 1194 1204 O
administered 203 215 1205 1217 O
agent 216 221 1218 1223 O

Currently 0 9 1224 1233 O
receiving 10 19 1234 1243 O
or 20 22 1244 1246 O
has 23 26 1247 1250 O
had 27 30 1251 1254 O
treatment 31 40 1255 1264 B-treatment
with 41 45 1265 1269 O
an 46 48 1270 1272 O
investigational 49 64 1273 1288 B-treatment
agent 65 70 1289 1294 I-treatment
or 71 73 1295 1297 O
used 74 78 1298 1302 O
an 79 81 1303 1305 O
investigational 82 97 1306 1321 B-treatment
device 98 104 1322 1328 I-treatment
within 105 111 1329 1335 O
4 112 113 1336 1337 B-upper_bound
weeks 114 119 1338 1343 I-upper_bound
of 120 122 1344 1346 O
study 123 128 1347 1352 O
day 129 132 1353 1356 O
1 133 134 1357 1358 O

Diagnosis 0 9 1359 1368 O
of 10 12 1369 1371 O
immunodeficiency 13 29 1372 1388 B-chronic_disease
or 30 32 1389 1391 O
is 33 35 1392 1394 O
receiving 36 45 1395 1404 O
systemic 46 54 1405 1413 B-treatment
steroid 55 62 1414 1421 I-treatment
therapy 63 70 1422 1429 I-treatment
or 71 73 1430 1432 O
any 74 77 1433 1436 O
other 78 83 1437 1442 O
form 84 88 1443 1447 O
of 89 91 1448 1450 O
immunosuppressive 92 109 1451 1468 B-treatment
therapy 110 117 1469 1476 I-treatment
within 118 124 1477 1483 O
7 125 126 1484 1485 B-upper_bound
days 127 131 1486 1490 I-upper_bound
prior 132 137 1491 1496 I-upper_bound
to 138 140 1497 1499 O
the 141 144 1500 1503 O
first 145 150 1504 1509 O
dose 151 155 1510 1514 O
of 156 158 1515 1517 O
trial 159 164 1518 1523 B-treatment
treatment 165 174 1524 1533 I-treatment

Female 0 6 1534 1540 B-gender
subjects 7 15 1541 1549 I-gender
of 16 18 1550 1552 O
childbearing 19 31 1553 1565 O
potential 32 41 1566 1575 O
should 42 48 1576 1582 O
be 49 51 1583 1585 O
willing 52 59 1586 1593 B-contraception_consent
to 60 62 1594 1596 I-contraception_consent
use 63 66 1597 1600 I-contraception_consent
2 67 68 1601 1602 I-contraception_consent
methods 69 76 1603 1610 I-contraception_consent
of 77 79 1611 1613 I-contraception_consent
birth 80 85 1614 1619 I-contraception_consent
control 86 93 1620 1627 I-contraception_consent
or 94 96 1628 1630 I-contraception_consent
be 97 99 1631 1633 I-contraception_consent
surgically 100 110 1634 1644 I-contraception_consent
sterile 111 118 1645 1652 I-contraception_consent
, 118 119 1652 1653 O
or 120 122 1654 1656 O
abstain 123 130 1657 1664 O
from 131 135 1665 1669 O
heterosexual 136 148 1670 1682 O
activity 149 157 1683 1691 O
for 158 161 1692 1695 O
the 162 165 1696 1699 O
course 166 172 1700 1706 O
of 173 175 1707 1709 O
the 176 179 1710 1713 O
study 180 185 1714 1719 O
through 186 193 1720 1727 O
120 194 197 1728 1731 B-upper_bound
days 198 202 1732 1736 I-upper_bound
after 203 208 1737 1742 I-upper_bound
the 209 212 1743 1746 O
last 213 217 1747 1751 O
dose 218 222 1752 1756 O
of 223 225 1757 1759 O
study 226 231 1760 1765 O
medication 232 242 1766 1776 B-treatment
; 242 243 1776 1777 O
subjects 244 252 1778 1786 O
of 253 255 1787 1789 O
childbearing 256 268 1790 1802 O
potential 269 278 1803 1812 O
are 279 282 1813 1816 O
those 283 288 1817 1822 O
who 289 292 1823 1826 O
have 293 297 1827 1831 O
not 298 301 1832 1835 O
been 302 306 1836 1840 O
surgically 307 317 1841 1851 O
sterilized 318 328 1852 1862 O
or 329 331 1863 1865 O
have 332 336 1866 1870 O
not 337 340 1871 1874 O
been 341 345 1875 1879 O
free 346 350 1880 1884 O
from 351 355 1885 1889 O
menses 356 362 1890 1896 O
for 363 366 1897 1900 O
> 367 368 1901 1902 O
1 369 370 1903 1904 B-lower_bound
year 371 375 1905 1909 I-lower_bound

Hemoglobin 0 10 1910 1920 B-clinical_variable
> 11 12 1921 1922 O
= 12 13 1922 1923 O
9 14 15 1924 1925 B-lower_bound
g 16 17 1926 1927 I-lower_bound
/ 17 18 1927 1928 I-lower_bound
dL 18 20 1928 1930 I-lower_bound
without 21 28 1931 1938 O
transfusion 29 40 1939 1950 O
dependency 41 51 1951 1961 O

History 0 7 1962 1969 O
or 8 10 1970 1972 O
current 11 18 1973 1980 O
evidence 19 27 1981 1989 O
of 28 30 1990 1992 O
any 31 34 1993 1996 O
condition 35 44 1997 2006 O
, 44 45 2006 2007 O
therapy 46 53 2008 2015 B-treatment
, 53 54 2015 2016 O
or 55 57 2017 2019 O
laboratory 58 68 2020 2030 O
abnormality 69 80 2031 2042 O
that 81 85 2043 2047 O
might 86 91 2048 2053 O
confound 92 100 2054 2062 O
the 101 104 2063 2066 O
results 105 112 2067 2074 O
of 113 115 2075 2077 O
the 116 119 2078 2081 O
trial 120 125 2082 2087 O
, 125 126 2087 2088 O
interfere 127 136 2089 2098 O
with 137 141 2099 2103 O
the 142 145 2104 2107 O
subject 146 153 2108 2115 O
's 153 155 2115 2117 O
participation 156 169 2118 2131 O
for 170 173 2132 2135 O
the 174 177 2136 2139 O
full 178 182 2140 2144 O
duration 183 191 2145 2153 O
of 192 194 2154 2156 O
the 195 198 2157 2160 O
trial 199 204 2161 2166 O
, 204 205 2166 2167 O
or 206 208 2168 2170 O
is 209 211 2171 2173 O
not 212 215 2174 2177 O
in 216 218 2178 2180 O
the 219 222 2181 2184 O
best 223 227 2185 2189 O
interest 228 236 2190 2198 O
of 237 239 2199 2201 O
the 240 243 2202 2205 O
subject 244 251 2206 2213 O
to 252 254 2214 2216 O
participate 255 266 2217 2228 O

Hypersensitivity 0 16 2229 2245 O
to 17 19 2246 2248 O
pembrolizumab 20 33 2249 2262 B-allergy_name
, 33 34 2262 2263 O
any 35 38 2264 2267 O
of 39 41 2268 2270 O
its 42 45 2271 2274 O
excipients 46 56 2275 2285 B-treatment
, 56 57 2285 2286 O
paclitaxel 58 68 2287 2297 B-treatment
, 68 69 2297 2298 O
or 70 72 2299 2301 O
any 73 76 2302 2305 O
of 77 79 2306 2308 O
its 80 83 2309 2312 O
excipients 84 94 2313 2323 O

Known 0 5 2324 2329 O
active 6 12 2330 2336 O
central 13 20 2337 2344 B-cancer
nervous 21 28 2345 2352 I-cancer
system 29 35 2353 2359 I-cancer
( 36 37 2360 2361 I-cancer
CNS 37 40 2361 2364 I-cancer
) 40 41 2364 2365 I-cancer
metastases 42 52 2366 2376 I-cancer
and/or 53 59 2377 2383 O
carcinomatous 60 73 2384 2397 B-cancer
meningitis 74 84 2398 2408 I-cancer
; 84 85 2408 2409 O
subjects 86 94 2410 2418 O
with 95 99 2419 2423 O
previously 100 110 2424 2434 O
treated 111 118 2435 2442 O
brain 119 124 2443 2448 B-cancer
metastases 125 135 2449 2459 I-cancer
may 136 139 2460 2463 O
participate 140 151 2464 2475 O
provided 152 160 2476 2484 O
they 161 165 2485 2489 O
are 166 169 2490 2493 O
stable 170 176 2494 2500 O
( 177 178 2501 2502 O
without 178 185 2502 2509 O
evidence 186 194 2510 2518 O
of 195 197 2519 2521 O
progression 198 209 2522 2533 O
by 210 212 2534 2536 O
imaging 213 220 2537 2544 O
for 221 224 2545 2548 O
at 225 227 2549 2551 O
least 228 233 2552 2557 O
four 234 238 2558 2562 B-lower_bound
weeks 239 244 2563 2568 I-lower_bound
prior 245 250 2569 2574 I-lower_bound
to 251 253 2575 2577 O
the 254 257 2578 2581 O
first 258 263 2582 2587 O
dose 264 268 2588 2592 O
of 269 271 2593 2595 O
trial 272 277 2596 2601 B-treatment
treatment 278 287 2602 2611 I-treatment
and 288 291 2612 2615 O
any 292 295 2616 2619 O
neurologic 296 306 2620 2630 O
symptoms 307 315 2631 2639 O
have 316 320 2640 2644 O
returned 321 329 2645 2653 O
to 330 332 2654 2656 O
baseline 333 341 2657 2665 O
) 341 342 2665 2666 O
, 342 343 2666 2667 O
have 344 348 2668 2672 O
no 349 351 2673 2675 O
evidence 352 360 2676 2684 O
of 361 363 2685 2687 O
new 364 367 2688 2691 O
or 368 370 2692 2694 O
enlarging 371 380 2695 2704 O
brain 381 386 2705 2710 O
metastases 387 397 2711 2721 O
, 397 398 2721 2722 O
and 399 402 2723 2726 O
are 403 406 2727 2730 O
not 407 410 2731 2734 O
using 411 416 2735 2740 O
steroids 417 425 2741 2749 B-treatment
for 426 429 2750 2753 O
at 430 432 2754 2756 O
least 433 438 2757 2762 O
7 439 440 2763 2764 B-lower_bound
days 441 445 2765 2769 I-lower_bound
prior 446 451 2770 2775 I-lower_bound
to 452 454 2776 2778 O
trial 455 460 2779 2784 O
treatment 461 470 2785 2794 O
; 470 471 2794 2795 O
this 472 476 2796 2800 O
exception 477 486 2801 2810 O
does 487 491 2811 2815 O
not 492 495 2816 2819 O
include 496 503 2820 2827 O
carcinomatous 504 517 2828 2841 O
meningitis 518 528 2842 2852 O
which 529 534 2853 2858 O
is 535 537 2859 2861 O
excluded 538 546 2862 2870 O
regardless 547 557 2871 2881 O
of 558 560 2882 2884 O
clinical 561 569 2885 2893 O
stability 570 579 2894 2903 O

Known 0 5 2904 2909 O
active 6 12 2910 2916 B-chronic_disease
hepatitis 13 22 2917 2926 I-chronic_disease
B 23 24 2927 2928 I-chronic_disease
( 25 26 2929 2930 O
e.g. 26 30 2930 2934 O
, 30 31 2934 2935 O
hepatitis 32 41 2936 2945 O
B 42 43 2946 2947 O
virus 44 49 2948 2953 O
surface 50 57 2954 2961 O
antigen 58 65 2962 2969 O
[ 66 67 2970 2971 O
HBsAg 67 72 2971 2976 O
] 72 73 2976 2977 O
reactive 74 82 2978 2986 O
) 82 83 2986 2987 O
or 84 86 2988 2990 O
hepatitis 87 96 2991 3000 B-chronic_disease
C 97 98 3001 3002 I-chronic_disease
( 99 100 3003 3004 O
e.g. 100 104 3004 3008 O
, 104 105 3008 3009 O
hepatitis 106 115 3010 3019 O
C 116 117 3020 3021 O
virus 118 123 3022 3027 O
[ 124 125 3028 3029 O
HCV 125 128 3029 3032 O
] 128 129 3032 3033 O
ribonucleic 130 141 3034 3045 O
acid 142 146 3046 3050 O
[ 147 148 3051 3052 O
RNA 148 151 3052 3055 O
] 151 152 3055 3056 O
[ 153 154 3057 3058 O
qualitative 154 165 3058 3069 O
] 165 166 3069 3070 O
is 167 169 3071 3073 O
detected 170 178 3074 3082 O
) 178 179 3082 3083 O

Known 0 5 3084 3089 O
additional 6 16 3090 3100 O
malignancy 17 27 3101 3111 B-cancer
that 28 32 3112 3116 O
is 33 35 3117 3119 O
progressing 36 47 3120 3131 O
or 48 50 3132 3134 O
requires 51 59 3135 3143 O
active 60 66 3144 3150 B-treatment
treatment 67 76 3151 3160 I-treatment
; 76 77 3160 3161 O
exceptions 78 88 3162 3172 O
include 89 96 3173 3180 O
basal 97 102 3181 3186 B-cancer
cell 103 107 3187 3191 I-cancer
carcinoma 108 117 3192 3201 I-cancer
of 118 120 3202 3204 O
the 121 124 3205 3208 O
skin 125 129 3209 3213 O
or 130 132 3214 3216 O
squamous 133 141 3217 3225 B-cancer
cell 142 146 3226 3230 I-cancer
carcinoma 147 156 3231 3240 I-cancer
of 157 159 3241 3243 O
the 160 163 3244 3247 O
skin 164 168 3248 3252 O
that 169 173 3253 3257 O
has 174 177 3258 3261 O
undergone 178 187 3262 3271 O
potentially 188 199 3272 3283 O
curative 200 208 3284 3292 B-treatment
therapy 209 216 3293 3300 I-treatment
or 217 219 3301 3303 O
in 220 222 3304 3306 B-cancer
situ 223 227 3307 3311 I-cancer
cervical 228 236 3312 3320 I-cancer
cancer 237 243 3321 3327 I-cancer

Known 0 5 3328 3333 O
history 6 13 3334 3341 O
of 14 16 3342 3344 O
active 17 23 3345 3351 B-chronic_disease
TB 24 26 3352 3354 I-chronic_disease

Known 0 5 3355 3360 O
history 6 13 3361 3368 O
of 14 16 3369 3371 O
human 17 22 3372 3377 B-chronic_disease
immunodeficiency 23 39 3378 3394 I-chronic_disease
virus 40 45 3395 3400 I-chronic_disease
( 46 47 3401 3402 I-chronic_disease
HIV 47 50 3402 3405 I-chronic_disease
) 50 51 3405 3406 I-chronic_disease
( 52 53 3407 3408 O
HIV 53 56 3408 3411 O
1/2 57 60 3412 3415 O
antibodies 61 71 3416 3426 O
) 71 72 3426 3427 O

Known 0 5 3428 3433 O
history 6 13 3434 3441 O
of 14 16 3442 3444 O
, 16 17 3444 3445 O
or 18 20 3446 3448 O
any 21 24 3449 3452 O
evidence 25 33 3453 3461 O
of 34 36 3462 3464 O
active 37 43 3465 3471 B-chronic_disease
, 43 44 3471 3472 O
non 45 48 3473 3476 B-chronic_disease
- 48 49 3476 3477 I-chronic_disease
infectious 49 59 3477 3487 I-chronic_disease
pneumonitis 60 71 3488 3499 I-chronic_disease

Known 0 5 3500 3505 O
psychiatric 6 17 3506 3517 B-chronic_disease
or 18 20 3518 3520 O
substance 21 30 3521 3530 O
abuse 31 36 3531 3536 O
disorders 37 46 3537 3546 O
that 47 51 3547 3551 O
would 52 57 3552 3557 O
interfere 58 67 3558 3567 O
with 68 72 3568 3572 O
cooperation 73 84 3573 3584 O
with 85 89 3585 3589 O
the 90 93 3590 3593 O
requirements 94 106 3594 3606 O
of 107 109 3607 3609 O
the 110 113 3610 3613 O
trial 114 119 3614 3619 O

Male 0 4 3620 3624 B-gender
subjects 5 13 3625 3633 I-gender
should 14 20 3634 3640 O
agree 21 26 3641 3646 B-contraception_consent
to 27 29 3647 3649 I-contraception_consent
use 30 33 3650 3653 I-contraception_consent
an 34 36 3654 3656 I-contraception_consent
adequate 37 45 3657 3665 I-contraception_consent
method 46 52 3666 3672 I-contraception_consent
of 53 55 3673 3675 I-contraception_consent
contraception 56 69 3676 3689 I-contraception_consent
starting 70 78 3690 3698 O
with 79 83 3699 3703 O
the 84 87 3704 3707 O
first 88 93 3708 3713 O
dose 94 98 3714 3718 O
of 99 101 3719 3721 O
study 102 107 3722 3727 O
therapy 108 115 3728 3735 B-treatment
through 116 123 3736 3743 O
120 124 127 3744 3747 B-upper_bound
days 128 132 3748 3752 I-upper_bound
after 133 138 3753 3758 I-upper_bound
the 139 142 3759 3762 O
last 143 147 3763 3767 O
dose 148 152 3768 3772 O
of 153 155 3773 3775 O
study 156 161 3776 3781 O
therapy 162 169 3782 3789 O

Patient 0 7 3790 3797 O
must 8 12 3798 3802 O
be 13 15 3803 3805 O
willing 16 23 3806 3813 O
to 24 26 3814 3816 O
provide 27 34 3817 3824 O
tissue 35 41 3825 3831 O
from 42 46 3832 3836 O
a 47 48 3837 3838 O
newly 49 54 3839 3844 O
obtained 55 63 3845 3853 O
core 64 68 3854 3858 B-treatment
or 69 71 3859 3861 O
excisional 72 82 3862 3872 B-treatment
biopsy 83 89 3873 3879 I-treatment
of 90 92 3880 3882 O
a 93 94 3883 3884 O
tumor 95 100 3885 3890 B-cancer
lesion 101 107 3891 3897 I-cancer
; 107 108 3897 3898 O
newly 109 114 3899 3904 O
- 114 115 3904 3905 O
obtained 115 123 3905 3913 O
is 124 126 3914 3916 O
defined 127 134 3917 3924 O
as 135 137 3925 3927 O
a 138 139 3928 3929 O
specimen 140 148 3930 3938 O
obtained 149 157 3939 3947 O
up 158 160 3948 3950 O
to 161 163 3951 3953 O
12 164 166 3954 3956 B-upper_bound
weeks 167 172 3957 3962 I-upper_bound
( 173 174 3963 3964 O
84 174 176 3964 3966 O
days 177 181 3967 3971 O
) 181 182 3971 3972 O
prior 183 188 3973 3978 O
to 189 191 3979 3981 O
initiation 192 202 3982 3992 O
of 203 205 3993 3995 O
treatment 206 215 3996 4005 B-treatment
on 216 218 4006 4008 O
day 219 222 4009 4012 O
1 223 224 4013 4014 O
; 224 225 4014 4015 O
archived 226 234 4016 4024 O
specimen 235 243 4025 4033 O
can 244 247 4034 4037 O
be 248 250 4038 4040 O
used 251 255 4041 4045 O
for 256 259 4046 4049 O
subjects 260 268 4050 4058 O
in 269 271 4059 4061 O
whom 272 276 4062 4066 O
newly 277 282 4067 4072 O
- 282 283 4072 4073 O
obtained 283 291 4073 4081 O
samples 292 299 4082 4089 O
can 300 303 4090 4093 O
not 303 306 4093 4096 O
be 307 309 4097 4099 O
provided 310 318 4100 4108 O

Patients 0 8 4109 4117 O
diagnosed 9 18 4118 4127 O
with 19 23 4128 4132 O
platinum 24 32 4133 4141 B-cancer
- 32 33 4141 4142 I-cancer
refractory 33 43 4142 4152 I-cancer
metastatic 44 54 4153 4163 I-cancer
urothelial 55 65 4164 4174 I-cancer
cancer 66 72 4175 4181 I-cancer
that 73 77 4182 4186 O
is 78 80 4187 4189 O
measureable 81 92 4190 4201 O
based 93 98 4202 4207 O
on 99 101 4208 4210 O
Response 102 110 4211 4219 O
Evaluation 111 121 4220 4230 O
Criteria 122 130 4231 4239 O
in 131 133 4240 4242 O
Solid 134 139 4243 4248 O
Tumors 140 146 4249 4255 O
( 147 148 4256 4257 O
RECIST 148 154 4257 4263 O
) 154 155 4263 4264 O
criteria 156 164 4265 4273 O
1.1 165 168 4274 4277 O

Performance 0 11 4278 4289 B-clinical_variable
status 12 18 4290 4296 I-clinical_variable
of 19 21 4297 4299 O
0 22 23 4300 4301 B-lower_bound
or 24 26 4302 4304 O
1 27 28 4305 4306 B-upper_bound
on 29 31 4307 4309 O
the 32 35 4310 4313 O
Eastern 36 43 4314 4321 B-clinical_variable
Cooperative 44 55 4322 4333 I-clinical_variable
Oncology 56 64 4334 4342 I-clinical_variable
Group 65 70 4343 4348 I-clinical_variable
( 71 72 4349 4350 I-clinical_variable
ECOG 72 76 4350 4354 I-clinical_variable
) 76 77 4354 4355 I-clinical_variable
performance 78 89 4356 4367 I-clinical_variable
scale 90 95 4368 4373 I-clinical_variable

Platelets 0 9 4374 4383 B-clinical_variable
> 10 11 4384 4385 O
= 11 12 4385 4386 O
80,000 13 19 4387 4393 B-lower_bound
/ 20 21 4394 4395 I-lower_bound
mcL 22 25 4396 4399 I-lower_bound

Pregnancy 0 9 4400 4409 B-pregnancy
or 10 12 4410 4412 O
breastfeeding 13 26 4413 4426 O
, 26 27 4426 4427 O
or 28 30 4428 4430 O
expecting 31 40 4431 4440 O
to 41 43 4441 4443 O
conceive 44 52 4444 4452 O
or 53 55 4453 4455 O
father 56 62 4456 4462 O
children 63 71 4463 4471 O
within 72 78 4472 4478 O
the 79 82 4479 4482 O
projected 83 92 4483 4492 O
duration 93 101 4493 4501 O
of 102 104 4502 4504 O
the 105 108 4505 4508 O
trial 109 114 4509 4514 O
, 114 115 4514 4515 O
starting 116 124 4516 4524 O
with 125 129 4525 4529 O
the 130 133 4530 4533 O
pre 134 137 4534 4537 O
- 137 138 4537 4538 O
screening 138 147 4538 4547 O
or 148 150 4548 4550 O
screening 151 160 4551 4560 O
visit 161 166 4561 4566 O
through 167 174 4567 4574 O
120 175 178 4575 4578 B-upper_bound
days 179 183 4579 4583 I-upper_bound
after 184 189 4584 4589 O
the 190 193 4590 4593 O
last 194 198 4594 4598 O
dose 199 203 4599 4603 O
of 204 206 4604 4606 O
trial 207 212 4607 4612 B-treatment
treatment 213 222 4613 4622 I-treatment

Prior 0 5 4623 4628 B-treatment
therapy 6 13 4629 4636 I-treatment
with 14 18 4637 4641 I-treatment
an 19 21 4642 4644 I-treatment
anti 22 26 4645 4649 I-treatment
- 26 27 4649 4650 I-treatment
programmed 27 37 4650 4660 I-treatment
cell 38 42 4661 4665 I-treatment
death 43 48 4666 4671 I-treatment
1 49 50 4672 4673 I-treatment
( 51 52 4674 4675 I-treatment
PD-1 52 56 4675 4679 I-treatment
) 56 57 4679 4680 I-treatment
, 57 58 4680 4681 O
anti 59 63 4682 4686 B-treatment
- 63 64 4686 4687 I-treatment
programmed 64 74 4687 4697 I-treatment
cell 75 79 4698 4702 I-treatment
death 80 85 4703 4708 I-treatment
- 85 86 4708 4709 I-treatment
ligand 86 92 4709 4715 I-treatment
1 93 94 4716 4717 I-treatment
( 95 96 4718 4719 I-treatment
PD 96 98 4719 4721 I-treatment
- 98 99 4721 4722 I-treatment
L1 99 101 4722 4724 I-treatment
) 101 102 4724 4725 I-treatment
, 102 103 4725 4726 O
or 104 106 4727 4729 O
anti 107 111 4730 4734 B-treatment
- 111 112 4734 4735 I-treatment
programmed 112 122 4735 4745 I-treatment
cell 123 127 4746 4750 I-treatment
death 128 133 4751 4756 I-treatment
- 133 134 4756 4757 I-treatment
ligand 134 140 4757 4763 I-treatment
2 141 142 4764 4765 I-treatment
( 143 144 4766 4767 I-treatment
PD 144 146 4767 4769 I-treatment
- 146 147 4769 4770 I-treatment
L2 147 149 4770 4772 I-treatment
) 149 150 4772 4773 I-treatment
agent 151 156 4774 4779 I-treatment

Received 0 8 4780 4788 O
a 9 10 4789 4790 O
live 11 15 4791 4795 B-treatment
vaccine 16 23 4796 4803 I-treatment
within 24 30 4804 4810 O
30 31 33 4811 4813 B-upper_bound
days 34 38 4814 4818 I-upper_bound
of 39 41 4819 4821 O
planned 42 49 4822 4829 O
start 50 55 4830 4835 O
of 56 58 4836 4838 O
study 59 64 4839 4844 O
therapy 65 72 4845 4852 B-treatment

Serum 0 5 4853 4858 B-clinical_variable
creatinine 6 16 4859 4869 I-clinical_variable
= 17 18 4870 4871 O
< 18 19 4871 4872 O
1.5 20 23 4873 4876 B-upper_bound
X 24 25 4877 4878 I-upper_bound
upper 26 31 4879 4884 I-upper_bound
limit 32 37 4885 4890 I-upper_bound
of 38 40 4891 4893 I-upper_bound
normal 41 47 4894 4900 I-upper_bound
( 48 49 4901 4902 I-upper_bound
ULN 49 52 4902 4905 I-upper_bound
) 52 53 4905 4906 I-upper_bound
OR 54 56 4907 4909 O
measured 57 65 4910 4918 O
or 66 68 4919 4921 O
calculated 69 79 4922 4932 O
creatinine 80 90 4933 4943 O
clearance 91 100 4944 4953 O
( 101 102 4954 4955 O
glomerular 102 112 4955 4965 B-clinical_variable
filtration 113 123 4966 4976 I-clinical_variable
rate 124 128 4977 4981 I-clinical_variable
[ 129 130 4982 4983 I-clinical_variable
GFR 130 133 4983 4986 I-clinical_variable
] 133 134 4986 4987 I-clinical_variable
can 135 138 4988 4991 O
also 139 143 4992 4996 O
be 144 146 4997 4999 O
used 147 151 5000 5004 O
in 152 154 5005 5007 O
place 155 160 5008 5013 O
of 161 163 5014 5016 O
creatinine 164 174 5017 5027 O
or 175 177 5028 5030 O
creatinine 178 188 5031 5041 B-clinical_variable
clearance 189 198 5042 5051 I-clinical_variable
rate 199 203 5052 5056 I-clinical_variable
[ 204 205 5057 5058 I-clinical_variable
CrCl 205 209 5058 5062 I-clinical_variable
] 209 210 5062 5063 I-clinical_variable
) 210 211 5063 5064 I-clinical_variable
> 212 213 5065 5066 O
= 213 214 5066 5067 O
35 215 217 5068 5070 B-lower_bound
mL 218 220 5071 5073 I-lower_bound
/ 220 221 5073 5074 I-lower_bound
min 221 224 5074 5077 I-lower_bound
for 225 228 5078 5081 O
subject 229 236 5082 5089 O
with 237 241 5090 5094 O
creatinine 242 252 5095 5105 B-clinical_variable
levels 253 259 5106 5112 I-clinical_variable
> 260 261 5113 5114 O
1.5 262 265 5115 5118 B-lower_bound
X 266 267 5119 5120 I-lower_bound
institutional 268 281 5121 5134 I-lower_bound
ULN 282 285 5135 5138 I-lower_bound

Serum 0 5 5139 5144 B-clinical_variable
total 6 11 5145 5150 I-clinical_variable
bilirubin 12 21 5151 5160 I-clinical_variable
= 22 23 5161 5162 O
< 23 24 5162 5163 O
1.5 25 28 5164 5167 B-upper_bound
X 29 30 5168 5169 I-upper_bound
ULN 31 34 5170 5173 I-upper_bound
OR 35 37 5174 5176 O
direct 38 44 5177 5183 B-clinical_variable
bilirubin 45 54 5184 5193 I-clinical_variable
= 55 56 5194 5195 O
< 56 57 5195 5196 O
ULN 58 61 5197 5200 O
for 62 65 5201 5204 O
subjects 66 74 5205 5213 O
with 75 79 5214 5218 O
total 80 85 5219 5224 B-clinical_variable
bilirubin 86 95 5225 5234 I-clinical_variable
levels 96 102 5235 5241 I-clinical_variable
> 103 104 5242 5243 O
1.5 105 108 5244 5247 B-lower_bound
ULN 109 112 5248 5251 I-lower_bound

A 0 1 0 1 O
upper 2 7 2 7 B-treatment
limb 8 12 8 12 I-treatment
amputation 13 23 13 23 I-treatment
at 24 26 24 26 O
the 27 30 27 30 O
transradial 31 42 31 42 O
level 43 48 43 48 O

Cognitive 0 9 49 58 B-chronic_disease
impairment 10 20 59 69 I-chronic_disease
sufficient 21 31 70 80 O
to 32 34 81 83 O
adversely 35 44 84 93 O
affect 45 51 94 100 O
understanding 52 65 101 114 O
of 66 68 115 117 O
or 69 71 118 120 O
compliance 72 82 121 131 O
with 83 87 132 136 O
study 88 93 137 142 O
requirements 94 106 143 155 O

Significant 0 11 156 167 O
new 12 15 168 171 O
injury 16 22 172 178 O
that 23 27 179 183 O
would 28 33 184 189 O
prevent 34 41 190 197 O
use 42 45 198 201 O
of 46 48 202 204 O
a 49 50 205 206 O
prosthesis 51 61 207 217 B-treatment
: 61 62 217 218 O
The 63 66 219 222 O
ability 67 74 223 230 O
to 75 77 231 233 O
consistently 78 90 234 246 O
wear 91 95 247 251 O
a 96 97 252 253 O
prosthesis 98 108 254 264 O
and 109 112 265 268 O
perform 113 120 269 276 O
activities 121 131 277 287 O
of 132 134 288 290 O
daily 135 140 291 296 O
living 141 147 297 303 O
and 148 151 304 307 O
specific 152 160 308 316 O
performance 161 172 317 328 O
tasks 173 178 329 334 O
is 179 181 335 337 O
necessary 182 191 338 347 O
to 192 194 348 350 O
evaluate 195 203 351 359 O
the 204 207 360 363 O
relative 208 216 364 372 O
benefits 217 225 373 381 O
of 226 228 382 384 O
the 229 232 385 388 O
interventions 233 246 389 402 O

Botox 0 5 0 5 B-treatment
injection 6 15 6 15 I-treatment
within 16 22 16 22 O
6 23 24 23 24 B-upper_bound
months 25 31 25 31 I-upper_bound
of 32 34 32 34 O
starting 35 43 35 43 O
the 44 47 44 47 O
study 48 53 48 53 O

ability 0 7 54 61 O
to 8 10 62 64 O
ambulate 11 19 65 73 O
without 20 27 74 81 O
orthotics 28 37 82 91 O
or 38 40 92 94 O
with 41 45 95 99 O
orthotics 46 55 100 109 O
that 56 60 110 114 O
do 61 63 115 117 O
not 64 67 118 121 O
cross 68 73 122 127 O
the 74 77 128 131 O
knee 78 82 132 136 O
for 83 86 137 140 O
more 87 91 141 145 O
than 92 96 146 150 O
10 97 99 151 153 B-lower_bound
meters 100 106 154 160 I-lower_bound

ability 0 7 161 168 O
to 8 10 169 171 O
walk 11 15 172 176 O
on 16 18 177 179 O
a 19 20 180 181 O
treadmill 21 30 182 191 O
for 31 34 192 195 O
more 35 39 196 200 O
than 40 44 201 205 O
20 45 47 206 208 B-lower_bound
minutes 48 55 209 216 I-lower_bound
with 56 60 217 221 O
partial 61 68 222 229 O
body 69 73 230 234 B-clinical_variable
weight 74 80 235 241 I-clinical_variable
support 81 88 242 249 O
as 89 91 250 252 O
needed 92 98 253 259 O
and 99 102 260 263 O
short 103 108 264 269 O
sitting 109 116 270 277 O
/ 116 117 277 278 O
standing 117 125 278 286 O
breaks 126 132 287 293 O

age 0 3 294 297 B-age
between 4 11 298 305 O
18 12 14 306 308 B-lower_bound
and 15 18 309 312 O
65 19 21 313 315 B-upper_bound
years 22 27 316 321 I-upper_bound

concomitant 0 11 322 333 O
central 12 19 334 341 O
or 20 22 342 344 O
peripheral 23 33 345 355 B-chronic_disease
neurological 34 46 356 368 I-chronic_disease
injury 47 53 369 375 I-chronic_disease
( 54 55 376 377 O
e.g. 55 59 377 381 O
traumatic 60 69 382 391 B-chronic_disease
head 70 74 392 396 I-chronic_disease
injury 75 81 397 403 I-chronic_disease
or 82 84 404 406 O
peripheral 85 95 407 417 B-chronic_disease
nerve 96 101 418 423 I-chronic_disease
damage 102 108 424 430 I-chronic_disease
in 109 111 431 433 I-chronic_disease
lower 112 117 434 439 I-chronic_disease
limbs 118 123 440 445 I-chronic_disease
) 123 124 445 446 O

current 0 7 447 454 O
receiving 8 17 455 464 O
physical 18 26 465 473 B-treatment
therapy 27 34 474 481 I-treatment
treatment 35 44 482 491 I-treatment

severe 0 6 492 498 B-chronic_disease
cardiovascular 7 21 499 513 I-chronic_disease
and 22 25 514 517 O
pulmonary 26 35 518 527 B-chronic_disease
disease 36 43 528 535 I-chronic_disease

Creatinine 0 10 0 10 B-clinical_variable
within 11 17 11 17 O
normal 18 24 18 24 O
institutional 25 38 25 38 O
limits 39 45 39 45 O
OR 46 48 46 48 O
creatinine 49 59 49 59 B-clinical_variable
clearance 60 69 60 69 I-clinical_variable
> 70 71 70 71 O
= 71 72 71 72 O
60 73 75 73 75 B-lower_bound
mL 76 78 76 78 I-lower_bound
/ 78 79 78 79 I-lower_bound
min/1.73 79 87 79 87 I-lower_bound
m^2 88 91 88 91 I-lower_bound
for 92 95 92 95 O
subjects 96 104 96 104 O
with 105 109 105 109 O
creatinine 110 120 110 120 B-clinical_variable
levels 121 127 121 127 I-clinical_variable
above 128 133 128 133 O
institutional 134 147 134 147 O
normal 148 154 148 154 O

Eastern 0 7 155 162 B-clinical_variable
Cooperative 8 19 163 174 I-clinical_variable
Oncology 20 28 175 183 I-clinical_variable
Group 29 34 184 189 I-clinical_variable
( 35 36 190 191 I-clinical_variable
ECOG 36 40 191 195 I-clinical_variable
) 40 41 195 196 I-clinical_variable
performance 42 53 197 208 I-clinical_variable
status 54 60 209 215 I-clinical_variable
= 61 62 216 217 O
< 62 63 217 218 O
2 64 65 219 220 B-upper_bound
( 66 67 221 222 O
Karnofsky 67 76 222 231 B-clinical_variable
> 77 78 232 233 O
= 78 79 233 234 O
60 80 82 235 237 B-lower_bound
% 82 83 237 238 I-lower_bound
) 83 84 238 239 O

Hemoglobin 0 10 240 250 B-clinical_variable
> 11 12 251 252 O
= 12 13 252 253 O
8.0 14 17 254 257 B-lower_bound
g 18 19 258 259 I-lower_bound
/ 19 20 259 260 I-lower_bound
dl 20 22 260 262 I-lower_bound
( 23 24 263 264 O
The 24 27 264 267 O
use 28 31 268 271 O
of 32 34 272 274 O
transfusion 35 46 275 286 O
or 47 49 287 289 O
other 50 55 290 295 O
invention 56 65 296 305 O
to 66 68 306 308 O
achieve 69 76 309 316 O
Hemoglobin 77 87 317 327 B-clinical_variable
[ 88 89 328 329 I-clinical_variable
Hgb 89 92 329 332 I-clinical_variable
] 92 93 332 333 I-clinical_variable
> 94 95 334 335 O
= 95 96 335 336 O
8.0 97 100 337 340 O
g 101 102 341 342 O
/ 102 103 342 343 O
dl 103 105 343 345 O
is 106 108 346 348 O
acceptable 109 119 349 359 O
) 119 120 359 360 O

History 0 7 361 368 O
of 8 10 369 371 O
other 11 16 372 377 O
malignancy 17 27 378 388 B-cancer
in 28 30 389 391 O
the 31 34 392 395 O
past 35 39 396 400 B-upper_bound
2 40 41 401 402 I-upper_bound
years 42 47 403 408 I-upper_bound

Human 0 5 409 414 B-chronic_disease
immunodeficiency 6 22 415 431 I-chronic_disease
virus 23 28 432 437 I-chronic_disease
( 29 30 438 439 I-chronic_disease
HIV)-positive 30 43 439 452 I-chronic_disease
patients 44 52 453 461 O
on 53 55 462 464 O
combination 56 67 465 476 B-treatment
antiretroviral 68 82 477 491 I-treatment
therapy 83 90 492 499 I-treatment
are 91 94 500 503 O
ineligible 95 105 504 514 O
because 106 113 515 522 O
of 114 116 523 525 O
the 117 120 526 529 O
potential 121 130 530 539 O
for 131 134 540 543 O
pharmacokinetic 135 150 544 559 B-treatment
interactions 151 163 560 572 I-treatment
with 164 168 573 577 O
ferumoxytol 169 180 578 589 B-treatment

Medical 0 7 590 597 O
contraindications 8 25 598 615 O
to 26 28 616 618 O
esophagectomy 29 42 619 632 B-treatment

Pathologically 0 14 633 647 O
confirmed 15 24 648 657 O
, 24 25 657 658 O
locally 26 33 659 666 O
advanced 34 42 667 675 O
, 42 43 675 676 O
malignancy 44 54 677 687 B-cancer
of 55 57 688 690 I-cancer
the 58 61 691 694 I-cancer
esophagus 62 71 695 704 I-cancer

Patients 0 8 705 713 O
must 9 13 714 718 O
have 14 18 719 723 O
regional 19 27 724 732 B-chronic_disease
adenopathy 28 38 733 743 I-chronic_disease

Patients 0 8 744 752 O
with 9 13 753 757 O
renal 14 19 758 763 B-chronic_disease
insufficiency 20 33 764 777 I-chronic_disease

Positron 0 8 778 786 B-treatment
emission 9 17 787 795 I-treatment
tomography 18 28 796 806 I-treatment
( 29 30 807 808 I-treatment
PET)/CT 30 37 808 815 I-treatment
of 38 40 816 818 O
the 41 44 819 822 O
whole 45 50 823 828 O
- 50 51 828 829 O
body 51 55 829 833 O
or 56 58 834 836 O
skull 59 64 837 842 O
base 65 69 843 847 O
to 70 72 848 850 O
mid 73 76 851 854 O
- 76 77 854 855 O
thigh 77 82 855 860 O

Pregnant 0 8 861 869 B-pregnancy
women 9 14 870 875 B-gender
are 15 18 876 879 O
excluded 19 27 880 888 O
from 28 32 889 893 O
this 33 37 894 898 O
study 38 43 899 904 O
because 44 51 905 912 O
chemoradiotherapy 52 69 913 930 B-treatment
has 70 73 931 934 O
the 74 77 935 938 O
potential 78 87 939 948 O
for 88 91 949 952 O
teratogenic 92 103 953 964 B-treatment
or 104 106 965 967 O
abortifacient 107 120 968 981 O
effects 121 128 982 989 O

Prior 0 5 990 995 O
systemic 6 14 996 1004 B-treatment
chemotherapy 15 27 1005 1017 I-treatment
for 28 31 1018 1021 O
esophageal 32 42 1022 1032 B-cancer
cancer 43 49 1033 1039 I-cancer

Serum 0 5 1040 1045 B-clinical_variable
ferritin 6 14 1046 1054 I-clinical_variable
< 15 16 1055 1056 O
2.0 17 20 1057 1060 B-upper_bound
X 21 22 1061 1062 I-upper_bound
institutional 23 36 1063 1076 I-upper_bound
upper 37 42 1077 1082 I-upper_bound
limit 43 48 1083 1088 I-upper_bound
of 49 51 1089 1091 I-upper_bound
normal 52 58 1092 1098 I-upper_bound

Subjects 0 8 1099 1107 O
who 9 12 1108 1111 O
have 13 17 1112 1116 O
a 18 19 1117 1118 O
contraindication 20 36 1119 1135 O
for 37 40 1136 1139 O
MRI 41 44 1140 1143 B-allergy_name

Subjects 0 8 1144 1152 O
with 9 13 1153 1157 O
cervical 14 22 1158 1166 B-cancer
or 23 25 1167 1169 O
Siewert 26 33 1170 1177 B-cancer
3 34 35 1178 1179 I-cancer
esophageal 36 46 1180 1190 I-cancer
carcinoma 47 56 1191 1200 I-cancer
, 56 57 1200 1201 O
that 58 62 1202 1206 O
are 63 66 1207 1210 O
recommended 67 78 1211 1222 O
by 79 81 1223 1225 O
the 82 85 1226 1229 O
multi 86 91 1230 1235 O
- 91 92 1235 1236 O
disciplinary 92 104 1236 1248 O
tumor 105 110 1249 1254 O
board 111 116 1255 1260 O
to 117 119 1261 1263 O
have 120 124 1264 1268 O
treatment 125 134 1269 1278 B-treatment
other 135 140 1279 1284 O
than 141 145 1285 1289 O
tri 146 149 1290 1293 B-treatment
- 149 150 1293 1294 I-treatment
modality 150 158 1294 1302 I-treatment
chemo 159 164 1303 1308 I-treatment
- 164 165 1308 1309 I-treatment
radiation 165 174 1309 1318 I-treatment
therapy 175 182 1319 1326 I-treatment
( 183 184 1327 1328 I-treatment
RT 184 186 1328 1330 I-treatment
) 186 187 1330 1331 I-treatment
followed 188 196 1332 1340 O
by 197 199 1341 1343 O
esophagectomy 200 213 1344 1357 B-treatment

Subjects 0 8 1358 1366 O
with 9 13 1367 1371 O
evidence 14 22 1372 1380 O
of 23 25 1381 1383 O
iron 26 30 1384 1388 B-chronic_disease
overload 31 39 1389 1397 I-chronic_disease

Total 0 5 1398 1403 B-clinical_variable
bilirubin 6 15 1404 1413 I-clinical_variable
= 16 17 1414 1415 O
< 17 18 1415 1416 O
1.5 19 22 1417 1420 B-upper_bound
X 23 24 1421 1422 I-upper_bound
institutional 25 38 1423 1436 I-upper_bound
upper 39 44 1437 1442 I-upper_bound
limit 45 50 1443 1448 I-upper_bound
of 51 53 1449 1451 I-upper_bound
normal 54 60 1452 1458 I-upper_bound

White 0 5 1459 1464 B-clinical_variable
blood 6 11 1465 1470 I-clinical_variable
cell 12 16 1471 1475 I-clinical_variable
count 17 22 1476 1481 I-clinical_variable
> 23 24 1482 1483 O
= 24 25 1483 1484 O
3.0 26 29 1485 1488 B-lower_bound
K 30 31 1489 1490 I-lower_bound
/ 31 32 1490 1491 I-lower_bound
cu 32 34 1491 1493 I-lower_bound
mm 35 37 1494 1496 I-lower_bound

a 0 1 1497 1498 O
known 2 7 1499 1504 O
history 8 15 1505 1512 O
of 16 18 1513 1515 O
hypersensitivity 19 35 1516 1532 O
to 36 38 1533 1535 O
ferumoxytol 39 50 1536 1547 B-allergy_name

based 0 5 1548 1553 O
on 6 8 1554 1556 O
multi 9 14 1557 1562 O
- 14 15 1562 1563 O
disciplinary 15 27 1563 1575 O
tumor 28 33 1576 1581 B-cancer
board 34 39 1582 1587 O
discussion 40 50 1588 1598 O
, 50 51 1598 1599 O
patients 52 60 1600 1608 O
are 61 64 1609 1612 O
candidates 65 75 1613 1623 O
for 76 79 1624 1627 O
tri 80 83 1628 1631 B-treatment
- 83 84 1631 1632 I-treatment
modality 84 92 1632 1640 I-treatment
treatment 93 102 1641 1650 I-treatment

because 0 7 1651 1658 O
there 8 13 1659 1664 O
is 14 16 1665 1667 O
an 17 19 1668 1670 O
unknown 20 27 1671 1678 O
but 28 31 1679 1682 O
potential 32 41 1683 1692 O
risk 42 46 1693 1697 O
for 47 50 1698 1701 O
adverse 51 58 1702 1709 O
events 59 65 1710 1716 O
in 66 68 1717 1719 O
nursing 69 76 1720 1727 O
infants 77 84 1728 1735 O
secondary 85 94 1736 1745 O
to 95 97 1746 1748 O
the 98 101 1749 1752 O
use 102 105 1753 1756 O
of 106 108 1757 1759 O
ferumoxytol 109 120 1760 1771 B-treatment
as 121 123 1772 1774 O
a 124 125 1775 1776 O
contrast 126 134 1777 1785 O
agent 135 140 1786 1791 O
in 141 143 1792 1794 O
the 144 147 1795 1798 O
mother 148 154 1799 1805 O

breast 0 6 1806 1812 B-cancer
ductal 7 13 1813 1819 I-cancer
carcinoma 14 23 1820 1829 I-cancer
in 24 26 1830 1832 I-cancer
situ 27 31 1833 1837 I-cancer
( 32 33 1838 1839 I-cancer
DCIS 33 37 1839 1843 I-cancer
) 37 38 1843 1844 I-cancer

have 0 4 1845 1849 O
an 5 7 1850 1852 O
allergy 8 15 1853 1860 O
to 16 18 1861 1863 O
gadolinium 19 29 1864 1874 B-allergy_name
( 30 31 1875 1876 I-allergy_name
Gd 31 33 1876 1878 I-allergy_name
) 33 34 1878 1879 I-allergy_name
contrast 35 43 1880 1888 I-allergy_name
material 44 52 1889 1897 I-allergy_name

have 0 4 1898 1902 O
undergone 5 14 1903 1912 O
endoscopic 15 25 1913 1923 B-treatment
biopsy 26 32 1924 1930 I-treatment
with 33 37 1931 1935 O
endoscopic 38 48 1936 1946 B-treatment
ultrasound 49 59 1947 1957 I-treatment
( 60 61 1958 1959 I-treatment
EUS)-proven 61 72 1959 1970 I-treatment
peri 73 77 1971 1975 O
- 77 78 1975 1976 O
esophageal 78 88 1976 1986 O
nodal 89 94 1987 1992 O
involvement 95 106 1993 2004 O

low 0 3 2005 2008 O
- 3 4 2008 2009 O
risk 4 8 2009 2013 O
prostate 9 17 2014 2022 B-cancer
adenocarcinoma 18 32 2023 2037 I-cancer

men 0 3 2038 2041 B-gender
who 4 7 2042 2045 O
are 8 11 2046 2049 O
sexually 12 20 2050 2058 O
active 21 27 2059 2065 O
and 28 31 2066 2069 O
not 32 35 2070 2073 B-contraception_consent
willing 36 43 2074 2081 I-contraception_consent
/ 43 44 2081 2082 I-contraception_consent
able 44 48 2082 2086 I-contraception_consent
to 49 51 2087 2089 I-contraception_consent
use 52 55 2090 2093 I-contraception_consent
medically 56 65 2094 2103 I-contraception_consent
acceptable 66 76 2104 2114 I-contraception_consent
forms 77 82 2115 2120 I-contraception_consent
of 83 85 2121 2123 I-contraception_consent
contraception 86 99 2124 2137 I-contraception_consent

non 0 3 2138 2141 B-cancer
- 3 4 2141 2142 I-cancer
melanomatous 4 16 2142 2154 I-cancer
skin 17 21 2155 2159 I-cancer
cancer 22 28 2160 2166 I-cancer

ongoing 0 7 2167 2174 O
or 8 10 2175 2177 O
active 11 17 2178 2184 B-chronic_disease
infection 18 27 2185 2194 I-chronic_disease

psychiatric 0 11 2195 2206 B-chronic_disease
illness 12 19 2207 2214 I-chronic_disease
/ 19 20 2214 2215 I-chronic_disease
social 20 26 2215 2221 I-chronic_disease
situations 27 37 2222 2232 I-chronic_disease
that 38 42 2233 2237 O
would 43 48 2238 2243 O
limit 49 54 2244 2249 O
compliance 55 65 2250 2260 O
with 66 70 2261 2265 O
study 71 76 2266 2271 O
requirements 77 89 2272 2284 O

radiation 0 9 2285 2294 B-treatment
for 10 13 2295 2298 O
esophageal 14 24 2299 2309 B-cancer
cancer 25 31 2310 2316 I-cancer

severely 0 8 2317 2325 B-chronic_disease
agitated 9 17 2326 2334 I-chronic_disease

subjects 0 8 2335 2343 O
who 9 12 2344 2347 O
have 13 17 2348 2352 O
had 18 21 2353 2356 O
an 22 24 2357 2359 O
allergic 25 33 2360 2368 O
reaction 34 42 2369 2377 O
to 43 45 2378 2380 O
any 46 49 2381 2384 O
intravenous 50 61 2385 2396 B-allergy_name
iron 62 66 2397 2401 I-allergy_name
replacement 67 78 2402 2413 I-allergy_name
product 79 86 2414 2421 I-allergy_name

symptomatic 0 11 2422 2433 B-chronic_disease
congestive 12 22 2434 2444 I-chronic_disease
heart 23 28 2445 2450 I-chronic_disease
failure 29 36 2451 2458 I-chronic_disease

unstable 0 8 2459 2467 B-chronic_disease
angina 9 15 2468 2474 I-chronic_disease
pectoris 16 24 2475 2483 I-chronic_disease

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

Advanced 0 8 25 33 O
medical 9 16 34 41 B-chronic_disease
illness 17 24 42 49 I-chronic_disease
( 25 26 50 51 O
severe 26 32 51 57 B-chronic_disease
systemic 33 41 58 66 I-chronic_disease
disease 42 49 67 74 I-chronic_disease
) 49 50 74 75 O

History 0 7 76 83 O
of 8 10 84 86 O
psychosis 11 20 87 96 B-chronic_disease
or 21 23 97 99 I-chronic_disease
psychiatric 24 35 100 111 I-chronic_disease
hospitalization 36 51 112 127 I-chronic_disease
, 51 52 127 128 O
suicidal 53 61 129 137 B-chronic_disease
ideation 62 70 138 146 I-chronic_disease
or 71 73 147 149 I-chronic_disease
attempt 74 81 150 157 I-chronic_disease

Non 0 3 158 161 O
- 3 4 161 162 O
structural 4 14 162 172 O
non 15 18 173 176 O
- 18 19 176 177 O
specific 19 27 177 185 O
chronic 28 35 186 193 O
low 36 39 194 197 O
back 40 44 198 202 O
pain 45 49 203 207 O
of 50 52 208 210 O
a 53 54 211 212 O
least 55 60 213 218 O
3 61 62 219 220 B-lower_bound
months 63 69 221 227 I-lower_bound
duration 70 78 228 236 O

Significant 0 11 237 248 O
psychiatric 12 23 249 260 O
history 24 31 261 268 O
: 31 32 268 269 O
a 33 34 270 271 O
diagnosis 35 44 272 281 O
of 45 47 282 284 O
schizophrenia 48 61 285 298 B-chronic_disease
, 61 62 298 299 O
bipolar 63 70 300 307 B-chronic_disease
disorder 71 79 308 316 I-chronic_disease
, 79 80 316 317 O
or 81 83 318 320 O
severe 84 90 321 327 B-chronic_disease
depression 91 101 328 338 I-chronic_disease

Ages 0 4 0 4 B-age
18 5 7 5 7 B-lower_bound
- 7 8 7 8 O
80 8 10 8 10 B-upper_bound

Neurological 0 12 11 23 O
diagnosis 13 22 24 33 O
of 23 25 34 36 O
amnestic 26 34 37 45 B-chronic_disease
mild 35 39 46 50 I-chronic_disease
cognitive 40 49 51 60 I-chronic_disease
impairment 50 60 61 71 I-chronic_disease
( 61 62 72 73 I-chronic_disease
aMCI 62 66 73 77 I-chronic_disease
) 66 67 77 78 I-chronic_disease

brain 0 5 79 84 B-cancer
tumors 6 12 85 91 I-cancer

diagnosis 0 9 92 101 O
of 10 12 102 104 O
cognitive 13 22 105 114 B-chronic_disease
impairment 23 33 115 125 I-chronic_disease

eczema 0 6 126 132 B-chronic_disease
or 7 9 133 135 O
sensitive 10 19 136 145 O
skin 20 24 146 150 O

epilepsy 0 8 151 159 B-chronic_disease

insomnia 0 8 160 168 B-chronic_disease

narcolepsy 0 10 169 179 B-chronic_disease

rapid 0 5 180 185 B-chronic_disease
eye 6 9 186 189 I-chronic_disease
movement 10 18 190 198 I-chronic_disease
( 19 20 199 200 I-chronic_disease
REM)-sleep 20 30 200 210 I-chronic_disease
behavior 31 39 211 219 I-chronic_disease
disorder 40 48 220 228 I-chronic_disease

restless 0 8 229 237 B-chronic_disease
legs 9 13 238 242 I-chronic_disease
syndrome 14 22 243 251 I-chronic_disease

sleep 0 5 252 257 B-chronic_disease
apnea 6 11 258 263 I-chronic_disease

trying 0 6 264 270 B-pregnancy
to 7 9 271 273 I-pregnancy
become 10 16 274 280 I-pregnancy
pregnant 17 25 281 289 I-pregnancy
during 26 32 290 296 O
the 33 36 297 300 O
study 37 42 301 306 O
period 43 49 307 313 O

For 0 3 0 3 O
Part 4 8 4 8 O
1 9 10 9 10 O
of 11 13 11 13 O
the 14 17 14 17 O
study 18 23 18 23 O
, 23 24 23 24 O
participants 25 37 25 37 O
must 38 42 38 42 O
have 43 47 43 47 O
histopathologically 48 67 48 67 O
confirmed 68 77 68 77 O
diagnosis 78 87 78 87 O
of 88 90 88 90 O
R 91 92 91 92 B-cancer
/ 92 93 92 93 I-cancer
R 93 94 93 94 I-cancer
, 94 95 94 95 O
DLBCL 96 101 96 101 B-cancer
, 101 102 101 102 O
FL 103 105 103 105 B-cancer
, 105 106 105 106 O
MZL 107 110 107 110 B-cancer
/ 110 111 110 111 I-cancer
MALT 111 115 111 115 I-cancer
, 115 116 115 116 O
MCL 117 120 117 120 B-cancer
, 120 121 120 121 O
or 122 124 122 124 O
other 125 130 125 130 O
Sponsor 131 138 131 138 O
approved 139 147 139 147 O
NHL 148 151 148 151 B-cancer
subtypes 152 160 152 160 O
according 161 170 161 170 O
to 171 173 171 173 O
the 174 177 174 177 O
World 178 183 178 183 O
Health 184 190 184 190 O
Organization 191 203 191 203 O
( 204 205 204 205 O
WHO 205 208 205 208 O
) 208 209 208 209 O
classification 210 224 210 224 O
2008 225 229 225 229 O
for 230 233 230 233 O
which 234 239 234 239 O
standard 240 248 240 248 O
measures 249 257 249 257 O
do 258 260 258 260 O
not 261 264 261 264 O
exist 265 270 265 270 O
or 271 273 271 273 O
are 274 277 274 277 O
no 278 280 278 280 O
longer 281 287 281 287 O
effective 288 297 288 297 O

For 0 3 298 301 O
Part 4 8 302 306 O
2 9 10 307 308 O
and 11 14 309 312 O
Part 15 19 313 317 O
3 20 21 318 319 O
of 22 24 320 322 O
the 25 28 323 326 O
study 29 34 327 332 O
, 34 35 332 333 O
participants 36 48 334 346 O
must 49 53 347 351 O
have 54 58 352 356 O
histopathologically 59 78 357 376 O
and 79 82 377 380 O
clinically 83 93 381 391 O
confirmed 94 103 392 401 O
diagnosis 104 113 402 411 O
of 114 116 412 414 O
relapsed 117 125 415 423 O
DLBCL 126 131 424 429 B-cancer

For 0 3 430 433 O
Part 4 8 434 438 O
2 9 10 439 440 O
and 11 14 441 444 O
Part 15 19 445 449 O
3 20 21 450 451 O
of 22 24 452 454 O
the 25 28 455 458 O
study 29 34 459 464 O
, 34 35 464 465 O
participants 36 48 466 478 O
that 49 53 479 483 O
are 54 57 484 487 O
eligible 58 66 488 496 O
to 67 69 497 499 O
undergo 70 77 500 507 O
first 78 83 508 513 B-treatment
time 84 88 514 518 I-treatment
HD 89 91 519 521 I-treatment
- 91 92 521 522 I-treatment
ASCT 92 96 522 526 I-treatment

For 0 3 527 530 O
Part 4 8 531 535 O
2 9 10 536 537 O
and 11 14 538 541 O
Part 15 19 542 546 O
3 20 21 547 548 O
of 22 24 549 551 O
the 25 28 552 555 O
study 29 34 556 561 O
, 34 35 561 562 O
patients 36 44 563 571 O
with 45 49 572 576 O
primary 50 57 577 584 B-chronic_disease
refractory 58 68 585 595 I-chronic_disease
DLBCL 69 74 596 601 I-chronic_disease
( 75 76 602 603 O
defined 76 83 603 610 O
as 84 86 611 613 O
progression 87 98 614 625 O
of 99 101 626 628 O
disease 102 109 629 636 O
within 110 116 637 643 O
24 117 119 644 646 B-upper_bound
weeks 120 125 647 652 I-upper_bound
after 126 131 653 658 O
first 132 137 659 664 O
line 138 142 665 669 O
of 143 145 670 672 O
treatment 146 155 673 682 O
) 155 156 682 683 O

Participants 0 12 684 696 O
must 13 17 697 701 O
have 18 22 702 706 O
Eastern 23 30 707 714 B-clinical_variable
Cooperative 31 42 715 726 I-clinical_variable
Oncology 43 51 727 735 I-clinical_variable
Group 52 57 736 741 I-clinical_variable
( 58 59 742 743 I-clinical_variable
ECOG 59 63 743 747 I-clinical_variable
) 63 64 747 748 I-clinical_variable
Performance 65 76 749 760 I-clinical_variable
Status 77 83 761 767 I-clinical_variable
0 84 85 768 769 B-lower_bound
- 86 87 770 771 O
2 88 89 772 773 B-upper_bound

Participants 0 12 774 786 O
must 13 17 787 791 O
have 18 22 792 796 O
evaluable 23 32 797 806 O
or 33 35 807 809 O
measurable 36 46 810 820 O
disease 47 54 821 828 O
in 55 57 829 831 O
accordance 58 68 832 842 O
with 69 73 843 847 O
the 74 77 848 851 O
International 78 91 852 865 O
Working 92 99 866 873 O
Group 100 105 874 879 O
Guidelines 106 116 880 890 O
for 117 120 891 894 O
Lymphoma 121 129 895 903 B-cancer

Participants 0 12 904 916 O
must 13 17 917 921 O
have 18 22 922 926 O
received 23 31 927 935 O
at 32 34 936 938 O
least 35 40 939 944 O
one 41 44 945 948 B-lower_bound
but 45 48 949 952 O
no 49 51 953 955 O
more 52 56 956 960 O
than 57 61 961 965 O
six 62 65 966 969 B-upper_bound
prior 66 71 970 975 O
treatment 72 81 976 985 O
regimens 82 90 986 994 O

Participants 0 12 995 1007 O
who 13 16 1008 1011 O
are 17 20 1012 1015 O
Hepatitis 21 30 1016 1025 B-chronic_disease
B 31 32 1026 1027 I-chronic_disease
surface 33 40 1028 1035 I-chronic_disease
antigen 41 48 1036 1043 I-chronic_disease
positive 49 57 1044 1052 I-chronic_disease
( 58 59 1053 1054 I-chronic_disease
HBsAg+ 59 65 1054 1060 I-chronic_disease
) 65 66 1060 1061 I-chronic_disease
( 67 68 1062 1063 O
must 68 72 1063 1067 O
be 73 75 1068 1070 O
PCR 76 79 1071 1074 O
negative 80 88 1075 1083 O
) 88 89 1083 1084 O
who 90 93 1085 1088 O
are 94 97 1089 1092 O
taking 98 104 1093 1099 O
antivirals 105 115 1100 1110 O
, 115 116 1110 1111 O
are 117 120 1112 1115 O
allowed 121 128 1116 1123 O
to 129 131 1124 1126 O
enroll 132 138 1127 1133 O

Participants 0 12 1134 1146 O
who 13 16 1147 1150 O
have 17 21 1151 1155 O
known 22 27 1156 1161 O
central 28 35 1162 1169 B-cancer
nervous 36 43 1170 1177 I-cancer
system 44 50 1178 1184 I-cancer
, 50 51 1184 1185 O
meningeal 52 61 1186 1195 B-cancer
, 61 62 1195 1196 O
or 63 65 1197 1199 O
epidural 66 74 1200 1208 B-cancer
disease 75 82 1209 1216 I-cancer
including 83 92 1217 1226 O
brain 93 98 1227 1232 B-cancer
metastases 99 109 1233 1243 I-cancer

Participants 0 12 1244 1256 O
who 13 16 1257 1260 O
have 17 21 1261 1265 O
received 22 30 1266 1274 O
prior 31 36 1275 1280 B-treatment
therapy 37 44 1281 1288 I-treatment
with 45 49 1289 1293 O
other 50 55 1294 1299 B-treatment
anti 56 60 1300 1304 I-treatment
- 60 61 1304 1305 I-treatment
CD37 61 65 1305 1309 I-treatment
- 65 66 1309 1310 I-treatment
targeting 66 75 1310 1319 I-treatment
therapy 76 83 1320 1327 I-treatment

Participants 0 12 1328 1340 O
who 13 16 1341 1344 O
received 17 25 1345 1353 O
at 26 28 1354 1356 O
least 29 34 1357 1362 O
only 35 39 1363 1367 O
one 40 43 1368 1371 B-lower_bound
line 44 48 1372 1376 O
of 49 51 1377 1379 O
previous 52 60 1380 1388 B-treatment
therapy 61 68 1389 1396 I-treatment
and 69 72 1397 1400 O
achieved 73 81 1401 1409 O
either 82 88 1410 1416 O
complete 89 97 1417 1425 B-clinical_variable
response 98 106 1426 1434 I-clinical_variable
( 107 108 1435 1436 I-clinical_variable
CR 108 110 1436 1438 I-clinical_variable
) 110 111 1438 1439 I-clinical_variable
or 112 114 1440 1442 O
partial 115 122 1443 1450 B-treatment
response 123 131 1451 1459 I-treatment
( 132 133 1460 1461 I-treatment
PR 133 135 1461 1463 I-treatment
) 135 136 1463 1464 I-treatment
for 137 140 1465 1468 O
at 141 143 1469 1471 O
least 144 149 1472 1477 O
24 150 152 1478 1480 B-lower_bound
weeks 153 158 1481 1486 I-lower_bound
( 159 160 1487 1488 O
from 160 164 1488 1492 O
the 165 168 1493 1496 O
last 169 173 1497 1501 O
day 174 177 1502 1505 O
of 178 180 1506 1508 O
the 181 184 1509 1512 O
last 185 189 1513 1517 O
cycle 190 195 1518 1523 O
) 195 196 1523 1524 O
after 197 202 1525 1530 O
their 203 208 1531 1536 O
first 209 214 1537 1542 O
line 215 219 1543 1547 O
of 220 222 1548 1550 O
therapy 223 230 1551 1558 O
, 230 231 1558 1559 O
but 232 235 1560 1563 O
are 236 239 1564 1567 O
not 240 243 1568 1571 O
eligible 244 252 1572 1580 O
for 253 256 1581 1584 O
high 257 261 1585 1589 O
dose 262 266 1590 1594 O
chemotherapy 267 279 1595 1607 B-treatment
with 280 284 1608 1612 O
autologous 285 295 1613 1623 B-treatment
stem 296 300 1624 1628 I-treatment
cell 301 305 1629 1633 I-treatment
transplantation 306 321 1634 1649 I-treatment
( 322 323 1650 1651 I-treatment
HD 323 325 1651 1653 I-treatment
- 325 326 1653 1654 I-treatment
ASCT 326 330 1654 1658 I-treatment
) 330 331 1658 1659 I-treatment

Participants 0 12 1660 1672 O
who 13 16 1673 1676 O
received 17 25 1677 1685 O
more 26 30 1686 1690 O
than 31 35 1691 1695 O
one 36 39 1696 1699 O
line 40 44 1700 1704 O
of 45 47 1705 1707 O
previous 48 56 1708 1716 O
therapy 57 64 1717 1724 B-treatment
( 65 66 1725 1726 O
including 66 75 1726 1735 O
HD 76 78 1736 1738 B-treatment
- 78 79 1738 1739 I-treatment
ASCT 79 83 1739 1743 I-treatment
) 83 84 1743 1744 O
, 84 85 1744 1745 O
and 86 89 1746 1749 O
have 90 94 1750 1754 O
achieved 95 103 1755 1763 O
a 104 105 1764 1765 O
duration 106 114 1766 1774 O
of 115 117 1775 1777 O
response 118 126 1778 1786 O
( 127 128 1787 1788 O
CR 128 130 1788 1790 B-treatment
or 131 133 1791 1793 O
PR 134 136 1794 1796 B-treatment
) 136 137 1796 1797 O
of 138 140 1798 1800 O
at 141 143 1801 1803 O
least 144 149 1804 1809 O
8 150 151 1810 1811 B-lower_bound
weeks 152 157 1812 1817 I-lower_bound
( 158 159 1818 1819 O
from 159 163 1819 1823 O
the 164 167 1824 1827 O
last 168 172 1828 1832 O
day 173 176 1833 1836 O
of 177 179 1837 1839 O
the 180 183 1840 1843 O
last 184 188 1844 1848 O
cycle 189 194 1849 1854 O
) 194 195 1854 1855 O
after 196 201 1856 1861 O
their 202 207 1862 1867 O
last 208 212 1868 1872 O
line 213 217 1873 1877 O
of 218 220 1878 1880 O
therapy 221 228 1881 1888 O

Participants 0 12 1889 1901 O
will 13 17 1902 1906 O
be 18 20 1907 1909 O
considered 21 31 1910 1920 O
to 32 34 1921 1923 O
have 35 39 1924 1928 O
a 40 41 1929 1930 O
relapsed 42 50 1931 1939 O
disease 51 58 1940 1947 O
if 59 61 1948 1950 O
they 62 66 1951 1955 O
showed 67 73 1956 1962 O
a 74 75 1963 1964 O
duration 76 84 1965 1973 O
of 85 87 1974 1976 O
response 88 96 1977 1985 O
of 97 99 1986 1988 O
at 100 102 1989 1991 O
least 103 108 1992 1997 O
24 109 111 1998 2000 B-lower_bound
weeks 112 117 2001 2006 I-lower_bound
after 118 123 2007 2012 O
their 124 129 2013 2018 O
first 130 135 2019 2024 B-treatment
line 136 140 2025 2029 I-treatment
of 141 143 2030 2032 I-treatment
therapy 144 151 2033 2040 I-treatment

Participants 0 12 2041 2053 O
with 13 17 2054 2058 O
a 18 19 2059 2060 O
diagnosis 20 29 2061 2070 O
of 30 32 2071 2073 O
chronic 33 40 2074 2081 B-cancer
lymphocytic 41 52 2082 2093 I-cancer
leukemia 53 61 2094 2102 I-cancer
( 62 63 2103 2104 I-cancer
CLL 63 66 2104 2107 I-cancer
) 66 67 2107 2108 I-cancer
or 68 70 2109 2111 O
small 71 76 2112 2117 B-cancer
lymphocytic 77 88 2118 2129 I-cancer
lymphoma 89 97 2130 2138 I-cancer
( 98 99 2139 2140 I-cancer
SLL 99 102 2140 2143 I-cancer
) 102 103 2143 2144 I-cancer

Participants 0 12 2145 2157 O
with 13 17 2158 2162 O
active 18 24 2163 2169 O
hepatitis 25 34 2170 2179 B-chronic_disease
A 35 36 2180 2181 I-chronic_disease
, 36 37 2181 2182 I-chronic_disease
B 38 39 2183 2184 I-chronic_disease
or 40 42 2185 2187 I-chronic_disease
C 43 44 2188 2189 I-chronic_disease
infection 45 54 2190 2199 I-chronic_disease

Participants 0 12 2200 2212 O
with 13 17 2213 2217 O
impaired 18 26 2218 2226 B-chronic_disease
cardiac 27 34 2227 2234 I-chronic_disease
function 35 43 2235 2243 I-chronic_disease
or 44 46 2244 2246 O
clinically 47 57 2247 2257 B-chronic_disease
significant 58 69 2258 2269 I-chronic_disease
cardiac 70 77 2270 2277 I-chronic_disease
disease 78 85 2278 2285 I-chronic_disease

Prior 0 5 2286 2291 O
treatment 6 15 2292 2301 O
with 16 20 2302 2306 O
an 21 23 2307 2309 O
anti 24 28 2310 2314 B-treatment
- 28 29 2314 2315 I-treatment
CD20 29 33 2315 2319 I-treatment
agent 34 39 2320 2325 I-treatment
, 39 40 2325 2326 O
either 41 47 2327 2333 O
alone 48 53 2334 2339 O
or 54 56 2340 2342 O
in 57 59 2343 2345 O
combination 60 71 2346 2357 O
, 71 72 2357 2358 O
is 73 75 2359 2361 O
allowed 76 83 2362 2369 O

The 0 3 2370 2373 O
following 4 13 2374 2383 O
participants 14 26 2384 2396 O
with 27 31 2397 2401 O
relapsed 32 40 2402 2410 O
DLBCL 41 46 2411 2416 B-cancer
will 47 51 2417 2421 O
be 52 54 2422 2424 O
enrolled 55 63 2425 2433 O

Women 0 5 2434 2439 B-gender
who 6 9 2440 2443 O
are 10 13 2444 2447 B-pregnancy
pregnant 14 22 2448 2456 I-pregnancy
or 23 25 2457 2459 O
breast 26 32 2460 2466 O
feeding 33 40 2467 2474 O

Current 0 7 0 7 O
persistent 8 18 8 18 B-chronic_disease
atrial 19 25 19 25 I-chronic_disease
fibrillation 26 38 26 38 I-chronic_disease

Pregnant 0 8 39 47 B-pregnancy
patients 9 17 48 56 O

at 0 2 57 59 O
least 3 8 60 65 O
18 9 11 66 68 B-lower_bound
years 12 17 69 74 I-lower_bound
old 18 21 75 78 O

evidence 0 8 0 8 O
of 9 11 9 11 O
current 12 19 12 19 O
( 20 21 20 21 O
within 21 27 21 27 O
the 28 31 28 31 O
past 32 36 32 36 O
week 37 41 37 41 O
) 41 42 41 42 O
suicidal 43 51 43 51 B-chronic_disease
ideation 52 60 52 60 I-chronic_disease

limited 0 7 61 68 B-language_fluency
English 8 15 69 76 I-language_fluency
proficiency 16 27 77 88 I-language_fluency

participation 0 13 89 102 O
in 14 16 103 105 O
another 17 24 106 113 O
family 25 31 114 120 O
- 31 32 120 121 O
based 32 37 121 126 O
psychosocial 38 50 127 139 O
intervention 51 63 140 152 O
trial 64 69 153 158 O
six 70 73 159 162 B-upper_bound
months 74 80 163 169 I-upper_bound
prior 81 86 170 175 I-upper_bound
to 87 89 176 178 O
study 90 95 179 184 O

plan 0 4 185 189 O
or 5 7 190 192 O
intent 8 14 193 199 O
on 15 17 200 202 O
the 18 21 203 206 O
Columbia 22 30 207 215 B-clinical_variable
Suicide 31 38 216 223 I-clinical_variable
Severity 39 47 224 232 I-clinical_variable
Rating 48 54 233 239 I-clinical_variable
Scale 55 60 240 245 I-clinical_variable
( 61 62 246 247 I-clinical_variable
C 62 63 247 248 I-clinical_variable
- 63 64 248 249 I-clinical_variable
SSRS 64 68 249 253 I-clinical_variable
) 68 69 253 254 I-clinical_variable
, 69 70 254 255 O
but 71 74 256 259 O
scoring 75 82 260 267 O
less 83 87 268 272 O
than 88 92 273 277 O
or 93 95 278 280 O
equal 96 101 281 286 O
to 102 104 287 289 O
4 105 106 290 291 B-upper_bound
on 107 109 292 294 O
the 110 113 295 298 O
C 114 115 299 300 B-clinical_variable
- 115 116 300 301 I-clinical_variable
SSRS 116 120 301 305 I-clinical_variable
Behavior 121 129 306 314 I-clinical_variable
Scale 130 135 315 320 I-clinical_variable
, 135 136 320 321 O
and 137 140 322 325 O
without 141 148 326 333 O
history 149 156 334 341 O
of 157 159 342 344 O
a 160 161 345 346 O
lethal 162 168 347 353 O
suicide 169 176 354 361 B-chronic_disease
attempt 177 184 362 369 I-chronic_disease
in 185 187 370 372 O
the 188 191 373 376 O
last 192 196 377 381 B-upper_bound
3 197 198 382 383 I-upper_bound
months 199 205 384 390 I-upper_bound

untreated 0 9 391 400 O
or 10 12 401 403 O
un 13 15 404 406 O
- 15 16 406 407 O
medicated 16 25 407 416 O
psychosis 26 35 417 426 B-chronic_disease

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
or 7 9 7 9 O
older 10 15 10 15 O

Biliary 0 7 16 23 B-chronic_disease
obstructive 8 19 24 35 I-chronic_disease
symptoms 20 28 36 44 I-chronic_disease
or 29 31 45 47 O
signs 32 37 48 53 O

Biliary 0 7 54 61 B-chronic_disease
strictures 8 18 62 72 I-chronic_disease
caused 19 25 73 79 O
by 26 28 80 82 O
confirmed 29 38 83 92 O
benign 39 45 93 99 B-chronic_disease
tumors 46 52 100 106 I-chronic_disease

Biliary 0 7 107 114 O
strictures 8 18 115 125 O
caused 19 25 126 132 O
by 26 28 133 135 O
malignancies 29 41 136 148 B-cancer
other 42 47 149 154 O
than 48 52 155 159 O
pancreatic 53 63 160 170 B-cancer
cancer 64 70 171 177 I-cancer
, 70 71 177 178 O
distal 72 78 179 185 B-cancer
CBD 79 82 186 189 I-cancer
cholangiocarcinoma 83 101 190 208 I-cancer
and 102 105 209 212 O
other 106 111 213 218 O
periampullary 112 125 219 232 B-cancer
cancers 126 133 233 240 I-cancer

Bilirubin 0 9 241 250 B-clinical_variable
level 10 15 251 256 I-clinical_variable
at 16 18 257 259 O
/ 18 19 259 260 O
above 19 24 260 265 O
100 25 28 266 269 B-lower_bound
umol 29 33 270 274 I-lower_bound
per 34 37 275 278 I-lower_bound
liter 38 43 279 284 I-lower_bound
( 44 45 285 286 O
5.8 45 48 286 289 O
mg 49 51 290 292 O
/ 51 52 292 293 O
dL 52 54 293 295 O
) 54 55 295 296 O

Diagnosis 0 9 297 306 O
of 10 12 307 309 O
probable 13 21 310 318 O
pancreatic 22 32 319 329 B-cancer
cancer 33 39 330 336 I-cancer
, 39 40 336 337 O
distal 41 47 338 344 O
common 48 54 345 351 B-cancer
bile 55 59 352 356 I-cancer
duct 60 64 357 361 I-cancer
( 65 66 362 363 I-cancer
CBD 66 69 363 366 I-cancer
) 69 70 366 367 I-cancer
cholangiocarcinoma 71 89 368 386 I-cancer
and 90 93 387 390 O
other 94 99 391 396 O
periampullary 100 113 397 410 B-cancer
cancers 114 121 411 418 I-cancer
( 122 123 419 420 O
histology 123 132 420 429 O
not 133 136 430 433 O
required 137 145 434 442 O
) 145 146 442 443 O

Distal 0 6 444 450 O
biliary 7 14 451 458 B-chronic_disease
obstruction 15 26 459 470 I-chronic_disease
consistent 27 37 471 481 O
with 38 42 482 486 O
pancreatic 43 53 487 497 B-cancer
cancer 54 60 498 504 I-cancer
, 60 61 504 505 O
distal 62 68 506 512 B-cancer
CBD 69 72 513 516 I-cancer
cholangiocarcinoma 73 91 517 535 I-cancer
or 92 94 536 538 O
other 95 100 539 544 O
periampullary 101 114 545 558 B-cancer
malignancy 115 125 559 569 I-cancer

Endoscopic 0 10 570 580 B-treatment
and 11 14 581 584 O
surgical 15 23 585 593 B-treatment
treatment 24 33 594 603 I-treatment
to 34 36 604 606 O
be 37 39 607 609 O
provided 40 48 610 618 O
by 49 51 619 621 O
same 52 56 622 626 O
team 57 61 627 631 O

Location 0 8 632 640 O
of 9 11 641 643 O
distal 12 18 644 650 B-chronic_disease
biliary 19 26 651 658 I-chronic_disease
obstruction 27 38 659 670 I-chronic_disease
is 39 41 671 673 O
such 42 46 674 678 O
that 47 51 679 683 O
it 52 54 684 686 O
would 55 60 687 692 O
allow 61 66 693 698 O
the 67 70 699 702 O
proximal 71 79 703 711 O
end 80 83 712 715 O
of 84 86 716 718 O
a 87 88 719 720 O
stent 89 94 721 726 O
to 95 97 727 729 O
be 98 100 730 732 O
positioned 101 111 733 743 O
at 112 114 744 746 O
least 115 120 747 752 O
2 121 122 753 754 B-lower_bound
cm 122 124 754 756 I-lower_bound
from 125 129 757 761 O
the 130 133 762 765 O
hilum 134 139 766 771 O

Neoadjuvant 0 11 772 783 B-treatment
chemotherapy 12 24 784 796 I-treatment
for 25 28 797 800 O
current 29 36 801 808 O
malignancy 37 47 809 819 B-cancer

Participation 0 13 820 833 O
in 14 16 834 836 O
another 17 24 837 844 O
investigational 25 40 845 860 O
trial 41 46 861 866 O
within 47 53 867 873 O
90 54 56 874 876 B-upper_bound
days 57 61 877 881 I-upper_bound

Pregnancy 0 9 882 891 B-pregnancy

Previous 0 8 892 900 B-treatment
biliary 9 16 901 908 I-treatment
drainage 17 25 909 917 I-treatment
by 26 28 918 920 I-treatment
ERCP 29 33 921 925 I-treatment
/ 33 34 925 926 I-treatment
PTC 34 37 926 929 I-treatment

Surgery 0 7 930 937 B-treatment
intent 8 14 938 944 O
within 15 21 945 951 O
4 22 23 952 953 B-upper_bound
weeks 24 29 954 959 I-upper_bound

Surgically 0 10 960 970 O
altered 11 18 971 978 O
biliary 19 26 979 986 O
tract 27 32 987 992 O
anatomy 33 40 993 1000 O
, 40 41 1000 1001 O
not 42 45 1002 1005 O
including 46 55 1006 1015 O
prior 56 61 1016 1021 B-treatment
cholecystectomy 62 77 1022 1037 I-treatment

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
and 16 19 16 19 O
older 20 25 20 25 O

Diabetes 0 8 26 34 B-chronic_disease
requiring 9 18 35 44 O
insulin 19 26 45 52 B-treatment

Fluent 0 6 53 59 B-language_fluency
in 7 9 60 62 I-language_fluency
English 10 17 63 70 I-language_fluency
or 18 20 71 73 O
Spanish 21 28 74 81 B-language_fluency

History 0 7 82 89 O
of 8 10 90 92 O
allergies 11 20 93 102 O
to 21 23 103 105 O
the 24 27 106 109 O
nicotine 28 36 110 118 B-allergy_name
patches 37 44 119 126 I-allergy_name

Pregnant 0 8 127 135 B-pregnancy
women 9 14 136 141 B-gender

Psychotic 0 9 142 151 B-chronic_disease
or 10 12 152 154 O
disabling 13 22 155 164 B-chronic_disease
psychiatric 23 34 165 176 I-chronic_disease
disorders 35 44 177 186 I-chronic_disease

Temporal 0 8 187 195 B-chronic_disease
- 8 9 195 196 I-chronic_disease
mandibular 9 19 196 206 I-chronic_disease
joint 20 25 207 212 I-chronic_disease
disease 26 33 213 220 I-chronic_disease

Treatment 0 9 221 230 B-treatment
for 10 13 231 234 I-treatment
vascular 14 22 235 243 I-treatment
problems 23 31 244 252 I-treatment

kidney 0 6 253 259 B-chronic_disease
disease 7 14 260 267 I-chronic_disease

women 0 5 268 273 B-gender
that 6 10 274 278 O
are 11 14 279 282 O
breastfeeding 15 28 283 296 O

taking 0 6 0 6 O
estrogen 7 15 7 15 B-treatment
supplements 16 27 16 27 I-treatment
or 28 30 28 30 O
oral 31 35 31 35 B-contraception_consent
contraceptive 36 49 36 49 I-contraception_consent
pills 50 55 50 55 I-contraception_consent
( 56 57 56 57 O
for 57 60 57 60 O
women 61 66 61 66 B-gender
) 66 67 66 67 O

A 0 1 0 1 O
life 2 6 2 6 B-clinical_variable
expectancy 7 17 7 17 I-clinical_variable
( 18 19 18 19 O
assessed 19 27 19 27 O
by 28 30 28 30 O
investigator 31 43 31 43 O
) 43 44 43 44 O
of 45 47 45 47 O
less 48 52 48 52 O
than 53 57 53 57 O
6 58 59 58 59 B-upper_bound
months 60 66 60 66 I-upper_bound

Be 0 2 67 69 O
an 3 5 70 72 O
experienced 6 17 73 84 O
opioid 18 24 85 91 O
user 25 29 92 96 O
, 29 30 96 97 O
defined 31 38 98 105 O
as 39 41 106 108 O
any 42 45 109 112 O
subject 46 53 113 120 O
treated 54 61 121 128 O
with 62 66 129 133 O
opioid 67 73 134 140 B-treatment
therapy 74 81 141 148 I-treatment
, 81 82 148 149 O
equivalent 83 93 150 160 O
or 94 96 161 163 O
equal 97 102 164 169 O
to 103 105 170 172 O
> 106 107 173 174 O
20 107 109 174 176 B-lower_bound
mg 110 112 177 179 I-lower_bound
per 113 116 180 183 O
day 117 120 184 187 O
of 121 123 188 190 O
morphine 124 132 191 199 B-treatment
, 132 133 199 200 O
for 134 137 201 204 O
a 138 139 205 206 O
period 140 146 207 213 O
of 147 149 214 216 O
3 150 151 217 218 O
consecutive 152 163 219 230 O
days 164 168 231 235 O
immediately 169 180 236 247 O
prior 181 186 248 253 O
to 187 189 254 256 O
first 190 195 257 262 O
day 196 199 263 266 O
of 200 202 267 269 O
dosing 203 209 270 276 O

Columbia 0 8 277 285 B-clinical_variable
- 8 9 285 286 I-clinical_variable
Suicide 9 16 286 293 I-clinical_variable
Severity 17 25 294 302 I-clinical_variable
Rating 26 32 303 309 I-clinical_variable
Scale 33 38 310 315 I-clinical_variable
( 39 40 316 317 I-clinical_variable
C 40 41 317 318 I-clinical_variable
- 41 42 318 319 I-clinical_variable
SSRS 42 46 319 323 I-clinical_variable
) 46 47 323 324 I-clinical_variable
for 48 51 325 328 O
suicidal 52 60 329 337 B-chronic_disease
ideation 61 69 338 346 I-chronic_disease
and 70 73 347 350 O
behavior 74 82 351 359 O
in 83 85 360 362 O
past 86 90 363 367 O
year 91 95 368 372 O

Hypersensitivity 0 16 373 389 O
to 17 19 390 392 O
morphine 20 28 393 401 B-allergy_name
, 28 29 401 402 O
naltrexone 30 40 403 413 B-allergy_name

Undergone 0 9 414 423 O
surgery 10 17 424 431 B-treatment
within 18 24 432 438 O
3 25 26 439 440 B-upper_bound
days 27 31 441 445 I-upper_bound
prior 32 37 446 451 I-upper_bound
to 38 40 452 454 O
the 41 44 455 458 O
first 45 50 459 464 O
day 51 54 465 468 O
of 55 57 469 471 O
dosing 58 64 472 478 O

with 0 4 479 483 O
moderate 5 13 484 492 O
to 14 16 493 495 O
severe 17 23 496 502 O
pain 24 28 503 507 O
requiring 29 38 508 517 O
around 39 45 518 524 O
the 46 49 525 528 O
clock 50 55 529 534 O
treatment 56 65 535 544 B-treatment
with 66 70 545 549 I-treatment
an 71 73 550 552 I-treatment
opioid 74 80 553 559 I-treatment
analgesic 81 90 560 569 I-treatment

Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
or 17 19 17 19 O
received 20 28 20 28 O
antibiotics 29 40 29 40 B-treatment
within 41 47 41 47 O
2 48 49 48 49 B-upper_bound
months 50 56 50 56 I-upper_bound
of 57 59 57 59 O
study 60 65 60 65 O
enrollment 66 76 66 76 O

Elevated 0 8 77 85 O
TMAO 9 13 86 90 B-clinical_variable
metabolizers 14 26 91 103 I-clinical_variable
( 27 28 104 105 O
> 28 29 105 106 O
5 29 30 106 107 B-lower_bound
µM 31 33 108 110 I-lower_bound
) 33 34 110 111 O
based 35 40 112 117 O
on 41 43 118 120 O
screening 44 53 121 130 O
test 54 58 131 135 O

Having 0 6 136 142 O
undergone 7 16 143 152 O
bariatric 17 26 153 162 B-treatment
procedures 27 37 163 173 I-treatment
or 38 40 174 176 O
surgeries 41 50 177 186 B-treatment
such 51 55 187 191 O
as 56 58 192 194 O
gastric 59 66 195 202 B-treatment
banding 67 74 203 210 I-treatment
or 75 77 211 213 O
bypass 78 84 214 220 B-treatment

Men 0 3 221 224 B-gender

Pregnancy 0 9 225 234 B-pregnancy

Significant 0 11 235 246 O
chronic 12 19 247 254 B-chronic_disease
illness 20 27 255 262 I-chronic_disease
or 28 30 263 265 O
end 31 34 266 269 B-chronic_disease
- 34 35 269 270 I-chronic_disease
organ 35 40 270 275 I-chronic_disease
dysfunction 41 52 276 287 I-chronic_disease
, 52 53 287 288 O
including 54 63 289 298 O
known 64 69 299 304 O
history 70 77 305 312 O
of 78 80 313 315 O
uncompensated 81 94 316 329 B-chronic_disease
heart 95 100 330 335 I-chronic_disease
failure 101 108 336 343 I-chronic_disease
, 108 109 343 344 O
renal 110 115 345 350 B-chronic_disease
failure 116 123 351 358 I-chronic_disease
, 123 124 358 359 O
pulmonary 125 134 360 369 B-chronic_disease
disease 135 142 370 377 I-chronic_disease
, 142 143 377 378 O
hematologic 144 155 379 390 B-chronic_disease
diseases 156 164 391 399 I-chronic_disease

Use 0 3 400 403 O
of 4 6 404 406 O
over 7 11 407 411 O
- 11 12 411 412 O
the 12 15 412 415 O
- 15 16 415 416 O
counter 16 23 416 423 O
probiotic 24 33 424 433 O
within 34 40 434 440 O
past 41 45 441 445 O
month 46 51 446 451 O
, 51 52 451 452 O
or 53 55 453 455 O
ingestion 56 65 456 465 O
of 66 68 466 468 O
yogurt 69 75 469 475 O
within 76 82 476 482 O
past 83 87 483 487 B-upper_bound
7 88 89 488 489 I-upper_bound
days 90 94 490 494 I-upper_bound

Willing 0 7 495 502 O
to 8 10 503 505 O
remain 11 17 506 512 O
on 18 20 513 515 O
aspirin 21 28 516 523 B-treatment
or 29 31 524 526 O
able 32 36 527 531 O
to 37 39 532 534 O
be 40 42 535 537 O
off 43 46 538 541 O
aspirin 47 54 542 549 O
or 55 57 550 552 O
aspirin 58 65 553 560 B-treatment
products 66 74 561 569 I-treatment
for 75 78 570 573 O
1 79 80 574 575 B-upper_bound
week 81 85 576 580 I-upper_bound
prior 86 91 581 586 I-upper_bound
to 92 94 587 589 O
starting 95 103 590 598 O
study 104 109 599 604 O
and 110 113 605 608 O
staying 114 121 609 616 O
on 122 124 617 619 O
the 125 128 620 623 O
same 129 133 624 628 O
aspirin 134 141 629 636 B-treatment
regimen 142 149 637 644 I-treatment
during 150 156 645 651 O
the 157 160 652 655 O
duration 161 169 656 664 O
of 170 172 665 667 O
the 173 176 668 671 O
12 177 179 672 674 B-upper_bound
- 179 180 674 675 I-upper_bound
week 180 184 675 679 I-upper_bound
study 185 190 680 685 O

age 0 3 686 689 B-age
18 4 6 690 692 B-lower_bound
years 7 12 693 698 I-lower_bound
or 13 15 699 701 O
above 16 21 702 707 O

women 0 5 708 713 B-gender

Children 0 8 0 8 O
diagnosis 9 18 9 18 O
with 19 23 19 23 O
Spastic 24 31 24 31 B-chronic_disease
Diplegia 32 40 32 40 I-chronic_disease
and 41 44 41 44 O
having 45 51 45 51 O
Selective 52 61 52 61 B-treatment
Dorsal 62 68 62 68 I-treatment
Rhizotomy 69 78 69 78 I-treatment
surgery 79 86 79 86 I-treatment

No 0 2 87 89 O
Selective 3 12 90 99 B-treatment
Dorsal 13 19 100 106 I-treatment
Rhizotomy 20 29 107 116 I-treatment
surgery 30 37 117 124 I-treatment

Institutionalized 0 17 0 17 O
women 18 23 18 23 B-gender
with 24 28 24 28 O
subacute 29 37 29 37 O
illnesses 38 47 38 47 O
surviving 48 57 48 57 O
or 58 60 58 60 O
discharged 61 71 61 71 O
in 72 74 72 74 O
< 75 76 75 76 O
3 77 78 77 78 B-upper_bound
years 79 84 79 84 I-upper_bound

Men 0 3 85 88 B-gender
because 4 11 89 96 O
osteoporosis 12 24 97 109 B-chronic_disease
is 25 27 110 112 O
less 28 32 113 117 O
common 33 39 118 124 O
in 40 42 125 127 O
men 43 46 128 131 B-gender

Patients 0 8 132 140 O
with 9 13 141 145 O
a 14 15 146 147 O
calculated 16 26 148 158 B-clinical_variable
creatinine 27 37 159 169 I-clinical_variable
clearance 38 47 170 179 I-clinical_variable
< 48 49 180 181 O
35 50 52 182 184 B-upper_bound
ml 53 55 185 187 I-upper_bound
/ 55 56 187 188 I-upper_bound
min 56 59 188 191 I-upper_bound

Women 0 5 192 197 B-gender
currently 6 15 198 207 O
on 16 18 208 210 O
bisphosphonate 19 33 211 225 B-treatment
, 33 34 225 226 O
denosumab 35 44 227 236 B-treatment
, 44 45 236 237 O
or 46 48 238 240 O
teriparatide 49 61 241 253 B-treatment
therapy 62 69 254 261 I-treatment
or 70 72 262 264 O
who 73 76 265 268 O
have 77 81 269 273 O
been 82 86 274 278 O
on 87 89 279 281 O
a 90 91 282 283 O
bisphosphonate 92 106 284 298 O
for 107 110 299 302 O
greater 111 118 303 310 O
than 119 123 311 315 O
1 124 125 316 317 B-lower_bound
year 126 130 318 322 I-lower_bound
during 131 137 323 329 O
the 138 141 330 333 O
previous 142 150 334 342 B-upper_bound
2 151 152 343 344 I-upper_bound
years 153 158 345 350 I-upper_bound
because 159 166 351 358 O
bisphosphonates 167 182 359 374 B-treatment
are 183 186 375 378 O
long 187 191 379 383 O
acting 192 198 384 390 O

age 0 3 391 394 B-age
≥65 4 7 395 398 O
years 8 13 399 404 I-lower_bound

have 0 4 405 409 O
a 5 6 410 411 O
contraindication 7 23 412 428 O
for 24 27 429 432 O
bisphosphonates 28 43 433 448 B-treatment
( 44 45 449 450 O
allergy 45 52 450 457 O
, 52 53 457 458 O
hypocalcemia 54 66 459 471 B-chronic_disease
) 66 67 471 472 O

initial 0 7 473 480 O
ZEST 8 12 481 485 O
1 13 14 486 487 O
study 15 20 488 493 O
only 21 25 494 498 O
included 26 34 499 507 O
women 35 40 508 513 B-gender

osteoporosis 0 12 514 526 B-chronic_disease
by 13 15 527 529 O
axial 16 21 530 535 O
bone 22 26 536 540 O
density 27 34 541 548 O
( 35 36 549 550 O
spine 36 41 550 555 O
, 41 42 555 556 O
hip 43 46 557 560 O
or 47 49 561 563 O
forearm 50 57 564 571 O
bone 58 62 572 576 B-clinical_variable
mineral 63 70 577 584 I-clinical_variable
density 71 78 585 592 I-clinical_variable
( 79 80 593 594 I-clinical_variable
BMD 80 83 594 597 I-clinical_variable
) 83 84 597 598 I-clinical_variable
T 85 86 599 600 I-clinical_variable
- 86 87 600 601 I-clinical_variable
score 87 92 601 606 I-clinical_variable
≤ 93 94 607 608 O
-2.5 95 99 609 613 O
SD 100 102 614 616 I-upper_bound
) 102 103 616 617 O

women 0 5 618 623 B-gender

would 0 5 624 629 O
be 6 8 630 632 O
treated 9 16 633 640 O
based 17 22 641 646 O
on 23 25 647 649 O
FRAX 26 30 650 654 O
National 31 39 655 663 O
Osteoporosis 40 52 664 676 O
Foundation 53 63 677 687 O
( 64 65 688 689 O
NOF 65 68 689 692 O
) 68 69 692 693 O
treatment 70 79 694 703 O
thresholds 80 90 704 714 O
of 91 93 715 717 O
a 94 95 718 719 O
10 96 98 720 722 O
year 99 103 723 727 O
risk 104 108 728 732 O
of 109 111 733 735 O
≥ 112 113 736 737 O
20 114 116 738 740 B-lower_bound
% 116 117 740 741 I-lower_bound
for 118 121 742 745 O
a 122 123 746 747 O
major 124 129 748 753 O
osteoporotic 130 142 754 766 O
fracture 143 151 767 775 O
or 152 154 776 778 O
≥ 155 156 779 780 O
3 157 158 781 782 B-lower_bound
% 158 159 782 783 I-lower_bound
for 160 163 784 787 O
hip 164 167 788 791 O
fracture 168 176 792 800 O
using 177 182 801 806 O
femoral 183 190 807 814 B-treatment
neck 191 195 815 819 I-treatment
BMD 196 199 820 823 I-treatment

Admission 0 9 0 9 O
within 10 16 10 16 O
72 17 19 17 19 B-upper_bound
hours 20 25 20 25 I-upper_bound
of 26 28 26 28 O
injury 29 35 29 35 O

Age 0 3 36 39 B-age
< 4 5 40 41 O
18 5 7 41 43 B-upper_bound

Age 0 3 44 47 B-age
≥ 4 5 48 49 O
18 6 8 50 52 B-lower_bound
years 9 14 53 58 I-lower_bound

Currently 0 9 59 68 O
treated 10 17 69 76 O
for 18 21 77 80 O
Chronic 22 29 81 88 B-chronic_disease
Obstructive 30 41 89 100 I-chronic_disease
Pulmonary 42 51 101 110 I-chronic_disease
Disease 52 59 111 118 I-chronic_disease
( 60 61 119 120 I-chronic_disease
COPD 61 65 120 124 I-chronic_disease
) 65 66 124 125 I-chronic_disease
, 66 67 125 126 O
asthma 68 74 127 133 B-chronic_disease
or 75 77 134 136 O
other 78 83 137 142 O
chronic 84 91 143 150 B-chronic_disease
pulmonary 92 101 151 160 I-chronic_disease
conditions 102 112 161 171 I-chronic_disease

History 0 7 172 179 O
of 8 10 180 182 O
Congestive 11 21 183 193 B-chronic_disease
Heart 22 27 194 199 I-chronic_disease
Failure 28 35 200 207 I-chronic_disease
( 36 37 208 209 I-chronic_disease
CHF 37 40 209 212 I-chronic_disease
) 40 41 212 213 I-chronic_disease
( 42 43 214 215 O
ejection 43 51 215 223 B-clinical_variable
fraction 52 60 224 232 I-clinical_variable
< 61 62 233 234 O
20 63 65 235 237 B-upper_bound
% 65 66 237 238 I-upper_bound
) 66 67 238 239 O

History 0 7 240 247 O
of 8 10 248 250 O
HIV 11 14 251 254 B-chronic_disease
or 15 17 255 257 O
AIDS 18 22 258 262 B-chronic_disease

History 0 7 263 270 O
of 8 10 271 273 O
cardiac 11 18 274 281 B-chronic_disease
arrhythmia 19 29 282 292 I-chronic_disease
requiring 30 39 293 302 O
medication 40 50 303 313 O

Malignancy 0 10 314 324 B-cancer
currently 11 20 325 334 O
undergoing 21 31 335 345 O
treatment 32 41 346 355 B-treatment
or 42 44 356 358 O
history 45 52 359 366 O
of 53 55 367 369 O
cancer 56 62 370 376 B-treatment
treatment 63 72 377 386 I-treatment
within 73 79 387 393 O
5 80 81 394 395 B-upper_bound
years 82 87 396 401 I-upper_bound

Medical 0 7 402 409 O
condition 8 17 410 419 O
requiring 18 27 420 429 O
glucocorticoid 28 42 430 444 B-treatment
treatment 43 52 445 454 I-treatment

Patients 0 8 455 463 O
unlikely 9 17 464 472 O
to 18 20 473 475 O
survive 21 28 476 483 O
injury 29 35 484 490 O
or 36 38 491 493 O
with 39 43 494 498 O
; 44 45 499 500 O
age 45 48 500 503 B-age
= 49 50 504 505 O
total 51 56 506 511 B-clinical_variable
burn 57 61 512 516 I-clinical_variable
size 62 66 517 521 I-clinical_variable
≥ 67 68 522 523 O
130 69 72 524 527 B-lower_bound

Pre 0 3 528 531 O
- 3 4 531 532 O
injury 4 10 532 538 O
medications 11 22 539 550 O
including 23 32 551 560 O
blocking 33 41 561 569 B-treatment
agents 42 48 570 576 I-treatment
( 49 50 577 578 I-treatment
alpha 50 55 578 583 I-treatment
or 56 58 584 586 I-treatment
beta 59 63 587 591 I-treatment
) 63 64 591 592 I-treatment
or 65 67 593 595 O
other 68 73 596 601 O
anti 74 78 602 606 B-treatment
- 78 79 606 607 I-treatment
arrhythmic 79 89 607 617 I-treatment
drugs 90 95 618 623 I-treatment

Pregnant 0 8 624 632 B-pregnancy
women 9 14 633 638 B-gender

≥ 0 1 639 640 O
20 2 4 641 643 B-lower_bound
% 4 5 643 644 I-lower_bound
Total 6 11 645 650 B-clinical_variable
Body 12 16 651 655 I-clinical_variable
Surface 17 24 656 663 I-clinical_variable
Area 25 29 664 668 I-clinical_variable
( 30 31 669 670 I-clinical_variable
TBSA 31 35 670 674 I-clinical_variable
) 35 36 674 675 I-clinical_variable
burn 37 41 676 680 O
with 42 46 681 685 O
anticipated 47 58 686 697 O
operation 59 68 698 707 O
need 69 73 708 712 O
on 74 76 713 715 O
admission 77 86 716 725 O

Any 0 3 0 3 O
dermatological 4 18 4 18 B-chronic_disease
disorder 19 27 19 27 I-chronic_disease
that 28 32 28 32 O
may 33 36 33 36 O
interfere 37 46 37 46 O
with 47 51 47 51 O
the 52 55 52 55 O
accurate 56 64 56 64 O
evaluation 65 75 65 75 O
of 76 78 76 78 O
the 79 82 79 82 O
subject 83 90 83 90 O
's 90 92 90 92 O
skin 93 97 93 97 O

Aspirin 0 7 98 105 B-treatment

Clinically 0 10 106 116 O
significant 11 22 117 128 O
unstable 23 31 129 137 B-chronic_disease
medical 32 39 138 145 I-chronic_disease
disorders 40 49 146 155 I-chronic_disease

Female 0 6 156 162 B-gender
subjects 7 15 163 171 I-gender

History 0 7 172 179 O
of 8 10 180 182 O
, 10 11 182 183 O
diabetes 12 20 184 192 B-chronic_disease
, 20 21 192 193 O
heart 22 27 194 199 B-chronic_disease
or 28 30 200 202 I-chronic_disease
kidney 31 37 203 209 I-chronic_disease
disease 38 45 210 217 I-chronic_disease

Hydochlorothiazide 0 18 218 236 B-treatment

Immunosuppressant 0 17 237 254 B-treatment
's 17 19 254 256 I-treatment

Males 0 5 257 262 B-gender

Muscle 0 6 263 269 B-treatment
relaxants 7 16 270 279 I-treatment

must 0 4 280 284 O
be 5 7 285 287 O
between 8 15 288 295 O
the 16 19 296 299 O
ages 20 24 300 304 B-age
of 25 27 305 307 O
30 28 30 308 310 B-lower_bound
to 31 33 311 313 O
65 34 36 314 316 B-upper_bound
years 37 42 317 322 I-upper_bound
of 43 45 323 325 O
age 46 49 326 329 O

planning 0 8 330 338 B-pregnancy
a 9 10 339 340 I-pregnancy
pregnancy 11 20 341 350 I-pregnancy

starting 0 8 351 359 O
two 9 12 360 363 B-upper_bound
weeks 13 18 364 369 I-upper_bound
before 19 25 370 376 O
onset 26 31 377 382 O
of 32 34 383 385 O
study 35 40 386 391 O
and 41 44 392 395 O
also 45 49 396 400 O
during 50 56 401 407 O
the 57 60 408 411 O
study 61 66 412 417 O

The 0 3 0 3 O
patient 4 11 4 11 O
carries 12 19 12 19 O
a 20 21 20 21 O
diagnosis 22 31 22 31 O
of 32 34 32 34 O
hereditary 35 45 35 45 B-chronic_disease
hemorrhagic 46 57 46 57 I-chronic_disease
telangiectasia 58 72 58 72 I-chronic_disease
( 73 74 73 74 I-chronic_disease
HHT 74 77 74 77 I-chronic_disease
) 77 78 77 78 I-chronic_disease

The 0 3 79 82 O
patient 4 11 83 90 O
has 12 15 91 94 O
a 16 17 95 96 O
history 18 25 97 104 O
of 26 28 105 107 O
HIV 29 32 108 111 B-chronic_disease
or 33 35 112 114 O
another 36 43 115 122 O
known 44 49 123 128 O
cause 50 55 129 134 O
of 56 58 135 137 O
immunosuppression 59 76 138 155 B-treatment

The 0 3 156 159 O
patient 4 11 160 167 O
has 12 15 168 171 O
had 16 19 172 175 O
prior 20 25 176 181 B-treatment
treatment 26 35 182 191 I-treatment
with 36 40 192 196 O
systemic 41 49 197 205 O
or 50 52 206 208 O
nasal 53 58 209 214 B-treatment
bevacizumab 59 70 215 226 I-treatment
within 71 77 227 233 O
the 78 81 234 237 O
past 82 86 238 242 B-upper_bound
year 87 91 243 247 I-upper_bound

The 0 3 248 251 O
patient 4 11 252 259 O
has 12 15 260 263 O
undergone 16 25 264 273 O
electrocautery 26 40 274 288 B-treatment
for 41 44 289 292 O
epistaxis 45 54 293 302 B-chronic_disease
within 55 61 303 309 O
the 62 65 310 313 O
6 66 67 314 315 B-upper_bound
months 68 74 316 322 I-upper_bound
prior 75 80 323 328 I-upper_bound
to 81 83 329 331 O
study 84 89 332 337 O
enrollment 90 100 338 348 O

The 0 3 349 352 O
patient 4 11 353 360 O
is 12 14 361 363 O
at 15 17 364 366 O
least 18 23 367 372 O
18 24 26 373 375 B-lower_bound
years 27 32 376 381 I-lower_bound
old 33 36 382 385 O

The 0 3 386 389 O
patient 4 11 390 397 O
is 12 14 398 400 O
pregnant 15 23 401 409 B-pregnancy

The 0 3 410 413 O
patient 4 11 414 421 O
is 12 14 422 424 O
to 15 17 425 427 O
undergo 18 25 428 435 O
treatment 26 35 436 445 B-treatment
with 36 40 446 450 O
electrocautery 41 55 451 465 B-treatment
in 56 58 466 468 O
the 59 62 469 472 O
operating 63 72 473 482 O
room 73 77 483 487 O
under 78 83 488 493 O
endoscopic 84 94 494 504 O
visualization 95 108 505 518 O

actively 0 8 519 527 O
taking 9 15 528 534 O
immunosuppressive 16 33 535 552 B-treatment
medications 34 45 553 564 I-treatment
due 46 49 565 568 O
to 50 52 569 571 O
organ 53 58 572 577 B-treatment
transplantation 59 74 578 593 I-treatment
, 74 75 593 594 O
rheumatoid 76 86 595 605 B-chronic_disease
disease 87 94 606 613 I-chronic_disease
, 94 95 613 614 O
or 96 98 615 617 O
other 99 104 618 623 O
medical 105 112 624 631 O
conditions 113 123 632 642 O

A 0 1 0 1 O
highly 2 8 2 8 O
probable 9 17 9 17 O
diagnosis 18 27 18 27 O
of 28 30 28 30 O
sarcoidosis 31 42 31 42 B-chronic_disease
, 42 43 42 43 O
as 44 46 44 46 O
determined 47 57 47 57 O
using 58 63 58 63 O
the 64 67 64 67 O
World 68 73 68 73 O
Association 74 85 74 85 O
for 86 89 86 89 O
Sarcoidosis 90 101 90 101 O
and 102 105 102 105 O
Other 106 111 106 111 O
Granulomatous 112 125 112 125 O
Disorders 126 135 126 135 O
( 136 137 136 137 O
WASOG 137 142 137 142 O
) 142 143 142 143 O
Sarcoidosis 144 155 144 155 O
Organ 156 161 156 161 O
Assessment 162 172 162 172 O
Instrument 173 183 173 183 O
( 184 185 184 185 O
Judson 185 191 185 191 O
et 192 194 192 194 O
al 195 197 195 197 O
. 197 198 197 198 O
, 198 199 198 199 O
2014 200 204 200 204 O
) 204 205 204 205 O
, 205 206 205 206 O
with 207 211 207 211 O
involvement 212 223 212 223 O
not 224 227 224 227 O
limited 228 235 228 235 O
to 236 238 236 238 O
the 239 242 239 242 O
central 243 250 243 250 O
nervous 251 258 251 258 O
system 259 265 259 265 O

If 0 2 266 268 O
on 3 5 269 271 O
steroids 6 14 272 280 B-treatment
, 14 15 280 281 O
on 16 18 282 284 O
a 19 20 285 286 O
stable 21 27 287 293 O
dose 28 32 294 298 O
of 33 35 299 301 O
the 36 39 302 305 O
medication 40 50 306 316 O
for 51 54 317 320 O
at 55 57 321 323 O
least 58 63 324 329 O
3 64 65 330 331 B-lower_bound
months 66 72 332 338 I-lower_bound

5th 0 3 0 3 O
edition 4 11 4 11 O
( 12 13 12 13 O
DSM 13 16 13 16 O
5 17 18 17 18 O
) 18 19 18 19 O
diagnosis 20 29 20 29 O
of 30 32 30 32 O
schizophrenia 33 46 33 46 B-chronic_disease
or 47 49 47 49 O
schizoaffective 50 65 50 65 B-chronic_disease
disorder 66 74 66 74 I-chronic_disease

A 0 1 75 76 O
minimum 2 9 77 84 O
average 10 17 85 92 O
rating 18 24 93 99 O
of 25 27 100 102 O
a 28 29 103 104 O
moderate 30 38 105 113 O
deficit 39 46 114 121 O
( 47 48 122 123 O
3 48 49 123 124 B-lower_bound
or 50 52 125 127 O
greater 53 60 128 135 O
on 61 63 136 138 O
a 64 65 139 140 O
0 66 67 141 142 B-lower_bound
- 67 68 142 143 O
4 68 69 143 144 B-upper_bound
scale 70 75 145 150 O
) 75 76 150 151 O
on 77 79 152 154 O
any 80 83 155 158 O
symptom 84 91 159 166 O
domain 92 98 167 173 O
within 99 105 174 180 O
the 106 109 181 184 O
affect 110 116 185 191 O
motivation 117 127 192 202 O
factor 128 134 203 209 O
of 135 137 210 212 O
the 138 141 213 216 O
Clinical 142 150 217 225 O
Assessment 151 161 226 236 O
Interview 162 171 237 246 O
for 172 175 247 250 O
Negative 176 184 251 259 O
Symptoms 185 193 260 268 O
( 194 195 269 270 O
CAINS 195 200 270 275 O
) 200 201 275 276 O

Age 0 3 277 280 B-age
between 4 11 281 288 O
18 12 14 289 291 B-lower_bound
and 15 18 292 295 O
75 19 21 296 298 B-upper_bound
years 22 27 299 304 I-upper_bound

Cognitive 0 9 305 314 B-chronic_disease
impairment 10 20 315 325 I-chronic_disease

Documented 0 10 326 336 O
history 11 18 337 344 O
of 19 21 345 347 O
serious 22 29 348 355 O
neurological 30 42 356 368 B-chronic_disease
disorder 43 51 369 377 I-chronic_disease

anhedonia 0 9 378 387 B-chronic_disease

avolition 0 9 388 397 B-chronic_disease

defined 0 7 398 405 O
as 8 10 406 408 O
a 11 12 409 410 O
total 13 18 411 416 B-clinical_variable
IQ 19 21 417 419 I-clinical_variable
score 22 27 420 425 I-clinical_variable
less 28 32 426 430 O
than 33 37 431 435 O
70 38 40 436 438 B-upper_bound
as 41 43 439 441 O
measured 44 52 442 450 O
by 53 55 451 453 O
the 56 59 454 457 O
Wechsler 60 68 458 466 O
Test 69 73 467 471 O
of 74 76 472 474 O
Adult 77 82 475 480 O
Reading 83 90 481 488 O
or 91 93 489 491 O
as 94 96 492 494 O
indicated 97 106 495 504 O
by 107 109 505 507 O
chart 110 115 508 513 O
review 116 122 514 520 O

head 0 4 521 525 B-chronic_disease
trauma 5 11 526 532 I-chronic_disease
with 12 16 533 537 O
loss 17 21 538 542 O
of 22 24 543 545 O
consciousness 25 38 546 559 O

symptoms 0 8 560 568 O
of 9 11 569 571 O
asociality 12 22 572 582 B-chronic_disease

BMI 0 3 0 3 B-bmi
less 4 8 4 8 O
than 9 13 9 13 O
or 14 16 14 16 O
equal 17 22 17 22 O
to 23 25 23 25 O
40 26 28 26 28 B-upper_bound

Neurological 0 12 29 41 B-chronic_disease
or 13 15 42 44 O
pulmonary 16 25 45 54 B-chronic_disease
problems 26 34 55 63 I-chronic_disease
that 35 39 64 68 O
severely 40 48 69 77 O
limit 49 54 78 83 O
function 55 63 84 92 O

Other 0 5 93 98 O
unstable 6 14 99 107 B-chronic_disease
orthopaedic 15 26 108 119 I-chronic_disease
conditions 27 37 120 130 I-chronic_disease
that 38 42 131 135 O
limit 43 48 136 141 O
function 49 57 142 150 O

Severe 0 6 151 157 B-clinical_variable
contralateral 7 20 158 171 I-clinical_variable
leg 21 24 172 175 I-clinical_variable
OA 25 27 176 178 I-clinical_variable
( 28 29 179 180 O
> 29 30 180 181 O
= 30 31 181 182 O
5/10 32 36 183 187 B-lower_bound
pain 37 41 188 192 O
with 42 46 193 197 O
stair 47 52 198 203 O
climbing 53 61 204 212 O
) 61 62 212 213 O

ALT 0 3 0 3 B-clinical_variable
( 4 5 4 5 I-clinical_variable
SGPT 5 9 5 9 I-clinical_variable
) 9 10 9 10 I-clinical_variable
less 11 15 11 15 O
than 16 20 16 20 O
or 21 23 21 23 O
equal 24 29 24 29 O
to 30 32 30 32 O
3.0 33 36 33 36 B-upper_bound
times 37 42 37 42 I-upper_bound
ULN 43 46 43 46 I-upper_bound

Age 0 3 47 50 B-age
> 4 5 51 52 O
18 5 7 52 54 B-lower_bound

Albumin 0 7 55 62 B-clinical_variable
> 8 9 63 64 O
2 10 11 65 66 B-lower_bound
g 12 13 67 68 I-lower_bound
/ 13 14 68 69 I-lower_bound
dL 14 16 69 71 I-lower_bound

Aspirin 0 7 72 79 B-treatment
or 8 10 80 82 O
salicylate 11 21 83 93 B-treatment
- 21 22 93 94 I-treatment
containing 22 32 94 104 I-treatment
products 33 41 105 113 I-treatment
, 41 42 113 114 O
which 43 48 115 120 O
may 49 52 121 124 O
increase 53 61 125 133 O
risk 62 66 134 138 O
of 67 69 139 141 O
hemorrhage 70 80 142 152 B-chronic_disease

At 0 2 153 155 O
least 3 8 156 161 O
3 9 10 162 163 B-lower_bound
half 11 15 164 168 O
- 15 16 168 169 O
lives 16 21 169 174 O
must 22 26 175 179 O
have 27 31 180 184 O
elapsed 32 39 185 192 O
since 40 45 193 198 O
monoclonal 46 56 199 209 B-treatment
antibody 57 65 210 218 I-treatment
treatment 66 75 219 228 I-treatment

At 0 2 229 231 O
least 3 8 232 237 O
six 9 12 238 241 B-lower_bound
weeks 13 18 242 247 I-lower_bound
must 19 23 248 252 O
have 24 28 253 257 O
elapsed 29 36 258 265 O
between 37 44 266 273 O
mitomycin 45 54 274 283 B-treatment
C 55 56 284 285 I-treatment
or 57 59 286 288 O
nitrosourea 60 71 289 300 B-treatment
treatment 72 81 301 310 I-treatment

Bilirubin 0 9 311 320 B-clinical_variable
( 10 11 321 322 I-clinical_variable
total 11 16 322 327 I-clinical_variable
) 16 17 327 328 I-clinical_variable
< 18 19 329 330 O
1.5 20 23 331 334 B-upper_bound
times 24 29 335 340 I-upper_bound
upper 30 35 341 346 I-upper_bound
limit 36 41 347 352 I-upper_bound
of 42 44 353 355 I-upper_bound
normal 45 51 356 362 I-upper_bound
( 52 53 363 364 I-upper_bound
ULN 53 56 364 367 I-upper_bound
) 56 57 367 368 I-upper_bound

Cardiac 0 7 369 376 O
Function 8 16 377 385 O
: 16 17 385 386 O
Left 18 22 387 391 B-clinical_variable
ventricular 23 34 392 403 I-clinical_variable
ejection 35 43 404 412 I-clinical_variable
fraction 44 52 413 421 I-clinical_variable
( 53 54 422 423 I-clinical_variable
EF 54 56 423 425 I-clinical_variable
) 56 57 425 426 I-clinical_variable
> 58 59 427 428 O
40 59 61 428 430 B-lower_bound
% 61 62 430 431 I-lower_bound
by 63 65 432 434 O
Echocardiogram 66 80 435 449 B-treatment
, 80 81 449 450 O
MUGA 82 86 451 455 B-treatment
, 86 87 455 456 O
or 88 90 457 459 O
cardiac 91 98 460 467 B-treatment
MR 99 101 468 470 I-treatment

Clinically 0 10 471 481 O
significant 11 22 482 493 O
systemic 23 31 494 502 O
illness 32 39 503 510 O
( 40 41 511 512 O
e.g. 41 45 512 516 O
serious 46 53 517 524 O
active 54 60 525 531 B-chronic_disease
infections 61 71 532 542 I-chronic_disease
or 72 74 543 545 O
significant 75 86 546 557 O
cardiac 87 94 558 565 B-chronic_disease
, 94 95 565 566 O
pulmonary 96 105 567 576 B-chronic_disease
, 105 106 576 577 O
hepatic 107 114 578 585 B-chronic_disease
or 115 117 586 588 O
other 118 123 589 594 O
organ 124 129 595 600 B-chronic_disease
dysfunction 130 141 601 612 I-chronic_disease
) 141 142 612 613 O
, 142 143 613 614 O
that 144 148 615 619 O
in 149 151 620 622 O
the 152 155 623 626 O
judgment 156 164 627 635 O
of 165 167 636 638 O
the 168 171 639 642 O
PI 172 174 643 645 O
would 175 180 646 651 O
compromise 181 191 652 662 O
the 192 195 663 666 O
patient 196 203 667 674 O
s 204 205 675 676 O
ability 206 213 677 684 O
to 214 216 685 687 O
tolerate 217 225 688 696 O
protocol 226 234 697 705 O
therapy 235 242 706 713 B-treatment
or 243 245 714 716 O
significantly 246 259 717 730 O
increase 260 268 731 739 O
the 269 272 740 743 O
risk 273 277 744 748 O
of 278 280 749 751 O
complications 281 294 752 765 O

Clopidogrel 0 11 766 777 B-treatment

Creatinine 0 10 778 788 B-clinical_variable
within 11 17 789 795 O
normal 18 24 796 802 B-clinical_variable
institutional 25 38 803 816 I-clinical_variable
limits 39 45 817 823 I-clinical_variable
or 46 48 824 826 O
creatinine 49 59 827 837 B-clinical_variable
clearance 60 69 838 847 I-clinical_variable
greater 70 77 848 855 O
than 78 82 856 860 O
or 83 85 861 863 O
equal 86 91 864 869 O
to 92 94 870 872 O
60 95 97 873 875 B-lower_bound
mL 98 100 876 878 I-lower_bound
/ 100 101 878 879 I-lower_bound
min/1.73 101 109 879 887 I-lower_bound
m^2 110 113 888 891 I-lower_bound
for 114 117 892 895 O
patients 118 126 896 904 O
with 127 131 905 909 O
creatinine 132 142 910 920 B-clinical_variable
levels 143 149 921 927 I-clinical_variable
above 150 155 928 933 O
institutional 156 169 934 947 B-clinical_variable
normal 170 176 948 954 I-clinical_variable

DLCO 0 4 955 959 B-clinical_variable
, 4 5 959 960 O
< 6 7 961 962 O
30 8 10 963 965 B-upper_bound
% 10 11 965 966 I-upper_bound
predicted 12 21 967 976 O
( 22 23 977 978 O
post 23 27 978 982 B-treatment
- 27 28 982 983 I-treatment
bronchodilator 28 42 983 997 I-treatment
) 42 43 997 998 O

Dextran 0 7 999 1006 B-treatment

Dipyridamole 0 12 1007 1019 B-treatment

Disease 0 7 1020 1027 O
amenable 8 16 1028 1036 O
to 17 19 1037 1039 O
biopsy 20 26 1040 1046 B-treatment
via 27 30 1047 1050 I-treatment
percutaneous 31 43 1051 1063 I-treatment
approach 44 52 1064 1072 O
or 53 55 1073 1075 O
other 56 61 1076 1081 O
minimally 62 71 1082 1091 B-treatment
invasive 72 80 1092 1100 I-treatment
procedures 81 91 1101 1111 I-treatment
such 92 96 1112 1116 O
as 97 99 1117 1119 O
thoracoscopy 100 112 1120 1132 B-treatment
, 112 113 1132 1133 O
bronchoscopy 114 126 1134 1146 B-treatment
, 126 127 1146 1147 O
laparoscopy 128 139 1148 1159 B-treatment
, 139 140 1159 1160 O
or 141 143 1161 1163 O
GI 144 146 1164 1166 B-treatment
endoscopy 147 156 1167 1176 I-treatment

ECOG 0 4 1177 1181 B-clinical_variable
status 5 11 1182 1188 I-clinical_variable
0 12 13 1189 1190 B-lower_bound
- 13 14 1190 1191 O
2 14 15 1191 1192 B-upper_bound

FEV 0 3 1193 1196 B-clinical_variable
, 3 4 1196 1197 O
< 5 6 1198 1199 O
30 7 9 1200 1202 B-upper_bound
% 9 10 1202 1203 I-upper_bound
predicted 11 20 1204 1213 O

Hemoglobin 0 10 1214 1224 B-clinical_variable
greater 11 18 1225 1232 O
than 19 23 1233 1237 O
or 24 26 1238 1240 O
equal 27 32 1241 1246 O
to 33 35 1247 1249 O
8 36 37 1250 1251 B-lower_bound
g 38 39 1252 1253 I-lower_bound
/ 39 40 1253 1254 I-lower_bound
dL 40 42 1254 1256 I-lower_bound
( 43 44 1257 1258 O
PRBC 44 48 1258 1262 B-treatment
transfusions 49 61 1263 1275 I-treatment
permitted 62 71 1276 1285 O
) 71 72 1285 1286 O

Hepatic 0 7 1287 1294 B-treatment
Function 8 16 1295 1303 I-treatment

Hypersensitivity 0 16 1304 1320 O
to 17 19 1321 1323 O
mithramycin 20 31 1324 1335 B-allergy_name

Normal 0 6 1336 1342 O
ionized 7 14 1343 1350 O
calcium 15 22 1351 1358 O
, 22 23 1358 1359 O
magnesium 24 33 1360 1369 O
and 34 37 1370 1373 O
phosphorus 38 48 1374 1384 O
( 49 50 1385 1386 O
can 50 53 1386 1389 O
be 54 56 1390 1392 O
on 57 59 1393 1395 O
oral 60 64 1396 1400 B-treatment
supplementation 65 80 1401 1416 I-treatment
) 80 81 1416 1417 O

Oxygen 0 6 1418 1424 B-clinical_variable
saturation 7 17 1425 1435 I-clinical_variable
greater 18 25 1436 1443 O
than 26 30 1444 1448 O
92 31 33 1449 1451 B-lower_bound
% 33 34 1451 1452 I-lower_bound
on 35 37 1453 1455 O
room 38 42 1456 1460 O
air 43 46 1461 1464 O

PT 0 2 1465 1467 B-clinical_variable
/ 2 3 1467 1468 I-clinical_variable
PTT 3 6 1468 1471 I-clinical_variable
within 7 13 1472 1478 O
normal 14 20 1479 1485 O
limits 21 27 1486 1492 O

Patients 0 8 1493 1501 O
may 9 12 1502 1505 O
have 13 17 1506 1510 O
received 18 26 1511 1519 O
localized 27 36 1520 1529 O
radiation 37 46 1530 1539 B-treatment
therapy 47 54 1540 1547 I-treatment
to 55 57 1548 1550 O
non 58 61 1551 1554 O
- 61 62 1554 1555 O
target 62 68 1555 1561 O
lesions 69 76 1562 1569 O
provided 77 85 1570 1578 O
that 86 90 1579 1583 O
the 91 94 1584 1587 O
radiotherapy 95 107 1588 1600 B-treatment
is 108 110 1601 1603 O
completed 111 120 1604 1613 O
14 121 123 1614 1616 B-upper_bound
days 124 128 1617 1621 I-upper_bound
prior 129 134 1622 1627 I-upper_bound
to 135 137 1628 1630 O
commencing 138 148 1631 1641 O
therapy 149 156 1642 1649 O
, 156 157 1649 1650 O
and 158 161 1651 1654 O
the 162 165 1655 1658 O
patient 166 173 1659 1666 O
has 174 177 1667 1670 O
recovered 178 187 1671 1680 O
from 188 192 1681 1685 O
any 193 196 1686 1689 O
toxicity 197 205 1690 1698 O

Patients 0 8 1699 1707 O
must 9 13 1708 1712 O
be 14 16 1713 1715 O
willing 17 24 1716 1723 O
to 25 27 1724 1726 O
undergo 28 35 1727 1734 O
2 36 37 1735 1736 O
tumor 38 43 1737 1742 B-cancer
biopsies 44 52 1743 1751 B-treatment

Patients 0 8 1752 1760 O
must 9 13 1761 1765 O
have 14 18 1766 1770 O
had 19 22 1771 1774 O
no 23 25 1775 1777 O
chemotherapy 26 38 1778 1790 B-treatment
, 38 39 1790 1791 O
biologic 40 48 1792 1800 B-treatment
therapy 49 56 1801 1808 I-treatment
, 56 57 1808 1809 O
or 58 60 1810 1812 O
radiation 61 70 1813 1822 B-treatment
therapy 71 78 1823 1830 I-treatment
for 79 82 1831 1834 O
their 83 88 1835 1840 O
malignancy 89 99 1841 1851 B-cancer
for 100 103 1852 1855 O
at 104 106 1856 1858 O
least 107 112 1859 1864 O
30 113 115 1865 1867 B-lower_bound
days 116 120 1868 1872 I-lower_bound
prior 121 126 1873 1878 I-lower_bound
to 127 129 1879 1881 O
treatment 130 139 1882 1891 B-treatment

Patients 0 8 1892 1900 O
must 9 13 1901 1905 O
have 14 18 1906 1910 O
had 19 22 1911 1914 O
or 23 25 1915 1917 O
refused 26 33 1918 1925 O
first 34 39 1926 1931 O
- 39 40 1931 1932 O
line 40 44 1932 1936 O
standard 45 53 1937 1945 O
chemotherapy 54 66 1946 1958 B-treatment
for 67 70 1959 1962 O
their 71 76 1963 1968 O
inoperable 77 87 1969 1979 B-cancer
malignancies 88 100 1980 1992 I-cancer

Patients 0 8 1993 2001 O
on 9 11 2002 2004 O
therapeutic 12 23 2005 2016 B-treatment
anticoagulation 24 39 2017 2032 I-treatment

Patients 0 8 2033 2041 O
who 9 12 2042 2045 O
are 13 16 2046 2049 O
concurrently 17 29 2050 2062 O
receiving 30 39 2063 2072 O
or 40 42 2073 2075 O
requiring 43 52 2076 2085 O
any 53 56 2086 2089 O
of 57 59 2090 2092 O
the 60 63 2093 2096 O
following 64 73 2097 2106 O
agents 74 80 2107 2113 O
, 80 81 2113 2114 O
which 82 87 2115 2120 O
may 88 91 2121 2124 O
increase 92 100 2125 2133 O
the 101 104 2134 2137 O
risk 105 109 2138 2142 O
for 110 113 2143 2146 O
mithramycin 114 125 2147 2158 B-treatment
related 126 133 2159 2166 O
toxicities 134 144 2167 2177 O
, 144 145 2177 2178 O
such 146 150 2179 2183 O
as 151 153 2184 2186 O
hemorrhage 154 164 2187 2197 B-chronic_disease

Patients 0 8 2198 2206 O
with 9 13 2207 2211 O
ABCB4 14 19 2212 2217 B-treatment
, 19 20 2217 2218 O
ABCB11 21 27 2219 2225 B-treatment
, 27 28 2225 2226 O
RALBP 29 34 2227 2232 B-treatment
or 35 37 2233 2235 O
CYP851 38 44 2236 2242 B-treatment
genotypes 45 54 2243 2252 O
associated 55 65 2253 2263 O
with 66 70 2264 2268 O
mithramycin 71 82 2269 2280 B-treatment
- 82 83 2280 2281 I-treatment
mediated 83 91 2281 2289 I-treatment
hepatotoxicity 92 106 2290 2304 I-treatment

Patients 0 8 2305 2313 O
with 9 13 2314 2318 O
any 14 17 2319 2322 O
of 18 20 2323 2325 O
the 21 24 2326 2329 O
following 25 34 2330 2339 O
pulmonary 35 44 2340 2349 B-chronic_disease
function 45 53 2350 2358 I-chronic_disease
abnormalities 54 67 2359 2372 I-chronic_disease

Patients 0 8 2373 2381 O
with 9 13 2382 2386 O
cerebral 14 22 2387 2395 B-cancer
metastases 23 33 2396 2406 I-cancer

Patients 0 8 2407 2415 O
with 9 13 2416 2420 O
evidence 14 22 2421 2429 O
of 23 25 2430 2432 O
active 26 32 2433 2439 B-chronic_disease
bleeding 33 41 2440 2448 I-chronic_disease
, 41 42 2448 2449 O
intratumoral 43 55 2450 2462 B-chronic_disease
hemorrhage 56 66 2463 2473 I-chronic_disease
or 67 69 2474 2476 O
history 70 77 2477 2484 O
of 78 80 2485 2487 O
bleeding 81 89 2488 2496 B-chronic_disease
diatheses 90 99 2497 2506 I-chronic_disease

Patients 0 8 2507 2515 O
with 9 13 2516 2520 O
history 14 21 2521 2528 O
of 22 24 2529 2531 O
HIV 25 28 2532 2535 B-chronic_disease
, 28 29 2535 2536 O
HBV 30 33 2537 2540 B-chronic_disease
or 34 36 2541 2543 O
HCV 37 40 2544 2547 B-chronic_disease
due 41 44 2548 2551 O
to 45 47 2552 2554 O
potentially 48 59 2555 2566 O
increased 60 69 2567 2576 O
risk 70 74 2577 2581 O
of 75 77 2582 2584 O
mithramycin 78 89 2585 2596 O
toxicity 90 98 2597 2605 O
in 99 101 2606 2608 O
this 102 106 2609 2613 O
population 107 117 2614 2624 O

Patients 0 8 2625 2633 O
with 9 13 2634 2638 O
measurable 14 24 2639 2649 O
inoperable 25 35 2650 2660 O
, 35 36 2660 2661 O
histologically 37 51 2662 2676 O
confirmed 52 61 2677 2686 O
primary 62 69 2687 2694 B-cancer
lung 70 74 2695 2699 I-cancer
and 75 78 2700 2703 O
esophageal 79 89 2704 2714 B-cancer
carcinomas 90 100 2715 2725 I-cancer
, 100 101 2725 2726 O
thymic 102 108 2727 2733 B-cancer
neoplasms 109 118 2734 2743 I-cancer
, 118 119 2743 2744 O
germ 120 124 2745 2749 B-cancer
cell 125 129 2750 2754 I-cancer
tumors 130 136 2755 2761 I-cancer
, 136 137 2761 2762 O
malignant 138 147 2763 2772 B-cancer
pleural 148 155 2773 2780 I-cancer
mesotheliomas 156 169 2781 2794 I-cancer
or 170 172 2795 2797 O
chest 173 178 2798 2803 B-cancer
wall 179 183 2804 2808 I-cancer
sarcomas 184 192 2809 2817 I-cancer

Peripheral 0 10 2818 2828 B-clinical_variable
ANC 11 14 2829 2832 I-clinical_variable
greater 15 22 2833 2840 O
than 23 27 2841 2845 O
or 28 30 2846 2848 O
equal 31 36 2849 2854 O
to 37 39 2855 2857 O
1500 40 44 2858 2862 B-lower_bound
/ 44 45 2862 2863 I-lower_bound
mm^3 45 49 2863 2867 I-lower_bound

Platelets 0 9 2868 2877 B-clinical_variable
greater 10 17 2878 2885 O
than 18 22 2886 2890 O
or 23 25 2891 2893 O
equal 26 31 2894 2899 O
to 32 34 2900 2902 O
100,000/ 35 43 2903 2911 B-lower_bound
mm^3 44 48 2912 2916 I-lower_bound
( 49 50 2917 2918 O
transfusion 50 61 2918 2929 B-treatment
independent 62 73 2930 2941 O
) 73 74 2941 2942 O

Sulfinpyrazone 0 14 2943 2957 B-treatment

Thrombolytic 0 12 2958 2970 B-treatment
agents 13 19 2971 2977 I-treatment

Valproic 0 8 2978 2986 B-treatment
acid 9 13 2987 2991 I-treatment

patients 0 8 2992 3000 O
with 9 13 3001 3005 O
gastric 14 21 3006 3013 B-cancer
, 21 22 3013 3014 O
colorectal 23 33 3015 3025 B-cancer
or 34 36 3026 3028 O
renal 37 42 3029 3034 B-cancer
cancers 43 50 3035 3042 I-cancer
and 51 54 3043 3046 O
sarcomas 55 63 3047 3055 B-cancer
metastatic 64 74 3056 3066 I-cancer
to 75 77 3067 3069 I-cancer
the 78 81 3070 3073 I-cancer
thorax 82 88 3074 3080 I-cancer

pregnant 0 8 3081 3089 B-pregnancy
females 9 16 3090 3097 B-gender
( 17 18 3098 3099 O
due 18 21 3099 3102 O
to 22 24 3103 3105 O
risk 25 29 3106 3110 O
to 30 32 3111 3113 O
fetus 33 38 3114 3119 O
or 39 41 3120 3122 O
newborn 42 49 3123 3130 O
, 49 50 3130 3131 O
and 51 54 3132 3135 O
lack 55 59 3136 3140 O
of 60 62 3141 3143 O
testing 63 70 3144 3151 O
for 71 74 3152 3155 O
excretion 75 84 3156 3165 O
in 85 87 3166 3168 O
breast 88 94 3169 3175 O
milk 95 99 3176 3180 O
) 99 100 3180 3181 O

prophylactic 0 12 3182 3194 B-treatment
anticoagulation 13 28 3195 3210 I-treatment
( 29 30 3211 3212 O
i.e. 30 34 3212 3216 O
intralumenal 35 47 3217 3229 B-treatment
heparin 48 55 3230 3237 I-treatment
) 55 56 3237 3238 O
for 57 60 3239 3242 O
venous 61 67 3243 3249 O
or 68 70 3250 3252 O
arterial 71 79 3253 3261 O
access 80 86 3262 3268 O
devices 87 94 3269 3276 O

specifically 0 12 3277 3289 O
occurring 13 22 3290 3299 O
as 23 25 3300 3302 O
an 26 28 3303 3305 O
isolated 29 37 3306 3314 O
incident 38 46 3315 3323 O
during 47 53 3324 3330 O
reversible 54 64 3331 3341 O
chemotherapy 65 77 3342 3354 B-treatment
induced 78 85 3355 3362 O
thrombocytopenia 86 102 3363 3379 B-chronic_disease

Participants 0 12 0 12 O
must 13 17 13 17 O
have 18 22 18 22 O
had 23 26 23 26 O
regular 27 34 27 34 O
( 35 36 35 36 O
22 36 38 36 38 B-lower_bound
- 38 39 38 39 O
45 39 41 39 41 B-upper_bound
day 42 45 42 45 I-upper_bound
) 45 46 45 46 O
menstrual 47 56 47 56 B-clinical_variable
cycles 57 63 57 63 I-clinical_variable
over 64 68 64 68 O
at 69 71 69 71 O
least 72 77 72 77 O
a 78 79 78 79 O
two 80 83 80 83 B-lower_bound
month 84 89 84 89 I-lower_bound
period 90 96 90 96 O
preceding 97 106 97 106 O
testing 107 114 107 114 O

Reproductive 0 12 115 127 O
age 13 16 128 131 B-age
women 17 22 132 137 B-gender
( 23 24 138 139 O
18 24 26 139 141 B-lower_bound
- 26 27 141 142 O
45 27 29 142 144 B-upper_bound
) 29 30 144 145 O

absence 0 7 146 153 O
of 8 10 154 156 O
regular 11 18 157 164 O
menses 19 25 165 171 O
( 26 27 172 173 O
including 27 36 173 182 O
current 37 44 183 190 O
pregnancy 45 54 191 200 B-pregnancy
, 54 55 200 201 O
recent 56 62 202 208 O
pregnancy 63 72 209 218 O
, 72 73 218 219 O
or 74 76 220 222 O
active 77 83 223 229 O
breast 84 90 230 236 O
feeding 91 98 237 244 O
) 98 99 244 245 O
unwilling 100 109 246 255 O
to 110 112 256 258 O
take 113 117 259 263 O
either 118 124 264 270 O
cyclic 125 131 271 277 O
or 132 134 278 280 O
combined 135 143 281 289 O
OCs 144 147 290 293 O

active 0 6 294 300 O
genitourinary 7 20 301 314 B-chronic_disease
infection 21 30 315 324 I-chronic_disease
in 31 33 325 327 O
the 34 37 328 331 O
last 38 42 332 336 B-upper_bound
four 43 47 337 341 I-upper_bound
weeks 48 53 342 347 I-upper_bound

presence 0 8 348 356 O
of 9 11 357 359 O
active 12 18 360 366 O
pelvic 19 25 367 373 B-cancer
or 26 28 374 376 I-cancer
abdominal 29 38 377 386 I-cancer
malignancies 39 51 387 399 I-cancer
( 52 53 400 401 O
primary 53 60 401 408 O
or 61 63 409 411 O
metastatic 64 74 412 422 O
) 74 75 422 423 O

presence 0 8 424 432 O
of 9 11 433 435 O
hypertension 12 24 436 448 B-chronic_disease
or 25 27 449 451 O
risk 28 32 452 456 O
for 33 36 457 460 O
developing 37 47 461 471 O
hypertension 48 60 472 484 O

unable 0 6 485 491 B-language_fluency
to 7 9 492 494 I-language_fluency
read 10 14 495 499 I-language_fluency
or 15 17 500 502 I-language_fluency
comprehend 18 28 503 513 I-language_fluency
the 29 32 514 517 I-language_fluency
informed 33 41 518 526 I-language_fluency
consent 42 49 527 534 I-language_fluency
in 50 52 535 537 I-language_fluency
English 53 60 538 545 I-language_fluency

unwilling 0 9 546 555 O
to 10 12 556 558 O
withdraw 13 21 559 567 O
from 22 26 568 572 O
OCs 27 30 573 576 O
for 31 34 577 580 O
two 35 38 581 584 B-upper_bound
months 39 45 585 591 I-upper_bound
prior 46 51 592 597 I-upper_bound
to 52 54 598 600 O
the 55 58 601 604 O
Aim 59 62 605 608 O
# 63 64 609 610 O
1 64 65 610 611 O
study 66 71 612 617 O
visit 72 77 618 623 O

Any 0 3 0 3 O
infant 4 10 4 10 O
who 11 14 11 14 O
, 14 15 14 15 O
in 16 18 16 18 O
the 19 22 19 22 O
opinion 23 30 23 30 O
of 31 33 31 33 O
his 34 37 34 37 O
or 38 40 38 40 O
her 41 44 41 44 O
pediatrician 45 57 45 57 O
or 58 60 58 60 O
the 61 64 61 64 O
investigators 65 78 65 78 O
, 78 79 78 79 O
has 80 83 80 83 O
a 84 85 84 85 O
major 86 91 86 91 O
medical 92 99 92 99 O
problem 100 107 100 107 O
( 108 109 108 109 O
such 109 113 109 113 O
as 114 116 114 116 O
cardiac 117 124 117 124 B-treatment
pathology 125 134 125 134 I-treatment
or 135 137 135 137 O
airway 138 144 138 144 B-chronic_disease
obstruction 145 156 145 156 I-chronic_disease
) 156 157 156 157 O
that 158 162 158 162 O
makes 163 168 163 168 O
participation 169 182 169 182 O
in 183 185 183 185 O
the 186 189 186 189 O
study 190 195 190 195 O
difficult 196 205 196 205 O

Infant 0 6 206 212 O
with 7 11 213 217 O
one 12 15 218 221 O
or 16 18 222 224 O
more 19 23 225 229 O
superficial 24 35 230 241 O
hemangiomas 36 47 242 253 B-cancer
in 48 50 254 256 O
the 51 54 257 260 O
preproliferative 55 71 261 277 O
phase 72 77 278 283 O
or 78 80 284 286 O
very 81 85 287 291 O
early 86 91 292 297 O
proliferative 92 105 298 311 O
growth 106 112 312 318 O
phase 113 118 319 324 O

Infants 0 7 325 332 O
already 8 15 333 340 O
on 16 18 341 343 O
other 19 24 344 349 O
treatment 25 34 350 359 B-treatment
prior 35 40 360 365 O
to 41 43 366 368 O
PDL 44 47 369 372 O
or 48 50 373 375 O
timolol 51 58 376 383 B-treatment
treatments 59 69 384 394 I-treatment
( 70 71 395 396 O
including 71 80 396 405 O
topical 81 88 406 413 B-treatment
, 88 89 413 414 O
systemic 90 98 415 423 B-treatment
steroids 99 107 424 432 I-treatment
or 108 110 433 435 O
other 111 116 436 441 B-treatment
agents 117 123 442 448 I-treatment
) 123 124 448 449 O

Infants 0 7 450 457 O
with 8 12 458 462 O
hemangiomas 13 24 463 474 B-cancer
that 25 29 475 479 O
threaten 30 38 480 488 O
vital 39 44 489 494 O
functions 45 54 495 504 O
( 55 56 505 506 O
e.g. 56 60 506 510 O
obstructing 61 72 511 522 O
the 73 76 523 526 O
airway 77 83 527 533 O
or 84 86 534 536 O
impairing 87 96 537 546 O
hearing 97 104 547 554 O
or 105 107 555 557 O
vision 108 114 558 564 O
) 114 115 564 565 O

More 0 4 566 570 O
pronounced 5 15 571 581 O
appearance 16 26 582 592 O
within 27 33 593 599 O
1 34 35 600 601 B-upper_bound
month 36 41 602 607 I-upper_bound
of 42 44 608 610 O
birth 45 50 611 616 O

Patients 0 8 617 625 O
with 9 13 626 630 O
asthma 14 20 631 637 B-chronic_disease
or 21 23 638 640 O
a 24 25 641 642 O
history 26 33 643 650 O
of 34 36 651 653 O
asthma 37 43 654 660 O
, 43 44 660 661 O
chronic 45 52 662 669 B-chronic_disease
obstructive 53 64 670 681 I-chronic_disease
pulmonary 65 74 682 691 I-chronic_disease
disease 75 82 692 699 I-chronic_disease
or 83 85 700 702 O
cardiovascular 86 100 703 717 B-chronic_disease
disease 101 108 718 725 I-chronic_disease
, 108 109 725 726 O
including 110 119 727 736 O
sinus 120 125 737 742 B-chronic_disease
bradycardia 126 137 743 754 I-chronic_disease
, 137 138 754 755 O
second 139 145 756 762 B-chronic_disease
or 146 148 763 765 I-chronic_disease
third 149 154 766 771 I-chronic_disease
degree 155 161 772 778 I-chronic_disease
atrioventricular 162 178 779 795 I-chronic_disease
block 179 184 796 801 I-chronic_disease
, 184 185 801 802 O
overt 186 191 803 808 B-chronic_disease
cardiac 192 199 809 816 I-chronic_disease
failure 200 207 817 824 I-chronic_disease
, 207 208 824 825 O
and 209 212 826 829 O
cardiogenic 213 224 830 841 B-chronic_disease
shock 225 230 842 847 I-chronic_disease
; 230 231 847 848 O
hypersensitivity 232 248 849 865 O
to 249 251 866 868 O
any 252 255 869 872 O
component 256 265 873 882 O
of 266 268 883 885 O
timolol 269 276 886 893 B-allergy_name
; 276 277 893 894 O
and 278 281 895 898 O
in 282 284 899 901 O
those 285 290 902 907 O
patients 291 299 908 916 O
receiving 300 309 917 926 O
systemic 310 318 927 935 O
administration 319 333 936 950 O
of 334 336 951 953 O
beta 337 341 954 958 B-allergy_name
- 341 342 958 959 I-allergy_name
blockers 342 350 959 967 I-allergy_name
or 351 353 968 970 O
ace 354 357 971 974 B-allergy_name
inhibitors 358 368 975 985 I-allergy_name

Scarring 0 8 986 994 O
or 9 11 995 997 O
infection 12 21 998 1007 B-chronic_disease
of 22 24 1008 1010 O
the 25 28 1011 1014 O
area 29 33 1015 1019 O
to 34 36 1020 1022 O
be 37 39 1023 1025 O
treated 40 47 1026 1033 O

Willingness 0 11 1034 1045 O
of 12 14 1046 1048 O
parent 15 21 1049 1055 O
/ 21 22 1055 1056 O
guardian 22 30 1056 1064 O
to 31 33 1065 1067 O
follow 34 40 1068 1074 O
the 41 44 1075 1078 O
treatment 45 54 1079 1088 B-treatment
schedule 55 63 1089 1097 O
and 64 67 1098 1101 O
post 68 72 1102 1106 O
treatment 73 82 1107 1116 O
care 83 87 1117 1121 O
requirements 88 100 1122 1134 O

Willingness 0 11 1135 1146 O
of 12 14 1147 1149 O
parent 15 21 1150 1156 O
/ 21 22 1156 1157 O
guardian 22 30 1157 1165 O
to 31 33 1166 1168 O
not 34 37 1169 1172 O
use 38 41 1173 1176 O
topical 42 49 1177 1184 B-treatment
or 50 52 1185 1187 I-treatment
systemic 53 61 1188 1196 I-treatment
( 62 63 1197 1198 I-treatment
oral 63 67 1198 1202 I-treatment
) 67 68 1202 1203 I-treatment
TREATMENT 69 78 1204 1213 I-treatment
medications 79 90 1214 1225 I-treatment
of 91 93 1226 1228 O
the 94 97 1229 1232 O
hemangioma 98 108 1233 1243 B-chronic_disease
other 109 114 1244 1249 O
than 115 119 1250 1254 O
those 120 125 1255 1260 O
prescribed 126 136 1261 1271 O
by 137 139 1272 1274 O
the 140 143 1275 1278 O
investigators 144 157 1279 1292 O
during 158 164 1293 1299 O
the 165 168 1300 1303 O
study 169 174 1304 1309 O
period 175 181 1310 1316 O

Willingness 0 11 1317 1328 O
of 12 14 1329 1331 O
parent 15 21 1332 1338 O
/ 21 22 1338 1339 O
guardian 22 30 1339 1347 O
to 31 33 1348 1350 O
receive 34 41 1351 1358 O
EXPERIMENTAL 42 54 1359 1371 O
treatment 55 64 1372 1381 B-treatment

aged 0 4 1382 1386 B-age
less 5 9 1387 1391 O
than 10 14 1392 1396 O
3 15 16 1397 1398 B-upper_bound
months 17 23 1399 1405 I-upper_bound

female 0 6 1406 1412 B-gender

male 0 4 1413 1417 B-gender

who 0 3 1418 1421 O
are 4 7 1422 1425 O
immunocompromised 8 25 1426 1443 B-chronic_disease

whose 0 5 1444 1449 O
parent 6 12 1450 1456 O
/ 12 13 1456 1457 O
guardian 13 21 1457 1465 O
is 22 24 1466 1468 O
unable 25 31 1469 1475 O
to 32 34 1476 1478 O
comply 35 41 1479 1485 O
with 42 46 1486 1490 O
treatment 47 56 1491 1500 B-treatment
, 56 57 1500 1501 O
home 58 62 1502 1506 O
care 63 67 1507 1511 O
or 68 70 1512 1514 O
follow 71 77 1515 1521 O
- 77 78 1521 1522 O
up 78 80 1522 1524 O
visits 81 87 1525 1531 O

Anabolic 0 8 0 8 B-treatment
or 9 11 9 11 I-treatment
Steroid 12 19 12 19 I-treatment
hormonal 20 28 20 28 I-treatment
therapy 29 36 29 36 I-treatment
; 36 37 36 37 O
within 38 44 38 44 O
the 45 48 45 48 O
past 49 53 49 53 O
year 54 58 54 58 O
and 59 62 59 62 O
longer 63 69 63 69 O
than 70 74 70 74 O
six 75 78 75 78 B-lower_bound
months 79 85 79 85 I-lower_bound

Any 0 3 86 89 O
patient 4 11 90 97 O
receiving 12 21 98 107 O
moderate 22 30 108 116 O
or 31 33 117 119 O
high 34 38 120 124 O
dose 39 43 125 129 O
corticosteroids 44 59 130 145 B-treatment
( 60 61 146 147 O
> 61 62 147 148 O
40 62 64 148 150 B-lower_bound
mg 65 67 151 153 I-lower_bound
/ 67 68 153 154 I-lower_bound
d 68 69 154 155 I-lower_bound
prednisone 70 80 156 166 B-treatment
or 81 83 167 169 O
an 84 86 170 172 O
equivalent 87 97 173 183 O
dose 98 102 184 188 O
of 103 105 189 191 O
other 106 111 192 197 O
corticosteroid 112 126 198 212 O
) 126 127 212 213 O
for 128 131 214 217 O
longer 132 138 218 224 O
than 139 143 225 229 O
one 144 147 230 233 B-lower_bound
week 148 152 234 238 I-lower_bound
, 152 153 238 239 O
not 154 157 240 243 O
including 158 167 244 253 O
drug 168 172 254 258 O
administered 173 185 259 271 O
in 186 188 272 274 O
an 189 191 275 277 O
attempt 192 199 278 285 O
to 200 202 286 288 O
preserve 203 211 289 297 O
neurological 212 224 298 310 O
function 225 233 311 319 O
at 234 236 320 322 O
the 237 240 323 326 O
time 241 245 327 331 O
of 246 248 332 334 O
acute 249 254 335 340 B-chronic_disease
SCI 255 258 341 344 I-chronic_disease

Any 0 3 345 348 O
patient 4 11 349 356 O
taking 12 18 357 363 O
a 19 20 364 365 O
bisphosphonate 21 35 366 380 B-treatment
for 36 39 381 384 O
heterotopic 40 51 385 396 B-chronic_disease
ossification 52 64 397 409 I-chronic_disease
( 65 66 410 411 I-chronic_disease
HO 66 68 411 413 I-chronic_disease
) 68 69 413 414 I-chronic_disease

Current 0 7 415 422 O
diagnosis 8 17 423 432 O
of 18 20 433 435 O
cancer 21 27 436 442 B-cancer

Cushing 0 7 443 450 B-chronic_disease
's 7 9 450 452 I-chronic_disease
disease 10 17 453 460 I-chronic_disease
or 18 20 461 463 I-chronic_disease
syndrome 21 29 464 472 I-chronic_disease

Diagnosis 0 9 473 482 O
of 10 12 483 485 O
Hypocalcemia 13 25 486 498 B-chronic_disease

Duration 0 8 499 507 O
of 9 11 508 510 O
injury 12 18 511 517 O
< 19 20 518 519 O
12 20 22 519 521 B-upper_bound
weeks 23 28 522 527 I-upper_bound

Extensive 0 9 528 537 O
life 10 14 538 542 O
- 14 15 542 543 O
threatening 15 26 543 554 O
injuries 27 35 555 563 O
in 36 38 564 566 O
addition 39 47 567 575 O
to 48 50 576 578 O
SCI 51 54 579 582 B-chronic_disease

Heterotopic 0 11 583 594 B-chronic_disease
ossification 12 24 595 607 I-chronic_disease
of 25 27 608 610 O
the 28 31 611 614 O
knee 32 36 615 619 O
region 37 43 620 626 O

History 0 7 627 634 O
of 8 10 635 637 O
chronic 11 18 638 645 B-chronic_disease
alcohol 19 26 646 653 I-chronic_disease
abuse 27 32 654 659 I-chronic_disease

History 0 7 660 667 O
of 8 10 668 670 O
prior 11 16 671 676 O
bone 17 21 677 681 B-chronic_disease
disease 22 29 682 689 I-chronic_disease
( 30 31 690 691 O
Paget 31 36 691 696 B-chronic_disease
's 36 38 696 698 I-chronic_disease
hyperparathyroidism 39 58 699 718 I-chronic_disease
, 58 59 718 719 O
osteoporosis 60 72 720 732 B-chronic_disease
, 72 73 732 733 O
etc 74 77 734 737 O
. 77 78 737 738 O
) 78 79 738 739 O

Hyperthyroidism 0 15 740 755 B-chronic_disease

Males 0 5 756 761 B-gender

Men 0 3 762 765 B-gender
with 4 8 766 770 O
known 9 14 771 776 O
hypogonadism 15 27 777 789 B-chronic_disease
prior 28 33 790 795 O
to 34 36 796 798 O
SCI 37 40 799 802 O

Post 0 4 803 807 O
menopausal 5 15 808 818 O
women 16 21 819 824 B-gender

Pregnancy 0 9 825 834 B-pregnancy

between 0 7 835 842 O
the 8 11 843 846 O
ages 12 16 847 851 B-age
of 17 19 852 854 O
18 20 22 855 857 B-lower_bound
and 23 26 858 861 O
50 27 29 862 864 B-upper_bound
years 30 35 865 870 I-upper_bound
old 36 39 871 874 I-upper_bound

between 0 7 875 882 O
the 8 11 883 886 O
ages 12 16 887 891 B-age
of 17 19 892 894 O
18 20 22 895 897 B-lower_bound
and 23 26 898 901 O
65 27 29 902 904 B-upper_bound
years 30 35 905 910 I-upper_bound
old 36 39 911 914 O

females 0 7 915 922 B-gender

history 0 7 923 930 O
of 8 10 931 933 O
cancer 11 17 934 940 B-cancer

A 0 1 0 1 O
non 2 5 2 5 O
- 5 6 5 6 O
traditional 6 17 6 17 O
form 18 22 18 22 O
of 23 25 23 25 O
HF 26 28 26 28 B-chronic_disease
( 29 30 29 30 O
hypertrophic 30 42 30 42 B-chronic_disease
or 43 45 43 45 O
restrictive 46 57 46 57 B-chronic_disease
forms 58 63 58 63 I-chronic_disease
of 64 66 64 66 I-chronic_disease
cardiomyopathy 67 81 67 81 I-chronic_disease
, 81 82 81 82 O
congenital 83 93 83 93 B-chronic_disease
heart 94 99 94 99 I-chronic_disease
disease 100 107 100 107 I-chronic_disease
or 108 110 108 110 O
Takotsubo 111 120 111 120 B-chronic_disease
cardiomyopathy 121 135 121 135 I-chronic_disease
) 135 136 135 136 O

Chronic 0 7 137 144 B-chronic_disease
renal 8 13 145 150 I-chronic_disease
failure 14 21 151 158 I-chronic_disease

Currently 0 9 159 168 O
enrolled 10 18 169 177 O
in 19 21 178 180 O
another 22 29 181 188 B-treatment
experimental 30 42 189 201 I-treatment
HF 43 45 202 204 I-treatment
research 46 54 205 213 I-treatment
study 55 60 214 219 I-treatment

Minimum 0 7 220 227 O
age 8 11 228 231 B-age
18 12 14 232 234 B-lower_bound
years 15 20 235 240 I-lower_bound
( 21 22 241 242 O
no 22 24 242 244 O
upper 25 30 245 250 O
age 31 34 251 254 O
limit 35 40 255 260 O
) 40 41 260 261 O

Not 0 3 262 265 O
referred 4 12 266 274 O
for 13 16 275 278 O
cardiac 17 24 279 286 B-treatment
transplantation 25 40 287 302 I-treatment

adhere 0 6 303 309 O
to 7 9 310 312 O
self 10 14 313 317 O
- 14 15 317 318 O
care 15 19 318 322 O
recommendations 20 35 323 338 O
( 36 37 339 340 O
Alzheimer 37 46 340 349 B-chronic_disease
's 46 48 349 351 I-chronic_disease
condition 49 58 352 361 O
, 58 59 361 362 O
dementia 60 68 363 371 B-chronic_disease
, 68 69 371 372 O
schizophrenia 70 83 373 386 B-chronic_disease
, 83 84 386 387 O
other 85 90 388 393 O
neurological 91 103 394 406 B-chronic_disease
history 104 111 407 414 O
that 112 116 415 419 O
impairs 117 124 420 427 O
memory 125 131 428 434 O
) 131 132 434 435 O

cachexia 0 8 436 444 B-chronic_disease
, 8 9 444 445 O
end 10 13 446 449 B-chronic_disease
stage 14 19 450 455 I-chronic_disease
liver 20 25 456 461 I-chronic_disease
disease 26 33 462 469 I-chronic_disease
or 34 36 470 472 O
cancer 37 43 473 479 B-cancer
or 44 46 480 482 O
non 47 50 483 486 B-chronic_disease
- 50 51 486 487 I-chronic_disease
ambulatory 51 61 487 497 I-chronic_disease
New 62 65 498 501 I-chronic_disease
York 66 70 502 506 I-chronic_disease
Heart 71 76 507 512 I-chronic_disease
Association 77 88 513 524 I-chronic_disease
functional 89 99 525 535 I-chronic_disease
class 100 105 536 541 I-chronic_disease
IV 106 108 542 544 I-chronic_disease
heart 109 114 545 550 I-chronic_disease
failure 115 122 551 558 I-chronic_disease

cognitive 0 9 559 568 B-chronic_disease
conditions 10 20 569 579 I-chronic_disease
that 21 25 580 584 O
limit 26 31 585 590 O
ability 32 39 591 598 O
to 40 42 599 601 O
understand 43 53 602 612 O

has 0 3 613 616 O
a 4 5 617 618 O
medical 6 13 619 626 O
condition 14 23 627 636 O
reflecting 24 34 637 647 O
less 35 39 648 652 O
than 40 44 653 657 O
1 45 46 658 659 B-upper_bound
year 47 51 660 664 I-upper_bound
of 52 54 665 667 O
survival 55 63 668 676 O

unable 0 6 677 683 O
to 7 9 684 686 O
carry 10 15 687 692 O
out 16 19 693 696 O
physical 20 28 697 705 O
activity 29 37 706 714 O
, 37 38 714 715 O
including 39 48 716 725 O
walking 49 56 726 733 O
, 56 57 733 734 O
due 57 60 734 737 O
to 61 63 738 740 O
a 64 65 741 742 O
chronic 66 73 743 750 B-chronic_disease
disability 74 84 751 761 I-chronic_disease
or 85 87 762 764 O
documented 88 98 765 775 O
medical 99 106 776 783 O
condition 107 116 784 793 O

Active 0 6 0 6 B-chronic_disease
psychosis 7 16 7 16 I-chronic_disease
and/or 17 23 17 23 O
a 24 25 24 25 O
suicide 26 33 26 33 B-chronic_disease
attempt 34 41 34 41 I-chronic_disease
in 42 44 42 44 O
the 45 48 45 48 O
previous 49 57 49 57 O
year 58 62 58 62 O

Eating 0 6 63 69 B-chronic_disease
disorders 7 16 70 79 I-chronic_disease

Enrolled 0 8 80 88 O
in 9 11 89 91 O
grades 12 18 92 98 B-lower_bound
3 19 20 99 100 I-lower_bound
- 20 21 100 101 O
7 21 22 101 102 B-upper_bound

Have 0 4 103 107 O
a 5 6 108 109 O
primary 7 14 110 117 O
clinical 15 23 118 126 O
problem 24 31 127 134 O
in 32 34 135 137 O
the 35 38 138 141 O
areas 39 44 142 147 O
of 45 47 148 150 O
anxiety 48 55 151 158 B-chronic_disease
, 55 56 158 159 O
depression 57 67 160 170 B-chronic_disease
, 67 68 170 171 O
conduct 69 76 172 179 O
, 76 77 179 180 O
or 78 80 181 183 O
posttraumatic 81 94 184 197 B-chronic_disease
stress 95 101 198 204 I-chronic_disease

Pervasive 0 9 205 214 B-chronic_disease
developmental 10 23 215 228 I-chronic_disease
disorder 24 32 229 237 I-chronic_disease

All 0 3 0 3 O
subjects 4 12 4 12 O
must 13 17 13 17 O
have 18 22 18 22 O
a 23 24 23 24 O
fresh 25 30 25 30 O
tumor 31 36 31 36 B-treatment
biopsy 37 43 37 43 I-treatment

Concomitant 0 11 44 55 O
malignancies 12 24 56 68 B-cancer

Major 0 5 69 74 B-clinical_variable
surgery 6 13 75 82 I-clinical_variable
less 14 18 83 87 O
than 19 23 88 92 O
4 24 25 93 94 B-upper_bound
weeks 26 31 95 100 I-upper_bound
before 32 38 101 107 O
the 39 42 108 111 O
start 43 48 112 117 O
of 49 51 118 120 O
the 52 55 121 124 O
study 56 61 125 130 O

Patients 0 8 131 139 O
with 9 13 140 144 O
known 14 19 145 150 O
allergies 20 29 151 160 O
to 30 32 161 163 O
egg 33 36 164 167 B-allergy_name
products 37 45 168 176 I-allergy_name
, 45 46 176 177 O
neomycin 47 55 178 186 B-allergy_name
, 55 56 186 187 O
or 57 59 188 190 O
tetanus 60 67 191 198 B-allergy_name
toxoid 68 74 199 205 I-allergy_name

Prior 0 5 206 211 O
adverse 6 13 212 219 O
reaction 14 22 220 228 O
to 23 25 229 231 O
tetanus 26 33 232 239 B-allergy_name
toxoid 34 40 240 246 I-allergy_name
- 40 41 246 247 I-allergy_name
containing 41 51 247 257 I-allergy_name
vaccines 52 60 258 266 I-allergy_name

Current 0 7 0 7 O
presence 8 16 8 16 O
of 17 19 17 19 O
a 20 21 20 21 O
clinically 22 32 22 32 O
significant 33 44 33 44 O
major 45 50 45 50 O
psychiatric 51 62 51 62 B-chronic_disease
disorder 63 71 63 71 I-chronic_disease
( 72 73 72 73 O
e.g. 73 77 73 77 O
major 78 83 78 83 B-chronic_disease
depressive 84 94 84 94 I-chronic_disease
disorder 95 103 95 103 I-chronic_disease
, 103 104 103 104 O
bipolar 105 112 105 112 B-chronic_disease
disorder 113 121 113 121 I-chronic_disease
, 121 122 121 122 O
schizophrenia 123 136 123 136 B-chronic_disease
, 136 137 136 137 O
etc 138 141 138 141 O
. 141 142 141 142 O
, 142 143 142 143 O
according 144 153 144 153 O
to 154 156 154 156 O
the 157 160 157 160 O
Diagnostic 161 171 161 171 O
and 172 175 172 175 O
Statistical 176 187 176 187 O
Manual 188 194 188 194 O
of 195 197 195 197 O
Mental 198 204 198 204 O
Disorders 205 214 205 214 O
, 214 215 214 215 O
4th 216 219 216 219 O
Edition 220 227 220 227 O
( 228 229 228 229 O
DSM 229 232 229 232 O
- 232 233 232 233 O
IV 233 235 233 235 O

Dermatological 0 14 236 250 O
skin 15 19 251 255 B-chronic_disease
disease 20 27 256 263 I-chronic_disease
of 28 30 264 266 O
the 31 34 267 270 O
scalp 35 40 271 276 O

History 0 7 277 284 O
of 8 10 285 287 O
cerebral 11 19 288 296 B-chronic_disease
infection 20 29 297 306 I-chronic_disease
/ 30 31 307 308 O
hemorrhage 32 42 309 319 B-chronic_disease

History 0 7 320 327 O
of 8 10 328 330 O
hydrocephalus 11 24 331 344 B-chronic_disease

History 0 7 345 352 O
of 8 10 353 355 O
subdural 11 19 356 364 B-chronic_disease
hygroma 20 27 365 372 I-chronic_disease
/ 28 29 373 374 O
subdural 30 38 375 383 B-chronic_disease
hematoma 39 47 384 392 I-chronic_disease

Must 0 4 393 397 O
be 5 7 398 400 O
55 8 10 401 403 B-lower_bound
years 11 16 404 409 I-lower_bound
of 17 19 410 412 O
age 20 23 413 416 B-age
or 24 26 417 419 O
older 27 32 420 425 O

Non 0 3 426 429 B-chronic_disease
- 3 4 429 430 I-chronic_disease
Alzheimer 4 13 430 439 I-chronic_disease
dementia 14 22 440 448 I-chronic_disease

Patient 0 7 449 456 O
currently 8 17 457 466 O
participating 18 31 467 480 O
in 32 34 481 483 O
another 35 42 484 491 B-treatment
Clinical 43 51 492 500 I-treatment
Trial 52 57 501 506 I-treatment

Patient 0 7 507 514 O
has 8 11 515 518 O
a 12 13 519 520 O
MMSE 14 18 521 525 B-treatment
score 19 24 526 531 I-treatment
of 25 27 532 534 O
between 28 35 535 542 O
10 36 38 543 545 B-lower_bound
- 38 39 545 546 O
20 39 41 546 548 B-upper_bound

Patient 0 7 549 556 O
has 8 11 557 560 O
estimated 12 21 561 570 B-clinical_variable
survival 22 30 571 579 I-clinical_variable
of 31 33 580 582 O
greater 34 41 583 590 O
than 42 46 591 595 O
12 47 49 596 598 B-lower_bound
months 50 56 599 605 I-lower_bound

Patient 0 7 606 613 O
has 8 11 614 617 O
evidence 12 20 618 626 O
of 21 23 627 629 O
substance 24 33 630 639 O
abuse 34 39 640 645 O
( 40 41 646 647 O
alcohol 41 48 647 654 O
/ 49 50 655 656 O
or 51 53 657 659 O
other 54 59 660 665 O
drugs 60 65 666 671 O
of 66 68 672 674 O
dependence 69 79 675 685 O
) 79 80 685 686 O
during 81 87 687 693 O
previous 88 96 694 702 B-upper_bound
12 97 99 703 705 I-upper_bound
months 100 106 706 712 I-upper_bound

Patient 0 7 713 720 O
is 8 10 721 723 O
taking 11 17 724 730 O
anti 18 22 731 735 B-treatment
- 22 23 735 736 I-treatment
epileptic 23 32 736 745 I-treatment
medication 33 43 746 756 I-treatment

Patient 0 7 757 764 O
must 8 12 765 769 O
meet 13 17 770 774 O
NINCDS 18 24 775 781 O
- 24 25 781 782 O
ADRDA 25 30 782 787 O
criteria 31 39 788 796 O
for 40 43 797 800 O
Alzheimer 44 53 801 810 B-chronic_disease
's 53 55 810 812 I-chronic_disease
Disease 56 63 813 820 I-chronic_disease

Patient 0 7 821 828 O
taking 8 14 829 835 O
Alzheimer 15 24 836 845 B-treatment
medication 25 35 846 856 I-treatment
, 35 36 856 857 O
i.e. 37 41 858 862 O
Exelon 42 48 863 869 B-treatment
, 48 49 869 870 O
Aricept 50 57 871 878 B-treatment
, 57 58 878 879 O
Namenda 59 66 880 887 B-treatment
, 66 67 887 888 O
Reminyl 68 75 889 896 B-treatment
or 76 78 897 899 O
Ebixa 79 84 900 905 B-treatment

Patient 0 7 906 913 O
with 8 12 914 918 O
history 13 20 919 926 O
of 21 23 927 929 O
focal 24 29 930 935 B-chronic_disease
neurological 30 42 936 948 I-chronic_disease
deficits 43 51 949 957 I-chronic_disease
( 52 53 958 959 O
with 53 57 959 963 O
the 58 61 964 967 O
exception 62 71 968 977 O
of 72 74 978 980 O
vibratory 75 84 981 990 B-chronic_disease
peripheral 85 95 991 1001 I-chronic_disease
neuropathy 96 106 1002 1012 I-chronic_disease

The 0 3 1013 1016 O
patient 4 11 1017 1024 O
has 12 15 1025 1028 O
a 16 17 1029 1030 O
history 18 25 1031 1038 O
of 26 28 1039 1041 O
cancer 29 35 1042 1048 B-cancer
except 36 42 1049 1055 O
non 43 46 1056 1059 B-cancer
- 46 47 1059 1060 I-cancer
melanoma 47 55 1060 1068 I-cancer
skin 56 60 1069 1073 I-cancer
cancer 61 67 1074 1080 I-cancer

Male 0 4 0 4 B-gender
inmates 5 12 5 12 O
at 13 15 13 15 O
specific 16 24 16 24 O
eastern 25 32 25 32 O
Kentucky 33 41 33 41 O
jail 42 46 42 46 O
sites 47 52 47 52 O

BMI 0 3 0 3 B-bmi
18.5 4 8 4 8 B-lower_bound
- 8 9 8 9 O
24.9kg 9 15 9 15 B-upper_bound
/ 15 16 15 16 I-upper_bound
m2 16 18 16 18 I-upper_bound

allergy 0 7 19 26 O
to 8 10 27 29 O
lidocaine 11 20 30 39 B-allergy_name
or 21 23 40 42 O
drug 24 28 43 47 B-allergy_name
excipients 29 39 48 58 I-allergy_name

currently 0 9 59 68 B-pregnancy
pregnant 10 18 69 77 I-pregnancy

history 0 7 78 85 O
of 8 10 86 88 O
difficulty 11 21 89 99 O
with 22 26 100 104 O
intravenous 27 38 105 116 B-treatment
line 39 43 117 121 I-treatment
placement 44 53 122 131 I-treatment

minimal 0 7 132 139 O
alcohol 8 15 140 147 B-clinical_variable
intake 16 22 148 154 I-clinical_variable
( 23 24 155 156 O
< 24 25 156 157 O
1 25 26 157 158 B-upper_bound
drink 27 32 159 164 I-upper_bound
per 33 36 165 168 I-upper_bound
day 37 40 169 172 I-upper_bound
) 40 41 172 173 O

personal 0 8 174 182 O
or 9 11 183 185 O
family 12 18 186 192 O
history 19 26 193 200 O
of 27 29 201 203 O
cardiac 30 37 204 211 B-chronic_disease
arrhythmias 38 49 212 223 I-chronic_disease
or 50 52 224 226 O
seizures 53 61 227 235 B-chronic_disease

unwilling 0 9 236 245 B-contraception_consent
to 10 12 246 248 I-contraception_consent
take 13 17 249 253 I-contraception_consent
acceptable 18 28 254 264 I-contraception_consent
birth 29 34 265 270 I-contraception_consent
control 35 42 271 278 I-contraception_consent
method 43 49 279 285 I-contraception_consent

Complete 0 8 0 8 O
active 9 15 9 15 B-treatment
treatment 16 25 16 25 I-treatment
( 26 27 26 27 O
surgery 27 34 27 34 B-treatment
, 34 35 34 35 O
chemotherapy 36 48 36 48 B-treatment
, 48 49 48 49 O
and/or 50 56 50 56 O
radiotherapy 57 69 57 69 B-treatment
) 69 70 69 70 O
at 71 73 71 73 O
least 74 79 74 79 O
one 80 83 80 83 B-lower_bound
month 84 89 84 89 I-lower_bound
prior 90 95 90 95 I-lower_bound
to 96 98 96 98 O
study 99 104 99 104 O
initiation 105 115 105 115 O
( 116 117 116 117 O
patients 117 125 117 125 O
on 126 128 126 128 O
continued 129 138 129 138 O
hormone 139 146 139 146 B-treatment
treatment 147 156 147 156 I-treatment
will 157 161 157 161 O
not 162 165 162 165 O
be 166 168 166 168 O
excluded 169 177 169 177 O
) 177 178 177 178 O

English 0 7 179 186 B-language_fluency
speaking 8 16 187 195 I-language_fluency

Have 0 4 196 200 O
non 5 8 201 204 B-chronic_disease
- 8 9 204 205 I-chronic_disease
musculoskeletal 9 24 205 220 I-chronic_disease
pain 25 29 221 225 I-chronic_disease
syndromes 30 39 226 235 I-chronic_disease
( 40 41 236 237 O
headache 41 49 237 245 O
, 49 50 245 246 O
facial 51 57 247 253 O
pain 58 62 254 258 O
, 62 63 258 259 O
chest 64 69 260 265 O
pain 70 74 266 270 O
, 74 75 270 271 O
visceral 76 84 272 280 O
abdominal 85 94 281 290 O
pain 95 99 291 295 O
) 99 100 295 296 O
if 101 103 297 299 O
these 104 109 300 305 O
are 110 113 306 309 O
the 114 117 310 313 O
sole 118 122 314 318 O
source 123 129 319 325 O
of 130 132 326 328 O
pain 133 137 329 333 O
, 137 138 333 334 O
but 139 142 335 338 O
can 143 146 339 342 O
be 147 149 343 345 O
present 150 157 346 353 O
as 158 160 354 356 O
co 161 163 357 359 O
- 163 164 359 360 O
morbid 164 170 360 366 O
conditions 171 181 367 377 O
as 182 184 378 380 O
long 185 189 381 385 O
as 190 192 386 388 O
a 193 194 389 390 O
patient 195 202 391 398 O
has 203 206 399 402 O
a 207 208 403 404 O
primary 209 216 405 412 O
musculoskeletal 217 232 413 428 B-chronic_disease
pain 233 237 429 433 I-chronic_disease
condition 238 247 434 443 I-chronic_disease
defined 248 255 444 451 O
s 256 257 452 453 O
above 258 263 454 459 O

Having 0 6 460 466 O
a 7 8 467 468 O
pain 9 13 469 473 O
rating 14 20 474 480 O
of 21 23 481 483 O
4 24 25 484 485 B-lower_bound
or 26 28 486 488 O
greater 29 36 489 496 O
in 37 39 497 499 O
worst 40 45 500 505 O
pain 46 50 506 510 O
on 51 53 511 513 O
a 54 55 514 515 O
1 56 57 516 517 B-lower_bound
- 57 58 517 518 O
10 58 60 518 520 B-upper_bound
numerical 61 70 521 530 O
rating 71 77 531 537 O
scale 78 83 538 543 O
in 84 86 544 546 O
the 87 90 547 550 O
preceding 91 100 551 560 O
week 101 105 561 565 O
( 106 107 566 567 O
Patients 107 115 567 575 O
with 116 120 576 580 O
a 121 122 581 582 O
neuropathic 123 134 583 594 O
component 135 144 595 604 O
to 145 147 605 607 O
their 148 153 608 613 O
pain 154 158 614 618 O
that 159 163 619 623 O
involves 164 172 624 632 O
the 173 176 633 636 O
extremities 177 188 637 648 O
or 189 191 649 651 O
back 192 196 652 656 O
will 197 201 657 661 O
be 202 204 662 664 O
eligible 205 213 665 673 O
) 213 214 673 674 O

Inflammatory 0 12 675 687 B-chronic_disease
arthritis 13 22 688 697 I-chronic_disease
that 23 27 698 702 O
require 28 35 703 710 O
disease 36 43 711 718 B-treatment
modifying 44 53 719 728 I-treatment
drugs 54 59 729 734 I-treatment
( 60 61 735 736 O
e.g. 61 65 736 740 O
rheumatoid 66 76 741 751 B-chronic_disease
arthritis 77 86 752 761 I-chronic_disease
) 86 87 761 762 O

Patients 0 8 763 771 O
with 9 13 772 776 O
a 14 15 777 778 O
history 16 23 779 786 O
of 24 26 787 789 O
metastatic 27 37 790 800 B-cancer
cancer 38 44 801 807 I-cancer
who 45 48 808 811 O
are 49 52 812 815 O
not 53 56 816 819 O
currently 57 66 820 829 O
NED 67 70 830 833 O

diagnosis 0 9 834 843 O
of 10 12 844 846 O
cancer 13 19 847 853 B-cancer
with 20 24 854 858 O
no 25 27 859 861 O
restrictions 28 40 862 874 O
placed 41 47 875 881 O
on 48 50 882 884 O
type 51 55 885 889 O
of 56 58 890 892 O
cancer 59 65 893 899 O
, 65 66 899 900 O
other 67 72 901 906 O
than 73 77 907 911 O
that 78 82 912 916 O
patients 83 91 917 925 O
with 92 96 926 930 O
metastatic 97 107 931 941 B-cancer
disease 108 115 942 949 I-cancer
will 116 120 950 954 O
be 121 123 955 957 O
excluded 124 132 958 966 O

< 0 1 0 1 O
age 2 5 2 5 B-age
12 6 8 6 8 B-upper_bound

Patient 0 7 9 16 O
and 8 11 17 20 O
parent 12 18 21 27 O
/ 18 19 27 28 O
legal 19 24 28 33 O
guardian 25 33 34 42 O
are 34 37 43 46 O
English 38 45 47 54 B-language_fluency
speaking 46 54 55 63 I-language_fluency

Primary 0 7 64 71 O
or 8 10 72 74 O
co 11 13 75 77 O
- 13 14 77 78 O
primary 14 21 78 85 O
diagnosis 22 31 86 95 O
of 32 34 96 98 O
OCD 35 38 99 102 B-chronic_disease
, 38 39 102 103 O
Separation 40 50 104 114 B-chronic_disease
Anxiety 51 58 115 122 I-chronic_disease
, 58 59 122 123 O
Social 60 66 124 130 B-chronic_disease
Anxiety 67 74 131 138 I-chronic_disease
, 74 75 138 139 O
Panic 76 81 140 145 B-chronic_disease
Disorder 82 90 146 154 I-chronic_disease
, 90 91 154 155 O
or 92 94 156 158 O
Specific 95 103 159 167 B-chronic_disease
Phobia 104 110 168 174 I-chronic_disease

Psychosis 0 9 175 184 B-chronic_disease
, 9 10 184 185 O
Pervasive 11 20 186 195 B-chronic_disease
Developmental 21 34 196 209 I-chronic_disease
Disorder 35 43 210 218 I-chronic_disease
, 43 44 218 219 O
or 45 47 220 222 O
Mental 48 54 223 229 B-chronic_disease
Retardation 55 66 230 241 I-chronic_disease

contraindication 0 16 0 16 O
to 17 19 17 19 O
magnetic 20 28 20 28 B-treatment
resonance 29 38 29 38 I-treatment
imaging 39 46 39 46 I-treatment

18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
45 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound

Female 0 6 12 18 B-gender
subjects 7 15 19 27 I-gender

Medical 0 7 28 35 O
conditions 8 18 36 46 O
that 19 23 47 51 O
can 24 27 52 55 O
explain 28 35 56 63 O
postural 36 44 64 72 B-chronic_disease
tachycardia 45 56 73 84 I-chronic_disease
( 57 58 85 86 O
e.g. 58 62 86 90 O
, 62 63 90 91 O
dehydration 64 75 92 103 B-chronic_disease
, 75 76 103 104 O
medications 77 88 105 116 B-treatment
) 88 89 116 117 O

Pregnancy 0 9 118 127 B-pregnancy

with 0 4 128 132 O
Postural 5 13 133 141 B-chronic_disease
Tachycardia 14 25 142 153 I-chronic_disease
Syndrome 26 34 154 162 I-chronic_disease
( 35 36 163 164 I-chronic_disease
POTS 36 40 164 168 I-chronic_disease
) 40 41 168 169 I-chronic_disease
as 42 44 170 172 O
defined 45 52 173 180 O
by 53 55 181 183 O
a 56 57 184 185 O
heart 58 63 186 191 B-clinical_variable
rate 64 68 192 196 I-clinical_variable
increase 69 77 197 205 I-clinical_variable
≥30 78 81 206 209 O
bpm 82 85 210 213 I-lower_bound
from 86 90 214 218 O
supine 91 97 219 225 O
within 98 104 226 232 O
10 105 107 233 235 B-upper_bound
min 108 111 236 239 I-upper_bound
of 112 114 240 242 O
standing 115 123 243 251 O
or 124 126 252 254 O
head 127 131 255 259 O
- 131 132 259 260 O
up 132 134 260 262 O
tilt 135 139 263 267 O
in 140 142 268 270 O
the 143 146 271 274 O
absence 147 154 275 282 O
of 155 157 283 285 O
orthostatic 158 169 286 297 B-chronic_disease
hypotension 170 181 298 309 I-chronic_disease
, 181 182 309 310 O
with 183 187 311 315 O
chronic 188 195 316 323 O
symptoms 196 204 324 332 O
( 205 206 333 334 O
> 206 207 334 335 O
6 208 209 336 337 B-lower_bound
months 210 216 338 344 I-lower_bound
) 216 217 344 345 O
, 217 218 345 346 O
and 219 222 347 350 O
in 223 225 351 353 O
the 226 229 354 357 O
absence 230 237 358 365 O
of 238 240 366 368 O
other 241 246 369 374 O
acute 247 252 375 380 O
cause 253 258 381 386 O
of 259 261 387 389 O
orthostatic 262 273 390 401 B-chronic_disease
tachycardia 274 285 402 413 I-chronic_disease

21 0 2 0 2 B-lower_bound
to 3 5 3 5 O
55 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
of 15 17 15 17 O
age 18 21 18 21 B-age

Males 0 5 22 27 B-gender

Positive 0 8 28 36 B-pregnancy
pregnancy 9 18 37 46 I-pregnancy
screen 19 25 47 53 O

females 0 7 54 61 B-gender

18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
65 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

Cognitively 0 11 19 30 O
able 12 16 31 35 O
to 17 19 36 38 O
understand 20 30 39 49 O
directions 31 41 50 60 O
and 42 45 61 64 O
complete 46 54 65 73 O
protocol 55 63 74 82 O
( 64 65 83 84 O
score 65 70 84 89 O
of 71 73 90 92 O
22 74 76 93 95 B-lower_bound
or 77 79 96 98 O
greater 80 87 99 106 O
on 88 90 107 109 O
MMSE 91 95 110 114 B-clinical_variable
) 95 96 114 115 O

Confirmed 0 9 116 125 O
clinical 10 18 126 134 O
diagnosis 19 28 135 144 O
of 29 31 145 147 O
MS 32 34 148 150 B-chronic_disease

Current 0 7 151 158 O
participation 8 21 159 172 O
in 22 24 173 175 O
physical 25 33 176 184 B-treatment
therapy 34 41 185 192 I-treatment

Current 0 7 193 200 O
self 8 12 201 205 O
- 12 13 205 206 O
reported 13 21 206 214 O
medical 22 29 215 222 O
history 30 37 223 230 O
of 38 40 231 233 O
unstable 41 49 234 242 B-chronic_disease
angina 50 56 243 249 I-chronic_disease
, 56 57 249 250 O
uncontrolled 58 70 251 263 B-chronic_disease
cardiac 71 78 264 271 I-chronic_disease
dysrhythmias 79 91 272 284 I-chronic_disease
causing 92 99 285 292 O
symptoms 100 108 293 301 O
, 108 109 301 302 O
symptomatic 110 121 303 314 B-chronic_disease
severe 122 128 315 321 I-chronic_disease
aortic 129 135 322 328 I-chronic_disease
stenosis 136 144 329 337 I-chronic_disease
, 144 145 337 338 O
uncontrolled 146 158 339 351 B-chronic_disease
symptomatic 159 170 352 363 I-chronic_disease
heart 171 176 364 369 I-chronic_disease
failure 177 184 370 377 I-chronic_disease
, 184 185 377 378 O
acute 186 191 379 384 B-chronic_disease
pulmonary 192 201 385 394 I-chronic_disease
embolus 202 209 395 402 I-chronic_disease
or 210 212 403 405 O
pulmonary 213 222 406 415 B-chronic_disease
infarction 223 233 416 426 I-chronic_disease
, 233 234 426 427 O
history 235 242 428 435 O
of 243 245 436 438 O
DVT 246 249 439 442 B-chronic_disease
, 249 250 442 443 O
acute 251 256 444 449 B-chronic_disease
myocarditis 257 268 450 461 I-chronic_disease
or 269 271 462 464 O
pericarditis 272 284 465 477 B-chronic_disease
, 284 285 477 478 O
acute 286 291 479 484 B-chronic_disease
systemic 292 300 485 493 I-chronic_disease
infection 301 310 494 503 I-chronic_disease
, 310 311 503 504 O
uncontrolled 312 324 505 517 B-chronic_disease
hypertension 325 337 518 530 I-chronic_disease
, 337 338 530 531 O
and 339 342 532 535 O
uncontrolled 343 355 536 548 B-chronic_disease
diabetes 356 364 549 557 I-chronic_disease
[ 365 366 558 559 O
11 366 368 559 561 O
] 368 369 561 562 O

PDDS 0 4 563 567 B-clinical_variable
score 5 10 568 573 I-clinical_variable
of 11 13 574 576 O
3 14 15 577 578 B-lower_bound
to 16 18 579 581 O
5 19 20 582 583 B-upper_bound
during 21 27 584 590 O
the 28 31 591 594 O
past 32 36 595 599 B-upper_bound
12 37 39 600 602 I-upper_bound
months 40 46 603 609 I-upper_bound

Requires 0 8 610 618 O
constant 9 17 619 627 O
bilateral 18 27 628 637 O
assistance 28 38 638 648 O
( 39 40 649 650 O
canes 40 45 650 655 O
or 46 48 656 658 O
crutches 49 57 659 667 O
) 57 58 667 668 O
for 59 62 669 672 O
ambulation 63 73 673 683 O
and/or 74 80 684 690 O
can 81 84 691 694 O
not 84 87 694 697 O
walk 88 92 698 702 O
at 93 95 703 705 O
least 96 101 706 711 O
100 102 105 712 715 B-lower_bound
meters 106 112 716 722 I-lower_bound
without 113 120 723 730 O
resting 121 128 731 738 O

Speaks 0 6 739 745 B-language_fluency
English 7 14 746 753 I-language_fluency
( 15 16 754 755 O
in 16 18 755 757 O
order 19 24 758 763 O
to 25 27 764 766 O
safely 28 34 767 773 O
complete 35 43 774 782 O
intervention 44 56 783 795 O

BMI>40 0 6 0 6 B-bmi

Pilon 0 5 7 12 B-chronic_disease
fractures 6 15 13 22 I-chronic_disease

Polytrauma 0 10 23 33 B-chronic_disease
patients 11 19 34 42 O

A 0 1 0 1 O
varus 2 7 2 7 B-clinical_variable
/ 7 8 7 8 I-clinical_variable
valgus 8 14 8 14 I-clinical_variable
deformity 15 24 15 24 I-clinical_variable
of 25 27 25 27 O
more 28 32 28 32 O
than 33 37 33 37 O
10o 38 41 38 41 B-lower_bound
, 41 42 41 42 O
a 43 44 43 44 O
deformity 45 54 45 54 O
requiring 55 64 55 64 O
osteotomy 65 74 65 74 B-treatment
or 75 77 75 77 O
complex 78 85 78 85 B-treatment
surgery 86 93 86 93 I-treatment

Consistent 0 10 94 104 O
use 11 14 105 108 O
of 15 17 109 111 O
NSAIDs 18 24 112 118 B-treatment
within 25 31 119 125 O
48 32 34 126 128 B-upper_bound
hours 35 40 129 134 I-upper_bound
of 41 43 135 137 O
procedure 44 53 138 147 O

Corticosteroid 0 14 148 162 B-treatment
injection 15 24 163 172 I-treatment
at 25 27 173 175 O
treatment 28 37 176 185 O
site 38 42 186 190 O
within 43 49 191 197 O
1 50 51 198 199 B-upper_bound
month 52 57 200 205 I-upper_bound

Diagnosis 0 9 206 215 O
of 10 12 216 218 O
a 13 14 219 220 O
transient 15 24 221 230 O
ischemic 25 33 231 239 O
attack 34 40 240 246 O
in 41 43 247 249 O
the 44 47 250 253 O
6 48 49 254 255 B-upper_bound
months 50 56 256 262 I-upper_bound
prior 57 62 263 268 I-upper_bound
to 63 65 269 271 O
screening 66 75 272 281 O

Greater 0 7 282 289 O
than 8 12 290 294 O
6 13 14 295 296 B-lower_bound
months 15 21 297 303 I-lower_bound
knee 22 26 304 308 O
pain 27 31 309 313 O
on 32 34 314 316 O
the 35 38 317 320 O
index 39 44 321 326 O
side 45 49 327 331 O
( 50 51 332 333 O
left 51 55 333 337 O
or 56 58 338 340 O
right 59 64 341 346 O
knee 65 69 347 351 O
) 69 70 351 352 O

Neoplastic 0 10 353 363 B-cancer
cancer 11 17 364 370 I-cancer
within 18 24 371 377 O
5 25 26 378 379 B-upper_bound
years 27 32 380 385 I-upper_bound
prior 33 38 386 391 I-upper_bound
to 39 41 392 394 O
screening 42 51 395 404 O

Patients 0 8 405 413 O
infected 9 17 414 422 O
with 18 22 423 427 O
hepatitis 23 32 428 437 B-chronic_disease
B 33 34 438 439 I-chronic_disease
, 34 35 439 440 I-chronic_disease
C 36 37 441 442 I-chronic_disease
or 38 40 443 445 O
HIV 41 44 446 449 B-chronic_disease

Patients 0 8 450 458 O
range 9 14 459 464 O
from 15 19 465 469 O
18 20 22 470 472 B-lower_bound
- 22 23 472 473 O
90 23 25 473 475 B-upper_bound
years 26 31 476 481 I-upper_bound
of 32 34 482 484 O
age 35 38 485 488 B-age

Patients 0 8 489 497 O
with 9 13 498 502 O
Body 14 18 503 507 B-bmi
Mass 19 23 508 512 I-bmi
Index 24 29 513 518 I-bmi
( 30 31 519 520 I-bmi
BMI 31 34 520 523 I-bmi
) 34 35 523 524 I-bmi
> 36 37 525 526 O
40kg 38 42 527 531 B-lower_bound
/ 42 43 531 532 I-lower_bound
m2 43 45 532 534 I-lower_bound

Patients 0 8 535 543 O
with 9 13 544 548 O
adequate 14 22 549 557 O
blood 23 28 558 563 O
coagulation 29 40 564 575 O
activity 41 49 576 584 O
, 49 50 584 585 O
PT(INR 51 57 586 592 B-clinical_variable
) 57 58 592 593 I-clinical_variable
< 59 60 594 595 O
1.5 61 64 596 599 B-upper_bound
, 64 65 599 600 O
APTT 66 70 601 605 B-clinical_variable

Patients 0 8 606 614 O
with 9 13 615 619 O
adequate 14 22 620 628 B-chronic_disease
cardiac 23 30 629 636 I-chronic_disease
and 31 34 637 640 I-chronic_disease
respiratory 35 46 641 652 I-chronic_disease
function 47 55 653 661 I-chronic_disease

Patients 0 8 662 670 O
with 9 13 671 675 O
adequate 14 22 676 684 O
renal 23 28 685 690 O
function 29 37 691 699 O
, 37 38 699 700 O
Creatinine 39 49 701 711 B-clinical_variable
≤ 50 51 712 713 O
1.5 52 55 714 717 B-upper_bound
mg 56 58 718 720 I-upper_bound
/ 58 59 720 721 I-upper_bound
dl 59 61 721 723 I-upper_bound

Patients 0 8 724 732 O
with 9 13 733 737 O
indication 14 24 738 748 O
of 25 27 749 751 O
Osteoarthritis 28 42 752 766 B-chronic_disease

( 0 1 0 1 O
fasting 1 8 1 8 O
blood 9 14 9 14 B-clinical_variable
sugar 15 20 15 20 I-clinical_variable
> 21 22 21 22 O
110 22 25 22 25 B-lower_bound
mg 26 28 26 28 I-lower_bound
/ 28 29 28 29 I-lower_bound
dL 29 31 29 31 I-lower_bound
) 31 32 31 32 O

Any 0 3 33 36 O
milk 4 8 37 41 B-allergy_name
allergies 9 18 42 51 O

Any 0 3 52 55 O
other 4 9 56 61 O
significant 10 21 62 73 O
respiratory 22 33 74 85 B-chronic_disease
or 34 36 86 88 O
cardiac 37 44 89 96 B-chronic_disease
disease 45 52 97 104 I-chronic_disease
or 53 55 105 107 O
the 56 59 108 111 O
presence 60 68 112 120 O
of 69 71 121 123 O
clinically 72 82 124 134 O
important 83 92 135 144 O
comorbidities 93 106 145 158 O
, 106 107 158 159 O
including 108 117 160 169 O
, 117 118 169 170 O
uncontrolled 119 131 171 183 O
coronary 132 140 184 192 B-chronic_disease
artery 141 147 193 199 I-chronic_disease
disease 148 155 200 207 I-chronic_disease
, 155 156 207 208 O
acute 157 162 209 214 O
or 163 165 215 217 O
and 166 169 218 221 O
chronic 170 177 222 229 O
renal 178 183 230 235 B-chronic_disease
failure 184 191 236 243 I-chronic_disease

Asthma 0 6 244 250 B-chronic_disease
diagnosed 7 16 251 260 O
by 17 19 261 263 O
a 20 21 264 265 O
medical 22 29 266 273 O
specialist 30 40 274 284 O
and/or 41 47 285 291 O
history 48 55 292 299 O
of 56 58 300 302 O
positive 59 67 303 311 O
methacholine 68 80 312 324 O
rest 81 85 325 329 O
and/or 86 92 330 336 O
reversibility 93 106 337 350 B-clinical_variable
of 107 109 351 353 O
> 110 111 354 355 O
10 111 113 355 357 B-lower_bound
% 113 114 357 358 I-lower_bound
of 115 117 359 361 O
FEV1 118 122 362 366 B-clinical_variable

BMI 0 3 367 370 B-bmi
> 4 5 371 372 O
40 5 7 372 374 B-lower_bound
kg 8 10 375 377 I-lower_bound
/ 10 11 377 378 I-lower_bound
m2 11 13 378 380 I-lower_bound

Coconut 0 7 381 388 B-allergy_name
allergies 8 17 389 398 O

Current 0 7 399 406 O
smoking 8 15 407 414 O
or 16 18 415 417 O
smoking 19 26 418 425 O
history 27 34 426 433 O
of 35 37 434 436 O
greater 38 45 437 444 O
than 46 50 445 449 O
10 51 53 450 452 B-lower_bound
pack 54 58 453 457 I-lower_bound
- 58 59 457 458 I-lower_bound
years 59 64 458 463 I-lower_bound

Diabetes 0 8 464 472 B-chronic_disease

FEV1 0 4 473 477 B-clinical_variable
is 5 7 478 480 O
within 8 14 481 487 O
acceptable 15 25 488 498 O
limits 26 32 499 505 O

Active 0 6 0 6 B-chronic_disease
systemic 7 15 7 15 I-chronic_disease
infection 16 25 16 25 I-chronic_disease
or 26 28 26 28 O
skin 29 33 29 33 B-chronic_disease
infection 34 43 34 43 I-chronic_disease
at 44 46 44 46 O
or 47 49 47 49 O
near 50 54 50 54 O
the 55 58 55 58 O
acupuncture 59 70 59 70 O
sites 71 76 71 76 O

Grade 0 5 77 82 O
0 6 7 83 84 B-lower_bound
- 8 9 85 86 O
None 10 14 87 91 O

Grade 0 5 92 97 O
4 6 7 98 99 O
- 8 9 100 101 O
Fibrosis 10 18 102 110 B-chronic_disease

Have 0 4 111 115 O
received 5 13 116 124 O
any 14 17 125 128 O
investigational 18 33 129 144 B-treatment
new 34 37 145 148 I-treatment
drug 38 42 149 153 I-treatment
within 43 49 154 160 O
the 50 53 161 164 O
past 54 58 165 169 B-upper_bound
30 59 61 170 172 I-upper_bound
days 62 66 173 177 I-upper_bound
or 67 69 178 180 O
planning 70 78 181 189 O
to 79 81 190 192 O
receive 82 89 193 200 O
such 90 94 201 205 O
during 95 101 206 212 O
the 102 105 213 216 O
study 106 111 217 222 O
period 112 118 223 229 O

History 0 7 230 237 O
of 8 10 238 240 O
xerostomia 11 21 241 251 B-chronic_disease
, 21 22 251 252 O
Sjogren 23 30 253 260 B-chronic_disease
's 30 32 260 262 I-chronic_disease
disease 33 40 263 270 I-chronic_disease
or 41 43 271 273 O
other 44 49 274 279 O
illness 50 57 280 287 O
known 58 63 288 293 O
to 64 66 294 296 O
affect 67 73 297 303 O
salivation 74 84 304 314 O
prior 85 90 315 320 O
to 91 93 321 323 O
head 94 98 324 328 B-treatment
/ 98 99 328 329 I-treatment
neck 99 103 329 333 I-treatment
radiation 104 113 334 343 I-treatment

Must 0 4 344 348 O
have 5 9 349 353 O
ECOG 10 14 354 358 B-clinical_variable
performance 15 26 359 370 I-clinical_variable
status 27 33 371 377 I-clinical_variable
of 34 36 378 380 O
0 37 38 381 382 B-lower_bound
- 38 39 382 383 O
2 39 40 383 384 B-upper_bound

Must 0 4 385 389 O
have 5 9 390 394 O
completed 10 19 395 404 O
radiotherapy 20 32 405 417 B-treatment
at 33 35 418 420 O
least 36 41 421 426 O
12 42 44 427 429 B-lower_bound
months 45 51 430 436 I-lower_bound
prior 52 57 437 442 I-lower_bound
to 58 60 443 445 O
entry 61 66 446 451 O

Must 0 4 452 456 O
have 5 9 457 461 O
received 10 18 462 470 O
external 19 27 471 479 B-treatment
beam 28 32 480 484 I-treatment
radiation 33 42 485 494 I-treatment
at 43 45 495 497 O
a 46 47 498 499 O
mean 48 52 500 504 O
dose 53 57 505 509 O
of 58 60 510 512 O
at 61 63 513 515 O
least 64 69 516 521 O
24 70 72 522 524 B-lower_bound
Gy 73 75 525 527 I-lower_bound
to 76 78 528 530 O
one 79 82 531 534 O
of 83 85 535 537 O
the 86 89 538 541 O
parotid 90 97 542 549 O
glands 98 104 550 556 O

Over 0 4 557 561 O
the 5 8 562 565 O
counter 9 16 566 573 O
products 17 25 574 582 O
used 26 30 583 587 O
for 31 34 588 591 O
salivary 35 43 592 600 B-treatment
substitution 44 56 601 613 I-treatment

Receiving 0 9 614 623 O
chemotherapy 10 22 624 636 B-treatment
during 23 29 637 643 O
study 30 35 644 649 O
period 36 42 650 656 O

The 0 3 657 660 O
other 4 9 661 666 O
gland 10 15 667 672 O
can 16 19 673 676 O
receive 20 27 677 684 O
less 28 32 685 689 O
than 33 37 690 694 O
24 38 40 695 697 B-upper_bound
Gy 41 43 698 700 I-upper_bound

Treatment 0 9 701 710 O
known 10 15 711 716 O
to 16 18 717 719 O
affect 19 25 720 726 O
salivation 26 36 727 737 O
should 37 43 738 744 O
be 44 46 745 747 O
stopped 47 54 748 755 O
at 55 57 756 758 O
least 58 63 759 764 O
14 64 66 765 767 B-lower_bound
days 67 71 768 772 I-lower_bound
prior 72 77 773 778 I-lower_bound
to 78 80 779 781 O
enrollment 81 91 782 792 O

able 0 4 793 797 B-language_fluency
to 5 7 798 800 I-language_fluency
read 8 12 801 805 I-language_fluency
, 12 13 805 806 I-language_fluency
write 14 19 807 812 I-language_fluency
and 20 23 813 816 I-language_fluency
understand 24 34 817 827 I-language_fluency
English 35 42 828 835 I-language_fluency

have 0 4 836 840 O
a 5 6 841 842 O
diagnosis 7 16 843 852 O
of 17 19 853 855 O
head 20 24 856 860 B-cancer
/ 24 25 860 861 I-cancer
neck 25 29 861 865 I-cancer
cance 30 35 866 871 I-cancer

have 0 4 872 876 O
received 5 13 877 885 O
bilateral 14 23 886 895 B-treatment
radiation 24 33 896 905 I-treatment
therapy 34 41 906 913 I-treatment
, 41 42 913 914 O
and 43 46 915 918 O
subsequently 47 59 919 931 O
developed 60 69 932 941 O
grade 70 75 942 947 O
2 76 77 948 949 O
or 78 80 950 952 O
3 81 82 953 954 O
xerostomia 83 93 955 965 O
, 93 94 965 966 O
according 95 104 967 976 O
to 105 107 977 979 O
modified 108 116 980 988 O
RTOG 117 121 989 993 O
scale 122 127 994 999 O

least 0 5 1000 1005 O
18 6 8 1006 1008 B-lower_bound
years 9 14 1009 1014 I-lower_bound
of 15 17 1015 1017 O
age 18 21 1018 1021 B-age

will 0 4 1022 1026 O
need 5 9 1027 1031 O
to 10 12 1032 1034 O
be 13 15 1035 1037 O
discontinued 16 28 1038 1050 O
for 29 32 1051 1054 O
at 33 35 1055 1057 O
least 36 41 1058 1063 O
24 42 44 1064 1066 B-lower_bound
hours 45 50 1067 1072 I-lower_bound
prior 51 56 1073 1078 I-lower_bound
to 57 59 1079 1081 O
saliva 60 66 1082 1088 O
and 67 70 1089 1092 O
questionnaire 71 84 1093 1106 O
data 85 89 1107 1111 O
collection 90 100 1112 1122 O

Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
with 17 21 17 21 O
completion 22 32 22 32 O
of 33 35 33 35 O
therapeutic 36 47 36 47 B-treatment
antibiotics 48 59 48 59 I-treatment
, 59 60 59 60 O
antivirals 61 71 61 71 B-treatment
, 71 72 71 72 O
or 73 75 73 75 O
antifungals 76 87 76 87 B-treatment
within 88 94 88 94 O
one 95 98 95 98 B-upper_bound
week 99 103 99 103 I-upper_bound
prior 104 109 104 109 I-upper_bound
to 110 112 110 112 O
C1D1 113 117 113 117 O

Active 0 6 118 124 B-chronic_disease
peptic 7 13 125 131 I-chronic_disease
ulcer 14 19 132 137 I-chronic_disease
disease 20 27 138 145 I-chronic_disease
or 28 30 146 148 O
other 31 36 149 154 O
active 37 43 155 161 B-chronic_disease
gastrointestinal 44 60 162 178 I-chronic_disease
bleeds 61 67 179 185 I-chronic_disease

Age 0 3 186 189 B-age
≥ 4 5 190 191 O
18 6 8 192 194 B-lower_bound
years 9 14 195 200 I-lower_bound

Life 0 4 201 205 B-clinical_variable
expectancy 5 15 206 216 I-clinical_variable
of 16 18 217 219 O
≥ 19 20 220 221 O
3 21 22 222 223 B-lower_bound
months 23 29 224 230 I-lower_bound

Palliative 0 10 231 241 B-treatment
steroids 11 19 242 250 I-treatment
for 20 23 251 254 O
disease 24 31 255 262 O
related 32 39 263 270 O
symptoms 40 48 271 279 O
< 49 50 280 281 O
7 51 52 282 283 B-upper_bound
days 53 57 284 288 I-upper_bound
prior 58 63 289 294 I-upper_bound
to 64 66 295 297 O
C1D1 67 71 298 302 O

Prophylactic 0 12 303 315 B-treatment
antibiotics 13 24 316 327 I-treatment
, 24 25 327 328 O
antivirals 26 36 329 339 B-treatment
or 37 39 340 342 O
antifungals 40 51 343 354 B-treatment
are 52 55 355 358 O
permitted 56 65 359 368 O

Time 0 4 369 373 O
since 5 10 374 379 O
the 11 14 380 383 O
last 15 19 384 388 O
prior 20 25 389 394 B-treatment
therapy 26 33 395 402 I-treatment
for 34 37 403 406 O
treatment 38 47 407 416 B-treatment
of 48 50 417 419 O
advanced 51 59 420 428 O
solid 60 65 429 434 B-cancer
malignancies 66 78 435 447 I-cancer
or 79 81 448 450 O
NHL 82 85 451 454 B-cancer

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
and 9 12 9 12 O
older 13 18 13 18 O

A 0 1 19 20 O
history 2 9 21 28 O
of 10 12 29 31 O
hypersensitivity 13 29 32 48 O
to 30 32 49 51 O
selumetinib 33 44 52 63 B-treatment
, 44 45 63 64 O
or 46 48 65 67 O
any 49 52 68 71 O
excipient 53 62 72 81 O
agents 63 69 82 88 O
( 70 71 89 90 O
e.g. 71 75 90 94 O
Captisol 76 84 95 103 B-treatment
or 85 87 104 106 O
TPGS- 88 93 107 112 B-treatment
a 94 95 113 114 O
water 96 101 115 120 O
soluble 102 109 121 128 O
form 110 114 129 133 O
of 115 117 134 136 O
Vitamin 118 125 137 144 O
E 126 127 145 146 O
) 127 128 146 147 O

Any 0 3 148 151 O
evidence 4 12 152 160 O
of 13 15 161 163 O
severe 16 22 164 170 O
or 23 25 171 173 O
uncontrolled 26 38 174 186 O
systemic 39 47 187 195 B-chronic_disease
disease 48 55 196 203 I-chronic_disease
, 55 56 203 204 O
including 57 66 205 214 O
, 66 67 214 215 O
but 68 71 216 219 O
not 72 75 220 223 O
limited 76 83 224 231 O
to 84 86 232 234 O
, 86 87 234 235 O
ongoing 88 95 236 243 O
or 96 98 244 246 O
active 99 105 247 253 B-chronic_disease
infection 106 115 254 263 I-chronic_disease
, 115 116 263 264 O
active 117 123 265 271 O
bleeding 124 132 272 280 B-chronic_disease
diatheses 133 142 281 290 I-chronic_disease
or 143 145 291 293 O
renal 146 151 294 299 B-treatment
transplant 152 162 300 310 I-treatment
, 162 163 310 311 O
including 164 173 312 321 O
any 174 177 322 325 O
patient 178 185 326 333 O
known 186 191 334 339 O
to 192 194 340 342 O
have 195 199 343 347 O
hepatitis 200 209 348 357 B-chronic_disease
B 210 211 358 359 I-chronic_disease
, 211 212 359 360 O
hepatitis 213 222 361 370 B-chronic_disease
C 223 224 371 372 I-chronic_disease
, 224 225 372 373 O
or 226 228 374 376 O
human 229 234 377 382 B-chronic_disease
immunodeficiency 235 251 383 399 I-chronic_disease
virus 252 257 400 405 I-chronic_disease
( 258 259 406 407 I-chronic_disease
HIV 259 262 407 410 I-chronic_disease

Any 0 3 411 414 O
prior 4 9 415 420 B-treatment
treatment 10 19 421 430 I-treatment
with 20 24 431 435 I-treatment
either 25 31 436 442 I-treatment
a 32 33 443 444 I-treatment
MEK 34 37 445 448 I-treatment
, 37 38 448 449 I-treatment
RAS 39 42 450 453 I-treatment
, 42 43 453 454 I-treatment
or 44 46 455 457 I-treatment
RAF 47 50 458 461 I-treatment
inhibitor 51 60 462 471 I-treatment
for 61 64 472 475 O
advanced 65 73 476 484 B-cancer
or 74 76 485 487 O
metastatic 77 87 488 498 B-cancer
NSCLC 88 93 499 504 I-cancer

Any 0 3 505 508 O
unresolved 4 14 509 519 O
toxicity 15 23 520 528 B-clinical_variable
> 24 25 529 530 O
CTCAE 26 31 531 536 B-lower_bound
grade 32 37 537 542 I-lower_bound
2 38 39 543 544 I-lower_bound
despite 40 47 545 552 O
optimal 48 55 553 560 O
care 56 60 561 565 O
/ 60 61 565 566 O
support 61 68 566 573 O
, 68 69 573 574 O
from 70 74 575 579 O
previous 75 83 580 588 B-treatment
anti 84 88 589 593 I-treatment
- 88 89 593 594 I-treatment
cancer 89 95 594 600 I-treatment
therapy 96 103 601 608 I-treatment
, 103 104 608 609 O
except 105 111 610 616 O
for 112 115 617 620 O
alopecia 116 124 621 629 B-chronic_disease
, 124 125 629 630 O
within 126 132 631 637 O
7 133 134 638 639 B-upper_bound
days 135 139 640 644 I-upper_bound
prior 140 145 645 650 I-upper_bound
to 146 148 651 653 O
Cycle 149 154 654 659 O
1 155 156 660 661 O
, 156 157 661 662 O
day 158 161 663 666 O
1 162 163 667 668 O

Brain 0 5 669 674 B-cancer
metastases 6 16 675 685 I-cancer
or 17 19 686 688 O
spinal 20 26 689 695 B-treatment
cord 27 31 696 700 I-treatment
compression 32 43 701 712 I-treatment
unless 44 50 713 719 O
asymptomatic 51 63 720 732 O
, 63 64 732 733 O
treated 65 72 734 741 B-treatment
and 73 76 742 745 I-treatment
stable 77 83 746 752 I-treatment
off 84 87 753 756 I-treatment
steroids 88 96 757 765 I-treatment
and 97 100 766 769 I-treatment
anti 101 105 770 774 I-treatment
- 105 106 774 775 I-treatment
convulsants 106 117 775 786 I-treatment
for 118 121 787 790 O
at 122 124 791 793 O
least 125 130 794 799 O
30 131 133 800 802 B-lower_bound
days 134 138 803 807 I-lower_bound

Caution 0 7 808 815 O
should 8 14 816 822 O
be 15 17 823 825 O
exercised 18 27 826 835 O
when 28 32 836 840 O
administering 33 46 841 854 O
paclitaxel 47 57 855 865 B-treatment
( 58 59 866 867 I-treatment
Taxol 59 64 867 872 I-treatment
) 64 65 872 873 I-treatment
concomitantly 66 79 874 887 O
with 80 84 888 892 O
medicines 85 94 893 902 B-treatment
known 95 100 903 908 O
to 101 103 909 911 O
inhibit 104 111 912 919 O
( 112 113 920 921 O
e.g. 113 117 921 925 O
ketoconazole 118 130 926 938 B-treatment
and 131 134 939 942 O
other 135 140 943 948 O
imidazole 141 150 949 958 B-treatment
antifungals 151 162 959 970 I-treatment
, 162 163 970 971 O
erythromycin 164 176 972 984 B-treatment
, 176 177 984 985 O
fluoxetine 178 188 986 996 B-treatment
, 188 189 996 997 O
gemfibrozil 190 201 998 1009 B-treatment
, 201 202 1009 1010 O
cimetidine 203 213 1011 1021 B-treatment
, 213 214 1021 1022 O
ritonavir 215 224 1023 1032 B-treatment
, 224 225 1032 1033 O
saquinavir 226 236 1034 1044 B-treatment
, 236 237 1044 1045 O
indinavir 238 247 1046 1055 B-treatment
and 248 251 1056 1059 O
nelfinavir 252 262 1060 1070 B-treatment
) 262 263 1070 1071 O
OR 264 266 1072 1074 O
induce 267 273 1075 1081 O
( 274 275 1082 1083 O
e.g. 275 279 1083 1087 O
rifampicin 280 290 1088 1098 B-treatment
, 290 291 1098 1099 O
carbamazepine 292 305 1100 1113 B-treatment
, 305 306 1113 1114 O
phenytoin 307 316 1115 1124 B-treatment
, 316 317 1124 1125 O
efavirenz 318 327 1126 1135 B-treatment
and 328 331 1136 1139 O
nevirapine 332 342 1140 1150 B-treatment
) 342 343 1150 1151 O
either 344 350 1152 1158 O
CYP2C8 351 357 1159 1165 O
or 358 360 1166 1168 O
CYP3A4 361 367 1169 1175 O
. 367 368 1175 1176 O
Based 369 374 1177 1182 O
on 375 377 1183 1185 O
the 378 381 1186 1189 O
in 382 384 1190 1192 O
vitro 385 390 1193 1198 O
data 391 395 1199 1203 O
and 396 399 1204 1207 O
SimCYP 400 406 1208 1214 O
simulations 407 418 1215 1226 O
, 418 419 1226 1227 O
selumetinib 420 431 1228 1239 B-treatment
is 432 434 1240 1242 O
considered 435 445 1243 1253 O
unlikely 446 454 1254 1262 O
to 455 457 1263 1265 O
perpetrate 458 468 1266 1276 O
clinically 469 479 1277 1287 O
significant 480 491 1288 1299 O
drug 492 496 1300 1304 O
- 496 497 1304 1305 O
drug 497 501 1305 1309 O
interaction 502 513 1310 1321 O
via 514 517 1322 1325 O
inhibition 518 528 1326 1336 O
or 529 531 1337 1339 O
induction 532 541 1340 1349 O
of 542 544 1350 1352 O
CYP 545 548 1353 1356 O
enzymes 549 556 1357 1364 O

Conception 0 10 1365 1375 O
while 11 16 1376 1381 O
on 17 19 1382 1384 O
treatment 20 29 1385 1394 B-treatment
must 30 34 1395 1399 O
be 35 37 1400 1402 O
avoided 38 45 1403 1410 O

Current 0 7 1411 1418 O
or 8 10 1419 1421 O
past 11 15 1422 1426 O
history 16 23 1427 1434 O
of 24 26 1435 1437 O
central 27 34 1438 1445 B-chronic_disease
serous 35 41 1446 1452 I-chronic_disease
retinopathy 42 53 1453 1464 I-chronic_disease
or 54 56 1465 1467 O
retinal 57 64 1468 1475 B-chronic_disease
vein 65 69 1476 1480 I-chronic_disease
occlusion 70 79 1481 1490 I-chronic_disease

ECOG 0 4 1491 1495 B-clinical_variable
Performance 5 16 1496 1507 I-clinical_variable
Status 17 23 1508 1514 I-clinical_variable
of 24 26 1515 1517 O
0 27 28 1518 1519 B-lower_bound
or 29 31 1520 1522 O
1 32 33 1523 1524 B-upper_bound

Estimated 0 9 1525 1534 B-clinical_variable
life 10 14 1535 1539 I-clinical_variable
expectancy 15 25 1540 1550 I-clinical_variable
, 25 26 1550 1551 O
in 27 29 1552 1554 O
the 30 33 1555 1558 O
judgment 34 42 1559 1567 O
of 43 45 1568 1570 O
the 46 49 1571 1574 O
investigator 50 62 1575 1587 O
, 62 63 1587 1588 O
which 64 69 1589 1594 O
will 70 74 1595 1599 O
permit 75 81 1600 1606 O
receipt 82 89 1607 1614 O
of 90 92 1615 1617 O
treatment 93 102 1618 1627 B-treatment
of 103 105 1628 1630 O
12 106 108 1631 1633 B-lower_bound
weeks 109 114 1634 1639 I-lower_bound
or 115 117 1640 1642 O
more 118 122 1643 1647 O

Female 0 6 1648 1654 B-gender
patients 7 15 1655 1663 I-gender
who 16 19 1664 1667 O
are 20 23 1668 1671 O
pregnant 24 32 1672 1680 B-pregnancy
or 33 35 1681 1683 O
breast 36 42 1684 1690 O
- 42 43 1690 1691 O
feeding 43 50 1691 1698 O
( 51 52 1699 1700 O
confirmation 52 64 1700 1712 O
that 65 69 1713 1717 O
the 70 73 1718 1721 O
patient 74 81 1722 1729 O
is 82 84 1730 1732 O
not 85 88 1733 1736 B-pregnancy
pregnant 89 97 1737 1745 I-pregnancy
must 98 102 1746 1750 O
be 103 105 1751 1753 O
by 106 108 1754 1756 O
a 109 110 1757 1758 O
negative 111 119 1759 1767 B-pregnancy
pregnancy 120 129 1768 1777 I-pregnancy
test 130 134 1778 1782 O
result 135 141 1783 1789 O
obtained 142 150 1790 1798 O
during 151 157 1799 1805 O
screening 158 167 1806 1815 O
; 167 168 1815 1816 O
pregnancy 169 178 1817 1826 O
testing 179 186 1827 1834 O
is 187 189 1835 1837 O
required 190 198 1838 1846 O
of 199 201 1847 1849 O
women 202 207 1850 1855 B-gender
of 208 210 1856 1858 O
childbearing 211 223 1859 1871 O
potential 224 233 1872 1881 O
but 234 237 1882 1885 O
not 238 241 1886 1889 O
required 242 250 1890 1898 O
for 251 254 1899 1902 O
post 255 259 1903 1907 O
- 259 260 1907 1908 O
menopausal 260 270 1908 1918 O
or 271 273 1919 1921 O
surgically 274 284 1922 1932 O
, 284 285 1932 1933 O
sterilized 286 296 1934 1944 O
women 297 302 1945 1950 O
) 302 303 1950 1951 O

Females 0 7 1952 1959 B-gender
of 8 10 1960 1962 O
child 11 16 1963 1968 O
bearing 17 24 1969 1976 O
potential 25 34 1977 1986 O
that 35 39 1987 1991 O
are 40 43 1992 1995 O
sexually 44 52 1996 2004 O
active 53 59 2005 2011 O
must 60 64 2012 2016 O
agree 65 70 2017 2022 B-contraception_consent
to 71 73 2023 2025 I-contraception_consent
either 74 80 2026 2032 I-contraception_consent
practice 81 89 2033 2041 I-contraception_consent
2 90 91 2042 2043 I-contraception_consent
medically 92 101 2044 2053 I-contraception_consent
accepted 102 110 2054 2062 I-contraception_consent
highly 111 117 2063 2069 I-contraception_consent
effective 118 127 2070 2079 I-contraception_consent
methods 128 135 2080 2087 I-contraception_consent
of 136 138 2088 2090 I-contraception_consent
contraception 139 152 2091 2104 I-contraception_consent
at 153 155 2105 2107 O
the 156 159 2108 2111 O
same 160 164 2112 2116 O
time 165 169 2117 2121 O
or 170 172 2122 2124 O
abstain 173 180 2125 2132 B-contraception_consent
from 181 185 2133 2137 I-contraception_consent
heterosexual 186 198 2138 2150 I-contraception_consent
intercourse 199 210 2151 2162 I-contraception_consent
from 211 215 2163 2167 O
the 216 219 2168 2171 O
time 220 224 2172 2176 O
of 225 227 2177 2179 O
signing 228 235 2180 2187 O
the 236 239 2188 2191 O
informed 240 248 2192 2200 O
consent 249 256 2201 2208 O
through 257 264 2209 2216 O
30 265 267 2217 2219 B-upper_bound
days 268 272 2220 2224 I-upper_bound
after 273 278 2225 2230 I-upper_bound
the 279 282 2231 2234 O
last 283 287 2235 2239 O
dose 288 292 2240 2244 O
of 293 295 2245 2247 O
study 296 301 2248 2253 O
drug 302 306 2254 2258 O

For 0 3 2259 2262 O
other 4 9 2263 2268 O
targeted 10 18 2269 2277 B-treatment
therapy 19 26 2278 2285 I-treatment
agents 27 33 2286 2292 I-treatment
, 33 34 2292 2293 O
the 35 38 2294 2297 O
washout 39 46 2298 2305 O
period 47 53 2306 2312 O
will 54 58 2313 2317 O
be 59 61 2318 2320 O
5 62 63 2321 2322 O
half 64 68 2323 2327 O
- 68 69 2327 2328 O
lives 69 74 2328 2333 O
, 74 75 2333 2334 O
prior 76 81 2335 2340 O
to 82 84 2341 2343 O
start 85 90 2344 2349 O
of 91 93 2350 2352 O
treatment 94 103 2353 2362 B-treatment
on 104 106 2363 2365 O
study 107 112 2366 2371 O

Histologically 0 14 2372 2386 O
and/or 15 21 2387 2393 O
cytologically 22 35 2394 2407 O
confirmed 36 45 2408 2417 O
, 45 46 2417 2418 O
non 47 50 2419 2422 B-cancer
- 50 51 2422 2423 I-cancer
small 51 56 2423 2428 I-cancer
cell 57 61 2429 2433 I-cancer
lung 62 66 2434 2438 I-cancer
cancer 67 73 2439 2445 I-cancer
( 74 75 2446 2447 I-cancer
NSCLC 75 80 2447 2452 I-cancer
) 80 81 2452 2453 I-cancer
of 82 84 2454 2456 O
adenocarcinoma 85 99 2457 2471 B-cancer
histology 100 109 2472 2481 O
at 110 112 2482 2484 O
the 113 116 2485 2488 O
time 117 121 2489 2493 O
of 122 124 2494 2496 O
initial 125 132 2497 2504 O
diagnosis 133 142 2505 2514 O

Intra 0 5 2515 2520 B-clinical_variable
- 5 6 2520 2521 I-clinical_variable
ocular 6 12 2521 2527 I-clinical_variable
pressure 13 21 2528 2536 I-clinical_variable
> 22 23 2537 2538 O
21 24 26 2539 2541 B-lower_bound
mmHg 27 31 2542 2546 I-lower_bound
, 31 32 2546 2547 O
or 33 35 2548 2550 O
uncontrolled 36 48 2551 2563 O
glaucoma 49 57 2564 2572 B-chronic_disease
( 58 59 2573 2574 O
irrespective 59 71 2574 2586 O
of 72 74 2587 2589 O
intra 75 80 2590 2595 O
- 80 81 2595 2596 O
ocular 81 87 2596 2602 O
pressure 88 96 2603 2611 O
) 96 97 2611 2612 O

Known 0 5 2613 2618 O
actionable 6 16 2619 2629 O
mutations 17 26 2630 2639 O
( 27 28 2640 2641 O
e.g. 28 32 2641 2645 O
, 32 33 2645 2646 O
EGFR 34 38 2647 2651 B-clinical_variable
, 38 39 2651 2652 O
ALK 40 43 2653 2656 B-clinical_variable
, 43 44 2656 2657 O
ROS1 45 49 2658 2662 B-clinical_variable
) 49 50 2662 2663 O
, 50 51 2663 2664 O
against 52 59 2665 2672 O
which 60 65 2673 2678 O
there 66 71 2679 2684 O
is 72 74 2685 2687 O
available 75 84 2688 2697 O
treatment 85 94 2698 2707 B-treatment

Major 0 5 2708 2713 B-treatment
surgical 6 14 2714 2722 I-treatment
procedure 15 24 2723 2732 O
within 25 31 2733 2739 O
21 32 34 2740 2742 B-upper_bound
days 35 39 2743 2747 I-upper_bound
prior 40 45 2748 2753 I-upper_bound
to 46 48 2754 2756 O
enrollment 49 59 2757 2767 O

Males 0 5 2768 2773 B-gender
of 6 8 2774 2776 O
child 9 14 2777 2782 O
bearing 15 22 2783 2790 O
potential 23 32 2791 2800 O
must 33 37 2801 2805 O
agree 38 43 2806 2811 B-contraception_consent
to 44 46 2812 2814 I-contraception_consent
practice 47 55 2815 2823 I-contraception_consent
effective 56 65 2824 2833 I-contraception_consent
barrier 66 73 2834 2841 I-contraception_consent
contraception 74 87 2842 2855 I-contraception_consent
during 88 94 2856 2862 O
the 95 98 2863 2866 O
entire 99 105 2867 2873 O
study 106 111 2874 2879 O
treatment 112 121 2880 2889 B-treatment
period 122 128 2890 2896 O
and 129 132 2897 2900 O
through 133 140 2901 2908 O
6 141 142 2909 2910 B-lower_bound
months 143 149 2911 2917 I-lower_bound
) 149 150 2917 2918 O
after 151 156 2919 2924 O
the 157 160 2925 2928 O
last 161 165 2929 2933 O
dose 166 170 2934 2938 O
of 171 173 2939 2941 O
study 174 179 2942 2947 O
drug 180 184 2948 2952 O
, 184 185 2952 2953 O
( 186 187 2954 2955 O
includes 187 195 2955 2963 O
males 196 201 2964 2969 B-gender
surgically 202 212 2970 2980 B-treatment
sterilized 213 223 2981 2991 I-treatment
( 224 225 2992 2993 O
i.e. 225 229 2993 2997 O
status 230 236 2998 3004 O
post 237 241 3005 3009 B-treatment
vasectomy 242 251 3010 3019 I-treatment
) 251 252 3019 3020 O

Measurable 0 10 3021 3031 O
disease 11 18 3032 3039 O
as 19 21 3040 3042 O
defined 22 29 3043 3050 O
by 30 32 3051 3053 O
RECIST 33 39 3054 3060 O
v1.1 40 44 3061 3065 O
criteria 45 53 3066 3074 O
. 53 54 3074 3075 O
Baseline 55 63 3076 3084 O
measurements 64 76 3085 3097 O
and 77 80 3098 3101 O
evaluation 81 91 3102 3112 O
of 92 94 3113 3115 O
ALL 95 98 3116 3119 B-cancer
sites 99 104 3120 3125 O
of 105 107 3126 3128 O
disease 108 115 3129 3136 O
must 116 120 3137 3141 O
be 121 123 3142 3144 O
obtained 124 132 3145 3153 O
within 133 139 3154 3160 O
4 140 141 3161 3162 B-upper_bound
weeks 142 147 3163 3168 I-upper_bound
prior 148 153 3169 3174 I-upper_bound
to 154 156 3175 3177 O
Enrollment 157 167 3178 3188 O

Mixed 0 5 3189 3194 B-cancer
tumors 6 12 3195 3201 I-cancer
will 13 17 3202 3206 O
be 18 20 3207 3209 O
categorized 21 32 3210 3221 O
by 33 35 3222 3224 O
the 36 39 3225 3228 O
predominant 40 51 3229 3240 O
cell 52 56 3241 3245 O
type 57 61 3246 3250 O

Negative 0 8 3251 3259 O
test 9 13 3260 3264 O
for 14 17 3265 3268 O
pregnancy 18 27 3269 3278 B-pregnancy
is 28 30 3279 3281 O
required 31 39 3282 3290 O
for 40 43 3291 3294 O
females 44 51 3295 3302 B-gender
of 52 54 3303 3305 O
child 55 60 3306 3311 O
- 60 61 3311 3312 O
bearing 61 68 3312 3319 O
potential 69 78 3320 3329 O
; 78 79 3329 3330 O
A 80 81 3331 3332 O
female 82 88 3333 3339 O
of 89 91 3340 3342 O
child 92 97 3343 3348 O
bearing 98 105 3349 3356 O
potential 106 115 3357 3366 O
is 116 118 3367 3369 O
any 119 122 3370 3373 O
woman 123 128 3374 3379 B-gender
, 128 129 3379 3380 O
regardless 130 140 3381 3391 O
of 141 143 3392 3394 O
sexual 144 150 3395 3401 O
orientation 151 162 3402 3413 O
or 163 165 3414 3416 O
whether 166 173 3417 3424 O
they 174 178 3425 3429 O
have 179 183 3430 3434 O
undergone 184 193 3435 3444 O
tubal 194 199 3445 3450 O
ligation 200 208 3451 3459 O
, 208 209 3459 3460 O
who 210 213 3461 3464 O
meets 214 219 3465 3470 O
the 220 223 3471 3474 O
following 224 233 3475 3484 O
criteria 234 242 3485 3493 O
: 242 243 3493 3494 O
1 244 245 3495 3496 O
. 245 246 3496 3497 O
has 247 250 3498 3501 O
not 251 254 3502 3505 O
undergone 255 264 3506 3515 O
a 265 266 3516 3517 O
hysterectomy 267 279 3518 3530 B-treatment
or 280 282 3531 3533 O
bilateral 283 292 3534 3543 B-treatment
oophorectomy 293 305 3544 3556 I-treatment
; 305 306 3556 3557 O
or 307 309 3558 3560 O
2 310 311 3561 3562 O
. 311 312 3562 3563 O
has 313 316 3564 3567 O
not 317 320 3568 3571 O
been 321 325 3572 3576 O
naturally 326 335 3577 3586 O
postmenopausal 336 350 3587 3601 O
for 351 354 3602 3605 O
at 355 357 3606 3608 O
least 358 363 3609 3614 O
24 364 366 3615 3617 B-lower_bound
consecutive 367 378 3618 3629 I-lower_bound
months 379 385 3630 3636 I-lower_bound
( 386 387 3637 3638 O
i.e. 387 391 3638 3642 O
, 391 392 3642 3643 O
has 393 396 3644 3647 O
had 397 400 3648 3651 O
menses 401 407 3652 3658 O
at 408 410 3659 3661 O
any 411 414 3662 3665 O
time 415 419 3666 3670 O
in 420 422 3671 3673 O
the 423 426 3674 3677 O
preceding 427 436 3678 3687 B-upper_bound
24 437 439 3688 3690 I-upper_bound
consecutive 440 451 3691 3702 I-upper_bound
months 452 458 3703 3709 I-upper_bound
or 459 461 3710 3712 O
730 462 465 3713 3716 B-upper_bound
days 466 470 3717 3721 I-upper_bound
) 470 471 3721 3722 O

Ophthalmological 0 16 3723 3739 B-chronic_disease
conditions 17 27 3740 3750 I-chronic_disease

Patients 0 8 3751 3759 O
who 9 12 3760 3763 O
progressed 13 23 3764 3774 O
on 24 26 3775 3777 O
such 27 31 3778 3782 O
treatment 32 41 3783 3792 B-treatment
, 41 42 3792 3793 O
i.e. 43 47 3794 3798 O
, 47 48 3798 3799 O
have 49 53 3800 3804 O
developed 54 63 3805 3814 O
acquired 64 72 3815 3823 O
resistance 73 83 3824 3834 O
and 84 87 3835 3838 O
are 88 91 3839 3842 O
no 92 94 3843 3845 O
longer 95 101 3846 3852 O
reasonably 102 112 3853 3863 O
expected 113 121 3864 3872 O
to 122 124 3873 3875 O
derive 125 131 3876 3882 O
therapeutic 132 143 3883 3894 O
benefit 144 151 3895 3902 O
are 152 155 3903 3906 O
eligible 156 164 3907 3915 O
for 165 168 3916 3919 O
the 169 172 3920 3923 O
trial 173 178 3924 3929 O

Prior 0 5 3930 3935 B-treatment
treatment 6 15 3936 3945 I-treatment
with 16 20 3946 3950 I-treatment
chemotherapy 21 33 3951 3963 I-treatment
or 34 36 3964 3966 O
immunotherapy 37 50 3967 3980 B-treatment
within 51 57 3981 3987 O
14 58 60 3988 3990 B-upper_bound
days 61 65 3991 3995 I-upper_bound
prior 66 71 3996 4001 I-upper_bound
to 72 74 4002 4004 O
enrollment 75 85 4005 4015 O

Received 0 8 4016 4024 O
an 9 11 4025 4027 O
investigational 12 27 4028 4043 B-treatment
drug 28 32 4044 4048 I-treatment
within 33 39 4049 4055 O
30 40 42 4056 4058 B-upper_bound
days 43 47 4059 4063 I-upper_bound
of 48 50 4064 4066 O
starting 51 59 4067 4075 O
treatment 60 69 4076 4085 B-treatment
, 69 70 4085 4086 O
or 71 73 4087 4089 O
have 74 78 4090 4094 O
not 79 82 4095 4098 O
recovered 83 92 4099 4108 O
from 93 97 4109 4113 O
side 98 102 4114 4118 O
effects 103 110 4119 4126 O
of 111 113 4127 4129 O
an 114 116 4130 4132 O
investigational 117 132 4133 4148 O
drug 133 137 4149 4153 O

Serious 0 7 4154 4161 O
medical 8 15 4162 4169 B-chronic_disease
or 16 18 4170 4172 O
psychiatric 19 30 4173 4184 B-chronic_disease
illness 31 38 4185 4192 I-chronic_disease
/ 38 39 4192 4193 I-chronic_disease
condition 39 48 4193 4202 I-chronic_disease
likely 49 55 4203 4209 O
in 56 58 4210 4212 O
the 59 62 4213 4216 O
judgment 63 71 4217 4225 O
of 72 74 4226 4228 O
the 75 78 4229 4232 O
Investigator 79 91 4233 4245 O
to 92 94 4246 4248 O
interfere 95 104 4249 4258 O
with 105 109 4259 4263 O
compliance 110 120 4264 4274 O
with 121 125 4275 4279 O
protocol 126 134 4280 4288 O
treatment 135 144 4289 4298 B-treatment
/ 144 145 4298 4299 O
research 145 153 4299 4307 O

Stage 0 5 4308 4313 B-lower_bound
IIIB 6 10 4314 4318 I-lower_bound
- 10 11 4318 4319 O
IV 11 13 4319 4321 B-upper_bound
, 13 14 4321 4322 O
locally 15 22 4323 4330 O
advanced 23 31 4331 4339 O
or 32 34 4340 4342 O
metastatic 35 45 4343 4353 B-cancer
disease 46 53 4354 4361 O
according 54 63 4362 4371 O
to 64 66 4372 4374 O
the 67 70 4375 4378 O
7 71 72 4379 4380 O
th 73 75 4381 4383 O
edition 76 83 4384 4391 O
of 84 86 4392 4394 O
the 87 90 4395 4398 O
AJCC 91 95 4399 4403 O
lung 96 100 4404 4408 B-cancer
cancer 101 107 4409 4415 I-cancer
TNM 108 111 4416 4419 O
classification 112 126 4420 4434 O
system 127 133 4435 4441 O

Subjects 0 8 4442 4450 O
receiving 9 18 4451 4460 O
palliative 19 29 4461 4471 B-treatment
radiation 30 39 4472 4481 I-treatment
to 40 42 4482 4484 O
CNS 43 46 4485 4488 B-chronic_disease
disease 47 54 4489 4496 I-chronic_disease
within 55 61 4497 4503 O
7 62 63 4504 4505 B-upper_bound
days 64 68 4506 4510 I-upper_bound
may 69 72 4511 4514 O
be 73 75 4515 4517 O
eligible 76 84 4518 4526 O
with 85 89 4527 4531 O
PI 90 92 4532 4534 O
approval 93 101 4535 4543 O

Has 0 3 0 3 O
known 4 9 4 9 O
allergy 10 17 10 17 O
to 18 20 18 20 O
Tc99 21 25 21 25 B-allergy_name
m 25 26 25 26 I-allergy_name
sestamibi 27 36 27 36 I-allergy_name

Has 0 3 37 40 O
known 4 9 41 46 O
contraindications 10 27 47 64 O
to 28 30 65 67 O
MRI 31 34 68 71 B-clinical_variable

Is 0 2 72 74 O
pregnant 3 11 75 83 B-pregnancy
( 12 13 84 85 O
confirmed 13 22 85 94 O
by 23 25 95 97 O
the 26 29 98 101 O
patient 30 37 102 109 O
as 38 40 110 112 O
imaging 41 48 113 120 O
clinic 49 55 121 127 O
standard 56 64 128 136 O
of 65 67 137 139 O
care 68 72 140 144 O
) 72 73 144 145 O

The 0 3 146 149 O
patient 4 11 150 157 O
has 12 15 158 161 O
proven 16 22 162 168 O
TNBC 23 27 169 173 B-cancer
, 27 28 173 174 O
defined 29 36 175 182 O
by 37 39 183 185 O
standard 40 48 186 194 O
pathologic 49 59 195 205 O
assays 60 66 206 212 O
as 67 69 213 215 O
negative 70 78 216 224 O
for 79 82 225 228 O
estrogen 83 91 229 237 B-clinical_variable
receptor 92 100 238 246 I-clinical_variable
( 101 102 247 248 I-clinical_variable
ER 102 104 248 250 I-clinical_variable
) 104 105 250 251 I-clinical_variable
and 106 109 252 255 O
progesterone 110 122 256 268 B-clinical_variable
receptor 123 131 269 277 I-clinical_variable
( 132 133 278 279 I-clinical_variable
PR 133 135 279 281 I-clinical_variable
) 135 136 281 282 I-clinical_variable
( 137 138 283 284 O
< 138 139 284 285 O
10 140 142 286 288 B-upper_bound
% 142 143 288 289 I-upper_bound
tumor 144 149 290 295 B-cancer
staining 150 158 296 304 O
) 158 159 304 305 O
and 160 163 306 309 O
negative 164 172 310 318 O
for 173 176 319 322 O
human 177 182 323 328 B-treatment
epidermal 183 192 329 338 I-treatment
growth 193 199 339 345 I-treatment
factor 200 206 346 352 I-treatment
2 207 208 353 354 I-treatment
( 209 210 355 356 I-treatment
HER2 210 214 356 360 I-treatment
) 214 215 360 361 I-treatment
( 216 217 362 363 B-clinical_variable
immunohistochemistry 217 237 363 383 I-clinical_variable
[ 238 239 384 385 I-clinical_variable
IHC 239 242 385 388 I-clinical_variable
] 242 243 388 389 I-clinical_variable
score 244 249 390 395 I-clinical_variable
< 250 251 396 397 O
3 252 253 398 399 B-upper_bound
, 253 254 399 400 O
gene 255 259 401 405 O
copy 260 264 406 410 O
number 265 271 411 417 O
not 272 275 418 421 O
amplified 276 285 422 431 O
) 285 286 431 432 O

Clinic 0 6 0 6 O
definition 7 17 7 17 O
: 17 18 17 18 O
did 19 22 19 22 O
not 23 26 23 26 O
have 27 31 27 31 O
a 32 33 32 33 O
visit 34 39 34 39 O
with 40 44 40 44 O
a 45 46 45 46 O
prescribing 47 58 47 58 O
provider 59 67 59 67 O
for 68 71 68 71 O
6 72 73 72 73 B-upper_bound
months 74 80 74 80 I-upper_bound

Residents 0 9 81 90 O
within 10 16 91 97 O
the 17 20 98 101 O
health 21 27 102 108 O
department 28 38 109 119 O
jurisdiction 39 51 120 132 O
with 52 56 133 137 O
newly 57 62 138 143 O
diagnosed 63 72 144 153 O
HIV 73 76 154 157 B-chronic_disease
infection 77 86 158 167 I-chronic_disease
who 87 90 168 171 O
have 91 95 172 176 O
not 96 99 177 180 O
linked 100 106 181 187 O
to 107 109 188 190 O
medical 110 117 191 198 O
care 118 122 199 203 O
within 123 129 204 210 O
90 130 132 211 213 B-upper_bound
days 133 137 214 218 I-upper_bound

ALT 0 3 0 3 B-clinical_variable
or 4 6 4 6 O
AST 7 10 7 10 B-clinical_variable
more 11 15 11 15 O
than 16 20 16 20 O
1.5 21 24 21 24 B-lower_bound
times 25 30 25 30 I-lower_bound
the 31 34 31 34 I-lower_bound
upper 35 40 35 40 I-lower_bound
limit 41 46 41 46 I-lower_bound
of 47 49 47 49 I-lower_bound
normal 50 56 50 56 I-lower_bound

Abnormal 0 8 57 65 B-clinical_variable
glucose 9 16 66 73 I-clinical_variable
tolerance 17 26 74 83 I-clinical_variable
( 27 28 84 85 O
fasting 28 35 85 92 B-clinical_variable
blood 36 41 93 98 I-clinical_variable
glucose 42 49 99 106 I-clinical_variable
of 50 52 107 109 O
100 53 56 110 113 B-lower_bound
mg 57 59 114 116 I-lower_bound
/ 59 60 116 117 I-lower_bound
dl 60 62 117 119 I-lower_bound
or 63 65 120 122 O
higher 66 72 123 129 O
, 72 73 129 130 O
or 74 76 131 133 O
2 77 78 134 135 B-lower_bound
- 78 79 135 136 I-lower_bound
hour 79 83 136 140 I-lower_bound
blood 84 89 141 146 I-lower_bound
glucose 90 97 147 154 I-lower_bound
of 98 100 155 157 I-lower_bound
140 101 104 158 161 I-lower_bound
or 105 107 162 164 O
higher 108 114 165 171 O
on 115 117 172 174 O
oral 118 122 175 179 O
glucose 123 130 180 187 O
tolerance 131 140 188 197 O
testing 141 148 198 205 O
) 148 149 205 206 O

Age 0 3 207 210 B-age
6 4 5 211 212 B-lower_bound
- 5 6 212 213 O
12 6 8 213 215 B-upper_bound
years 9 14 216 221 I-upper_bound
at 15 17 222 224 O
enrollment 18 28 225 235 O

Age 0 3 236 239 B-age
greater 4 11 240 247 O
than 12 16 248 252 O
or 17 19 253 255 O
equal 20 25 256 261 O
to 26 28 262 264 O
18 29 31 265 267 B-lower_bound
years 32 37 268 273 I-lower_bound

Body 0 4 274 278 B-clinical_variable
weight 5 11 279 285 I-clinical_variable
at 12 14 286 288 O
least 15 20 289 294 O
17 21 23 295 297 B-lower_bound
kg 24 26 298 300 I-lower_bound

Body 0 4 301 305 O
weight 5 11 306 312 O
less 12 16 313 317 O
than 17 21 318 322 O
50 22 24 323 325 B-upper_bound
kg 25 27 326 328 I-upper_bound

Certain 0 7 329 336 O
exceptions 8 18 337 347 O
are 19 22 348 351 O
permitted 23 32 352 361 O
, 32 33 361 362 O
including 34 43 363 372 O
topical 44 51 373 380 B-treatment
medications 52 63 381 392 I-treatment
and 64 67 393 396 O
vitamins 68 76 397 405 B-treatment

Certain 0 7 406 413 O
exceptions 8 18 414 424 O
are 19 22 425 428 O
permitted 23 32 429 438 O
, 32 33 438 439 O
including 34 43 440 449 O
topical 44 51 450 457 B-treatment
medications 52 63 458 469 I-treatment
, 63 64 469 470 O
vitamins 65 73 471 479 B-treatment
, 73 74 479 480 O
and 75 78 481 484 O
hormonal 79 87 485 493 B-treatment
contraceptives 88 102 494 508 I-treatment

Current 0 7 509 516 O
use 8 11 517 520 O
of 12 14 521 523 O
prescription 15 27 524 536 B-treatment
or 28 30 537 539 I-treatment
non 31 34 540 543 I-treatment
- 34 35 543 544 I-treatment
prescription 35 47 544 556 I-treatment
medication 48 58 557 567 I-treatment

Diabetes 0 8 568 576 B-chronic_disease
( 9 10 577 578 O
fasting 10 17 578 585 B-clinical_variable
blood 18 23 586 591 I-clinical_variable
glucose 24 31 592 599 I-clinical_variable
of 32 34 600 602 O
126 35 38 603 606 B-lower_bound
mg 39 41 607 609 I-lower_bound
/ 41 42 609 610 I-lower_bound
dl 42 44 610 612 I-lower_bound
or 45 47 613 615 O
higher 48 54 616 622 O
, 54 55 622 623 O
or 56 58 624 626 O
2 59 60 627 628 B-clinical_variable
- 60 61 628 629 I-clinical_variable
hour 61 65 629 633 I-clinical_variable
blood 66 71 634 639 I-clinical_variable
glucose 72 79 640 647 I-clinical_variable
of 80 82 648 650 O
200 83 86 651 654 B-lower_bound
or 87 89 655 657 O
higher 90 96 658 664 O
on 97 99 665 667 O
oral 100 104 668 672 O
glucose 105 112 673 680 O
tolerance 113 122 681 690 O
testing 123 130 691 698 O
) 130 131 698 699 O

Glycosuria 0 10 700 710 B-chronic_disease

Known 0 5 711 716 O
allergy 6 13 717 724 O
, 13 14 724 725 O
sensitivity 15 26 726 737 O
or 27 29 738 740 O
other 30 35 741 746 O
contraindication 36 52 747 763 O
to 53 55 764 766 O
any 56 59 767 770 O
study 60 65 771 776 B-allergy_name
food 66 70 777 781 I-allergy_name
or 71 73 782 784 O
drug 74 78 785 789 B-allergy_name
or 79 81 790 792 O
its 82 85 793 796 O
vehicle 86 93 797 804 B-allergy_name

Other 0 5 805 810 O
medications 6 17 811 822 B-treatment
may 18 21 823 826 O
be 22 24 827 829 O
permitted 25 34 830 839 O
at 35 37 840 842 O
the 38 41 843 846 O
discretion 42 52 847 857 O
of 53 55 858 860 O
the 56 59 861 864 O
investigators 60 73 865 878 O

Positive 0 8 879 887 B-pregnancy
urine 9 14 888 893 I-pregnancy
pregnancy 15 24 894 903 I-pregnancy
test 25 29 904 908 O

Prepubertal 0 11 909 920 O
( 12 13 921 922 O
Tanner 13 19 922 928 O
stage 20 25 929 934 O
I 26 27 935 936 O
breasts 28 35 937 944 O
in 36 38 945 947 O
girls 39 44 948 953 B-gender
, 44 45 953 954 O
or 46 48 955 957 O
testicular 49 59 958 968 B-clinical_variable
volumes 60 67 969 976 I-clinical_variable
less 68 72 977 981 O
than 73 77 982 986 O
or 78 80 987 989 O
equal 81 86 990 995 O
to 87 89 996 998 O
3 90 91 999 1000 B-upper_bound
mL 92 94 1001 1003 I-upper_bound
in 95 97 1004 1006 O
boys 98 102 1007 1011 B-gender
) 102 103 1011 1012 O

Psychiatric 0 11 1013 1024 B-chronic_disease
or 12 14 1025 1027 O
cognitive 15 24 1028 1037 B-chronic_disease
disorder 25 33 1038 1046 I-chronic_disease
that 34 38 1047 1051 O
will 39 43 1052 1056 O
, 43 44 1056 1057 O
in 45 47 1058 1060 O
the 48 51 1061 1064 O
opinion 52 59 1065 1072 O
of 60 62 1073 1075 O
the 63 66 1076 1079 O
investigators 67 80 1080 1093 O
, 80 81 1093 1094 O
limit 82 87 1095 1100 O
the 88 91 1101 1104 O
subject 92 99 1105 1112 O
's 99 101 1112 1114 O
ability 102 109 1115 1122 O
to 110 112 1123 1125 O
provide 113 120 1126 1133 O
assent 121 127 1134 1140 O
, 127 128 1140 1141 O
and/or 129 135 1142 1148 O
the 136 139 1149 1152 O
subject 140 147 1153 1160 O
s 148 149 1161 1162 O
parent 150 156 1163 1169 O
/ 156 157 1169 1170 O
guardian 157 165 1170 1178 O
to 166 168 1179 1181 O
provide 169 176 1182 1189 O
informed 177 185 1190 1198 O
consent 186 193 1199 1206 O
, 193 194 1206 1207 O
or 195 197 1208 1210 O
to 198 200 1211 1213 O
comply 201 207 1214 1220 O
with 208 212 1221 1225 O
study 213 218 1226 1231 O
procedures 219 229 1232 1242 O

Psychiatric 0 11 1243 1254 B-chronic_disease
or 12 14 1255 1257 I-chronic_disease
cognitive 15 24 1258 1267 I-chronic_disease
disorder 25 33 1268 1276 I-chronic_disease
that 34 38 1277 1281 O
will 39 43 1282 1286 O
, 43 44 1286 1287 O
in 45 47 1288 1290 O
the 48 51 1291 1294 O
opinion 52 59 1295 1302 O
of 60 62 1303 1305 O
the 63 66 1306 1309 O
investigators 67 80 1310 1323 O
, 80 81 1323 1324 O
limit 82 87 1325 1330 O
the 88 91 1331 1334 O
subject 92 99 1335 1342 O
's 99 101 1342 1344 O
ability 102 109 1345 1352 O
to 110 112 1353 1355 O
provide 113 120 1356 1363 O
informed 121 129 1364 1372 O
consent 130 137 1373 1380 O
, 137 138 1380 1381 O
or 139 141 1382 1384 O
to 142 144 1385 1387 O
comply 145 151 1388 1394 O
with 152 156 1395 1399 O
study 157 162 1400 1405 O
procedures 163 173 1406 1416 O

Recent 0 6 1417 1423 O
( 7 8 1424 1425 O
past 8 12 1425 1429 B-upper_bound
2 13 14 1430 1431 I-upper_bound
months 15 21 1432 1438 I-upper_bound
) 21 22 1438 1439 O
use 23 26 1440 1443 O
of 27 29 1444 1446 O
drugs 30 35 1447 1452 O
that 36 40 1453 1457 O
alter 41 46 1458 1463 O
glucose 47 54 1464 1471 O
metabolism 55 65 1472 1482 O
( 66 67 1483 1484 O
e.g. 67 71 1484 1488 O
metformin 72 81 1489 1498 B-treatment
) 81 82 1498 1499 O

Recent 0 6 1500 1506 O
( 7 8 1507 1508 O
past 8 12 1508 1512 B-upper_bound
2 13 14 1513 1514 I-upper_bound
months 15 21 1515 1521 I-upper_bound
) 21 22 1521 1522 O
use 23 26 1523 1526 O
of 27 29 1527 1529 O
drugs 30 35 1530 1535 O
that 36 40 1536 1540 O
alter 41 46 1541 1546 O
glucose 47 54 1547 1554 O
metabolism 55 65 1555 1565 O
( 66 67 1566 1567 O
e.g. 67 71 1567 1571 O
metformin 72 81 1572 1581 B-treatment
) 81 82 1581 1582 O
, 82 83 1582 1583 O
alter 84 89 1584 1589 O
gastric 90 97 1590 1597 O
pH 98 100 1598 1600 O
( 101 102 1601 1602 O
e.g. 102 106 1602 1606 O
proton 107 113 1607 1613 B-treatment
pump 114 118 1614 1618 I-treatment
inhibitors 119 129 1619 1629 I-treatment
) 129 130 1629 1630 O
or 131 133 1631 1633 O
gastric 134 141 1634 1641 O
emptying 142 150 1642 1650 O
( 151 152 1651 1652 O
e.g. 152 156 1652 1656 O
metoclopramide 157 171 1657 1671 B-treatment
) 171 172 1671 1672 O

alter 0 5 1673 1678 O
gastric 6 13 1679 1686 B-clinical_variable
pH 14 16 1687 1689 I-clinical_variable
( 17 18 1690 1691 O
e.g. 18 22 1691 1695 O
proton 23 29 1696 1702 B-treatment
pump 30 34 1703 1707 I-treatment
inhibitors 35 45 1708 1718 I-treatment
) 45 46 1718 1719 O

gastric 0 7 1720 1727 B-treatment
emptying 8 16 1728 1736 I-treatment
( 17 18 1737 1738 O
e.g. 18 22 1738 1742 O
metoclopramide 23 37 1743 1757 B-treatment
) 37 38 1757 1758 O

Active 0 6 0 6 O
malignancies 7 19 7 19 B-cancer
or 20 22 20 22 O
other 23 28 23 28 O
serious 29 36 29 36 O
concurrent 37 47 37 47 O
or 48 50 48 50 O
recent 51 57 51 57 O
medical 58 65 58 65 O
or 66 68 66 68 O
psychiatric 69 80 69 80 B-chronic_disease
condition 81 90 81 90 I-chronic_disease
which 91 96 91 96 O
, 96 97 96 97 O
in 98 100 98 100 O
the 101 104 101 104 O
opinion 105 112 105 112 O
of 113 115 113 115 O
the 116 119 116 119 O
Investigator 120 132 120 132 O
, 132 133 132 133 O
makes 134 139 134 139 O
the 140 143 140 143 O
patient 144 151 144 151 O
unsuitable 152 162 152 162 O
for 163 166 163 166 O
participation 167 180 167 180 O
in 181 183 181 183 O
this 184 188 184 188 O
study 189 194 189 194 O

Body 0 4 195 199 B-bmi
Mass 5 9 200 204 I-bmi
Index 10 15 205 210 I-bmi
( 16 17 211 212 I-bmi
BMI 17 20 212 215 I-bmi
) 20 21 215 216 I-bmi
< 22 23 217 218 O
18 23 25 218 220 B-upper_bound
or 26 28 221 223 O
> 29 30 224 225 O
30 30 32 225 227 B-lower_bound

Carbamylated 0 12 228 240 B-clinical_variable
albumin 13 20 241 248 I-clinical_variable
( 21 22 249 250 I-clinical_variable
C 22 23 250 251 I-clinical_variable
- 23 24 251 252 I-clinical_variable
Alb 24 27 252 255 I-clinical_variable
) 27 28 255 256 I-clinical_variable
> 29 30 257 258 O
7.7 31 34 259 262 B-lower_bound
mmol 35 39 263 267 I-lower_bound
/ 39 40 267 268 I-lower_bound
mol 40 43 268 271 I-lower_bound

Condition 0 9 272 281 O
with 10 14 282 286 O
prognosis 15 24 287 296 B-clinical_variable
< 25 26 297 298 O
1 26 27 298 299 B-upper_bound
year 28 32 300 304 I-upper_bound
at 33 35 305 307 O
time 36 40 308 312 O
of 41 43 313 315 O
study 44 49 316 321 O
entry 50 55 322 327 O

Current 0 7 328 335 O
active 8 14 336 342 B-treatment
treatment 15 24 343 352 I-treatment
in 25 27 353 355 O
another 28 35 356 363 O
investigational 36 51 364 379 B-treatment
study 52 57 380 385 I-treatment
or 58 60 386 388 O
participation 61 74 389 402 O
in 75 77 403 405 O
another 78 85 406 413 O
investigational 86 101 414 429 O
study 102 107 430 435 O
in 108 110 436 438 O
the 111 114 439 442 O
1 115 116 443 444 B-upper_bound
month 117 122 445 450 I-upper_bound
prior 123 128 451 456 I-upper_bound
to 129 131 457 459 O
screening 132 141 460 469 O

Dialysis 0 8 470 478 B-treatment
adequacy 9 17 479 487 O
recorded 18 26 488 496 O
as 27 29 497 499 O
Kt/ 30 33 500 503 B-clinical_variable
V 34 35 504 505 I-clinical_variable
> 36 37 506 507 O
1.2 38 41 508 511 B-lower_bound

HIV 0 3 512 515 B-chronic_disease
positive 4 12 516 524 O

History 0 7 525 532 O
of 8 10 533 535 O
allergy 11 18 536 543 O
to 19 21 544 546 O
any 22 25 547 550 O
amino 26 31 551 556 B-allergy_name
acid 32 36 557 561 I-allergy_name
compound 37 45 562 570 O

On 0 2 571 573 O
stable 3 9 574 580 B-treatment
hemodialysis 10 22 581 593 I-treatment
therapy 23 30 594 601 I-treatment
for 31 34 602 605 O
at 35 37 606 608 O
least 38 43 609 614 O
90 44 46 615 617 B-lower_bound
days 47 51 618 622 I-lower_bound
before 52 58 623 629 I-lower_bound
the 59 62 630 633 O
study 63 68 634 639 O
entry 69 74 640 645 O
, 74 75 645 646 O
defined 76 83 647 654 O
as 84 86 655 657 O
receiving 87 96 658 667 O
thrice 97 103 668 674 O
weekly 104 110 675 681 O
dialysis 111 119 682 690 O
and 120 123 691 694 O
carrying 124 132 695 703 O
a 133 134 704 705 O
diagnosis 135 144 706 715 O
of 145 147 716 718 O
ESRD 148 152 719 723 B-chronic_disease

On 0 2 724 726 O
stable 3 9 727 733 O
medical 10 17 734 741 B-treatment
therapy 18 25 742 749 I-treatment
in 26 28 750 752 O
the 29 32 753 756 O
last 33 37 757 761 B-upper_bound
30 38 40 762 764 I-upper_bound
days 41 45 765 769 I-upper_bound
before 46 52 770 776 I-upper_bound
the 53 56 777 780 O
study 57 62 781 786 O
entry 63 68 787 792 O
, 68 69 792 793 O
defined 70 77 794 801 O
as 78 80 802 804 O
no 81 83 805 807 O
change 84 90 808 814 O
, 90 91 814 815 O
addition 92 100 816 824 O
, 100 101 824 825 O
or 102 104 826 828 O
removal 105 112 829 836 O
of 113 115 837 839 O
medications 116 127 840 851 B-treatment

Poorly 0 6 852 858 O
controlled 7 17 859 869 O
hypertension 18 30 870 882 B-chronic_disease
( 31 32 883 884 O
systolic 32 40 884 892 B-clinical_variable
blood 41 46 893 898 I-clinical_variable
pressure 47 55 899 907 I-clinical_variable
> 56 57 908 909 O
180 58 61 910 913 B-lower_bound
mmHg 62 66 914 918 I-lower_bound
and/or 67 73 919 925 O
diastolic 74 83 926 935 B-clinical_variable
blood 84 89 936 941 I-clinical_variable
pressure 90 98 942 950 I-clinical_variable
> 99 100 951 952 O
110 101 104 953 956 B-lower_bound
mmHg 105 109 957 961 I-lower_bound
during 110 116 962 968 O
any 117 120 969 972 O
of 121 123 973 975 O
the 124 127 976 979 O
previous 128 136 980 988 B-treatment
3 137 138 989 990 I-treatment
dialysis 139 147 991 999 I-treatment
sessions 148 156 1000 1008 I-treatment
( 157 158 1009 1010 O
confirmed 158 167 1010 1019 O
by 168 170 1020 1022 O
repeat 171 177 1023 1029 O
) 177 178 1029 1030 O

Prescribed 0 10 1031 1041 O
a 11 12 1042 1043 O
dialysis 13 21 1044 1052 B-treatment
treatment 22 31 1053 1062 I-treatment
time 32 36 1063 1067 O
of 37 39 1068 1070 O
4 40 41 1071 1072 O
hours 42 47 1073 1078 O
per 48 51 1079 1082 O
session 52 59 1083 1090 O

Presence 0 8 1091 1099 O
of 9 11 1100 1102 O
asthma 12 18 1103 1109 B-chronic_disease

Received 0 8 1110 1118 O
parenteral 9 19 1119 1129 B-treatment
nutrition 20 29 1130 1139 I-treatment
within 30 36 1140 1146 O
last 37 41 1147 1151 B-upper_bound
90 42 44 1152 1154 I-upper_bound
days 45 49 1155 1159 I-upper_bound

Serum 0 5 1160 1165 B-clinical_variable
albumin 6 13 1166 1173 I-clinical_variable
≥ 14 15 1174 1175 O
3.0 16 19 1176 1179 B-lower_bound
g 20 21 1180 1181 I-lower_bound
/ 21 22 1181 1182 I-lower_bound
dL 22 24 1182 1184 I-lower_bound
( 25 26 1185 1186 I-lower_bound
30 26 28 1186 1188 I-lower_bound
g 29 30 1189 1190 I-lower_bound
/ 30 31 1190 1191 I-lower_bound
L 31 32 1191 1192 I-lower_bound
) 32 33 1192 1193 I-lower_bound

Severe 0 6 1194 1200 O
hepatic 7 14 1201 1208 B-chronic_disease
impairment 15 25 1209 1219 I-chronic_disease

Taking 0 6 1220 1226 O
any 7 10 1227 1230 O
type 11 15 1231 1235 O
of 16 18 1236 1238 O
amino 19 24 1239 1244 B-treatment
acid 25 29 1245 1249 I-treatment
supplementation 30 45 1250 1265 I-treatment
within 46 52 1266 1272 O
the 53 56 1273 1276 O
last 57 61 1277 1281 B-upper_bound
90 62 64 1282 1284 I-upper_bound
days 65 69 1285 1289 I-upper_bound

Willing 0 7 1290 1297 O
and 8 11 1298 1301 O
able 12 16 1302 1306 O
to 17 19 1307 1309 O
adhere 20 26 1310 1316 O
to 27 29 1317 1319 O
all 30 33 1320 1323 O
study 34 39 1324 1329 O
- 39 40 1329 1330 O
related 40 47 1330 1337 O
procedures 48 58 1338 1348 O
, 58 59 1348 1349 O
including 60 69 1350 1359 O
adherence 70 79 1360 1369 O
to 80 82 1370 1372 O
study 83 88 1373 1378 O
medication 89 99 1379 1389 B-treatment
regimen 100 107 1390 1397 I-treatment

Women 0 5 1398 1403 B-gender
of 6 8 1404 1406 O
childbearing 9 21 1407 1419 O
potential 22 31 1420 1429 O
must 32 36 1430 1434 O
be 37 39 1435 1437 O
practicing 40 50 1438 1448 B-contraception_consent
barrier 51 58 1449 1456 I-contraception_consent
or 59 61 1457 1459 I-contraception_consent
oral 62 66 1460 1464 I-contraception_consent
contraception 67 80 1465 1478 I-contraception_consent
, 80 81 1478 1479 O
for 82 85 1480 1483 O
the 86 89 1484 1487 O
duration 90 98 1488 1496 O
of 99 101 1497 1499 O
the 102 105 1500 1503 O
study 106 111 1504 1509 B-treatment
- 111 112 1509 1510 I-treatment
related 112 119 1510 1517 I-treatment
treatment 120 129 1518 1527 I-treatment
, 129 130 1527 1528 O
or 131 133 1529 1531 O
be 134 136 1532 1534 O
documented 137 147 1535 1545 O
as 148 150 1546 1548 O
surgically 151 161 1549 1559 O
sterile 162 169 1560 1567 O
or 170 172 1568 1570 O
one 173 176 1571 1574 O
year 177 181 1575 1579 O
post 182 186 1580 1584 O
- 186 187 1584 1585 O
menopausal 187 197 1585 1595 O

≥18 0 3 1596 1599 O
years 4 9 1600 1605 I-lower_bound
old 10 13 1606 1609 O

Be 0 2 0 2 O
classified 3 13 3 13 O
in 14 16 14 16 O
breast 17 23 17 23 B-cancer
cancer 24 30 24 30 I-cancer
stage 31 36 31 36 O
grouping 37 45 37 45 O
0 46 47 46 47 B-lower_bound
to 48 50 48 50 O
III 51 54 51 54 B-upper_bound
according 55 64 55 64 O
to 65 67 65 67 O
the 68 71 68 71 O
American 72 80 72 80 O
Joint 81 86 81 86 O
Committee 87 96 87 96 O
on 97 99 97 99 O
Cancer 100 106 100 106 O
Classification 107 121 107 121 O
of 122 124 122 124 O
Malignant 125 134 125 134 O
Tumors 135 141 135 141 O
( 142 143 142 143 O
TNM 143 146 143 146 O
) 146 147 146 147 O
Staging 148 155 148 155 O
System 156 162 156 162 O
( 163 164 163 164 O
2013 164 168 164 168 O
) 168 169 168 169 O

Diagnosed 0 9 170 179 O
with 10 14 180 184 O
breast 15 21 185 191 B-cancer
cancer 22 28 192 198 I-cancer

Fifty 0 5 199 204 B-lower_bound
years 6 11 205 210 I-lower_bound
of 12 14 211 213 O
age 15 18 214 217 B-age
or 19 21 218 220 O
older 22 27 221 226 O

Have 0 4 227 231 O
completed 5 14 232 241 O
adjuvant 15 23 242 250 B-treatment
curative 24 32 251 259 I-treatment
therapy 33 40 260 267 I-treatment
at 41 43 268 270 O
least 44 49 271 276 O
two 50 53 277 280 B-lower_bound
months 54 60 281 287 I-lower_bound
to 61 63 288 290 O
5 64 65 291 292 B-upper_bound
years 66 71 293 298 I-upper_bound
prior 72 77 299 304 I-upper_bound
to 78 80 305 307 O
recruitment 81 92 308 319 O

Women 0 5 320 325 B-gender
who 6 9 326 329 O
already 10 17 330 337 O
meet 18 22 338 342 O
the 23 26 343 346 O
national 27 35 347 355 O
standard 36 44 356 364 O
for 45 48 365 368 O
exercise 49 57 369 377 O
( 58 59 378 379 O
≥ 59 60 379 380 O
150 61 64 381 384 B-lower_bound
minutes 65 72 385 392 I-lower_bound
per 73 76 393 396 I-lower_bound
week 77 81 397 401 I-lower_bound
of 82 84 402 404 O
moderate 85 93 405 413 O
exercise 94 102 414 422 O
) 102 103 422 423 O

Women 0 5 424 429 B-gender
who 6 9 430 433 O
have 10 14 434 438 O
contraindications 15 32 439 456 O
to 33 35 457 459 O
exercise 36 44 460 468 B-allergy_name
, 44 45 468 469 O
such 46 50 470 474 O
as 51 53 475 477 O
extreme 54 61 478 485 O
fatigue 62 69 486 493 O
or 70 72 494 496 O
anemia 73 79 497 503 B-chronic_disease
, 79 80 503 504 O
unstable 81 89 505 513 O
cardiac 90 97 514 521 B-chronic_disease
disease 98 105 522 529 I-chronic_disease
; 105 106 529 530 O
uncontrolled 107 119 531 543 O
diabetes 120 128 544 552 B-chronic_disease
; 128 129 552 553 O
uncontrolled 130 142 554 566 O
hypertension 143 155 567 579 B-chronic_disease
; 155 156 579 580 O
coagulopathies 157 171 581 595 B-chronic_disease
; 171 172 595 596 O
inability 173 182 597 606 O
to 183 185 607 609 O
ambulate 186 194 610 618 O
independently 195 208 619 632 O

Women 0 5 633 638 B-gender
with 6 10 639 643 O
metastasis 11 21 644 654 B-cancer
or 22 24 655 657 O
secondary 25 34 658 667 B-cancer
cancers 35 42 668 675 I-cancer

Access 0 6 0 6 B-technology_access
to 7 9 7 9 I-technology_access
internet 10 18 10 18 I-technology_access

Aged 0 4 19 23 B-age
14 5 7 24 26 B-upper_bound
years 8 13 27 32 I-upper_bound
or 14 16 33 35 O
younger 17 24 36 43 O
or 25 27 44 46 O
25 28 30 47 49 B-lower_bound
years 31 36 50 55 I-lower_bound
or 37 39 56 58 O
older 40 45 59 64 O
at 46 48 65 67 O
time 49 53 68 72 O
of 54 56 73 75 O
screening 57 66 76 85 O

Aged 0 4 86 90 B-age
15 5 7 91 93 B-lower_bound
to 8 10 94 96 O
24 11 13 97 99 B-upper_bound
years 14 19 100 105 I-upper_bound
( 20 21 106 107 O
inclusive 21 30 107 116 O
) 30 31 116 117 O
at 32 34 118 120 O
time 35 39 121 125 O
of 40 42 126 128 O
screening 43 52 129 138 O

Assigned 0 8 139 147 O
male 9 13 148 152 B-gender
sex 14 17 153 156 O
at 18 20 157 159 O
birth 21 26 160 165 O
and 27 30 166 169 O
currently 31 40 170 179 O
identifies 41 51 180 190 O
as 52 54 191 193 O
male 55 59 194 198 O

Assigned 0 8 199 207 O
male 9 13 208 212 B-gender
sex 14 17 213 216 O
at 18 20 217 219 O
birth 21 26 220 225 O
but 27 30 226 229 O
identifies 31 41 230 240 O
as 42 44 241 243 O
transgender 45 56 244 255 O
or 57 59 256 258 O
gender 60 66 259 265 O
non 67 70 266 269 O
- 70 71 269 270 O
conforming 71 81 270 280 O

Does 0 4 281 285 B-language_fluency
not 5 8 286 289 I-language_fluency
speak 9 14 290 295 I-language_fluency
or 15 17 296 298 I-language_fluency
read 18 22 299 303 I-language_fluency
English 23 30 304 311 I-language_fluency

HIV 0 3 312 315 B-chronic_disease
- 3 4 315 316 O
positive 4 12 316 324 O

Not 0 3 325 328 O
be 4 6 329 331 O
on 7 9 332 334 O
PrEP 10 14 335 339 B-chronic_disease
at 15 17 340 342 O
time 18 22 343 347 O
of 23 25 348 350 O
enrollment 26 36 351 361 O

Report 0 6 362 368 O
having 7 13 369 375 O
consensual 14 24 376 386 O
anal 25 29 387 391 O
sex 30 33 392 395 O
with 34 38 396 400 O
a 39 40 401 402 O
male 41 45 403 407 B-gender
partner 46 53 408 415 O
in 54 56 416 418 O
the 57 60 419 422 O
prior 61 66 423 428 B-upper_bound
6 67 68 429 430 I-upper_bound
months 69 75 431 437 I-upper_bound

Self 0 4 438 442 O
- 4 5 442 443 O
report 5 11 443 449 O
as 12 14 450 452 O
HIV 15 18 453 456 B-chronic_disease
- 18 19 456 457 O
negative 19 27 457 465 O
or 28 30 466 468 O
sero 31 35 469 473 O
- 35 36 473 474 O
status 36 42 474 480 O
unaware 43 50 481 488 O

BMI 0 3 0 3 B-bmi
: 3 4 3 4 O
27 5 7 5 7 B-lower_bound
- 7 8 7 8 O
35 8 10 8 10 B-upper_bound

age 0 3 11 14 B-age
: 3 4 14 15 O
21 5 7 16 18 B-lower_bound
- 7 8 18 19 O
45 8 10 19 21 B-upper_bound
yrs 11 14 22 25 I-upper_bound

bariatric 0 9 26 35 B-treatment
surgery 10 17 36 43 I-treatment

contraindication 0 16 44 60 O
to 17 19 61 63 O
MRI 20 23 64 67 B-treatment

currently 0 9 68 77 B-pregnancy
pregnant 10 18 78 86 I-pregnancy
, 18 19 86 87 O
lactating 20 29 88 97 O
or 30 32 98 100 O
less 33 37 101 105 O
than 38 42 106 110 O
6 43 44 111 112 B-upper_bound
months 45 51 113 119 I-upper_bound
post 52 56 120 124 O
- 56 57 124 125 O
partum 57 63 125 131 O

history 0 7 132 139 O
of 8 10 140 142 O
cardiovascular 11 25 143 157 B-chronic_disease
disease 26 33 158 165 I-chronic_disease
( 34 35 166 167 I-chronic_disease
CVD 35 38 167 170 I-chronic_disease
) 38 39 170 171 I-chronic_disease
, 39 40 171 172 O
diabetes 41 49 173 181 B-chronic_disease
mellitus 50 58 182 190 I-chronic_disease
, 58 59 190 191 O
uncontrolled 60 72 192 204 B-chronic_disease
hypertension 73 85 205 217 I-chronic_disease
, 85 86 217 218 O
untreated 87 96 219 228 O
thyroid 97 104 229 236 B-chronic_disease
disease 105 112 237 244 I-chronic_disease
, 112 113 244 245 O
renal 114 119 246 251 B-chronic_disease
disease 120 127 252 259 I-chronic_disease
, 127 128 259 260 O
hepatic 129 136 261 268 B-chronic_disease
disease 137 144 269 276 I-chronic_disease
, 144 145 276 277 O
or 146 148 278 280 O
any 149 152 281 284 O
other 153 158 285 290 O
medical 159 166 291 298 O
condition 167 176 299 308 O
affecting 177 186 309 318 O
weight 187 193 319 325 O
or 194 196 326 328 O
energy 197 203 329 335 O
metabolism 204 214 336 346 O

major 0 5 347 352 O
psychiatric 6 17 353 364 B-chronic_disease
disorder 18 26 365 373 I-chronic_disease
, 26 27 373 374 O
presence 28 36 375 383 O
of 37 39 384 386 O
alcohol 40 47 387 394 O
or 48 50 395 397 O
substance 51 60 398 407 O
abuse 61 66 408 413 O
, 66 67 413 414 O
current 68 75 415 422 O
depression 76 86 423 433 B-chronic_disease
by 87 89 434 436 O
history 90 97 437 444 O
and/or 98 104 445 451 O
a 105 106 452 453 O
score 107 112 454 459 O
> 113 114 460 461 O
21 114 116 461 463 B-lower_bound
on 117 119 464 466 O
the 120 123 467 470 O
he 124 126 471 473 O
Center 127 133 474 480 B-clinical_variable
for 134 137 481 484 I-clinical_variable
Epidemiologic 138 151 485 498 I-clinical_variable
Studies 152 159 499 506 I-clinical_variable
Depression 160 170 507 517 I-clinical_variable
Scale 171 176 518 523 I-clinical_variable
( 177 178 524 525 I-clinical_variable
CES 178 181 525 528 I-clinical_variable
- 181 182 528 529 I-clinical_variable
D 182 183 529 530 I-clinical_variable
) 183 184 530 531 I-clinical_variable
, 184 185 531 532 O
history 186 193 533 540 O
of 194 196 541 543 O
eating 197 203 544 550 B-chronic_disease
disorders 204 213 551 560 I-chronic_disease
and/or 214 220 561 567 O
a 221 222 568 569 O
score 223 228 570 575 O
of 229 231 576 578 O
> 232 233 579 580 O
20 233 235 580 582 B-lower_bound
on 236 238 583 585 O
the 239 242 586 589 O
EATS-26 243 250 590 597 B-clinical_variable

medications 0 11 598 609 B-treatment
affecting 12 21 610 619 O
weight 22 28 620 626 O
, 28 29 626 627 O
Energy 30 36 628 634 O
Intake 37 43 635 641 O
( 44 45 642 643 O
EI 45 47 643 645 O
) 47 48 645 646 O
or 49 51 647 649 O
Energy 52 58 650 656 B-clinical_variable
Expenditure 59 70 657 668 I-clinical_variable
( 71 72 669 670 I-clinical_variable
EE 72 74 670 672 I-clinical_variable
) 74 75 672 673 I-clinical_variable
in 76 78 674 676 O
the 79 82 677 680 O
last 83 87 681 685 B-upper_bound
6 88 89 686 687 I-upper_bound
months 90 96 688 694 I-upper_bound

sedentary 0 9 695 704 O
( 10 11 705 706 O
less 11 15 706 710 O
than 16 20 711 715 O
1 21 22 716 717 B-upper_bound
hour 23 27 718 722 I-upper_bound
of 28 30 723 725 O
planned 31 38 726 733 O
physical 39 47 734 742 O
activity 48 56 743 751 O
by 57 59 752 754 O
self 60 64 755 759 O
- 64 65 759 760 O
report 65 71 760 766 O
) 71 72 766 767 O

unable 0 6 768 774 O
to 7 9 775 777 O
pass 10 14 778 782 O
screening 15 24 783 792 O
graded 25 31 793 799 O
exercise 32 40 800 808 B-treatment
treadmill 41 50 809 818 I-treatment
test 51 55 819 823 I-treatment

weight 0 6 824 830 B-clinical_variable
loss 7 11 831 835 I-clinical_variable
or 12 14 836 838 O
weight 15 21 839 845 B-clinical_variable
gain 22 26 846 850 I-clinical_variable
of 27 29 851 853 O
> 30 31 854 855 O
5 31 32 855 856 B-lower_bound
percent 33 40 857 864 I-lower_bound
in 41 43 865 867 O
past 44 48 868 872 B-upper_bound
6 49 50 873 874 I-upper_bound
months 51 57 875 881 I-upper_bound

weight 0 6 882 888 B-clinical_variable
stable 7 13 889 895 O
within 14 20 896 902 O
+ 21 22 903 904 B-upper_bound
/- 22 24 904 906 I-upper_bound
5 25 26 907 908 I-upper_bound
percent 27 34 909 916 I-upper_bound
in 35 37 917 919 O
the 38 41 920 923 O
last 42 46 924 928 B-upper_bound
6 47 48 929 930 I-upper_bound
months 49 55 931 937 I-upper_bound

history 0 7 0 7 O
of 8 10 8 10 O
severe 11 17 11 17 B-chronic_disease
psychiatric 18 29 18 29 I-chronic_disease
illness 30 37 30 37 I-chronic_disease
unrelated 38 47 38 47 O
to 48 50 48 50 O
PTSD 51 55 51 55 B-chronic_disease

between 0 7 0 7 O
18 8 10 8 10 B-lower_bound
and 11 14 11 14 O
50 15 17 15 17 B-upper_bound
years 18 23 18 23 I-upper_bound
of 24 26 24 26 O
age 27 30 27 30 B-age

currently 0 9 31 40 O
participating 10 23 41 54 O
in 24 26 55 57 O
, 26 27 57 58 O
or 28 30 59 61 O
has 31 34 62 65 O
recently 35 43 66 74 O
participated 44 56 75 87 O
in 57 59 88 90 O
( 60 61 91 92 O
discontinued 61 73 92 104 O
within 74 80 105 111 O
30 81 83 112 114 B-upper_bound
days 84 88 115 119 I-upper_bound
prior 89 94 120 125 I-upper_bound
to 95 97 126 128 O
this 98 102 129 133 O
study 103 108 134 139 O
) 108 109 139 140 O
in 110 112 141 143 O
an 113 115 144 146 O
investigational 116 131 147 162 O
drug 132 136 163 167 O
study 137 142 168 173 O
[ 143 144 174 175 O
self 144 148 175 179 O
- 148 149 179 180 O
reported 149 157 180 188 O
] 157 158 188 189 O

female 0 6 190 196 B-gender
and 7 10 197 200 O
is 11 13 201 203 O
unwilling 14 23 204 213 B-contraception_consent
to 24 26 214 216 I-contraception_consent
use 27 30 217 220 I-contraception_consent
effective 31 40 221 230 I-contraception_consent
birth 41 46 231 236 I-contraception_consent
control 47 54 237 244 I-contraception_consent
between 55 62 245 252 O
the 63 66 253 256 O
time 67 71 257 261 O
of 72 74 262 264 O
screening 75 84 265 274 O
and 85 88 275 278 O
study 89 94 279 284 O
procedure 95 104 285 294 O

has 0 3 295 298 O
Rayanud 4 11 299 306 B-chronic_disease
's 11 13 306 308 I-chronic_disease
disease 14 21 309 316 I-chronic_disease

has 0 3 317 320 O
a 4 5 321 322 O
BMI 6 9 323 326 B-bmi
between 10 17 327 334 O
18.0 18 22 335 339 B-lower_bound
and 23 26 340 343 O
30.0 27 31 344 348 B-upper_bound
[ 32 33 349 350 O
calculated 33 43 350 360 O
from 44 48 361 365 O
measured 49 57 366 374 O
height 58 64 375 381 O
& 65 66 382 383 O
weight 67 73 384 390 O
] 73 74 390 391 O

has 0 3 392 395 O
a 4 5 396 397 O
COHb 6 10 398 402 B-clinical_variable
greater 11 18 403 410 O
than 19 23 411 415 O
3 24 25 416 417 B-lower_bound
% 25 26 417 418 I-lower_bound
, 26 27 418 419 O
or 28 30 420 422 O
MetHb 31 36 423 428 B-clinical_variable
greater 37 44 429 436 O
than 45 49 437 441 O
2 50 51 442 443 B-lower_bound
% 51 52 443 444 I-lower_bound
[ 53 54 445 446 O
measured 54 62 446 454 O
by 63 65 455 457 O
venous 66 72 458 464 B-treatment
blood 73 78 465 470 I-treatment
sample 79 85 471 477 I-treatment
co 86 88 478 480 I-treatment
- 88 89 480 481 I-treatment
oximetry 89 97 481 489 I-treatment
] 97 98 489 490 O

has 0 3 491 494 O
a 4 5 495 496 O
clinically 6 16 497 507 O
significant 17 28 508 519 O
abnormal 29 37 520 528 B-chronic_disease
EKG 38 41 529 532 I-chronic_disease
[ 42 43 533 534 O
assessment 43 53 534 544 O
by 54 56 545 547 O
PI 57 59 548 550 O
or 60 62 551 553 O
delegate 63 71 554 562 O
] 71 72 562 563 O

has 0 3 564 567 O
a 4 5 568 569 O
clinically 6 16 570 580 O
significant 17 28 581 592 O
abnormal 29 37 593 601 B-treatment
pulmonary 38 47 602 611 I-treatment
function 48 56 612 620 I-treatment
test 57 61 621 625 I-treatment
via 62 65 626 629 O
spirometry 66 76 630 640 B-treatment
[ 77 78 641 642 O
assessment 78 88 642 652 O
by 89 91 653 655 O
PI 92 94 656 658 O
or 95 97 659 661 O
delegate 98 106 662 670 O
] 106 107 670 671 O

has 0 3 672 675 O
a 4 5 676 677 O
history 6 13 678 685 O
of 14 16 686 688 O
sickle 17 23 689 695 B-chronic_disease
cell 24 28 696 700 I-chronic_disease
disease 29 36 701 708 I-chronic_disease
[ 37 38 709 710 O
self 38 42 710 714 O
- 42 43 714 715 O
reported 43 51 715 723 O
] 51 52 723 724 O

has 0 3 725 728 O
a 4 5 729 730 O
prior 6 11 731 736 O
or 12 14 737 739 O
known 15 20 740 745 O
allergy 21 28 746 753 O
to 29 31 754 756 O
lidocaine 32 41 757 766 B-allergy_name
or 42 44 767 769 O
similar 45 52 770 777 B-allergy_name
pharmacologic 53 66 778 791 I-allergy_name
agents 67 73 792 798 I-allergy_name

has 0 3 799 802 O
anemia 4 10 803 809 B-chronic_disease
[ 11 12 810 811 O
measured 12 20 811 819 O
by 21 23 820 822 O
venous 24 30 823 829 O
blood 31 36 830 835 O
gas 37 40 836 839 O
sample 41 47 840 846 O
] 47 48 846 847 O

has 0 3 848 851 O
completed 4 13 852 861 O
the 14 17 862 865 O
appropriate 18 29 866 877 O
fasting 30 37 878 885 O
periods 38 45 886 893 O
for 46 49 894 897 O
solids 50 56 898 904 O
and 57 60 905 908 O
liquids 61 68 909 916 O
prior 69 74 917 922 O
to 75 77 923 925 O
the 78 81 926 929 O
administration 82 96 930 944 O
of 97 99 945 947 O
remifentanil 100 112 948 960 B-treatment

has 0 3 961 964 O
made 4 8 965 969 O
a 9 10 970 971 O
whole 11 16 972 977 O
blood 17 22 978 983 O
donation 23 31 984 992 O
or 32 34 993 995 O
has 35 38 996 999 O
had 39 42 1000 1003 O
at 43 45 1004 1006 O
least 46 51 1007 1012 O
450 52 55 1013 1016 B-lower_bound
ml 56 58 1017 1019 I-lower_bound
of 59 61 1020 1022 O
blood 62 67 1023 1028 O
drawn 68 73 1029 1034 O
within 74 80 1035 1041 O
8 81 82 1042 1043 B-lower_bound
weeks 83 88 1044 1049 I-lower_bound
prior 89 94 1050 1055 I-lower_bound
to 95 97 1056 1058 O
the 98 101 1059 1062 O
study 102 107 1063 1068 O
procedure 108 117 1069 1078 O
[ 118 119 1079 1080 O
self 119 123 1080 1084 O
- 123 124 1084 1085 O
reported 124 132 1085 1093 O
] 132 133 1093 1094 O

has 0 3 1095 1098 O
room 4 8 1099 1103 O
air 9 12 1104 1107 B-clinical_variable
saturation 13 23 1108 1118 I-clinical_variable
less 24 28 1119 1123 O
than 29 33 1124 1128 O
95 34 36 1129 1131 B-upper_bound
% 36 37 1131 1132 I-upper_bound
by 38 40 1133 1135 O
pulse 41 46 1136 1141 O
oximetry 47 55 1142 1150 O
[ 56 57 1151 1152 O
measurement 57 68 1152 1163 O
by 69 71 1164 1166 O
PI 72 74 1167 1169 O
or 75 77 1170 1172 O
delegate 78 86 1173 1181 O
] 86 87 1181 1182 O

is 0 2 1183 1185 O
American 3 11 1186 1194 B-clinical_variable
Society 12 19 1195 1202 I-clinical_variable
Anesthesiologist 20 36 1203 1219 I-clinical_variable
( 37 38 1220 1221 I-clinical_variable
ASA 38 41 1221 1224 I-clinical_variable
) 41 42 1224 1225 I-clinical_variable
status 43 49 1226 1232 I-clinical_variable
1 50 51 1233 1234 I-clinical_variable
[ 52 53 1235 1236 O
assessment 53 63 1236 1246 O
by 64 66 1247 1249 O
PI 67 69 1250 1252 O
or 70 72 1253 1255 O
delegate 73 81 1256 1264 O
] 81 82 1264 1265 O

is 0 2 1266 1268 O
female 3 9 1269 1275 B-gender
with 10 14 1276 1280 O
a 15 16 1281 1282 O
positive 17 25 1283 1291 B-pregnancy
pregnancy 26 35 1292 1301 I-pregnancy
test 36 40 1302 1306 O
[ 41 42 1307 1308 O
serum 42 47 1308 1313 O
or 48 50 1314 1316 O
urine 51 56 1317 1322 O
] 56 57 1322 1323 O

unwilling 0 9 1324 1333 B-contraception_consent
or 10 12 1334 1336 I-contraception_consent
unable 13 19 1337 1343 I-contraception_consent
to 20 22 1344 1346 I-contraception_consent
provide 23 30 1347 1354 I-contraception_consent
informed 31 39 1355 1363 I-contraception_consent
consent 40 47 1364 1371 I-contraception_consent
or 48 50 1372 1374 O
comply 51 57 1375 1381 O
with 58 62 1382 1386 O
the 63 66 1387 1390 O
study 67 72 1391 1396 O
procedures 73 83 1397 1407 O

weighs 0 6 1408 1414 O
greater 7 14 1415 1422 O
than 15 19 1423 1427 O
40 20 22 1428 1430 B-lower_bound
kilograms 23 32 1431 1440 I-lower_bound

Patients 0 8 0 8 O
with 9 13 9 13 O
NSCLC 14 19 14 19 B-cancer
diagnosis 20 29 20 29 O
who 30 33 30 33 O
have 34 38 34 38 O
been 39 43 39 43 O
referred 44 52 44 52 O
for 53 56 53 56 O
a 57 58 57 58 O
clinical 59 67 59 67 O
FDG 68 71 68 71 B-treatment
PET 72 75 72 75 I-treatment
/ 75 76 75 76 I-treatment
CT 76 78 76 78 I-treatment
staging 79 86 79 86 I-treatment
scan 87 91 87 91 I-treatment
as 92 94 92 94 O
part 95 99 95 99 O
of 100 102 100 102 O
their 103 108 103 108 O
standard 109 117 109 117 O
of 118 120 118 120 O
care 121 125 121 125 O

aged 0 4 126 130 B-age
18 5 7 131 133 B-lower_bound
or 8 10 134 136 O
over 11 15 137 141 O

at 0 2 142 144 O
least 3 8 145 150 O
18 9 11 151 153 B-lower_bound
years 12 17 154 159 I-lower_bound
of 18 20 160 162 O
age 21 24 163 166 B-age

A 0 1 0 1 O
condom 2 8 2 8 O
is 9 11 9 11 O
required 12 20 12 20 O
to 21 23 21 23 O
be 24 26 24 26 O
used 27 31 27 31 O
also 32 36 32 36 O
by 37 39 37 39 O
vasectomized 40 52 40 52 O
men 53 56 53 56 B-gender
as 57 59 57 59 O
well 60 64 60 64 O
during 65 71 65 71 O
intercourse 72 83 72 83 O
with 84 88 84 88 O
a 89 90 89 90 O
male 91 95 91 95 B-gender
partner 96 103 96 103 I-gender
in 104 106 104 106 O
order 107 112 107 112 O
to 113 115 113 115 O
prevent 116 123 116 123 O
delivery 124 132 124 132 O
of 133 135 133 135 O
the 136 139 136 139 O
drug 140 144 140 144 O
via 145 148 145 148 O
semen 149 154 149 154 O

Consumption 0 11 155 166 O
of 12 14 167 169 O
alcohol 15 22 170 177 O
within 23 29 178 184 O
3 30 31 185 186 B-upper_bound
days 32 36 187 191 I-upper_bound
prior 37 42 192 197 I-upper_bound
to 43 45 198 200 O
dosing 46 52 201 207 O
or 53 55 208 210 O
during 56 62 211 217 O
the 63 66 218 221 O
study 67 72 222 227 O

Sexually 0 8 228 236 O
active 9 15 237 243 O
males 16 21 244 249 B-gender
unless 22 28 250 256 O
they 29 33 257 261 O
use 34 37 262 265 B-contraception_consent
condom 38 44 266 272 I-contraception_consent
during 45 51 273 279 O
intercourse 52 63 280 291 O
while 64 69 292 297 O
taking 70 76 298 304 O
midostaurin 77 88 305 316 B-treatment
and 89 92 317 320 O
for 93 96 321 324 O
at 97 99 325 327 O
least 100 105 328 333 O
3 106 107 334 335 B-upper_bound
months 108 114 336 342 I-upper_bound
after 115 120 343 348 I-upper_bound
the 121 124 349 352 O
last 125 129 353 357 O
exposure 130 138 358 366 O
to 139 141 367 369 O
drug 142 146 370 374 O

Significant 0 11 375 386 O
neurologic 12 22 387 397 B-chronic_disease
or 23 25 398 400 O
psychiatric 26 37 401 412 B-chronic_disease
disorder 38 46 413 421 I-chronic_disease
which 47 52 422 427 O
could 53 58 428 433 O
compromise 59 69 434 444 O
participation 70 83 445 458 O
in 84 86 459 461 O
the 87 90 462 465 O
study 91 96 466 471 O

Subjects 0 8 472 480 O
with 9 13 481 485 O
cotinine 14 22 486 494 B-clinical_variable
levels 23 29 495 501 I-clinical_variable
greater 30 37 502 509 O
than 38 42 510 514 O
500ng 43 48 515 520 B-lower_bound
/ 48 49 520 521 I-lower_bound
mL 49 51 521 523 I-lower_bound
are 52 55 524 527 O
considered 56 66 528 538 O
as 67 69 539 541 O
smokers 70 77 542 549 O
and 78 81 550 553 O
will 82 86 554 558 O
not 87 90 559 562 O
be 91 93 563 565 O
enrolled 94 102 566 574 O

Subjects 0 8 575 583 O
with 9 13 584 588 O
known 14 19 589 594 O
ongoing 20 27 595 602 O
alcohol 28 35 603 610 O
and/or 36 42 611 617 O
drug 43 47 618 622 O
abuse 48 53 623 628 O
within 54 60 629 635 O
1 61 62 636 637 B-upper_bound
month 63 68 638 643 I-upper_bound
prior 69 74 644 649 I-upper_bound
to 75 77 650 652 O
dosing 78 84 653 659 O
or 85 87 660 662 O
evidence 88 96 663 671 O
of 97 99 672 674 O
such 100 104 675 679 O
abuse 105 110 680 685 O

Already 0 7 0 7 O
had 8 11 8 11 O
a 12 13 12 13 O
CRT 14 17 14 17 B-treatment
device 18 24 18 24 I-treatment
implanted 25 34 25 34 I-treatment

Atrial 0 6 35 41 B-chronic_disease
Fibrillation 7 19 42 54 I-chronic_disease

Cerebrovascular 0 15 55 70 B-chronic_disease
Accident 16 24 71 79 I-chronic_disease
( 25 26 80 81 I-chronic_disease
CVA 26 29 81 84 I-chronic_disease
) 29 30 84 85 I-chronic_disease
or 31 33 86 88 O
Transient 34 43 89 98 B-chronic_disease
Ischemic 44 52 99 107 I-chronic_disease
Attack 53 59 108 114 I-chronic_disease
( 60 61 115 116 I-chronic_disease
TIA 61 64 116 119 I-chronic_disease
) 64 65 119 120 I-chronic_disease
in 66 68 121 123 O
the 69 72 124 127 O
3 73 74 128 129 B-upper_bound
months 75 81 130 136 I-upper_bound
prior 82 87 137 142 I-upper_bound
the 88 91 143 146 O
enrollmen 92 101 147 156 O

Classification 0 14 157 171 O
of 15 17 172 174 O
Status 18 24 175 181 O
1 25 26 182 183 O
for 27 30 184 187 O
cardiac 31 38 188 195 B-treatment
transplantation 39 54 196 211 I-treatment
or 55 57 212 214 O
consideration 58 71 215 228 O
for 72 75 229 232 O
transplantation 76 91 233 248 O
over 92 96 249 253 O
the 97 100 254 257 O
next 101 105 258 262 B-lower_bound
12 106 108 263 265 I-lower_bound
months 109 115 266 272 I-lower_bound

History 0 7 273 280 O
or 8 10 281 283 O
incidence 11 20 284 293 O
of 21 23 294 296 O
Paroxysmal 24 34 297 307 B-chronic_disease
or 35 37 308 310 O
Persistent 38 48 311 321 B-chronic_disease
AF 49 51 322 324 I-chronic_disease
within 52 58 325 331 O
30 59 61 332 334 B-upper_bound
days 62 66 335 339 I-upper_bound
prior 67 72 340 345 I-upper_bound
the 73 76 346 349 O
enrollment 77 87 350 360 O

Less 0 4 361 365 O
than 5 9 366 370 O
18 10 12 371 373 B-upper_bound
years 13 18 374 379 I-upper_bound
of 19 21 380 382 O
age 22 25 383 386 B-age

Life 0 4 387 391 B-clinical_variable
expectancy 5 15 392 402 I-clinical_variable
< 16 17 403 404 O
12 18 20 405 407 B-upper_bound
months 21 27 408 414 I-upper_bound

Myocardial 0 10 415 425 B-chronic_disease
Infarction 11 21 426 436 I-chronic_disease

Permanent 0 9 437 446 O
AF 10 12 447 449 B-chronic_disease
not 13 16 450 453 O
treated 17 24 454 461 O
with 25 29 462 466 O
AV 30 32 467 469 B-treatment
node 33 37 470 474 I-treatment
ablation 38 46 475 483 I-treatment
within 47 53 484 490 O
2 54 55 491 492 B-upper_bound
weeks 56 61 493 498 I-upper_bound
from 62 66 499 503 O
the 67 70 504 507 O
CRT 71 74 508 511 B-treatment
implant 75 82 512 519 I-treatment

Persistent 0 10 520 530 B-chronic_disease
AF 11 13 531 533 I-chronic_disease
at 14 16 534 536 O
the 17 20 537 540 O
time 21 25 541 545 O
of 26 28 546 548 O
enrollment 29 39 549 559 O

Pregnant 0 8 560 568 B-pregnancy
or 9 11 569 571 O
are 12 15 572 575 O
planning 16 24 576 584 B-pregnancy
to 25 27 585 587 I-pregnancy
become 28 34 588 594 I-pregnancy
pregnant 35 43 595 603 I-pregnancy
during 44 50 604 610 O
the 51 54 611 614 O
duration 55 63 615 623 O
of 64 66 624 626 O
the 67 70 627 630 O
investigatio 71 83 631 643 O

Primary 0 7 644 651 O
valvular 8 16 652 660 B-chronic_disease
disease 17 24 661 668 I-chronic_disease

Recent 0 6 669 675 O
cardiac 7 14 676 683 B-treatment
revascularization 15 32 684 701 I-treatment
( 33 34 702 703 O
PTCA 34 38 703 707 B-treatment
, 38 39 707 708 O
Stent 40 45 709 714 B-treatment
or 46 48 715 717 O
CABG 49 53 718 722 B-treatment
) 53 54 722 723 O
in 55 57 724 726 O
the 58 61 727 730 O
4 62 63 731 732 B-upper_bound
weeks 64 69 733 738 I-upper_bound
prior 70 75 739 744 I-upper_bound
to 76 78 745 747 O
enrollment 79 89 748 758 O
or 90 92 759 761 O
planned 93 100 762 769 O
for 101 104 770 773 O
the 105 108 774 777 O
3 109 110 778 779 B-upper_bound
months 111 117 780 786 I-upper_bound
following 118 127 787 796 O

Undergone 0 9 797 806 O
a 10 11 807 808 O
cardiac 12 19 809 816 B-treatment
transplantation 20 35 817 832 I-treatment

unstable 0 8 833 841 B-chronic_disease
angina 9 15 842 848 I-chronic_disease
within 16 22 849 855 O
40 23 25 856 858 B-upper_bound
days 26 30 859 863 I-upper_bound
prior 31 36 864 869 I-upper_bound
the 37 40 870 873 O
enrollment 41 51 874 884 O

Already 0 7 0 7 O
taking 8 14 8 14 O
an 15 17 15 17 O
anti 18 22 18 22 B-treatment
- 22 23 22 23 I-treatment
oxidant 23 30 23 30 I-treatment
dietary 31 38 31 38 I-treatment
supplement 39 49 39 49 I-treatment
( 50 51 50 51 O
e.g. 51 55 51 55 O
, 55 56 55 56 O
Olive 57 62 57 62 B-treatment
Leaf 63 67 63 67 I-treatment
Extract 68 75 68 75 I-treatment
, 75 76 75 76 O
MitoQ 77 82 77 82 B-treatment
) 82 83 82 83 O

At 0 2 84 86 O
least18 3 10 87 94 O
years 11 16 95 100 I-lower_bound
old 17 20 101 104 I-lower_bound

History 0 7 105 112 O
of 8 10 113 115 O
a 11 12 116 117 O
post 13 17 118 122 B-chronic_disease
- 17 18 122 123 I-chronic_disease
spinal 18 24 123 129 I-chronic_disease
headache 25 33 130 138 I-chronic_disease
that 34 38 139 143 O
required 39 47 144 152 O
treatment 48 57 153 162 B-treatment
with 58 62 163 167 O
a 63 64 168 169 O
blood 65 70 170 175 B-treatment
patch 71 76 176 181 I-treatment

Known 0 5 182 187 O
allergy 6 13 188 195 O
to 14 16 196 198 O
NAC 17 20 199 202 B-allergy_name

PD 0 2 203 205 B-chronic_disease
diagnosed 3 12 206 215 O
within 13 19 216 222 O
the 20 23 223 226 O
past 24 28 227 231 B-upper_bound
5 29 30 232 233 I-upper_bound
years 31 36 234 239 I-upper_bound

Pregnant 0 8 240 248 B-pregnancy

Taking 0 6 249 255 O
a 7 8 256 257 O
monoamine 9 18 258 267 B-treatment
oxidase 19 26 268 275 I-treatment
( 27 28 276 277 I-treatment
MAO 28 31 277 280 I-treatment
) 31 32 280 281 I-treatment
inhibitor 33 42 282 291 I-treatment

Taking 0 6 292 298 O
levodopa 7 15 299 307 B-treatment
in 16 18 308 310 O
any 19 22 311 314 O
form 23 27 315 319 O

BMI 0 3 0 3 B-bmi
≤40 4 7 4 7 O
kg 8 10 8 10 I-upper_bound
/ 10 11 10 11 I-upper_bound
m2 11 13 11 13 I-upper_bound

Contraindications 0 17 14 31 O
to 18 20 32 34 O
or 21 23 35 37 O
known 24 29 38 43 O
drug 30 34 44 48 O
interactions 35 47 49 61 O
with 48 52 62 66 O
local 53 58 67 72 B-allergy_name
anesthetics 59 70 73 84 I-allergy_name

Male 0 4 85 89 B-gender

Patients 0 8 90 98 O
scheduled 9 18 99 108 O
to 19 21 109 111 O
undergo 22 29 112 119 O
unilateral 30 40 120 130 B-treatment
shoulder 41 49 131 139 I-treatment
surgery 50 57 140 147 I-treatment
at 58 60 148 150 O
Duke 61 65 151 155 O
University 66 76 156 166 O
Medical 77 84 167 174 O
Center 85 91 175 181 O
, 91 92 181 182 O
including 93 102 183 192 O
arthroscopic 103 115 193 205 B-treatment
rotator 116 123 206 213 I-treatment
cuff 124 128 214 218 I-treatment
repair 129 135 219 225 I-treatment
, 135 136 225 226 O
acromioplasty 137 150 227 240 B-treatment
, 150 151 240 241 O
hemiarthroplasty 152 168 242 258 B-treatment
, 168 169 258 259 O
and 170 173 260 263 O
total 174 179 264 269 B-treatment
shoulder 180 188 270 278 I-treatment
replacement 189 200 279 290 I-treatment

Patients 0 8 291 299 O
with 9 13 300 304 O
chronic 14 21 305 312 B-chronic_disease
pain 22 26 313 317 I-chronic_disease
( 27 28 318 319 O
pain 28 32 319 323 O
existing 33 41 324 332 O
for 42 45 333 336 O
longer 46 52 337 343 O
than 53 57 344 348 O
6 58 59 349 350 B-lower_bound
months 60 66 351 357 I-lower_bound
) 66 67 357 358 O

Pregnant 0 8 359 367 B-pregnancy
women 9 14 368 373 B-gender

Uncontrolled 0 12 374 386 O
anxiety 13 20 387 394 B-chronic_disease

abnormal 0 8 395 403 B-chronic_disease
clotting 9 17 404 412 I-chronic_disease

female 0 6 413 419 B-gender

moderate 0 8 420 428 B-chronic_disease
- 8 9 428 429 I-chronic_disease
severe 9 15 429 435 I-chronic_disease
COPD 16 20 436 440 I-chronic_disease
( 21 22 441 442 O
FEV1<80 22 29 442 449 B-clinical_variable
% 29 30 449 450 I-upper_bound
of 31 33 451 453 O
normal 34 40 454 460 O
values 41 47 461 467 O
and/or 48 54 468 474 O
FEV1 55 59 475 479 B-clinical_variable
/ 59 60 479 480 I-clinical_variable
FVC 60 63 480 483 I-clinical_variable
< 64 65 484 485 O
0.70 66 70 486 490 B-upper_bound
) 70 71 490 491 O

other 0 5 492 497 O
psychiatric 6 17 498 509 B-chronic_disease
disorder 18 26 510 518 I-chronic_disease

presence 0 8 519 527 O
of 9 11 528 530 O
neurological 12 24 531 543 B-chronic_disease
disorders 25 34 544 553 I-chronic_disease
or 35 37 554 556 O
cervical 38 46 557 565 B-chronic_disease
spine 47 52 566 571 I-chronic_disease
disease 53 60 572 579 I-chronic_disease

skin 0 4 580 584 B-chronic_disease
infection 5 14 585 594 I-chronic_disease
involving 15 24 595 604 O
the 25 28 605 608 O
neck 29 33 609 613 O

taking 0 6 614 620 O
chronic 7 14 621 628 B-treatment
opioids 15 22 629 636 I-treatment
( 23 24 637 638 O
greater 24 31 638 645 O
than 32 36 646 650 O
60 37 39 651 653 B-lower_bound
morphine 40 48 654 662 I-lower_bound
equivalents 49 60 663 674 I-lower_bound
per 61 64 675 678 I-lower_bound
day 65 68 679 682 I-lower_bound
) 68 69 682 683 O
at 70 72 684 686 O
time 73 77 687 691 O
of 78 80 692 694 O
surgery 81 88 695 702 B-treatment

≥18 0 3 703 706 O
years 4 9 707 712 I-lower_bound
of 10 12 713 715 O
age 13 16 716 719 B-age

< 0 1 0 1 O
15 1 3 1 3 B-upper_bound
% 3 4 3 4 I-upper_bound
of 5 7 5 7 O
residents 8 17 8 17 O
receiving 18 27 18 27 O
at 28 30 28 30 O
least 31 36 31 36 O
one 37 40 37 40 B-lower_bound
chlorhexidine 41 54 41 54 B-treatment
bath 55 59 55 59 I-treatment
or 60 62 60 62 O
nasal 63 68 63 68 B-treatment
decolonization 69 83 69 83 I-treatment
treatment 84 93 84 93 I-treatment
during 94 100 94 100 O
their 101 106 101 106 O
nursing 107 114 107 114 O
home 115 119 115 119 O
stay 120 124 120 124 O

Facilities 0 10 125 135 O
with 11 15 136 140 O
a 16 17 141 142 O
resident 18 26 143 151 O
population 27 37 152 162 O
with 38 42 163 167 O
> 43 44 168 169 O
= 44 45 169 170 O
20 45 47 170 172 B-lower_bound
% 47 48 172 173 I-lower_bound
combative 49 58 174 183 B-clinical_variable
patients 59 67 184 192 I-clinical_variable

Minimal 0 7 193 200 O
use 8 11 201 204 O
of 12 14 205 207 O
chlorhexidine 15 28 208 221 B-treatment
bathing 29 36 222 229 I-treatment

Minimal 0 7 230 237 O
use 8 11 238 241 O
of 12 14 242 244 O
nasal 15 20 245 250 B-treatment
decolonization 21 35 251 265 I-treatment

Age 0 3 0 3 B-age
45 4 6 4 6 B-lower_bound
to 7 9 7 9 O
75 10 12 10 12 B-upper_bound

Hamilton 0 8 13 21 B-clinical_variable
Depression 9 19 22 32 I-clinical_variable
Rating 20 26 33 39 I-clinical_variable
Scale 27 32 40 45 I-clinical_variable
> 33 34 46 47 O
20 35 37 48 50 B-lower_bound

ability 0 7 51 58 O
to 8 10 59 61 O
participate 11 22 62 73 O
in 23 25 74 76 O
MRI 26 29 77 80 B-treatment

dementia 0 8 81 89 B-chronic_disease
or 9 11 90 92 O
MCI 12 15 93 96 B-chronic_disease

history 0 7 97 104 O
or 8 10 105 107 O
presence 11 19 108 116 O
of 20 22 117 119 O
psychiatric 23 34 120 131 O
diagnoses 35 44 132 141 O
other 45 50 142 147 O
than 51 55 148 152 O
unipolar 56 64 153 161 O
, 64 65 161 162 O
non 66 69 163 166 B-chronic_disease
- 69 70 166 167 I-chronic_disease
psychotic 70 79 167 176 I-chronic_disease
major 80 85 177 182 I-chronic_disease
depression 86 96 183 193 I-chronic_disease
or 97 99 194 196 O
generalized 100 111 197 208 O
anxiety 112 119 209 216 B-chronic_disease
disorder 120 128 217 225 O

unipolar 0 8 226 234 B-chronic_disease
, 8 9 234 235 O
nonpsychotic 10 22 236 248 B-chronic_disease
major 23 28 249 254 I-chronic_disease
depression 29 39 255 265 I-chronic_disease
( 40 41 266 267 O
by 41 43 267 269 O
SCID 44 48 270 274 O
, 48 49 274 275 O
DSM 50 53 276 279 O
- 53 54 279 280 O
V 54 55 280 281 O
) 55 56 281 282 O

use 0 3 283 286 O
of 4 6 287 289 O
psychotropic 7 19 290 302 B-treatment
drugs 20 25 303 308 I-treatment
or 26 28 309 311 O
cholinesterase 29 43 312 326 B-treatment
inhibitors 44 54 327 337 I-treatment
other 55 60 338 343 O
than 61 65 344 348 O
mild 66 70 349 353 O
doses 71 76 354 359 O
of 77 79 360 362 O
benzodiazepines 80 95 363 378 B-treatment

Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
( 35 36 35 36 I-clinical_variable
ECOG 36 40 36 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
0 61 62 61 62 B-lower_bound
to 63 65 63 65 O
1 66 67 66 67 B-upper_bound

Evidence 0 8 68 76 O
of 9 11 77 79 O
active 12 18 80 86 O
, 18 19 86 87 O
noninfectious 20 33 88 101 B-chronic_disease
pneumonitis 34 45 102 113 I-chronic_disease
or 46 48 114 116 O
history 49 56 117 124 O
of 57 59 125 127 O
interstitial 60 72 128 140 B-chronic_disease
lung 73 77 141 145 I-chronic_disease
disease 78 85 146 153 I-chronic_disease

Evidence 0 8 154 162 O
of 9 11 163 165 O
hepatitis 12 21 166 175 B-chronic_disease
B 22 23 176 177 I-chronic_disease
virus 24 29 178 183 I-chronic_disease
or 30 32 184 186 O
hepatitis 33 42 187 196 B-chronic_disease
C 43 44 197 198 I-chronic_disease
virus 45 50 199 204 I-chronic_disease
infection 51 60 205 214 B-chronic_disease
or 61 63 215 217 O
risk 64 68 218 222 O
of 69 71 223 225 O
reactivation 72 84 226 238 O

Has 0 3 239 242 O
not 4 7 243 246 O
recovered 8 17 247 256 O
to 18 20 257 259 O
≤ 21 22 260 261 O
Grade 23 28 262 267 B-upper_bound
1 29 30 268 269 I-upper_bound
from 31 35 270 274 O
toxic 36 41 275 280 O
effects 42 49 281 288 O
of 50 52 289 291 O
prior 53 58 292 297 B-treatment
therapy 59 66 298 305 I-treatment

Known 0 5 306 311 O
active 6 12 312 318 O
central 13 20 319 326 B-cancer
nervous 21 28 327 334 I-cancer
system 29 35 335 341 I-cancer
metastases 36 46 342 352 I-cancer
and/or 47 53 353 359 O
carcinomatous 54 67 360 373 B-cancer
meningitis 68 78 374 384 I-cancer

Locally 0 7 385 392 O
advanced 8 16 393 401 O
or 17 19 402 404 O
metastatic 20 30 405 415 B-cancer
disease 31 38 416 423 I-cancer

Prior 0 5 424 429 O
treatment 6 15 430 439 O
with 16 20 440 444 O
any 21 24 445 448 O
tumor 25 30 449 454 B-treatment
necrosis 31 39 455 463 I-treatment
factor 40 46 464 470 O
super 47 52 471 476 O
family 53 59 477 483 O
agonist 60 67 484 491 O

Receipt 0 7 492 499 O
of 8 10 500 502 O
anticancer 11 21 503 513 B-treatment
medications 22 33 514 525 I-treatment
or 34 36 526 528 O
investigational 37 52 529 544 B-treatment
drugs 53 58 545 550 I-treatment
within 59 65 551 557 O
protocol 66 74 558 566 O
- 74 75 566 567 O
defined 75 82 567 574 O
intervals 83 92 575 584 O
before 93 99 585 591 O
the 100 103 592 595 O
first 104 109 596 601 O
administration 110 124 602 616 O
of 125 127 617 619 O
study 128 133 620 625 O
drug 134 138 626 630 O

Clonal 0 6 0 6 B-chronic_disease
cytopenias 7 17 7 17 I-chronic_disease
of 18 20 18 20 I-chronic_disease
unclear 21 28 21 28 I-chronic_disease
significance 29 41 29 41 I-chronic_disease
( 42 43 42 43 I-chronic_disease
CCUS 43 47 43 47 I-chronic_disease
) 47 48 47 48 I-chronic_disease

Idiopathic 0 10 49 59 B-chronic_disease
cytopenias 11 21 60 70 I-chronic_disease
of 22 24 71 73 I-chronic_disease
unclear 25 32 74 81 I-chronic_disease
significance 33 45 82 94 I-chronic_disease
( 46 47 95 96 I-chronic_disease
ICUS 47 51 96 100 I-chronic_disease
) 51 52 100 101 I-chronic_disease

Low 0 3 102 105 B-chronic_disease
Risk 4 8 106 110 I-chronic_disease
Myelodysplastic 9 24 111 126 I-chronic_disease
Syndromes 25 34 127 136 I-chronic_disease
( 35 36 137 138 O
MDS 36 39 138 141 B-chronic_disease
) 39 40 141 142 O

Marrow 0 6 143 149 B-chronic_disease
failure 7 14 150 157 I-chronic_disease
syndromes 15 24 158 167 I-chronic_disease
with 25 29 168 172 O
myeloid 30 37 173 180 B-cancer
malignancy 38 48 181 191 I-cancer
predisposition- 49 64 192 207 O
telomere 65 73 208 216 B-cancer
dysfunction 74 85 217 228 I-cancer
, 85 86 228 229 O
chromosomal 87 98 230 241 B-chronic_disease
breakage 99 107 242 250 I-chronic_disease
disorders 108 117 251 260 I-chronic_disease
, 117 118 260 261 O
etc 119 122 262 265 O

A 0 1 0 1 O
review 2 8 2 8 O
of 9 11 9 11 O
a 12 13 12 13 O
previous 14 22 14 22 B-treatment
MRI 23 26 23 26 I-treatment
examination 27 38 27 38 I-treatment
may 39 42 39 42 O
help 43 47 43 47 O
confirm 48 55 48 55 O
the 56 59 56 59 O
entry 60 65 60 65 O
criteria 66 74 66 74 O
on 75 77 75 77 O
subjects 78 86 78 86 O
selected 87 95 87 95 O
to 96 98 96 98 O
come 99 103 99 103 O
to 104 106 104 106 O
Stanford 107 115 107 115 O
for 116 119 116 119 O
the 120 123 120 123 O
MRI 124 127 124 127 O
screening 128 137 128 137 O

Alpha 0 5 138 143 B-treatment
- 5 6 143 144 I-treatment
blockers 6 14 144 152 I-treatment

Also 0 4 153 157 O
excluded 5 13 158 166 O
are 14 17 167 170 O
concomitant 18 29 171 182 O
use 30 33 183 186 O
of 34 36 187 189 O
organic 37 44 190 197 B-treatment
nitrates 45 53 198 206 I-treatment
, 53 54 206 207 O
alpha 55 60 208 213 B-treatment
- 60 61 213 214 I-treatment
blockers 61 69 214 222 I-treatment
, 69 70 222 223 O
amlodipine 71 81 224 234 B-treatment
, 81 82 234 235 O
or 83 85 236 238 O
cimetidine 86 96 239 249 B-treatment

Amlodipine 0 10 250 260 B-treatment

Assent 0 6 261 267 O
obtained 7 15 268 276 O
for 16 19 277 280 O
subjects 20 28 281 289 O
7 29 30 290 291 B-lower_bound
- 31 32 292 293 O
10 33 35 294 296 B-upper_bound
years 36 41 297 302 I-upper_bound
old 42 45 303 306 O

Be 0 2 307 309 O
at 3 5 310 312 O
the 6 9 313 316 O
minimum 10 17 317 324 O
weight 18 24 325 331 B-clinical_variable
of 25 27 332 334 O
8 28 29 335 336 B-lower_bound
kg 30 32 337 339 I-lower_bound
at 33 35 340 342 O
the 36 39 343 346 O
time 40 44 347 351 O
of 45 47 352 354 O
enrollment 48 58 355 365 O

Be 0 2 366 368 O
required 3 11 369 377 O
to 12 14 378 380 O
have 15 19 381 385 O
the 20 23 386 389 O
clinical 24 32 390 398 O
diagnosis 33 42 399 408 O
of 43 45 409 411 O
lymphatic 46 55 412 421 B-chronic_disease
malformation 56 68 422 434 I-chronic_disease
that 69 73 435 439 O
appears 74 81 440 447 O
to 82 84 448 450 O
be 85 87 451 453 O
over 88 92 454 458 O
3 93 94 459 460 B-lower_bound
cm 95 97 461 463 I-lower_bound
in 98 100 464 466 I-lower_bound
greatest 101 109 467 475 I-lower_bound
diameter 110 118 476 484 I-lower_bound
in 119 121 485 487 O
order 122 127 488 493 O
to 128 130 494 496 O
be 131 133 497 499 O
evaluated 134 143 500 509 O
for 144 147 510 513 O
entry 148 153 514 519 O

Can 0 3 520 523 O
not 3 6 523 526 O
confirm 7 14 527 534 O
that 15 19 535 539 O
the 20 23 540 543 O
lesion 24 30 544 550 O
is 31 33 551 553 O
a 34 35 554 555 O
lymphatic 36 45 556 565 B-chronic_disease
malformation 46 58 566 578 I-chronic_disease
or 59 61 579 581 O
the 62 65 582 585 O
lymphatic 66 75 586 595 O
malformation 76 88 596 608 O
is 89 91 609 611 O
less 92 96 612 616 O
than 97 101 617 621 O
3 102 103 622 623 B-lower_bound
cm 104 106 624 626 I-lower_bound
in 107 109 627 629 O
its 110 113 630 633 O
greatest 114 122 634 642 O
diameter 123 131 643 651 B-clinical_variable
during 132 138 652 658 O
the 139 142 659 662 O
MRI 143 146 663 666 B-treatment
screening 147 156 667 676 O

Cimetidine 0 10 677 687 B-treatment

Concomitant 0 11 688 699 O
use 12 15 700 703 O
of 16 18 704 706 O
REVATIO 19 26 707 714 B-treatment
with 27 31 715 719 I-treatment
ritonavir 32 41 720 729 I-treatment
and 42 45 730 733 I-treatment
other 46 51 734 739 I-treatment
potent 52 58 740 746 I-treatment
CYP3A 59 64 747 752 I-treatment
inhibitors 65 75 753 763 I-treatment
is 76 78 764 766 O
not 79 82 767 770 O
recommended 83 94 771 782 O

Consistent 0 10 783 793 O
with 11 15 794 798 O
its 16 19 799 802 O
known 20 25 803 808 O
effects 26 33 809 816 O
on 34 36 817 819 O
the 37 40 820 823 O
nitric 41 47 824 830 O
oxide 48 53 831 836 O
/ 53 54 836 837 O
cGMP 54 58 837 841 O
pathway 59 66 842 849 O
, 66 67 849 850 O
sildenafil 68 78 851 861 B-treatment
was 79 82 862 865 O
shown 83 88 866 871 O
to 89 91 872 874 O
potentiate 92 102 875 885 O
the 103 106 886 889 O
hypotensive 107 118 890 901 O
effects 119 126 902 909 O
of 127 129 910 912 O
nitrates 130 138 913 921 B-treatment

Has 0 3 922 925 O
a 4 5 926 927 O
history 6 13 928 935 O
of 14 16 936 938 O
priapism 17 25 939 947 B-chronic_disease
or 26 28 948 950 O
is 29 31 951 953 O
diagnosed 32 41 954 963 O
with 42 46 964 968 O
sickle 47 53 969 975 B-chronic_disease
cell 54 58 976 980 I-chronic_disease
anemia 59 65 981 987 I-chronic_disease
or 66 68 988 990 O
any 69 72 991 994 O
other 73 78 995 1000 O
disorder 79 87 1001 1009 O
which 88 93 1010 1015 O
may 94 97 1016 1019 O
predispose 98 108 1020 1030 O
to 109 111 1031 1033 O
priapism 112 120 1034 1042 O

Has 0 3 1043 1046 O
diagnosis 4 13 1047 1056 O
of 14 16 1057 1059 O
the 17 20 1060 1063 O
soft 21 25 1064 1068 B-cancer
tissue 26 32 1069 1075 I-cancer
tumor 33 38 1076 1081 I-cancer
as 39 41 1082 1084 O
LM 42 44 1085 1087 B-chronic_disease
not 45 48 1088 1091 O
clinically 49 59 1092 1102 O
certain 60 67 1103 1110 O

Has 0 3 1111 1114 O
had 4 7 1115 1118 O
extensive 8 17 1119 1128 O
prior 18 23 1129 1134 B-treatment
surgery 24 31 1135 1142 I-treatment
or 32 34 1143 1145 O
sclerotherapy 35 48 1146 1159 B-treatment
to 49 51 1160 1162 O
treat 52 57 1163 1168 O
LM 58 60 1169 1171 B-chronic_disease
such 61 65 1172 1176 O
that 66 70 1177 1181 O
scarring 71 79 1182 1190 O
may 80 83 1191 1194 O
interfere 84 93 1195 1204 O
with 94 98 1205 1209 O
evaluation 99 109 1210 1220 O
and 110 113 1221 1224 O
treatment 114 123 1225 1234 B-treatment
effect 124 130 1235 1241 O
of 131 133 1242 1244 O
sildenafil 134 144 1245 1255 B-treatment

Has 0 3 1256 1259 O
one 4 7 1260 1263 O
or 8 10 1264 1266 O
more 11 15 1267 1271 O
of 16 18 1272 1274 O
the 19 22 1275 1278 O
following 23 32 1279 1288 O
medical 33 40 1289 1296 B-chronic_disease
conditions 41 51 1297 1307 I-chronic_disease

Has 0 3 1308 1311 O
received 4 12 1312 1320 O
at 13 15 1321 1323 O
least 16 21 1324 1329 O
one 22 25 1330 1333 B-lower_bound
of 26 28 1334 1336 O
the 29 32 1337 1340 O
following 33 42 1341 1350 O
medications 43 54 1351 1362 B-treatment
contraindicated 55 70 1363 1378 O
in 71 73 1379 1381 O
association 74 85 1382 1393 O
with 86 90 1394 1398 O
sildenafil 91 101 1399 1409 B-treatment
within 102 108 1410 1416 O
15 109 111 1417 1419 B-upper_bound
days 112 116 1420 1424 I-upper_bound
of 117 119 1425 1427 O
inclusion 120 129 1428 1437 O

Has 0 3 1438 1441 O
ulcerated 4 13 1442 1451 O
or 14 16 1452 1454 O
currently 17 26 1455 1464 O
infected 27 35 1465 1473 O
LMs 36 39 1474 1477 B-chronic_disease

Have 0 4 1478 1482 O
a 5 6 1483 1484 O
required 7 15 1485 1493 O
MRI 16 19 1494 1497 B-treatment
examination 20 31 1498 1509 O
to 32 34 1510 1512 O
confirm 35 42 1513 1520 O
that 43 47 1521 1525 O
the 48 51 1526 1529 O
lymphatic 52 61 1530 1539 B-cancer
malformation 62 74 1540 1552 I-cancer
is 75 77 1553 1555 O
present 78 85 1556 1563 O
and 86 89 1564 1567 O
is 90 92 1568 1570 O
greater 93 100 1571 1578 O
than 101 105 1579 1583 O
3 106 107 1584 1585 B-lower_bound
cm 108 110 1586 1588 I-lower_bound
in 111 113 1589 1591 O
diameter 114 122 1592 1600 B-clinical_variable
in 123 125 1601 1603 O
order 126 131 1604 1609 O
for 132 135 1610 1613 O
the 136 139 1614 1617 O
subjects 140 148 1618 1626 O
to 149 151 1627 1629 O
receive 152 159 1630 1637 O
medication 160 170 1638 1648 B-treatment
, 170 171 1648 1649 O
which 172 177 1650 1655 O
happens 178 185 1656 1663 O
during 186 192 1664 1670 O
the 193 196 1671 1674 O
initial 197 204 1675 1682 O
screening 205 214 1683 1692 O
evaluation 215 225 1693 1703 O
portion 226 233 1704 1711 O
of 234 236 1712 1714 O
the 237 240 1715 1718 O
trial 241 246 1719 1724 O

Have 0 4 1725 1729 O
had 5 8 1730 1733 O
recurrent 9 18 1734 1743 B-chronic_disease
infection 19 28 1744 1753 I-chronic_disease
and 29 32 1754 1757 O
significant 33 44 1758 1769 O
scarring 45 53 1770 1778 O
of 54 56 1779 1781 O
the 57 60 1782 1785 O
lesion 61 67 1786 1792 O
secondary 68 77 1793 1802 O
to 78 80 1803 1805 O
infection 81 90 1806 1815 O
to 91 93 1816 1818 O
such 94 98 1819 1823 O
an 99 101 1824 1826 O
extent 102 108 1827 1833 O
that 109 113 1834 1838 O
the 114 117 1839 1842 O
that 118 122 1843 1847 O
scarring 123 131 1848 1856 O
may 132 135 1857 1860 O
interfere 136 145 1861 1870 O
with 146 150 1871 1875 O
evaluation 151 161 1876 1886 O
and 162 165 1887 1890 O
treatment 166 175 1891 1900 B-treatment
effect 176 182 1901 1907 O
of 183 185 1908 1910 O
sildenafil 186 196 1911 1921 B-treatment

Have 0 4 1922 1926 O
no 5 7 1927 1929 O
contraindication 8 24 1930 1946 O
to 25 27 1947 1949 O
MRI 28 31 1950 1953 B-treatment
examinations 32 44 1954 1966 O
such 45 49 1967 1971 O
as 50 52 1972 1974 O
metal 53 58 1975 1980 O
implants 59 67 1981 1989 O
, 67 68 1989 1990 O
etc 69 72 1991 1994 O

Have 0 4 1995 1999 O
no 5 7 2000 2002 O
contraindications 8 25 2003 2020 O
for 26 29 2021 2024 O
the 30 33 2025 2028 O
use 34 37 2029 2032 O
of 38 40 2033 2035 O
sildenafil 41 51 2036 2046 B-treatment

Have 0 4 2047 2051 O
the 5 8 2052 2055 O
lymphatic 9 18 2056 2065 B-chronic_disease
malformation 19 31 2066 2078 I-chronic_disease
cause 32 37 2079 2084 O
enough 38 44 2085 2091 O
disability 45 55 2092 2102 O
for 56 59 2103 2106 O
the 60 63 2107 2110 O
subject 64 71 2111 2118 O
that 72 76 2119 2123 O
requires 77 85 2124 2132 O
them 86 90 2133 2137 O
to 91 93 2138 2140 O
consider 94 102 2141 2149 O
systemic 103 111 2150 2158 B-treatment
therapy 112 119 2159 2166 I-treatment

Hepatic 0 7 2167 2174 B-chronic_disease
impairment 8 18 2175 2185 I-chronic_disease
, 18 19 2185 2186 O
severe 20 26 2187 2193 O
renal 27 32 2194 2199 B-chronic_disease
impairment 33 43 2200 2210 I-chronic_disease
, 43 44 2210 2211 O
lymphedema 45 55 2212 2222 B-chronic_disease
conditions 56 66 2223 2233 I-chronic_disease
such 67 71 2234 2238 O
as 72 74 2239 2241 O
Milroy 75 81 2242 2248 B-chronic_disease
disease 82 89 2249 2256 I-chronic_disease
, 89 90 2256 2257 O
Meige 91 96 2258 2263 B-chronic_disease
lymphedema 97 107 2264 2274 I-chronic_disease
, 107 108 2274 2275 O
Hennekam 109 117 2276 2284 B-chronic_disease
syndrome 118 126 2285 2293 I-chronic_disease
, 126 127 2293 2294 O
Njolstad 128 136 2295 2303 B-chronic_disease
syndrome 137 145 2304 2312 I-chronic_disease
, 145 146 2312 2313 O
Aagenaes 147 155 2314 2322 B-chronic_disease
syndrome 156 164 2323 2331 I-chronic_disease
, 164 165 2331 2332 O
and 166 169 2333 2336 O
Fabry 170 175 2337 2342 B-chronic_disease
disease 176 183 2343 2350 I-chronic_disease
, 183 184 2350 2351 O
hypotension 185 196 2352 2363 B-chronic_disease
or 197 199 2364 2366 O
at 200 202 2367 2369 O
risk 203 207 2370 2374 O
for 208 211 2375 2378 O
hypotension 212 223 2379 2390 O
, 223 224 2390 2391 O
seizures 225 233 2392 2400 B-chronic_disease
or 234 236 2401 2403 O
history 237 244 2404 2411 O
of 245 247 2412 2414 O
seizures 248 256 2415 2423 O

Known 0 5 2424 2429 O
to 6 8 2430 2432 O
have 9 13 2433 2437 O
an 14 16 2438 2440 O
allergy 17 24 2441 2448 O
to 25 27 2449 2451 O
sildenafil 28 38 2452 2462 B-allergy_name

Organic 0 7 2463 2470 B-treatment
nitrates 8 16 2471 2479 I-treatment
in 17 19 2480 2482 O
any 20 23 2483 2486 O
form 24 28 2487 2491 O
, 28 29 2491 2492 O
either 30 36 2493 2499 O
regularly 37 46 2500 2509 O
or 47 49 2510 2512 O
intermittently 50 64 2513 2527 O

Participating 0 13 2528 2541 O
in 14 16 2542 2544 O
another 17 24 2545 2552 B-treatment
clinical 25 33 2553 2561 I-treatment
study 34 39 2562 2567 I-treatment
which 40 45 2568 2573 O
may 46 49 2574 2577 O
interfere 50 59 2578 2587 O

Requires 0 8 2588 2596 O
concomitant 9 20 2597 2608 O
use 21 24 2609 2612 O
of 25 27 2613 2615 O
potent 28 34 2616 2622 B-treatment
cytochrome 35 45 2623 2633 I-treatment
P450 46 50 2634 2638 I-treatment
3A4 51 54 2639 2642 I-treatment
inhibitors 55 65 2643 2653 I-treatment
( 66 67 2654 2655 O
such 67 71 2655 2659 O
as 72 74 2660 2662 O
ketoconazole 75 87 2663 2675 B-treatment
, 87 88 2675 2676 O
itraconazole 89 101 2677 2689 B-treatment
, 101 102 2689 2690 O
erythromycin 103 115 2691 2703 B-treatment
, 115 116 2703 2704 O
saquinavir 117 127 2705 2715 B-treatment
) 127 128 2715 2716 O
, 128 129 2716 2717 O
or 130 132 2718 2720 O
concomitant 133 144 2721 2732 O
use 145 148 2733 2736 O
of 149 151 2737 2739 O
ritonavir 152 161 2740 2749 B-treatment

Ritonavir 0 9 2750 2759 B-treatment
and 10 13 2760 2763 O
other 14 19 2764 2769 O
Potent 20 26 2770 2776 B-treatment
CYP3A 27 32 2777 2782 I-treatment
Inhibitors 33 43 2783 2793 I-treatment

any 0 3 2794 2797 O
significant 4 15 2798 2809 O
cardiovascular 16 30 2810 2824 O
risk 31 35 2825 2829 O
factors 36 43 2830 2837 O
and 44 47 2838 2841 O
any 48 51 2842 2845 O
condition 52 61 2846 2855 O
which 62 67 2856 2861 O
requires 68 76 2862 2870 O
participants 77 89 2871 2883 O
to 90 92 2884 2886 O
use 93 96 2887 2890 O
nitric 97 103 2891 2897 O
oxide 104 109 2898 2903 O
donors 110 116 2904 2910 O
or 117 119 2911 2913 O
nitrates 120 128 2914 2922 O
in 129 131 2923 2925 O
any 132 135 2926 2929 O
form 136 140 2930 2934 O
, 140 141 2934 2935 O
underlying 142 152 2936 2946 O
anatomic 153 161 2947 2955 O
or 162 164 2956 2958 O
vascular 165 173 2959 2967 O
risk 174 178 2968 2972 O
factor 179 185 2973 2979 O
for 186 189 2980 2983 O
developing 190 200 2984 2994 O
non 201 204 2995 2998 B-chronic_disease
- 204 205 2998 2999 I-chronic_disease
arteritic 205 214 2999 3008 I-chronic_disease
anterior 215 223 3009 3017 I-chronic_disease
ischemic 224 232 3018 3026 I-chronic_disease
optic 233 238 3027 3032 I-chronic_disease
neuropathy 239 249 3033 3043 I-chronic_disease
( 250 251 3044 3045 I-chronic_disease
NAION 251 256 3045 3050 I-chronic_disease
) 256 257 3050 3051 I-chronic_disease
including 258 267 3052 3061 O
low 268 271 3062 3065 O
ocular 272 278 3066 3072 O
cup 279 282 3073 3076 O
to 283 285 3077 3079 O
disc 286 290 3080 3084 O
ratio 291 296 3085 3090 O
, 296 297 3090 3091 O
diabetes 298 306 3092 3100 B-chronic_disease
, 306 307 3100 3101 O
hypertension 308 320 3102 3114 B-chronic_disease
, 320 321 3114 3115 O
coronary 322 330 3116 3124 B-chronic_disease
artery 331 337 3125 3131 I-chronic_disease
disease 338 345 3132 3139 I-chronic_disease
, 345 346 3139 3140 O
or 347 349 3141 3143 O
hyperlipidemia 350 364 3144 3158 B-chronic_disease
Participants 365 377 3159 3171 O
with 378 382 3172 3176 O
Down 383 387 3177 3181 B-chronic_disease
syndrome 388 396 3182 3190 I-chronic_disease
, 396 397 3190 3191 O
Turner 398 404 3192 3198 B-chronic_disease
syndrome 405 413 3199 3207 I-chronic_disease
and 414 417 3208 3211 O
Noonan 418 424 3212 3218 B-chronic_disease
syndrome 425 433 3219 3227 I-chronic_disease
will 434 438 3228 3232 O
be 439 441 3233 3235 O
considered 442 452 3236 3246 O
on 453 455 3247 3249 O
a 456 457 3250 3251 O
case 458 462 3252 3256 O
- 462 463 3256 3257 O
by 463 465 3257 3259 O
- 465 466 3259 3260 O
case 466 470 3260 3264 O
basis 471 476 3265 3270 O

between 0 7 3271 3278 O
the 8 11 3279 3282 O
ages 12 16 3283 3287 B-age
of 17 19 3288 3290 O
6 20 21 3291 3292 B-lower_bound
months 22 28 3293 3299 I-lower_bound
- 29 30 3300 3301 O
10 31 33 3302 3304 B-upper_bound
years 34 39 3305 3310 I-upper_bound
of 40 42 3311 3313 O
age 43 46 3314 3317 O
at 47 49 3318 3320 O
the 50 53 3321 3324 O
time 54 58 3325 3329 O
of 59 61 3330 3332 O
entry 62 67 3333 3338 O
into 68 72 3339 3343 O
the 73 76 3344 3347 O
study 77 82 3348 3353 O

co 0 2 3354 3356 O
- 2 3 3356 3357 O
administering 3 16 3357 3370 O
alpha 17 22 3371 3376 B-treatment
- 22 23 3376 3377 I-treatment
blockers 23 31 3377 3385 I-treatment
with 32 36 3386 3390 O
REVATIO 37 44 3391 3398 B-treatment
because 45 52 3399 3406 O
of 53 55 3407 3409 O
additive 56 64 3410 3418 O
blood 65 70 3419 3424 O
pressure 71 79 3425 3433 O
- 79 80 3433 3434 O
lowering 80 88 3434 3442 O
effects 89 96 3443 3450 O

female 0 6 3451 3457 B-gender
subjects 7 15 3458 3466 I-gender

must 0 4 3467 3471 O
not 5 8 3472 3475 O
be 9 11 3476 3478 O
pregnant 12 20 3479 3487 B-pregnancy
or 21 23 3488 3490 O
breast 24 30 3491 3497 O
- 30 31 3497 3498 O
feeding 31 38 3498 3505 O

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
acute 13 18 13 18 B-chronic_disease
bacterial 19 28 19 28 I-chronic_disease
skin 29 33 29 33 I-chronic_disease
and 34 37 34 37 I-chronic_disease
skin 38 42 38 42 I-chronic_disease
structure 43 52 43 52 I-chronic_disease
infection 53 62 53 62 I-chronic_disease
( 63 64 63 64 I-chronic_disease
ABSSSI 64 70 64 70 I-chronic_disease
) 70 71 70 71 I-chronic_disease
, 71 72 71 72 O
with 73 77 73 77 O
a 78 79 78 79 O
regional 80 88 80 88 O
or 89 91 89 91 O
systemic 92 100 92 100 O
sign 101 105 101 105 O
of 106 108 106 108 O
infection 109 118 109 118 O

Male 0 4 119 123 B-gender
or 5 7 124 126 I-gender
female 8 14 127 133 I-gender
≥18 15 18 134 137 O
years 19 24 138 143 I-lower_bound
of 25 27 144 146 O
age 28 31 147 150 B-age

Primary 0 7 151 158 O
ABSSSI 8 14 159 165 B-chronic_disease
due 15 18 166 169 O
to 19 21 170 172 O
or 22 24 173 175 O
associated 25 35 176 186 O
with 36 40 187 191 O
any 41 44 192 195 O
of 45 47 196 198 O
the 48 51 199 202 O
following 52 61 203 212 O
: 61 62 212 213 O
diabetic 63 71 214 222 B-chronic_disease
foot 72 76 223 227 I-chronic_disease
infection 77 86 228 237 I-chronic_disease
, 86 87 237 238 O
gangrene 88 96 239 247 B-chronic_disease
, 96 97 247 248 O
or 98 100 249 251 O
perianal 101 109 252 260 B-chronic_disease
abscess 110 117 261 268 I-chronic_disease
; 117 118 268 269 O
concomitant 119 130 270 281 B-chronic_disease
infection 131 140 282 291 I-chronic_disease
at 141 143 292 294 O
another 144 151 295 302 O
site 152 156 303 307 O
; 156 157 307 308 O
infected 158 166 309 317 O
burns 167 172 318 323 O
; 172 173 323 324 O
decubitus 174 183 325 334 B-chronic_disease
, 183 184 334 335 O
chronic 185 192 336 343 O
, 192 193 343 344 O
or 194 196 345 347 O
ischemic 197 205 348 356 B-chronic_disease
ulcer 206 211 357 362 I-chronic_disease
; 211 212 362 363 O
evolving 213 221 364 372 O
necrotizing 222 233 373 384 O
process 234 241 385 392 O
; 241 242 392 393 O
infections 243 253 394 404 O
at 254 256 405 407 O
vascular 257 265 408 416 O
catheter 266 274 417 425 O
sites 275 280 426 431 O
or 281 283 432 434 O
involving 284 293 435 444 O
thrombophlebitis 294 310 445 461 B-chronic_disease

Requirement 0 11 462 473 O
for 12 15 474 477 O
intravenous 16 27 478 489 B-treatment
bacterial 28 37 490 499 I-treatment
treatment 38 47 500 509 I-treatment

Severe 0 6 510 516 B-chronic_disease
sepsis 7 13 517 523 I-chronic_disease
or 14 16 524 526 O
septic 17 23 527 533 B-chronic_disease
shock 24 29 534 539 I-chronic_disease

Uncomplicated 0 13 540 553 B-chronic_disease
skin 14 18 554 558 I-chronic_disease
and 19 22 559 562 I-chronic_disease
skin 23 27 563 567 I-chronic_disease
structure 28 37 568 577 I-chronic_disease
infection 38 47 578 587 I-chronic_disease

Use 0 3 588 591 O
of 4 6 592 594 O
any 7 10 595 598 O
systemic 11 19 599 607 B-treatment
antibacterial 20 33 608 621 I-treatment
treatment 34 43 622 631 I-treatment
within 44 50 632 638 O
14 51 53 639 641 B-upper_bound
days 54 58 642 646 I-upper_bound

A 0 1 0 1 O
fasting 2 9 2 9 B-clinical_variable
glucose 10 17 10 17 I-clinical_variable
≥ 18 19 18 19 O
126mg 20 25 20 25 B-lower_bound
/ 25 26 25 26 I-lower_bound
dl 26 28 26 28 I-lower_bound
or 29 31 29 31 O
an 32 34 32 34 O
HbA1c 35 40 35 40 B-clinical_variable
≥ 41 42 41 42 O
6.5 43 46 43 46 B-lower_bound
% 46 47 46 47 I-lower_bound
will 48 52 48 52 O
be 53 55 53 55 O
taken 56 61 56 61 O
as 62 64 62 64 O
evidence 65 73 65 73 O
of 74 76 74 76 O
type 77 81 77 81 B-chronic_disease
2 82 83 82 83 I-chronic_disease
diabetes 84 92 84 92 I-chronic_disease
and 93 96 93 96 O
therefore 97 106 97 106 O
patients 107 115 107 115 O
will 116 120 116 120 O
be 121 123 121 123 O
deemed 124 130 124 130 O
ineligible 131 141 131 141 O
for 142 145 142 145 O
participation 146 159 146 159 O

Active 0 6 160 166 O
, 6 7 166 167 O
severe 8 14 168 174 O
psychiatric 15 26 175 186 B-chronic_disease
disease 27 34 187 194 I-chronic_disease

Concurrent 0 10 195 205 O
use 11 14 206 209 O
of 15 17 210 212 O
insulin 18 25 213 220 B-treatment
or 26 28 221 223 O
any 29 32 224 227 O
other 33 38 228 233 O
GLP-1 39 44 234 239 B-treatment
receptor 45 53 240 248 I-treatment
agonist 54 61 249 256 I-treatment

Females 0 7 257 264 B-gender
who 8 11 265 268 O
are 12 15 269 272 O
sexually 16 24 273 281 O
active 25 31 282 288 O
and 32 35 289 292 O
able 36 40 293 297 O
to 41 43 298 300 O
become 44 50 301 307 O
pregnant 51 59 308 316 B-pregnancy
must 60 64 317 321 O
agree 65 70 322 327 B-contraception_consent
to 71 73 328 330 I-contraception_consent
use 74 77 331 334 I-contraception_consent
birth 78 83 335 340 I-contraception_consent
control 84 91 341 348 I-contraception_consent
for 92 95 349 352 O
duration 96 104 353 361 O
of 105 107 362 364 O
study 108 113 365 370 O
if 114 116 371 373 O
randomized 117 127 374 384 O
to 128 130 385 387 O
Saxenda 131 138 388 395 B-treatment
/ 138 139 395 396 O
Placebo 139 146 396 403 B-treatment

Hypersensitivity 0 16 404 420 O
to 17 19 421 423 O
liraglutide 20 31 424 435 B-allergy_name
or 32 34 436 438 O
any 35 38 439 442 O
product 39 46 443 450 O
components 47 57 451 461 O

Personal 0 8 462 470 O
or 9 11 471 473 O
family 12 18 474 480 O
history 19 26 481 488 O
of 27 29 489 491 O
medullary 30 39 492 501 B-cancer
thyroid 40 47 502 509 I-cancer
carcinoma 48 57 510 519 I-cancer
or 58 60 520 522 O
Multiple 61 69 523 531 B-cancer
Endocrine 70 79 532 541 I-cancer
Neoplasia 80 89 542 551 I-cancer
type 90 94 552 556 I-cancer
2 95 96 557 558 I-cancer

Prior 0 5 559 564 O
history 6 13 565 572 O
of 14 16 573 575 O
pancreatitis 17 29 576 588 B-chronic_disease
, 29 30 588 589 O
cholelithiasis 31 45 590 604 B-chronic_disease
or 46 48 605 607 O
cholecystitis 49 62 608 621 B-chronic_disease

Prior 0 5 622 627 O
use 6 9 628 631 O
of 10 12 632 634 O
glucose 13 20 635 642 B-treatment
lowering 21 29 643 651 I-treatment
medication 30 40 652 662 I-treatment
in 41 43 663 665 O
the 44 47 666 669 O
3 48 49 670 671 B-upper_bound
months 50 56 672 678 I-upper_bound
prior 57 62 679 684 I-upper_bound
to 63 65 685 687 O
screening 66 75 688 697 O

Seen 0 4 698 702 O
at 5 7 703 705 O
Mayo 8 12 706 710 O
Clinic 13 19 711 717 O
Nutrition 20 29 718 727 O
Clinic 30 36 728 734 O
and 37 40 735 738 O
have 41 45 739 743 O
received 46 54 744 752 O
authorization 55 68 753 766 O
for 69 72 767 770 O
bariatric 73 82 771 780 B-treatment
surgery 83 90 781 788 I-treatment

active 0 6 789 795 O
consideration 7 20 796 809 O
of 21 23 810 812 O
pregnancy 24 33 813 822 B-pregnancy
during 34 40 823 829 O
the 41 44 830 833 O
period 45 51 834 840 O
of 52 54 841 843 O
study 55 60 844 849 O
. 60 61 849 850 O
Subjects 62 70 851 859 O
will 71 75 860 864 O
be 76 78 865 867 O
discontinued 79 91 868 880 O
if 92 94 881 883 O
they 95 99 884 888 O
become 100 106 889 895 O
pregnant 107 115 896 904 B-pregnancy
during 116 122 905 911 O
the 123 126 912 915 O
study 127 132 916 921 O

A 0 1 0 1 O
prolonged 2 11 2 11 O
history 12 19 12 19 O
of 20 22 20 22 O
cigarette 23 32 23 32 O
smoking 33 40 33 40 O
( 41 42 41 42 O
20 42 44 42 44 B-upper_bound
pk 45 47 45 47 I-upper_bound
/ 47 48 47 48 I-upper_bound
year 48 52 48 52 I-upper_bound
of 53 55 53 55 O
smoking 56 63 56 63 O
within 64 70 64 70 O
the 71 74 71 74 O
past 75 79 75 79 B-upper_bound
2 80 81 80 81 I-upper_bound
years 82 87 82 87 I-upper_bound
) 87 88 87 88 O

Absolute 0 8 89 97 B-clinical_variable
neutrophil 9 19 98 108 I-clinical_variable
count 20 25 109 114 I-clinical_variable
greater 26 33 115 122 O
than 34 38 123 127 O
1000 39 43 128 132 B-lower_bound
/ 43 44 132 133 I-lower_bound
mm^3 44 48 133 137 I-lower_bound
without 49 56 138 145 O
the 57 60 146 149 O
support 61 68 150 157 O
of 69 71 158 160 O
filgrastim 72 82 161 171 B-treatment

Active 0 6 172 178 O
systemic 7 15 179 187 B-chronic_disease
infections 16 26 188 198 I-chronic_disease
, 26 27 198 199 O
( 28 29 200 201 O
e.g. 29 33 201 205 O
: 33 34 205 206 O
requiring 35 44 207 216 O
anti 45 49 217 221 B-treatment
- 49 50 221 222 I-treatment
infective 50 59 222 231 I-treatment
treatment 60 69 232 241 I-treatment
) 69 70 241 242 O
, 70 71 242 243 O
coagulation 72 83 244 255 B-chronic_disease
disorders 84 93 256 265 I-chronic_disease
or 94 96 266 268 O
any 97 100 269 272 O
other 101 106 273 278 O
active 107 113 279 285 O
major 114 119 286 291 O
medical 120 127 292 299 O
illnesses 128 137 300 309 O

Any 0 3 310 313 O
form 4 8 314 318 O
of 9 11 319 321 O
primary 12 19 322 329 B-chronic_disease
immunodeficiency 20 36 330 346 I-chronic_disease
( 37 38 347 348 O
such 38 42 348 352 O
as 43 45 353 355 O
Severe 46 52 356 362 B-chronic_disease
Combined 53 61 363 371 I-chronic_disease
Immunodeficiency 62 78 372 388 I-chronic_disease
Disease 79 86 389 396 I-chronic_disease
) 86 87 396 397 O

Clinical 0 8 398 406 B-clinical_variable
performance 9 20 407 418 I-clinical_variable
status 21 27 419 425 I-clinical_variable
of 28 30 426 428 O
ECOG 31 35 429 433 B-clinical_variable
0 36 37 434 435 B-lower_bound
or 38 40 436 438 O
1 41 42 439 440 B-upper_bound

Clinically 0 10 441 451 O
significant 11 22 452 463 O
atrial 23 29 464 470 B-chronic_disease
and 30 33 471 474 O
or 34 36 475 477 O
ventricular 37 48 478 489 B-chronic_disease
arrhythmias 49 60 490 501 I-chronic_disease
including 61 70 502 511 O
but 71 74 512 515 O
not 75 78 516 519 O
limited 79 86 520 527 O
to 87 89 528 530 O
: 89 90 530 531 O
atrial 91 97 532 538 B-chronic_disease
fibrillation 98 110 539 551 I-chronic_disease
, 110 111 551 552 O
ventricular 112 123 553 564 B-chronic_disease
tachycardia 124 135 565 576 I-chronic_disease
, 135 136 576 577 O
second 137 143 578 584 O
or 144 146 585 587 O
third 147 152 588 593 O
degree 153 159 594 600 O
heart 160 165 601 606 B-chronic_disease
block 166 171 607 612 I-chronic_disease
or 172 174 613 615 O
have 175 179 616 620 O
a 180 181 621 622 O
history 182 189 623 630 O
of 190 192 631 633 O
ischemic 193 201 634 642 B-chronic_disease
heart 202 207 643 648 I-chronic_disease
disease 208 215 649 656 I-chronic_disease
, 215 216 656 657 O
or 217 219 658 660 O
chest 220 225 661 666 O
pain 226 230 667 671 O

Concurrent 0 10 672 682 B-chronic_disease
opportunistic 11 24 683 696 I-chronic_disease
infections 25 35 697 707 I-chronic_disease
( 36 37 708 709 O
The 37 40 709 712 O
experimental 41 53 713 725 B-treatment
treatment 54 63 726 735 I-treatment
being 64 69 736 741 O
evaluated 70 79 742 751 O
in 80 82 752 754 O
this 83 87 755 759 O
protocol 88 96 760 768 O
depends 97 104 769 776 O
on 105 107 777 779 O
an 108 110 780 782 O
intact 111 117 783 789 O
immune 118 124 790 796 O
system 125 131 797 803 O
. 131 132 803 804 O
Patients 133 141 805 813 O
who 142 145 814 817 O
have 146 150 818 822 O
decreased 151 160 823 832 O
immune 161 167 833 839 O
competence 168 178 840 850 O
may 179 182 851 854 O
be 183 185 855 857 O
less 186 190 858 862 O
responsive 191 201 863 873 O
to 202 204 874 876 O
the 205 208 877 880 O
experimental 209 221 881 893 O
treatment 222 231 894 903 O
and 232 235 904 907 O
more 236 240 908 912 O
susceptible 241 252 913 924 O
to 253 255 925 927 O
its 256 259 928 931 O
toxicities 260 270 932 942 O
) 270 271 942 943 O

Concurrent 0 10 944 954 B-treatment
systemic 11 19 955 963 I-treatment
steroid 20 27 964 971 I-treatment
therapy 28 35 972 979 I-treatment

Documented 0 10 980 990 O
FEV1 11 15 991 995 B-clinical_variable
less 16 20 996 1000 O
than 21 25 1001 1005 O
or 26 28 1006 1008 O
equal 29 34 1009 1014 O
to 35 37 1015 1017 O
60 38 40 1018 1020 B-upper_bound
% 40 41 1020 1021 I-upper_bound
predicted 42 51 1022 1031 O
tested 52 58 1032 1038 O
in 59 61 1039 1041 O
patients 62 70 1042 1050 O
with 71 75 1051 1055 O

Documented 0 10 1056 1066 O
LVEF 11 15 1067 1071 B-clinical_variable
of 16 18 1072 1074 O
less 19 23 1075 1079 O
than 24 28 1080 1084 O
or 29 31 1085 1087 O
equal 32 37 1088 1093 O
to 38 40 1094 1096 O
45 41 43 1097 1099 B-upper_bound
% 43 44 1099 1100 I-upper_bound
testing 45 52 1101 1108 O
is 53 55 1109 1111 O
required 56 64 1112 1120 O
in 65 67 1121 1123 O
patients 68 76 1124 1132 O
who 77 80 1133 1136 O
are 81 84 1137 1140 O

Greater 0 7 1141 1148 O
than 8 12 1149 1153 O
or 13 15 1154 1156 O
equal 16 21 1157 1162 O
to 22 24 1163 1165 O
18 25 27 1166 1168 B-lower_bound
years 28 33 1169 1174 I-lower_bound
of 34 36 1175 1177 O
age 37 40 1178 1181 B-age
and 41 44 1182 1185 O
less 45 49 1186 1190 O
than 50 54 1191 1195 O
or 55 57 1196 1198 O
equal 58 63 1199 1204 O
to 64 66 1205 1207 O
age 67 70 1208 1211 O

History 0 7 1212 1219 O
of 8 10 1220 1222 O
any 11 14 1223 1226 O
cardiac 15 22 1227 1234 B-chronic_disease
events 23 29 1235 1241 I-chronic_disease
including 30 39 1242 1251 O
coronary 40 48 1252 1260 B-treatment
revascularization 49 66 1261 1278 I-treatment
or 67 69 1279 1281 O
ischemic 70 78 1282 1290 O
symptoms 79 87 1291 1299 O

History 0 7 1300 1307 O
of 8 10 1308 1310 O
severe 11 17 1311 1317 O
immediate 18 27 1318 1327 O
hypersensitivity 28 44 1328 1344 O
reaction 45 53 1345 1353 O
to 54 56 1354 1356 O
any 57 60 1357 1360 B-allergy_name
of 61 63 1361 1363 I-allergy_name
the 64 67 1364 1367 I-allergy_name
agents 68 74 1368 1374 I-allergy_name
used 75 79 1375 1379 I-allergy_name
in 80 82 1380 1382 I-allergy_name
this 83 87 1383 1387 I-allergy_name
study 88 93 1388 1393 I-allergy_name

If 0 2 1394 1396 O
hepatitis 3 12 1397 1406 B-treatment
C 13 14 1407 1408 I-treatment
antibody 15 23 1409 1417 I-treatment
test 24 28 1418 1422 O
is 29 31 1423 1425 O
positive 32 40 1426 1434 O
, 40 41 1434 1435 O
then 42 46 1436 1440 O
patient 47 54 1441 1448 O
must 55 59 1449 1453 O
be 60 62 1454 1456 O
tested 63 69 1457 1463 O
for 70 73 1464 1467 O
the 74 77 1468 1471 O
presence 78 86 1472 1480 O
of 87 89 1481 1483 O
antigen 90 97 1484 1491 O
by 98 100 1492 1494 O
RT 101 103 1495 1497 O
- 103 104 1497 1498 O
PCR 104 107 1498 1501 O
and 108 111 1502 1505 O
be 112 114 1506 1508 O
HCV 115 118 1509 1512 B-treatment
RNA 119 122 1513 1516 I-treatment
negative 123 131 1517 1525 O

Lesions 0 7 1526 1533 O
that 8 12 1534 1538 O
have 13 17 1539 1543 O
been 18 22 1544 1548 O
treated 23 30 1549 1556 O
with 31 35 1557 1561 O
stereotactic 36 48 1562 1574 B-treatment
radiosurgery 49 61 1575 1587 I-treatment
must 62 66 1588 1592 O
be 67 69 1593 1595 O
clinically 70 80 1596 1606 O
stable 81 87 1607 1613 O
for 88 91 1614 1617 O
1 92 93 1618 1619 B-upper_bound
month 94 99 1620 1625 I-upper_bound
after 100 105 1626 1631 I-upper_bound
treatment 106 115 1632 1641 B-treatment
for 116 119 1642 1645 O
the 120 123 1646 1649 O
patient 124 131 1650 1657 O
to 132 134 1658 1660 O
be 135 137 1661 1663 O
eligible 138 146 1664 1672 O
. 146 147 1672 1673 O
Patients 148 156 1674 1682 O
with 157 161 1683 1687 O
surgically 162 172 1688 1698 O
resected 173 181 1699 1707 O
brain 182 187 1708 1713 B-cancer
metastases 188 198 1714 1724 I-cancer
are 199 202 1725 1728 O
eligible 203 211 1729 1737 O

Metastatic 0 10 1738 1748 B-cancer
cancer 11 17 1749 1755 I-cancer
diagnosis 18 27 1756 1765 O
will 28 32 1766 1770 O
be 33 35 1771 1773 O
confirmed 36 45 1774 1783 O
by 46 48 1784 1786 O
the 49 52 1787 1790 O
Laboratory 53 63 1791 1801 O
of 64 66 1802 1804 O
Pathology 67 76 1805 1814 O
at 77 79 1815 1817 O
the 80 83 1818 1821 O
NCI 84 87 1822 1825 O

Metastatic 0 10 1826 1836 B-cancer
or 11 13 1837 1839 I-cancer
locally 14 21 1840 1847 I-cancer
advanced 22 30 1848 1856 I-cancer
refractory 31 41 1857 1867 I-cancer
/ 41 42 1867 1868 O
recurrent 42 51 1868 1877 O
cancer 52 58 1878 1884 B-cancer
that 59 63 1885 1889 O
expresses 64 73 1890 1899 O
MAGE 74 78 1900 1904 O
- 78 79 1904 1905 O
A3 79 81 1905 1907 O
as 82 84 1908 1910 O
assessed 85 93 1911 1919 O
by 94 96 1920 1922 O
one 97 100 1923 1926 O
of 101 103 1927 1929 O
the 104 107 1930 1933 O
following 108 117 1934 1943 O
methods 118 125 1944 1951 O
: 125 126 1951 1952 O
RT 127 129 1953 1955 O
- 129 130 1955 1956 O
PCR 130 133 1956 1959 O
on 134 136 1960 1962 O
tumor 137 142 1963 1968 B-cancer
tissue 143 149 1969 1975 O
defined 150 157 1976 1983 O
as 158 160 1984 1986 O
30,000 161 167 1987 1993 O
copies 168 174 1994 2000 O
of 175 177 2001 2003 O
MAGE 178 182 2004 2008 O
- 182 183 2008 2009 O
A3 183 185 2009 2011 O
per 186 189 2012 2015 O
10 190 192 2016 2018 O
^ 192 193 2018 2019 O
6 193 194 2019 2020 O
GAPDH 195 200 2021 2026 O
copies 201 207 2027 2033 O

More 0 4 2034 2038 O
than 5 9 2039 2043 O
four 10 14 2044 2048 B-lower_bound
weeks 15 20 2049 2054 I-lower_bound
must 21 25 2055 2059 O
have 26 30 2060 2064 O
elapsed 31 38 2065 2072 O
since 39 44 2073 2078 O
any 45 48 2079 2082 O
prior 49 54 2083 2088 B-treatment
systemic 55 63 2089 2097 I-treatment
therapy 64 71 2098 2105 I-treatment
at 72 74 2106 2108 O
the 75 78 2109 2112 O
time 79 83 2113 2117 O
the 84 87 2118 2121 O
patient 88 95 2122 2129 O
receives 96 104 2130 2138 O
the 105 108 2139 2142 O
preparative 109 120 2143 2154 B-treatment
regimen 121 128 2155 2162 I-treatment
, 128 129 2162 2163 O
and 130 133 2164 2167 O
patients 134 142 2168 2176 O
' 142 143 2176 2177 O
toxicities 144 154 2178 2188 O
must 155 159 2189 2193 O
have 160 164 2194 2198 O
recovered 165 174 2199 2208 O
to 175 177 2209 2211 O
a 178 179 2212 2213 O
grade 180 185 2214 2219 B-upper_bound
1 186 187 2220 2221 I-upper_bound
or 188 190 2222 2224 O
less 191 195 2225 2229 O
( 196 197 2230 2231 O
except 197 203 2231 2237 O
for 204 207 2238 2241 O
toxicities 208 218 2242 2252 O
such 219 223 2253 2257 O
as 224 226 2258 2260 O
alopecia 227 235 2261 2269 B-chronic_disease
or 236 238 2270 2272 O
vitiligo 239 247 2273 2281 B-chronic_disease
) 247 248 2281 2282 O

Patients 0 8 2283 2291 O
must 9 13 2292 2296 O
be 14 16 2297 2299 O
HLA 17 20 2300 2303 B-clinical_variable
- 20 21 2303 2304 I-clinical_variable
DP4 21 24 2304 2307 I-clinical_variable
positive 25 33 2308 2316 O

Patients 0 8 2317 2325 O
must 9 13 2326 2330 O
have 14 18 2331 2335 O
previously 19 29 2336 2346 O
received 30 38 2347 2355 O
prior 39 44 2356 2361 B-treatment
first 45 50 2362 2367 I-treatment
line 51 55 2368 2372 I-treatment
standard 56 64 2373 2381 I-treatment
therapy 65 72 2382 2389 I-treatment
( 73 74 2390 2391 O
or 74 76 2391 2393 O
effective 77 86 2394 2403 O
salvage 87 94 2404 2411 B-treatment
chemotherapy 95 107 2412 2424 I-treatment
regimens 108 116 2425 2433 I-treatment
) 116 117 2433 2434 O
for 118 121 2435 2438 O
their 122 127 2439 2444 O
disease 128 135 2445 2452 O
, 135 136 2452 2453 O
if 137 139 2454 2456 O
known 140 145 2457 2462 O
to 146 148 2463 2465 O
be 149 151 2466 2468 O
effective 152 161 2469 2478 O
for 162 165 2479 2482 O
that 166 170 2483 2487 O
disease 171 178 2488 2495 O
, 178 179 2495 2496 O
and 180 183 2497 2500 O
have 184 188 2501 2505 O
been 189 193 2506 2510 O
either 194 200 2511 2517 O
non 201 204 2518 2521 O
- 204 205 2521 2522 O
responders 205 215 2522 2532 O
( 216 217 2533 2534 O
progressive 217 228 2534 2545 O
disease 229 236 2546 2553 O
) 236 237 2553 2554 O
or 238 240 2555 2557 O
have 241 245 2558 2562 O
recurred 246 254 2563 2571 O

Patients 0 8 2572 2580 O
of 9 11 2581 2583 O
both 12 16 2584 2588 O
genders 17 24 2589 2596 O
must 25 29 2597 2601 O
be 30 32 2602 2604 O
willing 33 40 2605 2612 B-contraception_consent
to 41 43 2613 2615 I-contraception_consent
practice 44 52 2616 2624 I-contraception_consent
birth 53 58 2625 2630 I-contraception_consent
control 59 66 2631 2638 I-contraception_consent
from 67 71 2639 2643 O
the 72 75 2644 2647 O
time 76 80 2648 2652 O
of 81 83 2653 2655 O
enrollment 84 94 2656 2666 O
on 95 97 2667 2669 O
this 98 102 2670 2674 O
study 103 108 2675 2680 O
and 109 112 2681 2684 O
for 113 116 2685 2688 O
up 117 119 2689 2691 O
to 120 122 2692 2694 O
four 123 127 2695 2699 B-upper_bound
months 128 134 2700 2706 I-upper_bound
after 135 140 2707 2712 O
treatment 141 150 2713 2722 B-treatment

Patients 0 8 2723 2731 O
who 9 12 2732 2735 O
are 13 16 2736 2739 O
receiving 17 26 2740 2749 O
any 27 30 2750 2753 O
other 31 36 2754 2759 O
investigational 37 52 2760 2775 B-treatment
agents 53 59 2776 2782 I-treatment

Patients 0 8 2783 2791 O
who 9 12 2792 2795 O
have 13 17 2796 2800 O
previously 18 28 2801 2811 O
received 29 37 2812 2820 O
ipilimumab 38 48 2821 2831 B-treatment
and 49 52 2832 2835 O
have 53 57 2836 2840 O
documented 58 68 2841 2851 O
GI 69 71 2852 2854 B-chronic_disease
toxicity 72 80 2855 2863 I-chronic_disease
must 81 85 2864 2868 O
have 86 90 2869 2873 O
a 91 92 2874 2875 O
normal 93 99 2876 2882 O
colonoscopy 100 111 2883 2894 B-treatment
with 112 116 2895 2899 O
normal 117 123 2900 2906 O
colonic 124 131 2907 2914 B-treatment
biopsies 132 140 2915 2923 I-treatment

Patients 0 8 2924 2932 O
with 9 13 2933 2937 O
3 14 15 2938 2939 B-upper_bound
or 16 18 2940 2942 O
fewer 19 24 2943 2948 O
brain 25 30 2949 2954 B-clinical_variable
metastases 31 41 2955 2965 I-clinical_variable
that 42 46 2966 2970 O
are 47 50 2971 2974 O
less 51 55 2975 2979 O
than 56 60 2980 2984 O
1 61 62 2985 2986 B-upper_bound
cm 63 65 2987 2989 I-upper_bound
in 66 68 2990 2992 I-upper_bound
diameter 69 77 2993 3001 I-upper_bound
and 78 81 3002 3005 O
asymptomatic 82 94 3006 3018 O
are 95 98 3019 3022 O
eligible 99 107 3023 3031 O

Platelet 0 8 3032 3040 B-clinical_variable
count 9 14 3041 3046 I-clinical_variable
greater 15 22 3047 3054 O
than 23 27 3055 3059 O
or 28 30 3060 3062 O
equal 31 36 3063 3068 O
to 37 39 3069 3071 O
100,000 40 47 3072 3079 B-lower_bound
/ 47 48 3079 3080 I-lower_bound
mm^3 48 52 3080 3084 I-lower_bound

Serology 0 8 3085 3093 B-treatment

Seronegative 0 12 3094 3106 O
for 13 16 3107 3110 O
HIV 17 20 3111 3114 B-chronic_disease
antibody 21 29 3115 3123 O
. 29 30 3123 3124 O
( 31 32 3125 3126 O
The 32 35 3126 3129 O
experimental 36 48 3130 3142 O
treatment 49 58 3143 3152 B-treatment
being 59 64 3153 3158 O
evaluated 65 74 3159 3168 O
in 75 77 3169 3171 O
this 78 82 3172 3176 O
protocol 83 91 3177 3185 O
depends 92 99 3186 3193 O
on 100 102 3194 3196 O
an 103 105 3197 3199 O
intact 106 112 3200 3206 O
immune 113 119 3207 3213 O
system 120 126 3214 3220 O
. 126 127 3220 3221 O
Patients 128 136 3222 3230 O
who 137 140 3231 3234 O
are 141 144 3235 3238 O
HIV 145 148 3239 3242 O
seropositive 149 161 3243 3255 O
can 162 165 3256 3259 O
have 166 170 3260 3264 O
decreased 171 180 3265 3274 O
immune 181 187 3275 3281 O
- 187 188 3281 3282 O
competence 188 198 3282 3292 O
and 199 202 3293 3296 O
thus 203 207 3297 3301 O
be 208 210 3302 3304 O
less 211 215 3305 3309 O
responsive 216 226 3310 3320 O
to 227 229 3321 3323 O
the 230 233 3324 3327 O
experimental 234 246 3328 3340 O
treatment 247 256 3341 3350 O
and 257 260 3351 3354 O
more 261 265 3355 3359 O
susceptible 266 277 3360 3371 O
to 278 280 3372 3374 O
its 281 284 3375 3378 O
toxicities 285 295 3379 3389 O
. 295 296 3389 3390 O
) 296 297 3390 3391 O

Seronegative 0 12 3392 3404 O
for 13 16 3405 3408 O
hepatitis 17 26 3409 3418 B-chronic_disease
B 27 28 3419 3420 I-chronic_disease
antigen 29 36 3421 3428 O
, 36 37 3428 3429 O
and 38 41 3430 3433 O
seronegative 42 54 3434 3446 O
for 55 58 3447 3450 O
hepatitis 59 68 3451 3460 B-chronic_disease
C 69 70 3461 3462 I-chronic_disease
antibody 71 79 3463 3471 O

Serum 0 5 3472 3477 B-clinical_variable
ALT 6 9 3478 3481 I-clinical_variable
/ 9 10 3481 3482 I-clinical_variable
AST 10 13 3482 3485 I-clinical_variable
less 14 18 3486 3490 O
than 19 23 3491 3495 O
or 24 26 3496 3498 O
equal 27 32 3499 3504 O
to 33 35 3505 3507 O
2.5 36 39 3508 3511 B-upper_bound
times 40 45 3512 3517 I-upper_bound
the 46 49 3518 3521 I-upper_bound
upper 50 55 3522 3527 I-upper_bound
limit 56 61 3528 3533 I-upper_bound
of 62 64 3534 3536 I-upper_bound
normal 65 71 3537 3543 I-upper_bound

Serum 0 5 3544 3549 B-clinical_variable
creatinine 6 16 3550 3560 I-clinical_variable
less 17 21 3561 3565 O
than 22 26 3566 3570 O
or 27 29 3571 3573 O
equal 30 35 3574 3579 O
to 36 38 3580 3582 O
1.6 39 42 3583 3586 B-upper_bound
mg 43 45 3587 3589 I-upper_bound
/ 45 46 3589 3590 I-upper_bound
dl 46 48 3590 3592 I-upper_bound

Subjects 0 8 3593 3601 O
must 9 13 3602 3606 O
be 14 16 3607 3609 O
co 17 19 3610 3612 B-treatment
- 19 20 3612 3613 I-treatment
enrolled 20 28 3613 3621 I-treatment
in 29 31 3622 3624 I-treatment
protocol 32 40 3625 3633 I-treatment
03 41 43 3634 3636 I-treatment
- 43 44 3636 3637 I-treatment
C-0277 44 50 3637 3643 I-treatment

Symptoms 0 8 3644 3652 O
of 9 11 3653 3655 O
respiratory 12 23 3656 3667 B-chronic_disease
dysfunction 24 35 3668 3679 I-chronic_disease

Total 0 5 3680 3685 B-clinical_variable
bilirubin 6 15 3686 3695 I-clinical_variable
less 16 20 3696 3700 O
than 21 25 3701 3705 O
or 26 28 3706 3708 O
equal 29 34 3709 3714 O
to 35 37 3715 3717 O
1.5 38 41 3718 3721 B-upper_bound
mg 42 44 3722 3724 I-upper_bound
/ 44 45 3724 3725 I-upper_bound
dl 45 47 3725 3727 I-upper_bound
, 47 48 3727 3728 O
except 49 55 3729 3735 O
in 56 58 3736 3738 O
patients 59 67 3739 3747 O
with 68 72 3748 3752 O
Gilbert 73 80 3753 3760 B-chronic_disease
s 81 82 3761 3762 I-chronic_disease
Syndrome 83 91 3763 3771 I-chronic_disease
who 92 95 3772 3775 O
must 96 100 3776 3780 O
have 101 105 3781 3785 O
a 106 107 3786 3787 O
total 108 113 3788 3793 B-clinical_variable
bilirubin 114 123 3794 3803 I-clinical_variable
less 124 128 3804 3808 O
than 129 133 3809 3813 O
3.0 134 137 3814 3817 B-upper_bound
mg 138 140 3818 3820 I-upper_bound
/ 140 141 3820 3821 I-upper_bound
dl 141 143 3821 3823 I-upper_bound

WBC 0 3 3824 3827 B-clinical_variable
greater 4 11 3828 3835 O
than 12 16 3836 3840 O
or 17 19 3841 3843 O
equal 20 25 3844 3849 O
to 26 28 3850 3852 O
3000 29 33 3853 3857 B-lower_bound
/ 33 34 3857 3858 I-lower_bound
mm^3 34 38 3858 3862 I-lower_bound

Women 0 5 3863 3868 B-gender
of 6 8 3869 3871 O
child 9 14 3872 3877 O
- 14 15 3877 3878 O
bearing 15 22 3878 3885 O
potential 23 32 3886 3895 O
must 33 37 3896 3900 O
have 38 42 3901 3905 O
a 43 44 3906 3907 O
negative 45 53 3908 3916 B-pregnancy
pregnancy 54 63 3917 3926 I-pregnancy
test 64 68 3927 3931 O
because 69 76 3932 3939 O
of 77 79 3940 3942 O
the 80 83 3943 3946 O
potentially 84 95 3947 3958 O
dangerous 96 105 3959 3968 O
effects 106 113 3969 3976 O
of 114 116 3977 3979 O
the 117 120 3980 3983 O
treatment 121 130 3984 3993 B-treatment
on 131 133 3994 3996 O
the 134 137 3997 4000 O
fetus 138 143 4001 4006 O

Women 0 5 4007 4012 B-gender
of 6 8 4013 4015 O
child 9 14 4016 4021 O
- 14 15 4021 4022 O
bearing 15 22 4022 4029 O
potential 23 32 4030 4039 O
who 33 36 4040 4043 O
are 37 40 4044 4047 B-pregnancy
pregnant 41 49 4048 4056 I-pregnancy
or 50 52 4057 4059 O
breastfeeding 53 66 4060 4073 O
because 67 74 4074 4081 O
of 75 77 4082 4084 O
the 78 81 4085 4088 O
potentially 82 93 4089 4100 O
dangerous 94 103 4101 4110 O
effects 104 111 4111 4118 O
of 112 114 4119 4121 O
the 115 118 4122 4125 O
treatment 119 128 4126 4135 B-treatment
on 129 131 4136 4138 O
the 132 135 4139 4142 O
fetus 136 141 4143 4148 O
or 142 144 4149 4151 O
infant 145 151 4152 4158 O

by 0 2 4159 4161 O
immunohistochemistry 3 23 4162 4182 B-treatment
of 24 26 4183 4185 O
resected 27 35 4186 4194 O
tissue 36 42 4195 4201 O
defined 43 50 4202 4209 O
as 51 53 4210 4212 O
10 54 56 4213 4215 B-lower_bound
% 56 57 4215 4216 I-lower_bound
or 58 60 4217 4219 O
greater 61 68 4220 4227 O
of 69 71 4228 4230 O
tumor 72 77 4231 4236 B-cancer
cells 78 83 4237 4242 I-cancer
being 84 89 4243 4248 O
2 90 91 4249 4250 B-lower_bound
- 91 92 4250 4251 O
3 92 93 4251 4252 B-upper_bound
+ 93 94 4252 4253 I-upper_bound
for 95 98 4254 4257 O
MAGE 99 103 4258 4262 B-clinical_variable
- 103 104 4262 4263 I-clinical_variable
A3 104 106 4263 4265 I-clinical_variable
, 106 107 4265 4266 O
or 108 110 4267 4269 O
serum 111 116 4270 4275 O
antibody 117 125 4276 4284 O
reactive 126 134 4285 4293 O
with 135 139 4294 4298 O
MAGE 140 144 4299 4303 O
- 144 145 4303 4304 O
A3 145 147 4304 4306 O

greater 0 7 4307 4314 O
than 8 12 4315 4319 O
or 13 15 4320 4322 O
equal 16 21 4323 4328 O
to 22 24 4329 4331 O
65 25 27 4332 4334 B-lower_bound
years 28 33 4335 4340 I-lower_bound
old 34 37 4341 4344 O

18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
65 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

A 0 1 19 20 O
blood 2 7 21 26 B-clinical_variable
pressure 8 16 27 35 I-clinical_variable
of 17 19 36 38 O
one 20 23 39 42 O
reading 24 31 43 50 O
over 32 36 51 55 O
160/90 37 43 56 62 O
or 44 46 63 65 O
two 47 50 66 69 O
separate 51 59 70 78 O
readings 60 68 79 87 O
over 69 73 88 92 O
140/90 74 80 93 99 O
at 81 83 100 102 O
screen 84 90 103 109 O
or 91 93 110 112 O
baseline 94 102 113 121 O
visits 103 109 122 128 O

Current 0 7 129 136 O
diagnosis 8 17 137 146 O
of 18 20 147 149 O
bulimia 21 28 150 157 B-chronic_disease
nervosa 29 36 158 165 I-chronic_disease
or 37 39 166 168 O
anorexia 40 48 169 177 B-chronic_disease
nervosa 49 56 178 185 I-chronic_disease

Diagnosis 0 9 186 195 O
of 10 12 196 198 O
schizotypal 13 24 199 210 B-chronic_disease
or 25 27 211 213 O
antisocial 28 38 214 224 B-chronic_disease
personality 39 50 225 236 I-chronic_disease
disorder 51 59 237 245 I-chronic_disease

History 0 7 246 253 O
of 8 10 254 256 O
( 11 12 257 258 B-chronic_disease
hypo)mania 12 22 258 268 I-chronic_disease

History 0 7 269 276 O
of 8 10 277 279 O
autism 11 17 280 286 B-chronic_disease
, 17 18 286 287 O
mental 19 25 288 294 B-chronic_disease
retardation 26 37 295 306 I-chronic_disease
, 37 38 306 307 O
pervasive 39 48 308 317 B-chronic_disease
developmental 49 62 318 331 I-chronic_disease
disorders 63 72 332 341 I-chronic_disease
, 72 73 341 342 O
or 74 76 343 345 O
Tourette 77 85 346 354 B-chronic_disease
's 85 87 354 356 I-chronic_disease
syndrome 88 96 357 365 I-chronic_disease

History 0 7 366 373 O
of 8 10 374 376 O
one 11 14 377 380 B-lower_bound
or 15 17 381 383 O
more 18 22 384 388 O
seizures 23 31 389 397 B-chronic_disease
without 32 39 398 405 O
a 40 41 406 407 O
clear 42 47 408 413 O
and 48 51 414 417 O
resolved 52 60 418 426 O
etiology 61 69 427 435 O

Hormonal 0 8 436 444 B-treatment
treatment 9 18 445 454 I-treatment
( 19 20 455 456 O
e.g. 20 24 456 460 O
, 24 25 460 461 O
estrogen 26 34 462 470 B-treatment
) 34 35 470 471 O
started 36 43 472 479 O
in 44 46 480 482 O
the 47 50 483 486 O
3 51 52 487 488 O
months 53 59 489 495 O
prior 60 65 496 501 O
to 66 68 502 504 O
the 69 72 505 508 O
first 73 78 509 514 O
infusion 79 87 515 523 B-treatment
day 88 91 524 527 O

Men 0 3 528 531 B-gender

Participants 0 12 532 544 O
must 13 17 545 549 O
fulfill 18 25 550 557 O
DSM-5 26 31 558 563 B-clinical_variable
criteria 32 40 564 572 O
for 41 44 573 576 O
current 45 52 577 584 O
civilian 53 61 585 593 O
or 62 64 594 596 O
combat 65 71 597 603 O
- 71 72 603 604 O
related 72 79 604 611 O
PTSD 80 84 612 616 B-chronic_disease

Past 0 4 617 621 O
or 5 7 622 624 O
current 8 15 625 632 O
presence 16 24 633 641 O
of 25 27 642 644 O
psychotic 28 37 645 654 B-chronic_disease
symptoms 38 46 655 663 O

Patients 0 8 664 672 O
judged 9 15 673 679 O
clinically 16 26 680 690 O
to 27 29 691 693 O
be 30 32 694 696 O
at 33 35 697 699 O
serious 36 43 700 707 O
and 44 47 708 711 O
imminent 48 56 712 720 O
suicidal 57 65 721 729 B-chronic_disease
or 66 68 730 732 I-chronic_disease
homicidal 69 78 733 742 I-chronic_disease
risk 79 83 743 747 I-chronic_disease

Patients 0 8 748 756 O
who 9 12 757 760 O
report 13 19 761 767 O
current 20 27 768 775 O
treatment 28 37 776 785 O
with 38 42 786 790 O
a 43 44 791 792 O
benzodiazepine 45 59 793 807 B-treatment
, 59 60 807 808 O
an 61 63 809 811 O
opioid 64 70 812 818 B-treatment
medication 71 81 819 829 I-treatment
, 81 82 829 830 O
or 83 85 831 833 O
a 86 87 834 835 O
mood 88 92 836 840 B-treatment
stabilizer 93 103 841 851 I-treatment
( 104 105 852 853 O
such 105 109 853 857 O
as 110 112 858 860 O
valproic 113 121 861 869 B-treatment
acid 122 126 870 874 I-treatment
or 127 129 875 877 O
lithium 130 137 878 885 B-treatment
) 137 138 885 886 O
within 139 145 887 893 O
2 146 147 894 895 B-upper_bound
weeks 148 153 896 901 I-upper_bound
prior 154 159 902 907 I-upper_bound
to 160 162 908 910 O
randomization 163 176 911 924 O

Patients 0 8 925 933 O
with 9 13 934 938 O
uncorrected 14 25 939 950 O
hypothyroidism 26 40 951 965 B-chronic_disease
or 41 43 966 968 I-chronic_disease
hyperthyroidism 44 59 969 984 I-chronic_disease

Previous 0 8 985 993 O
recreational 9 21 994 1006 O
use 22 25 1007 1010 O
of 26 28 1011 1013 O
ketamine 29 37 1014 1022 B-treatment
or 38 40 1023 1025 O
PCP 41 44 1026 1029 B-treatment

Renal 0 5 1030 1035 B-chronic_disease
impairment 6 16 1036 1046 I-chronic_disease
, 16 17 1046 1047 O
as 18 20 1048 1050 O
reflected 21 30 1051 1060 O
by 31 33 1061 1063 O
a 34 35 1064 1065 O
BUN 36 39 1066 1069 B-clinical_variable
> 40 41 1070 1071 O
20 41 43 1071 1073 B-lower_bound
mg 44 46 1074 1076 I-lower_bound
/ 46 47 1076 1077 I-lower_bound
dL 47 49 1077 1079 I-lower_bound

Use 0 3 1080 1083 O
of 4 6 1084 1086 O
evidence 7 15 1087 1095 O
- 15 16 1095 1096 O
based 16 21 1096 1101 O
individual 22 32 1102 1112 O
psychotherapy 33 46 1113 1126 B-treatment
( 47 48 1127 1128 O
such 48 52 1128 1132 O
as 53 55 1133 1135 O
prolonged 56 65 1136 1145 O
exposure 66 74 1146 1154 O
) 74 75 1154 1155 O
during 76 82 1156 1162 O
the 83 86 1163 1166 O
study 87 92 1167 1172 O

Women 0 5 1173 1178 B-gender
of 6 8 1179 1181 O
childbearing 9 21 1182 1194 O
potential 22 31 1195 1204 O
must 32 36 1205 1209 O
have 37 41 1210 1214 O
a 42 43 1215 1216 O
negative 44 52 1217 1225 B-pregnancy
pregnancy 53 62 1226 1235 I-pregnancy
test 63 67 1236 1240 O
at 68 70 1241 1243 O
screening 71 80 1244 1253 O
and 81 84 1254 1257 O
prior 85 90 1258 1263 O
to 91 93 1264 1266 O
each 94 98 1267 1271 O
intravenous 99 110 1272 1283 B-treatment
infusion 111 119 1284 1292 I-treatment

cardiovascular 0 14 1293 1307 B-chronic_disease

creatinin 0 9 1308 1317 B-clinical_variable
clearance 10 19 1318 1327 I-clinical_variable
of 20 22 1328 1330 O
> 23 24 1331 1332 O
1.3 24 27 1332 1335 B-upper_bound
mg 28 30 1336 1338 I-upper_bound
/ 30 31 1338 1339 I-upper_bound
dL 31 33 1339 1341 I-upper_bound

dependence 0 10 1342 1352 O
within 11 17 1353 1359 O
the 18 21 1360 1363 O
preceding 22 31 1364 1373 B-upper_bound
3 32 33 1374 1375 I-upper_bound
months 34 40 1376 1382 I-upper_bound

diagnosis 0 9 1383 1392 O
of 10 12 1393 1395 O
a 13 14 1396 1397 O
lifetime 15 23 1398 1406 O
psychotic 24 33 1407 1416 B-chronic_disease
disorder 34 42 1417 1425 I-chronic_disease
including 43 52 1426 1435 O
schizophrenia 53 66 1436 1449 B-chronic_disease
or 67 69 1450 1452 O
schizoaffective 70 85 1453 1468 B-chronic_disease
disorder 86 94 1469 1477 I-chronic_disease

gastro 0 6 1478 1484 B-chronic_disease
- 6 7 1484 1485 I-chronic_disease
esophageal 7 17 1485 1495 I-chronic_disease
reflux 18 24 1496 1502 I-chronic_disease
disease 25 32 1503 1510 I-chronic_disease

hematologic 0 11 1511 1522 B-chronic_disease
disease 12 19 1523 1530 I-chronic_disease

history 0 7 1531 1538 O
of 8 10 1539 1541 O
difficulty 11 21 1542 1552 O
with 22 26 1553 1557 O
airway 27 33 1558 1564 O
management 34 44 1565 1575 O
during 45 51 1576 1582 O
previous 52 60 1583 1591 O
anesthetics 61 72 1592 1603 B-treatment
, 72 73 1603 1604 O
ischemic 74 82 1605 1613 B-chronic_disease
heart 83 88 1614 1619 I-chronic_disease
disease 89 96 1620 1627 I-chronic_disease
and 97 100 1628 1631 O
uncontrolled 101 113 1632 1644 B-chronic_disease
hypertension 114 126 1645 1657 I-chronic_disease

history 0 7 1658 1665 O
of 8 10 1666 1668 O
severe 11 17 1669 1675 O
head 18 22 1676 1680 B-chronic_disease
injury 23 29 1681 1687 I-chronic_disease

hyroid 0 6 1688 1694 B-chronic_disease
impairment 7 17 1695 1705 I-chronic_disease
, 17 18 1705 1706 O
as 19 21 1707 1709 O
reflected 22 31 1710 1719 O
by 32 34 1720 1722 O
TSH 35 38 1723 1726 B-clinical_variable
> 38 39 1726 1727 O
4.2 40 43 1728 1731 B-lower_bound
mU 44 46 1732 1734 I-lower_bound
/ 46 47 1734 1735 I-lower_bound
L 47 48 1735 1736 I-lower_bound

obstructive 0 11 1737 1748 B-chronic_disease
sleep 12 17 1749 1754 I-chronic_disease
apnea 18 23 1755 1760 I-chronic_disease

omen 0 4 1761 1765 B-gender
who 5 8 1766 1769 O
plan 9 13 1770 1774 B-pregnancy
to 14 16 1775 1777 I-pregnancy
become 17 23 1778 1784 I-pregnancy
pregnant 24 32 1785 1793 I-pregnancy

pregnant 0 8 1794 1802 B-pregnancy

women 0 5 1803 1808 B-gender

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
and 9 12 9 12 O
older 13 18 13 18 O

Additional 0 10 19 29 O
surgical 11 19 30 38 B-treatment
procedures 20 30 39 49 I-treatment
( 31 32 50 51 O
i.e. 32 36 51 55 O
UPPP 37 41 56 60 B-treatment
( 42 43 61 62 I-treatment
uvulopalatopharyngoplasty 43 68 62 87 I-treatment
) 68 69 87 88 I-treatment
, 69 70 88 89 O
septoplasty 71 82 90 101 B-treatment
, 82 83 101 102 O
inferior 84 92 103 111 B-treatment
turbinate 93 102 112 121 I-treatment
reduction 103 112 122 131 I-treatment
) 112 113 131 132 O
during 114 120 133 139 O
same 121 125 140 144 O
surgery 126 133 145 152 B-treatment

Contraindications 0 17 153 170 O
to 18 20 171 173 O
pain 21 25 174 178 O
regimen 26 33 179 186 O
medications 34 45 187 198 B-treatment
( 46 47 199 200 O
Tylenol 47 54 200 207 B-treatment
, 54 55 207 208 O
Norco 56 61 209 214 B-treatment
, 61 62 214 215 O
Percocet 63 71 216 224 B-treatment
, 71 72 224 225 O
Dilaudid 73 81 226 234 B-treatment
) 81 82 234 235 O

Contraindications 0 17 236 253 O
to 18 20 254 256 O
preoperative 21 33 257 269 O
Decadron 34 42 270 278 B-treatment

History 0 7 279 286 O
of 8 10 287 289 O
chronic 11 18 290 297 B-chronic_disease
pain 19 23 298 302 I-chronic_disease
or 24 26 303 305 O
daily 27 32 306 311 O
pain 33 37 312 316 O
medication 38 48 317 327 B-treatment
used 49 53 328 332 O
for 54 57 333 336 O
another 58 65 337 344 O
medical 66 73 345 352 O
problem 74 81 353 360 O

History 0 7 361 368 O
of 8 10 369 371 O
liver 11 16 372 377 B-chronic_disease
disease 17 24 378 385 I-chronic_disease

Indications 0 11 386 397 O
: 11 12 397 398 O
Suspected 13 22 399 408 O
malignancy 23 33 409 419 B-cancer

Pregnant 0 8 420 428 B-pregnancy
females 9 16 429 436 B-gender

Surgical 0 8 437 445 O
indications 9 20 446 457 O
: 20 21 457 458 O
Chronic 22 29 459 466 B-chronic_disease
tonsillitis 30 41 467 478 I-chronic_disease
, 41 42 478 479 O
Snoring 43 50 480 487 B-chronic_disease
, 50 51 487 488 O
Sleep 52 57 489 494 B-chronic_disease
apnea 58 63 495 500 I-chronic_disease

Surgical 0 8 501 509 B-treatment
procedure 9 18 510 519 I-treatment
: 18 19 519 520 O
Tonsillectomy 20 33 521 534 B-treatment
with 34 38 535 539 I-treatment
monopolar 39 48 540 549 I-treatment
cautery 49 56 550 557 I-treatment
, 56 57 557 558 O
hemostasis 58 68 559 569 B-treatment
with 69 73 570 574 I-treatment
monopolar 74 83 575 584 I-treatment
cautery 84 91 585 592 I-treatment
and/or 92 98 593 599 I-treatment
suction 99 106 600 607 I-treatment
cautery 107 114 608 615 I-treatment

The 0 3 616 619 O
surgical 4 12 620 628 B-treatment
procedure 13 22 629 638 O
can 23 26 639 642 O
also 27 31 643 647 O
include 32 39 648 655 O
Adenoidectomy 40 53 656 669 B-treatment
with 54 58 670 674 O
suction 59 66 675 682 O
cautery 67 74 683 690 O

Candidate 0 9 0 9 O
to 10 12 10 12 O
undergo 13 20 13 20 O
immune 21 27 21 27 B-treatment
checkpoint 28 38 28 38 I-treatment
inhibitor 39 48 39 48 I-treatment
( 49 50 49 50 I-treatment
ICI 50 53 50 53 I-treatment
) 53 54 53 54 I-treatment
therapy 55 62 55 62 I-treatment
for 63 66 63 66 O
SCLC 67 71 67 71 B-cancer
or 72 74 72 74 O
NSCLC 75 80 75 80 B-cancer
( 81 82 81 82 O
ICI 82 85 82 85 O
as 86 88 86 88 O
any 89 92 89 92 O
line 93 97 93 97 O
of 98 100 98 100 O
chemotherapy 101 113 101 113 B-treatment
is 114 116 114 116 O
acceptable 117 127 117 127 O
) 127 128 127 128 O
as 129 131 129 131 O
deemed 132 138 132 138 O
by 139 141 139 141 O
individual 142 152 142 152 O
's 152 154 152 154 O
treating 155 163 155 163 O
oncologist 164 174 164 174 O

Coagulopathy 0 12 175 187 B-chronic_disease
with 13 17 188 192 O
international 18 31 193 206 B-clinical_variable
normalized 32 42 207 217 I-clinical_variable
ratio 43 48 218 223 I-clinical_variable
( 49 50 224 225 I-clinical_variable
INR 50 53 225 228 I-clinical_variable
) 53 54 228 229 I-clinical_variable
> 55 56 230 231 O
2.0 57 60 232 235 B-lower_bound
or 61 63 236 238 O

Coagulopathy 0 12 239 251 B-treatment
with 13 17 252 256 O
platelets 18 27 257 266 B-clinical_variable
( 28 29 267 268 I-clinical_variable
Plt 29 32 268 271 I-clinical_variable
) 32 33 271 272 I-clinical_variable
< 34 35 273 274 O
10 36 38 275 277 B-upper_bound
k 39 40 278 279 I-upper_bound

Confirmed 0 9 280 289 O
diagnosis 10 19 290 299 O
of 20 22 300 302 O
non 23 26 303 306 B-cancer
- 26 27 306 307 I-cancer
small 27 32 307 312 I-cancer
cell 33 37 313 317 I-cancer
lung 38 42 318 322 I-cancer
cancer 43 49 323 329 I-cancer
( 50 51 330 331 I-cancer
NSCLC 51 56 331 336 I-cancer
) 56 57 336 337 I-cancer
or 58 60 338 340 O
small 61 66 341 346 B-cancer
cell 67 71 347 351 I-cancer
lung 72 76 352 356 I-cancer
cancer 77 83 357 363 I-cancer
( 84 85 364 365 I-cancer
SCLC 85 89 365 369 I-cancer
) 89 90 369 370 I-cancer

Enrollment 0 10 371 381 O
into 11 15 382 386 O
this 16 20 387 391 O
study 21 26 392 397 O
may 27 30 398 401 O
occur 31 36 402 407 O
in 37 39 408 410 O
tandem 40 46 411 417 O
with 47 51 418 422 O
other 52 57 423 428 B-treatment
clinical 58 66 429 437 I-treatment
therapeutics 67 79 438 450 I-treatment
trials 80 86 451 457 I-treatment
occurring 87 96 458 467 O
at 97 99 468 470 O
Vanderbilt 100 110 471 481 O
University 111 121 482 492 O
Medical 122 129 493 500 O
Center 130 136 501 507 O
( 137 138 508 509 O
VUMC 138 142 509 513 O
) 142 143 513 514 O
as 144 146 515 517 O
long 147 151 518 522 O
as 152 154 523 525 O
this 155 159 526 530 O
trial 160 165 531 536 O
does 166 170 537 541 O
not 171 174 542 545 O
violate 175 182 546 553 O
protocol 183 191 554 562 O
or 192 194 563 565 O
inclusion 195 204 566 575 O
criteria 205 213 576 584 O
of 214 216 585 587 O
that 217 221 588 592 O
study 222 227 593 598 O

Inability 0 9 599 608 O
to 10 12 609 611 O
perform 13 20 612 619 O
informed 21 29 620 628 O
consent 30 37 629 636 O
due 38 41 637 640 O
to 42 44 641 643 O
any 45 48 644 647 O
medical 49 56 648 655 B-chronic_disease
or 57 59 656 658 I-chronic_disease
psychiatric 60 71 659 670 I-chronic_disease
condition 72 81 671 680 I-chronic_disease

Prior 0 5 681 686 B-treatment
therapy 6 13 687 694 I-treatment
with 14 18 695 699 I-treatment
anti 19 23 700 704 I-treatment
- 23 24 704 705 I-treatment
PD-1 24 28 705 709 I-treatment
, 28 29 709 710 O
anti 30 34 711 715 B-treatment
- 34 35 715 716 I-treatment
PD 35 37 716 718 I-treatment
- 37 38 718 719 I-treatment
L1 38 40 719 721 I-treatment
, 40 41 721 722 O
anti 42 46 723 727 B-treatment
- 46 47 727 728 I-treatment
PD 47 49 728 730 I-treatment
- 49 50 730 731 I-treatment
L2 50 52 731 733 I-treatment
, 52 53 733 734 O
anti 54 58 735 739 B-treatment
- 58 59 739 740 I-treatment
CD137 59 64 740 745 I-treatment
, 64 65 745 746 O
or 66 68 747 749 O
anti 69 73 750 754 B-treatment
- 73 74 754 755 I-treatment
CTLA-4 74 80 755 761 I-treatment
antibody 81 89 762 770 I-treatment
( 90 91 771 772 O
including 91 100 772 781 O
ipilimumab 101 111 782 792 B-treatment
or 112 114 793 795 O
any 115 118 796 799 O
other 119 124 800 805 O
antibody 125 133 806 814 O
or 134 136 815 817 O
drug 137 141 818 822 O
specifically 142 154 823 835 O
targeting 155 164 836 845 O
T 165 166 846 847 B-cancer
- 166 167 847 848 I-cancer
cell 167 171 848 852 I-cancer
co 172 174 853 855 O
- 174 175 855 856 O
stimulation 175 186 856 867 O
or 187 189 868 870 O
checkpoint 190 200 871 881 O
pathways 201 209 882 890 O
) 209 210 890 891 O

Respiratory 0 11 892 903 B-chronic_disease
failure 12 19 904 911 I-chronic_disease
requiring 20 29 912 921 O
greater 30 37 922 929 O
than 38 42 930 934 O
6 43 44 935 936 B-lower_bound
Lpm 45 48 937 940 I-lower_bound
supplemental 49 61 941 953 B-treatment
oxygen 62 68 954 960 I-treatment
( 69 70 961 962 I-treatment
O2 70 72 962 964 I-treatment
) 72 73 964 965 I-treatment
by 74 76 966 968 O
nasal 77 82 969 974 B-treatment
cannula 83 90 975 982 I-treatment
or 91 93 983 985 O
mechanical 94 104 986 996 B-treatment
ventilation 105 116 997 1008 I-treatment
within 117 123 1009 1015 O
the 124 127 1016 1019 O
past 128 132 1020 1024 B-upper_bound
six 133 136 1025 1028 I-upper_bound
weeks 137 142 1029 1034 I-upper_bound

Subjects 0 8 1035 1043 O
with 9 13 1044 1048 O
an 14 16 1049 1051 O
active 17 23 1052 1058 O
or 24 26 1059 1061 O
recent 27 33 1062 1068 O
history 34 41 1069 1076 O
of 42 44 1077 1079 O
a 45 46 1080 1081 O
known 47 52 1082 1087 O
or 53 55 1088 1090 O
suspected 56 65 1091 1100 O
autoimmune 66 76 1101 1111 B-chronic_disease
disease 77 84 1112 1119 I-chronic_disease
or 85 87 1120 1122 O
recent 88 94 1123 1129 O
history 95 102 1130 1137 O
of 103 105 1138 1140 O
a 106 107 1141 1142 O
syndrome 108 116 1143 1151 B-chronic_disease
that 117 121 1152 1156 O
required 122 130 1157 1165 O
systemic 131 139 1166 1174 O
corticosteroids 140 155 1175 1190 O
/ 155 156 1190 1191 O
immunosuppressive 156 173 1191 1208 B-treatment
medications 174 185 1209 1220 I-treatment

able 0 4 0 4 O
to 5 7 5 7 O
speak 8 13 8 13 B-language_fluency
English 14 21 14 21 I-language_fluency
and/or 22 28 22 28 I-language_fluency
Spanish 29 36 29 36 I-language_fluency

be 0 2 37 39 O
at 3 5 40 42 O
least 6 11 43 48 O
18 12 14 49 51 B-lower_bound
years 15 20 52 57 I-lower_bound
old 21 24 58 61 O

either 0 6 62 68 O
partner 7 14 69 76 O
is 15 17 77 79 O
currently 18 27 80 89 O
on 28 30 90 92 O
PrEP 31 35 93 97 B-treatment
and 36 39 98 101 O
fully 40 45 102 107 O
adherent 46 54 108 116 O
, 54 55 116 117 O
or 56 58 118 120 O
enrolled 59 67 121 129 O
in 68 70 130 132 O
any 71 74 133 136 O
other 75 80 137 142 O
HIV 81 84 143 146 B-chronic_disease
prevention 85 95 147 157 O
study 96 101 158 163 O

either 0 6 164 170 O
partner 7 14 171 178 O
is 15 17 179 181 O
planning 18 26 182 190 O
on 27 29 191 193 O
ending 30 36 194 200 O
the 37 40 201 204 O
relationship 41 53 205 217 O
with 54 58 218 222 O
his 59 62 223 226 O
partner 63 70 227 234 O
in 71 73 235 237 O
the 74 77 238 241 O
next 78 82 242 246 B-upper_bound
8 83 84 247 248 I-upper_bound
months 85 91 249 255 I-upper_bound

either 0 6 256 262 O
partner 7 14 263 270 O
is 15 17 271 273 O
planning 18 26 274 282 O
to 27 29 283 285 O
move 30 34 286 290 O
outside 35 42 291 298 O
the 43 46 299 302 O
area 47 51 303 307 O
in 52 54 308 310 O
the 55 58 311 314 O
next 59 63 315 319 O
8 64 65 320 321 B-upper_bound
months 66 72 322 328 I-upper_bound

report 0 6 329 335 O
having 7 13 336 342 O
a 14 15 343 344 O
main 16 20 345 349 O
/ 20 21 349 350 O
primary 21 28 350 357 O
male 29 33 358 362 B-gender
partner 34 41 363 370 O
during 42 48 371 377 O
the 49 52 378 381 O
past 53 57 382 386 B-upper_bound
90 58 60 387 389 I-upper_bound
days 61 65 390 394 I-upper_bound
( 66 67 395 396 O
operationalized 67 82 396 411 O
as 83 85 412 414 O
a 86 87 415 416 O
man 88 91 417 420 B-gender
with 92 96 421 425 O
whom 97 101 426 430 O
he 102 104 431 433 O
has 105 108 434 437 O
had 109 112 438 441 O
a 113 114 442 443 O
sexual 115 121 444 450 O
relationship 122 134 451 463 O
during 135 141 464 470 O
the 142 145 471 474 O
past 146 150 475 479 O
90 151 153 480 482 O
days 154 158 483 487 O
and 159 162 488 491 O
has 163 166 492 495 O
a 167 168 496 497 O
strong 169 175 498 504 O
emotional 176 185 505 514 O
bond 186 190 515 519 O
) 190 191 519 520 O

reports 0 7 521 528 O
sexual 8 14 529 535 O
activity 15 23 536 544 O
in 24 26 545 547 O
the 27 30 548 551 O
past 31 35 552 556 B-upper_bound
90 36 38 557 559 I-upper_bound
days 39 43 560 564 I-upper_bound
as 44 46 565 567 O
described 47 56 568 577 O
in 57 59 578 580 O
the 60 63 581 584 O
screening 64 73 585 594 O
instrument 74 84 595 605 O

self 0 4 606 610 O
- 4 5 610 611 O
identify 5 13 611 619 O
as 14 16 620 622 O
Latino 17 23 623 629 B-ethnicity
/ 23 24 629 630 I-ethnicity
Hispanic 24 32 630 638 I-ethnicity
or 33 35 639 641 O
identify 36 44 642 650 O
as 45 47 651 653 O
having 48 54 654 660 O
a 55 56 661 662 O
main 57 61 663 667 O
partner 62 69 668 675 O
who 70 73 676 679 O
identifies 74 84 680 690 O
as 85 87 691 693 O
Latino 88 94 694 700 O
/ 94 95 700 701 O
Hispanic 95 103 701 709 O

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
old 9 12 9 12 O
or 13 15 13 15 O
older 16 21 16 21 O

change 0 6 22 28 O
in 7 9 29 31 O
psychiatric 10 21 32 43 B-treatment
medications 22 33 44 55 I-treatment
in 34 36 56 58 O
past 37 41 59 63 B-upper_bound
30 42 44 64 66 I-upper_bound
days 45 49 67 71 I-upper_bound

diagnosis 0 9 72 81 O
of 10 12 82 84 O
psychotic 13 22 85 94 B-chronic_disease
disorder 23 31 95 103 I-chronic_disease

evidence 0 8 104 112 O
of 9 11 113 115 O
developmental 12 25 116 129 B-chronic_disease
disability 26 36 130 140 I-chronic_disease

meeting 0 7 141 148 O
criteria 8 16 149 157 O
for 17 20 158 161 O
substance 21 30 162 171 O
abuse 31 36 172 177 O
/ 36 37 177 178 O
dependence 37 47 178 188 O
in 48 50 189 191 O
past 51 55 192 196 B-upper_bound
30 56 58 197 199 I-upper_bound
days 59 63 200 204 I-upper_bound

psychiatric 0 11 205 216 B-treatment
hospitalization 12 27 217 232 I-treatment
in 28 30 233 235 O
past 31 35 236 240 B-upper_bound
30 36 38 241 243 I-upper_bound
days 39 43 244 248 I-upper_bound

severe 0 6 249 255 O
auditory 7 15 256 264 B-chronic_disease
/ 15 16 264 265 I-chronic_disease
visual 16 22 265 271 I-chronic_disease
impairment 23 33 272 282 I-chronic_disease

Current 0 7 0 7 B-pregnancy
pregnancy 8 17 8 17 I-pregnancy

Participants 0 12 18 30 O
must 13 17 31 35 O
meet 18 22 36 40 O
a 23 24 41 42 O
breath 25 31 43 49 B-clinical_variable
carbon 32 38 50 56 I-clinical_variable
monoxide 39 47 57 65 I-clinical_variable
criterion 48 57 66 75 O
of 58 60 76 78 O
6 61 62 79 80 B-lower_bound
ppm 63 66 81 84 I-lower_bound
or 67 69 85 87 O
higher 70 76 88 94 O

Participants 0 12 95 107 O
must 13 17 108 112 O
speak 18 23 113 118 O
and 24 27 119 122 O
comprehend 28 38 123 133 B-language_fluency
English 39 46 134 141 I-language_fluency
well 47 51 142 146 O
enough 52 58 147 153 O
to 59 61 154 156 O
complete 62 70 157 165 O
study 71 76 166 171 O
procedures 77 87 172 182 O

Participants 0 12 183 195 O
who 13 16 196 199 O
are 17 20 200 203 O
seeking 21 28 204 211 O
treatment 29 38 212 221 B-treatment
for 39 42 222 225 O
their 43 48 226 231 O
smoking 49 56 232 239 O
or 57 59 240 242 O
who 60 63 243 246 O
report 64 70 247 253 O
that 71 75 254 258 O
they 76 80 259 263 O
intend 81 87 264 270 O
to 88 90 271 273 O
quit 91 95 274 278 O
smoking 96 103 279 286 O
within 104 110 287 293 O
the 111 114 294 297 O
next 115 119 298 302 B-upper_bound
30 120 122 303 305 I-upper_bound
days 123 127 306 310 I-upper_bound
and 128 131 311 314 O
have 132 136 315 319 O
made 137 141 320 324 O
a 142 143 325 326 O
24 144 146 327 329 O
- 146 147 329 330 O
hour 147 151 330 334 O
quit 152 156 335 339 O
attempt 157 164 340 347 O
in 165 167 348 350 O
the 168 171 351 354 O
past 172 176 355 359 O
year 177 181 360 364 O

Participants 0 12 365 377 O
who 13 16 378 381 O
report 17 23 382 388 O
current 24 31 389 396 O
suicidal 32 40 397 405 B-chronic_disease
ideation 41 49 406 414 I-chronic_disease
on 50 52 415 417 O
the 53 56 418 421 O
MINI 57 61 422 426 O
suicide 62 69 427 434 O
subscale 70 78 435 443 O
questions 79 88 444 453 O
4 89 90 454 455 O
& 91 92 456 457 O
5 93 94 458 459 O

current 0 7 460 467 O
daily 8 13 468 473 O
smoking 14 21 474 481 O
( 22 23 482 483 O
1 23 24 483 484 B-lower_bound
or 25 27 485 487 O
more 28 32 488 492 O
cigarettes 33 43 493 503 O
per 44 47 504 507 O
day 48 51 508 511 O
for 52 55 512 515 O
the 56 59 516 519 O
past 60 64 520 524 B-upper_bound
6 65 66 525 526 I-upper_bound
months 67 73 527 533 I-upper_bound
or 74 76 534 536 O
longer 77 83 537 543 O
) 83 84 543 544 O

A 0 1 0 1 O
known 2 7 2 7 O
history 8 15 8 15 O
of 16 18 16 18 O
sustained 19 28 19 28 O
ventricular 29 40 29 40 B-chronic_disease
tachycardia 41 52 41 52 I-chronic_disease
( 53 54 53 54 I-chronic_disease
VT 54 56 54 56 I-chronic_disease
) 56 57 56 57 I-chronic_disease
, 57 58 57 58 O
ventricular 59 70 59 70 B-chronic_disease
fibrillation 71 83 71 83 I-chronic_disease
( 84 85 84 85 I-chronic_disease
VF 85 87 85 87 I-chronic_disease
) 87 88 87 88 I-chronic_disease
, 88 89 88 89 O
Torsade 90 97 90 97 B-chronic_disease
de 98 100 98 100 I-chronic_disease
Pointes 101 108 101 108 I-chronic_disease
, 108 109 108 109 O
or 110 112 110 112 O
cardiac 113 120 113 120 B-chronic_disease
arrest 121 127 121 127 I-chronic_disease
unless 128 134 128 134 O
currently 135 144 135 144 O
addressed 145 154 145 154 O
with 155 159 155 159 O
an 160 162 160 162 O
automatic 163 172 163 172 B-treatment
implantable 173 184 173 184 I-treatment
cardioverter 185 197 185 197 I-treatment
defibrillator 198 211 198 211 I-treatment
( 212 213 212 213 I-treatment
AICD 213 217 213 217 I-treatment
) 217 218 217 218 I-treatment

Active 0 6 219 225 O
hepatitis 7 16 226 235 B-chronic_disease
B 17 18 236 237 I-chronic_disease
, 18 19 237 238 O
either 20 26 239 245 O
active 27 33 246 252 O
carrier 34 41 253 260 O
( 42 43 261 262 O
HBsAg 43 48 262 267 B-chronic_disease
+ 49 50 268 269 O
) 50 51 269 270 O
or 52 54 271 273 O
viremic 55 62 274 281 B-chronic_disease
( 63 64 282 283 O
HBV 64 67 283 286 B-clinical_variable
DNA 68 71 287 290 I-clinical_variable
> 72 73 291 292 O
/=10,000 73 81 292 300 O
copies 82 88 301 307 I-lower_bound
/ 88 89 307 308 I-lower_bound
mL 89 91 308 310 I-lower_bound
, 91 92 310 311 O
or 93 95 312 314 O
> 96 97 315 316 O
/= 97 99 316 318 O
2,000 100 105 319 324 B-lower_bound
IU 106 108 325 327 I-lower_bound
/ 108 109 327 328 I-lower_bound
mL 109 111 328 330 I-lower_bound
) 111 112 330 331 O

Active 0 6 332 338 O
uncontrolled 7 19 339 351 B-chronic_disease
bacterial 20 29 352 361 I-chronic_disease
, 29 30 361 362 O
viral 31 36 363 368 B-chronic_disease
or 37 39 369 371 O
fungal 40 46 372 378 B-chronic_disease
infections 47 57 379 389 I-chronic_disease

Age 0 3 390 393 B-age
18 4 6 394 396 B-lower_bound
to 7 9 397 399 O
70 10 12 400 402 B-upper_bound
years 13 18 403 408 I-upper_bound
of 19 21 409 411 O
age 22 25 412 415 B-age

An 0 2 416 418 O
EKG 3 6 419 422 O
recorded 7 15 423 431 O
at 16 18 432 434 O
screening 19 28 435 444 O
showing 29 36 445 452 O
evidence 37 45 453 461 O
of 46 48 462 464 O
cardiac 49 56 465 472 B-chronic_disease
ischemia 57 65 473 481 I-chronic_disease
( 66 67 482 483 O
ST 67 69 483 485 B-clinical_variable
depression 70 80 486 496 I-clinical_variable
depression 81 91 497 507 O
of 92 94 508 510 O
> 95 96 511 512 O
/= 96 98 512 514 O
2 99 100 515 516 B-lower_bound
mm 101 103 517 519 I-lower_bound
, 103 104 519 520 O
measured 105 113 521 529 O
from 114 118 530 534 O
isoelectric 119 130 535 546 B-clinical_variable
line 131 135 547 551 I-clinical_variable
to 136 138 552 554 O
the 139 142 555 558 O
ST 143 145 559 561 B-clinical_variable
segment 146 153 562 569 I-clinical_variable
) 153 154 569 570 O

Any 0 3 571 574 O
cardiac 4 11 575 582 B-chronic_disease
arrhythmia 12 22 583 593 I-chronic_disease
requiring 23 32 594 603 O
an 33 35 604 606 O
anti 36 40 607 611 B-treatment
- 40 41 611 612 I-treatment
arrhythmic 41 51 612 622 I-treatment
medication 52 62 623 633 I-treatment

Concomitant 0 11 634 645 O
use 12 15 646 649 O
of 16 18 650 652 O
CYP3A4 19 25 653 659 B-treatment
inhibitors 26 36 660 670 I-treatment
where 37 42 671 676 O
the 43 46 677 680 O
interaction 47 58 681 692 O
is 59 61 693 695 O
thought 62 69 696 703 O
too 70 73 704 707 O
great 74 79 708 713 O
to 80 82 714 716 O
proceed 83 90 717 724 O
with 91 95 725 729 O
romidepsin 96 106 730 740 B-treatment

Congenital 0 10 741 751 B-chronic_disease
QT 11 13 752 754 I-chronic_disease
syndrome 14 22 755 763 I-chronic_disease
, 22 23 763 764 O
QTc 24 27 765 768 B-clinical_variable
> 28 29 769 770 O
500 29 32 770 773 B-lower_bound
ms 33 35 774 776 I-lower_bound

Congestive 0 10 777 787 B-chronic_disease
heart 11 16 788 793 I-chronic_disease
failure 17 24 794 801 I-chronic_disease
( 25 26 802 803 I-chronic_disease
CHF 26 29 803 806 I-chronic_disease
) 29 30 806 807 I-chronic_disease
that 31 35 808 812 O
meets 36 41 813 818 O
New 42 45 819 822 O
York 46 50 823 827 O
Heart 51 56 828 833 O
Association 57 68 834 845 O
( 69 70 846 847 O
NYHA 70 74 847 851 O
) 74 75 851 852 O
Class 76 81 853 858 O
II 82 84 859 861 O
to 85 87 862 864 O
IV 88 90 865 867 O
definitions 91 102 868 879 O
and/or 103 109 880 886 O
ejection 110 118 887 895 B-clinical_variable
fraction 119 127 896 904 I-clinical_variable
< 128 129 905 906 O
40 129 131 906 908 B-upper_bound
% 131 132 908 909 I-upper_bound
by 133 135 910 912 O
MUGA 136 140 913 917 B-clinical_variable
scan 141 145 918 922 I-clinical_variable
or 146 148 923 925 O
< 149 150 926 927 O
50 150 152 927 929 B-upper_bound
% 152 153 929 930 I-upper_bound
by 154 156 931 933 O
echocardiogram 157 171 934 948 B-treatment
and/or 172 178 949 955 O
MRI 179 182 956 959 B-treatment

Diagnosis 0 9 960 969 O
of 10 12 970 972 O
either 13 19 973 979 O
Cutaneous 20 29 980 989 B-cancer
T 30 31 990 991 I-cancer
- 31 32 991 992 I-cancer
Cell 32 36 992 996 I-cancer
Lymphoma 37 45 997 1005 I-cancer
; 45 46 1005 1006 O
T 47 48 1007 1008 B-cancer
- 48 49 1008 1009 I-cancer
Prolymphocytic 49 63 1009 1023 I-cancer
Leukemia 64 72 1024 1032 I-cancer
; 72 73 1032 1033 O
T 74 75 1034 1035 B-cancer
- 75 76 1035 1036 I-cancer
Large 76 81 1036 1041 I-cancer
Granulocytic 82 94 1042 1054 I-cancer
Leukemia 95 103 1055 1063 I-cancer
; 103 104 1063 1064 O
T 105 106 1065 1066 B-cancer
- 106 107 1066 1067 I-cancer
Lymphoblastic 107 120 1067 1080 I-cancer
Leukemia 121 129 1081 1089 I-cancer
/ 129 130 1089 1090 I-cancer
lymphoma 130 138 1090 1098 I-cancer
; 138 139 1098 1099 O
or 140 142 1100 1102 O
Peripheral 143 153 1103 1113 B-cancer
T 154 155 1114 1115 I-cancer
- 155 156 1115 1116 I-cancer
Cell 156 160 1116 1120 I-cancer
Lymphoma 161 169 1121 1129 I-cancer
, 169 170 1129 1130 O
Natural 171 178 1131 1138 B-cancer
Killer 179 185 1139 1145 I-cancer
/ 185 186 1145 1146 I-cancer
T 186 187 1146 1147 I-cancer
- 187 188 1147 1148 I-cancer
cell 188 192 1148 1152 I-cancer
lymphoma 193 201 1153 1161 I-cancer
for 202 205 1162 1165 O
whom 206 210 1166 1170 O
allogeneic 211 221 1171 1181 B-treatment
stem 222 226 1182 1186 I-treatment
cell 227 231 1187 1191 I-treatment
transplantation 232 247 1192 1207 I-treatment
is 248 250 1208 1210 O
indicated 251 260 1211 1220 O

EF>/= 0 5 1221 1226 B-clinical_variable
50 6 8 1227 1229 B-lower_bound
% 8 9 1229 1230 I-lower_bound
on 10 12 1231 1233 O
MUGA 13 17 1234 1238 B-treatment
scan 18 22 1239 1243 I-treatment
or 23 25 1244 1246 O
Echocardiogram 26 40 1247 1261 B-treatment

Evidence 0 8 1262 1270 O
of 9 11 1271 1273 O
either 12 18 1274 1280 O
cirrhosis 19 28 1281 1290 B-chronic_disease
or 29 31 1291 1293 O
stage 32 37 1294 1299 B-lower_bound
3 38 39 1300 1301 I-lower_bound
- 39 40 1301 1302 O
4 40 41 1302 1303 B-upper_bound
liver 42 47 1304 1309 B-chronic_disease
fibrosis 48 56 1310 1318 I-chronic_disease
in 57 59 1319 1321 O
patients 60 68 1322 1330 O
with 69 73 1331 1335 O
chronic 74 81 1336 1343 B-chronic_disease
hepatitis 82 91 1344 1353 I-chronic_disease
C 92 93 1354 1355 I-chronic_disease
or 94 96 1356 1358 O
positive 97 105 1359 1367 O
hepatitis 106 115 1368 1377 O
C 116 117 1378 1379 O
serology 118 126 1380 1388 O

Exposure 0 8 1389 1397 O
to 9 11 1398 1400 O
other 12 17 1401 1406 O
investigational 18 33 1407 1422 B-treatment
drugs 34 39 1423 1428 I-treatment
within 40 46 1429 1435 O
4 47 48 1436 1437 B-upper_bound
weeks 49 54 1438 1443 I-upper_bound
before 55 61 1444 1450 O
enrollment 62 72 1451 1461 O

FEV1 0 4 1462 1466 B-clinical_variable
, 4 5 1466 1467 O
FVC 6 9 1468 1471 B-clinical_variable
and 10 13 1472 1475 O
corrected 14 23 1476 1485 O
DLCO 24 28 1486 1490 B-clinical_variable
> 29 30 1491 1492 O
/= 30 32 1492 1494 O
40 33 35 1495 1497 B-lower_bound
% 35 36 1497 1498 I-lower_bound

Female 0 6 1499 1505 B-gender
subject 7 14 1506 1513 I-gender
is 15 17 1514 1516 O
either 18 24 1517 1523 O
post 25 29 1524 1528 O
- 29 30 1528 1529 O
menopausal 30 40 1529 1539 O
or 41 43 1540 1542 O
surgically 44 54 1543 1553 O
sterilized 55 65 1554 1564 O
or 66 68 1565 1567 O
willing 69 76 1568 1575 B-contraception_consent
to 77 79 1576 1578 I-contraception_consent
use 80 83 1579 1582 I-contraception_consent
an 84 86 1583 1585 I-contraception_consent
acceptable 87 97 1586 1596 I-contraception_consent
method 98 104 1597 1603 I-contraception_consent
of 105 107 1604 1606 I-contraception_consent
birth 108 113 1607 1612 I-contraception_consent
control 114 121 1613 1620 I-contraception_consent
( 122 123 1621 1622 O
i.e. 123 127 1622 1626 O
, 127 128 1626 1627 O
a 129 130 1628 1629 O
hormonal 131 139 1630 1638 B-contraception_consent
contraceptive 140 153 1639 1652 I-contraception_consent
, 153 154 1652 1653 O
intra 155 160 1654 1659 B-contraception_consent
- 160 161 1659 1660 I-contraception_consent
uterine 161 168 1660 1667 I-contraception_consent
device 169 175 1668 1674 I-contraception_consent
, 175 176 1674 1675 O
diaphragm 177 186 1676 1685 B-contraception_consent
with 187 191 1686 1690 I-contraception_consent
spermicide 192 202 1691 1701 I-contraception_consent
, 202 203 1701 1702 O
condom 204 210 1703 1709 B-contraception_consent
with 211 215 1710 1714 I-contraception_consent
spermicide 216 226 1715 1725 I-contraception_consent
, 226 227 1725 1726 O
or 228 230 1727 1729 O
abstinence 231 241 1730 1740 B-contraception_consent
) 241 242 1740 1741 O
for 243 246 1742 1745 O
the 247 250 1746 1749 O
duration 251 259 1750 1758 O
of 260 262 1759 1761 O
the 263 266 1762 1765 O
study 267 272 1766 1771 O
. 272 273 1771 1772 O
Male 274 278 1773 1777 B-gender
subject 279 286 1778 1785 I-gender
agrees 287 293 1786 1792 B-contraception_consent
to 294 296 1793 1795 I-contraception_consent
use 297 300 1796 1799 I-contraception_consent
an 301 303 1800 1802 I-contraception_consent
acceptable 304 314 1803 1813 I-contraception_consent
method 315 321 1814 1820 I-contraception_consent
for 322 325 1821 1824 I-contraception_consent
contraception 326 339 1825 1838 I-contraception_consent
for 340 343 1839 1842 O
the 344 347 1843 1846 O
duration 348 356 1847 1855 O
of 357 359 1856 1858 O
the 360 363 1859 1862 O
study 364 369 1863 1868 O

Grade 0 5 1869 1874 O
> 6 7 1875 1876 O
/= 7 9 1876 1878 O
3 10 11 1879 1880 B-lower_bound
non 12 15 1881 1884 B-clinical_variable
- 15 16 1884 1885 I-clinical_variable
hematologic 16 27 1885 1896 I-clinical_variable
toxicity 28 36 1897 1905 I-clinical_variable
from 37 41 1906 1910 O
previous 42 50 1911 1919 B-treatment
therapy 51 58 1920 1927 I-treatment
that 59 63 1928 1932 O
has 64 67 1933 1936 O
not 68 71 1937 1940 O
resolved 72 80 1941 1949 O
to 81 83 1950 1952 O
< 84 85 1953 1954 O
/= 85 87 1954 1956 O
grade 88 93 1957 1962 B-upper_bound
1 94 95 1963 1964 I-upper_bound

HIV 0 3 1965 1968 B-chronic_disease
infection 4 13 1969 1978 I-chronic_disease

Hematopoetic 0 12 1979 1991 B-clinical_variable
Transplant 13 23 1992 2002 I-clinical_variable
Co 24 26 2003 2005 I-clinical_variable
- 26 27 2005 2006 I-clinical_variable
Morbidity 27 36 2006 2015 I-clinical_variable
Index 37 42 2016 2021 I-clinical_variable
( 43 44 2022 2023 I-clinical_variable
HCT 44 47 2023 2026 I-clinical_variable
- 47 48 2026 2027 I-clinical_variable
CI 48 50 2027 2029 I-clinical_variable
) 50 51 2029 2030 I-clinical_variable
> 52 53 2031 2032 O
4 53 54 2032 2033 B-lower_bound
unless 55 61 2034 2040 O
deemed 62 68 2041 2047 O
clinically 69 79 2048 2058 O
insignificant 80 93 2059 2072 O
by 94 96 2073 2075 O
primary 97 104 2076 2083 O
investigator 105 117 2084 2096 O
for 118 121 2097 2100 O
patients 122 130 2101 2109 O
receiving 131 140 2110 2119 O
Time 141 145 2120 2124 O
- 145 146 2124 2125 O
Sequential 146 156 2125 2135 O
Busulfan 157 165 2136 2144 B-treatment
( 166 167 2145 2146 O
total 167 172 2146 2151 O
exposure 173 181 2152 2160 O
20000 182 187 2161 2166 O
umol 188 192 2167 2171 O
- 192 193 2171 2172 O
min 193 196 2172 2175 O

Hypertrophic 0 12 2176 2188 B-chronic_disease
cardiomegaly 13 25 2189 2201 I-chronic_disease
or 26 28 2202 2204 O
restrictive 29 40 2205 2216 B-chronic_disease
cardiomyopathy 41 55 2217 2231 I-chronic_disease
from 56 60 2232 2236 O
prior 61 66 2237 2242 B-treatment
treatment 67 76 2243 2252 I-treatment
or 77 79 2253 2255 O
other 80 85 2256 2261 O
causes 86 92 2262 2268 O

Men 0 3 2269 2272 B-gender
and 4 7 2273 2276 I-gender
women 8 13 2277 2282 I-gender
of 14 16 2283 2285 O
reproductive 17 29 2286 2298 O
potential 30 39 2299 2308 O
must 40 44 2309 2313 O
agree 45 50 2314 2319 B-contraception_consent
to 51 53 2320 2322 I-contraception_consent
follow 54 60 2323 2329 I-contraception_consent
accepted 61 69 2330 2338 I-contraception_consent
birth 70 75 2339 2344 I-contraception_consent
control 76 83 2345 2352 I-contraception_consent
methods 84 91 2353 2360 I-contraception_consent
for 92 95 2361 2364 O
the 96 99 2365 2368 O
duration 100 108 2369 2377 O
of 109 111 2378 2380 O
the 112 115 2381 2384 O
study 116 121 2385 2390 O

Myocardial 0 10 2391 2401 B-chronic_disease
infarction 11 21 2402 2412 I-chronic_disease
within 22 28 2413 2419 O
1 29 30 2420 2421 B-upper_bound
year 31 35 2422 2426 I-upper_bound
of 36 38 2427 2429 O
study 39 44 2430 2435 O
entry 45 50 2436 2441 O

Other 0 5 2442 2447 O
significant 6 17 2448 2459 O
EKG 18 21 2460 2463 B-chronic_disease
abnormalities 22 35 2464 2477 I-chronic_disease
including 36 45 2478 2487 O
2nd 46 49 2488 2491 B-chronic_disease
degree 50 56 2492 2498 I-chronic_disease
atrio 57 62 2499 2504 I-chronic_disease
- 62 63 2504 2505 I-chronic_disease
ventricular 63 74 2505 2516 I-chronic_disease
( 75 76 2517 2518 I-chronic_disease
AV 76 78 2518 2520 I-chronic_disease
) 78 79 2520 2521 I-chronic_disease
block 80 85 2522 2527 I-chronic_disease
type 86 90 2528 2532 I-chronic_disease
II 91 93 2533 2535 I-chronic_disease
, 93 94 2535 2536 O
3rd 95 98 2537 2540 B-chronic_disease
degree 99 105 2541 2547 I-chronic_disease
AV 106 108 2548 2550 I-chronic_disease
block 109 114 2551 2556 I-chronic_disease
, 114 115 2556 2557 O
or 116 118 2558 2560 O
bradycardia 119 130 2561 2572 B-chronic_disease
( 131 132 2573 2574 O
ventricular 132 143 2574 2585 B-clinical_variable
rate 144 148 2586 2590 I-clinical_variable
less 149 153 2591 2595 O
than 154 158 2596 2600 O
50 159 161 2601 2603 B-upper_bound
beats 162 167 2604 2609 I-upper_bound
/ 167 168 2609 2610 O
min 168 171 2610 2613 O
) 171 172 2613 2614 O

Patient 0 7 2615 2622 O
with 8 12 2623 2627 O
active 13 19 2628 2634 O
CNS 20 23 2635 2638 B-chronic_disease
disease 24 31 2639 2646 I-chronic_disease

Patients 0 8 2647 2655 O
taking 9 15 2656 2662 O
drugs 16 21 2663 2668 O
leading 22 29 2669 2676 O
to 30 32 2677 2679 O
significant 33 44 2680 2691 O
QT 45 47 2692 2694 B-clinical_variable
prolongation 48 60 2695 2707 I-clinical_variable
where 61 66 2708 2713 O
the 67 70 2714 2717 O
interaction 71 82 2718 2729 O
is 83 85 2730 2732 O
too 86 89 2733 2736 O
great 90 95 2737 2742 O
to 96 98 2743 2745 O
proceed 99 106 2746 2753 O
with 107 111 2754 2758 O
romidepsin 112 122 2759 2769 B-treatment

Pregnancy 0 9 2770 2779 B-pregnancy
( 10 11 2780 2781 O
positive 11 19 2781 2789 O
Beta 20 24 2790 2794 O
HCG 25 28 2795 2798 O
test 29 33 2799 2803 O
in 34 36 2804 2806 O
a 37 38 2807 2808 O
woman 39 44 2809 2814 B-gender
with 45 49 2815 2819 O
child 50 55 2820 2825 O
bearing 56 63 2826 2833 O
potential 64 73 2834 2843 O
defined 74 81 2844 2851 O
as 82 84 2852 2854 O
not 85 88 2855 2858 O
post 89 93 2859 2863 O
- 93 94 2863 2864 O
menopausal 94 104 2864 2874 O
for 105 108 2875 2878 O
12 109 111 2879 2881 O
months 112 118 2882 2888 O
or 119 121 2889 2891 O
no 122 124 2892 2894 O
previous 125 133 2895 2903 B-treatment
surgical 134 142 2904 2912 I-treatment
sterilization 143 156 2913 2926 I-treatment
) 156 157 2926 2927 O
or 158 160 2928 2930 O
currently 161 170 2931 2940 O
breast 171 177 2941 2947 O
- 177 178 2947 2948 O
feeding 178 185 2948 2955 O
. 185 186 2955 2956 O
Pregnancy 187 196 2957 2966 O
testing 197 204 2967 2974 O
is 205 207 2975 2977 O
not 208 211 2978 2981 O
required 212 220 2982 2990 O
for 221 224 2991 2994 O
post 225 229 2995 2999 O
- 229 230 2999 3000 O
menopausal 230 240 3000 3010 O
or 241 243 3011 3013 O
surgically 244 254 3014 3024 B-treatment
sterilized 255 265 3025 3035 I-treatment
women 266 271 3036 3041 B-gender

Prior 0 5 3042 3047 B-treatment
autologous 6 16 3048 3058 I-treatment
SCT 17 20 3059 3062 I-treatment
in 21 23 3063 3065 O
the 24 27 3066 3069 O
prior 28 33 3070 3075 B-upper_bound
12 34 36 3076 3078 I-upper_bound
months 37 43 3079 3085 I-upper_bound

Prior 0 5 3086 3091 B-treatment
whole 6 11 3092 3097 I-treatment
brain 12 17 3098 3103 I-treatment
irradiation 18 29 3104 3115 I-treatment

Radiation 0 9 3116 3125 B-treatment
therapy 10 17 3126 3133 I-treatment
to 18 20 3134 3136 O
head 21 25 3137 3141 O
and 26 29 3142 3145 O
neck 30 34 3146 3150 O
( 35 36 3151 3152 O
excluding 36 45 3152 3161 O
eyes 46 50 3162 3166 O
) 50 51 3166 3167 O
, 51 52 3167 3168 O
and 53 56 3169 3172 O
internal 57 65 3173 3181 O
organs 66 72 3182 3188 O
of 73 75 3189 3191 O
chest 76 81 3192 3197 O
, 81 82 3197 3198 O
abdomen 83 90 3199 3206 O
or 91 93 3207 3209 O
pelvis 94 100 3210 3216 O
in 101 103 3217 3219 O
the 104 107 3220 3223 O
month 108 113 3224 3229 O
prior 114 119 3230 3235 O
to 120 122 3236 3238 O
enrollment 123 133 3239 3249 O

Subjects 0 8 3250 3258 O
with 9 13 3259 3263 O
a 14 15 3264 3265 O
history 16 23 3266 3273 O
of 24 26 3274 3276 O
myocardial 27 37 3277 3287 B-clinical_variable
infarction 38 48 3288 3298 I-clinical_variable
between 49 56 3299 3306 O
6 57 58 3307 3308 B-lower_bound
and 59 62 3309 3312 O
12 63 65 3313 3315 B-upper_bound
months 66 72 3316 3322 I-upper_bound
prior 73 78 3323 3328 I-upper_bound
to 79 81 3329 3331 O
study 82 87 3332 3337 O
entry 88 93 3338 3343 O
who 94 97 3344 3347 O
are 98 101 3348 3351 O
asymptomatic 102 114 3352 3364 O
and 115 118 3365 3368 O
have 119 123 3369 3373 O
had 124 127 3374 3377 O
a 128 129 3378 3379 O
negative 130 138 3380 3388 O
cardiac 139 146 3389 3396 O
risk 147 151 3397 3401 O
assessment 152 162 3402 3412 O
( 163 164 3413 3414 O
treadmill 164 173 3414 3423 O
stress 174 180 3424 3430 O
test 181 185 3431 3435 O
, 185 186 3435 3436 O
nuclear 187 194 3437 3444 O
medicine 195 203 3445 3453 O
stress 204 210 3454 3460 O
test 211 215 3461 3465 O
, 215 216 3465 3466 O
or 217 219 3467 3469 O
stress 220 226 3470 3476 O
echocardiogram 227 241 3477 3491 O
) 241 242 3491 3492 O
since 243 248 3493 3498 O
the 249 252 3499 3502 O
event 253 258 3503 3508 O
may 259 262 3509 3512 O
participate 263 274 3513 3524 O

Uncontrolled 0 12 3525 3537 B-chronic_disease
hypertension 13 25 3538 3550 I-chronic_disease
, 25 26 3550 3551 O
i.e. 27 31 3552 3556 O
, 31 32 3556 3557 O
blood 33 38 3558 3563 B-clinical_variable
pressure 39 47 3564 3572 I-clinical_variable
( 48 49 3573 3574 I-clinical_variable
BP 49 51 3574 3576 I-clinical_variable
) 51 52 3576 3577 I-clinical_variable
of 53 55 3578 3580 O
> 56 57 3581 3582 O
/= 57 59 3582 3584 O
160/95 60 66 3585 3591 B-lower_bound
; 66 67 3591 3592 O
patients 68 76 3593 3601 O
who 77 80 3602 3605 O
have 81 85 3606 3610 O
a 86 87 3611 3612 O
history 88 95 3613 3620 O
of 96 98 3621 3623 O
hypertension 99 111 3624 3636 O
controlled 112 122 3637 3647 O
by 123 125 3648 3650 O
medication 126 136 3651 3661 B-treatment
must 137 141 3662 3666 O
be 142 144 3667 3669 O
on 145 147 3670 3672 O
a 148 149 3673 3674 O
stable 150 156 3675 3681 O
dose 157 161 3682 3686 O
and 162 165 3687 3690 O
meet 166 170 3691 3695 O
all 171 174 3696 3699 O
other 175 180 3700 3705 O
inclusion 181 190 3706 3715 O
criteria 191 199 3716 3724 O

stable 0 6 3725 3731 O
doses 7 12 3732 3737 O
of 13 15 3738 3740 O
beta 16 20 3741 3745 B-treatment
- 20 21 3745 3746 I-treatment
blockers 21 29 3746 3754 I-treatment

As 0 2 0 2 O
a 3 4 3 4 O
rule 5 9 5 9 O
of 10 12 10 12 O
thumb 13 18 13 18 O
, 18 19 18 19 O
DAS 20 23 20 23 B-clinical_variable
scores 24 30 24 30 I-clinical_variable
of 31 33 31 33 O
9 34 35 34 35 B-lower_bound
or 36 38 36 38 O
higher 39 45 39 45 O
result 46 52 46 52 O
in 53 55 53 55 O
automatic 56 65 56 65 O
exclusion 66 75 66 75 O
from 76 80 76 80 O
the 81 84 81 84 O
study 85 90 85 90 O

If 0 2 91 93 O
a 3 4 94 95 O
potential 5 14 96 105 O
participant 15 26 106 117 O
reports 27 34 118 125 O
a 35 36 126 127 O
prior 37 42 128 133 O
history 43 50 134 141 O
of 51 53 142 144 O
IPV 54 57 145 148 B-treatment
, 57 58 148 149 O
s 59 60 150 151 O
/ 60 61 151 152 O
he 61 63 152 154 O
may 64 67 155 158 O
still 68 73 159 164 O
be 74 76 165 167 O
eligible 77 85 168 176 O
for 86 89 177 180 O
participation 90 103 181 194 O
pending 104 111 195 202 O
a 112 113 203 204 O
more 114 118 205 209 O
detailed 119 127 210 218 O
assessment 128 138 219 229 O
completed 139 148 230 239 O
by 149 151 240 242 O
trained 152 159 243 250 O
project 160 167 251 258 O
staff 168 173 259 264 O
using 174 179 265 270 O
the 180 183 271 274 O
Danger 184 190 275 281 O
Assessment 191 201 282 292 O
Scale 202 207 293 298 O
( 208 209 299 300 O
Campbell 209 217 300 308 O
, 217 218 308 309 O
2003 219 223 310 314 O
) 223 224 314 315 O

pregnancy 0 9 316 325 B-pregnancy
is 10 12 326 328 O
the 13 16 329 332 O
mother 17 23 333 339 O
's 23 25 339 341 O
first 26 31 342 347 O
with 32 36 348 352 O
the 37 40 353 356 O
baby 41 45 357 361 O
's 45 47 361 363 O
father 48 54 364 370 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,000 35 40 35 40 B-lower_bound
mm^3 41 45 41 45 I-lower_bound
Platelet 46 54 46 54 B-clinical_variable
count 55 60 55 60 I-clinical_variable
> 61 62 61 62 O
= 62 63 62 63 O
75,000 64 70 64 70 B-lower_bound
/ 70 71 70 71 I-lower_bound
mm^3 71 75 71 75 I-lower_bound

Active 0 6 76 82 O
hepatitis 7 16 83 92 B-chronic_disease
A 17 18 93 94 I-chronic_disease
, 18 19 94 95 I-chronic_disease
B 20 21 96 97 I-chronic_disease
or 22 24 98 100 I-chronic_disease
C 25 26 101 102 I-chronic_disease
virus 27 32 103 108 B-chronic_disease
infection 33 42 109 118 I-chronic_disease
, 42 43 118 119 O
or 44 46 120 122 O
known 47 52 123 128 O
human 53 58 129 134 B-chronic_disease
immunodeficiency 59 75 135 151 I-chronic_disease
virus 76 81 152 157 I-chronic_disease
( 82 83 158 159 I-chronic_disease
HIV 83 86 159 162 I-chronic_disease
) 86 87 162 163 I-chronic_disease
positive 88 96 164 172 O

Administration 0 14 173 187 O
or 15 17 188 190 O
planned 18 25 191 198 O
administration 26 40 199 213 O
of 41 43 214 216 O
any 44 47 217 220 O
other 48 53 221 226 O
concomitant 54 65 227 238 O
chemotherapy 66 78 239 251 B-treatment
, 78 79 251 252 O
immunotherapy 80 93 253 266 B-treatment
, 93 94 266 267 O
radiotherapy 95 107 268 280 B-treatment
, 107 108 280 281 O
or 109 111 282 284 O
any 112 115 285 288 O
ancillary 116 125 289 298 B-treatment
therapy 126 133 299 306 I-treatment
which 134 139 307 312 O
would 140 145 313 318 O
be 146 148 319 321 O
considered 149 159 322 332 O
a 160 161 333 334 O
treatment 162 171 335 344 B-treatment
of 172 174 345 347 O
multiple 175 183 348 356 B-cancer
myeloma 184 191 357 364 I-cancer
until 192 197 365 370 O
Day 198 201 371 374 O
+28 202 205 375 378 O
post 206 210 379 383 B-treatment
- 210 211 383 384 I-treatment
transplant 211 221 384 394 I-treatment
through 222 229 395 402 O
discontinuation 230 245 403 418 O
from 246 250 419 423 O
study 251 256 424 429 O

All 0 3 430 433 O
patients 4 12 434 442 O
must 13 17 443 447 O
be 18 20 448 450 O
counseled 21 30 451 460 O
at 31 33 461 463 O
a 34 35 464 465 O
minimum 36 43 466 473 O
of 44 46 474 476 O
every 47 52 477 482 O
28 53 55 483 485 B-lower_bound
days 56 60 486 490 I-lower_bound
about 61 66 491 496 O
pregnancy 67 76 497 506 B-pregnancy
precautions 77 88 507 518 O
and 89 92 519 522 O
risks 93 98 523 528 O
of 99 101 529 531 O
fetal 102 107 532 537 O
exposure 108 116 538 546 O

Any 0 3 547 550 O
serious 4 11 551 558 O
medical 12 19 559 566 B-chronic_disease
or 20 22 567 569 O
psychiatric 23 34 570 581 B-chronic_disease
illness 35 42 582 589 I-chronic_disease
that 43 47 590 594 O
could 48 53 595 600 O
, 53 54 600 601 O
in 55 57 602 604 O
the 58 61 605 608 O
investigator 62 74 609 621 O
's 74 76 621 623 O
opinion 77 84 624 631 O
, 84 85 631 632 O
potentially 86 97 633 644 O
interfere 98 107 645 654 O
with 108 112 655 659 O
the 113 116 660 663 O
completion 117 127 664 674 O
of 128 130 675 677 O
treatment 131 140 678 687 B-treatment
according 141 150 688 697 O
to 151 153 698 700 O
this 154 158 701 705 O
protocol 159 167 706 714 O

Between 0 7 715 722 O
the 8 11 723 726 O
ages 12 16 727 731 B-age
of 17 19 732 734 O
18 20 22 735 737 B-lower_bound
and 23 26 738 741 O
70 27 29 742 744 B-upper_bound
years 30 35 745 750 I-upper_bound
of 36 38 751 753 O
age 39 42 754 757 O
( 43 44 758 759 O
inclusive 44 53 759 768 O
) 53 54 768 769 O
at 55 57 770 772 O
time 58 62 773 777 O
of 63 65 778 780 O
enrollment 66 76 781 791 O

Cardiac 0 7 792 799 B-chronic_disease
syncope 8 15 800 807 I-chronic_disease

Concurrent 0 10 808 818 O
hematologic 11 22 819 830 B-cancer
or 23 25 831 833 O
non 26 29 834 837 B-cancer
- 29 30 837 838 I-cancer
hematologic 30 41 838 849 I-cancer
malignancy 42 52 850 860 I-cancer
requiring 53 62 861 870 O
treatment 63 72 871 880 B-treatment

Eastern 0 7 881 888 B-clinical_variable
Cooperative 8 19 889 900 I-clinical_variable
Oncology 20 28 901 909 I-clinical_variable
Group 29 34 910 915 I-clinical_variable
( 35 36 916 917 I-clinical_variable
ECOG 36 40 917 921 I-clinical_variable
) 40 41 921 922 I-clinical_variable
performance 42 53 923 934 I-clinical_variable
status 54 60 935 941 I-clinical_variable
and/or 61 67 942 948 O
other 68 73 949 954 O
performance 74 85 955 966 O
status 86 92 967 973 O
0 93 94 974 975 O
, 94 95 975 976 O
1 96 97 977 978 O
, 97 98 978 979 O
or 99 101 980 982 O

Evidence 0 8 983 991 O
of 9 11 992 994 O
MM 12 14 995 997 B-cancer
disease 15 22 998 1005 O
progression 23 34 1006 1017 O
any 35 38 1018 1021 O
time 39 43 1022 1026 O
prior 44 49 1027 1032 O
to 50 52 1033 1035 O
enrollment 53 63 1036 1046 O

Female 0 6 1047 1053 B-gender
patients 7 15 1054 1062 I-gender
who 16 19 1063 1066 O
are 20 23 1067 1070 O
lactating 24 33 1071 1080 O
or 34 36 1081 1083 O
have 37 41 1084 1088 O
a 42 43 1089 1090 O
positive 44 52 1091 1099 B-pregnancy
serum 53 58 1100 1105 I-pregnancy
pregnancy 59 68 1106 1115 I-pregnancy
test 69 73 1116 1120 O
during 74 80 1121 1127 O
the 81 84 1128 1131 O
screening 85 94 1132 1141 O
period 95 101 1142 1148 O

Grade 0 5 1149 1154 B-clinical_variable
> 6 7 1155 1156 O
= 7 8 1156 1157 O
3 9 10 1158 1159 O
peripheral 11 21 1160 1170 O
neuropathy 22 32 1171 1181 O

Histologically 0 14 1182 1196 O
confirmed 15 24 1197 1206 O
diagnosis 25 34 1207 1216 O
of 35 37 1217 1219 O
symptomatic 38 49 1220 1231 O
multiple 50 58 1232 1240 B-cancer
myeloma 59 66 1241 1248 I-cancer

History 0 7 1249 1256 O
of 8 10 1257 1259 O
plasma 11 17 1260 1266 B-cancer
cell 18 22 1267 1271 I-cancer
leukemia 23 31 1272 1280 I-cancer
or 32 34 1281 1283 O
MM 35 37 1284 1286 B-cancer
CNS 38 41 1287 1290 I-cancer
involvement 42 53 1291 1302 O

Infection 0 9 1303 1312 B-chronic_disease
requiring 10 19 1313 1322 O
systemic 20 28 1323 1331 B-treatment
antibiotic 29 39 1332 1342 I-treatment
therapy 40 47 1343 1350 I-treatment
or 48 50 1351 1353 O
other 51 56 1354 1359 O
serious 57 64 1360 1367 O
infection 65 74 1368 1377 B-chronic_disease
within 75 81 1378 1384 O
14 82 84 1385 1387 B-upper_bound
days 85 89 1388 1392 I-upper_bound
prior 90 95 1393 1398 I-upper_bound
to 96 98 1399 1401 O
start 99 104 1402 1407 O
of 105 107 1408 1410 O
study 108 113 1411 1416 O
treatment 114 123 1417 1426 B-treatment

Known 0 5 1427 1432 O
GI 6 8 1433 1435 B-chronic_disease
disease 9 16 1436 1443 I-chronic_disease
or 17 19 1444 1446 O
GI 20 22 1447 1449 B-treatment
procedure 23 32 1450 1459 I-treatment
that 33 37 1460 1464 O
could 38 43 1465 1470 O
interfere 44 53 1471 1480 O
with 54 58 1481 1485 O
the 59 62 1486 1489 O
oral 63 67 1490 1494 O
absorption 68 78 1495 1505 O
or 79 81 1506 1508 O
tolerance 82 91 1509 1518 O
of 92 94 1519 1521 O
ixazomib 95 103 1522 1530 B-treatment

Known 0 5 1531 1536 O
allergy 6 13 1537 1544 O
to 14 16 1545 1547 O
any 17 20 1548 1551 O
of 21 23 1552 1554 O
the 24 27 1555 1558 O
study 28 33 1559 1564 B-allergy_name
medications 34 45 1565 1576 I-allergy_name
, 45 46 1576 1577 O
their 47 52 1578 1583 O
analogues 53 62 1584 1593 O
, 62 63 1593 1594 O
or 64 66 1595 1597 O
excipients 67 77 1598 1608 O
in 78 80 1609 1611 O
the 81 84 1612 1615 O
various 85 92 1616 1623 O
formulations 93 105 1624 1636 O
of 106 108 1637 1639 O
any 109 112 1640 1643 O
agent 113 118 1644 1649 O

Major 0 5 1650 1655 B-treatment
surgery 6 13 1656 1663 I-treatment
within 14 20 1664 1670 O
14 21 23 1671 1673 B-upper_bound
days 24 28 1674 1678 I-upper_bound
prior 29 34 1679 1684 I-upper_bound
to 35 37 1685 1687 O
start 38 43 1688 1693 O
of 44 46 1694 1696 O
study 47 52 1697 1702 O
treatment 53 62 1703 1712 B-treatment

Participation 0 13 1713 1726 O
in 14 16 1727 1729 O
other 17 22 1730 1735 O
clinical 23 31 1736 1744 B-treatment
trials 32 38 1745 1751 I-treatment
, 38 39 1751 1752 O
including 40 49 1753 1762 O
those 50 55 1763 1768 O
with 56 60 1769 1773 O
other 61 66 1774 1779 O
investigational 67 82 1780 1795 B-treatment
agents 83 89 1796 1802 I-treatment
not 90 93 1803 1806 O
included 94 102 1807 1815 O
in 103 105 1816 1818 O
this 106 110 1819 1823 O
trial 111 116 1824 1829 O
, 116 117 1829 1830 O
within 118 124 1831 1837 O
30 125 127 1838 1840 B-upper_bound
days 128 132 1841 1845 I-upper_bound
prior 133 138 1846 1851 I-upper_bound
to 139 141 1852 1854 O
start 142 147 1855 1860 O
of 148 150 1861 1863 O
study 151 156 1864 1869 B-treatment
treatment 157 166 1870 1879 I-treatment
and 167 170 1880 1883 O
throughout 171 181 1884 1894 O
the 182 185 1895 1898 O
duration 186 194 1899 1907 O
of 195 197 1908 1910 O
this 198 202 1911 1915 O
trial 203 208 1916 1921 O

Patients 0 8 1922 1930 O
may 9 12 1931 1934 O
be 13 15 1935 1937 O
on 16 18 1938 1940 O
corticosteroids 19 34 1941 1956 B-treatment
if 35 37 1957 1959 O
they 38 42 1960 1964 O
are 43 46 1965 1968 O
being 47 52 1969 1974 O
given 53 58 1975 1980 O
for 59 62 1981 1984 O
disorders 63 72 1985 1994 O
other 73 78 1995 2000 O
than 79 83 2001 2005 O
multiple 84 92 2006 2014 B-cancer
myeloma 93 100 2015 2022 I-cancer
( 101 102 2023 2024 O
e.g. 102 106 2024 2028 O
, 106 107 2028 2029 O
adrenal 108 115 2030 2037 B-chronic_disease
insufficiency 116 129 2038 2051 I-chronic_disease
, 129 130 2051 2052 O
rheumatoid 131 141 2053 2063 B-chronic_disease
arthritis 142 151 2064 2073 I-chronic_disease
, 151 152 2073 2074 O
etc 153 156 2075 2078 O
. 156 157 2078 2079 O
) 157 158 2079 2080 O

Patients 0 8 2081 2089 O
with 9 13 2090 2094 O
multiple 14 22 2095 2103 O
myeloma 23 30 2104 2111 B-cancer
with 31 35 2112 2116 O
secondary 36 45 2117 2126 O
amyloidosis 46 57 2127 2138 B-chronic_disease

Per 0 3 2139 2142 O
standard 4 12 2143 2151 O
Revlimid 13 21 2152 2160 B-treatment
REMS 22 26 2161 2165 I-treatment
program 27 34 2166 2173 I-treatment
requirements 35 47 2174 2186 O
, 47 48 2186 2187 O
all 49 52 2188 2191 O
physicians 53 63 2192 2202 O
who 64 67 2203 2206 O
prescribe 68 77 2207 2216 O
lenalidomide 78 90 2217 2229 B-treatment
for 91 94 2230 2233 O
research 95 103 2234 2242 O
subjects 104 112 2243 2251 O
enrolled 113 121 2252 2260 O
into 122 126 2261 2265 O
this 127 131 2266 2270 O
trial 132 137 2271 2276 O
, 137 138 2276 2277 O
must 139 143 2278 2282 O
be 144 146 2283 2285 O
registered 147 157 2286 2296 O
in 158 160 2297 2299 O
, 160 161 2299 2300 O
and 162 165 2301 2304 O
must 166 170 2305 2309 O
comply 171 177 2310 2316 O
with 178 182 2317 2321 O
, 182 183 2321 2322 O
all 184 187 2323 2326 O
requirements 188 200 2327 2339 O
of 201 203 2340 2342 O
the 204 207 2343 2346 O
Revlimid 208 216 2347 2355 O
REMS 217 221 2356 2360 O
program 222 229 2361 2368 O

Prior 0 5 2369 2374 B-treatment
organ 6 11 2375 2380 I-treatment
transplant 12 22 2381 2391 I-treatment
requiring 23 32 2392 2401 O
immunosuppressive 33 50 2402 2419 B-treatment
therapy 51 58 2420 2427 I-treatment

Progression 0 11 2428 2439 O
from 12 16 2440 2444 O
smoldering 17 27 2445 2455 O
/ 27 28 2455 2456 O
asymptomatic 28 40 2456 2468 O
MM 41 43 2469 2471 B-cancer
to 44 46 2472 2474 O
symptomatic 47 58 2475 2486 O
MM 59 61 2487 2489 O

Received 0 8 2490 2498 O
at 9 11 2499 2501 O
least 12 17 2502 2507 O
two 18 21 2508 2511 B-lower_bound
cycles 22 28 2512 2518 O
of 29 31 2519 2521 O
any 32 35 2522 2525 O
regimen 36 43 2526 2533 B-treatment
as 44 46 2534 2536 O
initial 47 54 2537 2544 O
systemic 55 63 2545 2553 B-treatment
therapy 64 71 2554 2561 I-treatment
for 72 75 2562 2565 O
multiple 76 84 2566 2574 B-cancer
myeloma 85 92 2575 2582 I-cancer
and 93 96 2583 2586 O
are 97 100 2587 2590 O
within 101 107 2591 2597 O
2 108 109 2598 2599 B-lower_bound
- 109 110 2599 2600 O
16 110 112 2600 2602 B-upper_bound
months 113 119 2603 2609 I-upper_bound
of 120 122 2610 2612 O
the 123 126 2613 2616 O
first 127 132 2617 2622 O
dose 133 137 2623 2627 O
of 138 140 2628 2630 O
initial 141 148 2631 2638 B-treatment
therapy 149 156 2639 2646 I-treatment

Should 0 6 2647 2653 O
a 7 8 2654 2655 O
woman 9 14 2656 2661 B-gender
become 15 21 2662 2668 O
pregnant 22 30 2669 2677 B-pregnancy
or 31 33 2678 2680 O
suspect 34 41 2681 2688 B-pregnancy
she 42 45 2689 2692 I-pregnancy
is 46 48 2693 2695 I-pregnancy
pregnant 49 57 2696 2704 I-pregnancy
while 58 63 2705 2710 O
participating 64 77 2711 2724 O
in 78 80 2725 2727 O
this 81 85 2728 2732 O
study 86 91 2733 2738 O
, 91 92 2738 2739 O
she 93 96 2740 2743 O
must 97 101 2744 2748 O
inform 102 108 2749 2755 O
her 109 112 2756 2759 O
treating 113 121 2760 2768 O
physician 122 131 2769 2778 O
immediately 132 143 2779 2790 O

Tandem 0 6 2791 2797 B-treatment
autologous 7 17 2798 2808 I-treatment
transplantation 18 33 2809 2824 I-treatment

This 0 4 2825 2829 O
is 5 7 2830 2832 O
defined 8 15 2833 2840 O
as 16 18 2841 2843 O
either 19 25 2844 2850 O
committing 26 36 2851 2861 B-contraception_consent
to 37 39 2862 2864 I-contraception_consent
continued 40 49 2865 2874 I-contraception_consent
abstinence 50 60 2875 2885 I-contraception_consent
from 61 65 2886 2890 I-contraception_consent
heterosexual 66 78 2891 2903 I-contraception_consent
intercourse 79 90 2904 2915 I-contraception_consent
or 91 93 2916 2918 I-contraception_consent
beginning 94 103 2919 2928 I-contraception_consent
TWO 104 107 2929 2932 I-contraception_consent
acceptable 108 118 2933 2943 I-contraception_consent
methods 119 126 2944 2951 I-contraception_consent
of 127 129 2952 2954 I-contraception_consent
contraception 130 143 2955 2968 I-contraception_consent
( 144 145 2969 2970 O
one 145 148 2970 2973 O
highly 149 155 2974 2980 O
effective 156 165 2981 2990 O
method 166 172 2991 2997 O
and 173 176 2998 3001 O
one 177 180 3002 3005 O
additional 181 191 3006 3016 O
effective 192 201 3017 3026 O
method 202 208 3027 3033 O
AT 209 211 3034 3036 O
THE 212 215 3037 3040 O
SAME 216 220 3041 3045 O
TIME 221 225 3046 3050 O
) 225 226 3050 3051 O
at 227 229 3052 3054 O
least 230 235 3055 3060 O
28 236 238 3061 3063 B-upper_bound
days 239 243 3064 3068 I-upper_bound
prior 244 249 3069 3074 I-lower_bound
to 250 252 3075 3077 O
the 253 256 3078 3081 O
start 257 262 3082 3087 O
of 263 265 3088 3090 O
lenalidomide 266 278 3091 3103 B-treatment
, 278 279 3103 3104 O
for 280 283 3105 3108 O
the 284 287 3109 3112 O
duration 288 296 3113 3121 O
of 297 299 3122 3124 O
study 300 305 3125 3130 O
participation 306 319 3131 3144 O
, 319 320 3144 3145 O
and 321 324 3146 3149 O
for 325 328 3150 3153 O
28 329 331 3154 3156 O
days 332 336 3157 3161 O
following 337 346 3162 3171 O
the 347 350 3172 3175 O
last 351 355 3176 3180 O
dose 356 360 3181 3185 O
of 361 363 3186 3188 O
lenalidomide 364 376 3189 3201 O

Women 0 5 3202 3207 B-gender
of 6 8 3208 3210 O
childbearing 9 21 3211 3223 O
potential 22 31 3224 3233 O
must 32 36 3234 3238 O
also 37 41 3239 3243 O
agree 42 47 3244 3249 O
to 48 50 3250 3252 O
ongoing 51 58 3253 3260 O
pregnancy 59 68 3261 3270 B-pregnancy
testing 69 76 3271 3278 O

Women 0 5 3279 3284 B-gender
of 6 8 3285 3287 O
childbearing 9 21 3288 3300 O
potential 22 31 3301 3310 O
must 32 36 3311 3315 O
follow 37 43 3316 3322 O
pregnancy 44 53 3323 3332 B-pregnancy
testing 54 61 3333 3340 O
requirements 62 74 3341 3353 O
as 75 77 3354 3356 O
outlined 78 86 3357 3365 O
in 87 89 3366 3368 O
the 90 93 3369 3372 O
Revlimid 94 102 3373 3381 O
REMS 103 107 3382 3386 O
program 108 115 3387 3394 O
material 116 124 3395 3403 O

clinically 0 10 3404 3414 O
important 11 20 3415 3424 O
autonomic 21 30 3425 3434 B-chronic_disease
disease 31 38 3435 3442 I-chronic_disease

clinically 0 10 3443 3453 O
significant 11 22 3454 3465 O
repetitive 23 33 3466 3476 O
ventricular 34 45 3477 3488 B-chronic_disease
arrhythmias 46 57 3489 3500 I-chronic_disease
despite 58 65 3501 3508 O
antiarrhythmic 66 80 3509 3523 B-treatment
treatment 81 90 3524 3533 I-treatment

multiple 0 8 3534 3542 B-cancer
myeloma 9 16 3543 3550 I-cancer

myocardial 0 10 3551 3561 B-chronic_disease
infarction 11 21 3562 3572 I-chronic_disease
within 22 28 3573 3579 O
the 29 32 3580 3583 O
previous 33 41 3584 3592 B-upper_bound
six 42 45 3593 3596 I-upper_bound
months 46 52 3597 3603 I-upper_bound

secondary 0 9 3604 3613 B-chronic_disease
amyloidosis 10 21 3614 3625 I-chronic_disease

severe 0 6 3626 3632 O
orthostatic 7 18 3633 3644 B-chronic_disease
hypotension 19 30 3645 3656 I-chronic_disease

uncompensated 0 13 3657 3670 O
NYHA 14 18 3671 3675 B-clinical_variable
Class 19 24 3676 3681 B-lower_bound
3 25 26 3682 3683 I-lower_bound
or 27 29 3684 3686 O
4 30 31 3687 3688 B-upper_bound
congestive 32 42 3689 3699 B-chronic_disease
heart 43 48 3700 3705 I-chronic_disease
failure 49 56 3706 3713 I-chronic_disease

unstable 0 8 3714 3722 B-chronic_disease
angina 9 15 3723 3729 I-chronic_disease
pectoris 16 24 3730 3738 I-chronic_disease

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
21 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

Cardiogenic 0 11 15 26 B-chronic_disease
shock 12 17 27 32 I-chronic_disease
and/or 18 24 33 39 O
need 25 29 40 44 O
for 30 33 45 48 O
mechanical 34 44 49 59 O
/ 44 45 59 60 O
pharmacologic 45 58 60 73 O
hemodynamic 59 70 74 85 O
support 71 78 86 93 O

Inability 0 9 94 103 O
to 10 12 104 106 O
take 13 17 107 111 O
dual 18 22 112 116 O
antiplatelet 23 35 117 129 B-treatment
therapy 36 43 130 137 I-treatment
for 44 47 138 141 O
six 48 51 142 145 B-upper_bound
months 52 58 146 152 I-upper_bound

Known 0 5 153 158 O
left 6 10 159 163 B-clinical_variable
ventricular 11 22 164 175 I-clinical_variable
ejection 23 31 176 184 I-clinical_variable
fraction 32 40 185 193 I-clinical_variable
< 41 42 194 195 O
30 42 44 195 197 B-upper_bound
% 44 45 197 198 I-upper_bound

Left 0 4 199 203 B-chronic_disease
main 5 9 204 208 I-chronic_disease
disease 10 17 209 216 I-chronic_disease
requiring 18 27 217 226 O
revascularization 28 45 227 244 B-treatment

Life 0 4 245 249 B-clinical_variable
expectancy 5 15 250 260 I-clinical_variable
< 16 17 261 262 O
2 18 19 263 264 B-upper_bound
years 20 25 265 270 I-upper_bound

Ongoing 0 7 271 278 O
Non 8 11 279 282 O
STEMI 12 17 283 288 B-chronic_disease
with 18 22 289 293 O
biomarkers 23 33 294 304 O
( 34 35 305 306 O
cardiac 35 42 306 313 O
troponin 43 51 314 322 O
) 51 52 322 323 O
still 53 58 324 329 O
rising 59 65 330 336 O

Patients 0 8 337 345 O
with 9 13 346 350 O
a 14 15 351 352 O
non 16 19 353 356 B-chronic_disease
- 19 20 356 357 I-chronic_disease
dominant 20 28 357 365 I-chronic_disease
right 29 34 366 371 I-chronic_disease
coronary 35 43 372 380 I-chronic_disease
artery 44 50 381 387 I-chronic_disease
may 51 54 388 391 O
be 55 57 392 394 O
included 58 66 395 403 O
if 67 69 404 406 O
only 70 74 407 411 O
the 75 78 412 415 O
left 79 83 416 420 B-clinical_variable
anterior 84 92 421 429 I-clinical_variable
descending 93 103 430 440 I-clinical_variable
artery 104 110 441 447 I-clinical_variable
( 111 112 448 449 I-clinical_variable
LAD 112 115 449 452 I-clinical_variable
) 115 116 452 453 I-clinical_variable
and 117 120 454 457 O
left 121 125 458 462 B-clinical_variable
circumflex 126 136 463 473 I-clinical_variable
have 137 141 474 478 O
≥50 142 145 479 482 O
% 145 146 482 483 I-lower_bound
stenosis 147 155 484 492 O

Pregnancy 0 9 493 502 B-pregnancy

Previous 0 8 503 511 O
CABG 9 13 512 516 B-treatment

Recent 0 6 517 523 O
STEMI 7 12 524 529 B-clinical_variable
( 13 14 530 531 O
< 14 15 531 532 O
5 15 16 532 533 B-upper_bound
days 17 21 534 538 I-upper_bound
prior 22 27 539 544 I-upper_bound
to 28 30 545 547 O
randomization 31 44 548 561 O
) 44 45 561 562 O

Requirement 0 11 563 574 O
for 12 15 575 578 O
other 16 21 579 584 O
cardiac 22 29 585 592 B-treatment
or 30 32 593 595 I-treatment
non 33 36 596 599 I-treatment
- 36 37 599 600 I-treatment
cardiac 37 44 600 607 I-treatment
surgical 45 53 608 616 I-treatment
procedure 54 63 617 626 I-treatment
( 64 65 627 628 O
e.g. 65 69 628 632 O
, 69 70 632 633 O
valve 71 76 634 639 B-treatment
replacement 77 88 640 651 I-treatment
, 88 89 651 652 O
carotid 90 97 653 660 B-treatment
revascularization 98 115 661 678 I-treatment
) 115 116 678 679 O

Requiring 0 9 680 689 O
renal 10 15 690 695 B-treatment
replacement 16 27 696 707 I-treatment
therapy 28 35 708 715 I-treatment

Three 0 5 716 721 B-clinical_variable
vessel 6 12 722 728 I-clinical_variable
CAD 13 16 729 732 I-clinical_variable
, 16 17 732 733 O
defined 18 25 734 741 O
as 26 28 742 744 O
≥ 29 30 745 746 O
50 31 33 747 749 B-lower_bound
% 33 34 749 750 I-lower_bound
diameter 35 43 751 759 I-lower_bound
stenosis 44 52 760 768 O
by 53 55 769 771 O
visual 56 62 772 778 O
estimation 63 73 779 789 O
in 74 76 790 792 O
each 77 81 793 797 O
of 82 84 798 800 O
the 85 88 801 804 O
three 89 94 805 810 O
major 95 100 811 816 O
epicardial 101 111 817 827 O
vessels 112 119 828 835 O
or 120 122 836 838 O
major 123 128 839 844 O
side 129 133 845 849 O
branches 134 142 850 858 O
, 142 143 858 859 O
but 144 147 860 863 O
not 148 151 864 867 O
involving 152 161 868 877 O
left 162 166 878 882 O
main 167 171 883 887 O
coronary 172 180 888 896 O
artery 181 187 897 903 O
, 187 188 903 904 O
and 189 192 905 908 O
amenable 193 201 909 917 O
to 202 204 918 920 O
revascularization 205 222 921 938 B-treatment
by 223 225 939 941 O
both 226 230 942 946 O
PCI 231 234 947 950 B-treatment
and 235 238 951 954 O
CABG 239 243 955 959 B-treatment
as 244 246 960 962 O
determined 247 257 963 973 O
by 258 260 974 976 O
the 261 264 977 980 O
Heart 265 270 981 986 O
Team 271 275 987 991 O

Undergoing 0 10 992 1002 O
evaluation 11 21 1003 1013 O
for 22 25 1014 1017 O
organ 26 31 1018 1023 B-treatment
transplantation 32 47 1024 1039 I-treatment

with 0 4 1040 1044 O
angina 5 11 1045 1051 B-chronic_disease
and/or 12 18 1052 1058 O
evidence 19 27 1059 1067 O
of 28 30 1068 1070 O
myocardial 31 41 1071 1081 B-chronic_disease
ischemia 42 50 1082 1090 I-chronic_disease

21 0 2 0 2 B-lower_bound
- 2 3 2 3 O
65 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
old 12 15 12 15 I-upper_bound

a 0 1 16 17 O
history 2 9 18 25 O
of 10 12 26 28 O
bipolar 13 20 29 36 B-chronic_disease
, 20 21 36 37 O
schizophrenia 22 35 38 51 B-chronic_disease
, 35 36 51 52 O
other 37 42 53 58 O
psychotic 43 52 59 68 B-chronic_disease
disorder 53 61 69 77 I-chronic_disease
, 61 62 77 78 O
or 63 65 79 81 O
dementia 66 74 82 90 B-chronic_disease

consent 0 7 91 98 O
to 8 10 99 101 O
be 11 13 102 104 O
randomized 14 24 105 115 O
to 25 27 116 118 O
active 28 34 119 125 O
or 35 37 126 128 O
sham 38 42 129 133 B-treatment
TNS 43 46 134 137 I-treatment
treatment 47 56 138 147 I-treatment

current 0 7 148 155 O
substance 8 17 156 165 O
abuse 18 23 166 171 O
not 24 27 172 175 O
in 28 30 176 178 O
remission 31 40 179 188 O
for 41 44 189 192 O
at 45 47 193 195 O
least 48 53 196 201 O
3 54 55 202 203 B-lower_bound
months 56 62 204 210 I-lower_bound

current 0 7 211 218 O
suicidal 8 16 219 227 B-chronic_disease
or 17 19 228 230 O
homicidal 20 29 231 240 B-chronic_disease
ideation 30 38 241 249 I-chronic_disease
requiring 39 48 250 259 O
hospitalization 49 64 260 275 O

evidence 0 8 276 284 O
of 9 11 285 287 O
receiving 12 21 288 297 O
antidepressant 22 36 298 312 B-treatment
, 36 37 312 313 O
antianxiety 38 49 314 325 B-treatment
, 49 50 325 326 O
antipsychotic 51 64 327 340 B-treatment
, 64 65 340 341 O
or 66 68 342 344 O
mood 69 73 345 349 B-treatment
- 73 74 349 350 I-treatment
stabilizer 74 84 350 360 I-treatment
medication 85 95 361 371 I-treatment
where 96 101 372 377 O
the 102 105 378 381 O
dose 106 110 382 386 O
has 111 114 387 390 O
not 115 118 391 394 O
been 119 123 395 399 O
stable 124 130 400 406 O
for 131 134 407 410 O
a 135 136 411 412 O
minimum 137 144 413 420 O
of 145 147 421 423 O
six 148 151 424 427 B-lower_bound
weeks 152 157 428 433 I-lower_bound
prior 158 163 434 439 I-lower_bound
to 164 166 440 442 O
entering 167 175 443 451 O
the 176 179 452 455 O
randomization 180 193 456 469 O

evidence 0 8 470 478 O
of 9 11 479 481 O
receiving 12 21 482 491 O
psychosocial 22 34 492 504 B-treatment
or 35 37 505 507 I-treatment
medication 38 48 508 518 I-treatment
treatment 49 58 519 528 I-treatment
through 59 66 529 536 O
a 67 68 537 538 O
clinic 69 75 539 545 O
or 76 78 546 548 O
facility 79 87 549 557 O
other 88 93 558 563 O
than 94 98 564 568 O
the 99 102 569 572 O
VA 103 105 573 575 O
GLA 106 109 576 579 O
PTSD 110 114 580 584 O
Clinic 115 121 585 591 O

have 0 4 592 596 O
completed 5 14 597 606 O
a 15 16 607 608 O
course 17 23 609 615 O
of 24 26 616 618 O
PE 27 29 619 621 B-treatment
therapy 30 37 622 629 I-treatment
in 38 40 630 632 O
the 41 44 633 636 O
Resident 45 53 637 645 O
Psychotherapy 54 67 646 659 O
Program 68 75 660 667 O
in 76 78 668 670 O
the 79 82 671 674 O
PTSD 83 87 675 679 B-chronic_disease
Clinic 88 94 680 686 O
within 95 101 687 693 O
six 102 105 694 697 B-upper_bound
months 106 112 698 704 I-upper_bound
of 113 115 705 707 O
enrollment 116 126 708 718 O

meet 0 4 719 723 O
DSM 5 8 724 727 O
- 8 9 727 728 O
IV 9 11 728 730 O
criteria 12 20 731 739 O
for 21 24 740 743 O
current 25 32 744 751 O
warzone 33 40 752 759 O
- 40 41 759 760 O
related 41 48 760 767 O
PTSD 49 53 768 772 O
with 54 58 773 777 O
a 59 60 778 779 O
duration 61 69 780 788 O
of 70 72 789 791 O
at 73 75 792 794 O
least 76 81 795 800 O
3 82 83 801 802 B-lower_bound
months 84 90 803 809 I-lower_bound

report 0 6 810 816 O
of 7 9 817 819 O
severe 10 16 820 826 O
TBI 17 20 827 830 B-chronic_disease
with 21 25 831 835 O
coma 26 30 836 840 B-clinical_variable
duration 31 39 841 849 I-clinical_variable
( 40 41 850 851 O
30 41 43 851 853 B-lower_bound
minutes 44 51 854 861 I-lower_bound
or 52 54 862 864 O
more 55 59 865 869 O
) 59 60 869 870 O
during 61 67 871 877 O
the 68 71 878 881 O
screening 72 81 882 891 O
interview 82 91 892 901 O
and/or 92 98 902 908 O
duration 99 107 909 917 O
of 108 110 918 920 O
post 111 115 921 925 O

suicide 0 7 926 933 B-chronic_disease
attempt 8 15 934 941 I-chronic_disease
within 16 22 942 948 O
six 23 26 949 952 B-upper_bound
months 27 33 953 959 I-upper_bound

traumatic 0 9 960 969 B-chronic_disease
amnesia 10 17 970 977 I-chronic_disease
( 18 19 978 979 O
1hour 19 24 979 984 B-lower_bound
or 25 27 985 987 O
greater 28 35 988 995 O
) 35 36 995 996 O
on 37 39 997 999 O
the 40 43 1000 1003 O
Post 44 48 1004 1008 B-chronic_disease
- 48 49 1008 1009 I-chronic_disease
traumatic 49 58 1009 1018 I-chronic_disease
Amnesia 59 66 1019 1026 I-chronic_disease
Questionnaire 67 80 1027 1040 O
( 81 82 1041 1042 O
PTAQ 82 86 1042 1046 O
) 86 87 1046 1047 O

with 0 4 1048 1052 O
significant 5 16 1053 1064 O
residual 17 25 1065 1073 O
PTSD 26 30 1074 1078 B-chronic_disease
symptoms 31 39 1079 1087 O
as 40 42 1088 1090 O
evidenced 43 52 1091 1100 O
by 53 55 1101 1103 O
a 56 57 1104 1105 O
CAPS 58 62 1106 1110 B-clinical_variable
score 63 68 1111 1116 I-clinical_variable
> 69 70 1117 1118 O
50 70 72 1118 1120 B-lower_bound

Ambulatory 0 10 0 10 O
male 11 15 11 15 B-gender

Institutionalized 0 17 16 33 O
residents 18 27 34 43 O
with 28 32 44 48 O
subacute 33 41 49 57 O
illnesses 42 51 58 67 O
who 52 55 68 71 O
are 56 59 72 75 O
not 60 63 76 79 O
expected 64 72 80 88 O
to 73 75 89 91 O
survive 76 83 92 99 O
or 84 86 100 102 O
who 87 90 103 106 O
will 91 95 107 111 O
be 96 98 112 114 O
discharged 99 109 115 125 O
in 110 112 126 128 O
< 113 114 129 130 O
2 115 116 131 132 B-upper_bound
years 117 122 133 138 I-upper_bound

Patients 0 8 139 147 O
will 9 13 148 152 O
be 14 16 153 155 O
allowed 17 24 156 163 O
to 25 27 164 166 O
continue 28 36 167 175 O
on 37 39 176 178 O
glucocorticoids 40 55 179 194 B-treatment
and 56 59 195 198 O
anticonvulsants 60 75 199 214 B-treatment
because 76 83 215 222 O
their 84 89 223 228 O
use 90 93 229 232 O
is 94 96 233 235 O
common 97 103 236 242 O
in 104 106 243 245 O
this 107 111 246 250 O
population 112 122 251 261 O

Those 0 5 262 267 O
currently 6 15 268 277 O
on 16 18 278 280 O
therapy 19 26 281 288 B-treatment
( 27 28 289 290 O
including 28 37 290 299 O
bisphosphonate 38 52 300 314 B-treatment
, 52 53 314 315 O
denosumab 54 63 316 325 B-treatment
, 63 64 325 326 O
or 65 67 327 329 O
teriparatide 68 80 330 342 B-treatment
) 80 81 342 343 O
or 82 84 344 346 O
who 85 88 347 350 O
have 89 93 351 355 O
been 94 98 356 360 O
on 99 101 361 363 O
a 102 103 364 365 O
bisphosphonate 104 118 366 380 O
for 119 122 381 384 O
> 123 124 385 386 O
1year 125 130 387 392 B-lower_bound
during 131 137 393 399 O
the 138 141 400 403 O
previous 142 150 404 412 B-upper_bound
2 151 152 413 414 I-upper_bound
years 153 158 415 420 I-upper_bound
because 159 166 421 428 O
some 167 171 429 433 O
bisphosphonates 172 187 434 449 B-treatment
are 188 191 450 453 O
long 192 196 454 458 O
acting 197 203 459 465 O

Those 0 5 466 471 O
on 6 8 472 474 O
glucocorticoids 9 24 475 490 B-treatment
and 25 28 491 494 O
anticonvulsants 29 44 495 510 B-treatment
will 45 49 511 515 O
be 50 52 516 518 O
allowed 53 60 519 526 O
to 61 63 527 529 O
continue 64 72 530 538 O
in 73 75 539 541 O
the 76 79 542 545 O
study 80 85 546 551 O
because 86 93 552 559 O
their 94 99 560 565 O
use 100 103 566 569 O
is 104 106 570 572 O
common 107 113 573 579 O
in 114 116 580 582 O
this 117 121 583 587 O
population 122 132 588 598 O

Those 0 5 599 604 O
on 6 8 605 607 O
hormone 9 16 608 615 B-treatment
replacement 17 28 616 627 I-treatment
therapy 29 36 628 635 I-treatment
( 37 38 636 637 I-treatment
HRT 38 41 637 640 I-treatment
) 41 42 640 641 I-treatment
, 42 43 641 642 O
raloxifene 44 54 643 653 B-treatment
, 54 55 653 654 O
or 56 58 655 657 O
prescribed 59 69 658 668 B-treatment
protective 70 80 669 679 I-treatment
hip 81 84 680 683 I-treatment
pads 85 89 684 688 I-treatment
by 90 92 689 691 O
their 93 98 692 697 O
Primary 99 106 698 705 O
Care 107 111 706 710 O
Physician 112 121 711 720 O
( 122 123 721 722 O
PCP 123 126 722 725 O
) 126 127 725 726 O
will 128 132 727 731 O
be 133 135 732 734 O
allowed 136 143 735 742 O
to 144 146 743 745 O
participate 147 158 746 757 O
and 159 162 758 761 O
continue 163 171 762 770 O
on 172 174 771 773 O
these 175 180 774 779 O
therapies 181 190 780 789 B-treatment

Those 0 5 790 795 O
with 6 10 796 800 O
a 11 12 801 802 O
history 13 20 803 810 O
of 21 23 811 813 O
hypocalcemia 24 36 814 826 O
or 37 39 827 829 O
contraindication 40 56 830 846 O
for 57 60 847 850 O
treatment 61 70 851 860 B-treatment

Those 0 5 861 866 O
with 6 10 867 871 O
vitamin 11 18 872 879 B-clinical_variable
D 19 20 880 881 I-clinical_variable
levels 21 27 882 888 I-clinical_variable
< 28 29 889 890 O
25ng 30 34 891 895 B-upper_bound
/ 34 35 895 896 I-upper_bound
mL 35 37 896 898 I-upper_bound
will 38 42 899 903 O
be 43 45 904 906 O
treated 46 53 907 914 O
with 54 58 915 919 O
vitamin 59 66 920 927 O
D 67 68 928 929 O
50,000 69 75 930 936 O
IU 76 78 937 939 O
/ 78 79 939 940 O
wk 79 81 940 942 O
for 82 85 943 946 O
8 86 87 947 948 O
weeks 88 93 949 954 O

We 0 2 955 957 O
will 3 7 958 962 O
suggest 8 15 963 970 O
that 16 20 971 975 O
participants 21 33 976 988 O
stop 34 38 989 993 O
long 39 43 994 998 O
- 43 44 998 999 O
term 44 48 999 1003 O
calcitonin 49 59 1004 1014 B-clinical_variable
as 60 62 1015 1017 O
it 63 65 1018 1020 O
has 66 69 1021 1024 O
been 70 74 1025 1029 O
discontinued 75 87 1030 1042 O
in 88 90 1043 1045 O
Europe 91 97 1046 1052 O
due 98 101 1053 1056 O
to 102 104 1057 1059 O
cancer 105 111 1060 1066 B-cancer
concerns 112 120 1067 1075 O

Would 0 5 1076 1081 O
be 6 8 1082 1084 O
treated 9 16 1085 1092 O
based 17 22 1093 1098 O
on 23 25 1099 1101 O
FRAX 26 30 1102 1106 O
® 30 31 1106 1107 O
and 32 35 1108 1111 O
the 36 39 1112 1115 O
National 40 48 1116 1124 O
Osteoporosis 49 61 1125 1137 O
Foundation 62 72 1138 1148 O
( 73 74 1149 1150 O
NOF 74 77 1150 1153 O
) 77 78 1153 1154 O
treatment 79 88 1155 1164 O
thresholds 89 99 1165 1175 O
of 100 102 1176 1178 O
a 103 104 1179 1180 O
10 105 107 1181 1183 O
year 108 112 1184 1188 O
risk 113 117 1189 1193 O
of 118 120 1194 1196 O
≥ 121 122 1197 1198 O
20 123 125 1199 1201 B-lower_bound
% 125 126 1201 1202 I-lower_bound
for 127 130 1203 1206 O
a 131 132 1207 1208 O
major 133 138 1209 1214 O
fracture 139 147 1215 1223 O
or 148 150 1224 1226 O
≥ 151 152 1227 1228 O
3 153 154 1229 1230 B-lower_bound
% 154 155 1230 1231 I-lower_bound
for 156 159 1232 1235 O
hip 160 163 1236 1239 O
fracture 164 172 1240 1248 O
suing 173 178 1249 1254 O
femoral 179 186 1255 1262 O
neck 187 191 1263 1267 O
BMD 192 195 1268 1271 O

by 0 2 1272 1274 O
bone 3 7 1275 1279 O
density 8 15 1280 1287 O
[ 16 17 1288 1289 O
spine 17 22 1289 1294 O
, 22 23 1294 1295 O
hip 24 27 1296 1299 O
or 28 30 1300 1302 O
forearm 31 38 1303 1310 O
Bone 39 43 1311 1315 B-clinical_variable
Mineral 44 51 1316 1323 I-clinical_variable
Density 52 59 1324 1331 I-clinical_variable
( 60 61 1332 1333 I-clinical_variable
BMD 61 64 1333 1336 I-clinical_variable
) 64 65 1336 1337 I-clinical_variable
T 66 67 1338 1339 I-clinical_variable
- 67 68 1339 1340 I-clinical_variable
score 68 73 1340 1345 I-clinical_variable
≤ 74 75 1346 1347 O
-2.5 76 80 1348 1352 B-upper_bound
] 80 81 1352 1353 O

residents 0 9 1354 1363 O
with 10 14 1364 1368 O
osteoporosis 15 27 1369 1381 B-chronic_disease
or 28 30 1382 1384 O
low 31 34 1385 1388 B-chronic_disease
bone 35 39 1389 1393 I-chronic_disease
mass 40 44 1394 1398 I-chronic_disease
( 45 46 1399 1400 O
at 46 48 1400 1402 O
risk 49 53 1403 1407 O
for 54 57 1408 1411 O
fracture 58 66 1412 1420 O
) 66 67 1420 1421 O
ages 68 72 1422 1426 B-age
65 73 75 1427 1429 B-lower_bound
and 76 79 1430 1433 O
older 80 85 1434 1439 O

Patient 0 7 0 7 O
must 8 12 8 12 O
be 13 15 13 15 O
willing 16 23 16 23 B-contraception_consent
to 24 26 24 26 I-contraception_consent
use 27 30 27 30 I-contraception_consent
effective 31 40 31 40 I-contraception_consent
contraception 41 54 41 54 I-contraception_consent
if 55 57 55 57 O
female 58 64 58 64 B-gender
with 65 69 65 69 O
reproductive 70 82 70 82 O
capability 83 93 83 93 O

Patients 0 8 94 102 O
can 9 12 103 106 O
not 12 15 106 109 O
tolerate 16 24 110 118 O
concurrent 25 35 119 129 O
chemotherapy 36 48 130 142 B-treatment

Patients 0 8 143 151 O
must 9 13 152 156 O
be 14 16 157 159 O
18 17 19 160 162 B-lower_bound
years 20 25 163 168 I-lower_bound
of 26 28 169 171 O
age 29 32 172 175 B-age
or 33 35 176 178 O
older 36 41 179 184 O

Patients 0 8 185 193 O
must 9 13 194 198 O
have 14 18 199 203 O
FDG 19 22 204 207 O
- 22 23 207 208 O
avid 23 27 208 212 O
and 28 31 213 216 O
pathologically 32 46 217 231 O
proven 47 53 232 238 O
Stage 54 59 239 244 B-lower_bound
IIA 60 63 245 248 I-lower_bound
- 63 64 248 249 O
IIIB 64 68 249 253 B-upper_bound
non 69 72 254 257 B-cancer
- 72 73 257 258 I-cancer
small 73 78 258 263 I-cancer
cell 79 83 264 268 I-cancer
lung 84 88 269 273 I-cancer
cancer 89 95 274 280 I-cancer

Patients 0 8 281 289 O
with 9 13 290 294 O
any 14 17 295 298 O
component 18 27 299 308 O
of 28 30 309 311 O
small 31 36 312 317 B-cancer
cell 37 41 318 322 I-cancer
lung 42 46 323 327 I-cancer
carcinoma 47 56 328 337 I-cancer

Patients 0 8 338 346 O
with 9 13 347 351 O
evidence 14 22 352 360 O
of 23 25 361 363 O
a 26 27 364 365 O
malignant 28 37 366 375 B-cancer
pleural 38 45 376 383 I-cancer
or 46 48 384 386 I-cancer
pericardial 49 60 387 398 I-cancer
effusion 61 69 399 407 I-cancer

Pregnant 0 8 408 416 B-pregnancy
women 9 14 417 422 B-gender

Prior 0 5 423 428 B-treatment
radiotherapy 6 18 429 441 I-treatment
to 19 21 442 444 O
the 22 25 445 448 O
thorax 26 32 449 455 O
such 33 37 456 460 O
that 38 42 461 465 O
composite 43 52 466 475 O
radiation 53 62 476 485 B-treatment
would 63 68 486 491 O
significantly 69 82 492 505 O
overdose 83 91 506 514 O
critical 92 100 515 523 O
structures 101 111 524 534 O
, 111 112 534 535 O
either 113 119 536 542 O
per 120 123 543 546 O
estimation 124 134 547 557 O
of 135 137 558 560 O
the 138 141 561 564 O
treating 142 150 565 573 O
radiation 151 160 574 583 O
oncologist 161 171 584 594 O
or 172 174 595 597 O
defined 175 182 598 605 O
by 183 185 606 608 O
failure 186 193 609 616 O
to 194 196 617 619 O
meet 197 201 620 624 O
normal 202 208 625 631 O
tissue 209 215 632 638 O
tolerance 216 225 639 648 O
constraints 226 237 649 660 O

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
years 7 12 7 12 I-lower_bound

Any 0 3 13 16 O
severe 4 10 17 23 O
medical 11 18 24 31 B-chronic_disease
condition 19 28 32 41 I-chronic_disease
that 29 33 42 46 O
, 33 34 46 47 O
in 35 37 48 50 O
the 38 41 51 54 O
enrollee 42 50 55 63 O
's 50 52 63 65 O
opinion 53 60 66 73 O
, 60 61 73 74 O
is 62 64 75 77 O
likely 65 71 78 84 O
to 72 74 85 87 O
compromise 75 85 88 98 O
the 86 89 99 102 O
participant 90 101 103 114 O
's 101 103 114 116 O
ability 104 111 117 124 O
to 112 114 125 127 O
complete 115 123 128 136 O
the 124 127 137 140 O
trial 128 133 141 146 O

Ascites 0 7 147 154 B-chronic_disease

Bilirubin 0 9 155 164 B-clinical_variable
2 10 11 165 166 B-lower_bound
mg 12 14 167 169 I-lower_bound
/ 14 15 169 170 I-lower_bound
dL 15 17 170 172 I-lower_bound

Current 0 7 173 180 O
use 8 11 181 184 O
of 12 14 185 187 O
azathioprine 15 27 188 200 B-treatment
, 27 28 200 201 O
mercaptopurine 29 43 202 216 B-treatment
, 43 44 216 217 O
didanosine 45 55 218 228 B-treatment
, 55 56 228 229 O
cyclophosphamide 57 73 230 246 B-treatment
, 73 74 246 247 O
or 75 77 248 250 O
probenecid 78 88 251 261 B-treatment

Encephalopathy 0 14 262 276 B-chronic_disease

History 0 7 277 284 O
of 8 10 285 287 O
gout 11 15 288 292 B-chronic_disease
- 16 17 293 294 O
crystal 18 25 295 302 O
proven 26 32 303 309 O
or 33 35 310 312 O
historical 36 46 313 323 O
as 47 49 324 326 O
defined 50 57 327 334 O
by 58 60 335 337 O
ACR 61 64 338 341 O
criteria 65 73 342 350 O
listed 74 80 351 357 O
above 81 86 358 363 O

INR 0 3 364 367 O
1.7 4 7 368 371 O
, 7 8 371 372 O
not 9 12 373 376 O
on 13 15 377 379 O
Warfarin 16 24 380 388 B-treatment
therapy 25 32 389 396 I-treatment

Patients 0 8 397 405 O
who 9 12 406 409 O
are 13 16 410 413 O
not 17 20 414 417 O
candidates 21 31 418 428 O
for 32 35 429 432 O
any 36 39 433 436 O
of 40 42 437 439 O
the 43 46 440 443 O
recommended 47 58 444 455 O
prophylactic 59 71 456 468 B-treatment
medications 72 83 469 480 I-treatment
( 84 85 481 482 O
colchicine 85 95 482 492 B-treatment
, 95 96 492 493 O
naprosyn 97 105 494 502 B-treatment
or 106 108 503 505 O
glucocorticoids 109 124 506 521 B-treatment
) 124 125 521 522 O

Patients 0 8 523 531 O
with 9 13 532 536 O
a 14 15 537 538 O
history 16 23 539 546 O
of 24 26 547 549 O
prior 27 32 550 555 O
solid 33 38 556 561 B-treatment
organ 39 44 562 567 I-treatment
/ 45 46 568 569 I-treatment
hematopoietic 47 60 570 583 I-treatment
transplantation 61 76 584 599 I-treatment

Patients 0 8 600 608 O
with 9 13 609 613 O
chronic 14 21 614 621 B-chronic_disease
liver 22 27 622 627 I-chronic_disease
disease 28 35 628 635 I-chronic_disease

Patients 0 8 636 644 O
with 9 13 645 649 O
malignancies 14 26 650 662 B-cancer
that 27 31 663 667 O
are 32 35 668 671 O
currently 36 45 672 681 O
active 46 52 682 688 O

Patients 0 8 689 697 O
with 9 13 698 702 O
myelodysplasia 14 28 703 717 B-clinical_variable
and 29 32 718 721 O
hemoglobin 33 43 722 732 B-clinical_variable
of 44 46 733 735 O
< 47 48 736 737 O
8.5 49 52 738 741 B-upper_bound
g 53 54 742 743 I-upper_bound
/ 54 55 743 744 I-upper_bound
dL 55 57 744 746 I-upper_bound

Patients 0 8 747 755 O
with 9 13 756 760 O
serum 14 19 761 766 B-clinical_variable
uric 20 24 767 771 I-clinical_variable
acid 25 29 772 776 I-clinical_variable
levels 30 36 777 783 I-clinical_variable
> 37 38 784 785 O
15 38 40 785 787 B-lower_bound
mg 41 43 788 790 I-lower_bound
/ 43 44 790 791 I-lower_bound
dl 44 46 791 793 I-lower_bound

Previous 0 8 794 802 O
allergy 9 16 803 810 O
or 17 19 811 813 O
intolerance 20 31 814 825 O
to 32 34 826 828 O
allopurinol 35 46 829 840 B-allergy_name
or 47 49 841 843 O
febuxostat 50 60 844 854 B-allergy_name

Previous 0 8 855 863 O
history 9 16 864 871 O
of 17 19 872 874 O
failure 20 27 875 882 O
to 28 30 883 885 O
reach 31 36 886 891 O
target 37 43 892 898 O
uric 44 48 899 903 O
acid 49 53 904 908 O
levels 54 60 909 915 O
despite 61 68 916 923 O
therapy 69 76 924 931 B-treatment
with 77 81 932 936 I-treatment
allopurinol 82 93 937 948 I-treatment
at 94 96 949 951 O
dose 97 101 952 956 O
> 102 103 957 958 O
300 104 107 959 962 B-lower_bound
mg 108 110 963 965 I-lower_bound
/ 110 111 965 966 I-lower_bound
day 111 114 966 969 I-lower_bound

Prior 0 5 970 975 O
febuxostat 6 16 976 986 B-treatment
use 17 20 987 990 O

Serum 0 5 991 996 B-clinical_variable
albumin 6 13 997 1004 I-clinical_variable
< 14 15 1005 1006 O
3.5 15 18 1006 1009 B-upper_bound
g 19 20 1010 1011 I-upper_bound
/ 20 21 1011 1012 I-upper_bound
dL 21 23 1012 1014 I-upper_bound

Serum 0 5 1015 1020 B-clinical_variable
urate 6 11 1021 1026 I-clinical_variable
level 12 17 1027 1032 I-clinical_variable
6.8 18 21 1033 1036 O
mg 22 24 1037 1039 O
/ 24 25 1039 1040 O
dl 25 27 1040 1042 O

Stage 0 5 1043 1048 B-chronic_disease
4 6 7 1049 1050 I-chronic_disease
or 8 10 1051 1053 I-chronic_disease
5 11 12 1054 1055 I-chronic_disease
Chronic 13 20 1056 1063 I-chronic_disease
Kidney 21 27 1064 1070 I-chronic_disease
Disease 28 35 1071 1078 I-chronic_disease
( 36 37 1079 1080 I-chronic_disease
CKD 37 40 1080 1083 I-chronic_disease
) 40 41 1083 1084 I-chronic_disease
- 42 43 1085 1086 O
defined 44 51 1087 1094 O
as 52 54 1095 1097 O
eGFR 55 59 1098 1102 B-clinical_variable
of 60 62 1103 1105 O
< 63 64 1106 1107 O
30 64 66 1107 1109 B-upper_bound
ml 67 69 1110 1112 I-upper_bound
/ 69 70 1112 1113 I-upper_bound
min 70 73 1113 1116 I-upper_bound

Women 0 5 1117 1122 B-gender

less 0 4 1123 1127 O
than 5 9 1128 1132 O
50 10 12 1133 1135 B-upper_bound
years 13 18 1136 1141 I-upper_bound
of 19 21 1142 1144 O
age 22 25 1145 1148 B-age

non 0 3 1149 1152 B-cancer
- 3 4 1152 1153 I-cancer
melanoma 4 12 1153 1161 I-cancer
skin 13 17 1162 1166 I-cancer
cancer 18 24 1167 1173 I-cancer

ability 0 7 0 7 B-language_fluency
to 8 10 8 10 I-language_fluency
read 11 15 11 15 I-language_fluency
and 16 19 16 19 I-language_fluency
speak 20 25 20 25 I-language_fluency
English 26 33 26 33 I-language_fluency
or 34 36 34 36 I-language_fluency
Spanish 37 44 37 44 I-language_fluency

child 0 5 45 50 O
care 6 10 51 55 O
will 11 15 56 60 O
be 16 18 61 63 O
closed 19 25 64 70 O
for 26 29 71 74 O
more 30 34 75 79 O
than 35 39 80 84 O
1 40 41 85 86 B-lower_bound
month 42 47 87 92 I-lower_bound
at 48 50 93 95 O
a 51 52 96 97 O
time 53 57 98 102 O
in 58 60 103 105 O
the 61 64 106 109 O
forthcoming 65 76 110 121 O
year 77 81 122 126 O

has 0 3 127 130 O
no 4 6 131 133 O
children 7 15 134 142 O
in 16 18 143 145 O
their 19 24 146 151 O
care 25 29 152 156 O
between 30 37 157 164 O
the 38 41 165 168 O
ages 42 46 169 173 B-age
of 47 49 174 176 O
2 50 51 177 178 B-lower_bound
and 52 55 179 182 O
5 56 57 183 184 B-upper_bound
years 58 63 185 190 I-upper_bound
old 64 67 191 194 O

have 0 4 195 199 B-technology_access
a 5 6 200 201 I-technology_access
working 7 14 202 209 I-technology_access
phone 15 20 210 215 I-technology_access

have 0 4 216 220 O
at 5 7 221 223 O
least 8 13 224 229 O
1 14 15 230 231 B-lower_bound
children 16 24 232 240 O
in 25 27 241 243 O
their 28 33 244 249 O
care 34 38 250 254 O

have 0 4 255 259 O
either 5 11 260 266 O
a 12 13 267 268 O
DVD 14 17 269 272 B-technology_access
player 18 24 273 279 I-technology_access
or 25 27 280 282 O
internet 28 36 283 291 B-technology_access
access 37 43 292 298 I-technology_access
through 44 51 299 306 I-technology_access
computer 52 60 307 315 I-technology_access
or 61 63 316 318 I-technology_access
phone 64 69 319 324 I-technology_access

provide 0 7 325 332 O
at 8 10 333 335 O
least 11 16 336 341 O
2 17 18 342 343 B-lower_bound
meals 19 24 344 349 O
/ 24 25 349 350 O
snacks 25 31 350 356 O
to 32 34 357 359 O
the 35 38 360 363 O
children 39 47 364 372 O

under 0 5 373 378 O
18 6 8 379 381 B-lower_bound
years 9 14 382 387 I-lower_bound
of 15 17 388 390 O
age 18 21 391 394 B-age

A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
diabetes 15 23 15 23 B-chronic_disease
mellitus 24 32 24 32 I-chronic_disease
, 32 33 32 33 O
which 34 39 34 39 O
might 40 45 40 45 O
increase 46 54 46 54 O
the 55 58 55 58 O
risk 59 63 59 63 O
of 64 66 64 66 O
glucose 67 74 67 74 B-clinical_variable
infusion 75 83 75 83 I-clinical_variable

Acute 0 5 84 89 O
symptoms 6 14 90 98 O
( 15 16 99 100 O
7 16 17 100 101 B-upper_bound
days 18 22 102 106 I-upper_bound
duration 23 31 107 115 O
or 32 34 116 118 O
less 35 39 119 123 O
to 40 42 124 126 O
time 43 47 127 131 O
of 48 50 132 134 O
enrollment 51 61 135 145 O
) 61 62 145 146 O
such 63 67 147 151 O
as 68 70 152 154 O
abdominal 71 80 155 164 O
, 80 81 164 165 O
back 82 86 166 170 O
and/or 87 93 171 177 O
limb 94 98 178 182 O
pain 99 103 183 187 O
, 103 104 187 188 O
diagnosed 105 114 189 198 O
by 115 117 199 201 O
the 118 121 202 205 O
investigator 122 134 206 218 O
as 135 137 219 221 O
caused 138 144 222 228 O
by 145 147 229 231 O
porphyria 148 157 232 241 B-chronic_disease
after 158 163 242 247 O
initial 164 171 248 255 O
evaluation 172 182 256 266 O
has 183 186 267 270 O
excluded 187 195 271 279 O
other 196 201 280 285 O
causes 202 208 286 292 O

Diagnosis 0 9 293 302 O
of 10 12 303 305 O
acute 13 18 306 311 O
porphyria 19 28 312 321 O
documented 29 39 322 332 O
by 40 42 333 335 O
a 43 44 336 337 O
substantial 45 56 338 349 O
increase 57 65 350 358 O
in 66 68 359 361 O
urinary 69 76 362 369 O
or 77 79 370 372 O
serum 80 85 373 378 O
porphobilinogen 86 101 379 394 B-chronic_disease
( 102 103 395 396 I-chronic_disease
PBG 103 106 396 399 I-chronic_disease
) 106 107 399 400 I-chronic_disease

For 0 3 401 404 O
acute 4 9 405 410 B-chronic_disease
intermittent 10 22 411 423 I-chronic_disease
porphyria 23 32 424 433 I-chronic_disease
( 33 34 434 435 I-chronic_disease
AIP 34 37 435 438 I-chronic_disease
): 37 39 438 440 I-chronic_disease
Normal 40 46 441 447 O
or 47 49 448 450 O
only 50 54 451 455 O
slight 55 61 456 462 O
increases 62 71 463 472 O
in 72 74 473 475 O
plasma 75 81 476 482 O
and 82 85 483 486 O
fecal 86 91 487 492 O
porphyrins 92 102 493 503 O

For 0 3 504 507 O
hereditary 4 14 508 518 B-chronic_disease
coproporphyria 15 29 519 533 I-chronic_disease
( 30 31 534 535 I-chronic_disease
HCP 31 34 535 538 I-chronic_disease
): 34 36 538 540 I-chronic_disease
Substantial 37 48 541 552 O
increases 49 58 553 562 O
in 59 61 563 565 O
fecal 62 67 566 571 B-treatment
porphyrins 68 78 572 582 I-treatment
( 79 80 583 584 O
almost 80 86 584 590 O
entirely 87 95 591 599 O
coproporphyrin 96 110 600 614 O
III 111 114 615 618 O
) 114 115 618 619 O

For 0 3 620 623 O
variegate 4 13 624 633 B-chronic_disease
porphyria 14 23 634 643 I-chronic_disease
( 24 25 644 645 I-chronic_disease
VP 25 27 645 647 I-chronic_disease
): 27 29 647 649 I-chronic_disease
Substantial 30 41 650 661 O
increases 42 51 662 671 O
in 52 54 672 674 O
fecal 55 60 675 680 O
porphyrins 61 71 681 691 O
( 72 73 692 693 O
mostly 73 79 693 699 O
coproporphyrin 80 94 700 714 O
III 95 98 715 718 O
and 99 102 719 722 O
protoporphyrin 103 117 723 737 O
) 117 118 737 738 O
, 118 119 738 739 O
increased 120 129 740 749 O
plasma 130 136 750 756 O
total 137 142 757 762 O
porphyrins 143 153 763 773 O
and 154 157 774 777 O
a 158 159 778 779 O
fluorescence 160 172 780 792 O
emission 173 181 793 801 O
maximum 182 189 802 809 O
of 190 192 810 812 O
diluted 193 200 813 820 O
plasma 201 207 821 827 O
at 208 210 828 830 O
neutral 211 218 831 838 O
pH 219 221 839 841 O
near 222 226 842 846 O
626 227 230 847 850 O
nm 231 233 851 853 O
. 233 234 853 854 O
Almost 235 241 855 861 O
all 242 245 862 865 O
( 246 247 866 867 O
~95 247 250 867 870 O
percent 251 258 871 878 O
) 258 259 878 879 O
will 260 264 880 884 O
have 265 269 885 889 O
a 270 271 890 891 O
demonstrable 272 284 892 904 O
disease 285 292 905 912 O
- 292 293 912 913 O
causing 293 300 913 920 O
protoporphyrinogen 301 319 921 939 B-treatment
oxidase 320 327 940 947 I-treatment
( 328 329 948 949 I-treatment
PPO 329 332 949 952 I-treatment
) 332 333 952 953 I-treatment
mutation 334 342 954 962 O

Heart 0 5 963 968 B-chronic_disease
failure 6 13 969 976 I-chronic_disease
, 13 14 976 977 O
significant 15 26 978 989 O
chronic 27 34 990 997 O
anemia 35 41 998 1004 B-chronic_disease
or 42 44 1005 1007 O
any 45 48 1008 1011 O
disease 49 56 1012 1019 O
or 57 59 1020 1022 O
condition 60 69 1023 1032 O
that 70 74 1033 1037 O
the 75 78 1038 1041 O
investigator 79 91 1042 1054 O
judges 92 98 1055 1061 O
would 99 104 1062 1067 O
lead 105 109 1068 1072 O
to 110 112 1073 1075 O
an 113 115 1076 1078 O
unacceptable 116 128 1079 1091 O
risk 129 133 1092 1096 O
to 134 136 1097 1099 O
the 137 140 1100 1103 O
patient 141 148 1104 1111 O
or 149 151 1112 1114 O
interfere 152 161 1115 1124 O
with 162 166 1125 1129 O
the 167 170 1130 1133 O
successful 171 181 1134 1144 O
collection 182 192 1145 1155 O
of 193 195 1156 1158 O
date 196 200 1159 1163 O
for 201 204 1164 1167 O
the 205 208 1168 1171 O
trial 209 214 1172 1177 O

Known 0 5 1178 1183 O
or 6 8 1184 1186 O
suspected 9 18 1187 1196 O
allergy 19 26 1197 1204 O
to 27 29 1205 1207 O
Panhematin 30 40 1208 1218 B-allergy_name
™ 40 41 1218 1219 O
or 42 44 1220 1222 O
related 45 52 1223 1230 O
products 53 61 1231 1239 O

Male 0 4 1240 1244 B-gender

Most 0 4 1245 1249 O
( 5 6 1250 1251 O
~90 6 9 1251 1254 O
percent 10 17 1255 1262 O
) 17 18 1262 1263 O
will 19 23 1264 1268 O
have 24 28 1269 1273 O
deficient 29 38 1274 1283 O
activity 39 47 1284 1292 O
of 48 50 1293 1295 O
erythrocyte 51 62 1296 1307 B-treatment
porphobilinogen 63 78 1308 1323 I-treatment
deaminase 79 88 1324 1333 I-treatment
( 89 90 1334 1335 I-treatment
PBGD 90 94 1335 1339 I-treatment
) 94 95 1339 1340 I-treatment
, 95 96 1340 1341 O
and 97 100 1342 1345 O
almost 101 107 1346 1352 O
all 108 111 1353 1356 O
( 112 113 1357 1358 O
> 113 114 1358 1359 O
95 114 116 1359 1361 B-lower_bound
percent 117 124 1362 1369 I-lower_bound
) 124 125 1369 1370 O
will 126 130 1371 1375 O
have 131 135 1376 1380 O
a 136 137 1381 1382 O
demonstrable 138 150 1383 1395 O
disease 151 158 1396 1403 O
- 158 159 1403 1404 O
causing 159 166 1404 1411 O
PBGD 167 171 1412 1416 O
mutation 172 180 1417 1425 O

Preexisting 0 11 1426 1437 O
coagulation 12 23 1438 1449 O
defect 24 30 1450 1456 O
or 31 33 1457 1459 O
concurrent 34 44 1460 1470 O
treatment 45 54 1471 1480 B-treatment
with 55 59 1481 1485 O
an 60 62 1486 1488 O
anticoagulant 63 76 1489 1502 B-treatment

Previously 0 10 1503 1513 O
documented 11 21 1514 1524 O
renal 22 27 1525 1530 B-chronic_disease
impairment 28 38 1531 1541 I-chronic_disease
defined 39 46 1542 1549 O
as 47 49 1550 1552 O
a 50 51 1553 1554 O
serum 52 57 1555 1560 B-clinical_variable
creatinine 58 68 1561 1571 I-clinical_variable
above 69 74 1572 1577 O
1.7 75 78 1578 1581 B-lower_bound
mg 79 81 1582 1584 I-lower_bound
/ 81 82 1584 1585 I-lower_bound
dL 82 84 1585 1587 I-lower_bound
or 85 87 1588 1590 O
150 88 91 1591 1594 B-lower_bound
mmol 92 96 1595 1599 I-lower_bound
/ 96 97 1599 1600 I-lower_bound
L 97 98 1600 1601 I-lower_bound

Therapy 0 7 1602 1609 B-treatment
with 8 12 1610 1614 I-treatment
hemin 13 18 1615 1620 I-treatment
within 19 25 1621 1627 O
7 26 27 1628 1629 B-upper_bound
days 28 32 1630 1634 I-upper_bound
prior 33 38 1635 1640 I-upper_bound
to 39 41 1641 1643 O
enrollment 42 52 1644 1654 O
in 53 55 1655 1657 O
this 56 60 1658 1662 O
study 61 66 1663 1668 O

Type 0 4 1669 1673 O
of 5 7 1674 1676 O
acute 8 13 1677 1682 B-chronic_disease
porphyria 14 23 1683 1692 I-chronic_disease
confirmed 24 33 1693 1702 O
by 34 36 1703 1705 O
additional 37 47 1706 1716 O
testing 48 55 1717 1724 O
( 56 57 1725 1726 O
in 57 59 1726 1728 O
addition 60 68 1729 1737 O
to 69 71 1738 1740 O
increased 72 81 1741 1750 O
PBG 82 85 1751 1754 O
) 85 86 1754 1755 O
, 86 87 1755 1756 O
which 88 93 1757 1762 O
may 94 97 1763 1766 O
be 98 100 1767 1769 O
completed 101 110 1770 1779 O
before 111 117 1780 1786 O
or 118 120 1787 1789 O
after 121 126 1790 1795 O
treatment 127 136 1796 1805 B-treatment
begins 137 143 1806 1812 O
using 144 149 1813 1818 O
pretreatment 150 162 1819 1831 B-treatment
samples 163 170 1832 1839 O

aged 0 4 1840 1844 B-age
18 5 7 1845 1847 B-lower_bound
years 8 13 1848 1853 I-lower_bound

female 0 6 1854 1860 B-gender

-positive 0 9 0 9 O
and/or 10 16 10 16 O
PR 17 19 17 19 O
- 19 20 19 20 O
positive 20 28 20 28 O
/ 28 29 28 29 O
HER2- 29 34 29 34 B-cancer
disease 35 42 35 42 O
and 43 46 43 46 O
received 47 55 47 55 O
no 56 58 56 58 O
more 59 63 59 63 O
than 64 68 64 68 O
1 69 70 69 70 B-upper_bound
prior 71 76 71 76 B-treatment
non 77 80 77 80 I-treatment
- 80 81 80 81 I-treatment
hormonally 81 91 81 91 I-treatment
- 91 92 91 92 I-treatment
directed 92 100 92 100 I-treatment
or 101 103 101 103 I-treatment
cytotoxic 104 113 104 113 I-treatment
therapy 114 121 114 121 I-treatment
in 122 124 122 124 I-treatment
the 125 128 125 128 I-treatment
MBC 129 132 129 132 I-treatment
setting 133 140 133 140 I-treatment

Combination 0 11 141 152 O
Arm 12 15 153 156 O
: 15 16 156 157 O
HER2 17 21 158 162 B-cancer
- 21 22 162 163 I-cancer
positive 22 30 163 171 I-cancer
disease 31 38 172 179 I-cancer
and 39 42 180 183 O
received 43 51 184 192 O
at 52 54 193 195 O
least 55 60 196 201 O
2 61 62 202 203 B-lower_bound
prior 63 68 204 209 I-lower_bound
cytotoxic 69 78 210 219 O
regimens 79 87 220 228 O
in 88 90 229 231 O
the 91 94 232 235 O
incurable 95 104 236 245 O
, 104 105 245 246 O
unresectable 106 118 247 259 O
, 118 119 259 260 O
LA 120 122 261 263 O
/ 122 123 263 264 O
MBC 123 126 264 267 O
setting 127 134 268 275 O
( 135 136 276 277 O
not 136 139 277 280 O
enrolling 140 149 281 290 O
new 150 153 291 294 O
patients 154 162 295 303 O
) 162 163 303 304 O

Combination 0 11 305 316 O
Arm 12 15 317 320 O
: 15 16 320 321 O
hypersensitivity 17 33 322 338 O
to 34 36 339 341 O
trastuzumab 37 48 342 353 B-allergy_name

Eastern 0 7 354 361 B-clinical_variable
Cooperative 8 19 362 373 I-clinical_variable
Oncology 20 28 374 382 I-clinical_variable
Group 29 34 383 388 I-clinical_variable
performance 35 46 389 400 I-clinical_variable
status 47 53 401 407 I-clinical_variable
0 54 55 408 409 B-lower_bound
or 56 58 410 412 O
1 59 60 413 414 B-upper_bound

Malignant 0 9 415 424 B-cancer
CNS 10 13 425 428 I-cancer
disease 14 21 429 436 I-cancer
that 22 26 437 441 O
has 27 30 442 445 O
not 31 34 446 449 O
been 35 39 450 454 O
definitively 40 52 455 467 O
treated 53 60 468 475 O

Pathologically 0 14 476 490 O
confirmed 15 24 491 500 O
diagnosis 25 34 501 510 O
of 35 37 511 513 O
breast 38 44 514 520 B-cancer
cancer 45 51 521 527 I-cancer
with 52 56 528 532 O
radiographic 57 69 533 545 O
evidence 70 78 546 554 O
of 79 81 555 557 O
incurable 82 91 558 567 O
, 91 92 567 568 O
unresectable 93 105 569 581 O
, 105 106 581 582 O
locally 107 114 583 590 O
advanced 115 123 591 599 O
or 124 126 600 602 O
metastatic 127 137 603 613 B-cancer
disease 138 145 614 621 I-cancer
( 146 147 622 623 O
LA 147 149 623 625 O
/ 149 150 625 626 O
MBC 150 153 626 629 O
) 153 154 629 630 O

Pre 0 3 631 634 B-clinical_variable
- 3 4 634 635 I-clinical_variable
existing 4 12 635 643 I-clinical_variable
neuropathy 13 23 644 654 I-clinical_variable
Grade 24 29 655 660 B-lower_bound
2 30 31 661 662 I-lower_bound
or 32 34 663 665 O
higher 35 41 666 672 O

Prior 0 5 673 678 O
treatment 6 15 679 688 O
with 16 20 689 693 O
SGN 21 24 694 697 B-treatment
- 24 25 697 698 I-treatment
LIV1A 25 30 698 703 I-treatment

Triple 0 6 704 710 B-cancer
- 6 7 710 711 I-cancer
negative 7 15 711 719 I-cancer
disease 16 23 720 727 I-cancer
( 24 25 728 729 O
ER 25 27 729 731 O
/ 27 28 731 732 O
PR 28 30 732 734 O
/ 30 31 734 735 O
HER2 31 35 735 739 O
- 35 36 739 740 O
negative 36 44 740 748 O
) 44 45 748 749 O
and 46 49 750 753 O
received 50 58 754 762 O
at 59 61 763 765 O
least 62 67 766 771 O
2 68 69 772 773 O
prior 70 75 774 779 B-treatment
cytotoxic 76 85 780 789 I-treatment
regimens 86 94 790 798 I-treatment
in 95 97 799 801 O
the 98 101 802 805 O
incurable 102 111 806 815 O
, 111 112 815 816 O
unresectable 113 125 817 829 O
, 125 126 829 830 O
LA 127 129 831 833 O
/ 129 130 833 834 O
MBC 130 133 834 837 O
setting 134 141 838 845 O
; 141 142 845 846 O
or 143 145 847 849 O
ER 146 148 850 852 O
- 148 149 852 853 O
positive 149 157 853 861 O
and/or 158 164 862 868 O
PR 165 167 869 871 O
- 167 168 871 872 O
positive 168 176 872 880 O
/ 176 177 880 881 O
HER2 177 181 881 885 O
- 181 182 885 886 O
negative 182 190 886 894 O
disease 191 198 895 902 O
and 199 202 903 906 O
received 203 211 907 915 O
at 212 214 916 918 O
least 215 220 919 924 O
2 221 222 925 926 O
prior 223 228 927 932 O
cytotoxic 229 238 933 942 O
regimens 239 247 943 951 O
in 248 250 952 954 O
the 251 254 955 958 O
incurable 255 264 959 968 O
, 264 265 968 969 O
unresectable 266 278 970 982 O
, 278 279 982 983 O
LA 280 282 984 986 O
/ 282 283 986 987 O
MBC 283 286 987 990 O
setting 287 294 991 998 O
and 295 298 999 1002 O
are 299 302 1003 1006 O
no 303 305 1007 1009 O
longer 306 312 1010 1016 O
a 313 314 1017 1018 O
candidate 315 324 1019 1028 O
for 325 328 1029 1032 O
hormonal 329 337 1033 1041 B-treatment
therapy 338 345 1042 1049 I-treatment
( 346 347 1050 1051 O
not 347 350 1051 1054 O
enrolling 351 360 1055 1064 O
new 361 364 1065 1068 O
patients 365 373 1069 1077 O
) 373 374 1077 1078 O

Triple 0 6 1079 1085 B-cancer
- 6 7 1085 1086 I-cancer
negative 7 15 1086 1094 I-cancer
disease 16 23 1095 1102 I-cancer
and 24 27 1103 1106 O
received 28 36 1107 1115 O
1 37 38 1116 1117 O
prior 39 44 1118 1123 O
non 45 48 1124 1127 O
- 48 49 1127 1128 O
hormonally 49 59 1128 1138 O
- 59 60 1138 1139 O
directed 60 68 1139 1147 O
or 69 71 1148 1150 O
cytotoxic 72 81 1151 1160 B-treatment
therapy 82 89 1161 1168 I-treatment
in 90 92 1169 1171 O
the 93 96 1172 1175 O
MBC 97 100 1176 1179 O
setting 101 108 1180 1187 O

Triple 0 6 1188 1194 B-cancer
- 6 7 1194 1195 I-cancer
negative 7 15 1195 1203 I-cancer
disease 16 23 1204 1211 O
and 24 27 1212 1215 O
received 28 36 1216 1224 O
2 37 38 1225 1226 B-lower_bound
- 38 39 1226 1227 O
4 39 40 1227 1228 B-upper_bound
prior 41 46 1229 1234 I-upper_bound
non 47 50 1235 1238 B-treatment
- 50 51 1238 1239 I-treatment
hormonally 51 61 1239 1249 I-treatment
- 61 62 1249 1250 I-treatment
directed 62 70 1250 1258 I-treatment
therapies 71 80 1259 1268 I-treatment
in 81 83 1269 1271 O
the 84 87 1272 1275 O
MBC 88 91 1276 1279 B-clinical_variable
setting 92 99 1280 1287 O
( 100 101 1288 1289 O
not 101 104 1289 1292 O
enrolling 105 114 1293 1302 O
new 115 118 1303 1306 O
patients 119 127 1307 1315 O
) 127 128 1315 1316 O

prior 0 5 1317 1322 O
treatment 6 15 1323 1332 O
with 16 20 1333 1337 O
an 21 23 1338 1340 O
MMAE 24 28 1341 1345 B-treatment
- 28 29 1345 1346 I-treatment
containing 29 39 1346 1356 I-treatment
therapy 40 47 1357 1364 I-treatment

Absolute 0 8 0 8 B-clinical_variable
Neutrophil 9 19 9 19 I-clinical_variable
Count 20 25 20 25 I-clinical_variable
≤ 26 27 26 27 O
1500 28 32 28 32 B-upper_bound
per 33 36 33 36 I-upper_bound
mm3 37 40 37 40 I-upper_bound

Anti 0 4 41 45 B-treatment
- 4 5 45 46 I-treatment
Convulsants 5 16 46 57 I-treatment
: 16 17 57 58 O
carbamazepine 18 31 59 72 B-treatment
, 31 32 72 73 O
Phenobarbital 33 46 74 87 B-treatment
, 46 47 87 88 O
Anti 48 52 89 93 O
- 52 53 93 94 O
Convulsant 53 63 94 104 O
: 63 64 104 105 O
phenytoin 64 73 105 114 B-treatment
, 73 74 114 115 O
Anti 75 79 116 120 B-treatment
- 79 80 120 121 I-treatment
Mycobacterial 80 93 121 134 I-treatment
: 93 94 134 135 O
rifabutin 94 103 135 144 B-treatment
, 103 104 144 145 O
PDE5 105 109 146 150 B-treatment
Inhibitors 110 120 151 161 I-treatment
: 120 121 161 162 O
sildenafil 122 132 163 173 B-treatment
, 132 133 173 174 O
vardenafil 134 144 175 185 B-treatment
, 144 145 185 186 O
tadalafil 146 155 187 196 B-treatment
, 155 156 196 197 O
HMG 157 160 198 201 B-treatment
- 160 161 201 202 I-treatment
CoA 161 164 202 205 I-treatment
: 164 165 205 206 O
Reductase 166 175 207 216 B-treatment
Inhibitors 176 186 217 227 I-treatment
: 186 187 227 228 O
atorvastatin 188 200 229 241 B-treatment
, 200 201 241 242 O
rosuvastatin 202 214 243 255 B-treatment
, 214 215 255 256 O
Immuno 216 222 257 263 B-treatment
- 222 223 263 264 I-treatment
suppressants 223 235 264 276 I-treatment
: 235 236 276 277 O
cyclosporine 237 249 278 290 B-treatment
, 249 250 290 291 O
tacrolimus 250 260 291 301 B-treatment
, 260 261 301 302 O
sirolimus 262 271 303 312 B-treatment
, 271 272 312 313 O
Narcotic 273 281 314 322 B-treatment
Analgesic 282 291 323 332 I-treatment
: 291 292 332 333 O
methadone 293 302 334 343 B-treatment
, 302 303 343 344 O
Oral 304 308 345 349 B-treatment
Contraceptive 309 322 350 363 I-treatment
: 322 323 363 364 O
ethinyl 323 330 364 371 B-treatment
estradiol 331 340 372 381 I-treatment
, 340 341 381 382 O
Macrolide 342 351 383 392 B-treatment
Antibiotic 352 362 393 403 I-treatment
: 362 363 403 404 O
azithromycin 363 375 404 416 B-treatment
, 375 376 416 417 O
Inhaled 377 384 418 425 B-treatment
/ 384 385 425 426 I-treatment
nasal 385 390 426 431 I-treatment
steroid 391 398 432 439 I-treatment
fluticasone 399 410 440 451 I-treatment
, 410 411 451 452 O
Antidepressant 412 426 453 467 B-treatment
: 426 427 467 468 O
trazodone 428 437 469 478 B-treatment

Antiarrhythmics 0 15 479 494 B-treatment
: 15 16 494 495 O
amiodarone 16 26 495 505 B-treatment
, 26 27 505 506 O
quinidine 28 37 507 516 B-treatment
, 37 38 516 517 O
Antimycobacterial 39 56 518 535 B-treatment
: 56 57 535 536 O
rifampin 58 66 537 545 B-treatment
, 66 67 545 546 O
Ergot 68 73 547 552 B-treatment
Derivatives 74 85 553 564 I-treatment
: 85 86 564 565 O
dihydroergotamine 86 103 565 582 B-treatment
, 103 104 582 583 O
ergonovine 105 115 584 594 B-treatment
, 115 116 594 595 O
ergotamine 117 127 596 606 O
, 127 128 606 607 O
methylergonovine 129 145 608 624 B-treatment
, 145 146 624 625 O
Herbal 147 153 626 632 B-treatment
Products 154 162 633 641 I-treatment

Determined 0 10 642 652 O
by 11 13 653 655 O
the 14 17 656 659 O
treating 18 26 660 668 O
physician 27 36 669 678 O
to 37 39 679 681 O
be 40 42 682 684 O
a 43 44 685 686 O
candidate 45 54 687 696 O
for 55 58 697 700 O
organ 59 64 701 706 O
preserving 65 75 707 717 O
, 75 76 717 718 O
concurrent 77 87 719 729 O
standard 88 96 730 738 B-treatment
chemotherapy 97 109 739 751 I-treatment
and 110 113 752 755 O
radiation 114 123 756 765 B-treatment
therapy 124 131 766 773 I-treatment
to 132 134 774 776 O
the 135 138 777 780 O
head 139 143 781 785 O
and 144 147 786 789 O
neck 148 152 790 794 O
with 153 157 795 799 O
definitive 158 168 800 810 O
intent 169 175 811 817 O

Distant 0 7 818 825 B-cancer
metastases 8 18 826 836 I-cancer

ECOG 0 4 837 841 B-clinical_variable
Performance 5 16 842 853 I-clinical_variable
Status 17 23 854 860 I-clinical_variable
0 24 25 861 862 B-lower_bound
- 25 26 862 863 O
2 26 27 863 864 B-upper_bound

Histologically 0 14 865 879 O
confirmed 15 24 880 889 O
diagnosis 25 34 890 899 O
of 35 37 900 902 O
squamous 38 46 903 911 B-cancer
cell 47 51 912 916 I-cancer
carcinoma 52 61 917 926 I-cancer
of 62 64 927 929 O
the 65 68 930 933 O
oral 69 73 934 938 O
cavity 74 80 939 945 O
, 80 81 945 946 O
oropharynx 82 92 947 957 O
, 92 93 957 958 O
larynx 94 100 959 965 O
, 100 101 965 966 O
or 102 104 967 969 O
hypopharynx 105 116 970 981 O
stages 117 123 982 988 O
III 124 127 989 992 O
, 127 128 992 993 O
IVa 129 132 994 997 O
, 132 133 997 998 O
or 134 136 999 1001 O
IVb 137 140 1002 1005 O
, 140 141 1005 1006 O
p16 142 145 1007 1010 O
- 145 146 1010 1011 O
negative 146 154 1011 1019 O
on 155 157 1020 1022 O
immunohistochemistry 158 178 1023 1043 B-treatment

History 0 7 1044 1051 O
of 8 10 1052 1054 O
allergic 11 19 1055 1063 O
reactionsattributed 20 39 1064 1083 O
to 40 42 1084 1086 O
Flagyl 43 49 1087 1093 B-allergy_name
( 50 51 1094 1095 O
metronidazole 51 64 1095 1108 B-allergy_name
) 64 65 1108 1109 O
, 65 66 1109 1110 O
which 67 72 1111 1116 O
has 73 76 1117 1120 O
a 77 78 1121 1122 O
chemical 79 87 1123 1131 O
structure 88 97 1132 1141 O
similar 98 105 1142 1149 O
to 106 108 1150 1152 O
FMISO 109 114 1153 1158 B-allergy_name

Patients 0 8 1159 1167 O
must 9 13 1168 1172 O
sign 14 18 1173 1177 O
an 19 21 1178 1180 O
informed 22 30 1181 1189 O
consent 31 38 1190 1197 O
document 39 47 1198 1206 O
that 48 52 1207 1211 O
indicates 53 62 1212 1221 O
they 63 67 1222 1226 O
are 68 71 1227 1230 O
aware 72 77 1231 1236 O
of 78 80 1237 1239 O
the 81 84 1240 1243 O
investigational 85 100 1244 1259 O
nature 101 107 1260 1266 O
of 108 110 1267 1269 O
the 111 114 1270 1273 O
treatment 115 124 1274 1283 B-treatment
in 125 127 1284 1286 O
this 128 132 1287 1291 O
protocol 133 141 1292 1300 O
as 142 144 1301 1303 O
well 145 149 1304 1308 O
as 150 152 1309 1311 O
the 153 156 1312 1315 O
potential 157 166 1316 1325 O
risks 167 172 1326 1331 O
and 173 176 1332 1335 O
benefits 177 185 1336 1344 O

Patients 0 8 1345 1353 O
receiving 9 18 1354 1363 O
the 19 22 1364 1367 O
following 23 32 1368 1377 O
drugs 33 38 1378 1383 B-treatment
will 39 43 1384 1388 O
be 44 46 1389 1391 O
clinically 47 57 1392 1402 O
evaluated 58 67 1403 1412 O
as 68 70 1413 1415 O
to 71 73 1416 1418 O
whether 74 81 1419 1426 O
dosage 82 88 1427 1433 O
/ 88 89 1433 1434 O
medication 89 99 1434 1444 B-treatment
can 100 103 1445 1448 O
be 104 106 1449 1451 O
changed 107 114 1452 1459 O
to 115 117 1460 1462 O
permit 118 124 1463 1469 O
patient 125 132 1470 1477 O
on 133 135 1478 1480 O
study 136 141 1481 1486 O

Patients 0 8 1487 1495 O
with 9 13 1496 1500 O
known 14 19 1501 1506 O
HIV 20 23 1507 1510 B-chronic_disease
disease 24 31 1511 1518 I-chronic_disease

Patients 0 8 1519 1527 O
≥ 9 10 1528 1529 O
18 11 13 1530 1532 B-lower_bound
years 14 19 1533 1538 I-lower_bound
old 20 23 1539 1542 O

Platelet 0 8 1543 1551 B-clinical_variable
count 9 14 1552 1557 I-clinical_variable
≤ 15 16 1558 1559 O
100,000 17 24 1560 1567 B-upper_bound
per 25 28 1568 1571 I-upper_bound
mm3 29 32 1572 1575 I-upper_bound

Pregnant 0 8 1576 1584 B-pregnancy

Previous 0 8 1585 1593 O
therapy 9 16 1594 1601 B-treatment
with 17 21 1602 1606 O
a 22 23 1607 1608 O
human 24 29 1609 1614 B-chronic_disease
immunodeficiency 30 46 1615 1631 I-chronic_disease
virus 47 52 1632 1637 I-chronic_disease
( 53 54 1638 1639 I-chronic_disease
HIV 54 57 1639 1642 I-chronic_disease
) 57 58 1642 1643 I-chronic_disease
protease 59 67 1644 1652 B-treatment
inhibitor 68 77 1653 1662 I-treatment

Prior 0 5 1663 1668 B-treatment
chemotherapy 6 18 1669 1681 I-treatment
within 19 25 1682 1688 O
the 26 29 1689 1692 O
past 30 34 1693 1697 B-upper_bound
5 35 36 1698 1699 I-upper_bound
years 37 42 1700 1705 I-upper_bound

Prior 0 5 1706 1711 B-treatment
radiation 6 15 1712 1721 I-treatment
therapy 16 23 1722 1729 I-treatment
to 24 26 1730 1732 I-treatment
the 27 30 1733 1736 I-treatment
head 31 35 1737 1741 I-treatment
and 36 39 1742 1745 I-treatment
neck 40 44 1746 1750 I-treatment

Serum 0 5 1751 1756 B-clinical_variable
AST 6 9 1757 1760 I-clinical_variable
or 10 12 1761 1763 O
ALT 13 16 1764 1767 B-clinical_variable
> 17 18 1768 1769 O
2 19 20 1770 1771 B-lower_bound
times 21 26 1772 1777 I-lower_bound
the 27 30 1778 1781 I-lower_bound
upper 31 36 1782 1787 I-lower_bound
limit 37 42 1788 1793 I-lower_bound
of 43 45 1794 1796 I-lower_bound
normal 46 52 1797 1803 I-lower_bound

Serum 0 5 1804 1809 B-clinical_variable
bilirubin 6 15 1810 1819 I-clinical_variable
> 16 17 1820 1821 O
1.2 18 21 1822 1825 B-lower_bound
mg 22 24 1826 1828 I-lower_bound
/ 24 25 1828 1829 I-lower_bound
dl 25 27 1829 1831 I-lower_bound

Serum 0 5 1832 1837 B-clinical_variable
creatinine 6 16 1838 1848 I-clinical_variable
> 17 18 1849 1850 O
1.5 19 22 1851 1854 B-lower_bound
times 23 28 1855 1860 I-lower_bound
the 29 32 1861 1864 I-lower_bound
upper 33 38 1865 1870 I-lower_bound
limit 39 44 1871 1876 I-lower_bound
of 45 47 1877 1879 I-lower_bound
normal 48 54 1880 1886 I-lower_bound

Serum 0 5 1887 1892 O
pregnancy 6 15 1893 1902 B-pregnancy
testing 16 23 1903 1910 O
will 24 28 1911 1915 O
be 29 31 1916 1918 O
required 32 40 1919 1927 O
for 41 44 1928 1931 O
women 45 50 1932 1937 B-gender
of 51 53 1938 1940 O
childbearing 54 66 1941 1953 O
potential 67 76 1954 1963 O

Should 0 6 1964 1970 O
a 7 8 1971 1972 O
woman 9 14 1973 1978 B-gender
become 15 21 1979 1985 B-pregnancy
pregnant 22 30 1986 1994 I-pregnancy
or 31 33 1995 1997 O
suspect 34 41 1998 2005 O
she 42 45 2006 2009 O
is 46 48 2010 2012 O
pregnant 49 57 2013 2021 O
while 58 63 2022 2027 O
participating 64 77 2028 2041 O
in 78 80 2042 2044 O
this 81 85 2045 2049 O
study 86 91 2050 2055 O
, 91 92 2055 2056 O
she 93 96 2057 2060 O
should 97 103 2061 2067 O
inform 104 110 2068 2074 O
her 111 114 2075 2078 O
treating 115 123 2079 2087 O
physician 124 133 2088 2097 O
immediately 134 145 2098 2109 O

St. 0 3 2110 2113 B-treatment
John 3 7 2113 2117 I-treatment
's 7 9 2117 2119 I-treatment
wort 10 14 2120 2124 I-treatment
( 15 16 2125 2126 I-treatment
hypericum 16 25 2126 2135 I-treatment
perforatum 26 36 2136 2146 I-treatment
) 36 37 2146 2147 I-treatment
, 37 38 2147 2148 O
HMG 39 42 2149 2152 B-treatment
- 42 43 2152 2153 I-treatment
CoA 43 46 2153 2156 I-treatment
Reductase 47 56 2157 2166 I-treatment
Inhibitors 57 67 2167 2177 I-treatment
: 67 68 2177 2178 O
lovastatin 69 79 2179 2189 B-treatment
, 79 80 2189 2190 O
simvastatin 80 91 2190 2201 B-treatment
, 91 92 2201 2202 O
Neuroleptic 93 104 2203 2214 B-treatment
: 104 105 2214 2215 O
pimozide 105 113 2215 2223 B-treatment
, 113 114 2223 2224 O
Proton 115 121 2225 2231 B-treatment
Pump 122 126 2232 2236 I-treatment
Inhibitors 127 137 2237 2247 I-treatment
, 137 138 2247 2248 O
Sedative 139 147 2249 2257 B-treatment
/ 147 148 2257 2258 I-treatment
Hypnotics 148 157 2258 2267 I-treatment
: 157 158 2267 2268 O
midazolam 159 168 2269 2278 B-treatment
, 168 169 2278 2279 O
triazolam 170 179 2280 2289 B-treatment

Subjects 0 8 2290 2298 O
with 9 13 2299 2303 O
moderate 14 22 2304 2312 O
- 22 23 2312 2313 O
severe 23 29 2313 2319 O
renal 30 35 2320 2325 B-chronic_disease
disease 36 43 2326 2333 I-chronic_disease

These 0 5 2334 2339 O
patients 6 14 2340 2348 O
have 15 19 2349 2353 O
a 20 21 2354 2355 O
high 22 26 2356 2360 O
probability 27 38 2361 2372 O
of 39 41 2373 2375 O
treatment 42 51 2376 2385 B-treatment
with 52 56 2386 2390 I-treatment
anti 57 61 2391 2395 I-treatment
- 61 62 2395 2396 I-treatment
retroviral 62 72 2396 2406 I-treatment
therapy 73 80 2407 2414 I-treatment
which 81 86 2415 2420 O
may 87 90 2421 2424 O
interact 91 99 2425 2433 O
with 100 104 2434 2438 O
the 105 108 2439 2442 O
nelfinavir 109 119 2443 2453 B-treatment

Uncontrolled 0 12 2454 2466 O
intercurrent 13 25 2467 2479 O
illness 26 33 2480 2487 O
including 34 43 2488 2497 O
, 43 44 2497 2498 O
but 45 48 2499 2502 O
not 49 52 2503 2506 O
limited 53 60 2507 2514 O
to 61 63 2515 2517 O
symptomatic 64 75 2518 2529 O
congestive 76 86 2530 2540 B-chronic_disease
heart 87 92 2541 2546 I-chronic_disease
failure 93 100 2547 2554 I-chronic_disease
, 100 101 2554 2555 O
unstable 102 110 2556 2564 B-chronic_disease
angina 111 117 2565 2571 I-chronic_disease
pectoris 118 126 2572 2580 I-chronic_disease
, 126 127 2580 2581 O
or 128 130 2582 2584 O
psychiatric 131 142 2585 2596 B-chronic_disease
illness 143 150 2597 2604 I-chronic_disease
/ 150 151 2604 2605 O
social 151 157 2605 2611 O
situations 158 168 2612 2622 O
that 169 173 2623 2627 O
would 174 179 2628 2633 O
limit 180 185 2634 2639 O
compliance 186 196 2640 2650 O
with 197 201 2651 2655 O
study 202 207 2656 2661 O
requirements 208 220 2662 2674 O

Weight 0 6 2675 2681 B-clinical_variable
loss 7 11 2682 2686 O
of 12 14 2687 2689 O
> 15 16 2690 2691 O
10 17 19 2692 2694 B-lower_bound
% 19 20 2694 2695 I-lower_bound
over 21 25 2696 2700 O
the 26 29 2701 2704 O
past 30 34 2705 2709 B-upper_bound
6 35 36 2710 2711 I-upper_bound
months 37 43 2712 2718 I-upper_bound
which 44 49 2719 2724 O
is 50 52 2725 2727 O
due 53 56 2728 2731 O
to 57 59 2732 2734 O
tumor 60 65 2735 2740 B-chronic_disease
wasting 66 73 2741 2748 I-chronic_disease
syndrome 74 82 2749 2757 I-chronic_disease

Women 0 5 2758 2763 B-gender
of 6 8 2764 2766 O
childbearing 9 21 2767 2779 O
potential 22 31 2780 2789 O
who 32 35 2790 2793 O
have 36 40 2794 2798 O
a 41 42 2799 2800 O
positive 43 51 2801 2809 O
result 52 58 2810 2816 O
on 59 61 2817 2819 O
screening 62 71 2820 2829 O
urine 72 77 2830 2835 B-pregnancy
pregnancy 78 87 2836 2845 I-pregnancy
test 88 92 2846 2850 O

women 0 5 2851 2856 B-gender
of 6 8 2857 2859 O
childbearing 9 21 2860 2872 O
potential 22 31 2873 2882 O
and 32 35 2883 2886 O
men 36 39 2887 2890 O
must 40 44 2891 2895 O
agree 45 50 2896 2901 B-contraception_consent
to 51 53 2902 2904 I-contraception_consent
use 54 57 2905 2908 I-contraception_consent
adequate 58 66 2909 2917 I-contraception_consent
contraception 67 80 2918 2931 I-contraception_consent
( 81 82 2932 2933 O
hormonal 82 90 2933 2941 B-contraception_consent
or 91 93 2942 2944 I-contraception_consent
barrier 94 101 2945 2952 I-contraception_consent
method 102 108 2953 2959 I-contraception_consent
of 109 111 2960 2962 I-contraception_consent
birth 112 117 2963 2968 I-contraception_consent
control 118 125 2969 2976 I-contraception_consent
) 125 126 2976 2977 O
prior 127 132 2978 2983 O
to 133 135 2984 2986 O
study 136 141 2987 2992 O
entry 142 147 2993 2998 O
, 147 148 2998 2999 O
during 149 155 3000 3006 O
study 156 161 3007 3012 O
, 161 162 3012 3013 O
until 163 168 3014 3019 O
1 169 170 3020 3021 B-upper_bound
month 171 176 3022 3027 I-upper_bound
after 177 182 3028 3033 I-upper_bound
completion 183 193 3034 3044 O
of 194 196 3045 3047 O
the 197 200 3048 3051 O
final 201 206 3052 3057 O
FMISO 207 212 3058 3063 B-treatment
PET 213 216 3064 3067 I-treatment
/ 216 217 3067 3068 I-treatment
CT 217 219 3068 3070 I-treatment
scan 220 224 3071 3075 I-treatment

Allergy 0 7 0 7 O
or 8 10 8 10 O
intolerance 11 22 11 22 O
to 23 25 23 25 O
both 26 30 26 30 O
tetracyclines 31 44 31 44 B-allergy_name
AND 45 48 45 48 O
trimethoprim 49 61 49 61 B-allergy_name
, 61 62 61 62 O
sulfonamides 63 75 63 75 B-allergy_name
or 76 78 76 78 O
their 79 84 79 84 O
combination 85 96 85 96 O

Allergy 0 7 97 104 O
or 8 10 105 107 O
intolerance 11 22 108 119 O
to 23 25 120 122 O
tetracyclines 26 39 123 136 B-allergy_name
AND 40 43 137 140 O
known 44 49 141 146 O
potassium 50 59 147 156 B-clinical_variable
level 60 65 157 162 I-clinical_variable
> 66 67 163 164 O
5 68 69 165 166 B-lower_bound
mEq 70 73 167 170 I-lower_bound
/ 73 74 170 171 I-lower_bound
L 74 75 171 172 I-lower_bound
in 76 78 173 175 O
the 79 82 176 179 O
past 83 87 180 184 B-upper_bound
90 88 90 185 187 I-upper_bound
days 91 95 188 192 I-upper_bound

Allergy 0 7 193 200 O
or 8 10 201 203 O
intolerance 11 22 204 215 O
to 23 25 216 218 O
tetracyclines 26 39 219 232 B-allergy_name
AND 40 43 233 236 O
known 44 49 237 242 O
renal 50 55 243 248 O
insufficiency 56 69 249 262 O
( 70 71 263 264 O
defined 71 78 264 271 O
as 79 81 272 274 O
a 82 83 275 276 O
glomerular 84 94 277 287 B-clinical_variable
filtration 95 105 288 298 I-clinical_variable
rate 106 110 299 303 I-clinical_variable
( 111 112 304 305 I-clinical_variable
GFR 112 115 305 308 I-clinical_variable
) 115 116 308 309 I-clinical_variable
< 117 118 310 311 O
30 119 121 312 314 B-upper_bound
ml 122 124 315 317 I-upper_bound
within 125 131 318 324 O
the 132 135 325 328 O
previous 136 144 329 337 B-upper_bound
90 145 147 338 340 I-upper_bound
days 148 152 341 345 I-upper_bound
) 152 153 345 346 O

Concomitant 0 11 347 358 B-treatment
immunosuppression 12 29 359 376 I-treatment
with 30 34 377 381 O
azathioprine 35 47 382 394 B-treatment
, 47 48 394 395 O
mycophenolate 49 62 396 409 B-treatment
, 62 63 409 410 O
cyclophosphamide 64 80 411 427 B-treatment
, 80 81 427 428 O
or 82 84 429 431 O
cyclosporine 85 97 432 444 B-treatment

Contraindicated 0 15 445 460 O
for 16 19 461 464 O
antibiotic 20 30 465 475 B-allergy_name
therapy 31 38 476 483 I-allergy_name

If 0 2 484 486 O
the 3 6 487 490 O
enrolling 7 16 491 500 O
physician 17 26 501 510 O
feels 27 32 511 516 O
the 33 36 517 520 O
renal 37 42 521 526 B-chronic_disease
dysfunction 43 54 527 538 I-chronic_disease
has 55 58 539 542 O
resolved 59 67 543 551 O
, 67 68 551 552 O
documentation 69 82 553 566 O
to 83 85 567 569 O
that 86 90 570 574 O
effect 91 97 575 581 O
must 98 102 582 586 O
be 103 105 587 589 O
provided 106 114 590 598 O

Pregnant 0 8 599 607 B-pregnancy

Received 0 8 608 616 O
antimicrobial 9 22 617 630 B-treatment
therapy 23 30 631 638 I-treatment
in 31 33 639 641 O
the 34 37 642 645 O
past 38 42 646 650 B-upper_bound
30 43 45 651 653 I-upper_bound
days 46 50 654 658 I-upper_bound

Use 0 3 659 662 O
of 4 6 663 665 O
an 7 9 666 668 O
investigational 10 25 669 684 B-treatment
study 26 31 685 690 I-treatment
agent 32 37 691 696 I-treatment
for 38 41 697 700 O
IPF 42 45 701 704 B-treatment
therapy 46 53 705 712 I-treatment
within 54 60 713 719 O
the 61 64 720 723 O
past 65 69 724 728 B-upper_bound
30 70 72 729 731 I-upper_bound
days 73 77 732 736 I-upper_bound
, 77 78 736 737 O
or 79 81 738 740 O
an 82 84 741 743 O
IV 85 87 744 746 B-treatment
infusion 88 96 747 755 I-treatment
with 97 101 756 760 O
a 102 103 761 762 O
half 104 108 763 767 O
- 108 109 767 768 O
life 109 113 768 772 O
of 114 116 773 775 O
four 117 121 776 780 O
( 122 123 781 782 O
4 123 124 782 783 O
) 124 125 783 784 O
weeks 126 131 785 790 O

anticipate 0 10 791 801 B-pregnancy
becoming 11 19 802 810 I-pregnancy
pregnant 20 28 811 819 I-pregnancy

≥ 0 1 820 821 O
40 2 4 822 824 B-lower_bound
years 5 10 825 830 I-lower_bound
of 11 13 831 833 O
age 14 17 834 837 B-age

Active 0 6 0 6 O
pregnancy 7 16 7 16 B-pregnancy

Patients 0 8 17 25 O
age 9 12 26 29 B-age
< 13 14 30 31 O
18 14 16 31 33 B-upper_bound

Patients 0 8 34 42 O
receiving 9 18 43 52 O
antibiotic 19 29 53 63 B-treatment
doses 30 35 64 69 I-treatment
( 36 37 70 71 O
other 37 42 71 76 O
than 43 47 77 81 O
prescribed 48 58 82 92 O
for 59 62 93 96 O
the 63 66 97 100 O
study 67 72 101 106 O
) 72 73 106 107 O
within 74 80 108 114 O
the 81 84 115 118 O
seven 85 90 119 124 B-upper_bound
days 91 95 125 129 I-upper_bound
preceding 96 105 130 139 O
surgery 106 113 140 147 B-treatment

Positive 0 8 148 156 O
preoperative 9 21 157 169 O
urine 22 27 170 175 O
culture 28 35 176 183 O
within 36 42 184 190 O
3 43 44 191 192 B-upper_bound
months 45 51 193 199 I-upper_bound

Renal 0 5 200 205 B-chronic_disease
stone 6 11 206 211 I-chronic_disease
of 12 14 212 214 O
any 15 18 215 218 O
size 19 23 219 223 O
for 24 27 224 227 O
which 28 33 228 233 O
PCNL 34 38 234 238 B-treatment
is 39 41 239 241 O
recommended 42 53 242 253 O

both 0 4 254 258 O
men 5 8 259 262 B-gender
and 9 12 263 266 O
women 13 18 267 272 B-gender

Patients 0 8 0 8 O
less 9 13 9 13 O
than 14 18 14 18 O
12 19 21 19 21 B-upper_bound
months 22 28 22 28 I-upper_bound
of 29 31 29 31 O
age 32 35 32 35 B-age
who 36 39 36 39 O
have 40 44 40 44 O
been 45 49 45 49 O
admitted 50 58 50 58 O
to 59 61 59 61 O
the 62 65 62 65 O
hospital 66 74 66 74 O
after 75 80 75 80 O
brief 81 86 81 86 O
resolved 87 95 87 95 O
unexplained 96 107 96 107 O
event 108 113 108 113 O

Patients 0 8 114 122 O
with 9 13 123 127 O
any 14 17 128 131 O
pre 18 21 132 135 O
- 21 22 135 136 O
existing 22 30 136 144 O
significant 31 42 145 156 O
medical 43 50 157 164 O
diagnosis 51 60 165 174 O
( 61 62 175 176 O
congenital 62 72 176 186 B-chronic_disease
heart 73 78 187 192 I-chronic_disease
disease 79 86 193 200 I-chronic_disease
, 86 87 200 201 O
known 88 93 202 207 O
neurologic 94 104 208 218 B-chronic_disease
impairment 105 115 219 229 I-chronic_disease
with 116 120 230 234 O
or 121 123 235 237 O
without 124 131 238 245 O
seizure 132 139 246 253 B-chronic_disease
disorder 140 148 254 262 I-chronic_disease
, 148 149 262 263 O
other 150 155 264 269 O
congenital 156 166 270 280 B-chronic_disease
anomalies 167 176 281 290 I-chronic_disease
) 176 177 290 291 O

Patients 0 8 292 300 O
with 9 13 301 305 O
food 14 18 306 310 B-allergy_name
allergies 19 28 311 320 O
such 29 33 321 325 O
that 34 38 326 330 O
they 39 43 331 335 O
can 44 47 336 339 O
not 47 50 339 342 O
be 51 53 343 345 O
on 54 56 346 348 O
a 57 58 349 350 O
milk 59 63 351 355 O
or 64 66 356 358 O
rice 67 71 359 363 O
based 72 77 364 369 O
diet 78 82 370 374 O

Current 0 7 0 7 O
involvement 8 19 8 19 O
in 20 22 20 22 O
a 23 24 23 24 O
meditation 25 35 25 35 B-treatment
or 36 38 36 38 O
acupuncture 39 50 39 50 O
group 51 56 51 56 O

Currently 0 9 57 66 O
manic 10 15 67 72 B-chronic_disease

Currently 0 9 73 82 O
suffers 10 17 83 90 O
from 18 22 91 95 O
Gulf 23 27 96 100 B-chronic_disease
War 28 31 101 104 I-chronic_disease
Veterans 32 40 105 113 I-chronic_disease
' 40 41 113 114 I-chronic_disease
Illness 42 49 115 122 I-chronic_disease
( 50 51 123 124 O
i.e. 51 55 124 128 O
fatigue 56 63 129 136 B-chronic_disease
, 63 64 136 137 O
pain 65 69 138 142 B-chronic_disease
, 69 70 142 143 O
cognitive 71 80 144 153 B-chronic_disease
impairment 81 91 154 164 I-chronic_disease
) 91 92 164 165 O

Currently 0 9 166 175 O
suicidal 10 18 176 184 B-chronic_disease

Deployed 0 8 185 193 O
to 9 11 194 196 O
the 12 15 197 200 O
Gulf 16 20 201 205 O
War 21 24 206 209 O
between 25 32 210 217 O
1990 33 37 218 222 B-lower_bound
- 37 38 222 223 O
1991 38 42 223 227 B-upper_bound

Able 0 4 0 4 O
to 5 7 5 7 O
have 8 12 8 12 O
bronchoscopic 13 26 13 26 B-treatment
placement 27 36 27 36 I-treatment
of 37 39 37 39 I-treatment
Calypso 40 47 40 47 I-treatment
transponders 48 60 48 60 I-treatment
as 61 63 61 63 O
confirmed 64 73 64 73 O
on 74 76 74 76 O
a 77 78 77 78 O
recent 79 85 79 85 O
( 86 87 86 87 O
within 87 93 87 93 O
the 94 97 94 97 O
past 98 102 98 102 B-upper_bound
8 103 104 103 104 I-upper_bound
weeks 105 110 105 110 I-upper_bound
) 110 111 110 111 O
CT 112 114 112 114 O
scan 115 119 115 119 O

Active 0 6 120 126 O
implanted 7 16 127 136 O
devices 17 24 137 144 O
, 24 25 144 145 O
such 26 30 146 150 O
as 31 33 151 153 O
pacemakers 34 44 154 164 B-treatment
, 44 45 164 165 O
defibrillators 46 60 166 180 B-treatment
, 60 61 180 181 O
and 62 65 182 185 O
drug 66 70 186 190 B-treatment
infusion 71 79 191 199 I-treatment
pumps 80 85 200 205 I-treatment
since 86 91 206 211 O
the 92 95 212 215 O
effects 96 103 216 223 O
of 104 106 224 226 O
the 107 110 227 230 O
Calypso 111 118 231 238 B-treatment
System 119 125 239 245 I-treatment
operation 126 135 246 255 I-treatment
on 136 138 256 258 O
these 139 144 259 264 O
devices 145 152 265 272 O
are 153 156 273 276 O
unknown 157 164 277 284 O

Age 0 3 285 288 B-age
≥ 4 5 289 290 O
18 6 8 291 293 B-lower_bound
years 9 14 294 299 I-lower_bound
old 15 18 300 303 I-lower_bound

At 0 2 304 306 O
least 3 8 307 312 O
part 9 13 313 317 O
of 14 16 318 320 O
the 17 20 321 324 O
tumor 21 26 325 330 B-cancer
must 27 31 331 335 O
be 32 34 336 338 O
visible 35 42 339 346 O
as 43 45 347 349 O
observed 46 54 350 358 O
in 55 57 359 361 O
a 58 59 362 363 O
diagnostic 60 70 364 374 O
or 71 73 375 377 O
planning 74 82 378 386 O
CT 83 85 387 389 B-treatment

Bronchiectasis 0 14 390 404 B-chronic_disease
in 15 17 405 407 O
the 18 21 408 411 O
region 22 28 412 418 O
of 29 31 419 421 O
the 32 35 422 425 O
intended 36 44 426 434 O
implantation 45 57 435 447 O

Deemed 0 6 448 454 O
unable 7 13 455 461 O
to 14 16 462 464 O
safely 17 23 465 471 O
undergo 24 31 472 479 O
or 32 34 480 482 O
tolerate 35 43 483 491 O
flexible 44 52 492 500 B-treatment
bronchoscopy 53 65 501 513 I-treatment
as 66 68 514 516 O
per 69 72 517 520 O
institutional 73 86 521 534 O
guidelines 87 97 535 545 O

Female 0 6 546 552 B-gender
patients 7 15 553 561 O
who 16 19 562 565 O
are 20 23 566 569 B-pregnancy
pregnant 24 32 570 578 I-pregnancy

Histologic 0 10 579 589 O
proof 11 16 590 595 O
of 17 19 596 598 O
malignancy 20 30 599 609 B-cancer
suitable 31 39 610 618 O
for 40 43 619 622 O
thoracic 44 52 623 631 B-treatment
radiation 53 62 632 641 I-treatment
therapy 63 70 642 649 I-treatment

History 0 7 650 657 O
of 8 10 658 660 O
hypersensitivity 11 27 661 677 O
to 28 30 678 680 O
nickel 31 37 681 687 B-allergy_name

Implantation 0 12 688 700 O
of 13 15 701 703 O
transponders 16 28 704 716 O
will 29 33 717 721 O
degrade 34 41 722 729 O
MR 42 44 730 732 B-treatment
images 45 51 733 739 I-treatment

Karnofsky 0 9 740 749 B-clinical_variable
Performance 10 21 750 761 I-clinical_variable
Status 22 28 762 768 I-clinical_variable
≥ 29 30 769 770 O
60 31 33 771 773 B-lower_bound
% 33 34 773 774 I-lower_bound

Patient 0 7 775 782 O
is 8 10 783 785 O
planning 11 19 786 794 O
to 20 22 795 797 O
undergo 23 30 798 805 O
radiation 31 40 806 815 B-treatment
therapy 41 48 816 823 I-treatment
for 49 52 824 827 O
primary 53 60 828 835 O

Patients 0 8 836 844 O
whose 9 14 845 850 O
lung 15 19 851 855 B-cancer
tumors 20 26 856 862 I-cancer
are 27 30 863 866 O
being 31 36 867 872 O
monitored 37 46 873 882 O
by 47 49 883 885 O
MR 50 52 886 888 O
imaging 53 60 889 896 O
as 61 63 897 899 O
part 64 68 900 904 O
of 69 71 905 907 O
standard 72 80 908 916 O
clinical 81 89 917 925 O
care 90 94 926 930 O

Patients 0 8 931 939 O
with 9 13 940 944 O
clinically 14 24 945 955 O
significant 25 36 956 967 O
active 37 43 968 974 B-chronic_disease
infections 44 54 975 985 I-chronic_disease

Posterior 0 9 986 995 O
lesions 10 17 996 1003 O
that 18 22 1004 1008 O
would 23 28 1009 1014 O
be 29 31 1015 1017 O
> 32 33 1018 1019 O
19 33 35 1019 1021 B-lower_bound
cm 36 38 1022 1024 I-lower_bound
distance 39 47 1025 1033 O
from 48 52 1034 1038 O
Calypso 53 60 1039 1046 O
detector 61 69 1047 1055 O
plate 70 75 1056 1061 O

Unable 0 6 1062 1068 O
to 7 9 1069 1071 O
tolerate 10 18 1072 1080 O
anesthesia 19 29 1081 1091 B-treatment
or 30 32 1092 1094 O
sedation 33 41 1095 1103 B-treatment

recurrent 0 9 1104 1113 O
malignancies 10 22 1114 1126 B-cancer
of 23 25 1127 1129 I-cancer
the 26 29 1130 1133 I-cancer
lung 30 34 1134 1138 I-cancer
or 35 37 1139 1141 O
metastatic 38 48 1142 1152 B-cancer
malignancies 49 61 1153 1165 I-cancer
to 62 64 1166 1168 I-cancer
the 65 68 1169 1172 I-cancer
lung 69 73 1173 1177 I-cancer

> 0 1 0 1 O
= 1 2 1 2 O
Grade 3 8 3 8 B-lower_bound
2 9 10 9 10 I-lower_bound
hypercholesterolemia 11 31 11 31 B-clinical_variable

> 0 1 32 33 O
= 1 2 33 34 O
Grade 3 8 35 40 B-lower_bound
2 9 10 41 42 I-lower_bound
hypertriglyceridemia 11 31 43 63 B-clinical_variable

Absolute 0 8 64 72 B-clinical_variable
neutrophil 9 19 73 83 I-clinical_variable
count 20 25 84 89 I-clinical_variable
( 26 27 90 91 I-clinical_variable
ANC 27 30 91 94 I-clinical_variable
) 30 31 94 95 I-clinical_variable
> 32 33 96 97 O
= 33 34 97 98 O
1500 35 39 99 103 B-lower_bound
uL 40 42 104 106 I-lower_bound

Active 0 6 107 113 O
or 7 9 114 116 O
recent 10 16 117 123 O
history 17 24 124 131 O
of 25 27 132 134 O
hemoptysis 28 38 135 145 B-chronic_disease

Angina 0 6 146 152 B-chronic_disease
pectoris 7 15 153 161 I-chronic_disease

Any 0 3 162 165 O
illness 4 11 166 173 O
that 12 16 174 178 O
in 17 19 179 181 O
the 20 23 182 185 O
opinion 24 31 186 193 O
of 32 34 194 196 O
the 35 38 197 200 O
investigator 39 51 201 213 O
would 52 57 214 219 O
compromise 58 68 220 230 O
the 69 72 231 234 O
ability 73 80 235 242 O
of 81 83 243 245 O
the 84 87 246 249 O
patient 88 95 250 257 O
to 96 98 258 260 O
participate 99 110 261 272 O
safely 111 117 273 279 O
in 118 120 280 282 O
the 121 124 283 286 O
clinical 125 133 287 295 B-treatment
trial 134 139 296 301 I-treatment

Cardiac 0 7 302 309 B-chronic_disease
arrhythmia 8 18 310 320 I-chronic_disease

Eastern 0 7 321 328 B-clinical_variable
Cooperative 8 19 329 340 I-clinical_variable
Oncology 20 28 341 349 I-clinical_variable
Group 29 34 350 355 I-clinical_variable
( 35 36 356 357 I-clinical_variable
ECOG 36 40 357 361 I-clinical_variable
) 40 41 361 362 I-clinical_variable
performance 42 53 363 374 I-clinical_variable
status 54 60 375 381 I-clinical_variable
( 61 62 382 383 I-clinical_variable
PS 62 64 383 385 I-clinical_variable
) 64 65 385 386 I-clinical_variable
0 66 67 387 388 B-lower_bound
, 67 68 388 389 O
1 69 70 390 391 O
, 70 71 391 392 O
2 72 73 393 394 B-upper_bound

Hemoglobin 0 10 395 405 B-clinical_variable
( 11 12 406 407 I-clinical_variable
Hgb 12 15 407 410 I-clinical_variable
) 15 16 410 411 I-clinical_variable
> 17 18 412 413 O
= 18 19 413 414 O
9 20 21 415 416 B-lower_bound
g 22 23 417 418 I-lower_bound
/ 23 24 418 419 I-lower_bound
dL 24 26 419 421 I-lower_bound

Histologic 0 10 422 432 O
or 11 13 433 435 O
cytologic 14 23 436 445 O
confirmation 24 36 446 458 O
of 37 39 459 461 O
lung 40 44 462 466 B-cancer
cancer 45 51 467 473 I-cancer
( 52 53 474 475 O
squamous 53 61 475 483 B-cancer
, 61 62 483 484 O
ras 63 66 485 488 B-cancer
- 66 67 488 489 I-cancer
mutated 67 74 489 496 I-cancer
adenocarcinoma 75 89 497 511 I-cancer
or 90 92 512 514 O
small 93 98 515 520 B-cancer
cell 99 103 521 525 I-cancer
lung 104 108 526 530 I-cancer
cancer 109 115 531 537 I-cancer
) 115 116 537 538 O

History 0 7 539 546 O
of 8 10 547 549 O
congestive 11 21 550 560 B-clinical_variable
heart 22 27 561 566 I-clinical_variable
failure 28 35 567 574 I-clinical_variable
= 36 37 575 576 O
< 37 38 576 577 O
3 39 40 578 579 B-upper_bound
months 41 47 580 586 I-upper_bound

Human 0 5 587 592 B-chronic_disease
immunodeficiency 6 22 593 609 I-chronic_disease
virus 23 28 610 615 I-chronic_disease
( 29 30 616 617 I-chronic_disease
HIV)-positive 30 43 617 630 I-chronic_disease
patients 44 52 631 639 O
receiving 53 62 640 649 O
combination 63 74 650 661 O
anti 75 79 662 666 B-treatment
- 79 80 666 667 I-treatment
retroviral 80 90 667 677 I-treatment
therapy 91 98 678 685 I-treatment

Hypertension 0 12 686 698 B-chronic_disease

Interstitial 0 12 699 711 B-chronic_disease
pneumonia 13 22 712 721 I-chronic_disease
or 23 25 722 724 O
extensive 26 35 725 734 B-chronic_disease
and 36 39 735 738 I-chronic_disease
symptomatic 40 51 739 750 I-chronic_disease
interstitial 52 64 751 763 I-chronic_disease
fibrosis 65 73 764 772 I-chronic_disease
of 74 76 773 775 I-chronic_disease
the 77 80 776 779 I-chronic_disease
lung 81 85 780 784 I-chronic_disease

Life 0 4 785 789 B-clinical_variable
expectancy 5 15 790 800 I-clinical_variable
> 16 17 801 802 O
= 17 18 802 803 O
12 19 21 804 806 B-lower_bound
weeks 22 27 807 812 I-lower_bound

Major 0 5 813 818 B-treatment
surgery 6 13 819 826 I-treatment
( 14 15 827 828 O
i.e. 15 19 828 832 O
, 19 20 832 833 O
laparotomy 21 31 834 844 B-treatment
) 31 32 844 845 O
, 32 33 845 846 O
open 34 38 847 851 B-treatment
biopsy 39 45 852 858 I-treatment
, 45 46 858 859 O
or 47 49 860 862 O
significant 50 61 863 874 O
traumatic 62 71 875 884 B-chronic_disease
injury 72 78 885 891 I-chronic_disease
= 79 80 892 893 O
< 80 81 893 894 O
4 82 83 895 896 B-upper_bound
weeks 84 89 897 902 I-upper_bound
prior 90 95 903 908 I-upper_bound
to 96 98 909 911 O
registration 99 111 912 924 O
; 111 112 924 925 O
minor 113 118 926 931 B-treatment
surgery 119 126 932 939 I-treatment
= 127 128 940 941 O
< 128 129 941 942 O
2 130 131 943 944 B-upper_bound
weeks 132 137 945 950 I-upper_bound
prior 138 143 951 956 I-upper_bound
to 144 146 957 959 O
registration 147 159 960 972 O
; 159 160 972 973 O
insertion 161 170 974 983 O
of 171 173 984 986 O
a 174 175 987 988 O
vascular 176 184 989 997 B-treatment
access 185 191 998 1004 I-treatment
device 192 198 1005 1011 I-treatment
is 199 201 1012 1014 O
not 202 205 1015 1018 O
considered 206 216 1019 1029 O
major 217 222 1030 1035 B-treatment
or 223 225 1036 1038 I-treatment
minor 226 231 1039 1044 I-treatment
surgery 232 239 1045 1052 I-treatment
in 240 242 1053 1055 O
this 243 247 1056 1060 O
regard 248 254 1061 1067 O

Men 0 3 1068 1071 B-gender
or 4 6 1072 1074 O
women 7 12 1075 1080 B-gender
of 13 15 1081 1083 O
childbearing 16 28 1084 1096 O
potential 29 38 1097 1106 O
who 39 42 1107 1110 O
are 43 46 1111 1114 O
unwilling 47 56 1115 1124 B-contraception_consent
to 57 59 1125 1127 I-contraception_consent
employ 60 66 1128 1134 I-contraception_consent
adequate 67 75 1135 1143 I-contraception_consent
contraception 76 89 1144 1157 I-contraception_consent

Myocardial 0 10 1158 1168 B-chronic_disease
infarction 11 21 1169 1179 I-chronic_disease
= 22 23 1180 1181 O
< 23 24 1181 1182 O
6 25 26 1183 1184 B-upper_bound
months 27 33 1185 1191 I-upper_bound
prior 34 39 1192 1197 I-upper_bound
to 40 42 1198 1200 O
registration 43 55 1201 1213 O

Negative 0 8 1214 1222 B-pregnancy
serum 9 14 1223 1228 I-pregnancy
pregnancy 15 24 1229 1238 I-pregnancy
test 25 29 1239 1243 O
done 30 34 1244 1248 O
= 35 36 1249 1250 O
< 36 37 1250 1251 O
7 38 39 1252 1253 B-upper_bound
days 40 44 1254 1258 I-upper_bound
prior 45 50 1259 1264 I-upper_bound
to 51 53 1265 1267 O
registration 54 66 1268 1280 O
, 66 67 1280 1281 O
for 68 71 1282 1285 O
women 72 77 1286 1291 B-gender
of 78 80 1292 1294 O
childbearing 81 93 1295 1307 O
potential 94 103 1308 1317 O
only 104 108 1318 1322 O

Non 0 3 1323 1326 B-cancer
- 3 4 1326 1327 I-cancer
melanoma 4 12 1327 1335 I-cancer
skin 13 17 1336 1340 I-cancer
cancer 18 24 1341 1347 I-cancer

Nursing 0 7 1348 1355 O
women 8 13 1356 1361 B-gender

Other 0 5 1362 1367 O
active 6 12 1368 1374 O
malignancy 13 23 1375 1385 B-cancer

Patients 0 8 1386 1394 O
must 9 13 1395 1399 O
have 14 18 1400 1404 O
received 19 27 1405 1413 O
at 28 30 1414 1416 O
least 31 36 1417 1422 O
one 37 40 1423 1426 B-lower_bound
course 41 47 1427 1433 O
of 48 50 1434 1436 O
chemotherapy 51 63 1437 1449 B-treatment
consisting 64 74 1450 1460 O
of 75 77 1461 1463 O
a 78 79 1464 1465 O
platinum 80 88 1466 1474 O
doublet 89 96 1475 1482 O
and 97 100 1483 1486 O
must 101 105 1487 1491 O
have 106 110 1492 1496 O
no 111 113 1497 1499 O
acceptable 114 124 1500 1510 O
standard 125 133 1511 1519 O
treatment 134 143 1520 1529 B-treatment
options 144 151 1530 1537 O

Platelets 0 9 1538 1547 B-clinical_variable
( 10 11 1548 1549 I-clinical_variable
PLT 11 14 1549 1552 I-clinical_variable
) 14 15 1552 1553 I-clinical_variable
> 16 17 1554 1555 O
= 17 18 1555 1556 O
100,000 19 26 1557 1564 B-lower_bound
uL 27 29 1565 1567 I-lower_bound

Poorly 0 6 1568 1574 B-chronic_disease
controlled 7 17 1575 1585 I-chronic_disease
diabetes 18 26 1586 1594 I-chronic_disease

Pregnant 0 8 1595 1603 B-pregnancy
women 9 14 1604 1609 B-gender

Prior 0 5 1610 1615 B-treatment
radiation 6 15 1616 1625 I-treatment
therapy 16 23 1626 1633 I-treatment

Radiation 0 9 1634 1643 B-treatment
to 10 12 1644 1646 O
> 13 14 1647 1648 O
= 14 15 1648 1649 O
25 16 18 1650 1652 B-lower_bound
% 18 19 1652 1653 I-lower_bound
of 20 22 1654 1656 I-lower_bound
bone 23 27 1657 1661 I-lower_bound
marrow 28 34 1662 1668 I-lower_bound

Recovered 0 9 1669 1678 O
from 10 14 1679 1683 O
the 15 18 1684 1687 O
toxic 19 24 1688 1693 O
effects 25 32 1694 1701 O
of 33 35 1702 1704 O
radiation 36 45 1705 1714 B-treatment
treatment 46 55 1715 1724 I-treatment
before 56 62 1725 1731 O
study 63 68 1732 1737 O
entry 69 74 1738 1743 O

Symptomatic 0 11 1744 1755 O
, 11 12 1755 1756 O
untreated 13 22 1757 1766 O
, 22 23 1766 1767 O
or 24 26 1768 1770 O
uncontrolled 27 39 1771 1783 O
central 40 47 1784 1791 B-cancer
nervous 48 55 1792 1799 I-cancer
system 56 62 1800 1806 I-cancer
( 63 64 1807 1808 I-cancer
CNS 64 67 1808 1811 I-cancer
) 67 68 1811 1812 I-cancer
metastases 69 79 1813 1823 I-cancer
or 80 82 1824 1826 O
seizure 83 90 1827 1834 B-chronic_disease
disorder 91 99 1835 1843 I-chronic_disease

Total 0 5 1844 1849 B-clinical_variable
bilirubin 6 15 1850 1859 I-clinical_variable
= 16 17 1860 1861 O
< 17 18 1861 1862 O
1.5 19 22 1863 1866 B-upper_bound
x 23 24 1867 1868 I-upper_bound
upper 25 30 1869 1874 I-upper_bound
limit 31 36 1875 1880 I-upper_bound
of 37 39 1881 1883 I-upper_bound
normal 40 46 1884 1890 I-upper_bound
( 47 48 1891 1892 I-upper_bound
ULN 48 51 1892 1895 I-upper_bound
) 51 52 1895 1896 I-upper_bound
or 53 55 1897 1899 O
direct 56 62 1900 1906 B-clinical_variable
bilirubin 63 72 1907 1916 I-clinical_variable
= 73 74 1917 1918 O
< 74 75 1918 1919 O
ULN 76 79 1920 1923 O

Unable 0 6 1924 1930 O
to 7 9 1931 1933 O
discontinue 10 21 1934 1945 O
use 22 25 1946 1949 O
of 26 28 1950 1952 O
potent 29 35 1953 1959 O
cytochrome 36 46 1960 1970 B-treatment
P450 47 51 1971 1975 I-treatment
, 51 52 1975 1976 O
family 53 59 1977 1983 B-treatment
3 60 61 1984 1985 I-treatment
, 61 62 1985 1986 O
subfamily 63 72 1987 1996 B-treatment
A 73 74 1997 1998 I-treatment
, 74 75 1998 1999 O
polypeptide 76 87 2000 2011 B-treatment
4 88 89 2012 2013 I-treatment
( 90 91 2014 2015 I-treatment
CYP3A4 91 97 2015 2021 I-treatment
) 97 98 2021 2022 I-treatment
inhibitors 99 109 2023 2033 I-treatment
/ 109 110 2033 2034 I-treatment
inducers 110 118 2034 2042 I-treatment

Use 0 3 2043 2046 O
of 4 6 2047 2049 O
St. 7 10 2050 2053 B-treatment
John 11 15 2054 2058 I-treatment
's 15 17 2058 2060 I-treatment
Wort 18 22 2061 2065 I-treatment
because 23 30 2066 2073 O
of 31 33 2074 2076 O
its 34 37 2077 2080 O
effects 38 45 2081 2088 O
on 46 48 2089 2091 O
hepatic 49 56 2092 2099 O
drug 57 61 2100 2104 O
metabolism 62 72 2105 2115 O

alopecia 0 8 2116 2124 B-chronic_disease

carcinoma 0 9 2125 2134 B-cancer
- 9 10 2134 2135 I-cancer
in 10 12 2135 2137 I-cancer
- 12 13 2137 2138 I-cancer
situ 13 17 2138 2142 I-cancer
of 18 20 2143 2145 O
the 21 24 2146 2149 O
cervix 25 31 2150 2156 O

ejection 0 8 2157 2165 B-clinical_variable
fraction 9 17 2166 2174 I-clinical_variable
> 18 19 2175 2176 O
40 20 22 2177 2179 B-lower_bound
% 22 23 2179 2180 I-lower_bound

history 0 7 2181 2188 O
of 8 10 2189 2191 O
poor 11 15 2192 2196 O
compliance 16 26 2197 2207 O
with 27 31 2208 2212 O
antihypertensive 32 48 2213 2229 B-treatment
medication 49 59 2230 2240 I-treatment

labile 0 6 2241 2247 B-chronic_disease
hypertension 7 19 2248 2260 I-chronic_disease

localized 0 9 2261 2270 B-cancer
prostate 10 18 2271 2279 I-cancer
cancer 19 25 2280 2286 I-cancer

patients 0 8 2287 2295 O
with 9 13 2296 2300 O
treated 14 21 2301 2308 O
CNS 22 25 2309 2312 B-cancer
metastases 26 36 2313 2323 I-cancer
without 37 44 2324 2331 O
evidence 45 53 2332 2340 O
of 54 56 2341 2343 O
progression 57 68 2344 2355 O
and 69 72 2356 2359 O
without 73 80 2360 2367 O
uncontrolled 81 93 2368 2380 O
symptoms 94 102 2381 2389 O
or 103 105 2390 2392 O
need 106 110 2393 2397 O
for 111 114 2398 2401 O
steroids 115 123 2402 2410 B-treatment
may 124 127 2411 2414 O
enroll 128 134 2415 2421 O

English 0 7 0 7 B-language_fluency
speaking 8 16 8 16 I-language_fluency
due 17 20 17 20 O
to 21 23 21 23 O
feasibility 24 35 24 35 O
of 36 38 36 38 O
providing 39 48 39 48 O
the 49 52 49 52 O
web 53 56 53 56 O
- 56 57 56 57 O
based 57 62 57 62 O
intervention 63 75 63 75 O
only 76 80 76 80 O
in 81 83 81 83 O
English 84 91 84 91 O
at 92 94 92 94 O
this 95 99 95 99 O
time 100 104 100 104 O

Lack 0 4 105 109 O
of 5 7 110 112 O
access 8 14 113 119 B-technology_access
to 15 17 120 122 I-technology_access
a 18 19 123 124 I-technology_access
computer 20 28 125 133 I-technology_access
that 29 33 134 138 O
is 34 36 139 141 O
connected 37 46 142 151 O
to 47 49 152 154 O
the 50 53 155 158 O
worldwide 54 63 159 168 O
web 64 67 169 172 O

Reporting 0 9 173 182 O
a 10 11 183 184 O
pain 12 16 185 189 B-clinical_variable
severity 17 25 190 198 I-clinical_variable
score 26 31 199 204 I-clinical_variable
on 32 34 205 207 O
the 35 38 208 211 O
Brief 39 44 212 217 O
Pain 45 49 218 222 O
inventory 50 59 223 232 O
of 60 62 233 235 O
4 63 64 236 237 B-lower_bound
( 65 66 238 239 O
0 66 67 239 240 B-lower_bound
- 67 68 240 241 O
10 68 70 241 243 B-upper_bound
) 70 71 243 244 O
or 72 74 245 247 O
higher 75 81 248 254 O

Reporting 0 9 255 264 O
pain 10 14 265 269 O
of 15 17 270 272 O
at 18 20 273 275 O
least 21 26 276 281 O
3 27 28 282 283 B-lower_bound
months 29 35 284 290 I-lower_bound
duration 36 44 291 299 O

Significant 0 11 300 311 O
neurological 12 24 312 324 B-chronic_disease
or 25 27 325 327 O
psychiatric 28 39 328 339 B-chronic_disease
condition 40 49 340 349 I-chronic_disease
precluding 50 60 350 360 O
informed 61 69 361 369 O
consent 70 77 370 377 O

> 0 1 0 1 O
2 1 2 1 2 B-lower_bound
falls 3 8 3 8 O
/ 8 9 8 9 O
year 9 13 9 13 O

Active 0 6 14 20 O
cancer 7 13 21 27 B-cancer
or 14 16 28 30 O
infection 17 26 31 40 B-chronic_disease

Body 0 4 41 45 B-bmi
mass 5 9 46 50 I-bmi
index 10 15 51 56 I-bmi
: 15 16 56 57 O
< 17 18 58 59 O
40 18 20 59 61 B-upper_bound
kg 21 23 62 64 I-upper_bound
/ 23 24 64 65 I-upper_bound
sq 24 26 65 67 I-upper_bound
meter 27 32 68 73 I-upper_bound

Exercise 0 8 74 82 B-clinical_variable
training 9 17 83 91 I-clinical_variable
( 18 19 92 93 O
≥2 19 21 93 95 O
sessions 22 30 96 104 I-lower_bound
/ 30 31 104 105 I-lower_bound
week 31 35 105 109 I-lower_bound
) 35 36 109 110 O
or 37 39 111 113 O
≥10,000 40 47 114 121 O
steps 48 53 122 127 I-lower_bound
/ 53 54 127 128 I-lower_bound
day 54 57 128 131 I-lower_bound

Insulin 0 7 132 139 B-treatment
therapy 8 15 140 147 I-treatment
, 15 16 147 148 O
significant 17 28 149 160 O
diabetic 29 37 161 169 B-chronic_disease
complications 38 51 170 183 I-chronic_disease
, 51 52 183 184 O
or 53 55 185 187 O
A1c>8 56 61 188 193 B-clinical_variable
% 61 62 193 194 I-lower_bound

Non 0 3 195 198 O
- 3 4 198 199 O
diabetic 4 12 199 207 O
or 13 15 208 210 O
with 16 20 211 215 O
Type 21 25 216 220 B-chronic_disease
2 26 27 221 222 I-chronic_disease
Diabetes 28 36 223 231 I-chronic_disease
Mellitus 37 45 232 240 I-chronic_disease

Pre 0 3 241 244 B-chronic_disease
- 3 4 244 245 I-chronic_disease
diabetes 4 12 245 253 I-chronic_disease
per 13 16 254 257 O
American 17 25 258 266 O
Diabetes 26 34 267 275 O
Association 35 46 276 287 O
criteria 47 55 288 296 O

Recent 0 6 297 303 O
( 7 8 304 305 O
within 8 14 305 311 O
3 15 16 312 313 B-upper_bound
months 17 23 314 320 I-upper_bound
) 23 24 320 321 O
treatment 25 34 322 331 B-treatment
with 35 39 332 336 I-treatment
anabolic 40 48 337 345 I-treatment
steroids 49 57 346 354 I-treatment
, 57 58 354 355 O
systemic 59 67 356 364 B-treatment
corticosteroids 68 83 365 380 I-treatment
or 84 86 381 383 O
estrogen 87 95 384 392 B-treatment

Score 0 5 393 398 O
≥26 6 9 399 402 O
on 10 12 403 405 O
the 13 16 406 409 O
30 17 19 410 412 B-clinical_variable
- 19 20 412 413 I-clinical_variable
item 20 24 413 417 I-clinical_variable
Mini 25 29 418 422 I-clinical_variable
Mental 30 36 423 429 I-clinical_variable
State 37 42 430 435 I-clinical_variable
Examination 43 54 436 447 I-clinical_variable

Significant 0 11 448 459 O
cardiovascular 12 26 460 474 B-chronic_disease
, 26 27 474 475 O
liver 28 33 476 481 B-chronic_disease
, 33 34 481 482 O
renal 35 40 483 488 B-chronic_disease
, 40 41 488 489 O
blood 42 47 490 495 B-chronic_disease
, 47 48 495 496 O
or 49 51 497 499 O
respiratory 52 63 500 511 B-chronic_disease
disease 64 71 512 519 I-chronic_disease

weight 0 6 520 526 B-clinical_variable
loss 7 11 527 531 I-clinical_variable
> 12 13 532 533 O
5 13 14 533 534 B-lower_bound
% 14 15 534 535 I-lower_bound
in 16 18 536 538 O
the 19 22 539 542 O
past 23 27 543 547 B-upper_bound
6 28 29 548 549 I-upper_bound
months 30 36 550 556 I-upper_bound

Patients 0 8 0 8 O
with 9 13 9 13 O
a 14 15 14 15 O
Category 16 24 16 24 B-lower_bound
II 25 27 25 27 I-lower_bound
or 28 30 28 30 O
III 31 34 31 34 B-upper_bound
fetal 35 40 35 40 B-clinical_variable
heart 41 46 41 46 I-clinical_variable
rate 47 51 47 51 I-clinical_variable
tracing 52 59 52 59 I-clinical_variable

ages 0 4 60 64 B-age
of 5 7 65 67 O
18 8 10 68 70 B-lower_bound
and 11 14 71 74 O
45 15 17 75 77 B-upper_bound
years 18 23 78 83 I-upper_bound

at 0 2 84 86 O
term 3 7 87 91 O
gestation 8 17 92 101 B-clinical_variable
( 18 19 102 103 O
≥ 19 20 103 104 O
37 21 23 105 107 B-lower_bound
weeks 24 29 108 113 I-lower_bound
) 29 30 113 114 O

pregnant 0 8 115 123 B-pregnancy
females 9 16 124 131 B-gender

prolonged 0 9 132 141 B-chronic_disease
rupture 10 17 142 149 I-chronic_disease
of 18 20 150 152 I-chronic_disease
membranes 21 30 153 162 I-chronic_disease

Aspartate 0 9 0 9 B-clinical_variable
aminotransferase 10 26 10 26 I-clinical_variable
or 27 29 27 29 I-clinical_variable
alanine 30 37 30 37 I-clinical_variable
aminotransferase 38 54 38 54 I-clinical_variable
≥ 55 56 55 56 O
3X 57 59 57 59 B-lower_bound
ULN 60 63 60 63 I-lower_bound
or 64 66 64 66 O
total 67 72 67 72 O
bilirubin 73 82 73 82 B-clinical_variable
≥ 83 84 83 84 O
1.5X 85 89 85 89 B-lower_bound
ULN 90 93 90 93 I-lower_bound

BMI 0 3 94 97 B-bmi
outside 4 11 98 105 O
the 12 15 106 109 O
range 16 21 110 115 O
( 22 23 116 117 O
below 23 28 117 122 O
the 29 32 123 126 O
5th 33 36 127 130 B-upper_bound
percentile 37 47 131 141 I-upper_bound
or 48 50 142 144 O
above 51 56 145 150 O
the 57 60 151 154 O
95th 61 65 155 159 B-lower_bound
percentile 66 76 160 170 I-lower_bound
) 76 77 170 171 O
for 78 81 172 175 O
height 82 88 176 182 O

Disseminated 0 12 183 195 B-chronic_disease
intravascular 13 26 196 209 I-chronic_disease
coagulation 27 38 210 221 I-chronic_disease
as 39 41 222 224 O
evidenced 42 51 225 234 O
by 52 54 235 237 O
prothrombin 55 66 238 249 B-clinical_variable
time 67 71 250 254 I-clinical_variable
or 72 74 255 257 O
partial 75 82 258 265 B-clinical_variable
thromboplastin 83 97 266 280 I-clinical_variable
time 98 102 281 285 I-clinical_variable
≥ 103 104 286 287 O
2X 105 107 288 290 B-lower_bound
the 108 111 291 294 I-lower_bound
ULN 112 115 295 298 I-lower_bound
or 116 118 299 301 O
platelets 119 128 302 311 B-clinical_variable
< 129 130 312 313 O
50 131 133 314 316 B-upper_bound
% 133 134 316 317 I-upper_bound
of 135 137 318 320 I-upper_bound
the 138 141 321 324 I-upper_bound
lower 142 147 325 330 I-upper_bound
limit 148 153 331 336 I-upper_bound
of 154 156 337 339 I-upper_bound
normal 157 163 340 346 I-upper_bound

Evidence 0 8 347 355 O
of 9 11 356 358 O
significant 12 23 359 370 O
hepatic 24 31 371 378 B-chronic_disease
disease 32 39 379 386 I-chronic_disease
or 40 42 387 389 O
dysfunction 43 54 390 401 O
, 54 55 401 402 O
including 56 65 403 412 O
known 66 71 413 418 O
acute 72 77 419 424 B-chronic_disease
viral 78 83 425 430 I-chronic_disease
hepatitis 84 93 431 440 I-chronic_disease
or 94 96 441 443 O
hepatic 97 104 444 451 B-chronic_disease
encephalopathy 105 119 452 466 I-chronic_disease

Female 0 6 467 473 B-gender
adolescent 7 17 474 484 I-gender
subjects 18 26 485 493 I-gender
who 27 30 494 497 O
are 31 34 498 501 B-pregnancy
pregnant 35 43 502 510 I-pregnancy
or 44 46 511 513 O
breastfeeding 47 60 514 527 O
or 61 63 528 530 O
have 64 68 531 535 O
a 69 70 536 537 O
positive 71 79 538 546 B-pregnancy
serum 80 85 547 552 I-pregnancy
β 86 87 553 554 I-pregnancy
- 87 88 554 555 I-pregnancy
hCG 88 91 555 558 I-pregnancy
pregnancy 92 101 559 568 I-pregnancy
test 102 106 569 573 O
at 107 109 574 576 O
screening 110 119 577 586 O
and 120 123 587 590 O
at 124 126 591 593 O
pre 127 130 594 597 O
- 130 131 597 598 O
dose 131 135 598 602 O
Day 136 139 603 606 O
1 140 141 607 608 O

Females 0 7 609 616 B-gender
who 8 11 617 620 O
are 12 15 621 624 O
of 16 18 625 627 O
childbearing 19 31 628 640 O
potential 32 41 641 650 O
and 42 45 651 654 O
unwilling 46 55 655 664 O
to 56 58 665 667 O
practice 59 67 668 676 O
abstinence 68 78 677 687 O
or 79 81 688 690 O
use 82 85 691 694 O
at 86 88 695 697 O
least 89 94 698 703 O
two 95 98 704 707 O
methods 99 106 708 715 O
of 107 109 716 718 O
contraception 110 123 719 732 O
( 124 125 733 734 O
oral 125 129 734 738 O
contraceptives 130 144 739 753 O
, 144 145 753 754 O
barrier 146 153 755 762 O
methods 154 161 763 770 O
, 161 162 770 771 O
approved 163 171 772 780 O
contraceptive 172 185 781 794 O
implant 186 193 795 802 O
) 193 194 802 803 O
during 195 201 804 810 O
the 202 205 811 814 O
entire 206 212 815 821 O
study 213 218 822 827 O
period 219 225 828 834 O

Hypothermia 0 11 835 846 B-chronic_disease
( 12 13 847 848 O
core 13 17 848 852 B-clinical_variable
temperature 18 29 853 864 I-clinical_variable
< 30 31 865 866 O
35.6 32 36 867 871 B-upper_bound
ºC 37 39 872 874 I-upper_bound
or 40 42 875 877 O
96.1 43 47 878 882 B-upper_bound
ºF 48 50 883 885 I-upper_bound
) 50 51 885 886 O

If 0 2 887 889 O
female 3 9 890 896 B-gender
and 10 13 897 900 O
has 14 17 901 904 O
reached 18 25 905 912 O
menarche 26 34 913 921 O
, 34 35 921 922 O
or 36 38 923 925 O
has 39 42 926 929 O
reached 43 50 930 937 O
Tanner 51 57 938 944 O
Stage 58 63 945 950 O
3 64 65 951 952 O
breast 66 72 953 959 O
development 73 84 960 971 O
( 85 86 972 973 O
even 86 90 973 977 O
if 91 93 978 980 O
not 94 97 981 984 O
having 98 104 985 991 O
reached 105 112 992 999 O
menarche 113 121 1000 1008 O
) 121 122 1008 1009 O
, 122 123 1009 1010 O
the 124 127 1011 1014 O
subject 128 135 1015 1022 O
is 136 138 1023 1025 O
practicing 139 149 1026 1036 B-contraception_consent
appropriate 150 161 1037 1048 I-contraception_consent
birth 162 167 1049 1054 I-contraception_consent
control 168 175 1055 1062 I-contraception_consent
or 176 178 1063 1065 O
is 179 181 1066 1068 O
sexually 182 190 1069 1077 O
abstinent 191 200 1078 1087 O

Known 0 5 1088 1093 O
significant 6 17 1094 1105 O
hypersensitivity 18 34 1106 1122 O
to 35 37 1123 1125 O
any 38 41 1126 1129 O
beta 42 46 1130 1134 B-allergy_name
- 46 47 1134 1135 I-allergy_name
lactam 47 53 1135 1141 I-allergy_name
antibiotic 54 64 1142 1152 I-allergy_name

Male 0 4 1153 1157 B-gender

Males 0 5 1158 1163 B-gender
who 6 9 1164 1167 O
are 10 13 1168 1171 O
unwilling 14 23 1172 1181 O
to 24 26 1182 1184 O
practice 27 35 1185 1193 O
abstinence 36 46 1194 1204 O
or 47 49 1205 1207 O
use 50 53 1208 1211 O
an 54 56 1212 1214 O
acceptable 57 67 1215 1225 O
method 68 74 1226 1232 O
of 75 77 1233 1235 O
broth 78 83 1236 1241 O
control 84 91 1242 1249 O
during 92 98 1250 1256 O
the 99 102 1257 1260 O
entire 103 109 1261 1267 O
study 110 115 1268 1273 O
period 116 122 1274 1280 O
( 123 124 1281 1282 O
i.e. 124 128 1282 1286 O
condom 129 135 1287 1293 O
with 136 140 1294 1298 O
spermicide 141 151 1299 1309 O
) 151 152 1309 1310 O

Neutropenia 0 11 1311 1322 O
with 12 16 1323 1327 O
absolute 17 25 1328 1336 B-clinical_variable
neutrophil 26 36 1337 1347 I-clinical_variable
count 37 42 1348 1353 I-clinical_variable
( 43 44 1354 1355 I-clinical_variable
ANC 44 47 1355 1358 I-clinical_variable
) 47 48 1358 1359 I-clinical_variable
< 49 50 1360 1361 O
500 51 54 1362 1365 B-upper_bound
cells 55 60 1366 1371 I-upper_bound
/ 60 61 1371 1372 I-upper_bound
mm3 61 64 1372 1375 I-upper_bound

Prior 0 5 1376 1381 O
exposure 6 14 1382 1390 O
to 15 17 1391 1393 O
vaborbactam 18 29 1394 1405 B-treatment
or 30 32 1406 1408 O
Vabomere 33 41 1409 1417 B-treatment

Receipt 0 7 1418 1425 O
of 8 10 1426 1428 O
any 11 14 1429 1432 O
investigational 15 30 1433 1448 O
medication 31 41 1449 1459 O
or 42 44 1460 1462 O
investigational 45 60 1463 1478 O
device 61 67 1479 1485 O
within 68 74 1486 1492 O
30 75 77 1493 1495 B-upper_bound
days 78 82 1496 1500 I-upper_bound
prior 83 88 1501 1506 I-upper_bound
to 89 91 1507 1509 O
enrollment 92 102 1510 1520 O

Signs 0 5 1521 1526 O
of 6 8 1527 1529 O
severe 9 15 1530 1536 B-chronic_disease
sepsis 16 22 1537 1543 I-chronic_disease

The 0 3 1544 1547 O
subject 4 11 1548 1555 O
will 12 16 1556 1560 O
be 17 19 1561 1563 O
observed 20 28 1564 1572 O
in 29 31 1573 1575 O
the 32 35 1576 1579 O
hospital 36 44 1580 1588 O
for 45 48 1589 1592 O
at 49 51 1593 1595 O
least 52 57 1596 1601 O
6 58 59 1602 1603 B-lower_bound
hours 60 65 1604 1609 I-lower_bound
after 66 71 1610 1615 O
the 72 75 1616 1619 O
study 76 81 1620 1625 O
drug 82 86 1626 1630 O
is 87 89 1631 1633 O
administered 90 102 1634 1646 O

Use 0 3 1647 1650 O
of 4 6 1651 1653 O
meropenem 7 16 1654 1663 B-treatment
within 17 23 1664 1670 O
48 24 26 1671 1673 B-upper_bound
hours 27 32 1674 1679 I-upper_bound
of 33 35 1680 1682 O
administration 36 50 1683 1697 O
of 51 53 1698 1700 O
study 54 59 1701 1706 O
drug 60 64 1707 1711 O
or 65 67 1712 1714 O
12 68 70 1715 1717 B-upper_bound
hours 71 76 1718 1723 I-upper_bound
after 77 82 1724 1729 O
study 83 88 1730 1735 O
drug 89 93 1736 1740 O
administration 94 108 1741 1755 O

age 0 3 1756 1759 B-age
and 4 7 1760 1763 O
weight 8 14 1764 1770 B-clinical_variable
except 15 21 1771 1777 O
for 22 25 1778 1781 O
children 26 34 1782 1790 O
< 35 36 1791 1792 O
2 37 38 1793 1794 B-upper_bound
years 39 44 1795 1800 I-upper_bound
of 45 47 1801 1803 O
age 48 51 1804 1807 O

from 0 4 1808 1812 O
birth 5 10 1813 1818 O
to 11 13 1819 1821 O
< 14 15 1822 1823 O
18 16 18 1824 1826 B-upper_bound
years 19 24 1827 1832 I-upper_bound
of 25 27 1833 1835 O
age 28 31 1836 1839 B-age

subjects 0 8 1840 1848 O
receiving 9 18 1849 1858 O
peri 19 23 1859 1863 O
- 23 24 1863 1864 O
operative 24 33 1864 1873 O
prophylactic 34 46 1874 1886 O
use 47 50 1887 1890 O
of 51 53 1891 1893 O
antibiotics 54 65 1894 1905 B-treatment

> 0 1 0 1 O
2 2 3 2 3 B-lower_bound
weeks 4 9 4 9 I-lower_bound
of 10 12 10 12 O
age 13 16 13 16 B-age
and 17 20 17 20 O
< 21 22 21 22 O
18 23 25 23 25 B-upper_bound
years 26 31 26 31 I-upper_bound
of 32 34 32 34 O
age 35 38 35 38 O

> 0 1 39 40 O
60 2 4 41 43 B-lower_bound
% 4 5 43 44 I-lower_bound
calories 6 14 45 53 O
from 15 19 54 58 O
parenteral 20 30 59 69 O
nutrition 31 40 70 79 O

Acquired 0 8 80 88 O
or 9 11 89 91 O
congenital 12 22 92 102 B-chronic_disease
gastrointestinal 23 39 103 119 I-chronic_disease
disease 40 47 120 127 I-chronic_disease

Anticoagulant 0 13 128 141 B-treatment
therapy 14 21 142 149 I-treatment

Diabetes 0 8 150 158 B-chronic_disease

Direct 0 6 159 165 B-clinical_variable
bilirubin 7 16 166 175 I-clinical_variable
greater 17 24 176 183 O
or 25 27 184 186 O
equal 28 33 187 192 O
to 34 36 193 195 O
2 37 38 196 197 B-lower_bound
mg 39 41 198 200 I-lower_bound
/ 41 42 200 201 I-lower_bound
dL 42 44 201 203 I-lower_bound
on 45 47 204 206 O
2 48 49 207 208 O
consecutive 50 61 209 220 O
measurements 62 74 221 233 O

Documented 0 10 234 244 O
case 11 15 245 249 O
of 16 18 250 252 O
liver 19 24 253 258 B-chronic_disease
disease 25 32 259 266 I-chronic_disease
other 33 38 267 272 O
than 39 43 273 277 O
Parenteral 44 54 278 288 O
Nutrition 55 64 289 298 O
Associated 65 75 299 309 O
Cholestasis 76 87 310 321 O

Expected 0 8 322 330 O
parenteral 9 19 331 341 B-clinical_variable
nutrition 20 29 342 351 I-clinical_variable
course 30 36 352 358 I-clinical_variable
greater 37 44 359 366 O
than 45 49 367 371 O
30 50 52 372 374 B-lower_bound
days 53 57 375 379 I-lower_bound

Extracorporeal 0 14 380 394 B-treatment
Membrane 15 23 395 403 I-treatment
Oxygenation 24 35 404 415 I-treatment

Failed 0 6 416 422 O
standard 7 15 423 431 B-treatment
therapies 16 25 432 441 I-treatment
to 26 28 442 444 O
prevent 29 36 445 452 O
progression 37 48 453 464 O
of 49 51 465 467 O
liver 52 57 468 473 B-chronic_disease
disease 58 65 474 481 I-chronic_disease
( 66 67 482 483 O
Actigal 67 74 483 490 O
, 74 75 490 491 O
cyclic 76 82 492 498 O
parenteral 83 93 499 509 O
nutrition 94 103 510 519 O
, 103 104 519 520 O
avoidance 105 114 521 530 O
of 115 117 531 533 O
overfeeding 118 129 534 545 O
, 129 130 545 546 O
reduction 131 140 547 556 O
/ 140 141 556 557 O
removal 141 148 557 564 O
of 149 151 565 567 O
copper 152 158 568 574 O
from 159 163 575 579 O
parenteral 164 174 580 590 O
nutrition 175 184 591 600 O
if 185 187 601 603 O
elevated 188 196 604 612 O
my 197 199 613 615 O
laboratory 200 210 616 626 O
analysis 211 219 627 635 O
, 219 220 635 636 O
advancement 221 232 637 648 O
of 233 235 649 651 O
enteral 236 243 652 659 O
feeds 244 249 660 665 O
) 249 250 665 666 O

Fatal 0 5 667 672 B-chronic_disease
chromosomal 6 17 673 684 I-chronic_disease
disorder 18 26 685 693 I-chronic_disease

Patient 0 7 694 701 O
expected 8 16 702 710 O
to 17 19 711 713 O
weaned 20 26 714 720 O
from 27 31 721 725 O
parenteral 32 42 726 736 B-treatment
nutrition 43 52 737 746 I-treatment
in 53 55 747 749 O
30 56 58 750 752 B-upper_bound
days 59 63 753 757 I-upper_bound

Seafood 0 7 758 765 B-allergy_name
, 7 8 765 766 O
egg 9 12 767 770 B-allergy_name
, 12 13 770 771 O
or 14 16 772 774 O
Omegaven 17 25 775 783 B-allergy_name
allergy 26 33 784 791 O

Stroke 0 6 792 798 B-chronic_disease

pulmonary 0 9 799 808 B-chronic_disease
embolism 10 18 809 817 I-chronic_disease

recent 0 6 818 824 O
myocardial 7 17 825 835 B-chronic_disease
infarction 18 28 836 846 I-chronic_disease

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
18 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

Blood 0 5 15 20 B-clinical_variable
pressure 6 14 21 29 I-clinical_variable
of 15 17 30 32 O
> 18 19 33 34 O
140/90 19 25 34 40 B-lower_bound
mmHg 26 30 41 45 I-lower_bound
for 31 34 46 49 O
patients 35 43 50 58 O
less 44 48 59 63 O
than 49 53 64 68 O
60 54 56 69 71 B-upper_bound
years 57 62 72 77 I-upper_bound

Cognitively 0 11 78 89 B-chronic_disease
impaired 12 20 90 98 I-chronic_disease
persons 21 28 99 106 O

Conditions 0 10 107 117 O
with 11 15 118 122 O
visual 16 22 123 129 B-chronic_disease
field 23 28 130 135 I-chronic_disease
deterioration 29 42 136 149 I-chronic_disease
( 43 44 150 151 O
Anterior 44 52 151 159 B-chronic_disease
Ischemic 53 61 160 168 I-chronic_disease
Optic 62 67 169 174 I-chronic_disease
Neuropathy 68 78 175 185 I-chronic_disease
, 78 79 185 186 O
Glaucoma 80 88 187 195 B-chronic_disease
, 88 89 195 196 O
Optic 90 95 197 202 B-chronic_disease
Nerve 96 101 203 208 I-chronic_disease
Disorders 102 111 209 218 I-chronic_disease
) 111 112 218 219 O

Currently 0 9 220 229 O
receiving 10 19 230 239 O
3 20 21 240 241 O
anti 22 26 242 246 B-treatment
- 26 27 246 247 I-treatment
hypertensive 27 39 247 259 I-treatment
agents 40 46 260 266 I-treatment
, 46 47 266 267 O
one 48 51 268 271 O
of 52 54 272 274 O
which 55 60 275 280 O
is 61 63 281 283 O
a 64 65 284 285 O
diuretic 66 74 286 294 B-treatment
, 74 75 294 295 O
for 76 79 296 299 O
at 80 82 300 302 O
least 83 88 303 308 O
3 89 90 309 310 B-upper_bound
months 91 97 311 317 I-upper_bound

Pregnant 0 8 318 326 B-pregnancy
women 9 14 327 332 B-gender

2 0 1 0 1 B-lower_bound
- 1 2 1 2 O
10 2 4 2 4 B-upper_bound
weeks 5 10 5 10 I-upper_bound
post 11 15 11 15 O
sexual 16 22 16 22 O
assault 23 30 23 30 O

Access 0 6 31 37 B-technology_access
to 7 9 38 40 I-technology_access
a 10 11 41 42 I-technology_access
telephone 12 21 43 52 I-technology_access

Age 0 3 53 56 B-age
> 4 5 57 58 O
18 6 8 59 61 B-lower_bound
years 9 14 62 67 I-lower_bound

Drinking 0 8 68 76 O
more 9 13 77 81 O
than 14 18 82 86 O
3 19 20 87 88 B-lower_bound
drinks 21 27 89 95 O
on 28 30 96 98 O
one 31 34 99 102 O
occasion 35 43 103 111 O
in 44 46 112 114 O
the 47 50 115 118 O
last 51 55 119 123 O
month 56 61 124 129 O
and 62 65 130 133 O
at 66 68 134 136 O
least 69 74 137 142 O
two 75 78 143 146 B-lower_bound
reported 79 87 147 155 O
negative 88 96 156 164 O
consequences 97 109 165 177 O
of 110 112 178 180 O
alcohol 113 120 181 188 O
use 121 124 189 192 O

Exhibit 0 7 193 200 O
current 8 15 201 208 O
psychosis 16 25 209 218 B-chronic_disease

Identifies 0 10 219 229 O
as 11 13 230 232 O
female 14 20 233 239 B-gender

Previous 0 8 240 248 O
non 9 12 249 252 O
- 12 13 252 253 O
response 13 21 253 261 O
to 22 24 262 264 O
an 25 27 265 267 O
adequate 28 36 268 276 O
trial 37 42 277 282 O
( 43 44 283 284 O
8 44 45 284 285 B-lower_bound
or 46 48 286 288 O
more 49 53 289 293 O
sessions 54 62 294 302 O
) 62 63 302 303 O
of 64 66 304 306 O
Cognitive 67 76 307 316 B-treatment
Processing 77 87 317 327 I-treatment
Therapy 88 95 328 335 I-treatment
( 96 97 336 337 I-treatment
CPT 97 100 337 340 I-treatment
) 100 101 340 341 I-treatment

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,500 35 40 35 40 B-lower_bound
/ 40 41 40 41 I-lower_bound
mcl 41 44 41 44 I-lower_bound

Alkaline 0 8 45 53 B-clinical_variable
phosphatase 9 20 54 65 I-clinical_variable
= 21 22 66 67 O
< 22 23 67 68 O
3 24 25 69 70 B-upper_bound
x 26 27 71 72 I-upper_bound
ULN 28 31 73 76 I-upper_bound

Aspartate 0 9 77 86 B-clinical_variable
aminotransferase 10 26 87 103 I-clinical_variable
( 27 28 104 105 I-clinical_variable
AST 28 31 105 108 I-clinical_variable

Bilirubin 0 9 109 118 B-clinical_variable
= 10 11 119 120 O
< 11 12 120 121 O
1.5 13 16 122 125 B-upper_bound
x 17 18 126 127 I-upper_bound
ULN 19 22 128 131 I-upper_bound

Creatinine 0 10 132 142 B-clinical_variable
= 11 12 143 144 O
< 12 13 144 145 O
1.5 14 17 146 149 B-upper_bound
times 18 23 150 155 I-upper_bound
institutional 24 37 156 169 I-upper_bound
upper 38 43 170 175 I-upper_bound
limit 44 49 176 181 I-upper_bound
of 50 52 182 184 I-upper_bound
normal 53 59 185 191 I-upper_bound
( 60 61 192 193 I-upper_bound
ULN 61 64 193 196 I-upper_bound
) 64 65 196 197 I-upper_bound

Patients 0 8 198 206 O
judged 9 15 207 213 O
capable 16 23 214 221 O
of 24 26 222 224 O
tolerating 27 37 225 235 O
a 38 39 236 237 O
radical 40 47 238 245 O
course 48 54 246 252 O
of 55 57 253 255 O
chemoradiation 58 72 256 270 B-treatment
therapy 73 80 271 278 I-treatment

Patients 0 8 279 287 O
who 9 12 288 291 O
have 13 17 292 296 O
received 18 26 297 305 O
prior 27 32 306 311 B-treatment
pelvic 33 39 312 318 I-treatment
radiation 40 49 319 328 I-treatment
or 50 52 329 331 O
cytotoxic 53 62 332 341 B-treatment
chemotherapy 63 75 342 354 I-treatment

Patients 0 8 355 363 O
with 9 13 364 368 O
T2 14 16 369 371 B-cancer
or 17 19 372 374 I-cancer
T3 20 22 375 377 I-cancer
primary 23 30 378 385 I-cancer
tumors 31 37 386 392 I-cancer
( 38 39 393 394 I-cancer
N0 39 41 394 396 I-cancer
- 41 42 396 397 I-cancer
3 42 43 397 398 I-cancer
, 43 44 398 399 I-cancer
M0 45 47 400 402 I-cancer
) 47 48 402 403 I-cancer
not 49 52 404 407 O
amenable 53 61 408 416 O
to 62 64 417 419 O
surgical 65 73 420 428 B-treatment
resection 74 83 429 438 I-treatment
by 84 86 439 441 O
standard 87 95 442 450 O
radical 96 103 451 458 B-treatment
vulvectomy 104 114 459 469 I-treatment

Patients 0 8 470 478 O
with 9 13 479 483 O
a 14 15 484 485 O
GOG 16 19 486 489 B-clinical_variable
performance 20 31 490 501 I-clinical_variable
status 32 38 502 508 I-clinical_variable
of 39 41 509 511 O
0 42 43 512 513 B-lower_bound
, 43 44 513 514 O
1 45 46 515 516 O
, 46 47 516 517 O
or 48 50 518 520 O
2 51 52 521 522 B-upper_bound

Patients 0 8 523 531 O
with 9 13 532 536 O
evidence 14 22 537 545 O
of 23 25 546 548 O
active 26 32 549 555 O
septicemia 33 43 556 566 B-chronic_disease
, 43 44 566 567 O
severe 45 51 568 574 O
infection 52 61 575 584 B-chronic_disease
, 61 62 584 585 O
gastrointestinal 63 79 586 602 B-chronic_disease
bleeding 80 88 603 611 I-chronic_disease
or 89 91 612 614 O
severe 92 98 615 621 O
gastrointestinal 99 115 622 638 B-chronic_disease
symptoms 116 124 639 647 I-chronic_disease
requiring 125 134 648 657 O
medical 135 142 658 665 B-treatment
or 143 145 666 668 I-treatment
surgical 146 154 669 677 I-treatment
therapy 155 162 678 685 I-treatment

Patients 0 8 686 694 O
with 9 13 695 699 O
locally 14 21 700 707 O
advanced 22 30 708 716 O
, 30 31 716 717 O
previously 32 42 718 728 O
untreated 43 52 729 738 O
squamous 53 61 739 747 B-cancer
cell 62 66 748 752 I-cancer
carcinoma 67 76 753 762 I-cancer
of 77 79 763 765 I-cancer
the 80 83 766 769 I-cancer
vulva 84 89 770 775 I-cancer

Patients 0 8 776 784 O
with 9 13 785 789 O
recurrent 14 23 790 799 O
carcinoma 24 33 800 809 B-cancer
of 34 36 810 812 I-cancer
the 37 40 813 816 I-cancer
vulva 41 46 817 822 I-cancer
regardless 47 57 823 833 O
of 58 60 834 836 O
previous 61 69 837 845 O
treatment 70 79 846 855 B-treatment

Patients 0 8 856 864 O
with 9 13 865 869 O
vulvar 14 20 870 876 B-cancer
melanomas 21 30 877 886 I-cancer
or 31 33 887 889 O
sarcomas 34 42 890 898 B-cancer

Platelets 0 9 899 908 B-clinical_variable
> 10 11 909 910 O
= 11 12 910 911 O
100,000 13 20 912 919 B-lower_bound
/ 20 21 919 920 I-lower_bound
mcl 21 24 920 923 I-lower_bound

alanine 0 7 924 931 B-clinical_variable
aminotransferase 8 24 932 948 I-clinical_variable
( 25 26 949 950 I-clinical_variable
ALT 26 29 950 953 I-clinical_variable
) 29 30 953 954 I-clinical_variable
= 31 32 955 956 O
< 32 33 956 957 O
3.0 34 37 958 961 B-upper_bound
x 38 39 962 963 I-upper_bound
ULN 40 43 964 967 I-upper_bound

calculated 0 10 968 978 O
creatinine 11 21 979 989 B-clinical_variable
clearance 22 31 990 999 I-clinical_variable
> 32 33 1000 1001 O
= 33 34 1001 1002 O
60 35 37 1003 1005 B-lower_bound
mL 38 40 1006 1008 I-lower_bound
/ 40 41 1008 1009 I-lower_bound
min 41 44 1009 1012 I-lower_bound

Agrees 0 6 0 6 O
not 7 10 7 10 O
to 11 13 11 13 O
change 14 20 14 20 O
medications 21 32 21 32 B-treatment
during 33 39 33 39 O
the 40 43 40 43 O
study 44 49 44 49 O

Bipolar 0 7 50 57 B-chronic_disease
II 8 10 58 60 I-chronic_disease

Bipolar 0 7 61 68 B-chronic_disease
NOS 8 11 69 72 I-chronic_disease
, 11 12 72 73 O

Clinical 0 8 74 82 O
or 9 11 83 85 O
laboratory 12 22 86 96 O
evidence 23 31 97 105 O
of 32 34 106 108 O
hypothyroidism 35 49 109 123 B-chronic_disease
( 50 51 124 125 O
if 51 53 125 127 O
maintained 54 64 128 138 O
on 65 67 139 141 O
thyroid 68 75 142 149 B-treatment
medication 76 86 150 160 I-treatment
must 87 91 161 165 O
be 92 94 166 168 O
euthyroid 95 104 169 178 O
for 105 108 179 182 O
at 109 111 183 185 O
least 112 117 186 191 O
1 118 119 192 193 B-lower_bound
month 120 125 194 199 I-lower_bound
before 126 132 200 206 I-lower_bound
Visit 133 138 207 212 O
1 139 140 213 214 O
) 140 141 214 215 O

Conditions 0 10 216 226 O
which 11 16 227 232 O
may 17 20 233 236 O
be 21 23 237 239 O
negatively 24 34 240 250 O
affected 35 43 251 259 O
by 44 46 260 262 O
bezafibrate 47 58 263 274 B-treatment
treatment 59 68 275 284 I-treatment
, 68 69 284 285 O
such 70 74 286 290 O
as 75 77 291 293 O
hepatobiliary 78 91 294 307 B-chronic_disease
disease 92 99 308 315 I-chronic_disease

Current 0 7 316 323 O
use 8 11 324 327 O
of 12 14 328 330 O
a 15 16 331 332 O
fibrate 17 24 333 340 B-treatment
or 25 27 341 343 O
history 28 35 344 351 O
of 36 38 352 354 O
anaphylactic 39 51 355 367 O
reaction 52 60 368 376 O
or 61 63 377 379 O
intolerance 64 75 380 391 O
to 76 78 392 394 O
fibrates 79 87 395 403 B-treatment
or 88 90 404 406 O
any 91 94 407 410 O
component 95 104 411 420 O
of 105 107 421 423 O
the 108 111 424 427 O
preparation 112 123 428 439 O

Current 0 7 440 447 O
use 8 11 448 451 O
of 12 14 452 454 O
of 15 17 455 457 O
MAO 18 21 458 461 B-treatment
Inhibitors 22 32 462 472 I-treatment
, 32 33 472 473 O
statins 34 41 474 481 B-treatment
, 41 42 481 482 O
and 43 46 483 486 O
anticoagulants 47 61 487 501 B-treatment

Cyclothymia 0 11 502 513 B-chronic_disease

DSM 0 3 514 517 O
IV 4 6 518 520 O
diagnosis 7 16 521 530 O
of 17 19 531 533 O
Bipolar 20 27 534 541 B-chronic_disease
Disorder 28 36 542 550 I-chronic_disease
Type 37 41 551 555 I-chronic_disease
I 42 43 556 557 I-chronic_disease

History 0 7 558 565 O
of 8 10 566 568 O
Type 11 15 569 573 B-chronic_disease
1 16 17 574 575 I-chronic_disease
or 18 20 576 578 I-chronic_disease
Type 21 25 579 583 I-chronic_disease
II 26 28 584 586 I-chronic_disease
Diabetes 29 37 587 595 I-chronic_disease

History 0 7 596 603 O
of 8 10 604 606 O
significant 11 22 607 618 O
treatment 23 32 619 628 B-treatment
non 33 36 629 632 O
- 36 37 632 633 O
adherence 37 46 633 642 O
or 47 49 643 645 O
situations 50 60 646 656 O
where 61 66 657 662 O
the 67 70 663 666 O
subjects 71 79 667 675 O
is 80 82 676 678 O
unlikely 83 91 679 687 O
to 92 94 688 690 O
adhere 95 101 691 697 O
to 102 104 698 700 O
treatment 105 114 701 710 O
, 114 115 710 711 O
in 116 118 712 714 O
the 119 122 715 718 O
opinion 123 130 719 726 O
of 131 133 727 729 O
the 134 137 730 733 O
investigator 138 150 734 746 O

History 0 7 747 754 O
of 8 10 755 757 O
stroke 11 17 758 764 B-chronic_disease
or 18 20 765 767 O
cerebrovascular 21 36 768 783 B-chronic_disease
disease 37 44 784 791 I-chronic_disease

Meets 0 5 792 797 O
criteria 6 14 798 806 O
for 15 18 807 810 O
a 19 20 811 812 O
current 21 28 813 820 O
major 29 34 821 826 B-chronic_disease
depressive 35 45 827 837 I-chronic_disease
episode 46 53 838 845 I-chronic_disease
as 54 56 846 848 O
defined 57 64 849 856 O
and 65 68 857 860 O
operationalized 69 84 861 876 O
by 85 87 877 879 O
the 88 91 880 883 O
MINI 92 96 884 888 B-clinical_variable
and 97 100 889 892 O
by 101 103 893 895 O
a 104 105 896 897 O
MADRS 106 111 898 903 B-clinical_variable
score 112 117 904 909 I-clinical_variable
of 118 120 910 912 O
> 121 122 913 914 O
18 122 124 914 916 B-lower_bound
at 125 127 917 919 O
screen 128 134 920 926 O
and 135 138 927 930 O
baseline 139 147 931 939 O
( 148 149 940 941 O
randomization 149 162 941 954 O
) 162 163 954 955 O

Men 0 3 956 959 B-gender

OCD 0 3 960 963 B-chronic_disease
or 4 6 964 966 O
OCD 7 10 967 970 B-chronic_disease
- 10 11 970 971 I-chronic_disease
spectrum 11 19 971 979 I-chronic_disease
disorders 20 29 980 989 I-chronic_disease

Patients 0 8 990 998 O
who 9 12 999 1002 O
are 13 16 1003 1006 O
a 17 18 1007 1008 O
serious 19 26 1009 1016 B-chronic_disease
suicide 27 34 1017 1024 I-chronic_disease
or 35 37 1025 1027 O
homicide 38 46 1028 1036 B-chronic_disease
risk 47 51 1037 1041 I-chronic_disease

Pregnant 0 8 1042 1050 B-pregnancy
women 9 14 1051 1056 B-gender

Primary 0 7 1057 1064 O
diagnosis 8 17 1065 1074 O
of 18 20 1075 1077 O
anxiety 21 28 1078 1085 B-chronic_disease
disorders 29 38 1086 1095 I-chronic_disease
or 39 41 1096 1098 O
patients 42 50 1099 1107 O
where 51 56 1108 1113 O
the 57 60 1114 1117 O
anxiety 61 68 1118 1125 O
disorder 69 77 1126 1134 O
is 78 80 1135 1137 O
the 81 84 1138 1141 O
primary 85 92 1142 1149 O
focus 93 98 1150 1155 O
of 99 101 1156 1158 O
treatment 102 111 1159 1168 B-treatment

Schizoaffective 0 15 1169 1184 B-chronic_disease
Disorder 16 24 1185 1193 I-chronic_disease

Subjects 0 8 1194 1202 O
having 9 15 1203 1209 O
failed 16 22 1210 1216 O
two 23 26 1217 1220 B-lower_bound
or 27 29 1221 1223 O
more 30 34 1224 1228 O
trials 35 41 1229 1235 O
of 42 44 1236 1238 O
somatic 45 52 1239 1246 B-treatment
therapy 53 60 1247 1254 I-treatment

Suspected 0 9 1255 1264 O
or 10 12 1265 1267 O
known 13 18 1268 1273 O
clinically 19 29 1274 1284 O
unstable 30 38 1285 1293 O
systemic 39 47 1294 1302 B-chronic_disease
medical 48 55 1303 1310 I-chronic_disease
disorder 56 64 1311 1319 I-chronic_disease
including 65 74 1320 1329 O
epilepsy 75 83 1330 1338 B-chronic_disease
, 83 84 1338 1339 O
untreated 85 94 1340 1349 O
endocrine 95 104 1350 1359 B-chronic_disease
disease 105 112 1360 1367 I-chronic_disease
, 112 113 1367 1368 O
unstable 114 122 1369 1377 B-chronic_disease
angina 123 129 1378 1384 I-chronic_disease
, 129 130 1384 1385 O
recent 131 137 1386 1392 O
ulcers 138 144 1393 1399 B-chronic_disease
or 145 147 1400 1402 O
significant 148 159 1403 1414 O
esophagitis 160 171 1415 1426 B-chronic_disease

Taking 0 6 1427 1433 O
an 7 9 1434 1436 O
adequate 10 18 1437 1445 O
dose 19 23 1446 1450 O
of 24 26 1451 1453 O
any 27 30 1454 1457 O
FDA 31 34 1458 1461 O
- 34 35 1461 1462 O
approved 35 43 1462 1470 O
anti 44 48 1471 1475 B-treatment
- 48 49 1475 1476 I-treatment
manic 49 54 1476 1481 I-treatment
medication 55 65 1482 1492 I-treatment
for 66 69 1493 1496 O
at 70 72 1497 1499 O
least 73 78 1500 1505 O
two 79 82 1506 1509 B-lower_bound
weeks 83 88 1510 1515 I-lower_bound
prior 89 94 1516 1521 I-lower_bound
to 95 97 1522 1524 O
enrollment 98 108 1525 1535 O

ages 0 4 1536 1540 B-age
of 5 7 1541 1543 O
18 8 10 1544 1546 B-lower_bound
and 11 14 1547 1550 O
65 15 17 1551 1553 B-upper_bound

delusional 0 10 1554 1564 B-chronic_disease
disorder 11 19 1565 1573 I-chronic_disease

psychotic 0 9 1574 1583 B-chronic_disease
disorders 10 19 1584 1593 I-chronic_disease
not 20 23 1594 1597 O
elsewhere 24 33 1598 1607 O
classified 34 44 1608 1618 O

schizophrenia 0 13 1619 1632 B-chronic_disease

severe 0 6 1633 1639 O
borderline 7 17 1640 1650 B-chronic_disease
or 18 20 1651 1653 O
antisocial 21 31 1654 1664 B-chronic_disease
personality 32 43 1665 1676 I-chronic_disease
disorder 44 52 1677 1685 I-chronic_disease

substance 0 9 1686 1695 O
use 10 13 1696 1699 O
disorders 14 23 1700 1709 O
, 23 24 1709 1710 O
including 25 34 1711 1720 O
alcohol 35 42 1721 1728 O
, 42 43 1728 1729 O
active 44 50 1730 1736 O
within 51 57 1737 1743 O
the 58 61 1744 1747 O
3 62 63 1748 1749 B-upper_bound
months 64 70 1750 1756 I-upper_bound

women 0 5 1757 1762 B-gender

women 0 5 1763 1768 B-gender
of 6 8 1769 1771 O
child 9 14 1772 1777 O
bearing 15 22 1778 1785 O
potential 23 32 1786 1795 O
who 33 36 1796 1799 O
are 37 40 1800 1803 O
not 41 44 1804 1807 B-contraception_consent
using 45 50 1808 1813 I-contraception_consent
a 51 52 1814 1815 I-contraception_consent
medically 53 62 1816 1825 I-contraception_consent
accepted 63 71 1826 1834 I-contraception_consent
means 72 77 1835 1840 I-contraception_consent
of 78 80 1841 1843 I-contraception_consent
contraception 81 94 1844 1857 I-contraception_consent

BMI 0 3 0 3 B-bmi
between 4 11 4 11 O
18 12 14 12 14 B-lower_bound
- 14 15 14 15 O
35 15 17 15 17 B-upper_bound

Pregnant 0 8 18 26 B-pregnancy
females 9 16 27 34 B-gender

Subjects 0 8 35 43 O
will 9 13 44 48 O
be 14 16 49 51 O
of 17 19 52 54 O
generally 20 29 55 64 O
good 30 34 65 69 O
health 35 41 70 76 O
and 42 45 77 80 O
will 46 50 81 85 O
have 51 55 86 90 O
decided 56 63 91 98 O
to 64 66 99 101 O
undergo 67 74 102 109 O
ACL 75 78 110 113 B-treatment
reconstruction 79 93 114 128 I-treatment
surgery 94 101 129 136 I-treatment
and 102 105 137 140 O
agreed 106 112 141 147 O
to 113 115 148 150 O
participate 116 127 151 162 O
in 128 130 163 165 O
the 131 134 166 169 O
study 135 140 170 175 O
( 141 142 176 177 O
following 142 151 177 186 O
informed 152 160 187 195 O
consent 161 168 196 203 O
procedures 169 179 204 214 O
) 179 180 214 215 O

Use 0 3 216 219 O
of 4 6 220 222 O
a 7 8 223 224 O
quad 9 13 225 229 B-treatment
tendon 14 20 230 236 I-treatment
graft 21 26 237 242 I-treatment
or 27 29 243 245 O
BTB 30 33 246 249 B-treatment
graft 34 39 250 255 I-treatment

between 0 7 256 263 O
age 8 11 264 267 B-age
of 12 14 268 270 O
14 15 17 271 273 B-lower_bound
- 17 18 273 274 O
40 18 20 274 276 B-upper_bound

display 0 7 277 284 O
a 8 9 285 286 O
quantitative 10 22 287 299 B-clinical_variable
pivot 23 28 300 305 I-clinical_variable
shift 29 34 306 311 I-clinical_variable
test 35 39 312 316 I-clinical_variable
of 40 42 317 319 O
> 43 44 320 321 O
=3 44 46 321 323 O
mm 47 49 324 326 I-lower_bound
lateral 50 57 327 334 O
translation 58 69 335 346 O

have 0 4 347 351 O
a 5 6 352 353 O
contralateral 7 20 354 367 O
healthy 21 28 368 375 O
knee 29 33 376 380 O
and 34 37 381 384 O
within 38 44 385 391 O
12 45 47 392 394 B-upper_bound
months 48 54 395 401 I-upper_bound
of 55 57 402 404 O
grade 58 63 405 410 O
3 64 65 411 412 O
injury 66 72 413 419 O
to 73 75 420 422 O
the 76 79 423 426 O
ipsilateral 80 91 427 438 O
ACL 92 95 439 442 O

no 0 2 443 445 O
greater 3 10 446 453 O
than 11 15 454 458 O
grade 16 21 459 464 B-upper_bound
2 22 23 465 466 I-upper_bound
injury 24 30 467 473 O
to 31 33 474 476 O
MCL 34 37 477 480 O
or 38 40 481 483 O
LCL 41 44 484 487 O
and 45 48 488 491 O
absence 49 56 492 499 O
of 57 59 500 502 O
PCL 60 63 503 506 O
injury 64 70 507 513 O

A 0 1 0 1 O
past 2 6 2 6 O
medical 7 14 7 14 O
history 15 22 15 22 O
of 23 25 23 25 O
human 26 31 26 31 B-chronic_disease
immunodeficiency 32 48 32 48 I-chronic_disease
virus 49 54 49 54 I-chronic_disease
( 55 56 55 56 I-chronic_disease
HIV 56 59 56 59 I-chronic_disease
) 59 60 59 60 I-chronic_disease
or 61 63 61 63 O
hepatitis 64 73 64 73 B-chronic_disease
A 74 75 74 75 I-chronic_disease
, 75 76 75 76 I-chronic_disease
B 77 78 77 78 I-chronic_disease
, 78 79 78 79 I-chronic_disease
or 80 82 80 82 I-chronic_disease
C 83 84 83 84 I-chronic_disease
infection 85 94 85 94 I-chronic_disease

Any 0 3 95 98 O
injectable 4 14 99 109 B-treatment
intravitreal 15 27 110 122 I-treatment
treatment 28 37 123 132 O
to 38 40 133 135 O
the 41 44 136 139 O
treated 45 52 140 147 O
eye 53 56 148 151 O
or 57 59 152 154 O
intravitreal 60 72 155 167 O
device 73 79 168 174 O
in 80 82 175 177 O
the 83 86 178 181 O
treated 87 94 182 189 O
eye 95 98 190 193 O
within 99 105 194 200 O
6 106 107 201 202 B-upper_bound
months 108 114 203 209 I-upper_bound
prior 115 120 210 215 I-upper_bound
to 121 123 216 218 O
screening 124 133 219 228 O

Any 0 3 229 232 O
intraocular 4 15 233 244 B-treatment
surgery 16 23 245 252 I-treatment
or 24 26 253 255 O
laser 27 32 256 261 B-treatment
in 33 35 262 264 O
either 36 42 265 271 O
eye 43 46 272 275 O
planned 47 54 276 283 O
within 55 61 284 290 O
6 62 63 291 292 B-upper_bound
months 64 70 293 299 I-upper_bound
of 71 73 300 302 O
Day 74 77 303 306 O
0 78 79 307 308 O

Any 0 3 309 312 O
known 4 9 313 318 O
allergy 10 17 319 326 O
to 18 20 327 329 O
any 21 24 330 333 O
component 25 34 334 343 O
of 35 37 344 346 O
the 38 41 347 350 O
delivery 42 50 351 359 O
vehicle 51 58 360 367 O
or 59 61 368 370 O
diagnostic 62 72 371 381 O
agents 73 79 382 388 O
used 80 84 389 393 O
during 85 91 394 400 O
the 92 95 401 404 O
study 96 101 405 410 O
, 101 102 410 411 O
or 103 105 412 414 O
medications 106 117 415 426 B-treatment
planned 118 125 427 434 O
for 126 129 435 438 O
use 130 133 439 442 O
in 134 136 443 445 O
the 137 140 446 449 O
perioperative 141 154 450 463 O
period 155 161 464 470 O
particularly 162 174 471 483 O
topical 175 182 484 491 O
, 182 183 491 492 O
injected 184 192 493 501 O
or 193 195 502 504 O
systemic 196 204 505 513 O
corticosteroids 205 220 514 529 B-treatment

Any 0 3 530 533 O
periocular 4 14 534 544 B-treatment
injections 15 25 545 555 I-treatment
of 26 28 556 558 I-treatment
corticosteroids 29 44 559 574 I-treatment
to 45 47 575 577 O
the 48 51 578 581 O
treated 52 59 582 589 O
eye 60 63 590 593 O
within 64 70 594 600 O
4 71 72 601 602 B-upper_bound
months 73 79 603 609 I-upper_bound
prior 80 85 610 615 I-upper_bound
to 86 88 616 618 O
screening 89 98 619 628 O

Aphakia 0 7 629 636 B-treatment
or 8 10 637 639 O
prior 11 16 640 645 B-treatment
vitrectomy 17 27 646 656 I-treatment
in 28 30 657 659 O
the 31 34 660 663 O
study 35 40 664 669 O
eye 41 44 670 673 O

Cataract 0 8 674 682 B-treatment
surgery 9 16 683 690 I-treatment
with 17 21 691 695 O
intraocular 22 33 696 707 O
lens 34 38 708 712 B-treatment
implantation 39 51 713 725 I-treatment
within 52 58 726 732 O
6 59 60 733 734 B-upper_bound
months 61 67 735 741 I-upper_bound
of 68 70 742 744 O
enrolment 71 80 745 754 O

Concomitant 0 11 755 766 O
systemic 12 20 767 775 B-chronic_disease
diseases 21 29 776 784 I-chronic_disease
including 30 39 785 794 O
those 40 45 795 800 O
in 46 48 801 803 O
which 49 54 804 809 O
the 55 58 810 813 O
disease 59 66 814 821 O
itself 67 73 822 828 O
, 73 74 828 829 O
or 75 77 830 832 O
the 78 81 833 836 O
treatment 82 91 837 846 B-treatment
for 92 95 847 850 O
the 96 99 851 854 O
disease 100 107 855 862 O
, 107 108 862 863 O
can 109 112 864 867 O
alter 113 118 868 873 O
ocular 119 125 874 880 O
function 126 134 881 889 O

Concurrent 0 10 890 900 O
anti 11 15 901 905 B-treatment
- 15 16 905 906 I-treatment
retroviral 16 26 906 916 I-treatment
therapy 27 34 917 924 I-treatment
that 35 39 925 929 O
would 40 45 930 935 O
inactivate 46 56 936 946 O
the 57 60 947 950 O
investigational 61 76 951 966 B-treatment
agent 77 82 967 972 I-treatment

Contraindications 0 17 973 990 O
to 18 20 991 993 O
use 21 24 994 997 O
of 25 27 998 1000 O
anesthesia 28 38 1001 1011 B-treatment
( 39 40 1012 1013 O
local 40 45 1013 1018 O
or 46 48 1019 1021 O
general 49 56 1022 1029 O
, 56 57 1029 1030 O
as 58 60 1031 1033 O
appropriate 61 72 1034 1045 O
) 72 73 1045 1046 O

Current 0 7 1047 1054 O
or 8 10 1055 1057 O
anticipated 11 22 1058 1069 O
treatment 23 32 1070 1079 B-treatment
with 33 37 1080 1084 O
anticoagulant 38 51 1085 1098 B-treatment
therapy 52 59 1099 1106 I-treatment
or 60 62 1107 1109 O
the 63 66 1110 1113 O
use 67 70 1114 1117 O
of 71 73 1118 1120 O
anticoagulation 74 89 1121 1136 B-treatment
therapy 90 97 1137 1144 I-treatment
within 98 104 1145 1151 O
the 105 108 1152 1155 O
four 109 113 1156 1160 B-upper_bound
weeks 114 119 1161 1166 I-upper_bound
prior 120 125 1167 1172 I-upper_bound
to 126 128 1173 1175 O
surgery 129 136 1176 1183 B-treatment

Diagnosis 0 9 1184 1193 O
of 10 12 1194 1196 O
Stargardt 13 22 1197 1206 B-chronic_disease
's 22 24 1206 1208 I-chronic_disease
Macular 25 32 1209 1216 I-chronic_disease
Degeneration 33 45 1217 1229 I-chronic_disease
( 46 47 1230 1231 I-chronic_disease
SMD 47 50 1231 1234 I-chronic_disease
) 50 51 1234 1235 I-chronic_disease
, 51 52 1235 1236 O
with 53 57 1237 1241 O
at 58 60 1242 1244 O
least 61 66 1245 1250 O
one 67 70 1251 1254 B-lower_bound
pathogenic 71 81 1255 1265 O
mutant 82 88 1266 1272 O
ABCA4 89 94 1273 1278 O
allele 95 101 1279 1285 O
on 102 104 1286 1288 O
each 105 109 1289 1293 O
chromosome 110 120 1294 1304 O

Enlargement 0 11 1305 1316 O
in 12 14 1317 1319 O
the 15 18 1320 1323 O
area 19 23 1324 1328 O
of 24 26 1329 1331 O
central 27 34 1332 1339 O
macular 35 42 1340 1347 O
retinal 43 50 1348 1355 O
thinning 51 59 1356 1364 O
/ 59 60 1364 1365 O
photoreceptor 60 73 1365 1378 O
loss 74 78 1379 1383 O
by 79 81 1384 1386 O
ocular 82 88 1387 1393 B-treatment
coherence 89 98 1394 1403 I-treatment
tomography 99 109 1404 1414 I-treatment
at 110 112 1415 1417 O
a 113 114 1418 1419 O
rate 115 119 1420 1424 B-clinical_variable
of 120 122 1425 1427 O
≥0.5 123 127 1428 1432 O
mm^2 128 132 1433 1437 I-lower_bound

Enlargement 0 11 1438 1449 O
in 12 14 1450 1452 O
the 15 18 1453 1456 O
area 19 23 1457 1461 O
of 24 26 1462 1464 O
macular 27 34 1465 1472 O
RPE 35 38 1473 1476 O
atrophy 39 46 1477 1484 O
by 47 49 1485 1487 O
fundus 50 56 1488 1494 B-clinical_variable
autofluorescence 57 73 1495 1511 I-clinical_variable
at 74 76 1512 1514 O
a 77 78 1515 1516 O
rate 79 83 1517 1521 O
of 84 86 1522 1524 O
≥0.5 87 91 1525 1529 O
mm^2 92 96 1530 1534 I-lower_bound

Enrolment 0 9 1535 1544 O
in 10 12 1545 1547 O
any 13 16 1548 1551 O
other 17 22 1552 1557 O
clinical 23 31 1558 1566 O
treatment 32 41 1567 1576 B-treatment
study 42 47 1577 1582 O
throughout 48 58 1583 1593 O
the 59 62 1594 1597 O
duration 63 71 1598 1606 O
of 72 74 1607 1609 O
the 75 78 1610 1613 O
SAR422459 79 88 1614 1623 O
study 89 94 1624 1629 O

History 0 7 1630 1637 O
of 8 10 1638 1640 O
any 11 14 1641 1644 O
investigational 15 30 1645 1660 B-treatment
agent 31 36 1661 1666 I-treatment
within 37 43 1667 1673 O
28 44 46 1674 1676 B-upper_bound
days 47 51 1677 1681 I-upper_bound
prior 52 57 1682 1687 I-upper_bound
to 58 60 1688 1690 O
SAR422459 61 70 1691 1700 B-treatment
administration 71 85 1701 1715 O

History 0 7 1716 1723 O
or 8 10 1724 1726 O
signs 11 16 1727 1732 O
consistent 17 27 1733 1743 O
with 28 32 1744 1748 O
unilateral 33 43 1749 1759 B-chronic_disease
amblyopia 44 53 1760 1769 I-chronic_disease
( 54 55 1770 1771 O
strabismic 55 65 1771 1781 B-chronic_disease
, 65 66 1781 1782 O
anisometropic 67 80 1783 1796 B-chronic_disease
, 80 81 1796 1797 O
or 82 84 1798 1800 O
stimulus 85 93 1801 1809 B-treatment
deprivation 94 105 1810 1821 I-treatment
) 105 106 1821 1822 O

Laboratory 0 10 1823 1833 B-treatment
test 11 15 1834 1838 I-treatment
abnormalities 16 29 1839 1852 O
or 30 32 1853 1855 O
abnormalities 33 46 1856 1869 O
in 47 49 1870 1872 O
electrocardiogram 50 67 1873 1890 B-treatment
, 67 68 1890 1891 O
chest 69 74 1892 1897 B-treatment
X 75 76 1898 1899 I-treatment
- 76 77 1899 1900 I-treatment
rays 77 81 1900 1904 I-treatment
that 82 86 1905 1909 O
in 87 89 1910 1912 O
the 90 93 1913 1916 O
opinion 94 101 1917 1924 O
of 102 104 1925 1927 O
the 105 108 1928 1931 O
Principal 109 118 1932 1941 O
Investigator 119 131 1942 1954 O
would 132 137 1955 1960 O
make 138 142 1961 1965 O
the 143 146 1966 1969 O
patient 147 154 1970 1977 O
unsuitable 155 165 1978 1988 O
for 166 169 1989 1992 O
participation 170 183 1993 2006 O
in 184 186 2007 2009 O
the 187 190 2010 2013 O
study 191 196 2014 2019 O

Loss 0 4 2020 2024 O
of 5 7 2025 2027 O
≥1 8 10 2028 2030 O
line 11 15 2031 2035 O
of 16 18 2036 2038 O
Snellen 19 26 2039 2046 B-clinical_variable
visual 27 33 2047 2053 I-clinical_variable
acuity 34 40 2054 2060 I-clinical_variable
( 41 42 2061 2062 O
equivalent 42 52 2062 2072 O
to 53 55 2073 2075 O
5 56 57 2076 2077 O
ETDRS 58 63 2078 2083 O
letters 64 71 2084 2091 O
) 71 72 2091 2092 O

Males 0 5 2093 2098 B-gender
must 6 10 2099 2103 O
agree 11 16 2104 2109 B-contraception_consent
with 17 21 2110 2114 I-contraception_consent
their 22 27 2115 2120 I-contraception_consent
partner 28 35 2121 2128 I-contraception_consent
to 36 38 2129 2131 I-contraception_consent
use 39 42 2132 2135 I-contraception_consent
two 43 46 2136 2139 I-contraception_consent
forms 47 52 2140 2145 I-contraception_consent
of 53 55 2146 2148 I-contraception_consent
contraception 56 69 2149 2162 I-contraception_consent
for 70 73 2163 2166 O
at 74 76 2167 2169 O
least 77 82 2170 2175 O
three 83 88 2176 2181 B-lower_bound
months 89 95 2182 2188 I-lower_bound
following 96 105 2189 2198 O
SAR422459 106 115 2199 2208 B-treatment
administration 116 130 2209 2223 I-treatment

Participation 0 13 2224 2237 O
in 14 16 2238 2240 O
a 17 18 2241 2242 O
prior 19 24 2243 2248 B-treatment
ocular 25 31 2249 2255 I-treatment
gene 32 36 2256 2260 I-treatment
transfer 37 45 2261 2269 I-treatment
therapy 46 53 2270 2277 I-treatment
study 54 59 2278 2283 O

Patients 0 8 2284 2292 O
( 9 10 2293 2294 O
18 10 12 2294 2296 B-lower_bound
years 13 18 2297 2302 I-lower_bound
or 19 21 2303 2305 O
older 22 27 2306 2311 O
) 27 28 2311 2312 O
with 29 33 2313 2317 O
Stargardt 34 43 2318 2327 B-chronic_disease
's 43 45 2327 2329 I-chronic_disease
Macular 46 53 2330 2337 I-chronic_disease
Degeneration 54 66 2338 2350 I-chronic_disease

Patients 0 8 2351 2359 O
( 9 10 2360 2361 O
18 10 12 2361 2363 B-lower_bound
years 13 18 2364 2369 I-lower_bound
or 19 21 2370 2372 O
older 22 27 2373 2378 O
) 27 28 2378 2379 O
with 29 33 2380 2384 O
advanced 34 42 2385 2393 O
Stargardt 43 52 2394 2403 B-chronic_disease
's 52 54 2403 2405 I-chronic_disease
Macular 55 62 2406 2413 I-chronic_disease
Degeneration 63 75 2414 2426 I-chronic_disease

Patients 0 8 2427 2435 O
are 9 12 2436 2439 O
anticipated 13 24 2440 2451 O
to 25 27 2452 2454 O
experience 28 38 2455 2465 O
rapid 39 44 2466 2471 O
deterioration 45 58 2472 2485 O
in 59 61 2486 2488 O
visual 62 68 2489 2495 O
function 69 77 2496 2504 O
and/or 78 84 2505 2511 O
retinal 85 92 2512 2519 O
structure 93 102 2520 2529 O
as 103 105 2530 2532 O
determined 106 116 2533 2543 O
by 117 119 2544 2546 O
an 120 122 2547 2549 O
annual 123 129 2550 2556 O
progression 130 141 2557 2568 O
rate 142 146 2569 2573 O
in 147 149 2574 2576 O
at 150 152 2577 2579 O
least 153 158 2580 2585 O
one 159 162 2586 2589 B-lower_bound
of 163 165 2590 2592 O
the 166 169 2593 2596 O
following 170 179 2597 2606 O
parameters 180 190 2607 2617 O
occurring 191 200 2618 2627 O
in 201 203 2628 2630 O
at 204 206 2631 2633 O
least 207 212 2634 2639 O
one 213 216 2640 2643 O
eye 217 220 2644 2647 O
( 221 222 2648 2649 O
assessments 222 233 2649 2660 O
recorded 234 242 2661 2669 O
up 243 245 2670 2672 O
to 246 248 2673 2675 O
2 249 250 2676 2677 B-upper_bound
years 251 256 2678 2683 I-upper_bound
prior 257 262 2684 2689 I-upper_bound
to 263 265 2690 2692 O
the 266 269 2693 2696 O
screening 270 279 2697 2706 O
visit 280 285 2707 2712 O
date 286 290 2713 2717 O
may 291 294 2718 2721 O
be 295 297 2722 2724 O
considered 298 308 2725 2735 O
to 309 311 2736 2738 O
document 312 320 2739 2747 O
evidence 321 329 2748 2756 O
of 330 332 2757 2759 O
rapid 333 338 2760 2765 O
deterioration 339 352 2766 2779 O
) 352 353 2779 2780 O

Patients 0 8 2781 2789 O
must 9 13 2790 2794 O
agree 14 19 2795 2800 O
to 20 22 2801 2803 O
not 23 26 2804 2807 O
donate 27 33 2808 2814 O
blood 34 39 2815 2820 O
, 39 40 2820 2821 O
organs 41 47 2822 2828 O
, 47 48 2828 2829 O
tissues 49 56 2830 2837 O
or 57 59 2838 2840 O
cells 60 65 2841 2846 O
for 66 69 2847 2850 O
at 70 72 2851 2853 O
least 73 78 2854 2859 O
three 79 84 2860 2865 B-lower_bound
months 85 91 2866 2872 I-lower_bound
following 92 101 2873 2882 O
SAR422459 102 111 2883 2892 B-treatment
administration 112 126 2893 2907 O

Pre 0 3 2908 2911 O
- 3 4 2911 2912 O
existing 4 12 2912 2920 O
eye 13 16 2921 2924 B-chronic_disease
conditions 17 27 2925 2935 I-chronic_disease
that 28 32 2936 2940 O
would 33 38 2941 2946 O
preclude 39 47 2947 2955 O
the 48 51 2956 2959 O
planned 52 59 2960 2967 O
surgery 60 67 2968 2975 B-treatment
or 68 70 2976 2978 O
interfere 71 80 2979 2988 O
with 81 85 2989 2993 O
the 86 89 2994 2997 O
interpretation 90 104 2998 3012 O
of 105 107 3013 3015 O
study 108 113 3016 3021 O
endpoints 114 123 3022 3031 O

Pre 0 3 3032 3035 O
- 3 4 3035 3036 O
menopausal 4 14 3036 3046 O
or 15 17 3047 3049 O
non 18 21 3050 3053 O
- 21 22 3053 3054 O
surgically 22 32 3054 3064 O
sterile 33 40 3065 3072 O
women 41 46 3073 3078 B-gender
who 47 50 3079 3082 O
are 51 54 3083 3086 O
unwilling 55 64 3087 3096 B-contraception_consent
to 65 67 3097 3099 I-contraception_consent
use 68 71 3100 3103 I-contraception_consent
an 72 74 3104 3106 I-contraception_consent
effective 75 84 3107 3116 I-contraception_consent
form 85 89 3117 3121 I-contraception_consent
of 90 92 3122 3124 I-contraception_consent
contraception 93 106 3125 3138 I-contraception_consent
such 107 111 3139 3143 O
as 112 114 3144 3146 O
the 115 118 3147 3150 O
contraceptive 119 132 3151 3164 B-contraception_consent
pill 133 137 3165 3169 I-contraception_consent
or 138 140 3170 3172 O
intrauterine 141 153 3173 3185 B-contraception_consent
device 154 160 3186 3192 I-contraception_consent

Reduction 0 9 3193 3202 B-clinical_variable
in 10 12 3203 3205 I-clinical_variable
macular 13 20 3206 3213 I-clinical_variable
mean 21 25 3214 3218 I-clinical_variable
sensitivity 26 37 3219 3230 I-clinical_variable
of 38 40 3231 3233 O
≥1.2 41 45 3234 3238 O
dB 46 48 3239 3241 I-lower_bound
as 49 51 3242 3244 O
assessed 52 60 3245 3253 O
by 61 63 3254 3256 O
microperimetry 64 78 3257 3271 B-treatment

Reduction 0 9 3272 3281 O
in 10 12 3282 3284 O
macular 13 20 3285 3292 B-clinical_variable
mean 21 25 3293 3297 I-clinical_variable
sensitivity 26 37 3298 3309 I-clinical_variable
of 38 40 3310 3312 O
≥5 41 43 3313 3315 O
dB 44 46 3316 3318 I-lower_bound
or 47 49 3319 3321 O
reduction 50 59 3322 3331 B-clinical_variable
in 60 62 3332 3334 I-clinical_variable
hill 63 67 3335 3339 I-clinical_variable
of 68 70 3340 3342 I-clinical_variable
vision 71 77 3343 3349 I-clinical_variable
by 78 80 3350 3352 O
> 81 82 3353 3354 O
14 82 84 3354 3356 B-lower_bound
dB 85 87 3357 3359 I-lower_bound
- 87 88 3359 3360 I-lower_bound
sr 88 90 3360 3362 I-lower_bound
as 91 93 3363 3365 O
assessed 94 102 3366 3374 O
by 103 105 3375 3377 O
static 106 112 3378 3384 O
perimetry 113 122 3385 3394 B-treatment

Severe 0 6 3395 3401 O
cone 7 11 3402 3406 B-chronic_disease
- 11 12 3406 3407 I-chronic_disease
rod 12 15 3407 3410 I-chronic_disease
dysfunction 16 27 3411 3422 I-chronic_disease
with 28 32 3423 3427 O
no 33 35 3428 3430 O
detectable 36 46 3431 3441 O
or 47 49 3442 3444 O
severely 50 58 3445 3453 O
abnormal 59 67 3454 3462 O
full 68 72 3463 3467 B-treatment
- 72 73 3467 3468 I-treatment
field 73 78 3468 3473 I-treatment
electroretinogram 79 96 3474 3491 I-treatment
responses 97 106 3492 3501 O

Significant 0 11 3502 3513 O
intercurrent 12 24 3514 3526 B-chronic_disease
illness 25 32 3527 3534 I-chronic_disease
or 33 35 3535 3537 O
infection 36 45 3538 3547 O
during 46 52 3548 3554 O
the 53 56 3555 3558 O
28 57 59 3559 3561 B-upper_bound
days 60 64 3562 3566 I-upper_bound
prior 65 70 3567 3572 I-upper_bound
to 71 73 3573 3575 O
enrolment 74 83 3576 3585 O

Symptomatic 0 11 3586 3597 O
patients 12 20 3598 3606 O
( 21 22 3607 3608 O
from 22 26 3608 3612 O
6 27 28 3613 3614 B-lower_bound
years 29 34 3615 3620 I-lower_bound
to 35 37 3621 3623 O
26 38 40 3624 3626 B-upper_bound
years 41 46 3627 3632 I-upper_bound
old 47 50 3633 3636 O
) 50 51 3636 3637 O
with 52 56 3638 3642 O
early 57 62 3643 3648 O
or 63 65 3649 3651 O
childhood 66 75 3652 3661 O
- 75 76 3661 3662 O
onset 76 81 3662 3667 O
SMD 82 85 3668 3671 O
( 86 87 3672 3673 O
age 87 90 3673 3676 B-age
at 91 93 3677 3679 O
disease 94 101 3680 3687 O
onset 102 107 3688 3693 O
< 108 109 3694 3695 O
18 109 111 3695 3697 B-upper_bound
years 112 117 3698 3703 I-upper_bound
) 117 118 3703 3704 O
with 119 123 3705 3709 O
at 124 126 3710 3712 O
least 127 132 3713 3718 O
one 133 136 3719 3722 O
pathogenic 137 147 3723 3733 O
mutant 148 154 3734 3740 O
ABCA4 155 160 3741 3746 O
allele 161 167 3747 3753 O
on 168 170 3754 3756 O
each 171 175 3757 3761 O
chromosome 176 186 3762 3772 O
confirmed 187 196 3773 3782 O
by 197 199 3783 3785 O
direct 200 206 3786 3792 O
sequencing 207 217 3793 3803 O
and 218 221 3804 3807 O
co 222 224 3808 3810 O
- 224 225 3810 3811 O
segregation 225 236 3811 3822 O
analysis 237 245 3823 3831 O
within 246 252 3832 3838 O
the 253 256 3839 3842 O
patient 257 264 3843 3850 O
's 264 266 3850 3852 O
family 267 273 3853 3859 O

Visual 0 6 3860 3866 B-clinical_variable
Acuity 7 13 3867 3873 I-clinical_variable
≤20/200 14 21 3874 3881 O
in 22 24 3882 3884 O
the 25 28 3885 3888 O
worst 29 34 3889 3894 O
eye 35 38 3895 3898 O

Visual 0 6 3899 3905 B-clinical_variable
acuity 7 13 3906 3912 I-clinical_variable
of 14 16 3913 3915 O
≥20/100 17 24 3916 3923 O
in 25 27 3924 3926 O
both 28 32 3927 3931 O
eyes 33 37 3932 3936 O
at 38 40 3937 3939 O
the 41 44 3940 3943 O
time 45 49 3944 3948 O
of 50 52 3949 3951 O
screening 53 62 3952 3961 O
visit 63 68 3962 3967 O

Visual 0 6 3968 3974 B-clinical_variable
acuity 7 13 3975 3981 I-clinical_variable
of 14 16 3982 3984 O
≥20/200 17 24 3985 3992 O
in 25 27 3993 3995 O
both 28 32 3996 4000 O
eyes 33 37 4001 4005 O
at 38 40 4006 4008 O
the 41 44 4009 4012 O
time 45 49 4013 4017 O
of 50 52 4018 4020 O
the 53 56 4021 4024 O
screening 57 66 4025 4034 O
visit 67 72 4035 4040 O

Visual 0 6 4041 4047 B-clinical_variable
acuity 7 13 4048 4054 I-clinical_variable
≤20/100 14 21 4055 4062 O
in 22 24 4063 4065 O
the 25 28 4066 4069 O
worst 29 34 4070 4075 O
eye 35 38 4076 4079 O

Visual 0 6 4080 4086 B-clinical_variable
acuity 7 13 4087 4093 I-clinical_variable
≤20/200 14 21 4094 4101 O
in 22 24 4102 4104 O
the 25 28 4105 4108 O
worst 29 34 4109 4114 O
eye 35 38 4115 4118 O

Women 0 5 4119 4124 B-gender
of 6 8 4125 4127 O
childbearing 9 21 4128 4140 O
potential 22 31 4141 4150 O
must 32 36 4151 4155 O
have 37 41 4156 4160 O
a 42 43 4161 4162 O
negative 44 52 4163 4171 B-pregnancy
pregnancy 53 62 4172 4181 I-pregnancy
test 63 67 4182 4186 O
at 68 70 4187 4189 O
Day 71 74 4190 4193 O
-1 75 77 4194 4196 O
, 77 78 4196 4197 O
and 79 82 4198 4201 O
agree 83 88 4202 4207 B-contraception_consent
to 89 91 4208 4210 I-contraception_consent
use 92 95 4211 4214 I-contraception_consent
an 96 98 4215 4217 I-contraception_consent
effective 99 108 4218 4227 I-contraception_consent
form 109 113 4228 4232 I-contraception_consent
of 114 116 4233 4235 I-contraception_consent
contraception 117 130 4236 4249 I-contraception_consent
for 131 134 4250 4253 O
at 135 137 4254 4256 O
least 138 143 4257 4262 O
three 144 149 4263 4268 B-lower_bound
months 150 156 4269 4275 I-lower_bound
, 156 157 4275 4276 O
or 158 160 4277 4279 O
be 161 163 4280 4282 O
surgically 164 174 4283 4293 O
sterile 175 182 4294 4301 O
or 183 185 4302 4304 O
postmenopausal 186 200 4305 4319 O
, 200 201 4319 4320 O
with 202 206 4321 4325 O
the 207 210 4326 4329 O
last 211 215 4330 4334 O
menstrual 216 225 4335 4344 O
period 226 232 4345 4351 O
being 233 238 4352 4357 O
over 239 243 4358 4362 O
two 244 247 4363 4366 B-upper_bound
years 248 253 4367 4372 I-upper_bound
prior 254 259 4373 4378 I-upper_bound
to 260 262 4379 4381 O
enrollment 263 273 4382 4392 O

between 0 7 4393 4400 O
6 8 9 4401 4402 B-lower_bound
years 10 15 4403 4408 I-lower_bound
and 16 19 4409 4412 O
17 20 22 4413 4415 B-upper_bound
years 23 28 4416 4421 I-upper_bound
old 29 32 4422 4425 O

pregnant 0 8 4426 4434 B-pregnancy

with 0 4 4435 4439 O
early 5 10 4440 4445 O
or 11 13 4446 4448 O
childhood 14 23 4449 4458 O
- 23 24 4458 4459 O
onset 24 29 4459 4464 O
SMD 30 33 4465 4468 B-chronic_disease
with 34 38 4469 4473 O
at 39 41 4474 4476 O
least 42 47 4477 4482 O
one 48 51 4483 4486 B-lower_bound
pathogenic 52 62 4487 4497 O
mutant 63 69 4498 4504 O
ABCA4 70 75 4505 4510 O
allele 76 82 4511 4517 O
on 83 85 4518 4520 O
each 86 90 4521 4525 O
chromosome 91 101 4526 4536 O
confirmed 102 111 4537 4546 O
by 112 114 4547 4549 O
direct 115 121 4550 4556 O
sequencing 122 132 4557 4567 O
and 133 136 4568 4571 O
co 137 139 4572 4574 O
- 139 140 4574 4575 O
segregation 140 151 4575 4586 O
analysis 152 160 4587 4595 O
within 161 167 4596 4602 O
the 168 171 4603 4606 O
patient 172 179 4607 4614 O
's 179 181 4614 4616 O
family 182 188 4617 4623 O

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
Parkinson 13 22 13 22 B-chronic_disease
's 22 24 22 24 I-chronic_disease
Disease 25 32 25 32 I-chronic_disease
using 33 38 33 38 O
the 39 42 39 42 O
UK 43 45 43 45 O
Brain 46 51 46 51 O
Bank 52 56 52 56 O
Criteria 57 65 57 65 O

Features 0 8 66 74 O
suggestive 9 19 75 85 O
of 20 22 86 88 O
other 23 28 89 94 O
causes 29 35 95 101 O
of 36 38 102 104 O
parkinsonism 39 51 105 117 B-chronic_disease
, 51 52 117 118 O
including 53 62 119 128 O
cerebrovascular 63 78 129 144 B-chronic_disease
disease 79 86 145 152 I-chronic_disease
or 87 89 153 155 O
history 90 97 156 163 O
of 98 100 164 166 O
major 101 106 167 172 O
head 107 111 173 177 O
trauma 112 118 178 184 O

Medication 0 10 185 195 O
stable 11 17 196 202 O
for 18 21 203 206 O
at 22 24 207 209 O
least 25 30 210 215 O
30 31 33 216 218 B-lower_bound
days 34 38 219 223 I-lower_bound

Participants 0 12 224 236 O
whose 13 18 237 242 O
insurance 19 28 243 252 O
does 29 33 253 257 O
not 34 37 258 261 O
cover 38 43 262 267 O
Occupational 44 56 268 280 B-treatment
Therapy 57 64 281 288 I-treatment
costs 65 70 289 294 O
or 71 73 295 297 O
who 74 77 298 301 O
have 78 82 302 306 O
no 83 85 307 309 O
insurance 86 95 310 319 O

Active 0 6 0 6 O
/ 6 7 6 7 O
acute 7 12 7 12 B-chronic_disease
pancreatitis 13 25 13 25 I-chronic_disease
with 26 30 26 30 O
hyperlipidemia 31 45 31 45 B-chronic_disease

Allergy 0 7 46 53 O
to 8 10 54 56 O
egg 11 14 57 60 B-allergy_name
, 14 15 60 61 O
fish 16 20 62 66 B-allergy_name
, 20 21 66 67 O
or 22 24 68 70 O
soy 25 28 71 74 B-allergy_name
/ 28 29 74 75 O
legume 29 35 75 81 B-allergy_name
products 36 44 82 90 I-allergy_name

Diagnosis 0 9 91 100 O
of 10 12 101 103 O
a 13 14 104 105 O
hematological 15 28 106 119 B-cancer
malignancy 29 39 120 130 I-cancer
including 40 49 131 140 O
myelodysplasia 50 64 141 155 B-chronic_disease

GVHD 0 4 156 160 B-chronic_disease
prophylaxis 5 16 161 172 B-treatment
that 17 21 173 177 O
includes 22 30 178 186 O
rapamycin 31 40 187 196 B-treatment

History 0 7 197 204 O
of 8 10 205 207 O
parenteral 11 21 208 218 B-treatment
nutrition 22 31 219 228 I-treatment
use 32 35 229 232 I-treatment
with 36 40 233 237 I-treatment
SOLE 41 45 238 242 I-treatment
prior 46 51 243 248 I-treatment
to 52 54 249 251 I-treatment
HCT 55 58 252 255 I-treatment

Lipid 0 5 256 261 B-chronic_disease
nephrosis 6 15 262 271 I-chronic_disease

Other 0 5 272 277 O
contraindication 6 22 278 294 O
to 23 25 295 297 O
PN 26 28 298 300 B-treatment
or 29 31 301 303 O
intravenous 32 43 304 315 B-treatment
lipids 44 50 316 322 I-treatment

Pathological 0 12 323 335 O
hyperlipidemia 13 27 336 350 B-chronic_disease
( 28 29 351 352 O
2 29 30 352 353 O
consecutive 31 42 354 365 O
fasting 43 50 366 373 B-clinical_variable
triglyceride 51 63 374 386 I-clinical_variable
levels 64 70 387 393 I-clinical_variable
> 71 72 394 395 O
500 73 76 396 399 B-lower_bound
mg 77 79 400 402 I-lower_bound
/ 79 80 402 403 I-lower_bound
dL 80 82 403 405 I-lower_bound
) 82 83 405 406 O

Planned 0 7 407 414 O
myeloablative 8 21 415 428 O
allogeneic 22 32 429 439 O
bone 33 37 440 444 O
marrow 38 44 445 451 O
, 44 45 451 452 O
cord 46 50 453 457 O
, 50 51 457 458 O
or 52 54 459 461 O
peripheral 55 65 462 472 O
blood 66 71 473 478 O
stem 72 76 479 483 O
cell 77 81 484 488 O
( 82 83 489 490 O
from 83 87 490 494 O
any 88 91 495 498 O
donor 92 97 499 504 O
, 97 98 504 505 O
including 99 108 506 515 O
haploidentical 109 123 516 530 O
donor 124 129 531 536 O
) 129 130 536 537 O
HCT 131 134 538 541 B-treatment
conditioning 135 147 542 554 I-treatment
regimen 148 155 555 562 I-treatment
using 156 161 563 568 O
either 162 168 569 575 O
TBI 169 172 576 579 B-chronic_disease
( 173 174 580 581 O
planned 174 181 581 588 B-clinical_variable
cumulative 182 192 589 599 I-clinical_variable
dose 193 197 600 604 I-clinical_variable
> 198 199 605 606 O
1100 199 203 606 610 B-lower_bound
cGy 204 207 611 614 I-lower_bound
) 207 208 614 615 O
or 209 211 616 618 O
busulfan 212 220 619 627 B-treatment
in 221 223 628 630 O
addition 224 232 631 639 O
to 233 235 640 642 O
other 236 241 643 648 O
chemotherapeutic 242 258 649 665 B-treatment
agents 259 265 666 672 I-treatment

Planned 0 7 673 680 O
related 8 15 681 688 O
or 16 18 689 691 O
unrelated 19 28 692 701 O
bone 29 33 702 706 O
marrow 34 40 707 713 O
donor 41 46 714 719 O
matched 47 54 720 727 O
at 55 57 728 730 O
a 58 59 731 732 O
minimum 60 67 733 740 O
of 68 70 741 743 O
out 71 74 744 747 O
of 75 77 748 750 O
10 78 80 751 753 B-upper_bound
human 81 86 754 759 B-clinical_variable
leukocyte 87 96 760 769 I-clinical_variable
antigen 97 104 770 777 I-clinical_variable
( 105 106 778 779 I-clinical_variable
HLA 106 109 779 782 I-clinical_variable
) 109 110 782 783 I-clinical_variable
loci 111 115 784 788 O
( 116 117 789 790 O
HLA 117 120 790 793 B-clinical_variable
- 120 121 793 794 I-clinical_variable
A 121 122 794 795 I-clinical_variable
, 122 123 795 796 O
-B 124 126 797 799 O
, 126 127 799 800 O
-C 128 130 801 803 O
, 130 131 803 804 O
-DRB1 132 137 805 810 O
, 137 138 810 811 O
and 139 142 812 815 O
-DQ 143 146 816 819 O
) 146 147 819 820 O

Recent 0 6 821 827 O
stroke 7 13 828 834 B-chronic_disease
, 13 14 834 835 O
cardiac 15 22 836 843 B-chronic_disease
infarction 23 33 844 854 I-chronic_disease
or 34 36 855 857 O
embolism 37 45 858 866 B-chronic_disease

Unstable 0 8 867 875 O
diabetes 9 17 876 884 B-chronic_disease
mellitus 18 26 885 893 I-chronic_disease

active 0 6 894 900 O
/ 6 7 900 901 O
acute 7 12 901 906 B-chronic_disease
pancreatitis 13 25 907 919 I-chronic_disease
with 26 30 920 924 O
hyperlipidemia 31 45 925 939 B-chronic_disease

allergy 0 7 940 947 O
to 8 10 948 950 O
egg 11 14 951 954 B-allergy_name
, 14 15 954 955 O
fish 16 20 956 960 B-allergy_name
, 20 21 960 961 O
or 22 24 962 964 O
soy 25 28 965 968 B-allergy_name
/ 28 29 968 969 O
legume 29 35 969 975 B-allergy_name
products 36 44 976 984 I-allergy_name

co 0 2 985 987 O
- 2 3 987 988 O
enrollment 3 13 988 998 O
in 14 16 999 1001 O
other 17 22 1002 1007 O
interventional 23 37 1008 1022 B-treatment
clinical 38 46 1023 1031 I-treatment
studies 47 54 1032 1039 I-treatment

lipid 0 5 1040 1045 B-chronic_disease
nephrosis 6 15 1046 1055 I-chronic_disease

other 0 5 1056 1061 O
contraindication 6 22 1062 1078 O
to 23 25 1079 1081 O
PN 26 28 1082 1084 B-treatment
or 29 31 1085 1087 O
intravenous 32 43 1088 1099 B-treatment
lipids 44 50 1100 1106 I-treatment

pathological 0 12 1107 1119 O
hyperlipidemia 13 27 1120 1134 B-chronic_disease
( 28 29 1135 1136 O
2 29 30 1136 1137 O
consecutive 31 42 1138 1149 O
fasting 43 50 1150 1157 B-clinical_variable
triglyceride 51 63 1158 1170 I-clinical_variable
levels 64 70 1171 1177 I-clinical_variable
> 71 72 1178 1179 O
500 73 76 1180 1183 B-lower_bound
mg 77 79 1184 1186 I-lower_bound
/ 79 80 1186 1187 I-lower_bound
dL 80 82 1187 1189 I-lower_bound
) 82 83 1189 1190 O

planned 0 7 1191 1198 O
related 8 15 1199 1206 O
or 16 18 1207 1209 O
unrelated 19 28 1210 1219 O
cord 29 33 1220 1224 O
blood 34 39 1225 1230 O
donor 40 45 1231 1236 O
matched 46 53 1237 1244 O
at 54 56 1245 1247 O
a 57 58 1248 1249 O
minimum 59 66 1250 1257 O
of 67 69 1258 1260 O
4 70 71 1261 1262 B-lower_bound
out 72 75 1263 1266 O
of 76 78 1267 1269 O
6 79 80 1270 1271 B-upper_bound
HLA 81 84 1272 1275 B-clinical_variable
loci 85 89 1276 1280 I-clinical_variable
( 90 91 1281 1282 O
HLA 91 94 1282 1285 B-clinical_variable
- 94 95 1285 1286 I-clinical_variable
A 95 96 1286 1287 I-clinical_variable
, 96 97 1287 1288 O
-B 98 100 1289 1291 B-clinical_variable
, 100 101 1291 1292 O
and 102 105 1293 1296 O
-DRB1 106 111 1297 1302 O
) 111 112 1302 1303 O

recent 0 6 1304 1310 O
stroke 7 13 1311 1317 B-chronic_disease
, 13 14 1317 1318 O
cardiac 15 22 1319 1326 B-chronic_disease
infarction 23 33 1327 1337 I-chronic_disease
or 34 36 1338 1340 O
embolism 37 45 1341 1349 O

unstable 0 8 1350 1358 O
diabetes 9 17 1359 1367 B-chronic_disease
mellitus 18 26 1368 1376 I-chronic_disease

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
< 26 27 26 27 O
1000 27 31 27 31 B-upper_bound
/ 31 32 31 32 I-upper_bound
mL 32 34 32 34 I-upper_bound

Central 0 7 35 42 B-cancer
nervous 8 15 43 50 I-cancer
system 16 22 51 57 I-cancer
metastases 23 33 58 68 I-cancer

Child 0 5 69 74 B-clinical_variable
- 5 6 74 75 I-clinical_variable
Pugh 6 10 75 79 I-clinical_variable
class 11 16 80 85 I-clinical_variable
A 17 18 86 87 I-clinical_variable
with 19 23 88 92 O
no 24 26 93 95 O
clinically 27 37 96 106 O
apparent 38 46 107 115 O
ascites 47 54 116 123 O

Confirmed 0 9 124 133 O
diagnosis 10 19 134 143 O
of 20 22 144 146 O
HCC 23 26 147 150 B-cancer
by 27 29 151 153 O
histological 30 42 154 166 O
examination 43 54 167 178 O

Eastern 0 7 179 186 B-clinical_variable
Cooperative 8 19 187 198 I-clinical_variable
Oncology 20 28 199 207 I-clinical_variable
Group 29 34 208 213 I-clinical_variable
( 35 36 214 215 I-clinical_variable
ECOG 36 40 215 219 I-clinical_variable
) 40 41 219 220 I-clinical_variable
performance 42 53 221 232 I-clinical_variable
status 54 60 233 239 I-clinical_variable
of 61 63 240 242 O
0 64 65 243 244 B-lower_bound
- 65 66 244 245 O
1 66 67 245 246 B-upper_bound

For 0 3 247 250 O
Part 4 8 251 255 O
1 9 10 256 257 O
and 11 14 258 261 O
2 15 16 262 263 O
, 16 17 263 264 O
the 18 21 265 268 O
patient 22 29 269 276 O
has 30 33 277 280 O
unresectable 34 46 281 293 B-chronic_disease
disease 47 54 294 301 I-chronic_disease
and 55 58 302 305 O
has 59 62 306 309 O
been 63 67 310 314 O
previously 68 78 315 325 O
treated 79 86 326 333 O
with 87 91 334 338 O
sorafenib 92 101 339 348 B-treatment

For 0 3 349 352 O
Part 4 8 353 357 O
3 9 10 358 359 O
, 10 11 359 360 O
the 12 15 361 364 O
patient 16 23 365 372 O
has 24 27 373 376 O
not 28 31 377 380 O
received 32 40 381 389 O
prior 41 46 390 395 O
treatment 47 56 396 405 O
with 57 61 406 410 O
a 62 63 411 412 O
TKI 64 67 413 416 B-treatment

Hemoglobin 0 10 417 427 B-clinical_variable
< 11 12 428 429 O
8 12 13 429 430 B-upper_bound
g 14 15 431 432 I-upper_bound
/ 15 16 432 433 I-upper_bound
dL 16 18 433 435 I-upper_bound

International 0 13 436 449 B-clinical_variable
normalized 14 24 450 460 I-clinical_variable
ratio 25 30 461 466 I-clinical_variable
( 31 32 467 468 I-clinical_variable
INR 32 35 468 471 I-clinical_variable
) 35 36 471 472 I-clinical_variable
> 37 38 473 474 O
2.3 38 41 474 477 B-lower_bound

Platelet 0 8 478 486 B-clinical_variable
count 9 14 487 492 I-clinical_variable
< 15 16 493 494 O
75,000 16 22 494 500 B-upper_bound
/ 22 23 500 501 I-upper_bound
mL 23 25 501 503 I-upper_bound

Total 0 5 504 509 O
bilirubin 6 15 510 519 B-clinical_variable
> 16 17 520 521 O
2.5 17 20 521 524 B-lower_bound
mg 21 23 525 527 I-lower_bound
/ 23 24 527 528 I-lower_bound
dL 24 26 528 530 I-lower_bound

alanine 0 7 531 538 B-clinical_variable
aminotransferase 8 24 539 555 I-clinical_variable
( 25 26 556 557 I-clinical_variable
ALT 26 29 557 560 I-clinical_variable
) 29 30 560 561 I-clinical_variable
> 31 32 562 563 O
5x 32 34 563 565 B-lower_bound
the 35 38 566 569 I-lower_bound
upper 39 44 570 575 I-lower_bound
limit 45 50 576 581 I-lower_bound
of 51 53 582 584 I-lower_bound
normal 54 60 585 591 I-lower_bound
( 61 62 592 593 I-lower_bound
ULN 62 65 593 596 I-lower_bound
) 65 66 596 597 I-lower_bound

does 0 4 598 602 O
not 5 8 603 606 O
have 9 13 607 611 O
access 14 20 612 618 O
to 21 23 619 621 O
sorafenib 24 33 622 631 B-treatment

has 0 3 632 635 O
declined 4 12 636 644 O
treatment 13 22 645 654 B-treatment
with 23 27 655 659 I-treatment
sorafenib 28 37 660 669 I-treatment

measured 0 8 670 678 O
creatinine 9 19 679 689 B-clinical_variable
clearance 20 29 690 699 I-clinical_variable
< 30 31 700 701 O
40 31 33 701 703 B-upper_bound
mL 34 36 704 706 I-upper_bound
/ 36 37 706 707 I-upper_bound
min 37 40 707 710 I-upper_bound

prothrombin 0 11 711 722 B-clinical_variable
time 12 16 723 727 I-clinical_variable
( 17 18 728 729 I-clinical_variable
PT 18 20 729 731 I-clinical_variable
) 20 21 731 732 I-clinical_variable
> 22 23 733 734 O
6 23 24 734 735 B-lower_bound
seconds 25 32 736 743 I-lower_bound
above 33 38 744 749 O
control 39 46 750 757 O

spartate 0 8 758 766 B-clinical_variable
aminotransferase 9 25 767 783 I-clinical_variable
( 26 27 784 785 I-clinical_variable
AST 27 30 785 788 I-clinical_variable
) 30 31 788 789 I-clinical_variable

Diaphragmatic 0 13 0 13 B-chronic_disease
hernia 14 20 14 20 I-chronic_disease
: 20 21 20 21 O
right 22 27 22 27 O
- 27 28 27 28 O
sided 28 33 28 33 O
or 34 36 34 36 O
bilateral 37 46 37 46 O
, 46 47 46 47 O
major 48 53 48 53 O
associated 54 64 54 64 O
anomalies 65 74 65 74 O
, 74 75 74 75 O
isolated 76 84 76 84 O
left 85 89 85 89 O
- 89 90 89 90 O
sided 90 95 90 95 O
with 96 100 96 100 O
the 101 104 101 104 O
O 105 106 105 106 B-clinical_variable
/ 106 107 106 107 I-clinical_variable
E 107 108 107 108 I-clinical_variable
LHR 109 112 109 112 I-clinical_variable
≥ 113 114 113 114 O
30 115 117 115 117 B-lower_bound
% 117 118 117 118 I-lower_bound

History 0 7 119 126 O
of 8 10 127 129 O
natural 11 18 130 137 B-allergy_name
rubber 19 25 138 144 I-allergy_name
latex 26 31 145 150 I-allergy_name
allergy 32 39 151 158 O

Left 0 4 159 163 O
sided 5 10 164 169 O
diaphragmatic 11 24 170 183 B-chronic_disease
hernia 25 31 184 190 I-chronic_disease
with 32 36 191 195 O
liver 37 42 196 201 O
up 43 45 202 204 O

Maternal 0 8 205 213 O
contraindication 9 25 214 230 O
to 26 28 231 233 O
fetoscopic 29 39 234 244 B-allergy_name
surgery 40 47 245 252 I-allergy_name
or 48 50 253 255 O
severe 51 57 256 262 B-allergy_name
maternal 58 66 263 271 I-allergy_name
medical 67 74 272 279 I-allergy_name
condition 75 84 280 289 I-allergy_name
in 85 87 290 292 O
pregnancy 88 97 293 302 B-pregnancy

Maternal 0 8 303 311 B-chronic_disease
depression 9 19 312 322 I-chronic_disease
as 20 22 323 325 O
assessed 23 31 326 334 O
by 32 34 335 337 O
a 35 36 338 339 O
Beck 37 41 340 344 B-clinical_variable
Depression 42 52 345 355 I-clinical_variable
Inventory 53 62 356 365 I-clinical_variable
score 63 68 366 371 I-clinical_variable
equal 69 74 372 377 O
to 75 77 378 380 O
or 78 80 381 383 O
greater 81 88 384 391 O
than 89 93 392 396 O
17 94 96 397 399 B-lower_bound

Pregnant 0 8 400 408 B-pregnancy
women 9 14 409 414 B-gender

Singleton 0 9 415 424 O
pregnancy 10 19 425 434 B-pregnancy

Technical 0 9 435 444 O
limitations 10 21 445 456 O
precluding 22 32 457 467 O
fetoscopic 33 43 468 478 B-treatment
surgery 44 51 479 486 I-treatment

Women 0 5 487 492 B-gender
with 6 10 493 497 O
allergy 11 18 498 505 O
to 19 21 506 508 O
Latex 22 27 509 514 B-allergy_name

age 0 3 515 518 B-age
18 4 6 519 521 B-lower_bound
years 7 12 522 527 I-lower_bound
and 13 16 528 531 O
older 17 22 532 537 O

Ability 0 7 0 7 O
to 8 10 8 10 O
speak 11 16 11 16 B-language_fluency
English 17 24 17 24 I-language_fluency
well 25 29 25 29 O

All 0 3 30 33 O
patients 4 12 34 42 O
will 13 17 43 47 O
have 18 22 48 52 O
moderate 23 31 53 61 O
to 32 34 62 64 O
advanced 35 43 65 73 O
Parkinson 44 53 74 83 B-chronic_disease
's 53 55 83 85 I-chronic_disease
disease 56 63 86 93 I-chronic_disease

Essential 0 9 94 103 B-chronic_disease
Tremor 10 16 104 110 I-chronic_disease
, 16 17 110 111 O
and 18 21 112 115 O
Parkinson 22 31 116 125 B-chronic_disease
's 31 33 125 127 I-chronic_disease
plus 34 38 128 132 I-chronic_disease
disorders 39 48 133 142 I-chronic_disease

Parkinson 0 9 143 152 B-chronic_disease
's 9 11 152 154 I-chronic_disease
patients 12 20 155 163 O
with 21 25 164 168 O
concurrent 26 36 169 179 O
dementia 37 45 180 188 B-chronic_disease
as 46 48 189 191 O
measured 49 57 192 200 O
by 58 60 201 203 O
neurocognitive 61 75 204 218 B-treatment
testing 76 83 219 226 I-treatment
, 83 84 226 227 O
or 85 87 228 230 O
with 88 92 231 235 O
significant 93 104 236 247 O
strokes 105 112 248 255 B-chronic_disease
identified 113 123 256 266 O
on 124 126 267 269 O
MRI 127 130 270 273 B-treatment

Patients 0 8 274 282 O
must 9 13 283 287 O
be 14 16 288 290 O
medically 17 26 291 300 O
safe 27 31 301 305 O
for 32 35 306 309 O
asleep 36 42 310 316 B-treatment
or 43 45 317 319 O
awake 46 51 320 325 B-treatment
surgery 52 59 326 333 I-treatment

Patients 0 8 334 342 O
that 9 13 343 347 O
are 14 17 348 351 O
obese 18 23 352 357 B-chronic_disease
or 24 26 358 360 O
that 27 31 361 365 O
have 32 36 366 370 O
severe 37 43 371 377 O
potential 44 53 378 387 O
airway 54 60 388 394 O
issues 61 67 395 401 O

Active 0 6 0 6 O
duty 7 11 7 11 O
male 12 16 12 16 B-gender
or 17 19 17 19 I-gender
female 20 26 20 26 I-gender
, 26 27 26 27 O
of 28 30 28 30 O
any 31 34 31 34 O
race 35 39 35 39 O

Active 0 6 40 46 O
ophthalmic 7 17 47 57 B-chronic_disease
disease 18 25 58 65 I-chronic_disease
, 25 26 65 66 O
neovascularization 27 45 67 85 B-chronic_disease
of 46 48 86 88 I-chronic_disease
the 49 52 89 92 I-chronic_disease
cornea 53 59 93 99 I-chronic_disease
within 60 66 100 106 O
1 67 68 107 108 B-upper_bound
mm 69 71 109 111 I-upper_bound
of 72 74 112 114 O
the 75 78 115 118 O
intended 79 87 119 127 O
ablation 88 96 128 136 O
zone 97 101 137 141 O
, 101 102 141 142 O
or 103 105 143 145 O
lens 106 110 146 150 O
opacity 111 118 151 158 O

Any 0 3 159 162 O
physical 4 12 163 171 B-chronic_disease
or 13 15 172 174 I-chronic_disease
mental 16 22 175 181 I-chronic_disease
impairment 23 33 182 192 I-chronic_disease
which 34 39 193 198 O
would 40 45 199 204 O
preclude 46 54 205 213 O
participation 55 68 214 227 O
in 69 71 228 230 O
any 72 75 231 234 O
of 76 78 235 237 O
the 79 82 238 241 O
examinations 83 95 242 254 O
, 95 96 254 255 O
such 97 101 256 260 O
as 102 104 261 263 O
inability 105 114 264 273 O
to 115 117 274 276 O
give 118 122 277 281 O
verbal 123 129 282 288 O
responses 130 139 289 298 O
to 140 142 299 301 O
eye 143 146 302 305 O
charts 147 153 306 312 O

Best 0 4 313 317 O
spectacle 5 14 318 327 B-clinical_variable
corrected 15 24 328 337 I-clinical_variable
visual 25 31 338 344 I-clinical_variable
acuity 32 38 345 351 I-clinical_variable
of 39 41 352 354 O
20/25 42 47 355 360 B-upper_bound
or 48 50 361 363 O
better 51 57 364 370 O
in 58 60 371 373 O
both 61 65 374 378 O
eyes 66 70 379 383 O

Concurrent 0 10 384 394 B-treatment
topical 11 18 395 402 I-treatment
or 19 21 403 405 O
systemic 22 30 406 414 B-treatment
medications 31 42 415 426 I-treatment
which 43 48 427 432 O
may 49 52 433 436 O
impair 53 59 437 443 O
healing 60 67 444 451 O
, 67 68 451 452 O
including 69 78 453 462 O
corticosteroids 79 94 463 478 B-treatment
, 94 95 478 479 O
antimetabolites 96 111 480 495 B-treatment
, 111 112 495 496 O
isotretinoin 113 125 497 509 B-treatment
, 125 126 509 510 O
( 127 128 511 512 B-treatment
Accutane 128 136 512 520 I-treatment
™ 136 137 520 521 I-treatment
) 137 138 521 522 I-treatment
, 138 139 522 523 O
amiodarone 140 150 524 534 B-treatment
hydrochloride 151 164 535 548 I-treatment
( 165 166 549 550 I-treatment
Cordarone 166 175 550 559 I-treatment
™ 175 176 559 560 I-treatment
) 176 177 560 561 I-treatment
, 177 178 561 562 O
and/or 179 185 563 569 O
sumatriptan 186 197 570 581 B-treatment
( 198 199 582 583 I-treatment
Imitrex 199 206 583 590 I-treatment
™ 206 207 590 591 I-treatment
) 207 208 591 592 I-treatment

Evidence 0 8 593 601 O
of 9 11 602 604 O
glaucoma 12 20 605 613 B-chronic_disease
or 21 23 614 616 O
an 24 26 617 619 O
intraocular 27 38 620 631 B-clinical_variable
pressure 39 47 632 640 I-clinical_variable
greater 48 55 641 648 O
than 56 60 649 653 O
22 61 63 654 656 B-lower_bound
mm 64 66 657 659 I-lower_bound
Hg 67 69 660 662 I-lower_bound
at 70 72 663 665 I-lower_bound
baseline 73 81 666 674 I-lower_bound

Evidence 0 8 675 683 O
of 9 11 684 686 O
keratoconus 12 23 687 698 B-chronic_disease
, 23 24 698 699 O
corneal 25 32 700 707 B-chronic_disease
irregularity 33 45 708 720 I-chronic_disease
, 45 46 720 721 O
or 47 49 722 724 O
abnormal 50 58 725 733 O
videokeratography 59 76 734 751 B-treatment
in 77 79 752 754 O
either 80 86 755 761 O
eye 87 90 762 765 O

Female 0 6 766 772 B-gender
subjects 7 15 773 781 I-gender
who 16 19 782 785 O
are 20 23 786 789 B-pregnancy
pregnant 24 32 790 798 I-pregnancy
, 32 33 798 799 O
breast 34 40 800 806 O
- 40 41 806 807 O
feeding 41 48 807 814 O
, 48 49 814 815 O
or 50 52 816 818 O
intend 53 59 819 825 B-pregnancy
to 60 62 826 828 I-pregnancy
become 63 69 829 835 I-pregnancy
pregnant 70 78 836 844 I-pregnancy
during 79 85 845 851 O
the 86 89 852 855 O
course 90 96 856 862 O
of 97 99 863 865 O
the 100 103 866 869 O
study 104 109 870 875 O

Hard 0 4 876 880 O
contact 5 12 881 888 O
lens 13 17 889 893 O
users 18 23 894 899 O
( 24 25 900 901 O
PMMA 25 29 901 905 O
or 30 32 906 908 O
rigid 33 38 909 914 O
gas 39 42 915 918 O
permeable 43 52 919 928 O
lenses 53 59 929 935 O
) 59 60 935 936 O
must 61 65 937 941 O
have 66 70 942 946 O
removed 71 78 947 954 O
their 79 84 955 960 O
lenses 85 91 961 967 O
at 92 94 968 970 O
least 95 100 971 976 O
four 101 105 977 981 B-lower_bound
( 106 107 982 983 I-lower_bound
4 107 108 983 984 I-lower_bound
) 108 109 984 985 I-lower_bound
weeks 110 115 986 991 I-lower_bound
prior 116 121 992 997 I-lower_bound
to 122 124 998 1000 O
baseline 125 133 1001 1009 O
measurements 134 146 1010 1022 O

Manifest 0 8 1023 1031 B-clinical_variable
spherical 9 18 1032 1041 I-clinical_variable
equivalent 19 29 1042 1052 I-clinical_variable
( 30 31 1053 1054 I-clinical_variable
MSE 31 34 1054 1057 I-clinical_variable
) 34 35 1057 1058 I-clinical_variable
from 36 40 1059 1063 O
+3.00 41 46 1064 1069 B-lower_bound
D 47 48 1070 1071 I-lower_bound
to 49 51 1072 1074 O
-11.0D 52 58 1075 1081 B-upper_bound
with 59 63 1082 1086 O
refractive 64 74 1087 1097 B-clinical_variable
cylinder 75 83 1098 1106 I-clinical_variable
of 84 86 1107 1109 O
up 87 89 1110 1112 O
to 90 92 1113 1115 O
3.00 93 97 1116 1120 O
D 98 99 1121 1122 O

Medical 0 7 1123 1130 O
conditions 8 18 1131 1141 O
which 19 24 1142 1147 O
, 24 25 1147 1148 O
in 26 28 1149 1151 O
the 29 32 1152 1155 O
judgment 33 41 1156 1164 O
of 42 44 1165 1167 O
the 45 48 1168 1171 O
investigator 49 61 1172 1184 O
, 61 62 1184 1185 O
may 63 66 1186 1189 O
impair 67 73 1190 1196 O
healing 74 81 1197 1204 O
, 81 82 1204 1205 O
including 83 92 1206 1215 O
but 93 96 1216 1219 O
not 97 100 1220 1223 O
limited 101 108 1224 1231 O
to 109 111 1232 1234 O
thyroid 112 119 1235 1242 B-chronic_disease
disorders 120 129 1243 1252 I-chronic_disease
and 130 133 1253 1256 O
diabetes 134 142 1257 1265 B-chronic_disease

Patients 0 8 1266 1274 O
with 9 13 1275 1279 O
known 14 19 1280 1285 O
sensitivity 20 31 1286 1297 O
or 32 34 1298 1300 O
inappropriate 35 48 1301 1314 O
responsiveness 49 63 1315 1329 O
to 64 66 1330 1332 O
any 67 70 1333 1336 O
of 71 73 1337 1339 O
the 74 77 1340 1343 O
medications 78 89 1344 1355 B-allergy_name
used 90 94 1356 1360 I-allergy_name
in 95 97 1361 1363 I-allergy_name
the 98 101 1364 1367 I-allergy_name
post 102 106 1368 1372 I-allergy_name
- 106 107 1372 1373 I-allergy_name
operative 107 116 1373 1382 I-allergy_name
course 117 123 1383 1389 I-allergy_name

Soft 0 4 1390 1394 O
contact 5 12 1395 1402 O
lenses 13 19 1403 1409 O
must 20 24 1410 1414 O
have 25 29 1415 1419 O
been 30 34 1420 1424 O
removed 35 42 1425 1432 O
at 43 45 1433 1435 O
least 46 51 1436 1441 O
two 52 55 1442 1445 B-lower_bound
( 56 57 1446 1447 I-lower_bound
2 57 58 1447 1448 I-lower_bound
) 58 59 1448 1449 I-lower_bound
weeks 60 65 1450 1455 I-lower_bound
prior 66 71 1456 1461 I-lower_bound
to 72 74 1462 1464 O
baseline 75 83 1465 1473 O
measurements 84 96 1474 1486 O

Stable 0 6 1487 1493 O
spectacle 7 16 1494 1503 O
refraction 17 27 1504 1514 O
, 27 28 1514 1515 O
confirmed 29 38 1516 1525 O
by 39 41 1526 1528 O
clinical 42 50 1529 1537 O
records 51 58 1538 1545 O
. 58 59 1545 1546 O
Neither 60 67 1547 1554 O
the 68 71 1555 1558 O
spherical 72 81 1559 1568 O
nor 82 85 1569 1572 O
the 86 89 1573 1576 O
cylindrical 90 101 1577 1588 O
portion 102 109 1589 1596 O
of 110 112 1597 1599 O
the 113 116 1600 1603 O
refraction 117 127 1604 1614 O
may 128 131 1615 1618 O
have 132 136 1619 1623 O
changed 137 144 1624 1631 O
more 145 149 1632 1636 O
than 150 154 1637 1641 O
0.50 155 159 1642 1646 B-lower_bound
D 160 161 1647 1648 I-lower_bound
during 162 168 1649 1655 O
the 169 172 1656 1659 O
six 173 176 1660 1663 B-upper_bound
- 176 177 1663 1664 I-upper_bound
month 177 182 1664 1669 I-upper_bound
period 183 189 1670 1676 O
immediately 190 201 1677 1688 O
preceding 202 211 1689 1698 O
the 212 215 1699 1702 O
baseline 216 224 1703 1711 O
examination 225 236 1712 1723 O
for 237 240 1724 1727 O
myopic 241 247 1728 1734 O
patients 248 256 1735 1743 O
and 257 260 1744 1747 O
0.75 261 265 1748 1752 B-lower_bound
for 266 269 1753 1756 O
hyperopic 270 279 1757 1766 O
patients 280 288 1767 1775 O

Strong 0 6 1776 1782 O
motivation 7 17 1783 1793 O
for 18 21 1794 1797 O
attending 22 31 1798 1807 O
the 32 35 1808 1811 O
follow 36 42 1812 1818 O
- 42 43 1818 1819 O
up 43 45 1819 1821 O
visits 46 52 1822 1828 O
and 53 56 1829 1832 O
orders 57 63 1833 1839 O
to 64 66 1840 1842 O
remain 67 73 1843 1849 O
in 74 76 1850 1852 O
the 77 80 1853 1856 O
area 81 85 1857 1861 O
for 86 89 1862 1865 O
the 90 93 1866 1869 O
duration 94 102 1870 1878 O
of 103 105 1879 1881 O
at 106 108 1882 1884 O
least 109 114 1885 1890 O
twelve 115 121 1891 1897 B-lower_bound
months 122 128 1898 1904 I-lower_bound
of 129 131 1905 1907 O
follow 132 138 1908 1914 O
up 139 141 1915 1917 O

at 0 2 1918 1920 O
least 3 8 1921 1926 O
21 9 11 1927 1929 B-lower_bound
years 12 17 1930 1935 I-lower_bound
old 18 21 1936 1939 O
at 22 24 1940 1942 O
the 25 28 1943 1946 O
time 29 33 1947 1951 O
of 34 36 1952 1954 O
the 37 40 1955 1958 O
pre 41 44 1959 1962 O
- 44 45 1962 1963 O
operative 45 54 1963 1972 O
examination 55 66 1973 1984 O

Evidence 0 8 0 8 O
of 9 11 9 11 O
degenerative 12 24 12 24 B-chronic_disease
myopia 25 31 25 31 I-chronic_disease
regardless 32 42 32 42 O
of 43 45 43 45 O
the 46 49 46 49 O
refractive 50 60 50 60 O
error 61 66 61 66 O
in 67 69 67 69 O
the 70 73 70 73 O
study 74 79 74 79 O
eye 80 83 80 83 O

For 0 3 84 87 O
females 4 11 88 95 B-gender
of 12 14 96 98 O
childbearing 15 27 99 111 O
potential 28 37 112 121 O
: 37 38 121 122 O
A 39 40 123 124 O
negative 41 49 125 133 B-pregnancy
pregnancy 50 59 134 143 I-pregnancy
test 60 64 144 148 O
within 65 71 149 155 O
2 72 73 156 157 B-upper_bound
days 74 78 158 162 I-upper_bound
before 79 85 163 169 O
administration 86 100 170 184 O
of 101 103 185 187 O
study 104 109 188 193 O
agent 110 115 194 199 O

Refractive 0 10 200 210 B-clinical_variable
error 11 16 211 216 I-clinical_variable
of 17 19 217 219 O
≥ 20 21 220 221 O
-8.00 22 27 222 227 B-lower_bound
diopters 28 36 228 236 I-lower_bound
( 37 38 237 238 O
spherical 38 47 238 247 O
equivalent 48 58 248 258 O
) 58 59 258 259 O
of 60 62 260 262 O
myopia 63 69 263 269 B-chronic_disease
in 70 72 270 272 O
the 73 76 273 276 O
study 77 82 277 282 O
eye 83 86 283 286 O

A 0 1 0 1 O
patient 2 9 2 9 O
who 10 13 10 13 O
has 14 17 14 17 O
taken 18 23 18 23 O
both 24 28 24 28 O
bisphosphonate 29 43 29 43 B-treatment
and 44 47 44 47 O
Denosumab 48 57 48 57 B-treatment

Absence 0 7 58 65 O
of 8 10 66 68 O
tumor 11 16 69 74 B-cancer
in 17 19 75 77 I-cancer
the 20 23 78 81 I-cancer
jaw 24 27 82 85 I-cancer
at 28 30 86 88 O
the 31 34 89 92 O
time 35 39 93 97 O
of 40 42 98 100 O
recruitment 43 54 101 112 O

Female 0 6 113 119 B-gender
patients 7 15 120 128 I-gender
who 16 19 129 132 O
are 20 23 133 136 O
pregnant 24 32 137 145 B-pregnancy

History 0 7 146 153 O
of 8 10 154 156 O
exposure 11 19 157 165 O
to 20 22 166 168 O
antiresorptive 23 37 169 183 B-treatment
medications 38 49 184 195 O
such 50 54 196 200 O
as 55 57 201 203 O
bisphosphonates 58 73 204 219 B-treatment
or 74 76 220 222 O
RANK 77 81 223 227 B-treatment
- 81 82 227 228 I-treatment
L 82 83 228 229 I-treatment
inhibitors 84 94 230 240 I-treatment

Patient 0 7 241 248 O
with 8 12 249 253 O
history 13 20 254 261 O
of 21 23 262 264 O
prostate 24 32 265 273 B-cancer
cancer 33 39 274 280 I-cancer

Patients 0 8 281 289 O
taking 9 15 290 296 O
CYP1A2 16 22 297 303 B-treatment
inhibitors 23 33 304 314 I-treatment

Patients 0 8 315 323 O
taking 9 15 324 330 O
oral 16 20 331 335 O
anticoagulants 21 35 336 350 B-treatment

Patients 0 8 351 359 O
who 9 12 360 363 O
underwent 13 22 364 373 O
any 23 26 374 377 O
surgical 27 35 378 386 O
intervention 36 48 387 399 O
for 49 52 400 403 O
MRONJ 53 58 404 409 B-allergy_name
in 59 61 410 412 O
the 62 65 413 416 O
past 66 70 417 421 B-upper_bound
4 71 72 422 423 I-upper_bound
months 73 79 424 430 I-upper_bound

Patients 0 8 431 439 O
with 9 13 440 444 O
a 14 15 445 446 O
vitamin 16 23 447 454 B-chronic_disease
K 24 25 455 456 I-chronic_disease
deficiency 26 36 457 467 I-chronic_disease
due 37 40 468 471 O
to 41 43 472 474 O
any 44 47 475 478 O
cause 48 53 479 484 O

Patients 0 8 485 493 O
with 9 13 494 498 O
allergy 14 21 499 506 O
or 22 24 507 509 O
hypersensitivity 25 41 510 526 O
to 42 44 527 529 O
pentoxifylline 45 59 530 544 B-allergy_name
, 59 60 544 545 O
xanthines 61 70 546 555 B-allergy_name
, 70 71 555 556 O
or 72 74 557 559 O
tocopherol 75 85 560 570 B-allergy_name

Patients 0 8 571 579 O
with 9 13 580 584 O
an 14 16 585 587 O
expected 17 25 588 596 B-clinical_variable
survival 26 34 597 605 I-clinical_variable
less 35 39 606 610 O
than 40 44 611 615 O
1 45 46 616 617 B-upper_bound
year 47 51 618 622 I-upper_bound

Patients 0 8 623 631 O
with 9 13 632 636 O
history 14 21 637 644 O
of 22 24 645 647 O
external 25 33 648 656 B-treatment
radiation 34 43 657 666 I-treatment
therapy 44 51 667 674 I-treatment
to 52 54 675 677 O
the 55 58 678 681 O
jaws 59 63 682 686 O

Patients 0 8 687 695 O
with 9 13 696 700 O
ischemic 14 22 701 709 B-chronic_disease
heart 23 28 710 715 I-chronic_disease
diseases 29 37 716 724 I-chronic_disease

Patients 0 8 725 733 O
with 9 13 734 738 O
known 14 19 739 744 O
hemorrhagic 20 31 745 756 B-chronic_disease
and 32 35 757 760 I-chronic_disease
coagulation 36 47 761 772 I-chronic_disease
disorder 48 56 773 781 I-chronic_disease

Patients 0 8 782 790 O
with 9 13 791 795 O
serious 14 21 796 803 B-chronic_disease
cardiac 22 29 804 811 I-chronic_disease
arrhythmia 30 40 812 822 I-chronic_disease

Patients 0 8 823 831 O
with 9 13 832 836 O
severe 14 20 837 843 O
liver 21 26 844 849 B-chronic_disease
disease 27 34 850 857 I-chronic_disease

Patients 0 8 858 866 O
with 9 13 867 871 O
severe 14 20 872 878 B-chronic_disease
renal 21 26 879 884 I-chronic_disease
failure 27 34 885 892 I-chronic_disease

Stage 0 5 893 898 B-lower_bound
1 6 7 899 900 I-lower_bound
, 7 8 900 901 O
2 9 10 902 903 O
, 10 11 903 904 O
or 12 14 905 907 O
3 15 16 908 909 B-upper_bound
MRONJ 17 22 910 915 B-chronic_disease
as 23 25 916 918 O
defined 26 33 919 926 O
by 34 36 927 929 O
the 37 40 930 933 O
AAOMS 41 46 934 939 O
Position 47 55 940 948 O
Paper 56 61 949 954 O
on 62 64 955 957 O
Medication 65 75 958 968 O
- 75 76 968 969 O
Related 76 83 969 976 O
Osteonecrosis 84 97 977 990 O
of 98 100 991 993 O
the 101 104 994 997 O
Jaw—2014 105 113 998 1006 O
Update 114 120 1007 1013 O
( 121 122 1014 1015 O
Ruggiero 122 130 1015 1023 O
2014 131 135 1024 1028 O
) 135 136 1028 1029 O

ciprofloxacin 0 13 1030 1043 B-treatment

extensive 0 9 1044 1053 B-chronic_disease
retinal 10 17 1054 1061 I-chronic_disease
hemorrhage 18 28 1062 1072 I-chronic_disease

recent 0 6 1073 1079 O
myocardial 7 17 1080 1090 B-chronic_disease
infarction 18 28 1091 1101 I-chronic_disease

Current 0 7 0 7 O
smokers 8 15 8 15 O
or 16 18 16 18 O
history 19 26 19 26 O
of 27 29 27 29 O
heavy 30 35 30 35 B-clinical_variable
smoking 36 43 36 43 I-clinical_variable
( 44 45 44 45 O
> 45 46 45 46 O
2 46 47 46 47 B-lower_bound
packs 48 53 48 53 I-lower_bound
/ 53 54 53 54 I-lower_bound
day 54 57 54 57 I-lower_bound
) 57 58 57 58 O

Hypertension 0 12 59 71 B-chronic_disease
will 13 17 72 76 O
be 18 20 77 79 O
defined 21 28 80 87 O
as 29 31 88 90 O
a 32 33 91 92 O
systolic 34 42 93 101 B-clinical_variable
BP 43 45 102 104 I-clinical_variable
≥140 46 50 105 109 O
mm 51 53 110 112 I-lower_bound
Hg 54 56 113 115 I-lower_bound
and/or 57 63 116 122 O
a 64 65 123 124 O
diastolic 66 75 125 134 B-clinical_variable
BP 76 78 135 137 I-clinical_variable
≥ 79 80 138 139 O
90 81 83 140 142 B-lower_bound
mm 84 86 143 145 I-lower_bound
Hg 87 89 146 148 I-lower_bound
, 89 90 148 149 O
taken 91 96 150 155 O
in 97 99 156 158 O
the 100 103 159 162 O
seated 104 110 163 169 O
position 111 119 170 178 O
in 120 122 179 181 O
at 123 125 182 184 O
least 126 131 185 190 O
2 132 133 191 192 B-lower_bound
separate 134 142 193 201 O
occasions 143 152 202 211 O

Lean 0 4 212 216 B-treatment

Pregnancy 0 9 217 226 B-pregnancy

Subjects 0 8 227 235 O
with 9 13 236 240 O
any 14 17 241 244 O
chronic 18 25 245 252 B-chronic_disease
disease 26 33 253 260 I-chronic_disease

Subjects 0 8 261 269 O
with 9 13 270 274 O
morbid 14 20 275 281 B-clinical_variable
obesity 21 28 282 289 I-clinical_variable
( 29 30 290 291 O
BMI 30 33 291 294 B-clinical_variable
> 34 35 295 296 O
40 36 38 297 299 B-lower_bound
kg 39 41 300 302 I-lower_bound
/ 41 42 302 303 I-lower_bound
m2 42 44 303 305 I-lower_bound
) 44 45 305 306 O

between 0 7 307 314 O
18 8 10 315 317 B-lower_bound
and 11 14 318 321 O
65 15 17 322 324 B-upper_bound
years 18 23 325 330 I-upper_bound
of 24 26 331 333 O
age 27 30 334 337 B-age

cardiovascular 0 14 338 352 B-chronic_disease
disease 15 22 353 360 I-chronic_disease

diabetes 0 8 361 369 B-chronic_disease

diagnosis 0 9 370 379 O
of 10 12 380 382 O
sleep 13 18 383 388 B-chronic_disease
apnea 19 24 389 394 I-chronic_disease
or 25 27 395 397 O
a 28 29 398 399 O
high 30 34 400 404 O
score 35 40 405 410 O
in 41 43 411 413 O
the 44 47 414 417 O
Berlin 48 54 418 424 O
questionnaire 55 68 425 438 O
for 69 72 439 442 O
sleep 73 78 443 448 O
apnea 79 84 449 454 O

female 0 6 455 461 B-gender
subjects 7 15 462 470 I-gender

hypertension 0 12 471 483 B-chronic_disease

male 0 4 484 488 B-gender

obese 0 5 489 494 B-chronic_disease

A 0 1 0 1 O
suspicious 2 12 2 12 O
central 13 20 13 20 O
gland 21 26 21 26 O
lesion 27 33 27 33 O
on 34 36 34 36 O
MP 37 39 37 39 B-treatment
- 39 40 39 40 I-treatment
MRI 40 43 40 43 I-treatment
must 44 48 44 48 O
have 49 53 49 53 O
a 54 55 54 55 O
distinct 56 64 56 64 O
lesion 65 71 65 71 O
on 72 74 72 74 O
the 75 78 75 78 O
apparent 79 87 79 87 B-clinical_variable
diffusion 88 97 88 97 I-clinical_variable
coefficient 98 109 98 109 I-clinical_variable
( 110 111 110 111 I-clinical_variable
ADC 111 114 111 114 I-clinical_variable
) 114 115 114 115 I-clinical_variable

Age 0 3 116 119 B-age
≥ 4 5 120 121 O
35 6 8 122 124 B-lower_bound
and 9 12 125 128 O
≤ 13 14 129 130 O
85 15 17 131 133 B-upper_bound
years 18 23 134 139 I-upper_bound
at 24 26 140 142 O
signing 27 34 143 150 O
of 35 37 151 153 O
consent 38 45 154 161 O

An 0 2 162 164 O
anti 3 7 165 169 B-treatment
- 7 8 169 170 I-treatment
androgen 8 16 170 178 I-treatment
( 17 18 179 180 O
e.g. 18 22 180 184 O
, 22 23 184 185 O
bicalutamide 24 36 186 198 B-treatment
at 37 39 199 201 O
50 40 42 202 204 B-upper_bound
mg 43 45 205 207 I-upper_bound
per 46 49 208 211 I-upper_bound
day 50 53 212 215 I-upper_bound
po 54 56 216 218 O
) 56 57 218 219 O
is 58 60 220 222 O
recommended 61 72 223 234 O
to 73 75 235 237 O
start 76 81 238 243 O
prior 82 87 244 249 O
to 88 90 250 252 O
LHRH 91 95 253 257 B-treatment
agonist 96 103 258 265 I-treatment
injection 104 113 266 275 I-treatment
( 114 115 276 277 O
not 115 118 277 280 O
recommended 119 130 281 292 O
for 131 134 293 296 O
LHRH 135 139 297 301 B-treatment
antagonist 140 150 302 312 I-treatment
injection 151 160 313 322 I-treatment
) 160 161 322 323 O
and 162 165 324 327 O
is 166 168 328 330 O
recommended 169 180 331 342 O
to 181 183 343 345 O
not 184 187 346 349 O
be 188 190 350 352 O
administered 191 203 353 365 O

Androgen 0 8 366 374 B-treatment
deprivation 9 20 375 386 I-treatment
therapy 21 28 387 394 I-treatment
( 29 30 395 396 I-treatment
ADT 30 33 396 399 I-treatment
) 33 34 399 400 I-treatment
is 35 37 401 403 O
at 38 40 404 406 O
the 41 44 407 410 O
discretion 45 55 411 421 O
of 56 58 422 424 O
the 59 62 425 428 O
treating 63 71 429 437 O
physician 72 81 438 447 O

Biopsy 0 6 448 454 B-treatment
confirmed 7 16 455 464 O
adenocarcinoma 17 31 465 479 B-cancer
( 32 33 480 481 O
including 33 42 481 490 O
ductal 43 49 491 497 O
) 49 50 497 498 O
of 51 53 499 501 O
the 54 57 502 505 O
prostate 58 66 506 514 O

Distinct 0 8 515 523 O
lesion 9 15 524 530 O
on 16 18 531 533 O
dynamic 19 26 534 541 B-treatment
contrast 27 35 542 550 I-treatment
- 35 36 550 551 I-treatment
enhanced 36 44 551 559 I-treatment
MRI 45 48 560 563 I-treatment
( 49 50 564 565 I-treatment
DCE 50 53 565 568 I-treatment
- 53 54 568 569 I-treatment
MRI 54 57 569 572 I-treatment
) 57 58 572 573 I-treatment
with 59 63 574 578 O
early 64 69 579 584 O
enhancement 70 81 585 596 O
and 82 85 597 600 O
later 86 91 601 606 O
washout 92 99 607 614 O

Gleason 0 7 615 622 B-clinical_variable
8 8 9 623 624 B-lower_bound
- 9 10 624 625 O
10 10 12 625 627 B-upper_bound
or 13 15 628 630 O
a 16 17 631 632 O
PSA 18 21 633 636 B-clinical_variable
of 22 24 637 639 O
> 25 26 640 641 O
15 26 28 641 643 B-lower_bound
ng 29 31 644 646 I-lower_bound
/ 31 32 646 647 I-lower_bound
ml 32 34 647 649 I-lower_bound

Gleason 0 7 650 657 B-clinical_variable
score 8 13 658 663 I-clinical_variable
6 14 15 664 665 B-lower_bound
- 15 16 665 666 O
10 16 18 666 668 B-upper_bound

It 0 2 669 671 O
may 3 6 672 675 O
be 7 9 676 678 O
initiated 10 19 679 688 O
no 20 22 689 691 O
more 23 27 692 696 O
than 28 32 697 701 O
3 33 34 702 703 B-upper_bound
months 35 41 704 710 I-upper_bound
prior 42 47 711 716 I-upper_bound
to 48 50 717 719 O
the 51 54 720 723 O
signing 55 62 724 731 O
of 63 65 732 734 O
consent 66 73 735 742 O

It 0 2 743 745 O
must 3 7 746 750 O
be 8 10 751 753 O
started 11 18 754 761 O
prior 19 24 762 767 O
to 25 27 768 770 O
the 28 31 771 774 O
start 32 37 775 780 O
of 38 40 781 783 O
radiotherapy 41 53 784 796 B-treatment

Karnofsky 0 9 797 806 B-clinical_variable
or 10 12 807 809 O
Eastern 13 20 810 817 B-clinical_variable
Cooperative 21 32 818 829 I-clinical_variable
Oncology 33 41 830 838 I-clinical_variable
Group 42 47 839 844 I-clinical_variable
( 48 49 845 846 I-clinical_variable
ECOG 49 53 846 850 I-clinical_variable
) 53 54 850 851 I-clinical_variable
performance 55 66 852 863 I-clinical_variable
status 67 73 864 870 I-clinical_variable
may 74 77 871 874 O
be 78 80 875 877 O
used 81 85 878 882 O
to 86 88 883 885 O
estimate 89 97 886 894 O
Zubrod 98 104 895 901 B-clinical_variable

No 0 2 902 904 O
concurrent 3 13 905 915 O
, 13 14 915 916 O
active 15 21 917 923 O
malignancy 22 32 924 934 B-cancer
, 32 33 934 935 O
other 34 39 936 941 O
than 40 44 942 946 O
nonmetastatic 45 58 947 960 B-cancer
skin 59 63 961 965 I-cancer
cancer 64 70 966 972 I-cancer
or 71 73 973 975 O
early 74 79 976 981 O
stage 80 85 982 987 O
chronic 86 93 988 995 B-cancer
lymphocytic 94 105 996 1007 I-cancer
leukemia 106 114 1008 1016 I-cancer
( 115 116 1017 1018 O
well 116 120 1018 1022 O
- 120 121 1022 1023 O
differentiated 121 135 1023 1037 O
small 136 141 1038 1043 B-cancer
cell 142 146 1044 1048 I-cancer
lymphocytic 147 158 1049 1060 I-cancer
lymphoma 159 167 1061 1069 I-cancer
) 167 168 1069 1070 O

No 0 2 1071 1073 O
evidence 3 11 1074 1082 O
of 12 14 1083 1085 O
metastasis 15 25 1086 1096 B-cancer
by 26 28 1097 1099 O
any 29 32 1100 1103 O
clinical 33 41 1104 1112 O
criteria 42 50 1113 1121 O
or 51 53 1122 1124 O
available 54 63 1125 1134 O
radiographic 64 76 1135 1147 B-treatment
tests 77 82 1148 1153 I-treatment
( 83 84 1154 1155 O
N0M0 84 88 1155 1159 O
by 89 91 1160 1162 O
clinical 92 100 1163 1171 O
or 101 103 1172 1174 O
imaging 104 111 1175 1182 O
criteria 112 120 1183 1191 O
) 120 121 1191 1192 O

No 0 2 1193 1195 O
previous 3 11 1196 1204 O
history 12 19 1205 1212 O
of 20 22 1213 1215 O
radical 23 30 1216 1223 B-treatment
/ 30 31 1223 1224 I-treatment
total 31 36 1224 1229 I-treatment
prostatectomy 37 50 1230 1243 I-treatment
( 51 52 1244 1245 O
suprapubic 52 62 1245 1255 B-treatment
prostatectomy 63 76 1256 1269 I-treatment
is 77 79 1270 1272 O
acceptable 80 90 1273 1283 O
) 90 91 1283 1284 O

No 0 2 1285 1287 O
previous 3 11 1288 1296 O
pelvic 12 18 1297 1303 B-treatment
radiotherapy 19 31 1304 1316 I-treatment

Prostate 0 8 1317 1325 B-clinical_variable
- 8 9 1325 1326 I-clinical_variable
specific 9 17 1326 1334 I-clinical_variable
Antigen 18 25 1335 1342 I-clinical_variable
( 26 27 1343 1344 I-clinical_variable
PSA 27 30 1344 1347 I-clinical_variable
) 30 31 1347 1348 I-clinical_variable
≤ 32 33 1349 1350 O
100 34 37 1351 1354 B-upper_bound
ng 38 40 1355 1357 I-upper_bound
/ 40 41 1357 1358 I-upper_bound
mL 41 43 1358 1360 I-upper_bound
within 44 50 1361 1367 O
( 51 52 1368 1369 O
+ 52 53 1369 1370 O
/- 53 55 1370 1372 O
) 55 56 1372 1373 O
4 57 58 1374 1375 B-upper_bound
months 59 65 1376 1382 I-upper_bound
of 66 68 1383 1385 O
signing 69 76 1386 1393 O
of 77 79 1394 1396 O
consent 80 87 1397 1404 O

Subjects 0 8 1405 1413 O
with 9 13 1414 1418 O
T3 14 16 1419 1421 B-chronic_disease
disease 17 24 1422 1429 I-chronic_disease
based 25 30 1430 1435 O
on 31 33 1436 1438 O
digital 34 41 1439 1446 O
rectal 42 48 1447 1453 O
exam 49 53 1454 1458 O
( 54 55 1459 1460 O
DRE 55 58 1460 1463 O
) 58 59 1463 1464 O

Suspicious 0 10 1465 1475 O
peripheral 11 21 1476 1486 O
zone 22 26 1487 1491 O
or 27 29 1492 1494 O
central 30 37 1495 1502 O
gland 38 43 1503 1508 O
lesion 44 50 1509 1515 O
on 51 53 1516 1518 O
MP 54 56 1519 1521 B-treatment
- 56 57 1521 1522 I-treatment
MRI 57 60 1522 1525 I-treatment

T1 0 2 1526 1528 B-lower_bound
- 2 3 1528 1529 O
T3 3 5 1529 1531 B-upper_bound
disease 6 13 1532 1539 O
based 14 19 1540 1545 O
on 20 22 1546 1548 O
digital 23 30 1549 1556 O
rectal 31 37 1557 1563 O
exam 38 42 1564 1568 O

The 0 3 1569 1572 O
total 4 9 1573 1578 O
length 10 16 1579 1585 O
planned 17 24 1586 1593 O
must 25 29 1594 1598 O
be 30 32 1599 1601 O
≤ 33 34 1602 1603 O
30 35 37 1604 1606 B-upper_bound
months 38 44 1607 1613 I-upper_bound

Zubrod 0 6 1614 1620 B-clinical_variable
performance 7 18 1621 1632 I-clinical_variable
status 19 25 1633 1639 I-clinical_variable
≤ 26 27 1640 1641 O
2 28 29 1642 1643 B-upper_bound

distinct 0 8 1644 1652 O
lesion 9 15 1653 1659 O
on 16 18 1660 1662 O
the 19 22 1663 1666 O
ADC 23 26 1667 1670 B-clinical_variable
map 27 30 1671 1674 O
( 31 32 1675 1676 O
Value 32 37 1676 1681 B-clinical_variable
< 38 39 1682 1683 O
1000 39 43 1683 1687 B-upper_bound
) 43 44 1687 1688 O

map 0 3 1689 1692 O
( 4 5 1693 1694 O
Value 5 10 1694 1699 O
< 11 12 1700 1701 O
1000 12 16 1701 1705 B-upper_bound
) 16 17 1705 1706 O

must 0 4 1707 1711 O
be 5 7 1712 1714 O
decided 8 15 1715 1722 O
( 16 17 1723 1724 O
none 17 21 1724 1728 O
, 21 22 1728 1729 O
short 23 28 1730 1735 O
- 28 29 1735 1736 O
term 29 33 1736 1740 O
or 34 36 1741 1743 O
long 37 41 1744 1748 O
- 41 42 1748 1749 O
term 42 46 1749 1753 O
as 47 49 1754 1756 O
counted 50 57 1757 1764 O
from 58 62 1765 1769 O
the 63 66 1770 1773 O
luteinizing 67 78 1774 1785 B-treatment
hormone 79 86 1786 1793 I-treatment
- 86 87 1793 1794 I-treatment
releasing 87 96 1794 1803 I-treatment
hormone 97 104 1804 1811 I-treatment
( 105 106 1812 1813 I-treatment
LHRH 106 110 1813 1817 I-treatment
) 110 111 1817 1818 I-treatment
agonist 112 119 1819 1826 I-treatment
or 120 122 1827 1829 O
antagonist 123 133 1830 1840 B-treatment
injection 134 143 1841 1850 I-treatment
) 143 144 1850 1851 O
prior 145 150 1852 1857 O
to 151 153 1858 1860 O
enrollment 154 164 1861 1871 O

should 0 6 1872 1878 O
have 7 11 1879 1883 O
a 12 13 1884 1885 O
bone 14 18 1886 1890 B-treatment
scan 19 23 1891 1895 I-treatment
within 24 30 1896 1902 O
( 31 32 1903 1904 O
+ 32 33 1904 1905 O
/- 33 35 1905 1907 O
) 35 36 1907 1908 O
4 37 38 1909 1910 B-upper_bound
months 39 45 1911 1917 I-upper_bound
of 46 48 1918 1920 O
signing 49 56 1921 1928 O
of 57 59 1929 1931 O
consent 60 67 1932 1939 O
that 68 72 1940 1944 O
is 73 75 1945 1947 O
without 76 83 1948 1955 O
evidence 84 92 1956 1964 O
of 93 95 1965 1967 O
metastasis 96 106 1968 1978 B-cancer

< 0 1 0 1 O
/= 1 3 1 3 O
21 4 6 4 6 B-upper_bound
years 7 12 7 12 I-upper_bound
of 13 15 13 15 O
age 16 19 16 19 B-age

DLCO 0 4 20 24 B-clinical_variable
> 5 6 25 26 O
/= 6 8 26 28 O
40 9 11 29 31 B-lower_bound
% 11 12 31 32 I-lower_bound

Known 0 5 33 38 O
diagnosis 6 15 39 48 O
of 16 18 49 51 O
HIV 19 22 52 55 B-chronic_disease
I 23 24 56 57 I-chronic_disease
/ 24 25 57 58 I-chronic_disease
II 25 27 58 60 I-chronic_disease

LVEF 0 4 61 65 B-clinical_variable
> 5 6 66 67 O
/=40 6 10 67 71 O
% 10 11 71 72 I-lower_bound
or 12 14 73 75 O
LVSF 15 19 76 80 B-clinical_variable
> 20 21 81 82 O
/=26 21 25 82 86 O
% 25 26 86 87 I-lower_bound

Liver 0 5 88 93 B-clinical_variable
enzymes 6 13 94 101 I-clinical_variable
< 14 15 102 103 O
/= 15 17 103 105 O
5x 18 20 106 108 B-upper_bound
ULN 21 24 109 112 I-upper_bound

Negative 0 8 113 121 B-pregnancy
pregnancy 9 18 122 131 I-pregnancy
test 19 23 132 136 O

Performance 0 11 137 148 B-clinical_variable
status 12 18 149 155 I-clinical_variable
> 19 20 156 157 O
/= 20 22 157 159 O
40 23 25 160 162 B-lower_bound

Pregnant 0 8 163 171 B-pregnancy

Serum 0 5 172 177 B-clinical_variable
creatinine 6 16 178 188 I-clinical_variable
< 17 18 189 190 O
2x 19 21 191 193 B-upper_bound
ULN 22 25 194 197 I-upper_bound

Uncontrolled 0 12 198 210 O
invasive 13 21 211 219 B-clinical_variable
fungal 22 28 220 226 I-clinical_variable
or 29 31 227 229 O
bacterial 32 41 230 239 B-clinical_variable
infections 42 52 240 250 I-clinical_variable
within 53 59 251 257 O
1 60 61 258 259 B-upper_bound
month 62 67 260 265 I-upper_bound
prior 68 73 266 271 I-upper_bound
to 74 76 272 274 O
starting 77 85 275 283 O
alemtuzumab 86 97 284 295 B-treatment

Uncontrolled 0 12 296 308 O
viral 13 18 309 314 O
infection 19 28 315 324 B-chronic_disease
within 29 35 325 331 O
1 36 37 332 333 B-upper_bound
week 38 42 334 338 I-upper_bound
prior 43 48 339 344 I-upper_bound
to 49 51 345 347 O
starting 52 60 348 356 O
alemtuzumab 61 72 357 368 B-treatment

For 0 3 0 3 O
patients 4 12 4 12 O
with 13 17 13 17 O
positive 18 26 18 26 O
Hepatitis 27 36 27 36 B-treatment
C 37 38 37 38 I-treatment
Ab 39 41 39 41 I-treatment
, 41 42 41 42 O
negative 43 51 43 51 O
PCR 52 55 52 55 B-treatment
testing 56 63 56 63 I-treatment
must 64 68 64 68 O
be 69 71 69 71 O
documented 72 82 72 82 O

History 0 7 83 90 O
of 8 10 91 93 O
relevant 11 19 94 102 O
CNS 20 23 103 106 B-chronic_disease
pathology 24 33 107 116 I-chronic_disease
or 34 36 117 119 O
current 37 44 120 127 O
relevant 45 53 128 136 O
CNS 54 57 137 140 O
pathology 58 67 141 150 O
( 68 69 151 152 O
non 69 72 152 155 O
- 72 73 155 156 O
febrile 73 80 156 163 O
seizure 81 88 164 171 B-chronic_disease
disorder 89 97 172 180 I-chronic_disease
requiring 98 107 181 190 O
ongoing 108 115 191 198 O
anti 116 120 199 203 B-treatment
- 120 121 203 204 I-treatment
epileptic 121 130 204 213 I-treatment
medications 131 142 214 225 I-treatment
, 142 143 225 226 O
paresis 144 151 227 234 B-chronic_disease
, 151 152 234 235 O
aphasia 153 160 236 243 B-chronic_disease
, 160 161 243 244 O
cerebrovascular 162 177 245 260 B-chronic_disease
ischemia 178 186 261 269 I-chronic_disease
/ 186 187 269 270 O
hemorrhage 187 197 270 280 B-chronic_disease
, 197 198 280 281 O
severe 199 205 282 288 O
brain 206 211 289 294 B-chronic_disease
injuries 212 220 295 303 I-chronic_disease
, 220 221 303 304 O
dementia 222 230 305 313 B-chronic_disease
, 230 231 313 314 O
cerebellar 232 242 315 325 B-chronic_disease
disease 243 250 326 333 I-chronic_disease
, 250 251 333 334 O
organic 252 259 335 342 B-chronic_disease
brain 260 265 343 348 I-chronic_disease
syndrome 266 274 349 357 I-chronic_disease
, 274 275 357 358 O
psychosis 276 285 359 368 B-chronic_disease
, 285 286 368 369 O
coordination 287 299 370 382 B-chronic_disease
or 300 302 383 385 I-chronic_disease
movement 303 311 386 394 I-chronic_disease
disorder 312 320 395 403 I-chronic_disease
) 320 321 403 404 O

Lansky 0 6 405 411 B-clinical_variable
or 7 9 412 414 I-clinical_variable
Karnofsky 10 19 415 424 I-clinical_variable
performance 20 31 425 436 I-clinical_variable
status 32 38 437 443 I-clinical_variable
score 39 44 444 449 I-clinical_variable
of 45 47 450 452 O
≥ 48 49 453 454 O
50 50 52 455 457 B-lower_bound

Life 0 4 458 462 B-clinical_variable
expectancy 5 15 463 473 I-clinical_variable
of 16 18 474 476 O
≥ 19 20 477 478 O
8 21 22 479 480 B-lower_bound
weeks 23 28 481 486 I-lower_bound

Male 0 4 487 491 B-gender

Must 0 4 492 496 O
not 5 8 497 500 O
be 9 11 501 503 O
receiving 12 21 504 513 O
external 22 30 514 522 B-treatment
beam 31 35 523 527 I-treatment
radiation 36 45 528 537 I-treatment
therapy 46 53 538 545 I-treatment
at 54 56 546 548 O
the 57 60 549 552 O
time 61 65 553 557 O
of 66 68 558 560 O
study 69 74 561 566 O
enrollment 75 85 567 577 O

Negative 0 8 578 586 O
HIV 9 12 587 590 B-chronic_disease
antigen 13 20 591 598 O
and 21 24 599 602 O
antibody 25 33 603 611 O
, 33 34 611 612 O
Hepatitis 35 44 613 622 B-chronic_disease
B 45 46 623 624 I-chronic_disease
surface 47 54 625 632 O
antigen 55 62 633 640 O
and 63 66 641 644 O
Hepatitis 67 76 645 654 B-chronic_disease
C 77 78 655 656 I-chronic_disease
antibody 79 87 657 665 O
within 88 94 666 672 O
3 95 96 673 674 B-upper_bound
months 97 103 675 681 I-upper_bound
prior 104 109 682 687 I-upper_bound
to 110 112 688 690 O
enrollment 113 123 691 701 O

No 0 2 702 704 O
prior 3 8 705 710 B-treatment
genetically 9 20 711 722 I-treatment
modified 21 29 723 731 I-treatment
cell 30 34 732 736 I-treatment
therapy 35 42 737 744 I-treatment
that 43 47 745 749 O
is 48 50 750 752 O
still 51 56 753 758 O
detectable 57 67 759 769 O
or 68 70 770 772 O
prior 71 76 773 778 B-treatment
virotherapy 77 88 779 790 I-treatment

No 0 2 791 793 O
systemic 3 11 794 802 B-treatment
corticosteroids 12 27 803 818 I-treatment
( 28 29 819 820 O
unless 29 35 820 826 O
physiologic 36 47 827 838 O
replacement 48 59 839 850 O
dosing 60 66 851 857 O
) 66 67 857 858 O
within 68 74 859 865 O
7 75 76 866 867 B-upper_bound
days 77 81 868 872 I-upper_bound
of 82 84 873 875 O
enrollment 85 95 876 886 O

Patient 0 7 887 894 O
must 8 12 895 899 O
NOT 13 16 900 903 O
have 17 21 904 908 O
received 22 30 909 917 O
a 31 32 918 919 O
prior 33 38 920 925 B-treatment
allogeneic 39 49 926 936 I-treatment
hematopoietic 50 63 937 950 I-treatment
stem 64 68 951 955 I-treatment
cell 69 73 956 960 I-treatment
transplant 74 84 961 971 I-treatment

Patients 0 8 972 980 O
may 9 12 981 984 O
have 13 17 985 989 O
CNS 18 21 990 993 B-cancer
intracranial 22 34 994 1006 I-cancer
tumor 35 40 1007 1012 I-cancer

Patients 0 8 1013 1021 O
who 9 12 1022 1025 O
received 13 21 1026 1034 O
stem 22 26 1035 1039 B-treatment
cell 27 31 1040 1044 I-treatment
infusion 32 40 1045 1053 I-treatment
following 41 50 1054 1063 O
non 51 54 1064 1067 B-treatment
- 54 55 1067 1068 I-treatment
myelo 55 60 1068 1073 I-treatment
- 60 61 1073 1074 I-treatment
ablative 61 69 1074 1082 I-treatment
therapy 70 77 1083 1090 I-treatment

Pregnant 0 8 1091 1099 B-pregnancy

Presence 0 8 1100 1108 O
of 9 11 1109 1111 O
a 12 13 1112 1113 O
primary 14 21 1114 1121 O
immunodeficiency 22 38 1122 1138 B-chronic_disease
/ 38 39 1138 1139 O
bone 39 43 1139 1143 B-chronic_disease
marrow 44 50 1144 1150 I-chronic_disease
failure 51 58 1151 1158 I-chronic_disease
syndrome 59 67 1159 1167 I-chronic_disease

Presence 0 8 1168 1176 O
of 9 11 1177 1179 O
active 12 18 1180 1186 B-cancer
malignancy 19 29 1187 1197 I-cancer
other 30 35 1198 1203 O
than 36 40 1204 1208 O
NB 41 43 1209 1211 B-cancer

Presence 0 8 1212 1220 O
of 9 11 1221 1223 O
active 12 18 1224 1230 O
severe 19 25 1231 1237 B-chronic_disease
infection 26 35 1238 1247 I-chronic_disease

Presence 0 8 1248 1256 O
of 9 11 1257 1259 O
any 12 15 1260 1263 O
concurrent 16 26 1264 1274 O
medical 27 34 1275 1282 O
condition 35 44 1283 1292 O
that 45 49 1293 1297 O
, 49 50 1297 1298 O
in 51 53 1299 1301 O
the 54 57 1302 1305 O
opinion 58 65 1306 1313 O
of 66 68 1314 1316 O
the 69 72 1317 1320 O
protocol 73 81 1321 1329 O
PI 82 84 1330 1332 O
or 85 87 1333 1335 O
designee 88 96 1336 1344 O
, 96 97 1344 1345 O
would 98 103 1346 1351 O
prevent 104 111 1352 1359 O
the 112 115 1360 1363 O
patient 116 123 1364 1371 O
from 124 128 1372 1376 O
undergoing 129 139 1377 1387 O
protocol 140 148 1388 1396 B-treatment
- 148 149 1396 1397 I-treatment
based 149 154 1397 1402 I-treatment
therapy 155 162 1403 1410 I-treatment

Presence 0 8 1411 1419 O
of 9 11 1420 1422 O
known 12 17 1423 1428 O
intracranial 18 30 1429 1441 B-chronic_disease
metastatic 31 41 1442 1452 I-chronic_disease
neuroblastoma 42 55 1453 1466 I-chronic_disease

Prior 0 5 1467 1472 O
diagnosis 6 15 1473 1482 O
of 16 18 1483 1485 O
NB 19 21 1486 1488 B-cancer
or 22 24 1489 1491 I-cancer
ganglioneuroblastoma 25 45 1492 1512 I-cancer
either 46 52 1513 1519 O
by 53 55 1520 1522 O
histologic 56 66 1523 1533 O
verification 67 79 1534 1546 O
and/or 80 86 1547 1553 O
demonstration 87 100 1554 1567 O
of 101 103 1568 1570 O
tumor 104 109 1571 1576 B-cancer
cells 110 115 1577 1582 O
in 116 118 1583 1585 O
the 119 122 1586 1589 O
bone 123 127 1590 1594 O
marrow 128 134 1595 1601 O
with 135 139 1602 1606 O
increased 140 149 1607 1616 O
catecholamine 150 163 1617 1630 O
levels 164 170 1631 1637 O

Receiving 0 9 1638 1647 O
any 10 13 1648 1651 O
other 14 19 1652 1657 O
anti 20 24 1658 1662 B-treatment
- 24 25 1662 1663 I-treatment
cancer 25 31 1663 1669 I-treatment
agents 32 38 1670 1676 I-treatment
or 39 41 1677 1679 O
radiotherapy 42 54 1680 1692 B-treatment
at 55 57 1693 1695 O
the 58 61 1696 1699 O
time 62 66 1700 1704 O
of 67 69 1705 1707 O
study 70 75 1708 1713 O
entry 76 81 1714 1719 O

Recovered 0 9 1720 1729 O
from 10 14 1730 1734 O
significant 15 26 1735 1746 O
acute 27 32 1747 1752 O
toxic 33 38 1753 1758 O
effects 39 46 1759 1766 O
of 47 49 1767 1769 O
all 50 53 1770 1773 O
prior 54 59 1774 1779 O
chemotherapy 60 72 1780 1792 B-treatment
, 72 73 1792 1793 O
immunotherapy 74 87 1794 1807 B-treatment
, 87 88 1807 1808 O
or 89 91 1809 1811 O
radiotherapy 92 104 1812 1824 B-treatment
prior 105 110 1825 1830 O
to 111 113 1831 1833 O
enrollment 114 124 1834 1844 O
onto 125 129 1845 1849 O
this 130 134 1850 1854 O
study 135 140 1855 1860 O

Skull 0 5 1861 1866 B-cancer
based 6 11 1867 1872 I-cancer
disease 12 19 1873 1880 I-cancer
with 20 24 1881 1885 O
soft 25 29 1886 1890 O
tissue 30 36 1891 1897 O
extension 37 46 1898 1907 O

Unable 0 6 1908 1914 O
to 7 9 1915 1917 O
tolerate 10 18 1918 1926 O
apheresis 19 28 1927 1936 B-treatment
procedure 29 38 1937 1946 O
including 39 48 1947 1956 O
placement 49 58 1957 1966 O
of 59 61 1967 1969 O
temporary 62 71 1970 1979 O
apheresis 72 81 1980 1989 B-treatment
catheter 82 90 1990 1998 I-treatment

female 0 6 1999 2005 B-gender
subjects 7 15 2006 2014 I-gender

≤ 0 1 2015 2016 O
26 2 4 2017 2019 B-upper_bound
years 5 10 2020 2025 I-upper_bound
of 11 13 2026 2028 O
age 14 17 2029 2032 B-age

≥ 0 1 2033 2034 O
12 2 4 2035 2037 B-lower_bound
weeks 5 10 2038 2043 I-lower_bound
from 11 15 2044 2048 O
prior 16 21 2049 2054 B-treatment
I131 22 26 2055 2059 I-treatment
MIBG 27 31 2060 2064 I-treatment
therapy 32 39 2065 2072 I-treatment

≥ 0 1 2073 2074 O
3 2 3 2075 2076 B-lower_bound
half 4 8 2077 2081 I-lower_bound
- 8 9 2081 2082 I-lower_bound
lives 9 14 2082 2087 I-lower_bound
or 15 17 2088 2090 O
30 18 20 2091 2093 B-lower_bound
days 21 25 2094 2098 I-lower_bound
from 26 30 2099 2103 O
time 31 35 2104 2108 O
of 36 38 2109 2111 O
last 39 43 2112 2116 O
dose 44 48 2117 2121 O
of 49 51 2122 2124 O
anti 52 56 2125 2129 B-treatment
- 56 57 2129 2130 I-treatment
tumor 57 62 2130 2135 I-treatment
directed 63 71 2136 2144 I-treatment
antibody 72 80 2145 2153 I-treatment
therapy 81 88 2154 2161 I-treatment
, 88 89 2161 2162 O
whichever 90 99 2163 2172 O
is 100 102 2173 2175 O
shorter 103 110 2176 2183 O
from 111 115 2184 2188 O
time 116 120 2189 2193 O
of 121 123 2194 2196 O
enrollment 124 134 2197 2207 O

≥ 0 1 2208 2209 O
6 2 3 2210 2211 B-lower_bound
weeks 4 9 2212 2217 I-lower_bound
from 10 14 2218 2222 O
myeloablative 15 28 2223 2236 B-treatment
therapy 29 36 2237 2244 I-treatment
and 37 40 2245 2248 O
autologous 41 51 2249 2259 B-treatment
stem 52 56 2260 2264 I-treatment
cell 57 61 2265 2269 I-treatment
transplant 62 72 2270 2280 I-treatment
( 73 74 2281 2282 O
timed 74 79 2282 2287 O
from 80 84 2288 2292 O
stem 85 89 2293 2297 B-treatment
cell 90 94 2298 2302 I-treatment
infusion 95 103 2303 2311 I-treatment
) 103 104 2311 2312 O

≥ 0 1 2313 2314 O
7 2 3 2315 2316 B-lower_bound
days 4 8 2317 2321 I-lower_bound
since 9 14 2322 2327 O
last 15 19 2328 2332 O
chemotherapy 20 32 2333 2345 B-treatment
or 33 35 2346 2348 O
biologic 36 44 2349 2357 B-treatment
therapy 45 52 2358 2365 I-treatment
administration 53 67 2366 2380 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
750 35 38 35 38 B-lower_bound
/ 38 39 38 39 I-lower_bound
mcl 39 42 39 42 I-lower_bound

Adult 0 5 43 48 B-cancer
T 6 7 49 50 I-cancer
- 7 8 50 51 I-cancer
cell 8 12 51 55 I-cancer
lymphoma 13 21 56 64 I-cancer
/ 21 22 64 65 I-cancer
leukemia 22 30 65 73 I-cancer
( 31 32 74 75 I-cancer
ATLL 32 36 75 79 I-cancer
) 36 37 79 80 I-cancer

Age 0 3 81 84 B-age
> 4 5 85 86 O
= 5 6 86 87 O
18 7 9 88 90 B-lower_bound
years 10 15 91 96 I-lower_bound
to 16 18 97 99 O
< 19 20 100 101 O
60 21 23 102 104 B-upper_bound
years 24 29 105 110 I-upper_bound

All 0 3 111 114 O
patients 4 12 115 123 O
must 13 17 124 128 O
agree 18 23 129 134 B-contraception_consent
to 24 26 135 137 I-contraception_consent
use 27 30 138 141 I-contraception_consent
effective 31 40 142 151 I-contraception_consent
contraception 41 54 152 165 I-contraception_consent
while 55 60 166 171 O
on 61 63 172 174 O
study 64 69 175 180 O

All 0 3 181 184 O
study 4 9 185 190 O
participants 10 22 191 203 O
must 23 27 204 208 O
be 28 30 209 211 O
registered 31 41 212 222 O
into 42 46 223 227 O
the 47 50 228 231 O
mandatory 51 60 232 241 O
Revlimid 61 69 242 250 B-treatment
REMS 70 74 251 255 I-treatment
® 74 75 255 256 I-treatment
program 76 83 257 264 I-treatment
, 83 84 264 265 O
and 85 88 266 269 O
be 89 91 270 272 O
willing 92 99 273 280 O
and 100 103 281 284 O
able 104 108 285 289 O
to 109 111 290 292 O
comply 112 118 293 299 O
with 119 123 300 304 O
the 124 127 305 308 O
requirements 128 140 309 321 O
of 141 143 322 324 O
the 144 147 325 328 O
REMS 148 152 329 333 O
® 152 153 333 334 O
program 154 161 335 342 O

Anaplastic 0 10 343 353 B-cancer
large 11 16 354 359 I-cancer
cell 17 21 360 364 I-cancer
lymphoma 22 30 365 373 I-cancer

Anaplastic 0 10 374 384 B-cancer
large 11 16 385 390 I-cancer
cell 17 21 391 395 I-cancer
lymphoma 22 30 396 404 I-cancer
, 30 31 404 405 O
ALK 32 35 406 409 B-treatment
- 35 36 409 410 O
positive 36 44 410 418 O

Anaplastic 0 10 419 429 B-cancer
large 11 16 430 435 I-cancer
- 16 17 435 436 I-cancer
cell 17 21 436 440 I-cancer
lymphoma 22 30 441 449 I-cancer
, 30 31 449 450 O
primary 32 39 451 458 O
cutaneous 40 49 459 468 O
type 50 54 469 473 O

Angioimmunoblastic 0 18 474 492 B-cancer
T 19 20 493 494 I-cancer
- 20 21 494 495 I-cancer
cell 21 25 495 499 I-cancer
lymphoma 26 34 500 508 I-cancer

Aspartate 0 9 509 518 B-clinical_variable
aminotransferase 10 26 519 535 I-clinical_variable
( 27 28 536 537 I-clinical_variable
AST 28 31 537 540 I-clinical_variable
) 31 32 540 541 I-clinical_variable
( 33 34 542 543 O
serum 34 39 543 548 B-clinical_variable
glutamic 40 48 549 557 I-clinical_variable
oxaloacetic 49 60 558 569 I-clinical_variable
transaminase 61 73 570 582 I-clinical_variable
[ 74 75 583 584 I-clinical_variable
SGOT 75 79 584 588 I-clinical_variable
] 79 80 588 589 I-clinical_variable
) 80 81 589 590 O
and 82 85 591 594 O
alanine 86 93 595 602 B-clinical_variable
aminotransferase 94 110 603 619 I-clinical_variable
( 111 112 620 621 I-clinical_variable
ALT 112 115 621 624 I-clinical_variable
) 115 116 624 625 I-clinical_variable
( 117 118 626 627 O
serum 118 123 627 632 B-clinical_variable
pyruvate 124 132 633 641 I-clinical_variable
glutamate 133 142 642 651 I-clinical_variable
transaminase 143 155 652 664 I-clinical_variable
[ 156 157 665 666 I-clinical_variable
SPGT 157 161 666 670 I-clinical_variable
] 161 162 670 671 I-clinical_variable
) 162 163 671 672 O
= 164 165 673 674 O
< 165 166 674 675 O
3 167 168 676 677 B-upper_bound
x 169 170 678 679 I-upper_bound
ULN 171 174 680 683 I-upper_bound

Cardiac 0 7 684 691 B-chronic_disease
arrhythmia 8 18 692 702 I-chronic_disease

Creatinine 0 10 703 713 B-clinical_variable
= 11 12 714 715 O
< 12 13 715 716 O
2 14 15 717 718 B-upper_bound
x 16 17 719 720 I-upper_bound
ULN 18 21 721 724 I-upper_bound

Enteropathy 0 11 725 736 B-cancer
- 11 12 736 737 I-cancer
type 12 16 737 741 I-cancer
T 17 18 742 743 I-cancer
- 18 19 743 744 I-cancer
cell 19 23 744 748 I-cancer
lymphoma 24 32 749 757 I-cancer

Extranodal 0 10 758 768 B-cancer
natural 11 18 769 776 I-cancer
killer 19 25 777 783 I-cancer
( 26 27 784 785 I-cancer
NK)/T 27 32 785 790 I-cancer
- 32 33 790 791 I-cancer
cell 33 37 791 795 I-cancer
lymphoma 38 46 796 804 I-cancer
, 46 47 804 805 I-cancer
nasal 48 53 806 811 I-cancer
type 54 58 812 816 I-cancer

FCPB 0 4 817 821 O
must 5 9 822 826 O
have 10 14 827 831 O
a 15 16 832 833 O
negative 17 25 834 842 B-pregnancy
urine 26 31 843 848 I-pregnancy
or 32 34 849 851 I-pregnancy
serum 35 40 852 857 I-pregnancy
pregnancy 41 50 858 867 I-pregnancy
test 51 55 868 872 O
within 56 62 873 879 O
7 63 64 880 881 B-upper_bound
days 65 69 882 886 I-upper_bound
prior 70 75 887 892 I-upper_bound
to 76 78 893 895 O
registration 79 91 896 908 O
, 91 92 908 909 O
and 93 96 910 913 O
be 97 99 914 916 O
willing 100 107 917 924 O
to 108 110 925 927 O
adhere 111 117 928 934 O
to 118 120 935 937 O
the 121 124 938 941 O
scheduled 125 134 942 951 O
pregnancy 135 144 952 961 O
testing 145 152 962 969 O
as 153 155 970 972 O
required 156 164 973 981 O
in 165 167 982 984 O
the 168 171 985 988 O
Revlimid 172 180 989 997 O
Risk 181 185 998 1002 O
Evaluation 186 196 1003 1013 O
and 197 200 1014 1017 O
Mitigation 201 211 1018 1028 O
Strategies 212 222 1029 1039 O
( 223 224 1040 1041 O
REMS 224 228 1041 1045 O
® 228 229 1045 1046 O
) 229 230 1046 1047 O
program 231 238 1048 1055 O

Females 0 7 1056 1063 B-gender
of 8 10 1064 1066 O
childbearing 11 23 1067 1079 O
potential 24 33 1080 1089 O
( 34 35 1090 1091 O
FCBP 35 39 1091 1095 O
) 39 40 1095 1096 O
must 41 45 1097 1101 O
either 46 52 1102 1108 O
commit 53 59 1109 1115 B-contraception_consent
to 60 62 1116 1118 I-contraception_consent
continued 63 72 1119 1128 I-contraception_consent
abstinence 73 83 1129 1139 I-contraception_consent
from 84 88 1140 1144 I-contraception_consent
heterosexual 89 101 1145 1157 I-contraception_consent
intercourse 102 113 1158 1169 I-contraception_consent
or 114 116 1170 1172 O
begin 117 122 1173 1178 B-contraception_consent
TWO 123 126 1179 1182 I-contraception_consent
acceptable 127 137 1183 1193 I-contraception_consent
methods 138 145 1194 1201 I-contraception_consent
of 146 148 1202 1204 I-contraception_consent
birth 149 154 1205 1210 I-contraception_consent
control 155 162 1211 1218 I-contraception_consent
: 162 163 1218 1219 O
one 164 167 1220 1223 O
highly 168 174 1224 1230 O
effective 175 184 1231 1240 O
method 185 191 1241 1247 O
and 192 195 1248 1251 O
one 196 199 1252 1255 O
additional 200 210 1256 1266 O
effective 211 220 1267 1276 O
method 221 227 1277 1283 O
AT 228 230 1284 1286 O
THE 231 234 1287 1290 O
SAME 235 239 1291 1295 O
TIME 240 244 1296 1300 O
, 244 245 1300 1301 O
at 246 248 1302 1304 O
least 249 254 1305 1310 O
28 255 257 1311 1313 B-lower_bound
days 258 262 1314 1318 I-lower_bound
before 263 269 1319 1325 I-lower_bound
starting 270 278 1326 1334 O
lenalidomide 279 291 1335 1347 B-treatment
, 291 292 1347 1348 O
during 293 299 1349 1355 O
lenalidomide 300 312 1356 1368 B-treatment
therapy 313 320 1369 1376 I-treatment
, 320 321 1376 1377 O
during 322 328 1378 1384 O
dose 329 333 1385 1389 O
interruptions 334 347 1390 1403 O
, 347 348 1403 1404 O
and 349 352 1405 1408 O
for 353 356 1409 1412 O
at 357 359 1413 1415 O
least 360 365 1416 1421 O
28 366 368 1422 1424 O
days 369 373 1425 1429 O
following 374 383 1430 1439 O
discontinuation 384 399 1440 1455 O
of 400 402 1456 1458 O
lenalidomide 403 415 1459 1471 O
therapy 416 423 1472 1479 O

Hemoglobin 0 10 1480 1490 B-clinical_variable
> 11 12 1491 1492 O
= 12 13 1492 1493 O
8 14 15 1494 1495 B-lower_bound
g 16 17 1496 1497 I-lower_bound
/ 17 18 1497 1498 I-lower_bound
dl 18 20 1498 1500 I-lower_bound

Hepatosplenic 0 13 1501 1514 B-cancer
gamma 14 19 1515 1520 I-cancer
- 19 20 1520 1521 I-cancer
delta 20 25 1521 1526 I-cancer
T 26 27 1527 1528 I-cancer
- 27 28 1528 1529 I-cancer
cell 28 32 1529 1533 I-cancer
lymphoma 33 41 1534 1542 I-cancer

Histologically 0 14 1543 1557 O
confirmed 15 24 1558 1567 O
diagnosis 25 34 1568 1577 O
of 35 37 1578 1580 O
PTCL 38 42 1581 1585 B-cancer
( 43 44 1586 1587 O
using 44 49 1587 1592 O
the 50 53 1593 1596 O
most 54 58 1597 1601 O
recent 59 65 1602 1608 O
edition 66 73 1609 1616 O
of 74 76 1617 1619 O
the 77 80 1620 1623 O
World 81 86 1624 1629 O
Health 87 93 1630 1636 O
Organization 94 106 1637 1649 O
[ 107 108 1650 1651 O
WHO 108 111 1651 1654 O
] 111 112 1654 1655 O
Classification 113 127 1656 1670 O
of 128 130 1671 1673 O
Tumors 131 137 1674 1680 O
of 138 140 1681 1683 O
Hematopoietic 141 154 1684 1697 O
and 155 158 1698 1701 O
Lymphoid 159 167 1702 1710 O
Tissues 168 175 1711 1718 O
as 176 178 1719 1721 O
guidance 179 187 1722 1730 O
) 187 188 1730 1731 O

Mycosis 0 7 1732 1739 B-cancer
fungoides 8 17 1740 1749 I-cancer
/ 17 18 1749 1750 O
Sezary 18 24 1750 1756 B-cancer
syndrome 25 33 1757 1765 I-cancer

NK 0 2 1766 1768 B-cancer
- 2 3 1768 1769 I-cancer
cell 3 7 1769 1773 I-cancer
leukemia 8 16 1774 1782 I-cancer

Ongoing 0 7 1783 1790 O
or 8 10 1791 1793 O
active 11 17 1794 1800 B-chronic_disease
infection 18 27 1801 1810 I-chronic_disease

Patients 0 8 1811 1819 O
must 9 13 1820 1824 O
be 14 16 1825 1827 O
free 17 21 1828 1832 O
of 22 24 1833 1835 O
any 25 28 1836 1839 O
prior 29 34 1840 1845 O
malignancies 35 47 1846 1858 B-cancer
for 48 51 1859 1862 O
> 52 53 1863 1864 O
= 53 54 1864 1865 O
1 55 56 1866 1867 B-lower_bound
year 57 61 1868 1872 I-lower_bound

Patients 0 8 1873 1881 O
must 9 13 1882 1886 O
have 14 18 1887 1891 O
adequate 19 27 1892 1900 O
organ 28 33 1901 1906 O
and 34 37 1907 1910 O
marrow 38 44 1911 1917 O
function 45 53 1918 1926 O
( 54 55 1927 1928 O
documented 55 65 1928 1938 O
within 66 72 1939 1945 O
14 73 75 1946 1948 B-upper_bound
days 76 80 1949 1953 I-upper_bound
prior 81 86 1954 1959 I-upper_bound
to 87 89 1960 1962 O
registration 90 102 1963 1975 O
) 102 103 1975 1976 O

Patients 0 8 1977 1985 O
must 9 13 1986 1990 O
have 14 18 1991 1995 O
an 19 21 1996 1998 O
Eastern 22 29 1999 2006 B-clinical_variable
Cooperative 30 41 2007 2018 I-clinical_variable
Oncology 42 50 2019 2027 I-clinical_variable
Group 51 56 2028 2033 I-clinical_variable
( 57 58 2034 2035 I-clinical_variable
ECOG 58 62 2035 2039 I-clinical_variable
) 62 63 2039 2040 I-clinical_variable
performance 64 75 2041 2052 I-clinical_variable
status 76 82 2053 2059 I-clinical_variable
= 83 84 2060 2061 O
< 84 85 2061 2062 O
2 86 87 2063 2064 B-upper_bound

Patients 0 8 2065 2073 O
must 9 13 2074 2078 O
have 14 18 2079 2083 O
bi 19 21 2084 2086 B-clinical_variable
- 21 22 2086 2087 I-clinical_variable
dimensionally 22 35 2087 2100 I-clinical_variable
measurable 36 46 2101 2111 I-clinical_variable
disease 47 54 2112 2119 I-clinical_variable
( 55 56 2120 2121 O
> 56 57 2121 2122 O
= 57 58 2122 2123 O
1 59 60 2124 2125 B-lower_bound
cm 61 63 2126 2128 I-lower_bound
) 63 64 2128 2129 O
by 65 67 2130 2132 O
CT 68 70 2133 2135 B-treatment
imaging 71 78 2136 2143 O

Patients 0 8 2144 2152 O
must 9 13 2153 2157 O
not 14 17 2158 2161 O
have 18 22 2162 2166 O
received 23 31 2167 2175 O
prior 32 37 2176 2181 B-treatment
systemic 38 46 2182 2190 I-treatment
therapy 47 54 2191 2198 I-treatment
for 55 58 2199 2202 O
PTCL 59 63 2203 2207 B-cancer
( 64 65 2208 2209 O
except 65 71 2209 2215 O
for 72 75 2216 2219 O
corticosteroids 76 91 2220 2235 B-treatment
for 92 95 2236 2239 O
10 96 98 2240 2242 B-upper_bound
or 99 101 2243 2245 O
fewer 102 107 2246 2251 O
days 108 112 2252 2256 O
at 113 115 2257 2259 O
any 116 119 2260 2263 O
dose 120 124 2264 2268 O
, 124 125 2268 2269 O
no 126 128 2270 2272 O
washout 129 136 2273 2280 O
period 137 143 2281 2287 O
required 144 152 2288 2296 O
as 153 155 2297 2299 O
long 156 160 2300 2304 O
as 161 163 2305 2307 O
they 164 168 2308 2312 O
discontinue 169 180 2313 2324 O
prior 181 186 2325 2330 O
to 187 189 2331 2333 O
starting 190 198 2334 2342 O
study 199 204 2343 2348 O
therapy 205 212 2349 2356 O
) 212 213 2356 2357 O

Patients 0 8 2358 2366 O
receiving 9 18 2367 2376 O
ongoing 19 26 2377 2384 B-treatment
treatment 27 36 2385 2394 I-treatment
with 37 41 2395 2399 O
any 42 45 2400 2403 O
other 46 51 2404 2409 O
investigational 52 67 2410 2425 B-treatment
agents 68 74 2426 2432 I-treatment

Patients 0 8 2433 2441 O
who 9 12 2442 2445 O
are 13 16 2446 2449 O
pregnant 17 25 2450 2458 B-pregnancy
or 26 28 2459 2461 O
actively 29 37 2462 2470 O
nursing 38 45 2471 2478 O
an 46 48 2479 2481 O
infant 49 55 2482 2488 O

Patients 0 8 2489 2497 O
who 9 12 2498 2501 O
have 13 17 2502 2506 O
known 18 23 2507 2512 O
central 24 31 2513 2520 O
nervous 32 39 2521 2528 O
system 40 46 2529 2535 O
( 47 48 2536 2537 O
CNS 48 51 2537 2540 O
) 51 52 2540 2541 O
involvement 53 64 2542 2553 O
of 65 67 2554 2556 O
lymphoma 68 76 2557 2565 B-cancer

Patients 0 8 2566 2574 O
who 9 12 2575 2578 O
received 13 21 2579 2587 O
chemotherapy 22 34 2588 2600 B-treatment
( 35 36 2601 2602 O
including 36 45 2602 2611 O
monoclonal 46 56 2612 2622 B-treatment
antibodies 57 67 2623 2633 I-treatment
) 67 68 2633 2634 O
or 69 71 2635 2637 O
radiotherapy 72 84 2638 2650 B-treatment
, 84 85 2650 2651 O
administered 86 98 2652 2664 O
for 99 102 2665 2668 O
any 103 106 2669 2672 O
condition 107 116 2673 2682 O
, 116 117 2682 2683 O
within 118 124 2684 2690 O
4 125 126 2691 2692 B-upper_bound
weeks 127 132 2693 2698 I-upper_bound
prior 133 138 2699 2704 I-upper_bound
to 139 141 2705 2707 O
registration 142 154 2708 2720 O
are 155 158 2721 2724 O
not 159 162 2725 2728 O
eligible 163 171 2729 2737 O

Patients 0 8 2738 2746 O
who 9 12 2747 2750 O
received 13 21 2751 2759 O
prior 22 27 2760 2765 O
exposure 28 36 2766 2774 O
to 37 39 2775 2777 O
any 40 43 2778 2781 O
other 44 49 2782 2787 B-treatment
histone 50 57 2788 2795 I-treatment
deacetylase 58 69 2796 2807 I-treatment
( 70 71 2808 2809 I-treatment
HDAC 71 75 2809 2813 I-treatment
) 75 76 2813 2814 I-treatment
inhibitors 77 87 2815 2825 I-treatment
or 88 90 2826 2828 O
immunomodulatory 91 107 2829 2845 B-treatment
( 108 109 2846 2847 I-treatment
IMID 109 113 2847 2851 I-treatment
) 113 114 2851 2852 I-treatment
agents 115 121 2853 2859 I-treatment
for 122 125 2860 2863 O
any 126 129 2864 2867 O
reason 130 136 2868 2874 O

Patients 0 8 2875 2883 O
with 9 13 2884 2888 O
a 14 15 2889 2890 O
QT 16 18 2891 2893 B-clinical_variable
interval 19 27 2894 2902 I-clinical_variable
> 28 29 2903 2904 O
500 30 33 2905 2908 B-lower_bound
msec 34 38 2909 2913 I-lower_bound
( 39 40 2914 2915 O
using 40 45 2915 2920 O
the 46 49 2921 2924 O
Bazett 50 56 2925 2931 O
's 56 58 2931 2933 O
formula 59 66 2934 2941 O
) 66 67 2941 2942 O
within 68 74 2943 2949 O
28 75 77 2950 2952 B-upper_bound
days 78 82 2953 2957 I-upper_bound
prior 83 88 2958 2963 I-upper_bound
to 89 91 2964 2966 O
registration 92 104 2967 2979 O

Patients 0 8 2980 2988 O
with 9 13 2989 2993 O
a 14 15 2994 2995 O
known 16 21 2996 3001 O
human 22 27 3002 3007 B-chronic_disease
immunodeficiency 28 44 3008 3024 I-chronic_disease
( 45 46 3025 3026 I-chronic_disease
HIV 46 49 3026 3029 I-chronic_disease
) 49 50 3029 3030 I-chronic_disease
infection 51 60 3031 3040 O

Patients 0 8 3041 3049 O
with 9 13 3050 3054 O
adequate 14 22 3055 3063 O
archived 23 31 3064 3072 O
( 32 33 3073 3074 O
well 33 37 3074 3078 O
- 37 38 3078 3079 O
preserved 38 47 3079 3088 O
, 47 48 3088 3089 O
formalin 49 57 3090 3098 O
- 57 58 3098 3099 O
fixed 58 63 3099 3104 O
) 63 64 3104 3105 O
biopsy 65 71 3106 3112 B-treatment
tissue 72 78 3113 3119 O
remaining 79 88 3120 3129 O
will 89 93 3130 3134 O
be 94 96 3135 3137 O
required 97 105 3138 3146 O
to 106 108 3147 3149 O
submit 109 115 3150 3156 O
a 116 117 3157 3158 O
portion 118 125 3159 3166 O
for 126 129 3167 3170 O
exploratory 130 141 3171 3182 O
studies 142 149 3183 3190 O

Patients 0 8 3191 3199 O
with 9 13 3200 3204 O
marrow 14 20 3205 3211 B-chronic_disease
- 20 21 3211 3212 I-chronic_disease
only 21 25 3212 3216 I-chronic_disease
disease 26 33 3217 3224 I-chronic_disease

Peripheral 0 10 3225 3235 B-cancer
T 11 12 3236 3237 I-cancer
- 12 13 3237 3238 I-cancer
cell 13 17 3238 3242 I-cancer
lymphoma 18 26 3243 3251 I-cancer
, 26 27 3251 3252 O
unspecified 28 39 3253 3264 O
( 40 41 3265 3266 O
not 41 44 3266 3269 O
otherwise 45 54 3270 3279 O
specified 55 64 3280 3289 O
[ 65 66 3290 3291 O
NOS 66 69 3291 3294 O
] 69 70 3294 3295 O
) 70 71 3295 3296 O

Platelets 0 9 3297 3306 B-clinical_variable
> 10 11 3307 3308 O
= 11 12 3308 3309 O
50,000 13 19 3310 3316 B-lower_bound
/ 19 20 3316 3317 I-lower_bound
mcl 20 23 3317 3320 I-lower_bound

Precursor 0 9 3321 3330 B-cancer
T 10 11 3331 3332 I-cancer
- 11 12 3332 3333 I-cancer
lymphoblastic 12 25 3333 3346 I-cancer
lymphoma 26 34 3347 3355 I-cancer
/ 34 35 3355 3356 O
leukemia 35 43 3356 3364 B-cancer

Psychiatric 0 11 3365 3376 B-chronic_disease
illness 12 19 3377 3384 I-chronic_disease
/ 19 20 3384 3385 O
social 20 26 3385 3391 O
situations 27 37 3392 3402 O
that 38 42 3403 3407 O
would 43 48 3408 3413 O
limit 49 54 3414 3419 O
compliance 55 65 3420 3430 O
with 66 70 3431 3435 O
study 71 76 3436 3441 O
requirements 77 89 3442 3454 O

Subcutaneous 0 12 3455 3467 B-cancer
panniculitis 13 25 3468 3480 I-cancer
- 25 26 3480 3481 I-cancer
like 26 30 3481 3485 I-cancer
T 31 32 3486 3487 I-cancer
- 32 33 3487 3488 I-cancer
cell 33 37 3488 3492 I-cancer
lymphoma 38 46 3493 3501 I-cancer

Symptomatic 0 11 3502 3513 O
congestive 12 22 3514 3524 B-chronic_disease
heart 23 28 3525 3530 I-chronic_disease
failure 29 36 3531 3538 I-chronic_disease

T 0 1 3539 3540 B-cancer
- 1 2 3540 3541 I-cancer
cell 2 6 3541 3545 I-cancer
granular 7 15 3546 3554 I-cancer
lymphocytic 16 27 3555 3566 I-cancer
leukemia 28 36 3567 3575 I-cancer

T 0 1 3576 3577 B-cancer
- 1 2 3577 3578 I-cancer
cell 2 6 3578 3582 I-cancer
prolymphocytic 7 21 3583 3597 I-cancer
leukemia 22 30 3598 3606 I-cancer

Total 0 5 3607 3612 B-clinical_variable
bilirubin 6 15 3613 3622 I-clinical_variable
= 16 17 3623 3624 O
< 17 18 3624 3625 O
2 19 20 3626 3627 B-upper_bound
x 21 22 3628 3629 I-upper_bound
upper 23 28 3630 3635 I-upper_bound
limit 29 34 3636 3641 I-upper_bound
normal 35 41 3642 3648 I-upper_bound
( 42 43 3649 3650 I-upper_bound
ULN 43 46 3650 3653 I-upper_bound
) 46 47 3653 3654 I-upper_bound

Transformed 0 11 3655 3666 O
mycosis 12 19 3667 3674 B-cancer
fungoides 20 29 3675 3684 I-cancer

Unstable 0 8 3685 3693 B-chronic_disease
angina 9 15 3694 3700 I-chronic_disease
pectoris 16 24 3701 3709 I-chronic_disease

all 0 3 3710 3713 O
patients 4 12 3714 3722 O
must 13 17 3723 3727 O
agree 18 23 3728 3733 O
to 24 26 3734 3736 O
undergo 27 34 3737 3744 O
counseling 35 45 3745 3755 B-treatment
sessions 46 54 3756 3764 I-treatment
every 55 60 3765 3770 O
28 61 63 3771 3773 B-upper_bound
days 64 68 3774 3778 I-upper_bound
about 69 74 3779 3784 O
pregnancy 75 84 3785 3794 B-pregnancy
precautions 85 96 3795 3806 O
and 97 100 3807 3810 O
risks 101 106 3811 3816 O
of 107 109 3817 3819 O
fetal 110 115 3820 3825 O
exposure 116 124 3826 3834 O

anaplastic 0 10 3835 3845 B-cancer
large 11 16 3846 3851 I-cancer
cell 17 21 3852 3856 I-cancer
kinase 22 28 3857 3863 I-cancer
( 29 30 3864 3865 I-cancer
ALK)-negative 30 43 3865 3878 I-cancer

currently 0 9 3879 3888 O
treated 10 17 3889 3896 O
squamous 18 26 3897 3905 B-cancer
cell 27 31 3906 3910 I-cancer
and 32 35 3911 3914 O
basal 36 41 3915 3920 B-cancer
cell 42 46 3921 3925 I-cancer
carcinoma 47 56 3926 3935 I-cancer
of 57 59 3936 3938 I-cancer
the 60 63 3939 3942 I-cancer
skin 64 68 3943 3947 I-cancer
, 68 69 3947 3948 O
carcinoma 70 79 3949 3958 B-cancer
in 80 82 3959 3961 I-cancer
situ 83 87 3962 3966 I-cancer
of 88 90 3967 3969 I-cancer
the 91 94 3970 3973 I-cancer
cervix 95 101 3974 3980 I-cancer
, 101 102 3980 3981 O
breast 103 109 3982 3988 B-cancer
, 109 110 3988 3989 O
or 111 113 3990 3992 O
bladder 114 121 3993 4000 B-cancer
, 121 122 4000 4001 O
or 123 125 4002 4004 O
surgically 126 136 4005 4015 O
removed 137 144 4016 4023 O
melanoma 145 153 4024 4032 B-cancer
in 154 156 4033 4035 I-cancer
situ 157 161 4036 4040 I-cancer
of 162 164 4041 4043 I-cancer
the 165 168 4044 4047 I-cancer
skin 169 173 4048 4052 I-cancer
( 174 175 4053 4054 O
stage 175 180 4054 4059 O
0 181 182 4060 4061 O
) 182 183 4061 4062 O
with 184 188 4063 4067 O
histologically 189 203 4068 4082 O
confirmed 204 213 4083 4092 O
free 214 218 4093 4097 O
margins 219 226 4098 4105 O
of 227 229 4106 4108 O
excision 230 238 4109 4117 O

these 0 5 4118 4123 O
topical 6 13 4124 4131 B-treatment
therapies 14 23 4132 4141 I-treatment
should 24 30 4142 4148 O
be 31 33 4149 4151 O
stopped 34 41 4152 4159 O
at 42 44 4160 4162 O
time 45 49 4163 4167 O
of 50 52 4168 4170 O
registration 53 65 4171 4183 O

topical 0 7 4184 4191 B-chronic_disease
treatment 8 17 4192 4201 I-chronic_disease
may 18 21 4202 4205 O
have 22 26 4206 4210 O
been 27 31 4211 4215 O
given 32 37 4216 4221 O
for 38 41 4222 4225 O
prior 42 47 4226 4231 O
existence 48 57 4232 4241 O
of 58 60 4242 4244 O
cutaneous 61 70 4245 4254 B-cancer
lymphoma 71 79 4255 4263 I-cancer
that 80 84 4264 4268 O
has 85 88 4269 4272 O
since 89 94 4273 4278 O
become 95 101 4279 4285 O
systemic 102 110 4286 4294 O
PTCL 111 115 4295 4299 B-cancer

transformed 0 11 4300 4311 O
Mycosis 12 19 4312 4319 B-cancer
fungoides 20 29 4320 4329 I-cancer
[ 30 31 4330 4331 I-cancer
MF 31 33 4331 4333 I-cancer
] 33 34 4333 4334 I-cancer

with 0 4 4335 4339 O
a 5 6 4340 4341 O
cumulative 7 17 4342 4352 B-clinical_variable
illness 18 25 4353 4360 I-clinical_variable
rating 26 32 4361 4367 I-clinical_variable
scale 33 38 4368 4373 I-clinical_variable
( 39 40 4374 4375 I-clinical_variable
CIRS 40 44 4375 4379 I-clinical_variable
) 44 45 4379 4380 I-clinical_variable
score 46 51 4381 4386 I-clinical_variable
> 52 53 4387 4388 O
= 53 54 4388 4389 O
6 55 56 4390 4391 B-lower_bound
OR 57 59 4392 4394 O
deemed 60 66 4395 4401 O
ineligible 67 77 4402 4412 O
for 78 81 4413 4416 O
cytotoxic 82 91 4417 4426 B-treatment
chemotherapy 92 104 4427 4439 I-treatment
by 105 107 4440 4442 O
the 108 111 4443 4446 O
treating 112 120 4447 4455 O
investigator 121 133 4456 4468 O

Acute 0 5 0 5 B-chronic_disease
hepatitis 6 15 6 15 I-chronic_disease
or 16 18 16 18 O
liver 19 24 19 24 B-chronic_disease
failure 25 32 25 32 I-chronic_disease
( 33 34 33 34 O
direct 34 40 34 40 B-clinical_variable
bilirubin 41 50 41 50 I-clinical_variable
> 51 52 51 52 O
5 52 53 52 53 B-lower_bound
mg 54 56 54 56 I-lower_bound
/ 56 57 56 57 I-lower_bound
dL 57 59 57 59 I-lower_bound
) 59 60 59 60 O

Acute 0 5 61 66 B-chronic_disease
myocardial 6 16 67 77 I-chronic_disease
infarction 17 27 78 88 I-chronic_disease
within 28 34 89 95 O
48 35 37 96 98 B-upper_bound
hours 38 43 99 104 I-upper_bound
prior 44 49 105 110 I-upper_bound
to 50 52 111 113 O
enrollment 53 63 114 124 O

Acute 0 5 125 130 B-chronic_disease
stroke 6 12 131 137 I-chronic_disease

General 0 7 138 145 B-treatment
anesthesia 8 18 146 156 I-treatment
within 19 25 157 163 O
12 26 28 164 166 B-upper_bound
hours 29 34 167 172 I-upper_bound
prior 35 40 173 178 I-upper_bound
to 41 43 179 181 O
enrollment 44 54 182 192 O

Hypotension 0 11 193 204 B-chronic_disease
( 12 13 205 206 O
systolic 13 21 206 214 B-clinical_variable
blood 22 27 215 220 I-clinical_variable
pressure 28 36 221 229 I-clinical_variable
< 37 38 230 231 O
85 39 41 232 234 B-upper_bound
mmHg 42 46 235 239 I-upper_bound
) 46 47 239 240 O
requiring 48 57 241 250 O
a 58 59 251 252 O
vasopressor 60 71 253 264 O
at 72 74 265 267 O
a 75 76 268 269 O
dose 77 81 270 274 O
greater 82 89 275 282 O
than 90 94 283 287 O
norepinephrine 95 109 288 302 B-treatment
or 110 112 303 305 O
epinephrine 113 124 306 317 O
0.15 125 129 318 322 O
mcg 130 133 323 326 O
/ 133 134 326 327 O
kg 134 136 327 329 O
/ 136 137 329 330 O
min 137 140 330 333 O
or 141 143 334 336 O
vasopressin 144 155 337 348 B-clinical_variable
> 156 157 349 350 O
2.4 158 161 351 354 B-lower_bound
units 162 167 355 360 I-lower_bound
per 168 171 361 364 I-lower_bound
hour 172 176 365 369 I-lower_bound

Positive 0 8 370 378 O
pregnancy 9 18 379 388 B-pregnancy
test 19 23 389 393 O

Second 0 6 394 400 B-chronic_disease
or 7 9 401 403 I-chronic_disease
third 10 15 404 409 I-chronic_disease
degree 16 22 410 416 I-chronic_disease
heart 23 28 417 422 I-chronic_disease
block 29 34 423 428 I-chronic_disease
or 35 37 429 431 O
bradycardia 38 49 432 443 B-chronic_disease
( 50 51 444 445 O
heart 51 56 445 450 B-clinical_variable
rate 57 61 451 455 I-clinical_variable
< 62 63 456 457 O
50 64 66 458 460 B-upper_bound
beats 67 72 461 466 I-upper_bound
/ 72 73 466 467 I-upper_bound
min 73 76 467 470 I-upper_bound
) 76 77 470 471 O

Severe 0 6 472 478 O
cognition 7 16 479 488 B-chronic_disease
or 17 19 489 491 I-chronic_disease
communication 20 33 492 505 I-chronic_disease
problems 34 42 506 514 I-chronic_disease
( 43 44 515 516 O
such 44 48 516 520 O
as 49 51 521 523 O
coma 52 56 524 528 B-chronic_disease
, 56 57 528 529 O
deafness 58 66 530 538 B-chronic_disease
without 67 74 539 546 O
signing 75 82 547 554 O
literacy 83 91 555 563 O
, 91 92 563 564 O
physician 93 102 565 574 O
- 102 103 574 575 O
documented 103 113 575 585 O
dementia 114 122 586 594 O
) 122 123 594 595 O

currently 0 9 596 605 O
receiving 10 19 606 615 O
a 20 21 616 617 O
continuous 22 32 618 628 O
intravenous 33 44 629 640 B-treatment
infusion 45 53 641 649 I-treatment
of 54 56 650 652 I-treatment
a 57 58 653 654 I-treatment
sedative 59 67 655 663 I-treatment
/ 67 68 663 664 I-treatment
opioid 68 74 664 670 I-treatment
medication(s 75 87 671 683 I-treatment
) 87 88 683 684 I-treatment

must 0 4 685 689 O
pass 5 9 690 694 O
pre 10 13 695 698 O
- 13 14 698 699 O
Patient 14 21 699 706 O
- 21 22 706 707 O
Controlled 22 32 707 717 O
Sedation 33 41 718 726 O
( 42 43 727 728 O
PCS 43 46 728 731 O
) 46 47 731 732 O
screening 48 57 733 742 O
test 58 62 743 747 O
and 63 66 748 751 O
be 67 69 752 754 O
assessed 70 78 755 763 O
Richmond 79 87 764 772 B-clinical_variable
Agitation 88 97 773 782 I-clinical_variable
- 97 98 782 783 I-clinical_variable
Sedation 98 106 783 791 I-clinical_variable
Scale 107 112 792 797 I-clinical_variable
( 113 114 798 799 I-clinical_variable
RASS 114 118 799 803 I-clinical_variable
) 118 119 803 804 I-clinical_variable
-2 120 122 805 807 B-lower_bound
to 123 125 808 810 O
+1 126 128 811 813 B-upper_bound

received 0 8 814 822 O
at 9 11 823 825 O
least 12 17 826 831 O
one 18 21 832 835 B-lower_bound
intravenous 22 33 836 847 O
bolus 34 39 848 853 O
dose 40 44 854 858 O
of 45 47 859 861 O
a 48 49 862 863 O
sedative 50 58 864 872 O
/ 58 59 872 873 O
opioid 59 65 873 879 O
medication 66 76 880 890 O
in 77 79 891 893 O
the 80 83 894 897 O
previous 84 92 898 906 B-upper_bound
24 93 95 907 909 I-upper_bound
hours 96 101 910 915 I-upper_bound
( 102 103 916 917 O
fentanyl 103 111 917 925 B-treatment
, 111 112 925 926 O
hydromorphone 113 126 927 940 B-treatment
, 126 127 940 941 O
ketamine 128 136 942 950 B-treatment
, 136 137 950 951 O
morphine 138 146 952 960 B-treatment
, 146 147 960 961 O
midazolam 148 157 962 971 B-treatment
, 157 158 971 972 O
diazepam 159 167 973 981 B-treatment
, 167 168 981 982 O
lorazepam 169 178 983 992 B-treatment
, 178 179 992 993 O
propofol 180 188 994 1002 B-treatment
, 188 189 1002 1003 O
haloperidol 190 201 1004 1015 B-treatment
, 201 202 1015 1016 O
dexmedetomidine 203 218 1017 1032 B-treatment
) 218 219 1032 1033 O

uncontrolled 0 12 1034 1046 O
seizures 13 21 1047 1055 B-chronic_disease

vasopressor 0 11 1056 1067 B-treatment
dose 12 16 1068 1072 O
was 17 20 1073 1076 O
higher 21 27 1077 1083 O
than 28 32 1084 1088 O
norepinephrine 33 47 1089 1103 B-treatment
or 48 50 1104 1106 O
epinephrine 51 62 1107 1118 O
0.15 63 67 1119 1123 O
mcg 68 71 1124 1127 O
/ 71 72 1127 1128 O
kg 72 74 1128 1130 O
/ 74 75 1130 1131 O
min 75 78 1131 1134 O
, 78 79 1134 1135 O
vasopressin 80 91 1136 1147 B-treatment
> 92 93 1148 1149 O
2.4 94 97 1150 1153 B-lower_bound
units 98 103 1154 1159 I-lower_bound
per 104 107 1160 1163 I-lower_bound
hour 108 112 1164 1168 I-lower_bound
, 112 113 1168 1169 O
phenylephrine 114 127 1170 1183 B-treatment
> 128 129 1184 1185 O
3 129 130 1185 1186 B-lower_bound
mcg 131 134 1187 1190 I-lower_bound
/ 134 135 1190 1191 I-lower_bound
kg 135 137 1191 1193 I-lower_bound
/ 137 138 1193 1194 I-lower_bound
min 138 141 1194 1197 I-lower_bound
, 141 142 1197 1198 O
dopamine 143 151 1199 1207 B-treatment
> 152 153 1208 1209 O
10 153 155 1209 1211 B-lower_bound
mcg 156 159 1212 1215 I-lower_bound
/ 159 160 1215 1216 I-lower_bound
kg 160 162 1216 1218 I-lower_bound
/ 162 163 1218 1219 I-lower_bound
min 163 166 1219 1222 I-lower_bound
or 167 169 1223 1225 O
dobutamine 170 180 1226 1236 O
at 181 183 1237 1239 O
any 184 187 1240 1243 O
dose 188 192 1244 1248 O
in 193 195 1249 1251 O
the 196 199 1252 1255 O
prior 200 205 1256 1261 O
6 206 207 1262 1263 O
hours 208 213 1264 1269 O

Age 0 3 0 3 B-age
( 4 5 4 5 O
< 5 6 5 6 O
9 7 8 7 8 B-upper_bound
, 8 9 8 9 O
> 10 11 10 11 O
18 11 13 11 13 B-lower_bound
years 14 19 14 19 I-lower_bound
) 19 20 19 20 O

Youths 0 6 21 27 O
9 7 8 28 29 B-lower_bound
- 8 9 29 30 O
18 9 11 30 32 B-upper_bound
years 12 17 33 38 I-upper_bound
old 18 21 39 42 O

Active 0 6 0 6 B-chronic_disease
uncontrolled 7 19 7 19 I-chronic_disease
infection 20 29 20 29 I-chronic_disease

Aspartate 0 9 30 39 B-clinical_variable
aminotransferase 10 26 40 56 I-clinical_variable
( 27 28 57 58 I-clinical_variable
AST 28 31 58 61 I-clinical_variable
) 31 32 61 62 I-clinical_variable
or 33 35 63 65 O
alanine 36 43 66 73 B-clinical_variable
aminotransferase 44 60 74 90 I-clinical_variable
( 61 62 91 92 I-clinical_variable
ALT 62 65 92 95 I-clinical_variable
) 65 66 95 96 I-clinical_variable
> 67 68 97 98 O
5 69 70 99 100 B-lower_bound
times 71 76 101 106 I-lower_bound
upper 77 82 107 112 I-lower_bound
limit 83 88 113 118 I-lower_bound
of 89 91 119 121 I-lower_bound
normal 92 98 122 128 I-lower_bound
( 99 100 129 130 I-lower_bound
UNL 100 103 130 133 I-lower_bound
) 103 104 133 134 I-lower_bound

Bleeding 0 8 135 143 B-chronic_disease
diathesis 9 18 144 153 I-chronic_disease
, 18 19 153 154 O
not 20 23 155 158 O
correctable 24 35 159 170 O
by 36 38 171 173 O
usual 39 44 174 179 O
forms 45 50 180 185 O
of 51 53 186 188 O
therapy 54 61 189 196 B-treatment

Co 0 2 197 199 O
- 2 3 199 200 O
morbid 3 9 200 206 O
disease 10 17 207 214 O
of 18 20 215 217 O
condition 21 30 218 227 O
that 31 35 228 232 O
would 36 41 233 238 O
preclude 42 50 239 247 O
safe 51 55 248 252 O
delivery 56 64 253 261 O
of 65 67 262 264 O
TheraSphere 68 79 265 276 B-treatment
treatment 80 89 277 286 I-treatment
or 90 92 287 289 O
, 92 93 289 290 O
in 94 96 291 293 O
the 97 100 294 297 O
judgment 101 109 298 306 O
of 110 112 307 309 O
the 113 116 310 313 O
physician 117 126 314 323 O
, 126 127 323 324 O
place 128 133 325 330 O
the 134 137 331 334 O
patient 138 145 335 342 O
at 146 148 343 345 O
undue 149 154 346 351 O
risk 155 159 352 356 O

Diagnosis 0 9 357 366 O
of 10 12 367 369 O
intrahepatic 13 25 370 382 B-cancer
malignancy 26 36 383 393 I-cancer
including 37 46 394 403 O
but 47 50 404 407 O
not 51 54 408 411 O
limited 55 62 412 419 O
to 63 65 420 422 O
HCC 66 69 423 426 B-cancer
; 69 70 426 427 O
the 71 74 428 431 O
histopathology 75 89 432 446 O
confirmation 90 102 447 459 O
criterion 103 112 460 469 O
may 113 116 470 473 O
be 117 119 474 476 O
waived 120 126 477 483 O
in 127 129 484 486 O
patients 130 138 487 495 O
with 139 143 496 500 O
a 144 145 501 502 O
radiographically 146 162 503 519 O
identifiable 163 175 520 532 O
liver 176 181 533 538 O
mass 182 186 539 543 O
, 186 187 543 544 O
known 188 193 545 550 O
laboratory 194 204 551 561 O
or 205 207 562 564 O
clinical 208 216 565 573 O
risk 217 221 574 578 O
factors 222 229 579 586 O
for 230 233 587 590 O
cancer 234 240 591 597 B-cancer
or 241 243 598 600 O
elevated 244 252 601 609 O
tumor 253 258 610 615 B-cancer
markers 259 266 616 623 O
such 267 271 624 628 O
as 272 274 629 631 O
alpha 275 280 632 637 B-treatment
- 280 281 637 638 I-treatment
fetoprotein 281 292 638 649 I-treatment
( 293 294 650 651 I-treatment
AFP 294 297 651 654 I-treatment
) 297 298 654 655 I-treatment
and 299 302 656 659 O
clinical 303 311 660 668 O
findings 312 320 669 677 O

Eastern 0 7 678 685 B-clinical_variable
Cooperative 8 19 686 697 I-clinical_variable
Oncology 20 28 698 706 I-clinical_variable
Group 29 34 707 712 I-clinical_variable
( 35 36 713 714 I-clinical_variable
ECOG 36 40 714 718 I-clinical_variable
) 40 41 718 719 I-clinical_variable
performance 42 53 720 731 I-clinical_variable
status 54 60 732 738 I-clinical_variable
score 61 66 739 744 I-clinical_variable
0 67 68 745 746 B-lower_bound
- 69 70 747 748 O
2 71 72 749 750 B-upper_bound

Evidence 0 8 751 759 O
of 9 11 760 762 O
any 12 15 763 766 O
detectable 16 26 767 777 O
technetium-99 27 40 778 791 B-treatment
m 40 41 791 792 I-treatment
macroaggregated 42 57 793 808 I-treatment
serum 58 63 809 814 I-treatment
albumin 64 71 815 822 I-treatment
( 72 73 823 824 I-treatment
Tc-99 73 78 824 829 I-treatment
m 78 79 829 830 I-treatment
MAA 80 83 831 834 I-treatment
) 83 84 834 835 I-treatment
flow 85 89 836 840 O
to 90 92 841 843 O
the 93 96 844 847 O
stomach 97 104 848 855 O
or 105 107 856 858 O
duodenum 108 116 859 867 O
, 116 117 867 868 O
not 118 121 869 872 O
correctable 122 133 873 884 O
by 134 136 885 887 O
using 137 142 888 893 O
established 143 154 894 905 O
angiographic 155 167 906 918 B-treatment
techniques 168 178 919 929 O
to 179 181 930 932 O
stop 182 186 933 937 O
or 187 189 938 940 O
mitigate 190 198 941 949 O
such 199 203 950 954 O
flow 204 208 955 959 O

Evidence 0 8 960 968 O
of 9 11 969 971 O
potential 12 21 972 981 O
delivery 22 30 982 990 O
of 31 33 991 993 O
greater 34 41 994 1001 O
than 42 46 1002 1006 O
16.5 47 51 1007 1011 B-lower_bound
mCi 52 55 1012 1015 I-lower_bound
( 56 57 1016 1017 O
30 57 59 1017 1019 B-lower_bound
Gy 60 62 1020 1022 I-lower_bound
absorbed 63 71 1023 1031 O
dose 72 76 1032 1036 O
) 76 77 1036 1037 O
of 78 80 1038 1040 O
radiation 81 90 1041 1050 O
to 91 93 1051 1053 O
the 94 97 1054 1057 O
lungs 98 103 1058 1063 O
in 104 106 1064 1066 O
a 107 108 1067 1068 O
single 109 115 1069 1075 O
treatment 116 125 1076 1085 B-treatment

Evidence 0 8 1086 1094 O
of 9 11 1095 1097 O
pulmonary 12 21 1098 1107 B-chronic_disease
insufficiency 22 35 1108 1121 I-chronic_disease

History 0 7 1122 1129 O
of 8 10 1130 1132 O
severe 11 17 1133 1139 O
allergy 18 25 1140 1147 O
or 26 28 1148 1150 O
intolerance 29 40 1151 1162 O
to 41 43 1163 1165 O
any 44 47 1166 1169 O
contrast 48 56 1170 1178 B-allergy_name
media 57 62 1179 1184 I-allergy_name
, 62 63 1184 1185 O
narcotics 64 73 1186 1195 B-allergy_name
, 73 74 1195 1196 O
sedatives 75 84 1197 1206 B-allergy_name
, 84 85 1206 1207 O
or 86 88 1208 1210 O
atropine 89 97 1211 1219 B-allergy_name
that 98 102 1220 1224 O
can 103 106 1225 1228 O
not 106 109 1228 1231 O
be 110 112 1232 1234 O
corrected 113 122 1235 1244 O
or 123 125 1245 1247 O
premedicated 126 138 1248 1260 O

Ineligible 0 10 1261 1271 O
for 11 14 1272 1275 O
surgical 15 23 1276 1284 O
resection 24 33 1285 1294 B-treatment

Pregnancy 0 9 1295 1304 B-pregnancy

Serum 0 5 1305 1310 B-clinical_variable
bilirubin 6 15 1311 1320 I-clinical_variable
> 16 17 1321 1322 O
2.0 18 21 1323 1326 B-lower_bound
mg 22 24 1327 1329 I-lower_bound
/ 24 25 1329 1330 I-lower_bound
dl 25 27 1330 1332 I-lower_bound
( 28 29 1333 1334 O
unless 29 35 1334 1340 O
segmental 36 45 1341 1350 O
infusion 46 54 1351 1359 O
is 55 57 1360 1362 O
planned 58 65 1363 1370 O
) 65 66 1370 1371 O

Severe 0 6 1372 1378 O
peripheral 7 17 1379 1389 B-chronic_disease
vascular 18 26 1390 1398 I-chronic_disease
disease 27 34 1399 1406 I-chronic_disease
that 35 39 1407 1411 O
would 40 45 1412 1417 O
preclude 46 54 1418 1426 O
catheterization 55 70 1427 1442 B-treatment

Significant 0 11 1443 1454 O
extrahepatic 12 24 1455 1467 B-chronic_disease
disease 25 32 1468 1475 I-chronic_disease
representing 33 45 1476 1488 O
an 46 48 1489 1491 O
imminent 49 57 1492 1500 O
life 58 62 1501 1505 O
- 62 63 1505 1506 O
threatening 63 74 1506 1517 O
outcome 75 82 1518 1525 O

Significant 0 11 1526 1537 O
underlying 12 22 1538 1548 O
medical 23 30 1549 1556 O
or 31 33 1557 1559 O
psychiatric 34 45 1560 1571 B-chronic_disease
illness 46 53 1572 1579 I-chronic_disease

ny 0 2 1580 1582 O
contraindications 3 20 1583 1600 O
to 21 23 1601 1603 O
angiography 24 35 1604 1615 B-treatment
and 36 39 1616 1619 O
hepatic 40 47 1620 1627 B-treatment
artery 48 54 1628 1634 I-treatment
catheterization 55 70 1635 1650 I-treatment

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
must 32 36 32 36 O
be 37 39 37 39 O
> 40 41 40 41 O
= 41 42 41 42 O
1200 43 47 43 47 B-lower_bound
/ 47 48 47 48 I-lower_bound
mm^3 48 52 48 52 I-lower_bound

Active 0 6 53 59 O
cardiac 7 14 60 67 B-chronic_disease
disease 15 22 68 75 I-chronic_disease

Active 0 6 76 82 O
hepatitis 7 16 83 92 B-chronic_disease
B 17 18 93 94 I-chronic_disease
or 19 21 95 97 O
hepatitis 22 31 98 107 B-chronic_disease
C 32 33 108 109 I-chronic_disease
with 34 38 110 114 O
abnormal 39 47 115 123 O
liver 48 53 124 129 O
function 54 62 130 138 O
tests 63 68 139 144 O

Active 0 6 145 151 O
infection 7 16 152 161 B-chronic_disease
or 17 19 162 164 O
chronic 20 27 165 172 B-chronic_disease
infection 28 37 173 182 I-chronic_disease
requiring 38 47 183 192 O
chronic 48 55 193 200 O
suppressive 56 67 201 212 O
antibiotics 68 79 213 224 B-treatment

Adequate 0 8 225 233 O
renal 9 14 234 239 O
function 15 23 240 248 O
determined 24 34 249 259 O
within 35 41 260 266 O
6 42 43 267 268 B-upper_bound
weeks 44 49 269 274 I-upper_bound
prior 50 55 275 280 I-upper_bound
to 56 58 281 283 O
randomization 59 72 284 297 O
defined 73 80 298 305 O
as 81 83 306 308 O
the 84 87 309 312 O
most 88 92 313 317 O
recent 93 99 318 324 O
serum 100 105 325 330 B-clinical_variable
creatinine 106 116 331 341 I-clinical_variable
= 117 118 342 343 O
< 118 119 343 344 O
ULN 120 123 345 348 O
or 124 126 349 351 O
measured 127 135 352 360 O
or 136 138 361 363 O
calculated 139 149 364 374 B-clinical_variable
creatinine 150 160 375 385 I-clinical_variable
clearance 161 170 386 395 I-clinical_variable
> 171 172 396 397 O
60 173 175 398 400 B-lower_bound
mL 176 178 401 403 I-lower_bound
/ 178 179 403 404 I-lower_bound
min 179 182 404 407 I-lower_bound

Alkaline 0 8 408 416 B-clinical_variable
phosphatase 9 20 417 428 I-clinical_variable
must 21 25 429 433 O
be 26 28 434 436 O
= 29 30 437 438 O
< 30 31 438 439 O
2.5 32 35 440 443 B-upper_bound
x 36 37 444 445 I-upper_bound
ULN 38 41 446 449 I-upper_bound
for 42 45 450 453 O
the 46 49 454 457 O
lab 50 53 458 461 O

Angina 0 6 462 468 B-chronic_disease
pectoris 7 15 469 477 I-chronic_disease
that 16 20 478 482 O
requires 21 29 483 491 O
the 30 33 492 495 O
current 34 41 496 503 O
use 42 45 504 507 O
of 46 48 508 510 O
anti 49 53 511 515 B-treatment
- 53 54 515 516 I-treatment
anginal 54 61 516 523 I-treatment
medication 62 72 524 534 I-treatment

Any 0 3 535 538 O
continued 4 13 539 548 O
use 14 17 549 552 O
of 18 20 553 555 O
sex 21 24 556 559 B-treatment
hormonal 25 33 560 568 I-treatment
therapy 34 41 569 576 I-treatment
, 41 42 576 577 O
e.g. 43 47 578 582 O
, 47 48 582 583 O
birth 49 54 584 589 B-treatment
control 55 62 590 597 I-treatment
pills 63 68 598 603 I-treatment
, 68 69 603 604 O
ovarian 70 77 605 612 B-treatment
hormone 78 85 613 620 I-treatment
replacement 86 97 621 632 I-treatment
therapy 98 105 633 640 I-treatment

Any 0 3 641 644 O
previous 4 12 645 653 O
history 13 20 654 661 O
of 21 23 662 664 O
ipsilateral 24 35 665 676 O
invasive 36 44 677 685 O
breast 45 51 686 692 B-cancer
cancer 52 58 693 699 I-cancer
or 59 61 700 702 O
ipsilateral 62 73 703 714 O
DCIS 74 78 715 719 B-cancer

Aspartate 0 9 720 729 B-clinical_variable
aminotransferase 10 26 730 746 I-clinical_variable
( 27 28 747 748 I-clinical_variable
AST 28 31 748 751 I-clinical_variable
) 31 32 751 752 I-clinical_variable
must 33 37 753 757 O
be 38 40 758 760 O
= 41 42 761 762 O
< 42 43 762 763 O
1.5 44 47 764 767 B-upper_bound
x 48 49 768 769 I-upper_bound
ULN 50 53 770 773 I-upper_bound
for 54 57 774 777 O
the 58 61 778 781 O
lab 62 65 782 785 O

Axillary 0 8 786 794 B-treatment
lymphadenectomy 9 24 795 810 I-treatment
with 25 29 811 815 I-treatment
or 30 32 816 818 I-treatment
without 33 40 819 826 I-treatment
SN 41 43 827 829 I-treatment
isolation 44 53 830 839 I-treatment
procedure 54 63 840 849 I-treatment

By 0 2 850 852 O
pathologic 3 13 853 863 O
evaluation 14 24 864 874 O
, 24 25 874 875 O
primary 26 33 876 883 B-cancer
tumor 34 39 884 889 I-cancer
must 40 44 890 894 O
be 45 47 895 897 O
pT1 48 51 898 901 O
- 51 52 901 902 O
3 52 53 902 903 O

Cardiac 0 7 904 911 B-chronic_disease
disease 8 15 912 919 I-chronic_disease
( 16 17 920 921 O
history 17 24 921 928 O
of 25 27 929 931 O
and/or 28 34 932 938 O
active 35 41 939 945 O
disease 42 49 946 953 O
) 49 50 953 954 O
that 51 55 955 959 O
would 56 61 960 965 O
preclude 62 70 966 974 O
the 71 74 975 978 O
use 75 78 979 982 O
of 79 81 983 985 O
the 82 85 986 989 O
drugs 86 91 990 995 O
included 92 100 996 1004 O
in 101 103 1005 1007 O
the 104 107 1008 1011 O
treatment 108 117 1012 1021 B-treatment
regimens 118 126 1022 1030 I-treatment

Chemotherapy 0 12 1031 1043 B-treatment
administered 13 25 1044 1056 O
for 26 29 1057 1060 O
the 30 33 1061 1064 O
currently 34 43 1065 1074 O
diagnosed 44 53 1075 1084 O
breast 54 60 1085 1091 B-cancer
cancer 61 67 1092 1098 I-cancer
prior 68 73 1099 1104 O
to 74 76 1105 1107 O
randomization 77 90 1108 1121 O

Chronic 0 7 1122 1129 B-treatment
daily 8 13 1130 1135 I-treatment
treatment 14 23 1136 1145 I-treatment
with 24 28 1146 1150 I-treatment
corticosteroids 29 44 1151 1166 I-treatment
with 45 49 1167 1171 O
a 50 51 1172 1173 O
dose 52 56 1174 1178 O
of 57 59 1179 1181 O
> 60 61 1182 1183 O
= 61 62 1183 1184 O
10 63 65 1185 1187 B-lower_bound
mg 66 68 1188 1190 I-lower_bound
/ 68 69 1190 1191 I-lower_bound
day 69 72 1191 1194 I-lower_bound
methylprednisolone 73 91 1195 1213 B-treatment
equivalent 92 102 1214 1224 O
( 103 104 1225 1226 O
excluding 104 113 1226 1235 O
inhaled 114 121 1236 1243 B-treatment
steroids 122 130 1244 1252 I-treatment
) 130 131 1252 1253 O

Conditions 0 10 1254 1264 O
that 11 15 1265 1269 O
would 16 21 1270 1275 O
prohibit 22 30 1276 1284 O
administration 31 45 1285 1299 O
of 46 48 1300 1302 O
corticosteroids 49 64 1303 1318 B-treatment

Conduction 0 10 1319 1329 O
abnormality 11 22 1330 1341 O
requiring 23 32 1342 1351 O
a 33 34 1352 1353 O
pacemaker 35 44 1354 1363 B-treatment

Definitive 0 10 1364 1374 O
clinical 11 19 1375 1383 O
or 20 22 1384 1386 O
radiologic 23 33 1387 1397 O
evidence 34 42 1398 1406 O
of 43 45 1407 1409 O
metastatic 46 56 1410 1420 B-cancer
disease 57 64 1421 1428 I-cancer
; 64 65 1428 1429 O
required 66 74 1430 1438 O
imaging 75 82 1439 1446 O
studies 83 90 1447 1454 O
must 91 95 1455 1459 O
have 96 100 1460 1464 O
been 101 105 1465 1469 O
performed 106 115 1470 1479 O
within 116 122 1480 1486 O
90 123 125 1487 1489 B-upper_bound
days 126 130 1490 1494 I-upper_bound
prior 131 136 1495 1500 I-upper_bound
to 137 139 1501 1503 O
randomization 140 153 1504 1517 O

Documented 0 10 1518 1528 O
cardiomyopathy 11 25 1529 1543 B-chronic_disease

Eastern 0 7 1544 1551 B-clinical_variable
Cooperative 8 19 1552 1563 I-clinical_variable
Oncology 20 28 1564 1572 I-clinical_variable
Group 29 34 1573 1578 I-clinical_variable
( 35 36 1579 1580 I-clinical_variable
ECOG 36 40 1580 1584 I-clinical_variable
) 40 41 1584 1585 I-clinical_variable
performance 42 53 1586 1597 I-clinical_variable
status 54 60 1598 1604 I-clinical_variable
of 61 63 1605 1607 O
0 64 65 1608 1609 B-lower_bound
or 66 68 1610 1612 O
1 69 70 1613 1614 B-upper_bound

For 0 3 1615 1618 O
patients 4 12 1619 1627 O
who 13 16 1628 1631 O
undergo 17 24 1632 1639 O
lumpectomy 25 35 1640 1650 B-treatment
, 35 36 1650 1651 O
the 37 40 1652 1655 O
margins 41 48 1656 1663 O
of 49 51 1664 1666 O
the 52 55 1667 1670 O
resected 56 64 1671 1679 O
specimen 65 73 1680 1688 O
must 74 78 1689 1693 O
be 79 81 1694 1696 O
histologically 82 96 1697 1711 O
free 97 101 1712 1716 O
of 102 104 1717 1719 O
invasive 105 113 1720 1728 B-cancer
tumor 114 119 1729 1734 I-cancer
and 120 123 1735 1738 O
ductal 124 130 1739 1745 B-cancer
carcinoma 131 140 1746 1755 I-cancer
in 141 143 1756 1758 I-cancer
situ 144 148 1759 1763 I-cancer
( 149 150 1764 1765 I-cancer
DCIS 150 154 1765 1769 I-cancer
) 154 155 1769 1770 I-cancer
as 156 158 1771 1773 O
determined 159 169 1774 1784 O
by 170 172 1785 1787 O
the 173 176 1788 1791 O
local 177 182 1792 1797 O
pathologist 183 194 1798 1809 O

For 0 3 1810 1813 O
patients 4 12 1814 1822 O
who 13 16 1823 1826 O
undergo 17 24 1827 1834 O
mastectomy 25 35 1835 1845 B-treatment
, 35 36 1845 1846 O
the 37 40 1847 1850 O
margins 41 48 1851 1858 O
must 49 53 1859 1863 O
be 54 56 1864 1866 O
free 57 61 1867 1871 O
of 62 64 1872 1874 O
residual 65 73 1875 1883 O
gross 74 79 1884 1889 O
tumor 80 85 1890 1895 B-cancer

Hemoglobin 0 10 1896 1906 B-clinical_variable
must 11 15 1907 1911 O
be 16 18 1912 1914 O
> 19 20 1915 1916 O
= 20 21 1916 1917 O
10 22 24 1918 1920 B-lower_bound
g 25 26 1921 1922 I-lower_bound
/ 26 27 1922 1923 I-lower_bound
dL 27 29 1923 1925 I-lower_bound

History 0 7 1926 1933 O
of 8 10 1934 1936 O
cardiac 11 18 1937 1944 B-chronic_disease
disease 19 26 1945 1952 I-chronic_disease

History 0 7 1953 1960 O
of 8 10 1961 1963 O
documented 11 21 1964 1974 O
congestive 22 32 1975 1985 B-chronic_disease
heart 33 38 1986 1991 I-chronic_disease
failure 39 46 1992 1999 I-chronic_disease
( 47 48 2000 2001 I-chronic_disease
CHF 48 51 2001 2004 I-chronic_disease
) 51 52 2004 2005 I-chronic_disease

History 0 7 2006 2013 O
of 8 10 2014 2016 O
hospitalization 11 26 2017 2032 O
in 27 29 2033 2035 O
past 30 34 2036 2040 B-upper_bound
12 35 37 2041 2043 I-upper_bound
months 38 44 2044 2050 I-upper_bound
for 45 48 2051 2054 O
diabetic 49 57 2055 2063 B-chronic_disease
ketoacidosis 58 70 2064 2076 I-chronic_disease
( 71 72 2077 2078 I-chronic_disease
DKA 72 75 2078 2081 I-chronic_disease
) 75 76 2081 2082 I-chronic_disease
or 77 79 2083 2085 O
hyperosmolar 80 92 2086 2098 B-chronic_disease
hyperglycemic 93 106 2099 2112 I-chronic_disease
nonketotic 107 117 2113 2123 I-chronic_disease
syndrome 118 126 2124 2132 I-chronic_disease
( 127 128 2133 2134 I-chronic_disease
HHNS 128 132 2134 2138 I-chronic_disease
) 132 133 2138 2139 I-chronic_disease

History 0 7 2140 2147 O
of 8 10 2148 2150 O
non 11 14 2151 2154 B-cancer
- 14 15 2154 2155 I-cancer
breast 15 21 2155 2161 I-cancer
malignancies 22 34 2162 2174 I-cancer
( 35 36 2175 2176 O
except 36 42 2176 2182 O
for 43 46 2183 2186 O
in 47 49 2187 2189 B-cancer
situ 50 54 2190 2194 I-cancer
cancers 55 62 2195 2202 I-cancer
treated 63 70 2203 2210 O
only 71 75 2211 2215 O
by 76 78 2216 2218 O
local 79 84 2219 2224 B-treatment
excision 85 93 2225 2233 I-treatment
and 94 97 2234 2237 O
basal 98 103 2238 2243 B-cancer
cell 104 108 2244 2248 I-cancer
and 109 112 2249 2252 O
squamous 113 121 2253 2261 B-cancer
cell 122 126 2262 2266 I-cancer
carcinomas 127 137 2267 2277 I-cancer
of 138 140 2278 2280 I-cancer
the 141 144 2281 2284 I-cancer
skin 145 149 2285 2289 I-cancer
) 149 150 2289 2290 O
within 151 157 2291 2297 O
5 158 159 2298 2299 B-upper_bound
years 160 165 2300 2305 I-upper_bound
prior 166 171 2306 2311 I-upper_bound
to 172 174 2312 2314 O
randomization 175 188 2315 2328 O

IHC 0 3 2329 2332 B-treatment
2 4 5 2333 2334 O
+ 5 6 2334 2335 O
and 7 10 2336 2339 O
in 11 13 2340 2342 B-treatment
situ 14 18 2343 2347 I-treatment
hybridization 19 32 2348 2361 I-treatment
( 33 34 2362 2363 I-treatment
ISH 34 37 2363 2366 I-treatment
) 37 38 2366 2367 I-treatment
non 39 42 2368 2371 O
- 42 43 2371 2372 O
amplified 43 52 2372 2381 O
with 53 57 2382 2386 O
a 58 59 2387 2388 O
ratio 60 65 2389 2394 O
of 66 68 2395 2397 O
HER2 69 73 2398 2402 O
to 74 76 2403 2405 O
centromere 77 87 2406 2416 B-clinical_variable
enumerator 88 98 2417 2427 I-clinical_variable
probe 99 104 2428 2433 I-clinical_variable
17 105 107 2434 2436 I-clinical_variable
( 108 109 2437 2438 I-clinical_variable
CEP17 109 114 2438 2443 I-clinical_variable
) 114 115 2443 2444 I-clinical_variable
< 116 117 2445 2446 O
2.0 118 121 2447 2450 B-upper_bound
, 121 122 2450 2451 O
and 123 126 2452 2455 O
if 127 129 2456 2458 O
reported 130 138 2459 2467 O
, 138 139 2467 2468 O
average 140 147 2469 2476 B-clinical_variable
HER2 148 152 2477 2481 I-clinical_variable
gene 153 157 2482 2486 I-clinical_variable
copy 158 162 2487 2491 I-clinical_variable
number 163 169 2492 2498 I-clinical_variable
< 170 171 2499 2500 O
4 172 173 2501 2502 B-upper_bound
signals 174 181 2503 2510 I-upper_bound
/ 181 182 2510 2511 I-upper_bound
cells 182 187 2511 2516 I-upper_bound

ISH 0 3 2517 2520 B-chronic_disease
non 4 7 2521 2524 O
- 7 8 2524 2525 O
amplified 8 17 2525 2534 O
with 18 22 2535 2539 O
a 23 24 2540 2541 O
ratio 25 30 2542 2547 O
of 31 33 2548 2550 O
HER2 34 38 2551 2555 O
to 39 41 2556 2558 O
CEP17 42 47 2559 2564 B-clinical_variable
< 48 49 2565 2566 O
2.0 50 53 2567 2570 B-upper_bound
, 53 54 2570 2571 O
and 55 58 2572 2575 O
if 59 61 2576 2578 O
reported 62 70 2579 2587 O
, 70 71 2587 2588 O
average 72 79 2589 2596 B-clinical_variable
HER2 80 84 2597 2601 I-clinical_variable
gene 85 89 2602 2606 I-clinical_variable
copy 90 94 2607 2611 I-clinical_variable
number 95 101 2612 2618 I-clinical_variable
< 102 103 2619 2620 O
4 104 105 2621 2622 B-upper_bound
signals 106 113 2623 2630 I-upper_bound
/ 113 114 2630 2631 I-upper_bound
cells 114 119 2631 2636 I-upper_bound

Immunohistochemistry 0 20 2637 2657 B-clinical_variable
( 21 22 2658 2659 I-clinical_variable
IHC 22 25 2659 2662 I-clinical_variable
) 25 26 2662 2663 I-clinical_variable
0 27 28 2664 2665 B-lower_bound
- 28 29 2665 2666 O
1 29 30 2666 2667 B-upper_bound
+ 30 31 2667 2668 O

Intrinsic 0 9 2669 2678 B-chronic_disease
lung 10 14 2679 2683 I-chronic_disease
disease 15 22 2684 2691 I-chronic_disease
resulting 23 32 2692 2701 O
in 33 35 2702 2704 O
dyspnea 36 43 2705 2712 B-chronic_disease

Known 0 5 2713 2718 O
hypersensitivity 6 22 2719 2735 O
to 23 25 2736 2738 O
any 26 29 2739 2742 O
of 30 32 2743 2745 O
the 33 36 2746 2749 O
study 37 42 2750 2755 B-treatment
drugs 43 48 2756 2761 I-treatment
or 49 51 2762 2764 O
excipients 52 62 2765 2775 B-treatment
, 62 63 2775 2776 O
e.g. 64 68 2777 2781 O
, 68 69 2781 2782 O
polysorbate 70 81 2783 2794 B-treatment
80 82 84 2795 2797 I-treatment
and 85 88 2798 2801 O
Cremophor 89 98 2802 2811 B-treatment
® 98 99 2811 2812 I-treatment
EL 100 102 2813 2815 I-treatment

Left 0 4 2816 2820 B-clinical_variable
ventricular 5 16 2821 2832 I-clinical_variable
ejection 17 25 2833 2841 I-clinical_variable
fraction 26 34 2842 2850 I-clinical_variable
( 35 36 2851 2852 I-clinical_variable
LVEF 36 40 2852 2856 I-clinical_variable
) 40 41 2856 2857 I-clinical_variable
assessment 42 52 2858 2868 O
must 53 57 2869 2873 O
be 58 60 2874 2876 O
performed 61 70 2877 2886 O
within 71 77 2887 2893 O
90 78 80 2894 2896 B-upper_bound
days 81 85 2897 2901 I-upper_bound
prior 86 91 2902 2907 I-upper_bound
to 92 94 2908 2910 O
randomization 95 108 2911 2924 O
; 108 109 2924 2925 O
( 110 111 2926 2927 O
LVEF 111 115 2927 2931 O
assessment 116 126 2932 2942 O
performed 127 136 2943 2952 O
by 137 139 2953 2955 O
2 140 141 2956 2957 B-treatment
- 141 142 2957 2958 I-treatment
dimensional 142 153 2958 2969 I-treatment
[ 154 155 2970 2971 I-treatment
D 155 156 2971 2972 I-treatment
] 156 157 2972 2973 I-treatment
echocardiogram 158 172 2974 2988 I-treatment
is 173 175 2989 2991 O
preferred 176 185 2992 3001 O
; 185 186 3001 3002 O
however 187 194 3003 3010 O
, 194 195 3010 3011 O
multi 196 201 3012 3017 B-treatment
gated 202 207 3018 3023 I-treatment
acquisition 208 219 3024 3035 I-treatment
[ 220 221 3036 3037 I-treatment
MUGA 221 225 3037 3041 I-treatment
] 225 226 3041 3042 I-treatment
scan 227 231 3043 3047 I-treatment
may 232 235 3048 3051 O
be 236 238 3052 3054 O
substituted 239 250 3055 3066 O
based 251 256 3067 3072 O
on 257 259 3073 3075 O
institutional 260 273 3076 3089 O
preferences 274 285 3090 3101 O
;) 285 287 3101 3103 O
the 288 291 3104 3107 O
LVEF 292 296 3108 3112 O
must 297 301 3113 3117 O
be 302 304 3118 3120 O
> 305 306 3121 3122 O
= 306 307 3122 3123 O
50 308 310 3124 3126 B-lower_bound
% 310 311 3126 3127 I-lower_bound
regardless 312 322 3128 3138 O
of 323 325 3139 3141 O
the 326 329 3142 3145 O
cardiac 330 337 3146 3153 O
imaging 338 345 3154 3161 O
facility 346 354 3162 3170 O
's 354 356 3170 3172 O
lower 357 362 3173 3178 O
limit 363 368 3179 3184 O
of 369 371 3185 3187 O
normal 372 378 3188 3194 O

Myocardial 0 10 3195 3205 B-chronic_disease
infarction 11 21 3206 3216 I-chronic_disease
documented 22 32 3217 3227 O
by 33 35 3228 3230 O
elevated 36 44 3231 3239 O
cardiac 45 52 3240 3247 O
enzymes 53 60 3248 3255 O
or 61 63 3256 3258 O
persistent 64 74 3259 3269 O
regional 75 83 3270 3278 O
wall 84 88 3279 3283 O
abnormalities 89 102 3284 3297 O
on 103 105 3298 3300 O
assessment 106 116 3301 3311 O
of 117 119 3312 3314 O
left 120 124 3315 3319 O
ventricle 125 134 3320 3329 O
( 135 136 3330 3331 O
LV 136 138 3331 3333 O
) 138 139 3333 3334 O
function 140 148 3335 3343 O

Nervous 0 7 3344 3351 B-clinical_variable
system 8 14 3352 3358 I-clinical_variable
disorder 15 23 3359 3367 I-clinical_variable
( 24 25 3368 3369 O
paresthesia 25 36 3369 3380 B-chronic_disease
, 36 37 3380 3381 O
peripheral 38 48 3382 3392 B-chronic_disease
motor 49 54 3393 3398 I-chronic_disease
neuropathy 55 65 3399 3409 I-chronic_disease
, 65 66 3409 3410 O
or 67 69 3411 3413 O
peripheral 70 80 3414 3424 B-chronic_disease
sensory 81 88 3425 3432 I-chronic_disease
neuropathy 89 99 3433 3443 I-chronic_disease
) 99 100 3443 3444 O
> 101 102 3445 3446 O
= 102 103 3446 3447 O
grade 104 109 3448 3453 B-lower_bound
2 110 111 3454 3455 I-lower_bound
, 111 112 3455 3456 O
per 113 116 3457 3460 O
the 117 120 3461 3464 O
Common 121 127 3465 3471 O
Terminology 128 139 3472 3483 O
Criteria 140 148 3484 3492 O
for 149 152 3493 3496 O
Adverse 153 160 3497 3504 O
Events 161 167 3505 3511 O
( 168 169 3512 3513 O
CTCAE 169 174 3513 3518 O
) 174 175 3518 3519 O
version 176 183 3520 3527 O
( 184 185 3528 3529 O
v)4.0 185 190 3529 3534 O

Other 0 5 3535 3540 O
non 6 9 3541 3544 B-cancer
- 9 10 3544 3545 I-cancer
malignant 10 19 3545 3554 I-cancer
systemic 20 28 3555 3563 I-cancer
disease 29 36 3564 3571 I-cancer
that 37 41 3572 3576 O
would 42 47 3577 3582 O
preclude 48 56 3583 3591 O
the 57 60 3592 3595 O
patient 61 68 3596 3603 O
from 69 73 3604 3608 O
receiving 74 83 3609 3618 O
study 84 89 3619 3624 B-treatment
treatment 90 99 3625 3634 I-treatment
or 100 102 3635 3637 O
would 103 108 3638 3643 O
prevent 109 116 3644 3651 O
required 117 125 3652 3660 O
follow 126 132 3661 3667 O
- 132 133 3667 3668 O
up 133 135 3668 3670 O

Patients 0 8 3671 3679 O
known 9 14 3680 3685 O
to 15 17 3686 3688 O
be 18 20 3689 3691 O
human 21 26 3692 3697 B-chronic_disease
immunodeficiency 27 43 3698 3714 I-chronic_disease
virus 44 49 3715 3720 I-chronic_disease
( 50 51 3721 3722 I-chronic_disease
HIV 51 54 3722 3725 I-chronic_disease
) 54 55 3725 3726 I-chronic_disease
positive 56 64 3727 3735 O
with 65 69 3736 3740 O
a 70 71 3741 3742 O
baseline 72 80 3743 3751 O
cluster 81 88 3752 3759 O
of 89 91 3760 3762 O
differentiation 92 107 3763 3778 O
( 108 109 3779 3780 B-clinical_variable
CD)4 109 113 3780 3784 I-clinical_variable
count 114 119 3785 3790 I-clinical_variable
of 120 122 3791 3793 O
< 123 124 3794 3795 O
250 125 128 3796 3799 B-upper_bound
cells 129 134 3800 3805 I-upper_bound
/ 134 135 3805 3806 I-upper_bound
mm^3 135 139 3806 3810 I-upper_bound
or 140 142 3811 3813 O
have 143 147 3814 3818 O
a 148 149 3819 3820 O
history 150 157 3821 3828 O
of 158 160 3829 3831 O
acquired 161 169 3832 3840 B-chronic_disease
immune 170 176 3841 3847 I-chronic_disease
deficiency 177 187 3848 3858 I-chronic_disease
syndrome 188 196 3859 3867 I-chronic_disease
( 197 198 3868 3869 I-chronic_disease
AIDS 198 202 3869 3873 I-chronic_disease
) 202 203 3873 3874 I-chronic_disease
indicator 204 213 3875 3884 O
conditions 214 224 3885 3895 O

Patients 0 8 3896 3904 O
with 9 13 3905 3909 O
AST 14 17 3910 3913 B-clinical_variable
or 18 20 3914 3916 O
alkaline 21 29 3917 3925 B-clinical_variable
phosphatase 30 41 3926 3937 I-clinical_variable
> 42 43 3938 3939 O
ULN 44 47 3940 3943 O
are 48 51 3944 3947 O
eligible 52 60 3948 3956 O
for 61 64 3957 3960 O
inclusion 65 74 3961 3970 O
in 75 77 3971 3973 O
the 78 81 3974 3977 O
study 82 87 3978 3983 O
if 88 90 3984 3986 O
liver 91 96 3987 3992 O
imaging 97 104 3993 4000 O
( 105 106 4001 4002 O
computed 106 114 4002 4010 B-treatment
tomography 115 125 4011 4021 I-treatment
[ 126 127 4022 4023 I-treatment
CT 127 129 4023 4025 I-treatment
] 129 130 4025 4026 I-treatment
, 130 131 4026 4027 O
magnetic 132 140 4028 4036 B-treatment
resonance 141 150 4037 4046 I-treatment
imaging 151 158 4047 4054 I-treatment
[ 159 160 4055 4056 I-treatment
MRI 160 163 4056 4059 I-treatment
] 163 164 4059 4060 I-treatment
, 164 165 4060 4061 O
positron 166 174 4062 4070 B-treatment
emission 175 183 4071 4079 I-treatment
tomography 184 194 4080 4090 I-treatment
[ 195 196 4091 4092 I-treatment
PET]-CT 196 203 4092 4099 I-treatment
, 203 204 4099 4100 O
or 205 207 4101 4103 O
PET 208 211 4104 4107 B-treatment
scan 212 216 4108 4112 I-treatment
) 216 217 4112 4113 O
performed 218 227 4114 4123 O
within 228 234 4124 4130 O
90 235 237 4131 4133 B-upper_bound
days 238 242 4134 4138 I-upper_bound
prior 243 248 4139 4144 I-upper_bound
to 249 251 4145 4147 O
randomization 252 265 4148 4161 O
does 266 270 4162 4166 O
not 271 274 4167 4170 O
demonstrate 275 286 4171 4182 O
metastatic 287 297 4183 4193 B-cancer
disease 298 305 4194 4201 I-cancer
and 306 309 4202 4205 O
the 310 313 4206 4209 O
requirements 314 326 4210 4222 O
above 327 332 4223 4228 O
are 333 336 4229 4232 O
met 337 340 4233 4236 O

Patients 0 8 4237 4245 O
with 9 13 4246 4250 O
alkaline 14 22 4251 4259 B-clinical_variable
phosphatase 23 34 4260 4271 I-clinical_variable
that 35 39 4272 4276 O
is 40 42 4277 4279 O
> 43 44 4280 4281 O
ULN 45 48 4282 4285 O
but 49 52 4286 4289 O
= 53 54 4290 4291 O
< 54 55 4291 4292 O
2.5 56 59 4293 4296 B-upper_bound
x 60 61 4297 4298 I-upper_bound
ULN 62 65 4299 4302 I-upper_bound
or 66 68 4303 4305 O
unexplained 69 80 4306 4317 O
bone 81 85 4318 4322 O
pain 86 90 4323 4327 O
are 91 94 4328 4331 O
eligible 95 103 4332 4340 O
for 104 107 4341 4344 O
inclusion 108 117 4345 4354 O
in 118 120 4355 4357 O
the 121 124 4358 4361 O
study 125 130 4362 4367 O
if 131 133 4368 4370 O
a 134 135 4371 4372 O
bone 136 140 4373 4377 B-treatment
scan 141 145 4378 4382 I-treatment
, 145 146 4382 4383 O
PET 147 150 4384 4387 B-treatment
- 150 151 4387 4388 I-treatment
CT 151 153 4388 4390 I-treatment
scan 154 158 4391 4395 I-treatment
, 158 159 4395 4396 O
or 160 162 4397 4399 O
PET 163 166 4400 4403 B-treatment
scan 167 171 4404 4408 I-treatment
performed 172 181 4409 4418 O
within 182 188 4419 4425 O
90 189 191 4426 4428 B-upper_bound
days 192 196 4429 4433 I-upper_bound
prior 197 202 4434 4439 I-upper_bound
to 203 205 4440 4442 O
randomization 206 219 4443 4456 O
does 220 224 4457 4461 O
not 225 228 4462 4465 O
demonstrate 229 240 4466 4477 O
metastatic 241 251 4478 4488 B-cancer
disease 252 259 4489 4496 I-cancer

Platelet 0 8 4497 4505 B-clinical_variable
count 9 14 4506 4511 I-clinical_variable
must 15 19 4512 4516 O
be 20 22 4517 4519 O
> 23 24 4520 4521 O
= 24 25 4521 4522 O
100,000 26 33 4523 4530 B-lower_bound
/ 33 34 4530 4531 I-lower_bound
mm^3 34 38 4531 4535 I-lower_bound

Pregnancy 0 9 4536 4545 B-pregnancy
or 10 12 4546 4548 O
lactation 13 22 4549 4558 O
at 23 25 4559 4561 O
the 26 29 4562 4565 O
time 30 34 4566 4570 O
of 35 37 4571 4573 O
study 38 43 4574 4579 O
entry 44 49 4580 4585 O

Previous 0 8 4586 4594 O
therapy 9 16 4595 4602 B-treatment
with 17 21 4603 4607 O
anthracyclines 22 36 4608 4622 B-treatment
or 37 39 4623 4625 O
taxanes 40 47 4626 4633 B-treatment
for 48 51 4634 4637 O
any 52 55 4638 4641 O
malignancy 56 66 4642 4652 B-cancer

Psychiatric 0 11 4653 4664 B-chronic_disease
or 12 14 4665 4667 O
addictive 15 24 4668 4677 B-chronic_disease
disorders 25 34 4678 4687 I-chronic_disease
or 35 37 4688 4690 O
other 38 43 4691 4696 O
conditions 44 54 4697 4707 O
that 55 59 4708 4712 O
, 59 60 4712 4713 O
in 61 63 4714 4716 O
the 64 67 4717 4720 O
opinion 68 75 4721 4728 O
of 76 78 4729 4731 O
the 79 82 4732 4735 O
investigator 83 95 4736 4748 O
, 95 96 4748 4749 O
would 97 102 4750 4755 O
preclude 103 111 4756 4764 O
the 112 115 4765 4768 O
patient 116 123 4769 4776 O
from 124 128 4777 4781 O
meeting 129 136 4782 4789 O
the 137 140 4790 4793 O
study 141 146 4794 4799 O
requirements 147 159 4800 4812 O

Sentinel 0 8 4813 4821 B-treatment
lymphadenectomy 9 24 4822 4837 I-treatment
alone 25 30 4838 4843 O

Supraventricular 0 16 4844 4860 O
and 17 20 4861 4864 O
nodal 21 26 4865 4870 O
arrhythmias 27 38 4871 4882 B-chronic_disease
requiring 39 48 4883 4892 O
a 49 50 4893 4894 O
pacemaker 51 60 4895 4904 B-treatment
or 61 63 4905 4907 O
not 64 67 4908 4911 O
controlled 68 78 4912 4922 O
with 79 83 4923 4927 O
medication 84 94 4928 4938 B-treatment

Symptomatic 0 11 4939 4950 O
pericarditis 12 24 4951 4963 B-chronic_disease

Synchronous 0 11 4964 4975 O
or 12 14 4976 4978 O
previous 15 23 4979 4987 O
contralateral 24 37 4988 5001 B-cancer
invasive 38 46 5002 5010 I-cancer
breast 47 53 5011 5017 I-cancer
cancer 54 60 5018 5024 I-cancer

T4 0 2 5025 5027 B-cancer
tumors 3 9 5028 5034 I-cancer
including 10 19 5035 5044 O
inflammatory 20 32 5045 5057 B-cancer
breast 33 39 5058 5064 I-cancer
cancer 40 46 5065 5071 I-cancer

The 0 3 5072 5075 O
interval 4 12 5076 5084 O
between 13 20 5085 5092 O
the 21 24 5093 5096 O
last 25 29 5097 5101 O
surgery 30 37 5102 5109 B-treatment
for 38 41 5110 5113 O
breast 42 48 5114 5120 B-cancer
cancer 49 55 5121 5127 I-cancer
( 56 57 5128 5129 O
including 57 66 5129 5138 O
re 67 69 5139 5141 O
- 69 70 5141 5142 O
excision 70 78 5142 5150 O
of 79 81 5151 5153 O
margins 82 89 5154 5161 O
) 89 90 5161 5162 O
and 91 94 5163 5166 O
randomization 95 108 5167 5180 O
must 109 113 5181 5185 O
be 114 116 5186 5188 O
no 117 119 5189 5191 O
more 120 124 5192 5196 O
than 125 129 5197 5201 O
60 130 132 5202 5204 B-lower_bound
days 133 137 5205 5209 I-lower_bound

The 0 3 5210 5213 O
patient 4 11 5214 5221 O
must 12 16 5222 5226 O
have 17 21 5227 5231 O
undergone 22 31 5232 5241 O
either 32 38 5242 5248 O
a 39 40 5249 5250 O
mastectomy 41 51 5251 5261 B-treatment
( 52 53 5262 5263 O
total 53 58 5263 5268 O
, 58 59 5268 5269 O
skin 60 64 5270 5274 O
- 64 65 5274 5275 O
sparing 65 72 5275 5282 O
, 72 73 5282 5283 O
or 74 76 5284 5286 O
nipple 77 83 5287 5293 O
- 83 84 5293 5294 O
sparing 84 91 5294 5301 O
) 91 92 5301 5302 O
or 93 95 5303 5305 O
lumpectomy 96 106 5306 5316 B-treatment

The 0 3 5317 5320 O
tumor 4 9 5321 5326 B-cancer
must 10 14 5327 5331 O
be 15 17 5332 5334 O
unilateral 18 28 5335 5345 O
invasive 29 37 5346 5354 O
adenocarcinoma 38 52 5355 5369 B-cancer
of 53 55 5370 5372 I-cancer
the 56 59 5373 5376 I-cancer
breast 60 66 5377 5383 I-cancer
on 67 69 5384 5386 O
histologic 70 80 5387 5397 O
examination 81 92 5398 5409 O

The 0 3 5410 5413 O
tumor 4 9 5414 5419 B-cancer
must 10 14 5420 5424 O
have 15 19 5425 5429 O
been 20 24 5430 5434 O
determined 25 35 5435 5445 O
to 36 38 5446 5448 O
be 39 41 5449 5451 O
estrogen 42 50 5452 5460 O
receptor 51 59 5461 5469 O
( 60 61 5470 5471 O
ER)-and 61 68 5471 5478 O
progesterone 69 81 5479 5491 O
receptor 82 90 5492 5500 O
( 91 92 5501 5502 O
PgR)-negative 92 105 5502 5515 O
assessed 106 114 5516 5524 O
by 115 117 5525 5527 O
current 118 125 5528 5535 O
American 126 134 5536 5544 O
Society 135 142 5545 5552 O
of 143 145 5553 5555 O
Clinical 146 154 5556 5564 O
Oncology 155 163 5565 5573 O
( 164 165 5574 5575 O
ASCO)/College 165 178 5575 5588 O
of 179 181 5589 5591 O
American 182 190 5592 5600 O
Pathologists 191 203 5601 5613 O
( 204 205 5614 5615 O
CAP 205 208 5615 5618 O
) 208 209 5618 5619 O
guidelines 210 220 5620 5630 O

The 0 3 5631 5634 O
tumor 4 9 5635 5640 B-cancer
must 10 14 5641 5645 O
have 15 19 5646 5650 O
been 20 24 5651 5655 O
determined 25 35 5656 5666 O
to 36 38 5667 5669 O
be 39 41 5670 5672 O
human 42 47 5673 5678 B-cancer
epidermal 48 57 5679 5688 I-cancer
growth 58 64 5689 5695 I-cancer
factor 65 71 5696 5702 I-cancer
receptor 72 80 5703 5711 I-cancer
2 81 82 5712 5713 I-cancer
( 83 84 5714 5715 I-cancer
HER2)-negative 84 98 5715 5729 I-cancer

Total 0 5 5730 5735 B-clinical_variable
bilirubin 6 15 5736 5745 I-clinical_variable
must 16 20 5746 5750 O
be 21 23 5751 5753 O
= 24 25 5754 5755 O
< 25 26 5755 5756 O
upper 27 32 5757 5762 O
limit 33 38 5763 5768 O
of 39 41 5769 5771 O
normal 42 48 5772 5778 O
( 49 50 5779 5780 O
ULN 50 53 5780 5783 O
) 53 54 5783 5784 O
for 55 58 5785 5788 O
the 59 62 5789 5792 O
laboratory 63 73 5793 5803 O
( 74 75 5804 5805 O
lab 75 78 5805 5808 O
) 78 79 5808 5809 O
unless 80 86 5810 5816 O
the 87 90 5817 5820 O
patient 91 98 5821 5828 O
has 99 102 5829 5832 O
a 103 104 5833 5834 O
bilirubin 105 114 5835 5844 B-clinical_variable
elevation 115 124 5845 5854 I-clinical_variable
> 125 126 5855 5856 O
ULN 127 130 5857 5860 O
to 131 133 5861 5863 O
1.5 134 137 5864 5867 B-upper_bound
x 138 139 5868 5869 I-upper_bound
ULN 140 143 5870 5873 I-upper_bound
due 144 147 5874 5877 O
to 148 150 5878 5880 O
Gilbert 151 158 5881 5888 B-chronic_disease
's 158 160 5888 5890 I-chronic_disease
disease 161 168 5891 5898 I-chronic_disease
or 169 171 5899 5901 O
similar 172 179 5902 5909 O
syndrome 180 188 5910 5918 O
involving 189 198 5919 5928 O
slow 199 203 5929 5933 O
conjugation 204 215 5934 5945 O
of 216 218 5946 5948 O
bilirubin 219 228 5949 5958 O

Uncontrolled 0 12 5959 5971 B-chronic_disease
hypertension 13 25 5972 5984 I-chronic_disease
defined 26 33 5985 5992 O
as 34 36 5993 5995 O
sustained 37 46 5996 6005 O
systolic 47 55 6006 6014 B-clinical_variable
blood 56 61 6015 6020 I-clinical_variable
pressure 62 70 6021 6029 I-clinical_variable
( 71 72 6030 6031 I-clinical_variable
BP 72 74 6031 6033 I-clinical_variable
) 74 75 6033 6034 I-clinical_variable
> 76 77 6035 6036 O
150 78 81 6037 6040 B-lower_bound
mmHg 82 86 6041 6045 I-lower_bound
or 87 89 6046 6048 O
diastolic 90 99 6049 6058 B-clinical_variable
BP 100 102 6059 6061 I-clinical_variable
> 103 104 6062 6063 O
90 105 107 6064 6066 B-lower_bound
mmHg 108 112 6067 6071 I-lower_bound

Valvular 0 8 6072 6080 B-chronic_disease
disease 9 16 6081 6088 I-chronic_disease
with 17 21 6089 6093 O
documented 22 32 6094 6104 O
compromise 33 43 6105 6115 O
in 44 46 6116 6118 O
cardiac 47 54 6119 6126 O
function 55 63 6127 6135 O

Ventricular 0 11 6136 6147 B-chronic_disease
arrhythmias 12 23 6148 6159 I-chronic_disease
except 24 30 6160 6166 O
for 31 34 6167 6170 O
benign 35 41 6171 6177 O
premature 42 51 6178 6187 B-chronic_disease
ventricular 52 63 6188 6199 I-chronic_disease
contractions 64 76 6200 6212 I-chronic_disease

patients 0 8 6213 6221 O
with 9 13 6222 6226 O
< 14 15 6227 6228 O
1 16 17 6229 6230 B-upper_bound
% 17 18 6230 6231 I-upper_bound
ER 19 21 6232 6234 B-clinical_variable
and 22 25 6235 6238 O
PgR 26 29 6239 6242 B-clinical_variable
staining 30 38 6243 6251 O
by 39 41 6252 6254 O
IHC 42 45 6255 6258 B-clinical_variable
are 46 49 6259 6262 O
considered 50 60 6263 6273 O
negative 61 69 6274 6282 O

patients 0 8 6283 6291 O
with 9 13 6292 6296 O
margins 14 21 6297 6304 O
positive 22 30 6305 6313 O
for 31 34 6314 6317 O
lobular 35 42 6318 6325 B-cancer
carcinoma 43 52 6326 6335 I-cancer
in 53 55 6336 6338 I-cancer
situ 56 60 6339 6343 I-cancer
[ 61 62 6344 6345 I-cancer
LCIS 62 66 6345 6349 I-cancer
] 66 67 6349 6350 I-cancer
are 68 71 6351 6354 O
eligible 72 80 6355 6363 O
without 81 88 6364 6371 O
additional 89 99 6372 6382 O
resection 100 109 6383 6392 B-treatment

patients 0 8 6393 6401 O
with 9 13 6402 6406 O
microscopic 14 25 6407 6418 B-cancer
positive 26 34 6419 6427 I-cancer
margins 35 42 6428 6435 I-cancer
are 43 46 6436 6439 O
eligible 47 55 6440 6448 O
as 56 58 6449 6451 O
long 59 63 6452 6456 O
as 64 66 6457 6459 O
post 67 71 6460 6464 B-treatment
- 71 72 6464 6465 I-treatment
mastectomy 72 82 6465 6475 I-treatment
radiation 83 92 6476 6485 I-treatment
therapy 93 100 6486 6493 I-treatment
[ 101 102 6494 6495 I-treatment
RT 102 104 6495 6497 I-treatment
] 104 105 6497 6498 I-treatment
of 106 108 6499 6501 O
the 109 112 6502 6505 O
chest 113 118 6506 6511 O
wall 119 123 6512 6516 O
will 124 128 6517 6521 O
be 129 131 6522 6524 O
administered 132 144 6525 6537 O

patients 0 8 6538 6546 O
with 9 13 6547 6551 O
synchronous 14 25 6552 6563 O
and/or 26 32 6564 6570 O
previous 33 41 6571 6579 O
contralateral 42 55 6580 6593 B-cancer
DCIS 56 60 6594 6598 I-cancer
or 61 63 6599 6601 O
LCIS 64 68 6602 6606 B-cancer
are 69 72 6607 6610 O
eligible 73 81 6611 6619 O
) 81 82 6619 6620 O

patients 0 8 6621 6629 O
with 9 13 6630 6634 O
synchronous 14 25 6635 6646 O
or 26 28 6647 6649 O
previous 29 37 6650 6658 O
ipsilateral 38 49 6659 6670 B-cancer
LCIS 50 54 6671 6675 I-cancer
are 55 58 6676 6679 O
eligible 59 67 6680 6688 O

pregnancy 0 9 6689 6698 B-pregnancy
testing 10 17 6699 6706 O
according 18 27 6707 6716 O
to 28 30 6717 6719 O
institutional 31 44 6720 6733 O
standards 45 54 6734 6743 O
for 55 58 6744 6747 O
women 59 64 6748 6753 B-gender
of 65 67 6754 6756 O
childbearing 68 80 6757 6769 O
potential 81 90 6770 6779 O
must 91 95 6780 6784 O
be 96 98 6785 6787 O
performed 99 108 6788 6797 O
within 109 115 6798 6804 O
2 116 117 6805 6806 B-upper_bound
weeks 118 123 6807 6812 I-upper_bound
prior 124 129 6813 6818 I-upper_bound
to 130 132 6819 6821 O
randomization 133 146 6822 6835 O

Brainstem 0 9 0 9 B-chronic_disease
or 10 12 10 12 I-chronic_disease
cerebellar 13 23 13 23 I-chronic_disease
stroke 24 30 24 30 I-chronic_disease

Central 0 7 31 38 B-chronic_disease
nervous 8 15 39 46 I-chronic_disease
system 16 22 47 53 I-chronic_disease
disease 23 30 54 61 I-chronic_disease
or 31 33 62 64 O
disorder 34 42 65 73 O
other 43 48 74 79 O
than 49 53 80 84 O
stroke 54 60 85 91 B-chronic_disease

Age 0 3 0 3 B-age
and 4 7 4 7 O
gender 8 14 8 14 O
matched 15 22 15 22 O
patients 23 31 23 31 O
who 32 35 32 35 O
undergo 36 43 36 43 O
chest 44 49 44 49 B-treatment
CT 50 52 50 52 I-treatment
at 53 55 53 55 O
the 56 59 56 59 O
ACH 60 63 60 63 O
JHM 64 67 64 67 O
Radiology 68 77 68 77 O
Department 78 88 78 88 O
for 89 92 89 92 O
indications 93 104 93 104 O
other 105 110 105 110 O
than 111 115 111 115 O
Pectus 116 122 116 122 B-treatment
Excavatum 123 132 123 132 I-treatment

All 0 3 133 136 O
patients 4 12 137 145 O
evaluated 13 22 146 155 O
in 23 25 156 158 O
the 26 29 159 162 O
ACH 30 33 163 166 O
JHM 34 37 167 170 O
Pediatric 38 47 171 180 O
Surgery 48 55 181 188 O
or 56 58 189 191 O
Cardiac 59 66 192 199 O
Surgery 67 74 200 207 O
Clinics 75 82 208 215 O
, 82 83 215 216 O
as 84 86 217 219 O
well 87 91 220 224 O
as 92 94 225 227 O
in 95 97 228 230 O
the 98 101 231 234 O
outpatient 102 112 235 245 O
clinic 113 119 246 252 O
system 120 126 253 259 O
at 127 129 260 262 O
Johns 130 135 263 268 O
Hopkins 136 143 269 276 O
Hospital 144 152 277 285 O
, 152 153 285 286 O
for 154 157 287 290 O
surgical 158 166 291 299 B-treatment
correction 167 177 300 310 I-treatment
of 178 180 311 313 I-treatment
Pectus 181 187 314 320 I-treatment
Excavatum 188 197 321 330 I-treatment

Age 0 3 0 3 B-age
< 4 5 4 5 O
18 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound

Patients 0 8 15 23 O
with 9 13 24 28 O
normal 14 20 29 35 O
lung 21 25 36 40 O
function 26 34 41 49 O
undergoing 35 45 50 60 O
Whipple 46 53 61 68 B-treatment
procedures 54 64 69 79 I-treatment

forced 0 6 80 86 B-clinical_variable
expiratory 7 17 87 97 I-clinical_variable
volume 18 24 98 104 I-clinical_variable
1 25 26 105 106 I-clinical_variable
( 27 28 107 108 I-clinical_variable
FEV1)/forced 28 40 108 120 I-clinical_variable
vital 41 46 121 126 I-clinical_variable
capacity 47 55 127 135 I-clinical_variable
( 56 57 136 137 I-clinical_variable
FVC 57 60 137 140 I-clinical_variable
) 60 61 140 141 I-clinical_variable
< 62 63 142 143 O
0.70 63 67 143 147 B-upper_bound
and 68 71 148 151 O
FEV1 72 76 152 156 O
50 77 79 157 159 B-lower_bound
- 79 80 159 160 O
79 80 82 160 162 B-upper_bound
% 82 83 162 163 I-upper_bound
normal 84 90 164 170 O
) 90 91 170 171 O
undergoing 92 102 172 182 O
Whipple 103 110 183 190 O
procedures 111 121 191 201 O
or 122 124 202 204 O
other 125 130 205 210 O
major 131 136 211 216 B-treatment
surgeries 137 146 217 226 I-treatment

other 0 5 227 232 O
major 6 11 233 238 B-treatment
abdominal 12 21 239 248 I-treatment
surgeries 22 31 249 258 I-treatment

Must 0 4 0 4 O
be 5 7 5 7 O
18 8 10 8 10 B-lower_bound
years 11 16 11 16 I-lower_bound
of 17 19 17 19 O
age 20 23 20 23 B-age
or 24 26 24 26 O
older 27 32 27 32 O

Under 0 5 33 38 O
18 6 8 39 41 B-upper_bound
years 9 14 42 47 I-upper_bound
of 15 17 48 50 O
age 18 21 51 54 B-age

Age 0 3 0 3 B-age
≤ 4 5 4 5 O
17 6 8 6 8 B-upper_bound

Allergy 0 7 9 16 O
to 8 10 17 19 O
povidone 11 19 20 28 B-allergy_name
iodine 20 26 29 35 I-allergy_name

Any 0 3 36 39 O
condition 4 13 40 49 O
requiring 14 23 50 59 O
antibiotics 24 35 60 71 B-treatment
14 36 38 72 74 B-upper_bound
days 39 43 75 79 I-upper_bound
prior 44 49 80 85 I-upper_bound
to 50 52 86 88 O
arriving 53 61 89 97 O
for 62 65 98 101 O
surgery 66 73 102 109 B-treatment

Inability 0 9 110 119 O
to 10 12 120 122 O
provide 13 20 123 130 O
informed 21 29 131 139 O
consent 30 37 140 147 O
or 38 40 148 150 O
to 41 43 151 153 O
comply 44 50 154 160 O
with 51 55 161 165 O
study 56 61 166 171 O
assessments 62 73 172 183 O
( 74 75 184 185 O
e.g. 75 79 185 189 O
due 80 83 190 193 O
to 84 86 194 196 O
cognitive 87 96 197 206 B-chronic_disease
impairment 97 107 207 217 I-chronic_disease
or 108 110 218 220 O
geographic 111 121 221 231 O
distance 122 130 232 240 O
) 130 131 240 241 O

Patients 0 8 242 250 O
scheduled 9 18 251 260 O
to 19 21 261 263 O
undergo 22 29 264 271 O
revision 30 38 272 280 B-treatment
total 39 44 281 286 I-treatment
knee 45 49 287 291 I-treatment
arthroplasty 50 62 292 304 I-treatment
for 63 66 305 308 O
infectious 67 77 309 319 O
reasons 78 85 320 327 O

Patients 0 8 328 336 O
with 9 13 337 341 O
chronic 14 21 342 349 B-chronic_disease
immunosuppression 22 39 350 367 I-chronic_disease
( 40 41 368 369 O
such 41 45 369 373 O
as 46 48 374 376 O
HIV 49 52 377 380 B-chronic_disease
/ 52 53 380 381 O
AIDS 53 57 381 385 B-chronic_disease
) 57 58 385 386 O

Scheduled 0 9 387 396 O
to 10 12 397 399 O
undergo 13 20 400 407 O
revision 21 29 408 416 O
total 30 35 417 422 B-treatment
knee 36 40 423 427 I-treatment
arthroplasty 41 53 428 440 I-treatment

18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
55 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
old 12 15 12 15 O

Blood 0 5 16 21 O
donation 6 14 22 30 O
within 15 21 31 37 O
eight 22 27 38 43 B-upper_bound
weeks 28 33 44 49 I-upper_bound
of 34 36 50 52 O
the 37 40 53 56 O
start 41 46 57 62 O
of 47 49 63 65 O
the 50 53 66 69 O
study 54 59 70 75 O

Blood 0 5 76 81 B-clinical_variable
pressure 6 14 82 90 I-clinical_variable
> 15 16 91 92 O
140/80 16 22 92 98 B-lower_bound

Contraindication 0 16 99 115 O
to 17 19 116 118 O
MRI 20 23 119 122 B-treatment
scanning 24 32 123 131 O
including 33 42 132 141 O
claustrophobia 43 57 142 156 B-chronic_disease
and 58 61 157 160 O
presence 62 70 161 169 O
of 71 73 170 172 O
a 74 75 173 174 O
ferromagnetic 76 89 175 188 O
object 90 96 189 195 O
, 96 97 195 196 O
including 98 107 197 206 O
orthodontic 108 119 207 218 O
braces 120 126 219 225 O

Contraindications 0 17 226 243 O
to 18 20 244 246 O
PET 21 24 247 250 B-treatment
( 25 26 251 252 O
e.g. 26 30 252 256 O
, 30 31 256 257 O
past 32 36 258 262 O
or 37 39 263 265 O
current 40 47 266 273 O
diagnosis 48 57 274 283 O
of 58 60 284 286 O
cancer 61 67 287 293 B-cancer
, 67 68 293 294 O
poor 69 73 295 299 O
venous 74 80 300 306 O
access 81 87 307 313 O
for 88 91 314 317 O
placement 92 101 318 327 O
of 102 104 328 330 O
venous 105 111 331 337 O
lines 112 117 338 343 O
) 117 118 343 344 O

Current 0 7 345 352 O
diagnosis 8 17 353 362 O
of 18 20 363 365 O
MDD 21 24 366 369 B-chronic_disease
or 25 27 370 372 O
PTSD 28 32 373 377 B-chronic_disease
with 33 37 378 382 O
psychotic 38 47 383 392 O
features 48 56 393 401 O

Current 0 7 402 409 O
psychosis 8 17 410 419 B-chronic_disease
, 17 18 419 420 O
active 19 25 421 427 O
suicidal 26 34 428 436 O
or 35 37 437 439 O
homicidal 38 47 440 449 B-chronic_disease
ideation 48 56 450 458 I-chronic_disease

English 0 7 459 466 B-language_fluency
speaking 8 16 467 475 I-language_fluency

First 0 5 476 481 O
degree 6 12 482 488 O
relative 13 21 489 497 O
with 22 26 498 502 O
a 27 28 503 504 O
diagnosis 29 38 505 514 O
of 39 41 515 517 O
a 42 43 518 519 O
psychotic 44 53 520 529 B-chronic_disease
disorder 54 62 530 538 I-chronic_disease

Full 0 4 539 543 O
scale 5 10 544 549 O
IQ 11 13 550 552 B-clinical_variable
lower 14 19 553 558 O
than 20 24 559 563 O
70 25 27 564 566 B-upper_bound

History 0 7 567 574 O
of 8 10 575 577 O
prior 11 16 578 583 B-treatment
radiation 17 26 584 593 I-treatment
exposure 27 35 594 602 O
for 36 39 603 606 O
research 40 48 607 615 O
purposes 49 57 616 624 O
within 58 64 625 631 O
the 65 68 632 635 O
past 69 73 636 640 O
year 74 78 641 645 O
such 79 83 646 650 O
that 84 88 651 655 O
participation 89 102 656 669 O
in 103 105 670 672 O
this 106 110 673 677 O
study 111 116 678 683 O
would 117 122 684 689 O
place 123 128 690 695 O
them 129 133 696 700 O
over 134 138 701 705 O
FDA 139 142 706 709 O
limits 143 149 710 716 O
for 150 153 717 720 O
annual 154 160 721 727 O
radiation 161 170 728 737 O
exposure 171 179 738 746 O

Lifetime 0 8 747 755 O
history 9 16 756 763 O
of 17 19 764 766 O
neurologic 20 30 767 777 B-chronic_disease
abnormality 31 42 778 789 I-chronic_disease
including 43 52 790 799 O
significant 53 64 800 811 O
head 65 69 812 816 B-chronic_disease
trauma 70 76 817 823 I-chronic_disease

Meet 0 4 824 828 O
DSM 5 8 829 832 O
- 8 9 832 833 O
IV 9 11 833 835 O
diagnostic 12 22 836 846 O
criteria 23 31 847 855 O
for 32 35 856 859 O
Major 36 41 860 865 B-chronic_disease
Depressive 42 52 866 876 I-chronic_disease
Disorder 53 61 877 885 I-chronic_disease
, 61 62 885 886 O
and 63 66 887 890 O
for 67 70 891 894 O
a 71 72 895 896 O
current 73 80 897 904 O
depressive 81 91 905 915 O
episode 92 99 916 923 O

No 0 2 924 926 O
current 3 10 927 934 O
, 10 11 934 935 O
or 12 14 936 938 O
history 15 22 939 946 O
of 23 25 947 949 O
any 26 29 950 953 O
DSM 30 33 954 957 B-chronic_disease
- 33 34 957 958 I-chronic_disease
IV 34 36 958 960 I-chronic_disease
diagnosis 37 46 961 970 O

No 0 2 971 973 O
first 3 8 974 979 O
- 8 9 979 980 O
degree 9 15 980 986 O
relative 16 24 987 995 O
with 25 29 996 1000 O
history 30 37 1001 1008 O
of 38 40 1009 1011 O
psychotic 41 50 1012 1021 B-chronic_disease
, 50 51 1021 1022 O
mood 52 56 1023 1027 B-chronic_disease
, 56 57 1027 1028 O
or 58 60 1029 1031 O
anxiety 61 68 1032 1039 B-chronic_disease
disorder 69 77 1040 1048 I-chronic_disease

Previous 0 8 1049 1057 O
or 9 11 1058 1060 O
anticipated 12 23 1061 1072 O
radiation 24 33 1073 1082 O
exposure 34 42 1083 1091 O
at 43 45 1092 1094 O
work 46 50 1095 1099 O
within 51 57 1100 1106 O
one 58 61 1107 1110 B-upper_bound
year 62 66 1111 1115 I-upper_bound
of 67 69 1116 1118 O
the 70 73 1119 1122 O
proposed 74 82 1123 1131 O
research 83 91 1132 1140 O
PET 92 95 1141 1144 O
scans 96 101 1145 1150 O
that 102 106 1151 1155 O
precludes 107 116 1156 1165 O
study 117 122 1166 1171 O
participation 123 136 1172 1185 O

cerebrovascular 0 15 1186 1201 B-cancer
or 16 18 1202 1204 O
neoplastic 19 29 1205 1215 B-cancer
lesion 30 36 1216 1222 I-cancer

neurodegenerative 0 17 1223 1240 B-chronic_disease
disorder 18 26 1241 1249 I-chronic_disease

BMI 0 3 0 3 B-bmi
( 4 5 4 5 O
within 5 11 5 11 O
10 12 14 12 14 B-upper_bound
% 14 15 14 15 I-upper_bound
) 15 16 15 16 O

Contraindications 0 17 17 34 O
to 18 20 35 37 O
SPECT 21 26 38 43 B-treatment
/ 26 27 43 44 O
CT 27 29 44 46 O
, 29 30 46 47 O
pregnancy 31 40 48 57 B-pregnancy
, 40 41 57 58 O
breastfeeding 42 55 59 72 O
, 55 56 72 73 O
chronic 57 64 74 81 B-chronic_disease
renal 65 70 82 87 I-chronic_disease
disease 71 78 88 95 I-chronic_disease
( 79 80 96 97 O
eGFR 80 84 97 101 B-clinical_variable
< 85 86 102 103 O
60 87 89 104 106 B-upper_bound
ml 90 92 107 109 I-upper_bound
/ 92 93 109 110 I-upper_bound
min/1.73m2 93 103 110 120 I-upper_bound
) 103 104 120 121 O
, 104 105 121 122 O
proteinuria 106 117 123 134 B-treatment
, 117 118 134 135 O
genetic 119 126 136 143 B-treatment
diseases 127 135 144 152 I-treatment
of 136 138 153 155 I-treatment
the 139 142 156 159 I-treatment
kidney 143 149 160 166 I-treatment
, 149 150 166 167 O
inborn 151 157 168 174 O
defects 158 165 175 182 O
of 166 168 183 185 O
lipid 169 174 186 191 B-chronic_disease
metabolism 175 185 192 202 I-chronic_disease
, 185 186 202 203 O
alcohol 187 194 204 211 O
abuse 195 200 212 217 O
, 200 201 217 218 O
liver 202 207 219 224 B-chronic_disease
disease 208 215 225 232 I-chronic_disease
( 216 217 233 234 O
patients 217 225 234 242 O
with 226 230 243 247 O
highly 231 237 248 254 O
elevated 238 246 255 263 O
total 247 252 264 269 B-clinical_variable
bilirubin 253 262 270 279 I-clinical_variable
, 262 263 279 280 O
elevated 264 272 281 289 O
liver 273 278 290 295 O
enzymes 279 286 296 303 O
AST 287 290 304 307 B-clinical_variable
, 290 291 307 308 O
ALT 292 295 309 312 B-clinical_variable
and 296 299 313 316 O
alkaline 300 308 317 325 B-clinical_variable
phosphatase 309 320 326 337 I-clinical_variable
and 321 324 338 341 O
those 325 330 342 347 O
with 331 335 348 352 O
an 336 338 353 355 O
established 339 350 356 367 O
liver 351 356 368 373 O
disease 357 364 374 381 O
) 364 365 381 382 O
, 365 366 382 383 O
anemia 367 373 384 390 B-chronic_disease
, 373 374 390 391 O
and 375 378 392 395 O
pharmacological 379 394 396 411 B-treatment
treatment 395 404 412 421 I-treatment
with 405 409 422 426 I-treatment
insulin 410 417 427 434 I-treatment
or 418 420 435 437 I-treatment
insulin 421 428 438 445 I-treatment
- 428 429 445 446 I-treatment
sensitizing 429 440 446 457 I-treatment
drugs 441 446 458 463 I-treatment
such 447 451 464 468 O
as 452 454 469 471 O
thiazolidinediones 455 473 472 490 B-treatment
( 474 475 491 492 I-treatment
TZD 475 478 492 495 I-treatment
) 478 479 495 496 I-treatment

In 0 2 497 499 O
the 3 6 500 503 O
Control 7 14 504 511 O
group 15 20 512 517 O
( 21 22 518 519 O
N=10 22 26 519 523 O
) 26 27 523 524 O
, 27 28 524 525 O
we 29 31 526 528 O
will 32 36 529 533 O
include 37 44 534 541 O
volunteers 45 55 542 552 O
with 56 60 553 557 O
no 61 63 558 560 O
history 64 71 561 568 O
of 72 74 569 571 O
stone 75 80 572 577 B-chronic_disease
disease 81 88 578 585 I-chronic_disease
matched 89 96 586 593 O
for 97 100 594 597 O
age 101 104 598 601 B-age
( 105 106 602 603 O
within 106 112 603 609 O
5 113 114 610 611 B-upper_bound
years 115 120 612 617 I-upper_bound
) 120 121 617 618 O

age 0 3 619 622 B-age
> 4 5 623 624 O
21 6 8 625 627 B-lower_bound
years 9 14 628 633 I-lower_bound

diabetes 0 8 634 642 B-chronic_disease
status 9 15 643 649 O

are 0 3 0 3 O
taking 4 10 4 10 O
a 11 12 11 12 O
digitalis 13 22 13 22 B-treatment
preparation 23 34 23 34 I-treatment
or 35 37 35 37 O
calcium 38 45 38 45 B-treatment
channel 46 53 46 53 I-treatment
blocker 54 61 54 61 I-treatment

at 0 2 62 64 O
least 3 8 65 70 O
18 9 11 71 73 B-lower_bound
years 12 17 74 79 I-lower_bound
of 18 20 80 82 O
age 21 24 83 86 B-age

develop 0 7 87 94 O
an 8 10 95 97 O
arrhythmia 11 21 98 108 B-chronic_disease
prior 22 27 109 114 O
to 28 30 115 117 O
or 31 33 118 120 O
during 34 40 121 127 O
either 41 47 128 134 O
of 48 50 135 137 O
the 51 54 138 141 O
exercise 55 63 142 150 O
tests 64 69 151 156 O
; 69 70 156 157 O
SeeMore 71 78 158 165 O
should 79 85 166 172 O
not 86 89 173 176 O
be 90 92 177 179 O
administered 93 105 180 192 O

have 0 4 193 197 O
NYHA 5 9 198 202 B-chronic_disease
Grade 10 15 203 208 I-chronic_disease
IV 16 18 209 211 I-chronic_disease
heart 19 24 212 217 I-chronic_disease
failure 25 32 218 225 I-chronic_disease

have 0 4 226 230 O
a 5 6 231 232 O
history 7 14 233 240 O
of 15 17 241 243 O
torsades 18 26 244 252 B-chronic_disease
or 27 29 253 255 O
prolonged 30 39 256 265 B-clinical_variable
QT 40 42 266 268 I-clinical_variable
/ 42 43 268 269 I-clinical_variable
QTc 43 46 269 272 I-clinical_variable
interval 47 55 273 281 I-clinical_variable

have 0 4 282 286 O
abnormal 5 13 287 295 O
baseline 14 22 296 304 O
potassium 23 32 305 314 O
or 33 35 315 317 O
calcium 36 43 318 325 O
values 44 50 326 332 O
or 51 53 333 335 O
hemoglobin 54 64 336 346 B-clinical_variable
less 65 69 347 351 O
than 70 74 352 356 O
10 75 77 357 359 B-upper_bound
g 78 79 360 361 I-upper_bound
/ 79 80 361 362 I-upper_bound
dl 80 82 362 364 I-upper_bound

have 0 4 365 369 O
abnormal 5 13 370 378 B-chronic_disease
liver 14 19 379 384 I-chronic_disease
function 20 28 385 393 I-chronic_disease
tests 29 34 394 399 O
or 35 37 400 402 O
a 38 39 403 404 O
history 40 47 405 412 O
of 48 50 413 415 O
liver 51 56 416 421 B-chronic_disease
disease 57 64 422 429 I-chronic_disease

have 0 4 430 434 O
known 5 10 435 440 O
hypersensitivity 11 27 441 457 O
to 28 30 458 460 O
ondansetron 31 42 461 472 B-allergy_name
or 43 45 473 475 O
other 46 51 476 481 O
selective 52 61 482 491 O
serotonin 62 71 492 501 B-allergy_name
5HT3 72 76 502 506 I-allergy_name
receptor 77 85 507 515 I-allergy_name
blockers 86 94 516 524 I-allergy_name

have 0 4 525 529 O
uncontrolled 5 17 530 542 B-chronic_disease
hypertension 18 30 543 555 I-chronic_disease
( 31 32 556 557 O
Systolic 32 40 557 565 B-clinical_variable
Blood 41 46 566 571 I-clinical_variable
Pressure 47 55 572 580 I-clinical_variable
> 56 57 581 582 O
140 58 61 583 586 B-lower_bound
or 62 64 587 589 O
Diastolic 65 74 590 599 B-clinical_variable
BP 75 77 600 602 I-clinical_variable
> 78 79 603 604 O
90 80 82 605 607 B-lower_bound
consistently 83 95 608 620 O
at 96 98 621 623 O
baseline 99 107 624 632 O
) 107 108 632 633 O

if 0 2 634 636 O
female 3 9 637 643 B-gender
, 9 10 643 644 O
be 11 13 645 647 O
nonpregnant 14 25 648 659 B-pregnancy
as 26 28 660 662 O
evidenced 29 38 663 672 O
by 39 41 673 675 O
a 42 43 676 677 O
serum 44 49 678 683 O
pregnancy 50 59 684 693 B-pregnancy
test 60 64 694 698 O
and 65 68 699 702 O
using 69 74 703 708 B-contraception_consent
a 75 76 709 710 I-contraception_consent
medically 77 86 711 720 I-contraception_consent
- 86 87 720 721 I-contraception_consent
approved 87 95 721 729 I-contraception_consent
method 96 102 730 736 I-contraception_consent
of 103 105 737 739 I-contraception_consent
birth 106 111 740 745 I-contraception_consent
control 112 119 746 753 I-contraception_consent
, 119 120 753 754 O
or 121 123 755 757 O
post 124 128 758 762 O
- 128 129 762 763 O
menopausal 129 139 763 773 O
or 140 142 774 776 O
surgically 143 153 777 787 O
sterile 154 161 788 795 O

received 0 8 796 804 O
an 9 11 805 807 O
investigational 12 27 808 823 O
drug 28 32 824 828 O
or 33 35 829 831 O
device 36 42 832 838 O
within 43 49 839 845 O
30 50 52 846 848 B-upper_bound
days 53 57 849 853 I-upper_bound
prior 58 63 854 859 I-upper_bound
to 64 66 860 862 O
administration 67 81 863 877 O
of 82 84 878 880 O
SeeMore 85 92 881 888 O

Demonstrated 0 12 0 12 O
intolerance 13 24 13 24 O
or 25 27 25 27 O
inadequate 28 38 28 38 O
response 39 47 39 47 O
to 48 50 48 50 O
biologic 51 59 51 59 B-treatment
therapy 60 67 60 67 I-treatment
for 68 71 68 71 O
CD 72 74 72 74 B-chronic_disease

Diagnosis 0 9 75 84 O
of 10 12 85 87 O
CD 13 15 88 90 B-chronic_disease
for 16 19 91 94 O
at 20 22 95 97 O
least 23 28 98 103 O
3 29 30 104 105 B-lower_bound
months 31 37 106 112 I-lower_bound
prior 38 43 113 118 I-lower_bound
to 44 46 119 121 O
Baseline 47 55 122 130 O

Having 0 6 131 137 O
an 7 9 138 140 O
ostomy 10 16 141 147 B-treatment
or 17 19 148 150 I-treatment
ileoanal 20 28 151 159 I-treatment
pouch 29 34 160 165 I-treatment

Male 0 4 166 170 B-gender

Prior 0 5 171 176 O
exposure 6 14 177 185 O
to 15 17 186 188 O
p19 18 21 189 192 B-treatment
inhibitors 22 32 193 203 I-treatment
( 33 34 204 205 O
e.g. 34 38 205 209 O
, 38 39 209 210 O
risankizumab 40 52 211 223 B-treatment
) 52 53 223 224 O

Receipt 0 7 225 232 O
of 8 10 233 235 O
Crohn 11 16 236 241 B-chronic_disease
's 16 18 241 243 I-chronic_disease
disease 19 26 244 251 I-chronic_disease
approved 27 35 252 260 O
biologic 36 44 261 269 B-treatment
agents 45 51 270 276 I-treatment
( 52 53 277 278 O
infliximab 53 63 278 288 B-treatment
, 63 64 288 289 O
adalimumab 65 75 290 300 B-treatment
, 75 76 300 301 O
certolizumab 77 89 302 314 B-treatment
, 89 90 314 315 O
vedolizumab 91 102 316 327 B-treatment
, 102 103 327 328 O
natalizumab 104 115 329 340 B-treatment
within 116 122 341 347 O
8 123 124 348 349 B-upper_bound
weeks 125 130 350 355 I-upper_bound
prior 131 136 356 361 I-upper_bound
to 137 139 362 364 O
Baseline 140 148 365 373 O
or 149 151 374 376 O
ustekinumab 152 163 377 388 B-treatment
within 164 170 389 395 O
12 171 173 396 398 B-upper_bound
weeks 174 179 399 404 I-upper_bound
prior 180 185 405 410 I-upper_bound
to 186 188 411 413 O
Baseline 189 197 414 422 O
) 197 198 422 423 O

Subject 0 7 424 431 O
with 8 12 432 436 O
a 13 14 437 438 O
current 15 22 439 446 O
diagnosis 23 32 447 456 O
of 33 35 457 459 O
ulcerative 36 46 460 470 B-chronic_disease
colitis 47 54 471 478 I-chronic_disease
or 55 57 479 481 O
indeterminate 58 71 482 495 B-chronic_disease
colitis 72 79 496 503 I-chronic_disease

Subjects 0 8 504 512 O
with 9 13 513 517 O
unstable 14 22 518 526 O
doses 23 28 527 532 O
of 29 31 533 535 O
concomitant 32 43 536 547 O
Crohn 44 49 548 553 B-treatment
's 49 51 553 555 I-treatment
disease 52 59 556 563 I-treatment
therapy 60 67 564 571 I-treatment

Where 0 5 572 577 O
locally 6 13 578 585 O
permissible 14 25 586 597 O
, 25 26 597 598 O
subjects 27 35 599 607 O
16 36 38 608 610 B-lower_bound
to 39 41 611 613 O
< 42 43 614 615 O
18 44 46 616 618 B-upper_bound
years 47 52 619 624 I-upper_bound
of 53 55 625 627 O
age 56 59 628 631 B-age
who 60 63 632 635 O
meet 64 68 636 640 O
the 69 72 641 644 O
definition 73 83 645 655 O
of 84 86 656 658 O
Tanner 87 93 659 665 O
stage 94 99 666 671 O
5 100 101 672 673 O
for 102 105 674 677 O
development 106 117 678 689 O
at 118 120 690 692 O
the 121 124 693 696 O
Baseline 125 133 697 705 O
Visit 134 139 706 711 O

any 0 3 712 715 O
investigational 4 19 716 731 O
biologic 20 28 732 740 O
or 29 31 741 743 O
other 32 37 744 749 O
agent 38 43 750 755 O
or 44 46 756 758 O
procedure 47 56 759 768 O
within 57 63 769 775 O
minimally 64 73 776 785 O
35 74 76 786 788 B-upper_bound
days 77 81 789 793 I-upper_bound
or 82 84 794 796 O
5 85 86 797 798 B-upper_bound
half 87 91 799 803 I-upper_bound
- 91 92 803 804 I-upper_bound
lives 92 97 804 809 I-upper_bound
prior 98 103 810 815 I-upper_bound
to 104 106 816 818 O
Baseline 107 115 819 827 O
, 115 116 827 828 O
whichever 117 126 829 838 O
is 127 129 839 841 O
longer 130 136 842 848 O

female 0 6 849 855 B-gender

Active 0 6 0 6 O
or 7 9 7 9 O
prior 10 15 10 15 O
documented 16 26 16 26 O
autoimmune 27 37 27 37 B-chronic_disease
disease 38 45 38 45 I-chronic_disease
within 46 52 46 52 O
the 53 56 53 56 O
past 57 61 57 61 B-upper_bound
2 62 63 62 63 I-upper_bound
years 64 69 64 69 I-upper_bound

Active 0 6 70 76 O
or 7 9 77 79 O
prior 10 15 80 85 O
documented 16 26 86 96 O
inflammatory 27 39 97 109 B-chronic_disease
bowel 40 45 110 115 I-chronic_disease
disease 46 53 116 123 I-chronic_disease
( 54 55 124 125 O
e.g. 55 59 125 129 O
, 59 60 129 130 O
Crohn 61 66 131 136 B-chronic_disease
's 66 68 136 138 I-chronic_disease
disease 69 76 139 146 I-chronic_disease
, 76 77 146 147 O
ulcerative 78 88 148 158 B-chronic_disease
colitis 89 96 159 166 I-chronic_disease
) 96 97 166 167 O

Age 0 3 168 171 B-age
> 4 5 172 173 O
/= 5 7 173 175 O
18 8 10 176 178 B-lower_bound
years 11 16 179 184 I-lower_bound
at 17 19 185 187 O
time 20 24 188 192 O
of 25 27 193 195 O
study 28 33 196 201 O
entry 34 39 202 207 O

Any 0 3 208 211 O
MPM 4 7 212 215 B-cancer
histology 8 17 216 225 O
( 18 19 226 227 O
epithelial 19 29 227 237 B-cancer
, 29 30 237 238 O
mixed 31 36 239 244 O
, 36 37 244 245 O
sarcomatoid 38 49 246 257 B-cancer
) 49 50 257 258 O

Any 0 3 259 262 O
condition 4 13 263 272 O
that 14 18 273 277 O
, 18 19 277 278 O
in 20 22 279 281 O
the 23 26 282 285 O
opinion 27 34 286 293 O
of 35 37 294 296 O
the 38 41 297 300 O
investigator 42 54 301 313 O
, 54 55 313 314 O
would 56 61 315 320 O
interfere 62 71 321 330 O
with 72 76 331 335 O
the 77 80 336 339 O
evaluation 81 91 340 350 O
of 92 94 351 353 O
the 95 98 354 357 O
study 99 104 358 363 O
treatment 105 114 364 373 B-treatment
or 115 117 374 376 O
interpretation 118 132 377 391 O
of 133 135 392 394 O
subject 136 143 395 402 O
safety 144 150 403 409 O
or 151 153 410 412 O
study 154 159 413 418 O
results 160 167 419 426 O

Any 0 3 427 430 O
previous 4 12 431 439 O
treatment 13 22 440 449 B-treatment
with 23 27 450 454 O
a 28 29 455 456 O
PD1 30 33 457 460 B-treatment
or 34 36 461 463 O
PD 37 39 464 466 B-treatment
- 39 40 466 467 I-treatment
L1 40 42 467 469 I-treatment
inhibitor 43 52 470 479 I-treatment
, 52 53 479 480 O
including 54 63 481 490 O
MEDI4736 64 72 491 499 B-treatment

Any 0 3 500 503 O
prior 4 9 504 509 O
Grade 10 15 510 515 O
≥3 16 18 516 518 O
immune 19 25 519 525 B-clinical_variable
- 25 26 525 526 I-clinical_variable
related 26 33 526 533 I-clinical_variable
adverse 34 41 534 541 I-clinical_variable
event 42 47 542 547 I-clinical_variable
( 48 49 548 549 I-clinical_variable
irAE 49 53 549 553 I-clinical_variable
) 53 54 553 554 I-clinical_variable
while 55 60 555 560 O
receiving 61 70 561 570 O
any 71 74 571 574 O
previous 75 83 575 583 O
immunotherapy 84 97 584 597 B-treatment
agent 98 103 598 603 I-treatment
, 103 104 603 604 O
or 105 107 605 607 O
any 108 111 608 611 O
unresolved 112 122 612 622 O
irAE 123 127 623 627 O
> 128 129 628 629 O
Grade 129 134 629 634 B-lower_bound
1 135 136 635 636 I-lower_bound

Any 0 3 637 640 O
unresolved 4 14 641 651 O
toxicity 15 23 652 660 O
( 24 25 661 662 O
> 25 26 662 663 O
CTCAE 26 31 663 668 B-lower_bound
grade 32 37 669 674 I-lower_bound
2 38 39 675 676 I-lower_bound
) 39 40 676 677 O
from 41 45 678 682 O
previous 46 54 683 691 O
anti 55 59 692 696 B-treatment
- 59 60 696 697 I-treatment
cancer 60 66 697 703 I-treatment
therapy 67 74 704 711 I-treatment

Creatinine 0 10 712 722 B-clinical_variable
CL 11 13 723 725 I-clinical_variable
( 14 15 726 727 O
mL 15 17 727 729 O
/ 17 18 729 730 O
min 18 21 730 733 O
) 21 22 733 734 O
= 23 24 735 736 O
Weight 25 31 737 743 B-clinical_variable
( 32 33 744 745 I-clinical_variable
kg 33 35 745 747 I-clinical_variable
) 35 36 747 748 I-clinical_variable
× 37 38 749 750 O
( 39 40 751 752 O
140 40 43 752 755 B-lower_bound
- 44 45 756 757 O
Age 46 49 758 761 B-age
) 49 50 761 762 O
72 51 53 763 765 B-lower_bound
× 54 55 766 767 O
serum 56 61 768 773 B-clinical_variable
creatinine 62 72 774 784 I-clinical_variable
( 73 74 785 786 O
mg 74 76 786 788 O
/ 76 77 788 789 O
dL 77 79 789 791 O
) 79 80 791 792 O

Creatinine 0 10 793 803 B-clinical_variable
CL 11 13 804 806 I-clinical_variable
( 14 15 807 808 I-clinical_variable
mL 15 17 808 810 I-clinical_variable
/ 17 18 810 811 I-clinical_variable
min 18 21 811 814 I-clinical_variable
) 21 22 814 815 I-clinical_variable
= 23 24 816 817 O
Weight 25 31 818 824 B-clinical_variable
( 32 33 825 826 I-clinical_variable
kg 33 35 826 828 I-clinical_variable
) 35 36 828 829 I-clinical_variable
× 37 38 830 831 O
( 39 40 832 833 O
140 40 43 833 836 O
- 44 45 837 838 O
Age 46 49 839 842 B-age
) 49 50 842 843 O
× 51 52 844 845 O
0.85 53 57 846 850 O
72 58 60 851 853 O
× 61 62 854 855 O
serum 63 68 856 861 B-clinical_variable
creatinine 69 79 862 872 I-clinical_variable
( 80 81 873 874 I-clinical_variable
mg 81 83 874 876 I-clinical_variable
/ 83 84 876 877 I-clinical_variable
dL 84 86 877 879 I-clinical_variable
) 86 87 879 880 I-clinical_variable

Current 0 7 881 888 O
or 8 10 889 891 O
prior 11 16 892 897 O
use 17 20 898 901 O
of 21 23 902 904 O
immunosuppressive 24 41 905 922 B-treatment
medication 42 52 923 933 I-treatment
within 53 59 934 940 O
28 60 62 941 943 B-upper_bound
days 63 67 944 948 I-upper_bound
before 68 74 949 955 O
the 75 78 956 959 O
infusion 79 87 960 968 B-treatment
with 88 92 969 973 I-treatment
MEDI4736 93 101 974 982 I-treatment
or 102 104 983 985 I-treatment
MEDI4736 105 113 986 994 I-treatment
+ 114 115 995 996 I-treatment
tremelimumab 116 128 997 1009 I-treatment
and 129 132 1010 1013 O
through 133 140 1014 1021 O
90 141 143 1022 1024 O
days 144 148 1025 1029 O
post 149 153 1030 1034 O
infusion 154 162 1035 1043 O

Eastern 0 7 1044 1051 B-clinical_variable
Cooperative 8 19 1052 1063 I-clinical_variable
Oncology 20 28 1064 1072 I-clinical_variable
Group 29 34 1073 1078 I-clinical_variable
( 35 36 1079 1080 I-clinical_variable
ECOG 36 40 1080 1084 I-clinical_variable
) 40 41 1084 1085 I-clinical_variable
performance 42 53 1086 1097 I-clinical_variable
status 54 60 1098 1104 I-clinical_variable
of 61 63 1105 1107 O
0 64 65 1108 1109 B-lower_bound
or 66 68 1110 1112 O
1 69 70 1113 1114 B-upper_bound

Female 0 6 1115 1121 B-gender
subjects 7 15 1122 1130 I-gender
must 16 20 1131 1135 O
either 21 27 1136 1142 O
be 28 30 1143 1145 O
of 31 33 1146 1148 O
non 34 37 1149 1152 O
- 37 38 1152 1153 O
reproductive 38 50 1153 1165 O
potential 51 60 1166 1175 O
( 61 62 1176 1177 O
i.e. 62 66 1177 1181 O
, 66 67 1181 1182 O
post 68 72 1183 1187 O
- 72 73 1187 1188 O
menopausal 73 83 1188 1198 O
by 84 86 1199 1201 O
history 87 94 1202 1209 O
: 94 95 1209 1210 O
≥60 96 99 1211 1214 O
years 100 105 1215 1220 I-lower_bound
old 106 109 1221 1224 B-age
and 110 113 1225 1228 O
no 114 116 1229 1231 O
menses 117 123 1232 1238 O
for 124 127 1239 1242 O
> 128 129 1243 1244 O
/=1 129 132 1244 1247 O
year 133 137 1248 1252 I-lower_bound
without 138 145 1253 1260 O
an 146 148 1261 1263 O
alternative 149 160 1264 1275 O
medical 161 168 1276 1283 O
cause 169 174 1284 1289 O

Female 0 6 1290 1296 B-gender
subjects 7 15 1297 1305 I-gender
who 16 19 1306 1309 O
are 20 23 1310 1313 O
pregnant 24 32 1314 1322 B-pregnancy
, 32 33 1322 1323 O
breastfeeding 34 47 1324 1337 O
, 47 48 1337 1338 O
or 49 51 1339 1341 O
male 52 56 1342 1346 B-gender
or 57 59 1347 1349 I-gender
female 60 66 1350 1356 I-gender
subjects 67 75 1357 1365 I-gender
of 76 78 1366 1368 O
reproductive 79 91 1369 1381 O
potential 92 101 1382 1391 O
who 102 105 1392 1395 O
are 106 109 1396 1399 O
not 110 113 1400 1403 B-contraception_consent
employing 114 123 1404 1413 I-contraception_consent
an 124 126 1414 1416 I-contraception_consent
effective 127 136 1417 1426 I-contraception_consent
method 137 143 1427 1433 I-contraception_consent
of 144 146 1434 1436 I-contraception_consent
birth 147 152 1437 1442 I-contraception_consent
control 153 160 1443 1450 I-contraception_consent

Hemoglobin 0 10 1451 1461 B-clinical_variable
≥ 11 12 1462 1463 O
9.0 13 16 1464 1467 B-lower_bound
g 17 18 1468 1469 I-lower_bound
/ 18 19 1469 1470 I-lower_bound
dL 19 21 1470 1472 I-lower_bound
Absolute 22 30 1473 1481 B-clinical_variable
neutrophil 31 41 1482 1492 I-clinical_variable
count 42 47 1493 1498 I-clinical_variable
( 48 49 1499 1500 I-clinical_variable
ANC 49 52 1500 1503 I-clinical_variable
) 52 53 1503 1504 I-clinical_variable
≥ 54 55 1505 1506 O
1.5 56 59 1507 1510 B-lower_bound
× 60 61 1511 1512 I-lower_bound
109 62 65 1513 1516 I-lower_bound
/ 65 66 1516 1517 I-lower_bound
L 66 67 1517 1518 I-lower_bound
( 68 69 1519 1520 O
> 69 70 1520 1521 O
1500 71 75 1522 1526 B-lower_bound
per 76 79 1527 1530 I-lower_bound
mm3 80 83 1531 1534 I-lower_bound
) 83 84 1534 1535 O
Platelet 85 93 1536 1544 B-clinical_variable
count 94 99 1545 1550 I-clinical_variable
≥ 100 101 1551 1552 O
100 102 105 1553 1556 B-lower_bound
× 106 107 1557 1558 I-lower_bound
109 108 111 1559 1562 I-lower_bound
/ 111 112 1562 1563 I-lower_bound
L 112 113 1563 1564 I-lower_bound
( 114 115 1565 1566 O
> 115 116 1566 1567 O
100,000 116 123 1567 1574 B-lower_bound
per 124 127 1575 1578 I-lower_bound
mm3 128 131 1579 1582 I-lower_bound
) 131 132 1582 1583 O
Serum 133 138 1584 1589 B-clinical_variable
bilirubin 139 148 1590 1599 I-clinical_variable
≤ 149 150 1600 1601 O
1.5× 151 155 1602 1606 B-upper_bound
institutional 156 169 1607 1620 I-upper_bound
upper 170 175 1621 1626 I-upper_bound
limit 176 181 1627 1632 I-upper_bound
of 182 184 1633 1635 I-upper_bound
normal 185 191 1636 1642 I-upper_bound
( 192 193 1643 1644 I-upper_bound
ULN)AST<3.0 193 204 1644 1655 I-upper_bound
Creatinine 205 215 1656 1666 B-clinical_variable
clearance 216 225 1667 1676 I-clinical_variable
> 226 227 1677 1678 O
50mL 227 231 1678 1682 B-lower_bound
/ 231 232 1682 1683 I-lower_bound
miN 232 235 1683 1686 I-lower_bound
Aspartate 236 245 1687 1696 B-clinical_variable
transaminase 246 258 1697 1709 I-clinical_variable
( 259 260 1710 1711 I-clinical_variable
AST 260 263 1711 1714 I-clinical_variable
) 263 264 1714 1715 I-clinical_variable
and 265 268 1716 1719 O
alanine 269 276 1720 1727 B-clinical_variable
transaminase 277 289 1728 1740 I-clinical_variable
( 290 291 1741 1742 I-clinical_variable
ALT 291 294 1742 1745 I-clinical_variable
) 294 295 1745 1746 I-clinical_variable
≤ 296 297 1747 1748 O
2.5 298 301 1749 1752 B-upper_bound
× 302 303 1753 1754 I-upper_bound
ULN 304 307 1755 1758 I-upper_bound
( 308 309 1759 1760 O
≤ 309 310 1760 1761 O
5 311 312 1762 1763 O
× 313 314 1764 1765 O
ULN 315 318 1766 1769 O
if 319 321 1770 1772 O
documented 322 332 1773 1783 O
liver 333 338 1784 1789 B-cancer
metastasis 339 349 1790 1800 I-cancer
are 350 353 1801 1804 O
present 354 361 1805 1812 O
) 361 362 1812 1813 O

History 0 7 1814 1821 O
of 8 10 1822 1824 O
allogeneic 11 21 1825 1835 B-treatment
organ 22 27 1836 1841 I-treatment
transplant 28 38 1842 1852 I-treatment

History 0 7 1853 1860 O
of 8 10 1861 1863 O
hypersensitivity 11 27 1864 1880 O
to 28 30 1881 1883 O
MEDI4736 31 39 1884 1892 B-allergy_name
or 40 42 1893 1895 O
any 43 46 1896 1899 O
excipient 47 56 1900 1909 O

History 0 7 1910 1917 O
of 8 10 1918 1920 O
hypersensitivity 11 27 1921 1937 O
to 28 30 1938 1940 O
tremelimumab 31 43 1941 1953 B-allergy_name
or 44 46 1954 1956 O
the 47 50 1957 1960 O
combination 51 62 1961 1972 O
of 63 65 1973 1975 O
MEDI4736 66 74 1976 1984 B-allergy_name
+ 75 76 1985 1986 I-allergy_name
tremelimumab 77 89 1987 1999 I-allergy_name

History 0 7 2000 2007 O
of 8 10 2008 2010 O
interstitial 11 23 2011 2023 B-chronic_disease
lung 24 28 2024 2028 I-chronic_disease
disease 29 36 2029 2036 I-chronic_disease
/ 36 37 2036 2037 O
pneumonitis 37 48 2037 2048 B-chronic_disease

History 0 7 2049 2056 O
of 8 10 2057 2059 O
leptomeningeal 11 25 2060 2074 B-cancer
carcinomatosis 26 40 2075 2089 I-cancer

History 0 7 2090 2097 O
of 8 10 2098 2100 O
primary 11 18 2101 2108 B-chronic_disease
immunodeficiency 19 35 2109 2125 I-chronic_disease

Known 0 5 2126 2131 O
history 6 13 2132 2139 O
of 14 16 2140 2142 O
previous 17 25 2143 2151 O
clinical 26 34 2152 2160 O
diagnosis 35 44 2161 2170 O
of 45 47 2171 2173 O
tuberculosis 48 60 2174 2186 B-chronic_disease

N0 0 2 2187 2189 O
or 3 5 2190 2192 O
N1 6 8 2193 2195 B-chronic_disease
nodal 9 14 2196 2201 I-chronic_disease
disease 15 22 2202 2209 I-chronic_disease
as 23 25 2210 2212 O
present 26 33 2213 2220 O
on 34 36 2221 2223 O
perioperative 37 50 2224 2237 B-treatment
chest 51 56 2238 2243 I-treatment
CT 57 59 2244 2246 I-treatment
and/or 60 66 2247 2253 O
PET 67 70 2254 2257 B-treatment
CT 71 73 2258 2260 I-treatment

N2 0 2 2261 2263 B-cancer
nodal 3 8 2264 2269 I-cancer
disease 9 16 2270 2277 I-cancer
if 17 19 2278 2280 O
no 20 22 2281 2283 O
progression 23 34 2284 2295 O
after 35 40 2296 2301 O
2 41 42 2302 2303 O
cycles 43 49 2304 2310 O
of 50 52 2311 2313 O
standard 53 61 2314 2322 B-treatment
chemotherapy 62 74 2323 2335 I-treatment

N3 0 2 2336 2338 B-chronic_disease
nodal 3 8 2339 2344 I-chronic_disease
disease 9 16 2345 2352 I-chronic_disease

No 0 2 2353 2355 O
tissue 3 9 2356 2362 O
is 10 12 2363 2365 O
obtainable 13 23 2366 2376 O
at 24 26 2377 2379 O
the 27 30 2380 2383 O
time 31 35 2384 2388 O
of 36 38 2389 2391 O
thoracoscopy 39 51 2392 2404 B-treatment

Participation 0 13 2405 2418 O
in 14 16 2419 2421 O
another 17 24 2422 2429 B-treatment
clinical 25 33 2430 2438 I-treatment
study 34 39 2439 2444 I-treatment
with 40 44 2445 2449 I-treatment
an 45 47 2450 2452 I-treatment
investigational 48 63 2453 2468 I-treatment
product 64 71 2469 2476 I-treatment
during 72 78 2477 2483 O
the 79 82 2484 2487 O
last 83 87 2488 2492 B-upper_bound
3 88 89 2493 2494 I-upper_bound
months 90 96 2495 2501 I-upper_bound

Planned 0 7 2502 2509 O
resectional 8 19 2510 2521 B-treatment
surgery 20 27 2522 2529 I-treatment
for 28 31 2530 2533 O
MPM 32 35 2534 2537 B-cancer
[ 36 37 2538 2539 O
extrapleural 37 49 2539 2551 B-treatment
pneumonectomy 50 63 2552 2565 I-treatment
( 64 65 2566 2567 I-treatment
EPP 65 68 2567 2570 I-treatment
) 68 69 2570 2571 I-treatment
or 70 72 2572 2574 O
pleurectomy 73 84 2575 2586 B-treatment
and 85 88 2587 2590 I-treatment
decortication 89 102 2591 2604 I-treatment
( 103 104 2605 2606 I-treatment
P 104 105 2606 2607 I-treatment
/ 105 106 2607 2608 I-treatment
D 106 107 2608 2609 I-treatment
) 107 108 2609 2610 I-treatment
] 108 109 2610 2611 O

Progression 0 11 2612 2623 O
will 12 16 2624 2628 O
be 17 19 2629 2631 O
considered 20 30 2632 2642 O
if 31 33 2643 2645 O
additional 34 44 2646 2656 O
N1 45 47 2657 2659 B-chronic_disease
or 48 50 2660 2662 I-chronic_disease
N2 51 53 2663 2665 I-chronic_disease
disease 54 61 2666 2673 I-chronic_disease
develop 62 69 2674 2681 O
during 70 76 2682 2688 O
chemotherapy 77 89 2689 2701 B-treatment

Receipt 0 7 2702 2709 O
of 8 10 2710 2712 O
drugs 11 16 2713 2718 O
with 17 21 2719 2723 O
laxative 22 30 2724 2732 B-treatment
properties 31 41 2733 2743 O
and 42 45 2744 2747 O
herbal 46 52 2748 2754 O
or 53 55 2755 2757 O
natural 56 63 2758 2765 O
remedies 64 72 2766 2774 O
for 73 76 2775 2778 O
constipation 77 89 2779 2791 O
within 90 96 2792 2798 O
90 97 99 2799 2801 B-upper_bound
days 100 104 2802 2806 I-upper_bound
of 105 107 2807 2809 O
receiving 108 117 2810 2819 O
MEDI4736 118 126 2820 2828 B-treatment
or 127 129 2829 2831 O
MEDI 130 134 2832 2836 B-treatment
+ 135 136 2837 2838 I-treatment
tremelimumab 137 149 2839 2851 I-treatment

Receipt 0 7 2852 2859 O
of 8 10 2860 2862 O
live 11 15 2863 2867 B-treatment
attenuated 16 26 2868 2878 I-treatment
vaccination 27 38 2879 2890 I-treatment
within 39 45 2891 2897 O
30 46 48 2898 2900 B-upper_bound
days 49 53 2901 2905 I-upper_bound
prior 54 59 2906 2911 I-upper_bound
to 60 62 2912 2914 O
study 63 68 2915 2920 O
entry 69 74 2921 2926 O
or 75 77 2927 2929 O
within 78 84 2930 2936 O
6 85 86 2937 2938 B-upper_bound
months 87 93 2939 2945 I-upper_bound
of 94 96 2946 2948 O
receiving 97 106 2949 2958 O
MEDI4736 107 115 2959 2967 B-treatment
or 116 118 2968 2970 O
MEDI 119 123 2971 2975 B-treatment
+ 124 125 2976 2977 I-treatment
tremelimumab 126 138 2978 2990 I-treatment

Receipt 0 7 2991 2998 O
of 8 10 2999 3001 O
sunitinib 11 20 3002 3011 B-treatment
within 21 27 3012 3018 O
3 28 29 3019 3020 B-upper_bound
months 30 36 3021 3027 I-upper_bound
of 37 39 3028 3030 O
receiving 40 49 3031 3040 O
tremelimumab 50 62 3041 3053 O

Receipt 0 7 3054 3061 O
of 8 10 3062 3064 O
the 11 14 3065 3068 O
last 15 19 3069 3073 O
dose 20 24 3074 3078 O
of 25 27 3079 3081 O
anti 28 32 3082 3086 B-treatment
- 32 33 3086 3087 I-treatment
cancer 33 39 3087 3093 I-treatment
therapy 40 47 3094 3101 I-treatment
( 48 49 3102 3103 O
chemotherapy 49 61 3103 3115 B-treatment
, 61 62 3115 3116 O
immunotherapy 63 76 3117 3130 B-treatment
, 76 77 3130 3131 O
endocrine 78 87 3132 3141 B-treatment
therapy 88 95 3142 3149 I-treatment
, 95 96 3149 3150 O
targeted 97 105 3151 3159 B-treatment
therapy 106 113 3160 3167 I-treatment
, 113 114 3167 3168 O
biologic 115 123 3169 3177 B-treatment
therapy 124 131 3178 3185 I-treatment
, 131 132 3185 3186 O
tumor 133 138 3187 3192 B-treatment
embolization 139 151 3193 3205 I-treatment
, 151 152 3205 3206 O
monoclonal 153 163 3207 3217 O
antibodies 164 174 3218 3228 O
, 174 175 3228 3229 O
other 176 181 3230 3235 O
investigational 182 197 3236 3251 O
agent 198 203 3252 3257 O
) 203 204 3257 3258 O
30 205 207 3259 3261 B-upper_bound
days 208 212 3262 3266 I-upper_bound
prior 213 218 3267 3272 I-upper_bound
to 219 221 3273 3275 O
the 222 225 3276 3279 O
first 226 231 3280 3285 O
dose 232 236 3286 3290 O
of 237 239 3291 3293 O
study 240 245 3294 3299 O
drug 246 250 3300 3304 O
, 250 251 3304 3305 O
and 252 255 3306 3309 O
30 256 258 3310 3312 O
days 259 263 3313 3317 O
prior 264 269 3318 3323 O
to 270 272 3324 3326 O
the 273 276 3327 3330 O
first 277 282 3331 3336 O
dose 283 287 3337 3341 O
of 288 290 3342 3344 O
study 291 296 3345 3350 O
drug 297 301 3351 3355 O
for 302 305 3356 3359 O
subjects 306 314 3360 3368 O
who 315 318 3369 3372 O
have 319 323 3373 3377 O
received 324 332 3378 3386 O
prior 333 338 3387 3392 B-treatment
TKIs 339 343 3393 3397 I-treatment
[ 344 345 3398 3399 O
e.g. 345 349 3399 3403 O
, 349 350 3403 3404 O
erlotinib 351 360 3405 3414 B-treatment
, 360 361 3414 3415 O
gefitinib 362 371 3416 3425 O
and 372 375 3426 3429 O
crizotinib 376 386 3430 3440 B-treatment
] 386 387 3440 3441 O
and 388 391 3442 3445 O
within 392 398 3446 3452 O
6 399 400 3453 3454 B-upper_bound
weeks 401 406 3455 3460 I-upper_bound
for 407 410 3461 3464 O
nitrosourea 411 422 3465 3476 O
or 423 425 3477 3479 O
mitomycin 426 435 3480 3489 B-treatment
C 436 437 3490 3491 I-treatment
) 437 438 3491 3492 O

Serum 0 5 3493 3498 B-clinical_variable
creatinine 6 16 3499 3509 I-clinical_variable
≤ 17 18 3510 3511 O
2.0 19 22 3512 3515 B-upper_bound
mg 23 25 3516 3518 I-upper_bound
/ 25 26 3518 3519 I-upper_bound
dL 26 28 3519 3521 I-upper_bound
or 29 31 3522 3524 O
calculated 32 42 3525 3535 B-clinical_variable
creatinine 43 53 3536 3546 I-clinical_variable
clearance 54 63 3547 3556 I-clinical_variable
≥ 64 65 3557 3558 O
50 66 68 3559 3561 B-lower_bound
mL 69 71 3562 3564 I-lower_bound
/ 71 72 3564 3565 I-lower_bound
min 72 75 3565 3568 I-lower_bound
as 76 78 3569 3571 O
determined 79 89 3572 3582 O
by 90 92 3583 3585 O
the 93 96 3586 3589 O
Cockcroft 97 106 3590 3599 O
- 106 107 3599 3600 O
Gault 107 112 3600 3605 O
equation 113 121 3606 3614 O

Subjects 0 8 3615 3623 O
with 9 13 3624 3628 O
uncontrolled 14 26 3629 3641 O
seizures 27 35 3642 3650 B-chronic_disease

Subjects 0 8 3651 3659 O
with 9 13 3660 3664 O
vitiligo 14 22 3665 3673 B-chronic_disease
, 22 23 3673 3674 O
Grave 24 29 3675 3680 B-chronic_disease
's 29 31 3680 3682 I-chronic_disease
disease 32 39 3683 3690 I-chronic_disease
, 39 40 3690 3691 O
or 41 43 3692 3694 O
psoriasis 44 53 3695 3704 B-chronic_disease
not 54 57 3705 3708 O
requiring 58 67 3709 3718 O
systemic 68 76 3719 3727 B-treatment
treatment 77 86 3728 3737 I-treatment
( 87 88 3738 3739 O
within 88 94 3739 3745 O
the 95 98 3746 3749 O
past 99 103 3750 3754 B-upper_bound
2 104 105 3755 3756 I-upper_bound
years 106 111 3757 3762 I-upper_bound
) 111 112 3762 3763 O

Surgically 0 10 3764 3774 O
resectable 11 21 3775 3785 O
MPM 22 25 3786 3789 B-cancer
with 26 30 3790 3794 O
no 31 33 3795 3797 O
disease 34 41 3798 3805 O
extension 42 51 3806 3815 O
beyond 52 58 3816 3822 O
the 59 62 3823 3826 O
ipsilateral 63 74 3827 3838 O
hemithorax 75 85 3839 3849 O

Symptomatic 0 11 3850 3861 O
or 12 14 3862 3864 O
uncontrolled 15 27 3865 3877 O
brain 28 33 3878 3883 B-cancer
metastases 34 44 3884 3894 I-cancer
requiring 45 54 3895 3904 O
concurrent 55 65 3905 3915 B-treatment
treatment 66 75 3916 3925 I-treatment
, 75 76 3925 3926 O
inclusive 77 86 3927 3936 O
of 87 89 3937 3939 O
but 90 93 3940 3943 O
not 94 97 3944 3947 O
limited 98 105 3948 3955 O
to 106 108 3956 3958 O
surgery 109 116 3959 3966 B-treatment
, 116 117 3966 3967 O
radiation 118 127 3968 3977 B-treatment
, 127 128 3977 3978 O
and/or 129 135 3979 3985 O
corticosteroids 136 151 3986 4001 B-treatment

Uncontrolled 0 12 4002 4014 O
intercurrent 13 25 4015 4027 O
illness 26 33 4028 4035 O
including 34 43 4036 4045 O
, 43 44 4045 4046 O
but 45 48 4047 4050 O
not 49 52 4051 4054 O
limited 53 60 4055 4062 O
to 61 63 4063 4065 O
, 63 64 4065 4066 O
ongoing 65 72 4067 4074 O
or 73 75 4075 4077 O
active 76 82 4078 4084 B-chronic_disease
infection 83 92 4085 4094 I-chronic_disease
, 92 93 4094 4095 O
symptomatic 94 105 4096 4107 O
congestive 106 116 4108 4118 B-chronic_disease
heart 117 122 4119 4124 I-chronic_disease
failure 123 130 4125 4132 I-chronic_disease
, 130 131 4132 4133 O
uncontrolled 132 144 4134 4146 O
hypertension 145 157 4147 4159 B-chronic_disease
, 157 158 4159 4160 O
unstable 159 167 4161 4169 B-chronic_disease
angina 168 174 4170 4176 I-chronic_disease
pectoris 175 183 4177 4185 I-chronic_disease
, 183 184 4185 4186 O
cardiac 185 192 4187 4194 B-chronic_disease
arrhythmia 193 203 4195 4205 I-chronic_disease
, 203 204 4205 4206 O
active 205 211 4207 4213 O
peptic 212 218 4214 4220 B-chronic_disease
ulcer 219 224 4221 4226 I-chronic_disease
disease 225 232 4227 4234 I-chronic_disease
or 233 235 4235 4237 O
gastritis 236 245 4238 4247 B-chronic_disease
, 245 246 4247 4248 O
active 247 253 4249 4255 O
bleeding 254 262 4256 4264 B-chronic_disease
diatheses 263 272 4265 4274 I-chronic_disease
including 273 282 4275 4284 O
any 283 286 4285 4288 O
subject 287 294 4289 4296 O
known 295 300 4297 4302 O
to 301 303 4303 4305 O
have 304 308 4306 4310 O
evidence 309 317 4311 4319 O
of 318 320 4320 4322 O
acute 321 326 4323 4328 B-chronic_disease
or 327 329 4329 4331 I-chronic_disease
chronic 330 337 4332 4339 I-chronic_disease
hepatitis 338 347 4340 4349 I-chronic_disease
B 348 349 4350 4351 I-chronic_disease
, 349 350 4351 4352 O
hepatitis 351 360 4353 4362 B-chronic_disease
C 361 362 4363 4364 I-chronic_disease
or 363 365 4365 4367 O
human 366 371 4368 4373 B-chronic_disease
immunodeficiency 372 388 4374 4390 I-chronic_disease
virus 389 394 4391 4396 I-chronic_disease
( 395 396 4397 4398 I-chronic_disease
HIV 396 399 4398 4401 I-chronic_disease
) 399 400 4401 4402 I-chronic_disease
, 400 401 4402 4403 O
or 402 404 4404 4406 O
psychiatric 405 416 4407 4418 B-chronic_disease
illness 417 424 4419 4426 I-chronic_disease
/ 424 425 4426 4427 I-chronic_disease
social 425 431 4427 4433 I-chronic_disease
situations 432 442 4434 4444 I-chronic_disease
that 443 447 4445 4449 O
would 448 453 4450 4455 O
limit 454 459 4456 4461 O
compliance 460 470 4462 4472 O
with 471 475 4473 4477 O
study 476 481 4478 4483 O
requirements 482 494 4484 4496 O
or 495 497 4497 4499 O
compromise 498 508 4500 4510 O
the 509 512 4511 4514 O
ability 513 520 4515 4522 O
of 521 523 4523 4525 O
the 524 527 4526 4529 O
subject 528 535 4530 4537 O
to 536 538 4538 4540 O
give 539 543 4541 4545 O
written 544 551 4546 4553 O
informed 552 560 4554 4562 O
consent 561 568 4563 4570 O

history 0 7 4571 4578 O
of 8 10 4579 4581 O
bilateral 11 20 4582 4591 O
oophorectomy 21 33 4592 4604 B-treatment
) 33 34 4604 4605 O
or 35 37 4606 4608 O
must 38 42 4609 4613 O
have 43 47 4614 4618 O
a 48 49 4619 4620 O
negative 50 58 4621 4629 O
serum 59 64 4630 4635 O
pregnancy 65 74 4636 4645 O
test 75 79 4646 4650 O
upon 80 84 4651 4655 O
study 85 90 4656 4661 O
entry 91 96 4662 4667 O

history 0 7 4668 4675 O
of 8 10 4676 4678 O
bilateral 11 20 4679 4688 B-treatment
tubal 21 26 4689 4694 I-treatment
ligation 27 35 4695 4703 I-treatment

history 0 7 4704 4711 O
of 8 10 4712 4714 O
hysterectomy 11 23 4715 4727 B-treatment

intranasal 0 10 4728 4738 B-treatment
and 11 14 4739 4742 O
inhaled 15 22 4743 4750 B-treatment
corticosteroids 23 38 4751 4766 I-treatment
or 39 41 4767 4769 O
systemic 42 50 4770 4778 B-treatment
corticosteroids 51 66 4779 4794 I-treatment
at 67 69 4795 4797 O
physiological 70 83 4798 4811 O
doses 84 89 4812 4817 O
, 89 90 4817 4818 O
which 91 96 4819 4824 O
are 97 100 4825 4828 O
not 101 104 4829 4832 O
to 105 107 4833 4835 O
exceed 108 114 4836 4842 O
10 115 117 4843 4845 B-upper_bound
mg 118 120 4846 4848 I-upper_bound
/ 120 121 4848 4849 I-upper_bound
day 121 124 4849 4852 I-upper_bound
of 125 127 4853 4855 O
prednisone 128 138 4856 4866 B-treatment
, 138 139 4866 4867 O
or 140 142 4868 4870 O
an 143 145 4871 4873 O
equivalent 146 156 4874 4884 O
corticosteroid 157 171 4885 4899 O

Acute 0 5 0 5 B-chronic_disease
coronary 6 14 6 14 I-chronic_disease
syndrome 15 23 15 23 I-chronic_disease
within 24 30 24 30 O
seven 31 36 31 36 B-upper_bound
days 37 41 37 41 I-upper_bound

Acute 0 5 42 47 B-chronic_disease
stroke 6 12 48 54 I-chronic_disease

Age 0 3 55 58 B-age
≥18y 4 8 59 63 O

Chronic 0 7 64 71 B-chronic_disease
HD 8 10 72 74 I-chronic_disease
( 11 12 75 76 O
> 12 13 76 77 O
90 13 15 77 79 B-lower_bound
days 16 20 80 84 I-lower_bound
) 20 21 84 85 O

Expected 0 8 86 94 O
length 9 15 95 101 O
of 16 18 102 104 O
stay 19 23 105 109 O
< 24 25 110 111 O
24 25 27 111 113 B-upper_bound
hours 28 33 114 119 I-upper_bound
( 34 35 120 121 O
e.g. 35 39 121 125 O
admission 40 49 126 135 O
for 50 53 136 139 O
HD 54 56 140 142 O
access 57 63 143 149 O
procedure 64 73 150 159 O
) 73 74 159 160 O

Pre 0 3 161 164 B-treatment
- 3 4 164 165 I-treatment
dialysis 4 12 165 173 I-treatment
SBP 13 16 174 177 B-clinical_variable
> 17 18 178 179 O
180 18 21 179 182 B-lower_bound
mmHg 22 26 183 187 I-lower_bound

Pre 0 3 188 191 B-clinical_variable
- 3 4 191 192 I-clinical_variable
dialysis 4 12 192 200 I-clinical_variable
serum 13 18 201 206 I-clinical_variable
sodium 19 25 207 213 I-clinical_variable
< 26 27 214 215 O
= 27 28 215 216 O
128mmol 28 35 216 223 B-upper_bound
/ 35 36 223 224 I-upper_bound
L 36 37 224 225 I-upper_bound
or 38 40 226 228 O
> 41 42 229 230 O
145 43 46 231 234 B-lower_bound
mmol 47 51 235 239 I-lower_bound
/ 51 52 239 240 I-lower_bound
L 52 53 240 241 I-lower_bound

Pregnancy 0 9 242 251 B-pregnancy

Use 0 3 252 255 O
of 4 6 256 258 O
pressors 7 15 259 267 B-treatment

Able 0 4 0 4 O
to 5 7 5 7 O
meet 8 12 8 12 O
the 13 16 13 16 O
proposed 17 25 17 25 O
follow 26 32 26 32 O
- 32 33 32 33 O
up 33 35 33 35 O
schedule 36 44 36 44 O
at 45 47 45 47 O
6 48 49 48 49 B-lower_bound
mo 50 52 50 52 I-lower_bound
, 52 53 52 53 O
12 54 56 54 56 O
mo 57 59 57 59 O
, 59 60 59 60 O
and 61 64 61 64 O
24 65 67 65 67 B-upper_bound
mo 68 70 68 70 I-upper_bound

Active 0 6 71 77 O
systemic 7 15 78 86 B-chronic_disease
or 16 18 87 89 O
local 19 24 90 95 B-chronic_disease
infection 25 34 96 105 I-chronic_disease

Acute 0 5 106 111 B-chronic_disease
mental 6 12 112 118 I-chronic_disease
illness 13 20 119 126 I-chronic_disease
or 21 23 127 129 O
substance 24 33 130 139 O
abuse 34 39 140 145 O

Age 0 3 146 149 B-age
18 4 6 150 152 B-lower_bound
or 7 9 153 155 O
older 10 15 156 161 O
at 16 18 162 164 O
the 19 22 165 168 O
time 23 27 169 173 O
of 28 30 174 176 O
consent 31 38 177 184 O

Has 0 3 185 188 O
an 4 6 189 191 O
active 7 13 192 198 B-cancer
malignancy 14 24 199 209 I-cancer
defined 25 32 210 217 O
as 33 35 218 220 O
a 36 37 221 222 O
history 38 45 223 230 O
of 46 48 231 233 O
any 49 52 234 237 O
invasive 53 61 238 246 B-cancer
malignancy 62 72 247 257 I-cancer
( 73 74 258 259 O
except 74 80 259 265 O
non 81 84 266 269 B-cancer
- 84 85 269 270 I-cancer
melanoma 85 93 270 278 I-cancer
skin 94 98 279 283 I-cancer
cancer 99 105 284 290 I-cancer
) 105 106 290 291 O
, 106 107 291 292 O
unless 108 114 293 299 O
he 115 117 300 302 O
/ 117 118 302 303 O
she 118 121 303 306 O
has 122 125 307 310 O
been 126 130 311 315 O
treated 131 138 316 323 B-treatment
with 139 143 324 328 I-treatment
curative 144 152 329 337 I-treatment
intent 153 159 338 344 I-treatment
and 160 163 345 348 O
there 164 169 349 354 O
has 170 173 355 358 O
been 174 178 359 363 O
no 179 181 364 366 O
clinical 182 190 367 375 O
signs 191 196 376 381 O
or 197 199 382 384 O
symptoms 200 208 385 393 O
of 209 211 394 396 O
the 212 215 397 400 O
malignancy 216 226 401 411 O
for 227 230 412 415 O
at 231 233 416 418 O
least 234 239 419 424 O
5 240 241 425 426 B-lower_bound
years 242 247 427 432 I-lower_bound

Known 0 5 433 438 O
allergy 6 13 439 446 O
to 14 16 447 449 O
device 17 23 450 456 O
materials 24 33 457 466 O
titanium 34 42 467 475 B-allergy_name
, 42 43 475 476 O
polycarbonate 44 57 477 490 B-allergy_name
( 58 59 491 492 I-allergy_name
PCU 59 62 492 495 I-allergy_name
) 62 63 495 496 I-allergy_name
, 63 64 496 497 O
polyethylene 65 77 498 510 B-allergy_name
terepthalate 78 90 511 523 I-allergy_name
( 91 92 524 525 I-allergy_name
PET 92 95 525 528 I-allergy_name
) 95 96 528 529 I-allergy_name
, 96 97 529 530 O
or 98 100 531 533 O
hydroxyapatite 101 115 534 548 B-allergy_name
( 116 117 549 550 I-allergy_name
HA 117 119 550 552 I-allergy_name
) 119 120 552 553 I-allergy_name

Lytic 0 5 554 559 B-chronic_disease
spondylolisthesis 6 23 560 577 I-chronic_disease
at 24 26 578 580 O
the 27 30 581 584 O
index 31 36 585 590 O
level(s 37 44 591 598 O
) 44 45 598 599 O

Morbid 0 6 600 606 B-chronic_disease
obesity 7 14 607 614 I-chronic_disease
defined 15 22 615 622 O
as 23 25 623 625 O
a 26 27 626 627 O
body 28 32 628 632 B-bmi
mass 33 37 633 637 I-bmi
index 38 43 638 643 I-bmi
> 44 45 644 645 O
40 46 48 646 648 B-lower_bound
, 48 49 648 649 O
or 50 52 650 652 O
a 53 54 653 654 O
weight 55 61 655 661 B-clinical_variable
more 62 66 662 666 O
than 67 71 667 671 O
100 72 75 672 675 B-lower_bound
lbs 76 79 676 679 I-lower_bound
over 80 84 680 684 O
ideal 85 90 685 690 O
body 91 95 691 695 O
weight 96 102 696 702 O

Neuromuscular 0 13 703 716 B-chronic_disease
disorders 14 23 717 726 I-chronic_disease
such 24 28 727 731 O
as 29 31 732 734 O
muscular 32 40 735 743 B-chronic_disease
dystrophy 41 50 744 753 I-chronic_disease
, 50 51 753 754 O
spinal 52 58 755 761 B-chronic_disease
muscular 59 67 762 770 I-chronic_disease
atrophy 68 75 771 778 I-chronic_disease
, 75 76 778 779 O
amyotrophic 77 88 780 791 B-chronic_disease
lateral 89 96 792 799 I-chronic_disease
sclerosis 97 106 800 809 I-chronic_disease
, 106 107 809 810 O
etc 108 111 811 814 O

Participation 0 13 815 828 O
in 14 16 829 831 O
an 17 19 832 834 O
investigational 20 35 835 850 B-treatment
device 36 42 851 857 I-treatment
or 43 45 858 860 O
drug 46 50 861 865 B-treatment
clinical 51 59 866 874 I-treatment
trials 60 66 875 881 I-treatment
within 67 73 882 888 O
30 74 76 889 891 B-upper_bound
days 77 81 892 896 I-upper_bound
of 82 84 897 899 O
surgery 85 92 900 907 B-treatment

Pregnant 0 8 908 916 B-pregnancy
or 9 11 917 919 O
interested 12 22 920 930 O
in 23 25 931 933 O
becoming 26 34 934 942 B-pregnancy
pregnant 35 43 943 951 I-pregnancy
within 44 50 952 958 O
the 51 54 959 962 O
next 55 59 963 967 B-upper_bound
2 60 61 968 969 I-upper_bound
years 62 67 970 975 I-upper_bound

Prior 0 5 976 981 B-treatment
fusion 6 12 982 988 I-treatment
surgery 13 20 989 996 I-treatment
or 21 23 997 999 O
another 24 31 1000 1007 O
spinal 32 38 1008 1014 B-treatment
device 39 45 1015 1021 I-treatment
implanted 46 55 1022 1031 O
in 56 58 1032 1034 O
the 59 62 1035 1038 O
thoracic 63 71 1039 1047 O
, 71 72 1047 1048 O
lumbar 73 79 1049 1055 O
or 80 82 1056 1058 O
sacral 83 89 1059 1065 O
spine 90 95 1066 1071 O

Requires 0 8 1072 1080 O
treatment 9 18 1081 1090 B-treatment
of 19 21 1091 1093 O
more 22 26 1094 1098 O
than 27 31 1099 1103 O
two 32 35 1104 1107 O
vertebral 36 45 1108 1117 O
levels 46 52 1118 1124 O

Systemic 0 8 1125 1133 O
disease 9 16 1134 1141 O
including 17 26 1142 1151 O
AIDS 27 31 1152 1156 B-chronic_disease
, 31 32 1156 1157 O
HIV 33 36 1158 1161 B-chronic_disease
, 36 37 1161 1162 O
Hepatitis 38 47 1163 1172 B-chronic_disease
C 48 49 1173 1174 I-chronic_disease

Taking 0 6 1175 1181 O
medications 7 18 1182 1193 B-treatment
or 19 21 1194 1196 O
any 22 25 1197 1200 O
drug 26 30 1201 1205 O
known 31 36 1206 1211 O
to 37 39 1212 1214 O
potentially 40 51 1215 1226 O
interfere 52 61 1227 1236 O
with 62 66 1237 1241 O
bone 67 71 1242 1246 B-treatment
/ 71 72 1246 1247 I-treatment
soft 72 76 1247 1251 I-treatment
tissue 77 83 1252 1258 I-treatment
healing 84 91 1259 1266 I-treatment
( 92 93 1267 1268 O
e.g. 93 97 1268 1272 O
, 97 98 1272 1273 O
steroids 99 107 1274 1282 B-treatment
, 107 108 1282 1283 O
excluding 109 118 1284 1293 O
routine 119 126 1294 1301 O
NSAIDs 127 133 1302 1308 B-treatment
) 133 134 1308 1309 O

degenerative 0 12 1310 1322 B-chronic_disease
spondylolisthesis 13 30 1323 1340 I-chronic_disease
with 31 35 1341 1345 O
objective 36 45 1346 1355 O
evidence 46 54 1356 1364 O
of 55 57 1365 1367 O
neurologic 58 68 1368 1378 B-chronic_disease
impairment 69 79 1379 1389 I-chronic_disease

kyphosis 0 8 1390 1398 B-chronic_disease

pseudoarthrosis 0 15 1399 1414 B-chronic_disease
( 16 17 1415 1416 O
failed 17 23 1416 1422 O
previous 24 32 1423 1431 O
fusion 33 39 1432 1438 O
) 39 40 1438 1439 O

Primary 0 7 0 7 O
substance 8 17 8 17 O
exposure 18 26 18 26 O
in 27 29 27 29 O
- 29 30 29 30 O
utero 30 35 30 35 O
was 36 39 36 39 O
buprenorphine 40 53 40 53 B-treatment
, 53 54 53 54 O
or 55 57 55 57 O
was 58 61 58 61 O
not 62 65 62 65 O
opioids 66 73 66 73 O

Active 0 6 0 6 O
, 6 7 6 7 O
uncontrolled 8 20 8 20 O
bacterial 21 30 21 30 B-chronic_disease
, 30 31 30 31 O
viral 32 37 32 37 O
, 37 38 37 38 O
or 39 41 39 41 O
fungal 42 48 42 48 B-chronic_disease
infections 49 59 49 59 I-chronic_disease
, 59 60 59 60 O
requiring 61 70 61 70 O
systemic 71 79 71 79 B-treatment
therapy 80 87 80 87 I-treatment

Any 0 3 88 91 O
condition 4 13 92 101 O
that 14 18 102 106 O
prevents 19 27 107 115 O
compliance 28 38 116 126 O
with 39 43 127 131 O
the 44 47 132 135 O
protocol 48 56 136 144 O
or 57 59 145 147 O
adherence 60 69 148 157 O
to 70 72 158 160 O
therapy 73 80 161 168 B-treatment

Females 0 7 169 176 B-gender
who 8 11 177 180 O
are 12 15 181 184 O
pregnant 16 24 185 193 B-pregnancy
or 25 27 194 196 O
lactating 28 37 197 206 O
or 38 40 207 209 O
plan 41 45 210 214 B-pregnancy
to 46 48 215 217 I-pregnancy
become 49 55 218 224 I-pregnancy
pregnant 56 64 225 233 I-pregnancy
during 65 71 234 240 O
the 72 75 241 244 O
course 76 82 245 251 O
of 83 85 252 254 O
this 86 90 255 259 O
study 91 96 260 265 O

Fever 0 5 266 271 B-clinical_variable
( 6 7 272 273 O
> 7 8 273 274 O
38.1 9 13 275 279 B-lower_bound
° 13 14 279 280 I-lower_bound
C 14 15 280 281 I-lower_bound
) 15 16 281 282 O

Glioblastoma 0 12 283 295 B-cancer
or 13 15 296 298 O
gliosarcoma 16 27 299 310 B-cancer
disease 28 35 311 318 O
with 36 40 319 323 O
leptomeningeal 41 55 324 338 B-cancer
spread 56 62 339 345 O

Had 0 3 346 349 O
prior 4 9 350 355 O
exposure 10 18 356 364 O
to 19 21 365 367 O
gene 22 26 368 372 O
vector 27 33 373 379 O
delivery 34 42 380 388 O
products 43 51 389 397 O
within 52 58 398 404 O
6 59 60 405 406 B-upper_bound
months 61 67 407 413 I-upper_bound

Have 0 4 414 418 O
a 5 6 419 420 O
history 7 14 421 428 O
of 15 17 429 431 O
hypersensitivity 18 34 432 448 O
reaction 35 43 449 457 O
to 44 46 458 460 O
any 47 50 461 464 O
of 51 53 465 467 O
the 54 57 468 471 O
components 58 68 472 482 O
of 69 71 483 485 O
Temozolomide 72 84 486 498 B-allergy_name

Have 0 4 499 503 O
a 5 6 504 505 O
history 7 14 506 513 O
of 15 17 514 516 O
hypersensitivity 18 34 517 533 O
to 35 37 534 536 O
dacarbazine 38 49 537 548 B-allergy_name
( 50 51 549 550 I-allergy_name
DTIC 51 55 550 554 I-allergy_name
) 55 56 554 555 I-allergy_name

Have 0 4 556 560 O
diastolic 5 14 561 570 B-clinical_variable
blood 15 20 571 576 I-clinical_variable
pressure 21 29 577 585 I-clinical_variable
of 30 32 586 588 O
> 33 34 589 590 O
90 35 37 591 593 B-lower_bound
mm 38 40 594 596 I-lower_bound
Hg 41 43 597 599 I-lower_bound
resting 44 51 600 607 O
at 52 54 608 610 O
baseline 55 63 611 619 O
despite 64 71 620 627 O
medication 72 82 628 638 B-treatment

Have 0 4 639 643 O
recovered 5 14 644 653 O
from 15 19 654 658 O
any 20 23 659 662 O
previous 24 32 663 671 O
therapy 33 40 672 679 B-treatment
side 41 45 680 684 O
effects 46 53 685 692 O
or 54 56 693 695 O
toxicities 57 67 696 706 O

Histologically 0 14 707 721 O
confirmed 15 24 722 731 O
glioblastoma 25 37 732 744 B-cancer
or 38 40 745 747 O
gliosarcoma 41 52 748 759 B-cancer
in 53 55 760 762 O
1st 56 59 763 766 O
, 59 60 766 767 O
2nd 61 64 768 771 O
or 65 67 772 774 O
3rd 68 71 775 778 O
relapse 72 79 779 786 O

Histology 0 9 787 796 O
other 10 15 797 802 O
than 16 20 803 807 O
astrocytoma 21 32 808 819 B-cancer
grade 33 38 820 825 I-cancer
IV 39 41 826 828 I-cancer

Karnofsky 0 9 829 838 B-clinical_variable
performance 10 21 839 850 I-clinical_variable
status 22 28 851 857 I-clinical_variable
≥ 29 30 858 859 O
60 31 33 860 862 B-lower_bound
% 33 34 862 863 I-lower_bound

Male 0 4 864 868 B-gender

Males 0 5 869 874 B-gender
not 6 9 875 878 O
naturally 10 19 879 888 O
or 20 22 889 891 O
surgically 23 33 892 902 O
sterile 34 41 903 910 O
, 41 42 910 911 O
who 43 46 912 915 O
have 47 51 916 920 O
a 52 53 921 922 O
female 54 60 923 929 B-gender
partner 61 68 930 937 I-gender
of 69 71 938 940 O
childbearing 72 84 941 953 O
potential 85 94 954 963 O
, 94 95 963 964 O
must 96 100 965 969 O
agree 101 106 970 975 B-contraception_consent
to 107 109 976 978 I-contraception_consent
use 110 113 979 982 I-contraception_consent
two 114 117 983 986 I-contraception_consent
reliable 118 126 987 995 I-contraception_consent
methods 127 134 996 1003 I-contraception_consent
of 135 137 1004 1006 I-contraception_consent
contraception 138 151 1007 1020 I-contraception_consent
from 152 156 1021 1025 O
screening 157 166 1026 1035 O
and 167 170 1036 1039 O
up 171 173 1040 1042 O
to 174 176 1043 1045 O
30 177 179 1046 1048 B-upper_bound
days 180 184 1049 1053 I-upper_bound
after 185 190 1054 1059 I-upper_bound
discontinuation 191 206 1060 1075 O
of 207 209 1076 1078 O
study 210 215 1079 1084 O
treatment 216 225 1085 1094 B-treatment

Measurable 0 10 1095 1105 O
disease 11 18 1106 1113 O
on 19 21 1114 1116 O
MRI 22 25 1117 1120 B-treatment
performed 26 35 1121 1130 O
within 36 42 1131 1137 O
14 43 45 1138 1140 B-upper_bound
days 46 50 1141 1145 I-upper_bound
prior 51 56 1146 1151 I-upper_bound
to 57 59 1152 1154 O
registration 60 72 1155 1167 O

Moderate 0 8 1168 1176 O
to 9 11 1177 1179 O
severe 12 18 1180 1186 B-chronic_disease
hepatic 19 26 1187 1194 I-chronic_disease
impairment 27 37 1195 1205 I-chronic_disease

Organ 0 5 1206 1211 B-clinical_variable
function 6 14 1212 1220 I-clinical_variable
characterized 15 28 1221 1234 O
by 29 31 1235 1237 O
≤ 32 33 1238 1239 O
Grade 34 39 1240 1245 B-upper_bound
1 40 41 1246 1247 I-upper_bound

PT 0 2 1248 1250 B-clinical_variable
and 3 6 1251 1254 O
PTT 7 10 1255 1258 B-clinical_variable
≤ 11 12 1259 1260 O
1.5 13 16 1261 1264 B-upper_bound
X 17 18 1265 1266 I-upper_bound
ULN 19 22 1267 1270 I-upper_bound

Patients 0 8 1271 1279 O
must 9 13 1280 1284 O
be 14 16 1285 1287 O
willing 17 24 1288 1295 O
to 25 27 1296 1298 O
forego 28 34 1299 1305 O
other 35 40 1306 1311 O
cytotoxic 41 50 1312 1321 B-treatment
and 51 54 1322 1325 O
non 55 58 1326 1329 B-treatment
- 58 59 1329 1330 I-treatment
cytotoxic 59 68 1330 1339 I-treatment
drug 69 73 1340 1344 I-treatment
or 74 76 1345 1347 O
radiation 77 86 1348 1357 B-treatment
therapy 87 94 1358 1365 I-treatment
against 95 102 1366 1373 O
the 103 106 1374 1377 O
tumor 107 112 1378 1383 B-cancer
while 113 118 1384 1389 O
enrolled 119 127 1390 1398 O
in 128 130 1399 1401 O
the 131 134 1402 1405 O
study 135 140 1406 1411 O

Patients 0 8 1412 1420 O
who 9 12 1421 1424 O
are 13 16 1425 1428 O
currently 17 26 1429 1438 O
taking 27 33 1439 1445 O
Coumadin 34 42 1446 1454 B-treatment
or 43 45 1455 1457 O
Coumadin 46 54 1458 1466 B-treatment
derivatives 55 66 1467 1478 I-treatment
other 67 72 1479 1484 O
than 73 77 1485 1489 O
to 78 80 1490 1492 O
maintain 81 89 1493 1501 O
patency 90 97 1502 1509 O
of 98 100 1510 1512 O
venous 101 107 1513 1519 O
access 108 114 1520 1526 O
lines 115 120 1527 1532 O

Patients 0 8 1533 1541 O
with 9 13 1542 1546 O
a 14 15 1547 1548 O
history 16 23 1549 1556 O
of 24 26 1557 1559 O
any 27 30 1560 1563 O
other 31 36 1564 1569 O
cancer 37 43 1570 1576 B-cancer
, 43 44 1576 1577 O
unless 45 51 1578 1584 O
in 52 54 1585 1587 O
complete 55 63 1588 1596 O
remission 64 73 1597 1606 O
, 73 74 1606 1607 O
and 75 78 1608 1611 O
off 79 82 1612 1615 O
all 83 86 1616 1619 O
therapy 87 94 1620 1627 B-treatment
for 95 98 1628 1631 O
that 99 103 1632 1636 O
disease 104 111 1637 1644 O
for 112 115 1645 1648 O
a 116 117 1649 1650 O
minimum 118 125 1651 1658 O
of 126 128 1659 1661 O
5 129 130 1662 1663 B-lower_bound
years 131 136 1664 1669 I-lower_bound

Patients 0 8 1670 1678 O
with 9 13 1679 1683 O
serum 14 19 1684 1689 B-clinical_variable
aspartate 20 29 1690 1699 I-clinical_variable
aminotransferase 30 46 1700 1716 I-clinical_variable
, 46 47 1716 1717 O
alanine 48 55 1718 1725 B-clinical_variable
aminotransferase 56 72 1726 1742 I-clinical_variable
> 73 74 1743 1744 O
2.5 75 78 1745 1748 B-lower_bound
X 79 80 1749 1750 I-lower_bound
the 81 84 1751 1754 I-lower_bound
upper 85 90 1755 1760 I-lower_bound
limit 91 96 1761 1766 I-lower_bound
of 97 99 1767 1769 I-lower_bound
normal 100 106 1770 1776 I-lower_bound
( 107 108 1777 1778 I-lower_bound
ULN 108 111 1778 1781 I-lower_bound
) 111 112 1781 1782 I-lower_bound
and 113 116 1783 1786 O
bilirubin 117 126 1787 1796 B-clinical_variable
> 127 128 1797 1798 O
1.5 128 131 1798 1801 B-lower_bound
ULN 132 135 1802 1805 I-lower_bound

Planned 0 7 1806 1813 B-treatment
treatment 8 17 1814 1823 I-treatment
, 17 18 1823 1824 O
or 19 21 1825 1827 O
treatment 22 31 1828 1837 O
with 32 36 1838 1842 O
any 37 40 1843 1846 O
investigational 41 56 1847 1862 B-treatment
drug 57 61 1863 1867 I-treatment
within 62 68 1868 1874 O
4 69 70 1875 1876 B-upper_bound
weeks 71 76 1877 1882 I-upper_bound
prior 77 82 1883 1888 I-upper_bound
to 83 85 1889 1891 O
screening 86 95 1892 1901 O

Positive 0 8 1902 1910 O
results 9 16 1911 1918 O
from 17 21 1919 1923 O
HIV 22 25 1924 1927 B-chronic_disease
serology 26 34 1928 1936 O
testing 35 42 1937 1944 O
, 42 43 1944 1945 O
if 44 46 1946 1948 O
any 47 50 1949 1952 O
available 51 60 1953 1962 O

Prior 0 5 1963 1968 B-treatment
chemotherapy 6 18 1969 1981 I-treatment
for 19 22 1982 1985 O
recurrent 23 32 1986 1995 O
GBM 33 36 1996 1999 B-cancer
with 37 41 2000 2004 O
nitrosourea 42 53 2005 2016 B-treatment
compounds 54 63 2017 2026 I-treatment
including 64 73 2027 2036 O
Gliadel 74 81 2037 2044 B-treatment
® 81 82 2044 2045 I-treatment
wafers 83 89 2046 2052 I-treatment
or 90 92 2053 2055 O
bevacizumab 93 104 2056 2067 B-treatment

Prior 0 5 2068 2073 B-treatment
focal 6 11 2074 2079 I-treatment
radiotherapy 12 24 2080 2092 I-treatment
within 25 31 2093 2099 O
3 32 33 2100 2101 B-upper_bound
months 34 40 2102 2108 I-upper_bound
of 41 43 2109 2111 O
screening 44 53 2112 2121 O

Radiographic 0 12 2122 2134 O
demonstration 13 26 2135 2148 O
of 27 29 2149 2151 O
disease 30 37 2152 2159 O
progression 38 49 2160 2171 O
following 50 59 2172 2181 O
prior 60 65 2182 2187 B-treatment
therapy 66 73 2188 2195 I-treatment

Receiving 0 9 2196 2205 O
hematopoietic 10 23 2206 2219 B-treatment
growth 24 30 2220 2226 I-treatment
factors 31 38 2227 2234 I-treatment

Renal 0 5 2235 2240 B-clinical_variable
insufficiency 6 19 2241 2254 I-clinical_variable
or 20 22 2255 2257 I-clinical_variable
serum 23 28 2258 2263 I-clinical_variable
creatinine 29 39 2264 2274 I-clinical_variable
> 40 41 2275 2276 O
1.5 41 44 2276 2279 B-lower_bound
X 45 46 2280 2281 I-lower_bound
ULN 47 50 2282 2285 I-lower_bound
at 51 53 2286 2288 O
screening 54 63 2289 2298 O

Requiring 0 9 2299 2308 O
renal 10 15 2309 2314 B-treatment
dialysis 16 24 2315 2323 I-treatment

Serious 0 7 2324 2331 O
nonmalignant 8 20 2332 2344 B-chronic_disease
disease 21 28 2345 2352 I-chronic_disease

Substance 0 9 2353 2362 O
or 10 12 2363 2365 O
alcohol 13 20 2366 2373 O
abuse 21 26 2374 2379 O
or 27 29 2380 2382 O
dependence 30 40 2383 2393 O
, 40 41 2393 2394 O
within 42 48 2395 2401 O
12 49 51 2402 2404 B-upper_bound
months 52 58 2405 2411 I-upper_bound
prior 59 64 2412 2417 I-upper_bound
to 65 67 2418 2420 O
screening 68 77 2421 2430 O

Supine 0 6 2431 2437 B-clinical_variable
systolic 7 15 2438 2446 I-clinical_variable
blood 16 21 2447 2452 I-clinical_variable
pressure 22 30 2453 2461 I-clinical_variable
< 31 32 2462 2463 O
100 33 36 2464 2467 B-upper_bound
mmHg 37 41 2468 2472 I-upper_bound
or 42 44 2473 2475 O
supine 45 51 2476 2482 B-clinical_variable
diastolic 52 61 2483 2492 I-clinical_variable
blood 62 67 2493 2498 I-clinical_variable
pressure 68 76 2499 2507 I-clinical_variable
< 77 78 2508 2509 O
50 79 81 2510 2512 B-upper_bound
mmHg 82 86 2513 2517 I-upper_bound
at 87 89 2518 2520 O
screening 90 99 2521 2530 O
and 100 103 2531 2534 O
baseline 104 112 2535 2543 O

Treated 0 7 2544 2551 O
with 8 12 2552 2556 O
antibiotics 13 24 2557 2568 B-treatment
for 25 28 2569 2572 O
infection 29 38 2573 2582 B-chronic_disease
within 39 45 2583 2589 O
one 46 49 2590 2593 B-upper_bound
week 50 54 2594 2598 I-upper_bound
prior 55 60 2599 2604 I-upper_bound
to 61 63 2605 2607 O
study 64 69 2608 2613 O
entry 70 75 2614 2619 O

Tumor 0 5 2620 2625 B-cancer
foci 6 10 2626 2630 O
detected 11 19 2631 2639 O
below 20 25 2640 2645 O
the 26 29 2646 2649 O
tentorium 30 39 2650 2659 O
or 40 42 2660 2662 O
beyond 43 49 2663 2669 O
the 50 53 2670 2673 O
cranial 54 61 2674 2681 O
vault 62 67 2682 2687 O

Urinalysis 0 10 2688 2698 B-treatment
: 10 11 2698 2699 O
No 12 14 2700 2702 O
clinically 15 25 2703 2713 O
significant 26 37 2714 2725 O
abnormalities 38 51 2726 2739 O

Women 0 5 2740 2745 B-gender
of 6 8 2746 2748 O
childbearing 9 21 2749 2761 O
potential 22 31 2762 2771 O
must 32 36 2772 2776 O
agree 37 42 2777 2782 B-contraception_consent
to 43 45 2783 2785 I-contraception_consent
use 46 49 2786 2789 I-contraception_consent
two 50 53 2790 2793 I-contraception_consent
reliable 54 62 2794 2802 I-contraception_consent
methods 63 70 2803 2810 I-contraception_consent
of 71 73 2811 2813 I-contraception_consent
contraception 74 87 2814 2827 I-contraception_consent
from 88 92 2828 2832 O
screening 93 102 2833 2842 O
and 103 106 2843 2846 O
up 107 109 2847 2849 O
to 110 112 2850 2852 O
30 113 115 2853 2855 B-upper_bound
days 116 120 2856 2860 I-upper_bound
after 121 126 2861 2866 O
discontinuation 127 142 2867 2882 O
of 143 145 2883 2885 O
study 146 151 2886 2891 B-treatment
treatment 152 161 2892 2901 I-treatment

Women 0 5 2902 2907 B-gender
of 6 8 2908 2910 O
childbearing 9 21 2911 2923 O
potential 22 31 2924 2933 O
must 32 36 2934 2938 O
have 37 41 2939 2943 O
a 42 43 2944 2945 O
negative 44 52 2946 2954 B-pregnancy
serum 53 58 2955 2960 I-pregnancy
beta 59 63 2961 2965 I-pregnancy
- 63 64 2965 2966 I-pregnancy
HCG 64 67 2966 2969 I-pregnancy
pregnancy 68 77 2970 2979 I-pregnancy
test 78 82 2980 2984 O
documented 83 93 2985 2995 O
within 94 100 2996 3002 O
3 101 102 3003 3004 B-upper_bound
days 103 107 3005 3009 I-upper_bound
prior 108 113 3010 3015 I-upper_bound
to 114 116 3016 3018 O
study 117 122 3019 3024 O
initiation 123 133 3025 3035 O

female 0 6 3036 3042 B-gender
patients 7 15 3043 3051 I-gender

≥ 0 1 3052 3053 O
18 2 4 3054 3056 B-lower_bound
years 5 10 3057 3062 I-lower_bound
of 11 13 3063 3065 O
age 14 17 3066 3069 B-age

> 0 1 0 1 O
= 1 2 1 2 O
10 3 5 3 5 B-lower_bound
% 5 6 5 6 I-lower_bound
blasts 7 13 7 13 O
in 14 16 14 16 O
marrow 17 23 17 23 O
or 24 26 24 26 O
blood 27 32 27 32 O

AML 0 3 33 36 B-cancer
other 4 9 37 42 O
than 10 14 43 47 O
acute 15 20 48 53 B-cancer
promyelocytic 21 34 54 67 I-cancer
leukemia 35 43 68 76 I-cancer
( 44 45 77 78 I-cancer
APL 45 48 78 81 I-cancer
) 48 49 81 82 I-cancer
with 50 54 83 87 O
t(15;17)(q22;q12 55 71 88 104 B-clinical_variable
) 71 72 104 105 I-clinical_variable
or 73 75 106 108 O
variants 76 84 109 117 O
according 85 94 118 127 O
to 95 97 128 130 O
the 98 101 131 134 O
2008 102 106 135 139 O
World 107 112 140 145 O
Health 113 119 146 152 O
Organization 120 132 153 165 O
( 133 134 166 167 O
WHO 134 137 167 170 O
) 137 138 170 171 O
classification 139 153 172 186 O
; 153 154 186 187 O
patients 155 163 188 196 O
with 164 168 197 201 O
biphenotypic 169 181 202 214 B-cancer
AML 182 185 215 218 I-cancer

Active 0 6 219 225 O
systemic 7 15 226 234 B-chronic_disease
fungal 16 22 235 241 I-chronic_disease
, 22 23 241 242 O
bacterial 24 33 243 252 O
, 33 34 252 253 O
viral 35 40 254 259 O
, 40 41 259 260 O
or 42 44 261 263 O
other 45 50 264 269 O
infection 51 60 270 279 O
, 60 61 279 280 O
unless 62 68 281 287 O
disease 69 76 288 295 O
is 77 79 296 298 O
under 80 85 299 304 O
treatment 86 95 305 314 B-treatment
with 96 100 315 319 O
anti 101 105 320 324 O
- 105 106 324 325 O
microbials 106 116 325 335 O
and/or 117 123 336 342 O
controlled 124 134 343 353 O
or 135 137 354 356 O
stable 138 144 357 363 O
( 145 146 364 365 O
e.g. 146 150 365 369 O
if 151 153 370 372 O
specific 154 162 373 381 O
, 162 163 381 382 O
effective 164 173 383 392 O
therapy 174 181 393 400 O
is 182 184 401 403 O
not 185 188 404 407 O
available 189 198 408 417 O
/ 198 199 417 418 O
feasible 199 207 418 426 O
or 208 210 427 429 O
desired 211 218 430 437 O
[ 219 220 438 439 O
e.g. 220 224 439 443 O
chronic 225 232 444 451 B-chronic_disease
viral 233 238 452 457 I-chronic_disease
hepatitis 239 248 458 467 I-chronic_disease
, 248 249 467 468 O
human 250 255 469 474 B-chronic_disease
immunodeficiency 256 272 475 491 I-chronic_disease
virus 273 278 492 497 I-chronic_disease
( 279 280 498 499 I-chronic_disease
HIV 280 283 499 502 I-chronic_disease
) 283 284 502 503 I-chronic_disease
] 284 285 503 504 O
) 285 286 504 505 O

Bilirubin 0 9 506 515 B-clinical_variable
= 10 11 516 517 O
< 11 12 517 518 O
2 13 14 519 520 B-upper_bound
times 15 20 521 526 I-upper_bound
institutional 21 34 527 540 I-upper_bound
upper 35 40 541 546 I-upper_bound
limit 41 46 547 552 I-upper_bound
of 47 49 553 555 I-upper_bound
normal 50 56 556 562 I-upper_bound
unless 57 63 563 569 O
elevation 64 73 570 579 O
is 74 76 580 582 O
thought 77 84 583 590 O
to 85 87 591 593 O
be 88 90 594 596 O
due 91 94 597 600 O
to 95 97 601 603 O
hepatic 98 105 604 611 O
infiltration 106 118 612 624 O
by 119 121 625 627 O
AML 122 125 628 631 B-cancer
, 125 126 631 632 O
Gilbert 127 134 633 640 B-chronic_disease
's 134 136 640 642 I-chronic_disease
syndrome 137 145 643 651 I-chronic_disease
, 145 146 651 652 O
or 147 149 653 655 O
hemolysis 150 159 656 665 B-chronic_disease
( 160 161 666 667 O
assessed 161 169 667 675 O
within 170 176 676 682 O
10 177 179 683 685 B-upper_bound
days 180 184 686 690 I-upper_bound
prior 185 190 691 696 I-upper_bound
to 191 193 697 699 O
study 194 199 700 705 O
day 200 203 706 709 O
0 204 205 710 711 O
) 205 206 711 712 O

Concomitant 0 11 713 724 B-chronic_disease
illness 12 19 725 732 I-chronic_disease
associated 20 30 733 743 O
with 31 35 744 748 O
a 36 37 749 750 O
likely 38 44 751 757 O
survival 45 53 758 766 O
of 54 56 767 769 O
< 57 58 770 771 O
1 59 60 772 773 B-upper_bound
year 61 65 774 778 I-upper_bound

Pregnancy 0 9 779 788 B-pregnancy

The 0 3 789 792 O
use 4 7 793 796 O
of 8 10 797 799 O
hydroxyurea 11 22 800 811 B-treatment
prior 23 28 812 817 O
to 29 31 818 820 O
study 32 37 821 826 O
registration 38 50 827 839 O

Women 0 5 840 845 B-gender
of 6 8 846 848 O
childbearing 9 21 849 861 O
potential 22 31 862 871 O
and 32 35 872 875 O
men 36 39 876 879 O
must 40 44 880 884 O
agree 45 50 885 890 B-contraception_consent
to 51 53 891 893 I-contraception_consent
use 54 57 894 897 I-contraception_consent
adequate 58 66 898 906 I-contraception_consent
contraception 67 80 907 920 I-contraception_consent
beginning 81 90 921 930 O
at 91 93 931 933 O
the 94 97 934 937 O
signing 98 105 938 945 O
of 106 108 946 948 O
the 109 112 949 952 O
consent 113 120 953 960 O
until 121 126 961 966 O
at 127 129 967 969 O
least 130 135 970 975 O
3 136 137 976 977 B-lower_bound
months 138 144 978 984 I-lower_bound
after 145 150 985 990 O
the 151 154 991 994 O
last 155 159 995 999 O
dose 160 164 1000 1004 O
of 165 167 1005 1007 O
study 168 173 1008 1013 O
drug 174 178 1014 1018 O

high 0 4 1019 1023 O
- 4 5 1023 1024 O
risk 5 9 1024 1028 O
myeloproliferative 10 28 1029 1047 B-cancer
neoplasm 29 37 1048 1056 I-cancer

patient 0 7 1057 1064 O
needs 8 13 1065 1070 O
to 14 16 1071 1073 O
be 17 19 1074 1076 O
clinically 20 30 1077 1087 O
stable 31 37 1088 1094 O
as 38 40 1095 1097 O
defined 41 48 1098 1105 O
as 49 51 1106 1108 O
being 52 57 1109 1114 O
afebrile 58 66 1115 1123 O
and 67 70 1124 1127 O
hemodynamically 71 86 1128 1143 O
stable 87 93 1144 1150 O
for 94 97 1151 1154 O
24 98 100 1155 1157 B-lower_bound
- 100 101 1157 1158 O
48 101 103 1158 1160 B-upper_bound
hours 104 109 1161 1166 I-upper_bound
prior 110 115 1167 1172 I-upper_bound
to 116 118 1173 1175 O
study 119 124 1176 1181 O
day 125 128 1182 1185 O
0 129 130 1186 1187 O
, 130 131 1187 1188 O
unless 132 138 1189 1195 O
fever 139 144 1196 1201 O
is 145 147 1202 1204 O
thought 148 155 1205 1212 O
to 156 158 1213 1215 O
be 159 161 1216 1218 O
secondary 162 171 1219 1228 O
to 172 174 1229 1231 O
the 175 178 1232 1235 O
underlying 179 189 1236 1246 O
hematologic 190 201 1247 1258 B-chronic_disease
disease 202 209 1259 1266 I-chronic_disease

sorafenib 0 9 1267 1276 B-treatment

such 0 4 1277 1281 O
high 5 9 1282 1286 O
- 9 10 1286 1287 O
risk 10 14 1287 1291 O
MDS 15 18 1292 1295 B-chronic_disease
or 19 21 1296 1298 O
MPN 22 25 1299 1302 B-chronic_disease
have 26 30 1303 1307 O
natural 31 38 1308 1315 O
history 39 46 1316 1323 O
much 47 51 1324 1328 O
closer 52 58 1329 1335 O
to 59 61 1336 1338 O
AML 62 65 1339 1342 B-cancer
than 66 70 1343 1347 O
to 71 73 1348 1350 O
lower 74 79 1351 1356 O
risk 80 84 1357 1361 O
MDS 85 88 1362 1365 O
or 89 91 1366 1368 O
MPN 92 95 1369 1372 O
and 96 99 1373 1376 O
have 100 104 1377 1381 O
responded 105 114 1382 1391 O
similarly 115 124 1392 1401 O
to 125 127 1402 1404 O
AML 128 131 1405 1408 B-treatment
- 131 132 1408 1409 I-treatment
type 132 136 1409 1413 I-treatment
therapy 137 144 1414 1421 I-treatment

Active 0 6 0 6 O
forward 7 14 7 14 O
elevation 15 24 15 24 O
of 25 27 25 27 O
less 28 32 28 32 O
than 33 37 33 37 O
90 38 40 38 40 B-upper_bound
degrees 41 48 41 48 I-upper_bound

Advanced 0 8 49 57 B-chronic_disease
dementia 9 17 58 66 I-chronic_disease

Chronic 0 7 67 74 B-chronic_disease
rotator 8 15 75 82 I-chronic_disease
cuff 16 20 83 87 I-chronic_disease
tear 21 25 88 92 O
with 26 30 93 97 O
severe 31 37 98 104 O
retraction 38 48 105 115 O
, 48 49 115 116 O
atrophy 50 57 117 124 B-treatment
, 57 58 124 125 O
fatty 59 64 126 131 B-chronic_disease
infiltration 65 77 132 144 I-chronic_disease

Neuro 0 5 145 150 B-chronic_disease
- 5 6 150 151 I-chronic_disease
muscular 6 14 151 159 I-chronic_disease
disorder 15 23 160 168 I-chronic_disease
( 24 25 169 170 O
ie 25 27 170 172 O
: 27 28 172 173 O
Parkinson 29 38 174 183 B-chronic_disease
's 38 40 183 185 I-chronic_disease
) 40 41 185 186 O

Previous 0 8 187 195 O
shoulder 9 17 196 204 B-chronic_disease
infection 18 27 205 214 I-chronic_disease

Revision 0 8 215 223 B-treatment
arthroplasty 9 21 224 236 I-treatment

Shoulder 0 8 237 245 B-chronic_disease
pseudoparalysis 9 24 246 261 I-chronic_disease
due 25 28 262 265 O
to 29 31 266 268 O
chronic 32 39 269 276 B-chronic_disease
rotator 40 47 277 284 I-chronic_disease
cuff 48 52 285 289 I-chronic_disease
dysfunction 53 64 290 301 I-chronic_disease
with 65 69 302 306 O
or 70 72 307 309 O
without 73 80 310 317 O
glenohumeral 81 93 318 330 B-chronic_disease
arthritis 94 103 331 340 I-chronic_disease

Teres 0 5 341 346 B-chronic_disease
minor 6 11 347 352 I-chronic_disease
dysfunction 12 23 353 364 I-chronic_disease

Age 0 3 0 3 B-age
14 4 6 4 6 B-lower_bound
- 7 8 7 8 O
21 9 11 9 11 B-upper_bound
years 12 17 12 17 I-upper_bound

Allergy 0 7 18 25 O
or 8 10 26 28 O
intolerance 11 22 29 40 O
to 23 25 41 43 O
N 26 27 44 45 B-allergy_name
- 27 28 45 46 I-allergy_name
acetylcysteine 28 42 46 60 I-allergy_name

Current 0 7 61 68 O
use 8 11 69 72 O
of 12 14 73 75 O
N 15 16 76 77 B-treatment
- 16 17 77 78 I-treatment
acetylcysteine 17 31 78 92 I-treatment
or 32 34 93 95 O
any 35 38 96 99 O
supplement 39 49 100 110 O
containing 50 60 111 121 O
N 61 62 122 123 O
- 62 63 123 124 O
acetylcysteine 63 77 124 138 O
( 78 79 139 140 O
must 79 83 140 144 O
agree 84 89 145 150 O
not 90 93 151 154 O
to 94 96 155 157 O
take 97 101 158 162 O
any 102 105 163 166 O
such 106 110 167 171 O
supplement 111 121 172 182 O
throughout 122 132 183 193 O
study 133 138 194 199 O
participation 139 152 200 213 O
) 152 153 213 214 O

Females 0 7 215 222 B-gender
must 8 12 223 227 O
agree 13 18 228 233 B-contraception_consent
to 19 21 234 236 I-contraception_consent
use 22 25 237 240 I-contraception_consent
appropriate 26 37 241 252 I-contraception_consent
birth 38 43 253 258 I-contraception_consent
control 44 51 259 266 I-contraception_consent
methods 52 59 267 274 I-contraception_consent
during 60 66 275 281 O
study 67 72 282 287 O
participation 73 86 288 301 O
: 86 87 301 302 O
oral 88 92 303 307 B-contraception_consent
contraceptives 93 107 308 322 I-contraception_consent
, 107 108 322 323 O
contraceptive 109 122 324 337 B-contraception_consent
patch 123 128 338 343 I-contraception_consent
, 128 129 343 344 O
barrier 130 137 345 352 B-contraception_consent
( 138 139 353 354 I-contraception_consent
diaphragm 139 148 354 363 I-contraception_consent
or 149 151 364 366 I-contraception_consent
condom 152 158 367 373 I-contraception_consent
) 158 159 373 374 I-contraception_consent
, 159 160 374 375 O
levonorgestrel 161 175 376 390 B-contraception_consent
implant 176 183 391 398 I-contraception_consent
, 183 184 398 399 O
medroxyprogesterone 185 204 400 419 B-contraception_consent
acetate 205 212 420 427 I-contraception_consent
, 212 213 427 428 O
complete 214 222 429 437 B-contraception_consent
abstinence 223 233 438 448 I-contraception_consent
from 234 238 449 453 I-contraception_consent
sexual 239 245 454 460 I-contraception_consent
intercourse 246 257 461 472 I-contraception_consent
, 257 258 472 473 O
or 259 261 474 476 O
hormonal 262 270 477 485 B-contraception_consent
contraceptive 271 284 486 499 I-contraception_consent
vaginal 285 292 500 507 I-contraception_consent
ring 293 297 508 512 I-contraception_consent

Females 0 7 513 520 B-gender
who 8 11 521 524 O
are 12 15 525 528 O
pregnant 16 24 529 537 B-pregnancy
or 25 27 538 540 O
lactating 28 37 541 550 O

Must 0 4 551 555 O
meet 5 9 556 560 O
current 10 17 561 568 O
( 18 19 569 570 O
within 19 25 570 576 O
last 26 30 577 581 B-upper_bound
30 31 33 582 584 I-upper_bound
days 34 38 585 589 I-upper_bound
) 38 39 589 590 O
DSM-5 40 45 591 596 O
criteria 46 54 597 605 O
for 55 58 606 609 O
cannabis 59 67 610 618 B-chronic_disease
use 68 71 619 622 I-chronic_disease
disorder 72 80 623 631 I-chronic_disease

Use 0 3 632 635 O
of 4 6 636 638 O
carbamazepine 7 20 639 652 B-treatment
or 21 23 653 655 O
nitroglycerin 24 37 656 669 B-treatment
within 38 44 670 676 O
14 45 47 677 679 B-upper_bound
days 48 52 680 684 I-upper_bound
of 53 55 685 687 O
randomization 56 69 688 701 O
or 70 72 702 704 O
expectation 73 84 705 716 O
of 85 87 717 719 O
future 88 94 720 726 O
use 95 98 727 730 O
during 99 105 731 737 O
protocol 106 114 738 746 O
participation 115 128 747 760 O

under 0 5 761 766 O
18 6 8 767 769 B-upper_bound
years 9 14 770 775 I-upper_bound
old 15 18 776 779 B-age

All 0 3 0 3 O
patients 4 12 4 12 O
who 13 16 13 16 O
have 17 21 17 21 O
two 22 25 22 25 O
or 26 28 26 28 O
more 29 33 29 33 O
histologic 34 44 34 44 O
diagnoses 45 54 45 54 O
of 55 57 55 57 O
the 58 61 58 61 O
same 62 66 62 66 O
primary 67 74 67 74 B-cancer
tumor 75 80 75 80 I-cancer
type 81 85 81 85 O
involving 86 95 86 95 O
the 96 99 96 99 O
above 100 105 100 105 O
sites 106 111 106 111 O

MSKCC 0 5 112 117 O
patients 6 14 118 126 O
without 15 22 127 134 O
a 23 24 135 136 O
histologic 25 35 137 147 O
diagnosis 36 45 148 157 O
of 46 48 158 160 O
cancer 49 55 161 167 B-cancer
of 56 58 168 170 I-cancer
the 59 62 171 174 I-cancer
breast 63 69 175 181 I-cancer
, 69 70 181 182 O
bladder 71 78 183 190 B-cancer
, 78 79 190 191 O
kidney 80 86 192 198 B-cancer
, 86 87 198 199 O
colon 88 93 200 205 B-cancer
, 93 94 205 206 O
testicles 95 104 207 216 B-cancer
, 104 105 216 217 O
lungs 106 111 218 223 B-cancer
, 111 112 223 224 O
prostate 113 121 225 233 B-cancer
, 121 122 233 234 O
or 123 125 235 237 O
lymphoid 126 134 238 246 B-cancer
malignancy 135 145 247 257 I-cancer
( 146 147 258 259 O
including 147 156 259 268 O
all 157 160 269 272 O
types 161 166 273 278 O
of 167 169 279 281 O
lymphoma 170 178 282 290 B-cancer
) 178 179 290 291 O
will 180 184 292 296 O
not 185 188 297 300 O
be 189 191 301 303 O
eligible 192 200 304 312 O
for 201 204 313 316 O
the 205 208 317 320 O
AMDeC 209 214 321 326 O
sponsored 215 224 327 336 O
component 225 234 337 346 O
of 235 237 347 349 O
the 238 241 350 353 O
study 242 247 354 359 O

Patients 0 8 360 368 O
of 9 11 369 371 O
Ashkenazi 12 21 372 381 O
Jewish 22 28 382 388 O
ancestry 29 37 389 397 O
with 38 42 398 402 O
a 43 44 403 404 O
histologic 45 55 405 415 O
diagnosis 56 65 416 425 O
of 66 68 426 428 O
cancer 69 75 429 435 B-cancer
of 76 78 436 438 O
any 79 82 439 442 O
type 83 87 443 447 O

Patients 0 8 448 456 O
with 9 13 457 461 O
a 14 15 462 463 O
histologic 16 26 464 474 O
diagnosis 27 36 475 484 O
of 37 39 485 487 O
cancer 40 46 488 494 B-cancer
of 47 49 495 497 O
the 50 53 498 501 O
colon 54 59 502 507 B-cancer
, 59 60 507 508 O
breast 61 67 509 515 B-cancer
, 67 68 515 516 O
bladder 69 76 517 524 B-cancer
, 76 77 524 525 O
kidney 78 84 526 532 B-cancer
, 84 85 532 533 O
testicles 86 95 534 543 B-cancer
, 95 96 543 544 O
lungs 97 102 545 550 B-cancer
, 102 103 550 551 O
prostate 104 112 552 560 B-cancer
, 112 113 560 561 O
head 114 118 562 566 B-cancer
and 119 122 567 570 I-cancer
neck 123 127 571 575 I-cancer
, 127 128 575 576 O
or 129 131 577 579 O
lymphoid 132 140 580 588 B-cancer
organs 141 147 589 595 I-cancer
, 147 148 595 596 O
who 149 152 597 600 O
have 153 157 601 605 O
donated 158 165 606 613 O
a 166 167 614 615 O
diagnostic 168 178 616 626 O
blood 179 184 627 632 O
sample 185 191 633 639 O
as 192 194 640 642 O
either 195 201 643 649 O
an 202 204 650 652 O
inpatient 205 214 653 662 O
or 215 217 663 665 O
outpatient 218 228 666 676 O
at 229 231 677 679 O
MSKCC 232 237 680 685 O

22 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

Botulinum 0 9 25 34 B-treatment
toxin 10 15 35 40 I-treatment
injections 16 26 41 51 I-treatment
in 27 29 52 54 O
the 30 33 55 58 O
previous 34 42 59 67 B-upper_bound
6 43 44 68 69 I-upper_bound
months 45 51 70 76 I-upper_bound

Clinically 0 10 77 87 O
significant 11 22 88 99 O
mental 23 29 100 106 B-chronic_disease
illness 30 37 107 114 I-chronic_disease

Current 0 7 115 122 O
Pregnancy 8 17 123 132 B-pregnancy

Current 0 7 133 140 O
and 8 11 141 144 O
anticipated 12 23 145 156 O
need 24 28 157 161 O
for 29 32 162 165 O
opioid 33 39 166 172 B-treatment
pain 40 44 173 177 I-treatment
medications 45 56 178 189 I-treatment
or 57 59 190 192 O
pain 60 64 193 197 O
that 65 69 198 202 O
would 70 75 203 208 O
prevent 76 83 209 216 O
full 84 88 217 221 O
participation 89 102 222 235 O
in 103 105 236 238 O
the 106 109 239 242 O
rehabilitation 110 124 243 257 O
program 125 132 258 265 O

Diseases 0 8 266 274 O
and 9 12 275 278 O
conditions 13 23 279 289 O
that 24 28 290 294 O
would 29 34 295 300 O
increase 35 43 301 309 O
the 44 47 310 313 O
morbidity 48 57 314 323 O
and 58 61 324 327 O
mortality 62 71 328 337 O
of 72 74 338 340 O
spinal 75 81 341 347 B-treatment
cord 82 86 348 352 I-treatment
injury 87 93 353 359 I-treatment
surgery 94 101 360 367 I-treatment
( 102 103 368 369 O
e.g. 103 107 369 373 O
cardiopulmonary 108 123 374 389 B-chronic_disease
issues 124 130 390 396 O
) 130 131 396 397 O

Inability 0 9 398 407 O
to 10 12 408 410 O
withhold 13 21 411 419 O
antiplatelet 22 34 420 432 B-treatment
/ 34 35 432 433 I-treatment
anticoagulation 35 50 433 448 I-treatment
agents 51 57 449 455 I-treatment
perioperatively 58 73 456 471 O

Recurrent 0 9 472 481 O
urinary 10 17 482 489 B-chronic_disease
tract 18 23 490 495 I-chronic_disease
infection 24 33 496 505 I-chronic_disease
refractory 34 44 506 516 O
to 45 47 517 519 O
antibiotics 48 59 520 531 B-treatment

Stable 0 6 532 538 O
, 6 7 538 539 O
motor 8 13 540 545 B-chronic_disease
- 13 14 545 546 I-chronic_disease
complete 14 22 546 554 I-chronic_disease
paraplegia 23 33 555 565 I-chronic_disease

single 0 6 566 572 B-treatment
tilt 7 11 573 577 I-treatment
table 12 17 578 583 I-treatment
test 18 22 584 588 I-treatment
with 23 27 589 593 O
syncope 28 35 594 601 B-chronic_disease
, 35 36 601 602 O
presyncope 37 47 603 613 B-chronic_disease
, 47 48 613 614 O
or 49 51 615 617 O
SBP 52 55 618 621 B-clinical_variable
< 56 57 622 623 O
50 58 60 624 626 B-upper_bound
or 61 63 627 629 O
> 64 65 630 631 O
200 65 68 631 634 B-lower_bound

Active 0 6 0 6 O
acute 7 12 7 12 B-chronic_disease
or 13 15 13 15 I-chronic_disease
known 16 21 16 21 I-chronic_disease
chronic 22 29 22 29 I-chronic_disease
infections 30 40 30 40 I-chronic_disease

Any 0 3 41 44 O
other 4 9 45 50 O
pre 10 13 51 54 O
- 13 14 54 55 O
existing 14 22 55 63 O
laboratory 23 33 64 74 O
abnormality 34 45 75 86 O
, 45 46 86 87 O
medical 47 54 88 95 O
condition 55 64 96 105 O
, 64 65 105 106 O
or 66 68 107 109 O
disease 69 76 110 117 O
that 77 81 118 122 O
, 81 82 122 123 O
in 83 85 124 126 O
the 86 89 127 130 O
opinion 90 97 131 138 O
of 98 100 139 141 O
Investigator 101 113 142 154 O
, 113 114 154 155 O
may 115 118 156 159 O
cause 119 124 160 165 O
the 125 128 166 169 O
subject 129 136 170 177 O
to 137 139 178 180 O
be 140 142 181 183 O
unsuitable 143 153 184 194 O
for 154 157 195 198 O
the 158 161 199 202 O
study 162 167 203 208 O
or 168 170 209 211 O
place 171 176 212 217 O
the 177 180 218 221 O
subject 181 188 222 229 O
at 189 191 230 232 O
potential 192 201 233 242 O
risk 202 206 243 247 O
from 207 211 248 252 O
being 212 217 253 258 O
in 218 220 259 261 O
the 221 224 262 265 O
study 225 230 266 271 O
, 230 231 271 272 O
e.g. 232 236 273 277 O
a 237 238 278 279 O
malignancy 239 249 280 290 B-cancer
, 249 250 290 291 O
uncontrolled 251 263 292 304 B-chronic_disease
hypertension 264 276 305 317 I-chronic_disease
, 276 277 317 318 O
unstable 278 286 319 327 B-chronic_disease
ischemic 287 295 328 336 I-chronic_disease
heart 296 301 337 342 I-chronic_disease
disease 302 309 343 350 I-chronic_disease
, 309 310 350 351 O
or 311 313 352 354 O
uncontrolled 314 326 355 367 B-chronic_disease
diabetes 327 335 368 376 I-chronic_disease
mellitus 336 344 377 385 I-chronic_disease

Chronic 0 7 386 393 O
alcohol 8 15 394 401 O
or 16 18 402 404 O
drug 19 23 405 409 O
abuse 24 29 410 415 O
within 30 36 416 422 O
the 37 40 423 426 O
past 41 45 427 431 B-upper_bound
six 46 49 432 435 I-upper_bound
months 50 56 436 442 I-upper_bound

Confirmed 0 9 443 452 O
diagnosis 10 19 453 462 O
of 20 22 463 465 O
RLS 23 26 466 469 B-chronic_disease
based 27 32 470 475 O
on 33 35 476 478 O
the 36 39 479 482 O
Cambridge 40 49 483 492 O
- 49 50 492 493 O
Hopkins 50 57 493 500 O
Diagnostic 58 68 501 511 O
Questionnaire 69 82 512 525 O
( 83 84 526 527 O
CHDQ 84 88 527 531 O
) 88 89 531 532 O
and 90 93 533 536 O
the 94 97 537 540 O
Hopkins 98 105 541 548 O
- 105 106 548 549 O
Hening 106 112 549 555 O
Telephone 113 122 556 565 O
Diagnostic 123 133 566 576 O
Interview 134 143 577 586 O
( 144 145 587 588 O
HDTI 145 149 588 592 O
) 149 150 592 593 O

Current 0 7 594 601 O
( 8 9 602 603 O
past 9 13 603 607 B-upper_bound
4 14 15 608 609 I-upper_bound
weeks 16 21 610 615 I-upper_bound
) 21 22 615 616 O
use 23 26 617 620 O
of 27 29 621 623 O
drugs 30 35 624 629 O
that 36 40 630 634 O
may 41 44 635 638 O
cause 45 50 639 644 O
or 51 53 645 647 O
treat 54 59 648 653 O
RLS 60 63 654 657 B-chronic_disease
, 63 64 657 658 O
e.g. 65 69 659 663 O
opioids 70 77 664 671 B-treatment
, 77 78 671 672 O
calcium 79 86 673 680 B-treatment
channel 87 94 681 688 I-treatment
alpha-2 95 102 689 696 I-treatment
- 102 103 696 697 I-treatment
delta 103 108 697 702 I-treatment
ligands 109 116 703 710 I-treatment
, 116 117 710 711 O
anti 118 122 712 716 B-treatment
- 122 123 716 717 I-treatment
depressants 123 134 717 728 I-treatment
, 134 135 728 729 O
dopaminergic 136 148 730 742 B-treatment
agonist 149 156 743 750 I-treatment
or 157 159 751 753 I-treatment
antagonists 160 171 754 765 I-treatment
, 171 172 765 766 O
or 173 175 767 769 O
centrally 176 185 770 779 B-treatment
- 185 186 779 780 I-treatment
acting 186 192 780 786 I-treatment
antihistamines 193 207 787 801 I-treatment

Disorders 0 9 802 811 O
that 10 14 812 816 O
require 15 22 817 824 O
treatment 23 32 825 834 O
with 33 37 835 839 O
the 38 41 840 843 O
same 42 46 844 848 O
medications 47 58 849 860 O
used 59 63 861 865 O
for 64 67 866 869 O
RLS 68 71 870 873 B-chronic_disease

History 0 7 874 881 O
of 8 10 882 884 O
hemochromatosis 11 26 885 900 B-chronic_disease
, 26 27 900 901 O
hemosiderosis 28 41 902 915 B-chronic_disease
, 41 42 915 916 O
other 43 48 917 922 O
iron 49 53 923 927 B-chronic_disease
storage 54 61 928 935 I-chronic_disease
disorders 62 71 936 945 I-chronic_disease
or 72 74 946 948 O
iron 75 79 949 953 B-chronic_disease
metabolism 80 90 954 964 I-chronic_disease
disorders 91 100 965 974 I-chronic_disease

IRLSS 0 5 975 980 B-clinical_variable
score 6 11 981 986 I-clinical_variable
≥15 12 15 987 990 O
plus 16 20 991 995 O
RLS 21 24 996 999 O
symptoms 25 33 1000 1008 O
for 34 37 1009 1012 O
at 38 40 1013 1015 O
least 41 46 1016 1021 O
3 47 48 1022 1023 B-lower_bound
months 49 55 1024 1030 I-lower_bound
and 56 59 1031 1034 O
currently 60 69 1035 1044 O
occurring 70 79 1045 1054 O
≥2 80 82 1055 1057 O
nights 83 89 1058 1064 I-lower_bound
per 90 93 1065 1068 I-lower_bound
week 94 98 1069 1073 I-lower_bound

Iron 0 4 1074 1078 B-chronic_disease
- 4 5 1078 1079 I-chronic_disease
deficiency 5 15 1079 1089 I-chronic_disease
anemia 16 22 1090 1096 I-chronic_disease
defined 23 30 1097 1104 O
as 31 33 1105 1107 O
an 34 36 1108 1110 O
Hgb 37 40 1111 1114 B-clinical_variable
< 41 42 1115 1116 O
12 42 44 1116 1118 B-upper_bound
g 45 46 1119 1120 I-upper_bound
/ 46 47 1120 1121 I-upper_bound
dl 47 49 1121 1123 I-upper_bound
with 50 54 1124 1128 O
a 55 56 1129 1130 O
ferritin 57 65 1131 1139 B-clinical_variable
< 66 67 1140 1141 O
20 67 69 1141 1143 B-upper_bound
ng 70 72 1144 1146 I-upper_bound
/ 72 73 1146 1147 I-upper_bound
mL 73 75 1147 1149 I-upper_bound
, 75 76 1149 1150 O
or 77 79 1151 1153 O
ferritin 80 88 1154 1162 O
< 89 90 1163 1164 O
100 90 93 1164 1167 B-upper_bound
when 94 98 1168 1172 O
TSAT 99 103 1173 1177 B-clinical_variable
is 104 106 1178 1180 O
< 107 108 1181 1182 O
18 108 110 1182 1184 B-upper_bound
% 110 111 1184 1185 I-upper_bound

Known 0 5 1186 1191 O
hypersensitivity 6 22 1192 1208 O
reaction 23 31 1209 1217 O
to 32 34 1218 1220 O
any 35 38 1221 1224 O
component 39 48 1225 1234 O
of 49 51 1235 1237 O
Injectafer 52 62 1238 1248 B-allergy_name
® 62 63 1248 1249 O
( 64 65 1250 1251 O
ferric 65 71 1251 1257 B-allergy_name
carboxymaltose 72 86 1258 1272 I-allergy_name
) 86 87 1272 1273 O

Known 0 5 1274 1279 O
positive 6 14 1280 1288 O
HIV-1 15 20 1289 1294 B-chronic_disease
or 21 23 1295 1297 O
HIV-2 24 29 1298 1303 B-chronic_disease
antibodies 30 40 1304 1314 I-chronic_disease
( 41 42 1315 1316 O
anti 42 46 1316 1320 O
- 46 47 1320 1321 O
HIV 47 50 1321 1324 O
) 50 51 1324 1325 O

Known 0 5 1326 1331 O
positive 6 14 1332 1340 O
Hepatitis 15 24 1341 1350 B-chronic_disease
B 25 26 1351 1352 I-chronic_disease
antigen 27 34 1353 1360 I-chronic_disease
( 35 36 1361 1362 I-chronic_disease
HBs 36 39 1362 1365 I-chronic_disease
Ag 40 42 1366 1368 I-chronic_disease
) 42 43 1368 1369 I-chronic_disease
, 43 44 1369 1370 O
unless 45 51 1371 1377 O
positive 52 60 1378 1386 O
test 61 65 1387 1391 O
can 66 69 1392 1395 O
be 70 72 1396 1398 O
attributed 73 83 1399 1409 O
to 84 86 1410 1412 O
receipt 87 94 1413 1420 O
of 95 97 1421 1423 O
Hepatitis 98 107 1424 1433 B-treatment
B 108 109 1434 1435 I-treatment
vaccination 110 121 1436 1447 I-treatment
in 122 124 1448 1450 O
childhood 125 134 1451 1460 O
or 135 137 1461 1463 O
Hepatitis 138 147 1464 1473 B-chronic_disease
C 148 149 1474 1475 I-chronic_disease
viral 150 155 1476 1481 I-chronic_disease
antibody 156 164 1482 1490 I-chronic_disease
( 165 166 1491 1492 I-chronic_disease
HCV 166 169 1492 1495 I-chronic_disease
) 169 170 1495 1496 I-chronic_disease
with 171 175 1497 1501 O
evidence 176 184 1502 1510 O
of 185 187 1511 1513 O
active 188 194 1514 1520 B-chronic_disease
hepatitis 195 204 1521 1530 I-chronic_disease
( 205 206 1531 1532 O
i.e. 206 210 1532 1536 O
, 210 211 1536 1537 O
AST 212 215 1538 1541 B-clinical_variable
/ 215 216 1541 1542 O
ALT 216 219 1542 1545 B-clinical_variable
greater 220 227 1546 1553 O
than 228 232 1554 1558 O
two 233 236 1559 1562 B-lower_bound
times 237 242 1563 1568 I-lower_bound
the 243 246 1569 1572 I-lower_bound
ULN 247 250 1573 1576 I-lower_bound
) 250 251 1576 1577 O

Liver 0 5 1578 1583 B-clinical_variable
transaminases 6 19 1584 1597 I-clinical_variable
( 20 21 1598 1599 I-clinical_variable
AST 21 24 1599 1602 I-clinical_variable
or 25 27 1603 1605 I-clinical_variable
ALT 28 31 1606 1609 I-clinical_variable
) 31 32 1609 1610 I-clinical_variable
greater 33 40 1611 1618 O
than 41 45 1619 1623 O
two 46 49 1624 1627 B-lower_bound
times 50 55 1628 1633 I-lower_bound
the 56 59 1634 1637 I-lower_bound
upper 60 65 1638 1643 I-lower_bound
limit 66 71 1644 1649 I-lower_bound
of 72 74 1650 1652 I-lower_bound
normal 75 81 1653 1659 I-lower_bound
( 82 83 1660 1661 I-lower_bound
ULN 83 86 1661 1664 I-lower_bound
) 86 87 1664 1665 I-lower_bound

Male 0 4 1666 1670 B-gender

Parenteral 0 10 1671 1681 B-treatment
iron 11 15 1682 1686 I-treatment
, 15 16 1686 1687 O
erythropoiesis 17 31 1688 1702 B-treatment
stimulating 32 43 1703 1714 I-treatment
agent 44 49 1715 1720 I-treatment
use 50 53 1721 1724 O
or 54 56 1725 1727 O
blood 57 62 1728 1733 B-treatment
transfusion 63 74 1734 1745 I-treatment
within 75 81 1746 1752 O
six 82 85 1753 1756 B-upper_bound
weeks 86 91 1757 1762 I-upper_bound
prior 92 97 1763 1768 I-upper_bound
to 98 100 1769 1771 O
the 101 104 1772 1775 O
screening 105 114 1776 1785 O
visit 115 120 1786 1791 O

Planned 0 7 1792 1799 O
elective 8 16 1800 1808 B-treatment
surgery 17 24 1809 1816 I-treatment
during 25 31 1817 1823 O
the 32 35 1824 1827 O
study 36 41 1828 1833 O
year 42 46 1834 1838 O

Pregnant 0 8 1839 1847 B-pregnancy
and 9 12 1848 1851 O
lactating 13 22 1852 1861 O
women 23 28 1862 1867 B-gender

Previously 0 10 1868 1878 O
randomized 11 21 1879 1889 O
to 22 24 1890 1892 O
Injectafer 25 35 1893 1903 B-treatment
® 35 36 1903 1904 O
( 37 38 1905 1906 O
FCM 38 41 1906 1909 B-treatment
or 42 44 1910 1912 O
VIT-45 45 51 1913 1919 B-treatment
) 51 52 1919 1920 O
in 53 55 1921 1923 O
a 56 57 1924 1925 O
clinical 58 66 1926 1934 B-treatment
trial 67 72 1935 1940 I-treatment

Rheumatoid 0 10 1941 1951 B-chronic_disease
arthritis 11 20 1952 1961 I-chronic_disease
with 21 25 1962 1966 O
symptoms 26 34 1967 1975 O
or 35 37 1976 1978 O
signs 38 43 1979 1984 O
of 44 46 1985 1987 O
active 47 53 1988 1994 O
inflammation 54 66 1995 2007 O

Secondary 0 9 2008 2017 B-chronic_disease
RLS 10 13 2018 2021 I-chronic_disease
due 14 17 2022 2025 O
to 18 20 2026 2028 O
neurological 21 33 2029 2041 B-chronic_disease
conditions 34 44 2042 2052 I-chronic_disease
or 45 47 2053 2055 O
head 48 52 2056 2060 B-chronic_disease
trauma 53 59 2061 2067 I-chronic_disease

Subjects 0 8 2068 2076 O
at 9 11 2077 2079 O
risk 12 16 2080 2084 O
for 17 20 2085 2088 O
pregnancy 21 30 2089 2098 B-pregnancy
must 31 35 2099 2103 O
have 36 40 2104 2108 O
a 41 42 2109 2110 O
negative 43 51 2111 2119 B-pregnancy
pregnancy 52 61 2120 2129 I-pregnancy
test 62 66 2130 2134 O
at 67 69 2135 2137 O
screening 70 79 2138 2147 O
and 80 83 2148 2151 O
be 84 86 2152 2154 O
practicing 87 97 2155 2165 B-contraception_consent
an 98 100 2166 2168 I-contraception_consent
acceptable 101 111 2169 2179 I-contraception_consent
form 112 116 2180 2184 I-contraception_consent
of 117 119 2185 2187 I-contraception_consent
birth 120 125 2188 2193 I-contraception_consent
control 126 133 2194 2201 I-contraception_consent
, 133 134 2201 2202 O
have 135 139 2203 2207 O
had 140 143 2208 2211 O
a 144 145 2212 2213 O
hysterectomy 146 158 2214 2226 B-contraception_consent
or 159 161 2227 2229 O
tubal 162 167 2230 2235 B-contraception_consent
ligation 168 176 2236 2244 I-contraception_consent
, 176 177 2244 2245 O
or 178 180 2246 2248 O
otherwise 181 190 2249 2258 O
be 191 193 2259 2261 O
incapable 194 203 2262 2271 B-pregnancy
of 204 206 2272 2274 I-pregnancy
pregnancy 207 216 2275 2284 I-pregnancy
, 216 217 2284 2285 O
or 218 220 2286 2288 O
have 221 225 2289 2293 O
practiced 226 235 2294 2303 B-contraception_consent
any 236 239 2304 2307 I-contraception_consent
of 240 242 2308 2310 I-contraception_consent
the 243 246 2311 2314 I-contraception_consent
following 247 256 2315 2324 I-contraception_consent
methods 257 264 2325 2332 I-contraception_consent
of 265 267 2333 2335 I-contraception_consent
contraception 268 281 2336 2349 I-contraception_consent
for 282 285 2350 2353 O
at 286 288 2354 2356 O
least 289 294 2357 2362 O
one 295 298 2363 2366 B-lower_bound
month 299 304 2367 2372 I-lower_bound
prior 305 310 2373 2378 I-lower_bound
to 311 313 2379 2381 O
study 314 319 2382 2387 O
entry 320 325 2388 2393 O
: 325 326 2393 2394 O
hormonal 327 335 2395 2403 B-contraception_consent
contraceptives 336 350 2404 2418 I-contraception_consent
, 350 351 2418 2419 O
spermicide 352 362 2420 2430 B-contraception_consent
with 363 367 2431 2435 I-contraception_consent
barrier 368 375 2436 2443 I-contraception_consent
, 375 376 2443 2444 O
intrauterine 377 389 2445 2457 B-contraception_consent
device 390 396 2458 2464 I-contraception_consent
, 396 397 2464 2465 O
or 398 400 2466 2468 O
partner 401 408 2469 2476 B-contraception_consent
sterility 409 418 2477 2486 I-contraception_consent

Subjects 0 8 2487 2495 O
on 9 11 2496 2498 O
sleep 12 17 2499 2504 B-treatment
medication 18 28 2505 2515 I-treatment
must 29 33 2516 2520 O
be 34 36 2521 2523 O
on 37 39 2524 2526 O
a 40 41 2527 2528 O
stable 42 48 2529 2535 O
dose 49 53 2536 2540 O
for 54 57 2541 2544 O
at 58 60 2545 2547 O
least 61 66 2548 2553 O
6 67 68 2554 2555 B-upper_bound
months 69 75 2556 2562 I-upper_bound
prior 76 81 2563 2568 I-upper_bound
screening 82 91 2569 2578 O

female 0 6 2579 2585 B-gender

peripheral 0 10 2586 2596 B-chronic_disease
neuropathy 11 21 2597 2607 I-chronic_disease
and 22 25 2608 2611 O
neurodegenerative 26 43 2612 2629 B-chronic_disease
disorders 44 53 2630 2639 I-chronic_disease
( 54 55 2640 2641 O
i.e. 55 59 2641 2645 O
Parkinson 60 69 2646 2655 B-chronic_disease
's 69 71 2655 2657 I-chronic_disease
disease 72 79 2658 2665 I-chronic_disease
or 80 82 2666 2668 O
dementia 83 91 2669 2677 B-chronic_disease
) 91 92 2677 2678 O

subject 0 7 2679 2686 O
≥18 8 11 2687 2690 O
years 12 17 2691 2696 I-lower_bound
of 18 20 2697 2699 O
age 21 24 2700 2703 B-age
who 25 28 2704 2707 O
is 29 31 2708 2710 O
able 32 36 2711 2715 O
to 37 39 2716 2718 O
give 40 44 2719 2723 O
informed 45 53 2724 2732 O
consent 54 61 2733 2740 O

Adolescents 0 11 0 11 O
( 12 13 12 13 O
ages 13 17 13 17 B-age
12 18 20 18 20 B-lower_bound
years 21 26 21 26 I-lower_bound
or 27 29 27 29 O
older 30 35 30 35 O
) 35 36 35 36 O

Non 0 3 37 40 B-language_fluency
- 3 4 40 41 I-language_fluency
English 4 11 41 48 I-language_fluency
speaking 12 20 49 57 I-language_fluency
( 21 22 58 59 O
operationalized 22 37 59 74 O
as 38 40 75 77 O
the 41 44 78 81 O
inability 45 54 82 91 B-language_fluency
to 55 57 92 94 I-language_fluency
read 58 62 95 99 I-language_fluency
and 63 66 100 103 I-language_fluency
understand 67 77 104 114 I-language_fluency
the 78 81 115 118 I-language_fluency
consent 82 89 119 126 I-language_fluency
form 90 94 127 131 I-language_fluency
and 95 98 132 135 I-language_fluency
converse 99 107 136 144 I-language_fluency
in 108 110 145 147 I-language_fluency
spoken 111 117 148 154 I-language_fluency
English 118 125 155 162 I-language_fluency
) 125 126 162 163 O

Reflecting 0 10 164 174 O
the 11 14 175 178 O
demographics 15 27 179 191 O
of 28 30 192 194 O
the 31 34 195 198 O
community 35 44 199 208 O
in 45 47 209 211 O
which 48 53 212 217 O
we 54 56 218 220 O
are 57 60 221 224 O
recruiting 61 71 225 235 O
, 71 72 235 236 O
we 73 75 237 239 O
expect 76 82 240 246 O
approximately 83 96 247 260 O
70 97 99 261 263 O
% 99 100 263 264 O
of 101 103 265 267 O
the 104 107 268 271 O
sample 108 114 272 278 O
to 115 117 279 281 O
be 118 120 282 284 O
at 121 123 285 287 O
or 124 126 288 290 O
below 127 132 291 296 O
the 133 136 297 300 O
poverty 137 144 301 308 O
level 145 150 309 314 O
, 150 151 314 315 O
balanced 152 160 316 324 O
between 161 168 325 332 O
males 169 174 333 338 B-gender
and 175 178 339 342 I-gender
females 179 186 343 350 I-gender
, 186 187 350 351 O
with 188 192 352 356 O
the 193 196 357 360 O
majority 197 205 361 369 O
from 206 210 370 374 O
an 211 213 375 377 O
ethnic 214 220 378 384 O
minority 221 229 385 393 O
background 230 240 394 404 O

AML 0 3 0 3 B-cancer
, 3 4 3 4 O
ALL 5 8 5 8 B-cancer
: 8 9 8 9 O
Normal 10 16 10 16 O
values 17 23 17 23 O
for 24 27 24 27 O
absolute 28 36 28 36 B-clinical_variable
neutrophil 37 47 37 47 I-clinical_variable
count 48 53 48 53 I-clinical_variable
( 54 55 54 55 O
> 55 56 55 56 O
1000 56 60 56 60 B-lower_bound
/ 60 61 60 61 I-lower_bound
microL 61 67 61 67 I-lower_bound
) 67 68 67 68 O
and 69 72 69 72 O
platelet 73 81 73 81 B-clinical_variable
count 82 87 82 87 I-clinical_variable
( 88 89 88 89 O
> 89 90 89 90 O
100,000 90 97 90 97 B-lower_bound
/ 97 98 97 98 I-lower_bound
microL 98 104 98 104 I-lower_bound
) 104 105 104 105 O
; 105 106 105 106 O
Absence 107 114 107 114 O
of 115 117 115 117 O
extramedullary 118 132 118 132 O
leukemia 133 141 133 141 B-cancer
; 141 142 141 142 O
Less 143 147 143 147 O
than 148 152 148 152 O
5 153 154 153 154 B-upper_bound
percent 155 162 155 162 I-upper_bound
blast 163 168 163 168 I-upper_bound
cells 169 174 169 174 I-upper_bound
present 175 182 175 182 O
in 183 185 183 185 O
the 186 189 186 189 O
bone 190 194 190 194 O
marrow 195 201 195 201 O

Adequate 0 8 202 210 O
vital 9 14 211 216 O
organ 15 20 217 222 O
function 21 29 223 231 O
: 29 30 231 232 O
Left 31 35 233 237 B-clinical_variable
ventricular 36 47 238 249 I-clinical_variable
ejection 48 56 250 258 I-clinical_variable
fraction 57 65 259 267 I-clinical_variable
( 66 67 268 269 I-clinical_variable
LVEF 67 71 269 273 I-clinical_variable
) 71 72 273 274 I-clinical_variable
≥ 73 74 275 276 O
45 75 77 277 279 B-lower_bound
% 77 78 279 280 I-lower_bound
by 79 81 281 283 O
multigated 82 92 284 294 B-treatment
acquisition 93 104 295 306 I-treatment
( 105 106 307 308 I-treatment
MUGA 106 110 308 312 I-treatment
) 110 111 312 313 I-treatment
scan 112 116 314 318 I-treatment
or 117 119 319 321 O
echocardiogram 120 134 322 336 B-treatment
; 134 135 336 337 O
Forced 136 142 338 344 B-clinical_variable
expiratory 143 153 345 355 I-clinical_variable
volume 154 160 356 362 I-clinical_variable
in 161 163 363 365 I-clinical_variable
one 164 167 366 369 I-clinical_variable
second 168 174 370 376 I-clinical_variable
( 175 176 377 378 I-clinical_variable
FEV1 176 180 378 382 I-clinical_variable
) 180 181 382 383 I-clinical_variable
, 181 182 383 384 O
forced 183 189 385 391 B-clinical_variable
vital 190 195 392 397 I-clinical_variable
capacity 196 204 398 406 I-clinical_variable
( 205 206 407 408 I-clinical_variable
FVC 206 209 408 411 I-clinical_variable
) 209 210 411 412 I-clinical_variable
, 210 211 412 413 O
and 212 215 414 417 O
diffusing 216 225 418 427 B-clinical_variable
lung 226 230 428 432 I-clinical_variable
capacity 231 239 433 441 I-clinical_variable
oxygenation 240 251 442 453 I-clinical_variable
( 252 253 454 455 I-clinical_variable
DLCO 253 257 455 459 I-clinical_variable
) 257 258 459 460 I-clinical_variable
≥ 259 260 461 462 O
50 261 263 463 465 B-lower_bound
% 263 264 465 466 I-lower_bound
of 265 267 467 469 O
predicted 268 277 470 479 O
values 278 284 480 486 O
on 285 287 487 489 O
pulmonary 288 297 490 499 B-treatment
function 298 306 500 508 I-treatment
tests 307 312 509 514 I-treatment
; 312 313 514 515 O
Transaminases 314 327 516 529 B-clinical_variable
( 328 329 530 531 O
AST 329 332 531 534 B-clinical_variable
, 332 333 534 535 O
ALT 334 337 536 539 B-clinical_variable
) 337 338 539 540 O
< 339 340 541 542 O
3 341 342 543 544 B-upper_bound
times 343 348 545 550 I-upper_bound
upper 349 354 551 556 I-upper_bound
limit 355 360 557 562 I-upper_bound
of 361 363 563 565 I-upper_bound
normal 364 370 566 572 I-upper_bound
values 371 377 573 579 O
; 377 378 579 580 O
Creatinine 379 389 581 591 B-clinical_variable
clearance 390 399 592 601 I-clinical_variable
≥ 400 401 602 603 O
50cc 402 406 604 608 B-lower_bound
/ 406 407 608 609 I-lower_bound
min 407 410 609 612 I-lower_bound

Agreement 0 9 613 622 B-contraception_consent
to 10 12 623 625 I-contraception_consent
utilize 13 20 626 633 I-contraception_consent
effective 21 30 634 643 I-contraception_consent
contraceptive 31 44 644 657 I-contraception_consent
methods 45 52 658 665 O
during 53 59 666 672 O
the 60 63 673 676 O
study 64 69 677 682 O
( 70 71 683 684 O
for 71 74 684 687 O
one 75 78 688 691 O
year 79 83 692 696 O
) 83 84 696 697 O

Antithymocyte 0 13 698 711 B-treatment
globulin 14 22 712 720 I-treatment
( 23 24 721 722 I-treatment
ATG 24 27 722 725 I-treatment
) 27 28 725 726 I-treatment
as 29 31 727 729 O
part 32 36 730 734 O
of 37 39 735 737 O
the 40 43 738 741 O
conditioning 44 56 742 754 O
regimen 57 64 755 762 O

CLL 0 3 763 766 B-cancer
: 3 4 766 767 O
Absence 5 12 768 775 O
of 13 15 776 778 O
constitutional 16 30 779 793 O
symptoms 31 39 794 802 O
attributable 40 52 803 815 O
to 53 55 816 818 O
CLL 56 59 819 822 O
; 59 60 822 823 O
No 61 63 824 826 O
lymph 64 69 827 832 B-clinical_variable
nodes 70 75 833 838 I-clinical_variable
> 76 77 839 840 O
1.5 77 80 840 843 B-lower_bound
cm 81 83 844 846 I-lower_bound
in 84 86 847 849 O
diameter 87 95 850 858 B-clinical_variable
on 96 98 859 861 O
computed 99 107 862 870 B-treatment
tomography 108 118 871 881 I-treatment
; 118 119 881 882 O
No 120 122 883 885 O
hepatomegaly 123 135 886 898 O
or 136 138 899 901 O
splenomegaly 139 151 902 914 O
by 152 154 915 917 O
computed 155 163 918 926 O
tomography 164 174 927 937 O
; 174 175 937 938 O
Absolute 176 184 939 947 B-clinical_variable
neutrophil 185 195 948 958 I-clinical_variable
count 196 201 959 964 I-clinical_variable
> 202 203 965 966 O
1500 203 207 966 970 B-lower_bound
/ 207 208 970 971 I-lower_bound
microL 208 214 971 977 I-lower_bound
; 214 215 977 978 O
Platelet 216 224 979 987 B-clinical_variable
count 225 230 988 993 I-clinical_variable
> 231 232 994 995 O
100,000 232 239 995 1002 B-lower_bound
/ 239 240 1002 1003 I-lower_bound
microL 240 246 1003 1009 I-lower_bound
; 246 247 1009 1010 O
No 248 250 1011 1013 O
clonal 251 257 1014 1020 O
lymphocytes 258 269 1021 1032 O
in 270 272 1033 1035 O
the 273 276 1036 1039 O
peripheral 277 287 1040 1050 O
blood 288 293 1051 1056 O
by 294 296 1057 1059 O
immunophenotyping 297 314 1060 1077 B-treatment
; 314 315 1077 1078 O
Bone 316 320 1079 1083 O
marrow 321 327 1084 1090 O
with 328 332 1091 1095 O
no 333 335 1096 1098 O
evidence 336 344 1099 1107 O
of 345 347 1108 1110 O
clonal 348 354 1111 1117 B-cancer
CLL 355 358 1118 1121 I-cancer
( 359 360 1122 1123 O
by 360 362 1123 1125 O
flow 363 367 1126 1130 B-treatment
cytometry 368 377 1131 1140 I-treatment
and/or 378 384 1141 1147 O
immunohistochemistry 385 405 1148 1168 B-treatment

Eligible 0 8 1169 1177 O
donors 9 15 1178 1184 O
will 16 20 1185 1189 O
include 21 28 1190 1197 O
siblings 29 37 1198 1206 O
age 38 41 1207 1210 B-age
≥ 42 43 1211 1212 O
18 44 46 1213 1215 B-lower_bound
matched 47 54 1216 1223 O
with 55 59 1224 1228 O
the 60 63 1229 1232 O
recipient 64 73 1233 1242 O
at 74 76 1243 1245 O
HLA 77 80 1246 1249 O
- 80 81 1249 1250 O
A 81 82 1250 1251 O
, 82 83 1251 1252 O
B 84 85 1253 1254 O
, 85 86 1254 1255 O
C 87 88 1256 1257 O
, 88 89 1257 1258 O
and 90 93 1259 1262 O
DRB1 94 98 1263 1267 O

HIV 0 3 1268 1271 B-chronic_disease
negative 4 12 1272 1280 O
by 13 15 1281 1283 O
ELISA 16 21 1284 1289 B-treatment
or 22 24 1290 1292 O
reverse 25 32 1293 1300 B-treatment
transcription 33 46 1301 1314 I-treatment
polymerase 47 57 1315 1325 I-treatment
chain 58 63 1326 1331 I-treatment
reaction 64 72 1332 1340 I-treatment
( 73 74 1341 1342 I-treatment
RT 74 76 1342 1344 I-treatment
- 76 77 1344 1345 I-treatment
PCR 77 80 1345 1348 I-treatment
) 80 81 1348 1349 I-treatment
[ 82 83 1350 1351 O
if 83 85 1351 1353 O
ELISA 86 91 1354 1359 O
is 92 94 1360 1362 O
positive 95 103 1363 1371 O
and 104 107 1372 1375 O
RT 108 110 1376 1378 O
- 110 111 1378 1379 O
PCR 111 114 1379 1382 O
is 115 117 1383 1385 O
negative 118 126 1386 1394 O
, 126 127 1394 1395 O
the 128 131 1396 1399 O
ELISA 132 137 1400 1405 O
is 138 140 1406 1408 O
considered 141 151 1409 1419 O
false 152 157 1420 1425 O
positive 158 166 1426 1434 O
] 166 167 1434 1435 O

HL 0 2 1436 1438 O
: 2 3 1438 1439 O
No 4 6 1440 1442 O
clinical 7 15 1443 1451 O
evidence 16 24 1452 1460 O
of 25 27 1461 1463 O
disease 28 35 1464 1471 O
or 36 38 1472 1474 O
disease 39 46 1475 1482 O
- 46 47 1482 1483 O
related 47 54 1483 1490 O
symptoms 55 63 1491 1499 O
; 63 64 1499 1500 O
A 65 66 1501 1502 O
post 67 71 1503 1507 O
- 71 72 1507 1508 O
treatment 72 81 1508 1517 B-treatment
residual 82 90 1518 1526 O
mass 91 95 1527 1531 O
of 96 98 1532 1534 O
any 99 102 1535 1538 O
size 103 107 1539 1543 O
is 108 110 1544 1546 O
permitted 111 120 1547 1556 O
as 121 123 1557 1559 O
long 124 128 1560 1564 O
as 129 131 1565 1567 O
it 132 134 1568 1570 O
is 135 137 1571 1573 O
PET 138 141 1574 1577 O
negative 142 150 1578 1586 O
; 150 151 1586 1587 O
Spleen 152 158 1588 1594 O
and 159 162 1595 1598 O
liver 163 168 1599 1604 O
must 169 173 1605 1609 O
be 174 176 1610 1612 O
non 177 180 1613 1616 O
- 180 181 1616 1617 O
palpable 181 189 1617 1625 O
and 190 193 1626 1629 O
without 194 201 1630 1637 O
nodules 202 209 1638 1645 O
; 209 210 1645 1646 O
If 211 213 1647 1649 O
a 214 215 1650 1651 O
pre 216 219 1652 1655 B-treatment
- 219 220 1655 1656 I-treatment
treatment 220 229 1656 1665 I-treatment
bone 230 234 1666 1670 I-treatment
marrow 235 241 1671 1677 I-treatment
biopsy 242 248 1678 1684 I-treatment
was 249 252 1685 1688 O
positive 253 261 1689 1697 O
, 261 262 1697 1698 O
an 263 265 1699 1701 O
adequate 266 274 1702 1710 B-treatment
bone 275 279 1711 1715 I-treatment
marrow 280 286 1716 1722 I-treatment
biopsy 287 293 1723 1729 I-treatment
from 294 298 1730 1734 O
the 299 302 1735 1738 O
same 303 307 1739 1743 O
site 308 312 1744 1748 O
must 313 317 1749 1753 O
be 318 320 1754 1756 O
cleared 321 328 1757 1764 O
of 329 331 1765 1767 O
infiltrate 332 342 1768 1778 O
; 342 343 1778 1779 O
if 344 346 1780 1782 O
this 347 351 1783 1787 O
is 352 354 1788 1790 O
indeterminate 355 368 1791 1804 O
by 369 371 1805 1807 O
morphology 372 382 1808 1818 O
, 382 383 1818 1819 O
immunohistochemistry 384 404 1820 1840 B-treatment
should 405 411 1841 1847 O
be 412 414 1848 1850 O
negative 415 423 1851 1859 O

Hematologic 0 11 1860 1871 B-cancer
malignancies 12 24 1872 1884 I-cancer
- 25 26 1885 1886 O
Acute 27 32 1887 1892 B-cancer
myelogenous 33 44 1893 1904 I-cancer
leukemia 45 53 1905 1913 I-cancer
( 54 55 1914 1915 I-cancer
AML 55 58 1915 1918 I-cancer
) 58 59 1918 1919 I-cancer
, 59 60 1919 1920 O
acute 61 66 1921 1926 B-cancer
lymphoblastic 67 80 1927 1940 I-cancer
leukemia 81 89 1941 1949 I-cancer
( 90 91 1950 1951 I-cancer
ALL 91 94 1951 1954 I-cancer
) 94 95 1954 1955 I-cancer
, 95 96 1955 1956 O
myelodysplastic 97 112 1957 1972 B-cancer
syndrome 113 121 1973 1981 I-cancer
( 122 123 1982 1983 I-cancer
MDS 123 126 1983 1986 I-cancer
) 126 127 1986 1987 I-cancer
, 127 128 1987 1988 O
chronic 129 136 1989 1996 B-cancer
lymphocytic 137 148 1997 2008 I-cancer
leukemia 149 157 2009 2017 I-cancer
( 158 159 2018 2019 I-cancer
CLL 159 162 2019 2022 I-cancer
) 162 163 2022 2023 I-cancer
, 163 164 2023 2024 O
non 165 168 2025 2028 B-cancer
- 168 169 2028 2029 I-cancer
Hodgkin 169 176 2029 2036 I-cancer
lymphoma 177 185 2037 2045 I-cancer
( 186 187 2046 2047 I-cancer
NHL 187 190 2047 2050 I-cancer
) 190 191 2050 2051 I-cancer
, 191 192 2051 2052 O
Hodgkin 193 200 2053 2060 B-cancer
lymphoma 201 209 2061 2069 I-cancer
( 210 211 2070 2071 I-cancer
HL 211 213 2071 2073 I-cancer
) 213 214 2073 2074 I-cancer
, 214 215 2074 2075 O
multiple 216 224 2076 2084 B-cancer
myeloma 225 232 2085 2092 I-cancer
( 233 234 2093 2094 I-cancer
MM 234 236 2094 2096 I-cancer
) 236 237 2096 2097 I-cancer
- 238 239 2098 2099 O
in 240 242 2100 2102 O
complete 243 251 2103 2111 B-treatment
remission 252 261 2112 2121 I-treatment
( 262 263 2122 2123 I-treatment
CR 263 265 2123 2125 I-treatment
) 265 266 2125 2126 I-treatment
. 266 267 2126 2127 O
Complete 268 276 2128 2136 B-treatment
remission 277 286 2137 2146 I-treatment
is 287 289 2147 2149 O
defined 290 297 2150 2157 O
per 298 301 2158 2161 O
morphologic 302 313 2162 2173 O
, 313 314 2173 2174 O
cytogenetic 315 326 2175 2186 O
, 326 327 2186 2187 O
FISH 328 332 2188 2192 O
, 332 333 2192 2193 O
molecular 334 343 2194 2203 O
, 343 344 2203 2204 O
and 345 348 2205 2208 O
radiographic 349 361 2209 2221 O
imaging 362 369 2222 2229 O
studies 370 377 2230 2237 O
appropriate 378 389 2238 2249 O
for 390 393 2250 2253 O
each 394 398 2254 2258 O
condition 399 408 2259 2268 O
listed 409 415 2269 2275 O

Hepatitis 0 9 2276 2285 B-chronic_disease
B 10 11 2286 2287 I-chronic_disease
and 12 15 2288 2291 I-chronic_disease
C 16 17 2292 2293 I-chronic_disease
negative 18 26 2294 2302 O
by 27 29 2303 2305 O
serology 30 38 2306 2314 B-treatment
or 39 41 2315 2317 O
RT 42 44 2318 2320 B-treatment
- 44 45 2320 2321 I-treatment
PCR 45 48 2321 2324 I-treatment

MDS 0 3 2325 2328 O
: 3 4 2328 2329 O
Bone 5 9 2330 2334 B-clinical_variable
marrow 10 16 2335 2341 I-clinical_variable
with 17 21 2342 2346 O
≤5 22 24 2347 2349 O
percent 25 32 2350 2357 I-upper_bound
myeloblasts 33 44 2358 2369 I-upper_bound
with 45 49 2370 2374 O
normal 50 56 2375 2381 O
maturation 57 67 2382 2392 O
of 68 70 2393 2395 O
all 71 74 2396 2399 O
cell 75 79 2400 2404 O
lines 80 85 2405 2410 O
; 85 86 2410 2411 O
Peripheral 87 97 2412 2422 O
blood 98 103 2423 2428 O
demonstrates 104 116 2429 2441 O
hemoglobin 117 127 2442 2452 B-clinical_variable
≥11 128 131 2453 2456 O
g 132 133 2457 2458 I-lower_bound
/ 133 134 2458 2459 I-lower_bound
dL 134 136 2459 2461 I-lower_bound
, 136 137 2461 2462 O
platelets 138 147 2463 2472 B-clinical_variable
≥100 148 152 2473 2477 O
x 153 154 2478 2479 I-lower_bound
10 155 157 2480 2482 I-lower_bound
^ 157 158 2482 2483 I-lower_bound
9 158 159 2483 2484 I-lower_bound
/ 159 160 2484 2485 I-lower_bound
L 160 161 2485 2486 I-lower_bound
, 161 162 2486 2487 O
neutrophils 163 174 2488 2499 B-clinical_variable
≥1 175 177 2500 2502 O
x 178 179 2503 2504 I-lower_bound
10 180 182 2505 2507 I-lower_bound
^ 182 183 2507 2508 I-lower_bound
9 183 184 2508 2509 I-lower_bound
/ 184 185 2509 2510 I-lower_bound
L 185 186 2510 2511 I-lower_bound
, 186 187 2511 2512 O
and 188 191 2513 2516 O
no 192 194 2517 2519 O
circulating 195 206 2520 2531 O
blasts 207 213 2532 2538 O

MDS 0 3 2539 2542 B-cancer
: 3 4 2542 2543 O
Low 5 8 2544 2547 O
/ 8 9 2547 2548 O
intermediate-1 9 23 2548 2562 O
IPSS 24 28 2563 2567 O
risk 29 33 2568 2572 O
category 34 42 2573 2581 O
patients 43 51 2582 2590 O
are 52 55 2591 2594 O
eligible 56 64 2595 2603 O
only 65 69 2604 2608 O
if 70 72 2609 2611 O
they 73 77 2612 2616 O
have 78 82 2617 2621 O
failed 83 89 2622 2628 O
prior 90 95 2629 2634 B-treatment
therapy 96 103 2635 2642 I-treatment
or 104 106 2643 2645 O
are 107 110 2646 2649 O
transfusion 111 122 2650 2661 B-treatment
- 122 123 2661 2662 O
dependent 123 132 2662 2671 O

MDS 0 3 2672 2675 B-cancer
: 3 4 2675 2676 O
May 5 8 2677 2680 O
have 9 13 2681 2685 O
achieved 14 22 2686 2694 O
CR 23 25 2695 2697 O
through 26 33 2698 2705 O
either 34 40 2706 2712 O
hypomethylating 41 56 2713 2728 B-treatment
agent 57 62 2729 2734 I-treatment
therapy 63 70 2735 2742 I-treatment
, 70 71 2742 2743 O
induction 72 81 2744 2753 B-treatment
chemotherapy 82 94 2754 2766 I-treatment
, 94 95 2766 2767 O
or 96 98 2768 2770 O
other 99 104 2771 2776 B-treatment
therapy 105 112 2777 2784 I-treatment

MM 0 2 2785 2787 O
: 2 3 2787 2788 O
Absence 4 11 2789 2796 O
of 12 14 2797 2799 O
monoclonal 15 25 2800 2810 O
protein 26 33 2811 2818 O
in 34 36 2819 2821 O
serum 37 42 2822 2827 O
and 43 46 2828 2831 O
urine 47 52 2832 2837 O
by 53 55 2838 2840 O
immunofixation 56 70 2841 2855 O
with 71 75 2856 2860 O
no 76 78 2861 2863 O
current 79 86 2864 2871 O
evidence 87 95 2872 2880 O
of 96 98 2881 2883 O
soft 99 103 2884 2888 O
tissue 104 110 2889 2895 O
plasmacytoma 111 123 2896 2908 O
; 123 124 2908 2909 O
Bone 125 129 2910 2914 B-treatment
marrow 130 136 2915 2921 I-treatment
aspirate 137 145 2922 2930 I-treatment
and 146 149 2931 2934 O
biopsy 150 156 2935 2941 B-treatment
must 157 161 2942 2946 O
demonstrate 162 173 2947 2958 O
less 174 178 2959 2963 O
than 179 183 2964 2968 O
5 184 185 2969 2970 B-upper_bound
percent 186 193 2971 2978 I-upper_bound
clonal 194 200 2979 2985 O
plasma 201 207 2986 2992 O
cells 208 213 2993 2998 O
; 213 214 2998 2999 O
In 215 217 3000 3002 O
patients 218 226 3003 3011 O
who 227 230 3012 3015 O
lack 231 235 3016 3020 O
measurable 236 246 3021 3031 O
M 247 248 3032 3033 O
proteins 249 257 3034 3042 O
in 258 260 3043 3045 O
the 261 264 3046 3049 O
serum 265 270 3050 3055 O
and 271 274 3056 3059 O
urine 275 280 3060 3065 O
being 281 286 3066 3071 O
monitored 287 296 3072 3081 O
using 297 302 3082 3087 O
the 303 306 3088 3091 O
FLC 307 310 3092 3095 B-clinical_variable
levels 311 317 3096 3102 I-clinical_variable
, 317 318 3102 3103 O
the 319 322 3104 3107 O
definition 323 333 3108 3118 O
of 334 336 3119 3121 O
CR 337 339 3122 3124 O
requires 340 348 3125 3133 O
a 349 350 3134 3135 O
normalization 351 364 3136 3149 O
of 365 367 3150 3152 O
the 368 371 3153 3156 O
free 372 376 3157 3161 B-clinical_variable
light 377 382 3162 3167 I-clinical_variable
chain 383 388 3168 3173 I-clinical_variable
( 389 390 3174 3175 I-clinical_variable
FLC 390 393 3175 3178 I-clinical_variable
) 393 394 3178 3179 I-clinical_variable
ratio 395 400 3180 3185 I-clinical_variable
in 401 403 3186 3188 O
addition 404 412 3189 3197 O
to 413 415 3198 3200 O
the 416 419 3201 3204 O
above 420 425 3205 3210 O
criteria 426 434 3211 3219 O

Must 0 4 3220 3224 O
complete 5 13 3225 3233 O
full 14 18 3234 3238 O
screening 19 28 3239 3248 O
panel 29 34 3249 3254 O
: 34 35 3254 3255 O
HIV 36 39 3256 3259 B-chronic_disease
1 40 41 3260 3261 O
, 41 42 3261 3262 O
2 43 44 3263 3264 O
serology 45 53 3265 3273 O
and 54 57 3274 3277 O
RT 58 60 3278 3280 B-treatment
- 60 61 3280 3281 I-treatment
PCR 61 64 3281 3284 I-treatment
; 64 65 3284 3285 O
human 66 71 3286 3291 B-treatment
T 72 73 3292 3293 I-treatment
cell 74 78 3294 3298 I-treatment
lymphotropic 79 91 3299 3311 I-treatment
virus 92 97 3312 3317 I-treatment
types 98 103 3318 3323 I-treatment
1/2 104 107 3324 3327 I-treatment
( 108 109 3328 3329 I-treatment
HTLV-1/2 109 117 3329 3337 I-treatment
) 117 118 3337 3338 I-treatment
serology 119 127 3339 3347 I-treatment
; 127 128 3347 3348 O
rapid 129 134 3349 3354 B-treatment
plasma 135 141 3355 3361 I-treatment
reagin 142 148 3362 3368 I-treatment
( 149 150 3369 3370 I-treatment
RPR 150 153 3370 3373 I-treatment
) 153 154 3373 3374 I-treatment
serology 155 163 3375 3383 I-treatment
; 163 164 3383 3384 O
Epstein 165 172 3385 3392 B-treatment
- 172 173 3392 3393 I-treatment
Barr 173 177 3393 3397 I-treatment
virus 178 183 3398 3403 I-treatment
( 184 185 3404 3405 I-treatment
EBV 185 188 3405 3408 I-treatment
) 188 189 3408 3409 I-treatment
serology 190 198 3410 3418 I-treatment
; 198 199 3418 3419 O
Cytomegalovirus 200 215 3420 3435 B-treatment
( 216 217 3436 3437 I-treatment
CMV 217 220 3437 3440 I-treatment
) 220 221 3440 3441 I-treatment
serology 222 230 3442 3450 I-treatment
; 230 231 3450 3451 O
herpes 232 238 3452 3458 B-treatment
simplex 239 246 3459 3466 I-treatment
virus 247 252 3467 3472 I-treatment
( 253 254 3473 3474 I-treatment
HSV 254 257 3474 3477 I-treatment
) 257 258 3477 3478 I-treatment
serology 259 267 3479 3487 I-treatment
; 267 268 3487 3488 O
Varicella- 269 279 3489 3499 B-treatment
. 279 280 3499 3500 I-treatment
Zoster 281 287 3501 3507 I-treatment
Virus 288 293 3508 3513 I-treatment
( 294 295 3514 3515 I-treatment
VZV 295 298 3515 3518 I-treatment
) 298 299 3518 3519 I-treatment
serology 300 308 3520 3528 I-treatment

NHL 0 3 3529 3532 O
: 3 4 3532 3533 O
No 5 7 3534 3536 O
clinical 8 16 3537 3545 O
evidence 17 25 3546 3554 O
of 26 28 3555 3557 O
disease 29 36 3558 3565 O
or 37 39 3566 3568 O
disease 40 47 3569 3576 O
- 47 48 3576 3577 O
related 48 55 3577 3584 O
symptoms 56 64 3585 3593 O
; 64 65 3593 3594 O
Typically 66 75 3595 3604 O
FDG 76 79 3605 3608 B-treatment
- 79 80 3608 3609 I-cancer
avid 80 84 3609 3613 I-cancer
lymphomas 85 94 3614 3623 I-cancer
: 94 95 3623 3624 O
a 96 97 3625 3626 O
post 98 102 3627 3631 O
- 102 103 3631 3632 O
treatment 103 112 3632 3641 B-treatment
residual 113 121 3642 3650 O
mass 122 126 3651 3655 O
of 127 129 3656 3658 O
any 130 133 3659 3662 O
size 134 138 3663 3667 O
is 139 141 3668 3670 O
permitted 142 151 3671 3680 O
as 152 154 3681 3683 O
long 155 159 3684 3688 O
as 160 162 3689 3691 O
it 163 165 3692 3694 O
is 166 168 3695 3697 O
PET 169 172 3698 3701 O
negative 173 181 3702 3710 O
; 181 182 3710 3711 O
Variably 183 191 3712 3720 O
FDG 192 195 3721 3724 O
- 195 196 3724 3725 O
avid 196 200 3725 3729 O
lymphoma 201 209 3730 3738 O
/ 209 210 3738 3739 O
FDG 210 213 3739 3742 O
avidity 214 221 3743 3750 O
unknown 222 229 3751 3758 O
: 229 230 3758 3759 O
all 231 234 3760 3763 O
lymph 235 240 3764 3769 O
nodes 241 246 3770 3775 O
normal 247 253 3776 3782 O
size 254 258 3783 3787 O
by 259 261 3788 3790 O
CT 262 264 3791 3793 B-treatment
; 264 265 3793 3794 O
Spleen 266 272 3795 3801 O
and 273 276 3802 3805 O
liver 277 282 3806 3811 O
non 283 286 3812 3815 O
- 286 287 3815 3816 O
palpable 287 295 3816 3824 O
and 296 299 3825 3828 O
without 300 307 3829 3836 O
nodules 308 315 3837 3844 O
; 315 316 3844 3845 O
If 317 319 3846 3848 O
pretreatment 320 332 3849 3861 B-treatment
bone 333 337 3862 3866 I-treatment
marrow 338 344 3867 3873 I-treatment
biopsy 345 351 3874 3880 I-treatment
was 352 355 3881 3884 O
positive 356 364 3885 3893 O
, 364 365 3893 3894 O
repeat 366 372 3895 3901 O
bone 373 377 3902 3906 O
marrow 378 384 3907 3913 O
biopsy 385 391 3914 3920 O
must 392 396 3921 3925 O
be 397 399 3926 3928 O
negative 400 408 3929 3937 O
; 408 409 3937 3938 O
if 410 412 3939 3941 O
morphologically 413 428 3942 3957 O
indeterminate 429 442 3958 3971 O
, 442 443 3971 3972 O
immunohistochemistry 444 464 3973 3993 B-treatment
should 465 471 3994 4000 O
be 472 474 4001 4003 O
negative 475 483 4004 4012 O
If 484 486 4013 4015 O
pretreatment 487 499 4016 4028 O
bone 500 504 4029 4033 O
marrow 505 511 4034 4040 O
biopsy 512 518 4041 4047 O
was 519 522 4048 4051 O
positive 523 531 4052 4060 O
, 531 532 4060 4061 O
repeat 533 539 4062 4068 O
bone 540 544 4069 4073 O
marrow 545 551 4074 4080 O
biopsy 552 558 4081 4087 O
must 559 563 4088 4092 O
be 564 566 4093 4095 O
negative 567 575 4096 4104 O
; 575 576 4104 4105 O
if 577 579 4106 4108 O
morphologically 580 595 4109 4124 O
indeterminate 596 609 4125 4138 O
, 609 610 4138 4139 O
immunohistochemistry 611 631 4140 4160 O
should 632 638 4161 4167 O
be 639 641 4168 4170 O
negative 642 650 4171 4179 O

No 0 2 4180 4182 O
active 3 9 4183 4189 O
infection 10 19 4190 4199 B-chronic_disease
; 19 20 4199 4200 O
infection 21 30 4201 4210 O
controlled 31 41 4211 4221 O
with 42 46 4222 4226 O
antimicrobial 47 60 4227 4240 O
therapy 61 68 4241 4248 B-treatment
is 69 71 4249 4251 O
not 72 75 4252 4255 O
excluded 76 84 4256 4264 O

Performance 0 11 4265 4276 B-clinical_variable
status 12 18 4277 4283 I-clinical_variable
: 18 19 4283 4284 O
Karnofsky 20 29 4285 4294 B-clinical_variable
Performance 30 41 4295 4306 I-clinical_variable
Status 42 48 4307 4313 I-clinical_variable
Score 49 54 4314 4319 I-clinical_variable
≥ 55 56 4320 4321 O
60 57 59 4322 4324 B-lower_bound
% 59 60 4324 4325 I-lower_bound

Peripheral 0 10 4326 4336 O
blood 11 16 4337 4342 O
white 17 22 4343 4348 B-clinical_variable
blood 23 28 4349 4354 I-clinical_variable
count 29 34 4355 4360 I-clinical_variable
( 35 36 4361 4362 I-clinical_variable
WBC 36 39 4362 4365 I-clinical_variable
) 39 40 4365 4366 I-clinical_variable
greater 41 48 4367 4374 O
than 49 53 4375 4379 O
2,000 54 59 4380 4385 B-lower_bound
per 60 63 4386 4389 I-lower_bound
microliter 64 74 4390 4400 I-lower_bound
( 75 76 4401 4402 O
required 76 84 4402 4410 O
for 85 88 4411 4414 O
collection 89 99 4415 4425 O
of 100 102 4426 4428 O
dendritic 103 112 4429 4438 O
cell 113 117 4439 4443 O
precursors 118 128 4444 4454 O
) 128 129 4454 4455 O

At 0 2 0 2 O
least 3 8 3 8 O
18 9 11 9 11 B-lower_bound
years 12 17 12 17 I-lower_bound
of 18 20 18 20 O
age 21 24 21 24 B-age

At 0 2 25 27 O
least 3 8 28 33 O
one 9 12 34 37 B-lower_bound
site 13 17 38 42 O
of 18 20 43 45 O
disease 21 28 46 53 O
outside 29 36 54 61 O
of 37 39 62 64 O
the 40 43 65 68 O
liver 44 49 69 74 O
that 50 54 75 79 O
is 55 57 80 82 O
seen 58 62 83 87 O
on 63 65 88 90 O
standard 66 74 91 99 O
imaging 75 82 100 107 O
( 83 84 108 109 O
e.g. 84 88 109 113 O
CT 89 91 114 116 B-treatment
, 91 92 116 117 O
bone 93 97 118 122 B-treatment
scan 98 102 123 127 I-treatment
, 102 103 127 128 O
MRI 104 107 129 132 B-treatment
, 107 108 132 133 O
FDG 109 112 134 137 B-treatment
PET 113 116 138 141 I-treatment
/ 116 117 141 142 I-treatment
CT 117 119 142 144 I-treatment
) 119 120 144 145 O

Females 0 7 146 153 B-gender
who 8 11 154 157 O
are 12 15 158 161 B-pregnancy
pregnant 16 24 162 170 I-pregnancy
at 25 27 171 173 O
the 28 31 174 177 O
time 32 36 178 182 O
of 37 39 183 185 O
screening 40 49 186 195 O

History 0 7 196 203 O
of 8 10 204 206 O
ER+ 11 14 207 210 O
pathology 15 24 211 220 O
( 25 26 221 222 O
ER+ 26 29 222 225 O
may 30 33 226 229 O
be 34 36 230 232 O
confirmed 37 46 233 242 O
from 47 51 243 247 O
surgery 52 59 248 255 B-treatment
or 60 62 256 258 O
biopsy 63 69 259 265 B-treatment
of 70 72 266 268 O
primary 73 80 269 276 O
breast 81 87 277 283 B-cancer
cancer 88 94 284 290 I-cancer
or 95 97 291 293 O
lymph 98 103 294 299 B-cancer
nodes 104 109 300 305 I-cancer
, 109 110 305 306 O
and/or 111 117 307 313 O
surgery 118 125 314 321 O
or 126 128 322 324 O
biopsy 129 135 325 331 B-treatment
of 136 138 332 334 I-treatment
a 139 140 335 336 I-treatment
metastatic 141 151 337 347 I-treatment
site 152 156 348 352 I-treatment
, 156 157 352 353 O
metastatic 158 168 354 364 B-treatment
biopsy 169 175 365 371 I-treatment
is 176 178 372 374 O
not 179 182 375 378 O
required 183 191 379 387 O
) 191 192 387 388 O

History 0 7 389 396 O
of 8 10 397 399 O
HER2 11 15 400 404 B-cancer
/ 15 16 404 405 I-cancer
neu 16 19 405 408 I-cancer
positive 20 28 409 417 I-cancer
cancer 29 35 418 424 I-cancer
( 36 37 425 426 O
IHC 37 40 426 429 O
3 41 42 430 431 O
+ 42 43 431 432 O
and/or 44 50 433 439 O
FISH 51 55 440 444 O
positive 56 64 445 453 O
) 64 65 453 454 O
as 66 68 455 457 O
assessed 69 77 458 466 O
by 78 80 467 469 O
medical 81 88 470 477 O
record 89 95 478 484 O
review 96 102 485 491 O
at 103 105 492 494 O
screening 106 115 495 504 O

History 0 7 505 512 O
of 8 10 513 515 O
progression 11 22 516 527 O
or 23 25 528 530 O
recurrence 26 36 531 541 O
of 37 39 542 544 O
disease 40 47 545 552 O
while 48 53 553 558 O
on 54 56 559 561 O
an 57 59 562 564 O
endocrine 60 69 565 574 B-treatment
targeted 70 78 575 583 I-treatment
therapy 79 86 584 591 I-treatment
containing 87 97 592 602 O
regimen 98 105 603 610 O
as 106 108 611 613 O
assessed 109 117 614 622 O
by 118 120 623 625 O
medical 121 128 626 633 O
record 129 135 634 640 O
review 136 142 641 647 O
of 143 145 648 650 O
breast 146 152 651 657 B-cancer
cancer 153 159 658 664 I-cancer
history 160 167 665 672 O
at 168 170 673 675 O
screening 171 180 676 685 O

Recurrent 0 9 686 695 B-cancer
or 10 12 696 698 O
metastatic 13 23 699 709 B-cancer
cancer 24 30 710 716 I-cancer
that 31 35 717 721 O
is 36 38 722 724 O
of 39 41 725 727 O
known 42 47 728 733 O
or 48 50 734 736 O
suspected 51 60 737 746 O
breast 61 67 747 753 O
origin 68 74 754 760 O
- 75 76 761 762 O
may 77 80 763 766 O
be 81 83 767 769 O
biopsy 84 90 770 776 B-treatment
proven 91 97 777 783 O
or 98 100 784 786 O
identified 101 111 787 797 O
on 112 114 798 800 O
standard 115 123 801 809 O
imaging 124 131 810 817 O
( 132 133 818 819 O
e.g. 133 137 819 823 O
CT 138 140 824 826 B-treatment
, 140 141 826 827 O
bone 142 146 828 832 B-treatment
scan 147 151 833 837 I-treatment
, 151 152 837 838 O
MRI 153 156 839 842 B-treatment
, 156 157 842 843 O
FDG 158 161 844 847 B-treatment
PET 162 165 848 851 I-treatment
/ 165 166 851 852 I-treatment
CT 166 168 852 854 I-treatment
) 168 169 854 855 O

urine 0 5 856 861 O
pregnancy 6 15 862 871 B-pregnancy
test 16 20 872 876 O
will 21 25 877 881 O
be 26 28 882 884 O
performed 29 38 885 894 O
at 39 41 895 897 O
screening 42 51 898 907 O
in 52 54 908 910 O
women 55 60 911 916 B-gender
of 61 63 917 919 O
child 64 69 920 925 O
- 69 70 925 926 O
bearing 70 77 926 933 O
potential 78 87 934 943 O

History 0 7 0 7 O
of 8 10 8 10 O
previous 11 19 11 19 O
administration 20 34 20 34 O
of 35 37 35 37 O
rabies 38 44 38 44 B-treatment
vaccine 45 52 45 52 I-treatment
or 53 55 53 55 O
human 56 61 56 61 B-treatment
rabies 62 68 62 68 I-treatment
immune 69 75 69 75 I-treatment
globulin 76 84 76 84 I-treatment
( 85 86 85 86 I-treatment
HRIG 86 90 86 90 I-treatment
) 90 91 90 91 I-treatment

male 0 4 92 96 B-gender

The 0 3 0 3 O
patient 4 11 4 11 O
has 12 15 12 15 O
a 16 17 16 17 O
family 18 24 18 24 O
member 25 31 25 31 O
diagnosed 32 41 32 41 O
with 42 46 42 46 O
Dent 47 51 47 51 B-chronic_disease
Disease 52 59 52 59 I-chronic_disease

The 0 3 60 63 O
patient 4 11 64 71 O
has 12 15 72 75 O
been 16 20 76 80 O
diagnosed 21 30 81 90 O
, 30 31 90 91 O
or 32 34 92 94 O
in 35 37 95 97 O
the 38 41 98 101 O
process 42 49 102 109 O
of 50 52 110 112 O
being 53 58 113 118 O
diagnosed 59 68 119 128 O
with 69 73 129 133 O
Dent 74 78 134 138 B-chronic_disease
Disease 79 86 139 146 I-chronic_disease

< 0 1 0 1 O
18 1 3 1 3 B-upper_bound
years 4 9 4 9 I-upper_bound
old 10 13 10 13 O

Adult 0 5 14 19 O
patient 6 13 20 27 O
( 14 15 28 29 O
male 15 19 29 33 B-gender
or 20 22 34 36 I-gender
female 23 29 37 43 I-gender
) 29 30 43 44 O
requiring 31 40 45 54 O
emergency 41 50 55 64 O
endotracheal 51 63 65 77 B-treatment
intubation 64 74 78 88 I-treatment

Any 0 3 89 92 O
patient 4 11 93 100 O
who 12 15 101 104 O
has 16 19 105 108 O
been 20 24 109 113 O
previously 25 35 114 124 O
randomized 36 46 125 135 O
in 47 49 136 138 O
the 50 53 139 142 O
EvK 54 57 143 146 B-treatment
Trial 58 63 147 152 I-treatment

Women 0 5 153 158 B-gender
who 6 9 159 162 O
are 10 13 163 166 B-pregnancy
known 14 19 167 172 I-pregnancy
to 20 22 173 175 I-pregnancy
be 23 25 176 178 I-pregnancy
pregnant 26 34 179 187 I-pregnancy

who 0 3 188 191 O
require 4 11 192 199 O
endotracheal 12 24 200 212 B-treatment
intubation 25 35 213 223 I-treatment
without 36 43 224 231 O
sedative 44 52 232 240 O
medication 53 63 241 251 O

with 0 4 252 256 O
a 5 6 257 258 O
known 7 12 259 264 O
allergy 13 20 265 272 O
to 21 23 273 275 O
ketamine 24 32 276 284 B-allergy_name
or 33 35 285 287 O
etomidate 36 45 288 297 B-allergy_name

FR 0 2 0 2 B-clinical_variable
> 3 4 3 4 O
15ml 4 8 4 8 B-lower_bound
/ 8 9 8 9 I-lower_bound
Indwelling 9 19 9 19 I-lower_bound
catheter 20 28 20 28 I-lower_bound

History 0 7 29 36 O
of 8 10 37 39 O
prostate 11 19 40 48 B-cancer
cancer 20 26 49 55 I-cancer

IPSS 0 4 56 60 B-clinical_variable
< 5 6 61 62 O
8 6 7 62 63 B-upper_bound

Language 0 8 64 72 B-language_fluency
: 8 9 72 73 I-language_fluency
English 10 17 74 81 I-language_fluency
, 17 18 81 82 I-language_fluency
Spanish 19 26 83 90 I-language_fluency
, 26 27 90 91 I-language_fluency
Haitian 28 35 92 99 I-language_fluency
Creole 36 42 100 106 I-language_fluency
, 42 43 106 107 I-language_fluency
French 44 50 108 114 I-language_fluency
, 50 51 114 115 I-language_fluency
Portuguese 52 62 116 126 I-language_fluency

Male 0 4 127 131 B-gender

Neurogenic 0 10 132 142 B-chronic_disease
bladder 11 18 143 150 I-chronic_disease

PVR 0 3 151 154 B-clinical_variable
< 4 5 155 156 O
250 5 8 156 159 B-upper_bound

Untreated 0 9 160 169 B-chronic_disease
or 10 12 170 172 I-chronic_disease
uncorrected 13 24 173 184 I-chronic_disease
coagulopathy 25 37 185 197 I-chronic_disease

Age 0 3 0 3 B-age
≥ 4 5 4 5 O
35 6 8 6 8 B-lower_bound
years 9 14 9 14 I-lower_bound

Any 0 3 15 18 O
lifetime 4 12 19 27 O
history 13 20 28 35 O
of 21 23 36 38 O
a 24 25 39 40 O
suicide 26 33 41 48 B-chronic_disease
attempt 34 41 49 56 I-chronic_disease

Chronic 0 7 57 64 B-chronic_disease
kidney 8 14 65 71 I-chronic_disease
disease 15 22 72 79 I-chronic_disease
stage 23 28 80 85 I-chronic_disease
III 29 32 86 89 I-chronic_disease
or 33 35 90 92 O
greater 36 43 93 100 O
( 44 45 101 102 O
eGFR<60 45 52 102 109 B-clinical_variable
mL 53 55 110 112 I-upper_bound
/ 55 56 112 113 I-upper_bound
min 56 59 113 116 I-upper_bound
) 59 60 116 117 O

Current 0 7 118 125 O
or 8 10 126 128 O
history 11 18 129 136 O
of 19 21 137 139 O
treatment 22 31 140 149 B-treatment
with 32 36 150 154 O
medications 37 48 155 166 O
that 49 53 167 171 O
may 54 57 172 175 O
cause 58 63 176 181 O
significant 64 75 182 193 O
weight 76 82 194 200 O
gain 83 87 201 205 O
, 87 88 205 206 O
within 89 95 207 213 O
1 96 97 214 215 B-upper_bound
month 98 103 216 221 I-upper_bound
prior 104 109 222 227 I-upper_bound
to 110 112 228 230 O
screening 113 122 231 240 O
for 123 126 241 244 O
this 127 131 245 249 O
trial 132 137 250 255 O
, 137 138 255 256 O
including 139 148 257 266 O
systemic 149 157 267 275 B-treatment
corticosteroids 158 173 276 291 I-treatment
( 174 175 292 293 O
except 175 181 293 299 O
for 182 185 300 303 O
a 186 187 304 305 O
short 188 193 306 311 O
course 194 200 312 318 O
of 201 203 319 321 O
treatment 204 213 322 331 O
, 213 214 331 332 O
i.e. 215 219 333 337 O
, 219 220 337 338 O
7- 221 223 339 341 B-lower_bound
10 224 226 342 344 B-upper_bound
days 227 231 345 349 I-upper_bound
) 231 232 349 350 O
, 232 233 350 351 O
tri 234 237 352 355 B-treatment
- 237 238 355 356 I-treatment
cyclic 238 244 356 362 I-treatment
antidepressants 245 260 363 378 I-treatment
, 260 261 378 379 O
atypical 262 270 380 388 B-treatment
antipsychotic 271 284 389 402 I-treatment
and 285 288 403 406 O
mood 289 293 407 411 B-treatment
stabilizers 294 305 412 423 I-treatment
( 306 307 424 425 O
e.g. 307 311 425 429 O
, 311 312 429 430 O
imipramine 313 323 431 441 B-treatment
, 323 324 441 442 O
amitryptiline 325 338 443 456 B-treatment
, 338 339 456 457 O
mirtazapine 340 351 458 469 B-treatment
, 351 352 469 470 O
paroxetine 353 363 471 481 B-treatment
, 363 364 481 482 O
phenelzine 365 375 483 493 B-treatment
, 375 376 493 494 O
clorpromazine 377 390 495 508 B-treatment
, 390 391 508 509 O
thioridazine 392 404 510 522 B-treatment
, 404 405 522 523 O
clozapine 406 415 524 533 B-treatment
, 415 416 533 534 O
olanzapine 417 427 535 545 B-treatment
, 427 428 545 546 O
valproic 429 437 547 555 B-treatment
acid 438 442 556 560 I-treatment
and 443 446 561 564 O
its 447 450 565 568 O
derivatives 451 462 569 580 O
, 462 463 580 581 O
and 464 467 582 585 O
lithium 468 475 586 593 B-treatment
) 475 476 593 594 O

Current 0 7 595 602 O
participation 8 21 603 616 O
in 22 24 617 619 O
an 25 27 620 622 O
organized 28 37 623 632 O
weight 38 44 633 639 B-treatment
reduction 45 54 640 649 I-treatment
program 55 62 650 657 I-treatment
or 63 65 658 660 O
within 66 72 661 667 O
the 73 76 668 671 O
last 77 81 672 676 B-upper_bound
1 82 83 677 678 I-upper_bound
month 84 89 679 684 I-upper_bound
prior 90 95 685 690 I-upper_bound
to 96 98 691 693 O
screening 99 108 694 703 O
for 109 112 704 707 O
this 113 117 708 712 O
trial 118 123 713 718 O

Diet 0 4 719 723 O
attempts 5 13 724 732 O
using 14 19 733 738 O
herbal 20 26 739 745 O
supplements 27 38 746 757 O
or 39 41 758 760 O
over 42 46 761 765 O
- 46 47 765 766 O
the 47 50 766 769 O
- 50 51 769 770 O
counter 51 58 770 777 O
medications 59 70 778 789 O
within 71 77 790 796 O
1 78 79 797 798 B-upper_bound
month 80 85 799 804 I-upper_bound
prior 86 91 805 810 I-upper_bound
to 92 94 811 813 O
screening 95 104 814 823 O
for 105 108 824 827 O
this 109 113 828 832 O
trial 114 119 833 838 O

Familial 0 8 839 847 O
or 9 11 848 850 O
personal 12 20 851 859 O
history 21 28 860 867 O
of 29 31 868 870 O
multiple 32 40 871 879 O
endocrine 41 50 880 889 B-chronic_disease
neoplasia 51 60 890 899 I-chronic_disease
type 61 65 900 904 I-chronic_disease
2 66 67 905 906 I-chronic_disease
or 68 70 907 909 O
familial 71 79 910 918 O
medullary 80 89 919 928 B-cancer
thyroid 90 97 929 936 I-cancer
carcinoma 98 107 937 946 I-cancer

Females 0 7 947 954 B-gender
of 8 10 955 957 O
childbearing 11 23 958 970 O
potential 24 33 971 980 O
who 34 37 981 984 O
are 38 41 985 988 B-pregnancy
pregnant 42 50 989 997 I-pregnancy
, 50 51 997 998 O
breast 52 58 999 1005 O
- 58 59 1005 1006 O
feeding 59 66 1006 1013 O
or 67 69 1014 1016 O
intend 70 76 1017 1023 O
to 77 79 1024 1026 O
become 80 86 1027 1033 B-pregnancy
pregnant 87 95 1034 1042 I-pregnancy
or 96 98 1043 1045 O
are 99 102 1046 1049 O
not 103 106 1050 1053 B-contraception_consent
using 107 112 1054 1059 I-contraception_consent
adequate 113 121 1060 1068 I-contraception_consent
contraceptive 122 135 1069 1082 I-contraception_consent
methods 136 143 1083 1090 I-contraception_consent

History 0 7 1091 1098 O
of 8 10 1099 1101 O
Major 11 16 1102 1107 B-chronic_disease
Depressive 17 27 1108 1118 I-chronic_disease
Disorder 28 36 1119 1127 I-chronic_disease
within 37 43 1128 1134 O
the 44 47 1135 1138 O
last 48 52 1139 1143 B-upper_bound
2 53 54 1144 1145 I-upper_bound
years 55 60 1146 1151 I-upper_bound

History 0 7 1152 1159 O
of 8 10 1160 1162 O
chronic 11 18 1163 1170 B-chronic_disease
pancreatitis 19 31 1171 1183 I-chronic_disease
or 32 34 1184 1186 O
idiopathic 35 45 1187 1197 B-chronic_disease
acute 46 51 1198 1203 I-chronic_disease
pancreatitis 52 64 1204 1216 I-chronic_disease
( 65 66 1217 1218 O
current 66 73 1218 1225 O
or 74 76 1226 1228 O
prior 77 82 1229 1234 O
history 83 90 1235 1242 O
) 90 91 1242 1243 O

History 0 7 1244 1251 O
of 8 10 1252 1254 O
gallbladder 11 22 1255 1266 B-chronic_disease
disease 23 30 1267 1274 I-chronic_disease
( 31 32 1275 1276 O
cholelithiasis 32 46 1276 1290 B-chronic_disease
or 47 49 1291 1293 O
cholecystitis 50 63 1294 1307 B-chronic_disease
) 63 64 1307 1308 O

History 0 7 1309 1316 O
of 8 10 1317 1319 O
other 11 16 1320 1325 O
severe 17 23 1326 1332 B-chronic_disease
psychiatric 24 35 1333 1344 I-chronic_disease
disorders 36 45 1345 1354 I-chronic_disease
, 45 46 1354 1355 O
e.g. 47 51 1356 1360 O
, 51 52 1360 1361 O
schizophrenia 53 66 1362 1375 B-chronic_disease
, 66 67 1375 1376 O
bipolar 68 75 1377 1384 B-chronic_disease
disorder 76 84 1385 1393 I-chronic_disease

Known 0 5 1394 1399 O
or 6 8 1400 1402 O
suspected 9 18 1403 1412 O
hypersensitivity 19 35 1413 1429 O
to 36 38 1430 1432 O
trial 39 44 1433 1438 B-allergy_name
product(s 45 54 1439 1448 I-allergy_name
) 54 55 1448 1449 I-allergy_name
or 56 58 1450 1452 I-allergy_name
related 59 66 1453 1460 I-allergy_name
product(s 67 76 1461 1470 I-allergy_name
) 76 77 1470 1471 I-allergy_name

Obesity 0 7 1472 1479 B-chronic_disease
induced 8 15 1480 1487 O
by 16 18 1488 1490 O
other 19 24 1491 1496 O
endocrinologic 25 39 1497 1511 B-chronic_disease
disorders 40 49 1512 1521 I-chronic_disease
( 50 51 1522 1523 O
e.g. 51 55 1523 1527 O
Cushing 56 63 1528 1535 B-chronic_disease
Syndrome 64 72 1536 1544 I-chronic_disease
) 72 73 1544 1545 O

Participation 0 13 1546 1559 O
in 14 16 1560 1562 O
a 17 18 1563 1564 O
clinical 19 27 1565 1573 O
trial 28 33 1574 1579 O
within 34 40 1580 1586 O
the 41 44 1587 1590 O
last 45 49 1591 1595 B-upper_bound
3 50 51 1596 1597 I-upper_bound
months 52 58 1598 1604 I-upper_bound
prior 59 64 1605 1610 O
to 65 67 1611 1613 O
screening 68 77 1614 1623 O
for 78 81 1624 1627 O
this 82 86 1628 1632 O
trial 87 92 1633 1638 O

Receipt 0 7 1639 1646 O
of 8 10 1647 1649 O
any 11 14 1650 1653 O
anti 15 19 1654 1658 B-treatment
- 19 20 1658 1659 I-treatment
obesity 20 27 1659 1666 I-treatment
drug 28 32 1667 1671 I-treatment
or 33 35 1672 1674 I-treatment
supplement 36 46 1675 1685 I-treatment
within 47 53 1686 1692 O
1 54 55 1693 1694 B-upper_bound
month 56 61 1695 1700 I-upper_bound
prior 62 67 1701 1706 I-upper_bound
to 68 70 1707 1709 O
screening 71 80 1710 1719 O
for 81 84 1720 1723 O
this 85 89 1724 1728 O
trial 90 95 1729 1734 O

Self 0 4 1735 1739 O
- 4 5 1739 1740 O
reported 5 13 1740 1748 O
or 14 16 1749 1751 O
clinically 17 27 1752 1762 O
documented 28 38 1763 1773 O
history 39 46 1774 1781 O
of 47 49 1782 1784 O
significant 50 61 1785 1796 O
fluctuations 62 74 1797 1809 O
( 75 76 1810 1811 O
> 76 77 1811 1812 O
5 77 78 1812 1813 B-lower_bound
% 78 79 1813 1814 I-lower_bound
change 80 86 1815 1821 I-lower_bound
) 86 87 1821 1822 O
in 88 90 1823 1825 O
weight 91 97 1826 1832 B-clinical_variable
within 98 104 1833 1839 O
3 105 106 1840 1841 B-upper_bound
months 107 113 1842 1848 I-upper_bound
prior 114 119 1849 1854 I-upper_bound
to 120 122 1855 1857 O
screening 123 132 1858 1867 O
for 133 136 1868 1871 O
this 137 141 1872 1876 O
trial 142 147 1877 1882 O

Surgery 0 7 1883 1890 B-treatment
scheduled 8 17 1891 1900 O
for 18 21 1901 1904 O
the 22 25 1905 1908 O
trial 26 31 1909 1914 O
duration 32 40 1915 1923 O
period 41 47 1924 1930 O

blood 0 5 1931 1936 B-clinical_variable
pressure 6 14 1937 1945 I-clinical_variable
> 15 16 1946 1947 O
130/85 17 23 1948 1954 B-lower_bound
mmHg 24 28 1955 1959 I-lower_bound
or 29 31 1960 1962 O
on 32 34 1963 1965 O
treatment 35 44 1966 1975 B-treatment
for 45 48 1976 1979 O
hypertension 49 61 1980 1992 B-chronic_disease

fasting 0 7 1993 2000 B-clinical_variable
glucose 8 15 2001 2008 I-clinical_variable
> 16 17 2009 2010 O
100 18 21 2011 2014 B-lower_bound
mg 22 24 2015 2017 I-lower_bound
/ 24 25 2017 2018 I-lower_bound
dL 25 27 2018 2020 I-lower_bound

istory 0 6 2021 2027 O
of 7 9 2028 2030 O
diabetes 10 18 2031 2039 B-chronic_disease
mellitus 19 27 2040 2048 I-chronic_disease
( 28 29 2049 2050 O
type 29 33 2050 2054 B-lower_bound
1 34 35 2055 2056 I-lower_bound
or 36 38 2057 2059 O
2 39 40 2060 2061 B-upper_bound
) 40 41 2061 2062 O
or 42 44 2063 2065 O
on 45 47 2066 2068 O
treatment 48 57 2069 2078 O
with 58 62 2079 2083 O
anti 63 67 2084 2088 B-treatment
- 67 68 2088 2089 I-treatment
diabetes 68 76 2089 2097 I-treatment
medication 77 87 2098 2108 I-treatment

minor 0 5 2109 2114 B-treatment
surgical 6 14 2115 2123 I-treatment
procedures 15 25 2124 2134 I-treatment

triglycerides 0 13 2135 2148 B-clinical_variable
> 14 15 2149 2150 O
150 16 19 2151 2154 B-lower_bound
mg 20 22 2155 2157 I-lower_bound
/ 22 23 2157 2158 I-lower_bound
dL 23 25 2158 2160 I-lower_bound
or 26 28 2161 2163 O
on 29 31 2164 2166 O
treatment 32 41 2167 2176 O
for 42 45 2177 2180 O
hypertriglyceridemia 46 66 2181 2201 B-chronic_disease

waist 0 5 2202 2207 B-clinical_variable
circumference 6 19 2208 2221 I-clinical_variable
> 20 21 2222 2223 O
102 22 25 2224 2227 B-lower_bound
cm 26 28 2228 2230 I-lower_bound
( 29 30 2231 2232 I-lower_bound
40 30 32 2232 2234 I-lower_bound
in 33 35 2235 2237 I-lower_bound
) 35 36 2237 2238 I-lower_bound
in 37 39 2239 2241 O
men 40 43 2242 2245 B-gender
and 44 47 2246 2249 O
88 48 50 2250 2252 B-lower_bound
cm 51 53 2253 2255 I-lower_bound
( 54 55 2256 2257 I-lower_bound
35 55 57 2257 2259 I-lower_bound
in 58 60 2260 2262 I-lower_bound
) 60 61 2262 2263 I-lower_bound
in 62 64 2264 2266 O
women 65 70 2267 2272 B-gender

15 0 2 0 2 B-lower_bound
- 2 3 2 3 O
24 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

Had 0 3 19 22 O
vaginal 4 11 23 30 O
sex 12 15 31 34 O
with 16 20 35 39 O
at 21 23 40 42 O
least 24 29 43 48 O
one 30 33 49 52 B-lower_bound
woman 34 39 53 58 B-gender
in 40 42 59 61 O
the 43 46 62 65 O
past 47 51 66 70 B-upper_bound
2 52 53 71 72 I-upper_bound
months 54 60 73 79 I-upper_bound

Identifies 0 10 80 90 O
as 11 13 91 93 O
African 14 21 94 101 B-ethnicity
American 22 30 102 110 I-ethnicity
or 31 33 111 113 I-ethnicity
Black 34 39 114 119 I-ethnicity

Unable 0 6 120 126 B-language_fluency
to 7 9 127 129 I-language_fluency
speak 10 15 130 135 I-language_fluency
or 16 18 136 138 I-language_fluency
understand 19 29 139 149 I-language_fluency
English 30 37 150 157 I-language_fluency

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

ICDs 0 4 25 29 B-treatment
implanted 5 14 30 39 O

Pacemaker 0 9 40 49 B-treatment
or 10 12 50 52 O
ICD 13 16 53 56 B-treatment
implanted 17 26 57 66 O

Temporary 0 9 67 76 B-treatment
Pacemakers 10 20 77 87 I-treatment
( 21 22 88 89 O
e.g. 22 26 89 93 O
transvenous 27 38 94 105 B-treatment
temporary 39 48 106 115 I-treatment
wires 49 54 116 121 I-treatment
) 54 55 121 122 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1,800 34 39 34 39 B-lower_bound
cells 40 45 40 45 I-lower_bound
/ 45 46 45 46 I-lower_bound
mm^3 46 50 46 50 I-lower_bound

Acquired 0 8 51 59 B-chronic_disease
immune 9 15 60 66 I-chronic_disease
deficiency 16 26 67 77 I-chronic_disease
syndrome 27 35 78 86 I-chronic_disease
( 36 37 87 88 I-chronic_disease
AIDS 37 41 88 92 I-chronic_disease
) 41 42 92 93 I-chronic_disease
based 43 48 94 99 O
upon 49 53 100 104 O
current 54 61 105 112 O
Centers 62 69 113 120 O
for 70 73 121 124 O
Disease 74 81 125 132 O
Control 82 89 133 140 O
( 90 91 141 142 O
CDC 91 94 142 145 O
) 94 95 145 146 O
definition 96 106 147 157 O
( 107 108 158 159 O
HIV 108 111 159 162 B-chronic_disease
testing 112 119 163 170 O
is 120 122 171 173 O
not 123 126 174 177 O
required 127 135 178 186 O
for 136 139 187 190 O
entry 140 145 191 196 O
into 146 150 197 201 O
this 151 155 202 206 O
protocol 156 164 207 215 O
) 164 165 215 216 O

Acute 0 5 217 222 B-chronic_disease
bacterial 6 15 223 232 I-chronic_disease
or 16 18 233 235 O
fungal 19 25 236 242 B-chronic_disease
infection 26 35 243 252 I-chronic_disease
requiring 36 45 253 262 O
intravenous 46 57 263 274 B-treatment
antibiotics 58 69 275 286 I-treatment
at 70 72 287 289 O
the 73 76 290 293 O
time 77 81 294 298 O
of 82 84 299 301 O
registration 85 97 302 314 O

All 0 3 315 318 O
patients 4 12 319 327 O
must 13 17 328 332 O
have 18 22 333 337 O
a 23 24 338 339 O
Medical 25 32 340 347 B-treatment
Oncology 33 41 348 356 I-treatment
evaluation 42 52 357 367 O
within 53 59 368 374 O
4 60 61 375 376 B-upper_bound
weeks 62 67 377 382 I-upper_bound
prior 68 73 383 388 I-upper_bound
to 74 76 389 391 O
registration 77 89 392 404 O

Aspartate 0 9 405 414 B-clinical_variable
aminotransferase 10 26 415 431 I-clinical_variable
( 27 28 432 433 I-clinical_variable
AST 28 31 433 436 I-clinical_variable
) 31 32 436 437 I-clinical_variable
or 33 35 438 440 O
alanine 36 43 441 448 B-clinical_variable
aminotransferase 44 60 449 465 I-clinical_variable
( 61 62 466 467 I-clinical_variable
ALT 62 65 467 470 I-clinical_variable
) 65 66 470 471 I-clinical_variable
< 67 68 472 473 O
3 69 70 474 475 B-upper_bound
x 71 72 476 477 I-upper_bound
the 73 76 478 481 I-upper_bound
institutional 77 90 482 495 I-upper_bound
ULN 91 94 496 499 I-upper_bound

Hemoglobin 0 10 500 510 B-clinical_variable
≥ 11 12 511 512 O
8.0 13 16 513 516 B-lower_bound
g 17 18 517 518 I-lower_bound
/ 18 19 518 519 I-lower_bound
dL 19 21 519 521 I-lower_bound
( 22 23 522 523 O
the 23 26 523 526 O
use 27 30 527 530 O
of 31 33 531 533 O
transfusion 34 45 534 545 B-treatment
or 46 48 546 548 O
other 49 54 549 554 O
intervention 55 67 555 567 O
to 68 70 568 570 O
achieve 71 78 571 578 O
hemoglobin 79 89 579 589 B-clinical_variable
≥ 90 91 590 591 O
8.0 92 95 592 595 O
g 96 97 596 597 O
/ 97 98 597 598 O
dL 98 100 598 600 O
is 101 103 601 603 O
acceptable 104 114 604 614 O
) 114 115 614 615 O

High 0 4 616 620 B-clinical_variable
- 4 5 620 621 I-clinical_variable
grade 5 10 621 626 I-clinical_variable
acinic 11 17 627 633 I-clinical_variable
cell 18 22 634 638 I-clinical_variable
carcinoma 23 32 639 648 I-clinical_variable
or 33 35 649 651 I-clinical_variable
high 36 40 652 656 I-clinical_variable
- 40 41 656 657 I-clinical_variable
grade 41 46 657 662 I-clinical_variable
( 47 48 663 664 O
> 48 49 664 665 O
30 49 51 665 667 B-lower_bound
% 51 52 667 668 I-lower_bound
solid 53 58 669 674 O
component 59 68 675 684 O
) 68 69 684 685 O
adenoid 70 77 686 693 B-cancer
cystic 78 84 694 700 I-cancer
carcinoma 85 94 701 710 I-cancer

History 0 7 711 718 O
/ 7 8 718 719 O
physical 8 16 719 727 B-treatment
examination 17 28 728 739 I-treatment
within 29 35 740 746 O
8 36 37 747 748 B-upper_bound
weeks 38 43 749 754 I-upper_bound
prior 44 49 755 760 I-upper_bound
to 50 52 761 763 O
registration 53 65 764 776 O

Intermediate 0 12 777 789 O
- 12 13 789 790 O
grade 13 18 790 795 O
adenocarcinoma 19 33 796 810 B-cancer
or 34 36 811 813 O
intermediate 37 49 814 826 O
- 49 50 826 827 O
grade 50 55 827 832 O
mucoepidermoid 56 70 833 847 B-cancer
carcinoma 71 80 848 857 I-cancer

Negative 0 8 858 866 B-pregnancy
serum 9 14 867 872 I-pregnancy
pregnancy 15 24 873 882 I-pregnancy
test 25 29 883 887 O
within 30 36 888 894 O
2 37 38 895 896 B-upper_bound
weeks 39 44 897 902 I-upper_bound
prior 45 50 903 908 I-upper_bound
to 51 53 909 911 O
registration 54 66 912 924 O
for 67 70 925 928 O
women 71 76 929 934 B-gender
of 77 79 935 937 O
childbearing 80 92 938 950 O
potential 93 102 951 960 O

No 0 2 961 963 O
concurrent 3 13 964 974 O
erythropoiesis 14 28 975 989 B-treatment
- 28 29 989 990 I-treatment
stimulating 29 40 990 1001 I-treatment
agents 41 47 1002 1008 I-treatment

No 0 2 1009 1011 O
concurrent 3 13 1012 1022 O
hematopoietic 14 27 1023 1036 B-treatment
growth 28 34 1037 1043 I-treatment
factors 35 42 1044 1051 I-treatment
( 43 44 1052 1053 O
e.g. 44 48 1053 1057 O
, 48 49 1057 1058 O
G 50 51 1059 1060 B-treatment
- 51 52 1060 1061 I-treatment
CSF 52 55 1061 1064 I-treatment
or 56 58 1065 1067 O
pegfilgrastim 59 72 1068 1081 B-treatment
) 72 73 1081 1082 O
during 74 80 1083 1089 O
radiotherapy 81 93 1090 1102 B-treatment

No 0 2 1103 1105 O
patients 3 11 1106 1114 O
with 12 16 1115 1119 O
residual 17 25 1120 1128 B-chronic_disease
macroscopic 26 37 1129 1140 I-chronic_disease
disease 38 45 1141 1148 I-chronic_disease
after 46 51 1149 1154 O
surgery 52 59 1155 1162 B-treatment

No 0 2 1163 1165 O
prior 3 8 1166 1171 O
invasive 9 17 1172 1180 B-cancer
malignancy 18 28 1181 1191 I-cancer
( 29 30 1192 1193 O
except 30 36 1193 1199 O
non 37 40 1200 1203 B-cancer
- 40 41 1203 1204 I-cancer
melanomatous 41 53 1204 1216 I-cancer
skin 54 58 1217 1221 I-cancer
cancer 59 65 1222 1228 I-cancer
) 65 66 1228 1229 O
unless 67 73 1230 1236 O
disease 74 81 1237 1244 O
free 82 86 1245 1249 O
for 87 90 1250 1253 O
a 91 92 1254 1255 O
minimum 93 100 1256 1263 O
of 101 103 1264 1266 O
3 104 105 1267 1268 B-lower_bound
years 106 111 1269 1274 I-lower_bound
( 112 113 1275 1276 O
for 113 116 1276 1279 O
example 117 124 1280 1287 O
, 124 125 1287 1288 O
carcinoma 126 135 1289 1298 B-cancer
in 136 138 1299 1301 I-cancer
situ 139 143 1302 1306 I-cancer
of 144 146 1307 1309 I-cancer
the 147 150 1310 1313 I-cancer
breast 151 157 1314 1320 I-cancer
, 157 158 1320 1321 O
oral 159 163 1322 1326 B-cancer
cavity 164 170 1327 1333 I-cancer
, 170 171 1333 1334 O
or 172 174 1335 1337 O
cervix 175 181 1338 1344 B-cancer
are 182 185 1345 1348 O
all 186 189 1349 1352 O
permissible 190 201 1353 1364 O
) 201 202 1364 1365 O

No 0 2 1366 1368 O
prior 3 8 1369 1374 B-treatment
organ 9 14 1375 1380 I-treatment
transplant 15 25 1381 1391 I-treatment

No 0 2 1392 1394 O
prior 3 8 1395 1400 B-treatment
radiotherapy 9 21 1401 1413 I-treatment
to 22 24 1414 1416 O
the 25 28 1417 1420 O
region 29 35 1421 1427 O
of 36 38 1428 1430 O
the 39 42 1431 1434 O
study 43 48 1435 1440 O
cancer 49 55 1441 1447 B-cancer
that 56 60 1448 1452 O
would 61 66 1453 1458 O
result 67 73 1459 1465 O
in 74 76 1466 1468 O
overlap 77 84 1469 1476 O
of 85 87 1477 1479 O
radiation 88 97 1480 1489 B-treatment
therapy 98 105 1490 1497 I-treatment
fields 106 112 1498 1504 O

No 0 2 1505 1507 O
prior 3 8 1508 1513 B-treatment
systemic 9 17 1514 1522 I-treatment
chemotherapy 18 30 1523 1535 I-treatment
or 31 33 1536 1538 O
radiation 34 43 1539 1548 B-treatment
therapy 44 51 1549 1556 I-treatment
for 52 55 1557 1560 O
salivary 56 64 1561 1569 B-cancer
gland 65 70 1570 1575 I-cancer
malignancy 71 81 1576 1586 I-cancer

No 0 2 1587 1589 O
prior 3 8 1590 1595 B-treatment
systemic 9 17 1596 1604 I-treatment
chemotherapy 18 30 1605 1617 I-treatment
or 31 33 1618 1620 O
radiation 34 43 1621 1630 B-treatment
therapy 44 51 1631 1638 I-treatment
for 52 55 1639 1642 O
salivary 56 64 1643 1651 B-cancer
gland 65 70 1652 1657 I-cancer
malignancy 71 81 1658 1668 I-cancer
( 82 83 1669 1670 O
prior 83 88 1670 1675 B-treatment
chemotherapy 89 101 1676 1688 I-treatment
for 102 105 1689 1692 O
a 106 107 1693 1694 O
different 108 117 1695 1704 O
cancer 118 124 1705 1711 B-cancer
is 125 127 1712 1714 O
allowable 128 137 1715 1724 O
) 137 138 1724 1725 O

No 0 2 1726 1728 O
significant 3 14 1729 1740 O
pre 15 18 1741 1744 O
- 18 19 1744 1745 O
existing 19 27 1745 1753 O
hearing 28 35 1754 1761 B-chronic_disease
loss 36 40 1762 1766 I-chronic_disease
, 40 41 1766 1767 O
as 42 44 1768 1770 O
defined 45 52 1771 1778 O
by 53 55 1779 1781 O
the 56 59 1782 1785 O
patient 60 67 1786 1793 O
or 68 70 1794 1796 O
treating 71 79 1797 1805 O
physician 80 89 1806 1815 O

Not 0 3 1816 1819 B-pregnancy
pregnant 4 12 1820 1828 I-pregnancy
or 13 15 1829 1831 O
nursing 16 23 1832 1839 O

Pathologic 0 10 1840 1850 B-cancer
stage 11 16 1851 1856 I-cancer
T3 17 19 1857 1859 I-cancer
- 19 20 1859 1860 I-cancer
4 20 21 1860 1861 I-cancer
or 22 24 1862 1864 O
N1 25 27 1865 1867 O
- 27 28 1867 1868 O
3 28 29 1868 1869 O
or 30 32 1870 1872 O
T1 33 35 1873 1875 O
- 35 36 1875 1876 O
2 36 37 1876 1877 O
, 37 38 1877 1878 O
N0 39 41 1879 1881 O
with 42 46 1882 1886 O
a 47 48 1887 1888 O
close 49 54 1889 1894 O
( 55 56 1895 1896 O
≤ 56 57 1896 1897 O
1 58 59 1898 1899 B-upper_bound
mm 59 61 1899 1901 I-upper_bound
) 61 62 1901 1902 O
or 63 65 1903 1905 O
microscopically 66 81 1906 1921 O
positive 82 90 1922 1930 O
surgical 91 99 1931 1939 B-treatment
margin 100 106 1940 1946 O

Platelets 0 9 1947 1956 B-clinical_variable
≥ 10 11 1957 1958 O
100,000 12 19 1959 1966 B-lower_bound
cells 20 25 1967 1972 I-lower_bound
/ 25 26 1972 1973 I-lower_bound
mm^3 26 30 1973 1977 I-lower_bound

Pre 0 3 1978 1981 O
- 3 4 1981 1982 O
existing 4 12 1982 1990 O
≥ 13 14 1991 1992 O
grade 15 20 1993 1998 B-lower_bound
2 21 22 1999 2000 I-lower_bound
neuropathy 23 33 2001 2011 B-chronic_disease

Protocol 0 8 2012 2020 O
- 8 9 2020 2021 O
specific 9 17 2021 2029 O
requirements 18 30 2030 2042 O
may 31 34 2043 2046 O
also 35 39 2047 2051 O
exclude 40 47 2052 2059 O
immunocompromised 48 65 2060 2077 B-chronic_disease
patients 66 74 2078 2086 O

Radiologic 0 10 2087 2097 O
confirmation 11 23 2098 2110 O
of 24 26 2111 2113 O
the 27 30 2114 2117 O
absence 31 38 2118 2125 O
of 39 41 2126 2128 O
hematogenous 42 54 2129 2141 B-cancer
metastasis 55 65 2142 2152 I-cancer
within 66 72 2153 2159 O
12 73 75 2160 2162 B-upper_bound
weeks 76 81 2163 2168 I-upper_bound
prior 82 87 2169 2174 I-upper_bound
to 88 90 2175 2177 O
registration 91 103 2178 2190 O
; 103 104 2190 2191 O
at 105 107 2192 2194 O
a 108 109 2195 2196 O
minimum 110 117 2197 2204 O
, 117 118 2204 2205 O
contrast 119 127 2206 2214 O
CT 128 130 2215 2217 B-treatment
imaging 131 138 2218 2225 I-treatment
of 139 141 2226 2228 O
the 142 145 2229 2232 O
chest 146 151 2233 2238 O
is 152 154 2239 2241 O
required 155 163 2242 2250 O
( 164 165 2251 2252 O
PET 165 168 2252 2255 B-treatment
/ 168 169 2255 2256 I-treatment
CT 169 171 2256 2258 I-treatment
is 172 174 2259 2261 O
acceptable 175 185 2262 2272 O
) 185 186 2272 2273 O

Serum 0 5 2274 2279 B-clinical_variable
creatinine 6 16 2280 2290 I-clinical_variable
< 17 18 2291 2292 O
2.0 19 22 2293 2296 B-upper_bound
mg 23 25 2297 2299 I-upper_bound
/ 25 26 2299 2300 I-upper_bound
dL 26 28 2300 2302 I-upper_bound

Surgical 0 8 2303 2311 B-treatment
resection 9 18 2312 2321 I-treatment
with 19 23 2322 2326 O
curative 24 32 2327 2335 O
intent 33 39 2336 2342 O
within 40 46 2343 2349 O
8 47 48 2350 2351 B-upper_bound
weeks 49 54 2352 2357 I-upper_bound
prior 55 60 2358 2363 I-upper_bound
to 61 63 2364 2366 O
registration 64 76 2367 2379 O

Total 0 5 2380 2385 B-clinical_variable
bilirubin 6 15 2386 2395 I-clinical_variable
< 16 17 2396 2397 O
2 18 19 2398 2399 B-upper_bound
x 20 21 2400 2401 I-upper_bound
the 22 25 2402 2405 I-upper_bound
institutional 26 39 2406 2419 I-upper_bound
upper 40 45 2420 2425 I-upper_bound
limit 46 51 2426 2431 I-upper_bound
of 52 54 2432 2434 I-upper_bound
normal 55 61 2435 2441 I-upper_bound
( 62 63 2442 2443 I-upper_bound
ULN 63 66 2443 2446 I-upper_bound
) 66 67 2446 2447 I-upper_bound

Transmural 0 10 2448 2458 B-chronic_disease
myocardial 11 21 2459 2469 I-chronic_disease
infarction 22 32 2470 2480 I-chronic_disease
within 33 39 2481 2487 O
the 40 43 2488 2491 O
last 44 48 2492 2496 B-upper_bound
6 49 50 2497 2498 I-upper_bound
months 51 57 2499 2505 I-upper_bound

Unstable 0 8 2506 2514 B-chronic_disease
angina 9 15 2515 2521 I-chronic_disease
and/or 16 22 2522 2528 O
congestive 23 33 2529 2539 B-chronic_disease
heart 34 39 2540 2545 I-chronic_disease
failure 40 47 2546 2553 I-chronic_disease
requiring 48 57 2554 2563 O
hospitalization 58 73 2564 2579 B-treatment
within 74 80 2580 2586 O
the 81 84 2587 2590 O
last 85 89 2591 2595 B-upper_bound
6 90 91 2596 2597 I-upper_bound
months 92 98 2598 2604 I-upper_bound

Women 0 5 2605 2610 B-gender
of 6 8 2611 2613 O
childbearing 9 21 2614 2626 O
potential 22 31 2627 2636 O
and 32 35 2637 2640 O
male 36 40 2641 2645 B-gender
participants 41 53 2646 2658 I-gender
who 54 57 2659 2662 O
are 58 61 2663 2666 O
sexually 62 70 2667 2675 O
active 71 77 2676 2682 O
must 78 82 2683 2687 O
practice 83 91 2688 2696 B-contraception_consent
adequate 92 100 2697 2705 I-contraception_consent
contraception 101 114 2706 2719 I-contraception_consent
during 115 121 2720 2726 O
treatment 122 131 2727 2736 B-treatment
and 132 135 2737 2740 O
for 136 139 2741 2744 O
6 140 141 2745 2746 B-upper_bound
weeks 142 147 2747 2752 I-upper_bound
following 148 157 2753 2762 O
treatment 158 167 2763 2772 O

Zubrod 0 6 2773 2779 B-clinical_variable
performance 7 18 2780 2791 I-clinical_variable
status 19 25 2792 2798 I-clinical_variable
0 26 27 2799 2800 B-lower_bound
- 27 28 2800 2801 O
1 28 29 2801 2802 B-upper_bound

patients 0 8 2803 2811 O
must 9 13 2812 2816 O
be 14 16 2817 2819 O
free 17 21 2820 2824 O
of 22 24 2825 2827 O
distant 25 32 2828 2835 B-cancer
metastases 33 43 2836 2846 I-cancer
based 44 49 2847 2852 O
upon 50 54 2853 2857 O
the 55 58 2858 2861 O
following 59 68 2862 2871 O
minimum 69 76 2872 2879 O
diagnostic 77 87 2880 2890 O
workup 88 94 2891 2897 O

Women 0 5 0 5 B-gender

history 0 7 6 13 O
of 8 10 14 16 O
cardiovascular 11 25 17 31 B-chronic_disease
disease 26 33 32 39 I-chronic_disease

history 0 7 40 47 O
of 8 10 48 50 O
diabetes 11 19 51 59 B-chronic_disease

history 0 7 60 67 O
of 8 10 68 70 O
kidney 11 17 71 77 B-chronic_disease
disease 18 25 78 85 I-chronic_disease

men 0 3 86 89 B-gender

obesity 0 7 90 97 B-chronic_disease
( 8 9 98 99 O
BMI 9 12 99 102 B-bmi
> 13 14 103 104 O
30 15 17 105 107 B-lower_bound
kg 18 20 108 110 I-lower_bound
/ 20 21 110 111 I-lower_bound
m2 21 23 111 113 I-lower_bound
) 23 24 113 114 O

Adequate 0 8 0 8 O
hematologic 9 20 9 20 O
function 21 29 21 29 O
( 30 31 30 31 O
absolute 31 39 31 39 B-clinical_variable
neutrophil 40 50 40 50 I-clinical_variable
count 51 56 51 56 I-clinical_variable
[ 57 58 57 58 I-clinical_variable
ANC]≥1,500 58 68 58 68 I-clinical_variable
cells/µL 69 77 69 77 I-lower_bound
; 77 78 77 78 O
hemoglobin 79 89 79 89 B-clinical_variable
≥9 90 92 90 92 O
g 93 94 93 94 I-lower_bound
/ 94 95 94 95 I-lower_bound
dL 95 97 95 97 I-lower_bound
, 97 98 97 98 O
platelets 99 108 99 108 B-clinical_variable
≥75,000/µL 109 119 109 119 O
) 119 120 119 120 O

Adults 0 6 121 127 O
> 7 8 128 129 O
or 9 11 130 132 O
= 12 13 133 134 O
18 14 16 135 137 B-lower_bound
years 17 22 138 143 I-lower_bound
of 23 25 144 146 O
age 26 29 147 150 B-age

Baseline 0 8 151 159 B-clinical_variable
PSA 9 12 160 163 I-clinical_variable
must 13 17 164 168 O
be 18 20 169 171 O
≥ 21 22 172 173 O
0.2 23 26 174 177 B-lower_bound
ng 27 29 178 180 I-lower_bound
/ 29 30 180 181 I-lower_bound
mL 30 32 181 183 I-lower_bound
at 33 35 184 186 O
the 36 39 187 190 O
time 40 44 191 195 O
of 45 47 196 198 O
screening 48 57 199 208 O

Documented 0 10 209 219 O
hypersensitivity 11 27 220 236 O
reaction 28 36 237 245 O
to 37 39 246 248 O
any 40 43 249 252 O
product 44 51 253 260 B-allergy_name
with 52 56 261 265 I-allergy_name
GSE 57 60 266 269 I-allergy_name
( 61 62 270 271 O
see 62 65 271 274 O
complete 66 74 275 283 O
list 75 79 284 288 O
in 80 82 289 291 O
Appendix 83 91 292 300 O
1 92 93 301 302 O
) 93 94 302 303 O

Eastern 0 7 304 311 B-clinical_variable
Cooperative 8 19 312 323 I-clinical_variable
Oncology 20 28 324 332 I-clinical_variable
Group 29 34 333 338 I-clinical_variable
( 35 36 339 340 I-clinical_variable
ECOG 36 40 340 344 I-clinical_variable
) 40 41 344 345 I-clinical_variable
performance 42 53 346 357 I-clinical_variable
status 54 60 358 364 I-clinical_variable
0 61 62 365 366 B-lower_bound
- 62 63 366 367 O
2 63 64 367 368 B-upper_bound

Histologically 0 14 369 383 O
confirmed 15 24 384 393 O
prostate 25 33 394 402 B-cancer
adenocarcinoma 34 48 403 417 I-cancer

History 0 7 418 425 O
of 8 10 426 428 O
another 11 18 429 436 O
cancer 19 25 437 443 B-cancer
is 26 28 444 446 O
exclusionary 29 41 447 459 O
unless 42 48 460 466 O
it 49 51 467 469 O
is 52 54 470 472 O
believed 55 63 473 481 O
to 64 66 482 484 O
be 67 69 485 487 O
likely 70 76 488 494 O
cured 77 82 495 500 O
or 83 85 501 503 O
is 86 88 504 506 O
unlikely 89 97 507 515 O
to 98 100 516 518 O
be 101 103 519 521 O
fatal 104 109 522 527 O
in 110 112 528 530 O
the 113 116 531 534 O
next 117 121 535 539 B-upper_bound
3 122 123 540 541 I-upper_bound
years 124 129 542 547 I-upper_bound

Known 0 5 548 553 O
allergy 6 13 554 561 O
/ 13 14 561 562 O
intolerance 14 25 562 573 O
to 26 28 574 576 O
soy 29 32 577 580 B-allergy_name
, 32 33 580 581 O
phosphatidycholine 34 52 582 600 B-allergy_name
or 53 55 601 603 O
any 56 59 604 607 O
other 60 65 608 613 O
constituents 66 78 614 626 O
of 79 81 627 629 O
grape 82 87 630 635 B-allergy_name
seed 88 92 636 640 I-allergy_name
extract 93 100 641 648 I-allergy_name

Known 0 5 649 654 O
chronic 6 13 655 662 B-chronic_disease
infection 14 23 663 672 I-chronic_disease
with 24 28 673 677 O
human 29 34 678 683 B-chronic_disease
immunodeficiency 35 51 684 700 I-chronic_disease
virus 52 57 701 706 I-chronic_disease
( 58 59 707 708 I-chronic_disease
HIV 59 62 708 711 I-chronic_disease
) 62 63 711 712 I-chronic_disease
or 64 66 713 715 O
viral 67 72 716 721 B-chronic_disease
hepatitis 73 82 722 731 I-chronic_disease

Major 0 5 732 737 B-treatment
surgery 6 13 738 745 I-treatment
, 13 14 745 746 O
radiation 15 24 747 756 B-treatment
, 24 25 756 757 O
or 26 28 758 760 O
treatment 29 38 761 770 B-treatment
with 39 43 771 775 I-treatment
any 44 47 776 779 I-treatment
other 48 53 780 785 I-treatment
investigational 54 69 786 801 I-treatment
drug 70 74 802 806 I-treatment
within 75 81 807 813 O
2 82 83 814 815 B-upper_bound
weeks 84 89 816 821 I-upper_bound
of 90 92 822 824 O
study 93 98 825 830 B-treatment
treatment 99 108 831 840 I-treatment

Patients 0 8 841 849 O
must 9 13 850 854 O
have 14 18 855 859 O
sufficient 19 29 860 870 O
PSA 30 33 871 874 O
time 34 38 875 879 O
points 39 45 880 886 O
prior 46 51 887 892 O
to 52 54 893 895 O
enrollment 55 65 896 906 O
( 66 67 907 908 O
a 67 68 908 909 O
minimum 69 76 910 917 O
of 77 79 918 920 O
3 80 81 921 922 B-lower_bound
PSA 82 85 923 926 I-lower_bound
levels 86 92 927 933 I-lower_bound
within 93 99 934 940 O
a 100 101 941 942 O
six 102 105 943 946 B-upper_bound
month 106 111 947 952 I-upper_bound
period 112 118 953 959 O
) 118 119 959 960 O
to 120 122 961 963 O
calculate 123 132 964 973 O
a 133 134 974 975 O
baseline 135 143 976 984 O
PSA 144 147 985 988 O
doubling 148 156 989 997 O
time 157 161 998 1002 O

Patients 0 8 1003 1011 O
must 9 13 1012 1016 O
not 14 17 1017 1020 O
be 18 20 1021 1023 O
on 21 23 1024 1026 O
active 24 30 1027 1033 O
LHRH 31 35 1034 1038 B-treatment
agonist 36 43 1039 1046 I-treatment
/ 43 44 1046 1047 O
antagonist 44 54 1047 1057 B-treatment
therapy 55 62 1058 1065 I-treatment
and 63 66 1066 1069 O
must 67 71 1070 1074 O
have 72 76 1075 1079 O
testosterone 77 89 1080 1092 B-clinical_variable
level 90 95 1093 1098 I-clinical_variable
> 96 97 1099 1100 O
50 98 100 1101 1103 B-lower_bound
ng 101 103 1104 1106 I-lower_bound
/ 103 104 1106 1107 I-lower_bound
dL 104 106 1107 1109 I-lower_bound

Patients 0 8 1110 1118 O
must 9 13 1119 1123 O
not 14 17 1124 1127 O
be 18 20 1128 1130 O
on 21 23 1131 1133 O
active 24 30 1134 1140 O
anti 31 35 1141 1145 B-treatment
- 35 36 1145 1146 I-treatment
androgen 36 44 1146 1154 I-treatment
therapy 45 52 1155 1162 I-treatment
or 53 55 1163 1165 O
5 56 57 1166 1167 B-treatment
- 57 58 1167 1168 I-treatment
alpha 58 63 1168 1173 I-treatment
reductase 64 73 1174 1183 I-treatment
inhibitors 74 84 1184 1194 I-treatment

Patients 0 8 1195 1203 O
on 9 11 1204 1206 O
stable 12 18 1207 1213 O
dose 19 23 1214 1218 O
of 24 26 1219 1221 O
5 27 28 1222 1223 B-treatment
- 28 29 1223 1224 I-treatment
alpha 29 34 1224 1229 I-treatment
reductase 35 44 1230 1239 I-treatment
inhibitors 45 55 1240 1250 I-treatment
for 56 59 1251 1254 O
benign 60 66 1255 1261 B-chronic_disease
prostatic 67 76 1262 1271 I-chronic_disease
hypertrophy 77 88 1272 1283 I-chronic_disease
for 89 92 1284 1287 O
at 93 95 1288 1290 O
least 96 101 1291 1296 O
12 102 104 1297 1299 B-lower_bound
months 105 111 1300 1306 I-lower_bound
may 112 115 1307 1310 O
continue 116 124 1311 1319 O

Patients 0 8 1320 1328 O
who 9 12 1329 1332 O
are 13 16 1333 1336 O
candidates 17 27 1337 1347 O
for 28 31 1348 1351 O
local 32 37 1352 1357 O
salvage 38 45 1358 1365 B-treatment
therapy 46 53 1366 1373 I-treatment
must 54 58 1374 1378 O
have 59 63 1379 1383 O
had 64 67 1384 1387 O
this 68 72 1388 1392 O
option 73 79 1393 1399 O
pursued 80 87 1400 1407 O
or 88 90 1408 1410 O
discussed 91 100 1411 1420 O

Patients 0 8 1421 1429 O
who 9 12 1430 1433 O
have 13 17 1434 1438 O
PSA 18 21 1439 1442 O
recurrence 22 32 1443 1453 O
after 33 38 1454 1459 O
local 39 44 1460 1465 O
salvage 45 52 1466 1473 B-treatment
therapy 53 60 1474 1481 I-treatment
may 61 64 1482 1485 O
participate 65 76 1486 1497 O
in 77 79 1498 1500 O
this 80 84 1501 1505 O
study 85 90 1506 1511 O

Patients 0 8 1512 1520 O
with 9 13 1521 1525 O
hormone 14 21 1526 1533 B-chronic_disease
sensitive 22 31 1534 1543 I-chronic_disease
disease 32 39 1544 1551 I-chronic_disease
who 40 43 1552 1555 O
received 44 52 1556 1564 O
prior 53 58 1565 1570 B-treatment
androgen 59 67 1571 1579 I-treatment
deprivation 68 79 1580 1591 I-treatment
therapy 80 87 1592 1599 I-treatment
as 88 90 1600 1602 O
part 91 95 1603 1607 O
of 96 98 1608 1610 O
primary 99 106 1611 1618 B-treatment
/ 106 107 1618 1619 I-treatment
salvage 107 114 1619 1626 I-treatment
local 115 120 1627 1632 I-treatment
treatment 121 130 1633 1642 I-treatment

Symptomatic 0 11 1643 1654 O
prostate 12 20 1655 1663 B-cancer
cancer 21 27 1664 1670 I-cancer
as 28 30 1671 1673 O
determined 31 41 1674 1684 O
by 42 44 1685 1687 O
cancer 45 51 1688 1694 O
- 51 52 1694 1695 O
related 52 59 1695 1702 O
pain 60 64 1703 1707 O
requiring 65 74 1708 1717 O
narcotic 75 83 1718 1726 B-treatment
pain 84 88 1727 1731 I-treatment
medication 89 99 1732 1742 I-treatment

Very 0 4 1743 1747 O
fast 5 9 1748 1752 O
PSA 10 13 1753 1756 B-clinical_variable
doubling 14 22 1757 1765 O
time 23 27 1766 1770 O
of 28 30 1771 1773 O
less 31 35 1774 1778 O
than 36 40 1779 1783 O
4 41 42 1784 1785 B-upper_bound
weeks 43 48 1786 1791 I-upper_bound
, 48 49 1791 1792 O
if 50 52 1793 1795 O
the 53 56 1796 1799 O
absolute 57 65 1800 1808 O
PSA 66 69 1809 1812 O
is 70 72 1813 1815 O
> 73 74 1816 1817 O
2 75 76 1818 1819 B-lower_bound
ng 77 79 1820 1822 I-lower_bound
/ 79 80 1822 1823 I-lower_bound
mL 80 82 1823 1825 I-lower_bound

patient 0 7 1826 1833 O
must 8 12 1834 1838 O
have 13 17 1839 1843 O
either 18 24 1844 1850 O
declined 25 33 1851 1859 O
salvage 34 41 1860 1867 B-treatment
therapy 42 49 1868 1875 I-treatment
or 50 52 1876 1878 O
was 53 56 1879 1882 O
deemed 57 63 1883 1889 O
not 64 67 1890 1893 O
to 68 70 1894 1896 O
be 71 73 1897 1899 O
a 74 75 1900 1901 O
candidate 76 85 1902 1911 O
for 86 89 1912 1915 O
salvage 90 97 1916 1923 O
therapy 98 105 1924 1931 O

patients 0 8 1932 1940 O
receiving 9 18 1941 1950 O
intermittent 19 31 1951 1963 B-treatment
androgen 32 40 1964 1972 I-treatment
deprivation 41 52 1973 1984 I-treatment
therapy 53 60 1985 1992 I-treatment
will 61 65 1993 1997 O
be 66 68 1998 2000 O
allowed 69 76 2001 2008 O
to 77 79 2009 2011 O
participate 80 91 2012 2023 O

Active 0 6 0 6 O
systemic 7 15 7 15 B-chronic_disease
infection 16 25 16 25 I-chronic_disease

Adult 0 5 26 31 O
patients 6 14 32 40 O
> 15 16 41 42 O
18 16 18 42 44 B-lower_bound
years 19 24 45 50 I-lower_bound
old 25 28 51 54 O

End 0 3 55 58 O
stage 4 9 59 64 O
renal 10 15 65 70 B-chronic_disease
disease 16 23 71 78 I-chronic_disease
on 24 26 79 81 O
dialysis 27 35 82 90 B-treatment

Hospitalized 0 12 91 103 B-treatment
with 13 17 104 108 O
primary 18 25 109 116 O
or 26 28 117 119 O
secondary 29 38 120 129 O
diagnosis 39 48 130 139 O
of 49 51 140 142 O
Acute 52 57 143 148 B-chronic_disease
Decompensated 58 71 149 162 I-chronic_disease
Heart 72 77 163 168 I-chronic_disease
Failure 78 85 169 176 I-chronic_disease

Inadequate 0 10 177 187 B-technology_access
cell 11 15 188 192 I-technology_access
phone 16 21 193 198 I-technology_access
coverage 22 30 199 207 I-technology_access
( 31 32 208 209 O
including 32 41 209 218 O
international 42 55 219 232 O
patients 56 64 233 241 O
or 65 67 242 244 O
international 68 81 245 258 O
travel 82 88 259 265 O
during 89 95 266 272 O
study 96 101 273 278 O
period 102 108 279 285 O
) 108 109 285 286 O

Known 0 5 287 292 O
skin 6 10 293 297 O
allergy 11 18 298 305 O
to 19 21 306 308 O
adhesives 22 31 309 318 B-allergy_name
( 32 33 319 320 O
hydrocolloid 33 45 320 332 B-allergy_name
, 45 46 332 333 O
silicone 47 55 334 342 B-allergy_name
, 55 56 342 343 O
acrylic 57 64 344 351 B-allergy_name
) 64 65 351 352 O

Overall 0 7 353 360 O
life 8 12 361 365 B-clinical_variable
expectancy 13 23 366 376 I-clinical_variable
< 24 25 377 378 O
1 26 27 379 380 B-upper_bound
year 28 32 381 385 I-upper_bound

Pregnant 0 8 386 394 B-pregnancy

Subject 0 7 395 402 O
or 8 10 403 405 O
caregiver 11 20 406 415 O
is 21 23 416 418 O
not 24 27 419 422 B-technology_access
visually 28 36 423 431 I-technology_access
and 37 40 432 435 I-technology_access
tactile 41 48 436 443 I-technology_access
capable 49 56 444 451 I-technology_access
of 57 59 452 454 I-technology_access
smartphone 60 70 455 465 I-technology_access
and 71 74 466 469 O
home 75 79 470 474 O
device 80 86 475 481 O
usage 87 92 482 487 O

rales 0 5 488 493 B-chronic_disease
, 5 6 493 494 O
peripheral 7 17 495 505 B-chronic_disease
edema 18 23 506 511 I-chronic_disease
, 23 24 511 512 O
ascites 25 32 513 520 B-chronic_disease
, 32 33 520 521 O
or 34 36 522 524 O
pulmonary 37 46 525 534 B-chronic_disease
vascular 47 55 535 543 I-chronic_disease
congestion 56 66 544 554 I-chronic_disease
on 67 69 555 557 O
chest 70 75 558 563 B-treatment
radiography 76 87 564 575 I-treatment
) 87 88 575 576 O

shortness 0 9 577 586 B-chronic_disease
of 10 12 587 589 I-chronic_disease
breath 13 19 590 596 I-chronic_disease
, 19 20 596 597 O
orthopnea 21 30 598 607 B-chronic_disease
or 31 33 608 610 O
edema 34 39 611 616 B-chronic_disease

23 0 2 0 2 B-lower_bound
to 3 5 3 5 O
32 6 8 6 8 B-upper_bound
+6 9 11 9 11 O
Gestational 12 23 12 23 B-clinical_variable
age 24 27 24 27 I-clinical_variable

Bleeding 0 8 28 36 B-chronic_disease
Accreta 9 16 37 44 I-chronic_disease

Congenital 0 10 45 55 B-chronic_disease
anomalies 11 20 56 65 I-chronic_disease

Cord 0 4 66 70 B-chronic_disease
prolapse 5 13 71 79 I-chronic_disease

Hydrops 0 7 80 87 B-chronic_disease

Major 0 5 88 93 B-chronic_disease
cardiac 6 13 94 101 I-chronic_disease
defects 14 21 102 109 I-chronic_disease

Placental 0 9 110 119 B-chronic_disease
abruption 10 19 120 129 I-chronic_disease
or 20 22 130 132 I-chronic_disease
previa 23 29 133 139 I-chronic_disease
with 30 34 140 144 O
hemorrhage 35 45 145 155 B-chronic_disease

Active 0 6 0 6 O
systemic 7 15 7 15 B-chronic_disease
infection 16 25 16 25 I-chronic_disease
requiring 26 35 26 35 O
treatment 36 45 36 45 B-treatment
with 46 50 46 50 O
antibiotics 51 62 51 62 B-treatment

Any 0 3 63 66 O
allergy 4 11 67 74 O
or 12 14 75 77 O
intolerance 15 26 78 89 O
to 27 29 90 92 O
ionic 30 35 93 98 B-allergy_name
and 36 39 99 102 O
nonionic 40 48 103 111 B-allergy_name
contrast 49 57 112 120 I-allergy_name
media 58 63 121 126 I-allergy_name
, 63 64 126 127 O
anticoagulants 65 79 128 142 B-allergy_name
, 79 80 142 143 O
or 81 83 144 146 O
antiplatelet 84 96 147 159 B-allergy_name
therapy 97 104 160 167 I-allergy_name
drugs 105 110 168 173 I-allergy_name
that 111 115 174 178 O
can 116 119 179 182 O
not 119 122 182 185 O
be 123 125 186 188 O
adequately 126 136 189 199 O
premedicated 137 149 200 212 O

Any 0 3 213 216 O
prior 4 9 217 222 B-treatment
coronary 10 18 223 231 I-treatment
revascularization 19 36 232 249 I-treatment
within 37 43 250 256 O
the 44 47 257 260 O
last 48 52 261 265 B-upper_bound
6 53 54 266 267 I-upper_bound
months 55 61 268 274 I-upper_bound

At 0 2 275 277 O
least 3 8 278 283 O
18 9 11 284 286 B-lower_bound
years 12 17 287 292 I-lower_bound
of 18 20 293 295 O
age 21 24 296 299 B-age

Cardiac 0 7 300 307 B-chronic_disease
arrest 8 14 308 314 I-chronic_disease
within 15 21 315 321 O
24 22 24 322 324 B-upper_bound
hours 25 30 325 330 I-upper_bound
of 31 33 331 333 O
procedure 34 43 334 343 O
requiring 44 53 344 353 O
cardiopulmonary 54 69 354 369 B-treatment
resuscitation 70 83 370 383 I-treatment
( 84 85 384 385 I-treatment
CPR 85 88 385 388 I-treatment
) 88 89 388 389 I-treatment
or 90 92 390 392 O
defibrillation 93 107 393 407 B-treatment

Cardiogenic 0 11 408 419 B-chronic_disease
shock 12 17 420 425 I-chronic_disease
( 18 19 426 427 O
SBP 19 22 427 430 B-clinical_variable
< 23 24 431 432 O
90 24 26 432 434 B-upper_bound
mmHg 27 31 435 439 I-upper_bound
for 32 35 440 443 O
> 36 37 444 445 O
1 37 38 445 446 B-lower_bound
hour 39 43 447 451 I-lower_bound
with 44 48 452 456 O
either 49 55 457 463 O
cool 56 60 464 468 O
clammy 61 67 469 475 O
skin 68 72 476 480 O
OR 73 75 481 483 O
oliguria 76 84 484 492 O
OR 85 87 493 495 O
altered 88 95 496 503 O
sensorium 96 105 504 513 O
AND 106 109 514 517 O
cardiac 110 117 518 525 B-clinical_variable
index 118 123 526 531 I-clinical_variable
< 124 125 532 533 O
2.2 125 128 533 536 B-upper_bound
L 129 130 537 538 I-upper_bound
/ 130 131 538 539 I-upper_bound
min 131 134 539 542 I-upper_bound
/ 134 135 542 543 I-upper_bound
m2 135 137 543 545 I-upper_bound
) 137 138 545 546 O

Documented 0 10 547 557 O
presence 11 19 558 566 O
of 20 22 567 569 O
aortic 23 29 570 576 B-chronic_disease
stenosis 30 38 577 585 I-chronic_disease
( 39 40 586 587 O
orifice 40 47 587 594 B-clinical_variable
area 48 52 595 599 I-clinical_variable
of 53 55 600 602 O
1.5cm2 56 62 603 609 B-upper_bound
or 63 65 610 612 O
less 66 70 613 617 O
) 70 71 617 618 O

Emergency 0 9 619 628 O
PCI 10 13 629 632 B-treatment

Hemodynamic 0 11 633 644 B-treatment
support 12 19 645 652 I-treatment
with 20 24 653 657 I-treatment
the 25 28 658 661 I-treatment
HeartMate 29 38 662 671 I-treatment
PHP 39 42 672 675 I-treatment
post 43 47 676 680 I-treatment
- 47 48 680 681 I-treatment
PCI 48 51 681 684 I-treatment
is 52 54 685 687 O
anticipated 55 66 688 699 O

Hemodynamically 0 15 700 715 O
unstable 16 24 716 724 O
MI 25 27 725 727 B-chronic_disease
with 28 32 728 732 O
elevated 33 41 733 741 O
cardiac 42 49 742 749 B-clinical_variable
biomarker 50 59 750 759 I-clinical_variable
( 60 61 760 761 O
creatinine 61 71 761 771 B-clinical_variable
kinase 72 78 772 778 I-clinical_variable
- 78 79 778 779 I-clinical_variable
MB 79 81 779 781 I-clinical_variable
( 82 83 782 783 I-clinical_variable
CK 83 85 783 785 I-clinical_variable
- 85 86 785 786 I-clinical_variable
MB 86 88 786 788 I-clinical_variable
) 88 89 788 789 I-clinical_variable
or 90 92 790 792 O
troponin 93 101 793 801 B-clinical_variable
> 102 103 802 803 O
1X 103 105 803 805 B-lower_bound
upper 106 111 806 811 I-lower_bound
limit 112 117 812 817 I-lower_bound
of 118 120 818 820 I-lower_bound
normal 121 127 821 827 I-lower_bound
( 128 129 828 829 I-lower_bound
ULN 129 132 829 832 I-lower_bound
) 132 133 832 833 I-lower_bound
) 133 134 833 834 O
and 135 138 835 838 O
no 139 141 839 841 O
evidence 142 150 842 850 O
of 151 153 851 853 O
at 154 156 854 856 O
least 157 162 857 862 O
1 163 164 863 864 O
consecutive 165 176 865 876 O
CKMB 177 181 877 881 B-treatment
or 182 184 882 884 O
troponin 185 193 885 893 O
value 194 199 894 899 O
trending 200 208 900 908 O
downward 209 217 909 917 O
from 218 222 918 922 O
previous 223 231 923 931 O
value 232 237 932 937 O
( 238 239 938 939 O
at 239 241 939 941 O
least 242 247 942 947 O
4 248 249 948 949 B-lower_bound
hours 250 255 950 955 I-lower_bound
apart 256 261 956 961 O
) 261 262 961 962 O

History 0 7 963 970 O
of 8 10 971 973 O
aortic 11 17 974 980 B-treatment
valve 18 23 981 986 I-treatment
replacement 24 35 987 998 I-treatment
or 36 38 999 1001 O
repair 39 45 1002 1008 B-treatment

Known 0 5 1009 1014 O
abnormalities 6 19 1015 1028 O
of 20 22 1029 1031 O
the 23 26 1032 1035 O
aorta 27 32 1036 1041 O
that 33 37 1042 1046 O
would 38 43 1047 1052 O
preclude 44 52 1053 1061 O
surgery 53 60 1062 1069 B-treatment
, 60 61 1069 1070 O
including 62 71 1071 1080 O
aneurysms 72 81 1081 1090 B-chronic_disease
and 82 85 1091 1094 O
significant 86 97 1095 1106 O
tortuosity 98 108 1107 1117 O
or 109 111 1118 1120 O
calcifications 112 126 1121 1135 O

Liver 0 5 1136 1141 B-chronic_disease
dysfunction 6 17 1142 1153 I-chronic_disease
with 18 22 1154 1158 O
elevation 23 32 1159 1168 O
of 33 35 1169 1171 O
liver 36 41 1172 1177 B-clinical_variable
enzymes 42 49 1178 1185 I-clinical_variable
and 50 53 1186 1189 O
bilirubin 54 63 1190 1199 B-clinical_variable
levels 64 70 1200 1206 I-clinical_variable
to 71 73 1207 1209 O
≥ 74 75 1210 1211 O
3X 76 78 1212 1214 B-lower_bound
ULN 79 82 1215 1218 I-lower_bound
or 83 85 1219 1221 O
Internationalized 86 103 1222 1239 B-clinical_variable
Normalized 104 114 1240 1250 I-clinical_variable
Ratio 115 120 1251 1256 I-clinical_variable
( 121 122 1257 1258 I-clinical_variable
INR 122 125 1258 1261 I-clinical_variable
) 125 126 1261 1262 I-clinical_variable
≥2 127 129 1263 1265 O
or 130 132 1266 1268 O
lactate 133 140 1269 1276 B-clinical_variable
dehydrogenase 141 154 1277 1290 I-clinical_variable
( 155 156 1291 1292 I-clinical_variable
LDH 156 159 1292 1295 I-clinical_variable
) 159 160 1295 1296 I-clinical_variable
> 161 162 1297 1298 O
2.5X 163 167 1299 1303 B-lower_bound
ULN 168 171 1304 1307 I-lower_bound

Moderate 0 8 1308 1316 O
to 9 11 1317 1319 O
severe 12 18 1320 1326 O
aortic 19 25 1327 1333 B-chronic_disease
insufficiency 26 39 1334 1347 I-chronic_disease
by 40 42 1348 1350 O
echocardiographic 43 60 1351 1368 B-treatment
assessment 61 71 1369 1379 O

Mural 0 5 1380 1385 B-chronic_disease
thrombus 6 14 1386 1394 I-chronic_disease
in 15 17 1395 1397 I-chronic_disease
the 18 21 1398 1401 I-chronic_disease
left 22 26 1402 1406 I-chronic_disease
ventricle 27 36 1407 1416 I-chronic_disease

Participation 0 13 1417 1430 O
in 14 16 1431 1433 O
another 17 24 1434 1441 B-treatment
clinical 25 33 1442 1450 I-treatment
study 34 39 1451 1456 I-treatment
of 40 42 1457 1459 I-treatment
an 43 45 1460 1462 I-treatment
investigational 46 61 1463 1478 I-treatment
drug 62 66 1479 1483 I-treatment
or 67 69 1484 1486 I-treatment
device 70 76 1487 1493 I-treatment
that 77 81 1494 1498 O
has 82 85 1499 1502 O
not 86 89 1503 1506 O
met 90 93 1507 1510 O
its 94 97 1511 1514 O
primary 98 105 1515 1522 O
endpoint 106 114 1523 1531 O

Patient 0 7 1532 1539 O
is 8 10 1540 1542 O
undergoing 11 21 1543 1553 O
elective 22 30 1554 1562 B-treatment
or 31 33 1563 1565 O
urgent 34 40 1566 1572 B-treatment
high 41 45 1573 1577 I-treatment
risk 46 50 1578 1582 I-treatment
PCI 51 54 1583 1586 I-treatment
procedure 55 64 1587 1596 I-treatment
and 65 68 1597 1600 O
is 69 71 1601 1603 O
hemodynamically 72 87 1604 1619 O
stable 88 94 1620 1626 O

ST 0 2 1627 1629 B-clinical_variable
Elevation 3 12 1630 1639 I-clinical_variable
MI 13 15 1640 1642 I-clinical_variable
( 16 17 1643 1644 I-clinical_variable
STEMI 17 22 1644 1649 I-clinical_variable
) 22 23 1649 1650 I-clinical_variable
within 24 30 1651 1657 O
72 31 33 1658 1660 B-upper_bound
hours 34 39 1661 1666 I-upper_bound
prior 40 45 1667 1672 I-upper_bound
to 46 48 1673 1675 O
the 49 52 1676 1679 O
index 53 58 1680 1685 O
procedure 59 68 1686 1695 O
regardless 69 79 1696 1706 O
of 80 82 1707 1709 O
the 83 86 1710 1713 O
level 87 92 1714 1719 O
of 93 95 1720 1722 O
cardiac 96 103 1723 1730 B-clinical_variable
biomarker 104 113 1731 1740 I-clinical_variable

Severe 0 6 1741 1747 O
peripheral 7 17 1748 1758 B-chronic_disease
vascular 18 26 1759 1767 I-chronic_disease
disease 27 34 1768 1775 I-chronic_disease
that 35 39 1776 1780 O
will 40 44 1781 1785 O
preclude 45 53 1786 1794 O
the 54 57 1795 1798 O
use 58 61 1799 1802 O
of 62 64 1803 1805 O
a 65 66 1806 1807 O
14F 67 70 1808 1811 B-treatment
access 71 77 1812 1818 I-treatment
sheath 78 84 1819 1825 I-treatment
, 84 85 1825 1826 O
which 86 91 1827 1832 O
is 92 94 1833 1835 O
required 95 103 1836 1844 O
for 104 107 1845 1848 O
the 108 111 1849 1852 O
insertion 112 121 1853 1862 O
of 122 124 1863 1865 O
the 125 128 1866 1869 O
HeartMate 129 138 1870 1879 B-treatment
PHP 139 142 1880 1883 I-treatment
catheter 143 151 1884 1892 I-treatment

Staged 0 6 1893 1899 O
PCI 7 10 1900 1903 B-treatment
is 11 13 1904 1906 O
planned 14 21 1907 1914 O
within 22 28 1915 1921 O
90 29 31 1922 1924 B-upper_bound
days 32 36 1925 1929 I-upper_bound
following 37 46 1930 1939 O
device 47 53 1940 1946 O
removal 54 61 1947 1954 O

Stroke 0 6 1955 1961 B-chronic_disease
or 7 9 1962 1964 O
transient 10 19 1965 1974 B-chronic_disease
ischemic 20 28 1975 1983 I-chronic_disease
attack 29 35 1984 1990 I-chronic_disease
( 36 37 1991 1992 I-chronic_disease
TIA 37 40 1992 1995 I-chronic_disease
) 40 41 1995 1996 I-chronic_disease
within 42 48 1997 2003 O
6 49 50 2004 2005 B-upper_bound
months 51 57 2006 2012 I-upper_bound
of 58 60 2013 2015 O
procedure 61 70 2016 2025 O

Subject 0 7 2026 2033 O
is 8 10 2034 2036 O
on 11 13 2037 2039 O
hemodialysis 14 26 2040 2052 B-treatment

Subject 0 7 2053 2060 O
is 8 10 2061 2063 O
pregnant 11 19 2064 2072 B-pregnancy
( 20 21 2073 2074 O
For 21 24 2074 2077 O
a 25 26 2078 2079 O
female 27 33 2080 2086 B-gender
subject 34 41 2087 2094 I-gender
of 42 44 2095 2097 O
childbearing 45 57 2098 2110 O
potential 58 67 2111 2120 O
, 67 68 2120 2121 O
a 69 70 2122 2123 O
pregnancy 71 80 2124 2133 B-pregnancy
test 81 85 2134 2138 O
must 86 90 2139 2143 O
be 91 93 2144 2146 O
performed 94 103 2147 2156 O
within 104 110 2157 2163 O
14 111 113 2164 2166 B-upper_bound
days 114 118 2167 2171 I-upper_bound
( 119 120 2172 2173 O
≤14 120 123 2173 2176 O
days 124 128 2177 2181 O
) 128 129 2181 2182 O
prior 130 135 2183 2188 O
to 136 138 2189 2191 O
the 139 142 2192 2195 O
index 143 148 2196 2201 O
procedure 149 158 2202 2211 O
per 159 162 2212 2215 O
site 163 167 2216 2220 O
standard 168 176 2221 2229 O
test 177 181 2230 2234 O
) 181 182 2234 2235 O

The 0 3 2236 2239 O
presence 4 12 2240 2248 O
of 13 15 2249 2251 O
complex 16 23 2252 2259 O
coronary 24 32 2260 2268 B-chronic_disease
artery 33 39 2269 2275 I-chronic_disease
disease 40 47 2276 2283 I-chronic_disease
( 48 49 2284 2285 I-chronic_disease
CAD 49 52 2285 2288 I-chronic_disease
) 52 53 2288 2289 I-chronic_disease
makes 54 59 2290 2295 O
hemodynamic 60 71 2296 2307 B-chronic_disease
instability 72 83 2308 2319 I-chronic_disease
resulting 84 93 2320 2329 O
from 94 98 2330 2334 O
repeat 99 105 2335 2341 O
episodes 106 114 2342 2350 O
of 115 117 2351 2353 O
reversible 118 128 2354 2364 O
myocardial 129 139 2365 2375 B-chronic_disease
ischemia 140 148 2376 2384 I-chronic_disease
during 149 155 2385 2391 O
PCI 156 159 2392 2395 O
likely 160 166 2396 2402 O

Uncorrectable 0 13 2403 2416 O
abnormal 14 22 2417 2425 O
coagulation 23 34 2426 2437 O
parameters 35 45 2438 2448 O
( 46 47 2449 2450 O
platelet 47 55 2450 2458 B-clinical_variable
count 56 61 2459 2464 I-clinical_variable
≤75000 62 68 2465 2471 O
/ 68 69 2471 2472 I-upper_bound
mm3 69 72 2472 2475 I-upper_bound
or 73 75 2476 2478 O
INR 76 79 2479 2482 B-clinical_variable
≥2.0 80 84 2483 2487 O
or 85 87 2488 2490 O
fibrinogen 88 98 2491 2501 B-clinical_variable
≤1.5 99 103 2502 2506 O
g 104 105 2507 2508 I-upper_bound
/ 105 106 2508 2509 I-upper_bound
l 106 107 2509 2510 I-upper_bound
) 107 108 2510 2511 O

intervention 0 12 2512 2524 O
of 13 15 2525 2527 O
an 16 18 2528 2530 O
unprotected 19 30 2531 2542 B-chronic_disease
left 31 35 2543 2547 I-chronic_disease
main 36 40 2548 2552 I-chronic_disease
artery 41 47 2553 2559 I-chronic_disease

Active 0 6 0 6 O
Herpes 7 13 7 13 B-chronic_disease
Simplex 14 21 14 21 I-chronic_disease
or 22 24 22 24 O
Zoster 25 31 25 31 B-chronic_disease
at 32 34 32 34 O
the 35 38 35 38 O
time 39 43 39 43 O
of 44 46 44 46 O
treatment 47 56 47 56 O
or 57 59 57 59 O
having 60 66 60 66 O
experienced 67 78 67 78 O
more 79 83 79 83 O
than 84 88 84 88 O
three 89 94 89 94 B-lower_bound
episodes 95 103 95 103 O
of 104 106 104 106 O
Herpes 107 113 107 113 O
Simplex 114 121 114 121 O
/ 122 123 122 123 O
Zoster 124 130 124 130 B-chronic_disease
eruption 131 139 131 139 I-chronic_disease
within 140 146 140 146 O
a 147 148 147 148 O
year 149 153 149 153 O
of 154 156 154 156 O
study 157 162 157 162 O
enrollment 163 173 163 173 O

Adverse 0 7 174 181 O
reactions 8 17 182 191 O
to 18 20 192 194 O
compounds 21 30 195 204 O
of 31 33 205 207 O
any 34 37 208 211 O
external 38 46 212 220 O
agent 47 52 221 226 O
( 53 54 227 228 O
e.g. 54 58 228 232 O
, 58 59 232 233 O
gels 60 64 234 238 B-allergy_name
, 64 65 238 239 O
lotions 66 73 240 247 B-allergy_name
or 74 76 248 250 O
anesthetic 77 87 251 261 B-allergy_name
creams 88 94 262 268 I-allergy_name
) 94 95 268 269 O
required 96 104 270 278 O
for 105 108 279 282 O
use 109 112 283 286 O
in 113 115 287 289 O
the 116 119 290 293 O
study 120 125 294 299 O
, 125 126 299 300 O
if 127 129 301 303 O
no 130 132 304 306 O
alternative 133 144 307 318 O
to 145 147 319 321 O
the 148 151 322 325 O
said 152 156 326 330 O
agent 157 162 331 336 O
exists 163 169 337 343 O

All 0 3 344 347 O
wounds 4 10 348 354 O
in 11 13 355 357 O
the 14 17 358 361 O
area 18 22 362 366 O
of 23 25 367 369 O
interest 26 34 370 378 O
must 35 39 379 383 O
be 40 42 384 386 O
closed 43 49 387 393 O
for 50 53 394 397 O
at 54 56 398 400 O
least 57 62 401 406 O
two 63 66 407 410 B-lower_bound
months 67 73 411 417 I-lower_bound

Fitzpatrick 0 11 418 429 B-clinical_variable
skin 12 16 430 434 I-clinical_variable
types 17 22 435 440 I-clinical_variable
I 23 24 441 442 B-lower_bound
- 24 25 442 443 O
VI 25 27 443 445 B-upper_bound

Healthy 0 7 446 453 O
males 8 13 454 459 B-gender

History 0 7 460 467 O
of 8 10 468 470 O
collagen 11 19 471 479 B-chronic_disease
vascular 20 28 480 488 I-chronic_disease
disease 29 36 489 496 I-chronic_disease

History 0 7 497 504 O
of 8 10 505 507 O
immunosuppression 11 28 508 525 B-chronic_disease
/ 28 29 525 526 I-chronic_disease
immune 29 35 526 532 I-chronic_disease
deficiency 36 46 533 543 I-chronic_disease
disorders 47 56 544 553 I-chronic_disease
( 57 58 554 555 O
including 58 67 555 564 O
human 68 73 565 570 B-chronic_disease
immunodeficiency 74 90 571 587 I-chronic_disease
virus 91 96 588 593 I-chronic_disease
( 97 98 594 595 I-chronic_disease
HIV 98 101 595 598 I-chronic_disease
) 101 102 598 599 I-chronic_disease
infection 103 112 600 609 I-chronic_disease
or 113 115 610 612 O
acquired 116 124 613 621 B-chronic_disease
immunodeficiency 125 141 622 638 I-chronic_disease
syndrome 142 150 639 647 I-chronic_disease
( 151 152 648 649 I-chronic_disease
AIDS 152 156 649 653 I-chronic_disease
) 156 157 653 654 I-chronic_disease
or 158 160 655 657 O
use 161 164 658 661 O
of 165 167 662 664 O
immunosuppressive 168 185 665 682 B-treatment
medications 186 197 683 694 I-treatment

Participation 0 13 695 708 O
in 14 16 709 711 O
another 17 24 712 719 O
interventional 25 39 720 734 O
study 40 45 735 740 O
with 46 50 741 745 O
potential 51 60 746 755 O
exposure 61 69 756 764 O
to 70 72 765 767 O
an 73 75 768 770 O
investigational 76 91 771 786 O
drug 92 96 787 791 O
within 97 103 792 798 O
past 104 108 799 803 B-upper_bound
30 109 111 804 806 I-upper_bound
days 112 116 807 811 I-upper_bound

Patient 0 7 812 819 O
on 8 10 820 822 O
chemotherapy 11 23 823 835 B-treatment
( 24 25 836 837 O
but 25 28 837 840 O
not 29 32 841 844 O
tamoxifen 33 42 845 854 B-treatment
or 43 45 855 857 O
other 46 51 858 863 O
things 52 58 864 870 O
that 59 63 871 875 O
affect 64 70 876 882 O
wound 71 76 883 888 O
healing 77 84 889 896 O
) 84 85 896 897 O
and 86 89 898 901 O
also 90 94 902 906 O
active 95 101 907 913 O
XRT 102 105 914 917 B-clinical_variable

Pregnant 0 8 918 926 B-pregnancy
woman 9 14 927 932 B-gender
can 15 18 933 936 O
be 19 21 937 939 O
included 22 30 940 948 O
because 31 38 949 956 O
study 39 44 957 962 O
involves 45 53 963 971 O
local 54 59 972 977 O
intervention 60 72 978 990 O
, 72 73 990 991 O
no 74 76 992 994 O
new 77 80 995 998 O
drugs 81 86 999 1004 O

Prior 0 5 1005 1010 B-treatment
skin 6 10 1011 1015 I-treatment
treatment 11 20 1016 1025 I-treatment
with 21 25 1026 1030 I-treatment
laser 26 31 1031 1036 I-treatment
or 32 34 1037 1039 I-treatment
other 35 40 1040 1045 I-treatment
devices 41 48 1046 1053 I-treatment
in 49 51 1054 1056 O
the 52 55 1057 1060 O
treated 56 63 1061 1068 O
area 64 68 1069 1073 O
within 69 75 1074 1080 O
three 76 81 1081 1086 B-upper_bound
months 82 88 1087 1093 I-upper_bound
of 89 91 1094 1096 O
initial 92 99 1097 1104 B-treatment
treatment 100 109 1105 1114 I-treatment
or 110 112 1115 1117 O
during 113 119 1118 1124 O
the 120 123 1125 1128 O
course 124 130 1129 1135 O
of 131 133 1136 1138 O
the 134 137 1139 1142 O
study 138 143 1143 1148 O

Significant 0 11 1149 1160 O
concurrent 12 22 1161 1171 O
illness 23 30 1172 1179 O
, 30 31 1179 1180 O
such 32 36 1181 1185 O
as 37 39 1186 1188 O
uncontrolled 40 52 1189 1201 B-chronic_disease
diabetes 53 61 1202 1210 I-chronic_disease
( 62 63 1211 1212 O
with 63 67 1212 1216 O
a 68 69 1217 1218 O
hemoglobin 70 80 1219 1229 B-clinical_variable
A1C 81 84 1230 1233 I-clinical_variable
of 85 87 1234 1236 O
more 88 92 1237 1241 O
than 93 97 1242 1246 O
8) 98 100 1247 1249 B-lower_bound
( 101 102 1250 1251 O
i.e. 102 106 1251 1255 O
, 106 107 1255 1256 O
any 108 111 1257 1260 O
disease 112 119 1261 1268 O
state 120 125 1269 1274 O
that 126 130 1275 1279 O
in 131 133 1280 1282 O
the 134 137 1283 1286 O
opinion 138 145 1287 1294 O
of 146 148 1295 1297 O
the 149 152 1298 1301 O
Investigator 153 165 1302 1314 O
would 166 171 1315 1320 O
interfere 172 181 1321 1330 O
with 182 186 1331 1335 O
the 187 190 1336 1339 O
anesthesia 191 201 1340 1350 B-treatment
, 201 202 1350 1351 O
treatment 203 212 1352 1361 B-treatment
, 212 213 1361 1362 O
or 214 216 1363 1365 O
healing 217 224 1366 1373 O
process 225 232 1374 1381 O
) 232 233 1381 1382 O
; 233 234 1382 1383 O
Mentally 235 243 1384 1392 B-chronic_disease
incompetent 244 255 1393 1404 I-chronic_disease
, 255 256 1404 1405 O
prisoner 257 265 1406 1414 O
or 266 268 1415 1417 O
evidence 269 277 1418 1426 O
of 278 280 1427 1429 O
active 281 287 1430 1436 O
substance 288 297 1437 1446 O
or 298 300 1447 1449 O
alcohol 301 308 1450 1457 O
abuse 309 314 1458 1463 O

The 0 3 1464 1467 O
scars 4 9 1468 1473 O
must 10 14 1474 1478 O
be 15 17 1479 1481 O
deemed 18 24 1482 1488 O
stable 25 31 1489 1495 O
for 32 35 1496 1499 O
a 36 37 1500 1501 O
period 38 44 1502 1508 O
of 45 47 1509 1511 O
3 48 49 1512 1513 B-upper_bound
months 50 56 1514 1520 I-upper_bound
or 57 59 1521 1523 O
have 60 64 1524 1528 O
a 65 66 1529 1530 O
suitable 67 75 1531 1539 O
contralateral 76 89 1540 1553 O
control 90 97 1554 1561 O
before 98 104 1562 1568 O
initiation 105 115 1569 1579 O
of 116 118 1580 1582 O
treatment 119 128 1583 1592 O
. 128 129 1592 1593 O
This 130 134 1594 1598 O
will 135 139 1599 1603 O
be 140 142 1604 1606 O
determined 143 153 1607 1617 O
by 154 156 1618 1620 O
objective 157 166 1621 1630 O
measurements 167 179 1631 1643 O
of 180 182 1644 1646 O
scar 183 187 1647 1651 B-chronic_disease
erythema 188 196 1652 1660 I-chronic_disease
, 196 197 1660 1661 O
pliability 198 208 1662 1672 O
, 208 209 1672 1673 O
induration 210 220 1674 1684 O
, 220 221 1684 1685 O
thickness 222 231 1686 1695 O
at 232 234 1696 1698 O
enrollment 235 245 1699 1709 O
and 246 249 1710 1713 O
again 250 255 1714 1719 O
at 256 258 1720 1722 O
3 259 260 1723 1724 O
months 261 267 1725 1731 O

between 0 7 1732 1739 O
18 8 10 1740 1742 B-lower_bound
and 11 14 1743 1746 O
80 15 17 1747 1749 B-upper_bound
years 18 23 1750 1755 I-upper_bound
of 24 26 1756 1758 O
age 27 30 1759 1762 B-age

females 0 7 1763 1770 B-gender

with 0 4 1771 1775 O
radiation 5 14 1776 1785 B-chronic_disease
- 14 15 1785 1786 I-chronic_disease
induced 15 22 1786 1793 I-chronic_disease
fibrosis 23 31 1794 1802 I-chronic_disease
and 32 35 1803 1806 O
depigmentation 36 50 1807 1821 B-chronic_disease
. 50 51 1821 1822 O
The 52 55 1823 1826 O
fibrosis 56 64 1827 1835 O
must 65 69 1836 1840 O
have 70 74 1841 1845 O
occurred 75 83 1846 1854 O
at 84 86 1855 1857 O
least 87 92 1858 1863 O
1 93 94 1864 1865 B-lower_bound
year 95 99 1866 1870 I-lower_bound
prior 100 105 1871 1876 I-lower_bound
to 106 108 1877 1879 O
the 109 112 1880 1883 O
date 113 117 1884 1888 O
of 118 120 1889 1891 O
enrollment 121 131 1892 1902 O

AST(SGOT)/ALT(SGPT 0 18 0 18 B-clinical_variable
) 18 19 18 19 I-clinical_variable
less 20 24 20 24 O
than 25 29 25 29 O
or 30 32 30 32 O
equal 33 38 33 38 O
to 39 41 39 41 O
3 42 43 42 43 B-upper_bound
times 44 49 44 49 I-upper_bound
institutional 50 63 50 63 I-upper_bound
upper 64 69 64 69 I-upper_bound
limit 70 75 70 75 I-upper_bound
of 76 78 76 78 I-upper_bound
normal 79 85 79 85 I-upper_bound

Age 0 3 86 89 B-age
greater 4 11 90 97 O
than 12 16 98 102 O
or 17 19 103 105 O
equal 20 25 106 111 O
to 26 28 112 114 O
18 29 31 115 117 B-lower_bound
years 32 37 118 123 I-lower_bound
of 38 40 124 126 O
age 41 44 127 130 B-age

Any 0 3 131 134 O
gastrointestinal 4 20 135 151 B-chronic_disease
disease 21 28 152 159 I-chronic_disease
which 29 34 160 165 O
would 35 40 166 171 O
impair 41 47 172 178 O
ability 48 55 179 186 O
to 56 58 187 189 O
swallow 59 66 190 197 O
, 66 67 197 198 O
retain 68 74 199 205 O
, 74 75 205 206 O
or 76 78 207 209 O
absorb 79 85 210 216 O
drug 86 90 217 221 O
is 91 93 222 224 O
not 94 97 225 228 O
allowed 98 105 229 236 O

ECOG 0 4 237 241 B-clinical_variable
performance 5 16 242 253 I-clinical_variable
status 17 23 254 260 I-clinical_variable
less 24 28 261 265 O
than 29 33 266 270 O
or 34 36 271 273 O
equal 37 42 274 279 O
to 43 45 280 282 O
2 46 47 283 284 B-upper_bound

Eligibility 0 11 285 296 O
of 12 14 297 299 O
subjects 15 23 300 308 O
receiving 24 33 309 318 O
any 34 37 319 322 O
medications 38 49 323 334 B-treatment
or 50 52 335 337 O
substances 53 63 338 348 O
with 64 68 349 353 O
the 69 72 354 357 O
potential 73 82 358 367 O
to 83 85 368 370 O
affect 86 92 371 377 O
the 93 96 378 381 O
activity 97 105 382 390 O
or 106 108 391 393 O
pharmacokinetics 109 125 394 410 O
of 126 128 411 413 O
BMN 129 132 414 417 B-treatment
673 133 136 418 421 I-treatment
will 137 141 422 426 O
be 142 144 427 429 O
determined 145 155 430 440 O
following 156 165 441 450 O
review 166 172 451 457 O
by 173 175 458 460 O
the 176 179 461 464 O
principal 180 189 465 474 O
investigator 190 202 475 487 O

HIV 0 3 488 491 B-chronic_disease
- 3 4 491 492 O
positive 4 12 492 500 O
patients 13 21 501 509 O
on 22 24 510 512 O
combination 25 36 513 524 B-treatment
antiretroviral 37 51 525 539 I-treatment
therapy 52 59 540 547 I-treatment
are 60 63 548 551 O
ineligible 64 74 552 562 O

Life 0 4 563 567 B-clinical_variable
expectancy 5 15 568 578 I-clinical_variable
of 16 18 579 581 O
greater 19 26 582 589 O
than 27 31 590 594 O
3 32 33 595 596 B-lower_bound
months 34 40 597 603 I-lower_bound

Patients 0 8 604 612 O
who 9 12 613 616 O
are 13 16 617 620 O
receiving 17 26 621 630 O
any 27 30 631 634 O
other 31 36 635 640 O
investigational 37 52 641 656 B-treatment
agents 53 59 657 663 I-treatment

Patients 0 8 664 672 O
who 9 12 673 676 O
have 13 17 677 681 O
had 18 21 682 685 O
chemotherapy 22 34 686 698 B-treatment
or 35 37 699 701 O
radiotherapy 38 50 702 714 B-treatment

Patients 0 8 715 723 O
who 9 12 724 727 O
have 13 17 728 732 O
had 18 21 733 736 O
prior 22 27 737 742 B-treatment
treatment 28 37 743 752 I-treatment
with 38 42 753 757 I-treatment
any 43 46 758 761 I-treatment
PARP 47 51 762 766 I-treatment
inhibitors 52 62 767 777 I-treatment
are 63 66 778 781 O
ineligible 67 77 782 792 O

Patients 0 8 793 801 O
who 9 12 802 805 O
require 13 20 806 813 O
use 21 24 814 817 O
of 25 27 818 820 O
coumarin 28 36 821 829 O
- 36 37 829 830 O
derivative 37 47 830 840 O
anticoagulants 48 62 841 855 B-treatment
such 63 67 856 860 O
as 68 70 861 863 O
warfarin 71 79 864 872 B-treatment
are 80 83 873 876 O
excluded 84 92 877 885 O

Patients 0 8 886 894 O
whose 9 14 895 900 O
brain 15 20 901 906 B-cancer
metastatic 21 31 907 917 I-cancer
disease 32 39 918 925 I-cancer
status 40 46 926 932 O
has 47 50 933 936 O
remained 51 59 937 945 O
stable 60 66 946 952 O
for 67 70 953 956 O
greater 71 78 957 964 O
than 79 83 965 969 O
or 84 86 970 972 O
equal 87 92 973 978 O
to 93 95 979 981 O
4 96 97 982 983 B-lower_bound
weeks 98 103 984 989 I-lower_bound
following 104 113 990 999 O
treatment 114 123 1000 1009 B-treatment
of 124 126 1010 1012 O
brain 127 132 1013 1018 B-cancer
metastases 133 143 1019 1029 I-cancer
are 144 147 1030 1033 O
eligible 148 156 1034 1042 O
to 157 159 1043 1045 O
participate 160 171 1046 1057 O
at 172 174 1058 1060 O
the 175 178 1061 1064 O
discretion 179 189 1065 1075 O
of 190 192 1076 1078 O
the 193 196 1079 1082 O
principal 197 206 1083 1092 O
investigator 207 219 1093 1105 O

Patients 0 8 1106 1114 O
with 9 13 1115 1119 O
HER2 14 18 1120 1124 B-cancer
- 18 19 1124 1125 O
positive 19 27 1125 1133 O
advanced 28 36 1134 1142 O
breast 37 43 1143 1149 B-cancer
cancer 44 50 1150 1156 I-cancer
or 51 53 1157 1159 O
ovarian 54 61 1160 1167 B-cancer
cancer 62 68 1168 1174 I-cancer
should 69 75 1175 1181 O
have 76 80 1182 1186 O
received 81 89 1187 1195 O
at 90 92 1196 1198 O
least 93 98 1199 1204 O
two 99 102 1205 1208 O
lines 103 108 1209 1214 O
of 109 111 1215 1217 O
systemic 112 120 1218 1226 O
therapy 121 128 1227 1234 B-treatment
in 129 131 1235 1237 O
the 132 135 1238 1241 O
advanced 136 144 1242 1250 O
setting 145 152 1251 1258 O

Patients 0 8 1259 1267 O
with 9 13 1268 1272 O
known 14 19 1273 1278 O
active 20 26 1279 1285 O
brain 27 32 1286 1291 B-cancer
metastases 33 43 1292 1302 I-cancer
or 44 46 1303 1305 O
carcinomatous 47 60 1306 1319 B-cancer
meningitis 61 71 1320 1330 I-cancer
are 72 75 1331 1334 O
excluded 76 84 1335 1343 O
from 85 89 1344 1348 O
this 90 94 1349 1353 O
clinical 95 103 1354 1362 O
trial 104 109 1363 1368 O

Pregnant 0 8 1369 1377 B-pregnancy
women 9 14 1378 1383 B-gender
are 15 18 1384 1387 O
excluded 19 27 1388 1396 O
from 28 32 1397 1401 O
this 33 37 1402 1406 O
study 38 43 1407 1412 O

Uncontrolled 0 12 1413 1425 O
intercurrent 13 25 1426 1438 O
illness 26 33 1439 1446 O
including 34 43 1447 1456 O
, 43 44 1456 1457 O
but 45 48 1458 1461 O
not 49 52 1462 1465 O
limited 53 60 1466 1473 O
to 61 63 1474 1476 O
, 63 64 1476 1477 O
ongoing 65 72 1478 1485 O
or 73 75 1486 1488 O
active 76 82 1489 1495 B-chronic_disease
infection 83 92 1496 1505 I-chronic_disease
, 92 93 1505 1506 O
symptomatic 94 105 1507 1518 B-chronic_disease
congestive 106 116 1519 1529 I-chronic_disease
heart 117 122 1530 1535 I-chronic_disease
failure 123 130 1536 1543 I-chronic_disease
, 130 131 1543 1544 O
unstable 132 140 1545 1553 B-chronic_disease
angina 141 147 1554 1560 I-chronic_disease
pectoris 148 156 1561 1569 I-chronic_disease
, 156 157 1569 1570 O
cardiac 158 165 1571 1578 B-chronic_disease
arrhythmia 166 176 1579 1589 I-chronic_disease
, 176 177 1589 1590 O
or 178 180 1591 1593 O
psychiatric 181 192 1594 1605 B-chronic_disease
illness 193 200 1606 1613 I-chronic_disease
/ 200 201 1613 1614 O
social 201 207 1614 1620 O
situations 208 218 1621 1631 O
that 219 223 1632 1636 O
would 224 229 1637 1642 O
limit 230 235 1643 1648 O
compliance 236 246 1649 1659 O
with 247 251 1660 1664 O
study 252 257 1665 1670 O
requirements 258 270 1671 1683 O

Women 0 5 1684 1689 B-gender
who 6 9 1690 1693 O
are 10 13 1694 1697 O
currently 14 23 1698 1707 O
lactating 24 33 1708 1717 O

absolute 0 8 1718 1726 B-clinical_variable
neutrophil 9 19 1727 1737 I-clinical_variable
count 20 25 1738 1743 I-clinical_variable
greater 26 33 1744 1751 O
than 34 38 1752 1756 O
or 39 41 1757 1759 O
equal 42 47 1760 1765 O
to 48 50 1766 1768 O
1,500 51 56 1769 1774 B-lower_bound
/ 56 57 1774 1775 I-lower_bound
mcL 57 60 1775 1778 I-lower_bound

creatinine 0 10 1779 1789 B-clinical_variable
clearance 11 20 1790 1799 I-clinical_variable
greater 21 28 1800 1807 O
than 29 33 1808 1812 O
or 34 36 1813 1815 O
equal 37 42 1816 1821 O
to 43 45 1822 1824 O
60 46 48 1825 1827 B-lower_bound
mL 49 51 1828 1830 I-lower_bound
/ 51 52 1830 1831 I-lower_bound
min 52 55 1831 1834 I-lower_bound
for 56 59 1835 1838 O
patients 60 68 1839 1847 O
with 69 73 1848 1852 O
creatinine 74 84 1853 1863 B-clinical_variable
levels 85 91 1864 1870 I-clinical_variable
above 92 97 1871 1876 O
institutional 98 111 1877 1890 O
normal 112 118 1891 1897 O

creatinine 0 10 1898 1908 B-clinical_variable
less 11 15 1909 1913 O
than 16 20 1914 1918 O
or 21 23 1919 1921 O
equal 24 29 1922 1927 O
to 30 32 1928 1930 O
1.5 33 36 1931 1934 B-upper_bound
times 37 42 1935 1940 I-upper_bound
institutional 43 56 1941 1954 I-upper_bound
upper 57 62 1955 1960 I-upper_bound
limit 63 68 1961 1966 I-upper_bound
of 69 71 1967 1969 I-upper_bound
normal 72 78 1970 1976 I-upper_bound

for 0 3 1977 1980 O
the 4 7 1981 1984 O
duration 8 16 1985 1993 O
of 17 19 1994 1996 O
study 20 25 1997 2002 O
participation 26 39 2003 2016 O
, 39 40 2016 2017 O
and 41 44 2018 2021 O
for 45 48 2022 2025 O
30 49 51 2026 2028 O
days 52 56 2029 2033 O
after 57 62 2034 2039 O
completing 63 73 2040 2050 O
study 74 79 2051 2056 O
treatment 80 89 2057 2066 B-treatment

leukocytes 0 10 2067 2077 B-clinical_variable
greater 11 18 2078 2085 O
than 19 23 2086 2090 O
or 24 26 2091 2093 O
equal 27 32 2094 2099 O
to 33 35 2100 2102 O
3,000 36 41 2103 2108 B-lower_bound
/ 41 42 2108 2109 I-lower_bound
mcL 42 45 2109 2112 I-lower_bound

platelets 0 9 2113 2122 B-clinical_variable
greater 10 17 2123 2130 O
than 18 22 2131 2135 O
or 23 25 2136 2138 O
equal 26 31 2139 2144 O
to 32 34 2145 2147 O
100,000 35 42 2148 2155 B-lower_bound
/ 42 43 2155 2156 I-lower_bound
mcL 43 46 2156 2159 I-lower_bound

total 0 5 2160 2165 O
bilirubin 6 15 2166 2175 B-clinical_variable
less 16 20 2176 2180 O
than 21 25 2181 2185 O
or 26 28 2186 2188 O
equal 29 34 2189 2194 O
to 35 37 2195 2197 O
1.5 38 41 2198 2201 B-upper_bound
times 42 47 2202 2207 I-upper_bound
institutional 48 61 2208 2221 B-clinical_variable
upper 62 67 2222 2227 I-clinical_variable
limit 68 73 2228 2233 I-clinical_variable
of 74 76 2234 2236 I-clinical_variable
normal 77 83 2237 2243 I-clinical_variable

within 0 6 2244 2250 O
4 7 8 2251 2252 O
weeks 9 14 2253 2258 O
( 15 16 2259 2260 O
6 16 17 2260 2261 B-upper_bound
weeks 18 23 2262 2267 I-upper_bound
for 24 27 2268 2271 O
nitrosoureas 28 40 2272 2284 B-treatment
or 41 43 2285 2287 O
mitomycin 44 53 2288 2297 B-treatment
C 54 55 2298 2299 I-treatment
) 55 56 2299 2300 O
prior 57 62 2301 2306 O
to 63 65 2307 2309 O
entering 66 74 2310 2318 O
the 75 78 2319 2322 O
study 79 84 2323 2328 O
or 85 87 2329 2331 O
those 88 93 2332 2337 O
who 94 97 2338 2341 O
have 98 102 2342 2346 O
not 103 106 2347 2350 O
recovered 107 116 2351 2360 O
from 117 121 2361 2365 O
adverse 122 129 2366 2373 O
events 130 136 2374 2380 O
due 137 140 2381 2384 O
to 141 143 2385 2387 O
agents 144 150 2388 2394 O
administered 151 163 2395 2407 O
more 164 168 2408 2412 O
than 169 173 2413 2417 O
4 174 175 2418 2419 O
weeks 176 181 2420 2425 O
earlier 182 189 2426 2433 O

women 0 5 2434 2439 B-gender
of 6 8 2440 2442 O
childbearing 9 21 2443 2455 O
potential 22 31 2456 2465 O
and 32 35 2466 2469 O
men 36 39 2470 2473 O
must 40 44 2474 2478 O
agree 45 50 2479 2484 B-contraception_consent
to 51 53 2485 2487 I-contraception_consent
use 54 57 2488 2491 I-contraception_consent
adequate 58 66 2492 2500 I-contraception_consent
contraception 67 80 2501 2514 I-contraception_consent
( 81 82 2515 2516 I-contraception_consent
hormonal 82 90 2516 2524 I-contraception_consent
or 91 93 2525 2527 I-contraception_consent
barrier 94 101 2528 2535 I-contraception_consent
method 102 108 2536 2542 I-contraception_consent
of 109 111 2543 2545 I-contraception_consent
birth 112 117 2546 2551 I-contraception_consent
control 118 125 2552 2559 I-contraception_consent
; 125 126 2559 2560 I-contraception_consent
abstinence 127 137 2561 2571 I-contraception_consent
) 137 138 2571 2572 I-contraception_consent
prior 139 144 2573 2578 O
to 145 147 2579 2581 O
study 148 153 2582 2587 O
entry 154 159 2588 2593 O

Allergies 0 9 0 9 O
to 10 12 10 12 O
pig 13 16 13 16 B-allergy_name
- 16 17 16 17 I-allergy_name
derived 17 24 17 24 I-allergy_name
proteins 25 33 25 33 I-allergy_name

Contraindication 0 16 34 50 O
to 17 19 51 53 O
high 20 24 54 58 O
- 24 25 58 59 O
dose 25 29 59 63 O
corticosteroids 30 45 64 79 B-allergy_name
( 46 47 80 81 O
e.g. 47 51 81 85 O
uncontrolled 52 64 86 98 B-chronic_disease
blood 65 70 99 104 I-chronic_disease
sugar 71 76 105 110 I-chronic_disease
) 76 77 110 111 O

Diagnosis 0 9 112 121 O
of 10 12 122 124 O
any 13 16 125 128 O
underlying 17 27 129 139 B-chronic_disease
neurologic 28 38 140 150 I-chronic_disease
disorder 39 47 151 159 I-chronic_disease
that 48 52 160 164 O
would 53 58 165 170 O
potentially 59 70 171 182 O
confound 71 79 183 191 O
interpretation 80 94 192 206 O
of 95 97 207 209 O
the 98 101 210 213 O
study 102 107 214 219 O
results 108 115 220 227 O

Evidence 0 8 228 236 O
of 9 11 237 239 O
current 12 19 240 247 O
serious 20 27 248 255 B-chronic_disease
infection 28 37 256 265 I-chronic_disease
, 37 38 265 266 O
or 39 41 267 269 O
a 42 43 270 271 O
history 44 51 272 279 O
of 52 54 280 282 O
chronic 55 62 283 290 O
or 63 65 291 293 O
recurring 66 75 294 303 O
infections 76 86 304 314 O

History 0 7 315 322 O
of 8 10 323 325 O
malignancy 11 21 326 336 B-cancer

Hydrocephalus 0 13 337 350 B-chronic_disease

Neurologic 0 10 351 361 B-chronic_disease
deficits 11 19 362 370 I-chronic_disease
related 20 27 371 378 O
to 28 30 379 381 O
intraparenchymal 31 47 382 398 B-chronic_disease
brain 48 53 399 404 I-chronic_disease
, 53 54 404 405 O
spinal 55 61 406 412 B-chronic_disease
cord 62 66 413 417 I-chronic_disease
and/or 67 73 418 424 O
cauda 74 79 425 430 B-chronic_disease
equina 80 86 431 437 I-chronic_disease
involvement 87 98 438 449 O

Patient 0 7 450 457 O
with 8 12 458 462 O
sarcoidosis 13 24 463 474 B-chronic_disease
as 25 27 475 477 O
defined 28 35 478 485 O
by 36 38 486 488 O
ATS 39 42 489 492 O
/ 42 43 492 493 O
ERS 43 46 493 496 O
/ 46 47 496 497 O
WASOG 47 52 497 502 O
( 53 54 503 504 O
American 54 62 504 512 O
Thoracic 63 71 513 521 O
Society 72 79 522 529 O
/ 79 80 529 530 O
European 80 88 530 538 O
Thoracic 89 97 539 547 O
Society 98 105 548 555 O
/ 105 106 555 556 O
World 106 111 556 561 O
Association 112 123 562 573 O
for 124 127 574 577 O
Sarcoidosis 128 139 578 589 O
and 140 143 590 593 O
Other 144 149 594 599 O
Granulomatous 150 163 600 613 O
Disorders 164 173 614 623 O
) 173 174 623 624 O

Significant 0 11 625 636 O
change 12 18 637 643 O
in 19 21 644 646 O
corticosteroid 22 36 647 661 O
dose 37 41 662 666 O
within 42 48 667 673 O
the 49 52 674 677 O
past 53 57 678 682 B-upper_bound
4 58 59 683 684 I-upper_bound
weeks 60 65 685 690 I-upper_bound
, 65 66 690 691 O
or 67 69 692 694 O
other 70 75 695 700 O
immunosuppressive 76 93 701 718 B-treatment
medication 94 104 719 729 I-treatment
within 105 111 730 736 O
the 112 115 737 740 O
past 116 120 741 745 B-upper_bound
6 121 122 746 747 I-upper_bound
months 123 129 748 754 I-upper_bound

Stable 0 6 755 761 O
baseline 7 15 762 770 O
immunosuppressive 16 33 771 788 B-treatment
medications 34 45 789 800 I-treatment

Axillary 0 8 0 8 O
nodes 9 14 9 14 O
with 15 19 15 19 O
definite 20 28 20 28 O
evidence 29 37 29 37 O
of 38 40 38 40 O
microscopic 41 52 41 52 B-cancer
or 53 55 53 55 O
macroscopic 56 67 56 67 B-cancer
extracapsular 68 81 68 81 I-cancer
extension 82 91 82 91 I-cancer

Clear 0 5 92 97 O
delineation 6 17 98 109 O
of 18 20 110 112 O
the 21 24 113 116 O
extent 25 31 117 123 O
of 32 34 124 126 O
the 35 38 127 130 O
target 39 45 131 137 O
lumpectomy 46 56 138 148 B-treatment
cavity 57 63 149 155 O
not 64 67 156 159 O
possible 68 76 160 168 O

Documented 0 10 169 179 O
diagnosis 11 20 180 189 O
of 21 23 190 192 O
collagen 24 32 193 201 B-chronic_disease
vascular 33 41 202 210 I-chronic_disease
disease 42 49 211 218 I-chronic_disease
, 49 50 218 219 O
specifically 51 63 220 232 O
dermatomyositis 64 79 233 248 B-chronic_disease
with 80 84 249 253 O
a 85 86 254 255 O
creatinine 87 97 256 266 B-clinical_variable
phosphokinase 98 111 267 280 I-clinical_variable
( 112 113 281 282 I-clinical_variable
CPK 113 116 282 285 I-clinical_variable
) 116 117 285 286 I-clinical_variable
level 118 123 287 292 O
above 124 129 293 298 O
normal 130 136 299 305 O
or 137 139 306 308 O
with 140 144 309 313 O
an 145 147 314 316 O
active 148 154 317 323 O
skin 155 159 324 328 B-chronic_disease
rash 160 164 329 333 I-chronic_disease
, 164 165 333 334 O
systemic 166 174 335 343 B-chronic_disease
lupus 175 180 344 349 I-chronic_disease
erythematosus 181 194 350 363 I-chronic_disease
, 194 195 363 364 O
or 196 198 365 367 O
scleroderma 199 210 368 379 B-chronic_disease

Gross 0 5 380 385 B-chronic_disease
disease 6 13 386 393 I-chronic_disease
must 14 18 394 398 O
be 19 21 399 401 O
unifocal 22 30 402 410 O
with 31 35 411 415 O
pathologic 36 46 416 426 O
( 47 48 427 428 O
invasive 48 56 428 436 O
and/or 57 63 437 443 O
DCIS 64 68 444 448 B-cancer
) 68 69 448 449 O
tumor 70 75 450 455 B-cancer
size 76 80 456 460 O
3 81 82 461 462 B-upper_bound
cm 83 85 463 465 I-upper_bound
or 86 88 466 468 O
less 89 93 469 473 O

Men 0 3 474 477 B-gender
are 4 7 478 481 O
not 8 11 482 485 O
eligible 12 20 486 494 O
for 21 24 495 498 O
this 25 29 499 503 O
study 30 35 504 509 O

More 0 4 510 514 O
than 5 9 515 519 O
3 10 11 520 521 B-lower_bound
histologically 12 26 522 536 O
positive 27 35 537 545 O
axillary 36 44 546 554 B-cancer
nodes 45 50 555 560 I-cancer

Non 0 3 561 564 B-cancer
- 3 4 564 565 I-cancer
epithelial 4 14 565 575 I-cancer
breast 15 21 576 582 I-cancer
malignancies 22 34 583 595 I-cancer
such 35 39 596 600 O
as 40 42 601 603 O
sarcoma 43 50 604 611 B-cancer
or 51 53 612 614 O
lymphoma 54 62 615 623 B-cancer

On 0 2 624 626 O
histological 3 15 627 639 O
examination 16 27 640 651 O
, 27 28 651 652 O
the 29 32 653 656 O
tumor 33 38 657 662 B-cancer
must 39 43 663 667 O
be 44 46 668 670 O
ductal 47 53 671 677 B-cancer
carcinoma 54 63 678 687 I-cancer
in 64 66 688 690 I-cancer
situ 67 71 691 695 I-cancer
( 72 73 696 697 I-cancer
DCIS 73 77 697 701 I-cancer
) 77 78 701 702 I-cancer
or 79 81 703 705 O
invasive 82 90 706 714 O
adenocarcinoma 91 105 715 729 B-cancer
of 106 108 730 732 I-cancer
the 109 112 733 736 I-cancer
breast 113 119 737 743 I-cancer

Paget 0 5 744 749 B-cancer
's 5 7 749 751 I-cancer
disease 8 15 752 759 I-cancer
of 16 18 760 762 I-cancer
the 19 22 763 766 I-cancer
nipple 23 29 767 773 I-cancer

Palpable 0 8 774 782 O
or 9 11 783 785 O
radiographically 12 28 786 802 O
suspicious 29 39 803 813 O
ipsilateral 40 51 814 825 O
or 52 54 826 828 O
contralateral 55 68 829 842 B-chronic_disease
axillary 69 77 843 851 I-chronic_disease
, 77 78 851 852 O
supraclavicular 79 94 853 868 B-chronic_disease
, 94 95 868 869 O
infraclavicular 96 111 870 885 B-chronic_disease
, 111 112 885 886 O
or 113 115 887 889 O
internal 116 124 890 898 B-chronic_disease
mammary 125 132 899 906 I-chronic_disease
nodes 133 138 907 912 I-chronic_disease
at 139 141 913 915 O
time 142 146 916 920 O
of 147 149 921 923 O
enrollment 150 160 924 934 O
unless 161 167 935 941 O
there 168 173 942 947 O
is 174 176 948 950 O
histologic 177 187 951 961 O
confirmation 188 200 962 974 O
that 201 205 975 979 O
these 206 211 980 985 O
nodes 212 217 986 991 O
are 218 221 992 995 O
negative 222 230 996 1004 O
for 231 234 1005 1008 O
tumor 235 240 1009 1014 B-cancer

Patients 0 8 1015 1023 O
with 9 13 1024 1028 O
invasive 14 22 1029 1037 B-cancer
breast 23 29 1038 1044 I-cancer
cancer 30 36 1045 1051 I-cancer
are 37 40 1052 1055 O
required 41 49 1056 1064 O
to 50 52 1065 1067 O
have 53 57 1068 1072 O
axillary 58 66 1073 1081 O
staging 67 74 1082 1089 O
which 75 80 1090 1095 O
can 81 84 1096 1099 O
include 85 92 1100 1107 O
sentinel 93 101 1108 1116 B-treatment
node 102 106 1117 1121 I-treatment
biopsy 107 113 1122 1128 I-treatment
alone 114 119 1129 1134 O
( 120 121 1135 1136 O
if 121 123 1136 1138 O
sentinel 124 132 1139 1147 O
node 133 137 1148 1152 O
is 138 140 1153 1155 O
negative 141 149 1156 1164 O
) 149 150 1164 1165 O
, 150 151 1165 1166 O
sentinel 152 160 1167 1175 O
node 161 165 1176 1180 O
biopsy 166 172 1181 1187 O
followed 173 181 1188 1196 O
by 182 184 1197 1199 O
axillary 185 193 1200 1208 B-treatment
dissection 194 204 1209 1219 I-treatment
or 205 207 1220 1222 O
sampling 208 216 1223 1231 O
with 217 221 1232 1236 O
a 222 223 1237 1238 O
minimum 224 231 1239 1246 O
total 232 237 1247 1252 O
of 238 240 1253 1255 O
6 241 242 1256 1257 B-lower_bound
axillary 243 251 1258 1266 O
nodes 252 257 1267 1272 O
( 258 259 1273 1274 O
if 259 261 1274 1276 O
sentinel 262 270 1277 1285 O
node 271 275 1286 1290 O
is 276 278 1291 1293 O
positive 279 287 1294 1302 O
) 287 288 1302 1303 O
, 288 289 1303 1304 O
or 290 292 1305 1307 O
axillary 293 301 1308 1316 O
dissection 302 312 1317 1327 O
alone 313 318 1328 1333 O
( 319 320 1334 1335 O
with 320 324 1335 1339 O
a 325 326 1340 1341 O
minimum 327 334 1342 1349 O
of 335 337 1350 1352 O
6 338 339 1353 1354 O
axillary 340 348 1355 1363 O
nodes 349 354 1364 1369 O
) 354 355 1369 1370 O
; 355 356 1370 1371 O
axillary 357 365 1372 1380 O
staging 366 373 1381 1388 O
is 374 376 1389 1391 O
not 377 380 1392 1395 O
required 381 389 1396 1404 O
for 390 393 1405 1408 O
patients 394 402 1409 1417 O
with 403 407 1418 1422 O
DCIS 408 412 1423 1427 B-cancer

Pregnancy 0 9 1428 1437 B-pregnancy

Prior 0 5 1438 1443 B-treatment
radiation 6 15 1444 1453 I-treatment
to 16 18 1454 1456 I-treatment
the 19 22 1457 1460 I-treatment
index 23 28 1461 1466 I-treatment
breast 29 35 1467 1473 I-treatment

Proven 0 6 1474 1480 O
multicentric 7 19 1481 1493 B-cancer
carcinoma 20 29 1494 1503 I-cancer
( 30 31 1504 1505 O
invasive 31 39 1505 1513 B-cancer
cancer 40 46 1514 1520 I-cancer
or 47 49 1521 1523 O
DCIS 50 54 1524 1528 B-cancer
) 54 55 1528 1529 O
in 56 58 1530 1532 O
more 59 63 1533 1537 O
than 64 68 1538 1542 O
one 69 72 1543 1546 B-lower_bound
quadrant 73 81 1547 1555 O
or 82 84 1556 1558 O
separated 85 94 1559 1568 O
by 95 97 1569 1571 O
4 98 99 1572 1573 B-lower_bound
or 100 102 1574 1576 O
more 103 107 1577 1581 O
centimeters 108 119 1582 1593 O

Surgical 0 8 1594 1602 B-treatment
treatment 9 18 1603 1612 I-treatment
of 19 21 1613 1615 O
the 22 25 1616 1619 O
breast 26 32 1620 1626 O
must 33 37 1627 1631 O
have 38 42 1632 1636 O
been 43 47 1637 1641 O
lumpectomy 48 58 1642 1652 B-treatment

Suspicious 0 10 1653 1663 B-cancer
microcalcifications 11 30 1664 1683 I-cancer
, 30 31 1683 1684 O
or 32 34 1685 1687 O
densities 35 44 1688 1697 O
( 45 46 1698 1699 O
in 46 48 1699 1701 O
the 49 52 1702 1705 O
ipsilateral 53 64 1706 1717 O
or 65 67 1718 1720 O
contralateral 68 81 1721 1734 O
breast 82 88 1735 1741 O
as 89 91 1742 1744 O
documented 92 102 1745 1755 O
on 103 105 1756 1758 O
mammogram 106 115 1759 1768 B-treatment
or 116 118 1769 1771 O
breast 119 125 1772 1778 B-treatment
ultrasound 126 136 1779 1789 I-treatment
) 136 137 1789 1790 O
unless 138 144 1791 1797 O
biopsied 145 153 1798 1806 B-treatment
and 154 157 1807 1810 O
found 158 163 1811 1816 O
to 164 166 1817 1819 O
be 167 169 1820 1822 O
benign 170 176 1823 1829 O

Synchronous 0 11 1830 1841 B-cancer
bilateral 12 21 1842 1851 I-cancer
invasive 22 30 1852 1860 I-cancer
or 31 33 1861 1863 O
non 34 37 1864 1867 B-cancer
- 37 38 1867 1868 I-cancer
invasive 38 46 1868 1876 I-cancer
breast 47 53 1877 1883 I-cancer
cancer 54 60 1884 1890 I-cancer

T2 0 2 1891 1893 B-clinical_variable
( 3 4 1894 1895 O
> 4 5 1895 1896 O
3.0 6 9 1897 1900 B-lower_bound
cm 10 12 1901 1903 I-lower_bound
) 12 13 1903 1904 O
, 13 14 1904 1905 O
T3 15 17 1906 1908 B-clinical_variable
, 17 18 1908 1909 O
stage 19 24 1910 1915 B-cancer
III 25 28 1916 1919 I-cancer
, 28 29 1919 1920 O
or 30 32 1921 1923 O
stage 33 38 1924 1929 B-cancer
IV 39 41 1930 1932 I-cancer
breast 42 48 1933 1939 I-cancer
cancer 49 55 1940 1946 I-cancer

The 0 3 1947 1950 O
patient 4 11 1951 1958 O
must 12 16 1959 1963 O
have 17 21 1964 1968 O
stage 22 27 1969 1974 B-lower_bound
0 28 29 1975 1976 I-lower_bound
, 29 30 1976 1977 O
I 31 32 1978 1979 O
, 32 33 1979 1980 O
or 34 36 1981 1983 O
II 37 39 1984 1986 B-upper_bound
breast 40 46 1987 1993 B-cancer
cancer 47 53 1994 2000 I-cancer
; 53 54 2000 2001 O
if 55 57 2002 2004 O
stage 58 63 2005 2010 B-cancer
II 64 66 2011 2013 I-cancer
, 66 67 2013 2014 O
the 68 71 2015 2018 O
tumor 72 77 2019 2024 B-cancer
size 78 82 2025 2029 O
must 83 87 2030 2034 O
be 88 90 2035 2037 O
3 91 92 2038 2039 B-upper_bound
cm 93 95 2040 2042 I-upper_bound
or 96 98 2043 2045 O
less 99 103 2046 2050 O

The 0 3 2051 2054 O
target 4 10 2055 2061 O
lumpectomy 11 21 2062 2072 B-treatment
cavity 22 28 2073 2079 O
must 29 33 2080 2084 O
be 34 36 2085 2087 O
clearly 37 44 2088 2095 O
delineated 45 55 2096 2106 O
and 56 59 2107 2110 O
the 60 63 2111 2114 O
target 64 70 2115 2121 O
lumpectomy 71 81 2122 2132 O
cavity 82 88 2133 2139 O
/ 88 89 2139 2140 O
whole 89 94 2140 2145 O
breast 95 101 2146 2152 O
reference 102 111 2153 2162 O
volume 112 118 2163 2169 O
must 119 123 2170 2174 O
be 124 126 2175 2177 O
less 127 131 2178 2182 O
than 132 136 2183 2187 O
or 137 139 2188 2190 O
equal 140 145 2191 2196 O
to 146 148 2197 2199 O
30 149 151 2200 2202 B-upper_bound
% 151 152 2202 2203 I-upper_bound
based 153 158 2204 2209 O
on 159 161 2210 2212 O
the 162 165 2213 2216 O
postoperative 166 179 2217 2230 O
/ 179 180 2230 2231 O
pre 180 183 2231 2234 O
- 183 184 2234 2235 O
enrollment 184 194 2235 2245 O
computed 195 203 2246 2254 B-treatment
tomography 204 214 2255 2265 I-treatment
( 215 216 2266 2267 I-treatment
CT 216 218 2267 2269 I-treatment
) 218 219 2269 2270 I-treatment
scan 220 224 2271 2275 I-treatment

Treatment 0 9 2276 2285 O
plan 10 14 2286 2290 O
that 15 19 2291 2295 O
includes 20 28 2296 2304 O
regional 29 37 2305 2313 B-treatment
nodal 38 43 2314 2319 I-treatment
irradiation 44 55 2320 2331 I-treatment

Women 0 5 2332 2337 B-gender
of 6 8 2338 2340 O
reproductive 9 21 2341 2353 O
potential 22 31 2354 2363 O
must 32 36 2364 2368 O
agree 37 42 2369 2374 B-contraception_consent
to 43 45 2375 2377 I-contraception_consent
use 46 49 2378 2381 I-contraception_consent
an 50 52 2382 2384 I-contraception_consent
effective 53 62 2385 2394 I-contraception_consent
non 63 66 2395 2398 I-contraception_consent
- 66 67 2398 2399 I-contraception_consent
hormonal 67 75 2399 2407 I-contraception_consent
method 76 82 2408 2414 I-contraception_consent
of 83 85 2415 2417 I-contraception_consent
contraception 86 99 2418 2431 I-contraception_consent
during 100 106 2432 2438 O
therapy 107 114 2439 2446 O

patients 0 8 2447 2455 O
with 9 13 2456 2460 O
microscopic 14 25 2461 2472 O
multifocality 26 39 2473 2486 O
are 40 43 2487 2490 O
eligible 44 52 2491 2499 O
as 53 55 2500 2502 O
long 56 60 2503 2507 O
as 61 63 2508 2510 O
total 64 69 2511 2516 O
pathologic 70 80 2517 2527 B-clinical_variable
tumor 81 86 2528 2533 I-clinical_variable
size 87 91 2534 2538 O
is 92 94 2539 2541 O
3 95 96 2542 2543 B-upper_bound
cm 97 99 2544 2546 O
or 100 102 2547 2549 O
less 103 107 2550 2554 O

reexcision 0 10 2555 2565 B-treatment
of 11 13 2566 2568 I-treatment
surgical 14 22 2569 2577 I-treatment
margins 23 30 2578 2585 I-treatment

surgical 0 8 2586 2594 O
margins 9 16 2595 2602 O
are 17 20 2603 2606 O
rendered 21 29 2607 2615 O
free 30 34 2616 2620 O
of 35 37 2621 2623 O
disease 38 45 2624 2631 O
by 46 48 2632 2634 O
reexcision 49 59 2635 2645 B-treatment

the 0 3 2646 2649 O
margins 4 11 2650 2657 O
of 12 14 2658 2660 O
the 15 18 2661 2664 O
resected 19 27 2665 2673 O
specimen 28 36 2674 2682 O
must 37 41 2683 2687 O
be 42 44 2688 2690 O
histologically 45 59 2691 2705 O
free 60 64 2706 2710 O
of 65 67 2711 2713 O
tumor 68 73 2714 2719 B-cancer
( 74 75 2720 2721 O
DCIS 75 79 2721 2725 B-cancer
and 80 83 2726 2729 O
invasive 84 92 2730 2738 B-cancer
) 92 93 2738 2739 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
500 29 32 29 32 B-lower_bound
/ 32 33 32 33 I-lower_bound
mcL 33 36 33 36 I-lower_bound

Acute 0 5 37 42 B-chronic_disease
bacterial 6 15 43 52 I-chronic_disease
or 16 18 53 55 O
fungal 19 25 56 62 B-chronic_disease
infection 26 35 63 72 I-chronic_disease
requiring 36 45 73 82 O
intravenous 46 57 83 94 B-treatment
antibiotics 58 69 95 106 I-treatment
at 70 72 107 109 O
the 73 76 110 113 O
time 77 81 114 118 O
of 82 84 119 121 O
registration 85 97 122 134 O

Age 0 3 135 138 B-age
18 4 6 139 141 B-lower_bound
years 7 12 142 147 I-lower_bound
or 13 15 148 150 O
older 16 21 151 156 O

Brain 0 5 157 162 B-cancer
metastases 6 16 163 173 I-cancer
must 17 21 174 178 O
be 22 24 179 181 O
treated 25 32 182 189 O
prior 33 38 190 195 O
to 39 41 196 198 O
enrollment 42 52 199 209 O
in 53 55 210 212 O
the 56 59 213 216 O
study 60 65 217 222 O

CT 0 2 223 225 B-treatment
or 3 5 226 228 O
magnetic 6 14 229 237 B-treatment
resonance 15 24 238 247 I-treatment
imaging 25 32 248 255 I-treatment
( 33 34 256 257 I-treatment
MRI 34 37 257 260 I-treatment
) 37 38 260 261 I-treatment
of 39 41 262 264 O
the 42 45 265 268 O
brain 46 51 269 274 O
is 52 54 275 277 O
only 55 59 278 282 O
required 60 68 283 291 O
in 69 71 292 294 O
the 72 75 295 298 O
presence 76 84 299 307 O
of 85 87 308 310 O
neurologic 88 98 311 321 B-chronic_disease
symptoms 99 107 322 330 I-chronic_disease

Chronic 0 7 331 338 B-chronic_disease
obstructive 8 19 339 350 I-chronic_disease
pulmonary 20 29 351 360 I-chronic_disease
disease 30 37 361 368 I-chronic_disease
exacerbation 38 50 369 381 I-chronic_disease
or 51 53 382 384 O
other 54 59 385 390 O
respiratory 60 71 391 402 B-chronic_disease
illness 72 79 403 410 I-chronic_disease
requiring 80 89 411 420 O
hospitalization 90 105 421 436 O
or 106 108 437 439 O
precluding 109 119 440 450 O
study 120 125 451 456 B-treatment
therapy 126 133 457 464 I-treatment
within 134 140 465 471 O
30 141 143 472 474 B-upper_bound
days 144 148 475 479 I-upper_bound
prior 149 154 480 485 I-upper_bound
to 155 157 486 488 O
registration 158 170 489 501 O

Each 0 4 502 506 O
extracranial 5 17 507 519 B-clinical_variable
lesion 18 24 520 526 I-clinical_variable
must 25 29 527 531 O
be 30 32 532 534 O
= 33 34 535 536 O
< 34 35 536 537 O
6 36 37 538 539 B-upper_bound
cm 38 40 540 542 I-upper_bound
and 41 44 543 546 O
amenable 45 53 547 555 O
to 54 56 556 558 O
SBRT 57 61 559 563 B-treatment
or 62 64 564 566 O
surgical 65 73 567 575 B-treatment
excision 74 82 576 584 I-treatment

Eastern 0 7 585 592 B-clinical_variable
Cooperative 8 19 593 604 I-clinical_variable
Oncology 20 28 605 613 I-clinical_variable
Group 29 34 614 619 I-clinical_variable
( 35 36 620 621 I-clinical_variable
ECOG 36 40 621 625 I-clinical_variable
) 40 41 625 626 I-clinical_variable
performance 42 53 627 638 I-clinical_variable
status 54 60 639 645 I-clinical_variable
= 61 62 646 647 O
< 62 63 647 648 O
2 63 64 648 649 B-upper_bound

HIV 0 3 650 653 B-chronic_disease
testing 4 11 654 661 O
is 12 14 662 664 O
not 15 18 665 668 O
required 19 27 669 677 O
for 28 31 678 681 O
eligibility 32 43 682 693 O
for 44 47 694 697 O
this 48 52 698 702 O
protocol 53 61 703 711 O

Hemoglobin 0 10 712 722 B-clinical_variable
> 11 12 723 724 O
= 12 13 724 725 O
8.0 14 17 726 729 B-lower_bound
g 18 19 730 731 I-lower_bound
/ 19 20 731 732 I-lower_bound
dL 20 22 732 734 I-lower_bound

Human 0 5 735 740 B-chronic_disease
immunodeficiency 6 22 741 757 I-chronic_disease
virus 23 28 758 763 I-chronic_disease
( 29 30 764 765 I-chronic_disease
HIV 30 33 765 768 I-chronic_disease
) 33 34 768 769 I-chronic_disease
positive 35 43 770 778 O
with 44 48 779 783 O
cluster 49 56 784 791 O
of 57 59 792 794 O
differentiation 60 75 795 810 O
( 76 77 811 812 B-clinical_variable
CD)4 77 81 812 816 I-clinical_variable
count 82 87 817 822 I-clinical_variable
< 88 89 823 824 O
200 90 93 825 828 B-upper_bound
cells 94 99 829 834 I-upper_bound
/ 99 100 834 835 I-upper_bound
microliter 100 110 835 845 I-upper_bound

Known 0 5 846 851 O
active 6 12 852 858 O
invasive 13 21 859 867 O
malignancy 22 32 868 878 B-cancer
except 33 39 879 885 O
for 40 43 886 889 O
renal 44 49 890 895 B-cancer
cell 50 54 896 900 I-cancer
carcinoma 55 64 901 910 I-cancer
and/or 65 71 911 917 O
non 72 75 918 921 B-cancer
- 75 76 921 922 I-cancer
melanoma 76 84 922 930 I-cancer
skin 85 89 931 935 I-cancer
cancer 90 96 936 942 I-cancer

Life 0 4 943 947 B-clinical_variable
expectancy 5 15 948 958 I-clinical_variable
of 16 18 959 961 O
> 19 20 962 963 O
= 20 21 963 964 O
3 22 23 965 966 B-lower_bound
months 24 30 967 973 I-lower_bound

Patients 0 8 974 982 O
may 9 12 983 986 O
not 13 16 987 990 O
be 17 19 991 993 O
receiving 20 29 994 1003 O
any 30 33 1004 1007 O
systemic 34 42 1008 1016 B-treatment
anti 43 47 1017 1021 I-treatment
- 47 48 1021 1022 I-treatment
cancer 48 54 1022 1028 I-treatment
agents 55 61 1029 1035 I-treatment
or 62 64 1036 1038 O
other 65 70 1039 1044 B-treatment
investigational 71 86 1045 1060 I-treatment
agents 87 93 1061 1067 I-treatment
during 94 100 1068 1074 O
radiation 101 110 1075 1084 B-treatment
therapy 111 118 1085 1092 I-treatment

Patients 0 8 1093 1101 O
may 9 12 1102 1105 O
not 13 16 1106 1109 O
have 17 21 1110 1114 O
had 22 25 1115 1118 O
prior 26 31 1119 1124 O
bevacizumab 32 43 1125 1136 B-treatment
, 43 44 1136 1137 O
based 45 50 1138 1143 O
on 51 53 1144 1146 O
case 54 58 1147 1151 O
reports 59 66 1152 1159 O
of 67 69 1160 1162 O
tracheoesophageal 70 87 1163 1180 B-chronic_disease
fistula 88 95 1181 1188 I-chronic_disease
in 96 98 1189 1191 O
patients 99 107 1192 1200 O
treated 108 115 1201 1208 O
with 116 120 1209 1213 O
bevacizumab 121 132 1214 1225 O
and 133 136 1226 1229 O
radiotherapy 137 149 1230 1242 B-treatment

Patients 0 8 1243 1251 O
may 9 12 1252 1255 O
not 13 16 1256 1259 O
have 17 21 1260 1264 O
received 22 30 1265 1273 O
prior 31 36 1274 1279 B-treatment
radiation 37 46 1280 1289 I-treatment
therapy 47 54 1290 1297 I-treatment
to 55 57 1298 1300 O
a 58 59 1301 1302 O
site 60 64 1303 1307 O
of 65 67 1308 1310 O
recurrence 68 78 1311 1321 O
which 79 84 1322 1327 O
would 85 90 1328 1333 O
require 91 98 1334 1341 O
overlap 99 106 1342 1349 O
of 107 109 1350 1352 O
appreciable 110 121 1353 1364 O
radiation 122 131 1365 1374 O
dose 132 136 1375 1379 O

Patients 0 8 1380 1388 O
must 9 13 1389 1393 O
have 14 18 1394 1398 O
3 19 20 1399 1400 B-upper_bound
or 21 23 1401 1403 O
fewer 24 29 1404 1409 O
brain 30 35 1410 1415 B-cancer
metastases 36 46 1416 1426 I-cancer
, 46 47 1426 1427 O
of 48 50 1428 1430 O
size 51 55 1431 1435 B-clinical_variable
= 56 57 1436 1437 O
< 57 58 1437 1438 O
4 59 60 1439 1440 B-upper_bound
cm 61 63 1441 1443 I-upper_bound

Patients 0 8 1444 1452 O
must 9 13 1453 1457 O
have 14 18 1458 1462 O
between 19 26 1463 1470 O
1 27 28 1471 1472 B-lower_bound
to 29 31 1473 1475 O
5 32 33 1476 1477 B-upper_bound
new 34 37 1478 1481 O
or 38 40 1482 1484 O
recurrent 41 50 1485 1494 O
lesions 51 58 1495 1502 O
suspicious 59 69 1503 1513 O
for 70 73 1514 1517 O
metastatic 74 84 1518 1528 B-cancer
RCC 85 88 1529 1532 I-cancer
on 89 91 1533 1535 O
diagnostic 92 102 1536 1546 O
imaging 103 110 1547 1554 B-treatment

Patients 0 8 1555 1563 O
must 9 13 1564 1568 O
have 14 18 1569 1573 O
had 19 22 1574 1577 O
at 23 25 1578 1580 O
least 26 31 1581 1586 O
a 32 33 1587 1588 O
computed 34 42 1589 1597 B-treatment
tomography 43 53 1598 1608 I-treatment
( 54 55 1609 1610 I-treatment
CT 55 57 1610 1612 I-treatment
) 57 58 1612 1613 I-treatment
of 59 61 1614 1616 O
the 62 65 1617 1620 O
chest 66 71 1621 1626 O
, 71 72 1626 1627 O
abdomen 73 80 1628 1635 O
, 80 81 1635 1636 O
and 82 85 1637 1640 O
pelvis 86 92 1641 1647 O
within 93 99 1648 1654 O
4 100 101 1655 1656 B-upper_bound
weeks 102 107 1657 1662 I-upper_bound
of 108 110 1663 1665 O
registration 111 123 1666 1678 O
in 124 126 1679 1681 O
the 127 130 1682 1685 O
trial 131 136 1686 1691 O

Patients 0 8 1692 1700 O
must 9 13 1701 1705 O
have 14 18 1706 1710 O
had 19 22 1711 1714 O
no 23 25 1715 1717 O
radiotherapy 26 38 1718 1730 B-treatment
, 38 39 1730 1731 O
immunotherapy 40 53 1732 1745 B-treatment
, 53 54 1745 1746 O
chemotherapy 55 67 1747 1759 B-treatment
or 68 70 1760 1762 O
therapy 71 78 1763 1770 O
with 79 83 1771 1775 O
targeted 84 92 1776 1784 O
agents 93 99 1785 1791 O
within 100 106 1792 1798 O
the 107 110 1799 1802 O
last 111 115 1803 1807 B-upper_bound
1 116 117 1808 1809 I-upper_bound
month 118 123 1810 1815 I-upper_bound

Patients 0 8 1816 1824 O
must 9 13 1825 1829 O
have 14 18 1830 1834 O
histologically 19 33 1835 1849 O
or 34 36 1850 1852 O
cytologically 37 50 1853 1866 O
confirmed 51 60 1867 1876 O
metastatic 61 71 1877 1887 B-cancer
or 72 74 1888 1890 O
recurrent 75 84 1891 1900 O
RCC 85 88 1901 1904 B-cancer
( 89 90 1905 1906 O
any 90 93 1906 1909 O
histologic 94 104 1910 1920 O
subtype 105 112 1921 1928 O
) 112 113 1928 1929 O

Patients 0 8 1930 1938 O
must 9 13 1939 1943 O
have 14 18 1944 1948 O
normal 19 25 1949 1955 O
organ 26 31 1956 1961 O
and 32 35 1962 1965 O
marrow 36 42 1966 1972 O
function 43 51 1973 1981 O
within 52 58 1982 1988 O
30 59 61 1989 1991 B-upper_bound
days 62 66 1992 1996 I-upper_bound
of 67 69 1997 1999 O
registration 70 82 2000 2012 O

Patients 0 8 2013 2021 O
who 9 12 2022 2025 O
have 13 17 2026 2030 O
an 18 20 2031 2033 O
intact 21 27 2034 2040 O
unresected 28 38 2041 2051 O
primary 39 46 2052 2059 B-cancer
tumor 47 52 2060 2065 I-cancer
should 53 59 2066 2072 O
be 60 62 2073 2075 O
considered 63 73 2076 2086 O
for 74 77 2087 2090 O
radical 78 85 2091 2098 B-treatment
nephrectomy 86 97 2099 2110 I-treatment
and 98 101 2111 2114 O
primary 102 109 2115 2122 B-treatment
resection 110 119 2123 2132 I-treatment
prior 120 125 2133 2138 O
to 126 128 2139 2141 O
enrollment 129 139 2142 2152 O
in 140 142 2153 2155 O
the 143 146 2156 2159 O
study 147 152 2160 2165 O

Patients 0 8 2166 2174 O
who 9 12 2175 2178 O
have 13 17 2179 2183 O
had 18 21 2184 2187 O
any 22 25 2188 2191 O
prior 26 31 2192 2197 B-treatment
bevacizumab 32 43 2198 2209 I-treatment
, 43 44 2209 2210 O
due 45 48 2211 2214 O
to 49 51 2215 2217 O
case 52 56 2218 2222 O
reports 57 64 2223 2230 O
suggesting 65 75 2231 2241 O
a 76 77 2242 2243 O
possible 78 86 2244 2252 O
risk 87 91 2253 2257 O
of 92 94 2258 2260 O
severe 95 101 2261 2267 O
toxicity 102 110 2268 2276 O
in 111 113 2277 2279 O
combination 114 125 2280 2291 O
with 126 130 2292 2296 O
radiotherapy 131 143 2297 2309 B-treatment

Patients 0 8 2310 2318 O
who 9 12 2319 2322 O
have 13 17 2323 2327 O
had 18 21 2328 2331 O
prior 22 27 2332 2337 B-treatment
chemotherapy 28 40 2338 2350 I-treatment
, 40 41 2350 2351 O
immunotherapy 42 55 2352 2365 B-treatment
, 55 56 2365 2366 O
targeted 57 65 2367 2375 B-treatment
therapy 66 73 2376 2383 I-treatment
, 73 74 2383 2384 O
or 75 77 2385 2387 O
radiotherapy 78 90 2388 2400 B-treatment
within 91 97 2401 2407 O
1 98 99 2408 2409 B-upper_bound
month 100 105 2410 2415 I-upper_bound
of 106 108 2416 2418 O
enrollment 109 119 2419 2429 O

Patients 0 8 2430 2438 O
with 9 13 2439 2443 O
radiographic 14 26 2444 2456 O
or 27 29 2457 2459 O
clinical 30 38 2460 2468 O
findings 39 47 2469 2477 O
of 48 50 2478 2480 O
spinal 51 57 2481 2487 B-chronic_disease
cord 58 62 2488 2492 I-chronic_disease
compression 63 74 2493 2504 I-chronic_disease
or 75 77 2505 2507 O
cauda 78 83 2508 2513 B-chronic_disease
equina 84 90 2514 2520 I-chronic_disease
syndrome 91 99 2521 2529 I-chronic_disease
with 100 104 2530 2534 O
neurologic 105 115 2535 2545 O
deficit 116 123 2546 2553 O
thought 124 131 2554 2561 O
to 132 134 2562 2564 O
be 135 137 2565 2567 O
due 138 141 2568 2571 O
to 142 144 2572 2574 O
malignancy 145 155 2575 2585 B-cancer

Platelets 0 9 2586 2595 B-clinical_variable
> 10 11 2596 2597 O
= 11 12 2597 2598 O
50,000 13 19 2599 2605 B-lower_bound
/ 19 20 2605 2606 I-lower_bound
mcL 20 23 2606 2609 I-lower_bound

Pregnancy 0 9 2610 2619 B-pregnancy
or 10 12 2620 2622 O
women 13 18 2623 2628 B-gender
of 19 21 2629 2631 O
childbearing 22 34 2632 2644 O
potential 35 44 2645 2654 O
who 45 48 2655 2658 O
are 49 52 2659 2662 O
sexually 53 61 2663 2671 O
active 62 68 2672 2678 O
and 69 72 2679 2682 O
not 73 76 2683 2686 B-contraception_consent
willing 77 84 2687 2694 I-contraception_consent
/ 84 85 2694 2695 I-contraception_consent
able 85 89 2695 2699 I-contraception_consent
to 90 92 2700 2702 I-contraception_consent
use 93 96 2703 2706 I-contraception_consent
medically 97 106 2707 2716 I-contraception_consent
acceptable 107 117 2717 2727 I-contraception_consent
forms 118 123 2728 2733 I-contraception_consent
of 124 126 2734 2736 I-contraception_consent
contraception 127 140 2737 2750 I-contraception_consent
during 141 147 2751 2757 O
protocol 148 156 2758 2766 O
treatment 157 166 2767 2776 B-treatment
or 167 169 2777 2779 O
for 170 173 2780 2783 O
at 174 176 2784 2786 O
least 177 182 2787 2792 O
6 183 184 2793 2794 B-lower_bound
months 185 191 2795 2801 I-lower_bound
following 192 201 2802 2811 O
treatment 202 211 2812 2821 O

Severe 0 6 2822 2828 O
hepatic 7 14 2829 2836 B-chronic_disease
disease 15 22 2837 2844 I-chronic_disease
, 22 23 2844 2845 O
defined 24 31 2846 2853 O
as 32 34 2854 2856 O
a 35 36 2857 2858 O
diagnosis 37 46 2859 2868 O
of 47 49 2869 2871 O
Child 50 55 2872 2877 B-clinical_variable
- 55 56 2877 2878 I-clinical_variable
Pugh 56 60 2878 2882 I-clinical_variable
class 61 66 2883 2888 O
B 67 68 2889 2890 O
or 69 71 2891 2893 O
C 72 73 2894 2895 O
hepatic 74 81 2896 2903 O
disease 82 89 2904 2911 O
if 90 92 2912 2914 O
the 93 96 2915 2918 O
liver 97 102 2919 2924 O
is 103 105 2925 2927 O
involved 106 114 2928 2936 O
with 115 119 2937 2941 O
metastatic 120 130 2942 2952 B-cancer
disease 131 138 2953 2960 I-cancer

Transmural 0 10 2961 2971 B-chronic_disease
myocardial 11 21 2972 2982 I-chronic_disease
infarction 22 32 2983 2993 I-chronic_disease
within 33 39 2994 3000 O
the 40 43 3001 3004 O
last 44 48 3005 3009 B-upper_bound
6 49 50 3010 3011 I-upper_bound
months 51 57 3012 3018 I-upper_bound
prior 58 63 3019 3024 O
to 64 66 3025 3027 O
registration 67 79 3028 3040 O

Unstable 0 8 3041 3049 B-chronic_disease
angina 9 15 3050 3056 I-chronic_disease
and/or 16 22 3057 3063 O
congestive 23 33 3064 3074 B-chronic_disease
heart 34 39 3075 3080 I-chronic_disease
failure 40 47 3081 3088 I-chronic_disease
requiring 48 57 3089 3098 O
hospitalization 58 73 3099 3114 B-treatment
within 74 80 3115 3121 O
the 81 84 3122 3125 O
last 85 89 3126 3130 B-upper_bound
6 90 91 3131 3132 I-upper_bound
months 92 98 3133 3139 I-upper_bound
prior 99 104 3140 3145 I-upper_bound
to 105 107 3146 3148 O
registration 108 120 3149 3161 O

Women 0 5 3162 3167 B-gender
of 6 8 3168 3170 O
childbearing 9 21 3171 3183 O
potential 22 31 3184 3193 O
must 32 36 3194 3198 O
have 37 41 3199 3203 O
a 42 43 3204 3205 O
negative 44 52 3206 3214 B-pregnancy
pregnancy 53 62 3215 3224 I-pregnancy
test 63 67 3225 3229 O
within 68 74 3230 3236 O
14 75 77 3237 3239 B-upper_bound
days 78 82 3240 3244 I-upper_bound
of 83 85 3245 3247 O
registration 86 98 3248 3260 O

patients 0 8 3261 3269 O
who 9 12 3270 3273 O
are 13 16 3274 3277 O
HIV 17 20 3278 3281 B-chronic_disease
positive 21 29 3282 3290 O
are 30 33 3291 3294 O
eligible 34 42 3295 3303 O
, 42 43 3303 3304 O
provided 44 52 3305 3313 O
they 53 57 3314 3318 O
are 58 61 3319 3322 O
under 62 67 3323 3328 O
treatment 68 77 3329 3338 B-treatment
with 78 82 3339 3343 I-treatment
highly 83 89 3344 3350 I-treatment
active 90 96 3351 3357 I-treatment
antiretroviral 97 111 3358 3372 I-treatment
therapy 112 119 3373 3380 I-treatment
( 120 121 3381 3382 I-treatment
HAART 121 126 3382 3387 I-treatment
) 126 127 3387 3388 I-treatment
and 128 131 3389 3392 O
have 132 136 3393 3397 O
a 137 138 3398 3399 O
CD4 139 142 3400 3403 B-clinical_variable
count 143 148 3404 3409 I-clinical_variable
> 149 150 3410 3411 O
= 150 151 3411 3412 O
200 152 155 3413 3416 B-lower_bound
cells 156 161 3417 3422 I-lower_bound
/ 161 162 3422 3423 I-lower_bound
microliter 162 172 3423 3433 I-lower_bound
within 173 179 3434 3440 O
30 180 182 3441 3443 B-upper_bound
days 183 187 3444 3448 I-upper_bound
prior 188 193 3449 3454 I-upper_bound
to 194 196 3455 3457 O
registration 197 209 3458 3470 O

the 0 3 3471 3474 O
modality 4 12 3475 3483 O
of 13 15 3484 3486 O
treatment 16 25 3487 3496 B-treatment
of 26 28 3497 3499 O
brain 29 34 3500 3505 B-cancer
metastases 35 45 3506 3516 I-cancer
can 46 49 3517 3520 O
include 50 57 3521 3528 O
surgical 58 66 3529 3537 B-treatment
resection 67 76 3538 3547 I-treatment
, 76 77 3547 3548 O
whole 78 83 3549 3554 B-treatment
brain 84 89 3555 3560 I-treatment
radiotherapy 90 102 3561 3573 I-treatment
, 102 103 3573 3574 O
stereotactic 104 116 3575 3587 B-treatment
radiosurgery 117 129 3588 3600 I-treatment
, 129 130 3600 3601 O
or 131 133 3602 3604 O
any 134 137 3605 3608 O
combination 138 149 3609 3620 O
of 150 152 3621 3623 O
the 153 156 3624 3627 O
above 157 162 3628 3633 O

this 0 4 3634 3638 O
will 5 9 3639 3643 O
be 10 12 3644 3646 O
defined 13 20 3647 3654 O
as 21 23 3655 3657 O
a 24 25 3658 3659 O
primary 26 33 3660 3667 B-cancer
tumor 34 39 3668 3673 I-cancer
< 40 41 3674 3675 O
10 42 44 3676 3678 B-upper_bound
cm 45 47 3679 3681 I-upper_bound
in 48 50 3682 3684 O
size 51 55 3685 3689 O
or 56 58 3690 3692 O
a 59 60 3693 3694 O
primary 61 68 3695 3702 O
lesion 69 75 3703 3709 O
which 76 81 3710 3715 O
can 82 85 3716 3719 O
be 86 88 3720 3722 O
treated 89 96 3723 3730 O
to 97 99 3731 3733 O
a 100 101 3734 3735 O
dose 102 106 3736 3740 O
of 107 109 3741 3743 O
> 110 111 3744 3745 O
= 111 112 3745 3746 O
8 113 114 3747 3748 B-lower_bound
Gy 115 117 3749 3751 O
x 118 119 3752 3753 O
5 120 121 3754 3755 O
without 122 129 3756 3763 O
excessive 130 139 3764 3773 O
perceived 140 149 3774 3783 O
risk 150 154 3784 3788 O
of 155 157 3789 3791 O
toxicity 158 166 3792 3800 O

Estimated 0 9 0 9 O
life 10 14 10 14 B-clinical_variable
expectancy 15 25 15 25 I-clinical_variable
of 26 28 26 28 O
at 29 31 29 31 O
least 32 37 32 37 O
12 38 40 38 40 B-lower_bound
weeks 41 46 41 46 I-lower_bound

History 0 7 47 54 O
of 8 10 55 57 O
allergic 11 19 58 66 O
reactions 20 29 67 76 O
attributed 30 40 77 87 O
to 41 43 88 90 O
compounds 44 53 91 100 O
of 54 56 101 103 O
similar 57 64 104 111 O
chemical 65 73 112 120 O
or 74 76 121 123 O
biologic 77 85 124 132 O
composition 86 97 133 144 O
to 98 100 145 147 O
cetuximab 101 110 148 157 B-allergy_name
or 111 113 158 160 O
other 114 119 161 166 O
agents 120 126 167 173 O
used 127 131 174 178 O
in 132 134 179 181 O
the 135 138 182 185 O
study 139 144 186 191 O

Magnesium 0 9 192 201 B-clinical_variable
< 10 11 202 203 O
1.4 12 15 204 207 B-upper_bound
mg 16 18 208 210 I-upper_bound
/ 18 19 210 211 I-upper_bound
dl 19 21 211 213 I-upper_bound
( 22 23 214 215 O
< 23 24 215 216 O
0.4 25 28 217 220 B-upper_bound
mmol 29 33 221 225 I-upper_bound
/ 33 34 225 226 I-upper_bound
L 34 35 226 227 I-upper_bound
) 35 36 227 228 O
or 37 39 229 231 O
> 40 41 232 233 O
3 42 43 234 235 B-lower_bound
mg 44 46 236 238 I-lower_bound
/ 46 47 238 239 I-lower_bound
dl 47 49 239 241 I-lower_bound
( 50 51 242 243 O
> 51 52 243 244 O
1.23 53 57 245 249 B-lower_bound
mmol 58 62 250 254 I-lower_bound
/ 62 63 254 255 I-lower_bound
L 63 64 255 256 I-lower_bound
) 64 65 256 257 O
despite 66 73 258 265 O
intervention 74 86 266 278 O
to 87 89 279 281 O
normalize 90 99 282 291 O
levels 100 106 292 298 O

Negative 0 8 299 307 B-pregnancy
pregnancy 9 18 308 317 I-pregnancy
test 19 23 318 322 O

Patients 0 8 323 331 O
must 9 13 332 336 O
agree 14 19 337 342 O
to 20 22 343 345 O
pre- 23 27 346 350 O
and 28 31 351 354 O
post 32 36 355 359 O
- 36 37 359 360 O
treatment 37 46 360 369 O
biopsies 47 55 370 378 B-treatment

Patients 0 8 379 387 O
must 9 13 388 392 O
have 14 18 393 397 O
an 19 21 398 400 O
Eastern 22 29 401 408 B-clinical_variable
Cooperative 30 41 409 420 I-clinical_variable
Oncology 42 50 421 429 I-clinical_variable
Group 51 56 430 435 I-clinical_variable
( 57 58 436 437 I-clinical_variable
ECOG 58 62 437 441 I-clinical_variable
) 62 63 441 442 I-clinical_variable
performance 64 75 443 454 I-clinical_variable
status 76 82 455 461 I-clinical_variable
= 83 84 462 463 O
< 84 85 463 464 O
2 86 87 465 466 B-upper_bound

Patients 0 8 467 475 O
must 9 13 476 480 O
have 14 18 481 485 O
untreated 19 28 486 495 O
or 29 31 496 498 O
relapsed 32 40 499 507 O
SCCS 41 45 508 512 O
that 46 50 513 517 O
is 51 53 518 520 O
considered 54 64 521 531 O
to 65 67 532 534 O
be 68 70 535 537 O
aggressive 71 81 538 548 O
and 82 85 549 552 O
locally 86 93 553 560 O
advanced 94 102 561 569 O
by 103 105 570 572 O
the 106 109 573 576 O
following 110 119 577 586 O
criteria 120 128 587 595 O
: 128 129 595 596 O
tumors 130 136 597 603 B-cancer
2 137 138 604 605 B-lower_bound
cm 139 141 606 608 I-lower_bound
or 142 144 609 611 O
more 145 149 612 616 O
, 149 150 616 617 O
tumors 151 157 618 624 O
invading 158 166 625 633 O
deep 167 171 634 638 O
tissues 172 179 639 646 O
such 180 184 647 651 O
as 185 187 652 654 O
muscle 188 194 655 661 O
, 194 195 661 662 O
cartilage 196 205 663 672 O
or 206 208 673 675 O
bone 209 213 676 680 O
; 213 214 680 681 O
tumors 215 221 682 688 O
showing 222 229 689 696 O
perineural 230 240 697 707 O
invasion 241 249 708 716 O
, 249 250 716 717 O
and/or 251 257 718 724 O
tumors 258 264 725 731 O
metastatic 265 275 732 742 O
to 276 278 743 745 O
loco 279 283 746 750 O
- 283 284 750 751 O
regional 284 292 751 759 O
lymph 293 298 760 765 O
nodes 299 304 766 771 O
; 304 305 771 772 O
patients 306 314 773 781 O
may 315 318 782 785 O
have 319 323 786 790 O
had 324 327 791 794 O
prior 328 333 795 800 O
surgical 334 342 801 809 O
interventions 343 356 810 823 O
or 357 359 824 826 O
been 360 364 827 831 O
treated 365 372 832 839 O
with 373 377 840 844 O
investigational 378 393 845 860 O
agents 394 400 861 867 O
with 401 405 868 872 O
residual 406 414 873 881 O
or 415 417 882 884 O
recurrent 418 427 885 894 O
disease 428 435 895 902 O

Potassium 0 9 903 912 B-clinical_variable
< 10 11 913 914 O
3.5 12 15 915 918 B-upper_bound
mmol 16 20 919 923 I-upper_bound
/ 20 21 923 924 I-upper_bound
L 21 22 924 925 I-upper_bound
or 23 25 926 928 O
> 26 27 929 930 O
6 28 29 931 932 B-lower_bound
mmol 30 34 933 937 I-lower_bound
/ 34 35 937 938 I-lower_bound
L 35 36 938 939 I-lower_bound
despite 37 44 940 947 O
intervention 45 57 948 960 O
to 58 60 961 963 O
normalize 61 70 964 973 O
levels 71 77 974 980 O

Prior 0 5 981 986 B-treatment
radiation 6 15 987 996 I-treatment
therapy 16 23 997 1004 I-treatment
is 24 26 1005 1007 O
not 27 30 1008 1011 O
an 31 33 1012 1014 O
exclusion 34 43 1015 1024 O
however 44 51 1025 1032 O
, 51 52 1032 1033 O
patient 53 60 1034 1041 O
must 61 65 1042 1046 O
have 66 70 1047 1051 O
documented 71 81 1052 1062 O
progression 82 93 1063 1074 O
at 94 96 1075 1077 O
the 97 100 1078 1081 O
radiation 101 110 1082 1091 O
site 111 115 1092 1096 O

Second 0 6 1097 1103 O
primary 7 14 1104 1111 B-cancer
malignancy 15 25 1112 1122 I-cancer
only 26 30 1123 1127 O
if 31 33 1128 1130 O
treatment 34 43 1131 1140 B-treatment
would 44 49 1141 1146 O
interfere 50 59 1147 1156 O
with 60 64 1157 1161 O
the 65 68 1162 1165 O
patient 69 76 1166 1173 O
's 76 78 1173 1175 O
participation 79 92 1176 1189 O
in 93 95 1190 1192 O
this 96 100 1193 1197 O
trial 101 106 1198 1203 O
in 107 109 1204 1206 O
the 110 113 1207 1210 O
opinion 114 121 1211 1218 O
of 122 124 1219 1221 O
the 125 128 1222 1225 O
treating 129 137 1226 1234 O
physician 138 147 1235 1244 O

Serious 0 7 1245 1252 O
concomitant 8 19 1253 1264 O
systemic 20 28 1265 1273 B-chronic_disease
disorders 29 38 1274 1283 I-chronic_disease
( 39 40 1284 1285 O
including 40 49 1285 1294 O
active 50 56 1295 1301 B-chronic_disease
infections 57 67 1302 1312 I-chronic_disease
) 67 68 1312 1313 O
that 69 73 1314 1318 O
would 74 79 1319 1324 O
compromise 80 90 1325 1335 O
the 91 94 1336 1339 O
safety 95 101 1340 1346 O
of 102 104 1347 1349 O
the 105 108 1350 1353 O
patient 109 116 1354 1361 O
or 117 119 1362 1364 O
compromise 120 130 1365 1375 O
the 131 134 1376 1379 O
patient 135 142 1380 1387 O
's 142 144 1387 1389 O
ability 145 152 1390 1397 O
to 153 155 1398 1400 O
complete 156 164 1401 1409 O
the 165 168 1410 1413 O
study 169 174 1414 1419 O
, 174 175 1419 1420 O
at 176 178 1421 1423 O
the 179 182 1424 1427 O
discretion 183 193 1428 1438 O
of 194 196 1439 1441 O
the 197 200 1442 1445 O
investigator 201 213 1446 1458 O

Serum 0 5 1459 1464 B-clinical_variable
calcium 6 13 1465 1472 I-clinical_variable
( 14 15 1473 1474 I-clinical_variable
ionized 15 22 1474 1481 I-clinical_variable
or 23 25 1482 1484 I-clinical_variable
adjusted 26 34 1485 1493 I-clinical_variable
for 35 38 1494 1497 I-clinical_variable
albumin 39 46 1498 1505 I-clinical_variable
) 46 47 1505 1506 I-clinical_variable
< 48 49 1507 1508 O
8 50 51 1509 1510 B-upper_bound
mg 52 54 1511 1513 I-upper_bound
/ 54 55 1513 1514 I-upper_bound
dl 55 57 1514 1516 I-upper_bound
( 58 59 1517 1518 I-upper_bound
1.75 59 63 1518 1522 I-upper_bound
mmol 64 68 1523 1527 I-upper_bound
/ 68 69 1527 1528 I-upper_bound
L 69 70 1528 1529 I-upper_bound
) 70 71 1529 1530 I-upper_bound
or 72 74 1531 1533 O
> 75 76 1534 1535 O
12.5 77 81 1536 1540 B-lower_bound
mg 82 84 1541 1543 I-lower_bound
/ 84 85 1543 1544 I-lower_bound
dl 85 87 1544 1546 I-lower_bound
( 88 89 1547 1548 I-lower_bound
> 89 90 1548 1549 I-lower_bound
3.1 91 94 1550 1553 I-lower_bound
mmol 95 99 1554 1558 I-lower_bound
/ 99 100 1558 1559 I-lower_bound
L 100 101 1559 1560 I-lower_bound
) 101 102 1560 1561 I-lower_bound
despite 103 110 1562 1569 O
intervention 111 123 1570 1582 O
to 124 126 1583 1585 O
normalize 127 136 1586 1595 O
levels 137 143 1596 1602 O

Women 0 5 1603 1608 B-gender
who 6 9 1609 1612 O
are 10 13 1613 1616 O
pregnant 14 22 1617 1625 B-pregnancy

age 0 3 1626 1629 B-age
must 4 8 1630 1634 O
agree 9 14 1635 1640 O
to 15 17 1641 1643 O
undergo 18 25 1644 1651 O
a 26 27 1652 1653 O
pregnancy 28 37 1654 1663 B-pregnancy
test 38 42 1664 1668 O
prior 43 48 1669 1674 O
to 49 51 1675 1677 O
therapy 52 59 1678 1685 B-treatment
and 60 63 1686 1689 O
to 64 66 1690 1692 O
use 67 70 1693 1696 B-contraception_consent
adequate 71 79 1697 1705 I-contraception_consent
contraception 80 93 1706 1719 I-contraception_consent
( 94 95 1720 1721 O
hormonal 95 103 1721 1729 B-contraception_consent
or 104 106 1730 1732 I-contraception_consent
barrier 107 114 1733 1740 I-contraception_consent
method 115 121 1741 1747 I-contraception_consent
of 122 124 1748 1750 I-contraception_consent
birth 125 130 1751 1756 I-contraception_consent
control 131 138 1757 1764 I-contraception_consent
; 138 139 1764 1765 O
abstinence 140 150 1766 1776 B-contraception_consent
) 150 151 1776 1777 O
prior 152 157 1778 1783 O
to 158 160 1784 1786 O
study 161 166 1787 1792 O
entry 167 172 1793 1798 O
, 172 173 1798 1799 O
for 174 177 1800 1803 O
the 178 181 1804 1807 O
duration 182 190 1808 1816 O
of 191 193 1817 1819 O
study 194 199 1820 1825 O
participation 200 213 1826 1839 O
and 214 217 1840 1843 O
for 218 221 1844 1847 O
6 222 223 1848 1849 B-upper_bound
months 224 230 1850 1856 I-upper_bound
after 231 236 1857 1862 O
; 236 237 1862 1863 O
should 238 244 1864 1870 O
a 245 246 1871 1872 O
woman 247 252 1873 1878 B-gender
become 253 259 1879 1885 B-pregnancy
pregnant 260 268 1886 1894 I-pregnancy
or 269 271 1895 1897 O
suspect 272 279 1898 1905 O
she 280 283 1906 1909 O
is 284 286 1910 1912 O
pregnant 287 295 1913 1921 O
while 296 301 1922 1927 O
participating 302 315 1928 1941 O
in 316 318 1942 1944 O
this 319 323 1945 1949 O
study 324 329 1950 1955 O
, 329 330 1955 1956 O
she 331 334 1957 1960 O
should 335 341 1961 1967 O
inform 342 348 1968 1974 O
her 349 352 1975 1978 O
treating 353 361 1979 1987 O
physician 362 371 1988 1997 O
immediately 372 383 1998 2009 O

patient 0 7 2010 2017 O
had 8 11 2018 2021 O
a 12 13 2022 2023 O
second 14 20 2024 2030 B-cancer
primary 21 28 2031 2038 I-cancer
malignancy 29 39 2039 2049 I-cancer
but 40 43 2050 2053 O
has 44 47 2054 2057 O
been 48 52 2058 2062 O
treated 53 60 2063 2070 O
and 61 64 2071 2074 O
disease 65 72 2075 2082 O
free 73 77 2083 2087 O
for 78 81 2088 2091 O
at 82 84 2092 2094 O
least 85 90 2095 2100 O
3 91 92 2101 2102 B-lower_bound
years 93 98 2103 2108 I-lower_bound

women 0 5 2109 2114 B-gender
of 6 8 2115 2117 O
childbearing 9 21 2118 2130 O

A 0 1 0 1 O
reversible 2 12 2 12 O
cause 13 18 13 18 O
of 19 21 19 21 O
AF 22 24 22 24 B-chronic_disease
( 25 26 25 26 O
e.g. 26 30 26 30 O
, 30 31 30 31 O
thyrotoxicosis 32 46 32 46 B-chronic_disease
) 46 47 46 47 O

AF 0 2 48 50 B-chronic_disease
symptoms 3 11 51 59 O
present 12 19 60 67 O
at 20 22 68 70 O
least 23 28 71 76 O
once 29 33 77 81 B-lower_bound
per 34 37 82 85 I-lower_bound
month 38 43 86 91 I-lower_bound

Any 0 3 92 95 O
race 4 8 96 100 O
other 9 14 101 106 O
than 15 19 107 111 O
Caucasian 20 29 112 121 B-ethnicity

Cardiac 0 7 122 129 B-treatment
or 8 10 130 132 I-treatment
thoracic 11 19 133 141 I-treatment
surgery 20 27 142 149 I-treatment
within 28 34 150 156 O
the 35 38 157 160 O
previous 39 47 161 169 B-upper_bound
6 48 49 170 171 I-upper_bound
months 50 56 172 178 I-upper_bound

Contra 0 6 179 185 O
- 6 7 185 186 O
indication 7 17 186 196 O
to 18 20 197 199 O
a 21 22 200 201 O
class 23 28 202 207 B-allergy_name
III 29 32 208 211 I-allergy_name
AAD 33 36 212 215 I-allergy_name

Creatinine 0 10 216 226 B-clinical_variable
clearance 11 20 227 236 I-clinical_variable
< 21 22 237 238 O
40 22 24 238 240 B-upper_bound
ml 25 27 241 243 I-upper_bound
/ 27 28 243 244 I-upper_bound
min 28 31 244 247 I-upper_bound

ECG 0 3 248 251 B-clinical_variable
that 4 8 252 256 O
was 9 12 257 260 O
recorded 13 21 261 269 O
within 22 28 270 276 O
12 29 31 277 279 B-upper_bound
months 32 38 280 286 I-upper_bound
of 39 41 287 289 O
randomization 42 55 290 303 O
showing 56 63 304 311 O
AF 64 66 312 314 O

Females 0 7 315 322 B-gender
who 8 11 323 326 O
are 12 15 327 330 O
pregnant 16 24 331 339 B-pregnancy

History 0 7 340 347 O
of 8 10 348 350 O
severe 11 17 351 357 B-chronic_disease
AV 18 20 358 360 I-chronic_disease
node 21 25 361 365 I-chronic_disease
dysfunction 26 37 366 377 I-chronic_disease
unless 38 44 378 384 O
an 45 47 385 387 O
electronic 48 58 388 398 O
pacemaker 59 68 399 408 O
is 69 71 409 411 O
present 72 79 412 419 O

History 0 7 420 427 O
of 8 10 428 430 O
typical 11 18 431 438 O
or 19 21 439 441 O
lone 22 26 442 446 B-chronic_disease
symptomatic 27 38 447 458 I-chronic_disease
AF 39 41 459 461 I-chronic_disease

Medical 0 7 462 469 O
condition 8 17 470 479 O
that 18 22 480 484 O
is 23 25 485 487 O
likely 26 32 488 494 O
to 33 35 495 497 O
be 36 38 498 500 O
fatal 39 44 501 506 O
in 45 47 507 509 O
less 48 52 510 514 O
than 53 57 515 519 O
one 58 61 520 523 B-upper_bound
year 62 66 524 528 I-upper_bound

Permanent 0 9 529 538 O
AF 10 12 539 541 B-chronic_disease
or 13 15 542 544 O
isolated 16 24 545 553 O
atrial 25 31 554 560 B-chronic_disease
flutter 32 39 561 568 I-chronic_disease

Previous 0 8 569 577 O
use 9 12 578 581 O
of 13 15 582 584 O
amiodarone 16 26 585 595 B-treatment
other 27 32 596 601 O
than 33 37 602 606 O
short 38 43 607 612 O
- 43 44 612 613 O
term 44 48 613 617 O
use 49 52 618 621 O
( 53 54 622 623 O
e.g. 54 58 623 627 O
for 59 62 628 631 O
an 63 65 632 634 O
acute 66 71 635 640 O
arrhythmia 72 82 641 651 B-chronic_disease
in 83 85 652 654 O
hospital 86 94 655 663 O
) 94 95 663 664 O

Previously 0 10 665 675 O
treated 11 18 676 683 O
with 19 23 684 688 O
class 24 29 689 694 B-treatment
I 30 31 695 696 I-treatment
and 32 35 697 700 O
class 36 41 701 706 B-treatment
III 42 45 707 710 I-treatment
antiarrhythmic 46 60 711 725 I-treatment
drugs 61 66 726 731 I-treatment

Received 0 8 732 740 O
2 9 10 741 742 B-lower_bound
or 11 13 743 745 O
more 14 18 746 750 O
AADs 19 23 751 755 B-treatment
in 24 26 756 758 O
past 27 31 759 763 O

congenital 0 10 764 774 O
or 11 13 775 777 O
acquired 14 22 778 786 O
long 23 27 787 791 B-chronic_disease
QT 28 30 792 794 I-chronic_disease
syndrome 31 39 795 803 I-chronic_disease
with 40 44 804 808 O
QTc>450 45 52 809 816 B-clinical_variable
ms 53 55 817 819 I-lower_bound
at 56 58 820 822 O
baseline 59 67 823 831 O

history 0 7 832 839 O
of 8 10 840 842 O
MI 11 13 843 845 B-chronic_disease

structural 0 10 846 856 B-chronic_disease
heart 11 16 857 862 I-chronic_disease
disease 17 24 863 870 I-chronic_disease

≥ 0 1 871 872 O
18 2 4 873 875 B-lower_bound
years 5 10 876 881 I-lower_bound
of 11 13 882 884 O
age 14 17 885 888 B-age

On 0 2 0 2 O
- 2 3 2 3 O
treatment 3 12 3 12 O
systolic 13 21 13 21 B-clinical_variable
BP 22 24 22 24 I-clinical_variable
of 25 27 25 27 O
> 28 29 28 29 O
160 29 32 29 32 B-lower_bound
mmHg 33 37 33 37 I-lower_bound
at 38 40 38 40 O
screening 41 50 41 50 O
visit 51 56 51 56 O

active 0 6 57 63 O
cancer 7 13 64 70 B-cancer
other 14 19 71 76 O
than 20 24 77 81 O
non 25 28 82 85 B-cancer
- 28 29 85 86 I-cancer
melanoma 29 37 86 94 I-cancer
skin 38 42 95 99 I-cancer
or 43 45 100 102 I-cancer
low 46 49 103 106 I-cancer
- 49 50 106 107 I-cancer
risk 50 54 107 111 I-cancer
prostate 55 63 112 120 I-cancer
cancer 64 70 121 127 I-cancer

chronic 0 7 128 135 B-chronic_disease
kidney 8 14 136 142 I-chronic_disease
disease 15 22 143 150 I-chronic_disease
with 23 27 151 155 O
estimated 28 37 156 165 B-clinical_variable
glomerular 38 48 166 176 I-clinical_variable
filtration 49 59 177 187 I-clinical_variable
rate 60 64 188 192 I-clinical_variable
< 65 66 193 194 O
45 66 68 194 196 B-upper_bound
ml 69 71 197 199 I-upper_bound
/ 71 72 199 200 I-upper_bound
min/ 72 76 200 204 I-upper_bound
1.73m2 77 83 205 211 I-upper_bound

cirrhosis 0 9 212 221 B-chronic_disease

hemoglobin 0 10 222 232 B-clinical_variable
< 11 12 233 234 O
9 12 13 234 235 B-upper_bound
gm 14 16 236 238 I-upper_bound
/ 16 17 238 239 I-upper_bound
dL 17 19 239 241 I-upper_bound

hepatic 0 7 242 249 B-chronic_disease
disease 8 15 250 257 I-chronic_disease

left 0 4 258 262 B-clinical_variable
ventricular 5 16 263 274 I-clinical_variable
ejection 17 25 275 283 I-clinical_variable
fraction 26 34 284 292 I-clinical_variable
< 35 36 293 294 O
50 36 38 294 296 B-upper_bound
% 38 39 296 297 I-upper_bound

metabolic 0 9 298 307 B-chronic_disease
syndrome 10 18 308 316 I-chronic_disease

moderate 0 8 317 325 B-chronic_disease
or 9 11 326 328 I-chronic_disease
severe 12 18 329 335 I-chronic_disease
valvular 19 27 336 344 I-chronic_disease
heart 28 33 345 350 I-chronic_disease
disease 34 41 351 358 I-chronic_disease

myocardial 0 10 359 369 B-chronic_disease
infarction 11 21 370 380 I-chronic_disease
or 22 24 381 383 O
stroke 25 31 384 390 B-chronic_disease
within 32 38 391 397 O
the 39 42 398 401 O
prior 43 48 402 407 B-upper_bound
6 49 50 408 409 I-upper_bound
months 51 57 410 416 I-upper_bound

other 0 5 417 422 O
comorbidity 6 17 423 434 O
with 18 22 435 439 O
expected 23 31 440 448 B-clinical_variable
survival 32 40 449 457 I-clinical_variable
< 41 42 458 459 O
12 42 44 459 461 B-upper_bound
months 45 51 462 468 I-upper_bound

severely 0 8 469 477 B-chronic_disease
uncontrolled 9 21 478 490 I-chronic_disease
diabetes 22 30 491 499 I-chronic_disease

unoperated 0 10 500 510 O
aortic 11 17 511 517 B-chronic_disease
aneurysm 18 26 518 526 I-chronic_disease
for 27 30 527 530 O
which 31 36 531 536 O
surgery 37 44 537 544 B-treatment
is 45 47 545 547 O
indicated 48 57 548 557 O
, 57 58 557 558 O
prior 59 64 559 564 O
hyperkalemia 65 77 565 577 B-chronic_disease
requiring 78 87 578 587 O
urgent 88 94 588 594 O
treatment 95 104 595 604 B-treatment

with 0 4 605 609 O
HTN 5 8 610 613 B-chronic_disease

Age 0 3 0 3 B-age
: 3 4 3 4 O
21 5 7 5 7 B-lower_bound
- 7 8 7 8 O
40 8 10 8 10 B-upper_bound
years 11 16 11 16 I-upper_bound

Average 0 7 17 24 O
habitual 8 16 25 33 O
sleep 17 22 34 39 O
duration 23 31 40 48 O
of 32 34 49 51 O
6.5 35 38 52 55 B-upper_bound
hours 39 44 56 61 I-upper_bound
or 45 47 62 64 O
less 48 52 65 69 O
per 53 56 70 73 O
night 57 62 74 79 O

Body 0 4 80 84 B-bmi
mass 5 9 85 89 I-bmi
index 10 15 90 95 I-bmi
: 15 16 95 96 O
25.0 17 21 97 101 B-lower_bound
to 22 24 102 104 O
29.9 25 29 105 109 B-upper_bound
kg 30 32 110 112 I-upper_bound
/ 32 33 112 113 I-upper_bound
m2 33 35 113 115 I-upper_bound

claustrophobia 0 14 116 130 B-chronic_disease

diabetes 0 8 131 139 B-chronic_disease

obstructive 0 11 140 151 B-chronic_disease
sleep 12 17 152 157 I-chronic_disease
apnea 18 23 158 163 I-chronic_disease
or 24 26 164 166 O
history 27 34 167 174 O
of 35 37 175 177 O
any 38 41 178 181 O
other 42 47 182 187 O
sleep 48 53 188 193 B-chronic_disease
disorder 54 62 194 202 I-chronic_disease

pregnancy 0 9 203 212 B-pregnancy

prior 0 5 213 218 O
or 6 8 219 221 O
current 9 16 222 229 O
eating 17 23 230 236 B-chronic_disease
or 24 26 237 239 O
psychiatric 27 38 240 251 B-chronic_disease
disorders 39 48 252 261 I-chronic_disease

recent 0 6 262 268 O
( 7 8 269 270 O
< 8 9 270 271 O
4 10 11 272 273 B-upper_bound
week 12 16 274 278 I-upper_bound
) 16 17 278 279 O
travel 18 24 280 286 O
across 25 31 287 293 O
time 32 36 294 298 O
zones 37 42 299 304 O

stable 0 6 305 311 O
sleep 7 12 312 317 O
habits 13 19 318 324 O
for 20 23 325 328 O
the 24 27 329 332 O
past 28 32 333 337 B-upper_bound
6 33 34 338 339 I-upper_bound
months 35 41 340 346 I-upper_bound

subjects 0 8 347 355 O
who 9 12 356 359 O
have 13 17 360 364 O
received 18 26 365 373 O
iv 27 29 374 376 O
or 30 32 377 379 O
oral 33 37 380 384 B-treatment
contrast 38 46 385 393 I-treatment
in 47 49 394 396 O
the 50 53 397 400 O
past 54 58 401 405 B-upper_bound
2 59 60 406 407 I-upper_bound
weeks 61 66 408 413 I-upper_bound

Adult 0 5 0 5 O
patients 6 14 6 14 O
with 15 19 15 19 O
OSA 20 23 20 23 B-chronic_disease
considering 24 35 24 35 O
surgical 36 44 36 44 B-treatment
treatment 45 54 45 54 I-treatment

Allergy 0 7 55 62 O
to 8 10 63 65 O
propofol 11 19 66 74 B-allergy_name
, 19 20 74 75 O
soybean 21 28 76 83 B-allergy_name
oil 29 32 84 87 I-allergy_name
, 32 33 87 88 O
egg 34 37 89 92 B-allergy_name
lecithin 38 46 93 101 I-allergy_name
or 47 49 102 104 O
glycerol 50 58 105 113 B-allergy_name

Other 0 5 114 119 O
contraindication 6 22 120 136 O
to 23 25 137 139 O
use 26 29 140 143 O
of 30 32 144 146 O
propofol 33 41 147 155 B-treatment
( 42 43 156 157 O
decision 43 51 157 165 O
of 52 54 166 168 O
anesthesiologist 55 71 169 185 B-treatment
or 72 74 186 188 O
otolaryngologist 75 91 189 205 B-treatment
. 91 92 205 206 O
) 92 93 206 207 O

Pregnant 0 8 208 216 B-pregnancy
women 9 14 217 222 B-gender

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
≥ 26 27 26 27 O
1,500 28 33 28 33 B-lower_bound
/ 33 34 33 34 I-lower_bound
mcL 34 37 34 37 I-lower_bound

Age 0 3 38 41 B-age
18 4 6 42 44 B-lower_bound
years 7 12 45 50 I-lower_bound
or 13 15 51 53 O
older 16 21 54 59 O

Aspartate 0 9 60 69 B-clinical_variable
aminotransferase 10 26 70 86 I-clinical_variable
( 27 28 87 88 I-clinical_variable
AST)/Alanine 28 40 88 100 I-clinical_variable
aminotransferase 41 57 101 117 I-clinical_variable
( 58 59 118 119 I-clinical_variable
ALT 59 62 119 122 I-clinical_variable
) 62 63 122 123 I-clinical_variable
≤ 64 65 124 125 O
2.5 66 69 126 129 B-upper_bound
X 70 71 130 131 I-upper_bound
institutional 72 85 132 145 I-upper_bound
upper 86 91 146 151 I-upper_bound
limit 92 97 152 157 I-upper_bound
of 98 100 158 160 I-upper_bound
normal 101 107 161 167 I-upper_bound

Creatinine 0 10 168 178 B-clinical_variable
within 11 17 179 185 O
normal 18 24 186 192 O
institutional 25 38 193 206 O
limits 39 45 207 213 O
or 46 48 214 216 O
creatinine 49 59 217 227 B-clinical_variable
clearance 60 69 228 237 I-clinical_variable
≥ 70 71 238 239 O
60 72 74 240 242 B-lower_bound
mL 75 77 243 245 I-lower_bound
/ 77 78 245 246 I-lower_bound
min/1.73 78 86 246 254 I-lower_bound
m2 87 89 255 257 I-lower_bound
for 90 93 258 261 O
subjects 94 102 262 270 O
with 103 107 271 275 O
creatinine 108 118 276 286 B-clinical_variable
levels 119 125 287 293 I-clinical_variable
about 126 131 294 299 O
institutional 132 145 300 313 O
normal 146 152 314 320 O

Cryoablation 0 12 321 333 B-treatment
can 13 16 334 337 O
be 17 19 338 340 O
performed 20 29 341 350 O
near 30 34 351 355 O
vessels 35 42 356 363 O
of 43 45 364 366 O
the 46 49 367 370 O
head 50 54 371 375 O
and 55 58 376 379 O
neck 59 63 380 384 O
, 63 64 384 385 O
and 65 68 386 389 O
if 69 71 390 392 O
deemed 72 78 393 399 O
necessary 79 88 400 409 O
tumor 89 94 410 415 B-cancer
may 95 98 416 419 O
be 99 101 420 422 O
displaced 102 111 423 432 O
using 112 117 433 438 O
a 118 119 439 440 O
saline 120 126 441 447 B-treatment
injection 127 136 448 457 I-treatment
( 137 138 458 459 I-treatment
hydro 138 143 459 464 I-treatment
- 143 144 464 465 I-treatment
displacement 144 156 465 477 I-treatment
) 156 157 477 478 I-treatment

Eastern 0 7 479 486 B-clinical_variable
Cooperative 8 19 487 498 I-clinical_variable
Oncology 20 28 499 507 I-clinical_variable
Group 29 34 508 513 I-clinical_variable
( 35 36 514 515 I-clinical_variable
ECOG 36 40 515 519 I-clinical_variable
) 40 41 519 520 I-clinical_variable
performance 42 53 521 532 I-clinical_variable
status 54 60 533 539 I-clinical_variable
≤ 61 62 540 541 O
2 63 64 542 543 B-upper_bound

History 0 7 544 551 O
of 8 10 552 554 O
allergic 11 19 555 563 O
reactions 20 29 564 573 O
attributed 30 40 574 584 O
to 41 43 585 587 O
compounds 44 53 588 597 O
of 54 56 598 600 O
similar 57 64 601 608 O
chemical 65 73 609 617 O
or 74 76 618 620 O
biologic 77 85 621 629 O
composition 86 97 630 641 O
to 98 100 642 644 O
gadolinium 101 111 645 655 B-allergy_name
contrast 112 120 656 664 I-allergy_name
agents 121 127 665 671 I-allergy_name
, 127 128 671 672 O
if 129 131 673 675 O
contrast 132 140 676 684 O
use 141 144 685 688 O
is 145 147 689 691 O
anticipated 148 159 692 703 O
during 160 166 704 710 O
the 167 170 711 714 O
procedure 171 180 715 724 O

Leukocytes 0 10 725 735 B-clinical_variable
≥ 11 12 736 737 O
3,000 13 18 738 743 B-lower_bound
/ 18 19 743 744 I-lower_bound
microliter 19 29 744 754 I-lower_bound
( 30 31 755 756 I-lower_bound
mcL 31 34 756 759 I-lower_bound
) 34 35 759 760 I-lower_bound

Life 0 4 761 765 B-clinical_variable
expectancy 5 15 766 776 I-clinical_variable
of 16 18 777 779 O
greater 19 26 780 787 O
than 27 31 788 792 O
8 32 33 793 794 B-lower_bound
weeks 34 39 795 800 I-lower_bound
in 40 42 801 803 O
the 43 46 804 807 O
opinion 47 54 808 815 O
of 55 57 816 818 O
the 58 61 819 822 O
referring 62 71 823 832 O
clinician 72 81 833 842 O

Participants 0 12 843 855 O
with 13 17 856 860 O
malignant 18 27 861 870 B-cancer
locally 28 35 871 878 O
recurrent 36 45 879 888 O
and/or 46 52 889 895 O
metastatic 53 63 896 906 B-cancer
tumors 64 70 907 913 I-cancer

Participants 0 12 914 926 O
with 13 17 927 931 O
tumors 18 24 932 938 B-cancer
involving 25 34 939 948 O
the 35 38 949 952 O
optic 39 44 953 958 O
chiasm 45 51 959 965 O
, 51 52 965 966 O
brain 53 58 967 972 O
, 58 59 972 973 O
or 60 62 974 976 O
spinal 63 69 977 983 O
cord 70 74 984 988 O

Platelets 0 9 989 998 B-clinical_variable
≥ 10 11 999 1000 O
100,000 12 19 1001 1008 B-lower_bound
/ 19 20 1008 1009 I-lower_bound
microliter 20 30 1009 1019 I-lower_bound
( 31 32 1020 1021 I-lower_bound
mcL 32 35 1021 1024 I-lower_bound
) 35 36 1024 1025 I-lower_bound

Pregnant 0 8 1026 1034 B-pregnancy
women 9 14 1035 1040 B-gender

Since 0 5 1041 1046 O
positron 6 14 1047 1055 B-treatment
emission 15 23 1056 1064 I-treatment
tomography 24 34 1065 1075 I-treatment
- 34 35 1075 1076 I-treatment
computed 35 43 1076 1084 I-treatment
tomography 44 54 1085 1095 I-treatment
( 55 56 1096 1097 I-treatment
PET 56 59 1097 1100 I-treatment
- 59 60 1100 1101 I-treatment
CT 60 62 1101 1103 I-treatment
) 62 63 1103 1104 I-treatment
guidance 64 72 1105 1113 O
requires 73 81 1114 1122 O
the 82 85 1123 1126 O
nuclear 86 93 1127 1134 O
medicine 94 102 1135 1143 O
department 103 113 1144 1154 O
to 114 116 1155 1157 O
administer 117 127 1158 1168 O
a 128 129 1169 1170 O
radionuclide 130 142 1171 1183 O
material 143 151 1184 1192 O
, 151 152 1192 1193 O
the 153 156 1194 1197 O
default 157 164 1198 1205 O
will 165 169 1206 1210 O
be 170 172 1211 1213 O
to 173 175 1214 1216 O
try 176 179 1217 1220 O
to 180 182 1221 1223 O
use 183 186 1224 1227 O
MRI 187 190 1228 1231 B-treatment
guidance 191 199 1232 1240 O

Total 0 5 1241 1246 B-clinical_variable
bilirubin 6 15 1247 1256 I-clinical_variable
within 16 22 1257 1263 O
normal 23 29 1264 1270 O
institutional 30 43 1271 1284 O
limits 44 50 1285 1291 O

Tumor 0 5 1292 1297 B-cancer
displacement 6 18 1298 1310 O
from 19 23 1311 1315 O
nerves 24 30 1316 1322 O
may 31 34 1323 1326 O
be 35 37 1327 1329 O
required 38 46 1330 1338 O
and 47 50 1339 1342 O
will 51 55 1343 1347 O
be 56 58 1348 1350 O
performed 59 68 1351 1360 O
as 69 71 1361 1363 O
deemed 72 78 1364 1370 O
appropriate 79 90 1371 1382 O
to 91 93 1383 1385 O
avoid 94 99 1386 1391 O
nerve 100 105 1392 1397 O
injury 106 112 1398 1404 O

Tumors 0 6 1405 1411 B-cancer
that 7 11 1412 1416 O
are 12 15 1417 1420 O
not 16 19 1421 1424 O
clearly 20 27 1425 1432 O
seen 28 32 1433 1437 O
by 33 35 1438 1440 O
MRI 36 39 1441 1444 B-treatment
but 40 43 1445 1448 O
showing 44 51 1449 1456 O
on 52 54 1457 1459 O
PET 55 58 1460 1463 B-treatment
/ 58 59 1463 1464 O
CT 59 61 1464 1466 B-treatment
will 62 66 1467 1471 O
be 67 69 1472 1474 O
ablated 70 77 1475 1482 O
with 78 82 1483 1487 O
PET 83 86 1488 1491 O
/ 86 87 1491 1492 O
CT 87 89 1492 1494 O
guidance 90 98 1495 1503 O

Uncontrolled 0 12 1504 1516 O
intercurrent 13 25 1517 1529 B-chronic_disease
illness 26 33 1530 1537 I-chronic_disease
including 34 43 1538 1547 O
, 43 44 1547 1548 O
but 45 48 1549 1552 O
not 49 52 1553 1556 O
limited 53 60 1557 1564 O
to 61 63 1565 1567 O
ongoing 64 71 1568 1575 O
or 72 74 1576 1578 O
active 75 81 1579 1585 B-chronic_disease
infection 82 91 1586 1595 I-chronic_disease
, 91 92 1595 1596 O
symptomatic 93 104 1597 1608 O
congestive 105 115 1609 1619 B-chronic_disease
heart 116 121 1620 1625 I-chronic_disease
failure 122 129 1626 1633 I-chronic_disease
, 129 130 1633 1634 O
unstable 131 139 1635 1643 B-chronic_disease
angina 140 146 1644 1650 I-chronic_disease
pectoris 147 155 1651 1659 I-chronic_disease
, 155 156 1659 1660 O
cardiac 157 164 1661 1668 B-chronic_disease
arrhythmia 165 175 1669 1679 I-chronic_disease
, 175 176 1679 1680 O
or 177 179 1681 1683 O
psychiatric 180 191 1684 1695 B-chronic_disease
illness 192 199 1696 1703 I-chronic_disease
/ 199 200 1703 1704 O
social 200 206 1704 1710 B-chronic_disease
situations 207 217 1711 1721 I-chronic_disease
that 218 222 1722 1726 O
would 223 228 1727 1732 O
limit 229 234 1733 1738 O
compliance 235 245 1739 1749 O
with 246 250 1750 1754 O
study 251 256 1755 1760 O
requirements 257 269 1761 1773 O

impaired 0 8 1774 1782 B-chronic_disease
renal 9 14 1783 1788 I-chronic_disease
function 15 23 1789 1797 I-chronic_disease
( 24 25 1798 1799 O
eGFR 25 29 1799 1803 B-clinical_variable
< 30 31 1804 1805 O
60ml 32 36 1806 1810 B-upper_bound
/ 36 37 1810 1811 I-upper_bound
min 37 40 1811 1814 I-upper_bound
) 40 41 1814 1815 O

known 0 5 1816 1821 O
ischemic 6 14 1822 1830 B-chronic_disease
disease 15 22 1831 1838 I-chronic_disease

may 0 3 1839 1842 O
not 4 7 1843 1846 O
be 8 10 1847 1849 O
receiving 11 20 1850 1859 O
any 21 24 1860 1863 O
other 25 30 1864 1869 O
study 31 36 1870 1875 B-treatment
agents 37 43 1876 1882 I-treatment

men 0 3 1883 1886 B-gender

must 0 4 1887 1891 O
agree 5 10 1892 1897 B-contraception_consent
to 11 13 1898 1900 I-contraception_consent
use 14 17 1901 1904 I-contraception_consent
adequate 18 26 1905 1913 I-contraception_consent
contraception 27 40 1914 1927 I-contraception_consent
( 41 42 1928 1929 O
hormonal 42 50 1929 1937 B-contraception_consent
or 51 53 1938 1940 I-contraception_consent
barrier 54 61 1941 1948 I-contraception_consent
method 62 68 1949 1955 I-contraception_consent
of 69 71 1956 1958 I-contraception_consent
birth 72 77 1959 1964 I-contraception_consent
control 78 85 1965 1972 I-contraception_consent
; 85 86 1972 1973 O
abstinence 87 97 1974 1984 B-contraception_consent
) 97 98 1984 1985 O
prior 99 104 1986 1991 O
to 105 107 1992 1994 O
study 108 113 1995 2000 O
entry 114 119 2001 2006 O
and 120 123 2007 2010 O
for 124 127 2011 2014 O
the 128 131 2015 2018 O
duration 132 140 2019 2027 O
of 141 143 2028 2030 O
study 144 149 2031 2036 O
participation 150 163 2037 2050 O

must 0 4 2051 2055 O
have 5 9 2056 2060 O
a 10 11 2061 2062 O
mass 12 16 2063 2067 O
that 17 21 2068 2072 O
is 22 24 2073 2075 O
well 25 29 2076 2080 O
visualized 30 40 2081 2091 O
under 41 46 2092 2097 O
PET 47 50 2098 2101 B-treatment
/ 50 51 2101 2102 O
CT 51 53 2102 2104 B-treatment

must 0 4 2105 2109 O
have 5 9 2110 2114 O
a 10 11 2115 2116 O
mass 12 16 2117 2121 O
that 17 21 2122 2126 O
is 22 24 2127 2129 O
well 25 29 2130 2134 O
- 29 30 2134 2135 O
visualized 30 40 2135 2145 O
under 41 46 2146 2151 O
MRI 47 50 2152 2155 B-treatment

must 0 4 2156 2160 O
have 5 9 2161 2165 O
an 10 12 2166 2168 O
advanced 13 21 2169 2177 O
head 22 26 2178 2182 B-cancer
, 26 27 2182 2183 O
neck 28 32 2184 2188 B-cancer
or 33 35 2189 2191 O
spine 36 41 2192 2197 B-cancer
malignant 42 51 2198 2207 I-cancer
tumor 52 57 2208 2213 I-cancer
that 58 62 2214 2218 O
would 63 68 2219 2224 O
potentially 69 80 2225 2236 O
benefit 81 88 2237 2244 O
from 89 93 2245 2249 O
a 94 95 2250 2251 O
minimally 96 105 2252 2261 O
invasive 106 114 2262 2270 O
procedure 115 124 2271 2280 O

must 0 4 2281 2285 O
have 5 9 2286 2290 O
histologically 10 24 2291 2305 O
confirmed 25 34 2306 2315 O
malignant 35 44 2316 2325 B-cancer
tumor 45 50 2326 2331 I-cancer
that 51 55 2332 2336 O
is 56 58 2337 2339 O
metastatic 59 69 2340 2350 B-cancer
or 70 72 2351 2353 O
unresectable 73 85 2354 2366 O
and 86 89 2367 2370 O
for 90 93 2371 2374 O
which 94 99 2375 2380 O
standard 100 108 2381 2389 O
curative 109 117 2390 2398 O
or 118 120 2399 2401 O
palliative 121 131 2402 2412 O
measures 132 140 2413 2421 O
do 141 143 2422 2424 O
not 144 147 2425 2428 O
exist 148 153 2429 2434 O
or 154 156 2435 2437 O
are 157 160 2438 2441 O
no 161 163 2442 2444 O
longer 164 170 2445 2451 O
effective 171 180 2452 2461 O

must 0 4 2462 2466 O
have 5 9 2467 2471 O
sustained 10 19 2472 2481 O
all 20 23 2482 2485 O
available 24 33 2486 2495 O
treatment 34 43 2496 2505 B-treatment
options 44 51 2506 2513 O
( 52 53 2514 2515 O
radiation 53 62 2515 2524 B-treatment
, 62 63 2524 2525 O
chemotherapy 64 76 2526 2538 B-treatment
, 76 77 2538 2539 O
surgery 78 85 2540 2547 B-treatment
) 85 86 2547 2548 O
as 87 89 2549 2551 O
verified 90 98 2552 2560 O
by 99 101 2561 2563 O
the 102 105 2564 2567 O
Dana 106 110 2568 2572 O
Farber 111 117 2573 2579 O
Cancer 118 124 2580 2586 O
Institute 125 134 2587 2596 O
's 134 136 2596 2598 O
Head 137 141 2599 2603 O
and 142 145 2604 2607 O
Neck 146 150 2608 2612 O
Tumor 151 156 2613 2618 O
Board 157 162 2619 2624 O

tumors 0 6 2625 2631 B-cancer
that 7 11 2632 2636 O
encase 12 18 2637 2643 O
any 19 22 2644 2647 O
major 23 28 2648 2653 O
blood 29 34 2654 2659 O
vessel 35 41 2660 2666 O
( 42 43 2667 2668 O
carotid 43 50 2668 2675 O
, 50 51 2675 2676 O
jugular 52 59 2677 2684 O
, 59 60 2684 2685 O
vertebral 61 70 2686 2695 O
) 70 71 2695 2696 O

who 0 3 2697 2700 O
have 4 8 2701 2705 O
had 9 12 2706 2709 O
chemotherapy 13 25 2710 2722 B-treatment
or 26 28 2723 2725 O
radiotherapy 29 41 2726 2738 B-treatment
within 42 48 2739 2745 O
4 49 50 2746 2747 O
weeks 51 56 2748 2753 O
( 57 58 2754 2755 O
6 58 59 2755 2756 B-upper_bound
weeks 60 65 2757 2762 I-upper_bound
for 66 69 2763 2766 O
nitrosoureas 70 82 2767 2779 B-treatment
or 83 85 2780 2782 O
mitomycin 86 95 2783 2792 B-treatment
C 96 97 2793 2794 I-treatment
) 97 98 2794 2795 O
prior 99 104 2796 2801 O
to 105 107 2802 2804 O
entering 108 116 2805 2813 O
the 117 120 2814 2817 O
study 121 126 2818 2823 O
or 127 129 2824 2826 O
those 130 135 2827 2832 O
who 136 139 2833 2836 O
have 140 144 2837 2841 O
not 145 148 2842 2845 O
recovered 149 158 2846 2855 O
from 159 163 2856 2860 O
adverse 164 171 2861 2868 O
events 172 178 2869 2875 O
due 179 182 2876 2879 O
to 183 185 2880 2882 O
agents 186 192 2883 2889 O
administered 193 205 2890 2902 O
more 206 210 2903 2907 O
than 211 215 2908 2912 O
4 216 217 2913 2914 O
weeks 218 223 2915 2920 O
earlier 224 231 2921 2928 O

with 0 4 2929 2933 O
a 5 6 2934 2935 O
blood 7 12 2936 2941 B-clinical_variable
glucose 13 20 2942 2949 I-clinical_variable
level 21 26 2950 2955 I-clinical_variable
of 27 29 2956 2958 O
> 30 31 2959 2960 O
200mg 32 37 2961 2966 B-lower_bound
/ 37 38 2966 2967 I-lower_bound
dl 38 40 2967 2969 I-lower_bound
prior 41 46 2970 2975 I-lower_bound
to 47 49 2976 2978 O
the 50 53 2979 2982 O
baseline 54 62 2983 2991 O
study 63 68 2992 2997 O

with 0 4 2998 3002 O
known 5 10 3003 3008 O
brain 11 16 3009 3014 B-cancer
metastases 17 27 3015 3025 I-cancer
should 28 34 3026 3032 O
be 35 37 3033 3035 O
excluded 38 46 3036 3044 O
from 47 51 3045 3049 O
this 52 56 3050 3054 O
clinical 57 65 3055 3063 O
trial 66 71 3064 3069 O
because 72 79 3070 3077 O
of 80 82 3078 3080 O
their 83 88 3081 3086 O
poor 89 93 3087 3091 O
prognosis 94 103 3092 3101 O
and 104 107 3102 3105 O
because 108 115 3106 3113 O
they 116 120 3114 3118 O
often 121 126 3119 3124 O
develop 127 134 3125 3132 O
progressive 135 146 3133 3144 B-chronic_disease
neurologic 147 157 3145 3155 I-chronic_disease
dysfunction 158 169 3156 3167 I-chronic_disease
that 170 174 3168 3172 O
would 175 180 3173 3178 O
confound 181 189 3179 3187 O
the 190 193 3188 3191 O
evaluation 194 204 3192 3202 O
of 205 207 3203 3205 O
neurologic 208 218 3206 3216 O
and 219 222 3217 3220 O
other 223 228 3221 3226 O
adverse 229 236 3227 3234 O
events 237 243 3235 3241 O

women 0 5 3242 3247 B-gender
of 6 8 3248 3250 O
child 9 14 3251 3256 O
- 14 15 3256 3257 O
bearing 15 22 3257 3264 O
potential 23 32 3265 3274 O

Able 0 4 0 4 B-language_fluency
to 5 7 5 7 I-language_fluency
read 8 12 8 12 I-language_fluency
and 13 16 13 16 I-language_fluency
write 17 22 17 22 I-language_fluency
in 23 25 23 25 I-language_fluency
English 26 33 26 33 I-language_fluency

Acute 0 5 34 39 B-chronic_disease
respiratory 6 17 40 51 I-chronic_disease
distress 18 26 52 60 I-chronic_disease

Current 0 7 61 68 O
or 8 10 69 71 O
recent 11 17 72 78 O
former 18 24 79 85 O
smoker 25 31 86 92 O
( 32 33 93 94 O
defined 33 40 94 101 O
as 41 43 102 104 O
having 44 50 105 111 O
smoked 51 57 112 118 O
within 58 64 119 125 O
past 65 69 126 130 B-upper_bound
6 70 71 131 132 I-upper_bound
months 72 78 133 139 I-upper_bound
) 78 79 139 140 O

Former 0 6 141 147 O
smoker 7 13 148 154 O
greater 14 21 155 162 O
than 22 26 163 167 O
6 27 28 168 169 B-lower_bound
months 29 35 170 176 I-lower_bound

Hypotension 0 11 177 188 B-chronic_disease

Must 0 4 189 193 B-technology_access
have 5 9 194 198 I-technology_access
an 10 12 199 201 I-technology_access
active 13 19 202 208 I-technology_access
telephone 20 29 209 218 I-technology_access
number 30 36 219 225 I-technology_access

AVN 0 3 0 3 B-chronic_disease

Completed 0 9 4 13 O
a 10 11 14 15 O
course 12 18 16 22 O
of 19 21 23 25 O
conservative 22 34 26 38 B-treatment
therapy 35 42 39 46 I-treatment

Diagnosis 0 9 47 56 O
of 10 12 57 59 O
JOCD 13 17 60 64 B-chronic_disease

Diagnosis 0 9 65 74 O
of 10 12 75 77 O
metabolic 13 22 78 87 B-chronic_disease
bone 23 27 88 92 I-chronic_disease
disorder 28 36 93 101 I-chronic_disease

Diagnosis 0 9 102 111 O
of 10 12 112 114 O
sickle 13 19 115 121 B-chronic_disease
cell 20 24 122 126 I-chronic_disease
disease 25 32 127 134 I-chronic_disease

History 0 7 135 142 O
of 8 10 143 145 O
prolonged 11 20 146 155 O
corticosteroid 21 35 156 170 B-treatment

Patient 0 7 171 178 O
deemed 8 14 179 185 O
skeletally 15 25 186 196 O
immature 26 34 197 205 O
based 35 40 206 211 O
on 41 43 212 214 O
MRI 44 47 215 218 B-treatment

chemotherapy 0 12 219 231 B-treatment
treatment 13 22 232 241 O

discoid 0 7 242 249 B-chronic_disease
/ 7 8 249 250 O
meniscal 8 16 250 258 O
tear 17 21 259 263 O

inflammatory 0 12 264 276 B-chronic_disease
arthritis 13 22 277 286 I-chronic_disease

osteogenesis 0 12 287 299 B-chronic_disease
imperfecta 13 23 300 310 I-chronic_disease

A 0 1 0 1 O
quit 2 6 2 6 O
attempt 7 14 7 14 O
in 15 17 15 17 O
the 18 21 18 21 O
past 22 26 22 26 B-upper_bound
30 27 29 27 29 I-upper_bound
days 30 34 30 34 I-upper_bound
resulting 35 44 35 44 O
in 45 47 45 47 O
greater 48 55 48 55 O
than 56 60 56 60 O
3 61 62 61 62 B-lower_bound
days 63 67 63 67 I-lower_bound
of 68 70 68 70 O
abstinence 71 81 71 81 O

Be 0 2 82 84 O
in 3 5 85 87 O
good 6 10 88 92 O
physical 11 19 93 101 O
health 20 26 102 108 O
without 27 34 109 116 O
serious 35 42 117 124 B-chronic_disease
illness 43 50 125 132 I-chronic_disease
or 51 53 133 135 O
change 54 60 136 142 O
in 61 63 143 145 O
health 64 70 146 152 O
or 71 73 153 155 O
medication 74 84 156 166 O
( 85 86 167 168 O
not 86 89 168 171 O
including 90 99 172 181 O
methadone 100 109 182 191 B-treatment
or 110 112 192 194 O
buprenorphine 113 126 195 208 B-treatment
dose 127 131 209 213 O
) 131 132 213 214 O
in 133 135 215 217 O
the 136 139 218 221 O
past 140 144 222 226 B-upper_bound
three 145 150 227 232 I-upper_bound
months 151 157 233 239 I-upper_bound
as 158 160 240 242 O
determined 161 171 243 253 O
by 172 174 254 256 O
the 175 178 257 260 O
license 179 186 261 268 O
medical 187 194 269 276 O
professional 195 207 277 289 O
at 208 210 290 292 O
each 211 215 293 297 O
site 216 220 298 302 O

Be 0 2 303 305 O
without 3 10 306 313 O
current 11 18 314 321 O
( 19 20 322 323 O
within 20 26 323 329 O
the 27 30 330 333 O
past 31 35 334 338 O
year 36 40 339 343 O
) 40 41 343 344 O
serious 42 49 345 352 B-chronic_disease
mental 50 56 353 359 I-chronic_disease
disorder 57 65 360 368 I-chronic_disease
that 66 70 369 373 O
would 71 76 374 379 O
interfere 77 86 380 389 O
with 87 91 390 394 O
study 92 97 395 400 O
results 98 105 401 408 O
or 106 108 409 411 O
completion 109 119 412 422 O
as 120 122 423 425 O
determined 123 133 426 436 O
by 134 136 437 439 O
the 137 140 440 443 O
licensed 141 149 444 452 O
medical 150 157 453 460 O
professional 158 170 461 473 O
or 171 173 474 476 O
PI 174 176 477 479 O

Breath 0 6 480 486 B-clinical_variable
CO 7 9 487 489 I-clinical_variable
> 10 11 490 491 O
80 12 14 492 494 B-lower_bound
ppm 15 18 495 498 I-lower_bound

Breath 0 6 499 505 B-clinical_variable
alcohol 7 14 506 513 I-clinical_variable
level 15 20 514 519 I-clinical_variable
> 21 22 520 521 O
0.01 23 27 522 526 B-lower_bound
( 28 29 527 528 O
participants 30 42 529 541 O
with 43 47 542 546 O
a 48 49 547 548 O
positive 50 58 549 557 O
screen 59 65 558 564 O
will 66 70 565 569 O
be 71 73 570 572 O
allowed 74 81 573 580 O
to 82 84 581 583 O
re 85 87 584 586 O
- 87 88 586 587 O
screen 88 94 587 593 O
once 95 99 594 598 O
) 99 100 598 599 O

Current 0 7 600 607 O
symptoms 8 16 608 616 O
of 17 19 617 619 O
psychosis 20 29 620 629 B-chronic_disease
or 30 32 630 632 O
dementia 33 41 633 641 B-chronic_disease
, 41 42 641 642 O
or 43 45 643 645 O
mania 46 51 646 651 B-chronic_disease

Currently 0 9 652 661 O
taking 10 16 662 668 O
anticonvulsant 17 31 669 683 B-treatment
medications 32 43 684 695 I-treatment

Have 0 4 696 700 O
used 5 9 701 705 O
nicotine 10 18 706 714 B-treatment
replacement 19 30 715 726 I-treatment
, 30 31 726 727 O
bupropion 32 41 728 737 B-treatment
or 42 44 738 740 O
other 45 50 741 746 O
pharmacotherapies 51 68 747 764 B-treatment
as 69 71 765 767 O
cessation 72 81 768 777 O
aids 82 86 778 782 O
in 87 89 783 785 O
the 90 93 786 789 O
past 94 98 790 794 O
month 99 104 795 800 O

Heart 0 5 801 806 B-clinical_variable
rate 6 10 807 811 I-clinical_variable
is 11 13 812 814 O
greater 14 21 815 822 O
than 22 26 823 827 O
or 27 29 828 830 O
equal 30 35 831 836 O
to 36 38 837 839 O
115 39 42 840 843 B-lower_bound
bpm 43 46 844 847 I-lower_bound
or 47 49 848 850 O
less 50 54 851 855 O
than 55 59 856 860 O
45 60 62 861 863 B-upper_bound
bpm 63 66 864 867 I-upper_bound

Men 0 3 868 871 B-gender

Not 0 3 872 875 O
currently 4 13 876 885 O
enrolled 14 22 886 894 O
in 23 25 895 897 O
a 26 27 898 899 O
treatment 28 37 900 909 B-treatment
program 38 45 910 917 O
for 46 49 918 921 O
opioid 50 56 922 928 B-treatment
dependence 57 67 929 939 O
and/or 68 74 940 946 O
not 75 78 947 950 O
currently 79 88 951 960 O
stable 89 95 961 967 O
on 96 98 968 970 O
their 99 104 971 976 O
methadone 105 114 977 986 B-treatment
or 115 117 987 989 O
buprenorphine 118 131 990 1003 B-treatment
dose 132 136 1004 1008 O

Not 0 3 1009 1012 B-pregnancy
pregnant 4 12 1013 1021 I-pregnancy
or 13 15 1022 1024 O
nursing 16 23 1025 1032 O
, 23 24 1032 1033 O
and 25 28 1034 1037 O
report 29 35 1038 1044 O
using 36 41 1045 1050 B-contraception_consent
oral 42 46 1051 1055 I-contraception_consent
, 46 47 1055 1056 I-contraception_consent
implant 48 55 1057 1064 I-contraception_consent
, 55 56 1064 1065 I-contraception_consent
injection 57 66 1066 1075 I-contraception_consent
or 67 69 1076 1078 I-contraception_consent
barrier 70 77 1079 1086 I-contraception_consent
contraceptives 78 92 1087 1101 I-contraception_consent
, 92 93 1101 1102 O
or 94 96 1103 1105 O
report 97 103 1106 1112 O
being 104 109 1113 1118 O
surgically 110 120 1119 1129 O
sterile 121 128 1130 1137 O
, 128 129 1137 1138 O
or 130 132 1139 1141 O
post 133 137 1142 1146 O
menopausal 138 148 1147 1157 O

Participants 0 12 1158 1170 O
must 13 17 1171 1175 O
be 18 20 1176 1178 O
maintained 21 31 1179 1189 O
on 32 34 1190 1192 O
a 35 36 1193 1194 O
stable 37 43 1195 1201 O
methadone 44 53 1202 1211 B-treatment
or 54 56 1212 1214 O
buprenorphine 57 70 1215 1228 B-treatment
dose 71 75 1229 1233 O
for 76 79 1234 1237 O
the 80 83 1238 1241 O
past 84 88 1242 1246 O
month 89 94 1247 1252 O
, 94 95 1252 1253 O
with 96 100 1254 1258 O
no 101 103 1259 1261 O
evidence 104 112 1262 1270 O
of 113 115 1271 1273 O
regular 116 123 1274 1281 O
illicit 124 131 1282 1289 O
- 131 132 1289 1290 O
drug 132 136 1290 1294 O
abuse 137 142 1295 1300 O
( 143 144 1301 1302 O
< 144 145 1302 1303 O
30 145 147 1303 1305 B-upper_bound
% 147 148 1305 1306 I-upper_bound
positive 149 157 1307 1315 O
specimens 158 167 1316 1325 B-clinical_variable
in 168 170 1326 1328 O
the 171 174 1329 1332 O
past 175 179 1333 1337 B-upper_bound
30 180 182 1338 1340 I-upper_bound
days 183 187 1341 1345 I-upper_bound
) 187 188 1345 1346 O

Participants 0 12 1347 1359 O
must 13 17 1360 1364 O
provide 18 25 1365 1372 O
at 26 28 1373 1375 O
least 29 34 1376 1381 O
three 35 40 1382 1387 B-lower_bound
urine 41 46 1388 1393 O
samples 47 54 1394 1401 O
within 55 61 1402 1408 O
the 62 65 1409 1412 O
last 66 70 1413 1417 B-upper_bound
30 71 73 1418 1420 I-upper_bound
days 74 78 1421 1425 I-upper_bound

Participation 0 13 1426 1439 O
in 14 16 1440 1442 O
another 17 24 1443 1450 O
research 25 33 1451 1459 O
study 34 39 1460 1465 O
in 40 42 1466 1468 O
the 43 46 1469 1472 O
past 47 51 1473 1477 B-upper_bound
30 52 54 1478 1480 I-upper_bound
days 55 59 1481 1485 I-upper_bound

Planning 0 8 1486 1494 O
to 9 11 1495 1497 O
quit 12 16 1498 1502 O
smoking 17 24 1503 1510 O
in 25 27 1511 1513 O
the 28 31 1514 1517 O
next 32 36 1518 1522 O
30 37 39 1523 1525 B-upper_bound
days 40 44 1526 1530 I-upper_bound

Provide 0 7 1531 1538 O
an 8 10 1539 1541 O
intake 11 17 1542 1548 O
breath 18 24 1549 1555 B-clinical_variable
CO 25 27 1556 1558 I-clinical_variable
sample 28 34 1559 1565 I-clinical_variable
> 35 36 1566 1567 O
8 36 37 1567 1568 B-lower_bound
ppm 38 41 1569 1572 I-lower_bound

Report 0 6 1573 1579 O
no 7 9 1580 1582 O
significant 10 21 1583 1594 O
use 22 25 1595 1598 O
of 26 28 1599 1601 O
other 29 34 1602 1607 O
tobacco 35 42 1608 1615 O
or 43 45 1616 1618 O
nicotine 46 54 1619 1627 O
products 55 63 1628 1636 O
within 64 70 1637 1643 O
the 71 74 1644 1647 O
past 75 79 1648 1652 O
month 80 85 1653 1658 O
( 86 87 1659 1660 O
more 87 91 1660 1664 O
than 92 96 1665 1669 O
9 97 98 1670 1671 B-lower_bound
days 99 103 1672 1676 I-lower_bound
in 104 106 1677 1679 O
the 107 110 1680 1683 O
past 111 115 1684 1688 B-upper_bound
30 116 118 1689 1691 I-upper_bound
) 118 119 1691 1692 O

Report 0 6 1693 1699 O
smoking 7 14 1700 1707 B-clinical_variable
≥ 15 16 1708 1709 O
5 17 18 1710 1711 B-lower_bound
cigarettes 19 29 1712 1722 I-lower_bound
per 30 33 1723 1726 I-lower_bound
day 34 37 1727 1730 I-lower_bound

Self 0 4 1731 1735 O
- 4 5 1735 1736 O
report 5 11 1736 1742 O
of 12 14 1743 1745 O
binge 15 20 1746 1751 O
drinking 21 29 1752 1760 O
alcohol 30 37 1761 1768 O
( 38 39 1769 1770 O
more 39 43 1770 1774 O
than 44 48 1775 1779 O
9 49 50 1780 1781 B-lower_bound
days 51 55 1782 1786 I-lower_bound
in 56 58 1787 1789 O
the 59 62 1790 1793 O
past 63 67 1794 1798 B-upper_bound
30 68 70 1799 1801 I-upper_bound
days 71 75 1802 1806 I-upper_bound
, 75 76 1806 1807 O
4/5 77 80 1808 1811 O
drinks 81 87 1812 1818 O
in 88 90 1819 1821 O
a 91 92 1822 1823 O
2 93 94 1824 1825 O
hour 95 99 1826 1830 O
period 100 106 1831 1837 O
in 107 109 1838 1840 O
females 110 117 1841 1848 B-gender
/ 117 118 1848 1849 I-gender
males 118 123 1849 1854 I-gender
) 123 124 1854 1855 O

Suicidal 0 8 1856 1864 B-chronic_disease
ideation 9 17 1865 1873 I-chronic_disease
in 18 20 1874 1876 O
the 21 24 1877 1880 O
past 25 29 1881 1885 O
month 30 35 1886 1891 O

Suicide 0 7 1892 1899 B-chronic_disease
attempt 8 15 1900 1907 I-chronic_disease
in 16 18 1908 1910 O
the 19 22 1911 1914 O
past 23 27 1915 1919 B-upper_bound
6 28 29 1920 1921 I-upper_bound
months 30 36 1922 1928 I-upper_bound

ages 0 4 1929 1933 B-age
18 5 7 1934 1936 B-lower_bound
- 7 8 1936 1937 O
70 8 10 1937 1939 B-upper_bound

pressure 0 8 1940 1948 O
is 9 11 1949 1951 O
greater 12 19 1952 1959 O
than 20 24 1960 1964 O
or 25 27 1965 1967 O
equal 28 33 1968 1973 O
to 34 36 1974 1976 O
160/100 37 44 1977 1984 B-lower_bound
mmHg 45 49 1985 1989 I-lower_bound
or 50 52 1990 1992 O
below 53 58 1993 1998 O
90/50 59 64 1999 2004 B-lower_bound
mmHg 65 69 2005 2009 I-lower_bound

who 0 3 2010 2013 O
are 4 7 2014 2017 O
currently 8 17 2018 2027 O
receiving 18 27 2028 2037 O
methadone 28 37 2038 2047 B-treatment
or 38 40 2048 2050 O
buprenorphine 41 54 2051 2064 B-treatment
maintenance 55 66 2065 2076 O
treatment 67 76 2077 2086 B-treatment
for 77 80 2087 2090 O
opioid 81 87 2091 2097 O
dependence 88 98 2098 2108 O

women 0 5 2109 2114 B-gender

18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
80 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
of 12 14 12 14 O
age 15 18 15 18 B-age

Patients 0 8 19 27 O
18 9 11 28 30 B-lower_bound
- 11 12 30 31 O
80 12 14 31 33 B-upper_bound
years 15 20 34 39 I-upper_bound
of 21 23 40 42 O
age 24 27 43 46 B-age

Pregnant 0 8 47 55 B-pregnancy
women 9 14 56 61 B-gender
( 15 16 62 63 O
as 16 18 63 65 O
verbalized 19 29 66 76 O
by 30 32 77 79 O
participant 33 44 80 91 O
) 44 45 91 92 O

A 0 1 0 1 O
clinical 2 10 2 10 O
diagnosis 11 20 11 20 O
of 21 23 21 23 O
alcoholic 24 33 24 33 O
hepatitis 34 43 34 43 O
with 44 48 44 48 O
Maddrey 49 56 49 56 B-clinical_variable
's 56 58 56 58 I-clinical_variable
discriminant 59 71 59 71 I-clinical_variable
function 72 80 72 80 I-clinical_variable
score 81 86 81 86 I-clinical_variable
≥32 87 90 87 90 O

Age 0 3 91 94 B-age
18 4 6 95 97 B-lower_bound
years 7 12 98 103 I-lower_bound
or 13 15 104 106 O
older 16 21 107 112 O

Bilirubin 0 9 113 122 B-clinical_variable
< 10 11 123 124 O
5 11 12 124 125 B-upper_bound
mg 13 15 126 128 I-upper_bound
/ 15 16 128 129 I-upper_bound
dL 16 18 129 131 I-upper_bound

Known 0 5 132 137 O
HIV 6 9 138 141 B-chronic_disease
infection 10 19 142 151 I-chronic_disease

Renal 0 5 152 157 B-chronic_disease
failure 6 13 158 165 I-chronic_disease

Uncontrolled 0 12 166 178 B-chronic_disease
infection 13 22 179 188 I-chronic_disease

pregnant 0 8 189 197 B-pregnancy

uncontrolled 0 12 198 210 O
recent 13 19 211 217 O
upper 20 25 218 223 O
gastrointestinal 26 42 224 240 B-chronic_disease
bleeding 43 51 241 249 I-chronic_disease

Adult 0 5 0 5 O
primary 6 13 6 13 O
caregiver 14 23 14 23 O
of 24 26 24 26 O
children 27 35 27 35 O
treated 36 43 36 43 O
for 44 47 44 47 O
leukemia 48 56 48 56 B-cancer
or 57 59 57 59 O
lymphoblastic 60 73 60 73 B-cancer
lymphoma 74 82 74 82 I-cancer
( 83 84 83 84 I-cancer
LL 84 86 84 86 I-cancer
) 86 87 86 87 I-cancer
and 88 91 88 91 O
daily 92 97 92 97 O
contact 98 105 98 105 O
with 106 110 106 110 O
the 111 114 111 114 O
child 115 120 115 120 O

Child 0 5 121 126 O
has 6 9 127 130 O
completed 10 19 131 140 O
cancer 20 26 141 147 B-treatment
treatment 27 36 148 157 I-treatment
and 37 40 158 161 O
is 41 43 162 164 O
up 44 46 165 167 O
to 47 49 168 170 O
10 50 52 171 173 B-upper_bound
years 53 58 174 179 I-upper_bound
post 59 63 180 184 B-treatment
- 63 64 184 185 I-treatment
treatment 64 73 185 194 I-treatment

Child 0 5 195 200 B-language_fluency
understands 6 17 201 212 I-language_fluency
English 18 25 213 220 I-language_fluency
and 26 29 221 224 O
is 30 32 225 227 O
enrolled 33 41 228 236 O
in 42 44 237 239 O
school 45 51 240 246 O
( 52 53 247 248 O
but 53 56 248 251 O
can 57 60 252 255 O
be 61 63 256 258 O
bilingual 64 73 259 268 O
) 73 74 268 269 O

Children 0 8 270 278 O
treated 9 16 279 286 O
for 17 20 287 290 O
acute 21 26 291 296 B-cancer
leukemia 27 35 297 305 I-cancer
( 36 37 306 307 O
e.g. 37 41 307 311 O
acute 42 47 312 317 B-cancer
lymphoblastic 48 61 318 331 I-cancer
leukemia 62 70 332 340 I-cancer
[ 71 72 341 342 I-cancer
ALL 72 75 342 345 I-cancer
] 75 76 345 346 I-cancer
, 76 77 346 347 O
acute 78 83 348 353 B-cancer
myeloid 84 91 354 361 I-cancer
leukemia 92 100 362 370 I-cancer
[ 101 102 371 372 I-cancer
AML 102 105 372 375 I-cancer
] 105 106 375 376 I-cancer
) 106 107 376 377 O
, 107 108 377 378 O
LL 109 111 379 381 O
, 111 112 381 382 O
or 113 115 383 385 O
other 116 121 386 391 O
types 122 127 392 397 O
of 128 130 398 400 O
leukemia 131 139 401 409 O
( 140 141 410 411 O
if 141 143 411 413 O
treated 144 151 414 421 O
intensively 152 163 422 433 O
) 163 164 433 434 O
aged 165 169 435 439 B-age
5 170 171 440 441 B-lower_bound
- 171 172 441 442 O
12 172 174 442 444 B-upper_bound
years 175 180 445 450 I-upper_bound
and 181 184 451 454 O
their 185 190 455 460 O
parents 191 198 461 468 O
/ 198 199 468 469 O
caregivers 199 209 469 479 O

One 0 3 480 483 O
or 4 6 484 486 O
both 7 11 487 491 O
parents 12 19 492 499 O
self 20 24 500 504 O
- 24 25 504 505 O
identify 25 33 505 513 O
as 34 36 514 516 O
Hispanic 37 45 517 525 B-ethnicity
/ 45 46 525 526 O
Latino 46 52 526 532 B-ethnicity

Recent 0 6 533 539 O
or 7 9 540 542 O
current 10 17 543 550 O
participation 18 31 551 564 O
in 32 34 565 567 O
educational 35 46 568 579 B-treatment
/ 46 47 579 580 I-treatment
behavioral 47 57 580 590 I-treatment
intervention 58 70 591 603 I-treatment
study 71 76 604 609 I-treatment
with 77 81 610 614 I-treatment
similar 82 89 615 622 I-treatment
focus 90 95 623 628 I-treatment

istory 0 6 629 635 O
of 7 9 636 638 O
major 10 15 639 644 B-chronic_disease
psychiatric 16 27 645 656 I-chronic_disease
condition 28 37 657 666 I-chronic_disease
( 38 39 667 668 O
e.g. 39 43 668 672 O
psychosis 44 53 673 682 B-chronic_disease
) 53 54 682 683 O
in 55 57 684 686 O
parent 58 64 687 693 O
or 65 67 694 696 O
child 68 73 697 702 O

primary 0 7 703 710 O
participating 8 21 711 724 O
parent 22 28 725 731 O
/ 28 29 731 732 O
caregiver 29 38 732 741 O
is 39 41 742 744 O
monolingual 42 53 745 756 B-language_fluency
or 54 56 757 759 I-language_fluency
bilingual 57 66 760 769 I-language_fluency
Spanish 67 74 770 777 I-language_fluency
speaking 75 83 778 786 I-language_fluency

severe 0 6 787 793 B-chronic_disease
neurodevelopmental 7 25 794 812 I-chronic_disease
disorder 26 34 813 821 I-chronic_disease
in 35 37 822 824 O
child 38 43 825 830 O
( 44 45 831 832 O
e.g. 45 49 832 836 O
Down 50 54 837 841 B-chronic_disease
's 54 56 841 843 I-chronic_disease
syndrome 57 65 844 852 I-chronic_disease
) 65 66 852 853 O

Patients 0 8 0 8 O
taking 9 15 9 15 O
anti 16 20 16 20 B-treatment
- 20 21 20 21 I-treatment
thrombotic 21 31 21 31 I-treatment
agents 32 38 32 38 I-treatment
including 39 48 39 48 O
clopidogrel 49 60 49 60 B-treatment
, 60 61 60 61 O
ticlopidine 62 73 62 73 B-treatment
, 73 74 73 74 O
coumadin 75 83 75 83 B-treatment
, 83 84 83 84 O
heparin 85 92 85 92 B-treatment
, 92 93 92 93 O
enoxaparin 94 104 94 104 B-treatment
, 104 105 104 105 O
and 106 109 106 109 O
direct 110 116 110 116 B-treatment
II 117 119 117 119 I-treatment
or 120 122 120 122 O
Xa 123 125 123 125 B-treatment
inhibitors 126 136 126 136 I-treatment

Patients 0 8 137 145 O
who 9 12 146 149 O
have 13 17 150 154 O
evidence 18 26 155 163 O
of 27 29 164 166 O
active 30 36 167 173 O
gastrointestinal 37 53 174 190 B-chronic_disease
bleeding 54 62 191 199 I-chronic_disease
will 63 67 200 204 O
be 68 70 205 207 O
excluded 71 79 208 216 O

Patients 0 8 217 225 O
with 9 13 226 230 O
INR 14 17 231 234 B-clinical_variable
> 18 19 235 236 O
1.5 19 22 236 239 B-lower_bound
, 22 23 239 240 O
platelet 24 32 241 249 B-clinical_variable
count 33 38 250 255 I-clinical_variable
< 39 40 256 257 O
75,000 40 46 257 263 B-upper_bound

gastric 0 7 264 271 O
indications 8 19 272 283 O
include 20 27 284 291 O
upper 28 33 292 297 O
abdominal 34 43 298 307 O
pain 44 48 308 312 O
dyspepsia 49 58 313 322 O
abnormal 59 67 323 331 O
gastric 68 75 332 339 O
imaging 76 83 340 347 O
iron 84 88 348 352 O
deficiency 89 99 353 363 O
anemia 100 106 364 370 B-chronic_disease
gastric 107 114 371 378 O
ulcer 115 120 379 384 B-chronic_disease
management 121 131 385 395 O
of 132 134 396 398 O
GI 135 137 399 401 O
blood 138 143 402 407 O
loss 144 148 408 412 O
without 149 156 413 420 O
active 157 163 421 427 O
bleeding 164 172 428 436 O
reflux 173 179 437 443 O
weight 180 186 444 450 O
loss 187 191 451 455 O

presenting 0 10 456 466 O
for 11 14 467 470 O
upper 15 20 471 476 B-treatment
endoscopy 21 30 477 486 I-treatment
for 31 34 487 490 O
gastric 35 42 491 498 O
indications 43 54 499 510 O

younger 0 7 511 518 O
than 8 12 519 523 O
18 13 15 524 526 B-upper_bound

Have 0 4 0 4 O
Eastern 5 12 5 12 B-clinical_variable
Cooperative 13 24 13 24 I-clinical_variable
Oncology 25 33 25 33 I-clinical_variable
Group 34 39 34 39 I-clinical_variable
( 40 41 40 41 I-clinical_variable
ECOG 41 45 41 45 I-clinical_variable
) 45 46 45 46 I-clinical_variable
scale 47 52 47 52 I-clinical_variable
performance 53 64 53 64 I-clinical_variable
status 65 71 65 71 I-clinical_variable
of 72 74 72 74 O
0 75 76 75 76 B-lower_bound
or 77 79 77 79 O
1 80 81 80 81 B-upper_bound

Have 0 4 82 86 O
a 5 6 87 88 O
serious 7 14 89 96 O
concomitant 15 26 97 108 B-chronic_disease
systemic 27 35 109 117 I-chronic_disease
disorder 36 44 118 126 I-chronic_disease

Have 0 4 127 131 O
moderate 5 13 132 140 O
or 14 16 141 143 O
severe 17 23 144 150 O
cardiovascular 24 38 151 165 B-chronic_disease
disease 39 46 166 173 I-chronic_disease

The 0 3 174 177 O
participant 4 15 178 189 O
must 16 20 190 194 O
have 21 25 195 199 O
histological 26 38 200 212 O
or 39 41 213 215 O
cytological 42 53 216 227 O
evidence 54 62 228 236 O
of 63 65 237 239 O
cancer 66 72 240 246 B-cancer

Allergy 0 7 0 7 O
to 8 10 8 10 O
Lidocaine 11 20 11 20 B-allergy_name

Allergy 0 7 21 28 O
to 8 10 29 31 O
Oxymetazoline 11 24 32 45 B-allergy_name

Healthy 0 7 46 53 O
Subjects 8 16 54 62 O
undergoing 17 27 63 73 O
thyroid 28 35 74 81 B-treatment
or 36 38 82 84 I-treatment
other 39 44 85 90 I-treatment
open 45 49 91 95 I-treatment
neck 50 54 96 100 I-treatment
surgeries 55 64 101 110 I-treatment

History 0 7 111 118 O
of 8 10 119 121 O
Brain 11 16 122 127 B-treatment
Surgery 17 24 128 135 I-treatment

History 0 7 136 143 O
of 8 10 144 146 O
Diabetes 11 19 147 155 B-chronic_disease
Mellitus 20 28 156 164 I-chronic_disease

History 0 7 165 172 O
of 8 10 173 175 O
Neck 11 15 176 180 B-treatment
Surgery 16 23 181 188 I-treatment

History 0 7 189 196 O
of 8 10 197 199 O
Neurologic 11 21 200 210 B-chronic_disease
Disease 22 29 211 218 I-chronic_disease

History 0 7 219 226 O
of 8 10 227 229 O
Stroke 11 17 230 236 B-chronic_disease

Laryngopharyngeal 0 17 237 254 B-chronic_disease
Reflux 18 24 255 261 I-chronic_disease
Disease 25 32 262 269 I-chronic_disease

Recent 0 6 270 276 O
Laryngeal 7 16 277 286 B-treatment
Surgery 17 24 287 294 I-treatment
( 25 26 295 296 O
within 26 32 296 302 O
one 33 36 303 306 B-upper_bound
month 37 42 307 312 I-upper_bound
) 42 43 312 313 O

Aneurysm 0 8 0 8 B-chronic_disease
size 9 13 9 13 O
[ 14 15 14 15 O
largest 15 22 15 22 O
measurement 23 34 23 34 O
from 35 39 35 39 O
the 40 43 40 43 O
cross 44 49 44 49 O
sectional 50 59 50 59 O
images 60 66 60 66 O
to 67 69 67 69 O
determine 70 79 70 79 O
overall 80 87 80 87 O
aneurysm 88 96 88 96 B-chronic_disease
size 97 101 97 101 O
, 101 102 101 102 O
not 103 106 103 106 O
just 107 111 107 111 O
the 112 115 112 115 O
lumen 116 121 116 121 O
, 121 122 121 122 O
and 123 126 123 126 O
including 127 136 127 136 O
any 137 140 137 140 O
thrombosed 141 151 141 151 O
portions 152 160 152 160 O
] 160 161 160 161 O
≤ 162 163 162 163 O
4.9 164 167 164 167 B-upper_bound
mm 168 170 168 170 I-upper_bound

If 0 2 171 173 O
ruptured 3 11 174 182 O
aneurysm 12 20 183 191 B-chronic_disease
: 20 21 191 192 O
Hunt 22 26 193 197 B-clinical_variable
and 27 30 198 201 I-clinical_variable
Hess 31 35 202 206 I-clinical_variable
0 36 37 207 208 B-lower_bound
- 37 38 208 209 O
3 38 39 209 210 B-upper_bound

If 0 2 211 213 O
unruptured 3 13 214 224 O
aneurysm 14 22 225 233 O
: 22 23 233 234 O
Subject 24 31 235 242 O
grade 32 37 243 248 O
Modified 38 46 249 257 B-clinical_variable
Rankin 47 53 258 264 I-clinical_variable
Scale 54 59 265 270 I-clinical_variable
mRS 60 63 271 274 I-clinical_variable
0 64 65 275 276 B-lower_bound
- 66 67 277 278 O
2 68 69 279 280 B-upper_bound
The 70 73 281 284 O
investigator 74 86 285 297 O
believes 87 95 298 306 O
the 96 99 307 310 O
aneurysm 100 108 311 319 O
is 109 111 320 322 O
appropriate 112 123 323 334 O
for 124 127 335 338 O
the 128 131 339 342 O
designated 132 142 343 353 O
Phase 143 148 354 359 O
coiling 149 156 360 367 O
paradigm 157 165 368 376 O

Intended 0 8 377 385 O
or 9 11 386 388 O
planned 12 19 389 396 O
aneurysm 20 28 397 405 B-treatment
treatment 29 38 406 415 I-treatment
by 39 41 416 418 I-treatment
parent 42 48 419 425 I-treatment
vessel 49 55 426 432 I-treatment
occlusion 56 65 433 442 I-treatment

Life 0 4 443 447 B-clinical_variable
expectancy 5 15 448 458 I-clinical_variable
less 16 20 459 463 O
than 21 25 464 468 O
12 26 28 469 471 B-upper_bound
months 29 35 472 478 I-upper_bound

Patient 0 7 479 486 O
has 8 11 487 490 O
more 12 16 491 495 O
than 17 21 496 500 O
one 22 25 501 504 B-lower_bound
aneurysm 26 34 505 513 B-chronic_disease
requiring 35 44 514 523 O
treatment 45 54 524 533 O
in 55 57 534 536 O
the 58 61 537 540 O
current 62 69 541 548 O
treatment 70 79 549 558 O
session 80 87 559 566 O
, 87 88 566 567 O
and 89 92 568 571 O
only 93 97 572 576 O
one 98 101 577 580 O
of 102 104 581 583 O
those 105 110 584 589 O
to 111 113 590 592 O
be 114 116 593 595 O
treated 117 124 596 603 O
aneurysms 125 134 604 613 B-chronic_disease
fits 135 139 614 618 O
the 140 143 619 622 O
current 144 151 623 630 O
Study 152 157 631 636 O
inclusion 158 167 637 646 O
criteria 168 176 647 655 O

Presence 0 8 656 664 O
of 9 11 665 667 O
fusiform 12 20 668 676 O
, 20 21 676 677 O
mycotic 22 29 678 685 O
, 29 30 685 686 O
traumatic 31 40 687 696 O
, 40 41 696 697 O
dissecting 42 52 698 708 O
or 53 55 709 711 O
tumoral 56 63 712 719 B-chronic_disease
aneurysms 64 73 720 729 I-chronic_disease
in 74 76 730 732 O
any 77 80 733 736 O
location 81 89 737 745 O
10 90 92 746 748 O

Prior 0 5 749 754 O
treatment 6 15 755 764 B-treatment
( 16 17 765 766 O
surgical 17 25 766 774 O
or 26 28 775 777 O
endovascular 29 41 778 790 O
) 41 42 790 791 O
of 43 45 792 794 O
the 46 49 795 798 O
target 50 56 799 805 O
aneurysm 57 65 806 814 B-chronic_disease

Subject 0 7 815 822 O
age 8 11 823 826 B-age
≥ 12 13 827 828 O
18 14 16 829 831 B-lower_bound
and 17 20 832 835 O
≤ 21 22 836 837 O
80 23 25 838 840 B-upper_bound

Subject 0 7 841 848 O
with 8 12 849 853 O
social 13 19 854 860 O
, 19 20 860 861 O
medical 21 28 862 869 O
, 28 29 869 870 O
or 30 32 871 873 O
psychological 33 46 874 887 O
conditions 47 57 888 898 O
that 58 62 899 903 O
interfere 63 72 904 913 O
with 73 77 914 918 O
treatment 78 87 919 928 B-treatment
and 88 91 929 932 O
follow 92 98 933 939 O
- 98 99 939 940 O
up 99 101 940 942 O
evaluation 102 112 943 953 O

Use 0 3 954 957 O
( 4 5 958 959 O
current 5 12 959 966 O
or 13 15 967 969 O
prior 16 21 970 975 O
) 21 22 975 976 O
of 23 25 977 979 O
liquid 26 32 980 986 B-treatment
embolic 33 40 987 994 I-treatment
material 41 49 995 1003 I-treatment
in 50 52 1004 1006 O
the 53 56 1007 1010 O
treatment 57 66 1011 1020 B-treatment
of 67 69 1021 1023 O
the 70 73 1024 1027 O
target 74 80 1028 1034 O
aneurysm 81 89 1035 1043 B-chronic_disease

Use 0 3 1044 1047 O
of 4 6 1048 1050 O
other 7 12 1051 1056 O
modified 13 21 1057 1065 O
coils 22 27 1066 1071 O
( 28 29 1072 1073 O
Matrix 29 35 1073 1079 B-treatment
, 35 36 1079 1080 O
HydroCoil 37 46 1081 1090 B-treatment
® 46 47 1090 1091 I-treatment
or 48 50 1092 1094 O
fibered 51 58 1095 1102 B-treatment
coils 59 64 1103 1108 I-treatment
) 64 65 1108 1109 O

Women 0 5 1110 1115 B-gender
who 6 9 1116 1119 O
are 10 13 1120 1123 B-pregnancy
pregnant 14 22 1124 1132 I-pregnancy

plan 0 4 1133 1137 B-pregnancy
to 5 7 1138 1140 I-pregnancy
become 8 14 1141 1147 I-pregnancy
pregnant 15 23 1148 1156 I-pregnancy
during 24 30 1157 1163 O
the 31 34 1164 1167 O
Study 35 40 1168 1173 O

with 0 4 1174 1178 O
a 5 6 1179 1180 O
diagnosis 7 16 1181 1190 O
of 17 19 1191 1193 O
ruptured 20 28 1194 1202 B-chronic_disease
or 29 31 1203 1205 I-chronic_disease
unruptured 32 42 1206 1216 I-chronic_disease
saccular 43 51 1217 1225 I-chronic_disease
intracranial 52 64 1226 1238 I-chronic_disease
aneurysm 65 73 1239 1247 I-chronic_disease
judged 74 80 1248 1254 O
suitable 81 89 1255 1263 O
for 90 93 1264 1267 O
selective 94 103 1268 1277 B-treatment
endovascular 104 116 1278 1290 I-treatment
treatment 117 126 1291 1300 I-treatment
by 127 129 1301 1303 I-treatment
coil 130 134 1304 1308 I-treatment
occlusion 135 144 1309 1318 I-treatment

Patients 0 8 0 8 O
must 9 13 9 13 O
be 14 16 14 16 O
scheduled 17 26 17 26 O
for 27 30 27 30 O
a 31 32 31 32 O
procedure 33 42 33 42 O
capable 43 50 43 50 O
of 51 53 51 53 O
providing 54 63 54 63 O
a 64 65 64 65 O
definitive 66 76 66 76 O
pathologic 77 87 77 87 O
diagnosis 88 97 88 97 O
and 98 101 98 101 O
evaluating 102 112 102 112 O
for 113 116 113 116 O
complications 117 130 117 130 O
of 131 133 131 133 O
the 134 137 134 137 O
esophageal 138 148 138 148 O
sponge 149 155 149 155 O
on 156 158 156 158 O
the 159 162 159 162 O
same 163 167 163 167 O
day 168 171 168 171 O
as 172 174 172 174 O
the 175 178 175 178 O
study 179 184 179 184 O
procedure 185 194 185 194 O
, 194 195 194 195 O
either 196 202 196 202 O
upper 203 208 203 208 B-treatment
endoscopy 209 218 209 218 I-treatment
or 219 221 219 221 O
surgical 222 230 222 230 B-treatment
esophagectomy 231 244 231 244 I-treatment

Subjects 0 8 245 253 O
with 9 13 254 258 O
known 14 19 259 264 O
esophageal 20 30 265 275 B-cancer
cancer 31 37 276 282 I-cancer
( 38 39 283 284 O
adenocarcinoma 39 53 284 298 B-cancer
or 54 56 299 301 O
squamous 57 65 302 310 B-cancer
cell 66 70 311 315 I-cancer
carcinoma 71 80 316 325 I-cancer
) 80 81 325 326 O

Subjects 0 8 327 335 O
with 9 13 336 340 O
known 14 19 341 346 O
or 20 22 347 349 O
suspected 23 32 350 359 O
esophageal 33 43 360 370 B-chronic_disease
varices 44 51 371 378 I-chronic_disease

Subjects 0 8 379 387 O
with 9 13 388 392 O
risk 14 18 393 397 O
factors 19 26 398 405 O
for 27 30 406 409 O
esophageal 31 41 410 420 B-cancer
malignancy 42 52 421 431 I-cancer
including 53 62 432 441 O
Barrett?s 63 72 442 451 B-chronic_disease
esophagus 73 82 452 461 O
and 83 86 462 465 O
gastroesophageal 87 103 466 482 B-chronic_disease
reflux 104 110 483 489 I-chronic_disease
disease 111 118 490 497 I-chronic_disease
( 119 120 498 499 I-chronic_disease
GERD 120 124 499 503 I-chronic_disease
) 124 125 503 504 I-chronic_disease

Uncontrolled 0 12 505 517 B-chronic_disease
intercurrent 13 25 518 530 I-chronic_disease
illness 26 33 531 538 I-chronic_disease

cardiac 0 7 539 546 B-chronic_disease
arrhythmia 8 18 547 557 I-chronic_disease

ongoing 0 7 558 565 O
or 8 10 566 568 O
active 11 17 569 575 B-chronic_disease
infection 18 27 576 585 I-chronic_disease

psychiatric 0 11 586 597 B-chronic_disease
illness 12 19 598 605 I-chronic_disease
/ 19 20 605 606 I-chronic_disease
social 20 26 606 612 I-chronic_disease
situations 27 37 613 623 I-chronic_disease
that 38 42 624 628 O
would 43 48 629 634 O
limit 49 54 635 640 O
compliance 55 65 641 651 O
with 66 70 652 656 O
study 71 76 657 662 O
requirements 77 89 663 675 O

10 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
and 9 12 9 12 O
older 13 18 13 18 O

Age 0 3 19 22 B-age
6 4 5 23 24 B-lower_bound
months 6 12 25 31 I-lower_bound
to 13 15 32 34 O
30 16 18 35 37 B-upper_bound
years 19 24 38 43 I-upper_bound

Cardiac 0 7 44 51 B-chronic_disease
condition 8 17 52 61 I-chronic_disease
requiring 18 27 62 71 O
emergency 28 37 72 81 O
procedure 38 47 82 91 O

Female 0 6 92 98 B-gender
subjects 7 15 99 107 I-gender

Individuals 0 11 108 119 O
able 12 16 120 124 O
to 17 19 125 127 O
undergo 20 27 128 135 O
bone 28 32 136 140 B-treatment
marrow 33 39 141 147 I-treatment
aspirate 40 48 148 156 I-treatment
according 49 58 157 166 O
to 59 61 167 169 O
clinical 62 70 170 178 O
consultation 71 83 179 191 O
with 84 88 192 196 O
Hematology 89 99 197 207 O
( 100 101 208 209 O
cell 101 105 209 213 B-treatment
treatment 106 115 214 223 I-treatment
group 116 121 224 229 O
only 122 126 230 234 O
) 126 127 234 235 O

Individuals 0 11 236 247 O
requiring 12 21 248 257 O
cavopulmonary 22 35 258 271 B-treatment
shunt 36 41 272 277 I-treatment
at 42 44 278 280 O
the 45 48 281 284 O
time 49 53 285 289 O
of 54 56 290 292 O
surgical 57 65 293 301 B-treatment
Ebstein 66 73 302 309 I-treatment
repair 74 80 310 316 O

Individuals 0 11 317 328 O
who 12 15 329 332 O
have 16 20 333 337 O
other 21 26 338 343 O
clinical 27 35 344 352 O
concerns 36 44 353 361 O
as 45 47 362 364 O
documented 48 58 365 375 O
by 59 61 376 378 O
a 62 63 379 380 O
site 64 68 381 385 O
investigator 69 81 386 398 O
that 82 86 399 403 O
could 87 92 404 409 O
reasonably 93 103 410 420 O
increase 104 112 421 429 O
the 113 116 430 433 O
risk 117 121 434 438 O
of 122 124 439 441 O
complications 125 138 442 455 O
during 139 145 456 462 O
or 146 148 463 465 O
after 149 154 466 471 O
surgical 155 163 472 480 B-treatment
Ebstein 164 171 481 488 I-treatment
repair 172 178 489 495 I-treatment

Individuals 0 11 496 507 O
who 12 15 508 511 O
weigh 16 21 512 517 B-clinical_variable
more 22 26 518 522 O
than 27 31 523 527 O
90 32 34 528 530 B-lower_bound
kg 35 37 531 533 I-lower_bound

Individuals 0 11 534 545 O
with 12 16 546 550 O
bleeding 17 25 551 559 B-chronic_disease
disorders 26 35 560 569 I-chronic_disease

Individuals 0 11 570 581 O
with 12 16 582 586 O
current 17 24 587 594 O
IV 25 27 595 597 B-treatment
inotrope 28 36 598 606 I-treatment
requirements 37 49 607 619 O

Individuals 0 11 620 631 O
with 12 16 632 636 O
history 17 24 637 644 O
of 25 27 645 647 O
ventricular 28 39 648 659 B-chronic_disease
arrhythmia 40 50 660 670 I-chronic_disease
or 51 53 671 673 O
new 54 57 674 677 O
onset 58 63 678 683 O
ventricular 64 75 684 695 O
arrhythmia 76 86 696 706 O
after 87 92 707 712 O
enrollment 93 103 713 723 O
that 104 108 724 728 O
requires 109 117 729 737 O
medical 118 125 738 745 O
management 126 136 746 756 O

Individuals 0 11 757 768 O
with 12 16 769 773 O
preoperative 17 29 774 786 B-chronic_disease
ventricular 30 41 787 798 I-chronic_disease
arrhythmia 42 52 799 809 I-chronic_disease
requiring 53 62 810 819 O
medical 63 70 820 827 O
management 71 81 828 838 O

Individuals 0 11 839 850 O
with 12 16 851 855 O
pulmonary 17 26 856 865 B-chronic_disease
atresia 27 34 866 873 I-chronic_disease
or 35 37 874 876 O
atrioventricular 38 54 877 893 B-chronic_disease
discordance 55 66 894 905 I-chronic_disease
with 67 71 906 910 O
ventriculoarterial 72 90 911 929 B-chronic_disease
discordance 91 102 930 941 I-chronic_disease

Individuals 0 11 942 953 O
with 12 16 954 958 O
severe 17 23 959 965 B-chronic_disease
chronic 24 31 966 973 I-chronic_disease
diseases 32 40 974 982 I-chronic_disease

Individuals 0 11 983 994 O
with 12 16 995 999 O
the 17 20 1000 1003 O
following 21 30 1004 1013 O
conditions 31 41 1014 1024 O
within 42 48 1025 1031 O
60 49 51 1032 1034 B-upper_bound
days 52 56 1035 1039 I-upper_bound
prior 57 62 1040 1045 I-upper_bound
to 63 65 1046 1048 O
Ebstein 66 73 1049 1056 B-treatment
repair 74 80 1057 1063 I-treatment
surgery 81 88 1064 1071 I-treatment

Multi 0 5 1072 1077 B-chronic_disease
- 5 6 1077 1078 I-chronic_disease
system 6 12 1078 1084 I-chronic_disease
organ 13 18 1085 1090 I-chronic_disease
failure 19 26 1091 1098 I-chronic_disease
including 27 36 1099 1108 O
acute 37 42 1109 1114 B-chronic_disease
or 43 45 1115 1117 I-chronic_disease
chronic 46 53 1118 1125 I-chronic_disease
renal 54 59 1126 1131 I-chronic_disease
failure 60 67 1132 1139 I-chronic_disease

extensive 0 9 1140 1149 O
extra 10 15 1150 1155 B-chronic_disease
- 15 16 1155 1156 I-chronic_disease
cardiac 16 23 1156 1163 I-chronic_disease
syndromes 24 33 1164 1173 I-chronic_disease

history 0 7 1174 1181 O
of 8 10 1182 1184 O
any 11 14 1185 1188 O
cancer 15 21 1189 1195 B-cancer

history 0 7 1196 1203 O
of 8 10 1204 1206 O
thrombosis 11 21 1207 1217 B-chronic_disease

Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
( 35 36 35 36 I-clinical_variable
ECOG 36 40 36 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
less 61 65 61 65 O
than 66 70 66 70 O
or 71 73 71 73 O
equal 74 79 74 79 O
to 80 82 80 82 O
3 83 84 83 84 B-upper_bound

Pregnant 0 8 85 93 B-pregnancy

Previously 0 10 94 104 O
untreated 11 20 105 114 O
T 21 22 115 116 B-cancer
cell 23 27 117 121 I-cancer
ALL 28 31 122 125 I-cancer
including 32 41 126 135 O
T 42 43 136 137 B-cancer
cell 44 48 138 142 I-cancer
lymphoblastic 49 62 143 156 I-cancer
lymphoma 63 71 157 165 I-cancer

Serum 0 5 166 171 O
bilirubin 6 15 172 181 B-clinical_variable
less 16 20 182 186 O
than 21 25 187 191 O
or 26 28 192 194 O
equal 29 34 195 200 O
to 35 37 201 203 O
2.0 38 41 204 207 B-upper_bound
mg 42 44 208 210 I-upper_bound
/ 44 45 210 211 I-upper_bound
dL 45 47 211 213 I-upper_bound
unless 48 54 214 220 O
considered 55 65 221 231 O
due 66 69 232 235 O
to 70 72 236 238 O
involvement 73 84 239 250 O
by 85 87 251 253 O
tumor 88 93 254 259 B-cancer
when 94 98 260 264 O
an 99 101 265 267 O
upper 102 107 268 273 O
limit 108 113 274 279 O
of 114 116 280 282 O
5.0 117 120 283 286 O
mg 121 123 287 289 O
/ 123 124 289 290 O
dL 124 126 290 292 O
is 127 129 293 295 O
acceptable 130 140 296 306 O

Serum 0 5 307 312 B-clinical_variable
creatinine 6 16 313 323 I-clinical_variable
less 17 21 324 328 O
than 22 26 329 333 O
or 27 29 334 336 O
equal 30 35 337 342 O
to 36 38 343 345 O
2.0 39 42 346 349 B-upper_bound
mg 43 45 350 352 I-upper_bound
/ 45 46 352 353 I-upper_bound
dL 46 48 353 355 I-upper_bound
unless 49 55 356 362 O
considered 56 66 363 373 O
due 67 70 374 377 O
to 71 73 378 380 O
involvement 74 85 381 392 O
by 86 88 393 395 O
tumor 89 94 396 401 B-cancer
when 95 99 402 406 O
an 100 102 407 409 O
upper 103 108 410 415 O
limit 109 114 416 421 O
of 115 117 422 424 O
2.5 118 121 425 428 B-upper_bound
mg 122 124 429 431 I-upper_bound
/ 124 125 431 432 I-upper_bound
dL 125 127 432 434 I-upper_bound
is 128 130 435 437 O
acceptable 131 141 438 448 O

Serum 0 5 449 454 B-clinical_variable
glutamic 6 14 455 463 I-clinical_variable
oxaloacetic 15 26 464 475 I-clinical_variable
transaminase 27 39 476 488 I-clinical_variable
( 40 41 489 490 I-clinical_variable
SGOT 41 45 490 494 I-clinical_variable
) 45 46 494 495 I-clinical_variable
or 47 49 496 498 O
serum 50 55 499 504 B-clinical_variable
glutamate 56 65 505 514 I-clinical_variable
pyruvate 66 74 515 523 I-clinical_variable
transaminase 75 87 524 536 I-clinical_variable
( 88 89 537 538 I-clinical_variable
SGPT 89 93 538 542 I-clinical_variable
) 93 94 542 543 I-clinical_variable
less 95 99 544 548 O
than 100 104 549 553 O
or 105 107 554 556 O
equal 108 113 557 562 O
to 114 116 563 565 O
4 117 118 566 567 B-upper_bound
x 119 120 568 569 I-upper_bound
upper 121 126 570 575 I-upper_bound
limit 127 132 576 581 I-upper_bound
of 133 135 582 584 I-upper_bound
normal 136 142 585 591 I-upper_bound
( 143 144 592 593 I-upper_bound
ULN 144 147 593 596 I-upper_bound
) 147 148 596 597 I-upper_bound

failure 0 7 598 605 O
to 8 10 606 608 O
one 11 14 609 612 O
induction 15 24 613 622 O
course 25 31 623 629 O
of 32 34 630 632 O
chemotherapy 35 47 633 645 B-treatment
are 48 51 646 649 O
eligible 52 60 650 658 O

nursing 0 7 659 666 O
women 8 13 667 672 B-gender

patients 0 8 673 681 O
in 9 11 682 684 O
CR 12 14 685 687 B-chronic_disease
after 15 20 688 693 O
= 21 22 694 695 O
< 22 23 695 696 O
2 24 25 697 698 B-upper_bound
courses 26 33 699 706 O
are 34 37 707 710 O
also 38 42 711 715 O
eligible 43 51 716 724 O

12 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

History 0 7 25 32 O
of 8 10 33 35 O
drug 11 15 36 40 O
- 15 16 40 41 O
induced 16 23 41 48 O
psoriasis 24 33 49 58 B-chronic_disease
or 34 36 59 61 O
pustular 37 45 62 70 B-chronic_disease
psoriasis 46 55 71 80 I-chronic_disease

Pregnant 0 8 81 89 B-pregnancy

Psoriatic 0 9 90 99 O
group 10 15 100 105 O
only 16 20 106 110 O
: 20 21 110 111 O
Chronic 22 29 112 119 B-chronic_disease
plaque 30 36 120 126 I-chronic_disease
psoriasis 37 46 127 136 I-chronic_disease
( 47 48 137 138 O
patients 48 56 138 146 O
must 57 61 147 151 O
have 62 66 152 156 O
diagnosis 67 76 157 166 O
for 77 80 167 170 O
at 81 83 171 173 O
least 84 89 174 179 O
6 90 91 180 181 B-lower_bound
months 92 98 182 188 I-lower_bound
) 98 99 188 189 O
or 100 102 190 192 O
guttate 103 110 193 200 O
psoriasis 111 120 201 210 O
involving 121 130 211 220 O
2 131 132 221 222 B-lower_bound
% 133 134 223 224 I-lower_bound
or 135 137 225 227 O
greater 138 145 228 235 O
total 146 151 236 241 O
body 152 156 242 246 O
surface 157 164 247 254 O
area 165 169 255 259 O
or 170 172 260 262 O
2 173 174 263 264 O
plaques 175 182 265 272 O
, 182 183 272 273 O
each 184 188 274 278 O
measuring 189 198 279 288 O
> 199 200 289 290 O
8 201 202 291 292 B-lower_bound
cm2 203 206 293 296 I-lower_bound

Psoriatic 0 9 297 306 O
group 10 15 307 312 O
only 16 20 313 317 O
: 20 21 317 318 O
Psoriasis 22 31 319 328 B-chronic_disease
is 32 34 329 331 O
untreated 35 44 332 341 O
( 45 46 342 343 O
as 46 48 343 345 O
defined 49 56 346 353 O
in 57 59 354 356 O
Exclusion 60 69 357 366 O
criteria 70 78 367 375 O
4 79 80 376 377 O
) 80 81 377 378 O
or 82 84 379 381 O
subject 85 92 382 389 O
has 93 96 390 393 O
been 97 101 394 398 O
on 102 104 399 401 O
a 105 106 402 403 O
stable 107 113 404 410 O
topical 114 121 411 418 O
or 122 124 419 421 O
systemic 125 133 422 430 B-treatment
treatment 134 143 431 440 I-treatment
with 144 148 441 445 O
no 149 151 446 448 O
dose 152 156 449 453 O
alteration 157 167 454 464 O
or 168 170 465 467 O
regimen 171 178 468 475 B-clinical_variable
alteration 179 189 476 486 I-clinical_variable
for 190 193 487 490 O
> 194 195 491 492 O
12 195 197 492 494 B-lower_bound
months 198 204 495 501 I-lower_bound

Psoriatic 0 9 502 511 O
group 10 15 512 517 O
only 16 20 518 522 O
: 20 21 522 523 O
Use 22 25 524 527 O
of 26 28 528 530 O
biologic 29 37 531 539 B-treatment
treatment 38 47 540 549 I-treatment
for 48 51 550 553 O
psoriasis 52 61 554 563 B-chronic_disease
within 62 68 564 570 O
3 69 70 571 572 B-upper_bound
months 71 77 573 579 I-upper_bound
of 78 80 580 582 O
baseline 81 89 583 591 O

history 0 7 592 599 O
of 8 10 600 602 O
diabetes 11 19 603 611 B-chronic_disease
mellitus 20 28 612 620 I-chronic_disease

thyroid 0 7 621 628 B-chronic_disease
disease 8 15 629 636 I-chronic_disease
or 16 18 637 639 O
inflammatory 19 31 640 652 B-chronic_disease
bowel 32 37 653 658 I-chronic_disease
disease 38 45 659 666 I-chronic_disease

use 0 3 667 670 O
of 4 6 671 673 O
systemic 7 15 674 682 B-treatment
immunosuppressive 16 33 683 700 I-treatment
treatment 34 43 701 710 I-treatment
for 44 47 711 714 O
psoriasis 48 57 715 724 B-chronic_disease
within 58 64 725 731 O
4 65 66 732 733 B-upper_bound
weeks 67 72 734 739 I-upper_bound
of 73 75 740 742 O
baseline 76 84 743 751 O
, 84 85 751 752 O
or 86 88 753 755 O
use 89 92 756 759 O
of 93 95 760 762 O
topical 96 103 763 770 B-treatment
treatment 104 113 771 780 I-treatment
for 114 117 781 784 O
psoriasis 118 127 785 794 O
within 128 134 795 801 O
2 135 136 802 803 B-upper_bound
weeks 137 142 804 809 I-upper_bound

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥1.5 32 36 32 36 O
x 37 38 37 38 I-lower_bound
109 39 42 39 42 I-lower_bound
/ 42 43 42 43 I-lower_bound
L 43 44 43 44 I-lower_bound

Active 0 6 45 51 B-chronic_disease
, 6 7 51 52 O
uncontrolled 8 20 53 65 B-chronic_disease
bacterial 21 30 66 75 I-chronic_disease
, 30 31 75 76 O
viral 32 37 77 82 B-chronic_disease
, 37 38 82 83 O
fungal 39 45 84 90 B-chronic_disease
, 45 46 90 91 O
or 47 49 92 94 O
other 50 55 95 100 O
opportunistic 56 69 101 114 B-chronic_disease
infection 70 79 115 124 I-chronic_disease
requiring 80 89 125 134 O
systemic 90 98 135 143 B-treatment
therapy 99 106 144 151 I-treatment

Alanine 0 7 152 159 B-clinical_variable
transaminase 8 20 160 172 I-clinical_variable
( 21 22 173 174 I-clinical_variable
ALT 22 25 174 177 I-clinical_variable
) 25 26 177 178 I-clinical_variable
and 27 30 179 182 O
aspartate 31 40 183 192 B-clinical_variable
transaminase 41 53 193 205 I-clinical_variable
( 54 55 206 207 I-clinical_variable
AST 55 58 207 210 I-clinical_variable
) 58 59 210 211 I-clinical_variable
within 60 66 212 218 O
1.5x 67 71 219 223 B-upper_bound
upper 72 77 224 229 I-upper_bound
limit 78 83 230 235 I-upper_bound
of 84 86 236 238 I-upper_bound
normal 87 93 239 245 I-upper_bound

Angina 0 6 246 252 B-chronic_disease
pectoris 7 15 253 261 I-chronic_disease

Any 0 3 262 265 O
serious 4 11 266 273 O
and/or 12 18 274 280 O
unstable 19 27 281 289 O
pre 28 31 290 293 O
- 31 32 293 294 O
existing 32 40 294 302 O
medical 41 48 303 310 O
, 48 49 310 311 O
psychiatric 50 61 312 323 B-chronic_disease
, 61 62 323 324 O
or 63 65 325 327 O
other 66 71 328 333 O
condition 72 81 334 343 O
( 82 83 344 345 O
e.g. 83 87 345 349 O
, 87 88 349 350 O
severe 89 95 351 357 O
hepatic 96 103 358 365 B-chronic_disease
impairment 104 114 366 376 I-chronic_disease
) 114 115 376 377 O
or 116 118 378 380 O
current 119 126 381 388 O
unstable 127 135 389 397 O
or 136 138 398 400 O
uncompensated 139 152 401 414 O
respiratory 153 164 415 426 B-chronic_disease
or 165 167 427 429 O
cardiac 168 175 430 437 B-chronic_disease
conditions 176 186 438 448 I-chronic_disease
which 187 192 449 454 O
makes 193 198 455 460 O
it 199 201 461 463 O
undesirable 202 213 464 475 O
for 214 217 476 479 O
the 218 221 480 483 O
patient 222 229 484 491 O
to 230 232 492 494 O
participate 233 244 495 506 O
in 245 247 507 509 O
the 248 251 510 513 O
study 252 257 514 519 O
or 258 260 520 522 O
which 261 266 523 528 O
could 267 272 529 534 O
jeopardize 273 283 535 545 O
compliance 284 294 546 556 O
with 295 299 557 561 O
the 300 303 562 565 O
protocol 304 312 566 574 O

Calculated 0 10 575 585 B-clinical_variable
creatinine 11 21 586 596 I-clinical_variable
clearance 22 31 597 606 I-clinical_variable
> 32 33 607 608 O
50 33 35 608 610 B-lower_bound
mL 36 38 611 613 I-lower_bound
/ 38 39 613 614 I-lower_bound
min 39 42 614 617 I-lower_bound

Cancer 0 6 618 624 B-cancer
that 7 11 625 629 O
is 12 14 630 632 O
recurrent 15 24 633 642 O
, 24 25 642 643 O
metastatic 26 36 644 654 B-cancer
, 36 37 654 655 O
or 38 40 656 658 O
unresectable 41 53 659 671 O
and 54 57 672 675 O
for 58 61 676 679 O
which 62 67 680 685 O
no 68 70 686 688 O
effective 71 80 689 698 O
or 81 83 699 701 O
curative 84 92 702 710 O
measures 93 101 711 719 O
exist 102 107 720 725 O

Congestive 0 10 726 736 B-chronic_disease
heart 11 16 737 742 I-chronic_disease
failure 17 24 743 750 I-chronic_disease
of 25 27 751 753 O
New 28 31 754 757 B-clinical_variable
York 32 36 758 762 I-clinical_variable
Heart 37 42 763 768 I-clinical_variable
Association 43 54 769 780 I-clinical_variable
( 55 56 781 782 I-clinical_variable
NYHA 56 60 782 786 I-clinical_variable
) 60 61 786 787 I-clinical_variable
Grade 62 67 788 793 O
> 68 69 794 795 O
2 69 70 795 796 B-lower_bound

European 0 8 797 805 B-clinical_variable
Cooperative 9 20 806 817 I-clinical_variable
Oncology 21 29 818 826 I-clinical_variable
Group 30 35 827 832 I-clinical_variable
( 36 37 833 834 I-clinical_variable
ECOG 37 41 834 838 I-clinical_variable
) 41 42 838 839 I-clinical_variable
performance 43 54 840 851 I-clinical_variable
status 55 61 852 858 I-clinical_variable
0 62 63 859 860 B-lower_bound
or 64 66 861 863 O
1 67 68 864 865 B-upper_bound

HPV 0 3 866 869 B-chronic_disease
- 3 4 869 870 O
positive 4 12 870 878 O
status 13 19 879 885 O
( 20 21 886 887 O
In 22 24 888 890 O
HNSCC 25 30 891 896 B-cancer
patients 31 39 897 905 O
only 40 44 906 910 O
) 44 45 910 911 O

Hemoglobin 0 10 912 922 B-clinical_variable
≥9.0 11 15 923 927 O
g 16 17 928 929 I-lower_bound
/ 17 18 929 930 I-lower_bound
dL 18 20 930 932 I-lower_bound

History 0 7 933 940 O
of 8 10 941 943 O
clinically 11 21 944 954 O
significant 22 33 955 966 O
or 34 36 967 969 O
uncontrolled 37 49 970 982 O
cardiac 50 57 983 990 B-chronic_disease
disease 58 65 991 998 I-chronic_disease

Hormone 0 7 999 1006 B-treatment
treatments 8 18 1007 1017 I-treatment
must 19 23 1018 1022 O
be 24 26 1023 1025 O
discontinued 27 39 1026 1038 O
for 40 43 1039 1042 O
at 44 46 1043 1045 O
least 47 52 1046 1051 O
28 53 55 1052 1054 B-lower_bound
days 56 60 1055 1059 I-lower_bound
prior 61 66 1060 1065 I-lower_bound
to 67 69 1066 1068 O
the 70 73 1069 1072 O
first 74 79 1073 1078 O
administration 80 94 1079 1093 O
of 95 97 1094 1096 O
COTI-2 98 104 1097 1103 B-cancer

Inability 0 9 1104 1113 O
to 10 12 1114 1116 O
tolerate 13 21 1117 1125 O
oral 22 26 1126 1130 B-treatment
medications 27 38 1131 1142 I-treatment

Left 0 4 1143 1147 B-clinical_variable
ventricular 5 16 1148 1159 I-clinical_variable
ejection 17 25 1160 1168 I-clinical_variable
fraction 26 34 1169 1177 I-clinical_variable
( 35 36 1178 1179 I-clinical_variable
LVEF 36 40 1179 1183 I-clinical_variable
) 40 41 1183 1184 I-clinical_variable
≥55 42 45 1185 1188 O
% 45 46 1188 1189 I-lower_bound
( 47 48 1190 1191 O
or 48 50 1191 1193 O
the 51 54 1194 1197 O
institutional 55 68 1198 1211 O
lower 69 74 1212 1217 O
limit 75 80 1218 1223 O
of 81 83 1224 1226 O
normal 84 90 1227 1233 O
[ 91 92 1234 1235 O
LLN 92 95 1235 1238 O
] 95 96 1238 1239 O
) 96 97 1239 1240 O
as 98 100 1241 1243 O
evidenced 101 110 1244 1253 O
on 111 113 1254 1256 O
ECHO 114 118 1257 1261 B-treatment

Life 0 4 1262 1266 B-clinical_variable
expectancy 5 15 1267 1277 I-clinical_variable
≥3 16 18 1278 1280 O
months 19 25 1281 1287 I-lower_bound

Major 0 5 1288 1293 B-treatment
surgery 6 13 1294 1301 I-treatment
, 13 14 1301 1302 O
excluding 15 24 1303 1312 O
skin 25 29 1313 1317 B-treatment
biopsies 30 38 1318 1326 I-treatment
and 39 42 1327 1330 I-treatment
procedures 43 53 1331 1341 I-treatment
for 54 57 1342 1345 I-treatment
insertion 58 67 1346 1355 I-treatment
of 68 70 1356 1358 I-treatment
central 71 78 1359 1366 I-treatment
venous 79 85 1367 1373 I-treatment
access 86 92 1374 1380 I-treatment
devices 93 100 1381 1388 I-treatment
, 100 101 1388 1389 O
within 102 108 1390 1396 O
28 109 111 1397 1399 B-upper_bound
days 112 116 1400 1404 I-upper_bound
prior 117 122 1405 1410 I-upper_bound
to 123 125 1411 1413 O
the 126 129 1414 1417 O
start 130 135 1418 1423 O
of 136 138 1424 1426 O
COTI-2 139 145 1427 1433 B-treatment

Myocardial 0 10 1434 1444 B-chronic_disease
infarction 11 21 1445 1455 I-chronic_disease

Part 0 4 1456 1460 O
1 5 6 1461 1462 O
: 6 7 1462 1463 O
Ovarian 8 15 1464 1471 B-cancer
, 15 16 1471 1472 O
fallopian 17 26 1473 1482 B-cancer
tube 27 31 1483 1487 I-cancer
, 31 32 1487 1488 O
primary 33 40 1489 1496 B-cancer
peritoneal 41 51 1497 1507 I-cancer
, 51 52 1507 1508 O
endometrial 53 64 1509 1520 B-cancer
, 64 65 1520 1521 O
or 66 68 1522 1524 O
cervical 69 77 1525 1533 B-cancer
cancer 78 84 1534 1540 I-cancer

Part 0 4 1541 1545 O
2 5 6 1546 1547 O
: 6 7 1547 1548 O
HNSCC 8 13 1549 1554 B-cancer
, 13 14 1554 1555 O
with 15 19 1556 1560 O
confirmed 20 29 1561 1570 O
p53 30 33 1571 1574 O
mutations 34 43 1575 1584 O

Part 0 4 1585 1589 O
3 5 6 1590 1591 O
: 6 7 1591 1592 O
Gynecological 8 21 1593 1606 B-cancer
malignancies 22 34 1607 1619 I-cancer
, 34 35 1619 1620 O
HNSCC 36 41 1621 1626 B-cancer
, 41 42 1626 1627 O
colorectal 43 53 1628 1638 B-cancer
, 53 54 1638 1639 O
lung 55 59 1640 1644 B-cancer
, 59 60 1644 1645 O
pancreatic 61 71 1646 1656 B-cancer
cancer 72 78 1657 1663 I-cancer
, 78 79 1663 1664 O
or 80 82 1665 1667 O
other 83 88 1668 1673 O
tumors 89 95 1674 1680 B-cancer
with 96 100 1681 1685 O
Sponsor 101 108 1686 1693 O
approval 109 117 1694 1702 O

Partial 0 7 1703 1710 B-clinical_variable
thromboplastin 8 22 1711 1725 I-clinical_variable
time 23 27 1726 1730 I-clinical_variable
( 28 29 1731 1732 I-clinical_variable
PTT 29 32 1732 1735 I-clinical_variable
) 32 33 1735 1736 I-clinical_variable
within 34 40 1737 1743 O
1.5x 41 45 1744 1748 B-upper_bound
upper 46 51 1749 1754 I-upper_bound
limit 52 57 1755 1760 I-upper_bound
of 58 60 1761 1763 I-upper_bound
normal 61 67 1764 1770 I-upper_bound

Patients 0 8 1771 1779 O
enrolled 9 17 1780 1788 O
in 18 20 1789 1791 O
the 21 24 1792 1795 O
expansion 25 34 1796 1805 O
phase 35 40 1806 1811 O
must 41 45 1812 1816 O
be 46 48 1817 1819 O
willing 49 56 1820 1827 O
to 57 59 1828 1830 O
undergo 60 67 1831 1838 O
pre 68 71 1839 1842 O
and 72 75 1843 1846 O
post 76 80 1847 1851 O
- 80 81 1851 1852 O
Cycle 81 86 1852 1857 O
1 87 88 1858 1859 O
biopsies 89 97 1860 1868 B-treatment

Physiologically 0 15 1869 1884 O
incapable 16 25 1885 1894 O
of 26 28 1895 1897 O
becoming 29 37 1898 1906 B-pregnancy
pregnant 38 46 1907 1915 I-pregnancy
, 46 47 1915 1916 O
postmenopausal 48 62 1917 1931 O
, 62 63 1931 1932 O
or 64 66 1933 1935 O
negative 67 75 1936 1944 B-pregnancy
pregnancy 76 85 1945 1954 I-pregnancy
test 86 90 1955 1959 O
and 91 94 1960 1963 O
agree 95 100 1964 1969 B-contraception_consent
to 101 103 1970 1972 I-contraception_consent
use 104 107 1973 1976 I-contraception_consent
adequate 108 116 1977 1985 I-contraception_consent
contraception 117 130 1986 1999 I-contraception_consent
( 131 132 2000 2001 O
e.g. 132 136 2001 2005 O
, 136 137 2005 2006 O
oral 138 142 2007 2011 B-contraception_consent
contraceptive 143 156 2012 2025 I-contraception_consent
, 156 157 2025 2026 O
double 158 164 2027 2033 B-contraception_consent
barrier 165 172 2034 2041 I-contraception_consent
method 173 179 2042 2048 I-contraception_consent
, 179 180 2048 2049 O
intra 181 186 2050 2055 B-contraception_consent
- 186 187 2055 2056 I-contraception_consent
uterine 187 194 2056 2063 I-contraception_consent
device 195 201 2064 2070 I-contraception_consent
, 201 202 2070 2071 O
intra 203 208 2072 2077 B-contraception_consent
- 208 209 2077 2078 I-contraception_consent
muscular 209 217 2078 2086 I-contraception_consent
contraceptive 218 231 2087 2100 I-contraception_consent
) 231 232 2100 2101 O

Platelet 0 8 2102 2110 B-clinical_variable
count 9 14 2111 2116 I-clinical_variable
≥100 15 19 2117 2121 O
x 20 21 2122 2123 I-lower_bound
109 22 25 2124 2127 I-lower_bound
/ 25 26 2127 2128 I-lower_bound
L 26 27 2128 2129 I-lower_bound

Pregnant 0 8 2130 2138 B-pregnancy

Prior 0 5 2139 2144 B-treatment
chemotherapy 6 18 2145 2157 I-treatment
, 18 19 2157 2158 O
other 20 25 2159 2164 O
investigational 26 41 2165 2180 B-treatment
agents 42 48 2181 2187 I-treatment
, 48 49 2187 2188 O
or 50 52 2189 2191 O
radiation 53 62 2192 2201 B-treatment
must 63 67 2202 2206 O
be 68 70 2207 2209 O
discontinued 71 83 2210 2222 O
for 84 87 2223 2226 O
at 88 90 2227 2229 O
least 91 96 2230 2235 O
28 97 99 2236 2238 B-lower_bound
days 100 104 2239 2243 I-lower_bound
prior 105 110 2244 2249 I-lower_bound
to 111 113 2250 2252 O
the 114 117 2253 2256 O
first 118 123 2257 2262 O
administration 124 138 2263 2277 O
of 139 141 2278 2280 O
COTI-2 142 148 2281 2287 B-treatment

Prothrombin 0 11 2288 2299 B-clinical_variable
time 12 16 2300 2304 I-clinical_variable
( 17 18 2305 2306 I-clinical_variable
PT 18 20 2306 2308 I-clinical_variable
) 20 21 2308 2309 I-clinical_variable
or 22 24 2310 2312 O
international 25 38 2313 2326 B-clinical_variable
normalize 39 48 2327 2336 I-clinical_variable
rate 49 53 2337 2341 I-clinical_variable
( 54 55 2342 2343 I-clinical_variable
INR 55 58 2343 2346 I-clinical_variable
) 58 59 2346 2347 I-clinical_variable
within 60 66 2348 2354 O
1.5x 67 71 2355 2359 B-upper_bound
upper 72 77 2360 2365 I-upper_bound
limit 78 83 2366 2371 I-upper_bound
of 84 86 2372 2374 I-upper_bound
normal 87 93 2375 2381 I-upper_bound

Supraventricular 0 16 2382 2398 B-chronic_disease
arrhythmias 17 28 2399 2410 I-chronic_disease
including 29 38 2411 2420 O
atrial 39 45 2421 2427 B-chronic_disease
fibrillation 46 58 2428 2440 I-chronic_disease
, 58 59 2440 2441 O
which 60 65 2442 2447 O
are 66 69 2448 2451 O
uncontrolled 70 82 2452 2464 O

The 0 3 2465 2468 O
presence 4 12 2469 2477 O
of 13 15 2478 2480 O
or 16 18 2481 2483 O
imminent 19 27 2484 2492 O
occurrence 28 38 2493 2503 O
of 39 41 2504 2506 O
airway 42 48 2507 2513 B-chronic_disease
obstruction 49 60 2514 2525 I-chronic_disease
, 60 61 2525 2526 O
unless 62 68 2527 2533 O
tracheostomy 69 81 2534 2546 B-treatment
in 82 84 2547 2549 O
place 85 90 2550 2555 O

Total 0 5 2556 2561 B-clinical_variable
bilirubin 6 15 2562 2571 I-clinical_variable
within 16 22 2572 2578 O
normal 23 29 2579 2585 O
limits 30 36 2586 2592 O

Toxicity 0 8 2593 2601 B-clinical_variable
from 9 13 2602 2606 O
prior 14 19 2607 2612 B-treatment
therapy 20 27 2613 2620 I-treatment
( 28 29 2621 2622 O
except 29 35 2622 2628 O
alopecia 36 44 2629 2637 B-chronic_disease
) 44 45 2637 2638 O
has 46 49 2639 2642 O
resolved 50 58 2643 2651 O
to 59 61 2652 2654 O
≤Grade 62 68 2655 2661 O
1 69 70 2662 2663 I-upper_bound

Urine 0 5 2664 2669 B-clinical_variable
protein 6 13 2670 2677 I-clinical_variable
< 14 15 2678 2679 O
500 15 18 2679 2682 B-upper_bound
mg 19 21 2683 2685 I-upper_bound
or 22 24 2686 2688 O
urine 25 30 2689 2694 B-clinical_variable
protein 31 38 2695 2702 I-clinical_variable

Ventricular 0 11 2703 2714 B-chronic_disease
arrhythmias 12 23 2715 2726 I-chronic_disease
requiring 24 33 2727 2736 O
continuous 34 44 2737 2747 O
therapy 45 52 2748 2755 B-treatment

creatinine 0 10 2756 2766 B-clinical_variable
ratio 11 16 2767 2772 I-clinical_variable
( 17 18 2773 2774 I-clinical_variable
UPC 18 21 2774 2777 I-clinical_variable
) 21 22 2777 2778 I-clinical_variable
< 23 24 2779 2780 O
1.0 24 27 2780 2783 B-upper_bound

≥18 0 3 2784 2787 O
years 4 9 2788 2793 I-lower_bound
of 10 12 2794 2796 O
age 13 16 2797 2800 B-age

Aged 0 4 0 4 B-age
18 5 7 5 7 B-lower_bound
years 8 13 8 13 I-lower_bound
or 14 16 14 16 O
older 17 22 17 22 O

Chronic 0 7 23 30 B-chronic_disease
or 8 10 31 33 O
current 11 18 34 41 O
active 19 25 42 48 B-chronic_disease
infection 26 35 49 58 I-chronic_disease
requiring 36 45 59 68 O
systemic 46 54 69 77 B-treatment
antibiotic 55 65 78 88 I-treatment
, 65 66 88 89 O
antifungal 67 77 90 100 B-treatment
, 77 78 100 101 O
or 79 81 102 104 O
antiviral 82 91 105 114 B-treatment
treatment 92 101 115 124 I-treatment

Confirmed 0 9 125 134 O
diagnosis 10 19 135 144 O
of 20 22 145 147 O
select 23 29 148 154 O
advanced 30 38 155 163 B-cancer
malignancy 39 49 164 174 I-cancer

Elderly 0 7 175 182 O
subjects 8 16 183 191 O
( 17 18 192 193 O
≥ 18 19 193 194 O
65 20 22 195 197 B-lower_bound
years 23 28 198 203 I-lower_bound
) 28 29 203 204 O
with 30 34 205 209 O
newly 35 40 210 215 O
diagnosed 41 50 216 225 O
AML 51 54 226 229 B-cancer
must 55 59 230 234 O
be 60 62 235 237 O
treatment 63 72 238 247 B-treatment
naive 73 78 248 253 O
and 79 82 254 257 O
unfit 83 88 258 263 O
for 89 92 264 267 O
intensive 93 102 268 277 B-treatment
chemotherapy 103 115 278 290 I-treatment

Life 0 4 291 295 B-clinical_variable
expectancy 5 15 296 306 I-clinical_variable
> 16 17 307 308 O
12 18 20 309 311 B-lower_bound
weeks 21 26 312 317 I-lower_bound
or 27 29 318 320 O
≥ 30 31 321 322 O
24 32 34 323 325 B-lower_bound
weeks 35 40 326 331 I-lower_bound
for 41 44 332 335 O
Part 45 49 336 340 O
3 50 51 341 342 O
and 52 55 343 346 O
Part 56 60 347 351 O
4 61 62 352 353 O
MF 63 65 354 356 O
subjects 66 74 357 365 O

Myelofibrosis 0 13 366 379 B-cancer
subjects 14 22 380 388 O
must 23 27 389 393 O
have 28 32 394 398 O
been 33 37 399 403 O
treated 38 45 404 411 O
with 46 50 412 416 O
ruxolitinib 51 62 417 428 B-treatment
for 63 66 429 432 O
≥ 67 68 433 434 O
6 69 70 435 436 B-lower_bound
months 71 77 437 443 I-lower_bound
with 78 82 444 448 O
a 83 84 449 450 O
stable 85 91 451 457 O
dose 92 96 458 462 O
for 97 100 463 466 O
≥ 101 102 467 468 O
8 103 104 469 470 B-lower_bound
weeks 105 110 471 476 I-lower_bound
( 111 112 477 478 O
acceptable 112 122 478 488 O
doses 123 128 489 494 O
are 129 132 495 498 O
5 133 134 499 500 O
mg 135 137 501 503 O
twice 138 143 504 509 O
daily 144 149 510 515 O
[ 150 151 516 517 O
BID 151 154 517 520 O
] 154 155 520 521 O
to 156 158 522 524 O
25 159 161 525 527 O
mg 162 164 528 530 O
BID 165 168 531 534 O
) 168 169 534 535 O

Not 0 3 536 539 O
currently 4 13 540 549 O
a 14 15 550 551 O
candidate 16 25 552 561 O
for 26 29 562 565 O
curative 30 38 566 574 B-treatment
treatment 39 48 575 584 I-treatment

Prior 0 5 585 590 O
receipt 6 13 591 598 O
of 14 16 599 601 O
a 17 18 602 603 O
PIM 19 22 604 607 B-treatment
inhibitor 23 32 608 617 I-treatment

Radiotherapy 0 12 618 630 B-treatment
within 13 19 631 637 O
the 20 23 638 641 O
2 24 25 642 643 B-upper_bound
weeks 26 31 644 649 I-upper_bound
prior 32 37 650 655 I-upper_bound
to 38 40 656 658 O
initiation 41 51 659 669 O
of 52 54 670 672 O
treatment 55 64 673 682 B-treatment

Received 0 8 683 691 O
an 9 11 692 694 O
investigational 12 27 695 710 B-treatment
agent 28 33 711 716 I-treatment
within 34 40 717 723 O
5 41 42 724 725 B-upper_bound
half 43 47 726 730 I-upper_bound
- 47 48 730 731 I-upper_bound
lives 48 53 731 736 I-upper_bound
or 54 56 737 739 O
14 57 59 740 742 O
days 60 64 743 747 O
, 64 65 747 748 O
whichever 66 75 749 758 O
is 76 78 759 761 O
longer 79 85 762 768 O
, 85 86 768 769 O
prior 87 92 770 775 O
to 93 95 776 778 O
receiving 96 105 779 788 O
the 106 109 789 792 O
first 110 115 793 798 O
dose 116 120 799 803 O
of 121 123 804 806 O
study 124 129 807 812 B-treatment
drug 130 134 813 817 I-treatment

Received 0 8 818 826 O
non 9 12 827 830 B-treatment
- 12 13 830 831 I-treatment
biologic 13 21 831 839 I-treatment
anticancer 22 32 840 850 I-treatment
medication 33 43 851 861 I-treatment
within 44 50 862 868 O
5 51 52 869 870 B-upper_bound
half 53 57 871 875 I-upper_bound
- 57 58 875 876 I-upper_bound
lives 58 63 876 881 I-upper_bound
prior 64 69 882 887 I-upper_bound
to 70 72 888 890 O
receiving 73 82 891 900 O
the 83 86 901 904 O
first 87 92 905 910 O
dose 93 97 911 915 O
of 98 100 916 918 O
study 101 106 919 924 B-treatment
drug 107 111 925 929 I-treatment
( 112 113 930 931 O
within 113 119 931 937 O
6 120 121 938 939 B-upper_bound
weeks 122 127 940 945 I-upper_bound
for 128 131 946 949 O
mitomycin 132 141 950 959 B-treatment
- 141 142 959 960 I-treatment
C 142 143 960 961 I-treatment
or 144 146 962 964 O
nitrosoureas 147 159 965 977 B-treatment
) 159 160 977 978 O
, 160 161 978 979 O
within 162 168 980 986 O
28 169 171 987 989 B-upper_bound
days 172 176 990 994 I-upper_bound
for 177 180 995 998 O
any 181 184 999 1002 O
antibodies 185 195 1003 1013 B-treatment
or 196 198 1014 1016 O
biological 199 209 1017 1027 B-treatment
therapies 210 219 1028 1037 I-treatment

Screening 0 9 1038 1047 O
corrected 10 19 1048 1057 B-clinical_variable
QT 20 22 1058 1060 I-clinical_variable
interval 23 31 1061 1069 I-clinical_variable
( 32 33 1070 1071 I-clinical_variable
QTc 33 36 1071 1074 I-clinical_variable
) 36 37 1074 1075 I-clinical_variable
interval 38 46 1076 1084 I-clinical_variable
> 47 48 1085 1086 O
470 49 52 1087 1090 B-lower_bound
milliseconds 53 65 1091 1103 I-lower_bound

Subjects 0 8 1104 1112 O
with 9 13 1113 1117 O
relapsed 14 22 1118 1126 O
/ 22 23 1126 1127 O
refractory 23 33 1127 1137 O
AML 34 37 1138 1141 B-cancer
must 38 42 1142 1146 O
have 43 47 1147 1151 O
received 48 56 1152 1160 O
either 57 63 1161 1167 O
induction 64 73 1168 1177 B-treatment
chemotherapy 74 86 1178 1190 I-treatment
for 87 90 1191 1194 O
AML 91 94 1195 1198 O
or 95 97 1199 1201 O
hypomethylating 98 113 1202 1217 B-treatment
agents 114 120 1218 1224 I-treatment
for 121 124 1225 1228 O
hematologic 125 136 1229 1240 B-chronic_disease
disease 137 144 1241 1248 I-chronic_disease
before 145 151 1249 1255 O
AML 152 155 1256 1259 O

Unresponsive 0 12 1260 1272 O
to 13 15 1273 1275 O
currently 16 25 1276 1285 O
available 26 35 1286 1295 O
therapy 36 43 1296 1303 B-treatment
and 44 47 1304 1307 O
there 48 53 1308 1313 O
is 54 56 1314 1316 O
no 57 59 1317 1319 O
standard 60 68 1320 1328 O
- 68 69 1328 1329 O
of 69 71 1329 1331 O
- 71 72 1331 1332 O
care 72 76 1332 1336 O
therapy 77 84 1337 1344 O
available 85 94 1345 1354 O
in 95 97 1355 1357 O
the 98 101 1358 1361 O
judgment 102 110 1362 1370 O
of 111 113 1371 1373 O
the 114 117 1374 1377 O
investigator 118 130 1378 1390 O

Willingness 0 11 1391 1402 O
to 12 14 1403 1405 O
undergo 15 22 1406 1413 O
a 23 24 1414 1415 O
pretreatment 25 37 1416 1428 B-treatment
bone 38 42 1429 1433 I-treatment
marrow 43 49 1434 1440 I-treatment
biopsy 50 56 1441 1447 I-treatment
and/or 57 63 1448 1454 O
aspirate 64 72 1455 1463 B-treatment
, 72 73 1463 1464 O
or 74 76 1465 1467 O
archival 77 85 1468 1476 O
sample 86 92 1477 1483 O
obtained 93 101 1484 1492 O
since 102 107 1493 1498 O
completion 108 118 1499 1509 O
of 119 121 1510 1512 O
most 122 126 1513 1517 O
recent 127 133 1518 1524 O
therapy 134 141 1525 1532 B-treatment
( 142 143 1533 1534 O
as 143 145 1534 1536 O
appropriate 146 157 1537 1548 O
to 158 160 1549 1551 O
subjects 161 169 1552 1560 O
with 170 174 1561 1565 O
existing 175 183 1566 1574 O
bone 184 188 1575 1579 O
marrow 189 195 1580 1586 O
disease 196 203 1587 1594 O
or 204 206 1595 1597 O
for 207 210 1598 1601 O
whom 211 215 1602 1606 O
bone 216 220 1607 1611 O
marrow 221 227 1612 1618 O
examination 228 239 1619 1630 O
is 240 242 1631 1633 O
a 243 244 1634 1635 O
component 245 254 1636 1645 O
of 255 257 1646 1648 O
disease 258 265 1649 1656 O
status 266 272 1657 1663 O
assessment 273 283 1664 1674 O
) 283 284 1674 1675 O

Acute 0 5 0 5 O
or 6 8 6 8 O
chronic 9 16 9 16 O
, 16 17 16 17 O
clinically 18 28 18 28 O
significant 29 40 29 40 O
hematologic 41 52 41 52 B-chronic_disease
, 52 53 52 53 O
pulmonary 54 63 54 63 B-chronic_disease
, 63 64 63 64 O
cardiovascular 65 79 65 79 B-chronic_disease
, 79 80 79 80 O
or 81 83 81 83 O
hepatic 84 91 84 91 B-chronic_disease
or 92 94 92 94 O
renal 95 100 95 100 B-chronic_disease
functional 101 111 101 111 I-chronic_disease
abnormality 112 123 112 123 I-chronic_disease
as 124 126 124 126 O
determined 127 137 127 137 O
by 138 140 138 140 O
the 141 144 141 144 O
investigator 145 157 145 157 O
based 158 163 158 163 O
on 164 166 164 166 O
medical 167 174 167 174 O
history 175 182 175 182 O
, 182 183 182 183 O
physical 184 192 184 192 O
exam 193 197 193 197 O
, 197 198 197 198 O
and/or 199 205 199 205 O
laboratory 206 216 206 216 O
screening 217 226 217 226 O
test 227 231 227 231 O

Administration 0 14 232 246 O
of 15 17 247 249 O
chronic 18 25 250 257 O
( 26 27 258 259 O
defined 27 34 259 266 O
as 35 37 267 269 O
more 38 42 270 274 O
than 43 47 275 279 O
14 48 50 280 282 B-lower_bound
days 51 55 283 287 I-lower_bound
) 55 56 287 288 O
immunosuppressants 57 75 289 307 B-treatment

Any 0 3 308 311 O
chronic 4 11 312 319 B-chronic_disease
or 12 14 320 322 I-chronic_disease
active 15 21 323 329 I-chronic_disease
neurologic 22 32 330 340 I-chronic_disease
disorder 33 41 341 349 I-chronic_disease
, 41 42 349 350 O
including 43 52 351 360 O
seizures 53 61 361 369 B-chronic_disease
and 62 65 370 373 O
epilepsy 66 74 374 382 B-chronic_disease

Any 0 3 383 386 O
confirmed 4 13 387 396 O
evidence 14 22 397 405 O
of 23 25 406 408 O
hepatitis 26 35 409 418 B-chronic_disease
B 36 37 419 420 I-chronic_disease
or 38 40 421 423 I-chronic_disease
C 41 42 424 425 I-chronic_disease
infection 43 52 426 435 I-chronic_disease

Any 0 3 436 439 O
confirmed 4 13 440 449 O
or 14 16 450 452 O
suspected 17 26 453 462 O
immunosuppressive 27 44 463 480 B-chronic_disease
or 45 47 481 483 O
immunodeficient 48 63 484 499 B-chronic_disease
condition 64 73 500 509 I-chronic_disease
, 73 74 509 510 O
including 75 84 511 520 O
human 85 90 521 526 B-chronic_disease
immunodeficiency 91 107 527 543 I-chronic_disease
virus 108 113 544 549 I-chronic_disease
( 114 115 550 551 I-chronic_disease
HIV 115 118 551 554 I-chronic_disease
) 118 119 554 555 I-chronic_disease
infection 120 129 556 565 I-chronic_disease

For 0 3 566 569 O
corticosteroids 4 19 570 585 B-treatment
, 19 20 585 586 O
this 21 25 587 591 O
will 26 30 592 596 O
mean 31 35 597 601 O
prednisone 36 46 602 612 B-clinical_variable
, 46 47 612 613 O
or 48 50 614 616 O
equivalent 51 61 617 627 O
, 61 62 627 628 O
greater 63 70 629 636 O
than 71 75 637 641 O
or 76 78 642 644 O
equal 79 84 645 650 O
to 85 87 651 653 O
0.5 88 91 654 657 B-lower_bound
mg 92 94 658 660 I-lower_bound
/ 94 95 660 661 I-lower_bound
kg 95 97 661 663 I-lower_bound
/ 97 98 663 664 I-lower_bound
day 98 101 664 667 I-lower_bound

Healthy 0 7 668 675 O
adult 8 13 676 681 O
male 14 18 682 686 B-gender

History 0 7 687 694 O
of 8 10 695 697 O
severe 11 17 698 704 O
local 18 23 705 710 O
or 24 26 711 713 O
systemic 27 35 714 722 O
reactions 36 45 723 732 O
to 46 48 733 735 O
any 49 52 736 739 O
vaccination 53 64 740 751 B-allergy_name

History 0 7 752 759 O
or 8 10 760 762 O
serologic 11 20 763 772 O
evidence 21 29 773 781 O
of 30 32 782 784 O
prior 33 38 785 790 B-chronic_disease
infection 39 48 791 800 I-chronic_disease
with 49 53 801 805 I-chronic_disease
any 54 57 806 809 I-chronic_disease
hantavirus 58 68 810 820 I-chronic_disease
or 69 71 821 823 O
prior 72 77 824 829 O
participation 78 91 830 843 O
in 92 94 844 846 O
an 95 97 847 849 O
HTNV 98 102 850 854 B-treatment
or 103 105 855 857 I-treatment
PUUV 106 110 858 862 I-treatment
vaccine 111 118 863 870 I-treatment
trial 119 124 871 876 I-treatment

Intranasal 0 10 877 887 B-treatment
, 10 11 887 888 I-treatment
inhaled 12 19 889 896 I-treatment
, 19 20 896 897 I-treatment
and 21 24 898 901 I-treatment
topical 25 32 902 909 I-treatment
steroids 33 41 910 918 I-treatment

Negative 0 8 919 927 O
hantavirus 9 19 928 938 B-chronic_disease
PsVNA 20 25 939 944 I-treatment
test 26 30 945 949 O
result 31 37 950 956 O
at 38 40 957 959 O
screening 41 50 960 969 O

Ongoing 0 7 970 977 O
participation 8 21 978 991 O
in 22 24 992 994 O
another 25 32 995 1002 B-treatment
clinical 33 41 1003 1011 I-treatment
trial 42 47 1012 1017 I-treatment
( 48 49 1018 1019 O
subjects 49 57 1019 1027 O
continuing 58 68 1028 1038 O
through 69 76 1039 1046 O
Day 77 80 1047 1050 O
365 81 84 1051 1054 O
will 85 89 1055 1059 O
not 90 93 1060 1063 O
join 94 98 1064 1068 O
other 99 104 1069 1074 O
new 105 108 1075 1078 O
studies 109 116 1079 1086 O
until 117 122 1087 1092 O
their 123 128 1093 1098 O
final 129 134 1099 1104 O
visit 135 140 1105 1110 O
) 140 141 1110 1111 O

Pregnant 0 8 1112 1120 B-pregnancy

Receipt 0 7 1121 1128 O
of 8 10 1129 1131 O
licensed 11 19 1132 1140 B-treatment
vaccines 20 28 1141 1149 I-treatment
within 29 35 1150 1156 O
14 36 38 1157 1159 B-upper_bound
days 39 43 1160 1164 I-upper_bound
before 44 50 1165 1171 O
or 51 53 1172 1174 O
after 54 59 1175 1180 O
immunization 60 72 1181 1193 B-treatment
( 73 74 1194 1195 O
30 74 76 1195 1197 B-upper_bound
days 77 81 1198 1202 I-upper_bound
for 82 85 1203 1206 O
live 86 90 1207 1211 B-treatment
vaccines 91 99 1212 1220 I-treatment
) 99 100 1220 1221 O

ages 0 4 1222 1226 B-age
18 5 7 1227 1229 B-lower_bound
- 7 8 1229 1230 O
49 8 10 1230 1232 B-upper_bound
( 11 12 1233 1234 O
inclusive 12 21 1234 1243 O
) 21 22 1243 1244 O
at 23 25 1245 1247 O
the 26 29 1248 1251 O
time 30 34 1252 1256 O
of 35 37 1257 1259 O
screening 38 47 1260 1269 O

daily 0 5 1270 1275 O
inhaled 6 13 1276 1283 O
steroids 14 22 1284 1292 B-treatment
for 23 26 1293 1296 O
treatment 27 36 1297 1306 B-treatment
of 37 39 1307 1309 O
asthma 40 46 1310 1316 B-chronic_disease

female 0 6 1317 1323 B-gender
who 7 10 1324 1327 O
intends 11 18 1328 1335 B-pregnancy
to 19 21 1336 1338 I-pregnancy
become 22 28 1339 1345 I-pregnancy
pregnant 29 37 1346 1354 I-pregnancy
during 38 44 1355 1361 O
the 45 48 1362 1365 O
study 49 54 1366 1371 O
period 55 61 1372 1378 O

history 0 7 1379 1386 O
of 8 10 1387 1389 O
severe 11 17 1390 1396 B-chronic_disease
allergic 18 26 1397 1405 I-chronic_disease
reactions 27 36 1406 1415 I-chronic_disease

lactating 0 9 1416 1425 O
female 10 16 1426 1432 B-gender

planned 0 7 1433 1440 O
administration 8 22 1441 1455 O
during 23 29 1456 1462 O
the 30 33 1463 1466 O
study 34 39 1467 1472 O
period 40 46 1473 1479 O
Blood 47 52 1480 1485 O
donation 53 61 1486 1494 O
for 62 65 1495 1498 O
human 66 71 1499 1504 O
use 72 75 1505 1508 O
( 76 77 1509 1510 O
eg 77 79 1510 1512 O
, 79 80 1512 1513 O
American 81 89 1514 1522 O
Red 90 93 1523 1526 O
Cross 94 99 1527 1532 O
or 100 102 1533 1535 O
other 103 108 1536 1541 O
similar 109 116 1542 1549 O
blood 117 122 1550 1555 O
drives 123 129 1556 1562 O
) 129 130 1562 1563 O
within 131 137 1564 1570 O
the 138 141 1571 1574 O
56 142 144 1575 1577 B-upper_bound
days 145 149 1578 1582 I-upper_bound
preceding 150 159 1583 1592 O
study 160 165 1593 1598 O
entry 166 171 1599 1604 O

single 0 6 1605 1611 O
febrile 7 14 1612 1619 B-chronic_disease
seizure 15 22 1620 1627 I-chronic_disease
as 23 25 1628 1630 O
a 26 27 1631 1632 O
child 28 33 1633 1638 O

willing 0 7 1639 1646 O
to 8 10 1647 1649 O
use 11 14 1650 1653 B-contraception_consent
an 15 17 1654 1656 I-contraception_consent
effective 18 27 1657 1666 I-contraception_consent
method 28 34 1667 1673 I-contraception_consent
of 35 37 1674 1676 I-contraception_consent
contraception 38 51 1677 1690 I-contraception_consent
( 52 53 1691 1692 O
eg 53 55 1692 1694 O
, 55 56 1694 1695 O
hormonal 57 65 1696 1704 B-contraception_consent
contraception 66 79 1705 1718 I-contraception_consent
to 80 82 1719 1721 O
include 83 90 1722 1729 O
oral 91 95 1730 1734 B-contraception_consent
and 96 99 1735 1738 I-contraception_consent
implantable 100 111 1739 1750 I-contraception_consent
options 112 119 1751 1758 I-contraception_consent
, 119 120 1758 1759 O
diaphragm 121 130 1760 1769 B-contraception_consent
, 130 131 1769 1770 O
cervical 132 140 1771 1779 B-contraception_consent
cap 141 144 1780 1783 I-contraception_consent
, 144 145 1783 1784 O
intrauterine 146 158 1785 1797 B-contraception_consent
device 159 165 1798 1804 I-contraception_consent
, 165 166 1804 1805 O
condom 167 173 1806 1812 B-contraception_consent
, 173 174 1812 1813 O
or 175 177 1814 1816 O
anatomical 178 188 1817 1827 B-contraception_consent
sterility 189 198 1828 1837 I-contraception_consent
[ 199 200 1838 1839 O
self 200 204 1839 1843 O
or 205 207 1844 1846 O
partner 208 215 1847 1854 O
] 215 216 1854 1855 O
) 216 217 1855 1856 O
for 218 221 1857 1860 O
the 222 225 1861 1864 O
duration 226 234 1865 1873 O
of 235 237 1874 1876 O
study 238 243 1877 1882 O
participation 244 257 1883 1896 O
( 258 259 1897 1898 O
from 259 263 1898 1902 O
the 264 267 1903 1906 O
date 268 272 1907 1911 O
of 273 275 1912 1914 O
screening 276 285 1915 1924 O
) 285 286 1924 1925 O
until 287 292 1926 1931 O
at 293 295 1932 1934 O
least 296 301 1935 1940 O
3 302 303 1941 1942 B-lower_bound
months 304 310 1943 1949 I-lower_bound
after 311 316 1950 1955 O
the 317 320 1956 1959 O
last 321 325 1960 1964 O
injection 326 335 1965 1974 O

18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O
at 25 27 25 27 O
the 28 31 28 31 O
time 32 36 32 36 O
of 37 39 37 39 O
enrollment 40 50 40 50 O

Active 0 6 51 57 O
hepatitis 7 16 58 67 B-chronic_disease
B 17 18 68 69 I-chronic_disease
or 19 21 70 72 O
hepatitis 22 31 73 82 B-chronic_disease
C 32 33 83 84 I-chronic_disease

Estimated 0 9 85 94 B-clinical_variable
creatinine 10 20 95 105 I-clinical_variable
clearance 21 30 106 115 I-clinical_variable
< 31 32 116 117 O
15mL 32 36 117 121 B-upper_bound
/ 36 37 121 122 I-upper_bound
min 37 40 122 125 I-upper_bound

Has 0 3 126 129 O
received 4 12 130 138 O
any 13 16 139 142 O
prior 17 22 143 148 B-treatment
systemic 23 31 149 157 I-treatment
therapy 32 39 158 165 I-treatment
, 39 40 165 166 O
excluding 41 50 167 176 O
corticosteroids 51 66 177 192 B-treatment
, 66 67 192 193 O
within 68 74 194 200 O
7 75 76 201 202 B-upper_bound
days 77 81 203 207 I-upper_bound
( 82 83 208 209 O
or 83 85 209 211 O
5 86 87 212 213 B-upper_bound
half 88 92 214 218 I-upper_bound
- 92 93 218 219 I-upper_bound
lives 93 98 219 224 I-upper_bound
) 98 99 224 225 O
of 100 102 226 228 O
treatment 103 112 229 238 B-treatment

Known 0 5 239 244 O
secondary 6 15 245 254 O
HPS 16 19 255 258 B-chronic_disease
( 20 21 259 260 I-chronic_disease
Hemophagocytic 21 35 260 274 I-chronic_disease
Syndrome 36 44 275 283 I-chronic_disease
) 44 45 283 284 I-chronic_disease
that 46 50 285 289 O
is 51 53 290 292 O
otherwise 54 63 293 302 O
treatable 64 73 303 312 O
( 74 75 313 314 O
e.g. 75 79 314 318 O
non 80 83 319 322 B-cancer
- 83 84 322 323 I-cancer
Hodgkin 84 91 323 330 I-cancer
's 91 93 330 332 I-cancer
lymphoma 94 102 333 341 I-cancer
) 102 103 341 342 O

Malabsorption 0 13 343 356 B-chronic_disease

Males 0 5 357 362 B-gender

No 0 2 363 365 O
active 3 9 366 372 O
malignancy 10 20 373 383 B-cancer
at 21 23 384 386 O
the 24 27 387 390 O
time 28 32 391 395 O
of 33 35 396 398 O
enrollment 36 46 399 409 O
, 46 47 409 410 O
except 48 54 411 417 O
nonmelanoma 55 66 418 429 B-cancer
skin 67 71 430 434 I-cancer
cancers 72 79 435 442 I-cancer
or 80 82 443 445 O
carcinoma 83 92 446 455 B-cancer
in 93 95 456 458 I-cancer
situ 96 100 459 463 I-cancer

Patients 0 8 464 472 O
must 9 13 473 477 O
meet 14 18 478 482 O
the 19 22 483 486 O
diagnostic 23 33 487 497 O
criteria 34 42 498 506 O
for 43 46 507 510 O
HPS 47 50 511 514 B-chronic_disease

Patients 0 8 515 523 O
with 9 13 524 528 O
a 14 15 529 530 O
prior 16 21 531 536 O
history 22 29 537 544 O
of 30 32 545 547 O
malignancy 33 43 548 558 B-cancer
are 44 47 559 562 O
eligible 48 56 563 571 O
if 57 59 572 574 O
their 60 65 575 580 O
malignancy 66 76 581 591 O
has 77 80 592 595 O
been 81 85 596 600 O
definitely 86 96 601 611 O
treated 97 104 612 619 O
or 105 107 620 622 O
is 108 110 623 625 O
in 111 113 626 628 O
remission 114 123 629 638 O
and 124 127 639 642 O
does 128 132 643 647 O
not 133 136 648 651 O
require 137 144 652 659 O
ongoing 145 152 660 667 O
adjuvant 153 161 668 676 B-treatment
or 162 164 677 679 O
cancer 165 171 680 686 B-treatment
- 171 172 686 687 I-treatment
directed 172 180 687 695 I-treatment
therapies 181 190 696 705 I-treatment

Pregnant 0 8 706 714 B-pregnancy

absolute 0 8 715 723 B-clinical_variable
neutrophil 9 19 724 734 I-clinical_variable
count 20 25 735 740 I-clinical_variable
< 26 27 741 742 O
1000 27 31 742 746 B-upper_bound
/ 31 32 746 747 I-upper_bound
μL 32 34 747 749 I-upper_bound
) 34 35 749 750 O

all 0 3 751 754 O
females 4 11 755 762 B-gender
of 12 14 763 765 O
child 15 20 766 771 O
- 20 21 771 772 O
bearing 21 28 772 779 O
potential 29 38 780 789 O
must 39 43 790 794 O
have 44 48 795 799 O
a 49 50 800 801 O
negative 51 59 802 810 B-pregnancy
serum 60 65 811 816 I-pregnancy
pregnancy 66 75 817 826 I-pregnancy
test 76 80 827 831 O
within 81 87 832 838 O
7 88 89 839 840 B-upper_bound
days 90 94 841 845 I-upper_bound
of 95 97 846 848 O
treatment 98 107 849 858 B-treatment

females 0 7 859 866 B-gender

fever 0 5 867 872 B-clinical_variable
, 5 6 872 873 O
splenomegaly 7 19 874 886 B-clinical_variable
, 19 20 886 887 O
cytopenia 21 30 888 897 B-clinical_variable
involving 31 40 898 907 O
≥2 41 43 908 910 O
cell 44 48 911 915 O
lines 49 54 916 921 O
( 55 56 922 923 O
Hemoglobin 56 66 923 933 B-clinical_variable
< 67 68 934 935 O
9 68 69 935 936 B-upper_bound
g 70 71 937 938 I-upper_bound
/ 71 72 938 939 I-upper_bound
dL 72 74 939 941 I-upper_bound

hypertriglyceridemia 0 20 942 962 B-chronic_disease
or 21 23 963 965 O
hypofibrinogenemia 24 42 966 984 B-chronic_disease

known 0 5 985 990 O
HIV 6 9 991 994 B-chronic_disease
infection 10 19 995 1004 O

lactating 0 9 1005 1014 O
female 10 16 1015 1021 B-gender

lactating 0 9 1022 1031 O
females 10 17 1032 1039 B-gender
must 18 22 1040 1044 O
discontinue 23 34 1045 1056 O
breast 35 41 1057 1063 O
feeding 42 49 1064 1071 O

low 0 3 1072 1075 O
or 4 6 1076 1078 O
absent 7 13 1079 1085 O
NK 14 16 1086 1088 B-chronic_disease
( 17 18 1089 1090 I-chronic_disease
Natural 18 25 1090 1097 I-chronic_disease
Killer 26 32 1098 1104 I-chronic_disease
) 32 33 1104 1105 I-chronic_disease
cell 34 38 1106 1110 I-chronic_disease
activity 39 47 1111 1119 O

platelets 0 9 1120 1129 B-clinical_variable
< 10 11 1130 1131 O
100,000 11 18 1131 1138 B-upper_bound
/ 18 19 1138 1139 I-upper_bound
μL 19 21 1139 1141 I-upper_bound

reported 0 8 1142 1150 O
history 9 16 1151 1158 O
of 17 19 1159 1161 O
liver 20 25 1162 1167 O
cirrhosis 26 35 1168 1177 B-chronic_disease
with 36 40 1178 1182 O
a 41 42 1183 1184 O
Model 43 48 1185 1190 B-clinical_variable
for 49 52 1191 1194 I-clinical_variable
End 53 56 1195 1198 I-clinical_variable
- 56 57 1198 1199 I-clinical_variable
stage 57 62 1199 1204 I-clinical_variable
Liver 63 68 1205 1210 I-clinical_variable
Disease 69 76 1211 1218 I-clinical_variable
( 77 78 1219 1220 I-clinical_variable
MELD 78 82 1220 1224 I-clinical_variable
) 82 83 1224 1225 I-clinical_variable
score 84 89 1226 1231 I-clinical_variable
> 90 91 1232 1233 O
20 91 93 1233 1235 B-lower_bound

serum 0 5 1236 1241 B-clinical_variable
ferritin 6 14 1242 1250 I-clinical_variable
≥3000 15 20 1251 1256 O
ug 21 23 1257 1259 I-lower_bound
/ 23 24 1259 1260 I-lower_bound
L 24 25 1260 1261 I-lower_bound

soluble 0 7 1262 1269 B-clinical_variable
IL-2 8 12 1270 1274 I-clinical_variable
receptor 13 21 1275 1283 I-clinical_variable
( 22 23 1284 1285 I-clinical_variable
CD25 23 27 1285 1289 I-clinical_variable
) 27 28 1289 1290 I-clinical_variable
> 29 30 1291 1292 O
2400 30 34 1292 1296 B-lower_bound
U 35 36 1297 1298 I-lower_bound
/ 36 37 1298 1299 I-lower_bound
mL 37 39 1299 1301 I-lower_bound

tissue 0 6 1302 1308 O
demonstration 7 20 1309 1322 O
of 21 23 1323 1325 O
hemophagocytosis 24 40 1326 1342 B-cancer

agree 0 5 0 5 O
to 6 8 6 8 O
adhere 9 15 9 15 O
to 16 18 16 18 O
the 19 22 19 22 O
Fabry 23 28 23 28 B-treatment
Registry 29 37 29 37 I-treatment
recommended 38 49 38 49 O
schedule 50 58 50 58 O
of 59 61 59 61 O
assessments 62 73 62 73 O
for 74 77 74 77 O
medical 78 85 78 85 O
history 86 93 86 93 O

be 0 2 94 96 O
born 3 7 97 101 O
to 8 10 102 104 O
a 11 12 105 106 O
mother 13 19 107 113 O
who 20 23 114 117 O
is 24 26 118 120 O
receiving 27 36 121 130 O
Fabrazyme 37 46 131 140 B-treatment
during 47 53 141 147 O
lactation 54 63 148 157 O

be 0 2 158 160 O
enrolled 3 11 161 169 O
in 12 14 170 172 O
the 15 18 173 176 O
Fabry 19 24 177 182 O
Registry 25 33 183 191 O
and 34 37 192 195 O
receiving 38 47 196 205 O
Fabrazyme 48 57 206 215 B-treatment
while 58 63 216 221 O
lactating 64 73 222 231 O

genotyping 0 10 232 242 B-treatment

pregnancy 0 9 243 252 B-pregnancy
outcome 10 17 253 260 O

< 0 1 0 1 O
12 2 4 2 4 B-upper_bound
months 5 11 5 11 I-upper_bound
( 12 13 12 13 O
< 13 14 13 14 O
365 15 18 15 18 B-upper_bound
days 19 23 19 23 I-upper_bound
) 23 24 23 24 O
of 25 27 25 27 O
age 28 31 28 31 B-age
at 32 34 32 34 O
diagnosis 35 44 35 44 O
with 45 49 45 49 O
INRG 50 54 50 54 B-cancer
stage 55 60 55 60 I-cancer
L1 61 63 61 63 I-cancer

< 0 1 64 65 O
12 2 4 66 68 B-upper_bound
months 5 11 69 75 I-upper_bound
of 12 14 76 78 O
age 15 18 79 82 B-age
with 19 23 83 87 O
a 24 25 88 89 O
non 26 29 90 93 B-clinical_variable
- 29 30 93 94 I-clinical_variable
adrenal 30 37 94 101 I-clinical_variable
primary 38 45 102 109 I-clinical_variable
site 46 50 110 114 I-clinical_variable
< 51 52 115 116 O
5 53 54 117 118 B-upper_bound
cm 55 57 119 121 I-upper_bound
in 58 60 122 124 I-upper_bound
greatest 61 69 125 133 I-upper_bound
diameter 70 78 134 142 I-upper_bound

< 0 1 143 144 O
18 2 4 145 147 B-upper_bound
months 5 11 148 154 I-upper_bound
( 12 13 155 156 O
< 13 14 156 157 O
547 15 18 158 161 B-upper_bound
days 19 23 162 166 I-upper_bound
) 23 24 166 167 O
of 25 27 168 170 O
age 28 31 171 174 B-age
at 32 34 175 177 O
diagnosis 35 44 178 187 O
with 45 49 188 192 O
INRG 50 54 193 197 O
stage 55 60 198 203 O
L2 61 63 204 206 O
or 64 66 207 209 O
stage 67 72 210 215 O
Ms 73 75 216 218 O
neuroblastoma 76 89 219 232 B-cancer
/ 89 90 232 233 O
ganglioneuroblastoma 90 110 233 253 B-cancer

= 0 1 254 255 O
< 1 2 255 256 O
6 3 4 257 258 B-upper_bound
months 5 11 259 265 I-upper_bound
of 12 14 266 268 O
age 15 18 269 272 B-age
with 19 23 273 277 O
an 24 26 278 280 O
adrenal 27 34 281 288 B-clinical_variable
primary 35 42 289 296 I-clinical_variable
site 43 47 297 301 I-clinical_variable
and 48 51 302 305 I-clinical_variable
tumor 52 57 306 311 I-clinical_variable
= 58 59 312 313 O
< 59 60 313 314 O
3.1 61 64 315 318 B-upper_bound
cm 65 67 319 321 I-upper_bound
in 68 70 322 324 O
greatest 71 79 325 333 O
diameter 80 88 334 342 O

> 0 1 343 344 O
6 2 3 345 346 B-lower_bound
months 4 10 347 353 I-lower_bound
and 11 14 354 357 O
< 15 16 358 359 O
12 17 19 360 362 B-upper_bound
months 20 26 363 369 I-upper_bound
of 27 29 370 372 O
age 30 33 373 376 B-age
with 34 38 377 381 O
an 39 41 382 384 O
adrenal 42 49 385 392 O
primary 50 57 393 400 B-cancer
tumor 58 63 401 406 I-cancer
< 64 65 407 408 O
5 66 67 409 410 B-upper_bound
cm 68 70 411 413 I-upper_bound
in 71 73 414 416 O
greatest 74 82 417 425 O
diameter 83 91 426 434 O

Enrollment 0 10 435 445 O
on 11 13 446 448 O
ANBL00B1 14 22 449 457 B-treatment
or 23 25 458 460 O
APEC14B1 26 34 461 469 B-treatment
is 35 37 470 472 O
required 38 46 473 481 O
for 47 50 482 485 O
all 51 54 486 489 O
newly 55 60 490 495 O
diagnosed 61 70 496 505 O
patients 71 79 506 514 O

Greatest 0 8 515 523 O
tumor 9 14 524 529 B-clinical_variable
diameter 15 23 530 538 I-clinical_variable
< 24 25 539 540 O
5 26 27 541 542 B-upper_bound
cm 28 30 543 545 I-upper_bound
of 31 33 546 548 O
adrenal 34 41 549 556 O
or 42 44 557 559 O
non 45 48 560 563 O
- 48 49 563 564 O
adrenal 49 56 564 571 O
origin 57 63 572 578 O

Group 0 5 579 584 O
A 6 7 585 586 O
and 8 11 587 590 O
C 12 13 591 592 O
patients 14 22 593 601 O
, 22 23 601 602 O
not 24 27 603 606 O
required 28 36 607 615 O
to 37 39 616 618 O
undergo 40 47 619 626 O
tumor 48 53 627 632 B-cancer
biopsy 54 60 633 639 B-treatment
, 60 61 639 640 O
who 62 65 641 644 O
do 66 68 645 647 O
not 69 72 648 651 O
enroll 73 79 652 658 O
on 80 82 659 661 O
ANBL1232 83 91 662 670 O
within 92 98 671 677 O
4 99 100 678 679 B-upper_bound
weeks 101 106 680 685 I-upper_bound
of 107 109 686 688 O
confirmatory 110 122 689 701 O
imaging 123 130 702 709 O
study 131 136 710 715 O

Group 0 5 716 721 O
B 6 7 722 723 O
and 8 11 724 727 O
C 12 13 728 729 O
patients 14 22 730 738 O
who 23 26 739 742 O
do 27 29 743 745 O
not 30 33 746 749 O
enroll 34 40 750 756 O
on 41 43 757 759 O
ANBL1232 44 52 760 768 O
within 53 59 769 775 O
4 60 61 776 777 B-upper_bound
weeks 62 67 778 783 I-upper_bound
of 68 70 784 786 O
definitive 71 81 787 797 O
diagnostic 82 92 798 808 O
procedure 93 102 809 818 O

No 0 2 819 821 O
life 3 7 822 826 O
threatening 8 19 827 838 O
symptoms 20 28 839 847 O
or 29 31 848 850 O
no 32 34 851 853 O
impending 35 44 854 863 O
neurologic 45 55 864 874 O
or 56 58 875 877 O
other 59 64 878 883 O
organ 65 70 884 889 O
function 71 79 890 898 O
compromise 80 90 899 909 O
( 91 92 910 911 O
e.g. 92 96 911 915 O
epidural 97 105 916 924 B-cancer
or 106 108 925 927 O
intraspinal 109 120 928 939 B-cancer
tumors 121 127 940 946 I-cancer
with 128 132 947 951 O
existing 133 141 952 960 O
or 142 144 961 963 O
impending 145 154 964 973 O
neurologic 155 165 974 984 B-chronic_disease
impairment 166 176 985 995 I-chronic_disease
, 176 177 995 996 O
periorbital 178 189 997 1008 O
or 190 192 1009 1011 O
calvarial 193 202 1012 1021 O
- 202 203 1021 1022 O
based 203 208 1022 1027 O
lesions 209 216 1028 1035 O
with 217 221 1036 1040 O
existing 222 230 1041 1049 O
or 231 233 1050 1052 O
impending 234 243 1053 1062 O
cranial 244 251 1063 1070 B-chronic_disease
nerve 252 257 1071 1076 I-chronic_disease
impairment 258 268 1077 1087 I-chronic_disease
, 268 269 1087 1088 O
anatomic 270 278 1089 1097 O
or 279 281 1098 1100 O
mechanical 282 292 1101 1111 O
compromise 293 303 1112 1122 O
of 304 306 1123 1125 O
critical 307 315 1126 1134 O
organ 316 321 1135 1140 O
function 322 330 1141 1149 O
by 331 333 1150 1152 O
tumor 334 339 1153 1158 O
[ 340 341 1159 1160 O
abdominal 341 350 1160 1169 B-chronic_disease
compartment 351 362 1170 1181 I-chronic_disease
syndrome 363 371 1182 1190 I-chronic_disease
, 371 372 1190 1191 O
urinary 373 380 1192 1199 B-chronic_disease
obstruction 381 392 1200 1211 I-chronic_disease
, 392 393 1211 1212 O
etc 394 397 1213 1216 O
. 397 398 1216 1217 O
] 398 399 1217 1218 O
) 399 400 1218 1219 O
; 400 401 1219 1220 O
horner 402 408 1221 1227 B-chronic_disease
syndrome 409 417 1228 1236 I-chronic_disease
is 418 420 1237 1239 O
not 421 424 1240 1243 O
considered 425 435 1244 1254 O
neurologic 436 446 1255 1265 O
compromise 447 457 1266 1276 O

No 0 2 1277 1279 O
prior 3 8 1280 1285 B-treatment
radiotherapy 9 21 1286 1298 I-treatment
or 22 24 1299 1301 O
chemotherapy 25 37 1302 1314 B-treatment
, 37 38 1314 1315 O
with 39 43 1316 1320 O
the 44 47 1321 1324 O
exception 48 57 1325 1334 O
of 58 60 1335 1337 O
dexamethasone 61 74 1338 1351 B-treatment
, 74 75 1351 1352 O
which 76 81 1353 1358 O
is 82 84 1359 1361 O
allowed 85 92 1362 1369 O

No 0 2 1370 1372 O
prior 3 8 1373 1378 B-treatment
tumor 9 14 1379 1384 I-treatment
resection 15 24 1385 1394 I-treatment
or 25 27 1395 1397 O
biopsy 28 34 1398 1404 B-treatment

No 0 2 1405 1407 O
prior 3 8 1408 1413 B-treatment
tumor 9 14 1414 1419 I-treatment
resection 15 24 1420 1429 I-treatment
, 24 25 1429 1430 O
tumor 26 31 1431 1436 B-treatment
biopsy 32 38 1437 1443 I-treatment
ONLY 39 43 1444 1448 O

Only 0 4 1449 1453 O
patients 5 13 1454 1462 O
with 14 18 1463 1467 O
MYCN 19 23 1468 1472 B-cancer
non 24 27 1473 1476 I-cancer
- 27 28 1476 1477 I-cancer
amplified 28 37 1477 1486 I-cancer
tumors 38 44 1487 1493 I-cancer

Patients 0 8 1494 1502 O
less 9 13 1503 1507 O
than 14 18 1508 1512 O
6 19 20 1513 1514 B-upper_bound
months 21 27 1515 1521 I-upper_bound
of 28 30 1522 1524 O
age 31 34 1525 1528 B-age
with 35 39 1529 1533 O
an 40 42 1534 1536 O
adrenal 43 50 1537 1544 B-cancer
primary 51 58 1545 1552 I-cancer
tumor 59 64 1553 1558 I-cancer
> 65 66 1559 1560 O
3.1 67 70 1561 1564 B-lower_bound
and 71 74 1565 1568 O
< 75 76 1569 1570 O
5 77 78 1571 1572 B-upper_bound
cm 79 81 1573 1575 I-upper_bound
in 82 84 1576 1578 O
greatest 85 93 1579 1587 O
diameter 94 102 1588 1596 O

Patients 0 8 1597 1605 O
must 9 13 1606 1610 O
have 14 18 1611 1615 O
newly 19 24 1616 1621 O
diagnosed 25 34 1622 1631 O
v 35 36 1632 1633 O
- 36 37 1633 1634 O
myc 37 40 1634 1637 O
avian 41 46 1638 1643 O
myelocytomatosis 47 63 1644 1660 B-cancer
viral 64 69 1661 1666 O
oncogene 70 78 1667 1675 O
neuroblastoma 79 92 1676 1689 B-cancer
derived 93 100 1690 1697 O
homolog 101 108 1698 1705 O
( 109 110 1706 1707 O
MYCN 110 114 1707 1711 O
) 114 115 1711 1712 O
non 116 119 1713 1716 O
- 119 120 1716 1717 O
amplified 120 129 1717 1726 O
neuroblastoma 130 143 1727 1740 O
( 144 145 1741 1742 O
International 145 158 1742 1755 O
Classification 159 173 1756 1770 O
of 174 176 1771 1773 O
Diseases 177 185 1774 1782 O
for 186 189 1783 1786 O
Oncology 190 198 1787 1795 O
[ 199 200 1796 1797 O
ICD 200 203 1797 1800 O
- 203 204 1800 1801 O
O 204 205 1801 1802 O
] 205 206 1802 1803 O
morphology 207 217 1804 1814 O
9500/3 218 224 1815 1821 O
) 224 225 1821 1822 O
or 226 228 1823 1825 O
MYCN 229 233 1826 1830 O
non 234 237 1831 1834 O
- 237 238 1834 1835 O
amplified 238 247 1835 1844 O
ganglioneuroblastoma 248 268 1845 1865 B-cancer
verified 269 277 1866 1874 O
by 278 280 1875 1877 O
histology 281 290 1878 1887 O

Patients 0 8 1888 1896 O
must 9 13 1897 1901 O
meet 14 18 1902 1906 O
the 19 22 1907 1910 O
specified 23 32 1911 1920 O
criteria 33 41 1921 1929 O
for 42 45 1930 1933 O
one 46 49 1934 1937 O
of 50 52 1938 1940 O
the 53 56 1941 1944 O
treatment 57 66 1945 1954 B-treatment
groups 67 73 1955 1961 O
defined 74 81 1962 1969 O
below 82 87 1970 1975 O
; 87 88 1975 1976 O
genomic 89 96 1977 1984 O
features 97 105 1985 1993 O
include 106 113 1994 2001 O
MYCN 114 118 2002 2006 O
gene 119 123 2007 2011 O
amplification 124 137 2012 2025 O
, 137 138 2025 2026 O
segmental 139 148 2027 2036 O
chromosome 149 159 2037 2047 O
aberrations 160 171 2048 2059 O
( 172 173 2060 2061 O
somatic 173 180 2061 2068 O
copy 181 185 2069 2073 O
number 186 192 2074 2080 O
loss 193 197 2081 2085 O
at 198 200 2086 2088 O
1p 201 203 2089 2091 O
, 203 204 2091 2092 O
3p 205 207 2093 2095 O
, 207 208 2095 2096 O
4p 209 211 2097 2099 O
, 211 212 2099 2100 O
or 213 215 2101 2103 O
11q 216 219 2104 2107 O
or 220 222 2108 2110 O
somatic 223 230 2111 2118 O
copy 231 235 2119 2123 O
number 236 242 2124 2130 O
gain 243 247 2131 2135 O
at 248 250 2136 2138 O
1q 251 253 2139 2141 O
, 253 254 2141 2142 O
2p 255 257 2143 2145 O
, 257 258 2145 2146 O
or 259 261 2147 2149 O
17q 262 265 2150 2153 O
) 265 266 2153 2154 O
and 267 270 2155 2158 O
deoxyribonucleic 271 287 2159 2175 O
acid 288 292 2176 2180 O
( 293 294 2181 2182 O
DNA 294 297 2182 2185 O
) 297 298 2185 2186 O
index 299 304 2187 2192 O

Patients 0 8 2193 2201 O
with 9 13 2202 2206 O
MYCN 14 18 2207 2211 O
amplified 19 28 2212 2221 O
tumors 29 35 2222 2228 B-cancer

Patients 0 8 2229 2237 O
with 9 13 2238 2242 O
non 14 17 2243 2246 O
- 17 18 2246 2247 O
adrenal 18 25 2247 2254 O
primaries 26 35 2255 2264 O
are 36 39 2265 2268 O
eligible 40 48 2269 2277 O
, 48 49 2277 2278 O
but 50 53 2279 2282 O
must 54 58 2283 2287 O
have 59 63 2288 2292 O
positive 64 72 2293 2301 O
uptake 73 79 2302 2308 O
on 80 82 2309 2311 O
metaiodobenzylguanidine 83 106 2312 2335 B-treatment
( 107 108 2336 2337 I-treatment
MIBG 108 112 2337 2341 I-treatment
) 112 113 2341 2342 I-treatment
scan 114 118 2343 2347 O
or 119 121 2348 2350 O
elevated 122 130 2351 2359 O
catecholamine 131 144 2360 2373 B-clinical_variable
metabolites 145 156 2374 2385 O
( 157 158 2386 2387 O
urine 158 163 2387 2392 O
or 164 166 2393 2395 O
serum 167 172 2396 2401 O
) 172 173 2401 2402 O
to 174 176 2403 2405 O
support 177 184 2406 2413 O
the 185 188 2414 2417 O
diagnosis 189 198 2418 2427 O
of 199 201 2428 2430 O
neuroblastoma 202 215 2431 2444 B-cancer

genomic 0 7 2445 2452 O
features 8 16 2453 2461 O
are 17 20 2462 2465 O
defined 21 28 2466 2473 O
by 29 31 2474 2476 O
one 32 35 2477 2480 B-lower_bound
or 36 38 2481 2483 O
more 39 43 2484 2488 O
whole 44 49 2489 2494 O
- 49 50 2494 2495 O
chromosome 50 60 2495 2505 O
gains 61 66 2506 2511 O
or 67 69 2512 2514 O
hyperdiploid 70 82 2515 2527 B-cancer
tumor 83 88 2528 2533 I-cancer
( 89 90 2534 2535 O
DNA 90 93 2535 2538 B-clinical_variable
index 94 99 2539 2544 I-clinical_variable
> 100 101 2545 2546 O
1 102 103 2547 2548 B-lower_bound
) 103 104 2548 2549 O
in 105 107 2550 2552 O
the 108 111 2553 2556 O
absence 112 119 2557 2564 O
of 120 122 2565 2567 O
segmental 123 132 2568 2577 O
chromosome 133 143 2578 2588 O
aberrations 144 155 2589 2600 O

genomic 0 7 2601 2608 O
features 8 16 2609 2617 O
are 17 20 2618 2621 O
defined 21 28 2622 2629 O
by 29 31 2630 2632 O
the 32 35 2633 2636 O
presence 36 44 2637 2645 O
of 45 47 2646 2648 O
any 48 51 2649 2652 O
segmental 52 61 2653 2662 B-chronic_disease
chromosome 62 72 2663 2673 I-chronic_disease
aberration 73 83 2674 2684 I-chronic_disease
( 84 85 2685 2686 O
somatic 85 92 2686 2693 O
copy 93 97 2694 2698 O
number 98 104 2699 2705 O
loss 105 109 2706 2710 O
at 110 112 2711 2713 O
1p 113 115 2714 2716 O
, 115 116 2716 2717 O
3p 117 119 2718 2720 O
, 119 120 2720 2721 O
4p 121 123 2722 2724 O
, 123 124 2724 2725 O
or 125 127 2726 2728 O
11q 128 131 2729 2732 O
or 132 134 2733 2735 O
somatic 135 142 2736 2743 O
copy 143 147 2744 2748 O
number 148 154 2749 2755 O
gain 155 159 2756 2760 O
at 160 162 2761 2763 O
1q 163 165 2764 2766 O
, 165 166 2766 2767 O
2p 167 169 2768 2770 O
, 169 170 2770 2771 O
or 171 173 2772 2774 O
17q 174 177 2775 2778 O
) 177 178 2778 2779 O
or 179 181 2780 2782 O
diploid 182 189 2783 2790 B-cancer
tumor 190 195 2791 2796 I-cancer
( 196 197 2797 2798 O
DNA 197 200 2798 2801 B-clinical_variable
index 201 206 2802 2807 I-clinical_variable
= 207 208 2808 2809 O
1 209 210 2810 2811 O
) 210 211 2811 2812 O
; 211 212 2812 2813 O
this 213 217 2814 2818 O
includes 218 226 2819 2827 O
copy 227 231 2828 2832 O
neutral 232 239 2833 2840 O
loss 240 244 2841 2845 O
of 245 247 2846 2848 O
heterozygosity 248 262 2849 2863 O
( 263 264 2864 2865 O
LOH 264 267 2865 2868 O
) 267 268 2868 2869 O

patients 0 8 2870 2878 O
< 9 10 2879 2880 O
12 11 13 2881 2883 B-upper_bound
months 14 20 2884 2890 I-upper_bound
( 21 22 2891 2892 O
< 22 23 2892 2893 O
365 24 27 2894 2897 B-upper_bound
days 28 32 2898 2902 I-upper_bound
) 32 33 2902 2903 O
of 34 36 2904 2906 O
age 37 40 2907 2910 B-age
with 41 45 2911 2915 O
newly 46 51 2916 2921 O
diagnosed 52 61 2922 2931 O
INRG 62 66 2932 2936 O
stage 67 72 2937 2942 O
L1 73 75 2943 2945 O
neuroblastoma 76 89 2946 2959 B-cancer
/ 89 90 2959 2960 O
ganglioneuroblastoma 90 110 2960 2980 B-cancer

patients 0 8 2981 2989 O
< 9 10 2990 2991 O
18 11 13 2992 2994 B-upper_bound
months 14 20 2995 3001 I-upper_bound
( 21 22 3002 3003 O
< 22 23 3003 3004 O
547 24 27 3005 3008 B-upper_bound
days 28 32 3009 3013 I-upper_bound
) 32 33 3013 3014 O
of 34 36 3015 3017 O
age 37 40 3018 3021 B-age
with 41 45 3022 3026 O
newly 46 51 3027 3032 O
diagnosed 52 61 3033 3042 O
INRG 62 66 3043 3047 O
stage 67 72 3048 3053 O
L2 73 75 3054 3056 O
neuroblastoma 76 89 3057 3070 B-cancer
/ 89 90 3070 3071 O
ganglioneuroblastoma 90 110 3071 3091 B-cancer

patients 0 8 3092 3100 O
< 9 10 3101 3102 O
18 11 13 3103 3105 B-upper_bound
months 14 20 3106 3112 I-upper_bound
( 21 22 3113 3114 O
< 22 23 3114 3115 O
547 24 27 3116 3119 B-upper_bound
days 28 32 3120 3124 I-upper_bound
) 32 33 3124 3125 O
of 34 36 3126 3128 O
age 37 40 3129 3132 B-age
with 41 45 3133 3137 O
newly 46 51 3138 3143 O
diagnosed 52 61 3144 3153 O
INRG 62 66 3154 3158 O
stage 67 72 3159 3164 O
Ms 73 75 3165 3167 O
neuroblastoma 76 89 3168 3181 B-cancer
/ 89 90 3181 3182 O
ganglioneuroblastoma 90 110 3182 3202 B-cancer

abnormal 0 8 0 8 B-chronic_disease
placentation 9 21 9 21 I-chronic_disease
( 22 23 22 23 O
previa 23 29 23 29 B-chronic_disease
, 29 30 29 30 O
accreta 31 38 31 38 B-chronic_disease
, 38 39 38 39 O
etc 40 43 40 43 O
) 43 44 43 44 O

antenatal 0 9 45 54 B-chronic_disease
hemorrhage 10 20 55 65 I-chronic_disease

contraindication 0 16 66 82 O
to 17 19 83 85 O
oxytocin 20 28 86 94 B-allergy_name

diagnosis 0 9 95 104 O
of 10 12 105 107 O
preeclampsia 13 25 108 120 B-chronic_disease
( 26 27 121 122 O
PE 27 29 122 124 O
defined 30 37 125 132 O
using 38 43 133 138 O
standard 44 52 139 147 O
definitions 53 64 148 159 O
based 65 70 160 165 O
on 71 73 166 168 O
the 74 77 169 172 O
ACOG 78 82 173 177 O
bulletin 83 91 178 186 O
and 92 95 187 190 O
the 96 99 191 194 O
NIH 100 103 195 198 O
Working 104 111 199 206 O
Group 112 117 207 212 O
on 118 120 213 215 O
High 121 125 216 220 O
Blood 126 131 221 226 O
Pressure 132 140 227 235 O
in 141 143 236 238 O
Pregnancy 144 153 239 248 B-pregnancy
( 154 155 249 250 O
i.e. 155 159 250 254 O
, 159 160 254 255 O
a 161 162 256 257 O
systolic 163 171 258 266 B-clinical_variable
blood 172 177 267 272 I-clinical_variable
pressure 178 186 273 281 I-clinical_variable
greater 187 194 282 289 O
than 195 199 290 294 O
140 200 203 295 298 B-lower_bound
mm 204 206 299 301 I-lower_bound
Hg 207 209 302 304 I-lower_bound
or 210 212 305 307 O
a 213 214 308 309 O
diastolic 215 224 310 319 B-clinical_variable
blood 225 230 320 325 I-clinical_variable
pressure 231 239 326 334 I-clinical_variable
greater 240 247 335 342 O
than 248 252 343 347 O
90 253 255 348 350 B-lower_bound
mm 256 258 351 353 I-lower_bound
Hg 259 261 354 356 I-lower_bound
on 262 264 357 359 O
at 265 267 360 362 O
least 268 273 363 368 O
2 274 275 369 370 B-lower_bound
occasions 276 285 371 380 O
at 286 288 381 383 O
least 289 294 384 389 O
6 295 296 390 391 B-lower_bound
hours 297 302 392 397 I-lower_bound
apart 303 308 398 403 O
after 309 314 404 409 B-upper_bound
20 315 317 410 412 I-upper_bound
weeks 318 323 413 418 I-upper_bound
gestation 324 333 419 428 O
and 334 337 429 432 O
proteinuria 338 349 433 444 B-clinical_variable
of 350 352 445 447 O
> 353 354 448 449 O
300 355 358 450 453 B-lower_bound
mg 358 360 453 455 I-lower_bound
per 361 364 456 459 I-lower_bound
24 365 367 460 462 I-lower_bound
hour 368 372 463 467 I-lower_bound
period 373 379 468 474 I-lower_bound
or 380 382 475 477 O
> 383 384 478 479 O
1 385 386 480 481 O
+ 386 387 481 482 O
on 388 390 483 485 O
dipstick 391 399 486 494 B-clinical_variable
) 399 400 494 495 O

patients 0 8 496 504 O
treated 9 16 505 512 O
with 17 21 513 517 O
magnesium 22 31 518 527 B-treatment
sulfate 32 39 528 535 I-treatment
for 40 43 536 539 O
24 44 46 540 542 B-upper_bound
hours 47 52 543 548 I-upper_bound
post 53 57 549 553 O
partum 58 64 554 560 O
at 65 67 561 563 O
2g 68 70 564 566 O
/ 70 71 566 567 O
hr 71 73 567 569 O
( 74 75 570 571 O
standard 75 83 571 579 O
of 84 86 580 582 O
care 87 91 583 587 O
when 92 96 588 592 O
deemed 97 103 593 599 O
appropriate 104 115 600 611 O
by 116 118 612 614 O
clinician 119 128 615 624 O
for 129 132 625 628 O
seizure 133 140 629 636 B-treatment
prophylaxis 141 152 637 648 I-treatment
) 152 153 648 649 O

vaginal 0 7 650 657 O
or 8 10 658 660 O
cesarean 11 19 661 669 O
delivery 20 28 670 678 O
at 29 31 679 681 O
a 32 33 682 683 O
gestational 34 45 684 695 B-clinical_variable
age 46 49 696 699 I-clinical_variable
greater 50 57 700 707 O
than 58 62 708 712 O
or 63 65 713 715 O
equal 66 71 716 721 O
to 72 74 722 724 O
20 75 77 725 727 B-lower_bound
weeks 78 83 728 733 I-lower_bound
gestational 84 95 734 745 O
age 96 99 746 749 O

For 0 3 0 3 O
participants 4 16 4 16 O
> 17 18 17 18 O
17 18 20 18 20 B-lower_bound
years 21 26 21 26 I-lower_bound
— 26 27 26 27 O
unable 27 33 27 33 O
or 34 36 34 36 O
unwilling 37 46 37 46 O
to 47 49 47 49 O
identify 50 58 50 58 O
emergency 59 68 59 68 O
contact 69 76 69 76 O

If 0 2 77 79 O
subject 3 10 80 87 O
in 11 13 88 90 O
restricted 14 24 91 101 O
setting 25 32 102 109 O
/ 32 33 109 110 O
care 33 37 110 114 O
( 38 39 115 116 O
e.g. 39 43 116 120 O
detox 44 49 121 126 B-treatment
or 50 52 127 129 I-treatment
residential 53 64 130 141 I-treatment
treatment 65 74 142 151 I-treatment
) 74 75 151 152 O
for 76 79 153 156 O
≤ 80 81 157 158 O
2 82 83 159 160 B-upper_bound
weeks 84 89 161 166 I-upper_bound
, 89 90 166 167 O
then 91 95 168 172 O
use 96 99 173 176 O
≥ 100 101 177 178 O
50 102 104 179 181 B-lower_bound
% 104 105 181 182 I-lower_bound
of 106 108 183 185 O
days 109 113 186 190 O
while 114 119 191 196 O
outside 120 127 197 204 O
of 128 130 205 207 O
restricted 131 141 208 218 O
setting 142 149 219 226 O
( 150 151 227 228 O
e.g. 151 155 228 232 O
7 156 157 233 234 B-lower_bound
days 158 162 235 239 I-lower_bound
of 163 165 240 242 O
substance 166 175 243 252 O
use 176 179 253 256 O
out 180 183 257 260 O
of 184 186 261 263 O
14 187 189 264 266 B-upper_bound
days 190 194 267 271 I-upper_bound
in 195 197 272 274 O
unrestricted 198 210 275 287 O
setting 211 218 288 295 O
) 218 219 295 296 O

Male 0 4 297 301 B-gender

Meets 0 5 302 307 O
DSM-5 6 11 308 313 O
criteria 12 20 314 322 O
for 21 24 323 326 O
bipolar 25 32 327 334 B-chronic_disease
disorder 33 41 335 343 I-chronic_disease
or 42 44 344 346 O
disruptive 45 55 347 357 B-chronic_disease
mood 56 60 358 362 I-chronic_disease
dysregulation 61 74 363 376 I-chronic_disease
disorder 75 83 377 385 I-chronic_disease
or 84 86 386 388 O
DSM 87 90 389 392 O
IV 91 93 393 395 O
criteria 94 102 396 404 O
for 103 106 405 408 O
mood 107 111 409 413 B-chronic_disease
disorder 112 120 414 422 I-chronic_disease
NOS 121 124 423 426 I-chronic_disease

Placement 0 9 427 436 O
in 10 12 437 439 O
a 13 14 440 441 O
restricted 15 25 442 452 O
setting 26 33 453 460 O
( 34 35 461 462 O
e.g. 35 39 462 466 O
detox 40 45 467 472 B-treatment
or 46 48 473 475 O
residential 49 60 476 487 B-treatment
treatment 61 70 488 497 I-treatment
) 70 71 497 498 O
for 72 75 499 502 O
≥ 76 77 503 504 O
2 78 79 505 506 B-lower_bound
weeks 80 85 507 512 I-lower_bound
out 86 89 513 516 O
of 90 92 517 519 O
past 93 97 520 524 O
28 98 100 525 527 B-upper_bound
days 101 105 528 532 I-upper_bound
prior 106 111 533 538 I-upper_bound
to 112 114 539 541 O
screening 115 124 542 551 O
visit 125 130 552 557 O
, 130 131 557 558 O
or 132 134 559 561 O
placement 135 144 562 571 O
in 145 147 572 574 O
a 148 149 575 576 O
restricted 150 160 577 587 O
setting 161 168 588 595 O
at 169 171 596 598 O
anytime 172 179 599 606 O
during 180 186 607 613 O
study 187 192 614 619 O
participation 193 206 620 633 O

Subjects 0 8 634 642 O
need 9 13 643 647 O
to 14 16 648 650 O
have 17 21 651 655 O
been 22 26 656 660 O
in 27 29 661 663 O
an 30 32 664 666 O
unrestricted 33 45 667 679 O
setting 46 53 680 687 O
for 54 57 688 691 O
at 58 60 692 694 O
least 61 66 695 700 O
2 67 68 701 702 B-upper_bound
weeks 69 74 703 708 I-upper_bound
prior 75 80 709 714 O
to 81 83 715 717 O
screening 84 93 718 727 O

Symptoms 0 8 728 736 O
of 9 11 737 739 O
SMD 12 15 740 743 O
: 15 16 743 744 O
Youth 17 22 745 750 B-clinical_variable
Self 23 27 751 755 I-clinical_variable
Report 28 34 756 762 I-clinical_variable
( 35 36 763 764 I-clinical_variable
YSR 36 39 764 767 I-clinical_variable
) 39 40 767 768 I-clinical_variable
or 41 43 769 771 O
Adult 44 49 772 777 B-clinical_variable
Self 50 54 778 782 I-clinical_variable
Report 55 61 783 789 I-clinical_variable
( 62 63 790 791 I-clinical_variable
ASR 63 66 791 794 I-clinical_variable
) 66 67 794 795 I-clinical_variable
AAA 68 71 796 799 I-clinical_variable
≥180 72 76 800 804 O

age 0 3 805 808 B-age
15 4 6 809 811 B-lower_bound
to 7 9 812 814 O
24 10 12 815 817 B-upper_bound

female 0 6 818 824 B-gender

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
years 7 12 7 12 I-lower_bound
and 13 16 13 16 O
older 17 22 17 22 O

Patient 0 7 23 30 O
with 8 12 31 35 O
sufficient 13 23 36 46 O
evidence 24 32 47 55 O
of 33 35 56 58 O
cognitive 36 45 59 68 B-chronic_disease
impairment 46 56 69 79 I-chronic_disease
that 57 61 80 84 O
limits 62 68 85 91 O
the 69 72 92 95 O
subject 73 80 96 103 O
's 80 82 103 105 O
ability 83 90 106 113 O
to 91 93 114 116 O
understand 94 104 117 127 O
the 105 108 128 131 O
protocol 109 117 132 140 O

Patients 0 8 141 149 O
having 9 15 150 156 O
acute 16 21 157 162 B-chronic_disease
infection 22 31 163 172 I-chronic_disease

Person 0 6 173 179 O
with 7 11 180 184 O
Lidocaine 12 21 185 194 B-allergy_name
sensitivity 22 33 195 206 O

Women 0 5 207 212 B-gender
of 6 8 213 215 O
childbearing 9 21 216 228 O
age 22 25 229 232 B-age
who 26 29 233 236 O
have 30 34 237 241 O
the 35 38 242 245 O
possibility 39 50 246 257 B-pregnancy
of 51 53 258 260 I-pregnancy
being 54 59 261 266 I-pregnancy
pregnant 60 68 267 275 I-pregnancy
must 69 73 276 280 O
have 74 78 281 285 O
a 79 80 286 287 O
negative 81 89 288 296 B-pregnancy
pregnancy 90 99 297 306 I-pregnancy
test 100 104 307 311 O
prior 105 110 312 317 O
to 111 113 318 320 O
participation 114 127 321 334 O

Women 0 5 335 340 B-gender
with 6 10 341 345 O
the 11 14 346 349 O
possibility 15 26 350 361 O
of 27 29 362 364 O
having 30 36 365 371 O
the 37 40 372 375 O
pregnancy 41 50 376 385 B-pregnancy

who 0 3 386 389 O
are 4 7 390 393 O
undergoing 8 18 394 404 O
cystoscopy 19 29 405 415 B-treatment
as 30 32 416 418 O
part 33 37 419 423 O
of 38 40 424 426 O
their 41 46 427 432 O
routine 47 54 433 440 O
clinical 55 63 441 449 O
care 64 68 450 454 O

Patients 0 8 0 8 O
who 9 12 9 12 O
received 13 21 13 21 O
ED 22 24 22 24 B-treatment
migraine 25 33 25 33 I-treatment
medications 34 45 34 45 I-treatment
( 46 47 46 47 O
including 47 56 47 56 O
ibuprofen 57 66 57 66 B-treatment
or 67 69 67 69 O
other 70 75 70 75 O
NSAIDS 76 82 76 82 B-treatment
) 82 83 82 83 O
prior 84 89 84 89 O
to 90 92 90 92 O
study 93 98 93 98 O
evaluation 99 109 99 109 O

Patients 0 8 110 118 O
with 9 13 119 123 O
underlying 14 24 124 134 O
abnormal 25 33 135 143 O
brain 34 39 144 149 O
pathology 40 49 150 159 O
( 50 51 160 161 O
e.g. 51 55 161 165 O
mass 56 60 166 170 O
or 61 63 171 173 O
bleed 64 69 174 179 O
) 69 70 179 180 O
as 71 73 181 183 O
the 74 77 184 187 O
potential 78 87 188 197 O
cause 88 93 198 203 O
of 94 96 204 206 O
the 97 100 207 210 O
migraine 101 109 211 219 B-chronic_disease

Healthy 0 7 0 7 O
Older 8 13 8 13 O
Adults 14 20 14 20 O
Group 21 26 21 26 O
: 26 27 26 27 O
Intact 28 34 28 34 O
cognitive 35 44 35 44 O
profile 45 52 45 52 O
based 53 58 53 58 O
on 59 61 59 61 O
neuropsychology 62 77 62 77 O
testing 78 85 78 85 O
within 86 92 86 92 O
1 93 94 93 94 B-upper_bound
standard 95 103 95 103 O
deviation 104 113 104 113 O
for 114 117 114 117 O
age 118 121 118 121 B-age
and 122 125 122 125 O
education 126 135 126 135 O
status 136 142 136 142 O

age 0 3 143 146 B-age
≥60 4 7 147 150 O
years 8 13 151 156 I-lower_bound

history 0 7 157 164 O
of 8 10 165 167 O
seizures 11 19 168 176 B-chronic_disease
or 20 22 177 179 O
taking 23 29 180 186 O
medications 30 41 187 198 B-treatment
that 42 46 199 203 O
may 47 50 204 207 O
lower 51 56 208 213 O
the 57 60 214 217 O
seizure 61 68 218 225 O
threshold 69 78 226 235 O

moderate 0 8 236 244 O
- 8 9 244 245 O
severe 9 15 245 251 O
sleep 16 21 252 257 B-chronic_disease
apnea 22 27 258 263 I-chronic_disease
defined 28 35 264 271 O
by 36 38 272 274 O
apnea 39 44 275 280 B-clinical_variable
- 44 45 280 281 I-clinical_variable
hypopnea 45 53 281 289 I-clinical_variable
index 54 59 290 295 I-clinical_variable
≥15 60 63 296 299 O
events 64 70 300 306 I-lower_bound
/ 70 71 306 307 I-lower_bound
hour 71 75 307 311 I-lower_bound
or 76 78 312 314 O
periodic 79 87 315 323 B-clinical_variable
limb 88 92 324 328 I-clinical_variable
movement 93 101 329 337 I-clinical_variable
index 102 107 338 343 I-clinical_variable
≥15 108 111 344 347 O
/ 111 112 347 348 I-lower_bound
hour 112 116 348 352 I-lower_bound
on 117 119 353 355 O
the 120 123 356 359 O
screening 124 133 360 369 O
home 134 138 370 374 B-treatment
sleep 139 144 375 380 I-treatment
test 145 149 381 385 I-treatment

unstable 0 8 386 394 O
medical 9 16 395 402 B-chronic_disease
or 17 19 403 405 I-chronic_disease
psychiatric 20 31 406 417 I-chronic_disease
disorder 32 40 418 426 I-chronic_disease

women 0 5 427 432 B-gender

A 0 1 0 1 O
score 2 7 2 7 O
of 8 10 8 10 O
5 11 12 11 12 B-lower_bound
or 13 15 13 15 O
higher 16 22 16 22 O
on 23 25 23 25 O
the 26 29 26 29 O
gastroparesis 30 43 30 43 B-clinical_variable
subscale 44 52 44 52 I-clinical_variable
or 53 55 53 55 O
5 56 57 56 57 O
or 58 60 58 60 O
higher 61 67 61 67 O
on 68 70 68 70 O
the 71 74 71 74 O
constipation 75 87 75 87 B-clinical_variable
subscale 88 96 88 96 I-clinical_variable
of 97 99 97 99 I-clinical_variable
the 100 103 100 103 I-clinical_variable
Gastrointestinal 104 120 104 120 I-clinical_variable
Symptoms 121 129 121 129 I-clinical_variable
in 130 132 130 132 I-clinical_variable
Neurodegenerative 133 150 133 150 I-clinical_variable
Disease 151 158 151 158 I-clinical_variable
Scale 159 164 159 164 I-clinical_variable

A 0 1 165 166 O
total 2 7 167 172 O
score 8 13 173 178 O
of 14 16 179 181 O
2 17 18 182 183 B-lower_bound
or 19 21 184 186 O
higher 22 28 187 193 O
on 29 31 194 196 O
the 32 35 197 200 O
Gastroparesis 36 49 201 214 B-clinical_variable
Cardinal 50 58 215 223 I-clinical_variable
Symptoms 59 67 224 232 I-clinical_variable
Index 68 73 233 238 I-clinical_variable
( 74 75 239 240 O
total 75 80 240 245 O
score 81 86 246 251 O
equals 87 93 252 258 O
average 94 101 259 266 O
of 102 104 267 269 O
scores 105 111 270 276 O
on 112 114 277 279 O
the 115 118 280 283 O
3 119 120 284 285 O
subscales 121 130 286 295 O
) 130 131 295 296 O

Dementia 0 8 297 305 B-chronic_disease
( 9 10 306 307 O
Mini 10 14 307 311 B-clinical_variable
Mental 15 21 312 318 I-clinical_variable
Status 22 28 319 325 I-clinical_variable
Exam 29 33 326 330 I-clinical_variable
< 34 35 331 332 O
25 36 38 333 335 B-upper_bound
) 38 39 335 336 O

Hoehn 0 5 337 342 B-clinical_variable
& 6 7 343 344 I-clinical_variable
Yahr 8 12 345 349 I-clinical_variable
stages 13 19 350 356 B-lower_bound
1 20 21 357 358 I-lower_bound
- 21 22 358 359 O
3 22 23 359 360 B-upper_bound

Idiopathic 0 10 361 371 B-chronic_disease
Parkinson 11 20 372 381 I-chronic_disease
's 20 22 381 383 I-chronic_disease
Disease 23 30 384 391 I-chronic_disease
( 31 32 392 393 O
UK 32 34 393 395 O
Brain 35 40 396 401 O
Bank 41 45 402 406 O
Criteria 46 54 407 415 O
) 54 55 415 416 O

abnormal 0 8 417 425 B-chronic_disease
liver 9 14 426 431 I-chronic_disease
or 15 17 432 434 I-chronic_disease
kidney 18 24 435 441 I-chronic_disease
function 25 33 442 450 I-chronic_disease

active 0 6 451 457 B-chronic_disease
psychosis 7 16 458 467 I-chronic_disease
, 16 17 467 468 O
severe 18 24 469 475 B-chronic_disease
depression 25 35 476 486 I-chronic_disease
( 36 37 487 488 O
score 37 42 488 493 O
of 43 45 494 496 O
4 46 47 497 498 O
on 48 50 499 501 O
question 51 59 502 510 O
1.3 60 63 511 514 O
of 64 66 515 517 O
the 67 70 518 521 O
Movement 71 79 522 530 O
Disorder 80 88 531 539 O
Society 89 96 540 547 O
- 96 97 547 548 O
United 97 103 548 554 O
Parkinson 104 113 555 564 O
Disease 114 121 565 572 O
Rating 122 128 573 579 O
Scale 129 134 580 585 O
) 134 135 585 586 O

active 0 6 587 593 B-chronic_disease
suicidality 7 18 594 605 I-chronic_disease
as 19 21 606 608 O
measured 22 30 609 617 O
by 31 33 618 620 O
a 34 35 621 622 O
most 36 40 623 627 O
severe 41 47 628 634 O
suicide 48 55 635 642 B-clinical_variable
ideation 56 64 643 651 I-clinical_variable
score 65 70 652 657 I-clinical_variable
of 71 73 658 660 O
4 74 75 661 662 B-lower_bound
or 76 78 663 665 O
5 79 80 666 667 B-upper_bound
on 81 83 668 670 O
the 84 87 671 674 O
Columbia 88 96 675 683 B-clinical_variable
- 96 97 683 684 I-clinical_variable
Suicide 97 104 684 691 I-clinical_variable
Severity 105 113 692 700 I-clinical_variable
Rating 114 120 701 707 I-clinical_variable
Scale 121 126 708 713 I-clinical_variable
( 127 128 714 715 I-clinical_variable
C 128 129 715 716 I-clinical_variable
- 129 130 716 717 I-clinical_variable
SSRS 130 134 717 721 I-clinical_variable
) 134 135 721 722 I-clinical_variable

allergy 0 7 723 730 O
to 8 10 731 733 O
spirulina 11 20 734 743 B-allergy_name
, 20 21 743 744 O
egg 22 25 745 748 B-allergy_name
, 25 26 748 749 O
milk 27 31 750 754 B-allergy_name
, 31 32 754 755 O
or 33 35 756 758 O
wheat 36 41 759 764 B-allergy_name

cardiac 0 7 765 772 B-chronic_disease
arrhythmia 8 18 773 783 I-chronic_disease
( 19 20 784 785 O
past 20 24 785 789 O
or 25 27 790 792 O
present 28 35 793 800 O
) 35 36 800 801 O

diabetes 0 8 802 810 B-chronic_disease

female 0 6 811 817 B-gender
participants 7 19 818 830 O
who 20 23 831 834 O
are 24 27 835 838 O
pregnant 28 36 839 847 B-pregnancy
or 37 39 848 850 O
lactating 40 49 851 860 O

gastroesophageal 0 16 861 877 O
reflux 17 23 878 884 I-chronic_disease
disease 24 31 885 892 I-chronic_disease

history 0 7 893 900 O
of 8 10 901 903 O
any 11 14 904 907 O
gastrointestinal 15 31 908 924 B-treatment
surgery 32 39 925 932 I-treatment
that 40 44 933 937 O
might 45 50 938 943 O
impact 51 57 944 950 O
drug 58 62 951 955 O
absorption 63 73 956 966 O
( 74 75 967 968 O
e.g. 75 79 968 972 O
gastrectomy 80 91 973 984 B-treatment
) 91 92 984 985 O
, 92 93 985 986 O
use 94 97 987 990 O
of 98 100 991 993 O
apomorphine 101 112 994 1005 B-treatment
, 112 113 1005 1006 O
anticholinergics 114 130 1007 1023 B-treatment
, 130 131 1023 1024 O
or 132 134 1025 1027 O
carbidopa 135 144 1028 1037 B-treatment
/ 144 145 1037 1038 I-treatment
levodopa 145 153 1038 1046 I-treatment
intestinal 154 164 1047 1057 I-treatment
gel 165 168 1058 1061 I-treatment
for 169 172 1062 1065 O
Parkinson 173 182 1066 1075 B-chronic_disease
's 182 184 1075 1077 I-chronic_disease
Disease 185 192 1078 1085 I-chronic_disease

individuals 0 11 1086 1097 O
with 12 16 1098 1102 O
limited 17 24 1103 1110 O
English 25 32 1111 1118 B-language_fluency
proficiency 33 44 1119 1130 I-language_fluency

male 0 4 1131 1135 B-gender
or 5 7 1136 1138 O
female 8 14 1139 1145 B-gender
participants 15 27 1146 1158 I-gender
of 28 30 1159 1161 O
childbearing 31 43 1162 1174 O
age 44 47 1175 1178 B-age
who 48 51 1179 1182 O
are 52 55 1183 1186 O
not 56 59 1187 1190 B-contraception_consent
willing 60 67 1191 1198 I-contraception_consent
, 67 68 1198 1199 I-contraception_consent
or 69 71 1200 1202 I-contraception_consent
whose 72 77 1203 1208 I-contraception_consent
partners 78 86 1209 1217 I-contraception_consent
are 87 90 1218 1221 I-contraception_consent
not 91 94 1222 1225 I-contraception_consent
willing 95 102 1226 1233 I-contraception_consent
, 102 103 1233 1234 I-contraception_consent
to 104 106 1235 1237 I-contraception_consent
use 107 110 1238 1241 I-contraception_consent
contraception 111 124 1242 1255 I-contraception_consent
during 125 131 1256 1262 O
the 132 135 1263 1266 O
study 136 141 1267 1272 O

participants 0 12 1273 1285 O
may 13 16 1286 1289 O
be 17 19 1290 1292 O
on 20 22 1293 1295 O
oral 23 27 1296 1300 B-treatment
levodopa 28 36 1301 1309 I-treatment
, 36 37 1309 1310 O
dopamine 38 46 1311 1319 B-treatment
agonists 47 55 1320 1328 I-treatment
, 55 56 1328 1329 O
monoamine 57 66 1330 1339 B-treatment
oxidase 67 74 1340 1347 I-treatment
- 74 75 1347 1348 I-treatment
B 75 76 1348 1349 I-treatment
inhibitors 77 87 1350 1360 I-treatment
, 87 88 1360 1361 O
catechol 89 97 1362 1370 B-treatment
- 97 98 1370 1371 I-treatment
O 98 99 1371 1372 I-treatment
- 99 100 1372 1373 I-treatment
methyltransferase 100 117 1373 1390 I-treatment
inhibitors 118 128 1391 1401 I-treatment
, 128 129 1401 1402 O
and 130 133 1403 1406 O
amantadine 134 144 1407 1417 B-treatment
, 144 145 1417 1418 O
but 146 149 1419 1422 O
doses 150 155 1423 1428 O
must 156 160 1429 1433 O
have 161 165 1434 1438 O
remained 166 174 1439 1447 O
stable 175 181 1448 1454 O
for 182 185 1455 1458 O
28 186 188 1459 1461 O
days 189 193 1462 1466 O
prior 194 199 1467 1472 O
to 200 202 1473 1475 O
enrollment 203 213 1476 1486 O
and 214 217 1487 1490 O
should 218 224 1491 1497 O
be 225 227 1498 1500 O
anticipated 228 239 1501 1512 O
to 240 242 1513 1515 O
remain 243 249 1516 1522 O
stable 250 256 1523 1529 O
throughout 257 267 1530 1540 O
the 268 271 1541 1544 O
study 272 277 1545 1550 O
, 277 278 1550 1551 O
participants 279 291 1552 1564 O
may 292 295 1565 1568 O
have 296 300 1569 1573 O
deep 301 305 1574 1578 O
brain 306 311 1579 1584 O
stimulation 312 323 1585 1596 O
( 324 325 1597 1598 O
though 325 331 1598 1604 O
stimulator 332 342 1605 1615 O
settings 343 351 1616 1624 O
must 352 356 1625 1629 O
be 357 359 1630 1632 O
expected 360 368 1633 1641 O
to 369 371 1642 1644 O
remain 372 378 1645 1651 O
constant 379 387 1652 1660 O
throughout 388 398 1661 1671 O
the 399 402 1672 1675 O
study 403 408 1676 1681 O
) 408 409 1681 1682 O
or 410 412 1683 1685 O
ablative 413 421 1686 1694 B-treatment
surgery 422 429 1695 1702 I-treatment
for 430 433 1703 1706 O
Parkinson 434 443 1707 1716 B-chronic_disease
's 443 445 1716 1718 I-chronic_disease
Disease 446 453 1719 1726 I-chronic_disease

patients 0 8 1727 1735 O
who 9 12 1736 1739 O
, 12 13 1739 1740 O
in 14 16 1741 1743 O
the 17 20 1744 1747 O
opinion 21 28 1748 1755 O
of 29 31 1756 1758 O
the 32 35 1759 1762 O
investigator 36 48 1763 1775 O
, 48 49 1775 1776 O
present 50 57 1777 1784 O
a 58 59 1785 1786 O
risk 60 64 1787 1791 O
of 65 67 1792 1794 O
suicide 68 75 1795 1802 O
, 75 76 1802 1803 O
any 77 80 1804 1807 O
chronic 81 88 1808 1815 B-chronic_disease
gastrointestinal 89 105 1816 1832 I-chronic_disease
diseases 106 114 1833 1841 I-chronic_disease

symptomatic 0 11 1842 1853 B-chronic_disease
anemia 12 18 1854 1860 I-chronic_disease

Body 0 4 0 4 B-bmi
mass 5 9 5 9 I-bmi
index 10 15 10 15 I-bmi
< 16 17 16 17 O
35 18 20 18 20 B-upper_bound
based 21 26 21 26 O
on 27 29 27 29 O
dry 30 33 30 33 O
weight 34 40 34 40 O

Concurrent 0 10 41 51 O
sepsis 11 17 52 58 B-chronic_disease
or 18 20 59 61 O
active 21 27 62 68 B-chronic_disease
bacterial 28 37 69 78 I-chronic_disease
infection 38 47 79 88 I-chronic_disease

Currently 0 9 89 98 O
participating 10 23 99 112 O
in 24 26 113 115 O
or 27 29 116 118 O
has 30 33 119 122 O
participated 34 46 123 135 O
in 47 49 136 138 O
an 50 52 139 141 O
investigational 53 68 142 157 B-treatment
drug 69 73 158 162 I-treatment
or 74 76 163 165 O
medical 77 84 166 173 B-treatment
device 85 91 174 180 I-treatment
study 92 97 181 186 O
within 98 104 187 193 O
30 105 107 194 196 B-upper_bound
days 108 112 197 201 I-upper_bound
or 113 115 202 204 O
five 116 120 205 209 B-upper_bound
drug 121 125 210 214 I-upper_bound
half 126 130 215 219 I-upper_bound
- 130 131 219 220 I-upper_bound
lives 131 136 220 225 I-upper_bound
, 136 137 225 226 O
whichever 138 147 227 236 O
is 148 150 237 239 O
longer 151 157 240 246 O
, 157 158 246 247 O
prior 159 164 248 253 O
to 165 167 254 256 O
enrollment 168 178 257 267 O
into 179 183 268 272 O
this 184 188 273 277 O
study 189 194 278 283 O

Dry 0 3 284 287 O
weight 4 10 288 294 O
and 11 14 295 298 O
height 15 21 299 305 O
parameters 22 32 306 316 O
obtained 33 41 317 325 O
within 42 48 326 332 O
7 49 50 333 334 B-upper_bound
days 51 55 335 339 I-upper_bound
prior 56 61 340 345 I-upper_bound
to 62 64 346 348 O
study 65 70 349 354 O
entry 71 76 355 360 O
may 77 80 361 364 O
be 81 83 365 367 O
used 84 88 368 372 O

Estimated 0 9 373 382 B-clinical_variable
donor 10 15 383 388 I-clinical_variable
organ 16 21 389 394 I-clinical_variable
cold 22 26 395 399 I-clinical_variable
ischemia 27 35 400 408 I-clinical_variable
time 36 40 409 413 I-clinical_variable
less 41 45 414 418 O
than 46 50 419 423 O
30 51 53 424 426 B-upper_bound
hours 54 59 427 432 I-upper_bound
( 60 61 433 434 O
for 61 64 434 437 O
PMP 65 68 438 441 B-clinical_variable
kidneys 69 76 442 449 I-clinical_variable
less 77 81 450 454 O
than 82 86 455 459 O
40 87 89 460 462 B-upper_bound
hours 90 95 463 468 I-upper_bound
) 95 96 468 469 O

Female 0 6 470 476 B-gender
who 7 10 477 480 O
is 11 13 481 483 O
breastfeeding 14 27 484 497 O

Females 0 7 498 505 B-gender
of 8 10 506 508 O
childbearing 11 23 509 521 O
potential 24 33 522 531 O

Has 0 3 532 535 O
an 4 6 536 538 O
active 7 13 539 545 B-cancer
malignancy 14 24 546 556 I-cancer
or 25 27 557 559 O
history 28 35 560 567 O
of 36 38 568 570 O
solid 39 44 571 576 B-cancer
, 44 45 576 577 O
metastatic 46 56 578 588 B-cancer
or 57 59 589 591 O
hematologic 60 71 592 603 B-cancer
malignancy 72 82 604 614 I-cancer
with 83 87 615 619 O
the 88 91 620 623 O
exception 92 101 624 633 O
of 102 104 634 636 O
basal 105 110 637 642 B-cancer
or 111 113 643 645 O
squamous 114 122 646 654 B-cancer
cell 123 127 655 659 I-cancer
carcinoma 128 137 660 669 I-cancer
in 138 140 670 672 I-cancer
situ 141 145 673 677 I-cancer
of 146 148 678 680 I-cancer
the 149 152 681 684 I-cancer
skin 153 157 685 689 I-cancer
that 158 162 690 694 O
has 163 166 695 698 O
been 167 171 699 703 O
adequately 172 182 704 714 O
treated 183 190 715 722 O

Has 0 3 723 726 O
measurable 4 14 727 737 O
donor 15 20 738 743 O
- 20 21 743 744 O
specific 21 29 744 752 O
antibody 30 38 753 761 O
or 39 41 762 764 O
positive 42 50 765 773 O
cross 51 56 774 779 O
- 56 57 779 780 O
match 57 62 780 785 O
requiring 63 72 786 795 O
desensitization 73 88 796 811 B-treatment
prior 89 94 812 817 O
to 95 97 818 820 O
transplantation 98 113 821 836 B-treatment
or 114 116 837 839 O
deviation 117 126 840 849 O
from 127 131 850 854 O
standard 132 140 855 863 O
immunosuppressive 141 158 864 881 B-treatment
therapy 159 166 882 889 I-treatment

History 0 7 890 897 O
of 8 10 898 900 O
positive 11 19 901 909 O
human 20 25 910 915 B-chronic_disease
immunodeficiency 26 42 916 932 I-chronic_disease
virus 43 48 933 938 I-chronic_disease
test 49 53 939 943 O

Male 0 4 944 948 B-gender
patients 5 13 949 957 I-gender
must 14 18 958 962 O
agree 19 24 963 968 B-contraception_consent
to 25 27 969 971 I-contraception_consent
use 28 31 972 975 I-contraception_consent
condoms 32 39 976 983 I-contraception_consent
or 40 42 984 986 O
other 43 48 987 992 O
suitable 49 57 993 1001 O
means 58 63 1002 1007 O
of 64 66 1008 1010 O
pregnancy 67 76 1011 1020 B-pregnancy
prevention 77 87 1021 1031 O
such 88 92 1032 1036 O
as 93 95 1037 1039 O
abstinence 96 106 1040 1050 B-contraception_consent
during 107 113 1051 1057 O
the 114 117 1058 1061 O
initial 118 125 1062 1069 O
30 126 128 1070 1072 B-lower_bound
- 128 129 1072 1073 I-lower_bound
day 129 132 1073 1076 I-lower_bound
study 133 138 1077 1082 O
period 139 145 1083 1089 O

Males 0 5 1090 1095 B-gender
and 6 9 1096 1099 O
females 10 17 1100 1107 B-gender

Must 0 4 1108 1112 O
agree 5 10 1113 1118 B-contraception_consent
to 11 13 1119 1121 I-contraception_consent
use 14 17 1122 1125 I-contraception_consent
2 18 19 1126 1127 I-contraception_consent
forms 20 25 1128 1133 I-contraception_consent
of 26 28 1134 1136 I-contraception_consent
effective 29 38 1137 1146 I-contraception_consent
birth 39 44 1147 1152 I-contraception_consent
control 45 52 1153 1160 I-contraception_consent
regimen 53 60 1161 1168 I-contraception_consent
( 61 62 1169 1170 O
at 62 64 1170 1172 O
least 65 70 1173 1178 O
one 71 74 1179 1182 B-contraception_consent
- 74 75 1182 1183 I-contraception_consent
barrier 75 82 1183 1190 I-contraception_consent
method 83 89 1191 1197 I-contraception_consent
) 89 90 1197 1198 O
during 91 97 1199 1205 O
the 98 101 1206 1209 O
initial 102 109 1210 1217 O
30 110 112 1218 1220 B-upper_bound
- 112 113 1220 1221 I-upper_bound
day 113 116 1221 1224 I-upper_bound
study 117 122 1225 1230 O
period 123 129 1231 1237 O
OR 130 132 1238 1240 O
agree 133 138 1241 1246 O
to 139 141 1247 1249 O
maintain 142 150 1250 1258 O
total 151 156 1259 1264 O
abstinence 157 167 1265 1275 O
throughout 168 178 1276 1286 O
the 179 182 1287 1290 O
initial 183 190 1291 1298 O
30 191 193 1299 1301 O
- 193 194 1301 1302 O
day 194 197 1302 1305 O
study 198 203 1306 1311 O
period 204 210 1312 1318 O

Must 0 4 1319 1323 O
have 5 9 1324 1328 O
a 10 11 1329 1330 O
negative 12 20 1331 1339 B-pregnancy
serum 21 26 1340 1345 I-pregnancy
pregnancy 27 36 1346 1355 I-pregnancy
test 37 41 1356 1360 O
prior 42 47 1361 1366 B-treatment
to 48 50 1367 1369 I-treatment
transplantation 51 66 1370 1385 I-treatment

Oligo 0 5 1386 1391 B-chronic_disease
- 5 6 1391 1392 I-chronic_disease
anuric 6 12 1392 1398 I-chronic_disease
renal 13 18 1399 1404 I-chronic_disease
failure 19 26 1405 1412 I-chronic_disease
( 27 28 1413 1414 O
less 28 32 1414 1418 O
than 33 37 1419 1423 O
200 38 41 1424 1427 B-upper_bound
mL 42 44 1428 1430 I-upper_bound
of 45 47 1431 1433 O
UO 48 50 1434 1436 O
per 51 54 1437 1440 O
day 55 58 1441 1444 O
) 58 59 1444 1445 O
requiring 60 69 1446 1455 O
hemodialysis 70 82 1456 1468 B-treatment
or 83 85 1469 1471 O
peritoneal 86 96 1472 1482 B-treatment
dialysis 97 105 1483 1491 I-treatment
initiated 106 115 1492 1501 O
at 116 118 1502 1504 O
least 119 124 1505 1510 O
3 125 126 1511 1512 B-lower_bound
months 127 133 1513 1519 I-lower_bound
prior 134 139 1520 1525 I-lower_bound
to 140 142 1526 1528 O
transplantation 143 158 1529 1544 B-treatment

Patient 0 7 1545 1552 O
has 8 11 1553 1556 O
poor 12 16 1557 1561 O
renal 17 22 1562 1567 O
function 23 31 1568 1576 O
in 32 34 1577 1579 O
the 35 38 1580 1583 O
first 39 44 1584 1589 O
24 45 47 1590 1592 B-upper_bound
hours 48 53 1593 1598 I-upper_bound
post 54 58 1599 1603 B-treatment
- 58 59 1603 1604 I-treatment
transplantation 59 74 1604 1619 I-treatment
based 75 80 1620 1625 O
on 81 83 1626 1628 O
an 84 86 1629 1631 O
average 87 94 1632 1639 B-clinical_variable
UO 95 97 1640 1642 I-clinical_variable
of 98 100 1643 1645 O
less 101 105 1646 1650 O
than 106 110 1651 1655 O
50 111 113 1656 1658 B-upper_bound
mL 114 116 1659 1661 I-upper_bound
per 117 120 1662 1665 O
hour 121 125 1666 1670 O
over 126 130 1671 1675 O
any 131 134 1676 1679 O
8 135 136 1680 1681 B-upper_bound
consecutive 137 148 1682 1693 I-upper_bound
hours 149 154 1694 1699 I-upper_bound
, 154 155 1699 1700 O
to 156 158 1701 1703 O
maximize 159 167 1704 1712 O
the 168 171 1713 1716 O
likelihood 172 182 1717 1727 O
that 183 187 1728 1732 O
the 188 191 1733 1736 O
patient 192 199 1737 1744 O
requires 200 208 1745 1753 O
dialysis 209 217 1754 1762 B-treatment
within 218 224 1763 1769 O
the 225 228 1770 1773 O
first 229 234 1774 1779 O
7 235 236 1780 1781 B-upper_bound
days 237 241 1782 1786 I-upper_bound
post 242 246 1787 1791 O
- 246 247 1791 1792 O
transplant 247 257 1792 1802 O
, 257 258 1802 1803 O
irrespective 259 271 1804 1816 O
of 272 274 1817 1819 O
pre 275 278 1820 1823 B-treatment
- 278 279 1823 1824 I-treatment
transplant 279 289 1824 1834 I-treatment
donor 290 295 1835 1840 O
and 296 299 1841 1844 O
recipient 300 309 1845 1854 O
risk 310 314 1855 1859 O
factors 315 322 1860 1867 O

Patient 0 7 1868 1875 O
is 8 10 1876 1878 O
to 11 13 1879 1881 O
be 14 16 1882 1884 O
the 17 20 1885 1888 O
recipient 21 30 1889 1898 O
of 31 33 1899 1901 O
a 34 35 1902 1903 O
first 36 41 1904 1909 O
kidney 42 48 1910 1916 B-treatment
transplant 49 59 1917 1927 I-treatment
from 60 64 1928 1932 O
a 65 66 1933 1934 O
deceased 67 75 1935 1943 O
donor 76 81 1944 1949 O

Patients 0 8 1950 1958 O
can 9 12 1959 1962 O
not 12 15 1962 1965 O
be 16 18 1966 1968 O
given 19 24 1969 1974 O
another 25 32 1975 1982 O
investigational 33 48 1983 1998 B-treatment
agent 49 54 1999 2004 I-treatment
during 55 61 2005 2011 O
the 62 65 2012 2015 O
course 66 72 2016 2022 O
of 73 75 2023 2025 O
this 76 80 2026 2030 O
study 81 86 2031 2036 O
( 87 88 2037 2038 O
through 88 95 2038 2045 O
Day 96 99 2046 2049 O
360 100 103 2050 2053 O
) 103 104 2053 2054 O

Patients 0 8 2055 2063 O
may 9 12 2064 2067 O
participate 13 24 2068 2079 O
in 25 27 2080 2082 O
another 28 35 2083 2090 B-treatment
concurrent 36 46 2091 2101 I-treatment
study 47 52 2102 2107 I-treatment
only 53 57 2108 2112 O
if 58 60 2113 2115 O
that 61 65 2116 2120 O
study 66 71 2121 2126 O
is 72 74 2127 2129 O
a 75 76 2130 2131 O
non 77 80 2132 2135 O
- 80 81 2135 2136 O
interventional 81 95 2136 2150 O
, 95 96 2150 2151 O
observational 97 110 2152 2165 O
investigation 111 124 2166 2179 O

Reason 0 6 2180 2186 O
for 7 10 2187 2190 O
low 11 14 2191 2194 O
UO 15 17 2195 2197 B-clinical_variable
is 18 20 2198 2200 O
not 21 24 2201 2204 O
due 25 28 2205 2208 O
to 29 31 2209 2211 O
structural 32 42 2212 2222 O
or 43 45 2223 2225 O
vascular 46 54 2226 2234 O
abnormalities 55 68 2235 2248 O
which 69 74 2249 2254 O
, 74 75 2254 2255 O
when 76 80 2256 2260 O
indicated 81 90 2261 2270 O
should 91 97 2271 2277 O
be 98 100 2278 2280 O
confirmed 101 110 2281 2290 O
with 111 115 2291 2295 O
a 116 117 2296 2297 O
renal 118 123 2298 2303 O
ultrasound 124 134 2304 2314 O
with 135 139 2315 2319 O
Doppler 140 147 2320 2327 O
study 148 153 2328 2333 O
and/or 154 160 2334 2340 O
vascular 161 169 2341 2349 O
or 170 172 2350 2352 O
urinary 173 180 2353 2360 O
tract 181 186 2361 2366 O
contrast 187 195 2367 2375 O
studies 196 203 2376 2383 O

Recipient 0 9 2384 2393 O
of 10 12 2394 2396 O
a 13 14 2397 2398 O
kidney 15 21 2399 2405 O
preserved 22 31 2406 2415 O
by 32 34 2416 2418 O
normothermic 35 47 2419 2431 B-treatment
pulsatile 48 57 2432 2441 I-treatment
machine 58 65 2442 2449 I-treatment
perfusion 66 75 2450 2459 I-treatment

Recipient 0 9 2460 2469 O
of 10 12 2470 2472 O
an 13 15 2473 2475 O
ABO 16 19 2476 2479 B-treatment
- 19 20 2479 2480 I-treatment
incompatible 20 32 2480 2492 I-treatment
kidney 33 39 2493 2499 I-treatment

Requires 0 8 2500 2508 O
treatment 9 18 2509 2518 B-treatment
with 19 23 2519 2523 I-treatment
the 24 27 2524 2527 I-treatment
CYP1A2 28 34 2528 2534 I-treatment
inhibitors 35 45 2535 2545 I-treatment
, 45 46 2545 2546 O
ciprofloxacin 47 60 2547 2560 B-treatment
and/or 61 67 2561 2567 O
fluvoxamine 68 79 2568 2579 B-treatment

Scheduled 0 9 2580 2589 O
for 10 13 2590 2593 O
multiple 14 22 2594 2602 B-treatment
organ 23 28 2603 2608 I-treatment
transplantation 29 44 2609 2624 I-treatment
or 45 47 2625 2627 O
prior 48 53 2628 2633 B-treatment
recipient 54 63 2634 2643 I-treatment
of 64 66 2644 2646 I-treatment
a 67 68 2647 2648 I-treatment
transplanted 69 81 2649 2661 I-treatment
organ 82 87 2662 2667 I-treatment

Signs 0 5 2668 2673 O
and 6 9 2674 2677 O
symptoms 10 18 2678 2686 O
of 19 21 2687 2689 O
volume 22 28 2690 2696 B-chronic_disease
depletion 29 38 2697 2706 I-chronic_disease

Study 0 5 2707 2712 B-treatment
drug 6 10 2713 2717 I-treatment
can 11 14 2718 2721 O
be 15 17 2722 2724 O
administered 18 30 2725 2737 O
starting 31 39 2738 2746 O
within 40 46 2747 2753 O
30 47 49 2754 2756 B-upper_bound
hours 50 55 2757 2762 I-upper_bound
after 56 61 2763 2768 O
restoration 62 73 2769 2780 O
of 74 76 2781 2783 O
blood 77 82 2784 2789 O
flow 83 87 2790 2794 O
to 88 90 2795 2797 O
the 91 94 2798 2801 O
engrafted 95 104 2802 2811 O
kidney 105 111 2812 2818 O

including 0 9 2819 2828 O
perimenopausal 10 24 2829 2843 O
women 25 30 2844 2849 B-gender
who 31 34 2850 2853 O
have 35 39 2854 2858 O
had 40 43 2859 2862 O
a 44 45 2863 2864 O
menstrual 46 55 2865 2874 O
period 56 62 2875 2881 O
within 63 69 2882 2888 O
1 70 71 2889 2890 B-upper_bound
year 72 76 2891 2895 I-upper_bound

≥ 0 1 2896 2897 O
18 2 4 2898 2900 B-lower_bound
years 5 10 2901 2906 I-lower_bound
of 11 13 2907 2909 O
age 14 17 2910 2913 B-age

A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
acute 15 20 15 20 B-cancer
promyelocytic 21 34 21 34 I-cancer
leukemia 35 43 35 43 I-cancer
( 44 45 44 45 I-cancer
APML 45 49 45 49 I-cancer
) 49 50 49 50 I-cancer

Major 0 5 51 56 B-chronic_disease
psychiatric 6 17 57 68 I-chronic_disease
illness 18 25 69 76 I-chronic_disease
or 26 28 77 79 O
comorbid 29 37 80 88 B-chronic_disease
conditions 38 48 89 99 I-chronic_disease
prohibiting 49 60 100 111 O
compliance 61 71 112 122 O
with 72 76 123 127 O
study 77 82 128 133 O
procedures 83 93 134 144 O

Newly 0 5 145 150 O
diagnosed 6 15 151 160 O
patients 16 24 161 169 O
with 25 29 170 174 O
AML 30 33 175 178 B-cancer
≥ 34 35 179 180 O
60 36 38 181 183 B-lower_bound
years 39 44 184 189 I-lower_bound
of 45 47 190 192 O
age 48 51 193 196 B-age

Newly 0 5 197 202 O
diagnosed 6 15 203 212 O
therapy 16 23 213 220 O
- 23 24 220 221 O
related 24 31 221 228 O
AML 32 35 229 232 B-cancer

Primary 0 7 233 240 B-cancer
refractory 8 18 241 251 I-cancer
AML 19 22 252 255 I-cancer

AST 0 3 0 3 B-clinical_variable
/ 3 4 3 4 I-clinical_variable
ALT 4 7 4 7 I-clinical_variable
< 8 9 8 9 O
6 9 10 9 10 B-upper_bound
times 11 16 11 16 I-upper_bound
ULN 17 20 17 20 I-upper_bound

Absolute 0 8 21 29 O
neutrophil 9 19 30 40 B-clinical_variable
count 20 25 41 46 I-clinical_variable
> 26 27 47 48 O
= 27 28 48 49 O
1,500 29 34 50 55 B-lower_bound
/ 34 35 55 56 I-lower_bound
mcL 35 38 56 59 I-lower_bound

An 0 2 60 62 O
additional 3 13 63 73 O
cohort 14 20 74 80 O
of 21 23 81 83 O
10 24 26 84 86 O
patients 27 35 87 95 O
with 36 40 96 100 O
BCLC 41 45 101 105 B-cancer
stages 46 52 106 112 B-lower_bound
A 53 54 113 114 I-lower_bound
to 55 57 115 117 O
C 58 59 118 119 O
locally 60 67 120 127 O
advanced 68 76 128 136 O
or 77 79 137 139 O
metastatic 80 90 140 150 O
hepatocellular 91 105 151 165 B-cancer
carcinoma 106 115 166 175 I-cancer
( 116 117 176 177 I-cancer
HCC 117 120 177 180 I-cancer
) 120 121 180 181 I-cancer
that 122 126 182 186 O
is 127 129 187 189 O
not 130 133 190 193 O
surgically 134 144 194 204 O
resectable 145 155 205 215 O
will 156 160 216 220 O
also 161 165 221 225 O
be 166 168 226 228 O
enrolled 169 177 229 237 O
( 178 179 238 239 O
See 179 182 239 242 O
appendix 183 191 243 251 O
for 192 195 252 255 O
BCLC 196 200 256 260 O
staging 201 208 261 268 O
system 209 215 269 275 O
) 215 216 275 276 O

Aspartate 0 9 277 286 B-clinical_variable
aminotransferase 10 26 287 303 I-clinical_variable
( 27 28 304 305 I-clinical_variable
AST)(serum 28 38 305 315 I-clinical_variable
glutamic 39 47 316 324 I-clinical_variable
oxaloacetic 48 59 325 336 I-clinical_variable
transaminase 60 72 337 349 I-clinical_variable
[ 73 74 350 351 I-clinical_variable
SGOT])/alanine 74 88 351 365 I-clinical_variable
aminotransferase 89 105 366 382 I-clinical_variable
( 106 107 383 384 I-clinical_variable
ALT)(serum 107 117 384 394 I-clinical_variable
glutamate 118 127 395 404 I-clinical_variable
pyruvate 128 136 405 413 I-clinical_variable
transaminase 137 149 414 426 I-clinical_variable
[ 150 151 427 428 I-clinical_variable
SGPT 151 155 428 432 I-clinical_variable
] 155 156 432 433 I-clinical_variable
) 156 157 433 434 O
= 158 159 435 436 O
< 159 160 436 437 O
2.5 161 164 438 441 B-upper_bound
X 165 166 442 443 I-upper_bound
institutional 167 180 444 457 B-clinical_variable
upper 181 186 458 463 I-clinical_variable
limit 187 192 464 469 I-clinical_variable
of 193 195 470 472 I-clinical_variable
normal 196 202 473 479 I-clinical_variable

At 0 2 480 482 O
least 3 8 483 488 O
one 9 12 489 492 B-lower_bound
solid 13 18 493 498 O
liver 19 24 499 504 O
lesion 25 31 505 511 O
or 32 34 512 514 O
vascular 35 43 515 523 B-cancer
tumor 44 49 524 529 I-cancer
thrombosis 50 60 530 540 I-cancer
( 61 62 541 542 O
involving 62 71 542 551 O
portal 72 78 552 558 O
vein 79 83 559 563 O
, 83 84 563 564 O
IVC 85 88 565 568 B-clinical_variable
and/or 89 95 569 575 O
hepatic 96 103 576 583 O
vein 104 108 584 588 O
) 108 109 588 589 O
> 110 111 590 591 O
1 112 113 592 593 B-lower_bound
cm 114 116 594 596 I-lower_bound
with 117 121 597 601 O
arterial 122 130 602 610 O
enhancement 131 142 611 622 O
and 143 146 623 626 O
delayed 147 154 627 634 O
washout 155 162 635 642 O
on 163 165 643 645 O
multiphasic 166 177 646 657 O
computerized 178 190 658 670 B-treatment
tomography 191 201 671 681 I-treatment
( 202 203 682 683 I-treatment
CT 203 205 683 685 I-treatment
) 205 206 685 686 I-treatment
or 207 209 687 689 O
magnetic 210 218 690 698 B-treatment
resonance 219 228 699 708 I-treatment
imaging 229 236 709 716 I-treatment
( 237 238 717 718 I-treatment
MRI 238 241 718 721 I-treatment
) 241 242 721 722 I-treatment
in 243 245 723 725 O
the 246 249 726 729 O
setting 250 257 730 737 O
of 258 260 738 740 O
cirrhosis 261 270 741 750 B-chronic_disease
or 271 273 751 753 O
chronic 274 281 754 761 B-chronic_disease
hepatitis 282 291 762 771 I-chronic_disease
B 292 293 772 773 I-chronic_disease
or 294 296 774 776 I-chronic_disease
C 297 298 777 778 I-chronic_disease
without 299 306 779 786 O
cirrhosis 307 316 787 796 O

Creatinine 0 10 797 807 B-clinical_variable
clearance 11 20 808 817 I-clinical_variable
> 21 22 818 819 O
= 22 23 819 820 O
60 24 26 821 823 B-lower_bound
mL 27 29 824 826 I-lower_bound
/ 29 30 826 827 I-lower_bound
min/1.73 30 38 827 835 I-lower_bound
m^2 39 42 836 839 I-lower_bound
for 43 46 840 843 O
patients 47 55 844 852 O
with 56 60 853 857 O
creatinine 61 71 858 868 B-clinical_variable
levels 72 78 869 875 I-clinical_variable
above 79 84 876 881 O
institutional 85 98 882 895 O
normal 99 105 896 902 O

Creatinine 0 10 903 913 B-clinical_variable
within 11 17 914 920 O
normal 18 24 921 927 O
institutional 25 38 928 941 O
limits 39 45 942 948 O

Eastern 0 7 949 956 B-clinical_variable
Cooperative 8 19 957 968 I-clinical_variable
Oncology 20 28 969 977 I-clinical_variable
Group 29 34 978 983 I-clinical_variable
( 35 36 984 985 I-clinical_variable
ECOG 36 40 985 989 I-clinical_variable
) 40 41 989 990 I-clinical_variable
performance 42 53 991 1002 I-clinical_variable
status 54 60 1003 1009 I-clinical_variable
= 61 62 1010 1011 O
< 62 63 1011 1012 O
2 64 65 1013 1014 B-upper_bound

For 0 3 1015 1018 O
patients 4 12 1019 1027 O
whose 13 18 1028 1033 O
CURRENT 19 26 1034 1041 O
disease 27 34 1042 1049 O
is 35 37 1050 1052 O
vascular 38 46 1053 1061 O
only 47 51 1062 1066 O
: 51 52 1066 1067 O
Enhancing 53 62 1068 1077 O
vascular 63 71 1078 1086 B-chronic_disease
thrombosis 72 82 1087 1097 I-chronic_disease
( 83 84 1098 1099 O
involving 84 93 1099 1108 O
portal 94 100 1109 1115 O
vein 101 105 1116 1120 O
, 105 106 1120 1121 O
IVC 107 110 1122 1125 O
and/or 111 117 1126 1132 O
hepatic 118 125 1133 1140 O
vein 126 130 1141 1145 O
) 130 131 1145 1146 O
demonstrating 132 145 1147 1160 O
early 146 151 1161 1166 O
arterial 152 160 1167 1175 O
enhancement 161 172 1176 1187 O
and 173 176 1188 1191 O
delayed 177 184 1192 1199 O
washout 185 192 1200 1207 O
on 193 195 1208 1210 O
multi 196 201 1211 1216 B-treatment
- 201 202 1216 1217 I-treatment
phasic 202 208 1217 1223 I-treatment
CT 209 211 1224 1226 I-treatment
or 212 214 1227 1229 O
MRI 215 218 1230 1233 B-treatment
, 218 219 1233 1234 O
in 220 222 1235 1237 O
a 223 224 1238 1239 O
patient 225 232 1240 1247 O
with 233 237 1248 1252 O
known 238 243 1253 1258 O
HCC 244 247 1259 1262 B-cancer
( 248 249 1263 1264 O
diagnosed 249 258 1264 1273 O
according 259 268 1274 1283 O
to 269 271 1284 1286 O
criteria 272 280 1287 1295 O
in 281 283 1296 1298 O
( 284 285 1299 1300 O
a 285 286 1300 1301 O
) 286 287 1301 1302 O
or 288 290 1303 1305 O
( 291 292 1306 1307 O
b 292 293 1307 1308 O
) 293 294 1308 1309 O

History 0 7 1310 1317 O
of 8 10 1318 1320 O
allergic 11 19 1321 1329 O
reactions 20 29 1330 1339 O
attributed 30 40 1340 1350 O
to 41 43 1351 1353 O
compounds 44 53 1354 1363 O
of 54 56 1364 1366 O
similar 57 64 1367 1374 O
chemical 65 73 1375 1383 O
or 74 76 1384 1386 O
biologic 77 85 1387 1395 O
composition 86 97 1396 1407 O
to 98 100 1408 1410 O
propranolol 101 112 1411 1422 B-treatment

INR 0 3 1423 1426 B-clinical_variable
< 4 5 1427 1428 O
or 6 8 1429 1431 O
= 9 10 1432 1433 O
1.7 11 14 1434 1437 B-upper_bound

Karnofsky 0 9 1438 1447 B-clinical_variable
> 10 11 1448 1449 O
= 11 12 1449 1450 O
60 13 15 1451 1453 B-lower_bound
% 15 16 1453 1454 I-lower_bound

Leukocytes 0 10 1455 1465 B-clinical_variable
> 11 12 1466 1467 O
= 12 13 1467 1468 O
3,000 14 19 1469 1474 B-lower_bound
/ 19 20 1474 1475 I-lower_bound
mcL 20 23 1475 1478 I-lower_bound

Life 0 4 1479 1483 B-clinical_variable
expectancy 5 15 1484 1494 I-clinical_variable
of 16 18 1495 1497 O
greater 19 26 1498 1505 O
than 27 31 1506 1510 O
6 32 33 1511 1512 B-lower_bound
months 34 40 1513 1519 I-lower_bound

Parameters 0 10 1520 1530 O
for 11 14 1531 1534 O
the 15 18 1535 1538 O
HCC 19 22 1539 1542 B-cancer
cohort 23 29 1543 1549 O

Pathologically 0 14 1550 1564 O
( 15 16 1565 1566 O
histologically 16 30 1566 1580 O
or 31 33 1581 1583 O
cytologically 34 47 1584 1597 O
) 47 48 1597 1598 O
proven 49 55 1599 1605 O
diagnosis 56 65 1606 1615 O
of 66 68 1616 1618 O
HCC 69 72 1619 1622 B-cancer

Patients 0 8 1623 1631 O
( 9 10 1632 1633 O
except 10 16 1633 1639 O
for 17 20 1640 1643 O
the 21 24 1644 1647 O
HCC 25 28 1648 1651 B-cancer
cohort 29 35 1652 1658 O
) 35 36 1658 1659 O
must 37 41 1660 1664 O
have 42 46 1665 1669 O
normal 47 53 1670 1676 O
organ 54 59 1677 1682 O
and 60 63 1683 1686 O
marrow 64 70 1687 1693 O
function 71 79 1694 1702 O

Patients 0 8 1703 1711 O
may 9 12 1712 1715 O
have 13 17 1716 1720 O
had 18 21 1721 1724 O
any 22 25 1725 1728 O
number 26 32 1729 1735 O
of 33 35 1736 1738 O
prior 36 41 1739 1744 O
systemic 42 50 1745 1753 O
therapies 51 60 1754 1763 B-treatment

Patients 0 8 1764 1772 O
may 9 12 1773 1776 O
not 13 16 1777 1780 O
be 17 19 1781 1783 O
receiving 20 29 1784 1793 O
any 30 33 1794 1797 O
other 34 39 1798 1803 B-treatment
investigational 40 55 1804 1819 I-treatment
agents 56 62 1820 1826 I-treatment

Patients 0 8 1827 1835 O
must 9 13 1836 1840 O
have 14 18 1841 1845 O
histologically 19 33 1846 1860 O
- 33 34 1860 1861 O
proven 34 40 1861 1867 O
locally 41 48 1868 1875 O
- 48 49 1875 1876 O
recurrent 49 58 1876 1885 O
or 59 61 1886 1888 O
metastatic 62 72 1889 1899 B-cancer
solid 73 78 1900 1905 I-cancer
tumor 79 84 1906 1911 I-cancer

Patients 0 8 1912 1920 O
who 9 12 1921 1924 O
are 13 16 1925 1928 O
currently 17 26 1929 1938 O
receiving 27 36 1939 1948 O
a 37 38 1949 1950 O
beta 39 43 1951 1955 B-treatment
- 43 44 1955 1956 I-treatment
blocker 44 51 1956 1963 I-treatment
for 52 55 1964 1967 O
another 56 63 1968 1975 O
medical 64 71 1976 1983 O
condition 72 81 1984 1993 O

Patients 0 8 1994 2002 O
who 9 12 2003 2006 O
have 13 17 2007 2011 O
had 18 21 2012 2015 O
chemotherapy 22 34 2016 2028 B-treatment
or 35 37 2029 2031 O
radiotherapy 38 50 2032 2044 B-treatment
within 51 57 2045 2051 O
4 58 59 2052 2053 B-upper_bound
weeks 60 65 2054 2059 I-upper_bound
( 66 67 2060 2061 O
6 67 68 2061 2062 B-upper_bound
weeks 69 74 2063 2068 I-upper_bound
for 75 78 2069 2072 O
nitrosoureas 79 91 2073 2085 B-treatment
or 92 94 2086 2088 O
mitomycin 95 104 2089 2098 B-treatment
C 105 106 2099 2100 I-treatment
) 106 107 2100 2101 O
prior 108 113 2102 2107 O
to 114 116 2108 2110 O
entering 117 125 2111 2119 O
the 126 129 2120 2123 O
study 130 135 2124 2129 O
or 136 138 2130 2132 O
those 139 144 2133 2138 O
who 145 148 2139 2142 O
have 149 153 2143 2147 O
not 154 157 2148 2151 O
recovered 158 167 2152 2161 O
from 168 172 2162 2166 O
adverse 173 180 2167 2174 O
events 181 187 2175 2181 O
due 188 191 2182 2185 O
to 192 194 2186 2188 O
agents 195 201 2189 2195 O
administered 202 214 2196 2208 O
more 215 219 2209 2213 O
than 220 224 2214 2218 O
4 225 226 2219 2220 B-lower_bound
weeks 227 232 2221 2226 I-lower_bound
earlier 233 240 2227 2234 I-lower_bound

Patients 0 8 2235 2243 O
with 9 13 2244 2248 O
brain 14 19 2249 2254 B-cancer
metastases 20 30 2255 2265 I-cancer
may 31 34 2266 2269 O
participate 35 46 2270 2281 O
in 47 49 2282 2284 O
this 50 54 2285 2289 O
clinical 55 63 2290 2298 B-treatment
study 64 69 2299 2304 I-treatment
provided 70 78 2305 2313 O
that 79 83 2314 2318 O
symptoms 84 92 2319 2327 O
have 93 97 2328 2332 O
been 98 102 2333 2337 O
controlled 103 113 2338 2348 O
with 114 118 2349 2353 O
standard 119 127 2354 2362 O
therapies 128 137 2363 2372 B-treatment
and/or 138 144 2373 2379 O
appropriate 145 156 2380 2391 O
medications 157 168 2392 2403 B-treatment

Patients 0 8 2404 2412 O
with 9 13 2413 2417 O
liver 14 19 2418 2423 B-treatment
transplantation 20 35 2424 2439 I-treatment

Patients 0 8 2440 2448 O
with 9 13 2449 2453 O
significant 14 25 2454 2465 O
lung 26 30 2466 2470 B-chronic_disease
disease 31 38 2471 2478 I-chronic_disease
, 38 39 2478 2479 O
an 40 42 2480 2482 O
ejection 43 51 2483 2491 B-clinical_variable
fraction 52 60 2492 2500 I-clinical_variable
less 61 65 2501 2505 O
than 66 70 2506 2510 O
40 71 73 2511 2513 B-upper_bound
% 73 74 2513 2514 I-upper_bound
, 74 75 2514 2515 O
or 76 78 2516 2518 O
a 79 80 2519 2520 O
resting 81 88 2521 2528 B-clinical_variable
heart 89 94 2529 2534 I-clinical_variable
rate 95 99 2535 2539 I-clinical_variable
less 100 104 2540 2544 O
than 105 109 2545 2549 O
60 110 112 2550 2552 B-upper_bound
/ 112 113 2552 2553 I-upper_bound
min 113 116 2553 2556 I-upper_bound
will 117 121 2557 2561 O
not 122 125 2562 2565 O
be 126 128 2566 2568 O
enrolled 129 137 2569 2577 O

Patients 0 8 2578 2586 O
with 9 13 2587 2591 O
worsening 14 23 2592 2601 O
depression 24 34 2602 2612 B-chronic_disease
that 35 39 2613 2617 O
has 40 43 2618 2621 O
not 44 47 2622 2625 O
been 48 52 2626 2630 O
addressed 53 62 2631 2640 O
clinically 63 73 2641 2651 O

Platelets 0 9 2652 2661 B-clinical_variable
> 10 11 2662 2663 O
= 11 12 2663 2664 O
100,000 13 20 2665 2672 B-lower_bound
/ 20 21 2672 2673 I-lower_bound
mcL 21 24 2673 2676 I-lower_bound

Pregnant 0 8 2677 2685 B-pregnancy
women 9 14 2686 2691 B-gender

The 0 3 2692 2695 O
effects 4 11 2696 2703 O
of 12 14 2704 2706 O
propranolol 15 26 2707 2718 B-treatment
on 27 29 2719 2721 O
the 30 33 2722 2725 O
developing 34 44 2726 2736 O
human 45 50 2737 2742 O
fetus 51 56 2743 2748 O
may 57 60 2749 2752 O
be 61 63 2753 2755 O
detrimental 64 75 2756 2767 O

Total 0 5 2768 2773 B-clinical_variable
bilirubin 6 15 2774 2783 I-clinical_variable
within 16 22 2784 2790 O
normal 23 29 2791 2797 O
institutional 30 43 2798 2811 O
limits 44 50 2812 2818 O

Uncontrolled 0 12 2819 2831 O
hypertension 13 25 2832 2844 B-chronic_disease

Uncontrolled 0 12 2845 2857 O
intercurrent 13 25 2858 2870 O
illness 26 33 2871 2878 O
including 34 43 2879 2888 O
, 43 44 2888 2889 O
but 45 48 2890 2893 O
not 49 52 2894 2897 O
limited 53 60 2898 2905 O
to 61 63 2906 2908 O
, 63 64 2908 2909 O
ongoing 65 72 2910 2917 O
or 73 75 2918 2920 O
active 76 82 2921 2927 B-chronic_disease
infection 83 92 2928 2937 I-chronic_disease
, 92 93 2937 2938 O
symptomatic 94 105 2939 2950 O
congestive 106 116 2951 2961 B-chronic_disease
heart 117 122 2962 2967 I-chronic_disease
failure 123 130 2968 2975 I-chronic_disease
, 130 131 2975 2976 O
unstable 132 140 2977 2985 B-chronic_disease
angina 141 147 2986 2992 I-chronic_disease
pectoris 148 156 2993 3001 I-chronic_disease
, 156 157 3001 3002 O
cardiac 158 165 3003 3010 B-chronic_disease
arrhythmia 166 176 3011 3021 I-chronic_disease
, 176 177 3021 3022 O
or 178 180 3023 3025 O
psychiatric 181 192 3026 3037 B-chronic_disease
illness 193 200 3038 3045 I-chronic_disease
/ 200 201 3045 3046 I-chronic_disease
social 201 207 3046 3052 I-chronic_disease
situations 208 218 3053 3063 I-chronic_disease
that 219 223 3064 3068 O
would 224 229 3069 3074 O
limit 230 235 3075 3080 O
compliance 236 246 3081 3091 O
with 247 251 3092 3096 O
study 252 257 3097 3102 O
requirements 258 270 3103 3115 O

absolute 0 8 3116 3124 B-clinical_variable
neutrophil 9 19 3125 3135 I-clinical_variable
count 20 25 3136 3141 I-clinical_variable
> 26 27 3142 3143 O
or 28 30 3144 3146 O
= 31 32 3147 3148 O
1000 32 36 3148 3152 B-lower_bound
/ 36 37 3152 3153 I-lower_bound
mcl 37 40 3153 3156 I-lower_bound

creatinine 0 10 3157 3167 B-clinical_variable
clearance 11 20 3168 3177 I-clinical_variable
> 21 22 3178 3179 O
or 23 25 3180 3182 O
= 26 27 3183 3184 O
60mL 28 32 3185 3189 B-lower_bound
/ 32 33 3189 3190 I-lower_bound
min/1.73m2 33 43 3190 3200 I-lower_bound
for 44 47 3201 3204 O
patients 48 56 3205 3213 O
with 57 61 3214 3218 O
creatinine 62 72 3219 3229 B-clinical_variable
levels 73 79 3230 3236 I-clinical_variable
above 80 85 3237 3242 O
institutional 86 99 3243 3256 O
normal 100 106 3257 3263 O
level 107 112 3264 3269 O

creatinine 0 10 3270 3280 B-clinical_variable
within 11 17 3281 3287 O
normal 18 24 3288 3294 O
institutional 25 38 3295 3308 O
limits 39 45 3309 3315 O

leukocytes 0 10 3316 3326 B-clinical_variable
> 11 12 3327 3328 O
or 13 15 3329 3331 O
= 16 17 3332 3333 O
3000 18 22 3334 3338 B-lower_bound
/ 22 23 3338 3339 I-lower_bound
mcl 23 26 3339 3342 I-lower_bound

patients 0 8 3343 3351 O
need 9 13 3352 3356 O
not 14 17 3357 3360 O
have 18 22 3361 3365 O
exhausted 23 32 3366 3375 O
standard 33 41 3376 3384 O
therapy 42 49 3385 3392 B-treatment
for 50 53 3393 3396 O
their 54 59 3397 3402 O
disease 60 67 3403 3410 O
, 67 68 3410 3411 O
but 69 72 3412 3415 O
must 73 77 3416 3420 O
be 78 80 3421 3423 O
stable 81 87 3424 3430 O
and 88 91 3431 3434 O
must 92 96 3435 3439 O
not 97 100 3440 3443 O
have 101 105 3444 3448 O
actively 106 114 3449 3457 O
progressing 115 126 3458 3469 O

platelets 0 9 3470 3479 B-clinical_variable
> 10 11 3480 3481 O
or 12 14 3482 3484 O
= 15 16 3485 3486 O
70,000 17 23 3487 3493 B-lower_bound

preference 0 10 3494 3504 O
will 11 15 3505 3509 O
be 16 18 3510 3512 O
given 19 24 3513 3518 O
to 25 27 3519 3521 O
patients 28 36 3522 3530 O
with 37 41 3531 3535 O
metastatic 42 52 3536 3546 B-cancer
ovarian 53 60 3547 3554 I-cancer
cancer 61 67 3555 3561 I-cancer
, 67 68 3561 3562 O
breast 69 75 3563 3569 B-cancer
cancer 76 82 3570 3576 I-cancer
, 82 83 3576 3577 O
and 84 87 3578 3581 O
malignant 88 97 3582 3591 B-cancer
melanoma 98 106 3592 3600 I-cancer
, 106 107 3600 3601 O
as 108 110 3602 3604 O
these 111 116 3605 3610 O
malignancies 117 129 3611 3623 B-cancer
have 130 134 3624 3628 O
been 135 139 3629 3633 O
shown 140 145 3634 3639 O
to 146 148 3640 3642 O
be 149 151 3643 3645 O
sensitive 152 161 3646 3655 O
to 162 164 3656 3658 O
manipulation 165 177 3659 3671 O
of 178 180 3672 3674 O
the 181 184 3675 3678 O
beta 185 189 3679 3683 O
- 189 190 3683 3684 O
adrenergic 190 200 3684 3694 O
receptor 201 209 3695 3703 O

the 0 3 3704 3707 O
final 4 9 3708 3713 O
twenty 10 16 3714 3720 O
- 16 17 3720 3721 O
five 17 21 3721 3725 O
patients 22 30 3726 3734 O
to 31 33 3735 3737 O
be 34 36 3738 3740 O
accrued 37 44 3741 3748 O
must 45 49 3749 3753 O
have 50 54 3754 3758 O
locally 55 62 3759 3766 O
- 62 63 3766 3767 O
recurrent 63 72 3767 3776 O
or 73 75 3777 3779 O
metastatic 76 86 3780 3790 B-cancer
malignant 87 96 3791 3800 I-cancer
melanoma 97 105 3801 3809 I-cancer
that 106 110 3810 3814 O
is 111 113 3815 3817 O
not 114 117 3818 3821 O
surgically 118 128 3822 3832 O
resectable 129 139 3833 3843 O

the 0 3 3844 3847 O
first 4 9 3848 3853 O
10 10 12 3854 3856 O
patients 13 21 3857 3865 O
may 22 25 3866 3869 O
have 26 30 3870 3874 O
cancer 31 37 3875 3881 B-cancer
of 38 40 3882 3884 O
any 41 44 3885 3888 O
histology 45 54 3889 3898 O

total 0 5 3899 3904 O
bilirubin 6 15 3905 3914 B-clinical_variable
< 16 17 3915 3916 O
or 18 20 3917 3919 O
= 21 22 3920 3921 O
2mg 23 26 3922 3925 B-upper_bound
/ 26 27 3925 3926 I-upper_bound
dL 27 29 3926 3928 I-upper_bound

women 0 5 3929 3934 B-gender
of 6 8 3935 3937 O
child 9 14 3938 3943 O
- 14 15 3943 3944 O
bearing 15 22 3944 3951 O
potential 23 32 3952 3961 O
and 33 36 3962 3965 O
men 37 40 3966 3969 O
must 41 45 3970 3974 O
agree 46 51 3975 3980 B-contraception_consent
to 52 54 3981 3983 I-contraception_consent
use 55 58 3984 3987 I-contraception_consent
adequate 59 67 3988 3996 I-contraception_consent
contraception 68 81 3997 4010 I-contraception_consent
( 82 83 4011 4012 O
hormonal 83 91 4012 4020 B-contraception_consent
or 92 94 4021 4023 O
barrier 95 102 4024 4031 B-contraception_consent
method 103 109 4032 4038 I-contraception_consent
of 110 112 4039 4041 I-contraception_consent
birth 113 118 4042 4047 I-contraception_consent
control 119 126 4048 4055 I-contraception_consent

> 0 1 0 1 O
20cc 2 6 2 6 B-lower_bound
/ 6 7 6 7 I-lower_bound
hr 7 9 7 9 I-lower_bound
sputum 10 16 10 16 B-clinical_variable
production 17 27 17 27 I-clinical_variable
or 28 30 28 30 O
> 31 32 31 32 O
100 33 36 33 36 B-lower_bound
cc 37 39 37 39 I-lower_bound
's 39 41 39 41 I-lower_bound
hemoptysis/24 42 55 42 55 B-clinical_variable
hrs 56 59 56 59 O

Active 0 6 60 66 O
myocardial 7 17 67 77 B-chronic_disease
ischemia 18 26 78 86 I-chronic_disease
( 27 28 87 88 O
acute 28 33 88 93 O
ST 34 36 94 96 B-chronic_disease
elevation 37 46 97 106 I-chronic_disease
or 47 49 107 109 O
non 50 53 110 113 B-chronic_disease
ST 54 56 114 116 I-chronic_disease
elevation 57 66 117 126 I-chronic_disease
MI 67 69 127 129 I-chronic_disease

Age 0 3 130 133 B-age
> 4 5 134 135 O
/= 5 7 135 137 O
18 8 10 138 140 B-lower_bound
years 11 16 141 146 I-lower_bound
old 17 20 147 150 O

Airway 0 6 151 157 B-chronic_disease
or 7 9 158 160 O
facial 10 16 161 167 B-chronic_disease
trauma 17 23 168 174 I-chronic_disease
that 24 28 175 179 O
would 29 34 180 185 O
hinder 35 41 186 192 O
the 42 45 193 196 O
use 46 49 197 200 O
of 50 52 201 203 O
a 53 54 204 205 O
NIPPV 55 60 206 211 O
mask 61 65 212 216 O

Atrial 0 6 217 223 B-chronic_disease
fibrillation 7 19 224 236 I-chronic_disease
with 20 24 237 241 O
rapid 25 30 242 247 O
ventricular 31 42 248 259 O
response 43 51 260 268 O

Chest 0 5 269 274 B-treatment
radiograph 6 16 275 285 I-treatment
or 17 19 286 288 O
CT 20 22 289 291 B-treatment
scan 23 27 292 296 I-treatment
within 28 34 297 303 O
< 35 36 304 305 O
/= 36 38 305 307 O
3 39 40 308 309 B-upper_bound
months 41 47 310 316 I-upper_bound
prior 48 53 317 322 I-upper_bound
to 54 56 323 325 O
study 57 62 326 331 O
enrollment 63 73 332 342 O
rules 74 79 343 348 O
out 80 83 349 352 O
primary 84 91 353 360 B-cancer
or 92 94 361 363 O
metastatic 95 105 364 374 B-cancer
malignancy 106 116 375 385 I-cancer
in 117 119 386 388 I-cancer
the 120 123 389 392 I-cancer
lungs 124 129 393 398 I-cancer
or 130 132 399 401 O
pleural 133 140 402 409 B-cancer
space 141 146 410 415 I-cancer
as 147 149 416 418 O
a 150 151 419 420 O
significant 152 163 421 432 O
cause 164 169 433 438 O
of 170 172 439 441 O
respiratory 173 184 442 453 B-chronic_disease
insufficiency 185 198 454 467 I-chronic_disease

Clinical 0 8 468 476 O
evidence 9 17 477 485 O
of 18 20 486 488 O
left 21 25 489 493 B-chronic_disease
heart 26 31 494 499 I-chronic_disease
failure 32 39 500 507 I-chronic_disease
as 40 42 508 510 O
the 43 46 511 514 O
main 47 51 515 519 O
etiology 52 60 520 528 O
for 61 64 529 532 O
respiratory 65 76 533 544 O
compromise 77 87 545 555 O

Contraindications 0 17 556 573 O
to 18 20 574 576 O
NIPPV 21 26 577 582 B-treatment
therapy 27 34 583 590 I-treatment

Evidence 0 8 591 599 O
of 9 11 600 602 O
active 12 18 603 609 O
intrathoracic 19 32 610 623 B-cancer
malignancy 33 43 624 634 I-cancer
( 44 45 635 636 I-cancer
primary 45 52 636 643 I-cancer
or 53 55 644 646 I-cancer
metastatic 56 66 647 657 I-cancer
) 66 67 657 658 I-cancer
in 68 70 659 661 O
the 71 74 662 665 O
lungs 75 80 666 671 O
or 81 83 672 674 O
pleural 84 91 675 682 O
space 92 97 683 688 O
that 98 102 689 693 O
is 103 105 694 696 O
a 106 107 697 698 O
significant 108 119 699 710 O
cause 120 125 711 716 O
of 126 128 717 719 O
respiratory 129 140 720 731 B-chronic_disease
insufficiency 141 154 732 745 I-chronic_disease

GCS 0 3 746 749 B-clinical_variable
< 4 5 750 751 O
8 6 7 752 753 B-upper_bound
or 8 10 754 756 O
inadequate 11 21 757 767 O
airway 22 28 768 774 O
protective 29 39 775 785 O
reflexes 40 48 786 794 O

HR 0 2 795 797 B-clinical_variable
> 3 4 798 799 O
120 5 8 800 803 B-lower_bound
bpm 9 12 804 807 I-lower_bound

Have 0 4 808 812 O
a 5 6 813 814 O
diagnosed 7 16 815 824 O
malignancy 17 27 825 835 B-cancer

Inability 0 9 836 845 O
to 10 12 846 848 O
cooperate 13 22 849 858 O
with 23 27 859 863 O
NIPPV 28 33 864 869 B-treatment

Oliguric 0 8 870 878 O
acute 9 14 879 884 B-chronic_disease
renal 15 20 885 890 I-chronic_disease
failure 21 28 891 898 I-chronic_disease

PaO2 0 4 899 903 B-clinical_variable
: 4 5 903 904 O
FiO2 5 9 904 908 B-clinical_variable
ratio 10 15 909 914 I-clinical_variable
< 16 17 915 916 O
/= 17 19 916 918 O
300 20 23 919 922 B-upper_bound
mmHg 24 28 923 927 I-upper_bound
OR 29 31 928 930 O
a 32 33 931 932 O
SpO2 34 38 933 937 B-clinical_variable
: 38 39 937 938 O
FiO2 39 43 938 942 O
< 44 45 943 944 O
/= 45 47 944 946 O
357 48 51 947 950 B-upper_bound

Patient 0 7 951 958 O
already 8 15 959 966 O
on 16 18 967 969 O
NIPPV 19 24 970 975 B-treatment
at 25 27 976 978 O
the 28 31 979 982 O
time 32 36 983 987 O
of 37 39 988 990 O
screening 40 49 991 1000 O

Patients 0 8 1001 1009 O
with 9 13 1010 1014 O
acute 14 19 1015 1020 B-chronic_disease
chronic 20 27 1021 1028 I-chronic_disease
obstructive 28 39 1029 1040 I-chronic_disease
disease 40 47 1041 1048 I-chronic_disease
exacerbation 48 60 1049 1061 I-chronic_disease
as 61 63 1062 1064 O
the 64 67 1065 1068 O
primary 68 75 1069 1076 O
etiology 76 84 1077 1085 O
for 85 88 1086 1089 O
respiratory 89 100 1090 1101 O
failure 101 108 1102 1109 O

Probability 0 11 1110 1121 O
of 12 14 1122 1124 O
survival 15 23 1125 1133 B-clinical_variable
is 24 26 1134 1136 O
at 27 29 1137 1139 O
least 30 35 1140 1145 O
6 36 37 1146 1147 B-lower_bound
months 38 44 1148 1154 I-lower_bound

Recent 0 6 1155 1161 B-treatment
esophageal 7 17 1162 1172 I-treatment
, 17 18 1172 1173 I-treatment
gastric 19 26 1174 1181 I-treatment
or 27 29 1182 1184 I-treatment
bowel 30 35 1185 1190 I-treatment
surgery 36 43 1191 1198 I-treatment
( 44 45 1199 1200 O
within 45 51 1200 1206 O
3 52 53 1207 1208 B-upper_bound
weeks 54 59 1209 1214 I-upper_bound
of 60 62 1215 1217 O
study 63 68 1218 1223 O
enrollment 69 79 1224 1234 O
) 79 80 1234 1235 O

Refusal 0 7 1236 1243 O
to 8 10 1244 1246 O
receive 11 18 1247 1254 O
NIPPV 19 24 1255 1260 B-treatment

Respiratory 0 11 1261 1272 B-chronic_disease
arrest 12 18 1273 1279 I-chronic_disease

Risk 0 4 1280 1284 O
for 5 8 1285 1288 O
gastric 9 16 1289 1296 B-treatment
aspiration 17 27 1297 1307 I-treatment
( 28 29 1308 1309 O
ie 29 31 1309 1311 O
; 31 32 1311 1312 O
ileus 33 38 1313 1318 B-chronic_disease
, 38 39 1318 1319 O
esophageal 40 50 1320 1330 B-chronic_disease
or 51 53 1331 1333 O
bowel 54 59 1334 1339 B-chronic_disease
obstruction 60 71 1340 1351 I-chronic_disease
, 71 72 1351 1352 O
active 73 79 1353 1359 O
vomiting 80 88 1360 1368 O
) 88 89 1368 1369 O

Shock 0 5 1370 1375 B-chronic_disease

Supraventricular 0 16 1376 1392 B-chronic_disease
tachycardia 17 28 1393 1404 I-chronic_disease

Third 0 5 1405 1410 B-chronic_disease
degree 6 12 1411 1417 I-chronic_disease
heart 13 18 1418 1423 I-chronic_disease
block 19 24 1424 1429 I-chronic_disease

Uncontrolled 0 12 1430 1442 O
tachy 13 18 1443 1448 B-chronic_disease
or 19 21 1449 1451 O
bradyarrhythmia 22 37 1452 1467 B-chronic_disease
or 38 40 1468 1470 O
active 41 47 1471 1477 O
myocardial 48 58 1478 1488 B-chronic_disease
ischemia 59 67 1489 1497 I-chronic_disease

Undrained 0 9 1498 1507 O
pneumothorax 10 22 1508 1520 B-chronic_disease
/ 22 23 1520 1521 O
pneumomediastinum 23 40 1521 1538 B-chronic_disease

Ventricular 0 11 1539 1550 B-chronic_disease
tachycardia 12 23 1551 1562 I-chronic_disease
or 24 26 1563 1565 O
nonsustained 27 39 1566 1578 B-chronic_disease
ventricular 40 51 1579 1590 I-chronic_disease
tachycardia 52 63 1591 1602 I-chronic_disease

any 0 3 1603 1606 O
heart 4 9 1607 1612 B-clinical_variable
rate 10 14 1613 1617 I-clinical_variable
less 15 19 1618 1622 O
than 20 24 1623 1627 O
40 25 27 1628 1630 B-upper_bound
bpm 28 31 1631 1634 I-upper_bound

need 0 4 1635 1639 O
for 5 8 1640 1643 O
vasopressor 9 20 1644 1655 B-treatment
therapy 21 28 1656 1663 I-treatment
or 29 31 1664 1666 O
MAP 32 35 1667 1670 O
< 36 37 1671 1672 O
60 38 40 1673 1675 B-upper_bound
despite 41 48 1676 1683 O
fluid 49 54 1684 1689 O
administration 55 69 1690 1704 O

pH 0 2 1705 1707 B-clinical_variable
< 3 4 1708 1709 O
7.30 4 8 1709 1713 B-upper_bound
or 9 11 1714 1716 O
pCO2 12 16 1717 1721 B-clinical_variable
> 17 18 1722 1723 O
50 18 20 1723 1725 B-lower_bound
( 21 22 1726 1727 O
if 22 24 1727 1729 O
available 25 34 1730 1739 O
) 34 35 1739 1740 O

urine 0 5 1741 1746 B-clinical_variable
output 6 12 1747 1753 I-clinical_variable
< 13 14 1754 1755 O
500 15 18 1756 1759 B-upper_bound
ml 19 21 1760 1762 I-upper_bound
/ 21 22 1762 1763 I-upper_bound
day 22 25 1763 1766 I-upper_bound

Any 0 3 0 3 O
current 4 11 4 11 O
major 12 17 12 17 B-chronic_disease
neurological 18 30 18 30 I-chronic_disease
or 31 33 31 33 I-chronic_disease
psychiatric 34 45 34 45 I-chronic_disease
disorder 46 54 46 54 I-chronic_disease
such 55 59 55 59 O
as 60 62 60 62 O
( 63 64 63 64 O
but 64 67 64 67 O
not 68 71 68 71 O
limited 72 79 72 79 O
to 80 82 80 82 O
) 82 83 82 83 O
stroke 84 90 84 90 B-chronic_disease
, 90 91 90 91 O
Parkinson 92 101 92 101 B-chronic_disease
disease 102 109 102 109 I-chronic_disease
, 109 110 109 110 O
Alzheimer 111 120 111 120 B-chronic_disease
disease 121 128 121 128 I-chronic_disease
, 128 129 128 129 O
schizophrenia 130 143 130 143 B-chronic_disease
or 144 146 144 146 O
major 147 152 147 152 B-chronic_disease
depression 153 163 153 163 I-chronic_disease

Any 0 3 164 167 O
current 4 11 168 175 O
major 12 17 176 181 B-chronic_disease
neurological 18 30 182 194 I-chronic_disease
or 31 33 195 197 O
psychiatric 34 45 198 209 B-chronic_disease
disorder 46 54 210 218 I-chronic_disease
unrelated 55 64 219 228 O
to 65 67 229 231 O
TBI 68 71 232 235 B-chronic_disease
, 71 72 235 236 O
such 73 77 237 241 O
as 78 80 242 244 O
( 81 82 245 246 O
but 82 85 246 249 O
not 86 89 250 253 O
limited 90 97 254 261 O
to 98 100 262 264 O
) 100 101 264 265 O
stroke 102 108 266 272 B-chronic_disease
, 108 109 272 273 O
Parkinson 110 119 274 283 B-chronic_disease
disease 120 127 284 291 I-chronic_disease
, 127 128 291 292 O
Alzheimer 129 138 293 302 B-chronic_disease
disease 139 146 303 310 I-chronic_disease
, 146 147 310 311 O
schizophrenia 148 161 312 325 B-chronic_disease
or 162 164 326 328 O
major 165 170 329 334 B-chronic_disease
depression 171 181 335 345 I-chronic_disease

History 0 7 346 353 O
of 8 10 354 356 O
mild 11 15 357 361 B-chronic_disease
to 16 18 362 364 I-chronic_disease
moderate 19 27 365 373 I-chronic_disease
TBI 28 31 374 377 I-chronic_disease

ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
1,000 6 11 6 11 B-lower_bound

Adequate 0 8 12 20 O
organ 9 14 21 26 O
function 15 23 27 35 O
for 24 27 36 39 O
anthracycline 28 41 40 53 B-treatment
and 42 45 54 57 O
taxane 46 52 58 64 B-treatment
based 53 58 65 70 I-treatment
therapy 59 66 71 78 I-treatment

Creatinine 0 10 79 89 B-clinical_variable
< 11 12 90 91 O
1.5 13 16 92 95 B-upper_bound

Dexlansoprazole 0 15 96 111 B-treatment
( 16 17 112 113 I-treatment
Dexilant 17 25 113 121 I-treatment
) 25 26 121 122 I-treatment

ECOG 0 4 123 127 B-clinical_variable
Performance 5 16 128 139 I-clinical_variable
Status 17 23 140 146 I-clinical_variable
0 24 25 147 148 B-lower_bound
- 25 26 148 149 O
1 26 27 149 150 B-upper_bound

ER 0 2 151 153 B-clinical_variable
and 3 6 154 157 O
PR 7 9 158 160 B-clinical_variable
< 10 11 161 162 O
10 12 14 163 165 B-upper_bound
% 14 15 165 166 I-upper_bound

Esomeprazole 0 12 167 179 B-treatment
( 13 14 180 181 I-treatment
Nexium 14 20 181 187 I-treatment
) 20 21 187 188 I-treatment

HER2 0 4 189 193 O
: 4 5 193 194 O
CEP17 6 11 195 200 B-clinical_variable
ratio 12 17 201 206 I-clinical_variable
< 18 19 207 208 O
2.0 20 23 209 212 B-upper_bound
or 24 26 213 215 O
HER2 27 31 216 220 B-clinical_variable
total 32 37 221 226 I-clinical_variable
copy 38 42 227 231 I-clinical_variable
number 43 49 232 238 I-clinical_variable
< 50 51 239 240 O
6 51 52 240 241 B-upper_bound

Has 0 3 242 245 O
not 4 7 246 249 O
had 8 11 250 253 O
menses 12 18 254 260 O
at 19 21 261 263 O
any 22 25 264 267 O
time 26 30 268 272 O
in 31 33 273 275 O
the 34 37 276 279 O
preceding 38 47 280 289 O
24 48 50 290 292 B-upper_bound
consecutive 51 62 293 304 I-upper_bound
months 63 69 305 311 I-upper_bound

Hgb 0 3 312 315 B-clinical_variable
> 4 5 316 317 O
8.5 6 9 318 321 B-lower_bound

IHC 0 3 322 325 B-clinical_variable
0 4 5 326 327 B-lower_bound
or 6 8 328 330 O
1 9 10 331 332 B-upper_bound
+ 10 11 332 333 I-upper_bound

IHC 0 3 334 337 B-clinical_variable
2 4 5 338 339 B-lower_bound
+ 5 6 339 340 O
and 7 10 341 344 O
FISH 11 15 345 349 B-treatment
equivocal 16 25 350 359 O
and 26 29 360 363 O
no 30 32 364 366 O
indication 33 43 367 377 O
for 44 47 378 381 O
HER2 48 52 382 386 B-treatment
targeted 53 61 387 395 I-treatment
therapy 62 69 396 403 I-treatment
based 70 75 404 409 O
on 76 78 410 412 O
the 79 82 413 416 O
treating 83 91 417 425 O
investigators 92 105 426 439 O
discretion 106 116 440 450 O

IHC 0 3 451 454 B-treatment
2 4 5 455 456 O
+ 5 6 456 457 O
and 7 10 458 461 O
FISH 11 15 462 466 B-treatment
negative 16 24 467 475 O

Known 0 5 476 481 O
hypersensitivity 6 22 482 498 O
to 23 25 499 501 O
any 26 29 502 505 O
component 30 39 506 515 O
of 40 42 516 518 O
the 43 46 519 522 O
formulation 47 58 523 534 O
or 59 61 535 537 O
substituted 62 73 538 549 O
benzimidazoles 74 88 550 564 B-allergy_name

LVEF 0 4 565 569 B-clinical_variable
> 5 6 570 571 O
LLN 7 10 572 575 O
based 11 16 576 581 O
on 17 19 582 584 O
cardiac 20 27 585 592 B-treatment
ECHO 28 32 593 597 I-treatment
or 33 35 598 600 O
MUGA 36 40 601 605 B-treatment

Lansoprazole 0 12 606 618 B-treatment
( 13 14 619 620 O
Prevacid 14 22 620 628 B-treatment
) 22 23 628 629 O

Newly 0 5 630 635 O
diagnosed 6 15 636 645 O
triple 16 22 646 652 B-cancer
negative 23 31 653 661 I-cancer
breast 32 38 662 668 I-cancer
cancer 39 45 669 675 I-cancer
( 46 47 676 677 I-cancer
TNBC 47 51 677 681 I-cancer
) 51 52 681 682 I-cancer
clinical 53 61 683 691 B-clinical_variable
stage 62 67 692 697 I-clinical_variable
Ic 68 70 698 700 B-lower_bound
, 70 71 700 701 O
II 72 74 702 704 O
, 74 75 704 705 O
or 76 78 706 708 O
III 79 82 709 712 B-upper_bound

Omeprazole 0 10 713 723 B-treatment
( 11 12 724 725 O
Prilosec 12 20 725 733 B-treatment
, 20 21 733 734 O
Zegerid 22 29 735 742 B-treatment
) 29 30 742 743 O

Pantoprazole 0 12 744 756 B-treatment
( 13 14 757 758 I-treatment
Protonix 14 22 758 766 I-treatment
) 22 23 766 767 I-treatment

Planned 0 7 768 775 O
neoadjuvant 8 19 776 787 B-treatment
treatment 20 29 788 797 I-treatment
with 30 34 798 802 O
anthracycline 35 48 803 816 B-treatment
and 49 52 817 820 O
taxane 53 59 821 827 B-treatment
containing 60 70 828 838 O
chemotherapy 71 83 839 851 B-treatment

Platelets 0 9 852 861 B-clinical_variable
> 10 11 862 863 O
100,000 12 19 864 871 B-lower_bound

Prior 0 5 872 877 B-treatment
hysterectomy 6 18 878 890 I-treatment

Prior 0 5 891 896 O
osteoporotic 6 18 897 909 B-chronic_disease
fracture 19 27 910 918 I-chronic_disease

Rabeprazole 0 11 919 930 B-treatment
( 12 13 931 932 O
Aciphex 13 20 932 939 B-treatment
) 20 21 939 940 O

T. 0 2 941 943 B-clinical_variable
bili 3 7 944 948 I-clinical_variable
< 8 9 949 950 O
1.3 10 13 951 954 B-upper_bound

Use 0 3 955 958 O
of 4 6 959 961 O
OTC 7 10 962 965 B-treatment
PPIs 11 15 966 970 I-treatment
within 16 22 971 977 O
6 23 24 978 979 B-upper_bound
months 25 31 980 986 I-upper_bound
prior 32 37 987 992 I-upper_bound
to 38 40 993 995 O
study 41 46 996 1001 O
entry 47 52 1002 1007 O

Use 0 3 1008 1011 O
of 4 6 1012 1014 O
Orlistat 7 15 1015 1023 B-treatment
or 16 18 1024 1026 O
any 19 22 1027 1030 O
other 23 28 1031 1036 O
known 29 34 1037 1042 O
FASN 35 39 1043 1047 B-treatment
inhibitor 40 49 1048 1057 I-treatment
within 50 56 1058 1064 O
6 57 58 1065 1066 B-upper_bound
months 59 65 1067 1073 I-upper_bound
prior 66 71 1074 1079 I-upper_bound
to 72 74 1080 1082 O
study 75 80 1083 1088 O
entry 81 86 1089 1094 O

Use 0 3 1095 1098 O
of 4 6 1099 1101 O
prescription 7 19 1102 1114 O
PPIs 20 24 1115 1119 B-treatment
within 25 31 1120 1126 O
12 32 34 1127 1129 B-upper_bound
months 35 41 1130 1136 I-upper_bound
prior 42 47 1137 1142 I-upper_bound
to 48 50 1143 1145 O
study 51 56 1146 1151 O
entry 57 62 1152 1157 O

Women 0 5 1158 1163 B-gender
of 6 8 1164 1166 O
childbearing 9 21 1167 1179 O
potential 22 31 1180 1189 O
definition 32 42 1190 1200 O
must 43 47 1201 1205 O
have 48 52 1206 1210 O
a 53 54 1211 1212 O
negative 55 63 1213 1221 B-pregnancy
pregnancy 64 73 1222 1231 I-pregnancy
test 74 78 1232 1236 O
within 79 85 1237 1243 O
14 86 88 1244 1246 B-upper_bound
days 89 93 1247 1251 I-upper_bound
of 94 96 1252 1254 O
registration 97 109 1255 1267 O

bilateral 0 9 1268 1277 B-treatment
oophorectomy 10 22 1278 1290 I-treatment

≥ 0 1 1291 1292 O
18 2 4 1293 1295 B-lower_bound
years 5 10 1296 1301 I-lower_bound
old 11 14 1302 1305 O
at 15 17 1306 1308 O
the 18 21 1309 1312 O
time 22 26 1313 1317 O
of 27 29 1318 1320 O
informed 30 38 1321 1329 O
consent 39 46 1330 1337 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,500 35 40 35 40 B-lower_bound
cells 41 46 41 46 I-lower_bound
/ 46 47 46 47 I-lower_bound
mm^3 47 51 47 51 I-lower_bound

Aspartate 0 9 52 61 B-clinical_variable
aminotransferase 10 26 62 78 I-clinical_variable
( 27 28 79 80 I-clinical_variable
AST 28 31 80 83 I-clinical_variable
) 31 32 83 84 I-clinical_variable
( 33 34 85 86 O
serum 34 39 86 91 B-clinical_variable
glutamic 40 48 92 100 I-clinical_variable
oxaloacetic 49 60 101 112 I-clinical_variable
transaminase 61 73 113 125 I-clinical_variable
[ 74 75 126 127 I-clinical_variable
SGOT])/alanine 75 89 127 141 I-clinical_variable
aminotransferase 90 106 142 158 I-clinical_variable
( 107 108 159 160 I-clinical_variable
ALT 108 111 160 163 I-clinical_variable
) 111 112 163 164 I-clinical_variable
( 113 114 165 166 O
serum 114 119 166 171 B-clinical_variable
glutamate 120 129 172 181 I-clinical_variable
pyruvate 130 138 182 190 I-clinical_variable
transaminase 139 151 191 203 I-clinical_variable
[ 152 153 204 205 I-clinical_variable
SGPT 153 157 205 209 I-clinical_variable
] 157 158 209 210 I-clinical_variable
) 158 159 210 211 O
< 160 161 212 213 O
2.5 162 165 214 217 B-upper_bound
X 166 167 218 219 I-upper_bound
institutional 168 181 220 233 I-upper_bound
ULN 182 185 234 237 I-upper_bound

Before 0 6 238 244 O
administering 7 20 245 258 O
liposomal 21 30 259 268 B-treatment
doxorubicin 31 42 269 280 I-treatment
, 42 43 280 281 O
patients 44 52 282 290 O
must 53 57 291 295 O
wait 58 62 296 300 O
4 63 64 301 302 B-lower_bound
- 64 65 302 303 O
6 65 66 303 304 B-upper_bound
weeks 67 72 305 310 I-upper_bound
after 73 78 311 316 O
surgery 79 86 317 324 O

Computed 0 8 325 333 B-treatment
tomography 9 19 334 344 I-treatment
of 20 22 345 347 O
the 23 26 348 351 O
chest 27 32 352 357 O
, 32 33 357 358 O
abdomen 34 41 359 366 O
, 41 42 366 367 O
and 43 46 368 371 O
pelvis 47 53 372 378 O
( 54 55 379 380 O
CT 55 57 380 382 B-treatment
CAP 58 61 383 386 I-treatment
) 61 62 386 387 O
and 63 66 388 391 O
bone 67 71 392 396 O
scan 72 76 397 401 O
performed 77 86 402 411 O
within 87 93 412 418 O
30 94 96 419 421 B-upper_bound
days 97 101 422 426 I-upper_bound
prior 102 107 427 432 I-upper_bound
to 108 110 433 435 O
study 111 116 436 441 O
entry 117 122 442 447 O
and 123 126 448 451 O
does 127 131 452 456 O
not 132 135 457 460 O
demonstrate 136 147 461 472 O
metastatic 148 158 473 483 B-cancer
disease 159 166 484 491 I-cancer

Creatinine 0 10 492 502 B-clinical_variable
< 11 12 503 504 O
2.5 13 16 505 508 B-upper_bound
mg 17 19 509 511 I-upper_bound
/ 19 20 511 512 I-upper_bound
dL 20 22 512 514 I-upper_bound

Definitive 0 10 515 525 O
clinical 11 19 526 534 O
or 20 22 535 537 O
radiologic 23 33 538 548 O
evidence 34 42 549 557 O
of 43 45 558 560 O
metastatic 46 56 561 571 B-cancer
disease 57 64 572 579 I-cancer

Diagnosis 0 9 580 589 O
of 10 12 590 592 O
inflammatory 13 25 593 605 B-cancer
breast 26 32 606 612 I-cancer
cancer 33 39 613 619 I-cancer

Evidence 0 8 620 628 O
of 9 11 629 631 O
bleeding 12 20 632 640 B-chronic_disease
diathesis 21 30 641 650 I-chronic_disease
or 31 33 651 653 O
coagulopathy 34 46 654 666 B-chronic_disease

Hemoglobin 0 10 667 677 B-clinical_variable
> 11 12 678 679 O
9.0 13 16 680 683 B-lower_bound
g 17 18 684 685 I-lower_bound
/ 18 19 685 686 I-lower_bound
dL 19 21 686 688 I-lower_bound

History 0 7 689 696 O
of 8 10 697 699 O
a 11 12 700 701 O
major 13 18 702 707 B-treatment
organ 19 24 708 713 I-treatment
allograft 25 34 714 723 I-treatment
or 35 37 724 726 O
condition 38 47 727 736 O
requiring 48 57 737 746 O
chronic 58 65 747 754 B-treatment
immunosuppression 66 83 755 772 I-treatment
, 83 84 772 773 O
e.g. 85 89 774 778 O
, 89 90 778 779 O
kidney 91 97 780 786 O
, 97 98 786 787 O
liver 99 104 788 793 O
, 104 105 793 794 O
lung 106 110 795 799 O
, 110 111 799 800 O
heart 112 117 801 806 O
, 117 118 806 807 O
bone 119 123 808 812 O
marrow 124 130 813 819 O
transplant 131 141 820 830 O
, 141 142 830 831 O
or 143 145 832 834 O
autoimmune 146 156 835 845 B-chronic_disease
diseases 157 165 846 854 I-chronic_disease

History 0 7 855 862 O
of 8 10 863 865 O
hypersensitivity 11 27 866 882 O
reactions 28 37 883 892 O
attributed 38 48 893 903 O
to 49 51 904 906 O
a 52 53 907 908 O
conventional 54 66 909 921 O
formulation 67 78 922 933 O
of 79 81 934 936 O
doxorubicin 82 93 937 948 B-allergy_name
hydrochloride 94 107 949 962 I-allergy_name
( 108 109 963 964 I-allergy_name
HCL 109 112 964 967 I-allergy_name
) 112 113 967 968 I-allergy_name
or 114 116 969 971 O
the 117 120 972 975 O
components 121 131 976 986 O
of 132 134 987 989 O
doxil 135 140 990 995 B-allergy_name
, 140 141 995 996 O
paclitaxel 142 152 997 1007 B-allergy_name
, 152 153 1007 1008 O
or 154 156 1009 1011 O
carboplatin 157 168 1012 1023 B-allergy_name

Imaging 0 7 1024 1031 O
by 8 10 1032 1034 O
magnetic 11 19 1035 1043 O
resonance 20 29 1044 1053 O
imaging 30 37 1054 1061 O
( 38 39 1062 1063 O
MRI 39 42 1063 1066 O
) 42 43 1066 1067 O
, 43 44 1067 1068 O
ultrasound 45 55 1069 1079 O
and/or 56 62 1080 1086 O
mammogram 63 72 1087 1096 O
and 73 76 1097 1100 O
physical 77 85 1101 1109 O
exam 86 90 1110 1114 O
to 91 93 1115 1117 O
document 94 102 1118 1126 O
lesions 103 110 1127 1134 O
size 111 115 1135 1139 O
must 116 120 1140 1144 O
be 121 123 1145 1147 O
performed 124 133 1148 1157 O
within 134 140 1158 1164 O
30 141 143 1165 1167 B-upper_bound
days 144 148 1168 1172 I-upper_bound
of 149 151 1173 1175 O
study 152 157 1176 1181 O
entry 158 163 1182 1187 O

Intrinsic 0 9 1188 1197 B-chronic_disease
lung 10 14 1198 1202 I-chronic_disease
disease 15 22 1203 1210 I-chronic_disease
resulting 23 32 1211 1220 O
in 33 35 1221 1223 O
moderate 36 44 1224 1232 O
to 45 47 1233 1235 O
severe 48 54 1236 1242 O
dyspnea 55 62 1243 1250 B-chronic_disease

Known 0 5 1251 1256 O
or 6 8 1257 1259 O
active 9 15 1260 1266 O
hepatitis 16 25 1267 1276 B-chronic_disease
B 26 27 1277 1278 I-chronic_disease
or 28 30 1279 1281 I-chronic_disease
C 31 32 1282 1283 I-chronic_disease
with 33 37 1284 1288 O
abnormal 38 46 1289 1297 B-chronic_disease
liver 47 52 1298 1303 I-chronic_disease
function 53 61 1304 1312 I-chronic_disease
tests 62 67 1313 1318 O

Life 0 4 1319 1323 B-clinical_variable
expectancy 5 15 1324 1334 I-clinical_variable
> 16 17 1335 1336 O
= 17 18 1336 1337 O
52 19 21 1338 1340 B-lower_bound
weeks 22 27 1341 1346 I-lower_bound
excluding 28 37 1347 1356 O
their 38 43 1357 1362 O
diagnosis 44 53 1363 1372 O
of 54 56 1373 1375 O
breast 57 63 1376 1382 B-cancer
cancer 64 70 1383 1389 I-cancer

Myocardial 0 10 1390 1400 B-chronic_disease
infarct 11 18 1401 1408 I-chronic_disease
or 19 21 1409 1411 O
unstable 22 30 1412 1420 B-chronic_disease
angina 31 37 1421 1427 I-chronic_disease
within 38 44 1428 1434 O
6 45 46 1435 1436 B-upper_bound
months 47 53 1437 1443 I-upper_bound
before 54 60 1444 1450 O
enrollment 61 71 1451 1461 O
, 71 72 1461 1462 O
New 73 76 1463 1466 B-clinical_variable
York 77 81 1467 1471 I-clinical_variable
Heart 82 87 1472 1477 I-clinical_variable
Association 88 99 1478 1489 I-clinical_variable
( 100 101 1490 1491 I-clinical_variable
NYHA 101 105 1491 1495 I-clinical_variable
) 105 106 1495 1496 I-clinical_variable
class 107 112 1497 1502 B-lower_bound
II 113 115 1503 1505 I-lower_bound
or 116 118 1506 1508 O
greater 119 126 1509 1516 O
heart 127 132 1517 1522 B-chronic_disease
failure 133 140 1523 1530 I-chronic_disease
, 140 141 1530 1531 O
uncontrolled 142 154 1532 1544 O
angina 155 161 1545 1551 O
, 161 162 1551 1552 O
severe 163 169 1553 1559 O
uncontrolled 170 182 1560 1572 O
ventricular 183 194 1573 1584 B-chronic_disease
arrhythmias 195 206 1585 1596 I-chronic_disease
, 206 207 1596 1597 O
clinically 208 218 1598 1608 O
significant 219 230 1609 1620 O
pericardial 231 242 1621 1632 B-chronic_disease
disease 243 250 1633 1640 I-chronic_disease
, 250 251 1640 1641 O
valvular 252 260 1642 1650 B-chronic_disease
disease 261 268 1651 1658 I-chronic_disease
with 269 273 1659 1663 O
documented 274 284 1664 1674 O
compromise 285 295 1675 1685 O
in 296 298 1686 1688 O
cardiac 299 306 1689 1696 O
function 307 315 1697 1705 O
, 315 316 1705 1706 O
or 317 319 1707 1709 O
electrocardiographic 320 340 1710 1730 B-treatment
evidence 341 349 1731 1739 O
of 350 352 1740 1742 O
acute 353 358 1743 1748 B-chronic_disease
ischemic 359 367 1749 1757 I-chronic_disease
or 368 370 1758 1760 O
active 371 377 1761 1767 B-chronic_disease
conduction 378 388 1768 1778 I-chronic_disease
system 389 395 1779 1785 I-chronic_disease
abnormalities 396 409 1786 1799 I-chronic_disease

Negative 0 8 1800 1808 B-pregnancy
serum 9 14 1809 1814 I-pregnancy
or 15 17 1815 1817 I-pregnancy
urine 18 23 1818 1823 I-pregnancy
beta 24 28 1824 1828 I-pregnancy
- 28 29 1828 1829 I-pregnancy
human 29 34 1829 1834 I-pregnancy
chorionic 35 44 1835 1844 I-pregnancy
gonadotropin 45 57 1845 1857 I-pregnancy
( 58 59 1858 1859 I-pregnancy
hCG 59 62 1859 1862 I-pregnancy
) 62 63 1862 1863 I-pregnancy
pregnancy 64 73 1864 1873 I-pregnancy
test 74 78 1874 1878 O
at 79 81 1879 1881 O
screening 82 91 1882 1891 O
for 92 95 1892 1895 O
patients 96 104 1896 1904 O
of 105 107 1905 1907 O
child 108 113 1908 1913 O
- 113 114 1913 1914 O
bearing 114 121 1914 1921 O
potential 122 131 1922 1931 O
within 132 138 1932 1938 O
one 139 142 1939 1942 B-upper_bound
week 143 147 1943 1947 I-upper_bound
prior 148 153 1948 1953 I-upper_bound
to 154 156 1954 1956 O
enrollment 157 167 1957 1967 O

Nervous 0 7 1968 1975 B-chronic_disease
system 8 14 1976 1982 I-chronic_disease
disorder 15 23 1983 1991 I-chronic_disease
( 24 25 1992 1993 O
paresthesias 25 37 1993 2005 B-chronic_disease
, 37 38 2005 2006 O
peripheral 39 49 2007 2017 B-chronic_disease
motor 50 55 2018 2023 I-chronic_disease
neuropathy 56 66 2024 2034 I-chronic_disease
, 66 67 2034 2035 O
or 68 70 2036 2038 O
peripheral 71 81 2039 2049 B-chronic_disease
sensory 82 89 2050 2057 I-chronic_disease
neuropathy 90 100 2058 2068 I-chronic_disease
) 100 101 2068 2069 O
> 102 103 2070 2071 O
= 103 104 2071 2072 O
grade 105 110 2073 2078 B-lower_bound
2 111 112 2079 2080 I-lower_bound
, 112 113 2080 2081 O
per 114 117 2082 2085 O
the 118 121 2086 2089 O
Common 122 128 2090 2096 O
Terminology 129 140 2097 2108 O
Criteria 141 149 2109 2117 O
for 150 153 2118 2121 O
Adverse 154 161 2122 2129 O
Events 162 168 2130 2136 O
version 169 176 2137 2144 O
4.0 177 180 2145 2148 O
( 181 182 2149 2150 O
CTCAE 182 187 2150 2155 O
v4.0 188 192 2156 2160 O
) 192 193 2160 2161 O

Patients 0 8 2162 2170 O
may 9 12 2171 2174 O
not 13 16 2175 2178 O
receive 17 24 2179 2186 O
concurrent 25 35 2187 2197 O
treatment 36 45 2198 2207 B-treatment
with 46 50 2208 2212 O
other 51 56 2213 2218 O
investigational 57 72 2219 2234 B-treatment
or 73 75 2235 2237 I-treatment
commercial 76 86 2238 2248 I-treatment
agent(s 87 94 2249 2256 I-treatment
) 94 95 2256 2257 I-treatment
for 96 99 2258 2261 O
treatment 100 109 2262 2271 O
of 110 112 2272 2274 O
their 113 118 2275 2280 O
breast 119 125 2281 2287 B-cancer
cancer 126 132 2288 2294 I-cancer

Patients 0 8 2295 2303 O
must 9 13 2304 2308 O
be 14 16 2309 2311 O
eligible 17 25 2312 2320 O
to 26 28 2321 2323 O
undergo 29 36 2324 2331 O
surgery 37 44 2332 2339 B-treatment
, 44 45 2339 2340 O
either 46 52 2341 2347 O
lumpectomy 53 63 2348 2358 B-treatment
or 64 66 2359 2361 O
mastectomy 67 77 2362 2372 B-treatment
for 78 81 2373 2376 O
local 82 87 2377 2382 B-treatment
treatment 88 97 2383 2392 I-treatment
of 98 100 2393 2395 O
the 101 104 2396 2399 O
breast 105 111 2400 2406 B-cancer
cancer 112 118 2407 2413 I-cancer

Patients 0 8 2414 2422 O
must 9 13 2423 2427 O
have 14 18 2428 2432 O
an 19 21 2433 2435 O
Eastern 22 29 2436 2443 B-clinical_variable
Cooperative 30 41 2444 2455 I-clinical_variable
Oncology 42 50 2456 2464 I-clinical_variable
Group 51 56 2465 2470 I-clinical_variable
( 57 58 2471 2472 I-clinical_variable
ECOG 58 62 2472 2476 I-clinical_variable
) 62 63 2476 2477 I-clinical_variable
performance 64 75 2478 2489 I-clinical_variable
status 76 82 2490 2496 I-clinical_variable
< 83 84 2497 2498 O
2 85 86 2499 2500 B-upper_bound

Patients 0 8 2501 2509 O
with 9 13 2510 2514 O
reproductive 14 26 2515 2527 O
potential 27 36 2528 2537 O
must 37 41 2538 2542 O
use 42 45 2543 2546 B-contraception_consent
an 46 48 2547 2549 I-contraception_consent
adequate 49 57 2550 2558 I-contraception_consent
contraceptive 58 71 2559 2572 I-contraception_consent
method 72 78 2573 2579 I-contraception_consent
( 79 80 2580 2581 O
e.g. 80 84 2581 2585 O
abstinence 85 95 2586 2596 B-contraception_consent
, 95 96 2596 2597 O
intrauterine 97 109 2598 2610 B-contraception_consent
device 110 116 2611 2617 I-contraception_consent
, 116 117 2617 2618 O
oral 118 122 2619 2623 B-contraception_consent
contraceptives 123 137 2624 2638 I-contraception_consent
, 137 138 2638 2639 O
barrier 139 146 2640 2647 B-contraception_consent
device 147 153 2648 2654 I-contraception_consent
with 154 158 2655 2659 I-contraception_consent
spermicide 159 169 2660 2670 I-contraception_consent
or 170 172 2671 2673 O
surgical 173 181 2674 2682 B-contraception_consent
sterilization 182 195 2683 2696 I-contraception_consent
) 195 196 2696 2697 O
during 197 203 2698 2704 O
treatment 204 213 2705 2714 B-treatment
and 214 217 2715 2718 O
for 218 221 2719 2722 O
three 222 227 2723 2728 B-upper_bound
months 228 234 2729 2735 I-upper_bound
after 235 240 2736 2741 O
completing 241 251 2742 2752 O
treatment 252 261 2753 2762 O

Platelets 0 9 2763 2772 B-clinical_variable
> 10 11 2773 2774 O
= 11 12 2774 2775 O
100,000 13 20 2776 2783 B-lower_bound
cells 21 26 2784 2789 I-lower_bound
/ 26 27 2789 2790 I-lower_bound
mm^3 27 31 2790 2794 I-lower_bound

Prior 0 5 2795 2800 O
anthracycline 6 19 2801 2814 B-treatment
, 19 20 2814 2815 O
platinum 21 29 2816 2824 O
salt 30 34 2825 2829 O
, 34 35 2829 2830 O
or 36 38 2831 2833 O
taxane 39 45 2834 2840 B-treatment
for 46 49 2841 2844 O
any 50 53 2845 2848 O
malignancy 54 64 2849 2859 B-cancer

Second 0 6 2860 2866 B-cancer
primary 7 14 2867 2874 I-cancer
malignancy 15 25 2875 2885 I-cancer
except 26 32 2886 2892 O
most 33 37 2893 2897 O
situ 38 42 2898 2902 B-cancer
carcinoma 43 52 2903 2912 I-cancer
( 53 54 2913 2914 O
e.g. 54 58 2914 2918 O
in 59 61 2919 2921 B-cancer
situ 62 66 2922 2926 I-cancer
carcinoma 67 76 2927 2936 I-cancer
of 77 79 2937 2939 I-cancer
the 80 83 2940 2943 I-cancer
cervix 84 90 2944 2950 I-cancer
, 90 91 2950 2951 O
adequately 92 102 2952 2962 O
treated 103 110 2963 2970 O
non 111 114 2971 2974 B-cancer
- 114 115 2974 2975 I-cancer
melanomatous 115 127 2975 2987 I-cancer
carcinoma 128 137 2988 2997 I-cancer
of 138 140 2998 3000 I-cancer
the 141 144 3001 3004 I-cancer
skin 145 149 3005 3009 I-cancer
) 149 150 3009 3010 O
or 151 153 3011 3013 O
other 154 159 3014 3019 O
malignancy 160 170 3020 3030 O
treated 171 178 3031 3038 O
at 179 181 3039 3041 O
least 182 187 3042 3047 O
5 188 189 3048 3049 B-lower_bound
years 190 195 3050 3055 I-lower_bound
previously 196 206 3056 3066 O
with 207 211 3067 3071 O
no 212 214 3072 3074 O
evidence 215 223 3075 3083 O
of 224 226 3084 3086 O
recurrence 227 237 3087 3097 O

Serious 0 7 3098 3105 O
concomitant 8 19 3106 3117 B-chronic_disease
systemic 20 28 3118 3126 I-chronic_disease
disorders 29 38 3127 3136 I-chronic_disease
( 39 40 3137 3138 O
including 40 49 3138 3147 O
active 50 56 3148 3154 B-chronic_disease
infections 57 67 3155 3165 I-chronic_disease
or 68 70 3166 3168 O
chronic 71 78 3169 3176 B-chronic_disease
infection 79 88 3177 3186 I-chronic_disease
requiring 89 98 3187 3196 O
suppressive 99 110 3197 3208 B-treatment
antibiotics 111 122 3209 3220 I-treatment
) 122 123 3220 3221 O
that 124 128 3222 3226 O
would 129 134 3227 3232 O
compromise 135 145 3233 3243 O
the 146 149 3244 3247 O
safety 150 156 3248 3254 O
of 157 159 3255 3257 O
the 160 163 3258 3261 O
patient 164 171 3262 3269 O
or 172 174 3270 3272 O
compromise 175 185 3273 3283 O
the 186 189 3284 3287 O
patient 190 197 3288 3295 O
's 197 199 3295 3297 O
ability 200 207 3298 3305 O
to 208 210 3306 3308 O
complete 211 219 3309 3317 O
the 220 223 3318 3321 O
study 224 229 3322 3327 O
, 229 230 3327 3328 O
at 231 233 3329 3331 O
the 234 237 3332 3335 O
discretion 238 248 3336 3346 O
of 249 251 3347 3349 O
the 252 255 3350 3353 O
investigator 256 268 3354 3366 O

Significant 0 11 3367 3378 O
vascular 12 20 3379 3387 B-chronic_disease
disease 21 28 3388 3395 I-chronic_disease
( 29 30 3396 3397 O
e.g. 30 34 3397 3401 O
, 34 35 3401 3402 O
aortic 36 42 3403 3409 B-chronic_disease
aneurysm 43 51 3410 3418 I-chronic_disease
, 51 52 3418 3419 O
aortic 53 59 3420 3426 B-chronic_disease
dissection 60 70 3427 3437 I-chronic_disease
) 70 71 3437 3438 O

Submission 0 10 3439 3449 O
of 11 13 3450 3452 O
tumor 14 19 3453 3458 B-cancer
samples 20 27 3459 3466 O
from 28 32 3467 3471 O
the 33 36 3472 3475 O
diagnostic 37 47 3476 3486 O
biopsy 48 54 3487 3493 B-treatment
and 55 58 3494 3497 O
breast 59 65 3498 3504 B-treatment
surgery 66 73 3505 3512 I-treatment
is 74 76 3513 3515 O
required 77 85 3516 3524 O
for 86 89 3525 3528 O
all 90 93 3529 3532 O
patients 94 102 3533 3541 O

Symptomatic 0 11 3542 3553 O
peripheral 12 22 3554 3564 B-chronic_disease
vascular 23 31 3565 3573 I-chronic_disease
disease 32 39 3574 3581 I-chronic_disease

Total 0 5 3582 3587 O
bilirubin 6 15 3588 3597 B-clinical_variable
< 16 17 3598 3599 O
1.5 18 21 3600 3603 B-upper_bound
X 22 23 3604 3605 I-upper_bound
upper 24 29 3606 3611 I-upper_bound
limit 30 35 3612 3617 I-upper_bound
of 36 38 3618 3620 I-upper_bound
normal 39 45 3621 3627 I-upper_bound
( 46 47 3628 3629 I-upper_bound
ULN 47 50 3629 3632 I-upper_bound
) 50 51 3632 3633 I-upper_bound

Women 0 5 3634 3639 B-gender
who 6 9 3640 3643 O
are 10 13 3644 3647 B-pregnancy
pregnant 14 22 3648 3656 I-pregnancy

Women 0 5 3657 3662 B-gender
with 6 10 3663 3667 O
previously 11 21 3668 3678 O
untreated 22 31 3679 3688 O
, 31 32 3688 3689 O
unilateral 33 43 3690 3700 O
stage 44 49 3701 3706 B-lower_bound
II 50 52 3707 3709 I-lower_bound
- 52 53 3709 3710 O
III 53 56 3710 3713 B-upper_bound
breast 57 63 3714 3720 B-cancer
cancer 64 70 3721 3727 I-cancer
, 70 71 3727 3728 O
ER 72 74 3729 3731 B-clinical_variable
/ 74 75 3731 3732 O
PgR 75 78 3732 3735 B-clinical_variable
/ 78 79 3735 3736 O
HER2 79 83 3736 3740 B-clinical_variable
negative 84 92 3741 3749 O
( 93 94 3750 3751 O
ER 94 96 3751 3753 O
= 97 98 3754 3755 O
< 98 99 3755 3756 O
5 100 101 3757 3758 B-upper_bound
% 101 102 3758 3759 I-upper_bound
, 102 103 3759 3760 O
PgR 104 107 3761 3764 O
= 108 109 3765 3766 O
< 109 110 3766 3767 O
5 111 112 3768 3769 O
% 112 113 3769 3770 O
, 113 114 3770 3771 O
HER2 115 119 3772 3776 O
0 120 121 3777 3778 B-lower_bound
- 121 122 3778 3779 O
1 122 123 3779 3780 B-upper_bound
+ 123 124 3780 3781 O
by 125 127 3782 3784 O
immunohistochemistry 128 148 3785 3805 B-treatment
[ 149 150 3806 3807 I-treatment
IHC 150 153 3807 3810 I-treatment
] 153 154 3810 3811 I-treatment
or 155 157 3812 3814 O
fluorescence 158 170 3815 3827 B-treatment
in 171 173 3828 3830 I-treatment
situ 174 178 3831 3835 I-treatment
hybridization 179 192 3836 3849 I-treatment
[ 193 194 3850 3851 I-treatment
FISH 194 198 3851 3855 I-treatment
] 198 199 3855 3856 I-treatment
= 200 201 3857 3858 O
< 201 202 3858 3859 O
2.0 203 206 3860 3863 B-upper_bound
) 206 207 3863 3864 O
; 207 208 3864 3865 O
if 209 211 3866 3868 O
clinically 212 222 3869 3879 O
negative 223 231 3880 3888 O
lymph 232 237 3889 3894 O
nodes 238 243 3895 3900 O
, 243 244 3900 3901 O
tumor 245 250 3902 3907 B-cancer
size 251 255 3908 3912 O
should 256 262 3913 3919 O
be 263 265 3920 3922 O
minimum 266 273 3923 3930 O
1.0 274 277 3931 3934 B-lower_bound
cm 278 280 3935 3937 I-lower_bound
and 281 284 3938 3941 O
identifiable 285 297 3942 3954 O
under 298 303 3955 3960 O
office 304 310 3961 3967 O
- 310 311 3967 3968 O
based 311 316 3968 3973 O
ultrasound 317 327 3974 3984 B-treatment
guidance 328 336 3985 3993 O

axillary 0 8 3994 4002 B-treatment
exploration 9 20 4003 4014 I-treatment
at 21 23 4015 4017 O
discretion 24 34 4018 4028 O
of 35 37 4029 4031 O
surgeon 38 45 4032 4039 O
but 46 49 4040 4043 O
all 50 53 4044 4047 O
patients 54 62 4048 4056 O
minimally 63 72 4057 4066 O
have 73 77 4067 4071 O
sentinel 78 86 4072 4080 O
lymph 87 92 4081 4086 O
node 93 97 4087 4091 O
evaluation 98 108 4092 4102 O
at 109 111 4103 4105 O
time 112 116 4106 4110 O
of 117 119 4111 4113 O
surgery 120 127 4114 4121 B-treatment

imaging 0 7 4122 4129 O
must 8 12 4130 4134 O
have 13 17 4135 4139 O
been 18 22 4140 4144 O
performed 23 32 4145 4154 O
no 33 35 4155 4157 O
greater 36 43 4158 4165 O
than 44 48 4166 4170 O
30 49 51 4171 4173 B-upper_bound
days 52 56 4174 4178 I-upper_bound
prior 57 62 4179 4184 I-upper_bound
to 63 65 4185 4187 O
initiation 66 76 4188 4198 O
of 77 79 4199 4201 O
chemotherapy 80 92 4202 4214 B-treatment

patients 0 8 4215 4223 O
who 9 12 4224 4227 O
have 13 17 4228 4232 O
received 18 26 4233 4241 O
corneal 27 34 4242 4249 B-treatment
transplants 35 46 4250 4261 I-treatment
, 46 47 4261 4262 O
cadaver 48 55 4263 4270 B-treatment
skin 56 60 4271 4275 I-treatment
, 60 61 4275 4276 O
or 62 64 4277 4279 O
bone 65 69 4280 4284 B-treatment
transplants 70 81 4285 4296 I-treatment
are 82 85 4297 4300 O
eligible 86 94 4301 4309 O

this 0 4 4310 4314 O
includes 5 13 4315 4323 O
treatment 14 23 4324 4333 B-treatment
with 24 28 4334 4338 O
corticosteroids 29 44 4339 4354 B-treatment
within 45 51 4355 4361 O
one 52 55 4362 4365 B-upper_bound
month 56 61 4366 4371 I-upper_bound
( 62 63 4372 4373 O
dose 63 67 4373 4377 O
of 68 70 4378 4380 O
> 71 72 4381 4382 O
= 72 73 4382 4383 O
10 74 76 4384 4386 B-lower_bound
mg 77 79 4387 4389 I-lower_bound
/ 79 80 4389 4390 I-lower_bound
day 80 83 4390 4393 I-lower_bound
methylprednisolone 84 102 4394 4412 B-treatment
equivalent 103 113 4413 4423 O
) 113 114 4423 4424 O
( 115 116 4425 4426 O
excluding 116 125 4426 4435 O
inhaled 126 133 4436 4443 O
steroids 134 142 4444 4452 O
) 142 143 4452 4453 O

Coronary 0 8 0 8 B-treatment
stent 9 14 9 14 I-treatment
placement 15 24 15 24 I-treatment
within 25 31 25 31 O
the 32 35 32 35 O
previous 36 44 36 44 B-upper_bound
6 45 46 45 46 I-upper_bound
months 47 53 47 53 I-upper_bound

Creatinine 0 10 54 64 B-clinical_variable
clearance 11 20 65 74 I-clinical_variable
less 21 25 75 79 O
than 26 30 80 84 O
30 31 33 85 87 B-upper_bound
mL 34 36 88 90 I-upper_bound
/ 36 37 90 91 I-upper_bound
min 37 40 91 94 I-upper_bound

Disseminated 0 12 95 107 B-chronic_disease
intravascular 13 26 108 121 I-chronic_disease
coagulation 27 38 122 133 I-chronic_disease

History 0 7 134 141 O
of 8 10 142 144 O
CVA 11 14 145 148 B-chronic_disease
, 14 15 148 149 O
MI 16 18 150 152 B-chronic_disease
, 18 19 152 153 O
or 20 22 154 156 O
VTE 23 26 157 160 B-chronic_disease
within 27 33 161 167 O
the 34 37 168 171 O
previous 38 46 172 180 B-upper_bound
30 47 49 181 183 I-upper_bound
days 50 54 184 188 I-upper_bound

History 0 7 189 196 O
of 8 10 197 199 O
unprovoked 11 21 200 210 B-cancer
VTE 22 25 211 214 I-cancer
and/or 26 32 215 221 O
recurrent 33 42 222 231 B-cancer
VTE 43 46 232 235 I-cancer

Intracranial 0 12 236 248 B-chronic_disease
hemorrhage 13 23 249 259 I-chronic_disease

Known 0 5 260 265 O
history 6 13 266 273 O
of 14 16 274 276 O
Factor 17 23 277 283 B-chronic_disease
V 24 25 284 285 I-chronic_disease
Leiden 26 32 286 292 I-chronic_disease
, 32 33 292 293 O
protein 34 41 294 301 B-chronic_disease
C 42 43 302 303 I-chronic_disease
/ 43 44 303 304 I-chronic_disease
S 44 45 304 305 I-chronic_disease
deficiency 46 56 306 316 I-chronic_disease
, 56 57 316 317 O
prothrombin 58 69 318 329 B-chronic_disease
gene 70 74 330 334 I-chronic_disease
mutation 75 83 335 343 I-chronic_disease
, 83 84 343 344 O
anti 85 89 345 349 B-chronic_disease
- 89 90 349 350 I-chronic_disease
thrombin 90 98 350 358 I-chronic_disease
deficiency 99 109 359 369 I-chronic_disease
, 109 110 369 370 O
anti 111 115 371 375 B-chronic_disease
- 115 116 375 376 I-chronic_disease
phospholipid 116 128 376 388 I-chronic_disease
antibody 129 137 389 397 I-chronic_disease
syndrome 138 146 398 406 I-chronic_disease
, 146 147 406 407 O
lupus 148 153 408 413 B-chronic_disease
anticoagulan 154 166 414 426 I-chronic_disease

Surgically 0 10 427 437 O
treated 11 18 438 445 O
with 19 23 446 450 O
sliding 24 31 451 458 O
hip 32 35 459 462 O
screw 36 41 463 468 O
or 42 44 469 471 O
cephalomedullary 45 61 472 488 B-treatment
nail 62 66 489 493 I-treatment
( 67 68 494 495 O
short 68 73 495 500 O
or 74 76 501 503 O
long 77 81 504 508 O
) 81 82 508 509 O

able 0 4 0 4 O
to 5 7 5 7 O
travel 8 14 8 14 O
to 15 17 15 17 O
the 18 21 18 21 O
exercise 22 30 22 30 O
facility 31 39 31 39 O
a 40 41 40 41 O
minimum 42 49 42 49 O
of 50 52 50 52 O
3 53 54 53 54 B-lower_bound
times 55 60 55 60 I-lower_bound
/ 60 61 60 61 I-lower_bound
week 61 65 61 65 I-lower_bound

angina 0 6 66 72 B-chronic_disease
and/or 7 13 73 79 O
evidence 14 22 80 88 O
of 23 25 89 91 O
acute 26 31 92 97 B-chronic_disease
myocardial 32 42 98 108 I-chronic_disease
ischemia 43 51 109 117 I-chronic_disease
during 52 58 118 124 O
a 59 60 125 126 O
treadmill 61 70 127 136 O
test 71 75 137 141 O

anti 0 4 142 146 B-treatment
- 4 5 146 147 I-treatment
resorptive 5 15 147 157 I-treatment
drug 16 20 158 162 I-treatment
use 21 24 163 166 O
in 25 27 167 169 O
the 28 31 170 173 O
last 32 36 174 178 O
2 37 38 179 180 B-upper_bound
years 39 44 181 186 I-upper_bound

initiation 0 10 187 197 O
of 11 13 198 200 O
treatments 14 24 201 211 B-treatment
that 25 29 212 216 O
could 30 35 217 222 O
impact 36 42 223 229 O
bone 43 47 230 234 O
metabolism 48 58 235 245 O
( 59 60 246 247 O
diuretics 60 69 247 256 O
, 69 70 256 257 O
hormones 71 79 258 266 O
, 79 80 266 267 O
bine 81 85 268 272 O
anabolic 86 94 273 281 O
agents 95 101 282 288 O
) 101 102 288 289 O
in 103 105 290 292 O
the 106 109 293 296 O
prior 110 115 297 302 B-upper_bound
6 116 117 303 304 I-upper_bound
months 118 124 305 311 I-upper_bound

not 0 3 312 315 O
physically 4 14 316 326 O
active 15 21 327 333 O
( 22 23 334 335 O
less 23 27 335 339 O
than 28 32 340 344 O
60 33 35 345 347 B-upper_bound
minutes 36 43 348 355 I-upper_bound
of 44 46 356 358 O
purposeful 47 57 359 369 O
exercise 58 66 370 378 O
/ 66 67 378 379 O
week 67 71 379 383 O
) 71 72 383 384 O

resting 0 7 385 392 O
blood 8 13 393 398 B-clinical_variable
pressure 14 22 399 407 I-clinical_variable
above 23 28 408 413 O
150 29 32 414 417 B-lower_bound
mmHg 33 37 418 422 I-lower_bound
systolic 38 46 423 431 B-clinical_variable
of 47 49 432 434 O
90 50 52 435 437 B-lower_bound
mmHg 53 57 438 442 I-lower_bound
diastolic 58 67 443 452 B-clinical_variable

serum 0 5 453 458 B-clinical_variable
vitamin 6 13 459 466 I-clinical_variable
D 14 15 467 468 I-clinical_variable
concentration 16 29 469 482 I-clinical_variable
< 30 31 483 484 O
20 31 33 484 486 B-upper_bound
ng 34 36 487 489 I-upper_bound
/ 36 37 489 490 I-upper_bound
mL 37 39 490 492 I-upper_bound

use 0 3 493 496 O
of 4 6 497 499 O
glucocorticoids 7 22 500 515 B-treatment

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
a 13 14 13 14 O
periprosthetic 15 29 15 29 B-chronic_disease
joint 30 35 30 35 I-chronic_disease
infection 36 45 36 45 I-chronic_disease
of 46 48 46 48 O
a 49 50 49 50 O
primary 51 58 51 58 B-treatment
total 59 64 59 64 I-treatment
knee 65 69 65 69 I-treatment
arthroplasty 70 82 70 82 I-treatment
with 83 87 83 87 O
a 88 89 88 89 O
planned 90 97 90 97 O
two 98 101 98 101 O
- 101 102 101 102 O
stage 102 107 102 107 O
exchange 108 116 108 116 O
procedure 117 126 117 126 O

Extensive 0 9 127 136 O
bone 10 14 137 141 O
loss 15 19 142 146 O
preventing 20 30 147 157 O
the 31 34 158 161 O
use 35 38 162 165 O
of 39 41 166 168 O
an 42 44 169 171 O
articulating 45 57 172 184 B-treatment
spacer 58 64 185 191 I-treatment

Infection 0 9 192 201 B-chronic_disease
of 10 12 202 204 O
a 13 14 205 206 O
revision 15 23 207 215 O
as 24 26 216 218 O
opposed 27 34 219 226 O
to 35 37 227 229 O
a 38 39 230 231 O
primary 40 47 232 239 B-treatment
total 48 53 240 245 I-treatment
knee 54 58 246 250 I-treatment
arthroplasty 59 71 251 263 I-treatment

Known 0 5 264 269 O
allergy 6 13 270 277 O
to 14 16 278 280 O
polymethylmethacrylate 17 39 281 303 B-allergy_name
, 39 40 303 304 O
tobramycin 41 51 305 315 B-allergy_name
or 52 54 316 318 O
vancomycin 55 65 319 329 B-allergy_name

Medically 0 9 330 339 O
unfit 10 15 340 345 O
for 16 19 346 349 O
operative 20 29 350 359 B-treatment
intervention 30 42 360 372 I-treatment

Soft 0 4 373 377 B-chronic_disease
tissue 5 11 378 384 I-chronic_disease
defects 12 19 385 392 I-chronic_disease
that 20 24 393 397 O
prevent 25 32 398 405 O
the 33 36 406 409 O
use 37 40 410 413 O
of 41 43 414 416 O
an 44 46 417 419 O
articulating 47 59 420 432 B-treatment
spacer 60 66 433 439 I-treatment

Blunt 0 5 0 5 O
and/or 6 12 6 12 O
penetrating 13 24 13 24 B-chronic_disease
trauma 25 31 25 31 I-chronic_disease
patient 32 39 32 39 O

Injury 0 6 40 46 B-clinical_variable
Severity 7 15 47 55 I-clinical_variable
Score 16 21 56 61 I-clinical_variable
( 22 23 62 63 I-clinical_variable
ISS 23 26 63 66 I-clinical_variable
) 26 27 66 67 I-clinical_variable
greater 28 35 68 75 O
than 36 40 76 80 O
or 41 43 81 83 O
equal 44 49 84 89 O
to 50 52 90 92 O
15 53 55 93 95 B-lower_bound

Lactate 0 7 96 103 B-clinical_variable
≥ 8 9 104 105 O
2 10 11 106 107 B-lower_bound

Patient 0 7 108 115 O
undergoing 8 18 116 126 O
elective 19 27 127 135 B-treatment
hip 28 31 136 139 I-treatment
repair 32 38 140 146 I-treatment
for 39 42 147 150 O
non 43 46 151 154 O
- 46 47 154 155 O
infectious 47 57 155 165 O
reasons 58 65 166 173 O

Patients 0 8 174 182 O
not 9 12 183 186 O
expected 13 21 187 195 O
to 22 24 196 198 O
survive 25 32 199 206 O
greater 33 40 207 214 O
than 41 45 215 219 O
48 46 48 220 222 B-lower_bound
hours 49 54 223 228 I-lower_bound

Patients 0 8 229 237 O
receiving 9 18 238 247 O
chronic 19 26 248 255 O
corticosteroids 27 42 256 271 B-treatment
or 43 45 272 274 O
immunosuppression 46 63 275 292 B-treatment
therapies 64 73 293 302 I-treatment

Patients 0 8 303 311 O
with 9 13 312 316 O
End 14 17 317 320 B-chronic_disease
Stage 18 23 321 326 I-chronic_disease
Renal 24 29 327 332 I-chronic_disease
Disease 30 37 333 340 I-chronic_disease

Patients 0 8 341 349 O
with 9 13 350 354 O
any 14 17 355 358 O
pre 18 21 359 362 O
- 21 22 362 363 O
existing 22 30 363 371 O
hematological 31 44 372 385 B-chronic_disease
disease 45 52 386 393 I-chronic_disease

Pre 0 3 394 397 O
- 3 4 397 398 O
existing 4 12 398 406 O
conditions 13 23 407 417 O
such 24 28 418 422 O
as 29 31 423 425 O
pathological 32 44 426 438 B-chronic_disease
fractures 45 54 439 448 I-chronic_disease
, 54 55 448 449 O
cancer 56 62 450 456 B-cancer
, 62 63 456 457 O
history 64 71 458 465 O
of 72 74 466 468 O
HIV 75 78 469 472 B-chronic_disease
, 78 79 472 473 O
or 80 82 474 476 O
history 83 90 477 484 O
of 91 93 485 487 O
connective 94 104 488 498 B-chronic_disease
tissue 105 111 499 505 I-chronic_disease
disease 112 119 506 513 I-chronic_disease

Pregnancy 0 9 514 523 B-pregnancy

Previous 0 8 524 532 B-treatment
Chemotherapy 9 21 533 545 I-treatment
or 22 24 546 548 O
Radiation 25 34 549 558 B-treatment

Previous 0 8 559 567 O
bone 9 13 568 572 B-treatment
marrow 14 20 573 579 I-treatment
transplantation 21 36 580 595 I-treatment

age 0 3 596 599 B-age
≥18 4 7 600 603 O

age 0 3 604 607 B-age
≥18 4 7 608 611 O
to 8 10 612 614 O
54 11 13 615 617 B-upper_bound

base 0 4 618 622 B-clinical_variable
deficit 5 12 623 630 I-clinical_variable
( 13 14 631 632 I-clinical_variable
BD 14 16 632 634 I-clinical_variable
) 16 17 634 635 I-clinical_variable
≥ 18 19 636 637 O
5 20 21 638 639 B-lower_bound
meq 22 25 640 643 I-lower_bound

hemorrhagic 0 11 644 655 B-chronic_disease
shock 12 17 656 661 I-chronic_disease

mean 0 4 662 666 B-clinical_variable
arterial 5 13 667 675 I-clinical_variable
pressure≤ 14 23 676 685 I-clinical_variable
65 24 26 686 688 B-upper_bound
mmHg 27 31 689 693 I-upper_bound

systolic 0 8 694 702 B-clinical_variable
BP 9 11 703 705 I-clinical_variable
( 12 13 706 707 I-clinical_variable
SBP 13 16 707 710 I-clinical_variable
) 16 17 710 711 I-clinical_variable
≤ 18 19 712 713 O
90 20 22 714 716 B-upper_bound
mmHg 23 27 717 721 I-upper_bound

Patients 0 8 0 8 O
> 9 10 9 10 O
18 10 12 10 12 B-lower_bound
years 13 18 13 18 I-lower_bound
of 19 21 19 21 O
age 22 25 22 25 B-age

Patients 0 8 26 34 O
with 9 13 35 39 O
contraindication 14 30 40 56 O
to 31 33 57 59 O
IV 34 36 60 62 B-allergy_name
contrast 37 45 63 71 I-allergy_name
such 46 50 72 76 O
as 51 53 77 79 O
allergy 54 61 80 87 O
or 62 64 88 90 O
severe 65 71 91 97 B-chronic_disease
kidney 72 78 98 104 I-chronic_disease
dysfunction 79 90 105 116 I-chronic_disease

Patients 0 8 117 125 O
with 9 13 126 130 O
either 14 20 131 137 O
symptomatic 21 32 138 149 O
or 33 35 150 152 O
asymptomatic 36 48 153 165 O
AAA 49 52 166 169 B-chronic_disease
as 53 55 170 172 O
defined 56 63 173 180 O
by 64 66 181 183 O
aortic 67 73 184 190 B-clinical_variable
diameter 74 82 191 199 I-clinical_variable
≥ 83 84 200 201 O
1.5x 85 89 202 206 B-lower_bound
normal 90 96 207 213 I-lower_bound
diameter 97 105 214 222 I-lower_bound

Patients 0 8 223 231 O
with 9 13 232 236 O
non 14 17 237 240 B-chronic_disease
- 17 18 240 241 I-chronic_disease
aneurysmal 18 28 241 251 I-chronic_disease
aortas 29 35 252 258 I-chronic_disease
who 36 39 259 262 O
require 40 47 263 270 O
aortic 48 54 271 277 O
contrast 55 63 278 286 O
imaging 64 71 287 294 O
or 72 74 295 297 O
echocardiography 75 91 298 314 O
for 92 95 315 318 O
preoperative 96 108 319 331 O
planning 109 117 332 340 O
or 118 120 341 343 O
other 121 126 344 349 O
reason 127 133 350 356 O

Terminally 0 10 357 367 O
ill 11 14 368 371 O
patients 15 23 372 380 O
, 23 24 380 381 O
and 25 28 382 385 O
patients 29 37 386 394 O
with 38 42 395 399 O
estimated 43 52 400 409 O
life 53 57 410 414 B-clinical_variable
expectancy 58 68 415 425 I-clinical_variable
of 69 71 426 428 O
≤ 72 73 429 430 O
6 74 75 431 432 B-upper_bound
months 76 82 433 439 I-upper_bound

Be 0 2 0 2 O
expected 3 11 3 11 O
to 12 14 12 14 O
require 15 22 15 22 O
intravenous 23 34 23 34 B-treatment
nutrition 35 44 35 44 I-treatment
for 45 48 45 48 O
at 49 51 49 51 O
least 52 57 52 57 O
an 58 60 58 60 O
additional 61 71 61 71 O
28 72 74 72 74 B-lower_bound
days 75 79 75 79 I-lower_bound

Be 0 2 80 82 O
greater 3 10 83 90 O
than 11 15 91 95 O
14 16 18 96 98 B-lower_bound
days 19 23 99 103 I-lower_bound
old 24 27 104 107 O
and 28 31 108 111 O
less 32 36 112 116 O
than 37 41 117 121 O
5 42 43 122 123 B-upper_bound
years 44 49 124 129 I-upper_bound
old 50 53 130 133 O

Conjugated 0 10 134 144 B-clinical_variable
bilirubin 11 20 145 154 I-clinical_variable
greater 21 28 155 162 O
than 29 33 163 167 O
2 34 35 168 169 B-lower_bound
mg 36 38 170 172 I-lower_bound
/ 38 39 172 173 I-lower_bound
dL 39 41 173 175 I-lower_bound

Have 0 4 176 180 O
evidence 5 13 181 189 O
of 14 16 190 192 O
a 17 18 193 194 O
viral 19 24 195 200 B-chronic_disease
hepatitis 25 34 201 210 I-chronic_disease
or 35 37 211 213 O
primary 38 45 214 221 B-chronic_disease
liver 46 51 222 227 I-chronic_disease
disease 52 59 228 235 I-chronic_disease
as 60 62 236 238 O
the 63 66 239 242 O
primary 67 74 243 250 O
etiology 75 83 251 259 O
of 84 86 260 262 O
their 87 92 263 268 O
cholestasis 93 104 269 280 O

Have 0 4 281 285 O
other 5 10 286 291 O
health 11 17 292 298 O
problems 18 26 299 307 O
such 27 31 308 312 O
that 32 36 313 317 O
survival 37 45 318 326 O
is 46 48 327 329 O
extremely 49 58 330 339 O
unlikely 59 67 340 348 O
even 68 72 349 353 O
if 73 75 354 356 O
the 76 79 357 360 O
infant 80 86 361 367 O
's 86 88 367 369 O
cholestasis 89 100 370 381 B-chronic_disease
improves 101 109 382 390 O

Men 0 3 0 3 B-gender
and 4 7 4 7 O
women 8 13 8 13 B-gender
who 14 17 14 17 O
have 18 22 18 22 O
worked 23 29 23 29 O
or 30 32 30 32 O
volunteered 33 44 33 44 O
as 45 47 45 47 O
rescue 48 54 48 54 O
, 54 55 54 55 O
recovery 56 64 56 64 O
or 65 67 65 67 O
clean 68 73 68 73 O
- 73 74 73 74 O
up 74 76 74 76 O
workers 77 84 77 84 O
at 85 87 85 87 O
the 88 91 88 91 O
WTC 92 95 92 95 O
site 96 100 96 100 O
following 101 110 101 110 O
the 111 114 111 114 O
9/11 115 119 115 119 O
attacks 120 127 120 127 O
, 127 128 127 128 O
or 129 131 129 131 O
who 132 135 132 135 O
were 136 140 136 140 O
living 141 147 141 147 O
as 148 150 148 150 O
a 151 152 151 152 O
resident 153 161 153 161 O
or 162 164 162 164 O
working 165 172 165 172 O
as 173 175 173 175 O
an 176 178 176 178 O
employee 179 187 179 187 O
within 188 194 188 194 O
the 195 198 195 198 O
NYC 199 202 199 202 O
disaster 203 211 203 211 O
area 212 216 212 216 O
during 217 223 217 223 O
the 224 227 224 227 O
9/11 228 232 228 232 O
attacks 233 240 233 240 O

are 0 3 241 244 O
currently 4 13 245 254 O
still 14 19 255 260 O
experiencing 20 32 261 273 O
significant 33 44 274 285 O
posttraumatic 45 58 286 299 B-chronic_disease
stress 59 65 300 306 I-chronic_disease
symptoms 66 74 307 315 O
related 75 82 316 323 O
to 83 85 324 326 O
what 86 90 327 331 O
they 91 95 332 336 O
witnessed 96 105 337 346 O
or 106 108 347 349 O
lived 109 114 350 355 O
through 115 122 356 363 O
during 123 129 364 370 O
the 130 133 371 374 O
9/11 134 138 375 379 O
attacks 139 146 380 387 O
or 147 149 388 390 O
their 150 155 391 396 O
WTC 156 159 397 400 O
recovery 160 168 401 409 O
work 169 173 410 414 O

are 0 3 415 418 O
currently 4 13 419 428 O
taking 14 20 429 435 O
antipsychotic 21 34 436 449 B-treatment
medication 35 45 450 460 I-treatment
, 45 46 460 461 O
lithium 47 54 462 469 B-treatment
or 55 57 470 472 O
valproic 58 66 473 481 B-treatment
acid 67 71 482 486 I-treatment

are 0 3 487 490 O
not 4 7 491 494 O
currently 8 17 495 504 O
receiving 18 27 505 514 O
psychotherapy 28 41 515 528 B-treatment
or 42 44 529 531 O
counseling 45 55 532 542 B-treatment

do 0 2 543 545 O
not 3 6 546 549 O
have 7 11 550 554 O
psychosis 12 21 555 564 B-chronic_disease
, 21 22 564 565 O
a 23 24 566 567 O
psychotic 25 34 568 577 B-chronic_disease
disorder 35 43 578 586 I-chronic_disease
, 43 44 586 587 O
or 45 47 588 590 O
bipolar 48 55 591 598 B-chronic_disease
disorder 56 64 599 607 I-chronic_disease

have 0 4 608 612 O
a 5 6 613 614 O
current 7 14 615 622 O
uncontrolled 15 27 623 635 O
medical 28 35 636 643 B-chronic_disease
illness 36 43 644 651 I-chronic_disease
, 43 44 651 652 O
neurological 45 57 653 665 B-chronic_disease
disorder 58 66 666 674 I-chronic_disease
affecting 67 76 675 684 O
the 77 80 685 688 O
central 81 88 689 696 O
nervous 89 96 697 704 O
system 97 103 705 711 O
, 103 104 711 712 O
or 105 107 713 715 O
history 108 115 716 723 O
of 116 118 724 726 O
head 119 123 727 731 B-chronic_disease
injury 124 130 732 738 I-chronic_disease

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
1500 28 32 28 32 B-lower_bound
/ 32 33 32 33 I-lower_bound
mm^3 33 37 33 37 I-lower_bound

Active 0 6 38 44 B-chronic_disease
coronary 7 15 45 53 I-chronic_disease
artery 16 22 54 60 I-chronic_disease
disease 23 30 61 68 I-chronic_disease

Active 0 6 69 75 O
or 7 9 76 78 O
clinically 10 20 79 89 O
significant 21 32 90 101 O
cardiac 33 40 102 109 B-chronic_disease
disease 41 48 110 117 I-chronic_disease

Alanine 0 7 118 125 O
aminotransferase 8 24 126 142 I-clinical_variable
( 25 26 143 144 I-clinical_variable
ALT 26 29 144 147 I-clinical_variable
) 29 30 147 148 I-clinical_variable
and 31 34 149 152 O
aspartate 35 44 153 162 B-clinical_variable
aminotransferase 45 61 163 179 I-clinical_variable
( 62 63 180 181 I-clinical_variable
AST 63 66 181 184 I-clinical_variable
) 66 67 184 185 I-clinical_variable
= 68 69 186 187 O
< 69 70 187 188 O
2.5 71 74 189 192 B-upper_bound
x 75 76 193 194 I-upper_bound
ULN 77 80 195 198 I-upper_bound
(= 81 83 199 201 O
< 83 84 201 202 O
5 85 86 203 204 O
x 87 88 205 206 O
ULN 89 92 207 210 O
for 93 96 211 214 O
subjects 97 105 215 223 O
with 106 110 224 228 O
liver 111 116 229 234 O
involvement 117 128 235 246 O
of 129 131 247 249 O
their 132 137 250 255 O
cancer 138 144 256 262 O
) 144 145 262 263 O

Alkaline 0 8 264 272 B-clinical_variable
phosphatase 9 20 273 284 I-clinical_variable
limit 21 26 285 290 I-clinical_variable
= 27 28 291 292 O
< 28 29 292 293 O
2.5 30 33 294 297 B-upper_bound
x 34 35 298 299 I-upper_bound
ULN 36 39 300 303 I-upper_bound
(= 40 42 304 306 O
< 42 43 306 307 O
5 44 45 308 309 O
x 46 47 310 311 O
ULN 48 51 312 315 O
for 52 55 316 319 O
subjects 56 64 320 328 O
with 65 69 329 333 O
liver 70 75 334 339 O
involvement 76 87 340 351 O
of 88 90 352 354 O
their 91 96 355 360 O
cancer 97 103 361 367 B-cancer
) 103 104 367 368 O

Any 0 3 369 372 O
hemorrhage 4 14 373 383 O
or 15 17 384 386 O
bleeding 18 26 387 395 O
event 27 32 396 401 O
grade 33 38 402 407 O
3 39 40 408 409 O
within 41 47 410 416 O
4 48 49 417 418 B-upper_bound
weeks 50 55 419 424 I-upper_bound
prior 56 61 425 430 I-upper_bound
to 62 64 431 433 O
registration 65 77 434 446 O

Any 0 3 447 450 O
malabsorption 4 17 451 464 B-chronic_disease
condition 18 27 465 474 O

Cardiac 0 7 475 482 B-chronic_disease
arrhythmias 8 19 483 494 I-chronic_disease
requiring 20 29 495 504 O
anti 30 34 505 509 B-treatment
- 34 35 509 510 I-treatment
arrhythmic 35 45 510 520 I-treatment
therapy 46 53 521 528 I-treatment
other 54 59 529 534 O
than 60 64 535 539 O
beta 65 69 540 544 B-treatment
blockers 70 78 545 553 I-treatment
or 79 81 554 556 O
digoxin 82 89 557 564 B-treatment

Concurrent 0 10 565 575 O
anti 11 15 576 580 B-treatment
- 15 16 580 581 I-treatment
cancer 16 22 581 587 I-treatment
therapy 23 30 588 595 I-treatment
( 31 32 596 597 O
chemotherapy 32 44 597 609 B-treatment
, 44 45 609 610 O
surgery 46 53 611 618 B-treatment
, 53 54 618 619 O
immunotherapy 55 68 620 633 B-treatment
, 68 69 633 634 O
biologic 70 78 635 643 B-treatment
therapy 79 86 644 651 I-treatment
, 86 87 651 652 O
or 88 90 653 655 O
tumor 91 96 656 661 B-treatment
embolization 97 109 662 674 I-treatment
) 109 110 674 675 O
other 111 116 676 681 O
than 117 121 682 686 O
study 122 127 687 692 O
treatment 128 137 693 702 O
( 138 139 703 704 O
regorafenib 139 150 704 715 B-treatment
) 150 151 715 716 O

Congestive 0 10 717 727 B-chronic_disease
heart 11 16 728 733 I-chronic_disease
failure 17 24 734 741 I-chronic_disease
- 25 26 742 743 O
New 27 30 744 747 O
York 31 35 748 752 O
Heart 36 41 753 758 O
Association 42 53 759 770 O
> 54 55 771 772 O
class 56 61 773 778 O
II 62 64 779 781 O

Dehydration 0 11 782 793 B-clinical_variable
> 12 13 794 795 O
grade 14 19 796 801 B-lower_bound
1 20 21 802 803 I-lower_bound

Eastern 0 7 804 811 B-clinical_variable
Cooperative 8 19 812 823 I-clinical_variable
Oncology 20 28 824 832 I-clinical_variable
Group 29 34 833 838 I-clinical_variable
( 35 36 839 840 I-clinical_variable
ECOG 36 40 840 844 I-clinical_variable
) 40 41 844 845 I-clinical_variable
performance 42 53 846 857 I-clinical_variable
status 54 60 858 864 I-clinical_variable
( 61 62 865 866 I-clinical_variable
PS 62 64 866 868 I-clinical_variable
) 64 65 868 869 I-clinical_variable
0 66 67 870 871 B-lower_bound
or 68 70 872 874 O
1 71 72 875 876 B-upper_bound

Evidence 0 8 877 885 O
of 9 11 886 888 O
abdominal 12 21 889 898 B-chronic_disease
fistula 22 29 899 906 I-chronic_disease
, 29 30 906 907 O
gastrointestinal 31 47 908 924 B-chronic_disease
( 48 49 925 926 I-chronic_disease
GI 49 51 926 928 I-chronic_disease
) 51 52 928 929 I-chronic_disease
perforation 53 64 930 941 I-chronic_disease
or 65 67 942 944 O
intraabdominal 68 82 945 959 B-chronic_disease
abscess 83 90 960 967 I-chronic_disease

Evidence 0 8 968 976 O
of 9 11 977 979 O
significant 12 23 980 991 O
central 24 31 992 999 B-chronic_disease
nervous 32 39 1000 1007 I-chronic_disease
system 40 46 1008 1014 I-chronic_disease
disease 47 54 1015 1022 I-chronic_disease
including 55 64 1023 1032 O
seizure 65 72 1033 1040 B-chronic_disease
disorder 73 81 1041 1049 I-chronic_disease
requiring 82 91 1050 1059 O
medication 92 102 1060 1070 O
, 102 103 1070 1071 O
symptomatic 104 115 1072 1083 B-cancer
metastatic 116 126 1084 1094 I-cancer
brain 127 132 1095 1100 I-cancer
or 133 135 1101 1103 O
meningeal 136 145 1104 1113 B-cancer
tumors 146 152 1114 1120 I-cancer

Evidence 0 8 1121 1129 O
or 9 11 1130 1132 O
history 12 19 1133 1140 O
of 20 22 1141 1143 O
bleeding 23 31 1144 1152 B-chronic_disease
diathesis 32 41 1153 1162 I-chronic_disease
or 42 44 1163 1165 O
coagulopathy 45 57 1166 1178 B-chronic_disease

Exceptions 0 10 1179 1189 O
include 11 18 1190 1197 O
cervical 19 27 1198 1206 B-cancer
cancer 28 34 1207 1213 I-cancer
in 35 37 1214 1216 I-cancer
- 37 38 1216 1217 I-cancer
situ 38 42 1217 1221 I-cancer
, 42 43 1221 1222 O
treated 44 51 1223 1230 O
basal 52 57 1231 1236 B-cancer
cell 58 62 1237 1241 I-cancer
carcinoma 63 72 1242 1251 I-cancer
, 72 73 1251 1252 O
or 74 76 1253 1255 O
superficial 77 88 1256 1267 B-cancer
bladder 89 96 1268 1275 I-cancer
tumor 97 102 1276 1281 I-cancer

Hemoglobin 0 10 1282 1292 B-clinical_variable
> 11 12 1293 1294 O
9 13 14 1295 1296 B-lower_bound
g 15 16 1297 1298 I-lower_bound
/ 16 17 1298 1299 I-lower_bound
dL 17 19 1299 1301 I-lower_bound

Histologically 0 14 1302 1316 O
confirmed 15 24 1317 1326 O
angiosarcoma 25 37 1327 1339 B-cancer

History 0 7 1340 1347 O
of 8 10 1348 1350 O
organ 11 16 1351 1356 B-treatment
allograft 17 26 1357 1366 I-treatment
( 27 28 1367 1368 O
including 28 37 1368 1377 O
corneal 38 45 1378 1385 B-treatment
transplant 46 56 1386 1396 I-treatment
) 56 57 1396 1397 O

International 0 13 1398 1411 B-clinical_variable
normalized 14 24 1412 1422 I-clinical_variable
ratio 25 30 1423 1428 I-clinical_variable
( 31 32 1429 1430 I-clinical_variable
INR)/partial 32 44 1430 1442 I-clinical_variable
thromboplastin 45 59 1443 1457 I-clinical_variable
time 60 64 1458 1462 I-clinical_variable
( 65 66 1463 1464 I-clinical_variable
PTT 66 69 1464 1467 I-clinical_variable
) 69 70 1467 1468 I-clinical_variable
< 71 72 1469 1470 O
1.5 73 76 1471 1474 B-upper_bound
x 77 78 1475 1476 I-upper_bound
ULN 79 82 1477 1480 I-upper_bound

Interstitial 0 12 1481 1493 B-chronic_disease
lung 13 17 1494 1498 I-chronic_disease
disease 18 25 1499 1506 I-chronic_disease
with 26 30 1507 1511 O
ongoing 31 38 1512 1519 O
signs 39 44 1520 1525 O
and 45 48 1526 1529 O
symptoms 49 57 1530 1538 O
at 58 60 1539 1541 O
the 61 64 1542 1545 O
time 65 69 1546 1550 O
of 70 72 1551 1553 O
registration 73 85 1554 1566 O

Known 0 5 1567 1572 O
history 6 13 1573 1580 O
of 14 16 1581 1583 O
human 17 22 1584 1589 B-chronic_disease
immunodeficiency 23 39 1590 1606 I-chronic_disease
virus 40 45 1607 1612 I-chronic_disease
( 46 47 1613 1614 I-chronic_disease
HIV 47 50 1614 1617 I-chronic_disease
) 50 51 1617 1618 I-chronic_disease
infection 52 61 1619 1628 I-chronic_disease
or 62 64 1629 1631 O
current 65 72 1632 1639 O
chronic 73 80 1640 1647 O
or 81 83 1648 1650 O
active 84 90 1651 1657 O
hepatitis 91 100 1658 1667 B-chronic_disease
B 101 102 1668 1669 I-chronic_disease
or 103 105 1670 1672 I-chronic_disease
C 106 107 1673 1674 I-chronic_disease
infection 108 117 1675 1684 I-chronic_disease
requiring 118 127 1685 1694 O
treatment 128 137 1695 1704 O
with 138 142 1705 1709 O
antiviral 143 152 1710 1719 B-treatment
therapy 153 160 1720 1727 I-treatment

Life 0 4 1728 1732 B-clinical_variable
expectancy 5 15 1733 1743 I-clinical_variable
of 16 18 1744 1746 O
at 19 21 1747 1749 O
least 22 27 1750 1755 O
4 28 29 1756 1757 B-lower_bound
months 30 36 1758 1764 I-lower_bound

Lipase 0 6 1765 1771 B-clinical_variable
= 7 8 1772 1773 O
< 8 9 1773 1774 O
1.5 10 13 1775 1778 B-upper_bound
x 14 15 1779 1780 I-upper_bound
the 16 19 1781 1784 I-upper_bound
ULN 20 23 1785 1788 I-upper_bound

Low 0 3 1789 1792 O
dose 4 8 1793 1797 O
aspirin 9 16 1798 1805 B-clinical_variable
(= 17 19 1806 1808 O
< 19 20 1808 1809 O
100 21 24 1810 1813 B-upper_bound
mg 25 27 1814 1816 I-upper_bound
daily 28 33 1817 1822 I-upper_bound
) 33 34 1822 1823 O

Low 0 3 1824 1827 O
dose 4 8 1828 1832 O
warfarin 9 17 1833 1841 B-treatment
( 18 19 1842 1843 O
1 19 20 1843 1844 O
mg 21 23 1845 1847 O
orally 24 30 1848 1854 O
, 30 31 1854 1855 O
once 32 36 1856 1860 O
daily 37 42 1861 1866 O
) 42 43 1866 1867 O
with 44 48 1868 1872 O
prothrombin 49 60 1873 1884 B-clinical_variable
time 61 65 1885 1889 I-clinical_variable
( 66 67 1890 1891 I-clinical_variable
PT)-international 67 84 1891 1908 I-clinical_variable
normalized 85 95 1909 1919 I-clinical_variable
ratio 96 101 1920 1925 I-clinical_variable
( 102 103 1926 1927 I-clinical_variable
INR 103 106 1927 1930 I-clinical_variable
) 106 107 1930 1931 I-clinical_variable
= 108 109 1932 1933 O
< 109 110 1933 1934 O
1.5 111 114 1935 1938 B-upper_bound
x 115 116 1939 1940 I-upper_bound
ULN 117 120 1941 1944 I-upper_bound
is 121 123 1945 1947 O
permitted 124 133 1948 1957 O

Major 0 5 1958 1963 O
surgical 6 14 1964 1972 O
procedure 15 24 1973 1982 O
, 24 25 1982 1983 O
open 26 30 1984 1988 B-treatment
biopsy 31 37 1989 1995 I-treatment
, 37 38 1995 1996 O
or 39 41 1997 1999 O
significant 42 53 2000 2011 O
traumatic 54 63 2012 2021 O
injury 64 70 2022 2028 O
within 71 77 2029 2035 O
28 78 80 2036 2038 B-upper_bound
days 81 85 2039 2043 I-upper_bound
before 86 92 2044 2050 O
registration 93 105 2051 2063 O

Ongoing 0 7 2064 2071 O
infection 8 17 2072 2081 B-clinical_variable
> 18 19 2082 2083 O
grade 20 25 2084 2089 B-lower_bound
2 26 27 2090 2091 I-lower_bound

Patients 0 8 2092 2100 O
who 9 12 2101 2104 O
are 13 16 2105 2108 O
prophylactically 17 33 2109 2125 B-treatment
treated 34 41 2126 2133 I-treatment
with 42 46 2134 2138 O
an 47 49 2139 2141 O
agent 50 55 2142 2147 O
such 56 60 2148 2152 O
as 61 63 2153 2155 O
warfarin 64 72 2156 2164 B-treatment
or 73 75 2165 2167 O
heparin 76 83 2168 2175 B-treatment
will 84 88 2176 2180 O
be 89 91 2181 2183 O
allowed 92 99 2184 2191 O
to 100 102 2192 2194 O
participate 103 114 2195 2206 O
provided 115 123 2207 2215 O
that 124 128 2216 2220 O
no 129 131 2221 2223 O
prior 132 137 2224 2229 O
evidence 138 146 2230 2238 O
of 147 149 2239 2241 O
underlying 150 160 2242 2252 O
abnormality 161 172 2253 2264 O
in 173 175 2265 2267 O
coagulation 176 187 2268 2279 O
parameters 188 198 2280 2290 O
exists 199 205 2291 2297 O

Patients 0 8 2298 2306 O
with 9 13 2307 2311 O
pheochromocytoma 14 30 2312 2328 B-cancer

Patients 0 8 2329 2337 O
with 9 13 2338 2342 O
severe 14 20 2343 2349 B-chronic_disease
hepatic 21 28 2350 2357 I-chronic_disease
impairment 29 39 2358 2368 I-chronic_disease
( 40 41 2369 2370 O
Child 41 46 2370 2375 B-clinical_variable
- 46 47 2375 2376 I-clinical_variable
Pugh 47 51 2376 2380 I-clinical_variable
class 52 57 2381 2386 O
C 58 59 2387 2388 O
) 59 60 2388 2389 O

Platelet 0 8 2390 2398 B-clinical_variable
count 9 14 2399 2404 I-clinical_variable
> 15 16 2405 2406 O
100000 17 23 2407 2413 B-lower_bound
/ 23 24 2413 2414 I-lower_bound
mm^3 24 28 2414 2418 I-lower_bound

Pleural 0 7 2419 2426 B-chronic_disease
effusion 8 16 2427 2435 I-chronic_disease
or 17 19 2436 2438 O
ascites 20 27 2439 2446 B-chronic_disease
that 28 32 2447 2451 O
causes 33 39 2452 2458 O
respiratory 40 51 2459 2470 O
compromise 52 62 2471 2481 O
( 63 64 2482 2483 O
> 64 65 2483 2484 O
= 65 66 2484 2485 O
grade 67 72 2486 2491 B-lower_bound
2 73 74 2492 2493 I-lower_bound
dyspnea 75 82 2494 2501 B-clinical_variable
) 82 83 2501 2502 O

Presence 0 8 2503 2511 O
of 9 11 2512 2514 O
a 12 13 2515 2516 O
non 14 17 2517 2520 B-chronic_disease
- 17 18 2520 2521 I-chronic_disease
healing 18 25 2521 2528 I-chronic_disease
wound 26 31 2529 2534 I-chronic_disease
, 31 32 2534 2535 O
non 33 36 2536 2539 B-chronic_disease
- 36 37 2539 2540 I-chronic_disease
healing 37 44 2540 2547 I-chronic_disease
ulcer 45 50 2548 2553 I-chronic_disease
, 50 51 2553 2554 O
or 52 54 2555 2557 O
bone 55 59 2558 2562 B-chronic_disease
fracture 60 68 2563 2571 I-chronic_disease

Prior 0 5 2572 2577 O
use 6 9 2578 2581 O
of 10 12 2582 2584 O
regorafenib 13 24 2585 2596 B-treatment

Prior 0 5 2597 2602 O
use 6 9 2603 2606 O
of 10 12 2607 2609 O
sorafenib 13 22 2610 2619 B-treatment

Progressive 0 11 2620 2631 B-chronic_disease
disease 12 19 2632 2639 I-chronic_disease
under 20 25 2640 2645 O
last 26 30 2646 2650 O
palliative 31 41 2651 2661 B-treatment
therapy 42 49 2662 2669 I-treatment
with 50 54 2670 2674 O
a 55 56 2675 2676 O
history 57 64 2677 2684 O
of 65 67 2685 2687 O
prior 68 73 2688 2693 O
ifosfamide 74 84 2694 2704 B-treatment

Prophylactic 0 12 2705 2717 O
doses 13 18 2718 2723 O
of 19 21 2724 2726 O
heparin 22 29 2727 2734 B-treatment

Radiation 0 9 2735 2744 B-treatment
directed 10 18 2745 2753 O
at 19 21 2754 2756 O
target 22 28 2757 2763 O
lesion 29 35 2764 2770 B-chronic_disease
within 36 42 2771 2777 O
28 43 45 2778 2780 B-upper_bound
days 46 50 2781 2785 I-upper_bound
of 51 53 2786 2788 O
registration 54 66 2789 2801 O

Renal 0 5 2802 2807 B-chronic_disease
failure 6 13 2808 2815 I-chronic_disease
requiring 14 23 2816 2825 O
hemo 24 28 2826 2830 B-treatment
- 28 29 2830 2831 I-treatment
or 29 31 2831 2833 I-treatment
peritoneal 32 42 2834 2844 I-treatment
dialysis 43 51 2845 2853 I-treatment

Serum 0 5 2854 2859 B-clinical_variable
creatinine 6 16 2860 2870 I-clinical_variable
= 17 18 2871 2872 O
< 18 19 2872 2873 O
1.5 20 23 2874 2877 B-upper_bound
x 24 25 2878 2879 I-upper_bound
the 26 29 2880 2883 I-upper_bound
ULN 30 33 2884 2887 I-upper_bound

Subjects 0 8 2888 2896 O
( 9 10 2897 2898 O
men 10 13 2898 2901 B-gender
and 14 17 2902 2905 I-gender
women 18 23 2906 2911 I-gender
) 23 24 2911 2912 O
of 25 27 2913 2915 O
childbearing 28 40 2916 2928 O
potential 41 50 2929 2938 O
must 51 55 2939 2943 O
agree 56 61 2944 2949 B-contraception_consent
to 62 64 2950 2952 I-contraception_consent
use 65 68 2953 2956 I-contraception_consent
adequate 69 77 2957 2965 I-contraception_consent
contraception 78 91 2966 2979 I-contraception_consent
beginning 92 101 2980 2989 O
at 102 104 2990 2992 O
registration 105 117 2993 3005 O
until 118 123 3006 3011 O
at 124 126 3012 3014 O
least 127 132 3015 3020 O
3 133 134 3021 3022 B-lower_bound
months 135 141 3023 3029 I-lower_bound
after 142 147 3030 3035 O
the 148 151 3036 3039 O
last 152 156 3040 3044 O
dose 157 161 3045 3049 O
of 162 164 3050 3052 O
study 165 170 3053 3058 O
drug 171 175 3059 3063 O
; 175 176 3063 3064 O
the 177 180 3065 3068 O
definition 181 191 3069 3079 O
of 192 194 3080 3082 O
adequate 195 203 3083 3091 O
contraception 204 217 3092 3105 O
will 218 222 3106 3110 O
be 223 225 3111 3113 O
based 226 231 3114 3119 O
on 232 234 3120 3122 O
the 235 238 3123 3126 O
judgment 239 247 3127 3135 O
of 248 250 3136 3138 O
the 251 254 3139 3142 O
principal 255 264 3143 3152 O
investigator 265 277 3153 3165 O

Subjects 0 8 3166 3174 O
with 9 13 3175 3179 O
any 14 17 3180 3183 O
previously 18 28 3184 3194 O
untreated 29 38 3195 3204 O
or 39 41 3205 3207 O
concurrent 42 52 3208 3218 O
cancer 53 59 3219 3225 B-cancer
unrelated 60 69 3226 3235 O
to 70 72 3236 3238 O
angiosarcoma 73 85 3239 3251 B-cancer

Subjects 0 8 3252 3260 O
with 9 13 3261 3265 O
thrombotic 14 24 3266 3276 B-chronic_disease
, 24 25 3276 3277 O
embolic 26 33 3278 3285 B-chronic_disease
, 33 34 3285 3286 O
venous 35 41 3287 3293 O
, 41 42 3293 3294 O
or 43 45 3295 3297 O
arterial 46 54 3298 3306 O
events 55 61 3307 3313 O

Therapeutic 0 11 3314 3325 B-treatment
anticoagulation 12 27 3326 3341 I-treatment
with 28 32 3342 3346 I-treatment
Vitamin 33 40 3347 3354 I-treatment
- 40 41 3354 3355 I-treatment
K 41 42 3355 3356 I-treatment
antagonists 43 54 3357 3368 I-treatment
( 55 56 3369 3370 O
e.g. 56 60 3370 3374 O
, 60 61 3374 3375 O
warfarin 62 70 3376 3384 B-treatment
) 70 71 3384 3385 O
or 72 74 3386 3388 O
with 75 79 3389 3393 O
heparins 80 88 3394 3402 B-treatment
and 89 92 3403 3406 O
heparinoids 93 104 3407 3418 B-treatment

Total 0 5 3419 3424 O
bilirubin 6 15 3425 3434 B-clinical_variable
= 16 17 3435 3436 O
< 17 18 3436 3437 O
1.5 19 22 3438 3441 B-upper_bound
x 23 24 3442 3443 I-upper_bound
the 25 28 3444 3447 I-upper_bound
upper 29 34 3448 3453 I-upper_bound
limits 35 41 3454 3460 I-upper_bound
of 42 44 3461 3463 I-upper_bound
normal 45 51 3464 3470 I-upper_bound
( 52 53 3471 3472 I-upper_bound
ULN 53 56 3472 3475 I-upper_bound
) 56 57 3475 3476 I-upper_bound

Tumor 0 5 3477 3482 B-cancer
deemed 6 12 3483 3489 O
unresectable 13 25 3490 3502 O
or 26 28 3503 3505 O
metastatic 29 39 3506 3516 O

Uncontrolled 0 12 3517 3529 O
hypertension 13 25 3530 3542 B-chronic_disease
( 26 27 3543 3544 O
systolic 27 35 3544 3552 B-clinical_variable
pressure 36 44 3553 3561 I-clinical_variable
> 45 46 3562 3563 O
140 47 50 3564 3567 B-lower_bound
mmHg 51 55 3568 3572 I-lower_bound
or 56 58 3573 3575 O
diastolic 59 68 3576 3585 B-clinical_variable
pressure 69 77 3586 3594 I-clinical_variable
> 78 79 3595 3596 O
90 80 82 3597 3599 B-lower_bound
mmHg 83 87 3600 3604 I-lower_bound
on 88 90 3605 3607 O
repeated 91 99 3608 3616 O
measurement 100 111 3617 3628 O
) 111 112 3628 3629 O
despite 113 120 3630 3637 O
optimal 121 128 3638 3645 O
medical 129 136 3646 3653 O
management 137 147 3654 3664 O

Unstable 0 8 3665 3673 B-chronic_disease
angina 9 15 3674 3680 I-chronic_disease
( 16 17 3681 3682 O
anginal 17 24 3682 3689 O
symptoms 25 33 3690 3698 O
at 34 36 3699 3701 O
rest 37 41 3702 3706 O
) 41 42 3706 3707 O
, 42 43 3707 3708 O
new 44 47 3709 3712 O
- 47 48 3712 3713 O
onset 48 53 3713 3718 O
angina 54 60 3719 3725 O
within 61 67 3726 3732 O
3 68 69 3733 3734 B-upper_bound
months 70 76 3735 3741 I-upper_bound
before 77 83 3742 3748 O
registration 84 96 3749 3761 O
, 96 97 3761 3762 O
or 98 100 3763 3765 O
myocardial 101 111 3766 3776 B-chronic_disease
infarction 112 122 3777 3787 I-chronic_disease
within 123 129 3788 3794 O
6 130 131 3795 3796 B-upper_bound
months 132 138 3797 3803 I-upper_bound
before 139 145 3804 3810 O
registration 146 158 3811 3823 O

Use 0 3 3824 3827 O
of 4 6 3828 3830 O
cytotoxic 7 16 3831 3840 B-treatment
chemotherapy 17 29 3841 3853 I-treatment
within 30 36 3854 3860 O
21 37 39 3861 3863 B-upper_bound
days 40 44 3864 3868 I-upper_bound
of 45 47 3869 3871 O
registration 48 60 3872 3884 O

Use 0 3 3885 3888 O
of 4 6 3889 3891 O
targeted 7 15 3892 3900 B-treatment
therapy 16 23 3901 3908 I-treatment
within 24 30 3909 3915 O
two 31 34 3916 3919 B-upper_bound
half 35 39 3920 3924 I-upper_bound
- 39 40 3924 3925 I-upper_bound
lives 40 45 3925 3930 I-upper_bound
of 46 48 3931 3933 O
registration 49 61 3934 3946 O

Women 0 5 3947 3952 B-gender
of 6 8 3953 3955 O
childbearing 9 21 3956 3968 O
potential 22 31 3969 3978 O
must 32 36 3979 3983 O
have 37 41 3984 3988 O
a 42 43 3989 3990 O
negative 44 52 3991 3999 B-pregnancy
serum 53 58 4000 4005 I-pregnancy
pregnancy 59 68 4006 4015 I-pregnancy
test 69 73 4016 4020 I-pregnancy
performed 74 83 4021 4030 O
within 84 90 4031 4037 O
7 91 92 4038 4039 B-upper_bound
days 93 97 4040 4044 I-upper_bound
prior 98 103 4045 4050 I-upper_bound
to 104 106 4051 4053 O
the 107 110 4054 4057 O
start 111 116 4058 4063 O
of 117 119 4064 4066 O
study 120 125 4067 4072 O
drug 126 130 4073 4077 O

Women 0 5 4078 4083 B-gender
who 6 9 4084 4087 O
are 10 13 4088 4091 B-pregnancy
pregnant 14 22 4092 4100 I-pregnancy

all 0 3 4101 4104 O
treatments 4 14 4105 4115 O
must 15 19 4116 4120 O
have 20 24 4121 4125 O
been 25 29 4126 4130 O
completed 30 39 4131 4140 O
at 40 42 4141 4143 O
least 43 48 4144 4149 O
3 49 50 4150 4151 B-upper_bound
years 51 56 4152 4157 I-upper_bound
prior 57 62 4158 4163 I-upper_bound
to 63 65 4164 4166 O
registration 66 78 4167 4179 O

cerebrovascular 0 15 4180 4195 B-chronic_disease
accident 16 24 4196 4204 I-chronic_disease
( 25 26 4205 4206 O
including 26 35 4206 4215 O
transient 36 45 4216 4225 B-chronic_disease
ischemic 46 54 4226 4234 I-chronic_disease
attacks 55 62 4235 4242 I-chronic_disease
) 62 63 4242 4243 O
, 63 64 4243 4244 O
deep 65 69 4245 4249 B-chronic_disease
vein 70 74 4250 4254 I-chronic_disease
thrombosis 75 85 4255 4265 I-chronic_disease
or 86 88 4266 4268 O
pulmonary 89 98 4269 4278 B-chronic_disease
embolism 99 107 4279 4287 I-chronic_disease
within 108 114 4288 4294 O
6 115 116 4295 4296 B-upper_bound
months 117 123 4297 4303 I-upper_bound
of 124 126 4304 4306 O
informed 127 135 4307 4315 O
consent 136 143 4316 4323 O

doxorubicin 0 11 4324 4335 B-treatment
or 12 14 4336 4338 O
taxane 15 21 4339 4345 B-treatment
therapy 22 29 4346 4353 I-treatment
for 30 33 4354 4357 O
angiosarcoma 34 46 4358 4370 B-cancer

infrequent 0 10 4371 4381 O
bleeding 11 19 4382 4390 O
or 20 22 4391 4393 O
elevations 23 33 4394 4404 O
in 34 36 4405 4407 O
PT 37 39 4408 4410 B-treatment
- 39 40 4410 4411 I-treatment
INR 40 43 4411 4414 I-treatment
have 44 48 4415 4419 O
been 49 53 4420 4424 O
reported 54 62 4425 4433 O
in 63 65 4434 4436 O
some 66 70 4437 4441 O
subjects 71 79 4442 4450 O
taking 80 86 4451 4457 O
warfarin 87 95 4458 4466 B-treatment
while 96 101 4467 4472 O
on 102 104 4473 4475 O
regorafenib 105 116 4476 4487 B-treatment
therapy 117 124 4488 4495 I-treatment
; 124 125 4495 4496 O
therefore 126 135 4497 4506 O
, 135 136 4506 4507 O
subjects 137 145 4508 4516 O
taking 146 152 4517 4523 O
concomitant 153 164 4524 4535 B-treatment
warfarin 165 173 4536 4544 I-treatment
should 174 180 4545 4551 O
be 181 183 4552 4554 O
monitored 184 193 4555 4564 O
regularly 194 203 4565 4574 O
for 204 207 4575 4578 O
changes 208 215 4579 4586 O
in 216 218 4587 4589 O
PT 219 221 4590 4592 O
, 221 222 4592 4593 O
PT 223 225 4594 4596 O
- 225 226 4596 4597 O
INR 226 229 4597 4600 O
or 230 232 4601 4603 O
clinical 233 241 4604 4612 O
bleeding 242 250 4613 4621 O
episodes 251 259 4622 4630 O

patients 0 8 4631 4639 O
must 9 13 4640 4644 O
have 14 18 4645 4649 O
a 19 20 4650 4651 O
24 21 23 4652 4654 B-clinical_variable
- 23 24 4654 4655 I-clinical_variable
hour 24 28 4655 4659 I-clinical_variable
urine 29 34 4660 4665 I-clinical_variable
protein 35 42 4666 4673 I-clinical_variable
value 43 48 4674 4679 I-clinical_variable
< 49 50 4680 4681 O
grade 51 56 4682 4687 B-upper_bound
3 57 58 4688 4689 I-upper_bound
( 59 60 4690 4691 O
> 60 61 4691 4692 O
3.5 62 65 4693 4696 B-lower_bound
g/24 66 70 4697 4701 I-lower_bound
hours 71 76 4702 4707 I-lower_bound
) 76 77 4707 4708 O
to 78 80 4709 4711 O
be 81 83 4712 4714 O
eligible 84 92 4715 4723 O

post 0 4 4724 4728 O
- 4 5 4728 4729 O
menopausal 5 15 4729 4739 O
women 16 21 4740 4745 B-gender
( 22 23 4746 4747 O
defined 23 30 4747 4754 O
as 31 33 4755 4757 O
age 34 37 4758 4761 B-age
> 38 39 4762 4763 O
= 39 40 4763 4764 O
50 41 43 4765 4767 B-lower_bound
years 44 49 4768 4773 I-lower_bound
and 50 53 4774 4777 O
no 54 56 4778 4780 O
menses 57 63 4781 4787 O
for 64 67 4788 4791 O
at 68 70 4792 4794 O
least 71 76 4795 4800 O
1 77 78 4801 4802 B-lower_bound
year 79 83 4803 4807 I-lower_bound
) 83 84 4807 4808 O

subjects 0 8 4809 4817 O
surviving 9 18 4818 4827 O
a 19 20 4828 4829 O
cancer 21 27 4830 4836 O
that 28 32 4837 4841 O
was 33 36 4842 4845 O
curatively 37 47 4846 4856 O
treated 48 55 4857 4864 O
and 56 59 4865 4868 O
without 60 67 4869 4876 O
evidence 68 76 4877 4885 O
of 77 79 4886 4888 O
disease 80 87 4889 4896 O
for 88 91 4897 4900 O
more 92 96 4901 4905 O
than 97 101 4906 4910 O
3 102 103 4911 4912 B-lower_bound
years 104 109 4913 4918 I-lower_bound
before 110 116 4919 4925 O
registration 117 129 4926 4938 O
are 130 133 4939 4942 O
allowed 134 141 4943 4950 O

surgically 0 10 4951 4961 O
sterilized 11 21 4962 4972 O
women 22 27 4973 4978 B-gender
are 28 31 4979 4982 O
not 32 35 4983 4986 O
required 36 44 4987 4995 O
to 45 47 4996 4998 O
undergo 48 55 4999 5006 O
a 56 57 5007 5008 O
pregnancy 58 67 5009 5018 O
test 68 72 5019 5023 O

up 0 2 5024 5026 O
to 3 5 5027 5029 O
4 6 7 5030 5031 B-upper_bound
prior 8 13 5032 5037 B-treatment
therapies 14 23 5038 5047 I-treatment
are 24 27 5048 5051 O
allowed 28 35 5052 5059 O

> 0 1 0 1 O
24 2 4 2 4 B-lower_bound
weeks 5 10 5 10 I-lower_bound
gestation 11 20 11 20 O

allergy 0 7 21 28 O
to 8 10 29 31 O
chlorhexidine 11 24 32 45 B-allergy_name

scheduled 0 9 46 55 O
for 10 13 56 59 O
a 14 15 60 61 O
primary 16 23 62 69 B-treatment
or 24 26 70 72 I-treatment
repeat 27 33 73 79 I-treatment
cesarean 34 42 80 88 I-treatment
section 43 50 89 96 I-treatment

unplanned 0 9 97 106 O
or 10 12 107 109 O
emergency 13 22 110 119 O
cesarean 23 31 120 128 B-treatment
section 32 39 129 136 I-treatment

women 0 5 137 142 B-gender

Aged 0 4 0 4 B-age
55 5 7 5 7 B-lower_bound
years 8 13 8 13 I-lower_bound
or 14 16 14 16 O
older 17 22 17 22 O

Blood 0 5 23 28 B-clinical_variable
pressure 6 14 29 37 I-clinical_variable
> 15 16 38 39 O
200/120 16 23 39 46 B-lower_bound
mm 24 26 47 49 I-lower_bound
Hg 27 29 50 52 I-lower_bound

Caregivers 0 10 53 63 O
enrolled 11 19 64 72 O
in 20 22 73 75 O
another 23 30 76 83 O
intervention 31 43 84 96 O
study 44 49 97 102 O
or 50 52 103 105 O
receiving 53 62 106 115 O
psychotherapy 63 76 116 129 B-treatment
to 77 79 130 132 O
improve 80 87 133 140 O
well 88 92 141 145 O
- 92 93 145 146 O
being 93 98 146 151 O
or 99 101 152 154 O
reduce 102 108 155 161 O
distress 109 117 162 170 O

Cognitive 0 9 171 180 B-chronic_disease
impairment 10 20 181 191 I-chronic_disease

Glucocorticoid 0 14 192 206 B-treatment
use 15 18 207 210 O
in 19 21 211 213 O
the 22 25 214 217 O
2 26 27 218 219 B-upper_bound
weeks 28 33 220 225 I-upper_bound
prior 34 39 226 231 I-upper_bound
to 40 42 232 234 O
enrollment 43 53 235 245 O

Neither 0 7 246 253 O
the 8 11 254 257 O
caregiver 12 21 258 267 O
nor 22 25 268 271 O
Alzheimer 26 35 272 281 B-chronic_disease
's 35 37 281 283 O
patient 38 45 284 291 O
can 46 49 292 295 O
be 50 52 296 298 O
diagnosed 53 62 299 308 O
with 63 67 309 313 O
a 68 69 314 315 O
terminal 70 78 316 324 O
illness 79 86 325 332 O
with 87 91 333 337 O
a 92 93 338 339 O
life 94 98 340 344 B-clinical_variable
expectancy 99 109 345 355 I-clinical_variable
of 110 112 356 358 O
less 113 117 359 363 O
than 118 122 364 368 O
1 123 124 369 370 B-upper_bound
year 125 129 371 375 I-upper_bound

Providing 0 9 376 385 O
in 10 12 386 388 O
- 12 13 388 389 O
home 13 17 389 393 O
care 18 22 394 398 O
to 23 25 399 401 O
a 26 27 402 403 O
spouse 28 34 404 410 O
with 35 39 411 415 O
dementia 40 48 416 424 B-chronic_disease

Taking 0 6 425 431 O
Aldomet 7 14 432 439 B-treatment
or 15 17 440 442 O
labetalol 18 27 443 452 B-treatment

Taking 0 6 453 459 O
Coumarin 7 15 460 468 B-treatment
anticoagulants 16 30 469 483 I-treatment

Taking 0 6 484 490 O
nitrates 7 15 491 499 B-treatment
or 16 18 500 502 O
niacin 19 25 503 509 B-treatment

Taking 0 6 510 516 O
non 7 10 517 520 B-treatment
- 10 11 520 521 I-treatment
selective 11 20 521 530 I-treatment
β 21 22 531 532 I-treatment
- 22 23 532 533 I-treatment
blockers 23 31 533 541 I-treatment

Adult 0 5 0 5 O
outpatients 6 17 6 17 O
meeting 18 25 18 25 O
Diagnostic 26 36 26 36 O
and 37 40 37 40 O
Statistical 41 52 41 52 O
Manual 53 59 53 59 O
of 60 62 60 62 O
Mental 63 69 63 69 O
Disorders 70 79 70 79 O
, 79 80 79 80 O
Fourth 81 87 81 87 O
Edition 88 95 88 95 O
, 95 96 95 96 O
Text 97 101 97 101 O
Revision 102 110 102 110 O
( 111 112 111 112 O
DSM 112 115 112 115 O
- 115 116 115 116 O
IV 116 118 116 118 O
- 118 119 118 119 O
TR 119 121 119 121 O
) 121 122 121 122 O
criteria 123 131 123 131 O
for 132 135 132 135 O
bipolar 136 143 136 143 B-chronic_disease
I 144 145 144 145 I-chronic_disease
disorder 146 154 146 154 I-chronic_disease
( 155 156 155 156 I-chronic_disease
296.70 156 162 156 162 I-chronic_disease
) 162 163 162 163 I-chronic_disease
, 163 164 163 164 O
bipolar 165 172 165 172 B-chronic_disease
II 173 175 173 175 I-chronic_disease
disorder 176 184 176 184 I-chronic_disease
( 185 186 185 186 I-chronic_disease
296.89 186 192 186 192 I-chronic_disease
) 192 193 192 193 I-chronic_disease
, 193 194 193 194 O
or 195 197 195 197 O
bipolar 198 205 198 205 B-chronic_disease
disorder 206 214 206 214 I-chronic_disease
not 215 218 215 218 O
otherwise 219 228 219 228 O
specified 229 238 229 238 O
( 239 240 239 240 O
296.80 240 246 240 246 O
) 246 247 246 247 O
, 247 248 247 248 O
with 249 253 249 253 O
concurrent 254 264 254 264 O
insomnia 265 273 265 273 B-chronic_disease
related 274 281 274 281 O
to 282 284 282 284 O
bipolar 285 292 285 292 B-chronic_disease
disorder 293 301 293 301 I-chronic_disease
( 302 303 302 303 I-chronic_disease
307.42 303 309 303 309 I-chronic_disease
) 309 310 309 310 I-chronic_disease

Clinically 0 10 311 321 O
significant 11 22 322 333 O
abnormalities 23 36 334 347 O
on 37 39 348 350 O
baseline 40 48 351 359 O
laboratory 49 59 360 370 O
tests 60 65 371 376 O
( 66 67 377 378 O
comprehensive 67 80 378 391 B-treatment
metabolic 81 90 392 401 I-treatment
panel 91 96 402 407 I-treatment
, 96 97 407 408 O
fasting 98 105 409 416 B-treatment
lipid 106 111 417 422 I-treatment
panel 112 117 423 428 I-treatment
, 117 118 428 429 O
Complete 119 127 430 438 B-treatment
Blood 128 133 439 444 I-treatment
Count 134 139 445 450 I-treatment
( 140 141 451 452 I-treatment
CBC 141 144 452 455 I-treatment
) 144 145 455 456 I-treatment
with 146 150 457 461 I-treatment
differential 151 163 462 474 I-treatment
, 163 164 474 475 O
thyroid 165 172 476 483 B-treatment
stimulating 173 184 484 495 I-treatment
hormone 185 192 496 503 I-treatment
) 192 193 503 504 O

Current 0 7 505 512 O
( 8 9 513 514 O
past 9 13 514 518 B-upper_bound
6 14 15 519 520 I-upper_bound
months 16 22 521 527 I-upper_bound
) 22 23 527 528 O
alcohol 24 31 529 536 O
or 32 34 537 539 O
substance 35 44 540 549 O
use 45 48 550 553 O
disorder 49 57 554 562 O

Current 0 7 563 570 O
hypo 8 12 571 575 O
/ 12 13 575 576 O
manic 13 18 576 581 O
symptoms 19 27 582 590 O
, 27 28 590 591 O
as 29 31 592 594 O
evidenced 32 41 595 604 O
by 42 44 605 607 O
the 45 48 608 611 O
Young 49 54 612 617 B-clinical_variable
Mania 55 60 618 623 I-clinical_variable
Rating 61 67 624 630 I-clinical_variable
Scale 68 73 631 636 I-clinical_variable
( 74 75 637 638 I-clinical_variable
YMRS 75 79 638 642 I-clinical_variable
) 79 80 642 643 I-clinical_variable
total 81 86 644 649 I-clinical_variable
score 87 92 650 655 I-clinical_variable
≥ 93 94 656 657 O
12 95 97 658 660 B-lower_bound

Current 0 7 661 668 O
psychosis 8 17 669 678 B-chronic_disease

Currently 0 9 679 688 O
taking 10 16 689 695 O
≥ 17 18 696 697 O
1 19 20 698 699 B-lower_bound
prescription 21 33 700 712 O
psychotropic 34 46 713 725 B-treatment
medication 47 57 726 736 I-treatment
( 58 59 737 738 O
hypnotic 59 67 738 746 B-treatment
agents 68 74 747 753 I-treatment
, 74 75 753 754 O
anxiolytics 76 87 755 766 B-treatment
, 87 88 766 767 O
atypical 89 97 768 776 B-treatment
antipsychotics 98 112 777 791 I-treatment
, 112 113 791 792 O
mood 114 118 793 797 B-treatment
stabilizers 119 130 798 809 I-treatment
, 130 131 809 810 O
and/or 132 138 811 817 O
antidepressants 139 154 818 833 B-treatment
) 154 155 833 834 O
for 156 159 835 838 O
management 160 170 839 849 O
of 171 173 850 852 O
bipolar 174 181 853 860 B-chronic_disease
disorder 182 190 861 869 I-chronic_disease

Patients 0 8 870 878 O
who 9 12 879 882 O
are 13 16 883 886 O
actively 17 25 887 895 O
suicidal 26 34 896 904 B-chronic_disease
or 35 37 905 907 O
evaluated 38 47 908 917 O
as 48 50 918 920 O
being 51 56 921 926 O
a 57 58 927 928 O
high 59 63 929 933 O
suicide 64 71 934 941 O
risk 72 76 942 946 O

Presence 0 8 947 955 O
of 9 11 956 958 O
any 12 15 959 962 O
unstable 16 24 963 971 O
and/or 25 31 972 978 O
potentially 32 43 979 990 O
confounding 44 55 991 1002 O
neurological 56 68 1003 1015 B-chronic_disease
and/or 69 75 1016 1022 O
medical 76 83 1023 1030 B-chronic_disease
disorder 84 92 1031 1039 I-chronic_disease

Subjective 0 10 1040 1050 B-clinical_variable
total 11 16 1051 1056 I-clinical_variable
sleep 17 22 1057 1062 I-clinical_variable
time 23 27 1063 1067 I-clinical_variable
( 28 29 1068 1069 I-clinical_variable
sTST 29 33 1069 1073 I-clinical_variable
) 33 34 1073 1074 I-clinical_variable
< 35 36 1075 1076 O
6 37 38 1077 1078 B-upper_bound
hours 39 44 1079 1084 I-upper_bound
on 45 47 1085 1087 O
≥ 48 49 1088 1089 O
1 50 51 1090 1091 B-lower_bound
night 52 57 1092 1097 O
during 58 64 1098 1104 O
the 65 68 1105 1108 O
prior 69 74 1109 1114 O
week 75 79 1115 1119 O

Women 0 5 1120 1125 B-gender
who 6 9 1126 1129 O
are 10 13 1130 1133 O
currently 14 23 1134 1143 B-pregnancy
pregnant 24 32 1144 1152 I-pregnancy

Agree 0 5 0 5 O
not 6 9 6 9 O
to 10 12 10 12 O
take 13 17 13 17 O
any 18 21 18 21 O
Pro 22 25 22 25 B-treatment
- 25 26 25 26 I-treatment
re 26 28 26 28 I-treatment
- 28 29 28 29 I-treatment
nata 29 33 29 33 I-treatment
( 34 35 34 35 I-treatment
PRN 35 38 35 38 I-treatment
) 38 39 38 39 I-treatment
medications 40 51 40 51 I-treatment
on 52 54 52 54 O
the 55 58 55 58 O
mornings 59 67 59 67 O
of 68 70 68 70 O
drug 71 75 71 75 O
sessions 76 84 76 84 O

Agree 0 5 85 90 O
not 6 9 91 94 O
to 10 12 95 97 O
take 13 17 98 102 O
sildenafil 18 28 103 113 B-treatment
( 29 30 114 115 I-treatment
Viagra 30 36 115 121 I-treatment
® 36 37 121 122 I-treatment
) 37 38 122 123 I-treatment
, 38 39 123 124 O
tadalafil 40 49 125 134 B-treatment
, 49 50 134 135 O
or 51 53 136 138 O
similar 54 61 139 146 O
medications 62 73 147 158 B-treatment
within 74 80 159 165 O
72 81 83 166 168 B-upper_bound
hours 84 89 169 174 I-upper_bound
of 90 92 175 177 O
each 93 97 178 182 O
drug 98 102 183 187 O
administration 103 117 188 202 O

Agree 0 5 203 208 O
to 6 8 209 211 O
consume 9 16 212 219 O
approximately 17 30 220 233 O
the 31 34 234 237 O
same 35 39 238 242 O
amount 40 46 243 249 O
of 47 49 250 252 O
caffeine 50 58 253 261 O
- 58 59 261 262 O
containing 59 69 262 272 O
beverage 70 78 273 281 O
( 79 80 282 283 O
e.g. 80 84 283 287 O
, 84 85 287 288 O
coffee 86 92 289 295 O
, 92 93 295 296 O
tea 94 97 297 300 O
) 97 98 300 301 O
that 99 103 302 306 O
he 104 106 307 309 O
/ 106 107 309 310 O
she 107 110 310 313 O
consumes 111 119 314 322 O
on 120 122 323 325 O
a 123 124 326 327 O
usual 125 130 328 333 O
morning 131 138 334 341 O
, 138 139 341 342 O
before 140 146 343 349 O
arriving 147 155 350 358 O
at 156 158 359 361 O
the 159 162 362 365 O
research 163 171 366 374 O
unit 172 176 375 379 O
on 177 179 380 382 O
the 180 183 383 386 O
mornings 184 192 387 395 O
of 193 195 396 398 O
psilocybin 196 206 399 409 B-treatment
session 207 214 410 417 I-treatment
days 215 219 418 422 O

Agree 0 5 423 428 O
to 6 8 429 431 O
refrain 9 16 432 439 O
from 17 21 440 444 O
using 22 27 445 450 O
any 28 31 451 454 O
psychoactive 32 44 455 467 B-treatment
drugs 45 50 468 473 I-treatment
, 50 51 473 474 O
including 52 61 475 484 O
alcoholic 62 71 485 494 O
beverages 72 81 495 504 O
and 82 85 505 508 O
nicotine 86 94 509 517 O
, 94 95 517 518 O
24 96 98 519 521 B-upper_bound
hours 99 104 522 527 I-upper_bound
before 105 111 528 534 O
and 112 115 535 538 O
after 116 121 539 544 O
each 122 126 545 549 O
drug 127 131 550 554 O
administration 132 146 555 569 O

Be 0 2 570 572 O
healthy 3 10 573 580 O
and 11 14 581 584 O
psychologically 15 30 585 600 O
stable 31 37 601 607 O
as 38 40 608 610 O
determined 41 51 611 621 O
by 52 54 622 624 O
screening 55 64 625 634 O
for 65 68 635 638 O
medical 69 76 639 646 O
and 77 80 647 650 O
psychiatric 81 92 651 662 B-chronic_disease
problems 93 101 663 671 I-chronic_disease
via 102 105 672 675 O
a 106 107 676 677 O
personal 108 116 678 686 O
interview 117 126 687 696 O
, 126 127 696 697 O
a 128 129 698 699 O
medical 130 137 700 707 O
questionnaire 138 151 708 721 O
, 151 152 721 722 O
a 153 154 723 724 O
physical 155 163 725 733 O
examination 164 175 734 745 O
, 175 176 745 746 O
an 177 179 747 749 O
electrocardiogram 180 197 750 767 B-treatment
( 198 199 768 769 I-treatment
ECG 199 202 769 772 I-treatment
) 202 203 772 773 I-treatment
, 203 204 773 774 O
and 205 208 775 778 O
routine 209 216 779 786 O
medical 217 224 787 794 O
blood 225 230 795 800 O
and 231 234 801 804 O
urinalysis 235 245 805 815 O
laboratory 246 256 816 826 O
tests 257 262 827 832 O

Cardiovascular 0 14 833 847 B-chronic_disease
conditions 15 25 848 858 I-chronic_disease
: 25 26 858 859 O
coronary 27 35 860 868 B-chronic_disease
artery 36 42 869 875 I-chronic_disease
disease 43 50 876 883 I-chronic_disease
, 50 51 883 884 O
stroke 52 58 885 891 B-chronic_disease
, 58 59 891 892 O
angina 60 66 893 899 B-chronic_disease
, 66 67 899 900 O
uncontrolled 68 80 901 913 O
hypertension 81 93 914 926 B-chronic_disease
, 93 94 926 927 O
a 95 96 928 929 O
clinically 97 107 930 940 O
significant 108 119 941 952 O
Electrocardiogram 120 137 953 970 B-treatment
( 138 139 971 972 I-treatment
ECG 139 142 972 975 I-treatment
) 142 143 975 976 I-treatment
abnormality 144 155 977 988 O
( 156 157 989 990 O
e.g. 157 161 990 994 O
, 161 162 994 995 O
symptomatic 163 174 996 1007 B-chronic_disease
atrial 175 181 1008 1014 I-chronic_disease
fibrillation 182 194 1015 1027 I-chronic_disease
) 194 195 1027 1028 O
, 195 196 1028 1029 O
or 197 199 1030 1032 O
Transient 200 209 1033 1042 B-chronic_disease
Ischemic 210 218 1043 1051 I-chronic_disease
Attack 219 225 1052 1058 I-chronic_disease
( 226 227 1059 1060 I-chronic_disease
TIA 227 230 1060 1063 I-chronic_disease
) 230 231 1063 1064 I-chronic_disease
in 232 234 1065 1067 O
the 235 238 1068 1071 O
past 239 243 1072 1076 B-upper_bound
year 244 248 1077 1081 I-upper_bound

Current 0 7 1082 1089 O
or 8 10 1090 1092 O
past 11 15 1093 1097 O
history 16 23 1098 1105 O
of 24 26 1106 1108 O
meeting 27 34 1109 1116 O
Diagnostic 35 45 1117 1127 O
and 46 49 1128 1131 O
Statistics 50 60 1132 1142 O
Manual 61 67 1143 1149 O
( 68 69 1150 1151 O
DSM)-5 69 75 1151 1157 O
criteria 76 84 1158 1166 O
for 85 88 1167 1170 O
Schizophrenia 89 102 1171 1184 B-chronic_disease

Current 0 7 1185 1192 O
or 8 10 1193 1195 O
past 11 15 1196 1200 O
history 16 23 1201 1208 O
within 24 30 1209 1215 O
the 31 34 1216 1219 O
last 35 39 1220 1224 B-upper_bound
5 40 41 1225 1226 I-upper_bound
years 42 47 1227 1232 I-upper_bound
of 48 50 1233 1235 O
meeting 51 58 1236 1243 O
DSM-5 59 64 1244 1249 O
criteria 65 73 1250 1258 O
for 74 77 1259 1262 O
alcohol 78 85 1263 1270 O
or 86 88 1271 1273 O
substance 89 98 1274 1283 O
use 99 102 1284 1287 O
disorder 103 111 1288 1296 O
( 112 113 1297 1298 O
excluding 113 122 1298 1307 O
caffeine 123 131 1308 1316 O
and 132 135 1317 1320 O
nicotine 136 144 1321 1329 O
) 144 145 1329 1330 O
or 146 148 1331 1333 O
severe 149 155 1334 1340 O
major 156 161 1341 1346 B-chronic_disease
depression 162 172 1347 1357 I-chronic_disease

Currently 0 9 1358 1367 O
taking 10 16 1368 1374 O
on 17 19 1375 1377 O
a 20 21 1378 1379 O
regular 22 29 1380 1387 O
( 30 31 1388 1389 O
e.g. 31 35 1389 1393 O
, 35 36 1393 1394 O
daily 37 42 1395 1400 O
) 42 43 1400 1401 O
basis 44 49 1402 1407 O
any 50 53 1408 1411 O
medications 54 65 1412 1423 B-treatment
having 66 72 1424 1430 O
a 73 74 1431 1432 O
primary 75 82 1433 1440 O
centrally 83 92 1441 1450 O
- 92 93 1450 1451 O
acting 93 99 1451 1457 O
pharmacological 100 115 1458 1473 O
effect 116 122 1474 1480 O
on 123 125 1481 1483 O
serotonin 126 135 1484 1493 B-treatment
neurons 136 143 1494 1501 O
or 144 146 1502 1504 O
medications 147 158 1505 1516 O
that 159 163 1517 1521 O
are 164 167 1522 1525 O
Mono 168 172 1526 1530 B-treatment
amine 173 178 1531 1536 I-treatment
Oxidase 179 186 1537 1544 I-treatment
( 187 188 1545 1546 I-treatment
MAO 188 191 1546 1549 I-treatment
) 191 192 1549 1550 I-treatment
inhibitors 193 203 1551 1561 I-treatment

Currently 0 9 1562 1571 O
taking 10 16 1572 1578 O
psychoactive 17 29 1579 1591 B-treatment
prescription 30 42 1592 1604 I-treatment
medication 43 53 1605 1615 I-treatment
on 54 56 1616 1618 O
a 57 58 1619 1620 O
regular 59 66 1621 1628 O
( 67 68 1629 1630 O
e.g. 68 72 1630 1634 O
, 72 73 1634 1635 O
daily 74 79 1636 1641 O
) 79 80 1641 1642 O
basis 81 86 1643 1648 O

Epilepsy 0 8 1649 1657 B-chronic_disease
with 9 13 1658 1662 O
history 14 21 1663 1670 O
of 22 24 1671 1673 O
seizures 25 33 1674 1682 B-chronic_disease

Exceptions 0 10 1683 1693 O
will 11 15 1694 1698 O
be 16 18 1699 1701 O
evaluated 19 28 1702 1711 O
by 29 31 1712 1714 O
the 32 35 1715 1718 O
study 36 41 1719 1724 O
investigators 42 55 1725 1738 O
and 56 59 1739 1742 O
will 60 64 1743 1747 O
include 65 72 1748 1755 O
acetaminophen 73 86 1756 1769 B-treatment
, 86 87 1769 1770 O
non 88 91 1771 1774 B-treatment
- 91 92 1774 1775 I-treatment
steroidal 92 101 1775 1784 I-treatment
anti 102 106 1785 1789 I-treatment
- 106 107 1789 1790 I-treatment
inflammatory 107 119 1790 1802 I-treatment
drugs 120 125 1803 1808 I-treatment
, 125 126 1808 1809 O
and 127 130 1810 1813 O
common 131 137 1814 1820 O
doses 138 143 1821 1826 O
of 144 146 1827 1829 O
vitamins 147 155 1830 1838 O
and 156 159 1839 1842 O
minerals 160 168 1843 1851 O

Has 0 3 1852 1855 O
a 4 5 1856 1857 O
psychiatric 6 17 1858 1869 B-chronic_disease
condition 18 27 1870 1879 I-chronic_disease
judged 28 34 1880 1886 O
to 35 37 1887 1889 O
be 38 40 1890 1892 O
incompatible 41 53 1893 1905 O
with 54 58 1906 1910 O
establishment 59 72 1911 1924 O
of 73 75 1925 1927 O
rapport 76 83 1928 1935 O
or 84 86 1936 1938 O
safe 87 91 1939 1943 O
exposure 92 100 1944 1952 O
to 101 103 1953 1955 O
psilocybin 104 114 1956 1966 O

Have 0 4 1967 1971 O
a 5 6 1972 1973 O
first 7 12 1974 1979 O
or 13 15 1980 1982 O
second 16 22 1983 1989 O
- 22 23 1989 1990 O
degree 23 29 1990 1996 O
relative 30 38 1997 2005 O
with 39 43 2006 2010 O
Schizophrenia 44 57 2011 2024 B-chronic_disease
, 57 58 2024 2025 O
Psychotic 59 68 2026 2035 B-chronic_disease
Disorder 69 77 2036 2044 I-chronic_disease
( 78 79 2045 2046 O
unless 79 85 2046 2052 O
substance 86 95 2053 2062 O
induced 96 103 2063 2070 O
or 104 106 2071 2073 O
due 107 110 2074 2077 O
to 111 113 2078 2080 O
a 114 115 2081 2082 O
medical 116 123 2083 2090 O
condition 124 133 2091 2100 O
) 133 134 2100 2101 O
, 134 135 2101 2102 O
or 136 138 2103 2105 O
Bipolar 139 146 2106 2113 B-chronic_disease
I 147 148 2114 2115 I-chronic_disease
or 149 151 2116 2118 I-chronic_disease
II 152 154 2119 2121 I-chronic_disease
Disorder 155 163 2122 2130 I-chronic_disease

Insulin 0 7 2131 2138 B-chronic_disease
- 7 8 2138 2139 I-chronic_disease
dependent 8 17 2139 2148 I-chronic_disease
diabetes 18 26 2149 2157 I-chronic_disease
; 26 27 2157 2158 O
if 28 30 2159 2161 O
taking 31 37 2162 2168 O
oral 38 42 2169 2173 B-treatment
hypoglycemic 43 55 2174 2186 I-treatment
agent 56 61 2187 2192 O
, 61 62 2192 2193 O
then 63 67 2194 2198 O
no 68 70 2199 2201 O
history 71 78 2202 2209 O
of 79 81 2210 2212 O
hypoglycemia 82 94 2213 2225 B-chronic_disease

More 0 4 2226 2230 O
than 5 9 2231 2235 O
20 10 12 2236 2238 B-lower_bound
% 12 13 2238 2239 I-lower_bound
outside 14 21 2240 2247 O
the 22 25 2248 2251 O
upper 26 31 2252 2257 O
or 32 34 2258 2260 O
lower 35 40 2261 2266 O
range 41 46 2267 2272 O
of 47 49 2273 2275 O
ideal 50 55 2276 2281 O
body 56 60 2282 2286 B-clinical_variable
weight 61 67 2287 2293 I-clinical_variable
according 68 77 2294 2303 O
to 78 80 2304 2306 O
Metropolitan 81 93 2307 2319 O
Life 94 98 2320 2324 O
height 99 105 2325 2331 O
and 106 109 2332 2335 O
weight 110 116 2336 2342 O
table 117 122 2343 2348 O

Psychotic 0 9 2349 2358 B-chronic_disease
Disorder 10 18 2359 2367 I-chronic_disease
( 19 20 2368 2369 O
unless 20 26 2369 2375 O
substance 27 36 2376 2385 O
- 36 37 2385 2386 O
induced 37 44 2386 2393 O
or 45 47 2394 2396 O
due 48 51 2397 2400 O
to 52 54 2401 2403 O
a 55 56 2404 2405 O
medical 57 64 2406 2413 O
condition 65 74 2414 2423 O
) 74 75 2423 2424 O
, 75 76 2424 2425 O
or 77 79 2426 2428 O
Bipolar 80 87 2429 2436 B-chronic_disease
I 88 89 2437 2438 I-chronic_disease
or 90 92 2439 2441 I-chronic_disease
II 93 95 2442 2444 I-chronic_disease
Disorder 96 104 2445 2453 I-chronic_disease

Women 0 5 2454 2459 B-gender
who 6 9 2460 2463 O
are 10 13 2464 2467 B-pregnancy
pregnant 14 22 2468 2476 I-pregnancy
( 23 24 2477 2478 O
as 24 26 2478 2480 O
indicated 27 36 2481 2490 O
by 37 39 2491 2493 O
a 40 41 2494 2495 O
positive 42 50 2496 2504 B-pregnancy
urine 51 56 2505 2510 I-pregnancy
pregnancy 57 66 2511 2520 I-pregnancy
test 67 71 2521 2525 O
assessed 72 80 2526 2534 O
at 81 83 2535 2537 O
intake 84 90 2538 2544 O
and 91 94 2545 2548 O
before 95 101 2549 2555 O
each 102 106 2556 2560 O
drug 107 111 2561 2565 O
session 112 119 2566 2573 O
) 119 120 2573 2574 O
or 121 123 2575 2577 O
nursing 124 131 2578 2585 O

women 0 5 2586 2591 B-gender
who 6 9 2592 2595 O
are 10 13 2596 2599 O
of 14 16 2600 2602 O
child 17 22 2603 2608 O
- 22 23 2608 2609 O
bearing 23 30 2609 2616 O
potential 31 40 2617 2626 O
and 41 44 2627 2630 O
sexually 45 53 2631 2639 O
active 54 60 2640 2646 O
who 61 64 2647 2650 O
are 65 68 2651 2654 O
not 69 72 2655 2658 B-contraception_consent
practicing 73 83 2659 2669 I-contraception_consent
an 84 86 2670 2672 I-contraception_consent
effective 87 96 2673 2682 I-contraception_consent
means 97 102 2683 2688 I-contraception_consent
of 103 105 2689 2691 I-contraception_consent
birth 106 111 2692 2697 I-contraception_consent
control 112 119 2698 2705 I-contraception_consent

< 0 1 0 1 O
85 2 4 2 4 B-upper_bound
( 5 6 5 6 O
less 6 10 6 10 O
than 11 15 11 15 O
or 16 18 16 18 O
equal 19 24 19 24 O
to 25 27 25 27 O
85 28 30 28 30 B-upper_bound
years 31 36 31 36 I-upper_bound
at 37 39 37 39 O
the 40 43 40 43 O
time 44 48 44 48 O
of 49 51 49 51 O
signing 52 59 52 59 O
the 60 63 60 63 O
Informed 64 72 64 72 O
Consent 73 80 73 80 O
Form 81 85 81 85 O

Advanced 0 8 86 94 B-chronic_disease
pulmonary 9 18 95 104 I-chronic_disease
disease 19 26 105 112 I-chronic_disease

Apple 0 5 113 118 O
shaped 6 12 119 125 O
adiposity 13 22 126 135 B-chronic_disease

Be 0 2 136 138 O
a 3 4 139 140 O
female 5 11 141 147 B-gender
who 12 15 148 151 O
is 16 18 152 154 O
pregnant 19 27 155 163 B-pregnancy

Be 0 2 164 166 O
an 3 5 167 169 O
organ 6 11 170 175 B-treatment
transplant 12 22 176 186 I-treatment
recipient 23 32 187 196 O

Be 0 2 197 199 O
serum 3 8 200 205 O
positive 9 17 206 214 O
for 18 21 215 218 O
HIV 22 25 219 222 B-chronic_disease

Elevated 0 8 223 231 B-chronic_disease
triglycerides 9 22 232 245 I-chronic_disease

Female 0 6 246 252 B-gender
subjects 7 15 253 261 I-gender
must 16 20 262 266 O
undergo 21 28 267 274 O
a 29 30 275 276 O
blood 31 36 277 282 B-pregnancy
or 37 39 283 285 I-pregnancy
urine 40 45 286 291 I-pregnancy
pregnancy 46 55 292 301 I-pregnancy
test 56 60 302 306 O
at 61 63 307 309 O
screening 64 73 310 319 O
and 74 77 320 323 O
within 78 84 324 330 O
36 85 87 331 333 B-upper_bound
hours 88 93 334 339 I-upper_bound
prior 94 99 340 345 I-upper_bound
to 100 102 346 348 O
infusion 103 111 349 357 O

GFR 0 3 358 361 B-clinical_variable
< 4 5 362 363 O
or 6 8 364 366 O
equal 9 14 367 372 O
to 15 17 373 375 O
35 18 20 376 378 B-upper_bound

Have 0 4 379 383 O
a 5 6 384 385 O
clinical 7 15 386 394 O
history 16 23 395 402 O
of 24 26 403 405 O
malignancy 27 37 406 416 B-cancer
within 38 44 417 423 O
3 45 46 424 425 B-upper_bound
years 47 52 426 431 I-upper_bound

Have 0 4 432 436 O
a 5 6 437 438 O
history 7 14 439 446 O
of 15 17 447 449 O
drug 18 22 450 454 O
or 23 25 455 457 O
alcohol 26 33 458 465 O
abuse 34 39 466 471 O
within 40 46 472 478 O
the 47 50 479 482 O
past 51 55 483 487 B-upper_bound
24 56 58 488 490 I-upper_bound
months 59 65 491 497 I-upper_bound

Have 0 4 498 502 O
known 5 10 503 508 O
allergies 11 20 509 518 O
to 21 23 519 521 O
penicillin 24 34 522 532 B-allergy_name
or 35 37 533 535 O
streptomycin 38 50 536 548 B-allergy_name

Hemoglobin 0 10 549 559 B-clinical_variable
A1C 11 14 560 563 I-clinical_variable
greater 15 22 564 571 O
than 23 27 572 576 O
7 28 29 577 578 B-lower_bound

Hypersensitivity 0 16 579 595 O
to 17 19 596 598 O
dimethyl 20 28 599 607 B-allergy_name
sulfoxide 29 38 608 617 I-allergy_name
( 39 40 618 619 I-allergy_name
DMSO 40 44 619 623 I-allergy_name
) 44 45 623 624 I-allergy_name

Liver 0 5 625 630 B-chronic_disease
disease 6 13 631 638 I-chronic_disease

Proliferative 0 13 639 652 B-chronic_disease
diabetic 14 22 653 661 I-chronic_disease
retinopathy 23 34 662 673 I-chronic_disease

chronic 0 7 674 681 B-chronic_disease
kidney 8 14 682 688 I-chronic_disease
disease 15 22 689 696 I-chronic_disease
stage 23 28 697 702 B-lower_bound
3 29 30 703 704 I-lower_bound
or 31 33 705 707 O
higher 34 40 708 714 O

curatively- 0 11 715 726 O
treated 12 19 727 734 O
basal 20 25 735 740 B-cancer
cell 26 30 741 745 I-cancer
carcinoma 31 40 746 755 I-cancer

heart 0 5 756 761 B-chronic_disease
failure 6 13 762 769 I-chronic_disease
patients 14 22 770 778 O

hepatitis 0 9 779 788 B-chronic_disease
BsAg 10 14 789 793 I-chronic_disease
or 15 17 794 796 O
Viremic 18 25 797 804 B-chronic_disease
hepatitis 26 35 805 814 I-chronic_disease
C 36 37 815 816 I-chronic_disease

less 0 4 817 821 O
than 5 9 822 826 O
1 10 11 827 828 B-upper_bound
expected 12 20 829 837 O
life 21 25 838 842 B-clinical_variable
span 26 30 843 847 I-clinical_variable

melanoma 0 8 848 856 B-cancer
in 9 11 857 859 I-cancer
situ 12 16 860 864 I-cancer
or 17 19 865 867 O
cervical 20 28 868 876 B-cancer
carcinoma 29 38 877 886 I-cancer

participated 0 12 887 899 O
within 13 19 900 906 O
the 20 23 907 910 O
previous 24 32 911 919 B-upper_bound
30 33 35 920 922 I-upper_bound
days 36 40 923 927 I-upper_bound

squamous 0 8 928 936 B-cancer
cell 9 13 937 941 I-cancer
carcinoma 14 23 942 951 I-cancer

subjects 0 8 952 960 O
with 9 13 961 965 O
prior 14 19 966 971 B-cancer
malignancy 20 30 972 982 I-cancer
must 31 35 983 987 O
be 36 38 988 990 O
disease 39 46 991 998 O
free 47 51 999 1003 O
for 52 55 1004 1007 O
3 56 57 1008 1009 O
years 58 63 1010 1015 O

Patients 0 8 0 8 O
anticipated 9 20 9 20 O
to 21 23 21 23 O
receive 24 31 24 31 O
metronidazole 32 45 32 45 B-treatment
after 46 51 46 51 O
enrollment 52 62 52 62 O

Patients 0 8 63 71 O
receiving 9 18 72 81 O
≥ 19 20 82 83 O
1 21 22 84 85 B-lower_bound
high 23 27 86 90 O
or 28 30 91 93 O
medium 31 37 94 100 O
risk 38 42 101 105 O
antibiotic 43 53 106 116 B-treatment
for 54 57 117 120 O
treatment 58 67 121 130 B-treatment
of 68 70 131 133 O
an 71 73 134 136 O
infection 74 83 137 146 O
other 84 89 147 152 O
than 90 94 153 157 O
CDI 95 98 158 161 B-chronic_disease
, 98 99 161 162 O
for 100 103 163 166 O
an 104 106 167 169 O
anticipated 107 118 170 181 O
duration 119 127 182 190 O
of 128 130 191 193 O
≥ 131 132 194 195 O
5 133 134 196 197 B-lower_bound
days 135 139 198 202 I-lower_bound
from 140 144 203 207 O
the 145 148 208 211 O
time 149 153 212 216 O
of 154 156 217 219 O
enrollment 157 167 220 230 O

Patients 0 8 231 239 O
who 9 12 240 243 O
already 13 20 244 251 O
received 21 29 252 260 O
oral 30 34 261 265 O
vancomycin 35 45 266 276 B-treatment
or 46 48 277 279 O
metronidazole 49 62 280 293 B-treatment
( 63 64 294 295 O
either 64 70 295 301 O
oral 71 75 302 306 O
or 76 78 307 309 O
intravenous 79 90 310 321 B-treatment
) 90 91 321 322 O
for 92 95 323 326 O
> 96 97 327 328 O
24 98 100 329 331 B-lower_bound
hours 101 106 332 337 I-lower_bound
within 107 113 338 344 O
the 114 117 345 348 O
preceding 118 127 349 358 O
72 128 130 359 361 B-upper_bound
hours 131 136 362 367 I-upper_bound
at 137 139 368 370 O
the 140 143 371 374 O
time 144 148 375 379 O
of 149 151 380 382 O
enrollment 152 162 383 393 O

Patients 0 8 394 402 O
with 9 13 403 407 O
severe 14 20 408 414 O
- 20 21 414 415 O
complicated 21 32 415 426 O
disease 33 40 427 434 O
that 41 45 435 439 O
would 46 51 440 445 O
compromise 52 62 446 456 O
oral 63 67 457 461 B-treatment
therapy 68 75 462 469 I-treatment
( 76 77 470 471 O
hypotenstion 77 89 471 483 B-chronic_disease
or 90 92 484 486 O
shock 93 98 487 492 O
, 98 99 492 493 O
ileus 100 105 494 499 B-chronic_disease
or 106 108 500 502 I-chronic_disease
bowel 109 114 503 508 I-chronic_disease
obstruction 115 126 509 520 I-chronic_disease
, 126 127 520 521 O
megacolon 128 137 522 531 B-chronic_disease
) 137 138 531 532 O

with 0 4 533 537 O
> 5 6 538 539 O
3 6 7 539 540 B-lower_bound
unformed 8 16 541 549 O
stools/24 17 26 550 559 O
hours 27 32 560 565 O
with 33 37 566 570 O
positive 38 46 571 579 O
stool 47 52 580 585 O
test 53 57 586 590 O
for 58 61 591 594 O
C 62 63 595 596 O

History 0 7 0 7 O
of 8 10 8 10 O
priapism 11 19 11 19 B-chronic_disease

IIEF 0 4 20 24 B-clinical_variable
score 5 10 25 30 I-clinical_variable
less 11 15 31 35 O
than 16 20 36 40 O
13 21 23 41 43 B-upper_bound

Men 0 3 44 47 B-gender
with 4 8 48 52 O
neurological 9 21 53 65 B-chronic_disease
disease 22 29 66 73 I-chronic_disease

Pelvic 0 6 74 80 B-chronic_disease
neuropathy 7 17 81 91 I-chronic_disease

Penile 0 6 92 98 O
skin 7 11 99 103 O
lesions 12 19 104 111 O
or 20 22 112 114 O
ulcers 23 29 115 121 B-chronic_disease

Post 0 4 122 126 O
- 4 5 126 127 O
prostatectomy 5 18 127 140 B-treatment

Spinal 0 6 141 147 B-chronic_disease
cord 7 11 148 152 I-chronic_disease
injury 12 18 153 159 I-chronic_disease

mild 0 4 160 164 O
- 4 5 164 165 O
moderate 5 13 165 173 O
erectile 14 22 174 182 B-chronic_disease
dysfunction 23 34 183 194 I-chronic_disease
based 35 40 195 200 O
on 41 43 201 203 O
International 44 57 204 217 B-clinical_variable
Index 58 63 218 223 I-clinical_variable
of 64 66 224 226 I-clinical_variable
Erectile 67 75 227 235 I-clinical_variable
Function 76 84 236 244 I-clinical_variable
( 85 86 245 246 I-clinical_variable
IIEF 86 90 246 250 I-clinical_variable
) 90 91 250 251 I-clinical_variable
erectile 92 100 252 260 I-clinical_variable
function 101 109 261 269 I-clinical_variable
score 110 115 270 275 I-clinical_variable
13 116 118 276 278 B-lower_bound
- 118 119 278 279 O
25 119 121 279 281 B-upper_bound

Adequate 0 8 0 8 O
renal 9 14 9 14 O
function 15 23 15 23 O
with 24 28 24 28 O
estimated 29 38 29 38 O
creatinine 39 49 39 49 B-clinical_variable
clearance 50 59 50 59 I-clinical_variable
≥50 60 63 60 63 O
mL 64 66 64 66 I-lower_bound
/ 66 67 66 67 I-lower_bound
min 67 70 67 70 I-lower_bound
( 71 72 71 72 O
by 72 74 72 74 O
the 75 78 75 78 O
Cockcroft 79 88 79 88 O
Gault 89 94 89 94 O
equation 95 103 95 103 O
) 103 104 103 104 O

Any 0 3 105 108 O
serious 4 11 109 116 O
and/or 12 18 117 123 O
unstable 19 27 124 132 O
pre 28 31 133 136 O
- 31 32 136 137 O
existing 32 40 137 145 O
medical 41 48 146 153 O
, 48 49 153 154 O
psychiatric 50 61 155 166 O
, 61 62 166 167 O
or 63 65 168 170 O
other 66 71 171 176 O
medical 72 79 177 184 B-chronic_disease
condition 80 89 185 194 I-chronic_disease
that 90 94 195 199 O
could 95 100 200 205 O
interfere 101 110 206 215 O
with 111 115 216 220 O
subject 116 123 221 228 O
's 123 125 228 230 O
safety 126 132 231 237 O
, 132 133 237 238 O
provision 134 143 239 248 O
of 144 146 249 251 O
informed 147 155 252 260 O
consent 156 163 261 268 O
, 163 164 268 269 O
or 165 167 270 272 O
compliance 168 178 273 283 O
with 179 183 284 288 O
study 184 189 289 294 O
procedures 190 200 295 305 O

Available 0 9 306 315 O
prior 10 15 316 321 O
CT 16 18 322 324 O
or 19 21 325 327 O
PET 22 25 328 331 O
/ 25 26 331 332 O
CT 26 28 332 334 O
scan 29 33 335 339 O
done 34 38 340 344 O
in 39 41 345 347 O
the 42 45 348 351 O
last 46 50 352 356 B-upper_bound
8 51 52 357 358 I-upper_bound
weeks 53 58 359 364 I-upper_bound
for 59 62 365 368 O
comparison 63 73 369 379 O

Body 0 4 380 384 B-clinical_variable
weight 5 11 385 391 I-clinical_variable
over 12 16 392 396 O
300 17 20 397 400 B-lower_bound
pounds 21 27 401 407 I-lower_bound

DLBCL 0 5 408 413 B-cancer
without 6 13 414 421 O
myc 14 17 422 425 O
translocation 18 31 426 439 O
or 32 34 440 442 O
overexpression 35 49 443 457 O
by 50 52 458 460 O
the 53 56 461 464 O
above 57 62 465 470 O
methods 63 70 471 478 O

Double 0 6 479 485 O
hit 7 10 486 489 O
lymphoma 11 19 490 498 B-cancer

Histologically 0 14 499 513 O
confirmed 15 24 514 523 O
DLBCL 25 30 524 529 B-cancer
or 31 33 530 532 O
BCLU 34 38 533 537 B-cancer

No 0 2 538 540 O
contraindications 3 20 541 558 O
to 21 23 559 561 O
MRI 24 27 562 565 B-treatment
( 28 29 566 567 O
e.g. 29 33 567 571 O
pacemaker 34 43 572 581 B-treatment
, 43 44 581 582 O
aneurysm 45 53 583 591 B-treatment
clips 54 59 592 597 I-treatment
, 59 60 597 598 O
severe 61 67 599 605 O
claustrophobia 68 82 606 620 B-chronic_disease
) 82 83 620 621 O

Presence 0 8 622 630 O
of 9 11 631 633 O
palpable 12 20 634 642 O
or 21 23 643 645 O
radiographically 24 40 646 662 O
measurable 41 51 663 673 O
disease 52 59 674 681 O
of 60 62 682 684 O
at 63 65 685 687 O
least 66 71 688 693 O
1.5 72 75 694 697 B-lower_bound
cm 76 78 698 700 I-lower_bound
in 79 81 701 703 O
longest 82 89 704 711 O
dimension 90 99 712 721 O

Prior 0 5 722 727 B-treatment
MRI 6 9 728 731 I-treatment
with 10 14 732 736 O
gadolinium 15 25 737 747 B-clinical_variable
performed 26 35 748 757 I-clinical_variable
< 36 37 758 759 O
24 37 39 759 761 B-upper_bound
hours 40 45 762 767 O
before 46 52 768 774 O
the 53 56 775 778 O
study 57 62 779 784 O
scan 63 67 785 789 O

Prior 0 5 790 795 B-treatment
chemotherapy 6 18 796 808 I-treatment
or 19 21 809 811 O
radiation 22 31 812 821 B-treatment
to 32 34 822 824 O
the 35 38 825 828 O
measurable 39 49 829 839 O
lesion 50 56 840 846 O
must 57 61 847 851 O
be 62 64 852 854 O
completed 65 74 855 864 O
at 75 77 865 867 O
least 78 83 868 873 O
14 84 86 874 876 B-lower_bound
days 87 91 877 881 I-lower_bound
prior 92 97 882 887 I-lower_bound

intolerance 0 11 888 899 O
to 12 14 900 902 O
gadolinium 15 25 903 913 B-treatment

Age 0 3 0 3 B-age
≥8 4 6 4 6 O
years 7 12 7 12 I-lower_bound

Amblyopia 0 9 13 22 B-chronic_disease
associated 10 20 23 33 O
with 21 25 34 38 O
strabismus 26 36 39 49 B-chronic_disease
and/or 37 43 50 56 O
anisometropia 44 57 57 70 B-chronic_disease

Amblyopic 0 9 71 80 B-clinical_variable
eye 10 13 81 84 I-clinical_variable
visual 14 20 85 91 I-clinical_variable
acuity 21 27 92 98 I-clinical_variable
of 28 30 99 101 O
20/50 31 36 102 107 B-lower_bound
- 37 38 108 109 O
20/400 39 45 110 116 B-upper_bound

Available 0 9 117 126 O
for 10 13 127 130 O
at 14 16 131 133 O
least 17 22 134 139 O
6 23 24 140 141 B-lower_bound
months 25 31 142 148 I-lower_bound
of 32 34 149 151 O
follow 35 41 152 158 O
- 41 42 158 159 O
up 42 44 159 161 O

Complete 0 8 162 170 O
eye 9 12 171 174 O
examination 13 24 175 186 O
within 25 31 187 193 O
6 32 33 194 195 B-upper_bound
months 34 40 196 202 I-upper_bound
prior 41 46 203 208 I-upper_bound
to 47 49 209 211 O
enrollment 50 60 212 222 O

Current 0 7 223 230 O
use 8 11 231 234 O
of 12 14 235 237 O
medication 15 25 238 248 B-treatment
for 26 29 249 252 O
the 30 33 253 256 O
treatment 34 43 257 266 B-treatment
of 44 46 267 269 O
ADHD 47 51 270 274 B-chronic_disease
or 52 54 275 277 O
psychological 55 68 278 291 B-chronic_disease
disorders 69 78 292 301 I-chronic_disease

Current 0 7 302 309 O
vision 8 14 310 316 B-treatment
therapy 15 22 317 324 I-treatment
or 23 25 325 327 O
orthoptics 26 36 328 338 B-treatment

Females 0 7 339 346 B-gender
who 8 11 347 350 O
are 12 15 351 354 B-pregnancy
pregnant 16 24 355 363 I-pregnancy

For 0 3 364 367 O
8 4 5 368 369 B-lower_bound
to 6 8 370 372 O
17 9 11 373 375 B-upper_bound
year 12 16 376 380 I-upper_bound
olds 17 21 381 385 O
, 21 22 385 386 O
current 23 30 387 394 O
amblyopia 31 40 395 404 B-treatment
treatment 41 50 405 414 I-treatment
of 51 53 415 417 O
at 54 56 418 420 O
least 57 62 421 426 O
2 63 64 427 428 B-lower_bound
hours 65 70 429 434 I-lower_bound
of 71 73 435 437 O
daily 74 79 438 443 O
patching 80 88 444 452 O
for 89 92 453 456 O
at 93 95 457 459 O
least 96 101 460 465 O
4 102 103 466 467 B-lower_bound
weeks 104 109 468 473 I-lower_bound
during 110 116 474 480 O
the 117 120 481 484 O
pre 121 124 485 488 O
- 124 125 488 489 O
enrollment 125 135 489 499 O
period 136 142 500 506 O
with 143 147 507 511 O
no 148 150 512 514 O
improvement 151 162 515 526 O
in 163 165 527 529 O
best 166 170 530 534 O
- 170 171 534 535 O
corrected 171 180 535 544 O
amblyopic 181 190 545 554 B-clinical_variable
eye 191 194 555 558 I-clinical_variable
visual 195 201 559 565 I-clinical_variable
acuity 202 208 566 572 I-clinical_variable
( 209 210 573 574 O
< 210 211 574 575 O
5 211 212 575 576 B-upper_bound
letters 213 220 577 584 I-upper_bound
or 221 223 585 587 O
1 224 225 588 589 O
logMAR 226 232 590 596 O
line 233 237 597 601 O
between 238 245 602 609 O
2 246 247 610 611 O
consecutive 248 259 612 623 O
visual 260 266 624 630 O
acuity 267 273 631 637 O
measurements 274 286 638 650 O
at 287 289 651 653 O
least 290 295 654 659 O
4 296 297 660 661 O
weeks 298 303 662 667 O
apart 304 309 668 673 O
while 310 315 674 679 O
on 316 318 680 682 O
current 319 326 683 690 O
treatment 327 336 691 700 O
) 336 337 700 701 O

For 0 3 702 705 O
≥18 4 7 706 709 O
year 8 12 710 714 I-lower_bound
olds 13 17 715 719 O

History 0 7 720 727 O
of 8 10 728 730 O
gastrointestinal 11 27 731 747 B-chronic_disease
bleeding 28 36 748 756 I-chronic_disease
from 37 41 757 761 O
peptic 42 48 762 768 B-chronic_disease
ulcer 49 54 769 774 I-chronic_disease
disease 55 62 775 782 I-chronic_disease

Inability 0 9 783 792 O
to 10 12 793 795 O
swallow 13 20 796 803 O
pills 21 26 804 809 O
equivalent 27 37 810 820 O
in 38 40 821 823 O
size 41 45 824 828 O
to 46 48 829 831 O
the 49 52 832 835 O
5 53 54 836 837 O
mg 55 57 838 840 O
donepezil 58 67 841 850 B-treatment
tablet 68 74 851 857 I-treatment

Known 0 5 858 863 O
allergies 6 15 864 873 O
or 16 18 874 876 O
contraindications 19 36 877 894 O
to 37 39 895 897 O
the 40 43 898 901 O
use 44 47 902 905 O
of 48 50 906 908 O
acetylcholinesterase 51 71 909 929 B-allergy_name
inhibitors 72 82 930 940 I-allergy_name

Known 0 5 941 946 O
psychological 6 19 947 960 B-chronic_disease
problems 20 28 961 969 I-chronic_disease

Known 0 5 970 975 O
skin 6 10 976 980 O
reaction 11 19 981 989 O
to 20 22 990 992 O
patch 23 28 993 998 B-allergy_name
or 29 31 999 1001 O
bandage 32 39 1002 1009 B-allergy_name
adhesives 40 49 1010 1019 I-allergy_name
for 50 53 1020 1023 O
8 54 55 1024 1025 B-lower_bound
to 56 58 1026 1028 O
17 59 61 1029 1031 B-upper_bound
year 62 66 1032 1036 I-upper_bound
olds 67 71 1037 1041 O

Myopia 0 6 1042 1048 B-chronic_disease
more 7 11 1049 1053 O
than 12 16 1054 1058 O
-6.00 17 22 1059 1064 O
D 23 24 1065 1066 I-lower_bound
spherical 25 34 1067 1076 O
equivalent 35 45 1077 1087 O

Presence 0 8 1088 1096 O
of 9 11 1097 1099 O
cardiac 12 19 1100 1107 B-chronic_disease
condition 20 29 1108 1117 O
, 29 30 1117 1118 O
asthma 31 37 1119 1125 B-chronic_disease
, 37 38 1125 1126 O
obstructive 39 50 1127 1138 B-chronic_disease
pulmonary 51 60 1139 1148 I-chronic_disease
disease 61 68 1149 1156 I-chronic_disease
, 68 69 1156 1157 O
seizure 70 77 1158 1165 B-chronic_disease
disorder 78 86 1166 1174 I-chronic_disease
, 86 87 1174 1175 O
urinary 88 95 1176 1183 B-chronic_disease
incontinence 96 108 1184 1196 I-chronic_disease
, 108 109 1196 1197 O
and/or 110 116 1198 1204 O
peptic 117 123 1205 1211 B-chronic_disease
ulcer 124 129 1212 1217 I-chronic_disease
disease 130 137 1218 1225 I-chronic_disease
receiving 138 147 1226 1235 O
concurrent 148 158 1236 1246 O
NSAIDs 159 165 1247 1253 B-treatment

Previous 0 8 1254 1262 B-treatment
intraocular 9 20 1263 1274 I-treatment
or 21 23 1275 1277 O
refractive 24 34 1278 1288 B-treatment
surgery 35 42 1289 1296 I-treatment

Prior 0 5 1297 1302 B-treatment
acetylcholinesterase 6 26 1303 1323 I-treatment
inhibitor 27 36 1324 1333 I-treatment
treatment 37 46 1334 1343 I-treatment

Sound 0 5 1344 1349 B-clinical_variable
eye 6 9 1350 1353 I-clinical_variable
visual 10 16 1354 1360 I-clinical_variable
acuity 17 23 1361 1367 I-clinical_variable
of 24 26 1368 1370 O
≥20/25 27 33 1371 1377 O

Strabismus 0 10 1378 1388 B-treatment
surgery 11 18 1389 1396 I-treatment
planned 19 26 1397 1404 O
within 27 33 1405 1411 O
22 34 36 1412 1414 B-upper_bound
weeks 37 42 1415 1420 I-upper_bound

Treatment 0 9 1421 1430 B-treatment
with 10 14 1431 1435 O
topical 15 22 1436 1443 O
atropine 23 31 1444 1452 O
within 32 38 1453 1459 O
the 39 42 1460 1463 O
past 43 47 1464 1468 B-upper_bound
4 48 49 1469 1470 I-upper_bound
weeks 50 55 1471 1476 I-upper_bound

Wearing 0 7 1477 1484 O
optimal 8 15 1485 1492 O
optical 16 23 1493 1500 O
correction 24 34 1501 1511 O
with 35 39 1512 1516 O
stable 40 46 1517 1523 O
amblyopic 47 56 1524 1533 O
eye 57 60 1534 1537 O
visual 61 67 1538 1544 O
acuity 68 74 1545 1551 O
( 75 76 1552 1553 O
< 76 77 1553 1554 O
5 77 78 1554 1555 B-upper_bound
letters 79 86 1556 1563 O
or 87 89 1564 1566 O
1 90 91 1567 1568 B-upper_bound
logMAR 92 98 1569 1575 O
line 99 103 1576 1580 O
of 104 106 1581 1583 O
improvement 107 118 1584 1595 O
during 119 125 1596 1602 O
2 126 127 1603 1604 O
consecutive 128 139 1605 1616 O
visual 140 146 1617 1623 O
acuity 147 153 1624 1630 O
measurements 154 166 1631 1643 O
at 167 169 1644 1646 O
least 170 175 1647 1652 O
4 176 177 1653 1654 B-lower_bound
weeks 178 183 1655 1660 I-lower_bound
apart 184 189 1661 1666 O
) 189 190 1666 1667 O

have 0 4 1668 1672 O
access 5 11 1673 1679 B-technology_access
to 12 14 1680 1682 I-technology_access
a 15 16 1683 1684 I-technology_access
phone 17 22 1685 1690 I-technology_access

history 0 7 1691 1698 O
of 8 10 1699 1701 O
prior 11 16 1702 1707 B-treatment
amblyopia 17 26 1708 1717 I-treatment
treatment 27 36 1718 1727 I-treatment
with 37 41 1728 1732 I-treatment
patching 42 50 1733 1741 I-treatment

intending 0 9 1742 1751 O
to 10 12 1752 1754 O
become 13 19 1755 1761 B-pregnancy
pregnant 20 28 1762 1770 I-pregnancy
within 29 35 1771 1777 O
the 36 39 1778 1781 O
next 40 44 1782 1786 B-upper_bound
6 45 46 1787 1788 I-upper_bound
months 47 53 1789 1795 I-upper_bound

Acute 0 5 0 5 B-chronic_disease
hepatitis 6 15 6 15 I-chronic_disease

Acute 0 5 16 21 B-chronic_disease
liver 6 11 22 27 I-chronic_disease
failure 12 19 28 35 I-chronic_disease

Acute 0 5 36 41 B-chronic_disease
myocardial 6 16 42 52 I-chronic_disease
infarction 17 27 53 63 I-chronic_disease

Acute 0 5 64 69 O
seizures 6 14 70 78 B-chronic_disease

Acute 0 5 79 84 B-chronic_disease
stroke 6 12 85 91 I-chronic_disease

Burn 0 4 92 96 B-clinical_variable
injury 5 11 97 103 I-clinical_variable
experienced 12 23 104 115 I-clinical_variable
< 24 25 116 117 O
48 25 27 117 119 B-upper_bound
hours 28 33 120 125 I-upper_bound
prior 34 39 126 131 I-upper_bound
to 40 42 132 134 O
admission 43 52 135 144 O
to 53 55 145 147 O
the 56 59 148 151 O
Burn 60 64 152 156 O
Center 65 71 157 163 O
for 72 75 164 167 O
care 76 80 168 172 O

Chemical 0 8 173 181 B-chronic_disease
or 9 11 182 184 O
electrical 12 22 185 195 B-chronic_disease
burn 23 27 196 200 I-chronic_disease
injury 28 34 201 207 I-chronic_disease

Expected 0 8 208 216 O
stay 9 13 217 221 O
on 14 16 222 224 O
the 17 20 225 228 O
Burn 21 25 229 233 O
Center 26 32 234 240 O
for 33 36 241 244 O
3 37 38 245 246 B-lower_bound
or 39 41 247 249 I-lower_bound
more 42 46 250 254 I-lower_bound
days 47 51 255 259 I-lower_bound

Patients 0 8 260 268 O
age 9 12 269 272 B-age
18- 13 16 273 276 B-lower_bound
89 17 19 277 279 B-upper_bound

Patients 0 8 280 288 O
who 9 12 289 292 O
are 13 16 293 296 B-pregnancy
pregnant 17 25 297 305 I-pregnancy

Patients 0 8 306 314 O
with 9 13 315 319 O
current 14 21 320 327 O
hemodynamic 22 33 328 339 B-chronic_disease
instability 34 45 340 351 I-chronic_disease
( 46 47 352 353 O
current 47 54 353 360 O
hypotension 55 66 361 372 B-clinical_variable
systolic 67 75 373 381 I-clinical_variable
blood 76 81 382 387 I-clinical_variable
pressure 82 90 388 396 I-clinical_variable
< 91 92 397 398 O
100 92 95 398 401 B-upper_bound
mmHg 96 100 402 406 I-upper_bound
, 100 101 406 407 O
sustained 102 111 408 417 B-clinical_variable
heart 112 117 418 423 I-clinical_variable
rate 118 122 424 428 I-clinical_variable
< 123 124 429 430 O
60 125 127 431 433 B-upper_bound
beats 128 133 434 439 I-upper_bound
/ 133 134 439 440 I-upper_bound
min 134 137 440 443 I-upper_bound
without 138 145 444 451 O
a 146 147 452 453 O
pacemaker 148 157 454 463 O
, 157 158 463 464 O
symptomatic 159 170 465 476 B-chronic_disease
bradycardia 171 182 477 488 I-chronic_disease
, 182 183 488 489 O
or 184 186 490 492 O
second 187 193 493 499 B-chronic_disease
or 194 196 500 502 I-chronic_disease
third 197 202 503 508 I-chronic_disease
degree 203 209 509 515 I-chronic_disease
heart 210 215 516 521 I-chronic_disease
block 216 221 522 527 I-chronic_disease
) 221 222 527 528 O

Read 0 4 529 533 B-language_fluency
, 4 5 533 534 I-language_fluency
write 6 11 535 540 I-language_fluency
and 12 15 541 544 I-language_fluency
speak 16 21 545 550 I-language_fluency
English 22 29 551 558 I-language_fluency

Severe 0 6 559 565 O
cognition 7 16 566 575 O
or 17 19 576 578 O
communication 20 33 579 592 O
difficulties 34 46 593 605 O
( 47 48 606 607 O
e.g. 48 52 607 611 O
, 52 53 611 612 O
coma 54 58 613 617 B-chronic_disease
, 58 59 617 618 O
deafness 60 68 619 627 O
without 69 76 628 635 O
signing 77 84 636 643 O
literacy 85 93 644 652 O
, 93 94 652 653 O
dementia 95 103 654 662 B-chronic_disease
, 103 104 662 663 O
non 105 108 664 667 B-language_fluency
- 108 109 667 668 I-language_fluency
English 109 116 668 675 I-language_fluency
speaking 117 125 676 684 I-language_fluency
) 125 126 684 685 O

admitted 0 8 686 694 O
for 9 12 695 698 O
initial 13 20 699 706 O
management 21 31 707 717 O
of 32 34 718 720 O
a 35 36 721 722 O
thermal 37 44 723 730 O
burn 45 49 731 735 O
injury 50 56 736 742 O
( 57 58 743 744 O
flame 58 63 744 749 O
, 63 64 749 750 O
scald 65 70 751 756 O
, 70 71 756 757 O
contact 72 79 758 765 O
) 79 80 765 766 O
with 81 85 767 771 O
> 86 87 772 773 O
1 87 88 773 774 B-lower_bound
% 88 89 774 775 I-lower_bound
total 90 95 776 781 B-clinical_variable
body 96 100 782 786 I-clinical_variable
surface 101 108 787 794 I-clinical_variable
area 109 113 795 799 I-clinical_variable

A 0 1 0 1 O
patient 2 9 2 9 O
with 10 14 10 14 O
an 15 17 15 17 O
intracerebral 18 31 18 31 B-chronic_disease
hemorrhage 32 42 32 42 I-chronic_disease

Acute 0 5 43 48 O
bleeding 6 14 49 57 O
associated 15 25 58 68 O
with 26 30 69 73 O
a 31 32 74 75 O
fall 33 37 76 80 O
in 38 40 81 83 O
hemoglobin 41 51 84 94 B-clinical_variable
level 52 57 95 100 I-clinical_variable
by 58 60 101 103 O
≥2 61 63 104 106 O
g 64 65 107 108 I-lower_bound
/ 65 66 108 109 I-lower_bound
dL 66 68 109 111 I-lower_bound

Acute 0 5 112 117 B-chronic_disease
bleeding 6 14 118 126 I-chronic_disease
associated 15 25 127 137 O
with 26 30 138 142 O
a 31 32 143 144 O
hemoglobin 33 43 145 155 B-clinical_variable
level 44 49 156 161 I-clinical_variable
of 50 52 162 164 O
≤8 53 55 165 167 O
g 56 57 168 169 I-upper_bound
/ 57 58 169 170 I-upper_bound
dL 58 60 170 172 I-upper_bound
if 61 63 173 175 O
no 64 66 176 178 O
baseline 67 75 179 187 O
hemoglobin 76 86 188 198 O
is 87 89 199 201 O
available 90 99 202 211 O

Acute 0 5 212 217 B-chronic_disease
bleeding 6 14 218 226 I-chronic_disease
in 15 17 227 229 O
a 18 19 230 231 O
critical 20 28 232 240 O
area 29 33 241 245 O
or 34 36 246 248 O
organ 37 42 249 254 O
such 43 47 255 259 O
as 48 50 260 262 O
intraspinal 51 62 263 274 O
, 62 63 274 275 O
pericardial 64 75 276 287 O
, 75 76 287 288 O
or 77 79 289 291 O
intracranial 80 92 292 304 O

Acute 0 5 305 310 B-chronic_disease
bleeding 6 14 311 319 I-chronic_disease
that 15 19 320 324 O
is 20 22 325 327 O
potentially 23 34 328 339 O
life 35 39 340 344 O
- 39 40 344 345 O
threatening 40 51 345 356 O

Dabigatran 0 10 357 367 B-treatment

Expected 0 8 368 376 O
survival 9 17 377 385 O
of 18 20 386 388 O
less 21 25 389 393 O
than 26 30 394 398 O
1 31 32 399 400 B-upper_bound
month 33 38 401 406 I-upper_bound

For 0 3 407 410 O
patients 4 12 411 419 O
with 13 17 420 424 O
intracranial 18 30 425 437 B-chronic_disease
bleeding 31 39 438 446 I-chronic_disease
, 39 40 446 447 O
there 41 46 448 453 O
must 47 51 454 458 O
be 52 54 459 461 O
a 55 56 462 463 O
reasonable 57 67 464 474 O
expectation 68 79 475 486 O
that 80 84 487 491 O
andexanet 85 94 492 501 B-treatment
treatment 95 104 502 511 I-treatment
will 105 109 512 516 O
commence 110 118 517 525 O
within 119 125 526 532 O
2 126 127 533 534 B-upper_bound
hours 128 133 535 540 I-upper_bound
of 134 136 541 543 O
the 137 140 544 547 O
baseline 141 149 548 556 O
imaging 150 157 557 564 O
evaluation 158 168 565 575 O

Glasgow 0 7 576 583 B-clinical_variable
coma 8 12 584 588 I-clinical_variable
score 13 18 589 594 I-clinical_variable
< 19 20 595 596 O
7 21 22 597 598 B-upper_bound

Intracerebral 0 13 599 612 B-clinical_variable
hematoma 14 22 613 621 I-clinical_variable
> 23 24 622 623 O
60 25 27 624 626 B-lower_bound
cc 28 30 627 629 I-lower_bound
as 31 33 630 632 O
assessed 34 42 633 641 O
by 43 45 642 644 O
CT 46 48 645 647 O
or 49 51 648 650 O
MRI 52 55 651 654 O

Patient 0 7 655 662 O
has 8 11 663 666 O
received 12 20 667 675 O
any 21 24 676 679 O
of 25 27 680 682 O
the 28 31 683 686 O
following 32 41 687 696 O
drugs 42 47 697 702 B-treatment
or 48 50 703 705 I-treatment
blood 51 56 706 711 I-treatment
products 57 65 712 720 I-treatment
within 66 72 721 727 O
7 73 74 728 729 B-upper_bound
days 75 79 730 734 I-upper_bound
of 80 82 735 737 O
Screening 83 92 738 747 O

Patient 0 7 748 755 O
received 8 16 756 764 O
or 17 19 765 767 O
is 20 22 768 770 O
believed 23 31 771 779 O
to 32 34 780 782 O
have 35 39 783 787 O
received 40 48 788 796 O
one 49 52 797 800 O
of 53 55 801 803 O
the 56 59 804 807 O
following 60 69 808 817 O
within 70 76 818 824 O
18 77 79 825 827 B-upper_bound
hours 80 85 828 833 I-upper_bound
prior 86 91 834 839 I-upper_bound
to 92 94 840 842 O
andexanet 95 104 843 852 B-treatment
administration 105 119 853 867 O
: 119 120 867 868 O
apixaban 121 129 869 877 B-treatment
, 129 130 877 878 O
rivaroxaban 131 142 879 890 B-treatment
, 142 143 890 891 O
edoxaban 144 152 892 900 B-treatment
or 153 155 901 903 O
enoxaparin 156 166 904 914 B-treatment

Planned 0 7 915 922 O
administration 8 22 923 937 O
of 23 25 938 940 O
PCC 26 29 941 944 B-treatment
, 29 30 944 945 O
fresh 31 36 946 951 B-treatment
frozen 37 43 952 958 I-treatment
plasma 44 50 959 965 I-treatment
( 51 52 966 967 I-treatment
FFP 52 55 967 970 I-treatment
) 55 56 970 971 I-treatment
or 57 59 972 974 O
rfVIIa 60 66 975 981 B-treatment
from 67 71 982 986 O
Screening 72 81 987 996 O
until 82 87 997 1002 O
within 88 94 1003 1009 O
12 95 97 1010 1012 B-upper_bound
hours 98 103 1013 1018 I-upper_bound
after 104 109 1019 1024 O
the 110 113 1025 1028 O
end 114 117 1029 1032 O
of 118 120 1033 1035 O
the 121 124 1036 1039 O
andexanet 125 134 1040 1049 B-treatment
infusion 135 143 1050 1058 I-treatment

Pregnant 0 8 1059 1067 B-pregnancy

Prothrombin 0 11 1068 1079 B-treatment
Complex 12 19 1080 1087 I-treatment
Concentrate 20 31 1088 1099 I-treatment
products 32 40 1100 1108 I-treatment
( 41 42 1109 1110 I-treatment
PCC 42 45 1110 1113 I-treatment
) 45 46 1113 1114 I-treatment
or 47 49 1115 1117 O
recombinant 50 61 1118 1129 B-treatment
factor 62 68 1130 1136 I-treatment
VIIa 69 73 1137 1141 I-treatment
( 74 75 1142 1143 I-treatment
rfVIIa 75 81 1143 1149 I-treatment
) 81 82 1149 1150 I-treatment

Recent 0 6 1151 1157 O
history 7 14 1158 1165 O
( 15 16 1166 1167 O
within 16 22 1167 1173 O
2 23 24 1174 1175 B-upper_bound
weeks 25 30 1176 1181 I-upper_bound
) 30 31 1181 1182 O
of 32 34 1183 1185 O
a 35 36 1186 1187 O
diagnosed 37 46 1188 1197 O
thrombotic 47 57 1198 1208 O
event 58 63 1209 1214 O
( 64 65 1215 1216 O
TE 65 67 1216 1218 O
) 67 68 1218 1219 O

Severe 0 6 1220 1226 B-chronic_disease
sepsis 7 13 1227 1233 I-chronic_disease
or 14 16 1234 1236 O
septic 17 23 1237 1243 B-chronic_disease
shock 24 29 1244 1249 I-chronic_disease
at 30 32 1250 1252 O
the 33 36 1253 1256 O
time 37 41 1257 1261 O
of 42 44 1262 1264 O
Screening 45 54 1265 1274 O

The 0 3 1275 1278 O
patient 4 11 1279 1286 O
is 12 14 1287 1289 O
scheduled 15 24 1290 1299 O
to 25 27 1300 1302 O
undergo 28 35 1303 1310 O
surgery 36 43 1311 1318 B-treatment
in 44 46 1319 1321 O
less 47 51 1322 1326 O
than 52 56 1327 1331 O
12 57 59 1332 1334 B-upper_bound
hours 60 65 1335 1340 I-upper_bound

Treated 0 7 1341 1348 O
with 8 12 1349 1353 O
an 13 15 1354 1356 O
investigational 16 31 1357 1372 B-clinical_variable
drug 32 36 1373 1377 I-clinical_variable
< 37 38 1378 1379 O
30 38 40 1379 1381 B-upper_bound
days 41 45 1382 1386 I-upper_bound
prior 46 51 1387 1392 I-upper_bound
to 52 54 1393 1395 O
Screening 55 64 1396 1405 O

Vitamin 0 7 1406 1413 B-treatment
K 8 9 1414 1415 I-treatment
antagonist 10 20 1416 1426 I-treatment
( 21 22 1427 1428 I-treatment
VKA 22 25 1428 1431 I-treatment
) 25 26 1431 1432 I-treatment

lactating 0 9 1433 1442 O
female 10 16 1443 1449 B-gender

minimally 0 9 1450 1459 O
invasive 10 18 1460 1468 B-treatment
surgery 19 26 1469 1476 I-treatment
/ 26 27 1476 1477 I-treatment
procedures 27 37 1477 1487 I-treatment

venous 0 6 1488 1494 B-chronic_disease
thromboembolism 7 22 1495 1510 I-chronic_disease
, 22 23 1510 1511 O
myocardial 24 34 1512 1522 B-chronic_disease
infarction 35 45 1523 1533 I-chronic_disease
, 45 46 1533 1534 O
disseminated 47 59 1535 1547 B-chronic_disease
intravascular 60 73 1548 1561 I-chronic_disease
coagulation 74 85 1562 1573 I-chronic_disease
( 86 87 1574 1575 I-chronic_disease
DIC 87 90 1575 1578 I-chronic_disease
) 90 91 1578 1579 I-chronic_disease
, 91 92 1579 1580 O
cerebral 93 101 1581 1589 O
vascular 102 110 1590 1598 O
accident 111 119 1599 1607 O
, 119 120 1607 1608 O
transient 121 130 1609 1618 B-chronic_disease
ischemic 131 139 1619 1627 I-chronic_disease
attack 140 146 1628 1634 I-chronic_disease
, 146 147 1634 1635 O
unstable 148 156 1636 1644 B-chronic_disease
angina 157 163 1645 1651 I-chronic_disease
pectoris 164 172 1652 1660 I-chronic_disease
hospitalization 173 188 1661 1676 O
or 189 191 1677 1679 O
severe 192 198 1680 1686 O
peripheral 199 209 1687 1697 B-chronic_disease
vascular 210 218 1698 1706 I-chronic_disease
disease 219 226 1707 1714 I-chronic_disease
within 227 233 1715 1721 O
2 234 235 1722 1723 B-upper_bound
weeks 236 241 1724 1729 I-upper_bound
prior 242 247 1730 1735 I-upper_bound
to 248 250 1736 1738 O
screening 251 260 1739 1748 O

Patients 0 8 0 8 O
taking 9 15 9 15 O
carbamazepine 16 29 16 29 B-treatment
or 30 32 30 32 O
nitroglycerin 33 46 33 46 B-treatment

Patients 0 8 47 55 O
that 9 13 56 60 O
require 14 21 61 68 O
a 22 23 69 70 O
thoracostomy 24 36 71 83 B-treatment
tube 37 41 84 88 I-treatment
for 42 45 89 92 O
a 46 47 93 94 O
pneumothorax 48 60 95 107 B-chronic_disease

Patients 0 8 108 116 O
with 9 13 117 121 O
an 14 16 122 124 O
indication 17 27 125 135 O
for 28 31 136 139 O
a 32 33 140 141 O
thoracostomy 34 46 142 154 B-treatment
tube 47 51 155 159 I-treatment
placement 52 61 160 169 I-treatment
for 62 65 170 173 O
a 66 67 174 175 O
pleural 68 75 176 183 B-chronic_disease
effusion 76 84 184 192 I-chronic_disease

Pregnant 0 8 193 201 B-pregnancy
women 9 14 202 207 B-gender

Sensitivity 0 11 208 219 O
to 12 14 220 222 O
t 15 16 223 224 B-allergy_name
- 16 17 224 225 I-allergy_name
PA 17 19 225 227 I-allergy_name
, 19 20 227 228 O
or 21 23 229 231 O
DNase 24 29 232 237 B-allergy_name

age 0 3 238 241 B-age
18 4 6 242 244 B-lower_bound
years 7 12 245 250 I-lower_bound
or 13 15 251 253 O
older 16 21 254 259 O

45 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

A 0 1 25 26 O
documented 2 12 27 37 O
Karnofsky 13 22 38 47 B-clinical_variable
performance 23 34 48 59 I-clinical_variable
status 35 41 60 66 I-clinical_variable
of 42 44 67 69 O
at 45 47 70 72 O
least 48 53 73 78 O
70 54 56 79 81 B-lower_bound

Clinical 0 8 82 90 B-cancer
stage 9 14 91 96 I-cancer
T1c 15 18 97 100 I-cancer
or 19 21 101 103 I-cancer
T2a 22 25 104 107 I-cancer

Estimated 0 9 108 117 B-clinical_variable
survival 10 18 118 126 I-clinical_variable
of 19 21 127 129 O
5 22 23 130 131 B-lower_bound
years 24 29 132 137 I-lower_bound
or 30 32 138 140 O
greater 33 40 141 148 O
, 40 41 148 149 O
as 42 44 150 152 O
determined 45 55 153 163 O
by 56 58 164 166 O
treating 59 67 167 175 O
physician 68 77 176 185 O

Gleason 0 7 186 193 B-clinical_variable
score 8 13 194 199 I-clinical_variable
of 14 16 200 202 O
7 17 18 203 204 O
( 19 20 205 206 O
3 20 21 206 207 B-lower_bound
+ 21 22 207 208 I-lower_bound
4 22 23 208 209 I-lower_bound
or 24 26 210 212 O
4 27 28 213 214 B-upper_bound
+ 28 29 214 215 I-upper_bound
3 29 30 215 216 I-upper_bound
) 30 31 216 217 O
or 32 34 218 220 O
less 35 39 221 225 O

MR 0 2 226 228 B-treatment
- 2 3 228 229 I-treatment
guided 3 9 229 235 I-treatment
biopsy 10 16 236 242 I-treatment
confirmation 17 29 243 255 O
of 30 32 256 258 O
one 33 36 259 262 O
or 37 39 263 265 O
more 40 44 266 270 O
radiographically 45 61 271 287 O
visible 62 69 288 295 O
prostate 70 78 296 304 O
lesion(s 79 87 305 313 O
) 87 88 313 314 O
with 89 93 315 319 O
Gleason 94 101 320 327 B-clinical_variable
score 102 107 328 333 I-clinical_variable
of 108 110 334 336 O
7 111 112 337 338 B-upper_bound
( 113 114 339 340 I-upper_bound
3 114 115 340 341 I-upper_bound
+ 115 116 341 342 I-upper_bound
4 116 117 342 343 I-upper_bound
or 118 120 344 346 I-upper_bound
4 121 122 347 348 I-upper_bound
+ 122 123 348 349 I-upper_bound
3 123 124 349 350 I-upper_bound
) 124 125 350 351 I-upper_bound
or 126 128 352 354 O
less 129 133 355 359 O

Three 0 5 360 365 O
or 6 8 366 368 O
fewer 9 14 369 374 O
biopsy 15 21 375 381 B-treatment
cores 22 27 382 387 O
with 28 32 388 392 O
prostate 33 41 393 401 B-cancer
cancer 42 48 402 408 I-cancer

AST 0 3 0 3 B-clinical_variable
/ 3 4 3 4 I-clinical_variable
ALT 4 7 4 7 I-clinical_variable
≤2.5 8 12 8 12 O
× 13 14 13 14 I-upper_bound
ULN 15 18 15 18 I-upper_bound

Age 0 3 19 22 B-age
≥18 4 7 23 26 O
years 8 13 27 32 I-lower_bound

Concurrent 0 10 33 43 O
anticancer 11 21 44 54 B-treatment
therapy 22 29 55 62 I-treatment
( 30 31 63 64 O
including 31 40 64 73 O
other 41 46 74 79 O
investigational 47 62 80 95 B-treatment
agents 63 69 96 102 I-treatment
) 69 70 102 103 O

DLCO 0 4 104 108 B-clinical_variable
/ 4 5 108 109 I-clinical_variable
VA 5 7 109 111 I-clinical_variable
and 8 11 112 115 O
FEV1 12 16 116 120 B-clinical_variable
≥ 17 18 121 122 O
50 19 21 123 125 B-lower_bound
% 21 22 125 126 I-lower_bound
of 23 25 127 129 O
predicted 26 35 130 139 O
on 36 38 140 142 O
PFTs 39 43 143 147 O

ECOG 0 4 148 152 B-clinical_variable
performance 5 16 153 164 I-clinical_variable
status 17 23 165 171 I-clinical_variable
≤1 24 26 172 174 O
( 27 28 175 176 O
Karnofsky 28 37 176 185 B-clinical_variable
≥70 38 41 186 189 O
% 41 42 189 190 I-lower_bound
) 42 43 190 191 O

Evaluable 0 9 192 201 O
or 10 12 202 204 O
measurable 13 23 205 215 B-chronic_disease
disease 24 31 216 223 I-chronic_disease
, 31 32 223 224 O
defined 33 40 225 232 O
as 41 43 233 235 O
by 44 46 236 238 O
Response 47 55 239 247 O
Evaluation 56 66 248 258 O
Criteria 67 75 259 267 O
in 76 78 268 270 O
Solid 79 84 271 276 O
Tumors 85 91 277 283 O
( 92 93 284 285 O
RECIST 93 99 285 291 O
) 99 100 291 292 O

HIV 0 3 293 296 B-chronic_disease
positive 4 12 297 305 O
patients 13 21 306 314 O

Histologically 0 14 315 329 O
confirmed 15 24 330 339 O
solid 25 30 340 345 B-cancer
tumor 31 36 346 351 I-cancer
malignancy 37 47 352 362 B-cancer
that 48 52 363 367 O
is 53 55 368 370 O
metastatic 56 66 371 381 B-cancer
or 67 69 382 384 O
unresectable 70 82 385 397 O
and 83 86 398 401 O
have 87 91 402 406 O
progressed 92 102 407 417 O
on 103 105 418 420 O
at 106 108 421 423 O
least 109 114 424 429 O
1 115 116 430 431 B-lower_bound
prior 117 122 432 437 I-lower_bound
therapy 123 130 438 445 B-treatment
and 131 134 446 449 O
for 135 138 450 453 O
whom 139 143 454 458 O
standard 144 152 459 467 O
curative 153 161 468 476 O
or 162 164 477 479 O
palliative 165 175 480 490 O
measures 176 184 491 499 O
do 185 187 500 502 O
not 188 191 503 506 O
exist 192 197 507 512 O
or 198 200 513 515 O
are 201 204 516 519 O
associated 205 215 520 530 O
with 216 220 531 535 O
minimal 221 228 536 543 O
subject 229 236 544 551 O
survival 237 245 552 560 O
benefit 246 253 561 568 O

History 0 7 569 576 O
of 8 10 577 579 O
allergic 11 19 580 588 O
reactions 20 29 589 598 O
attributed 30 40 599 609 O
to 41 43 610 612 O
compounds 44 53 613 622 B-allergy_name
of 54 56 623 625 I-allergy_name
similar 57 64 626 633 I-allergy_name
chemical 65 73 634 642 I-allergy_name
or 74 76 643 645 I-allergy_name
biologic 77 85 646 654 I-allergy_name
composition 86 97 655 666 I-allergy_name
to 98 100 667 669 I-allergy_name
hetIL-15 101 109 670 678 I-allergy_name

History 0 7 679 686 O
of 8 10 687 689 O
autoimmune 11 21 690 700 B-chronic_disease
disease 22 29 701 708 I-chronic_disease

History 0 7 709 716 O
of 8 10 717 719 O
severe 11 17 720 726 O
asthma 18 24 727 733 B-chronic_disease
or 25 27 734 736 O
absolute 28 36 737 745 O
requirement 37 48 746 757 O
for 49 52 758 761 O
chronic 53 60 762 769 O
inhaled 61 68 770 777 O
corticosteroid 69 83 778 792 B-treatment
medications 84 95 793 804 I-treatment

Life 0 4 805 809 B-clinical_variable
expectancy 5 15 810 820 I-clinical_variable
> 16 17 821 822 O
3 18 19 823 824 B-lower_bound
months 20 26 825 831 I-lower_bound

Positive 0 8 832 840 O
hepatitis 9 18 841 850 B-chronic_disease
B 19 20 851 852 I-chronic_disease
or 21 23 853 855 O
C 24 25 856 857 B-chronic_disease
serology 26 34 858 866 O

Primary 0 7 867 874 O
brain 8 13 875 880 B-cancer
cancers 14 21 881 888 I-cancer
or 22 24 889 891 O
active 25 31 892 898 O
CNS 32 35 899 902 B-cancer
metastases 36 46 903 913 I-cancer

Prior 0 5 914 919 B-treatment
IL-15 6 11 920 925 I-treatment
treatment 12 21 926 935 I-treatment
or 22 24 936 938 O
cytotoxic 25 34 939 948 B-treatment
therapy 35 42 949 956 I-treatment
, 42 43 956 957 O
immunotherapy 44 57 958 971 B-treatment
, 57 58 971 972 O
radiotherapy 59 71 973 985 B-treatment
, 71 72 985 986 O
major 73 78 987 992 B-treatment
surgery 79 86 993 1000 I-treatment
, 86 87 1000 1001 O
antitumor 88 97 1002 1011 B-treatment
vaccines 98 106 1012 1020 I-treatment
or 107 109 1021 1023 O
monoclonal 110 120 1024 1034 B-treatment
antibodies 121 131 1035 1045 I-treatment
in 132 134 1046 1048 O
the 135 138 1049 1052 O
4 139 140 1053 1054 B-upper_bound
weeks 141 146 1055 1060 I-upper_bound
prior 147 152 1061 1066 I-upper_bound
or 153 155 1067 1069 O
for 156 159 1070 1073 O
checkpoint 160 170 1074 1084 O
inhibitors 171 181 1085 1095 O
such 182 186 1096 1100 O
as 187 189 1101 1103 O
anti 190 194 1104 1108 B-treatment
- 194 195 1108 1109 I-treatment
CTLA-4 195 201 1109 1115 I-treatment
or 202 204 1116 1118 O
anti 205 209 1119 1123 B-treatment
PD1 210 213 1124 1127 I-treatment
/ 213 214 1127 1128 I-treatment
PD 214 216 1128 1130 I-treatment
- 216 217 1130 1131 I-treatment
L1 217 219 1131 1133 I-treatment
or 220 222 1134 1136 O
nitrosoureas 223 235 1137 1149 B-treatment
or 236 238 1150 1152 O
mitomycin 239 248 1153 1162 B-treatment
C 249 250 1163 1164 I-treatment
for 251 254 1165 1168 O
6 255 256 1169 1170 B-upper_bound
weeks 257 262 1171 1176 I-upper_bound
prior 263 268 1177 1182 I-upper_bound
to 269 271 1183 1185 O
C1D1 272 276 1186 1190 O

Recovered 0 9 1191 1200 O
to 10 12 1201 1203 O
≤ 13 14 1204 1205 O
grade 15 20 1206 1211 B-upper_bound
1 21 22 1212 1213 I-upper_bound
NCI 23 26 1214 1217 B-clinical_variable
CTCAE 27 32 1218 1223 I-clinical_variable
version 33 40 1224 1231 O
4.0 41 44 1232 1235 O
from 45 49 1236 1240 O
toxicity 50 58 1241 1249 O
of 59 61 1250 1252 O
prior 62 67 1253 1258 B-treatment
chemotherapy 68 80 1259 1271 I-treatment
or 81 83 1272 1274 O
biologic 84 92 1275 1283 B-treatment
therapy 93 100 1284 1291 I-treatment
administered 101 113 1292 1304 O
more 114 118 1305 1309 O
than 119 123 1310 1314 O
4 124 125 1315 1316 B-lower_bound
weeks 126 131 1317 1322 I-lower_bound
earlier 132 139 1323 1330 O

Subjects 0 8 1331 1339 O
on 9 11 1340 1342 O
bisphosphonates 12 27 1343 1358 B-treatment
for 28 31 1359 1362 O
any 32 35 1363 1366 O
cancer 36 42 1367 1373 B-cancer
or 43 45 1374 1376 O
on 46 48 1377 1379 O
hormone 49 56 1380 1387 B-treatment
therapy 57 64 1388 1395 I-treatment
for 65 68 1396 1399 O
prostate 69 77 1400 1408 B-cancer
cancer 78 84 1409 1415 I-cancer
may 85 88 1416 1419 O
continue 89 97 1420 1428 O
this 98 102 1429 1433 O
therapy 103 110 1434 1441 O

Subjects 0 8 1442 1450 O
with 9 13 1451 1455 O
inactive 14 22 1456 1464 O
central 23 30 1465 1472 B-cancer
nervous 31 38 1473 1480 I-cancer
system 39 45 1481 1487 I-cancer
( 46 47 1488 1489 I-cancer
CNS 47 50 1489 1492 I-cancer
) 50 51 1492 1493 I-cancer
metastasis 52 62 1494 1504 I-cancer

Uncontrolled 0 12 1505 1517 O
intercurrent 13 25 1518 1530 O
illness 26 33 1531 1538 O
including 34 43 1539 1548 O
, 43 44 1548 1549 O
but 45 48 1550 1553 O
not 49 52 1554 1557 O
limited 53 60 1558 1565 O
to 61 63 1566 1568 O
, 63 64 1568 1569 O
ongoing 65 72 1570 1577 O
or 73 75 1578 1580 O
active 76 82 1581 1587 B-chronic_disease
infection 83 92 1588 1597 I-chronic_disease
, 92 93 1597 1598 O
symptomatic 94 105 1599 1610 O
congestive 106 116 1611 1621 B-chronic_disease
heart 117 122 1622 1627 I-chronic_disease
failure 123 130 1628 1635 I-chronic_disease
, 130 131 1635 1636 O
unstable 132 140 1637 1645 B-chronic_disease
angina 141 147 1646 1652 I-chronic_disease
pectoris 148 156 1653 1661 I-chronic_disease
, 156 157 1661 1662 O
cardiac 158 165 1663 1670 B-chronic_disease
arrhythmia 166 176 1671 1681 I-chronic_disease
, 176 177 1681 1682 O
cognitive 178 187 1683 1692 B-chronic_disease
impairment 188 198 1693 1703 I-chronic_disease
, 198 199 1703 1704 O
active 200 206 1705 1711 O
substance 207 216 1712 1721 O
abuse 217 222 1722 1727 O
, 222 223 1727 1728 O
or 224 226 1729 1731 O
psychiatric 227 238 1732 1743 B-chronic_disease
illness 239 246 1744 1751 I-chronic_disease
/ 246 247 1751 1752 O
social 247 253 1752 1758 O
situations 254 264 1759 1769 O
that 265 269 1770 1774 O
, 269 270 1774 1775 O
in 271 273 1776 1778 O
the 274 277 1779 1782 O
view 278 282 1783 1787 O
of 283 285 1788 1790 O
the 286 289 1791 1794 O
Investigator 290 302 1795 1807 O
, 302 303 1807 1808 O
would 304 309 1809 1814 O
preclude 310 318 1815 1823 O
safe 319 323 1824 1828 O
treatment 324 333 1829 1838 B-treatment
or 334 336 1839 1841 O
the 337 340 1842 1845 O
ability 341 348 1846 1853 O
to 349 351 1854 1856 O
give 352 356 1857 1861 O
informed 357 365 1862 1870 O
consent 366 373 1871 1878 O
and 374 377 1879 1882 O
limit 378 383 1883 1888 O
compliance 384 394 1889 1899 O
with 395 399 1900 1904 O
study 400 405 1905 1910 O
requirements 406 418 1911 1923 O

Women 0 5 1924 1929 B-gender
of 6 8 1930 1932 O
child 9 14 1933 1938 O
- 14 15 1938 1939 O
bearing 15 22 1939 1946 O
potential 23 32 1947 1956 O
and 33 36 1957 1960 O
men 37 40 1961 1964 O
must 41 45 1965 1969 O
agree 46 51 1970 1975 B-contraception_consent
to 52 54 1976 1978 I-contraception_consent
use 55 58 1979 1982 I-contraception_consent
adequate 59 67 1983 1991 I-contraception_consent
contraception 68 81 1992 2005 I-contraception_consent
prior 82 87 2006 2011 O
to 88 90 2012 2014 O
study 91 96 2015 2020 O
entry 97 102 2021 2026 O
, 102 103 2026 2027 O
during 104 110 2028 2034 O
the 111 114 2035 2038 O
treatment 115 124 2039 2048 B-treatment
portion 125 132 2049 2056 O
of 133 135 2057 2059 O
the 136 139 2060 2063 O
study 140 145 2064 2069 O
and 146 149 2070 2073 O
for 150 153 2074 2077 O
4 154 155 2078 2079 B-upper_bound
months 156 162 2080 2086 I-upper_bound
after 163 168 2087 2092 I-upper_bound
completion 169 179 2093 2103 O
of 180 182 2104 2106 O
hetIL-15 183 191 2107 2115 O
administration 192 206 2116 2130 O

absolute 0 8 2131 2139 B-clinical_variable
neutrophil 9 19 2140 2150 I-clinical_variable
count 20 25 2151 2156 I-clinical_variable
( 26 27 2157 2158 I-clinical_variable
ANC 27 30 2158 2161 I-clinical_variable
) 30 31 2161 2162 I-clinical_variable
≥1,500 32 38 2163 2169 O
/ 38 39 2169 2170 I-lower_bound
mcL 39 42 2170 2173 I-lower_bound

autoimmune 0 10 2174 2184 O
event 11 16 2185 2190 O
associated 17 27 2191 2201 O
with 28 32 2202 2206 O
prior 33 38 2207 2212 B-treatment
ipilimumab 39 49 2213 2223 I-treatment
( 50 51 2224 2225 I-treatment
anti 51 55 2225 2229 I-treatment
- 55 56 2229 2230 I-treatment
CTLA-4 56 62 2230 2236 I-treatment
) 62 63 2236 2237 I-treatment
therapy 64 71 2238 2245 I-treatment
that 72 76 2246 2250 O
has 77 80 2251 2254 O
been 81 85 2255 2259 O
completely 86 96 2260 2270 O
resolved 97 105 2271 2279 O
for 106 109 2280 2283 O
more 110 114 2284 2288 O
than 115 119 2289 2293 O
4 120 121 2294 2295 B-lower_bound
weeks 122 127 2296 2301 I-lower_bound
prior 128 133 2302 2307 I-lower_bound
to 134 136 2308 2310 O
C1D1 137 141 2311 2315 O

creatinine 0 10 2316 2326 B-clinical_variable
< 11 12 2327 2328 O
1.5 12 15 2328 2331 B-upper_bound
× 16 17 2332 2333 I-upper_bound
institutional 18 31 2334 2347 I-upper_bound
ULN 32 35 2348 2351 I-upper_bound

creatinine 0 10 2352 2362 B-clinical_variable
clearance 11 20 2363 2372 I-clinical_variable
≥60 21 24 2373 2376 O
mL 25 27 2377 2379 I-lower_bound
/ 27 28 2379 2380 I-lower_bound
min/1.73 28 36 2380 2388 I-lower_bound
m2 37 39 2389 2391 I-lower_bound
for 40 43 2392 2395 O
subjects 44 52 2396 2404 O
with 53 57 2405 2409 O
serum 58 63 2410 2415 B-clinical_variable
creatinine 64 74 2416 2426 I-clinical_variable
levels 75 81 2427 2433 I-clinical_variable
> 82 83 2434 2435 O
1.5 83 86 2435 2438 B-lower_bound
× 87 88 2439 2440 I-lower_bound
higher 89 95 2441 2447 I-lower_bound
than 96 100 2448 2452 I-lower_bound
ULN 101 104 2453 2456 I-lower_bound

hormone 0 7 2457 2464 B-treatment
therapy 8 15 2465 2472 I-treatment
for 16 19 2473 2476 O
prostate 20 28 2477 2485 B-cancer
cancer 29 35 2486 2492 I-cancer

leukocytes 0 10 2493 2503 B-clinical_variable
≥3,000 11 17 2504 2510 O
/ 17 18 2510 2511 I-lower_bound
mcL 18 21 2511 2514 I-lower_bound

platelets 0 9 2515 2524 B-clinical_variable
≥100,000 10 18 2525 2533 O
/ 18 19 2533 2534 I-lower_bound
mcL 19 22 2534 2537 I-lower_bound

total 0 5 2538 2543 B-clinical_variable
bilirubin 6 15 2544 2553 I-clinical_variable
within 16 22 2554 2560 O
normal 23 29 2561 2567 O
institutional 30 43 2568 2581 O
limits 44 50 2582 2588 O

Apixaban 0 8 0 8 B-treatment

Clarithromycin 0 14 9 23 B-treatment

Dabigatran 0 10 24 34 B-treatment

Edoxaban 0 8 35 43 B-treatment

Indinavir 0 9 44 53 B-treatment

Itraconazole 0 12 54 66 B-treatment

Ketoconazole 0 12 67 79 B-treatment

Lopinavir 0 9 80 89 B-treatment

NSTEMI 0 6 90 96 B-chronic_disease
as 7 9 97 99 O
evidenced 10 19 100 109 O
by 20 22 110 112 O
elevation 23 32 113 122 O
of 33 35 123 125 O
troponin 36 44 126 134 O
levels 45 51 135 141 O
( 52 53 142 143 O
Troponin 53 61 143 151 B-clinical_variable
> 62 63 152 153 O
0.034 64 69 154 159 B-lower_bound
ng 70 72 160 162 I-lower_bound
/ 72 73 162 163 I-lower_bound
ml 73 75 163 165 I-lower_bound
) 75 76 165 166 O

Nelfinavir 0 10 167 177 B-treatment

Patients 0 8 178 186 O
with 9 13 187 191 O
unstable 14 22 192 200 B-chronic_disease
angina 23 29 201 207 I-chronic_disease

Ritonavir 0 9 208 217 B-treatment

Rivaroxaban 0 11 218 229 B-treatment

Telithormycin 0 13 230 243 B-treatment

Voriconazole 0 12 244 256 B-treatment

administration 0 14 257 271 O
of 15 17 272 274 O
GP 18 20 275 277 B-treatment
IIb 21 24 278 281 I-treatment
/ 24 25 281 282 I-treatment
IIIa 25 29 282 286 I-treatment
inhibitors 30 40 287 297 I-treatment

anemia 0 6 298 304 B-chronic_disease
with 7 11 305 309 O
HCT<30 12 18 310 316 B-clinical_variable
% 18 19 316 317 I-upper_bound

anti 0 4 318 322 B-treatment
- 4 5 322 323 I-treatment
retroviral 5 15 323 333 I-treatment
agents 16 22 334 340 I-treatment

antifungal 0 10 341 351 B-treatment
agents 11 17 352 358 I-treatment
and 18 21 359 362 O
some 22 26 363 367 O
antibiotics 27 38 368 379 B-treatment

associated 0 10 380 390 O
therapy 11 18 391 398 O
with 19 23 399 403 O
a 24 25 404 405 O
strong 26 32 406 412 O
cytochrome 33 43 413 423 B-clinical_variable
P-450 44 49 424 429 I-clinical_variable
inhibitors 50 60 430 440 O

increased 0 9 441 450 O
risk 10 14 451 455 O
of 15 17 456 458 O
bradycardia 18 29 459 470 B-chronic_disease

major 0 5 471 476 O
bleeding 6 14 477 485 O
episode 15 22 486 493 O
within 23 29 494 500 O
2 30 31 501 502 B-upper_bound
weeks 32 37 503 508 I-upper_bound

need 0 4 509 513 O
for 5 8 514 517 O
oral 9 13 518 522 B-treatment
anticoagulation 14 29 523 538 I-treatment
therapy 30 37 539 546 I-treatment

need 0 4 547 551 O
for 5 8 552 555 O
vasopressor 9 20 556 567 B-treatment
or 21 23 568 570 O
inotropic 24 33 571 580 B-treatment
agents 34 40 581 587 I-treatment

surgery<4 0 9 588 597 B-treatment
weeks 10 15 598 603 I-upper_bound

thrombocytopenia 0 16 604 620 B-chronic_disease
( 17 18 621 622 O
Platelet 18 26 622 630 B-clinical_variable
count 27 32 631 636 I-clinical_variable
< 33 34 637 638 O
100000 35 41 639 645 B-upper_bound
) 41 42 645 646 O

troponin 0 8 647 655 O
negative 9 17 656 664 O
ACS 18 21 665 668 B-chronic_disease

use 0 3 669 672 O
of 4 6 673 675 O
any 7 10 676 679 O
thienopyridines 11 26 680 695 B-treatment
( 27 28 696 697 O
Clopidogrel 28 39 697 708 B-treatment
, 39 40 708 709 O
Prasugrel 41 50 710 719 B-treatment
) 50 51 719 720 O
7 52 53 721 722 B-upper_bound
days 54 58 723 727 I-upper_bound
prior 59 64 728 733 I-upper_bound
to 65 67 734 736 O
randomization 68 81 737 750 O

Participated 0 12 0 12 O
in 13 15 13 15 O
United 16 22 16 22 B-treatment
Therapeutics 23 35 23 35 I-treatment
Study 36 41 36 41 I-treatment
TDE 42 45 42 45 I-treatment
- 45 46 45 46 I-treatment
PH-310 46 52 46 52 I-treatment

18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
85 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
old 12 15 12 15 O

ASA 0 3 16 19 B-clinical_variable
Physical 4 12 20 28 I-clinical_variable
Status 13 19 29 35 I-clinical_variable
1 20 21 36 37 B-lower_bound
- 21 22 37 38 O
3 22 23 38 39 B-upper_bound

Anticoagulants 0 14 40 54 B-treatment
considered 15 25 55 65 O
to 26 28 66 68 O
be 29 31 69 71 O
a 32 33 72 73 O
contraindication 34 50 74 90 O
for 51 54 91 94 O
epidural 55 63 95 103 B-treatment
or 64 66 104 106 O
TAP 67 70 107 110 B-treatment
blocks 71 77 111 117 I-treatment

Bupivacaine 0 11 118 129 B-allergy_name
sensitivity 12 23 130 141 O

Expected 0 8 142 150 O
requirement 9 20 151 162 O
for 21 24 163 166 O
parenteral 25 35 167 177 B-treatment
opioids 36 43 178 185 I-treatment
for 44 47 186 189 O
at 48 50 190 192 O
least 51 56 193 198 O
72 57 59 199 201 B-lower_bound
hours 60 65 202 207 I-lower_bound
for 66 69 208 211 O
postoperative 70 83 212 225 O
pain 84 88 226 230 O

Hepatic 0 7 231 238 B-chronic_disease
disease 8 15 239 246 I-chronic_disease
, 15 16 246 247 O
e.g. 17 21 248 252 O
twice 22 27 253 258 O
the 28 31 259 262 O
normal 32 38 263 269 O
levels 39 45 270 276 O
of 46 48 277 279 O
liver 49 54 280 285 O
enzymes 55 62 286 293 O

Surgeries 0 9 294 303 B-treatment
with 10 14 304 308 O
high 15 19 309 313 O
port 20 24 314 318 O
sites 25 30 319 324 O

Women 0 5 325 330 B-gender
who 6 9 331 334 O
are 10 13 335 338 B-pregnancy
pregnant 14 22 339 347 I-pregnancy

laparoscopic 0 12 348 360 B-treatment
abdominal 13 22 361 370 I-treatment
surgery 23 30 371 378 I-treatment

18 0 2 0 2 B-lower_bound
to 3 5 3 5 O
50 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
old 15 18 15 18 O

American 0 8 19 27 B-clinical_variable
Society 9 16 28 35 I-clinical_variable
of 17 19 36 38 I-clinical_variable
Anesthesiologists 20 37 39 56 I-clinical_variable
Physical 38 46 57 65 I-clinical_variable
Status 47 53 66 72 I-clinical_variable
( 54 55 73 74 I-clinical_variable
ASA 55 58 74 77 I-clinical_variable
PS 59 61 78 80 I-clinical_variable
) 61 62 80 81 I-clinical_variable
score 63 68 82 87 I-clinical_variable
of 69 71 88 90 O
I 72 73 91 92 B-lower_bound
or 74 76 93 95 O
II 77 79 96 98 B-upper_bound

Current 0 7 99 106 B-pregnancy
or 8 10 107 109 I-pregnancy
planned 11 18 110 117 I-pregnancy
pregnancy 19 28 118 127 I-pregnancy

Radiographic 0 12 128 140 O
signs 13 18 141 146 O
of 19 21 147 149 O
osteoarthritis 22 36 150 164 B-chronic_disease
( 37 38 165 166 O
> 38 39 166 167 O
Tonis 40 45 168 173 B-lower_bound
grade 46 51 174 179 I-lower_bound
1 52 53 180 181 I-lower_bound
) 53 54 181 182 O

Scheduled 0 9 183 192 O
for 10 13 193 196 O
arthroscopic 14 26 197 209 B-treatment
labral 27 33 210 216 I-treatment
repair 34 40 217 223 I-treatment
with 41 45 224 228 O
or 46 48 229 231 O
without 49 56 232 239 O
osteoplasty 57 68 240 251 B-treatment
of 69 71 252 254 I-treatment
the 72 75 255 258 I-treatment
hip 76 79 259 262 I-treatment

18 0 2 0 2 B-lower_bound
to 3 5 3 5 O
70 6 8 6 8 B-upper_bound
years 9 14 9 14 I-upper_bound
of 15 17 15 17 O
age 18 21 18 21 B-age

> 0 1 22 23 O
than 2 6 24 28 O
15 7 9 29 31 B-lower_bound
Eos 10 13 32 35 B-clinical_variable
phf 14 17 36 39 I-clinical_variable

Clinical 0 8 40 48 O
evidence 9 17 49 57 O
of 18 20 58 60 O
infectious 21 31 61 71 O
process 32 39 72 79 O
potentially 40 51 80 91 O
contributing 52 64 92 104 O
to 65 67 105 107 O
dysphagia 68 77 108 117 B-chronic_disease
( 78 79 118 119 O
e.g. 79 83 119 123 O
candidiasis 84 95 124 135 B-chronic_disease
, 95 96 135 136 O
CMV 97 100 137 140 B-chronic_disease
, 100 101 140 141 O
herpes 102 108 142 148 B-chronic_disease
) 108 109 148 149 O

Esophageal 0 10 150 160 B-clinical_variable
minimal 11 18 161 168 I-clinical_variable
diameter 19 27 169 177 I-clinical_variable
< 28 29 178 179 O
13 30 32 180 182 B-upper_bound
mm 33 35 183 185 I-upper_bound
on 36 38 186 188 O
structured 39 49 189 199 B-treatment
barium 50 56 200 206 I-treatment
esophagram 57 67 207 217 I-treatment

Other 0 5 218 223 O
cause 6 11 224 229 O
of 12 14 230 232 O
dysphagia 15 24 233 242 B-chronic_disease
identified 25 35 243 253 O
at 36 38 254 256 O
endoscopy 39 48 257 266 B-treatment
( 49 50 267 268 O
e.g. 50 54 268 272 O
reflux 55 61 273 279 B-chronic_disease
esophagitis 62 73 280 291 I-chronic_disease
, 73 74 291 292 O
stricture 75 84 293 302 B-chronic_disease
, 84 85 302 303 O
web 86 89 304 307 B-chronic_disease
, 89 90 307 308 O
ring 91 95 309 313 B-chronic_disease
, 95 96 313 314 O
achalasia 97 106 315 324 B-chronic_disease
, 106 107 324 325 O
esophageal 108 118 326 336 B-cancer
neoplasm 119 127 337 345 I-cancer
) 127 128 345 346 O

Cirrhotic 0 9 0 9 B-chronic_disease
patients 10 18 10 18 O

Contraindication 0 16 19 35 O
to 17 19 36 38 O
epidural 20 28 39 47 B-allergy_name
catheter 29 37 48 56 I-allergy_name
placement 38 47 57 66 O
including 48 57 67 76 O
bleeding 58 66 77 85 B-chronic_disease
diathesis 67 76 86 95 I-chronic_disease
( 77 78 96 97 O
essential 78 87 97 106 B-chronic_disease
thrombocythemia 88 103 107 122 I-chronic_disease
, 103 104 122 123 O
idiopathic 105 115 124 134 B-chronic_disease
thrombocytopenic 116 132 135 151 I-chronic_disease
purpura 133 140 152 159 I-chronic_disease
, 140 141 159 160 O
von 142 145 161 164 B-chronic_disease
Willebrand 146 156 165 175 I-chronic_disease
disease 157 164 176 183 I-chronic_disease
, 164 165 183 184 O
and 166 169 185 188 O
hemophilia 170 180 189 199 B-chronic_disease
A 181 182 200 201 I-chronic_disease
or 183 185 202 204 I-chronic_disease
B 186 187 205 206 I-chronic_disease
) 187 188 206 207 O
, 188 189 207 208 O
neurological 190 202 209 221 B-chronic_disease
dysfunction 203 214 222 233 I-chronic_disease
( 215 216 234 235 O
multiple 216 224 235 243 B-chronic_disease
sclerosis 225 234 244 253 I-chronic_disease
, 234 235 253 254 O
subacute 236 244 255 263 B-chronic_disease
myelo 245 250 264 269 I-chronic_disease
- 250 251 269 270 I-chronic_disease
opticoneuropathy 251 267 270 286 I-chronic_disease
or 268 270 287 289 O
preexisting 271 282 290 301 B-chronic_disease
lower 283 288 302 307 I-chronic_disease
limb 289 293 308 312 I-chronic_disease
neurological 294 306 313 325 I-chronic_disease
deficit 307 314 326 333 I-chronic_disease
) 314 315 333 334 O
, 315 316 334 335 O
prior 317 322 336 341 B-treatment
extensive 323 332 342 351 I-treatment
spinal 333 339 352 358 I-treatment
surgery 340 347 359 366 I-treatment
or 348 350 367 369 O
major 351 356 370 375 B-chronic_disease
spinal 357 363 376 382 I-chronic_disease
deformity 364 373 383 392 I-chronic_disease
, 373 374 392 393 O
pre 375 378 394 397 O
- 378 379 397 398 O
operative 379 388 398 407 O
use 389 392 408 411 O
of 393 395 412 414 O
anti 396 400 415 419 B-treatment
- 400 401 419 420 I-treatment
coagulant 401 410 420 429 I-treatment
with 411 415 430 434 O
planned 416 423 435 442 O
use 424 427 443 446 O
of 428 430 447 449 O
therapeutic 431 442 450 461 O
dose 443 447 462 466 O
of 448 450 467 469 O
anti 451 455 470 474 O
- 455 456 474 475 O
coagulant 456 465 475 484 O
in 466 468 485 487 O
post 469 473 488 492 O
- 473 474 492 493 O
operatively 474 485 493 504 O
, 485 486 504 505 O
documented 487 497 506 516 O
pre 498 501 517 520 B-chronic_disease
- 501 502 520 521 I-chronic_disease
operative 502 511 521 530 I-chronic_disease
coagulopathy 512 524 531 543 I-chronic_disease
( 525 526 544 545 O
INR 526 529 545 548 B-clinical_variable
greater 530 537 549 556 O
than 538 542 557 561 O
1.3 543 546 562 565 B-lower_bound
not 547 550 566 569 O
on 551 553 570 572 O
Coumadin 554 562 573 581 B-clinical_variable
or 563 565 582 584 O
PTT 566 569 585 588 B-clinical_variable
greater 570 577 589 596 O
than 578 582 597 601 O
42 583 585 602 604 B-lower_bound
) 585 586 604 605 O
, 586 587 605 606 O
platelets 588 597 607 616 B-clinical_variable
less 598 602 617 621 O
than 603 607 622 626 O
100,000 608 615 627 634 B-upper_bound
/ 615 616 634 635 I-upper_bound
μL 616 618 635 637 I-upper_bound
, 618 619 637 638 O
or 620 622 639 641 O
evidence 623 631 642 650 O
of 632 634 651 653 O
infection 635 644 654 663 O
at 645 647 664 666 O
potential 648 657 667 676 O
epidural 658 666 677 685 O
site 667 671 686 690 O

Patients 0 8 691 699 O
receiving 9 18 700 709 O
high 19 23 710 714 O
dose 24 28 715 719 O
opioids 29 36 720 727 B-treatment
on 37 39 728 730 O
a 40 41 731 732 O
chronic 42 49 733 740 O
basis 50 55 741 746 O
( 56 57 747 748 O
greater 57 64 748 755 O
than 65 69 756 760 O
or 70 72 761 763 O
equivalent 73 83 764 774 O
to 84 86 775 777 O
60 87 89 778 780 B-lower_bound
mg 89 91 780 782 I-lower_bound
of 92 94 783 785 O
morphine 95 103 786 794 B-clinical_variable
per 104 107 795 798 O
day 108 111 799 802 O
) 111 112 802 803 O

Patients 0 8 804 812 O
taking 9 15 813 819 O
any 16 19 820 823 O
opioid 20 26 824 830 B-treatment
agonist 27 34 831 838 I-treatment
/ 34 35 838 839 O
antagonist 35 45 839 849 B-treatment
medication 46 56 850 860 I-treatment
( 57 58 861 862 O
i.e. 58 62 862 866 O
Buprenorphine 63 76 867 880 B-treatment
) 76 77 880 881 O

Patients 0 8 882 890 O
undergoing 9 19 891 901 O
open 20 24 902 906 B-treatment
elective 25 33 907 915 I-treatment
liver 34 39 916 921 I-treatment
resection 40 49 922 931 I-treatment
for 50 53 932 935 O
primary 54 61 936 943 O
liver 62 67 944 949 O
pathology 68 77 950 959 O
( 78 79 960 961 O
benign 79 85 961 967 O
or 86 88 968 970 O
malignant 89 98 971 980 O
) 98 99 980 981 O
or 100 102 982 984 O
secondary 103 112 985 994 O
metastatic 113 123 995 1005 B-cancer
liver 124 129 1006 1011 I-cancer
disease 130 137 1012 1019 I-cancer
, 137 138 1019 1020 O
including 139 148 1021 1030 O
patients 149 157 1031 1039 O
undergoing 158 168 1040 1050 O
concomitant 169 180 1051 1062 B-treatment
surgical 181 189 1063 1071 I-treatment
procedures 190 200 1072 1082 I-treatment
( 201 202 1083 1084 O
such 202 206 1084 1088 O
as 207 209 1089 1091 O
colorectal 210 220 1092 1102 B-treatment
resection 221 230 1103 1112 I-treatment
or 231 233 1113 1115 O
debulking 234 243 1116 1125 B-treatment
procedures 244 254 1126 1136 I-treatment
) 254 255 1136 1137 O
, 255 256 1137 1138 O
with 257 261 1139 1143 O
no 262 264 1144 1146 O
contraindication 265 281 1147 1163 O
to 282 284 1164 1166 O
the 285 288 1167 1170 O
insertion 289 298 1171 1180 O
of 299 301 1181 1183 O
an 302 304 1184 1186 O
epidural 305 313 1187 1195 B-treatment
catheter 314 322 1196 1204 I-treatment
( 323 324 1205 1206 O
localized 324 333 1206 1215 B-chronic_disease
infection 334 343 1216 1225 I-chronic_disease
, 343 344 1225 1226 O
septicemia 345 355 1227 1237 B-chronic_disease
, 355 356 1237 1238 O
or 357 359 1239 1241 O
pre 360 363 1242 1245 B-treatment
- 363 364 1245 1246 I-treatment
operative 364 373 1246 1255 I-treatment
coagulopathy 374 386 1256 1268 I-treatment
) 386 387 1268 1269 O

Patients 0 8 1270 1278 O
with 9 13 1279 1283 O
a 14 15 1284 1285 O
history 16 23 1286 1293 O
of 24 26 1294 1296 O
documented 27 37 1297 1307 O
anaphylaxis 38 49 1308 1319 O
or 50 52 1320 1322 O
contraindication 53 69 1323 1339 O
to 70 72 1340 1342 O
any 73 76 1343 1346 O
of 77 79 1347 1349 O
the 80 83 1350 1353 O
study 84 89 1354 1359 O
medications 90 101 1360 1371 O
or 102 104 1372 1374 O
standardized 105 117 1375 1387 O
intra 118 123 1388 1393 O
- 123 124 1393 1394 O
operative 124 133 1394 1403 O
medications 134 145 1404 1415 O
. 145 146 1415 1416 O
These 147 152 1417 1422 O
include 153 160 1423 1430 O
dilaudid 161 169 1431 1439 B-allergy_name
, 169 170 1439 1440 O
fentanyl 171 179 1441 1449 B-allergy_name
, 179 180 1449 1450 O
and 181 184 1451 1454 O
bupivacaine 185 196 1455 1466 B-allergy_name

Patients 0 8 1467 1475 O
with 9 13 1476 1480 O
pain 14 18 1481 1485 O
at 19 21 1486 1488 O
rest 22 26 1489 1493 O
or 27 29 1494 1496 O
with 30 34 1497 1501 O
movement 35 43 1502 1510 O
measured 44 52 1511 1519 O
by 53 55 1520 1522 O
NRS 56 59 1523 1526 B-clinical_variable
> 60 61 1527 1528 O
2 61 62 1528 1529 B-lower_bound

Patients 0 8 1530 1538 O
with 9 13 1539 1543 O
severe 14 20 1544 1550 O
chronic 21 28 1551 1558 B-chronic_disease
obstructive 29 40 1559 1570 I-chronic_disease
pulmonary 41 50 1571 1580 I-chronic_disease
disease 51 58 1581 1588 I-chronic_disease
( 59 60 1589 1590 I-chronic_disease
COPD 60 64 1590 1594 I-chronic_disease
) 64 65 1594 1595 I-chronic_disease
defined 66 73 1596 1603 O
as 74 76 1604 1606 O
an 77 79 1607 1609 O
FEV1 80 84 1610 1614 B-clinical_variable
< 85 86 1615 1616 O
50 86 88 1616 1618 B-upper_bound
% 88 89 1618 1619 I-upper_bound

Patients 0 8 1620 1628 O
with 9 13 1629 1633 O
significant 14 25 1634 1645 O
cognitive 26 35 1646 1655 B-chronic_disease
impairment 36 46 1656 1666 I-chronic_disease
or 47 49 1667 1669 O
documented 50 60 1670 1680 O
psychologic 61 72 1681 1692 B-chronic_disease
impairment 73 83 1693 1703 I-chronic_disease

age 0 3 1704 1707 B-age
18 4 6 1708 1710 B-lower_bound
years 7 12 1711 1716 I-lower_bound
or 13 15 1717 1719 O
older 16 21 1720 1725 O

Ages 0 4 0 4 B-age
18 5 7 5 7 B-lower_bound
- 8 9 8 9 O
65 10 12 10 12 B-upper_bound
years 13 18 13 18 I-upper_bound
old 19 22 19 22 I-upper_bound

Females 0 7 23 30 B-gender

Had 0 3 31 34 O
Gulf 4 8 35 39 B-chronic_disease
War 9 12 40 43 I-chronic_disease
Veterans 13 21 44 52 I-chronic_disease
' 21 22 52 53 I-chronic_disease
Illnesses 23 32 54 63 I-chronic_disease
( 33 34 64 65 I-chronic_disease
GWVI 34 38 65 69 I-chronic_disease
) 38 39 69 70 I-chronic_disease
, 39 40 70 71 O
but 41 44 72 75 O
did 45 48 76 79 O
not 49 52 80 83 O
answer 53 59 84 90 O
' 60 61 91 92 O
Yes 61 64 92 95 O
' 64 65 95 96 O
to 66 68 97 99 O
the 69 72 100 103 O
following 73 82 104 113 O
questions 83 92 114 123 O
: 92 93 123 124 O
1 94 95 125 126 O
) 95 96 126 127 O
Difficulty 97 107 128 138 O
concentrating 108 121 139 152 O
and/or 122 128 153 159 O
2 129 130 160 161 O
) 130 131 161 162 O
Difficulty 132 142 163 173 O
remembering 143 154 174 185 O
recent 155 161 186 192 O
information 162 173 193 204 O

Less 0 4 205 209 O
than 5 9 210 214 O
age 10 13 215 218 B-age
18 14 16 219 221 B-upper_bound
, 16 17 221 222 O
or 18 20 223 225 O
greater 21 28 226 233 O
than 29 33 234 238 O
age 34 37 239 242 O
60 38 40 243 245 B-lower_bound

Males 0 5 246 251 B-gender

Must 0 4 252 256 O
be 5 7 257 259 O
physically 8 18 260 270 O
able 19 23 271 275 O
to 24 26 276 278 O
travel 27 33 279 285 O
to 34 36 286 288 O
the 37 40 289 292 O
VA 41 43 293 295 O
Boston 44 50 296 302 O
Healthcare 51 61 303 313 O
System 62 68 314 320 O
, 68 69 320 321 O
Jamaica 70 77 322 329 O
Plain 78 83 330 335 O
, 83 84 335 336 O
for 85 88 337 340 O
Neuropsychological 89 107 341 359 B-treatment
testing 108 115 360 367 I-treatment
and 116 119 368 371 O
transcranial 120 132 372 384 B-treatment
LED 133 136 385 388 I-treatment
treatments 137 147 389 399 I-treatment

Must 0 4 400 404 O
meet 5 9 405 409 O
screening 10 19 410 419 O
criteria 20 28 420 428 O
for 29 32 429 432 O
a 33 34 433 434 O
PTSD 35 39 435 439 B-chronic_disease
diagnosis 40 49 440 449 O

Not 0 3 450 453 O
meeting 4 11 454 461 O
criteria 12 20 462 470 O
for 21 24 471 474 O
post 25 29 475 479 B-treatment
- 29 30 479 480 I-treatment
traumatic 30 39 480 489 I-treatment
stress 40 46 490 496 I-treatment
disorder 47 55 497 505 I-treatment
and 56 59 506 509 O
for 60 63 510 513 O
mild 64 68 514 518 O
or 69 71 519 521 O
moderate 72 80 522 530 O
traumatic 81 90 531 540 O
brain 91 96 541 546 O
injury 97 103 547 553 O

Physical 0 8 554 562 O
limitations 9 20 563 574 O
that 21 25 575 579 O
would 26 31 580 585 O
prevent 32 39 586 593 O
traveling 40 49 594 603 O
to 50 52 604 606 O
the 53 56 607 610 O
VA 57 59 611 613 O
Boston 60 66 614 620 O
Healthcare 67 77 621 631 O
System 78 84 632 638 O
, 84 85 638 639 O
Jamaica 86 93 640 647 O
Plain 94 99 648 653 O
, 99 100 653 654 O
for 101 104 655 658 O
Neuropsychological 105 123 659 677 B-treatment
testing 124 131 678 685 I-treatment
and 132 135 686 689 O
transcranial 136 148 690 702 B-treatment
LED 149 152 703 706 I-treatment
treatments 153 163 707 717 I-treatment

Presence 0 8 718 726 O
of 9 11 727 729 O
a 12 13 730 731 O
life 14 18 732 736 O
- 18 19 736 737 O
threatening 19 30 737 748 O
disease 31 38 749 756 O
such 39 43 757 761 O
as 44 46 762 764 O
cancer 47 53 765 771 B-cancer

Presence 0 8 772 780 O
of 9 11 781 783 O
a 12 13 784 785 O
neurodegenerative 14 31 786 803 B-chronic_disease
disease 32 39 804 811 I-chronic_disease
such 40 44 812 816 O
as 45 47 817 819 O
Amyotrophic 48 59 820 831 B-chronic_disease
Lateral 60 67 832 839 I-chronic_disease
Sclerosis 68 77 840 849 I-chronic_disease
( 78 79 850 851 I-chronic_disease
ALS 79 82 851 854 I-chronic_disease
) 82 83 854 855 I-chronic_disease
, 83 84 855 856 O
Parkinson 85 94 857 866 B-chronic_disease
's 94 96 866 868 I-chronic_disease
, 96 97 868 869 O
Dementia 98 106 870 878 B-chronic_disease

Presence 0 8 879 887 O
of 9 11 888 890 O
a 12 13 891 892 O
severe 14 20 893 899 O
mental 21 27 900 906 B-chronic_disease
disorder 28 36 907 915 I-chronic_disease
such 37 41 916 920 O
as 42 44 921 923 O
schizophrenia 45 58 924 937 B-chronic_disease
, 58 59 937 938 O
or 60 62 939 941 O
severe 63 69 942 948 O
depression 70 80 949 959 B-chronic_disease

Alanine 0 7 0 7 B-clinical_variable
aminotransferase 8 24 8 24 I-clinical_variable
( 25 26 25 26 I-clinical_variable
ALT 26 29 26 29 I-clinical_variable
) 29 30 29 30 I-clinical_variable
or 31 33 31 33 O
aspartate 34 43 34 43 B-clinical_variable
aminotransferase 44 60 44 60 I-clinical_variable
( 61 62 61 62 I-clinical_variable
AST 62 65 62 65 I-clinical_variable
) 65 66 65 66 I-clinical_variable
must 67 71 67 71 O
be 72 74 72 74 O
less 75 79 75 79 O
than 80 84 80 84 O
3 85 86 85 86 B-upper_bound
times 87 92 87 92 I-upper_bound
the 93 96 93 96 I-upper_bound
upper 97 102 97 102 I-upper_bound
limit 103 108 103 108 I-upper_bound
of 109 111 109 111 I-upper_bound
the 112 115 112 115 I-upper_bound
normal 116 122 116 122 I-upper_bound
range 123 128 123 128 I-upper_bound

Carriers 0 8 129 137 O
of 9 11 138 140 O
hepatitis 12 21 141 150 B-chronic_disease
B 22 23 151 152 I-chronic_disease
virus 24 29 153 158 I-chronic_disease
should 30 36 159 165 O
be 37 39 166 168 O
closely 40 47 169 176 O
monitored 48 57 177 186 O
for 58 61 187 190 O
clinical 62 70 191 199 O
and 71 74 200 203 O
laboratory 75 85 204 214 O
signs 86 91 215 220 O
of 92 94 221 223 O
active 95 101 224 230 O
hepatitis 102 111 231 240 B-chronic_disease
B 112 113 241 242 I-chronic_disease
virus 114 119 243 248 I-chronic_disease
infection 120 129 249 258 I-chronic_disease
and 130 133 259 262 O
for 134 137 263 266 O
signs 138 143 267 272 O
of 144 146 273 275 O
hepatitis 147 156 276 285 O
throughout 157 167 286 296 O
study 168 173 297 302 O
participation 174 187 303 316 O

Composite 0 9 317 326 B-cancer
lymphoma 10 18 327 335 I-cancer
containing 19 29 336 346 O
both 30 34 347 351 O
indolent 35 43 352 360 O
and 44 47 361 364 O
large 48 53 365 370 O
cell 54 58 371 375 O
features 59 67 376 384 O
will 68 72 385 389 O
be 73 75 390 392 O
included 76 84 393 401 O

Eastern 0 7 402 409 B-clinical_variable
Cooperative 8 19 410 421 I-clinical_variable
Oncology 20 28 422 430 I-clinical_variable
Group 29 34 431 436 I-clinical_variable
( 35 36 437 438 I-clinical_variable
ECOG 36 40 438 442 I-clinical_variable
) 40 41 442 443 I-clinical_variable
performance 42 53 444 455 I-clinical_variable
status 54 60 456 462 I-clinical_variable
of 61 63 463 465 O
0 64 65 466 467 B-lower_bound
- 65 66 467 468 O
3 66 67 468 469 B-upper_bound

Has 0 3 470 473 O
received 4 12 474 482 O
no 13 15 483 485 O
prior 16 21 486 491 B-treatment
therapy 22 29 492 499 I-treatment
for 30 33 500 503 O
DLBCL 34 39 504 509 B-cancer
or 40 42 510 512 O
HT 43 45 513 515 B-chronic_disease
with 46 50 516 520 O
the 51 54 521 524 O
exception 55 64 525 534 O
of 65 67 535 537 O
a 68 69 538 539 O
course 70 76 540 546 O
of 77 79 547 549 O
prednisone 80 90 550 560 B-treatment
of 91 93 561 563 O
less 94 98 564 568 O
than 99 103 569 573 O
or 104 106 574 576 O
equal 107 112 577 582 O
to 113 115 583 585 O
7 116 117 586 587 B-upper_bound
days 118 122 588 592 I-upper_bound
given 123 128 593 598 O
for 129 132 599 602 O
lymphoma 133 141 603 611 B-cancer
related 142 149 612 619 O
symptoms 150 158 620 628 O
; 158 159 628 629 O
prior 160 165 630 635 O
therapy 166 173 636 643 O
for 174 177 644 647 O
follicular 178 188 648 658 B-cancer
lymphoma 189 197 659 667 I-cancer
is 198 200 668 670 O
accepted 201 209 671 679 O
, 209 210 679 680 O
but 211 214 681 684 O
no 215 217 685 687 O
prior 218 223 688 693 B-treatment
anthracycline 224 237 694 707 I-treatment
- 237 238 707 708 I-treatment
containing 238 248 708 718 I-treatment
therapy 249 256 719 726 I-treatment

History 0 7 727 734 O
of 8 10 735 737 O
solid 11 16 738 743 B-treatment
organ 17 22 744 749 I-treatment
transplantation 23 38 750 765 I-treatment
, 38 39 765 766 O
or 40 42 767 769 O
post 43 47 770 774 B-chronic_disease
- 47 48 774 775 I-chronic_disease
transplant 48 58 775 785 I-chronic_disease
lymphoproliferative 59 78 786 805 I-chronic_disease
disorder 79 87 806 814 I-chronic_disease

History 0 7 815 822 O
of 8 10 823 825 O
, 10 11 825 826 O
or 12 14 827 829 O
clinically 15 25 830 840 O
apparent 26 34 841 849 O
central 35 42 850 857 B-cancer
nervous 43 50 858 865 I-cancer
system 51 57 866 872 I-cancer
( 58 59 873 874 I-cancer
CNS 59 62 874 877 I-cancer
) 62 63 877 878 I-cancer
lymphoma 64 72 879 887 I-cancer

New 0 3 888 891 B-clinical_variable
York 4 8 892 896 I-clinical_variable
Heart 9 14 897 902 I-clinical_variable
Association 15 26 903 914 I-clinical_variable
class 27 32 915 920 B-chronic_disease
III 33 36 921 924 I-chronic_disease
heart 37 42 925 930 I-chronic_disease
failure 43 50 931 938 I-chronic_disease
or 51 53 939 941 O
ejection 54 62 942 950 B-clinical_variable
fraction 63 71 951 959 I-clinical_variable
of 72 74 960 962 O
less 75 79 963 967 O
than 80 84 968 972 O
30 85 87 973 975 B-upper_bound
% 87 88 975 976 I-upper_bound
on 89 91 977 979 O
echocardiogram 92 106 980 994 B-treatment
or 107 109 995 997 O
Multi 110 115 998 1003 B-treatment
Gated 116 121 1004 1009 I-treatment
Acquisition 122 133 1010 1021 I-treatment
Scan 134 138 1022 1026 I-treatment
( 139 140 1027 1028 I-treatment
MUGA 140 144 1028 1032 I-treatment
) 144 145 1032 1033 I-treatment

Patient 0 7 1034 1041 O
has 8 11 1042 1045 O
a 12 13 1046 1047 O
calculated 14 24 1048 1058 O
or 25 27 1059 1061 O
measured 28 36 1062 1070 O
creatinine 37 47 1071 1081 B-clinical_variable
clearance 48 57 1082 1091 I-clinical_variable
of 58 60 1092 1094 O
< 61 62 1095 1096 O
30 62 64 1096 1098 B-upper_bound
mL 65 67 1099 1101 I-upper_bound
/ 67 68 1101 1102 I-upper_bound
minute 68 74 1102 1108 I-upper_bound
within 75 81 1109 1115 O
14 82 84 1116 1118 B-upper_bound
days 85 89 1119 1123 I-upper_bound
before 90 96 1124 1130 O
enrollment 97 107 1131 1141 O

Patient 0 7 1142 1149 O
has 8 11 1150 1153 O
a 12 13 1154 1155 O
platelet 14 22 1156 1164 B-clinical_variable
count 23 28 1165 1170 I-clinical_variable
of 29 31 1171 1173 O
≤50,000 32 39 1174 1181 O
/ 39 40 1181 1182 I-upper_bound
mm3 40 43 1182 1185 I-upper_bound
within 44 50 1186 1192 O
14 51 53 1193 1195 B-upper_bound
days 54 58 1196 1200 I-upper_bound
before 59 65 1201 1207 O
enrollment 66 76 1208 1218 O

Patient 0 7 1219 1226 O
has 8 11 1227 1230 O
an 12 14 1231 1233 O
absolute 15 23 1234 1242 B-clinical_variable
neutrophil 24 34 1243 1253 I-clinical_variable
count 35 40 1254 1259 I-clinical_variable
of 41 43 1260 1262 O
< 44 45 1263 1264 O
1,000 46 51 1265 1270 B-upper_bound
/ 51 52 1270 1271 I-upper_bound
mm3 52 55 1271 1274 I-upper_bound
within 56 62 1275 1281 O
14 63 65 1282 1284 B-upper_bound
days 66 70 1285 1289 I-upper_bound
before 71 77 1290 1296 O
enrollment 78 88 1297 1307 O

Patient 0 7 1308 1315 O
has 8 11 1316 1319 O
concomitant 12 23 1320 1331 O
active 24 30 1332 1338 B-cancer
malignancy 31 41 1339 1349 I-cancer
that 42 46 1350 1354 O
the 47 50 1355 1358 O
treating 51 59 1359 1367 O
physician 60 69 1368 1377 O
or 70 72 1378 1380 O
PI 73 75 1381 1383 O
feels 76 81 1384 1389 O
may 82 85 1390 1393 O
interfere 86 95 1394 1403 O
with 96 100 1404 1408 O
the 101 104 1409 1412 O
ability 105 112 1413 1420 O
to 113 115 1421 1423 O
measure 116 123 1424 1431 O
the 124 127 1432 1435 O
primary 128 135 1436 1443 O
or 136 138 1444 1446 O
secondary 139 148 1447 1456 O
outcomes 149 157 1457 1465 O

Patient 0 7 1466 1473 O
has 8 11 1474 1477 O
received 12 20 1478 1486 O
other 21 26 1487 1492 O
investigational 27 42 1493 1508 O
drugs 43 48 1509 1514 O
with 49 53 1515 1519 O
14 54 56 1520 1522 B-upper_bound
days 57 61 1523 1527 I-upper_bound
before 62 68 1528 1534 O
enrollment 69 79 1535 1545 O

Patient 0 7 1546 1553 O
has 8 11 1554 1557 O
≥Grade 12 18 1558 1564 O
2 19 20 1565 1566 I-lower_bound
peripheral 21 31 1567 1577 B-clinical_variable
neuropathy 32 42 1578 1588 I-clinical_variable
within 43 49 1589 1595 O
14 50 52 1596 1598 B-upper_bound
days 53 57 1599 1603 I-upper_bound
before 58 64 1604 1610 O
enrollment 65 75 1611 1621 O

Patient 0 7 1622 1629 O
is 8 10 1630 1632 O
known 11 16 1633 1638 O
to 17 19 1639 1641 O
be 20 22 1642 1644 O
HIV 23 26 1645 1648 B-chronic_disease
positive 27 35 1649 1657 O
( 36 37 1658 1659 O
test 37 41 1659 1663 O
result 42 48 1664 1670 O
not 49 52 1671 1674 O
required 53 61 1675 1683 O
for 62 65 1684 1687 O
enrollment 66 76 1688 1698 O
) 76 77 1698 1699 O

Patient 0 7 1700 1707 O
is 8 10 1708 1710 O
receiving 11 20 1711 1720 O
peritoneal 21 31 1721 1731 B-treatment
dialysis 32 40 1732 1740 I-treatment
or 41 43 1741 1743 O
hemodialysis 44 56 1744 1756 B-treatment

Patients 0 8 1757 1765 O
with 9 13 1766 1770 O
HT 14 16 1771 1773 B-chronic_disease
must 17 21 1774 1778 O
not 22 25 1779 1782 O
have 26 30 1783 1787 O
received 31 39 1788 1796 O
an 40 42 1797 1799 O
anthracycline 43 56 1800 1813 B-treatment
- 56 57 1813 1814 O
containing 57 67 1814 1824 O
regimen 68 75 1825 1832 O
in 76 78 1833 1835 O
the 79 82 1836 1839 O
past 83 87 1840 1844 O

Patients 0 8 1845 1853 O
with 9 13 1854 1858 O
a 14 15 1859 1860 O
history 16 23 1861 1868 O
of 24 26 1869 1871 O
curative 27 35 1872 1880 O
, 35 36 1880 1881 O
surgically 37 47 1882 1892 O
treated 48 55 1893 1900 O
basal 56 61 1901 1906 B-cancer
or 62 64 1907 1909 I-cancer
squamous 65 73 1910 1918 I-cancer
cell 74 78 1919 1923 I-cancer
carcinoma 79 88 1924 1933 I-cancer
or 89 91 1934 1936 O
stage 92 97 1937 1942 B-cancer
1 98 99 1943 1944 I-cancer
melanoma 100 108 1945 1953 I-cancer
of 109 111 1954 1956 I-cancer
the 112 115 1957 1960 I-cancer
skin 116 120 1961 1965 I-cancer
or 121 123 1966 1968 O
in 124 126 1969 1971 B-cancer
situ 127 131 1972 1976 I-cancer
carcinoma 132 141 1977 1986 I-cancer
of 142 144 1987 1989 I-cancer
the 145 148 1990 1993 I-cancer
cervix 149 155 1994 2000 I-cancer
are 156 159 2001 2004 O
eligible 160 168 2005 2013 O

Patients 0 8 2014 2022 O
with 9 13 2023 2027 O
a 14 15 2028 2029 O
malignancy 16 26 2030 2040 B-cancer
that 27 31 2041 2045 O
has 32 35 2046 2049 O
been 36 40 2050 2054 O
treated 41 48 2055 2062 O
with 49 53 2063 2067 O
surgery 54 61 2068 2075 B-treatment
alone 62 67 2076 2081 O
with 68 72 2082 2086 O
curative 73 81 2087 2095 O
intent 82 88 2096 2102 O
will 89 93 2103 2107 O
also 94 98 2108 2112 O
be 99 101 2113 2115 O
excluded 102 110 2116 2124 O
, 110 111 2124 2125 O
unless 112 118 2126 2132 O
the 119 122 2133 2136 O
malignancy 123 133 2137 2147 O
has 134 137 2148 2151 O
been 138 142 2152 2156 O
in 143 145 2157 2159 O
documented 146 156 2160 2170 O
remission 157 166 2171 2180 O
without 167 174 2181 2188 O
treatment 175 184 2189 2198 B-treatment
for 185 188 2199 2202 O
≥ 189 190 2203 2204 O
3 191 192 2205 2206 B-lower_bound
years 193 198 2207 2212 I-lower_bound
prior 199 204 2213 2218 I-lower_bound
to 205 207 2219 2221 O
enrollment 208 218 2222 2232 O

Prior 0 5 2233 2238 O
exposure 6 14 2239 2247 O
to 15 17 2248 2250 O
anthracycline 18 31 2251 2264 B-treatment

Serious 0 7 2265 2272 B-chronic_disease
medical 8 15 2273 2280 I-chronic_disease
or 16 18 2281 2283 I-chronic_disease
psychiatric 19 30 2284 2295 I-chronic_disease
illness 31 38 2296 2303 I-chronic_disease
likely 39 45 2304 2310 O
to 46 48 2311 2313 O
interfere 49 58 2314 2323 O
with 59 63 2324 2328 O
participation 64 77 2329 2342 O
in 78 80 2343 2345 O
this 81 85 2346 2350 O
clinical 86 94 2351 2359 O
study 95 100 2360 2365 O

Total 0 5 2366 2371 O
bilirubin 6 15 2372 2381 B-clinical_variable
must 16 20 2382 2386 O
be 21 23 2387 2389 O
less 24 28 2390 2394 O
than 29 33 2395 2399 O
1.5 34 37 2400 2403 B-upper_bound
times 38 43 2404 2409 I-upper_bound
the 44 47 2410 2413 I-upper_bound
upper 48 53 2414 2419 I-upper_bound
limit 54 59 2420 2425 I-upper_bound
of 60 62 2426 2428 I-upper_bound
normal 63 69 2429 2435 I-upper_bound
( 70 71 2436 2437 I-upper_bound
ULN 71 74 2437 2440 I-upper_bound
) 74 75 2440 2441 I-upper_bound
unless 76 82 2442 2448 O
the 83 86 2449 2452 O
elevation 87 96 2453 2462 O
is 97 99 2463 2465 O
known 100 105 2466 2471 O
to 106 108 2472 2474 O
be 109 111 2475 2477 O
due 112 115 2478 2481 O
to 116 118 2482 2484 O
Gilbert 119 126 2485 2492 B-chronic_disease
syndrome 127 135 2493 2501 I-chronic_disease

aged 0 4 2502 2506 B-age
greater 5 12 2507 2514 O
than 13 17 2515 2519 O
or 18 20 2520 2522 O
equal 21 26 2523 2528 O
to 27 29 2529 2531 O
75 30 32 2532 2534 B-lower_bound
years 33 38 2535 2540 I-lower_bound
of 39 41 2541 2543 O
age 42 45 2544 2547 O

women 0 5 2548 2553 B-gender

ECOG 0 4 0 4 B-clinical_variable
PS 5 7 5 7 I-clinical_variable
of 8 10 8 10 O
3 11 12 11 12 O

Eastern 0 7 13 20 B-clinical_variable
Cooperative 8 19 21 32 I-clinical_variable
Oncology 20 28 33 41 I-clinical_variable
Group 29 34 42 47 I-clinical_variable
performance 35 46 48 59 I-clinical_variable
status 47 53 60 66 I-clinical_variable
( 54 55 67 68 I-clinical_variable
ECOG 55 59 68 72 I-clinical_variable
PS 60 62 73 75 I-clinical_variable
) 62 63 75 76 I-clinical_variable
of 64 66 77 79 O
≤ 67 68 80 81 O
2 69 70 82 83 B-upper_bound

cognitive 0 9 84 93 B-chronic_disease
impairment 10 20 94 104 I-chronic_disease
or 21 23 105 107 O
inability 24 33 108 117 O
to 34 36 118 120 O
consent 37 44 121 128 O
to 45 47 129 131 O
treatment 48 57 132 141 O
, 57 58 141 142 O
as 59 61 143 145 O
determined 62 72 146 156 O
by 73 75 157 159 O
the 76 79 160 163 O
patient 80 87 164 171 O
's 87 89 171 173 O
oncologist 90 100 174 184 O

confined 0 8 185 193 O
to 9 11 194 196 O
bed 12 15 197 200 O
or 16 18 201 203 O
chair 19 24 204 209 O
> 25 26 210 211 O
50 27 29 212 214 B-lower_bound
% 29 30 214 215 I-lower_bound
of 31 33 216 218 O
waking 34 40 219 225 O
hours 41 46 226 231 O

hematologic 0 11 232 243 B-cancer
malignancy 12 22 244 254 I-cancer

Any 0 3 0 3 O
patient 4 11 4 11 O
falling 12 19 12 19 O
within 20 26 20 26 O
age 27 30 27 30 B-age
group 31 36 31 36 O
with 37 41 37 41 O
granulation 42 53 42 53 O
tissue 54 60 54 60 O
around 61 67 61 67 O
G 68 69 68 69 O
tube 70 74 70 74 O
site 75 79 75 79 O

Patients 0 8 80 88 O
falling 9 16 89 96 O
outside 17 24 97 104 O
of 25 27 105 107 O
age 28 31 108 111 B-age
group 32 37 112 117 O
range 38 43 118 123 O

No 0 2 0 2 O
history 3 10 3 10 O
of 11 13 11 13 O
dementia 14 22 14 22 B-chronic_disease
or 23 25 23 25 O
other 26 31 26 31 O
serious 32 39 32 39 B-chronic_disease
cognitive 40 49 40 49 I-chronic_disease
condition 50 59 50 59 I-chronic_disease
that 60 64 60 64 O
would 65 70 65 70 O
prevent 71 78 71 78 O
them 79 83 79 83 O
from 84 88 84 88 O
being 89 94 89 94 O
interviewed 95 106 95 106 O
or 107 109 107 109 O
completing 110 120 110 120 O
a 121 122 121 122 O
survey 123 129 123 129 O
questionnaire 130 143 130 143 O

Able 0 4 0 4 O
to 5 7 5 7 O
speak 8 13 8 13 B-language_fluency
and 14 17 14 17 I-language_fluency
read 18 22 18 22 I-language_fluency
English 23 30 23 30 I-language_fluency
( 31 32 31 32 O
to 32 34 32 34 O
allow 35 40 35 40 O
for 41 44 41 44 O
participation 45 58 45 58 O
in 59 61 59 61 O
study 62 67 62 67 O
intervention 68 80 68 80 O
sessions 81 89 81 89 O
) 89 90 89 90 O

Bone 0 4 91 95 B-treatment
fracture 5 13 96 104 I-treatment
/ 13 14 104 105 I-treatment
surgery 14 21 105 112 I-treatment
of 22 24 113 115 O
an 25 27 116 118 O
extremity 28 37 119 128 O
during 38 44 129 135 O
the 45 48 136 139 O
preceding 49 58 140 149 B-upper_bound
6 59 60 150 151 I-upper_bound
months 61 67 152 158 I-upper_bound

Current 0 7 159 166 O
use 8 11 167 170 O
of 12 14 171 173 O
corticosteroids 15 30 174 189 B-treatment
, 30 31 189 190 O
defined 32 39 191 198 O
as 40 42 199 201 O
oral 43 47 202 206 B-treatment
, 47 48 206 207 O
intravenous 49 60 208 219 B-treatment
( 61 62 220 221 I-treatment
IV 62 64 221 223 I-treatment
) 64 65 223 224 I-treatment
, 65 66 224 225 O
or 67 69 226 228 O
injections 70 80 229 239 B-treatment
of 81 83 240 242 I-treatment
corticosteroids 84 99 243 258 I-treatment
in 100 102 259 261 O
the 103 106 262 265 O
past 107 111 266 270 B-upper_bound
4 112 113 271 272 I-upper_bound
weeks 114 119 273 278 I-upper_bound

Experiencing 0 12 279 291 O
ongoing 13 20 292 299 O
pain 21 25 300 304 O
and/or 26 32 305 311 O
stiffness 33 42 312 321 O
in 43 45 322 324 O
one 46 49 325 328 O
or 50 52 329 331 O
more 53 57 332 336 O
joints 58 64 337 343 O
, 64 65 343 344 O
which 66 71 345 350 O
started 72 79 351 358 O
or 80 82 359 361 O
worsened 83 91 362 370 O
after 92 97 371 376 O
initiation 98 108 377 387 O
of 109 111 388 390 O
AI 112 114 391 393 B-treatment
therapy 115 122 394 401 I-treatment

Female 0 6 402 408 B-gender

Fibromyalgia 0 12 409 421 B-chronic_disease

Having 0 6 422 428 O
a 7 8 429 430 O
baseline 9 17 431 439 O
worst 18 23 440 445 O
pain 24 28 446 450 O
score 29 34 451 456 O
over 35 39 457 461 O
the 40 43 462 465 O
past 44 48 466 470 O
week 49 53 471 475 O
on 54 56 476 478 O
the 57 60 479 482 O
Brief 61 66 483 488 B-clinical_variable
Pain 67 71 489 493 I-clinical_variable
Inventory 72 81 494 503 I-clinical_variable
- 81 82 503 504 I-clinical_variable
Short 82 87 504 509 I-clinical_variable
Form 88 92 510 514 I-clinical_variable
( 93 94 515 516 I-clinical_variable
BPI 94 97 516 519 I-clinical_variable
- 97 98 519 520 I-clinical_variable
SF 98 100 520 522 I-clinical_variable
) 100 101 522 523 I-clinical_variable
of 102 104 524 526 O
≥ 105 106 527 528 O
3 107 108 529 530 B-lower_bound
on 109 111 531 533 O
a 112 113 534 535 O
0 114 115 536 537 B-lower_bound
to 116 118 538 540 O
10 119 121 541 543 B-upper_bound
scale 122 127 544 549 O

Metastatic 0 10 550 560 B-cancer
( 11 12 561 562 I-cancer
Stage 12 17 562 567 I-cancer
IV 18 20 568 570 I-cancer
) 20 21 570 571 I-cancer
breast 22 28 572 578 I-cancer
cancer 29 35 579 585 I-cancer
, 35 36 585 586 O
as 37 39 587 589 O
their 40 45 590 595 O
treatment 46 55 596 605 O
and 56 59 606 609 O
outcomes 60 68 610 618 O
typically 69 78 619 628 O
follow 79 85 629 635 O
a 86 87 636 637 O
different 88 97 638 647 O
course 98 104 648 654 O

Non 0 3 655 658 B-treatment
- 3 4 658 659 I-treatment
steroidal 4 13 659 668 I-treatment
joint 14 19 669 674 I-treatment
injection 20 29 675 684 I-treatment
within 30 36 685 691 O
the 37 40 692 695 O
last 41 45 696 700 B-upper_bound
3 46 47 701 702 I-upper_bound
months 48 54 703 709 I-upper_bound

Over 0 4 710 714 O
age 5 8 715 718 O
18 9 11 719 721 B-lower_bound

Past 0 4 722 726 O
cancer 5 11 727 733 B-cancer

Regular 0 7 734 741 O
use 8 11 742 745 O
of 12 14 746 748 O
narcotics 15 24 749 758 B-treatment

patients 0 8 759 767 O
will 9 13 768 772 O
be 14 16 773 775 O
eligible 17 25 776 784 O
if 26 28 785 787 O
they 29 33 788 792 O
have 34 38 793 797 O
a 39 40 798 799 O
history 41 48 800 807 O
of 49 51 808 810 O
non 52 55 811 814 B-cancer
- 55 56 814 815 I-cancer
metastatic 56 66 815 825 I-cancer
, 66 67 825 826 O
non 68 71 827 830 B-cancer
- 71 72 830 831 I-cancer
melanomatous 72 84 831 843 I-cancer
skin 85 89 844 848 I-cancer
cancer 90 96 849 855 I-cancer

Disorders 0 9 0 9 B-chronic_disease
of 10 12 10 12 I-chronic_disease
Cellular 13 21 13 21 I-chronic_disease
Migration 22 31 22 31 I-chronic_disease
and 32 35 32 35 I-chronic_disease
Proliferation 36 49 36 49 I-chronic_disease

Metabolic 0 9 50 59 B-chronic_disease
Disorders 10 19 60 69 I-chronic_disease

Neoplasm 0 8 70 78 B-cancer

Other 0 5 79 84 O
neurologic 6 16 85 95 B-chronic_disease
disorders 17 26 96 105 I-chronic_disease
unrelated 27 36 106 115 O
to 37 39 116 118 O
stroke 40 46 119 125 B-chronic_disease

Small 0 5 126 131 B-clinical_variable
for 6 9 132 135 I-clinical_variable
gestational 10 21 136 147 I-clinical_variable
age 22 25 148 151 I-clinical_variable
( 26 27 152 153 I-clinical_variable
SGA 27 30 153 156 I-clinical_variable
): 30 32 156 158 I-clinical_variable
Infants 33 40 159 166 O
are 41 44 167 170 O
smaller 45 52 171 178 O
in 53 55 179 181 O
size 56 60 182 186 O
than 61 65 187 191 O
normal 66 72 192 198 O
for 73 76 199 202 O
the 77 80 203 206 O
gestational 81 92 207 218 O
age 93 96 219 222 O

age 0 3 223 226 B-age
between 4 11 227 234 O
3 12 13 235 236 B-lower_bound
and 14 17 237 240 O
12 18 20 241 243 B-upper_bound
months 21 27 244 250 I-upper_bound
of 28 30 251 253 O
age 31 34 254 257 O

Patients 0 8 0 8 O
with 9 13 9 13 O
a 14 15 14 15 O
history 16 23 16 23 O
of 24 26 24 26 O
head 27 31 27 31 B-cancer
and 32 35 32 35 I-cancer
neck 36 40 36 40 I-cancer
cancer 41 47 41 47 I-cancer
or 48 50 48 50 O
oral 51 55 51 55 B-cancer
premalignant 56 68 56 68 I-cancer
disease 69 76 69 76 I-cancer
but 77 80 77 80 O
without 81 88 81 88 O
any 89 92 89 92 O
clinical 93 101 93 101 O
evidence 102 110 102 110 O
of 111 113 111 113 O
disease 114 121 114 121 O

Patients 0 8 122 130 O
with 9 13 131 135 O
either 14 20 136 142 O
pre 21 24 143 146 O
- 24 25 146 147 O
malignant 25 34 147 156 O
or 35 37 157 159 O
a 38 39 160 161 O
history 40 47 162 169 O
of 48 50 170 172 O
oral 51 55 173 177 B-cancer
cancer 56 62 178 184 I-cancer
based 63 68 185 190 O
on 69 71 191 193 O
patient 72 79 194 201 O
history 80 87 202 209 O
and 88 91 210 213 O
clinical 92 100 214 222 O
presentations 101 114 223 236 O

Persons 0 7 237 244 O
with 8 12 245 249 O
any 13 16 250 253 O
other 17 22 254 259 O
condition 23 32 260 269 O
( 33 34 270 271 O
such 34 38 271 275 O
as 39 41 276 278 O
lichen 42 48 279 285 B-chronic_disease
planus 49 55 286 292 I-chronic_disease
, 55 56 292 293 O
Fanconi 57 64 294 301 B-chronic_disease
anemia 65 71 302 308 I-chronic_disease
, 71 72 308 309 O
heavy 73 78 310 315 O
tobacco 79 86 316 323 O
use 87 90 324 327 O
, 90 91 327 328 O
etc 92 95 329 332 O
) 95 96 332 333 O
making 97 103 334 340 O
them 104 108 341 345 O
at 109 111 346 348 O
higher 112 118 349 355 O
risk 119 123 356 360 O
for 124 127 361 364 O
oral 128 132 365 369 B-cancer
cancer 133 139 370 376 I-cancer
development 140 151 377 388 O

Subjects 0 8 389 397 O
with 9 13 398 402 O
premalignant 14 26 403 415 B-cancer
lesion 27 33 416 422 I-cancer
, 33 34 422 423 O
or 35 37 424 426 O
potentially 38 49 427 438 O
premalignant 50 62 439 451 O
lesion 63 69 452 458 O
, 69 70 458 459 O
of 71 73 460 462 O
the 74 77 463 466 O
oral 78 82 467 471 O
cavity 83 89 472 478 O
mucosa 90 96 479 485 O
( 97 98 486 487 O
leukoplakia 98 109 487 498 B-chronic_disease
or 110 112 499 501 O
erythroplakia 113 126 502 515 B-chronic_disease
) 126 127 515 516 O

Acute 0 5 0 5 B-cancer
lymphocytic 6 17 6 17 I-cancer
leukemia 18 26 18 26 I-cancer
or 27 29 27 29 O
acute 30 35 30 35 B-cancer
myelogenous 36 47 36 47 I-cancer
leukemia 48 56 48 56 I-cancer
who 57 60 57 60 O
are 61 64 61 64 O
not 65 68 65 68 O
in 69 71 69 71 O
first 72 77 72 77 O
remission 78 87 78 87 O
or 88 90 88 90 O
second 91 97 91 97 O
remission 98 107 98 107 O
i.e. 108 112 108 112 O
after 113 118 113 118 O
failing 119 126 119 126 O
induction 127 136 127 136 B-treatment
therapy 137 144 137 144 I-treatment
, 144 145 144 145 O
or 146 148 146 148 O
in 149 151 149 151 O
relapse 152 159 152 159 O
or 160 162 160 162 O
beyond 163 169 163 169 O
second 170 176 170 176 O
remission 177 186 177 186 O
; 186 187 186 187 O
( 188 189 188 189 O
prior 189 194 189 194 B-treatment
therapy 195 202 195 202 I-treatment
with 203 207 203 207 O
VP-16 208 213 208 213 B-treatment
and 214 217 214 217 O
Cytoxan 218 225 218 225 B-treatment
is 226 228 226 228 O
allowed 229 236 229 236 O
) 236 237 236 237 O

Agreement 0 9 238 247 O
of 10 12 248 250 O
men 13 16 251 254 B-gender
AND 17 20 255 258 I-gender
women 21 26 259 264 I-gender
- 26 27 264 265 O
of 27 29 265 267 O
- 29 30 267 268 O
child 30 35 268 273 O
- 35 36 273 274 O
bearing 36 43 274 281 O
- 43 44 281 282 O
potential 44 53 282 291 O
to 54 56 292 294 O
use 57 60 295 298 B-chronic_disease
adequate 61 69 299 307 I-chronic_disease
contraception 70 83 308 321 I-chronic_disease
( 84 85 322 323 O
hormonal 85 93 323 331 B-contraception_consent
or 94 96 332 334 O
barrier 97 104 335 342 B-contraception_consent
method 105 111 343 349 I-contraception_consent
of 112 114 350 352 I-contraception_consent
birth 115 120 353 358 I-contraception_consent
control 121 128 359 366 I-contraception_consent
or 129 131 367 369 O
abstinence 132 142 370 380 B-contraception_consent
) 142 143 380 381 O
prior 144 149 382 387 O
to 150 152 388 390 O
study 153 158 391 396 O
entry 159 164 397 402 O
and 165 168 403 406 O
for 169 172 407 410 O
six 173 176 411 414 B-upper_bound
months 177 183 415 421 I-upper_bound
following 184 193 422 431 O
duration 194 202 432 440 O
of 203 205 441 443 O
study 206 211 444 449 O
participation 212 225 450 463 O
; 225 226 463 464 O
should 227 233 465 471 O
a 234 235 472 473 O
woman 236 241 474 479 B-gender
become 242 248 480 486 O
pregnant 249 257 487 495 B-pregnancy
or 258 260 496 498 O
suspect 261 268 499 506 O
that 269 273 507 511 O
she 274 277 512 515 O
is 278 280 516 518 O
pregnant 281 289 519 527 O
while 290 295 528 533 O
participating 296 309 534 547 O
on 310 312 548 550 O
the 313 316 551 554 O
trial 317 322 555 560 O
, 322 323 560 561 O
she 324 327 562 565 O
should 328 334 566 572 O
inform 335 341 573 579 O
her 342 345 580 583 O
treating 346 354 584 592 O
physician 355 364 593 602 O
immediately 365 376 603 614 O

All 0 3 615 618 O
candidates 4 14 619 629 O
for 15 18 630 633 O
this 19 23 634 638 O
study 24 29 639 644 O
must 30 34 645 649 O
have 35 39 650 654 O
a 40 41 655 656 O
human 42 47 657 662 B-treatment
leukocyte 48 57 663 672 I-treatment
antigen 58 65 673 680 I-treatment
( 66 67 681 682 I-treatment
HLA 67 70 682 685 I-treatment
) 70 71 685 686 I-treatment
( 72 73 687 688 O
A 73 74 688 689 O
, 74 75 689 690 O
B 76 77 691 692 O
, 77 78 692 693 O
C 79 80 694 695 O
, 80 81 695 696 O
DR 82 84 697 699 O
) 84 85 699 700 O
identical 86 95 701 710 O
siblings 96 104 711 719 O
who 105 108 720 723 O
is 109 111 724 726 O
willing 112 119 727 734 O
to 120 122 735 737 O
donate 123 129 738 744 O
bone 130 134 745 749 O
marrow 135 141 750 756 O
or 142 144 757 759 O
primed 145 151 760 766 O
blood 152 157 767 772 O
stem 158 162 773 777 O
cells 163 168 778 783 O
or 169 171 784 786 O
a 172 173 787 788 O
10/10 174 179 789 794 O
allele 180 186 795 801 O
matched 187 194 802 809 O
unrelated 195 204 810 819 O
donor 205 210 820 825 O

Chemotherapy 0 12 826 838 B-treatment
given 13 18 839 844 O
within 19 25 845 851 O
14 26 28 852 854 B-upper_bound
days 29 33 855 859 I-upper_bound
of 34 36 860 862 O
planned 37 44 863 870 O
study 45 50 871 876 O
enrollment 51 61 877 887 O
for 62 65 888 891 O
the 66 69 892 895 O
purpose 70 77 896 903 O
of 78 80 904 906 O
controlling 81 92 907 918 O
counts 93 99 919 925 O
is 100 102 926 928 O
permitted 103 112 929 938 O

Echocardiogram 0 14 939 953 B-treatment
( 15 16 954 955 I-treatment
ECHO 16 20 955 959 I-treatment
) 20 21 959 960 I-treatment
or 22 24 961 963 O
multi 25 30 964 969 B-treatment
gated 31 36 970 975 I-treatment
acquisition 37 48 976 987 I-treatment
scan 49 53 988 992 I-treatment
( 54 55 993 994 I-treatment
MUGA 55 59 994 998 I-treatment
): 59 61 998 1000 I-treatment
ejection 62 70 1001 1009 B-clinical_variable
fraction 71 79 1010 1018 I-clinical_variable
of 80 82 1019 1021 O
> 83 84 1022 1023 O
= 84 85 1023 1024 O
50 86 88 1025 1027 B-lower_bound
% 88 89 1027 1028 I-lower_bound

Karnofsky 0 9 1029 1038 B-clinical_variable
performance 10 21 1039 1050 I-clinical_variable
status 22 28 1051 1057 I-clinical_variable
> 29 30 1058 1059 O
= 30 31 1059 1060 O
70 32 34 1061 1063 B-lower_bound
% 34 35 1063 1064 I-lower_bound
= 36 37 1065 1066 O
< 37 38 1066 1067 O
2 39 40 1068 1069 B-upper_bound

Measured 0 8 1070 1078 B-clinical_variable
creatinine 9 19 1079 1089 I-clinical_variable
clearance 20 29 1090 1099 I-clinical_variable
> 30 31 1100 1101 O
= 31 32 1101 1102 O
80 33 35 1103 1105 B-lower_bound
ml 36 38 1106 1108 I-lower_bound
/ 38 39 1108 1109 I-lower_bound
min 39 42 1109 1112 I-lower_bound
per 43 46 1113 1116 O
24 47 49 1117 1119 O
hour 50 54 1120 1124 O
urine 55 60 1125 1130 O
collection 61 71 1131 1141 O
OR 72 74 1142 1144 O
serum 75 80 1145 1150 B-clinical_variable
creatinine 81 91 1151 1161 I-clinical_variable
= 92 93 1162 1163 O
< 93 94 1163 1164 O
1.3 95 98 1165 1168 B-upper_bound
mg 99 101 1169 1171 I-upper_bound
/ 101 102 1171 1172 I-upper_bound
dL 102 104 1172 1174 I-upper_bound

Plans 0 5 1175 1180 O
during 6 12 1181 1187 O
the 13 16 1188 1191 O
trial 17 22 1192 1197 O
to 23 25 1198 1200 O
receive 26 33 1201 1208 O
any 34 37 1209 1212 O
other 38 43 1213 1218 O
( 44 45 1219 1220 O
non 45 48 1220 1223 O
- 48 49 1223 1224 O
trial 49 54 1224 1229 O
) 54 55 1229 1230 O
investigational 56 71 1231 1246 B-treatment
agents 72 78 1247 1253 I-treatment
, 78 79 1253 1254 O
or 80 82 1255 1257 O
concurrent 83 93 1258 1268 O
biological 94 104 1269 1279 O
, 104 105 1279 1280 O
chemotherapy 106 118 1281 1293 B-treatment
, 118 119 1293 1294 O
or 120 122 1295 1297 O
radiation 123 132 1298 1307 B-treatment
therapy 133 140 1308 1315 I-treatment

Prior 0 5 1316 1321 B-treatment
radiation 6 15 1322 1331 I-treatment
therapy 16 23 1332 1339 I-treatment
that 24 28 1340 1344 O
would 29 34 1345 1350 O
exclude 35 42 1351 1358 O
the 43 46 1359 1362 O
use 47 50 1363 1366 O
of 51 53 1367 1369 O
TMLI 54 58 1370 1374 O

Pulmonary 0 9 1375 1384 O
function 10 18 1385 1393 O
tests 19 24 1394 1399 O
: 24 25 1399 1400 O
Forced 26 32 1401 1407 B-clinical_variable
expiratory 33 43 1408 1418 I-clinical_variable
volume 44 50 1419 1425 I-clinical_variable
in 51 53 1426 1428 I-clinical_variable
one 54 57 1429 1432 I-clinical_variable
second 58 64 1433 1439 I-clinical_variable
( 65 66 1440 1441 I-clinical_variable
FEV1 66 70 1441 1445 I-clinical_variable
) 70 71 1445 1446 I-clinical_variable
and 72 75 1447 1450 O
carbon 76 82 1451 1457 B-clinical_variable
monoxide 83 91 1458 1466 I-clinical_variable
diffusion 92 101 1467 1476 I-clinical_variable
capacity 102 110 1477 1485 I-clinical_variable
( 111 112 1486 1487 I-clinical_variable
DLCO 112 116 1487 1491 I-clinical_variable
) 116 117 1491 1492 I-clinical_variable
( 118 119 1493 1494 O
adjusted 119 127 1494 1502 O
for 128 131 1503 1506 O
Hb 132 134 1507 1509 B-clinical_variable
) 134 135 1509 1510 O
> 136 137 1511 1512 O
= 137 138 1512 1513 O
50 139 141 1514 1516 B-lower_bound
% 141 142 1516 1517 I-lower_bound
adjusted 143 151 1518 1526 O
of 152 154 1527 1529 O
predicted 155 164 1530 1539 O
normal 165 171 1540 1546 O
value 172 177 1547 1552 O

Serum 0 5 1553 1558 B-clinical_variable
glutamic 6 14 1559 1567 I-clinical_variable
oxaloacetic 15 26 1568 1579 I-clinical_variable
transaminase 27 39 1580 1592 I-clinical_variable
( 40 41 1593 1594 I-clinical_variable
SGOT 41 45 1594 1598 I-clinical_variable
) 45 46 1598 1599 I-clinical_variable
and 47 50 1600 1603 O
serum 51 56 1604 1609 B-clinical_variable
glutamate 57 66 1610 1619 I-clinical_variable
pyruvate 67 75 1620 1628 I-clinical_variable
transaminase 76 88 1629 1641 I-clinical_variable
( 89 90 1642 1643 I-clinical_variable
SGPT 90 94 1643 1647 I-clinical_variable
) 94 95 1647 1648 I-clinical_variable
= 96 97 1649 1650 O
< 97 98 1650 1651 O
5 99 100 1652 1653 B-upper_bound
x 101 102 1654 1655 I-upper_bound
ULN 103 106 1656 1659 I-upper_bound

The 0 3 1660 1663 O
time 4 8 1664 1668 O
from 9 13 1669 1673 O
the 14 17 1674 1677 O
end 18 21 1678 1681 O
last 22 26 1682 1686 O
induction 27 36 1687 1696 O
, 36 37 1696 1697 O
re 38 40 1698 1700 O
- 40 41 1700 1701 O
induction 41 50 1701 1710 O
, 50 51 1710 1711 O
or 52 54 1712 1714 O
consolidation 55 68 1715 1728 B-clinical_variable
regimen 69 76 1729 1736 I-clinical_variable
should 77 83 1737 1743 O
be 84 86 1744 1746 O
greater 87 94 1747 1754 O
than 95 99 1755 1759 O
or 100 102 1760 1762 O
equal 103 108 1763 1768 O
to 109 111 1769 1771 O
14 112 114 1772 1774 B-lower_bound
days 115 119 1775 1779 I-lower_bound
from 120 124 1780 1784 O
planned 125 132 1785 1792 O
start 133 138 1793 1798 O
of 139 141 1799 1801 O
study 142 147 1802 1807 O
treatment 148 157 1808 1817 B-treatment

Total 0 5 1818 1823 B-clinical_variable
bilirubin 6 15 1824 1833 I-clinical_variable
= 16 17 1834 1835 O
< 17 18 1835 1836 O
1.5 19 22 1837 1840 B-upper_bound
x 23 24 1841 1842 I-upper_bound
upper 25 30 1843 1848 I-upper_bound
limit 31 36 1849 1854 I-upper_bound
of 37 39 1855 1857 I-upper_bound
normal 40 46 1858 1864 I-upper_bound
( 47 48 1865 1866 I-upper_bound
ULN 48 51 1866 1869 I-upper_bound
) 51 52 1869 1870 I-upper_bound
OR 53 55 1871 1873 O
3 56 57 1874 1875 B-upper_bound
x 58 59 1876 1877 I-upper_bound
ULN 60 63 1878 1881 I-upper_bound
for 64 67 1882 1885 O
Gilbert 68 75 1886 1893 B-chronic_disease
's 75 77 1893 1895 I-chronic_disease
disease 78 85 1896 1903 I-chronic_disease

Uncontrolled 0 12 1904 1916 O
illness 13 20 1917 1924 B-chronic_disease
including 21 30 1925 1934 O
ongoing 31 38 1935 1942 O
or 39 41 1943 1945 O
active 42 48 1946 1952 O
infection 49 58 1953 1962 B-chronic_disease

Women 0 5 1963 1968 B-gender
of 6 8 1969 1971 O
child 9 14 1972 1977 O
bearing 15 22 1978 1985 O
potential 23 32 1986 1995 O
only 33 37 1996 2000 O
: 37 38 2000 2001 O
Negative 39 47 2002 2010 O
urine 48 53 2011 2016 O
or 54 56 2017 2019 O
serum 57 62 2020 2025 O
pregnancy 63 72 2026 2035 B-pregnancy
test 73 77 2036 2040 O

the 0 3 2041 2044 O
patient 4 11 2045 2052 O
, 11 12 2052 2053 O
family 13 19 2054 2060 O
member 20 26 2061 2067 O
and 27 30 2068 2071 O
transplant 31 41 2072 2082 B-treatment
staff 42 47 2083 2088 O
physician 48 57 2089 2098 O
( 58 59 2099 2100 O
physician 59 68 2100 2109 O
, 68 69 2109 2110 O
nurse 70 75 2111 2116 O
, 75 76 2116 2117 O
and 77 80 2118 2121 O
social 81 87 2122 2128 O
worker 88 94 2129 2135 O
) 94 95 2135 2136 O
meet 96 100 2137 2141 O
at 101 103 2142 2144 O
least 104 109 2145 2150 O
once 110 114 2151 2155 O
prior 115 120 2156 2161 O
to 121 123 2162 2164 O
starting 124 132 2165 2173 O
the 133 136 2174 2177 O
transplant 137 147 2178 2188 O
procedure 148 157 2189 2198 O

> 0 1 0 1 O
70 1 3 1 3 B-lower_bound
( 4 5 4 5 O
see 5 8 5 8 O
Appendix 9 17 9 17 O
A 18 19 18 19 O
) 19 20 19 20 O
within 21 27 21 27 O
two 28 31 28 31 B-upper_bound
weeks 32 37 32 37 I-upper_bound
of 38 40 38 40 O
enrollment 41 51 41 51 O

A 0 1 52 53 O
measure 2 9 54 61 O
of 10 12 62 64 O
general 13 20 65 72 O
well 21 25 73 77 O
being 26 31 78 83 O
and 32 35 84 87 O
activities 36 46 88 98 O
of 47 49 99 101 O
daily 50 55 102 107 O
living 56 62 108 114 O
; 62 63 114 115 O
scores 64 70 116 122 O
range 71 76 123 128 O
from 77 81 129 133 O
0 82 83 134 135 B-lower_bound
to 84 86 136 138 O
100 87 90 139 142 B-upper_bound
where 91 96 143 148 O
100 97 100 149 152 O
represents 101 111 153 163 O
perfect 112 119 164 171 O
health 120 126 172 178 O
) 126 127 178 179 O

Documented 0 10 180 190 O
evidence 11 19 191 199 O
of 20 22 200 202 O
distant 23 30 203 210 B-cancer
metastases 31 41 211 221 I-cancer

EBV 0 3 222 225 B-chronic_disease
( 4 5 226 227 O
+ 5 6 227 228 O
) 6 7 228 229 O
Nasopharyngeal 8 22 230 244 O
Carcinoma 23 32 245 254 O
in 33 35 255 257 O
the 36 39 258 261 O
protocol 40 48 262 270 O
treated 49 56 271 278 O
tumor 57 62 279 284 B-cancer

Estimated 0 9 285 294 B-clinical_variable
Creatinine 10 20 295 305 I-clinical_variable
clearance 21 30 306 315 I-clinical_variable
> 31 32 316 317 O
30cc 32 36 317 321 B-lower_bound
/ 36 37 321 322 I-lower_bound
min 37 40 322 325 I-lower_bound

HPV(+ 0 5 326 331 B-chronic_disease
) 5 6 331 332 O
or 7 9 333 335 O
p16(+ 10 15 336 341 O
) 15 16 341 342 O
locally 17 24 343 350 O
/ 24 25 350 351 O
regionally 25 35 351 361 O
advanced 36 44 362 370 O
( 45 46 371 372 B-cancer
T4 46 48 372 374 I-cancer
or 49 51 375 377 I-cancer
N3 52 54 378 380 I-cancer
) 54 55 380 381 I-cancer
oropharyngeal 56 69 382 395 I-cancer
cancer 70 76 396 402 I-cancer

HPV(‐ 0 5 403 408 B-chronic_disease
) 5 6 408 409 O
( 7 8 410 411 O
Human 8 13 411 416 B-chronic_disease
Papillomavirus 14 28 417 431 I-chronic_disease
) 28 29 431 432 O
or 30 32 433 435 O
p16(- 33 38 436 441 O
) 38 39 441 442 O
locally 40 47 443 450 O
/ 47 48 450 451 O
regionally 48 58 451 461 O
advanced 59 67 462 470 O
( 68 69 471 472 B-cancer
T3‐4 69 73 472 476 I-cancer
or 74 76 477 479 I-cancer
N2‐3 77 81 480 484 I-cancer
) 81 82 484 485 I-cancer
oropharyngeal 83 96 486 499 I-cancer
cancer 97 103 500 506 I-cancer

Locally 0 7 507 514 O
/ 7 8 514 515 O
regionally 8 18 515 525 O
advanced 19 27 526 534 O
( 28 29 535 536 O
stage 29 34 536 541 B-cancer
T3‐4 35 39 542 546 I-cancer
and/or 40 46 547 553 O
N3 47 49 554 556 B-cancer
) 49 50 556 557 O
nasopharyngeal 51 65 558 572 B-cancer
cancer 66 72 573 579 I-cancer
which 73 78 580 585 O
is 79 81 586 588 O
EBV 82 85 589 592 B-chronic_disease
( 86 87 593 594 I-chronic_disease
‐ 87 88 594 595 I-chronic_disease
) 88 89 595 596 I-chronic_disease
( 90 91 597 598 I-chronic_disease
Epstein‐Barr 91 103 598 610 I-chronic_disease
Virus 104 109 611 616 I-chronic_disease
) 109 110 616 617 I-chronic_disease

Patients 0 8 618 626 O
are 9 12 627 630 O
adults 13 19 631 637 O
( 20 21 638 639 O
Age 21 24 639 642 B-age
> 25 26 643 644 O
18 26 28 644 646 B-lower_bound
) 28 29 646 647 O

Patients 0 8 648 656 O
must 9 13 657 661 O
be 14 16 662 664 O
able 17 21 665 669 O
to 22 24 670 672 O
receive 25 32 673 680 O
protocol 33 41 681 689 O
chemotherapy 42 54 690 702 B-treatment
in 55 57 703 705 O
the 58 61 706 709 O
judgment 62 70 710 718 O
of 71 73 719 721 O
the 74 77 722 725 O
treating 78 86 726 734 O
Medical 87 94 735 742 O
Oncologist 95 105 743 753 O

Patients 0 8 754 762 O
should 9 15 763 769 O
have 16 20 770 774 O
no 21 23 775 777 O
contraindications 24 41 778 795 O
to 42 44 796 798 O
having 45 51 799 805 O
a 52 53 806 807 O
contrast 54 62 808 816 O
enhanced 63 71 817 825 O
MRI 72 75 826 829 B-treatment
scan 76 80 830 834 I-treatment

Patients 0 8 835 843 O
with 9 13 844 848 O
active 14 20 849 855 B-chronic_disease
infection 21 30 856 865 I-chronic_disease

Pregnant 0 8 866 874 B-pregnancy
women 9 14 875 880 B-gender

Pre‐treatment 0 13 881 894 B-treatment
laboratory 14 24 895 905 O
criteria 25 33 906 914 O
within 34 40 915 921 O
four 41 45 922 926 O
weeks 46 51 927 932 O
of 52 54 933 935 O
enrollment 55 65 936 946 O

Primary 0 7 947 954 B-cancer
tumor 8 13 955 960 I-cancer
( 14 15 961 962 I-cancer
T4 15 17 962 964 I-cancer
) 17 18 964 965 I-cancer
with 19 23 966 970 O
or 24 26 971 973 O
without 27 34 974 981 O
metastatic 35 45 982 992 B-cancer
lymph 46 51 993 998 I-cancer
nodes 52 57 999 1004 I-cancer

Prior 0 5 1005 1010 B-treatment
head 6 10 1011 1015 I-treatment
and 11 14 1016 1019 I-treatment
neck 15 19 1020 1024 I-treatment
radiation 20 29 1025 1034 I-treatment

Stage 0 5 1035 1040 B-lower_bound
III 6 9 1041 1044 I-lower_bound
/ 9 10 1044 1045 O
IV 10 12 1045 1047 B-lower_bound
oral 13 17 1048 1052 O
cavity 18 24 1053 1059 O
or 25 27 1060 1062 O
paranasal 28 37 1063 1072 B-cancer
sinus 38 43 1073 1078 I-cancer
cancers 44 51 1079 1086 I-cancer
in 52 54 1087 1089 O
patients 55 63 1090 1098 O
who 64 67 1099 1102 O
refuse 68 74 1103 1109 O
surgery 75 82 1110 1117 B-treatment
or 83 85 1118 1120 O
are 86 89 1121 1124 O
unfit 90 95 1125 1130 O
for 96 99 1131 1134 O
surgery 100 107 1135 1142 O

T3 0 2 1143 1145 B-cancer
or 3 5 1146 1148 O
T4 6 8 1149 1151 B-cancer
laryngeal 9 18 1152 1161 I-cancer
or 19 21 1162 1164 O
hypopharyngeal 22 36 1165 1179 B-cancer
cancer 37 43 1180 1186 I-cancer
that 44 48 1187 1191 O
is 49 51 1192 1194 O
locally 52 59 1195 1202 O
advanced 60 68 1203 1211 O

Total 0 5 1212 1217 O
Bilirubin 6 15 1218 1227 B-clinical_variable
< 16 17 1228 1229 O
1.5 18 21 1230 1233 B-upper_bound
X 22 23 1234 1235 I-upper_bound
ULN 24 27 1236 1239 I-upper_bound

bulky 0 5 1240 1245 B-clinical_variable
( 6 7 1246 1247 O
> 7 8 1247 1248 B-lower_bound
40 8 10 1248 1250 I-lower_bound
cc 11 13 1251 1253 I-lower_bound
* 13 14 1253 1254 O
) 14 15 1254 1255 O

non‐metastatic 0 14 1256 1270 B-cancer
locally 15 22 1271 1278 O
/ 22 23 1278 1279 O
regionally 23 33 1279 1289 O
advanced 34 42 1290 1298 B-cancer
squamous 43 51 1299 1307 I-cancer
cell 52 56 1308 1312 I-cancer
carcinoma 57 66 1313 1322 I-cancer
of 67 69 1323 1325 O
the 70 73 1326 1329 O
head 74 78 1330 1334 O
and 79 82 1335 1338 O
neck 83 87 1339 1343 O

patient 0 7 1344 1351 O
refuses 8 15 1352 1359 O
surgery 16 23 1360 1367 B-treatment
, 23 24 1367 1368 O
or 25 27 1369 1371 O
surgery 28 35 1372 1379 O
is 36 38 1380 1382 O
not 39 42 1383 1386 O
possible 43 51 1387 1395 O
due 52 55 1396 1399 O
to 56 58 1400 1402 O
comorbidities 59 72 1403 1416 O

referred 0 8 1417 1425 O
for 9 12 1426 1429 O
definitive 13 23 1430 1440 B-treatment
chemo‐RT 24 32 1441 1449 I-treatment

unresectable 0 12 1450 1462 O
, 12 13 1462 1463 O
or 14 16 1464 1466 O
patient 17 24 1467 1474 O
declines 25 33 1475 1483 O
surgery 34 41 1484 1491 B-treatment

A 0 1 0 1 O
positive 2 10 2 10 O
hepatitis 11 20 11 20 B-chronic_disease
B 21 22 21 22 I-chronic_disease
serology 23 31 23 31 O
indicative 32 42 32 42 O
of 43 45 43 45 O
previous 46 54 46 54 B-treatment
immunization 55 67 55 67 I-treatment
( 68 69 68 69 O
i.e. 69 73 69 73 O
, 73 74 73 74 O
hepatitis 75 84 75 84 O
B 85 86 85 86 O
surface 87 94 87 94 O
antibody 95 103 95 103 O
[ 104 105 104 105 O
HBsAb 105 110 105 110 O
] 110 111 110 111 O
positive 112 120 112 120 O
and 121 124 121 124 O
hepatitis 125 134 125 134 O
B 135 136 135 136 O
core 137 141 137 141 O
antibody 142 150 142 150 O
[ 151 152 151 152 O
HBcAb 152 157 152 157 O
] 157 158 157 158 O
negative 159 167 159 167 O
) 167 168 167 168 O
, 168 169 168 169 O
or 170 172 170 172 O
a 173 174 173 174 O
fully 175 180 175 180 O
resolved 181 189 181 189 O
acute 190 195 190 195 O
HBV 196 199 196 199 B-chronic_disease
infection 200 209 200 209 I-chronic_disease

AIDS 0 4 210 214 B-chronic_disease
- 4 5 214 215 O
related 5 12 215 222 O
non 13 16 223 226 B-cancer
- 16 17 226 227 I-cancer
Hodgkin 17 24 227 234 I-cancer
lymphoma 25 33 235 243 I-cancer
and 34 37 244 247 O
other 38 43 248 253 O
non 44 47 254 257 O
- 47 48 257 258 O
Hodgkin 48 55 258 265 O
lymphoma 56 64 266 274 O

Active 0 6 275 281 B-chronic_disease
tuberculosis 7 19 282 294 I-chronic_disease
( 20 21 295 296 I-chronic_disease
TB 21 23 296 298 I-chronic_disease
) 23 24 298 299 I-chronic_disease

Cirrhosis 0 9 300 309 B-chronic_disease
with 10 14 310 314 O
Child 15 20 315 320 O
- 20 21 320 321 O
Pugh 21 25 321 325 O
score 26 31 326 331 O
of 32 34 332 334 O
B 35 36 335 336 O
or 37 39 337 339 O
C 40 41 340 341 O

Clinical 0 8 342 350 O
evidence 9 17 351 359 O
of 18 20 360 362 O
vitiligo 21 29 363 371 B-chronic_disease
or 30 32 372 374 O
other 33 38 375 380 O
forms 39 44 381 386 O
of 45 47 387 389 O
depigmenting 48 60 390 402 O
illness 61 68 403 410 O

Extensive 0 9 411 420 O
active 10 16 421 427 O
brain 17 22 428 433 B-chronic_disease
disease 23 30 434 441 I-chronic_disease
including 31 40 442 451 O
symptomatic 41 52 452 463 O
brain 53 58 464 469 B-cancer
metastases 59 69 470 480 I-cancer
or 70 72 481 483 O
the 73 76 484 487 O
presence 77 85 488 496 O
of 86 88 497 499 O
leptomeningeal 89 103 500 514 B-cancer
disease 104 111 515 522 I-cancer
, 111 112 522 523 O
and 113 116 524 527 O
all 117 120 528 531 O
patients 121 129 532 540 O
with 130 134 541 545 O
infratentorial 135 149 546 560 B-cancer
tumors 150 156 561 567 I-cancer

Failed 0 6 568 574 O
standard 7 15 575 583 O
first 16 21 584 589 O
- 21 22 589 590 O
line 22 26 590 594 O
therapy 27 34 595 602 B-treatment

Grade 0 5 603 608 O
3 6 7 609 610 O
or 8 10 611 613 O
4 11 12 614 615 O
immune 13 19 616 622 O
related 20 27 623 630 O
toxicity 28 36 631 639 O
associated 37 47 640 650 O
with 48 52 651 655 O
prior 53 58 656 661 B-treatment
ipilimumab 59 69 662 672 I-treatment
therapy 70 77 673 680 I-treatment
that 78 82 681 685 O
has 83 86 686 689 O
not 87 90 690 693 O
resolved 91 99 694 702 O
to 100 102 703 705 O
grade 103 108 706 711 O
0 109 110 712 713 O
or 111 113 714 716 O
1 114 115 717 718 O

Mild 0 4 719 723 O
autoimmunity 5 17 724 736 O
not 18 21 737 740 O
impacting 22 31 741 750 O
the 32 35 751 754 O
function 36 44 755 763 O
of 45 47 764 766 O
major 48 53 767 772 O
organs 54 60 773 779 O
( 61 62 780 781 O
e.g. 62 66 781 785 O
, 66 67 785 786 O
limited 68 75 787 794 O
psoriasis 76 85 795 804 B-chronic_disease
) 85 86 804 805 O

Patients 0 8 806 814 O
who 9 12 815 818 O
are 13 16 819 822 O
receiving 17 26 823 832 O
any 27 30 833 836 O
other 31 36 837 842 O
investigational 37 52 843 858 B-treatment
agents 53 59 859 865 I-treatment
for 60 63 866 869 O
cancer 64 70 870 876 B-cancer

Patients 0 8 877 885 O
who 9 12 886 889 O
are 13 16 890 893 O
undergoing 17 27 894 904 O
first 28 33 905 910 O
month 34 39 911 916 O
of 40 42 917 919 O
therapy 43 50 920 927 B-treatment
( 51 52 928 929 O
RIPE 52 56 929 933 B-treatment
or 57 59 934 936 O
equivalent 60 70 937 947 O
) 70 71 947 948 O
for 72 75 949 952 O
active 76 82 953 959 O
TB 83 85 960 962 B-chronic_disease

Patients 0 8 963 971 O
who 9 12 972 975 O
have 13 17 976 980 O
been 18 22 981 985 O
successfully 23 35 986 998 O
treated 36 43 999 1006 O
for 44 47 1007 1010 O
HCV 48 51 1011 1014 B-chronic_disease
as 52 54 1015 1017 O
long 55 59 1018 1022 O
as 60 62 1023 1025 O
therapy 63 70 1026 1033 B-treatment
for 71 74 1034 1037 O
HCV 75 78 1038 1041 O
has 79 82 1042 1045 O
been 83 87 1046 1050 O
completed 88 97 1051 1060 O

Patients 0 8 1061 1069 O
with 9 13 1070 1074 O
TB 14 16 1075 1077 B-chronic_disease
immune 17 23 1078 1084 I-chronic_disease
reconstitution 24 38 1085 1099 I-chronic_disease
syndrome 39 47 1100 1108 I-chronic_disease
( 48 49 1109 1110 O
IRIS 49 53 1110 1114 O
) 53 54 1114 1115 O
requiring 55 64 1116 1125 O
corticosteroids 65 80 1126 1141 B-treatment

Patients 0 8 1142 1150 O
with 9 13 1151 1155 O
chronic 14 21 1156 1163 O
HBV 22 25 1164 1167 B-chronic_disease
suppressed 26 36 1168 1178 O
by 37 39 1179 1181 O
appropriate 40 51 1182 1193 O
antiretroviral 52 66 1194 1208 B-treatment
therapy 67 74 1209 1216 I-treatment
with 75 79 1217 1221 O
activity 80 88 1222 1230 O
against 89 96 1231 1238 O
HBV 97 100 1239 1242 O
, 100 101 1242 1243 O
as 102 104 1244 1246 O
outlined 105 113 1247 1255 O
in 114 116 1256 1258 O
DHHS 117 121 1259 1263 O
guidelines 122 132 1264 1274 O

Positive 0 8 1275 1283 O
HCV 9 12 1284 1287 B-chronic_disease
serology 13 21 1288 1296 O
but 22 25 1297 1300 O
no 26 28 1301 1303 O
detectable 29 39 1304 1314 O
HCV 40 43 1315 1318 O
RNA 44 47 1319 1322 O
, 47 48 1322 1323 O
indicative 49 59 1324 1334 O
of 60 62 1335 1337 O
spontaneously 63 76 1338 1351 O
cleared 77 84 1352 1359 O
HCV 85 88 1360 1363 B-chronic_disease
infection 89 98 1364 1373 I-chronic_disease

The 0 3 1374 1377 O
presence 4 12 1378 1386 O
of 13 15 1387 1389 O
laboratory 16 26 1390 1400 O
evidence 27 35 1401 1409 O
of 36 38 1410 1412 O
autoimmune 39 49 1413 1423 B-chronic_disease
disease 50 57 1424 1431 I-chronic_disease
( 58 59 1432 1433 O
e.g. 59 63 1433 1437 O
, 63 64 1437 1438 O
positive 65 73 1439 1447 O
antinuclear 74 85 1448 1459 O
antibody 86 94 1460 1468 O
[ 95 96 1469 1470 O
ANA 96 99 1470 1473 O
] 99 100 1473 1474 O
titer 101 106 1475 1480 O
or 107 109 1481 1483 O
lupus 110 115 1484 1489 B-chronic_disease
anticoagulant 116 129 1490 1503 O
) 129 130 1503 1504 O
without 131 138 1505 1512 O
associated 139 149 1513 1523 O
symptoms 150 158 1524 1532 O

Uncontrolled 0 12 1533 1545 O
hepatitis 13 22 1546 1555 B-chronic_disease
B 23 24 1556 1557 I-chronic_disease
virus 25 30 1558 1563 I-chronic_disease
( 31 32 1564 1565 I-chronic_disease
HBV 32 35 1565 1568 I-chronic_disease
) 35 36 1568 1569 I-chronic_disease
infection 37 46 1570 1579 I-chronic_disease
, 46 47 1579 1580 O
defined 48 55 1581 1588 O
as 56 58 1589 1591 O
plasma 59 65 1592 1598 O
HBV 66 69 1599 1602 O
DNA 70 73 1603 1606 O
detectable 74 84 1607 1617 O
by 85 87 1618 1620 O
polymerase 88 98 1621 1631 O
chain 99 104 1632 1637 O
reaction 105 113 1638 1646 O
( 114 115 1647 1648 O
PCR 115 118 1648 1651 O
) 118 119 1651 1652 O

Uncontrolled 0 12 1653 1665 O
hepatitis 13 22 1666 1675 B-chronic_disease
C 23 24 1676 1677 I-chronic_disease
virus 25 30 1678 1683 O
( 31 32 1684 1685 O
HCV 32 35 1685 1688 B-chronic_disease
) 35 36 1688 1689 O
infection 37 46 1690 1699 O
, 46 47 1699 1700 O
defined 48 55 1701 1708 O
as 56 58 1709 1711 O
plasma 59 65 1712 1718 O
HCV 66 69 1719 1722 O
RNA 70 73 1723 1726 O
detectable 74 84 1727 1737 O
by 85 87 1738 1740 O
PCR 88 91 1741 1744 O

active 0 6 1745 1751 O
angina 7 13 1752 1758 B-chronic_disease
pectoris 14 22 1759 1767 I-chronic_disease

congestive 0 10 1768 1778 B-chronic_disease
heart 11 16 1779 1784 I-chronic_disease
failure 17 24 1785 1792 I-chronic_disease
( 25 26 1793 1794 O
New 26 29 1794 1797 B-clinical_variable
York 30 34 1798 1802 I-clinical_variable
Heart 35 40 1803 1808 I-clinical_variable
Association 41 52 1809 1820 I-clinical_variable
class 53 58 1821 1826 I-clinical_variable
III 59 62 1827 1830 B-lower_bound
or 63 65 1831 1833 O
IV 66 68 1834 1836 B-upper_bound
) 68 69 1836 1837 O

patients 0 8 1838 1846 O
who 9 12 1847 1850 O
are 13 16 1851 1854 O
receiving 17 26 1855 1864 O
therapy 27 34 1865 1872 B-treatment
beyond 35 41 1873 1879 O
month 42 47 1880 1885 B-lower_bound
one 48 51 1886 1889 I-lower_bound
of 52 54 1890 1892 O
initial 55 62 1893 1900 B-treatment
therapy 63 70 1901 1908 I-treatment
with 71 75 1909 1913 O
no 76 78 1914 1916 O
evidence 79 87 1917 1925 O
of 88 90 1926 1928 O
TB 91 93 1929 1931 B-chronic_disease
IRIS 94 98 1932 1936 I-chronic_disease
requiring 99 108 1937 1946 O
corticosteroid 109 123 1947 1961 B-treatment
therapy 124 131 1962 1969 I-treatment
, 131 132 1969 1970 O
or 133 135 1971 1973 O
those 136 141 1974 1979 O
receiving 142 151 1980 1989 O
treatment 152 161 1990 1999 B-treatment
for 162 165 2000 2003 O
latent 166 172 2004 2010 B-chronic_disease
tuberculosis 173 185 2011 2023 I-chronic_disease
( 186 187 2024 2025 O
INH 187 190 2025 2028 O
or 191 193 2029 2031 O
alternative 194 205 2032 2043 O
) 205 206 2043 2044 O
may 207 210 2045 2048 O
be 211 213 2049 2051 O
eligible 214 222 2052 2060 O
after 223 228 2061 2066 O
discussion 229 239 2067 2077 O
with 240 244 2078 2082 O
the 245 248 2083 2086 O
protocol 249 257 2087 2095 O
P.I 258 261 2096 2099 O

recent 0 6 2100 2106 O
myocardial 7 17 2107 2117 B-chronic_disease
infarction 18 28 2118 2128 I-chronic_disease
( 29 30 2129 2130 O
within 30 36 2130 2136 O
the 37 40 2137 2140 O
last 41 45 2141 2145 B-upper_bound
6 46 47 2146 2147 I-upper_bound
months 48 54 2148 2154 I-upper_bound
) 54 55 2154 2155 O

< 0 1 0 1 O
18 1 3 1 3 B-upper_bound
years 4 9 4 9 I-upper_bound
old 10 13 10 13 O

breastfeeding 0 13 14 27 O
( 14 15 28 29 O
n.b 15 18 29 32 O
: 18 19 32 33 O
pregnancy 20 29 34 43 B-pregnancy
status 30 36 44 50 O
will 37 41 51 55 O
continue 42 50 56 64 O
to 51 53 65 67 O
be 54 56 68 70 O
evaluated 57 66 71 80 O
throughout 67 77 81 91 O
the 78 81 92 95 O
study 82 87 96 101 O
at 88 90 102 104 O
each 91 95 105 109 O
visit 96 101 110 115 O
) 101 102 115 116 O

currently 0 9 117 126 B-pregnancy
pregnant 10 18 127 135 I-pregnancy

history 0 7 136 143 O
of 8 10 144 146 O
cardiac 11 18 147 154 B-chronic_disease
event 19 24 155 160 I-chronic_disease
or 25 27 161 163 I-chronic_disease
distress 28 36 164 172 I-chronic_disease
within 37 43 173 179 O
the 44 47 180 183 O
past 48 52 184 188 B-upper_bound
3 53 54 189 190 I-upper_bound
months 55 61 191 197 I-upper_bound

never 0 5 198 203 O
purchased 6 15 204 213 O
or 16 18 214 216 O
regularly 19 28 217 226 O
used 29 33 227 231 O
a 34 35 232 233 O
tank 36 40 234 238 O
system 41 47 239 245 O
, 47 48 245 246 O
mechanical 49 59 247 257 O
mod 60 63 258 261 O
, 63 64 261 262 O
or 65 67 263 265 O
advanced 68 76 266 274 O
personal 77 85 275 283 O
vaporizer 86 95 284 293 O
EC 96 98 294 296 O
, 98 99 296 297 O
though 100 106 298 304 O
previous 107 115 305 313 O
use 116 119 314 317 O
of 120 122 318 320 O
cig 123 126 321 324 O
- 126 127 324 325 O
a 127 128 325 326 O
- 128 129 326 327 O
like 129 133 327 331 O
devices 134 141 332 339 O
will 142 146 340 344 O
be 147 149 345 347 O
allowed 150 157 348 355 O
but 158 161 356 359 O
not 162 165 360 363 O
in 166 168 364 366 O
the 169 172 367 370 O
last 173 177 371 375 B-upper_bound
3 178 179 376 377 I-upper_bound
months 180 186 378 384 I-upper_bound

no 0 2 385 387 O
quit 3 7 388 392 O
attempt 8 15 393 400 O
in 16 18 401 403 O
the 19 22 404 407 O
prior 23 28 408 413 B-upper_bound
3 29 30 414 415 I-upper_bound
months 31 37 416 422 I-upper_bound
and 38 41 423 426 O
no 42 44 427 429 O
plan 45 49 430 434 O
to 50 52 435 437 O
quit 53 57 438 442 O
in 58 60 443 445 O
the 61 64 446 449 O
next 65 69 450 454 B-upper_bound
3 70 71 455 456 I-upper_bound
months 72 78 457 463 I-upper_bound

planning 0 8 464 472 B-pregnancy
to 9 11 473 475 I-pregnancy
become 12 18 476 482 I-pregnancy
pregnant 19 27 483 491 I-pregnancy

speak 0 5 492 497 B-language_fluency
in 6 8 498 500 I-language_fluency
English 9 16 501 508 I-language_fluency

unstable 0 8 509 517 O
or 9 11 518 520 O
significant 12 23 521 532 O
medical 24 31 533 540 O
condition 32 41 541 550 O
such 42 46 551 555 O
as 47 49 556 558 O
respiratory 50 61 559 570 B-chronic_disease
, 61 62 570 571 O
kidney 63 69 572 578 B-chronic_disease
, 69 70 578 579 O
or 71 73 580 582 O
liver 74 79 583 588 B-chronic_disease
disease 80 87 589 596 I-chronic_disease
that 88 92 597 601 O
could 93 98 602 607 O
potentially 99 110 608 619 O
affect 111 117 620 626 O
biomarker 118 127 627 636 O
data 128 132 637 641 O

unstable 0 8 642 650 O
or 9 11 651 653 O
significant 12 23 654 665 O
psychiatric 24 35 666 677 B-chronic_disease
conditions 36 46 678 688 I-chronic_disease
( 47 48 689 690 O
past 48 52 690 694 O
and 53 56 695 698 O
stable 57 63 699 705 O
conditions 64 74 706 716 O
will 75 79 717 721 O
be 80 82 722 724 O
allowed 83 90 725 732 O
) 90 91 732 733 O

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
a 13 14 13 14 O
solid 15 20 15 20 O
extra 21 26 21 26 B-cancer
- 26 27 26 27 I-cancer
cranial 27 34 27 34 I-cancer
tumor 35 40 35 40 I-cancer
like 41 45 41 45 O
malignant 46 55 46 55 B-cancer
lymphoma 56 64 56 64 I-cancer
or 65 67 65 67 O
malignant 68 77 68 77 B-cancer
sarcoma 78 85 78 85 I-cancer

Hemosiderosis 0 13 86 99 B-chronic_disease
/ 13 14 99 100 O
hemochromatosis 14 29 100 115 B-chronic_disease
( 30 31 116 117 O
patients 31 39 117 125 O
can 40 43 126 129 O
still 44 49 130 135 O
be 50 52 136 138 O
included 53 61 139 147 O
in 62 64 148 150 O
2nd 65 68 151 154 O
branch 69 75 155 161 O
without 76 83 162 169 O
ferumoxytol 84 95 170 181 B-treatment
) 95 96 181 182 O

Pregnant 0 8 183 191 B-pregnancy
women 9 14 192 197 B-gender

Pt 0 2 198 200 O
with 3 7 201 205 O
iron 8 12 206 210 O
- 12 13 210 211 O
overload 13 21 211 219 O
will 22 26 220 224 O
not 27 30 225 228 O
receive 31 38 229 236 O
Ferumoxytol 39 50 237 248 B-treatment

Scheduled 0 9 249 258 O
for 10 13 259 262 O
or 14 16 263 265 O
completed 17 26 266 275 O
a 27 28 276 277 O
18F 29 32 278 281 B-treatment
- 32 33 281 282 I-treatment
FDG 33 36 282 285 I-treatment
- 36 37 285 286 I-treatment
PET 37 40 286 289 I-treatment
or 41 43 290 292 I-treatment
18F 44 47 293 296 I-treatment
- 47 48 296 297 I-treatment
FDG 48 51 297 300 I-treatment
- 51 52 300 301 I-treatment
PET 52 55 301 304 I-treatment
/ 55 56 304 305 I-treatment
CT 56 58 305 307 I-treatment
tumor 59 64 308 313 I-treatment
staging 65 72 314 321 I-treatment
procedure 73 82 322 331 I-treatment

Very 0 4 332 336 O
young 5 10 337 342 O
children 11 19 343 351 O
who 20 23 352 355 O
need 24 28 356 360 O
sedation 29 37 361 369 B-treatment
or 38 40 370 372 O
anesthesia 41 51 373 383 B-treatment

need 0 4 384 388 O
of 5 7 389 391 O
sedation 8 16 392 400 B-treatment
or 17 19 401 403 O
claustrophobia 20 34 404 418 B-chronic_disease

patients 0 8 419 427 O
with 9 13 428 432 O
a 14 15 433 434 O
positive 16 24 435 443 O
history 25 32 444 451 O
of 33 35 452 454 O
allergic 36 44 455 463 O
reaction 45 53 464 472 O
to 54 56 473 475 O
iron 57 61 476 480 B-allergy_name
compounds 62 71 481 490 I-allergy_name
or 72 74 491 493 O
other 75 80 494 499 O
severe 81 87 500 506 O
allergic 88 96 507 515 O
reactions 97 106 516 525 O

Any 0 3 0 3 O
other 4 9 4 9 O
medical 10 17 10 17 B-chronic_disease
condition 18 27 18 27 I-chronic_disease
that 28 32 28 32 O
, 32 33 32 33 O
in 34 36 34 36 O
the 37 40 37 40 O
opinion 41 48 41 48 O
of 49 51 49 51 O
the 52 55 52 55 O
investigator 56 68 56 68 O
, 68 69 68 69 O
might 70 75 70 75 O
interfere 76 85 76 85 O
with 86 90 86 90 O
the 91 94 91 94 O
patient 95 102 95 102 O
's 102 104 102 104 O
participation 105 118 105 118 O
in 119 121 119 121 O
the 122 125 122 125 O
study 126 131 126 131 O
, 131 132 131 132 O
poses 133 138 133 138 O
an 139 141 139 141 O
added 142 147 142 147 O
risk 148 152 148 152 O
for 153 156 153 156 O
the 157 160 157 160 O
patient 161 168 161 168 O
, 168 169 168 169 O
or 170 172 170 172 O
confound 173 181 173 181 O
the 182 185 182 185 O
assessment 186 196 186 196 O
of 197 199 197 199 O
the 200 203 200 203 O
patient 204 211 204 211 O

Any 0 3 212 215 O
systemic 4 12 216 224 B-chronic_disease
bacterial 13 22 225 234 I-chronic_disease
or 23 25 235 237 O
other 26 31 238 243 O
infection 32 41 244 253 B-chronic_disease
, 41 42 253 254 O
which 43 48 255 260 O
is 49 51 261 263 O
clinically 52 62 264 274 O
significant 63 74 275 286 O
in 75 77 287 289 O
the 78 81 290 293 O
opinion 82 89 294 301 O
of 90 92 302 304 O
the 93 96 305 308 O
investigator 97 109 309 321 O
and 110 113 322 325 O
has 114 117 326 329 O
not 118 121 330 333 O
been 122 126 334 338 O
treated 127 134 339 346 O
with 135 139 347 351 O
appropriate 140 151 352 363 O
antibiotics 152 163 364 375 B-treatment

Body 0 4 376 380 O
weight 5 11 381 387 B-clinical_variable
≥10 12 15 388 391 O
kg 16 18 392 394 I-lower_bound

CMS 0 3 395 398 O
subtype 4 11 399 406 O
diagnosis 12 21 407 416 O
of 22 24 417 419 O
acetylcholinesterase 25 45 420 440 B-chronic_disease
deficiency 46 56 441 451 I-chronic_disease
, 56 57 451 452 O
slow 58 62 453 457 B-chronic_disease
- 62 63 457 458 I-chronic_disease
channel 63 70 458 465 I-chronic_disease
syndrome 71 79 466 474 I-chronic_disease
, 79 80 474 475 O
LRP4 81 85 476 480 B-chronic_disease
deficiency 86 96 481 491 I-chronic_disease
, 96 97 491 492 O
and 98 101 493 496 O
plectin 102 109 497 504 B-chronic_disease
deficiency 110 120 505 515 I-chronic_disease

Cardiac 0 7 516 523 B-chronic_disease
conduction 8 18 524 534 I-chronic_disease
defects 19 26 535 542 I-chronic_disease
on 27 29 543 545 O
Screening 30 39 546 555 O
ECG 40 43 556 559 B-treatment

Female 0 6 560 566 B-gender
patients 7 15 567 575 I-gender
of 16 18 576 578 O
childbearing 19 31 579 591 O
potential 32 41 592 601 O
must 42 46 602 606 O
have 47 51 607 611 O
a 52 53 612 613 O
negative 54 62 614 622 B-pregnancy
pregnancy 63 72 623 632 I-pregnancy
test 73 77 633 637 O
( 78 79 638 639 O
serum 79 84 639 644 O
human 85 90 645 650 O
chorionic 91 100 651 660 O
gonadotropin 101 113 661 673 O
[ 114 115 674 675 O
HCG 115 118 675 678 O
] 118 119 678 679 O
at 120 122 680 682 O
Screening 123 132 683 692 O
) 132 133 692 693 O

Genetically 0 11 694 705 O
- 11 12 705 706 O
confirmed 12 21 706 715 O
CMS 22 25 716 719 B-chronic_disease
involving 26 35 720 729 O
acetylcholine 36 49 730 743 B-chronic_disease
receptor 50 58 744 752 I-chronic_disease
defect 59 65 753 759 I-chronic_disease
, 65 66 759 760 O
Rapsyn 67 73 761 767 B-chronic_disease
deficiency 74 84 768 778 I-chronic_disease
, 84 85 778 779 O
MuSK 86 90 780 784 B-chronic_disease
deficiency 91 101 785 795 I-chronic_disease
, 101 102 795 796 O
Dok-7 103 108 797 802 B-chronic_disease
deficiency 109 119 803 813 I-chronic_disease
, 119 120 813 814 O
SYT2 121 125 815 819 B-chronic_disease
deficiency 126 136 820 830 I-chronic_disease
, 136 137 830 831 O
SNAP25B 137 144 831 838 B-chronic_disease
deficiency 145 155 839 849 I-chronic_disease
, 155 156 849 850 O
and 157 160 851 854 O
fast 161 165 855 859 B-chronic_disease
channel 166 173 860 867 I-chronic_disease
syndrome 174 182 868 876 I-chronic_disease

History 0 7 877 884 O
of 8 10 885 887 O
drug 11 15 888 892 O
allergy 16 23 893 900 O
to 24 26 901 903 O
any 27 30 904 907 O
pyridine 31 39 908 916 B-allergy_name
- 39 40 916 917 I-allergy_name
containing 40 50 917 927 I-allergy_name
substances 51 61 928 938 I-allergy_name
or 62 64 939 941 O
any 65 68 942 945 O
amifampridine 69 82 946 959 B-allergy_name
phosphate 83 92 960 969 I-allergy_name
excipient(s 93 104 970 981 O
) 104 105 981 982 O

In 0 2 983 985 O
patients 3 11 986 994 O
naïve 12 17 995 1000 O
to 18 20 1001 1003 O
3,4 21 24 1004 1007 B-treatment
- 24 25 1007 1008 I-treatment
DAP 25 28 1008 1011 I-treatment
or 29 31 1012 1014 O
amifampridine 32 45 1015 1028 B-treatment
phosphate 46 55 1029 1038 I-treatment
, 55 56 1038 1039 O
improvement 57 68 1040 1051 O
of 69 71 1052 1054 O
> 72 73 1055 1056 O
20 73 75 1056 1058 B-lower_bound
% 75 76 1058 1059 I-lower_bound
in 77 79 1060 1062 O
MFM20 80 85 1063 1068 B-clinical_variable
or 86 88 1069 1071 I-clinical_variable
MFM32 89 94 1072 1077 I-clinical_variable
scores 95 101 1078 1084 I-clinical_variable
after 102 107 1085 1090 O
open 108 112 1091 1095 O
label 113 118 1096 1101 O
period 119 125 1102 1108 O
of 126 128 1109 1111 O
up 129 131 1112 1114 O
titration 132 141 1115 1124 O
of 142 144 1125 1127 O
dose 145 149 1128 1132 O

In 0 2 1133 1135 O
patients 3 11 1136 1144 O
previously 12 22 1145 1155 O
stabilized 23 33 1156 1166 O
on 34 36 1167 1169 O
3,4 37 40 1170 1173 B-treatment
- 40 41 1173 1174 I-treatment
DAP 41 44 1174 1177 I-treatment
or 45 47 1178 1180 I-treatment
amifampridine 48 61 1181 1194 I-treatment
phosphate 62 71 1195 1204 I-treatment
, 71 72 1204 1205 O
history 73 80 1206 1213 O
of 81 83 1214 1216 O
meaningful 84 94 1217 1227 O
improvement 95 106 1228 1239 O
in 107 109 1240 1242 O
motor 110 115 1243 1248 O
function 116 124 1249 1257 O
( 125 126 1258 1259 O
in 126 128 1259 1261 O
opinion 129 136 1262 1269 O
of 137 139 1270 1272 O
investigator 140 152 1273 1285 O
) 152 153 1285 1286 O

MFM 0 3 1287 1290 B-clinical_variable
20 4 6 1291 1293 O
or 7 9 1294 1296 O
32 10 12 1297 1299 O
score 13 18 1300 1305 O
equal 19 24 1306 1311 O
or 25 27 1312 1314 O
less 28 32 1315 1319 O
than 33 37 1320 1324 O
48 38 40 1325 1327 B-lower_bound
or 41 43 1328 1330 O
76 44 46 1331 1333 B-lower_bound
, 46 47 1333 1334 O
respectively 48 60 1335 1347 O
, 60 61 1347 1348 O
at 62 64 1349 1351 O
Screening 65 74 1352 1361 O

Male 0 4 1362 1366 B-gender

Pregnancy 0 9 1367 1376 B-pregnancy

Seizure 0 7 1377 1384 B-chronic_disease
disorder 8 16 1385 1393 I-chronic_disease

Treatment 0 9 1394 1403 B-treatment
with 10 14 1404 1408 I-treatment
an 15 17 1409 1411 I-treatment
investigational 18 33 1412 1427 I-treatment
drug 34 38 1428 1432 I-treatment
( 39 40 1433 1434 O
other 40 45 1434 1439 O
than 46 50 1440 1444 O
amifampridine 51 64 1445 1458 B-treatment
phosphate 65 74 1459 1468 I-treatment
) 74 75 1468 1469 O
, 75 76 1469 1470 O
device 77 83 1471 1477 B-treatment
, 83 84 1477 1478 O
or 85 87 1479 1481 O
biological 88 98 1482 1492 B-treatment
agent 99 104 1493 1498 I-treatment
within 105 111 1499 1505 O
30 112 114 1506 1508 B-upper_bound
days 115 119 1509 1513 I-upper_bound
before 120 126 1514 1520 O
Screening 127 136 1521 1530 O
or 137 139 1531 1533 O
while 140 145 1534 1539 O
participating 146 159 1540 1553 O
in 160 162 1554 1556 O
this 163 167 1557 1561 O
study 168 173 1562 1567 O

Willingness 0 11 1568 1579 O
of 12 14 1580 1582 O
patients 15 23 1583 1591 O
receiving 24 33 1592 1601 O
pyridostigmine 34 48 1602 1616 B-treatment
, 48 49 1616 1617 O
prednisone 50 60 1618 1628 B-treatment
, 60 61 1628 1629 O
albuterol 62 71 1630 1639 B-treatment
, 71 72 1639 1640 O
ephedrine 73 82 1641 1650 B-treatment
, 82 83 1650 1651 O
or 84 86 1652 1654 O
fluoxetine 87 97 1655 1665 B-treatment
to 98 100 1666 1668 O
remain 101 107 1669 1675 O
on 108 110 1676 1678 O
a 111 112 1679 1680 O
stable 113 119 1681 1687 O
dose 120 124 1688 1692 O
of 125 127 1693 1695 O
these 128 133 1696 1701 O
medications 134 145 1702 1713 B-treatment
throughout 146 156 1714 1724 O
the 157 160 1725 1728 O
study 161 166 1729 1734 O
interval 167 175 1735 1743 O

age 0 3 1744 1747 B-age
2 4 5 1748 1749 B-lower_bound
and 6 9 1750 1753 O
above 10 15 1754 1759 O

female 0 6 1760 1766 B-gender

must 0 4 1767 1771 O
practice 5 13 1772 1780 B-contraception_consent
effective 14 23 1781 1790 I-contraception_consent
, 23 24 1790 1791 I-contraception_consent
reliable 25 33 1792 1800 I-contraception_consent
contraceptive 34 47 1801 1814 I-contraception_consent
regimen 48 55 1815 1822 I-contraception_consent
during 56 62 1823 1829 O
the 63 66 1830 1833 O
study 67 72 1834 1839 O

planning 0 8 1840 1848 O
to 9 11 1849 1851 O
become 12 18 1852 1858 O
pregnant 19 27 1859 1867 B-pregnancy
at 28 30 1868 1870 O
any 31 34 1871 1874 O
time 35 39 1875 1879 O
during 40 46 1880 1886 O
the 47 50 1887 1890 O
study 51 56 1891 1896 O

Active 0 6 0 6 B-chronic_disease
and 7 10 7 10 I-chronic_disease
uncontrolled 11 23 11 23 I-chronic_disease
infections 24 34 24 34 I-chronic_disease
will 35 39 35 39 O
cause 40 45 40 45 O
patients 46 54 46 54 O
to 55 57 55 57 O
be 58 60 58 60 O
excluded 61 69 61 69 O

All 0 3 70 73 O
allograft 4 13 74 83 O
patients 14 22 84 92 O
> 23 24 93 94 O
2 25 26 95 96 B-lower_bound
years 27 32 97 102 I-lower_bound
of 33 35 103 105 O
age 36 39 106 109 B-age

Children 0 8 110 118 O
less 9 13 119 123 O
than 14 18 124 128 O
2 19 20 129 130 B-upper_bound
years 21 26 131 136 I-upper_bound
of 27 29 137 139 O
age 30 33 140 143 B-age
will 34 38 144 148 O
be 39 41 149 151 O
excluded 42 50 152 160 O
due 51 54 161 164 O
to 55 57 165 167 O
increased 58 67 168 177 O
hepatotoxicity 68 82 178 192 B-chronic_disease
from 83 87 193 197 O
valproic 88 96 198 206 B-treatment
acid 97 101 207 211 I-treatment
in 102 104 212 214 O
this 105 109 215 219 O
age 110 113 220 223 O
group 114 119 224 229 O

Karnofsky 0 9 230 239 B-clinical_variable
score 10 15 240 245 I-clinical_variable
greater 16 23 246 253 O
than 24 28 254 258 O
or 29 31 259 261 O
equal 32 37 262 267 O
to 38 40 268 270 O
70 41 43 271 273 B-lower_bound
% 43 44 273 274 I-lower_bound
or 45 47 275 277 O
Performance 48 59 278 289 B-clinical_variable
status 60 66 290 296 I-clinical_variable
of 67 69 297 299 O
< 70 71 300 301 O
or 72 74 302 304 O
= 75 76 305 306 O
2 77 78 307 308 B-upper_bound
by 79 81 309 311 O
the 82 85 312 315 O
Eastern 86 93 316 323 B-clinical_variable
Cooperative 94 105 324 335 I-clinical_variable
Oncology 106 114 336 344 I-clinical_variable
Group 115 120 345 350 I-clinical_variable
( 121 122 351 352 I-clinical_variable
ECOG 122 126 352 356 I-clinical_variable
) 126 127 356 357 I-clinical_variable
scale 128 133 358 363 I-clinical_variable

Low 0 3 364 367 O
risk 4 8 368 372 O
AML 9 12 373 376 B-cancer
in 13 15 377 379 O
complete 16 24 380 388 O
remission 25 34 389 398 O
1 35 36 399 400 O
, 36 37 400 401 O
will 38 42 402 406 O
not 43 46 407 410 O
be 47 49 411 413 O
candidates 50 60 414 424 O
for 61 64 425 428 O
this 65 69 429 433 O
study 70 75 434 439 O

Patients 0 8 440 448 O
already 9 16 449 456 O
receiving 17 26 457 466 O
valproic 27 35 467 475 B-treatment
acid 36 40 476 480 I-treatment
or 41 43 481 483 O
receiving 44 53 484 493 O
other 54 59 494 499 O
anticonvulsants 60 75 500 515 B-treatment
will 76 80 516 520 O
be 81 83 521 523 O
excluded 84 92 524 532 O

Patients 0 8 533 541 O
must 9 13 542 546 O
have 14 18 547 551 O
undergone 19 28 552 561 O
allogeneic 29 39 562 572 B-treatment
stem 40 44 573 577 I-treatment
cell 45 49 578 582 I-treatment
transplant 50 60 583 593 I-treatment
within 61 67 594 600 O
40 68 70 601 603 B-lower_bound
- 70 71 603 604 O
60 71 73 604 606 B-upper_bound
days 74 78 607 611 I-upper_bound
before 79 85 612 618 O
starting 86 94 619 627 O
treatment 95 104 628 637 B-treatment
and 105 108 638 641 O
be 109 111 642 644 O
self 112 116 645 649 O
- 116 117 649 650 O
sufficient 117 127 650 660 O
in 128 130 661 663 O
caloric 131 138 664 671 O
intake 139 145 672 678 O
along 146 151 679 684 O
with 152 156 685 689 O
no 157 159 690 692 O
active 160 166 693 699 O
graft 167 172 700 705 B-chronic_disease
vs. 173 176 706 709 I-chronic_disease
host 177 181 710 714 I-chronic_disease
disease 182 189 715 722 I-chronic_disease

Patients 0 8 723 731 O
with 9 13 732 736 O
an 14 16 737 739 O
absolute 17 25 740 748 B-clinical_variable
neutrophil 26 36 749 759 I-clinical_variable
count 37 42 760 765 I-clinical_variable
less 43 47 766 770 O
than 48 52 771 775 O
1500 53 57 776 780 B-upper_bound
will 58 62 781 785 O
be 63 65 786 788 O
excluded 66 74 789 797 O

Patients 0 8 798 806 O
with 9 13 807 811 O
platelets 14 23 812 821 B-clinical_variable
less 24 28 822 826 O
than 29 33 827 831 O
50,000 34 40 832 838 B-upper_bound
will 41 45 839 843 O
be 46 48 844 846 O
excluded 49 57 847 855 O

Patients 0 8 856 864 O
with 9 13 865 869 O
refractory 14 24 870 880 O
or 25 27 881 883 O
relapsed 28 36 884 892 O
: 36 37 892 893 O
acute 38 43 894 899 B-cancer
myelogenous 44 55 900 911 I-cancer
leukemia 56 64 912 920 I-cancer
( 65 66 921 922 I-cancer
AML 66 69 922 925 I-cancer
) 69 70 925 926 I-cancer
( 71 72 927 928 O
including 72 81 928 937 O
inv16 82 87 938 943 O
, 87 88 943 944 O
t(8;21 89 95 945 951 O
) 95 96 951 952 O
or 97 99 953 955 O
t(15;17 100 107 956 963 O
) 107 108 963 964 O
) 108 109 964 965 O
or 110 112 966 968 O
high 113 117 969 973 B-cancer
risk 118 122 974 978 I-cancer
myelodysplastic 123 138 979 994 I-cancer
syndrome 139 147 995 1003 I-cancer
( 148 149 1004 1005 I-cancer
MDS 149 152 1005 1008 I-cancer
) 152 153 1008 1009 I-cancer

bilirubin 0 9 1010 1019 B-clinical_variable
of 10 12 1020 1022 O
< 13 14 1023 1024 O
2mg 15 18 1025 1028 B-upper_bound
/ 18 19 1028 1029 I-upper_bound
dL 19 21 1029 1031 I-upper_bound
, 21 22 1031 1032 O
serum 23 28 1033 1038 B-clinical_variable
glutamate 29 38 1039 1048 I-clinical_variable
pyruvate 39 47 1049 1057 I-clinical_variable
transaminase 48 60 1058 1070 I-clinical_variable
< 61 62 1071 1072 O
3 63 64 1073 1074 B-upper_bound
* 65 66 1075 1076 I-upper_bound
ULN 67 70 1077 1080 I-upper_bound

creatinine 0 10 1081 1091 B-clinical_variable
< 11 12 1092 1093 O
2mg 13 16 1094 1097 B-upper_bound
/ 16 17 1097 1098 I-upper_bound
dL 17 19 1098 1100 I-upper_bound

defined 0 7 1101 1108 O
as 8 10 1109 1111 O
bone 11 15 1112 1116 B-clinical_variable
marrow 16 22 1117 1123 I-clinical_variable
blasts 23 29 1124 1130 I-clinical_variable
> 30 31 1131 1132 O
or 32 34 1133 1135 O
= 35 36 1136 1137 O
5 37 38 1138 1139 B-lower_bound
% 38 39 1139 1140 I-lower_bound

pregnant 0 8 1141 1149 B-pregnancy
females 9 16 1150 1157 B-gender
are 17 20 1158 1161 O
excluded 21 29 1162 1170 O

Active 0 6 0 6 B-cancer
Central 7 14 7 14 I-cancer
Nervous 15 22 15 22 I-cancer
System 23 29 23 29 I-cancer
( 30 31 30 31 I-cancer
CNS 31 34 31 34 I-cancer
) 34 35 34 35 I-cancer
leukemia 36 44 36 44 I-cancer

Burkitt 0 7 45 52 B-cancer
leukemia 8 16 53 61 I-cancer

CD19 0 4 62 66 B-cancer
- 4 5 66 67 I-cancer
negative 5 13 67 75 I-cancer
B 14 15 76 77 I-cancer
- 15 16 77 78 I-cancer
cell 16 20 78 82 I-cancer
leukemia 21 29 83 91 I-cancer

Estimated 0 9 92 101 O
life 10 14 102 106 B-clinical_variable
expectancy 15 25 107 117 I-clinical_variable
≥ 26 27 118 119 O
12 28 30 120 122 B-lower_bound
weeks 31 36 123 128 I-lower_bound

Patient 0 7 129 136 O
with 8 12 137 141 O
relapsed 13 21 142 150 O
or 22 24 151 153 O
refractory 25 35 154 164 O
CD19 36 40 165 169 O
- 40 41 169 170 O
positive 41 49 170 178 O
B 50 51 179 180 B-cancer
- 51 52 180 181 I-cancer
acute 52 57 181 186 I-cancer
lymphoblastic 58 71 187 200 I-cancer
leukaemia 72 81 201 210 I-cancer
( 82 83 211 212 I-cancer
B 83 84 212 213 I-cancer
- 84 85 213 214 I-cancer
ALL 85 88 214 217 I-cancer
) 88 89 217 218 I-cancer
who 90 93 219 222 O
have 94 98 223 227 O
exhausted 99 108 228 237 O
alternative 109 120 238 249 O
treatment 121 130 250 259 O
options 131 138 260 267 O

ctive 0 5 268 273 O
acute 6 11 274 279 B-chronic_disease
or 12 14 280 282 I-chronic_disease
chronic 15 22 283 290 I-chronic_disease
Graft 23 28 291 296 I-chronic_disease
- 28 29 296 297 I-chronic_disease
versus 29 35 297 303 I-chronic_disease
- 35 36 303 304 I-chronic_disease
Host 36 40 304 308 I-chronic_disease
Disease 41 48 309 316 I-chronic_disease
( 49 50 317 318 I-chronic_disease
GvHD 50 54 318 322 I-chronic_disease
) 54 55 322 323 I-chronic_disease
requiring 56 65 324 333 O
systemic 66 74 334 342 B-treatment
use 75 78 343 346 I-treatment
therapy 79 86 347 354 I-treatment

Adult 0 5 0 5 O
men 6 9 6 9 B-gender

Female 0 6 10 16 B-gender
subjects 7 15 17 25 I-gender
who 16 19 26 29 O
are 20 23 30 33 O
pregnant 24 32 34 42 B-pregnancy

Has 0 3 43 46 O
ever 4 8 47 51 O
taken 9 14 52 57 O
the 15 18 58 61 O
any 19 22 62 65 O
anti 23 27 66 70 B-treatment
- 27 28 70 71 I-treatment
platelet 28 36 71 79 I-treatment
or 37 39 80 82 O
anti 40 44 83 87 B-treatment
- 44 45 87 88 I-treatment
coagulant 45 54 88 97 I-treatment
agents 55 61 98 104 I-treatment

Has 0 3 105 108 O
taken 4 9 109 114 O
NSAIDs 10 16 115 121 B-treatment
or 17 19 122 124 O
anti 20 24 125 129 B-treatment
- 24 25 129 130 I-treatment
secretory 25 34 130 139 I-treatment
agents 35 41 140 146 I-treatment
( 42 43 147 148 O
proton 43 49 148 154 B-treatment
pump 50 54 155 159 I-treatment
inhibitors 55 65 160 170 I-treatment
or 66 68 171 173 O
H2 69 71 174 176 B-treatment
receptor 72 80 177 185 I-treatment
antagonists 81 92 186 197 I-treatment
) 92 93 197 198 O
within 94 100 199 205 O
14 101 103 206 208 B-upper_bound
days 104 108 209 213 I-upper_bound
prior 109 114 214 219 I-upper_bound
to 115 117 220 222 O
study 118 123 223 228 O
drug 124 128 229 233 O
administration 129 143 234 248 O

Has 0 3 249 252 O
taken 4 9 253 258 O
any 10 13 259 262 O
prescription 14 26 263 275 B-treatment
medication 27 37 276 286 I-treatment
other 38 43 287 292 O
than 44 48 293 297 O
hormone 49 56 298 305 B-treatment
replacement 57 68 306 317 I-treatment
therapy 69 76 318 325 I-treatment
( 77 78 326 327 O
including 78 87 327 336 O
males 88 93 337 342 B-gender
taking 94 100 343 349 O
testosterone 101 113 350 362 O
as 114 116 363 365 O
a 117 118 366 367 O
hormone 119 126 368 375 O
replacement 127 138 376 387 O
to 139 141 388 390 O
treat 142 147 391 396 O
a 148 149 397 398 O
documented 150 160 399 409 O
low 161 164 410 413 O
testosterone 165 177 414 426 O
level 178 183 427 432 O
) 183 184 432 433 O
, 184 185 433 434 O
thyroid 186 193 435 442 B-treatment
replacement 194 205 443 454 I-treatment
hormones 206 214 455 463 I-treatment
, 214 215 463 464 O
anti 216 220 465 469 B-treatment
- 220 221 469 470 I-treatment
hyperlipidemic 221 235 470 484 I-treatment
agents 236 242 485 491 I-treatment
, 242 243 491 492 O
or 244 246 493 495 O
anti 247 251 496 500 B-treatment
- 251 252 500 501 I-treatment
hypertensive 252 264 501 513 I-treatment
medications 265 276 514 525 I-treatment
. 276 277 525 526 O
Individuals 278 289 527 538 O
taking 290 296 539 545 O
other 297 302 546 551 O
/ 302 303 551 552 O
additional 303 313 552 562 O
chronic 314 321 563 570 O
stable 322 328 571 577 O
medications 329 340 578 589 O
can 341 344 590 593 O
be 345 347 594 596 O
considered 348 358 597 607 O
on 359 361 608 610 O
a 362 363 611 612 O
case 364 368 613 617 O
- 368 369 617 618 O
by 369 371 618 620 O
- 371 372 620 621 O
case 372 376 621 625 O
basis 377 382 626 631 O
for 383 386 632 635 O
inclusion 387 396 636 645 O
in 397 399 646 648 O
the 400 403 649 652 O
study 404 409 653 658 O
if 410 412 659 661 O
agreed 413 419 662 668 O
upon 420 424 669 673 O
by 425 427 674 676 O
judgment 428 436 677 685 O
of 437 439 686 688 O
the 440 443 689 692 O
investigators 444 457 693 706 O

History 0 7 707 714 O
of 8 10 715 717 O
cancer 11 17 718 724 B-cancer
within 18 24 725 731 O
the 25 28 732 735 O
last 29 33 736 740 B-upper_bound
5 34 35 741 742 I-upper_bound
years 36 41 743 748 I-upper_bound

History 0 7 749 756 O
of 8 10 757 759 O
significant 11 22 760 771 O
cardiovascular 23 37 772 786 B-chronic_disease
disease 38 45 787 794 I-chronic_disease
( 46 47 795 796 O
including 47 56 796 805 O
stroke 57 63 806 812 B-chronic_disease
or 64 66 813 815 O
TIA 67 70 816 819 O
) 70 71 819 820 O
, 71 72 820 821 O
renal 73 78 822 827 O
, 78 79 827 828 O
hepatic 80 87 829 836 O
, 87 88 836 837 O
respiratory 89 100 838 849 O

Used 0 4 850 854 O
dietary 5 12 855 862 B-treatment
or 13 15 863 865 I-treatment
herbal 16 22 866 872 I-treatment
supplements 23 34 873 884 I-treatment
containing 35 45 885 895 O
salicylates 46 57 896 907 B-treatment
, 57 58 907 908 O
Vitamin 59 66 909 916 B-treatment
E 67 68 917 918 I-treatment
, 68 69 918 919 O
fish 70 74 920 924 B-treatment
oil 75 78 925 928 I-treatment
, 78 79 928 929 O
or 80 82 930 932 O
any 83 86 933 936 O
other 87 92 937 942 O
herbal 93 99 943 949 O
supplements 100 111 950 961 O
, 111 112 961 962 O
within 113 119 963 969 O
14 120 122 970 972 B-upper_bound
days 123 127 973 977 I-upper_bound
of 128 130 978 980 O
study 131 136 981 986 O
drug 137 141 987 991 O
administration 142 156 992 1006 O

Volunteers 0 10 1007 1017 O
with 11 15 1018 1022 O
adequately 16 26 1023 1033 O
controlled 27 37 1034 1044 O
hypertension 38 50 1045 1057 B-chronic_disease
and 51 54 1058 1061 O
hyperlipidemia 55 69 1062 1076 B-chronic_disease

coagulation 0 11 1077 1088 B-chronic_disease
, 11 12 1088 1089 O
bleeding 13 21 1090 1098 B-chronic_disease
or 22 24 1099 1101 O
blood 25 30 1102 1107 B-chronic_disease
disorders 31 40 1108 1117 I-chronic_disease

cutaneous 0 9 1118 1127 B-cancer
basal 10 15 1128 1133 I-cancer
cell 16 20 1134 1138 I-cancer
or 21 23 1139 1141 O
squamous 24 32 1142 1150 B-cancer
cell 33 37 1151 1155 I-cancer
cancer 38 44 1156 1162 I-cancer
resolved 45 53 1163 1171 O
by 54 56 1172 1174 O
excision 57 65 1175 1183 B-treatment
, 65 66 1183 1184 O
or 67 69 1185 1187 O
carcinoma 70 79 1188 1197 B-cancer
in 80 82 1198 1200 I-cancer
situ 83 87 1201 1205 I-cancer
of 88 90 1206 1208 I-cancer
the 91 94 1209 1212 I-cancer
cervix 95 101 1213 1219 I-cancer
adequately 102 112 1220 1230 O
treated 113 120 1231 1238 O

documented 0 10 1239 1249 O
history 11 18 1250 1257 O
of 19 21 1258 1260 O
any 22 25 1261 1264 O
gastrointestinal 26 42 1265 1281 B-chronic_disease
disorders 43 52 1282 1291 I-chronic_disease
, 52 53 1291 1292 O
including 54 63 1293 1302 O
bleeding 64 72 1303 1311 B-chronic_disease
ulcers 73 79 1312 1318 I-chronic_disease

greater 0 7 1319 1326 O
than 8 12 1327 1331 O
18 13 15 1332 1334 B-lower_bound
years 16 21 1335 1340 I-lower_bound
of 22 24 1341 1343 O
age 25 28 1344 1347 B-age

history 0 7 1348 1355 O
of 8 10 1356 1358 O
drug 11 15 1359 1363 O
or 16 18 1364 1366 O
alcohol 19 26 1367 1374 O
abuse 27 32 1375 1380 O
within 33 39 1381 1387 O
the 40 43 1388 1391 O
last 44 48 1392 1396 B-upper_bound
6 49 50 1397 1398 I-upper_bound
months 51 57 1399 1405 I-upper_bound

immune 0 6 1406 1412 B-chronic_disease
, 6 7 1412 1413 O
endocrine 8 17 1414 1423 B-chronic_disease
, 17 18 1423 1424 O
hematopoietic 19 32 1425 1438 B-chronic_disease
disorder 33 41 1439 1447 I-chronic_disease
or 42 44 1448 1450 O
neurological 45 57 1451 1463 B-chronic_disease
disorders 58 67 1464 1473 I-chronic_disease

infections 0 10 1474 1484 O
which 11 16 1485 1490 O
longer 17 23 1491 1497 O
> 24 25 1498 1499 O
6 26 27 1500 1501 B-lower_bound
months 28 34 1502 1508 I-lower_bound
prior 35 40 1509 1514 I-lower_bound
to 41 43 1515 1517 O
screening 44 53 1518 1527 O

received 0 8 1528 1536 O
an 9 11 1537 1539 O
investigational 12 27 1540 1555 B-treatment
drug 28 32 1556 1560 I-treatment
or 33 35 1561 1563 O
used 36 40 1564 1568 O
an 41 43 1569 1571 O
experimental 44 56 1572 1584 O
medical 57 64 1585 1592 O
device 65 71 1593 1599 O
within 72 78 1600 1606 O
30 79 81 1607 1609 B-upper_bound
days 82 86 1610 1614 I-upper_bound
prior 87 92 1615 1620 I-upper_bound
to 93 95 1621 1623 O
screening 96 105 1624 1633 O
, 105 106 1633 1634 O
or 107 109 1635 1637 O
who 110 113 1638 1641 O
gave 114 118 1642 1646 O
a 119 120 1647 1648 O
blood 121 126 1649 1654 O
donation 127 135 1655 1663 O
of 136 138 1664 1666 O
≥ 139 140 1667 1668 O
one 141 144 1669 1672 B-lower_bound
pint 145 149 1673 1677 O
within 150 156 1678 1684 O
8 157 158 1685 1686 B-upper_bound
weeks 159 164 1687 1692 I-upper_bound
prior 165 170 1693 1698 I-upper_bound
to 171 173 1699 1701 O
screening 174 183 1702 1711 O

sensitive 0 9 1712 1721 O
or 10 12 1722 1724 O
allergic 13 21 1725 1733 O
to 22 24 1734 1736 O
aspirin 25 32 1737 1744 B-allergy_name
or 33 35 1745 1747 O
other 36 41 1748 1753 O
NSAIDs 42 48 1754 1760 B-allergy_name

sensitive 0 9 1761 1770 O
or 10 12 1771 1773 O
allergic 13 21 1774 1782 O
to 22 24 1783 1785 O
celecoxib 25 34 1786 1795 B-allergy_name
( 35 36 1796 1797 I-allergy_name
Celebrex 36 44 1797 1805 I-allergy_name
) 44 45 1805 1806 I-allergy_name
or 46 48 1807 1809 O
naproxen 49 57 1810 1818 B-allergy_name
( 58 59 1819 1820 I-allergy_name
Naprosyn 59 67 1820 1828 I-allergy_name
) 67 68 1828 1829 I-allergy_name
or 69 71 1830 1832 O
their 72 77 1833 1838 O
components 78 88 1839 1849 O

total 0 5 1850 1855 B-clinical_variable
cholesterol 6 17 1856 1867 I-clinical_variable
of 18 20 1868 1870 O
≤270 21 25 1871 1875 O
mg 26 28 1876 1878 I-upper_bound
/ 28 29 1878 1879 I-upper_bound
dL 29 31 1879 1881 I-upper_bound

women 0 5 1882 1887 B-gender

18 0 2 0 2 O
years 3 8 3 8 O
of 9 11 9 11 O
age 12 15 12 15 B-age

Patients 0 8 16 24 O
with 9 13 25 29 O
a 14 15 30 31 O
known 16 21 32 37 O
allergy 22 29 38 45 O
to 30 32 46 48 O
Benadryl 33 41 49 57 B-allergy_name

55 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
enrolled 16 24 16 24 O
at 25 27 25 27 O
participating 28 41 28 41 O
VA 42 44 42 44 O
sites 45 50 45 50 O
able 51 55 51 55 O
to 56 58 56 58 O
provide 59 66 59 66 O
informed 67 75 67 75 O
consent 76 83 76 83 O

Active 0 6 84 90 O
suicidal 7 15 91 99 B-chronic_disease
intent 16 22 100 106 I-chronic_disease
indicating 23 33 107 117 O
significant 34 45 118 129 O
clinical 46 54 130 138 O
risk 55 59 139 143 O
, 59 60 143 144 O
which 61 66 145 150 O
would 67 72 151 156 O
suggest 73 80 157 164 O
that 81 85 165 169 O
a 86 87 170 171 O
treatment 88 97 172 181 B-treatment
specifically 98 110 182 194 O
targeting 111 120 195 204 O
this 121 125 205 209 O
intent 126 132 210 216 O
was 133 136 217 220 O
indicated 137 146 221 230 O

Auditory 0 8 231 239 B-chronic_disease
or 9 11 240 242 O
visual 12 18 243 249 B-chronic_disease
impairments 19 30 250 261 I-chronic_disease
that 31 35 262 266 O
would 36 41 267 272 O
compromise 42 52 273 283 O
ability 53 60 284 291 O
to 61 63 292 294 O
participate 64 75 295 306 O
or 76 78 307 309 O
benefit 79 86 310 317 O

Clients 0 7 318 325 O
who 8 11 326 329 O
report 12 18 330 336 O
suicidal 19 27 337 345 B-chronic_disease
ideation 28 36 346 354 I-chronic_disease
without 37 44 355 362 O
imminent 45 53 363 371 O
risk 54 58 372 376 O
will 59 63 377 381 O
be 64 66 382 384 O
admitted 67 75 385 393 O
into 76 80 394 398 O
the 81 84 399 402 O
study 85 90 403 408 O

Current 0 7 409 416 O
diagnosis 8 17 417 426 O
of 18 20 427 429 O
moderate 21 29 430 438 O
or 30 32 439 441 O
severe 33 39 442 448 O
substance 40 49 449 458 O
( 50 51 459 460 O
alcohol 51 58 460 467 O
) 58 59 467 468 O
use 60 63 469 472 O
disorder 64 72 473 481 O
using 73 78 482 487 O
DSM-5 79 84 488 493 O
criteria 85 93 494 502 O
within 94 100 503 509 O
the 101 104 510 513 O
past 105 109 514 518 B-upper_bound
30 110 112 519 521 I-upper_bound
days 113 117 522 526 I-upper_bound

Diagnosis 0 9 527 536 O
of 10 12 537 539 O
PTSD 13 17 540 544 B-chronic_disease
based 18 23 545 550 O
on 24 26 551 553 O
the 27 30 554 557 O
Clinician 31 40 558 567 O
Administered 41 53 568 580 O
PTSD 54 58 581 585 O
Scale 59 64 586 591 O

English 0 7 592 599 B-language_fluency
speaking 8 16 600 608 I-language_fluency
, 16 17 608 609 O
able 18 22 610 614 O
to 23 25 615 617 O
travel 26 32 618 624 O
to 33 35 625 627 O
the 36 39 628 631 O
primary 40 47 632 639 O
care 48 52 640 644 O
clinics 53 60 645 652 O
weekly 61 67 653 659 O
for 68 71 660 663 O
10 72 74 664 666 B-upper_bound
sessions 75 83 667 675 I-upper_bound
and 84 87 676 679 O
for 88 91 680 683 O
the 92 95 684 687 O
follow 96 102 688 694 O
- 102 103 694 695 O
up 103 105 695 697 O
assessments 106 117 698 709 O

Enrollees 0 9 710 719 O
will 10 14 720 724 O
be 15 17 725 727 O
asked 18 23 728 733 O
to 24 26 734 736 O
hold 27 31 737 741 O
the 32 35 742 745 O
doses 36 41 746 751 O
of 42 44 752 754 O
the 45 48 755 758 O
current 49 56 759 766 B-treatment
medications 57 68 767 778 I-treatment
stable 69 75 779 785 O
over 76 80 786 790 O
the 81 84 791 794 O
course 85 91 795 801 O
of 92 94 802 804 O
enrollment 95 105 805 815 O
( 106 107 816 817 O
though 107 113 817 823 O
changes 114 121 824 831 O
in 122 124 832 834 O
medications 125 136 835 846 O
after 137 142 847 852 O
enrollment 143 153 853 863 O
will 154 158 864 868 O
not 159 162 869 872 O
exclude 163 170 873 880 O
them 171 175 881 885 O
from 176 180 886 890 O
on 181 183 891 893 O
- 183 184 893 894 O
going 184 189 894 899 O
participation 190 203 900 913 O
) 203 204 913 914 O

Individuals 0 11 915 926 O
with 12 16 927 931 O
other 17 22 932 937 O
psychiatric 23 34 938 949 B-chronic_disease
diagnoses 35 44 950 959 O
will 45 49 960 964 O
not 50 53 965 968 O
be 54 56 969 971 O
excluded 57 65 972 980 O
except 66 72 981 987 O
for 73 76 988 991 O
bipolar 77 84 992 999 B-chronic_disease
disorder 85 93 1000 1008 I-chronic_disease
and 94 97 1009 1012 O
psychotic 98 107 1013 1022 B-chronic_disease
disorders 108 117 1023 1032 I-chronic_disease
( 118 119 1033 1034 O
requirement 119 130 1034 1045 O
to 131 133 1046 1048 O
refrain 134 141 1049 1056 O
from 142 146 1057 1061 O
additional 147 157 1062 1072 O
treatments 158 168 1073 1083 B-treatment
might 169 174 1084 1089 O
be 175 177 1090 1092 O
harmful 178 185 1093 1100 O
) 185 186 1100 1101 O

Initiated 0 9 1102 1111 O
psychotropic 10 22 1112 1124 B-treatment
medication 23 33 1125 1135 I-treatment
, 33 34 1135 1136 O
including 35 44 1137 1146 O
Prazosin 45 53 1147 1155 B-treatment
, 53 54 1155 1156 O
within 55 61 1157 1163 O
4 62 63 1164 1165 B-upper_bound
weeks 64 69 1166 1171 I-upper_bound
or 70 72 1172 1174 O
changed 73 80 1175 1182 O
dosage 81 87 1183 1189 O
within 88 94 1190 1196 O
2 95 96 1197 1198 B-upper_bound
weeks 97 102 1199 1204 I-upper_bound
prior 103 108 1205 1210 I-upper_bound
to 109 111 1211 1213 O
the 112 115 1214 1217 O
first 116 121 1218 1223 O
assessment 122 132 1224 1234 O
, 132 133 1234 1235 O
as 134 136 1236 1238 O
this 137 141 1239 1243 O
would 142 147 1244 1249 O
make 148 152 1250 1254 O
it 153 155 1255 1257 O
difficult 156 165 1258 1267 O
to 166 168 1268 1270 O
determine 169 178 1271 1280 O
which 179 184 1281 1286 O
treatment 185 194 1287 1296 B-treatment
contributed 195 206 1297 1308 O
to 207 209 1309 1311 O
change 210 216 1312 1318 O
in 217 219 1319 1321 O
the 220 223 1322 1325 O
CABA 224 228 1326 1330 O
condition 229 238 1331 1340 O
; 238 239 1340 1341 O
additionally 240 252 1342 1354 O
, 252 253 1354 1355 O
started 254 261 1356 1363 O
or 262 264 1364 1366 O
changed 265 272 1367 1374 O
dosage 273 279 1375 1381 O
of 280 282 1382 1384 O
sleep 283 288 1385 1390 B-treatment
medication 289 299 1391 1401 I-treatment
or 300 302 1402 1404 O
low 303 306 1405 1408 O
dosages 307 314 1409 1416 O
of 315 317 1417 1419 O
tricyclic 318 327 1420 1429 B-treatment
antidepressant 328 342 1430 1444 I-treatment
or 343 345 1445 1447 O
trazodone 346 355 1448 1457 B-treatment
for 356 359 1458 1461 O
pain 360 364 1462 1466 O
or 365 367 1467 1469 O
sleep 368 373 1470 1475 O
within 374 380 1476 1482 O
1 381 382 1483 1484 B-upper_bound
week 383 387 1485 1489 I-upper_bound
prior 388 393 1490 1495 I-upper_bound
to 394 396 1496 1498 O
the 397 400 1499 1502 O
first 401 406 1503 1508 O
assessment 407 417 1509 1519 O

Participants 0 12 1520 1532 O
could 13 18 1533 1538 O
be 19 21 1539 1541 O
reconsidered 22 34 1542 1554 O
for 35 38 1555 1558 O
eligibility 39 50 1559 1570 O
after 51 56 1571 1576 O
stability 57 66 1577 1586 O
on 67 69 1587 1589 O
medication 70 80 1590 1600 B-treatment
was 81 84 1601 1604 O
achieved 85 93 1605 1613 O

Veterans 0 8 1614 1622 O
with 9 13 1623 1627 O
a 14 15 1628 1629 O
history 16 23 1630 1637 O
indicated 24 33 1638 1647 O
by 34 36 1648 1650 O
medical 37 44 1651 1658 O
record 45 51 1659 1665 O
review 52 58 1666 1672 O
of 59 61 1673 1675 O
a 62 63 1676 1677 O
diagnosis 64 73 1678 1687 O
of 74 76 1688 1690 O
moderate 77 85 1691 1699 O
, 85 86 1699 1700 O
severe 87 93 1701 1707 O
, 93 94 1707 1708 O
or 95 97 1709 1711 O
penetrating 98 109 1712 1723 O
TBI 110 113 1724 1727 B-chronic_disease
, 113 114 1727 1728 O
or 115 117 1729 1731 O
self 118 122 1732 1736 O
- 122 123 1736 1737 O
reported 123 131 1737 1745 O
history 132 139 1746 1753 O
on 140 142 1754 1756 O
the 143 146 1757 1760 O
Structured 147 157 1761 1771 O
Interview 158 167 1772 1781 O
for 168 171 1782 1785 O
Collecting 172 182 1786 1796 O
Head 183 187 1797 1801 O
Trauma 188 194 1802 1808 O
Event 195 200 1809 1814 O
Characteristics 201 216 1815 1830 O
of 217 219 1831 1833 O
TBI 220 223 1834 1837 O
with 224 228 1838 1842 O
Post 229 233 1843 1847 B-clinical_variable
- 233 234 1847 1848 I-clinical_variable
Traumatic 234 243 1848 1857 I-clinical_variable
Amnesia 244 251 1858 1865 I-clinical_variable
( 252 253 1866 1867 I-clinical_variable
PTA 253 256 1867 1870 I-clinical_variable
) 256 257 1870 1871 I-clinical_variable
greater 258 265 1872 1879 O
than 266 270 1880 1884 O
24 271 273 1885 1887 B-lower_bound
hours 274 279 1888 1893 I-lower_bound
or 280 282 1894 1896 O
loss 283 287 1897 1901 B-clinical_variable
of 288 290 1902 1904 I-clinical_variable
consciousness 291 304 1905 1918 I-clinical_variable
( 305 306 1919 1920 I-clinical_variable
LOC 306 309 1920 1923 I-clinical_variable
) 309 310 1923 1924 I-clinical_variable
greater 311 318 1925 1932 O
than 319 323 1933 1937 O
30 324 326 1938 1940 B-lower_bound
minutes 327 334 1941 1948 I-lower_bound

endorsed 0 8 1949 1957 O
any 9 12 1958 1961 O
of 13 15 1962 1964 O
the 16 19 1965 1968 O
Neurobehavioral 20 35 1969 1984 B-clinical_variable
Symptom 36 43 1985 1992 I-clinical_variable
Inventory 44 53 1993 2002 I-clinical_variable
( 54 55 2003 2004 I-clinical_variable
NSI 55 58 2004 2007 I-clinical_variable
) 58 59 2007 2008 I-clinical_variable
cognitive 60 69 2009 2018 O
symptoms 70 78 2019 2027 O
items 79 84 2028 2033 O

Histologically 0 14 0 14 O
confirmed 15 24 15 24 O
prostate 25 33 25 33 B-cancer
adenocarcinoma 34 48 34 48 I-cancer

Active 0 6 0 6 O
cancer 7 13 7 13 B-cancer

Already 0 7 14 21 O
exercise 8 16 22 30 B-clinical_variable
2x 17 19 31 33 B-lower_bound
/ 19 20 33 34 I-lower_bound
week 20 24 34 38 I-lower_bound
or 25 27 39 41 O
more 28 32 42 46 O

BMI 0 3 47 50 B-bmi
> 4 5 51 52 O
30 5 7 52 54 B-lower_bound
kg 8 10 55 57 I-lower_bound
/ 10 11 57 58 I-lower_bound
m2 11 13 58 60 I-lower_bound

No 0 2 61 63 O
current 3 10 64 71 O
plan 11 15 72 76 O
for 16 19 77 80 O
surgical 20 28 81 89 B-treatment
revascularization 29 46 90 107 I-treatment

Unstable 0 8 108 116 B-chronic_disease
angina 9 15 117 123 I-chronic_disease
or 16 18 124 126 O
a 19 20 127 128 O
recent 21 27 129 135 O
heart 28 33 136 141 B-chronic_disease
attack 34 40 142 148 I-chronic_disease

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1.5 35 38 35 38 B-lower_bound
x 39 40 39 40 I-lower_bound
10 41 43 41 43 I-lower_bound
^ 43 44 43 44 I-lower_bound
9 44 45 44 45 I-lower_bound
/ 45 46 45 46 I-lower_bound
L 46 47 46 47 I-lower_bound

Active 0 6 48 54 B-chronic_disease
GVHD 7 11 55 59 I-chronic_disease
or 12 14 60 62 O
recent 15 21 63 69 O
GVHD 22 26 70 74 O
and 27 30 75 78 O
still 31 36 79 84 O
on 37 39 85 87 O
> 40 41 88 89 O
10 42 44 90 92 B-lower_bound
mg 45 47 93 95 I-lower_bound
prednisone 48 58 96 106 B-treatment
( 59 60 107 108 O
or 60 62 108 110 O
equivalent 63 73 111 121 O
) 73 74 121 122 O

Active 0 6 123 129 O
congestive 7 17 130 140 B-chronic_disease
heart 18 23 141 146 I-chronic_disease
failure 24 31 147 154 I-chronic_disease
( 32 33 155 156 O
New 33 36 156 159 O
York 37 41 160 164 O
Heart 42 47 165 170 O
Association 48 59 171 182 O
[ 60 61 183 184 O
NYHA 61 65 184 188 O
] 65 66 188 189 O
class 67 72 190 195 O
III 73 76 196 199 O
to 77 79 200 202 O
IV 80 82 203 205 O
) 82 83 205 206 O

Active 0 6 207 213 B-chronic_disease
life 7 11 214 218 I-chronic_disease
- 11 12 218 219 I-chronic_disease
threatening 12 23 219 230 I-chronic_disease
autoimmune 24 34 231 241 I-chronic_disease
disease 35 42 242 249 I-chronic_disease

Acute 0 5 250 255 B-chronic_disease
active 6 12 256 262 I-chronic_disease
infection 13 22 263 272 I-chronic_disease
requiring 23 32 273 282 O
intravenous 33 44 283 294 B-treatment
antibiotics 45 56 295 306 I-treatment

Age 0 3 307 310 B-age
> 4 5 311 312 O
/= 5 7 312 314 O
18 8 10 315 317 B-lower_bound
years 11 16 318 323 I-lower_bound
to 17 19 324 326 O
< 20 21 327 328 O
/= 21 23 328 330 O
80 24 26 331 333 B-upper_bound
years 27 32 334 339 I-upper_bound

Cardiac 0 7 340 347 B-clinical_variable
ejection 8 16 348 356 I-clinical_variable
fraction 17 25 357 365 I-clinical_variable
( 26 27 366 367 I-clinical_variable
EF 27 29 367 369 I-clinical_variable
) 29 30 369 370 I-clinical_variable
> 31 32 371 372 O
= 32 33 372 373 O
45 34 36 374 376 B-lower_bound
% 36 37 376 377 I-lower_bound
by 38 40 378 380 O
2 41 42 381 382 B-treatment
- 42 43 382 383 I-treatment
dimensional 43 54 383 394 I-treatment
echocardiogram 55 69 395 409 I-treatment
( 70 71 410 411 I-treatment
2D 71 73 411 413 I-treatment
- 73 74 413 414 I-treatment
ECHO 74 78 414 418 I-treatment
) 78 79 418 419 I-treatment
within 80 86 420 426 O
3 87 88 427 428 B-upper_bound
months 89 95 429 435 I-upper_bound
of 96 98 436 438 O
study 99 104 439 444 O
entry 105 110 445 450 O
( 111 112 451 452 O
or 112 114 452 454 O
within 115 121 455 461 O
1 122 123 462 463 B-upper_bound
month 124 129 464 469 I-upper_bound
if 130 132 470 472 O
received 133 141 473 481 O
chemotherapy 142 154 482 494 B-treatment
within 155 161 495 501 O
the 162 165 502 505 O
past 166 170 506 510 B-upper_bound
3 171 172 511 512 I-upper_bound
months 173 179 513 519 I-upper_bound
) 179 180 519 520 O

Deep 0 4 521 525 B-chronic_disease
vein 5 9 526 530 I-chronic_disease
thrombosis 10 20 531 541 I-chronic_disease
or 21 23 542 544 O
pulmonary 24 33 545 554 B-chronic_disease
embolism 34 42 555 563 I-chronic_disease
within 43 49 564 570 O
3 50 51 571 572 B-upper_bound
months 52 58 573 579 I-upper_bound
of 59 61 580 582 O
study 62 67 583 588 O
entry 68 73 589 594 O

Direct 0 6 595 601 B-clinical_variable
bilirubin 7 16 602 611 I-clinical_variable
< 17 18 612 613 O
1.6 19 22 614 617 B-upper_bound
( 23 24 618 619 O
unless 24 30 619 625 O
related 31 38 626 633 O
to 39 41 634 636 O
Gilbert 42 49 637 644 B-chronic_disease
's 49 51 644 646 I-chronic_disease
disease 52 59 647 654 I-chronic_disease
or 60 62 655 657 O
medications 63 74 658 669 O
) 74 75 669 670 O

Females 0 7 671 678 B-gender
of 8 10 679 681 O
childbearing 11 23 682 694 O
potential 24 33 695 704 O
( 34 35 705 706 O
FCBP 35 39 706 710 O
) 39 40 710 711 O
must 41 45 712 716 O
have 46 50 717 721 O
a 51 52 722 723 O
negative 53 61 724 732 B-pregnancy
serum 62 67 733 738 I-pregnancy
or 68 70 739 741 I-pregnancy
urine 71 76 742 747 I-pregnancy
pregnancy 77 86 748 757 I-pregnancy
test 87 91 758 762 O
with 92 96 763 767 O
a 97 98 768 769 O
sensitivity 99 110 770 781 O
of 111 113 782 784 O
at 114 116 785 787 O
least 117 122 788 793 O
50 123 125 794 796 B-lower_bound
mIU 126 129 797 800 I-lower_bound
/ 129 130 800 801 I-lower_bound
mL 130 132 801 803 I-lower_bound
within 133 139 804 810 O
10 140 142 811 813 B-lower_bound
- 142 143 813 814 O
14 143 145 814 816 B-upper_bound
days 146 150 817 821 I-upper_bound
prior 151 156 822 827 I-upper_bound
to 157 159 828 830 O
study 160 165 831 836 O
entry 166 171 837 842 O

Forced 0 6 843 849 B-clinical_variable
expiratory 7 17 850 860 I-clinical_variable
volume 18 24 861 867 I-clinical_variable
in 25 27 868 870 I-clinical_variable
one 28 31 871 874 I-clinical_variable
second 32 38 875 881 I-clinical_variable
( 39 40 882 883 I-clinical_variable
FEV1 40 44 883 887 I-clinical_variable
) 44 45 887 888 I-clinical_variable

Hematologic 0 11 889 900 B-cancer
or 12 14 901 903 I-cancer
lymphoid 15 23 904 912 I-cancer
malignancy 24 34 913 923 I-cancer

Immunotherapy 0 13 924 937 B-treatment
or 14 16 938 940 O
chemotherapy 17 29 941 953 B-treatment
with 30 34 954 958 O
approved 35 43 959 967 O
or 44 46 968 970 O
investigational 47 62 971 986 O
anticancer 63 73 987 997 O
therapeutics 74 86 998 1010 O
within 87 93 1011 1017 O
4 94 95 1018 1019 B-upper_bound
weeks 96 101 1020 1025 I-upper_bound
of 102 104 1026 1028 O
first 105 110 1029 1034 O
dose 111 115 1035 1039 O

Known 0 5 1040 1045 O
human 6 11 1046 1051 B-chronic_disease
immunodeficiency 12 28 1052 1068 I-chronic_disease
virus 29 34 1069 1074 I-chronic_disease
( 35 36 1075 1076 I-chronic_disease
HIV 36 39 1076 1079 I-chronic_disease
) 39 40 1079 1080 I-chronic_disease
seropositive 41 53 1081 1093 O

Known 0 5 1094 1099 O
hypersensitivity 6 22 1100 1116 O
to 23 25 1117 1119 O
thalidomide 26 37 1120 1131 B-allergy_name
, 37 38 1131 1132 O
lenalidomide 39 51 1133 1145 B-allergy_name
or 52 54 1146 1148 O
ipilimumab 55 65 1149 1159 B-allergy_name

No 0 2 1160 1162 O
active 3 9 1163 1169 B-chronic_disease
infection 10 19 1170 1179 I-chronic_disease

Patients 0 8 1180 1188 O
on 9 11 1189 1191 O
alemtuzumab 12 23 1192 1203 B-treatment
within 24 30 1204 1210 O
6 31 32 1211 1212 B-upper_bound
weeks 33 38 1213 1218 I-upper_bound
prior 39 44 1219 1224 I-upper_bound
to 45 47 1225 1227 O
consenting 48 58 1228 1238 O

Patients 0 8 1239 1247 O
with 9 13 1248 1252 O
other 14 19 1253 1258 O
known 20 25 1259 1264 O
malignancies 26 38 1265 1277 B-cancer
within 39 45 1278 1284 O
the 46 49 1285 1288 O
past 50 54 1289 1293 B-upper_bound
three 55 60 1294 1299 I-upper_bound
years 61 66 1300 1305 I-upper_bound

Performance 0 11 1306 1317 O
status 12 18 1318 1324 O
: 18 19 1324 1325 O
Eastern 20 27 1326 1333 B-clinical_variable
Cooperative 28 39 1334 1345 I-clinical_variable
Oncology 40 48 1346 1354 I-clinical_variable
Group 49 54 1355 1360 I-clinical_variable
( 55 56 1361 1362 I-clinical_variable
ECOG 56 60 1362 1366 I-clinical_variable
) 60 61 1366 1367 I-clinical_variable
2 62 63 1368 1369 B-upper_bound
or 64 66 1370 1372 O
less 67 71 1373 1377 O
or 72 74 1378 1380 O
Karnofsky 75 84 1381 1390 B-clinical_variable
of 85 87 1391 1393 O
at 88 90 1394 1396 O
least 91 96 1397 1402 O
60 97 99 1403 1405 B-lower_bound

Platelets 0 9 1406 1415 B-clinical_variable
> 10 11 1416 1417 O
75 12 14 1418 1420 B-lower_bound
x 15 16 1421 1422 I-lower_bound
10 17 19 1423 1425 I-lower_bound
^ 19 20 1425 1426 I-lower_bound
9 20 21 1426 1427 I-lower_bound
/ 21 22 1427 1428 I-lower_bound
L 22 23 1428 1429 I-lower_bound

Pregnant 0 8 1430 1438 B-pregnancy

Prior 0 5 1439 1444 O
auto 6 10 1445 1449 B-chronic_disease
- 10 11 1449 1450 I-chronic_disease
immune 11 17 1450 1456 I-chronic_disease
disease 18 25 1457 1464 I-chronic_disease

Serum 0 5 1465 1470 B-clinical_variable
creatinine 6 16 1471 1481 I-clinical_variable
= 17 18 1482 1483 O
< 18 19 1483 1484 O
1.6 20 23 1485 1488 B-upper_bound
mg 24 26 1489 1491 I-upper_bound
/ 26 27 1491 1492 I-upper_bound
dL 27 29 1492 1494 I-upper_bound
and 30 33 1495 1498 O
creatinine 34 44 1499 1509 B-clinical_variable
clearance 45 54 1510 1519 I-clinical_variable
> 55 56 1520 1521 O
= 56 57 1521 1522 O
30 58 60 1523 1525 B-lower_bound
ml 61 63 1526 1528 I-lower_bound
/ 63 64 1528 1529 I-lower_bound
min 64 67 1529 1532 I-lower_bound

Serum 0 5 1533 1538 B-clinical_variable
glutamate 6 15 1539 1548 I-clinical_variable
pyruvate 16 24 1549 1557 I-clinical_variable
transaminase 25 37 1558 1570 I-clinical_variable
( 38 39 1571 1572 I-clinical_variable
SGPT 39 43 1572 1576 I-clinical_variable
) 43 44 1576 1577 I-clinical_variable
, 44 45 1577 1578 O
serum 46 51 1579 1584 B-clinical_variable
glutamic 52 60 1585 1593 I-clinical_variable
oxaloacetic 61 72 1594 1605 I-clinical_variable
transaminase 73 85 1606 1618 I-clinical_variable
( 86 87 1619 1620 I-clinical_variable
SGOT 87 91 1620 1624 I-clinical_variable
) 91 92 1624 1625 I-clinical_variable
less 93 97 1626 1630 O
than 98 102 1631 1635 O
2 103 104 1636 1637 B-upper_bound
x 105 106 1638 1639 I-upper_bound
the 107 110 1640 1643 I-upper_bound
upper 111 116 1644 1649 I-upper_bound
limit 117 122 1650 1655 I-upper_bound
of 123 125 1656 1658 I-upper_bound
normal 126 132 1659 1665 I-upper_bound
range 133 138 1666 1671 I-upper_bound
( 139 140 1672 1673 O
unless 140 146 1673 1679 O
related 147 154 1680 1687 O
to 155 157 1688 1690 O
Gilbert 158 165 1691 1698 B-chronic_disease
's 165 167 1698 1700 I-chronic_disease
disease 168 175 1701 1708 I-chronic_disease
or 176 178 1709 1711 O
medications 179 190 1712 1723 O
) 190 191 1723 1724 O

Significant 0 11 1725 1736 O
neuropathy 12 22 1737 1747 B-chronic_disease
( 23 24 1748 1749 O
grades 24 30 1749 1755 B-lower_bound
3 31 32 1756 1757 I-lower_bound
to 33 35 1758 1760 O
4 36 37 1761 1762 B-upper_bound
or 38 40 1763 1765 O
grade 41 46 1766 1771 O
2 47 48 1772 1773 O
pain 49 53 1774 1778 O
) 53 54 1778 1779 O

adequately 0 10 1780 1790 O
treated 11 18 1791 1798 O
basal 19 24 1799 1804 B-cancer
or 25 27 1805 1807 I-cancer
squamous 28 36 1808 1816 I-cancer
cell 37 41 1817 1821 I-cancer
skin 42 46 1822 1826 I-cancer
cancer 47 53 1827 1833 I-cancer

antifungal 0 10 1834 1844 B-treatment
agents 11 17 1845 1851 I-treatment
within 18 24 1852 1858 O
14 25 27 1859 1861 B-upper_bound
days 28 32 1862 1866 I-upper_bound
of 33 35 1867 1869 O
first 36 41 1870 1875 O
dose 42 46 1876 1880 O

antiviral 0 9 1881 1890 O
( 10 11 1891 1892 O
except 11 17 1892 1898 O
antiviral 18 27 1899 1908 O
directed 28 36 1909 1917 O
at 37 39 1918 1920 O
hepatitis 40 49 1921 1930 B-chronic_disease
B 50 51 1931 1932 I-chronic_disease
) 51 52 1932 1933 O

breast 0 6 1934 1940 B-cancer
cancer 7 13 1941 1947 I-cancer
in 14 16 1948 1950 I-cancer
situ 17 21 1951 1955 I-cancer
with 22 26 1956 1960 O
full 27 31 1961 1965 B-treatment
surgical 32 40 1966 1974 I-treatment
resection 41 50 1975 1984 I-treatment

breast 0 6 1985 1991 O
- 6 7 1991 1992 O
feeding 7 14 1992 1999 O
females 15 22 2000 2007 B-gender

carcinoma 0 9 2008 2017 B-cancer
in 10 12 2018 2020 I-cancer
situ 13 17 2021 2025 I-cancer
of 18 20 2026 2028 I-cancer
the 21 24 2029 2032 I-cancer
cervix 25 31 2033 2039 I-cancer

creatinine 0 10 2040 2050 B-clinical_variable
clearance 11 20 2051 2060 I-clinical_variable
will 21 25 2061 2065 O
be 26 28 2066 2068 O
calculated 29 39 2069 2079 O
using 40 45 2080 2085 O
the 46 49 2086 2089 O
Cockcroft 50 59 2090 2099 B-clinical_variable
- 59 60 2099 2100 I-clinical_variable
Gault 60 65 2100 2105 I-clinical_variable
equation 66 74 2106 2114 I-clinical_variable

diffusing 0 9 2115 2124 B-clinical_variable
capacity 10 18 2125 2133 I-clinical_variable
of 19 21 2134 2136 I-clinical_variable
the 22 25 2137 2140 I-clinical_variable
lung 26 30 2141 2145 I-clinical_variable
for 31 34 2146 2149 I-clinical_variable
carbon 35 41 2150 2156 I-clinical_variable
monoxide 42 50 2157 2165 I-clinical_variable
( 51 52 2166 2167 I-clinical_variable
DLCO 52 56 2167 2171 I-clinical_variable
) 56 57 2171 2172 I-clinical_variable
> 58 59 2173 2174 O
= 59 60 2174 2175 O
40 61 63 2176 2178 B-lower_bound
% 63 64 2178 2179 I-lower_bound
within 65 71 2180 2186 O
3 72 73 2187 2188 B-upper_bound
months 74 80 2189 2195 I-upper_bound
of 81 83 2196 2198 O
study 84 89 2199 2204 O
entry 90 95 2205 2210 O
( 96 97 2211 2212 O
or 97 99 2212 2214 O
within 100 106 2215 2221 O
1 107 108 2222 2223 B-upper_bound
month 109 114 2224 2229 I-upper_bound
if 115 117 2230 2232 O
received 118 126 2233 2241 O
chemotherapy 127 139 2242 2254 B-treatment
within 140 146 2255 2261 O
the 147 150 2262 2265 O
past 151 155 2266 2270 B-upper_bound
3 156 157 2271 2272 I-upper_bound
months 158 164 2273 2279 I-upper_bound
) 164 165 2279 2280 O

forced 0 6 2281 2287 B-clinical_variable
vital 7 12 2288 2293 I-clinical_variable
capacity 13 21 2294 2302 I-clinical_variable
( 22 23 2303 2304 I-clinical_variable
FVC 23 26 2304 2307 I-clinical_variable
) 26 27 2307 2308 I-clinical_variable

hepatitis 0 9 2309 2318 B-chronic_disease
B 10 11 2319 2320 I-chronic_disease

hepatitis 0 9 2321 2330 B-chronic_disease
C 10 11 2331 2332 I-chronic_disease
infection 12 21 2333 2342 O

lactating 0 9 2343 2352 O
females 10 17 2353 2360 B-gender
must 18 22 2361 2365 O
agree 23 28 2366 2371 O
not 29 32 2372 2375 O
to 33 35 2376 2378 O
breast 36 42 2379 2385 O
- 42 43 2385 2386 O
feed 43 47 2386 2390 O
while 48 53 2391 2396 O
taking 54 60 2397 2403 O
lenalidomide 61 73 2404 2416 B-treatment

myocardial 0 10 2417 2427 B-chronic_disease
infarction 11 21 2428 2438 I-chronic_disease
within 22 28 2439 2445 O
6 29 30 2446 2447 B-upper_bound
months 31 37 2448 2454 I-upper_bound
of 38 40 2455 2457 O
study 41 46 2458 2463 O
entry 47 52 2464 2469 O

patients 0 8 2470 2478 O
with 9 13 2479 2483 O
hepatitis 14 23 2484 2493 B-chronic_disease
B 24 25 2494 2495 I-chronic_disease
surface 26 33 2496 2503 I-chronic_disease
antigen 34 41 2504 2511 I-chronic_disease
[ 42 43 2512 2513 O
Sag 43 46 2513 2516 O
] 46 47 2516 2517 O
or 48 50 2518 2520 O
core 51 55 2521 2525 O
antibody 56 64 2526 2534 O
receiving 65 74 2535 2544 O
and 75 78 2545 2548 O
responding 79 89 2549 2559 O
to 90 92 2560 2562 O
antiviral 93 102 2563 2572 B-treatment
therapy 103 110 2573 2580 I-treatment
directed 111 119 2581 2589 O
at 120 122 2590 2592 O
hepatitis 123 132 2593 2602 O
B 133 134 2603 2604 O

prostate 0 8 2605 2613 B-cancer
cancer 9 15 2614 2620 I-cancer
with 16 20 2621 2625 O
Gleason 21 28 2626 2633 B-clinical_variable
score 29 34 2634 2639 I-clinical_variable
< 35 36 2640 2641 O
6 37 38 2642 2643 B-upper_bound
with 39 43 2644 2648 O
stable 44 50 2649 2655 O
prostate 51 59 2656 2664 B-clinical_variable
- 59 60 2664 2665 I-clinical_variable
specific 60 68 2665 2673 I-clinical_variable
antigen 69 76 2674 2681 I-clinical_variable
( 77 78 2682 2683 I-clinical_variable
PSA 78 81 2683 2686 I-clinical_variable
) 81 82 2686 2687 I-clinical_variable
over 83 87 2688 2692 O
the 88 91 2693 2696 O
past 92 96 2697 2701 B-upper_bound
three 97 102 2702 2707 I-upper_bound
months 103 109 2708 2714 I-upper_bound

symptomatic 0 11 2715 2726 B-chronic_disease
ischemia 12 20 2727 2735 I-chronic_disease
or 21 23 2736 2738 O
conduction 24 34 2739 2749 O
abnormalities 35 48 2750 2763 O
uncontrolled 49 61 2764 2776 O
by 62 64 2777 2779 O
conventional 65 77 2780 2792 O
interventions 78 91 2793 2806 O

A 0 1 0 1 O
negative 2 10 2 10 B-pregnancy
pregnancy 11 20 11 20 I-pregnancy
test 21 25 21 25 O
will 26 30 26 30 O
be 31 33 31 33 O
required 34 42 34 42 O
for 43 46 43 46 O
all 47 50 47 50 O
female 51 57 51 57 B-gender
subjects 58 66 58 66 I-gender
with 67 71 67 71 O
child 72 77 72 77 O
bearing 78 85 78 85 O
potential 86 95 86 95 O

Age 0 3 96 99 B-age
≥ 4 5 100 101 O
6 6 7 102 103 B-lower_bound
months 8 14 104 110 I-lower_bound

Any 0 3 111 114 O
additional 4 14 115 125 O
medical 15 22 126 133 B-chronic_disease
condition 23 32 134 143 I-chronic_disease
, 32 33 143 144 O
serious 34 41 145 152 O
intercurrent 42 54 153 165 B-chronic_disease
illness 55 62 166 173 I-chronic_disease
, 62 63 173 174 O
or 64 66 175 177 O
other 67 72 178 183 O
extenuating 73 84 184 195 O
circumstance 85 97 196 208 O
that 98 102 209 213 O
, 102 103 213 214 O
in 104 106 215 217 O
the 107 110 218 221 O
opinion 111 118 222 229 O
of 119 121 230 232 O
the 122 125 233 236 O
investigator 126 138 237 249 O
, 138 139 249 250 O
may 140 143 251 254 O
significantly 144 157 255 268 O
interfere 158 167 269 278 O
with 168 172 279 283 O
study 173 178 284 289 O
compliance 179 189 290 300 O

Female 0 6 301 307 B-gender
must 7 11 308 312 O
also 12 16 313 317 O
be 17 19 318 320 O
non 20 23 321 324 O
- 23 24 324 325 O
lactating 24 33 325 334 O

Histologically 0 14 335 349 O
diagnosed 15 24 350 359 O
neuroendocrine 25 39 360 374 B-cancer
tumor 40 45 375 380 I-cancer
or 46 48 381 383 O
other 49 54 384 389 O
tumor 55 60 390 395 O
with 61 65 396 400 O
probable 66 74 401 409 O
somatostatin 75 87 410 422 O
receptors 88 97 423 432 O
subtype 98 105 433 440 O
2 106 107 441 442 O

If 0 2 443 445 O
a 3 4 446 447 O
false 5 10 448 453 O
pregnancy 11 20 454 463 B-pregnancy
test 21 25 464 468 O
is 26 28 469 471 O
suspected 29 38 472 481 O
, 38 39 481 482 O
e.g. 40 44 483 487 O
, 44 45 487 488 O
perimenopausal 46 60 489 503 O
condition 61 70 504 513 O
, 70 71 513 514 O
an 72 74 515 517 O
obstetrician 75 87 518 530 O
will 88 92 531 535 O
be 93 95 536 538 O
consulted 96 105 539 548 O
to 106 108 549 551 O
determine 109 118 552 561 O
if 119 121 562 564 O
she 122 125 565 568 O
is 126 128 569 571 O
/ 128 129 571 572 O
is 129 131 572 574 O
not 132 135 575 578 O
capable 136 143 579 586 O
of 144 146 587 589 O
becoming 147 155 590 598 B-pregnancy
pregnant 156 164 599 607 I-pregnancy

Inability 0 9 608 617 O
to 10 12 618 620 O
complete 13 21 621 629 O
the 22 25 630 633 O
needed 26 32 634 640 O
investigational 33 48 641 656 O
and 49 52 657 660 O
standard 53 61 661 669 O
- 61 62 669 670 O
of 62 64 670 672 O
- 64 65 672 673 O
care 65 69 673 677 O
imaging 70 77 678 685 O
examinations 78 90 686 698 O
due 91 94 699 702 O
to 95 97 703 705 O
other 98 103 706 711 O
reasons 104 111 712 719 O
( 112 113 720 721 O
severe 113 119 721 727 O
claustrophobia 120 134 728 742 B-chronic_disease
, 134 135 742 743 O
radiation 136 145 744 753 B-chronic_disease
phobia 146 152 754 760 I-chronic_disease
, 152 153 760 761 O
etc 154 157 762 765 O
. 157 158 765 766 O
) 158 159 766 767 O

Inability 0 9 768 777 O
to 10 12 778 780 O
lie 13 16 781 784 O
still 17 22 785 790 O
for 23 26 791 794 O
the 27 30 795 798 O
entire 31 37 799 805 O
imaging 38 45 806 813 O
time 46 50 814 818 O
( 51 52 819 820 O
due 52 55 820 823 O
to 56 58 824 826 O
cough 59 64 827 832 O
, 64 65 832 833 O
severe 66 72 834 840 O
arthritis 73 82 841 850 B-chronic_disease
, 82 83 850 851 O
etc 84 87 852 855 O
. 87 88 855 856 O
) 88 89 856 857 O

Karnofsky 0 9 858 867 B-clinical_variable
performance 10 21 868 879 I-clinical_variable
status 22 28 880 886 I-clinical_variable
or 29 31 887 889 O
Lansky 32 38 890 896 B-clinical_variable
Play 39 43 897 901 I-clinical_variable
Scale 44 49 902 907 I-clinical_variable
status 50 56 908 914 I-clinical_variable
of 57 59 915 917 O
≥ 60 61 918 919 O
60 62 64 920 922 B-lower_bound
( 65 66 923 924 O
or 66 68 924 926 O
ECOG 69 73 927 931 O
/ 73 74 931 932 O
WHO 74 77 932 935 O
equivalent 78 88 936 946 O
) 88 89 946 947 O

Lanreotide 0 10 948 958 B-treatment
injection 11 20 959 968 I-treatment
within 21 27 969 975 O
8 28 29 976 977 B-upper_bound
weeks 30 35 978 983 I-upper_bound
of 36 38 984 986 O
Ga-68 39 44 987 992 B-treatment
DOTATOC 45 52 993 1000 I-treatment
PET 53 56 1001 1004 I-treatment
/ 56 57 1004 1005 I-treatment
CT 57 59 1005 1007 I-treatment
( 60 61 1008 1009 O
+ 61 62 1009 1010 O
/-5 62 65 1010 1013 O
% 65 66 1013 1014 O
) 66 67 1014 1015 O

Peptide 0 7 1016 1023 B-treatment
receptor 8 16 1024 1032 I-treatment
radionuclide 17 29 1033 1045 I-treatment
therapy 30 37 1046 1053 I-treatment
( 38 39 1054 1055 I-treatment
PRRT 39 43 1055 1059 I-treatment
) 43 44 1059 1060 I-treatment
within 45 51 1061 1067 O
4 52 53 1068 1069 B-upper_bound
weeks 54 59 1070 1075 I-upper_bound
of 60 62 1076 1078 O
Ga-68 63 68 1079 1084 O
DOTATOC 69 76 1085 1092 O
PET 77 80 1093 1096 B-treatment
/ 80 81 1096 1097 O
CT 81 83 1097 1099 B-treatment
scan 84 88 1100 1104 I-treatment

SQ 0 2 1105 1107 B-clinical_variable
Octreotide 3 13 1108 1118 I-clinical_variable
within 14 20 1119 1125 O
12 21 23 1126 1128 B-upper_bound
hours 24 29 1129 1134 I-upper_bound

Subject 0 7 1135 1142 O
is 8 10 1143 1145 O
male 11 15 1146 1150 B-gender

Subject 0 7 1151 1158 O
weighs 8 14 1159 1165 B-clinical_variable
more 15 19 1166 1170 O
than 20 24 1171 1175 O
450 25 28 1176 1179 B-lower_bound
pounds 29 35 1180 1186 I-lower_bound

Subjects 0 8 1187 1195 O
who 9 12 1196 1199 O
weigh 13 18 1200 1205 B-clinical_variable
more 19 23 1206 1210 O
than 24 28 1211 1215 O
450 29 32 1216 1219 B-lower_bound
pounds 33 39 1220 1226 I-lower_bound
will 40 44 1227 1231 O
not 45 48 1232 1235 O
be 49 51 1236 1238 O
able 52 56 1239 1243 O
to 57 59 1244 1246 O
fit 60 63 1247 1250 O
inside 64 70 1251 1257 O
the 71 74 1258 1261 O
imaging 75 82 1262 1269 O
machines 83 91 1270 1278 O

Treatment 0 9 1279 1288 B-treatment
with 10 14 1289 1293 I-treatment
Sandostatin 15 26 1294 1305 I-treatment
LAR 27 30 1306 1309 I-treatment
within 31 37 1310 1316 O
4 38 39 1317 1318 B-upper_bound
weeks 40 45 1319 1324 I-upper_bound

female 0 6 1325 1331 B-gender
who 7 10 1332 1335 O
is 11 13 1336 1338 O
either 14 20 1339 1345 O
surgically 21 31 1346 1356 O
sterile 32 39 1357 1364 O
( 40 41 1365 1366 O
has 41 44 1366 1369 O
had 45 48 1370 1373 O
a 49 50 1374 1375 O
documented 51 61 1376 1386 O
bilateral 62 71 1387 1396 O
oophorectomy 72 84 1397 1409 B-treatment
and/or 85 91 1410 1416 O
documented 92 102 1417 1427 O
hysterectomy 103 115 1428 1440 B-treatment
) 115 116 1440 1441 O

postmenopausal 0 14 1442 1456 O
( 15 16 1457 1458 O
> 16 17 1458 1459 O
1 18 19 1460 1461 B-lower_bound
years 20 25 1462 1467 I-lower_bound
without 26 33 1468 1475 O
menses 34 40 1476 1482 O
) 40 41 1482 1483 O

≥60 0 3 1484 1487 O
years 4 9 1488 1493 I-lower_bound
old 10 13 1494 1497 O
, 13 14 1497 1498 O
or 14 16 1498 1500 O
of 17 19 1501 1503 O
childbearing 20 32 1504 1516 O
potential 33 42 1517 1526 O
for 43 46 1527 1530 O
whom 47 51 1531 1535 O
a 52 53 1536 1537 O
pregnancy 54 63 1538 1547 B-pregnancy
test 64 68 1548 1552 O
( 69 70 1553 1554 O
with 70 74 1554 1558 O
the 75 78 1559 1562 O
results 79 86 1563 1570 O
known 87 92 1571 1576 O
prior 93 98 1577 1582 O
to 99 101 1583 1585 O
investigational 102 117 1586 1601 B-treatment
product 118 125 1602 1609 I-treatment
administration 126 140 1610 1624 O
) 140 141 1624 1625 O
is 142 144 1626 1628 O
negative 145 153 1629 1637 O

A 0 1 0 1 O
previous 2 10 2 10 O
CLIA 11 15 11 15 O
certified 16 25 16 25 O
genetic 26 33 26 33 O
lab 34 37 34 37 O
result 38 44 38 44 O
showing 45 52 45 52 O
the 53 56 53 56 O
LHON 57 61 57 61 B-treatment
G11778A 62 69 62 69 I-treatment
mutation 70 78 70 78 O
will 79 83 79 83 O
be 84 86 84 86 O
accepted 87 95 87 95 O
for 96 99 96 99 O
inclusion 100 109 100 109 O

Age 0 3 110 113 B-age
15 4 6 114 116 B-lower_bound
or 7 9 117 119 O
older 10 15 120 125 O

Allergy 0 7 126 133 O
to 8 10 134 136 O
pupil 11 16 137 142 B-allergy_name
dilating 17 25 143 151 I-allergy_name
drops 26 31 152 157 I-allergy_name
or 32 34 158 160 O
narrow 35 41 161 167 B-allergy_name
angles 42 48 168 174 I-allergy_name
precluding 49 59 175 185 I-allergy_name
safe 60 64 186 190 I-allergy_name
dilation 65 73 191 199 I-allergy_name

Aspartate 0 9 200 209 B-clinical_variable
transaminase 10 22 210 222 I-clinical_variable
( 23 24 223 224 I-clinical_variable
AST)/alanine 24 36 224 236 I-clinical_variable
transaminase 37 49 237 249 I-clinical_variable
( 50 51 250 251 I-clinical_variable
ALT 51 54 251 254 I-clinical_variable
) 54 55 254 255 I-clinical_variable
> 56 57 256 257 O
5.0 57 60 257 260 B-lower_bound
x 61 62 261 262 I-lower_bound
upper 63 68 263 268 I-lower_bound
limit 69 74 269 274 I-lower_bound
of 75 77 275 277 I-lower_bound
normal 78 84 278 284 I-lower_bound
( 85 86 285 286 I-lower_bound
ULN 86 89 286 289 I-lower_bound
) 89 90 289 290 I-lower_bound
; 90 91 290 291 O
Total 92 97 292 297 B-clinical_variable
bilirubin 98 107 298 307 I-clinical_variable
> 108 109 308 309 O
3 109 110 309 310 B-lower_bound
x 111 112 311 312 I-lower_bound
ULN 113 116 313 316 I-lower_bound
; 116 117 316 317 O
Hemoglobin 118 128 318 328 B-clinical_variable
< 129 130 329 330 O
8 131 132 331 332 B-upper_bound
g 133 134 333 334 I-upper_bound
/ 134 135 334 335 I-upper_bound
dL 135 137 335 337 I-upper_bound
; 137 138 337 338 O
neutrophil 139 149 339 349 B-clinical_variable
count 150 155 350 355 I-clinical_variable
< 156 157 356 357 O
1.0 157 160 357 360 B-upper_bound
x 161 162 361 362 I-upper_bound
109 163 166 363 366 I-upper_bound
/ 166 167 366 367 I-upper_bound
L 167 168 367 368 I-upper_bound
; 168 169 368 369 O
or 170 172 370 372 O
platelet 173 181 373 381 B-clinical_variable
count 182 187 382 387 I-clinical_variable
< 188 189 388 389 O
50 190 192 390 392 B-upper_bound
x 193 194 393 394 I-upper_bound
109 195 198 395 398 I-upper_bound
/ 198 199 398 399 I-upper_bound
L 199 200 399 400 I-upper_bound

History 0 7 401 408 O
of 8 10 409 411 O
autoimmune 11 21 412 422 B-chronic_disease
conditions 22 32 423 433 I-chronic_disease
( 33 34 434 435 O
e.g. 34 38 435 439 O
systemic 39 47 440 448 B-chronic_disease
lupus 48 53 449 454 I-chronic_disease
erythematosus 54 67 455 468 I-chronic_disease
) 67 68 468 469 O

History 0 7 470 477 O
of 8 10 478 480 O
cancer 11 17 481 487 B-cancer
within 18 24 488 494 O
five 25 29 495 499 B-upper_bound
years 30 35 500 505 I-upper_bound
other 36 41 506 511 O
than 42 46 512 516 O
localized 47 56 517 526 O
basal 57 62 527 532 B-cancer
or 63 65 533 535 O
squamous 66 74 536 544 B-cancer
cell 75 79 545 549 I-cancer
carcinoma 80 89 550 559 I-cancer
not 90 93 560 563 O
near 94 98 564 568 O
the 99 102 569 572 O
orbital 103 110 573 580 O
area 111 115 581 585 O

History 0 7 586 593 O
of 8 10 594 596 O
neurodegenerative 11 28 597 614 B-chronic_disease
conditions 29 39 615 625 I-chronic_disease
( 40 41 626 627 O
e.g. 41 45 627 631 O
multiple 46 54 632 640 B-chronic_disease
sclerosis 55 64 641 650 I-chronic_disease
, 64 65 650 651 O
neuromyelitis 66 79 652 665 B-chronic_disease
optica 80 86 666 672 I-chronic_disease
, 86 87 672 673 O
Parkinson 88 97 674 683 B-chronic_disease
disease 98 105 684 691 I-chronic_disease
) 105 106 691 692 O

Ocular 0 6 693 699 B-chronic_disease
diseases 7 15 700 708 I-chronic_disease
or 16 18 709 711 O
visual 19 25 712 718 B-chronic_disease
dysfunction 26 37 719 730 I-chronic_disease
conditions 38 48 731 741 O
other 49 54 742 747 O
than 55 59 748 752 O
refractive 60 70 753 763 B-chronic_disease
error 71 76 764 769 I-chronic_disease
( 77 78 770 771 O
e.g. 78 82 771 775 O
amblyopia 83 92 776 785 B-chronic_disease
, 92 93 785 786 O
glaucoma 94 102 787 795 B-chronic_disease
, 102 103 795 796 O
etc 104 107 797 800 O
. 107 108 800 801 O
) 108 109 801 802 O
in 110 112 803 805 O
the 113 116 806 809 O
eye 117 120 810 813 O
selected 121 129 814 822 O
for 130 133 823 826 O
the 134 137 827 830 O
injection 138 147 831 840 O

Patients 0 8 841 849 O
with 9 13 850 854 O
LHON 14 18 855 859 B-chronic_disease
and 19 22 860 863 O
the 23 26 864 867 O
G11778A 27 34 868 875 B-clinical_variable
mitochondrial 35 48 876 889 I-clinical_variable
DNA 49 52 890 893 O
mutation 53 61 894 902 O

Patients 0 8 903 911 O
with 9 13 912 916 O
a 14 15 917 918 O
prior 16 21 919 924 O
history 22 29 925 932 O
of 30 32 933 935 O
cancer 33 39 936 942 B-cancer
will 40 44 943 947 O
need 45 49 948 952 O
documentation 50 63 953 966 O
from 64 68 967 971 O
their 69 74 972 977 O
cancer 75 81 978 984 O
specialist 82 92 985 995 O
that 93 97 996 1000 O
the 98 101 1001 1004 O
cancer 102 108 1005 1011 O
was 109 112 1012 1015 O
cured 113 118 1016 1021 O
at 119 121 1022 1024 O
least 122 127 1025 1030 O
5 128 129 1031 1032 B-lower_bound
years 130 135 1033 1038 I-lower_bound
before 136 142 1039 1045 O
study 143 148 1046 1051 O
entry 149 154 1052 1057 O

Pregnant 0 8 1058 1066 B-pregnancy
or 9 11 1067 1069 O
nursing 12 19 1070 1077 O
women 20 25 1078 1083 B-gender
or 26 28 1084 1086 O
unwillingness 29 42 1087 1100 B-contraception_consent
for 43 46 1101 1104 I-contraception_consent
subject 47 54 1105 1112 I-contraception_consent
with 55 59 1113 1117 I-contraception_consent
childbearing 60 72 1118 1130 I-contraception_consent
potential 73 82 1131 1140 I-contraception_consent
to 83 85 1141 1143 I-contraception_consent
use 86 89 1144 1147 I-contraception_consent
contraception 90 103 1148 1161 I-contraception_consent
during 104 110 1162 1168 O
the 111 114 1169 1172 O
first 115 120 1173 1178 O
year 121 125 1179 1183 O
of 126 128 1184 1186 O
the 129 132 1187 1190 O
study 133 138 1191 1196 O

Previous 0 8 1197 1205 B-treatment
eye 9 12 1206 1209 I-treatment
surgery 13 20 1210 1217 I-treatment
in 21 23 1218 1220 O
the 24 27 1221 1224 O
eye 28 31 1225 1228 O
selected 32 40 1229 1237 O
for 41 44 1238 1241 O
injection 45 54 1242 1251 O

Type 0 4 1252 1256 B-chronic_disease
I 5 6 1257 1258 I-chronic_disease
diabetes 7 15 1259 1267 I-chronic_disease
or 16 18 1268 1270 O
the 19 22 1271 1274 O
presence 23 31 1275 1283 O
of 32 34 1284 1286 O
diabetic 35 43 1287 1295 B-chronic_disease
retinopathy 44 55 1296 1307 I-chronic_disease

Individuals 0 11 0 11 O
who 12 15 12 15 O
do 16 18 16 18 O
not 19 22 19 22 B-language_fluency
read 23 27 23 27 I-language_fluency
or 28 30 28 30 I-language_fluency
speak 31 36 31 36 I-language_fluency
proficient 37 47 37 47 I-language_fluency
English 48 55 48 55 I-language_fluency

Able 0 4 0 4 B-language_fluency
to 5 7 5 7 I-language_fluency
read 8 12 8 12 I-language_fluency
and 13 16 13 16 I-language_fluency
speak 17 22 17 22 I-language_fluency
English 23 30 23 30 I-language_fluency

Diagnosed 0 9 31 40 O
with 10 14 41 45 O
a 15 16 46 47 O
primary 17 24 48 55 O
glioma 25 31 56 62 B-cancer
and 32 35 63 66 O
going 36 41 67 72 O
to 42 44 73 75 O
receive 45 52 76 83 O
at 53 55 84 86 O
least 56 61 87 92 O
4 62 63 93 94 B-lower_bound
weeks 64 69 95 100 I-lower_bound
of 70 72 101 103 O
radiotherapy 73 85 104 116 B-treatment
with 86 90 117 121 O
at 91 93 122 124 O
least 94 99 125 130 O
20 100 102 131 133 B-lower_bound
fractions 103 112 134 143 O

Karnofsky 0 9 144 153 B-clinical_variable
performance 10 21 154 165 I-clinical_variable
status 22 28 166 172 I-clinical_variable
( 29 30 173 174 I-clinical_variable
KPS 30 33 174 177 I-clinical_variable
) 33 34 177 178 I-clinical_variable
of 35 37 179 181 O
80 38 40 182 184 B-lower_bound
or 41 43 185 187 O
above 44 49 188 193 O

for 0 3 194 197 O
phase 4 9 198 203 O
1 10 11 204 205 O
only 12 16 206 210 O
, 16 17 210 211 O
physician 18 27 212 221 O
- 27 28 221 222 O
rated 28 33 222 227 O
life 34 38 228 232 B-clinical_variable
expectancy 39 49 233 243 I-clinical_variable
of 50 52 244 246 O
less 53 57 247 251 O
than 58 62 252 256 O
6 63 64 257 258 B-upper_bound
months 65 71 259 265 I-upper_bound

for 0 3 266 269 O
phase 4 9 270 275 O
1 10 11 276 277 O
only 12 16 278 282 O
, 16 17 282 283 O
regularly 18 27 284 293 O
( 28 29 294 295 O
self 29 33 295 299 O
- 33 34 299 300 O
defined 34 41 300 307 O
) 41 42 307 308 O
participated 43 55 309 321 O
in 56 58 322 324 O
a 59 60 325 326 O
yoga 61 65 327 331 O
practice 66 74 332 340 O
in 75 77 341 343 O
the 78 81 344 347 O
year 82 86 348 352 O
prior 87 92 353 358 B-treatment
to 93 95 359 361 I-treatment
diagnosis 96 105 362 371 I-treatment

( 0 1 0 1 O
Inattentive 1 12 1 12 O
Symptoms 13 21 13 21 O
, 21 22 21 22 O
Hyperactive 23 34 23 34 O
- 34 35 34 35 O
Impulsive 35 44 35 44 O
Symptoms 45 53 45 53 O
, 53 54 53 54 O
Total 55 60 55 60 O
Symptoms 61 69 61 69 O
or 70 72 70 72 O
ADHD 73 77 73 77 B-chronic_disease
Index 78 83 78 83 O
) 83 84 83 84 O
on 85 87 85 87 O
both 88 92 88 92 O
the 93 96 93 96 O
Self 97 101 97 101 O
- 101 102 101 102 O
Report 102 108 102 108 O

18 0 2 109 111 B-lower_bound
- 2 3 111 112 O
55 3 5 112 114 B-upper_bound
years 6 11 115 120 I-upper_bound
of 12 14 121 123 O
age 15 18 124 127 B-age

ADHD 0 4 128 132 B-chronic_disease
Diagnosis 5 14 133 142 O

ADHD 0 4 143 147 B-chronic_disease
Symptom 5 12 148 155 O
Ratings 13 20 156 163 O

Cognitive 0 9 164 173 B-clinical_variable
functioning 10 21 174 185 I-clinical_variable
> 22 23 186 187 O
80 24 26 188 190 B-lower_bound
as 27 29 191 193 O
assessed 30 38 194 202 O
by 39 41 203 205 O
the 42 45 206 209 O
KBIT 46 50 210 214 O
- 50 51 214 215 O
II 51 53 215 217 O

Estimated 0 9 218 227 O
IQ 10 12 228 230 B-clinical_variable
< 13 14 231 232 O
80 15 17 233 235 B-upper_bound
on 18 20 236 238 O
Kaufmann 21 29 239 247 B-clinical_variable
Brief 30 35 248 253 I-clinical_variable
Intelligence 36 48 254 266 I-clinical_variable
Test 49 53 267 271 I-clinical_variable
, 53 54 271 272 O
Second 55 61 273 279 O
Edition 62 69 280 287 O

For 0 3 288 291 O
ADHD 4 8 292 296 B-chronic_disease
Groups 9 15 297 303 O
: 15 16 303 304 O
T 17 18 305 306 B-clinical_variable
- 18 19 306 307 I-clinical_variable
Score 19 24 307 312 I-clinical_variable
> 25 26 313 314 O
65 27 29 315 317 B-lower_bound
on 30 32 318 320 O
one 33 36 321 324 O
of 37 39 325 327 O
the 40 43 328 331 O
DSM 44 47 332 335 O
- 47 48 335 336 O
IV 48 50 336 338 O
relevant 51 59 339 347 O
scales 60 66 348 354 O

For 0 3 355 358 O
Control 4 11 359 366 O
Group 12 17 367 372 O
: 17 18 372 373 O
NO 19 21 374 376 O
diagnosis 22 31 377 386 O
of 32 34 387 389 O
ADHD 35 39 390 394 B-chronic_disease
as 40 42 395 397 O
determined 43 53 398 408 O
by 54 56 409 411 O
clinician 57 66 412 421 O
administered 67 79 422 434 O
CAADID 80 86 435 441 O
and 87 90 442 445 O
clinical 91 99 446 454 O
interview 100 109 455 464 O

For 0 3 465 468 O
Control 4 11 469 476 O
Group 12 17 477 482 O
: 17 18 482 483 O
T 19 20 484 485 B-clinical_variable
- 20 21 485 486 I-clinical_variable
Score 21 26 486 491 I-clinical_variable
< 27 28 492 493 O
60 29 31 494 496 B-upper_bound
on 32 34 497 499 O
all 35 38 500 503 O
of 39 41 504 506 O
the 42 45 507 510 O
DSM 46 49 511 514 O
- 49 50 514 515 O
IV 50 52 515 517 O
relevant 53 61 518 526 O
scales 62 68 527 533 O

Has 0 3 534 537 O
a 4 5 538 539 O
primary 6 13 540 547 O
diagnosis 14 23 548 557 O
of 24 26 558 560 O
any 27 30 561 564 O
Axis 31 35 565 569 B-chronic_disease
II 36 38 570 572 I-chronic_disease
Disorder 39 47 573 581 I-chronic_disease

Has 0 3 582 585 O
a 4 5 586 587 O
primary 6 13 588 595 O
diagnosis 14 23 596 605 O
of 24 26 606 608 O
any 27 30 609 612 O
other 31 36 613 618 O
Axis 37 41 619 623 B-chronic_disease
I 42 43 624 625 I-chronic_disease
Disorder 44 52 626 634 I-chronic_disease
( 53 54 635 636 O
determined 54 64 636 646 O
by 65 67 647 649 O
the 68 71 650 653 O
Structured 72 82 654 664 O
Diagnostic 83 93 665 675 O
Interview 94 103 676 685 O
for 104 107 686 689 O
DSM 108 111 690 693 O
; 111 112 693 694 O
SCID 113 117 695 699 O
) 117 118 699 700 O
that 119 123 701 705 O
is 124 126 706 708 O
significantly 127 140 709 722 O
impairing 141 150 723 732 O
and 151 154 733 736 O
would 155 160 737 742 O
contraindicate 161 175 743 757 O
participation 176 189 758 771 O
in 190 192 772 774 O
the 193 196 775 778 O
present 197 204 779 786 O
study 205 210 787 792 O

Male 0 4 793 797 B-gender

Provides 0 8 798 806 O
an 9 11 807 809 O
afternoon 12 21 810 819 O
exhaled 22 29 820 827 B-clinical_variable
carbon 30 36 828 834 I-clinical_variable
monoxide 37 45 835 843 I-clinical_variable
reading 46 53 844 851 I-clinical_variable
of 54 56 852 854 O
at 57 59 855 857 O
least 60 65 858 863 O
10 66 68 864 866 B-lower_bound
ppm 69 72 867 870 I-lower_bound

Self 0 4 871 875 O
- 4 5 875 876 O
report 5 11 876 882 O
smoking 12 19 883 890 O
at 20 22 891 893 O
least 23 28 894 899 O
10 29 31 900 902 B-lower_bound
cigarettes 32 42 903 913 I-lower_bound
/ 42 43 913 914 I-lower_bound
day 43 46 914 917 I-lower_bound

Use 0 3 918 921 O
of 4 6 922 924 O
any 7 10 925 928 O
psychoactive 11 23 929 941 B-treatment
medication 24 34 942 952 I-treatment
in 35 37 953 955 O
the 38 41 956 959 O
past 42 46 960 964 B-upper_bound
12 47 49 965 967 I-upper_bound
months 50 56 968 974 I-upper_bound
, 56 57 974 975 O
other 58 63 976 981 O
than 64 68 982 986 O
FDA 69 72 987 990 B-treatment
- 72 73 990 991 I-treatment
approved 73 81 991 999 I-treatment
medication 82 92 1000 1010 I-treatment
for 93 96 1011 1014 O
the 97 100 1015 1018 O
ADHD 101 105 1019 1023 B-chronic_disease
group 106 111 1024 1029 O
only 112 116 1030 1034 O

female 0 6 1035 1041 B-gender

Diagnosis 0 9 0 9 O
of 10 12 10 12 O
autism 13 19 13 19 B-chronic_disease
using 20 25 20 25 O
ADOS 26 30 26 30 B-treatment

In 0 2 31 33 O
need 3 7 34 38 O
of 8 10 39 41 O
an 11 13 42 44 O
oral 14 18 45 49 O
cleaning 19 27 50 58 O
( 28 29 59 60 O
no 29 31 60 62 O
previous 32 40 63 71 O
cleaning 41 49 72 80 O
within 50 56 81 87 O
past 57 61 88 92 B-upper_bound
four 62 66 93 97 I-upper_bound
months 67 73 98 104 I-upper_bound
) 73 74 104 105 O

Parents 0 7 106 113 O
speak 8 13 114 119 B-language_fluency
English 14 21 120 127 I-language_fluency
or 22 24 128 130 I-language_fluency
Spanish 25 32 131 138 I-language_fluency

Prescription 0 12 139 151 O
of 13 15 152 154 O
anti 16 20 155 159 B-treatment
- 20 21 159 160 I-treatment
cholinergic 21 32 160 171 I-treatment
drugs 33 38 172 177 I-treatment
( 39 40 178 179 O
which 40 45 179 184 O
may 46 49 185 188 O
alter 50 55 189 194 O
EDA 56 59 195 198 O
) 59 60 198 199 O

Significant 0 11 200 211 O
motor 12 17 212 217 B-chronic_disease
impairment 18 28 218 228 I-chronic_disease

cerebral 0 8 229 237 B-chronic_disease
palsy 9 14 238 243 I-chronic_disease

Aged 0 4 0 4 B-age
18 5 7 5 7 B-lower_bound
years 8 13 8 13 I-lower_bound
or 14 16 14 16 O
older 17 22 17 22 O

Albinism 0 8 23 31 B-chronic_disease

Clinical 0 8 32 40 O
and/or 9 15 41 47 O
MRI 16 19 48 51 B-treatment
evidence 20 28 52 60 O
of 29 31 61 63 O
a 32 33 64 65 O
named 34 39 66 71 O
cranial 40 47 72 79 O
or 48 50 80 82 O
cervical 51 59 83 91 O
nerve 60 65 92 97 O
involvement 66 77 98 109 O
by 78 80 110 112 O
tumour 81 87 113 119 B-cancer

Complete 0 8 120 128 O
macroscopic 9 20 129 140 B-treatment
resection 21 30 141 150 I-treatment
of 31 33 151 153 O
all 34 37 154 157 O
known 38 43 158 163 O
disease 44 51 164 171 O

ECOG 0 4 172 176 B-clinical_variable
performance 5 16 177 188 I-clinical_variable
status 17 23 189 195 I-clinical_variable
score 24 29 196 201 I-clinical_variable
of 30 32 202 204 O
2 33 34 205 206 B-upper_bound
or 35 37 207 209 O
less 38 42 210 214 O

High 0 4 215 219 O
risk 5 9 220 224 O
for 10 13 225 228 O
poor 14 18 229 233 O
compliance 19 29 234 244 O
with 30 34 245 249 O
therapy 35 42 250 257 B-treatment
or 43 45 258 260 O
follow 46 52 261 267 O
- 52 53 267 268 O
up 53 55 268 270 O
as 56 58 271 273 O
assessed 59 67 274 282 O
by 68 70 283 285 O
investigator 71 83 286 298 O

Histologically 0 14 299 313 O
confirmed 15 24 314 323 O
neurotropic 25 36 324 335 B-cancer
primary 37 44 336 343 I-cancer
melanoma 45 53 344 352 I-cancer

Inability 0 9 353 362 O
to 10 12 363 365 O
localise 13 21 366 374 O
surgical 22 30 375 383 O
bed 31 34 384 387 O
on 35 37 388 390 O
CT 38 40 391 393 B-treatment
scans 41 46 394 399 I-treatment
and/or 47 53 400 406 O
surgical 54 62 407 415 O
margins 63 70 416 423 O
( 71 72 424 425 O
cm 72 74 425 427 O
) 74 75 427 428 O
not 76 79 429 432 O
known 80 85 433 438 O

Intercurrent 0 12 439 451 O
illness 13 20 452 459 O
that 21 25 460 464 O
will 26 30 465 469 O
interfere 31 40 470 479 O
with 41 45 480 484 O
the 46 49 485 488 O
radiation 50 59 489 498 B-treatment
therapy 60 67 499 506 I-treatment
such 68 72 507 511 O
as 73 75 512 514 O
immunosuppression 76 93 515 532 B-treatment
due 94 97 533 536 O
to 98 100 537 539 O
medication 101 111 540 550 O
or 112 114 551 553 O
medical 115 122 554 561 B-chronic_disease
condition 123 132 562 571 I-chronic_disease

Life 0 4 572 576 B-clinical_variable
expectancy 5 15 577 587 I-clinical_variable
greater 16 23 588 595 O
than 24 28 596 600 O
6 29 30 601 602 B-lower_bound
months 31 37 603 609 I-lower_bound

Neurotropism 0 12 610 622 B-chronic_disease
is 13 15 623 625 O
identified 16 26 626 636 O
pathologically 27 41 637 651 O
by 42 44 652 654 O
the 45 48 655 658 O
presence 49 57 659 667 O
of 58 60 668 670 O
melanoma 61 69 671 679 B-cancer
cells 70 75 680 685 O
around 76 82 686 692 O
nerve 83 88 693 698 O
sheaths 89 96 699 706 O
( 97 98 707 708 O
perineural 98 108 708 718 O
invasion 109 117 719 727 O
) 117 118 727 728 O
or 119 121 729 731 O
within 122 128 732 738 O
nerves 129 135 739 745 O
( 136 137 746 747 O
intraneural 137 148 747 758 O
invasion 149 157 759 767 O
) 157 158 767 768 O

No 0 2 769 771 O
evidence 3 11 772 780 O
of 12 14 781 783 O
in 15 17 784 786 B-cancer
- 17 18 786 787 I-cancer
transit 18 25 787 794 I-cancer
, 25 26 794 795 I-cancer
nodal 27 32 796 801 I-cancer
or 33 35 802 804 I-cancer
distant 36 43 805 812 I-cancer
metastases 44 54 813 823 I-cancer
as 55 57 824 826 O
determined 58 68 827 837 O
by 69 71 838 840 O
clinical 72 80 841 849 O
examination 81 92 850 861 O
, 92 93 861 862 O
CT 94 96 863 865 B-treatment
or 97 99 866 868 O
MRI 100 103 869 872 B-treatment

No 0 2 873 875 O
previous 3 11 876 884 O
surgery 12 19 885 892 B-treatment
for 20 23 893 896 O
melanoma 24 32 897 905 B-cancer
( 33 34 906 907 O
other 34 39 907 912 O
than 40 44 913 917 O
complete 45 53 918 926 O
macroscopic 54 65 927 938 B-treatment
resection 66 75 939 948 I-treatment
as 76 78 949 951 O
stated 79 85 952 958 O
above)(i.e 86 96 959 969 O
. 96 97 969 970 O
Not 98 101 971 974 O
recurrent 102 111 975 984 O
disease 112 119 985 992 O
) 119 120 992 993 O

Occasionally 0 12 994 1006 O
, 12 13 1006 1007 O
the 14 17 1008 1011 O
tumour 18 24 1012 1018 B-cancer
itself 25 31 1019 1025 O
may 32 35 1026 1029 O
form 36 40 1030 1034 O
neuroid 41 48 1035 1042 O
structures 49 59 1043 1053 O
( 60 61 1054 1055 O
termed 61 67 1055 1061 O
' 68 69 1062 1063 O
neural 69 75 1063 1069 O
transformation 76 90 1070 1084 O
' 90 91 1084 1085 O
; 91 92 1085 1086 O
this 93 97 1087 1091 O
is 98 100 1092 1094 O
also 101 105 1095 1099 O
regarded 106 114 1100 1108 O
as 115 117 1109 1111 O
neurotropism 118 130 1112 1124 O
) 130 131 1124 1125 O

Participation 0 13 1126 1139 O
in 14 16 1140 1142 O
other 17 22 1143 1148 B-treatment
clinical 23 31 1149 1157 I-treatment
trials 32 38 1158 1164 I-treatment
with 39 43 1165 1169 O
the 44 47 1170 1173 O
same 48 52 1174 1178 O
primary 53 60 1179 1186 O
endpoint 61 69 1187 1195 O

Patients 0 8 1196 1204 O
capable 9 16 1205 1212 O
of 17 19 1213 1215 O
childbearing 20 32 1216 1228 O
are 33 36 1229 1232 O
using 37 42 1233 1238 B-contraception_consent
adequate 43 51 1239 1247 I-contraception_consent
contraception 52 65 1248 1261 I-contraception_consent

Patients 0 8 1262 1270 O
with 9 13 1271 1275 O
prior 14 19 1276 1281 O
cancers 20 27 1282 1289 B-cancer
, 27 28 1289 1290 O
except 29 35 1291 1297 O
: 35 36 1297 1298 O
those 37 42 1299 1304 O
diagnosed 43 52 1305 1314 O
≥ 53 54 1315 1316 O
5 55 56 1317 1318 B-lower_bound
years 57 62 1319 1324 I-lower_bound
ago 63 66 1325 1328 O
with 67 71 1329 1333 O
no 72 74 1334 1336 O
evidence 75 83 1337 1345 O
of 84 86 1346 1348 O
disease 87 94 1349 1356 O
relapse 95 102 1357 1364 O
and 103 106 1365 1368 O
clinical 107 115 1369 1377 O
expectation 116 127 1378 1389 O
of 128 130 1390 1392 O
relapse 131 138 1393 1400 O
of 139 141 1401 1403 O
less 142 146 1404 1408 O
than 147 151 1409 1413 O
5 152 153 1414 1415 B-upper_bound
% 153 154 1415 1416 I-upper_bound
; 154 155 1416 1417 O
prior 156 161 1418 1423 O
successfully 162 174 1424 1436 O
treated 175 182 1437 1444 O
Level 183 188 1445 1450 B-cancer
1 189 190 1451 1452 I-cancer
cutaneous 191 200 1453 1462 I-cancer
melanomas 201 210 1463 1472 I-cancer
≥ 211 212 1473 1474 O
2 213 214 1475 1476 B-lower_bound
years 215 220 1477 1482 I-lower_bound
ago 221 224 1483 1486 O
; 224 225 1486 1487 O
or 226 228 1488 1490 O
non 229 232 1491 1494 B-cancer
- 232 233 1494 1495 I-cancer
melanoma 233 241 1495 1503 I-cancer
skin 242 246 1504 1508 I-cancer
cancer 247 253 1509 1515 I-cancer
; 253 254 1515 1516 O
or 255 257 1517 1519 O
carcinoma 258 267 1520 1529 B-cancer
in 268 270 1530 1532 O
situ 271 275 1533 1537 O
of 276 278 1538 1540 O
the 279 282 1541 1544 O
cervix 283 289 1545 1551 O

Previous 0 8 1552 1560 B-treatment
radical 9 16 1561 1568 I-treatment
radiation 17 26 1569 1578 I-treatment
therapy 27 34 1579 1586 I-treatment
to 35 37 1587 1589 I-treatment
the 38 41 1590 1593 I-treatment
head 42 46 1594 1598 I-treatment
and 47 50 1599 1602 I-treatment
neck 51 55 1603 1607 I-treatment
, 55 56 1607 1608 O
excluding 57 66 1609 1618 O
superficial 67 78 1619 1630 B-treatment
radiation 79 88 1631 1640 I-treatment
therapy 89 96 1641 1648 I-treatment
to 97 99 1649 1651 O
cutaneous 100 109 1652 1661 B-cancer
SCC 110 113 1662 1665 I-cancer
or 114 116 1666 1668 O
basal 117 122 1669 1674 B-cancer
cell 123 127 1675 1679 I-cancer
carcinoma 128 137 1680 1689 I-cancer
, 137 138 1689 1690 O
which 139 144 1691 1696 O
is 145 147 1697 1699 O
not 148 151 1700 1703 O
within 152 158 1704 1710 O
or 159 161 1711 1713 O
overlapping 162 173 1714 1725 O
the 174 177 1726 1729 O
tumour 178 184 1730 1736 B-cancer
bed 185 188 1737 1740 O

Tumour 0 6 1741 1747 B-cancer
located 7 14 1748 1755 O
above 15 20 1756 1761 O
the 21 24 1762 1765 O
clavicle 25 33 1766 1774 O
and 34 37 1775 1778 O
below 38 43 1779 1784 O
the 44 47 1785 1788 O
jaw 48 51 1789 1792 O
or 52 54 1793 1795 O
occiput 55 62 1796 1803 O
( 63 64 1804 1805 O
neck 64 68 1805 1809 O
primary 69 76 1810 1817 O
) 76 77 1817 1818 O
or 78 80 1819 1821 O
above 81 86 1822 1827 O
the 87 90 1828 1831 O
jaw 91 94 1832 1835 O
/ 94 95 1835 1836 O
occiput 95 102 1836 1843 O
( 103 104 1844 1845 O
head 104 108 1845 1849 O
primary 109 116 1850 1857 O
) 116 117 1857 1858 O

Women 0 5 1859 1864 B-gender
who 6 9 1865 1868 O
are 10 13 1869 1872 B-pregnancy
pregnant 14 22 1873 1881 I-pregnancy
or 23 25 1882 1884 O
lactating 26 35 1885 1894 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
≥ 26 27 26 27 O
1,500 28 33 28 33 B-lower_bound

Active 0 6 34 40 O
or 7 9 41 43 O
clinically 10 20 44 54 O
significant 21 32 55 66 O
cardiac 33 40 67 74 B-chronic_disease
disease 41 48 75 82 I-chronic_disease

Age 0 3 83 86 B-age
+ 4 5 87 88 O
/ 5 6 88 89 O
> 6 7 89 90 O
70 8 10 91 93 B-lower_bound

Alanine 0 7 94 101 B-clinical_variable
aminotransferase 8 24 102 118 I-clinical_variable
& 25 26 119 120 I-clinical_variable
Asparate 27 35 121 129 I-clinical_variable
aminotransferase 36 52 130 146 I-clinical_variable
≤ 53 54 147 148 O
2.5 55 58 149 152 B-upper_bound
x 59 60 153 154 I-upper_bound
upper 61 66 155 160 I-upper_bound
limit 67 72 161 166 I-upper_bound
or 73 75 167 169 I-upper_bound
normal 76 82 170 176 I-upper_bound

Any 0 3 177 180 O
hemorrhage 4 14 181 191 B-clinical_variable
or 15 17 192 194 O
bleeding 18 26 195 203 B-clinical_variable
event 27 32 204 209 I-clinical_variable
≥ 33 34 210 211 O
grade 35 40 212 217 B-lower_bound
3 41 42 218 219 I-lower_bound
within 43 49 220 226 O
4 50 51 227 228 B-upper_bound
weeks 52 57 229 234 I-upper_bound

Any 0 3 235 238 O
malabsorption 4 17 239 252 B-chronic_disease
condition 18 27 253 262 O

Currently 0 9 263 272 O
receiving 10 19 273 282 O
other 20 25 283 288 B-treatment
systemic 26 34 289 297 I-treatment
therapy 35 42 298 305 I-treatment
for 43 46 306 309 O
metastatic 47 57 310 320 B-cancer
colorectal 58 68 321 331 I-cancer
cancer 69 75 332 338 I-cancer

Dehydration 0 11 339 350 B-clinical_variable
≥ 12 13 351 352 O
grade 14 19 353 358 B-lower_bound
1 20 21 359 360 I-lower_bound

Evidence 0 8 361 369 O
or 9 11 370 372 O
history 12 19 373 380 O
of 20 22 381 383 O
bleeding 23 31 384 392 B-chronic_disease
diathesis 32 41 393 402 I-chronic_disease
or 42 44 403 405 O
coagulopathy 45 57 406 418 B-chronic_disease

Glomerular 0 10 419 429 B-clinical_variable
filtration 11 21 430 440 I-clinical_variable
rate 22 26 441 445 I-clinical_variable
≥ 27 28 446 447 O
60 29 31 448 450 B-lower_bound
ml 32 34 451 453 I-lower_bound
/ 34 35 453 454 I-lower_bound
min 35 38 454 457 I-lower_bound

Histologically 0 14 458 472 O
confirmed 15 24 473 482 O
colorectal 25 35 483 493 B-cancer
adenocarcinoma 36 50 494 508 I-cancer

History 0 7 509 516 O
of 8 10 517 519 O
organ 11 16 520 525 B-treatment
allograft 17 26 526 535 I-treatment
including 27 36 536 545 O
corneal 37 44 546 553 B-treatment
transplant 45 55 554 564 I-treatment

History 0 7 565 572 O
of 8 10 573 575 O
other 11 16 576 581 O
active 17 23 582 588 O
malignancy 24 34 589 599 B-cancer
within 35 41 600 606 O
past 42 46 607 611 B-upper_bound
2 47 48 612 613 I-upper_bound
years 49 54 614 619 I-upper_bound

International 0 13 620 633 B-clinical_variable
normalized 14 24 634 644 I-clinical_variable
ratio 25 30 645 650 I-clinical_variable
/ 30 31 650 651 O
prothrombin 31 42 651 662 B-clinical_variable
time 43 47 663 667 I-clinical_variable
≤ 48 49 668 669 O
1.5 50 53 670 673 B-upper_bound
x 54 55 674 675 I-upper_bound
upper 56 61 676 681 I-upper_bound
limit 62 67 682 687 I-upper_bound
or 68 70 688 690 I-upper_bound
normal 71 77 691 697 I-upper_bound

Known 0 5 698 703 O
history 6 13 704 711 O
of 14 16 712 714 O
human 17 22 715 720 B-chronic_disease
immunodeficiency 23 39 721 737 I-chronic_disease
virus 40 45 738 743 I-chronic_disease
infection 46 55 744 753 I-chronic_disease
or 56 58 754 756 O
current 59 66 757 764 O
chronic 67 74 765 772 O
/ 74 75 772 773 O
active 75 81 773 779 O
hepatitis 82 91 780 789 B-chronic_disease
B 92 93 790 791 I-chronic_disease
or 94 96 792 794 I-chronic_disease
C 97 98 795 796 I-chronic_disease
infection 99 108 797 806 I-chronic_disease

Known 0 5 807 812 O
or 6 8 813 815 O
suspected 9 18 816 825 O
allergy 19 26 826 833 O
or 27 29 834 836 O
hypersensitivity 30 46 837 853 O
to 47 49 854 856 O
the 50 53 857 860 O
study 54 59 861 866 B-allergy_name
drug 60 64 867 871 I-allergy_name

Life 0 4 872 876 B-clinical_variable
expectancy 5 15 877 887 I-clinical_variable
> 16 17 888 889 O
/= 17 19 889 891 O
12 20 22 892 894 B-lower_bound
weeks 23 28 895 900 I-lower_bound

Measurable 0 10 901 911 O
metastatic 11 21 912 922 B-chronic_disease
disease 22 29 923 930 I-chronic_disease

Must 0 4 931 935 O
be 5 7 936 938 O
able 8 12 939 943 O
to 13 15 944 946 O
swallow 16 23 947 954 O
and 24 27 955 958 O
retain 28 34 959 965 O
oral 35 39 966 970 B-treatment
medications 40 51 971 982 I-treatment

Ongoing 0 7 983 990 O
infection 8 17 991 1000 B-clinical_variable
> 18 19 1001 1002 O
grade 20 25 1003 1008 B-lower_bound
2 26 27 1009 1010 I-lower_bound

Patients 0 8 1011 1019 O
with 9 13 1020 1024 O
phaeochromocytoma 14 31 1025 1042 B-cancer

Patients 0 8 1043 1051 O
with 9 13 1052 1056 O
seizure 14 21 1057 1064 B-chronic_disease
disorder 22 30 1065 1073 I-chronic_disease
requiring 31 40 1074 1083 O
medication 41 51 1084 1094 B-treatment

Persistent 0 10 1095 1105 B-clinical_variable
proteinuria 11 22 1106 1117 I-clinical_variable
≥ 23 24 1118 1119 O
grade 25 30 1120 1125 B-lower_bound
3 31 32 1126 1127 I-lower_bound
Interstitial 33 45 1128 1140 B-chronic_disease
lung 46 50 1141 1145 I-chronic_disease
disease 51 58 1146 1153 I-chronic_disease
with 59 63 1154 1158 O
ongoing 64 71 1159 1166 O
signs 72 77 1167 1172 O
and 78 81 1173 1176 O
symptoms 82 90 1177 1185 O
at 91 93 1186 1188 O
the 94 97 1189 1192 O
time 98 102 1193 1197 O
of 103 105 1198 1200 O
informed 106 114 1201 1209 O
consent 115 122 1210 1217 O

Platelet 0 8 1218 1226 B-clinical_variable
count 9 14 1227 1232 I-clinical_variable
≥ 15 16 1233 1234 O
100,000 17 24 1235 1242 B-lower_bound
, 24 25 1242 1243 O
hemoglobin 26 36 1244 1254 B-clinical_variable
≥ 37 38 1255 1256 O
9 39 40 1257 1258 B-lower_bound
g 41 42 1259 1260 I-lower_bound
/ 42 43 1260 1261 I-lower_bound
dL 43 45 1261 1263 I-lower_bound

Pleural 0 7 1264 1271 B-chronic_disease
effusion 8 16 1272 1280 I-chronic_disease
or 17 19 1281 1283 O
ascites 20 27 1284 1291 B-chronic_disease
that 28 32 1292 1296 O
causes 33 39 1297 1303 O
respiratory 40 51 1304 1315 O
compromise 52 62 1316 1326 O
, 62 63 1326 1327 O
grade 64 69 1328 1333 B-chronic_disease
2 70 71 1334 1335 I-chronic_disease
dyspnea 72 79 1336 1343 I-chronic_disease

Presence 0 8 1344 1352 O
of 9 11 1353 1355 O
non 12 15 1356 1359 B-chronic_disease
- 15 16 1359 1360 I-chronic_disease
healing 16 23 1360 1367 I-chronic_disease
wound 24 29 1368 1373 I-chronic_disease
, 29 30 1373 1374 O
non 31 34 1375 1378 B-chronic_disease
- 34 35 1378 1379 I-chronic_disease
healing 35 42 1379 1386 I-chronic_disease
ulcer 43 48 1387 1392 I-chronic_disease
, 48 49 1392 1393 O
or 50 52 1394 1396 O
bone 53 57 1397 1401 O
fracture 58 66 1402 1410 O

Previous 0 8 1411 1419 O
assignment 9 19 1420 1430 O
to 20 22 1431 1433 O
treatment 23 32 1434 1443 B-treatment
during 33 39 1444 1450 O
this 40 44 1451 1455 O
study 45 50 1456 1461 O
. 50 51 1461 1462 O
Subjects 52 60 1463 1471 O
permanently 61 72 1472 1483 O
withdrawn 73 82 1484 1493 O
from 83 87 1494 1498 O
study 88 93 1499 1504 O
participation 94 107 1505 1518 O
will 108 112 1519 1523 O
not 113 116 1524 1527 O
be 117 119 1528 1530 O
allowed 120 127 1531 1538 O
to 128 130 1539 1541 O
re 131 133 1542 1544 O
- 133 134 1544 1545 O
enter 134 139 1545 1550 O
study 140 145 1551 1556 O

Progression 0 11 1557 1568 O
on 12 14 1569 1571 O
standard 15 23 1572 1580 B-treatment
therapy 24 31 1581 1588 I-treatment
, 31 32 1588 1589 O
not 33 36 1590 1593 O
a 37 38 1594 1595 O
candidate 39 48 1596 1605 O
for 49 52 1606 1609 O
further 53 60 1610 1617 O
chemotherapy 61 73 1618 1630 B-treatment
or 74 76 1631 1633 O
patient 77 84 1634 1641 O
declines 85 93 1642 1650 O
other 94 99 1651 1656 O
options 100 107 1657 1664 O

Renal 0 5 1665 1670 B-chronic_disease
failure 6 13 1671 1678 I-chronic_disease
requiring 14 23 1679 1688 O
hemo- 24 29 1689 1694 B-treatment
or 30 32 1695 1697 O
peritoneal 33 43 1698 1708 B-treatment
dialysis 44 52 1709 1717 I-treatment

Serum 0 5 1718 1723 B-clinical_variable
creatinine 6 16 1724 1734 I-clinical_variable
≤ 17 18 1735 1736 O
1.5 19 22 1737 1740 B-upper_bound
x 23 24 1741 1742 I-upper_bound
upper 25 30 1743 1748 I-upper_bound
limit 31 36 1749 1754 I-upper_bound
or 37 39 1755 1757 I-upper_bound
normal 40 46 1758 1764 I-upper_bound

Subjects 0 8 1765 1773 O
of 9 11 1774 1776 O
childbearing 12 24 1777 1789 O
potential 25 34 1790 1799 O
must 35 39 1800 1804 O
agree 40 45 1805 1810 B-contraception_consent
to 46 48 1811 1813 I-contraception_consent
use 49 52 1814 1817 I-contraception_consent
adequate 53 61 1818 1826 I-contraception_consent
contraception 62 75 1827 1840 I-contraception_consent
beginning 76 85 1841 1850 O
at 86 88 1851 1853 O
the 89 92 1854 1857 O
signing 93 100 1858 1865 O
informed 101 109 1866 1874 O
consent 110 117 1875 1882 O
form 118 122 1883 1887 O
until 123 128 1888 1893 O
at 129 131 1894 1896 O
least 132 137 1897 1902 O
3 138 139 1903 1904 B-lower_bound
months 140 146 1905 1911 I-lower_bound
after 147 152 1912 1917 I-lower_bound
the 153 156 1918 1921 O
last 157 161 1922 1926 O
dose 162 166 1927 1931 O
of 167 169 1932 1934 O
study 170 175 1935 1940 B-treatment
drug 176 180 1941 1945 I-treatment

Subjects 0 8 1946 1954 O
with 9 13 1955 1959 O
thrombotic 14 24 1960 1970 O
, 24 25 1970 1971 O
embolic 26 33 1972 1979 O
, 33 34 1979 1980 O
venous 35 41 1981 1987 O
, 41 42 1987 1988 O
or 43 45 1989 1991 O
arterial 46 54 1992 2000 O
events 55 61 2001 2007 O
, 61 62 2007 2008 O
such 63 67 2009 2013 O
as 68 70 2014 2016 O
cerebrovascular 71 86 2017 2032 B-chronic_disease
accident 87 95 2033 2041 I-chronic_disease
, 95 96 2041 2042 O
deep 97 101 2043 2047 B-chronic_disease
vein 102 106 2048 2052 I-chronic_disease
thrombosis 107 117 2053 2063 I-chronic_disease
or 118 120 2064 2066 O
pulmonary 121 130 2067 2076 B-chronic_disease
embolus 131 138 2077 2084 I-chronic_disease
within 139 145 2085 2091 O
6 146 147 2092 2093 B-upper_bound
months 148 154 2094 2100 I-upper_bound
of 155 157 2101 2103 O
informed 158 166 2104 2112 O
consent 167 174 2113 2120 O

Substance 0 9 2121 2130 O
abuse 10 15 2131 2136 O
, 15 16 2136 2137 O
medical 17 24 2138 2145 O
, 24 25 2145 2146 O
psychological 26 39 2147 2160 B-chronic_disease
, 39 40 2160 2161 O
or 41 43 2162 2164 O
social 44 50 2165 2171 O
conditions 51 61 2172 2182 O
that 62 66 2183 2187 O
may 67 70 2188 2191 O
interfere 71 80 2192 2201 O
with 81 85 2202 2206 O
the 86 89 2207 2210 O
subject 90 97 2211 2218 O
's 97 99 2218 2220 O
participation 100 113 2221 2234 O
in 114 116 2235 2237 O
the 117 120 2238 2241 O
study 121 126 2242 2247 O

Symptomatic 0 11 2248 2259 B-cancer
metastatic 12 22 2260 2270 I-cancer
brain 23 28 2271 2276 I-cancer
or 29 31 2277 2279 O
meningeal 32 41 2280 2289 B-cancer
tumors 42 48 2290 2296 I-cancer

Total 0 5 2297 2302 B-clinical_variable
bili 6 10 2303 2307 I-clinical_variable
≤ 11 12 2308 2309 O
1.5 13 16 2310 2313 B-upper_bound
x 17 18 2314 2315 I-upper_bound
upper 19 24 2316 2321 I-upper_bound
limit 25 30 2322 2327 I-upper_bound
or 31 33 2328 2330 I-upper_bound
normal 34 40 2331 2337 I-upper_bound

Uncontrolled 0 12 2338 2350 B-chronic_disease
hypertension 13 25 2351 2363 I-chronic_disease
despite 26 33 2364 2371 O
optimal 34 41 2372 2379 B-treatment
medical 42 49 2380 2387 I-treatment
management 50 60 2388 2398 I-treatment

Individuals 0 11 0 11 O
with 12 16 12 16 O
a 17 18 17 18 O
documented 19 29 19 29 O
reaction 30 38 30 38 O
/ 38 39 38 39 O
allergy 39 46 39 46 O
to 47 49 47 49 O
Pregnenolone 50 62 50 62 B-allergy_name

Average 0 7 0 7 O
pain 8 12 8 12 O
of 13 15 13 15 O
at 16 18 16 18 O
least 19 24 19 24 O
4 25 26 25 26 B-lower_bound
on 27 29 27 29 O
a 30 31 30 31 O
numeric 32 39 32 39 O
rating 40 46 40 46 O
scale 47 52 47 52 O
in 53 55 53 55 O
the 56 59 56 59 O
previous 60 68 60 68 O
week 69 73 69 73 O
( 74 75 74 75 O
NRS 75 78 75 78 B-clinical_variable
; 78 79 78 79 O
ranging 80 87 80 87 O
from 88 92 88 92 O
0 93 94 93 94 B-lower_bound
to 95 97 95 97 O
10 98 100 98 100 B-upper_bound
) 100 101 100 101 O

Head 0 4 102 106 B-chronic_disease
injury 5 11 107 113 I-chronic_disease
resulting 12 21 114 123 O
in 22 24 124 126 O
loss 25 29 127 131 O
of 30 32 132 134 O
consciousness 33 46 135 148 O
for 47 50 149 152 O
at 51 53 153 155 O
least 54 59 156 161 O
30 60 62 162 164 B-lower_bound
min 63 66 165 168 I-lower_bound
or 67 69 169 171 O
pos 70 73 172 175 B-chronic_disease
- 73 74 175 176 I-chronic_disease
traumatic 74 83 176 185 I-chronic_disease
amnesia 84 91 186 193 I-chronic_disease
for 92 95 194 197 O
greater 96 103 198 205 O
than 104 108 206 210 O
24 109 111 211 213 B-lower_bound
hours 112 117 214 219 I-lower_bound
, 117 118 219 220 O
as 119 121 221 223 O
self 122 126 224 228 O
- 126 127 228 229 O
reported 127 135 229 237 O

History 0 7 238 245 O
of 8 10 246 248 O
neurosurgery 11 23 249 261 B-treatment
, 23 24 261 262 O
as 25 27 263 265 O
self 28 32 266 270 O
- 32 33 270 271 O
reported 33 41 271 279 O

History 0 7 280 287 O
of 8 10 288 290 O
unexplained 11 22 291 302 O
fainting 23 31 303 311 O
spells 32 38 312 318 O
or 39 41 319 321 O
loss 42 46 322 326 O
of 47 49 327 329 O
consciousness 50 63 330 343 O
as 64 66 344 346 O
self 67 71 347 351 O
- 71 72 351 352 O
reported 72 80 352 360 O
during 81 87 361 367 O
the 88 91 368 371 O
last 92 96 372 376 B-upper_bound
2 97 98 377 378 I-upper_bound
years 99 104 379 384 I-upper_bound

If 0 2 385 387 O
the 3 6 388 391 O
subject 7 14 392 399 O
is 15 17 400 402 O
taking 18 24 403 409 O
any 25 28 410 413 O
medications 29 40 414 425 O
, 40 41 425 426 O
dosages 42 49 427 434 O
must 50 54 435 439 O
be 55 57 440 442 O
stable 58 64 443 449 O
for 65 68 450 453 O
at 69 71 454 456 O
least 72 77 457 462 O
2 78 79 463 464 B-lower_bound
weeks 80 85 465 470 I-lower_bound
prior 86 91 471 476 O
to 92 94 477 479 O
the 95 98 480 483 O
enrollment 99 109 484 494 O
of 110 112 495 497 O
the 113 116 498 501 O
study 117 122 502 507 O

Presence 0 8 508 516 O
of 9 11 517 519 O
the 12 15 520 523 O
following 16 25 524 533 O
contraindication 26 42 534 550 O
to 43 45 551 553 O
transcranial 46 58 554 566 O
direct 59 65 567 573 O
current 66 73 574 581 O
stimulation 74 85 582 593 O
Ferromagnetic 86 99 594 607 O
metal 100 105 608 613 O
in 106 108 614 616 O
the 109 112 617 620 O
head 113 117 621 625 O
( 118 119 626 627 O
e.g. 119 123 627 631 O
, 123 124 631 632 O
plates 125 131 633 639 O
or 132 134 640 642 O
pins 135 139 643 647 O
, 139 140 647 648 O
bullets 141 148 649 656 O
, 148 149 656 657 O
shrapnel 150 158 658 666 O
) 158 159 666 667 O
Implanted 160 169 668 677 O
head 170 174 678 682 O
electronic 175 185 683 693 O
medical 186 193 694 701 O
devices 194 201 702 709 O
( 202 203 710 711 O
e.g. 203 207 711 715 O
, 207 208 715 716 O
cochlear 209 217 717 725 B-treatment
implants 218 226 726 734 I-treatment
) 226 227 734 735 O

Subject 0 7 736 743 O
is 8 10 744 746 O
older 11 16 747 752 O
than 17 21 753 757 O
18 22 24 758 760 B-lower_bound
years 25 30 761 766 I-lower_bound

Suffering 0 9 767 776 O
from 10 14 777 781 O
severe 15 21 782 788 O
depression 22 32 789 799 B-chronic_disease
( 33 34 800 801 O
as 34 36 801 803 O
defined 37 44 804 811 O
by 45 47 812 814 O
a 48 49 815 816 O
score 50 55 817 822 O
of 56 58 823 825 O
> 59 60 826 827 O
30 60 62 827 829 B-lower_bound
in 63 65 830 832 O
the 66 69 833 836 O
Beck 70 74 837 841 B-clinical_variable
Depression 75 85 842 852 I-clinical_variable
Inventory 86 95 853 862 I-clinical_variable
) 95 96 862 863 O

Uncontrolled 0 12 864 876 O
Epilepsy 13 21 877 885 B-chronic_disease

Unstable 0 8 886 894 O
medical 9 16 895 902 B-chronic_disease
conditions 17 27 903 913 I-chronic_disease
( 28 29 914 915 O
e.g. 29 33 915 919 O
uncontrolled 34 46 920 932 B-chronic_disease
diabetes 47 55 933 941 I-chronic_disease
, 55 56 941 942 O
uncompensated 57 70 943 956 B-chronic_disease
cardiac 71 78 957 964 I-chronic_disease
issues 79 85 965 971 I-chronic_disease
, 85 86 971 972 O
heart 87 92 973 978 B-chronic_disease
failure 93 100 979 986 I-chronic_disease
or 101 103 987 989 O
chronic 104 111 990 997 B-chronic_disease
obstructive 112 123 998 1009 I-chronic_disease
pulmonary 124 133 1010 1019 I-chronic_disease
disease 134 141 1020 1027 I-chronic_disease
) 141 142 1027 1028 O

Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,000 29 34 29 34 B-lower_bound
/ 34 35 34 35 I-lower_bound
mcL 35 38 35 38 I-lower_bound

All 0 3 39 42 O
patients 4 12 43 51 O
must 13 17 52 56 O
have 18 22 57 61 O
received 23 31 62 70 O
a 32 33 71 72 O
prior 34 39 73 78 B-treatment
platinum 40 48 79 87 I-treatment
- 48 49 87 88 I-treatment
based 49 54 88 93 I-treatment
chemotherapy 55 67 94 106 I-treatment
regimen 68 75 107 114 I-treatment
for 76 79 115 118 I-treatment
treatment 80 89 119 128 I-treatment
of 90 92 129 131 O
urothelial 93 103 132 142 B-cancer
cancer 104 110 143 149 I-cancer
and 111 114 150 153 O
must 115 119 154 158 O
now 120 123 159 162 O
be 124 126 163 165 O
considered 127 137 166 176 O
refractory 138 148 177 187 O
to 149 151 188 190 O
platinum 152 160 191 199 O
- 160 161 199 200 O
based 161 166 200 205 O
chemotherapy 167 179 206 218 O
; 179 180 218 219 O
patients 181 189 220 228 O
may 190 193 229 232 O
have 194 198 233 237 O
received 199 207 238 246 O
the 208 211 247 250 O
platinum 212 220 251 259 B-treatment
- 220 221 259 260 I-treatment
containing 221 231 260 270 I-treatment
regimen 232 239 271 278 I-treatment
either 240 246 279 285 O
in 247 249 286 288 O
the 250 253 289 292 O
peri 254 258 293 297 B-treatment
- 258 259 297 298 I-treatment
operative 259 268 298 307 I-treatment
or 269 271 308 310 O
metastatic 272 282 311 321 B-treatment
setting 283 290 322 329 I-treatment

Aspartate 0 9 330 339 B-clinical_variable
aminotransferase 10 26 340 356 I-clinical_variable
( 27 28 357 358 I-clinical_variable
AST 28 31 358 361 I-clinical_variable
) 31 32 361 362 I-clinical_variable
( 33 34 363 364 I-clinical_variable
serum 34 39 364 369 I-clinical_variable
glutamic 40 48 370 378 I-clinical_variable
oxaloacetic 49 60 379 390 I-clinical_variable
transaminase 61 73 391 403 I-clinical_variable
[ 74 75 404 405 I-clinical_variable
SGOT])/alanine 75 89 405 419 I-clinical_variable
aminotransferase 90 106 420 436 I-clinical_variable
( 107 108 437 438 I-clinical_variable
ALT)(serum 108 118 438 448 I-clinical_variable
glutamate 119 128 449 458 I-clinical_variable
pyruvate 129 137 459 467 I-clinical_variable
transaminase 138 150 468 480 I-clinical_variable
[ 151 152 481 482 I-clinical_variable
SGPT 152 156 482 486 I-clinical_variable
] 156 157 486 487 I-clinical_variable
) 157 158 487 488 I-clinical_variable
= 159 160 489 490 O
< 160 161 490 491 O
2.5 162 165 492 495 B-upper_bound
X 166 167 496 497 I-upper_bound
IULN 168 172 498 502 I-upper_bound

Calculated 0 10 503 513 B-clinical_variable
creatinine 11 21 514 524 I-clinical_variable
clearance 22 31 525 534 I-clinical_variable
> 32 33 535 536 O
= 33 34 536 537 O
30 35 37 538 540 B-lower_bound
mL 38 40 541 543 I-lower_bound
/ 40 41 543 544 I-lower_bound
min 41 44 544 547 I-lower_bound
by 45 47 548 550 O
the 48 51 551 554 O
modified 52 60 555 563 O
Cockcroft 61 70 564 573 O
and 71 74 574 577 O
Gault 75 80 578 583 O
Formula 81 88 584 591 O
OR 89 91 592 594 O
glomerular 92 102 595 605 B-clinical_variable
filtration 103 113 606 616 I-clinical_variable
rate 114 118 617 621 I-clinical_variable
> 119 120 622 623 O
= 120 121 623 624 O
30 122 124 625 627 B-lower_bound
mL 125 127 628 630 I-lower_bound
/ 127 128 630 631 I-lower_bound
min 128 131 631 634 I-lower_bound
/ 131 132 634 635 I-lower_bound
body 132 136 635 639 I-lower_bound
surface 137 144 640 647 I-lower_bound
area 145 149 648 652 I-lower_bound
( 150 151 653 654 I-lower_bound
BSA 151 154 654 657 I-lower_bound
) 154 155 657 658 I-lower_bound
by 156 158 659 661 O
Modification 159 171 662 674 O
of 172 174 675 677 O
Diet 175 179 678 682 O
in 180 182 683 685 O
Renal 183 188 686 691 O
Disease 189 196 692 699 O
or 197 199 700 702 O
Chronic 200 207 703 710 O
Kidney 208 214 711 717 O
Disease 215 222 718 725 O
Epidemiology 223 235 726 738 O
Collaboration 236 249 739 752 O
( 250 251 753 754 O
CKD 251 254 754 757 O
- 254 255 757 758 O
EPI 255 258 758 761 O
) 258 259 761 762 O
formula 260 267 763 770 O

Eastern 0 7 771 778 B-clinical_variable
Cooperative 8 19 779 790 I-clinical_variable
Oncology 20 28 791 799 I-clinical_variable
Group 29 34 800 805 I-clinical_variable
( 35 36 806 807 I-clinical_variable
ECOG 36 40 807 811 I-clinical_variable
) 40 41 811 812 I-clinical_variable
performance 42 53 813 824 I-clinical_variable
status 54 60 825 831 I-clinical_variable
0 61 62 832 833 B-lower_bound
- 62 63 833 834 O
1 63 64 834 835 B-upper_bound

Hemoglobin 0 10 836 846 B-clinical_variable
> 11 12 847 848 O
= 12 13 848 849 O
8.5g 14 18 850 854 B-lower_bound
/ 18 19 854 855 I-lower_bound
dL 19 21 855 857 I-lower_bound

Inability 0 9 858 867 O
to 10 12 868 870 O
take 13 17 871 875 O
oral 18 22 876 880 B-treatment
medications 23 34 881 892 I-treatment

Patients 0 8 893 901 O
may 9 12 902 905 O
not 13 16 906 909 O
be 17 19 910 912 O
receiving 20 29 913 922 O
any 30 33 923 926 O
other 34 39 927 932 O
investigational 40 55 933 948 B-treatment
agents 56 62 949 955 I-treatment

Patients 0 8 956 964 O
must 9 13 965 969 O
have 14 18 970 974 O
histologically 19 33 975 989 O
or 34 36 990 992 O
cytologically 37 50 993 1006 O
confirmed 51 60 1007 1016 O
urothelial 61 71 1017 1027 B-cancer
tract 72 77 1028 1033 I-cancer
carcinoma 78 87 1034 1043 I-cancer

Patients 0 8 1044 1052 O
must 9 13 1053 1057 O
have 14 18 1058 1062 O
locally 19 26 1063 1070 O
advanced 27 35 1071 1079 O
or 36 38 1080 1082 O
metastatic 39 49 1083 1093 B-cancer
urothelial 50 60 1094 1104 I-cancer
cancer 61 67 1105 1111 I-cancer
that 68 72 1112 1116 O
is 73 75 1117 1119 O
not 76 79 1120 1123 O
amenable 80 88 1124 1132 O
to 89 91 1133 1135 O
surgical 92 100 1136 1144 B-treatment
treatment 101 110 1145 1154 I-treatment

Patients 0 8 1155 1163 O
must 9 13 1164 1168 O
have 14 18 1169 1173 O
measurable 19 29 1174 1184 O
disease 30 37 1185 1192 O
, 37 38 1192 1193 O
defined 39 46 1194 1201 O
as 47 49 1202 1204 O
at 50 52 1205 1207 O
least 53 58 1208 1213 O
one 59 62 1214 1217 B-lower_bound
lesion 63 69 1218 1224 O
that 70 74 1225 1229 O
can 75 78 1230 1233 O
be 79 81 1234 1236 O
accurately 82 92 1237 1247 O
measured 93 101 1248 1256 O
in 102 104 1257 1259 O
at 105 107 1260 1262 O
least 108 113 1263 1268 O
one 114 117 1269 1272 O
dimension 118 127 1273 1282 O
( 128 129 1283 1284 O
longest 129 136 1284 1291 O
diameter 137 145 1292 1300 O
to 146 148 1301 1303 O
be 149 151 1304 1306 O
recorded 152 160 1307 1315 O
) 160 161 1315 1316 O
as 162 164 1317 1319 O
> 165 166 1320 1321 O
= 166 167 1321 1322 O
20 168 170 1323 1325 B-lower_bound
mm 171 173 1326 1328 I-lower_bound
with 174 178 1329 1333 O
conventional 179 191 1334 1346 O
techniques 192 202 1347 1357 O
or 203 205 1358 1360 O
as 206 208 1361 1363 O
> 209 210 1364 1365 O
= 210 211 1365 1366 O
10 212 214 1367 1369 B-lower_bound
mm 215 217 1370 1372 I-lower_bound
with 218 222 1373 1377 O
spiral 223 229 1378 1384 B-treatment
computed 230 238 1385 1393 I-treatment
tomography 239 249 1394 1404 I-treatment
( 250 251 1405 1406 I-treatment
CT 251 253 1406 1408 I-treatment
) 253 254 1408 1409 I-treatment
scan 255 259 1410 1414 I-treatment
for 260 263 1415 1418 O
the 264 267 1419 1422 O
evaluation 268 278 1423 1433 O
of 279 281 1434 1436 O
measurable 282 292 1437 1447 O
disease 293 300 1448 1455 O
( 301 302 1456 1457 O
Response 302 310 1457 1465 O
Evaluation 311 321 1466 1476 O
Criteria 322 330 1477 1485 O
in 331 333 1486 1488 O
Solid 334 339 1489 1494 B-cancer
Tumors 340 346 1495 1501 I-cancer
version 347 354 1502 1509 O
1.1 355 358 1510 1513 O
[ 359 360 1514 1515 O
RECIST 360 366 1515 1521 O
v1.1 367 371 1522 1526 O
] 371 372 1526 1527 O
) 372 373 1527 1528 O

Patients 0 8 1529 1537 O
with 9 13 1538 1542 O
known 14 19 1543 1548 O
prior 20 25 1549 1554 O
human 26 31 1555 1560 B-chronic_disease
immunodeficiency 32 48 1561 1577 I-chronic_disease
virus 49 54 1578 1583 I-chronic_disease
( 55 56 1584 1585 I-chronic_disease
HIV)-positive 56 69 1585 1598 I-chronic_disease
status 70 76 1599 1605 O
on 77 79 1606 1608 O
combination 80 91 1609 1620 B-treatment
antiretroviral 92 106 1621 1635 I-treatment
therapy 107 114 1636 1643 I-treatment
are 115 118 1644 1647 O
ineligible 119 129 1648 1658 O
; 129 130 1658 1659 O
known 131 136 1660 1665 O
prior 137 142 1666 1671 O
HIV 143 146 1672 1675 O
- 146 147 1675 1676 O
positive 147 155 1676 1684 O
patients 156 164 1685 1693 O
with 165 169 1694 1698 O
CD4 170 173 1699 1702 B-clinical_variable
+ 173 174 1702 1703 I-clinical_variable
= 175 176 1704 1705 O
< 176 177 1705 1706 O
500 178 181 1707 1710 B-upper_bound
/ 181 182 1710 1711 I-upper_bound
mm^3 182 186 1711 1715 I-upper_bound
are 187 190 1716 1719 O
ineligible 191 201 1720 1730 O
( 202 203 1731 1732 O
HIV 203 206 1732 1735 O
testing 207 214 1736 1743 O
is 215 217 1744 1746 O
not 218 221 1747 1750 O
required 222 230 1751 1759 O
as 231 233 1760 1762 O
part 234 238 1763 1767 O
of 239 241 1768 1770 O
this 242 246 1771 1775 O
study 247 252 1776 1781 O
) 252 253 1781 1782 O

Patients 0 8 1783 1791 O
with 9 13 1792 1796 O
untreated 14 23 1797 1806 O
known 24 29 1807 1812 O
brain 30 35 1813 1818 B-cancer
metastases 36 46 1819 1829 I-cancer
, 46 47 1829 1830 O
or 48 50 1831 1833 O
treated 51 58 1834 1841 O
brain 59 64 1842 1847 O
metastases 65 75 1848 1858 O
that 76 80 1859 1863 O
are 81 84 1864 1867 O
clinically 85 95 1868 1878 O
unstable 96 104 1879 1887 O

Platelets 0 9 1888 1897 B-clinical_variable
> 10 11 1898 1899 O
= 11 12 1899 1900 O
100,000 13 20 1901 1908 B-lower_bound
/ 20 21 1908 1909 I-lower_bound
mcL 21 24 1909 1912 I-lower_bound

Pre 0 3 1913 1916 O
- 3 4 1916 1917 O
existing 4 12 1917 1925 O
interstitial 13 25 1926 1938 B-chronic_disease
lung 26 30 1939 1943 I-chronic_disease
disease 31 38 1944 1951 I-chronic_disease

Prior 0 5 1952 1957 B-treatment
therapy 6 13 1958 1965 I-treatment
with 14 18 1966 1970 I-treatment
afatinib 19 27 1971 1979 I-treatment

Total 0 5 1980 1985 B-clinical_variable
bilirubin 6 15 1986 1995 I-clinical_variable
= 16 17 1996 1997 O
< 17 18 1997 1998 O
1.5 19 22 1999 2002 B-upper_bound
institutional 23 36 2003 2016 I-upper_bound
upper 37 42 2017 2022 I-upper_bound
limit 43 48 2023 2028 I-upper_bound
of 49 51 2029 2031 I-upper_bound
normal 52 58 2032 2038 I-upper_bound
( 59 60 2039 2040 I-upper_bound
IULN 60 64 2040 2044 I-upper_bound
) 64 65 2044 2045 I-upper_bound

Uncontrolled 0 12 2046 2058 O
intercurrent 13 25 2059 2071 B-chronic_disease
illness 26 33 2072 2079 I-chronic_disease
including 34 43 2080 2089 O
, 43 44 2089 2090 O
but 45 48 2091 2094 O
not 49 52 2095 2098 O
limited 53 60 2099 2106 O
to 61 63 2107 2109 O
, 63 64 2109 2110 O
ongoing 65 72 2111 2118 O
or 73 75 2119 2121 O
active 76 82 2122 2128 B-chronic_disease
infection 83 92 2129 2138 I-chronic_disease
, 92 93 2138 2139 O
symptomatic 94 105 2140 2151 O
congestive 106 116 2152 2162 B-chronic_disease
heart 117 122 2163 2168 I-chronic_disease
failure 123 130 2169 2176 I-chronic_disease
, 130 131 2176 2177 O
unstable 132 140 2178 2186 O
angina 141 147 2187 2193 B-treatment
pectoris 148 156 2194 2202 I-treatment
, 156 157 2202 2203 O
or 158 160 2204 2206 O
psychiatric 161 172 2207 2218 B-treatment
illness 173 180 2219 2226 I-treatment
/ 180 181 2226 2227 O
social 181 187 2227 2233 O
situations 188 198 2234 2244 O
that 199 203 2245 2249 O
would 204 209 2250 2255 O
limit 210 215 2256 2261 O
compliance 216 226 2262 2272 O
with 227 231 2273 2277 O
study 232 237 2278 2283 O
requirements 238 250 2284 2296 O

Women 0 5 2297 2302 B-gender

Women 0 5 2303 2308 B-gender
known 6 11 2309 2314 O
to 12 14 2315 2317 O
be 15 17 2318 2320 O
pregnant 18 26 2321 2329 B-pregnancy

Women 0 5 2330 2335 B-gender
who 6 9 2336 2339 O
are 10 13 2340 2343 O
breastfeeding 14 27 2344 2357 O
and 28 31 2358 2361 O
who 32 35 2362 2365 O
are 36 39 2366 2369 O
unwilling 40 49 2370 2379 O
to 50 52 2380 2382 O
stop 53 57 2383 2387 O
breastfeeding 58 71 2388 2401 O
prior 72 77 2402 2407 O
to 78 80 2408 2410 O
study 81 86 2411 2416 O
entry 87 92 2417 2422 O

child 0 5 2423 2428 O
- 5 6 2428 2429 O
bearing 6 13 2429 2436 O
potential 14 23 2437 2446 O
must 24 28 2447 2451 O
agree 29 34 2452 2457 B-contraception_consent
to 35 37 2458 2460 I-contraception_consent
use 38 41 2461 2464 I-contraception_consent
adequate 42 50 2465 2473 I-contraception_consent
contraception 51 64 2474 2487 I-contraception_consent
( 65 66 2488 2489 O
hormonal 66 74 2489 2497 B-contraception_consent
or 75 77 2498 2500 O
barrier 78 85 2501 2508 B-contraception_consent
method 86 92 2509 2515 I-contraception_consent
of 93 95 2516 2518 I-contraception_consent
birth 96 101 2519 2524 I-contraception_consent
control 102 109 2525 2532 I-contraception_consent

men 0 3 2533 2536 B-gender

patients 0 8 2537 2545 O
with 9 13 2546 2550 O
urothelial 14 24 2551 2561 B-cancer
carcinoma 25 34 2562 2571 I-cancer
of 35 37 2572 2574 O
the 38 41 2575 2578 O
bladder 42 49 2579 2586 O
, 49 50 2586 2587 O
upper 51 56 2588 2593 O
tract 57 62 2594 2599 O
, 62 63 2599 2600 O
or 64 66 2601 2603 O
urethra 67 74 2604 2611 O

should 0 6 2612 2618 O
a 7 8 2619 2620 O
woman 9 14 2621 2626 B-gender
become 15 21 2627 2633 B-pregnancy
pregnant 22 30 2634 2642 I-pregnancy
or 31 33 2643 2645 O
suspect 34 41 2646 2653 O
she 42 45 2654 2657 O
is 46 48 2658 2660 B-pregnancy
pregnant 49 57 2661 2669 I-pregnancy
while 58 63 2670 2675 O
participating 64 77 2676 2689 O
in 78 80 2690 2692 O
this 81 85 2693 2697 O
study 86 91 2698 2703 O
, 91 92 2703 2704 O
she 93 96 2705 2708 O
should 97 103 2709 2715 O
inform 104 110 2716 2722 O
her 111 114 2723 2726 O
treating 115 123 2727 2735 O
physician 124 133 2736 2745 O
immediately 134 145 2746 2757 O

Bloodstream 0 11 0 11 B-chronic_disease
or 12 14 12 14 I-chronic_disease
non 15 18 15 18 I-chronic_disease
- 18 19 18 19 I-chronic_disease
bloodstream 19 30 19 30 I-chronic_disease
concomitant 31 42 31 42 I-chronic_disease
infections 43 53 43 53 I-chronic_disease
with 54 58 54 58 O
Gram 59 63 59 63 O
- 63 64 63 64 O
negative 64 72 64 72 O
bacteria 73 81 73 81 O
that 82 86 82 86 O
are 87 90 87 90 O
known 91 96 91 96 O
to 97 99 97 99 O
be 100 102 100 102 O
non 103 106 103 106 O
- 106 107 106 107 O
susceptible 107 118 107 118 O
to 119 121 119 121 O
either 122 128 122 128 O
ceftobiprole 129 141 129 141 B-treatment
or 142 144 142 144 O
aztreonam 145 154 145 154 B-treatment

Community- 0 10 155 165 O
or 11 13 166 168 O
hospital 14 22 169 177 O
- 22 23 177 178 O
acquired 23 31 178 186 O
pneumonia 32 41 187 196 B-chronic_disease

Definite 0 8 197 205 O
native 9 15 206 212 B-chronic_disease
- 15 16 212 213 I-chronic_disease
valve 16 21 213 218 I-chronic_disease
right 22 27 219 224 I-chronic_disease
- 27 28 224 225 I-chronic_disease
sided 28 33 225 230 I-chronic_disease
infective 34 43 231 240 I-chronic_disease
endocarditis 44 56 241 253 I-chronic_disease
by 57 59 254 256 O
Modified 60 68 257 265 O
Duke 69 73 266 270 O
's 73 75 270 272 O
Criteria 76 84 273 281 O

Male 0 4 282 286 B-gender

Other 0 5 287 292 O
forms 6 11 293 298 O
of 12 14 299 301 O
complicated 15 26 302 313 O
SAB 27 30 314 317 B-chronic_disease

Prosthetic 0 10 318 328 B-treatment
cardiac 11 18 329 336 I-treatment
valves 19 25 337 343 I-treatment
or 26 28 344 346 O
valve 29 34 347 352 B-treatment
support 35 42 353 360 I-treatment
rings 43 48 361 366 I-treatment

Requirement 0 11 367 378 O
for 12 15 379 382 O
continuous 16 26 383 393 O
renal 27 32 394 399 B-treatment
- 32 33 399 400 I-treatment
replacement 33 44 400 411 I-treatment
therapy 45 52 412 419 I-treatment

Staphylococcus 0 14 420 434 B-chronic_disease
aureus 15 21 435 441 I-chronic_disease
bacteremia 22 32 442 452 I-chronic_disease
( 33 34 453 454 I-chronic_disease
SAB 34 37 454 457 I-chronic_disease
) 37 38 457 458 I-chronic_disease
, 38 39 458 459 O
based 40 45 460 465 O
on 46 48 466 468 O
at 49 51 469 471 O
least 52 57 472 477 O
one 58 61 478 481 B-lower_bound
positive 62 70 482 490 O
blood 71 76 491 496 O
culture 77 84 497 504 O
obtained 85 93 505 513 O
within 94 100 514 520 O
the 101 104 521 524 O
72 105 107 525 527 B-upper_bound
h 108 109 528 529 I-upper_bound
prior 110 115 530 535 I-upper_bound
to 116 118 536 538 O
randomization 119 132 539 552 O

Treatment 0 9 553 562 B-treatment
with 10 14 563 567 O
potentially 15 26 568 579 O
effective 27 36 580 589 O
( 37 38 590 591 O
anti 38 42 591 595 B-treatment
- 42 43 595 596 I-treatment
staphylococcal 43 57 596 610 I-treatment
) 57 58 610 611 O
systemic 59 67 612 620 B-treatment
antibacterial 68 81 621 634 I-treatment
treatment 82 91 635 644 I-treatment
for 92 95 645 648 O
more 96 100 649 653 O
than 101 105 654 658 O
48 106 108 659 661 B-lower_bound
h 109 110 662 663 I-lower_bound
within 111 117 664 670 O
the 118 121 671 674 O
7 122 123 675 676 B-upper_bound
days 124 128 677 681 I-upper_bound
prior 129 134 682 687 I-upper_bound
to 135 137 688 690 O
randomization 138 151 691 704 O

Women 0 5 705 710 B-gender
who 6 9 711 714 O
are 10 13 715 718 O
pregnant 14 22 719 727 B-pregnancy

female 0 6 728 734 B-gender
≥ 7 8 735 736 O
18 9 11 737 739 B-lower_bound
years 12 17 740 745 I-lower_bound
of 18 20 746 748 O
age 21 24 749 752 B-age

tachycardia 0 11 753 764 B-chronic_disease
( 12 13 765 766 O
heart 13 18 766 771 B-clinical_variable
rate 19 23 772 776 I-clinical_variable
> 24 25 777 778 O
90 26 28 779 781 B-lower_bound
bpm 29 32 782 785 I-lower_bound
) 32 33 785 786 O

white 0 5 787 792 B-clinical_variable
blood 6 11 793 798 I-clinical_variable
cell 12 16 799 803 I-clinical_variable
count 17 22 804 809 I-clinical_variable
> 23 24 810 811 O
10,000 25 31 812 818 B-lower_bound
or 32 34 819 821 O
< 35 36 822 823 O
4,000 37 42 824 829 B-upper_bound
cells/µL 43 51 830 838 I-upper_bound
, 51 52 838 839 O
or 53 55 840 842 O
> 56 57 843 844 O
10 58 60 845 847 B-lower_bound
% 60 61 847 848 I-lower_bound
immature 62 70 849 857 B-clinical_variable
neutrophils 71 82 858 869 I-clinical_variable
( 83 84 870 871 I-clinical_variable
bands 84 89 871 876 I-clinical_variable
) 89 90 876 877 I-clinical_variable

Life 0 4 0 4 B-clinical_variable
expectancy 5 15 5 15 I-clinical_variable
of 16 18 16 18 O
less 19 23 19 23 O
than 24 28 24 28 O
6 29 30 29 30 B-upper_bound
months 31 37 31 37 I-upper_bound

Major 0 5 38 43 O
medical 6 13 44 51 O
or 14 16 52 54 O
psychiatric 17 28 55 66 B-chronic_disease
illness 29 36 67 74 I-chronic_disease
that 37 41 75 79 O
, 41 42 79 80 O
in 43 45 81 83 O
the 46 49 84 87 O
investigator 50 62 88 100 O
's 62 64 100 102 O
opinion 65 72 103 110 O
, 72 73 110 111 O
would 74 79 112 117 O
prevent 80 87 118 125 O
completion 88 98 126 136 O
of 99 101 137 139 O
treatment 102 111 140 149 B-treatment
, 111 112 149 150 O
completion 113 123 151 161 O
of 124 126 162 164 O
the 127 130 165 168 O
study 131 136 169 174 O
protocol 137 145 175 183 O
, 145 146 183 184 O
or 147 149 185 187 O
interfere 150 159 188 197 O
with 160 164 198 202 O
follow 165 171 203 209 O
- 171 172 209 210 O
up 172 174 210 212 O

Medical 0 7 213 220 O
contraindication 8 24 221 237 O
to 25 27 238 240 O
MR 28 30 241 243 B-treatment
imaging 31 38 244 251 I-treatment
( 39 40 252 253 O
e.g. 40 44 253 257 O
pacemakers 45 55 258 268 B-treatment
, 55 56 268 269 O
metallic 57 65 270 278 B-treatment
implants 66 74 279 287 I-treatment
, 74 75 287 288 O
aneurysm 76 84 289 297 B-treatment
clips 85 90 298 303 I-treatment
, 90 91 303 304 O
known 92 97 305 310 O
contrast 98 106 311 319 O
allergy 107 114 320 327 O
to 115 117 328 330 O
gadolinium 118 128 331 341 B-treatment
contrast 129 137 342 350 I-treatment
, 137 138 350 351 O
pregnancy 139 148 352 361 B-pregnancy
, 148 149 361 362 O
nursing 150 157 363 370 O
mothers 158 165 371 378 O
, 165 166 378 379 O
weight 167 173 380 386 B-clinical_variable
greater 174 181 387 394 O
than 182 186 395 399 O
350 187 190 400 403 B-lower_bound
pounds 191 197 404 410 I-lower_bound
, 197 198 410 411 O
GFR 199 202 412 415 B-clinical_variable
< 203 204 416 417 O
30 205 207 418 420 B-upper_bound
) 207 208 420 421 O

Patients 0 8 422 430 O
must 9 13 431 435 O
have 14 18 436 440 O
histologically 19 33 441 455 O
confirmed 34 43 456 465 O
stage 44 49 466 471 B-lower_bound
IB2 50 53 472 475 I-lower_bound
- 53 54 475 476 O
IVA 54 57 476 479 B-upper_bound
epithelial 58 68 480 490 B-cancer
carcinoma 69 78 491 500 I-cancer
of 79 81 501 503 I-cancer
the 82 85 504 507 I-cancer
cervix 86 92 508 514 I-cancer
, 92 93 514 515 O
including 94 103 516 525 O
squamous 104 112 526 534 B-cancer
cell 113 117 535 539 I-cancer
, 117 118 539 540 O
adeno- 119 125 541 547 B-cancer
, 125 126 547 548 I-cancer
and 127 130 549 552 I-cancer
undifferentiated 131 147 553 569 I-cancer
carcinoma 148 157 570 579 I-cancer
, 157 158 579 580 O
and 159 162 581 584 O
excluding 163 172 585 594 O
small 173 178 595 600 B-cancer
cell 179 183 601 605 I-cancer
/ 183 184 605 606 I-cancer
neuroendocrine 184 198 606 620 I-cancer
carcinoma 199 208 621 630 I-cancer
, 208 209 630 631 O
who 210 213 632 635 O
will 214 218 636 640 O
undergo 219 226 641 648 O
radiation 227 236 649 658 B-treatment
therapy 237 244 659 666 I-treatment
for 245 248 667 670 O
cervical 249 257 671 679 B-cancer
cancer 258 264 680 686 I-cancer
with 265 269 687 691 O
curative 270 278 692 700 O
intent 279 285 701 707 O

Patients 0 8 708 716 O
who 9 12 717 720 O
have 13 17 721 725 O
received 18 26 726 734 O
any 27 30 735 738 O
prior 31 36 739 744 B-treatment
pelvic 37 43 745 751 I-treatment
radiation 44 53 752 761 I-treatment
therapy 54 61 762 769 I-treatment
in 62 64 770 772 O
the 65 68 773 776 O
area 69 73 777 781 O
of 74 76 782 784 O
the 77 80 785 788 O
tumor 81 86 789 794 B-cancer
that 87 91 795 799 O
precludes 92 101 800 809 O
the 102 105 810 813 O
delivery 106 114 814 822 O
of 115 117 823 825 O
a 118 119 826 827 O
curative 120 128 828 836 O
dose 129 133 837 841 O
of 134 136 842 844 O
pelvic 137 143 845 851 O
radiation 144 153 852 861 O

Patients 0 8 862 870 O
who 9 12 871 874 O
will 13 17 875 879 O
undergo 18 25 880 887 O
standard 26 34 888 896 O
radiation 35 44 897 906 B-treatment
therapy 45 52 907 914 I-treatment
with 53 57 915 919 O
concurrent 58 68 920 930 O
cisplatin 69 78 931 940 B-treatment
- 78 79 940 941 I-treatment
based 79 84 941 946 I-treatment
chemotherapy 85 97 947 959 I-treatment
for 98 101 960 963 O
cervical 102 110 964 972 B-cancer
cancer 111 117 973 979 I-cancer

Patients 0 8 980 988 O
with 9 13 989 993 O
no 14 16 994 996 O
contra 17 23 997 1003 O
- 23 24 1003 1004 O
indications 24 35 1004 1015 O
to 36 38 1016 1018 O
magnetic 39 47 1019 1027 B-treatment
resonance 48 57 1028 1037 I-treatment
( 58 59 1038 1039 I-treatment
MR 59 61 1039 1041 I-treatment
) 61 62 1041 1042 I-treatment
imaging 63 70 1043 1050 I-treatment

Patients 0 8 1051 1059 O
with 9 13 1060 1064 O
no 14 16 1065 1067 O
prior 17 22 1068 1073 O
radiation 23 32 1074 1083 B-treatment
therapy 33 40 1084 1091 I-treatment
to 41 43 1092 1094 O
the 44 47 1095 1098 O
pelvis 48 54 1099 1105 O

Patients 0 8 1106 1114 O
with 9 13 1115 1119 O
small 14 19 1120 1125 B-cancer
cell 20 24 1126 1130 I-cancer
/ 24 25 1130 1131 I-cancer
neuroendocrine 25 39 1131 1145 I-cancer
cervical 40 48 1146 1154 I-cancer
carcinoma 49 58 1155 1164 I-cancer

Surgical 0 8 1165 1173 B-treatment
staging 9 16 1174 1181 I-treatment
with 17 21 1182 1186 O
retroperitoneal 22 37 1187 1202 B-treatment
staging 38 45 1203 1210 I-treatment
and 46 49 1211 1214 O
lymphadenectomy 50 65 1215 1230 B-treatment

for 0 3 1231 1234 O
the 4 7 1235 1238 O
test 8 12 1239 1243 O
- 12 13 1243 1244 O
retest 13 19 1244 1250 O
sub 20 23 1251 1254 O
- 23 24 1254 1255 O
study 24 29 1255 1260 O
MRI 30 33 1261 1264 B-treatment
, 33 34 1264 1265 O
patients 35 43 1266 1274 O
must 44 48 1275 1279 O
have 49 53 1280 1284 O
a 54 55 1285 1286 O
GFR 56 59 1287 1290 B-clinical_variable
of 60 62 1291 1293 O
> 63 64 1294 1295 O
60 65 67 1296 1298 B-lower_bound
mL 68 70 1299 1301 I-lower_bound
/ 70 71 1301 1302 I-lower_bound
min/1.73m^2 71 82 1302 1313 I-lower_bound

glomerular 0 10 1314 1324 B-clinical_variable
filtration 11 21 1325 1335 I-clinical_variable
rate 22 26 1336 1340 I-clinical_variable
( 27 28 1341 1342 I-clinical_variable
GFR 28 31 1342 1345 I-clinical_variable
) 31 32 1345 1346 I-clinical_variable
> 33 34 1347 1348 O
30 35 37 1349 1351 B-lower_bound
mL 38 40 1352 1354 I-lower_bound
/ 40 41 1354 1355 I-lower_bound
min/1.73 41 49 1355 1363 I-lower_bound
m^2 50 53 1364 1367 I-lower_bound

Active 0 6 0 6 B-chronic_disease
bacterial 7 16 7 16 I-chronic_disease
, 16 17 16 17 I-chronic_disease
viral 18 23 18 23 I-chronic_disease
, 23 24 23 24 I-chronic_disease
fungal 25 31 25 31 I-chronic_disease
, 31 32 31 32 I-chronic_disease
or 33 35 33 35 I-chronic_disease
opportunistic 36 49 36 49 I-chronic_disease
infection 50 59 50 59 I-chronic_disease

Anti 0 4 60 64 B-clinical_variable
- 4 5 64 65 I-clinical_variable
nuclear 5 12 65 72 I-clinical_variable
antibody 13 21 73 81 I-clinical_variable
( 22 23 82 83 I-clinical_variable
ANA 23 26 83 86 I-clinical_variable
) 26 27 86 87 I-clinical_variable
titer 28 33 88 93 I-clinical_variable
of 34 36 94 96 O
1:80 37 41 97 101 B-lower_bound
, 41 42 101 102 O
or 43 45 103 105 O
greater 46 53 106 113 O
, 53 54 113 114 O
as 55 57 115 117 O
determined 58 68 118 128 O
by 69 71 129 131 O
immunofluorescence 72 90 132 150 O
assay 91 96 151 156 O
( 97 98 157 158 O
IFA 98 101 158 161 O
) 101 102 161 162 O

Between 0 7 163 170 O
15 8 10 171 173 B-lower_bound
and 11 14 174 177 O
49 15 17 178 180 B-upper_bound
years 18 23 181 186 I-upper_bound
of 24 26 187 189 O
age 27 30 190 193 B-age

Co 0 2 194 196 O
- 2 3 196 197 O
morbidities 3 14 197 208 O
requiring 15 24 209 218 O
systemic 25 33 219 227 B-treatment
corticosteroid 34 48 228 242 I-treatment
therapy 49 56 243 250 I-treatment
greater 57 64 251 258 O
than 65 69 259 263 O
10 70 72 264 266 B-lower_bound
mg 73 75 267 269 I-lower_bound
of 76 78 270 272 O
prednisone 79 89 273 283 B-treatment
per 90 93 284 287 O
day 94 97 288 291 O
, 97 98 291 292 O
or 99 101 293 295 O
equivalent 102 112 296 306 O
, 112 113 306 307 O
or 114 116 308 310 O
a 117 118 311 312 O
change 119 125 313 319 O
in 126 128 320 322 O
corticosteroid 129 143 323 337 O
dose 144 148 338 342 O
within 149 155 343 349 O
the 156 159 350 353 O
3 160 161 354 355 B-upper_bound
months 162 168 356 362 I-upper_bound
prior 169 174 363 368 I-upper_bound
to 175 177 369 371 O
Visit 178 183 372 377 O
1 184 185 378 379 O

Evidence 0 8 380 388 O
of 9 11 389 391 O
infection 12 21 392 401 O
with 22 26 402 406 O
human 27 32 407 412 B-chronic_disease
immunodeficiency 33 49 413 429 I-chronic_disease
virus 50 55 430 435 I-chronic_disease
( 56 57 436 437 I-chronic_disease
HIV 57 60 437 440 I-chronic_disease
) 60 61 440 441 I-chronic_disease
, 61 62 441 442 O
Hepatitis 63 72 443 452 B-chronic_disease
B 73 74 453 454 I-chronic_disease
, 74 75 454 455 O
or 76 78 456 458 O
Hepatitis 79 88 459 468 B-chronic_disease
C 89 90 469 470 I-chronic_disease

History 0 7 471 478 O
of 8 10 479 481 O
primary 11 18 482 489 B-chronic_disease
immunodeficiency 19 35 490 506 I-chronic_disease

Participants 0 12 507 519 O
must 13 17 520 524 O
have 18 22 525 529 O
at 23 25 530 532 O
least 26 31 533 538 O
one 32 35 539 542 B-lower_bound
( 36 37 543 544 O
but 37 40 544 547 O
not 41 44 548 551 O
three 45 50 552 557 O
or 51 53 558 560 O
more 54 58 561 565 O
) 58 59 565 566 O
additional 60 70 567 577 O
clinical 71 79 578 586 O
or 80 82 587 589 O
laboratory 83 93 590 600 O
criterion 94 103 601 610 O
from 104 108 611 615 O
the 109 112 616 619 O
2012 113 117 620 624 O
Systemic 118 126 625 633 O
Lupus 127 132 634 639 O
International 133 146 640 653 O
Collaborating 147 160 654 667 O
Clinics 161 168 668 675 O
( 169 170 676 677 O
SLICC 170 175 677 682 O
) 175 176 682 683 O
classification 177 191 684 698 O
criteria 192 200 699 707 O

Pregnant 0 8 708 716 B-pregnancy
, 8 9 716 717 O
breastfeeding 10 23 718 731 O
, 23 24 731 732 O
or 25 27 733 735 O
unwilling 28 37 736 745 B-contraception_consent
to 38 40 746 748 I-contraception_consent
practice 41 49 749 757 I-contraception_consent
birth 50 55 758 763 I-contraception_consent
control 56 63 764 771 I-contraception_consent
during 64 70 772 778 O
participation 71 84 779 792 O
in 85 87 793 795 O
the 88 91 796 799 O
study 92 97 800 805 O

Starting 0 8 806 814 O
, 8 9 814 815 O
stopping 10 18 816 824 O
, 18 19 824 825 O
or 20 22 826 828 O
changing 23 31 829 837 O
the 32 35 838 841 O
dose 36 40 842 846 O
of 41 43 847 849 O
over 44 48 850 854 O
the 49 52 855 858 O
counter 53 60 859 866 O
or 61 63 867 869 O
prescription 64 76 870 882 O
non 77 80 883 886 B-treatment
- 80 81 886 887 I-treatment
steroidal 81 90 887 896 I-treatment
anti 91 95 897 901 I-treatment
- 95 96 901 902 I-treatment
inflammatory 96 108 902 914 I-treatment
drugs 109 114 915 920 I-treatment
( 115 116 921 922 I-treatment
NSAIDs 116 122 922 928 I-treatment
) 122 123 928 929 I-treatment
in 124 126 930 932 O
the 127 130 933 936 O
three 131 136 937 942 B-upper_bound
months 137 143 943 949 I-upper_bound
prior 144 149 950 955 I-upper_bound
to 150 152 956 958 O
Visit 153 158 959 964 O
1 159 160 965 966 O

The 0 3 967 970 O
subject 4 11 971 978 O
has 12 15 979 982 O
been 16 20 983 987 O
diagnosed 21 30 988 997 O
with 31 35 998 1002 O
another 36 43 1003 1010 O
autoimmune 44 54 1011 1021 B-chronic_disease
disorder 55 63 1022 1030 I-chronic_disease
, 63 64 1030 1031 O
other 65 70 1032 1037 O
than 71 75 1038 1042 O
autoimmune 76 86 1043 1053 B-chronic_disease
thyroid 87 94 1054 1061 I-chronic_disease
conditions 95 105 1062 1072 I-chronic_disease

The 0 3 1073 1076 O
subject 4 11 1077 1084 O
has 12 15 1085 1088 O
other 16 21 1089 1094 O
contraindications 22 39 1095 1112 O
to 40 42 1113 1115 O
treatment 43 52 1116 1125 B-treatment
with 53 57 1126 1130 I-treatment
hydroxychloroquine 58 76 1131 1149 I-treatment
including 77 86 1150 1159 O
pre 87 90 1160 1163 O
- 90 91 1163 1164 O
existing 91 99 1164 1172 O
ocular 100 106 1173 1179 B-chronic_disease
disease 107 114 1180 1187 I-chronic_disease
, 114 115 1187 1188 O
hepatic 116 123 1189 1196 B-chronic_disease
impairment 124 134 1197 1207 I-chronic_disease
, 134 135 1207 1208 O
psoriasis 136 145 1209 1218 B-chronic_disease
, 145 146 1218 1219 O
porphyria 147 156 1220 1229 B-chronic_disease
, 156 157 1229 1230 O
or 158 160 1231 1233 O
allergy 161 168 1234 1241 O
to 169 171 1242 1244 O
the 172 175 1245 1248 O
drug 176 180 1249 1253 B-allergy_name
or 181 183 1254 1256 I-allergy_name
class 184 189 1257 1262 I-allergy_name

The 0 3 1263 1266 O
subject 4 11 1267 1274 O
has 12 15 1275 1278 O
previously 16 26 1279 1289 O
been 27 31 1290 1294 O
or 32 34 1295 1297 O
is 35 37 1298 1300 O
currently 38 47 1301 1310 O
being 48 53 1311 1316 O
treated 54 61 1317 1324 O
with 62 66 1325 1329 O
oral 67 71 1330 1334 B-treatment
antimalarial 72 84 1335 1347 I-treatment
agents 85 91 1348 1354 I-treatment
including 92 101 1355 1364 O
hydroxychloroquine 102 120 1365 1383 B-treatment
, 120 121 1383 1384 O
chloroquine 122 133 1385 1396 O
, 133 134 1396 1397 O
or 135 137 1398 1400 O
quinacrine 138 148 1401 1411 B-treatment

The 0 3 1412 1415 O
subject 4 11 1416 1423 O
has 12 15 1424 1427 O
significant 16 27 1428 1439 O
findings 28 36 1440 1448 O
on 37 39 1449 1451 O
ophthalmological 40 56 1452 1468 B-treatment
examination 57 68 1469 1480 I-treatment
that 69 73 1481 1485 O
, 73 74 1485 1486 O
in 75 77 1487 1489 O
the 78 81 1490 1493 O
opinion 82 89 1494 1501 O
of 90 92 1502 1504 O
the 93 96 1505 1508 O
examining 97 106 1509 1518 O
Ophthalmologist 107 122 1519 1534 O
, 122 123 1534 1535 O
prevent 124 131 1536 1543 O
safe 132 136 1544 1548 O
use 137 140 1549 1552 O
of 141 143 1553 1555 O
hydroxychloroquine 144 162 1556 1574 B-treatment

The 0 3 1575 1578 O
subject 4 11 1579 1586 O
is 12 14 1587 1589 O
currently 15 24 1590 1599 O
or 25 27 1600 1602 O
has 28 31 1603 1606 O
been 32 36 1607 1611 O
treated 37 44 1612 1619 O
with 45 49 1620 1624 O
immunosuppressive 50 67 1625 1642 B-treatment
, 67 68 1642 1643 O
immune 69 75 1644 1650 B-treatment
modifying 76 85 1651 1660 I-treatment
, 85 86 1660 1661 O
or 87 89 1662 1664 O
cytotoxic 90 99 1665 1674 B-treatment
medications 100 111 1675 1686 I-treatment
as 112 114 1687 1689 O
listed 115 121 1690 1696 O
in 122 124 1697 1699 O
Section 125 132 1700 1707 O
7.2 133 136 1708 1711 O

Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
years 7 12 7 12 I-lower_bound
or 13 15 13 15 O
older 16 21 16 21 O

Known 0 5 22 27 O
allergy 6 13 28 35 O
to 14 16 36 38 O
iodinated 17 26 39 48 B-allergy_name
contrast 27 35 49 57 I-allergy_name
agents 36 42 58 64 I-allergy_name

Presence 0 8 65 73 O
of 9 11 74 76 O
transcatheter 12 25 77 90 B-treatment
or 26 28 91 93 I-treatment
surgical 29 37 94 102 I-treatment
bioprosthetic 38 51 103 116 I-treatment
aortic 52 58 117 123 I-treatment
valve 59 64 124 129 I-treatment
implanted 65 74 130 139 O
at 75 77 140 142 O
least 78 83 143 148 O
48 84 86 149 151 B-lower_bound
hours 87 92 152 157 I-lower_bound
prior 93 98 158 163 I-lower_bound
to 99 101 164 166 O
enrollment 102 112 167 177 O

Renal 0 5 178 183 B-chronic_disease
insufficiency 6 19 184 197 I-chronic_disease
( 20 21 198 199 O
creatinine 21 31 199 209 B-clinical_variable
> 32 33 210 211 O
1.5 34 37 212 215 B-lower_bound
mg 38 40 216 218 I-lower_bound
/ 40 41 218 219 I-lower_bound
dL 41 43 219 221 I-lower_bound
) 43 44 221 222 O

Cognitive 0 9 0 9 B-chronic_disease
impairment 10 20 10 20 I-chronic_disease

Elective 0 8 21 29 B-treatment
abdominal 9 18 30 39 I-treatment
surgery 19 26 40 47 I-treatment

No 0 2 48 50 B-technology_access
access 3 9 51 57 I-technology_access
to 10 12 58 60 I-technology_access
telephone 13 22 61 70 I-technology_access

Unwillingness 0 13 71 84 O
to 14 16 85 87 O
be 17 19 88 90 O
randomized 20 30 91 101 O
to 31 33 102 104 O
either 34 40 105 111 O
intervention 41 53 112 124 O
arm 54 57 125 128 O
, 57 58 128 129 O
submit 59 65 130 136 O
to 66 68 137 139 O
study 69 74 140 145 O
testing 75 82 146 153 O
, 82 83 153 154 O
or 84 86 155 157 O
continuously 87 99 158 170 O
participate 100 111 171 182 O
in 112 114 183 185 O
the 115 118 186 189 O
intervention 119 131 190 202 O
for 132 135 203 206 O
six 136 139 207 210 B-upper_bound
weeks 140 145 211 216 I-upper_bound

